PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ray, WA; Murray, KT				Ray, Wayne A.; Murray, Katherine T.			Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ray, Wayne A.] Vanderbilt Univ, Dept Hlth Policy, Sch Med, Nashville, TN USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Ray, WA (corresponding author), Village Vanderbilt, Dept Hlth Policy, 1501 21st Ave S,Ste 2600, Nashville, TN 37212 USA.	wayne.ray@vumc.org			National Heart, Lung, and Blood Institute	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Ray reported receiving grants from the National Heart, Lung, and Blood Institute during the conduct of the study. Dr Murray reported having a patent pending with Vanderbilt University Medical Center from Metabolic Technologies.	McHorney CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194099; McHorney CA, 2016, CLIN THER, V37, P2477, DOI 10.1016/j.clinthera.2016.09.014; Ray WA, 2021, JAMA-J AM MED ASSOC, V326, P2395, DOI 10.1001/jama.2021.21222	3	0	0	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1290	1290		10.1001/jama.2022.1425	http://dx.doi.org/10.1001/jama.2022.1425			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380586				2022-12-28	WOS:000783965500025
J	Luke, JJ; Rutkowski, P; Queirolo, P; Del Vecchio, M; Mackiewicz, J; Chiarion-Sileni, V; Merino, LD; Khattak, MA; Schadendorf, D; Long, GV; Ascierto, PA; Mandala, M; De Galitiis, F; Haydon, A; Dummer, R; Grob, JJ; Robert, C; Carlino, MS; Mohr, P; Poklepovic, A; Sondak, VK; Scolyer, RA; Kirkwood, JM; Chen, K; Diede, SJ; Ahsan, S; Ibrahim, N; Eggermont, AMM				Luke, Jason J.; Rutkowski, Piotr; Queirolo, Paola; Del Vecchio, Michele; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Merino, Luis de la Cruz; Khattak, Muhammad A.; Schadendorf, Dirk; Long, Georgina, V; Ascierto, Paolo A.; Mandala, Mario; De Galitiis, Federica; Haydon, Andrew; Dummer, Reinhard; Grob, Jean-Jacques; Robert, Caroline; Carlino, Matteo S.; Mohr, Peter; Poklepovic, Andrew; Sondak, Vernon K.; Scolyer, Richard A.; Kirkwood, John M.; Chen, Ke; Diede, Scott J.; Ahsan, Sama; Ibrahim, Nageatte; Eggermont, Alexander M. M.		KEYNOTE-716 Investigators	Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial	LANCET			English	Article							IPILIMUMAB; DABRAFENIB; NIVOLUMAB; SURVIVAL	Background Pembrolizumab prolongs progression-free and overall survival among patients with advanced melanoma and recurrence-free survival in resected stage III disease. KEYNOTE-716 assessed pembrolizumab as adjuvant therapy in patients with completely resected, high-risk, stage II melanoma. We report results from the planned first and second interim analyses for recurrence-free survival. Methods In this double-blind, randomised, placebo-controlled phase 3 study, involving 160 academic medical centres and hospitals in 16 countries (Australia, Belgium, Brazil, Canada, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, the UK, and the USA), patients aged 12 years or older with newly diagnosed, completely resected stage IIB or IIC melanoma (TNM stage T3b or T4 with a negative sentinel lymph node biopsy) were recruited. Eligible patients were randomly assigned (1:1), in blocks of four and stratified by T-category (3b, 4a, and 4b) and paediatric status (age 12-17 years vs >= 18 years), using an interactive response technology system to intravenous pembrolizumab 200 mg (2 mg/kg in paediatric patients) or placebo every 3 weeks for 17 cycles or until disease recurrence or unacceptable toxicity. All patients, clinical investigators, and analysts were masked to treatment assignment. The primary endpoint was investigator-assessed recurrence-free survival (defined as time from randomisation to recurrence or death) in the intention-to-treat (ITT) population (ie, all patients randomly assigned to treatment). The primary endpoint was met if recurrence-free survival was significantly improved for pembrolizumab versus placebo at either the first interim analysis (after approximately 128 patients had events) or second interim analysis (after 179 patients had events) under multiplicity control. Safety was assessed in all patients randomly assigned to treatment who received at least one dose of study treatment. This study is registered with ClinicalTrials.gov, NCT03553836, and is closed to accrual. Findings Between Sept 23, 2018, and Nov 4, 2020, 1182 patients were screened, of whom 976 were randomly assigned to pembrolizumab (n=487) or placebo (n=489; ITT population). The median age was 61 years (IQR 52-69) and 387 (40%) patients were female and 589 (60%) were male. 874 (90%) of 976 patients were White and 799 (82%) were not Hispanic or Latino. 483 (99%) of 487 patients in the pembrolizumab group and 486 (99%) of 489 in the placebo group received assigned treatment. At the first interim analysis (data cutoff on Dec 4, 2020; median follow-up of 14middot4 months [IQR 10middot2-18middot7] in the pembrolizumab group and 14middot3 months [10middot1-18middot7] in the placebo group), 54 (11%) of 487 patients in the pembrolizumab group and 82 (17%) of 489 in the placebo group had a first recurrence of disease or died (hazard ratio [HR] 0middot65 [95% CI 0middot46-0middot92]; p=0middot0066). At the second interim analysis (data cutoff on June 21, 2021; median follow-up of 20middot9 months [16middot7-25middot3] in the pembrolizumab group and 20middot9 months [16middot6-25middot3] in the placebo group), 72 (15%) patients in the pembrolizumab group and 115 (24%) in the placebo group had a first recurrence or died (HR 0middot61 [95% CI 0middot45-0middot82]). Median recurrence-free survival was not reached in either group at either assessment timepoint. At the first interim analysis, grade 3-4 treatment-related adverse events occurred in 78 (16%) of 483 patients in the pembrolizumab groups versus 21 (4%) of 486 in the placebo group. At the first interim analysis, four patients died from an adverse event, all in the placebo group (one each due to pneumonia, COVID-19-related pneumonia, suicide, and recurrent cancer), and at the second interim analysis, one additional patient, who was in the pembrolizumab group, died from an adverse event (COVID-19-related pneumonia). No deaths due to study treatment occurred. Interpretation Pembrolizumab as adjuvant therapy for up to approximately 1 year for stage IIB or IIC melanoma resulted in a significant reduction in the risk of disease recurrence or death versus placebo, with a manageable safety profile. Funding Merck Sharp & Dohme, a subsidiary of Merck & Co, Kenilworth, NJ, USA. Copyright (c) 2022 Elsevier Ltd. All rights reserved.	[Luke, Jason J.; Kirkwood, John M.] UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA; [Rutkowski, Piotr] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland; [Queirolo, Paola] Ist Europe Oncol IRCCS, Milan, Italy; [Queirolo, Paola] Osped San Martino IRCCS, Genoa, Italy; [Del Vecchio, Michele] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Mackiewicz, Jacek] Poznan Univ Med Sci, Poznan, Poland; [Mackiewicz, Jacek] Greater Poland Canc Ctr, Poznan, Poland; [Chiarion-Sileni, Vanna] IOV IRCCS, Ist Oncol Veneto, Padua, Italy; [Merino, Luis de la Cruz] Hosp Univ Virgen Macarena, Clin Oncol Dept, Seville, Spain; [Merino, Luis de la Cruz] Univ Seville, Med Dept, Seville, Spain; [Khattak, Muhammad A.] Fiona Stanley Hosp, Perth, WA, Australia; [Khattak, Muhammad A.] Edith Cowan Univ, Perth, WA, Australia; [Schadendorf, Dirk] Univ Hosp Essen, Essen, Germany; [Schadendorf, Dirk] German Canc Consortium Partner Site, Essen, Germany; [Long, Georgina, V; Carlino, Matteo S.; Scolyer, Richard A.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina, V; Scolyer, Richard A.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Long, Georgina, V; Scolyer, Richard A.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Long, Georgina, V] Royal North Shore & Mater Hosp, Sydney, NSW, Australia; [Ascierto, Paolo A.] Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy; [Mandala, Mario] Univ Perugia, Perugia, Italy; [Mandala, Mario] Osped Papa Giovanni XXIII, Bergamo, Italy; [De Galitiis, Federica] IDI IRCCS, Dermopath Inst Immaculate, Rome, Italy; [Haydon, Andrew] Monash Univ, Alfred Hosp, Melbourne, Vic, Australia; [Dummer, Reinhard] Univ Zurich, Univ Hosp Zurich, Skin Canc Ctr, Zurich, Switzerland; [Grob, Jean-Jacques] Aix Marseille Univ, AP HM Hosp, Marseille, France; [Robert, Caroline] Inst Gustave Roussy, Villejuif, France; [Carlino, Matteo S.] Westmead & Blacktown Hosp, Sydney, NSW, Australia; [Mohr, Peter] Elbe Kliniken Buxtehude, Buxtehude, Germany; [Poklepovic, Andrew] Massey Canc Ctr, Richmond, VA USA; [Sondak, Vernon K.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Scolyer, Richard A.] Royal Prince Alfred Hosp Sydney, Sydney, NSW, Australia; [Scolyer, Richard A.] NSW Hlth Pathol, Sydney, NSW, Australia; [Chen, Ke; Diede, Scott J.; Ahsan, Sama; Ibrahim, Nageatte] Merck & Co Inc, Kenilworth, NJ USA; [Eggermont, Alexander M. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Eggermont, Alexander M. M.] Princess Maxima Ctr, Utrecht, Netherlands; [Eggermont, Alexander M. M.] Comprehens Canc Ctr Munich, Munich, Germany	University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii; IRCCS Istituto Oncologico Veneto (IOV); Hospital Universitario Virgen Macarena; University of Sevilla; Edith Cowan University; University of Duisburg Essen; Melanoma Institute Australia; University of Sydney; University of Sydney; University of Sydney; Royal North Shore Hospital; IRCCS Fondazione Pascale; University of Perugia; ASST Papa Giovanni XXIII; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Florey Institute of Neuroscience & Mental Health; Monash University; University of Zurich; University Zurich Hospital; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Gustave Roussy; Blacktown & Mount Druitt Hospital; Virginia Commonwealth University; H Lee Moffitt Cancer Center & Research Institute; Merck & Company; Utrecht University; Utrecht University Medical Center	Luke, JJ (corresponding author), UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA.; Luke, JJ (corresponding author), UPMC Hillman Canc Ctr, Med, Pittsburgh, PA 15232 USA.	lukejj@upmc.edu	Scolyer, Richard/AAE-8511-2019; Carlino, Matteo/GRS-7198-2022; Robert, Caroline/G-6157-2018; sileni, vanna chiarion/B-9042-2018; Long, Georgina/C-1771-2013	Scolyer, Richard/0000-0002-8991-0013; Robert, Caroline/0000-0002-9493-0238; sileni, vanna chiarion/0000-0001-9191-9124; Long, Georgina/0000-0001-8894-3545; Kirkwood, John/0000-0002-3570-4476	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	Merck Sharp & Dohme, a subsidiary of Merck & Co, Kenilworth, NJ, USA.	Bottomley A, 2021, LANCET ONCOL, V22, P655, DOI 10.1016/S1470-2045(21)00081-4; Eggermont AMM, 2021, LANCET ONCOL, V22, P643, DOI 10.1016/S1470-2045(21)00065-6; Eggermont AMM, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.02110; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Garbe C, 2020, J CLIN ONCOL, V38, P2543, DOI 10.1200/JCO.19.03034; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Livingstone A, 2021, PATIENT, V14, P635, DOI 10.1007/s40271-021-00507-1; Livingstone A, 2020, ANN SURG ONCOL, V27, P571, DOI 10.1245/s10434-019-07963-y; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Poklepovic AS, 2020, CANCER-AM CANCER SOC, V126, P1166, DOI 10.1002/cncr.32585; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Suciu S, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx133; Swetter SM, 2021, J NATL COMPR CANC NE, V19, P365, DOI 10.6004/jnccn.2021.0018; US Food Drug and Administration, 2021, HISTORY; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Yushak Melinda, 2019, Am Soc Clin Oncol Educ Book, V39, pe207, DOI 10.1200/EDBK_239283	20	38	39	5	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2022	399	10336					1718	1729		10.1016/S0140-6736(22)00562-1	http://dx.doi.org/10.1016/S0140-6736(22)00562-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1K4GY	35367007				2022-12-28	WOS:000798562500021
J	Tollefson, J				Tollefson, Jeff			EXTREME STEPS NEEDED TO AVERT CLIMATE DISASTER	NATURE			English	News Item						Climate change; Climate sciences; Policy													0	0	0	12	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2022	604	7906					413	414		10.1038/d41586-022-00951-5	http://dx.doi.org/10.1038/d41586-022-00951-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Q5OI	35379978	Bronze			2022-12-28	WOS:000784967400006
J	Li, C; Zhan, WQ; Yang, ZL; Tu, C; Hu, GW; Zhang, X; Song, WP; Du, SJ; Zhu, YF; Huang, KK; Kong, Y; Zhang, M; Mao, QY; Gu, XD; Zhang, Y; Xie, YH; Deng, Q; Song, YL; Chen, ZG; Lu, L; Jiang, SB; Wu, YL; Sun, L; Ying, TL				Li, Cheng; Zhan, Wuqiang; Yang, Zhenlin; Tu, Chao; Hu, Gaowei; Zhang, Xiang; Song, Wenping; Du, Shujuan; Zhu, Yuanfei; Huang, Keke; Kong, Yu; Zhang, Meng; Mao, Qiyu; Gu, Xiaodan; Zhang, Yi; Xie, Youhua; Deng, Qiang; Song, Yuanlin; Chen, Zhenguo; Lu, Lu; Jiang, Shibo; Wu, Yanling; Sun, Lei; Ying, Tianlei			Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody	CELL			English	Article							RECEPTOR-BINDING DOMAIN; INFLUENZA; TARGETS; REVEALS; EPITOPE	The effectiveness of SARS-CoV-2 vaccines and therapeutic antibodies have been limited by the continuous emergence of viral variants and by the restricted diffusion of antibodies from circulation into the sites of respiratory virus infection. Here, we report the identification of two highly conserved regions on the Omicron variant receptor-binding domain recognized by broadly neutralizing antibodies. Furthermore, we generated a bispecific single-domain antibody that was able to simultaneously and synergistically bind these two regions on a single Omicron variant receptor-binding domain as revealed by cryo-EM structures. We demonstrated that this bispecific antibody can be effectively delivered to lung via inhalation administration and exhibits exquisite neutralization breadth and therapeutic efficacy in mouse models of SARS-CoV-2 infections. Importantly, this study also deciphered an uncommon and highly conserved cryptic epitope within the spike trimeric interface that may have implications for the design of broadly protective SARS-CoV-2 vaccines and therapeutics.	[Li, Cheng; Zhan, Wuqiang; Hu, Gaowei; Zhang, Xiang; Song, Wenping; Du, Shujuan; Zhu, Yuanfei; Huang, Keke; Kong, Yu; Zhang, Meng; Mao, Qiyu; Gu, Xiaodan; Xie, Youhua; Deng, Qiang; Chen, Zhenguo; Lu, Lu; Jiang, Shibo; Wu, Yanling; Sun, Lei; Ying, Tianlei] Fudan Univ, Peoples Hosp Shanghai 5, Sch Basic Med Sci,MOE NHC CAMS Key Lab Med Mol Vi, Shanghai Inst Infect Dis & Biosecur,Inst Biomed S, Shanghai 200032, Peoples R China; [Yang, Zhenlin; Song, Yuanlin] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai Key Lab Lung Inflammat & Injury, Shanghai 200032, Peoples R China; [Yang, Zhenlin; Wu, Yanling; Ying, Tianlei] Shanghai Engn Res Ctr Synthet Immunol, Shanghai 200032, Peoples R China; [Tu, Chao; Zhang, Yi] Biomissile Corp, Shanghai 201203, Peoples R China	Fudan University; Fudan University	Wu, YL; Sun, L; Ying, TL (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Sch Basic Med Sci,MOE NHC CAMS Key Lab Med Mol Vi, Shanghai Inst Infect Dis & Biosecur,Inst Biomed S, Shanghai 200032, Peoples R China.; Wu, YL; Ying, TL (corresponding author), Shanghai Engn Res Ctr Synthet Immunol, Shanghai 200032, Peoples R China.	yanlingwu@fudan.edu.cn; llsun@fudan.edu.cn; tlying@fudan.edu.Cn		Yang, zhenlin/0000-0001-9735-4742; Mao, Qiyu/0000-0003-4924-2820; Shibo, Jiang/0000-0001-8283-7135	National Key R&D Program of China [2019YFA0904400]; National Natural Science Foundation of China [81902108, 82041003, 81822027, 32070938]; Chinese Academy of Medical Sciences [2019PT350002]; Shanghai Municipal Education Commission "Chenguang program'' [C620297]; Shanghai Municipal Health Commission [GWV-10.2-XD01, GWV-10.2-YQ06]; Science and Technology Commission of Shanghai Municipality [20411950402, 20XD1401200, 18DZ2210200, 20DZ2254600, 20DZ2261200]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences; Shanghai Municipal Education Commission "Chenguang program''; Shanghai Municipal Health Commission; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We are grateful to Qi Shao and Zhixin Jing from Sinepharm for the support in NGI experiments and Qian Wang, Yiwei Zhong, and other staff from Core Facility of Microbiology and Parasitology, Shanghai Medical College, for help with experiments. This work was supported by grants from the National Key R&D Program of China (2019YFA0904400), National Natural Science Foundation of China (81902108, 82041003, 81822027, and 32070938), Chinese Acad-emy of Medical Sciences (2019PT350002), Shanghai Municipal Education Commission "Chenguang program'' (C620297), Shanghai Municipal Health Commission (GWV-10.2-XD01 and GWV-10.2-YQ06), and Science and Technology Commission of Shanghai Municipality (20411950402, 20XD1401200, 18DZ2210200, 20DZ2254600, and 20DZ2261200).	Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bianco F, 2021, RESP RES, V22, DOI 10.1186/s12931-020-01585-9; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Cunningham S, 2021, LANCET RESP MED, V9, P21, DOI 10.1016/S2213-2600(20)30320-9; De Gasparo R, 2021, NATURE, V593, P424, DOI 10.1038/s41586-021-03461-y; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Li C, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00536-0; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Lu L, 2021, CELL, V184, P1604, DOI 10.1016/j.cell.2021.02.013; Ma XC, 2020, IMMUNITY, V53, P1315, DOI 10.1016/j.immuni.2020.11.015; Mannar D., 2021, BIORXIV, DOI 10; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Sakagami M, 2020, ADV DRUG DELIVER REV, V161, P63, DOI 10.1016/j.addr.2020.07.025; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Turner HL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000139; Ullah I, 2021, IMMUNITY, V54, P2143, DOI 10.1016/j.immuni.2021.08.015; Watanabe A, 2019, CELL, V177, P1124, DOI 10.1016/j.cell.2019.03.048; Wu Y, 2019, CELL, V177, P1086, DOI 10.1016/j.cell.2019.04.034; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Yamin R, 2021, NATURE, V599, P465, DOI 10.1038/s41586-021-04017-w; Yang ZL, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00810-1; Yu F, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00318-0; Yu F, 2017, CELL HOST MICROBE, V22, P471, DOI 10.1016/j.chom.2017.08.011; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269	35	19	20	41	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1389	+		10.1016/j.cell.2022.03.009	http://dx.doi.org/10.1016/j.cell.2022.03.009			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	3F9YN	35344711	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000831015400002
J	Okereke, OI; Mischoulon, D; Manson, JE				Okereke, Olivia, I; Mischoulon, David; Manson, JoAnn E.			Mediterranean Diet or Mindfulness-Based Stress Reduction and Prevention of Small-for-Gestational-Age Birth Weights in Newborns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Okereke, Olivia, I; Mischoulon, David] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Okereke, OI (corresponding author), Massachusetts Gen Hosp, One Bowdoin Sq,Seventh Floor, Boston, MA 02114 USA.	olivia.okereke@mgh.harvard.edu						Bublitz M, 2021, JAMA-J AM MED ASSOC, V326, P2137, DOI 10.1001/jama.2021.19923; Crovetto F, 2021, JAMA-J AM MED ASSOC, V326, P2150, DOI 10.1001/jama.2021.20178; Ramos-Lopez O, 2021, INFLAMM RES, V70, P29, DOI 10.1007/s00011-020-01425-y; Sadeghi O, 2021, NUTR NEUROSCI, V24, P248, DOI 10.1080/1028415X.2019.1620425; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157	5	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1292	1293		10.1001/jama.2022.2164	http://dx.doi.org/10.1001/jama.2022.2164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380587				2022-12-28	WOS:000783965500029
J	Ng, SM; Corbett, T; Doble, E; Brooks, A; Kar, P				Ng, Sze May; Corbett, Tracy; Doble, Emma; Brooks, Abigail; Kar, Partha			Managing the psychosocial impact of type 1 diabetes in young people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENTS; CHILDREN; PARENTS; RATES		[Ng, Sze May] Southport & Ormskirk NHS Trust, Paediat Dept, Ormskirk, England; [Ng, Sze May] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; Univ Bolton, Bolton, Greater Manches, England; [Brooks, Abigail] Priory Med Grp, York, N Yorkshire, England; [Brooks, Abigail] Portsmouth Hosp Univ NHS Trust, Diabet & Endocrine Dept, Portsmouth, Hants, England	University of Liverpool; University of Bolton	Ng, SM (corresponding author), Southport & Ormskirk NHS Trust, Paediat Dept, Ormskirk, England.; Ng, SM (corresponding author), Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England.	may.ng@nhs.net	Ng, Sze/E-2646-2012	Ng, Sze/0000-0002-3449-0541; Corbett, Tracy/0000-0003-1461-8015				Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603; Corbett T, 2020, DIABETES CARE CHILDR, V9, P53; Corbett Tracy, 2020, Nurs Stand, V35, P77, DOI 10.7748/ns.2020.e11556; Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x; Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x; Hood KK, 2011, PEDIATR DIABETES, V12, P718, DOI 10.1111/j.1399-5448.2011.00771.x; Jaser Sarah S, 2010, Adolesc Med State Art Rev, V21, P138; Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36; National Paediatric Diabetes Audit, ANN REP 2019 20; Ng SM, 2020, DIABETIC MED, V37, P1407, DOI 10.1111/dme.14336; Ng SM, 2019, DIABETES TECHNOL THE, V21, P133, DOI 10.1089/dia.2018.0347; Seiffge-Krenke I, 2000, J YOUTH ADOLESCENCE, V29, P617, DOI 10.1023/A:1026440304695; Staite E, 2018, DIABETIC MED, V35, P1329, DOI 10.1111/dme.13700; Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								e070530	10.1136/bmj-2022-070530	http://dx.doi.org/10.1136/bmj-2022-070530			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N8UW	35379655				2022-12-28	WOS:000783107700006
J	Luther, JM; Schelhas, LT				Luther, Joseph M.; Schelhas, Laura T.			Perovskite solar cells can take the heat	SCIENCE			English	Editorial Material							PHOTOVOLTAICS		[Luther, Joseph M.; Schelhas, Laura T.] Natl Renewable Energy Lab, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Luther, JM (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	joey.luther@nrel.gov; laura.shelhas@nrel.gov			US Department of Energy (DOE) [DE-AC36-08GO28308]; US DOE Office of Energy Efficiency and Renewable Energy Solar Energy Technologies Office; US DOE Operational Energy Capability Improvement Fund of the Department of Defense	US Department of Energy (DOE)(United States Department of Energy (DOE)); US DOE Office of Energy Efficiency and Renewable Energy Solar Energy Technologies Office(United States Department of Energy (DOE)); US DOE Operational Energy Capability Improvement Fund of the Department of Defense	Thiswork was authored bythe National Renewable Energy Laboratory,operated by theAlliance for Sustainable Energy, LLC, for theUS Department of Energy (DOE)under contract no. DE-AC36-08GO28308.The authors acknowledge the US DOE Office of Energy Efficiency and Renewable Energy Solar Energy Technologies Office and theOperational Energy Capability Improvement Fund of the Department of Defense for support. The views expressed in thearticle donot necessarily represent the views ofthe DOE or the US Government.	[Anonymous], 2021, 6121511 IEC; Azmi R, 2022, SCIENCE, V376, P73, DOI 10.1126/science.abm5784; Blancon JC, 2017, SCIENCE, V355, P1288, DOI 10.1126/science.aal4211; Cheacharoen R, 2018, SUSTAIN ENERG FUELS, V2, P2398, DOI 10.1039/c8se00250a; Grancini G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15684; Kempe MD, 2014, PROG PHOTOVOLTAICS, V22, P1159, DOI 10.1002/pip.2374; Khenkin MV, 2020, NAT ENERGY, V5, P35, DOI 10.1038/s41560-019-0529-5; Kim YH, 2021, SCIENCE, V371, P1129, DOI 10.1126/science.abf5291; Kurtz S, 2011, PROG PHOTOVOLTAICS, V19, P954, DOI 10.1002/pip.1103; Rong YG, 2018, SCIENCE, V361, DOI 10.1126/science.aat8235; Snaith HJ, 2018, NAT ENERGY, V3, P459, DOI 10.1038/s41560-018-0174-4; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911	12	1	1	24	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		28	29		10.1126/science.abo3368	http://dx.doi.org/10.1126/science.abo3368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357945				2022-12-28	WOS:000780195200011
J	Flament, N; Bodur, OF; Williams, SE; Merdith, AS				Flament, Nicolas; Bodur, Omer F.; Williams, Simon E.; Merdith, Andrew S.			Assembly of the basal mantle structure beneath Africa	NATURE			English	Article							LARGE IGNEOUS PROVINCES; SHEAR VELOCITY STRUCTURE; THERMAL EXPANSIVITY; CLUSTER-ANALYSIS; DYNAMICS; EARTH; MODELS; TIME; TECTONICS; BOUNDARY	Plate tectonics shapes Earth's surface, and is linked to motions within its deep interior(1,2). Cold oceanic lithosphere sinks into the mantle, and hot mantle plumes rise from the deep Earth, leading to volcanism(3,4). Volcanic eruptions over the past 320 million years have been linked to two large structures at the base of the mantle presently under Africa and the Pacific Ocean(5,6). This has led to the hypothesis that these basal mantle structures have been stationary over geological time(7,8), in contrast to observations and models suggesting that tectonic plates(9,10), subduction zone(11-14) and mantle plumes(15,16) have been mobile, and that basal mantle structures are presently deforming(17,18). Here we reconstruct mantle flow from one billion years ago to the present day to show that the history of volcanism is statistically as consistent with mobile basal mantle structures as with fixed ones. In our reconstructions, cold lithosphere sank deep into the African hemisphere between 740 and 500 million years ago, and from 400 million years ago the structure beneath Africa progressively assembled, pushed by peri-Gondwana slabs, to become a coherent structure as recently as 60 million years ago. Our mantle flow models suggest that basal mantle structures are mobile, and aggregate and disperse overtime, similarly to continents at Earth's surface'. Our models also predict the presence of continental material in the mantle beneath Africa, consistent with geochemical date'.	[Flament, Nicolas; Bodur, Omer F.] Univ Wollongong, GeoQuEST Res Ctr, Sch Earth Atmospher & Life Sci, Wollongong, NSW, Australia; [Williams, Simon E.] Northwest Univ, Dept Geol, Xian, Peoples R China; [Merdith, Andrew S.] Univ Lyon 1, ENS Lyon, UnivLyon, CNRS,UMR 5276,LGL TPE, Villeurbanne, France; [Merdith, Andrew S.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	University of Wollongong; Northwest University Xi'an; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Leeds	Flament, N (corresponding author), Univ Wollongong, GeoQuEST Res Ctr, Sch Earth Atmospher & Life Sci, Wollongong, NSW, Australia.	nflament@uow.edu.au	Bodur, Ömer/HGC-3188-2022; Flament, Nicolas/I-5904-2019	Flament, Nicolas/0000-0002-3237-0757; Bodur, Omer Faruk/0000-0001-6836-0107; Williams, Simon/0000-0003-4670-8883; Merdith, Andrew/0000-0002-7564-8149	Australian Research Council [LP170100863, DP180102280, DP200100966]; National Natural Science Foundation of China [41972237]; Deep Carbon Observatory; Richard Lounsbery Foundation; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)	Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deep Carbon Observatory; Richard Lounsbery Foundation; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	N.F. and o.F.B. were supported by Australian Research Council grant LP170100863 (industry partner: De Beers). S.E.W. was supported by National Natural Science Foundation of China grant 41972237 and by Australian Research Council grants DP180102280 and DP200100966. A.S.M. was supported by the Deep Carbon Observatory and the Richard Lounsbery Foundation. This research was supported by the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS), with access to computational resources provided by the National Computational Infrastructure (NCI) through the National Computational Merit Allocation Scheme and through the University of Wollongong (UOW).	Ahrens J., 2005, VISUALIZATION HDB, P717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Auer L, 2014, J GEOPHYS RES-SOL EA, V119, P3006, DOI 10.1002/2013JB010773; Austermann J, 2014, GEOPHYS J INT, V197, P1, DOI 10.1093/gji/ggt500; BERCOVICI D, 1989, SCIENCE, V244, P950, DOI 10.1126/science.244.4907.950; Billen MI, 2008, ANNU REV EARTH PL SC, V36, P325, DOI 10.1146/annurev.earth.36.031207.124129; Bower DJ, 2015, PHYS EARTH PLANET IN, V238, P8, DOI 10.1016/j.pepi.2014.10.013; Bower DJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P44, DOI 10.1029/2012GC004267; Bryan SE, 2008, EARTH-SCI REV, V86, P175, DOI 10.1016/j.earscirev.2007.08.008; Bunge HP, 1998, SCIENCE, V280, P91, DOI 10.1126/science.280.5360.91; Burke K, 2008, EARTH PLANET SC LETT, V265, P49, DOI 10.1016/j.epsl.2007.09.042; Campbell IH, 2005, ELEMENTS, V1, P265, DOI 10.2113/gselements.1.5.265; CHOPELAS A, 1992, GEOPHYS RES LETT, V19, P1983, DOI 10.1029/92GL02144; Coffin M., 2006, OCEANOGRAPHY, V19, P150, DOI [10.5670/oceanog.2006.13, DOI 10.5670/OCEANOG.2006.13]; Coltice N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4295; Conrad CP, 2013, NATURE, V498, P479, DOI 10.1038/nature12203; Davaille A, 2020, TECTONICS, V39, DOI 10.1029/2020TC006265; Davies DR, 2015, SPRINGER GEOPHYS, P441, DOI 10.1007/978-3-319-15627-9_14; Davies DR, 2015, EARTH PLANET SC LETT, V411, P121, DOI 10.1016/j.epsl.2014.11.052; Domeier M, 2018, GEOSCI FRONT, V9, P789, DOI 10.1016/j.gsf.2017.11.012; Domeier M, 2016, GONDWANA RES, V36, P275, DOI 10.1016/j.gr.2015.08.003; Domeier M, 2014, GEOSCI FRONT, V5, P303, DOI 10.1016/j.gsf.2014.01.002; Doubrovine PV, 2016, GEOCHEM GEOPHY GEOSY, V17, P1130, DOI 10.1002/2015GC006044; Doucet LS, 2020, NAT GEOSCI, V13, P511, DOI 10.1038/s41561-020-0599-9; Dziewonski AM, 2010, EARTH PLANET SC LETT, V299, P69, DOI 10.1016/j.epsl.2010.08.013; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Ernst RE, 2014, LARGE IGNEOUS PROVINCES, P1; Flament N., 2017, NAT COMMUN, V8; Flament N, 2019, GEOPHYS J INT, V216, P2158, DOI 10.1093/gji/ggy526; Flament N, 2014, EARTH PLANET SC LETT, V387, P107, DOI 10.1016/j.epsl.2013.11.017; French SW, 2014, GEOPHYS J INT, V199, P1303, DOI 10.1093/gji/ggu334; Frost DA, 2014, EARTH PLANET SC LETT, V403, P380, DOI 10.1016/j.epsl.2014.06.046; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Garnero EJ, 2016, NAT GEOSCI, V9, P481, DOI [10.1038/ngeo2733, 10.1038/NGEO2733]; Gurnis M, 2012, COMPUT GEOSCI-UK, V38, P35, DOI 10.1016/j.cageo.2011.04.014; Hassan R, 2016, NATURE, V533, P239, DOI 10.1038/nature17422; Hassan R, 2015, GEOCHEM GEOPHY GEOSY, V16, P1465, DOI 10.1002/2015GC005751; Hernlund JW, 2008, EARTH PLANET SC LETT, V265, P423, DOI 10.1016/j.epsl.2007.10.042; Houser C, 2008, GEOPHYS J INT, V174, P195, DOI 10.1111/J.1365-246X.2008.03763.X; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; IRVING E, 1977, NATURE, V270, P304, DOI 10.1038/270304a0; Jackson MG, 2021, GEOCHEM GEOPHY GEOSY, V22, DOI 10.1029/2020GC009525; Jaupart C., 2007, MANTLE DYNAMICS TREA, V7, P253, DOI [10.1016/B978-0-444-53802-4.00126-3, DOI 10.1016/B978-0-444-53802-4.00126-3, 10.1016/B978-044452748-6/00114-0, DOI 10.1016/B978-044452748-6/00114-0, DOI 10.1016/B978-044452748-6.00114-0]; Johansson L, 2018, GEOPHYS RES LETT, V45, P5380, DOI 10.1029/2017GL076691; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; Lau HCP, 2017, NATURE, V551, P321, DOI 10.1038/nature24452; Lekic V, 2012, EARTH PLANET SC LETT, V357, P68, DOI 10.1016/j.epsl.2012.09.014; Li ZX, 2019, PRECAMBRIAN RES, V323, P1, DOI 10.1016/j.precamres.2019.01.009; Lynner C, 2014, GEOPHYS RES LETT, V41, P3447, DOI 10.1002/2014GL059875; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Matthews KJ, 2016, GLOBAL PLANET CHANGE, V146, P226, DOI 10.1016/j.gloplacha.2016.10.002; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Megnin C, 2000, GEOPHYS J INT, V143, P709, DOI 10.1046/j.1365-246X.2000.00298.x; Merdith AS, 2021, EARTH-SCI REV, V214, DOI 10.1016/j.earscirev.2020.103477; Merdith AS, 2017, GONDWANA RES, V50, P84, DOI 10.1016/j.gr.2017.04.001; Moresi L, 2014, NATURE, V508, P245, DOI 10.1038/nature13033; Muller RD, 2018, GEOCHEM GEOPHY GEOSY, V19, P2243, DOI 10.1029/2018GC007584; Muller RD, 2016, ANNU REV EARTH PL SC, V44, P107, DOI 10.1146/annurev-earth-060115-012211; Ni SD, 2002, SCIENCE, V296, P1850, DOI 10.1126/science.1070698; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Rudolph ML, 2014, GEOCHEM GEOPHY GEOSY, V15, P3645, DOI 10.1002/2014GC005457; Simmons NA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007631; Stadler G, 2010, SCIENCE, V329, P1033, DOI 10.1126/science.1191223; Steinberger B, 2006, GEOPHYS J INT, V167, P1461, DOI 10.1111/j.1365-246X.2006.03131.x; Tappe S, 2018, EARTH PLANET SC LETT, V484, P1, DOI 10.1016/j.epsl.2017.12.013; Tarduno J, 2009, SCIENCE, V324, P50, DOI 10.1126/science.1161256; Tkalcic H, 2015, SCI REP-UK, V5, DOI 10.1038/srep18416; Torsvik TH, 2002, GEOPHYS J INT, V151, P771, DOI 10.1046/j.1365-246X.2002.01799.x; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Torsvik TH, 2014, P NATL ACAD SCI USA, V111, P8735, DOI 10.1073/pnas.1318135111; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Tosi N, 2013, PHYS EARTH PLANET IN, V217, P48, DOI 10.1016/j.pepi.2013.02.004; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Williams S, 2021, GEOSCI FRONT, V12, P769, DOI 10.1016/j.gsf.2020.06.004; Young A, 2019, GEOSCI FRONT, V10, P989, DOI 10.1016/j.gsf.2018.05.011; Zhong SJ, 2015, GEOCHEM GEOPHY GEOSY, V16, P1599, DOI 10.1002/2015GC005782; Zhong SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002048	82	6	5	9	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					846	+		10.1038/s41586-022-04538-y	http://dx.doi.org/10.1038/s41586-022-04538-y			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35355006				2022-12-28	WOS:000776361600031
J	Griffin, S				Griffin, Shaun			Cancer care: Staff shortages are limiting progress in England, says expert panel	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					House of Commons Health and Social Care Committee, 2022, 4 SPEC REP SESS 2021; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o682	2	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o862	10.1136/bmj.o862	http://dx.doi.org/10.1136/bmj.o862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361707				2022-12-28	WOS:000779990000009
J	Iacobucci, G				Iacobucci, Gareth			Pandemic saw large rise in patients self-funding hip and knee replacements	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Private Healthcare Information Network, 2022, PRIV MARK UPD MARCH	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o822	10.1136/bmj.o822	http://dx.doi.org/10.1136/bmj.o822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361618				2022-12-28	WOS:000779990000014
J	Liberti, WA; Schmid, TA; Forli, A; Snyder, M; Yartsev, MM				Liberti, William A.; Schmid, Tobias A.; Forli, Angelo; Snyder, Madeleine; Yartsev, Michael M.			A stable hippocampal code in freely flying bats	NATURE			English	Article							SPATIAL REPRESENTATION; COGNITIVE MAP; UNIT-ACTIVITY; PLACE CELLS; NAVIGATION; STABILITY; DIRECTION; DYNAMICS; PATTERNS; TRACKING	Neural activity in the hippocampus is known to reflect how animals move through an environment(1,2). Although navigational behaviour may show considerable stability(3-6), the tuning stability of individual hippocampal neurons remains unclear(7-12). Here we used wireless calcium imaging to longitudinally monitor the activity of dorsal CA1 hippocampal neurons in freely flying bats performing highly reproducible flights in a familiar environment. We find that both the participation and the spatial selectivity of most neurons remain stable over days and weeks. We also find that apparent changes in tuning can be largely attributed to variations in the flight behaviour of the bats. Finally, we show that bats navigating in the same environment under different room lighting conditions (lights on versus lights off) exhibit substantial changes in flight behaviour that can give the illusion of neuronal instability. However, when similar flight paths are compared across conditions, the stability of the hippocampal code persists. Taken together, we show that the underlying hippocampal code is highly stable over days and across contexts if behaviour is taken into account.	[Liberti, William A.; Forli, Angelo; Snyder, Madeleine; Yartsev, Michael M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schmid, Tobias A.; Yartsev, Michael M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yartsev, MM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Yartsev, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	myartsev@berkeley.edu	Forli, Angelo/AFS-0884-2022	Yartsev, Michael/0000-0003-0952-2801	New York Stem Cell Foundation [NYSCF-R-NI40]; Air Force Office of Scientific Research [FA9550-17-1-0412]; Packard Fellowship [2017-66825]; National Institute of Neurological Disorders and Stroke [R01NS118422-01]; Valle Foundation [VS-2020-34]; Office of Naval Research [N00014-21-1-2063]; Searle Scholars Program [SSP-2016-1412]; National Science Foundation Graduate Research Fellowship	New York Stem Cell Foundation; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Packard Fellowship(The David & Lucile Packard Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Valle Foundation; Office of Naval Research(Office of Naval Research); Searle Scholars Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	We thank the members of the Yartsev laboratory and D. Foster laboratory for discussion and comments; E. Azim, B. Styr, J. Widloski and K. Qi for reading and comments on the manuscript; P. Golshani; T. Shuman, D. Cai and G. Blair for initial training on calcium imaging surgical techniques; N. Doston and D. Genzel for assistance with the experimental set-up; V. Shvareva and A. Rakuljic for help with histology; H. Aaron, F. Ives and staff at the CRL Molecular Imaging Center for assistance with the use of core imaging facilities; Y. Minton and L. Loomis for experimental room maintenance and animal care; G. Lawson, K. Jensen, J. Frohlich and the staff of the Office of Laboratory Animal Care for support with animal husbandry and care. This research was supported by the New York Stem Cell Foundation (NYSCF-R-NI40), Air Force Office of Scientific Research (FA9550-17-1-0412), the Packard Fellowship (2017-66825), National Institute of Neurological Disorders and Stroke (R01NS118422-01), the Valle Foundation (VS-2020-34), The Office of Naval Research (N00014-21-1-2063), the Searle Scholars Program (SSP-2016-1412) (to M.M.Y.) and the National Science Foundation Graduate Research Fellowship (to T.A.S).	Barchi JR, 2013, J EXP BIOL, V216, P1053, DOI 10.1242/jeb.073197; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Carpenter J., 2021, P SOC NEUROSCI; Clopath C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0161; Danilovich S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6503; de Groot A, 2020, ELIFE, V9, DOI 10.7554/eLife.49987; Dotson NM, 2021, SCIENCE, V373, P242, DOI 10.1126/science.abg1278; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; El-Mansi AA, 2020, MICRON, V137, DOI 10.1016/j.micron.2020.102897; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; Genzel D, 2021, J NEUROSCI METH, V348, DOI 10.1016/j.jneumeth.2020.108970; Geva-Sagiv M, 2016, NAT NEUROSCI, V19, P952, DOI 10.1038/nn.4310; Geva-Sagiv M, 2015, NAT REV NEUROSCI, V16, P94, DOI 10.1038/nrn3888; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gonzalez WG, 2019, SCIENCE, V365, P821, DOI 10.1126/science.aav9199; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hainmueller T, 2018, NATURE, V558, P292, DOI 10.1038/s41586-018-0191-2; Harten L, 2020, SCIENCE, V369, P194, DOI 10.1126/science.aay3354; Holland RA, 2004, J EXP BIOL, V207, P4361, DOI 10.1242/jeb.01288; Huang L, 2021, ELIFE, V10, DOI 10.7554/eLife.51675; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kinsky NR., 2020, NAT COMMUN, V11; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lee WJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003148; Levy SJ, 2021, HIPPOCAMPUS, V31, P244, DOI 10.1002/hipo.23272; Liberti WA, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6806; Lutcke H, 2013, TRENDS NEUROSCI, V36, P375, DOI 10.1016/j.tins.2013.03.008; Mallory CS, 2018, CURR OPIN NEUROBIOL, V49, P158, DOI 10.1016/j.conb.2018.02.014; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 2017, NAT NEUROSCI, V20, P1448, DOI 10.1038/nn.4653; MULLER RU, 1987, J NEUROSCI, V7, P1935; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Payne HL, 2021, SCIENCE, V373, P343, DOI 10.1126/science.abg2009; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Rubin A, 2014, J NEUROSCI, V34, P1067, DOI 10.1523/JNEUROSCI.5393-12.2014; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Sheintuch L, 2017, CELL REP, V21, P1102, DOI 10.1016/j.celrep.2017.10.013; Shuman T, 2020, NAT NEUROSCI, V23, P229, DOI 10.1038/s41593-019-0559-0; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Tchernichovski O, 1998, BIOL CYBERN, V78, P423, DOI 10.1007/s004220050446; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Toledo S, 2020, SCIENCE, V369, P188, DOI 10.1126/science.aax6904; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Wohlgemuth MJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00270; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yartsev MM, 2017, SCIENCE, V358, P466, DOI 10.1126/science.aan8865; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yovel Y, 2011, J COMP PHYSIOL A, V197, P515, DOI 10.1007/s00359-011-0639-4; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	58	4	4	3	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					98	+		10.1038/s41586-022-04560-0	http://dx.doi.org/10.1038/s41586-022-04560-0		MAR 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355012				2022-12-28	WOS:000776020400001
J	Gasparri, G; Eissa, M; Imbago-Jacome, D; Nandini, B				Gasparri, Giulia; Eissa, Mohamed; Imbago-Jacome, David; Nandini, Bhavya			Climate emergency: how should COP27 do better for adolescents and young people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gasparri, Giulia; Imbago-Jacome, David; Nandini, Bhavya] PMNCH, Geneva, Switzerland; [Eissa, Mohamed] Int Federat Med Students Assoc, Copenhagen, Denmark		Gasparri, G (corresponding author), PMNCH, Geneva, Switzerland.		Bhattacharya, Nandini/HGU-4374-2022	Eissa, Mohamed/0000-0002-8386-6736; Gasparri, Giulia/0000-0002-3408-114X				[Anonymous], 2021, SEX REPR HLTH RIGHTS; [Anonymous], 2016, TIM TRANS AD HUM SET; [Anonymous], 2021, GLASGOW CLIMATE PACT; COP26, 2021, BBC NEWS 1106; Gender and Climate Change, 2016, CLOS LOOK EX EV; Glasgow Climate Pact, RECOGNIZES IMPORTANT; Majeed H, 2017, LANCET PLANET HEALTH, V1, pE94, DOI 10.1016/S2542-5196(17)30045-1; McGushin A, 2021, ADOLESCENT WELL BEIN; Thiery W, 2021, SCIENCE, V374, P158, DOI 10.1126/science.abi7339; UNICEF, 2021, CLIM CRIS IS CHILD R; United Nations Population Fund, WORLD POP DASHB	11	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o816	10.1136/bmj.o816	http://dx.doi.org/10.1136/bmj.o816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346951	Bronze			2022-12-28	WOS:000778641000006
J	Schlich, T; Lutters, B				Schlich, Thomas; Lutters, Bart			Historical perspectives on xenotransplantation	LANCET			English	Editorial Material									[Lutters, Bart] Univ Med Ctr Utrecht, Dept Med Humanities, Utrecht, Netherlands; [Schlich, Thomas] McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	Utrecht University; Utrecht University Medical Center; McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	thomas.schlich@mcgill.ca							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1220	1221						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339217				2022-12-28	WOS:000779495000013
J	Beckett, AG; Viaud, L; Heisler, M; Mukherjee, J				Beckett, Anne G.; Viaud, Loune; Heisler, Michele; Mukherjee, Joia			Misusing Public Health as a Pretext to End Asylum - Title 42	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Misusing Public Health as a Pretext to End Asylum There is no public health evidence that singling out asylum seekers or other migrants for exclusion from the United States is effective in stemming the spread of Covid-19; a federal order supporting such exclusion violates both international obligations and U.S. laws.	[Beckett, Anne G.] Boston Univ, Sch Med, Dept Med, Boston 02215, MA USA; [Viaud, Loune; Mukherjee, Joia] Partners Hlth, Boston, MA USA; [Mukherjee, Joia] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Mukherjee, Joia] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA USA; [Viaud, Loune] Zanmi Lasante, Port Au Prince, Haiti; [Heisler, Michele] Phys Human Rights, New York, NY USA; [Heisler, Michele] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA; [Heisler, Michele] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA	Boston University; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beckett, AG (corresponding author), Boston Univ, Sch Med, Dept Med, Boston 02215, MA USA.		Heisler, Michele/B-5774-2015	Heisler, Michele/0000-0002-6889-2063				[Anonymous], 2021, PUBLIC HLTH REASSESS; Customs and Border Protection, 2022, NAT ENC; Hampton K, 2021, NEITHER SAFETY HLTH; Human Rights First, 2022, SHAM REC BID ADM US; National Immigration Forum, 2018, FACT SHEET US AS PRO	5	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2022	386	16								10.1056/NEJMp2200274	http://dx.doi.org/10.1056/NEJMp2200274		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1F4SD	35320660	Bronze			2022-12-28	WOS:000780224900001
J	Wang, JM; Zhang, Y; Mendonca, CA; Yukselen, O; Muneeruddin, K; Ren, LZ; Liang, JL; Zhou, C; Xie, J; Li, J; Jiang, Z; Kucukural, A; Shaffer, SA; Gao, GP; Wang, D				Wang, Jiaming; Zhang, Yue; Mendonca, Craig A.; Yukselen, Onur; Muneeruddin, Khaja; Ren, Lingzhi; Liang, Jialing; Zhou, Chen; Xie, Jun; Li, Jia; Jiang, Zhong; Kucukural, Alper; Shaffer, Scott A.; Gao, Guangping; Wang, Dan			AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice	NATURE			English	Article							IN-VIVO; GENE-THERAPY; STATISTICAL-MODEL; TRANSLATION; TERMINATION; CODONS; SYNTHETASE; FEATURES	Gene therapy is a potentially curative medicine for many currently untreatable diseases, and recombinant adeno-associated virus (rAAV) isthe most successful gene delivery vehicle for in vivo applications(1-)(3). However, rAAV-based gene therapy suffers from several limitations, such as constrained DNA cargo size and toxicities caused by non-physiological expression of a transgene(4-)(6). Here we show that rAAV delivery of a suppressor tRNA (rAAV.sup-tRNA) safely and efficiently rescued a genetic disease in a mouse model carrying a nonsense mutation, and effects lasted for more than 6 months after a single treatment. Mechanistically, this was achieved through a synergistic effect of premature stop codon readthrough and inhibition of nonsense-mediated mRNA decay. rAAV.sup-tRNA had a limited effect on global readthrough at normal stop codons and did not perturb endogenoustRNA homeostasis, as determined by ribosome profiling and tRNA sequencing, respectively. By optimizing the AAV capsid and the route of administration, therapeutic efficacy in various target tissues was achieved, including liver, heart, skeletal muscle and brain. This study demonstratesthe feasibility of developing a toolbox of AAV-delivered nonsense suppressor tRNAs operating on premature termination codons (AAV-NoSTOP) to rescue pathogenic nonsense mutations and restore gene function under endogenous regulation. As nonsense mutations account for 11% of pathogenic mutations, AAV-NoSTOP can benefit a large number of patients. AAV-NoSTOP obviates the need to deliver a full-length protein-coding gene that may exceed the rAAV packaging limit, elicit adverse immune responses or cause transgene-related toxicities. It therefore represents a valuable addition to gene therapeutics.	[Wang, Jiaming; Zhang, Yue; Mendonca, Craig A.; Ren, Lingzhi; Liang, Jialing; Zhou, Chen; Xie, Jun; Li, Jia; Gao, Guangping; Wang, Dan] Univ Massachusetts, Horae Gene Therapy Ctr, Chan Med Sch, Worcester, MA 01605 USA; [Yukselen, Onur; Kucukural, Alper] Univ Massachusetts, Program Mol Med, Chan Med Sch, Worcester, MA 01605 USA; [Yukselen, Onur; Kucukural, Alper] Univ Massachusetts, Bioinformat Core, Chan Med Sch, Worcester, MA 01605 USA; [Muneeruddin, Khaja; Shaffer, Scott A.] Univ Massachusetts, Mass Spectrometry Facil, Chan Med Sch, Worcester, MA 01605 USA; [Muneeruddin, Khaja; Shaffer, Scott A.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Chan Med Sch, Shrewsbury, MA USA; [Xie, Jun; Gao, Guangping] Univ Massachusetts, Dept Microbiol & Physiol Syst, Chan Med Sch, Worcester, MA 01605 USA; [Jiang, Zhong] Univ Massachusetts, Dept Pathol, Chan Med Sch, Worcester, MA 01605 USA; [Wang, Dan] Univ Massachusetts, RNA Therapeut Inst, Chan Med Sch, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gao, GP; Wang, D (corresponding author), Univ Massachusetts, Horae Gene Therapy Ctr, Chan Med Sch, Worcester, MA 01605 USA.; Gao, GP (corresponding author), Univ Massachusetts, Dept Microbiol & Physiol Syst, Chan Med Sch, Worcester, MA 01605 USA.; Wang, D (corresponding author), Univ Massachusetts, RNA Therapeut Inst, Chan Med Sch, Worcester, MA 01605 USA.	Guangping.Gao@umassmed.edu; Dan.Wang@umassmed.edu	; Wang, Jiaming/H-8136-2017	Mendonca, Craig/0000-0001-9938-6481; Wang, Jiaming/0000-0002-4834-967X	National Institutes of Health (NIH) [P01HL158506]; Grace Science Foundation; Pitt-Hopkins Research Foundation; Believe in a Cure; NIH [R01NS076991, P01AI100263, P01HL131471, R01AI121135, UG3HL147367, UH3HL147367, R01HL152723, R01HL097088, U19AI149646]; Cystic Fibrosis Foundation; National Center for Advancing Translational Sciences [UL1TR001453]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grace Science Foundation; Pitt-Hopkins Research Foundation; Believe in a Cure; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We are grateful to P. D. Zamore, O. J. Rando, D. D. Nedialkova and members of the Wang laboratory and the Gao laboratory for helpful discussions. We thank staff at the Viral Vector Core at University of Massachusetts Chan Medical School for producing the AAV vectors used in this study. The Wang laboratory is supported by grants from the National Institutes of Health (NIH) (P01HL158506), the Grace Science Foundation, the Pitt-Hopkins Research Foundation, and Believe in a Cure. The Gao laboratory is supported by grants from the NIH (R01NS076991, P01AI100263, P01HL131471, R01AI121135, UG3HL147367, UH3HL147367, R01HL152723, R01HL097088 and U19AI149646) and the Cystic Fibrosis Foundation. O.Y. and A.K. are supported by the National Center for Advancing Translational Sciences (UL1TR001453). Illustrations were created with BioRender.com.	Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Behrens A, 2021, MOL CELL, V81, P1802, DOI 10.1016/j.molcel.2021.01.028; Bigger BW, 2018, MOL GENET METAB, V125, P322, DOI 10.1016/j.ymgme.2018.08.003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bunge S, 1998, BBA-MOL BASIS DIS, V1407, P249, DOI 10.1016/S0925-4439(98)00046-5; Buvoli M, 2000, MOL CELL BIOL, V20, P3116, DOI 10.1128/MCB.20.9.3116-3124.2000; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; CHANG JC, 1979, NATURE, V281, P602, DOI 10.1038/281602a0; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Colombo M, 2017, RNA, V23, P189, DOI 10.1261/rna.059055.116; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Davidoff AM, 2003, BLOOD, V102, P480, DOI 10.1182/blood-2002-09-2889; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Evans ME, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx514; Fechter P, 2000, BIOCHEMISTRY-US, V39, P1725, DOI 10.1021/bi992276t; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Golebiowski D, 2017, HUM GENE THER, V28, P510, DOI 10.1089/hum.2016.109; Hampe CS, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020189; Hashimoto S, 2019, FEBS LETT, V593, P777, DOI 10.1002/1873-3468.13362; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hordeaux J, 2020, HUM GENE THER, V31, P808, DOI 10.1089/hum.2020.167; Huang LL, 2019, NUCLEIC ACID THER, V29, P175, DOI 10.1089/nat.2019.0779; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Koukuntla R, 2013, J GENE MED, V15, P93, DOI 10.1002/jgm.2696; Kramarski L, 2020, NUCLEIC ACIDS RES, V48, P3747, DOI 10.1093/nar/gkaa136; Kurosaki T, 2019, NAT REV MOL CELL BIO, V20, P406, DOI 10.1038/s41580-019-0126-2; Kuzmin DA, 2021, NAT REV DRUG DISCOV, V20, P173, DOI [10.1038/d41573-021-00017, 10.1038/d41573-021-00017-7]; Li A, 2020, MOL THER, V28, P1432, DOI 10.1016/j.ymthe.2020.04.017; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Lombardi S, 2020, RNA BIOL, V17, P254, DOI 10.1080/15476286.2019.1676115; Lueck JD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08329-4; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mendell JR, 2021, MOL THER, V29, P464, DOI 10.1016/j.ymthe.2020.12.007; Moreno AM, 2019, NAT BIOMED ENG, V3, P806, DOI 10.1038/s41551-019-0431-2; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oussoren E, 2013, MOL GENET METAB, V109, P377, DOI 10.1016/j.ymgme.2013.05.016; Parker DJ, 2020, CELL SYST, V11, P121, DOI 10.1016/j.cels.2020.07.005; PHILLIPSJONES MK, 1995, MOL CELL BIOL, V15, P6593; Porter JJ, 2021, WIRES RNA, V12, DOI 10.1002/wrna.1641; Roy B, 2016, P NATL ACAD SCI USA, V113, P12508, DOI 10.1073/pnas.1605336113; TEMPLE GF, 1982, NATURE, V296, P537, DOI 10.1038/296537a0; Van Alstyne M, 2021, NAT NEUROSCI, V24, P930, DOI 10.1038/s41593-021-00827-3; VANTOL H, 1988, NUCLEIC ACIDS RES, V16, P1951, DOI 10.1093/nar/16.5.1951; Wang D, 2020, CELL, V181, P136, DOI 10.1016/j.cell.2020.03.023; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang D, 2018, NAT BIOTECHNOL, V36, P839, DOI 10.1038/nbt.4219; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Wang D, 2010, MOL GENET METAB, V99, P62, DOI 10.1016/j.ymgme.2009.08.002; Wang JM, 2021, MOL THER, V29, P128; Wangen JR, 2020, ELIFE, V9, DOI 10.7554/eLife.52611; Xie J, 2017, MOL THER, V25, P1363, DOI 10.1016/j.ymthe.2017.03.028; Xue XJ, 2017, HUM MOL GENET, V26, P3116, DOI 10.1093/hmg/ddx196; Yukselen O, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6714-x	61	6	5	9	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 14	2022	604	7905					343	+		10.1038/s41586-022-04533-3	http://dx.doi.org/10.1038/s41586-022-04533-3		MAR 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0M9OF	35322228				2022-12-28	WOS:000772363100003
J	Sen, A; Gemes, K; Stalhammar, G; Svensen, C; Tornvall, P; Jonsson, M; Varmdal, T; Endreseth, BH; Janszky, I; Moller, J				Sen, Abhijit; Gemes, Katalin; Stalhammar, Gustav; Svensen, Christer; Tornvall, Per; Jonsson, Magnus; Varmdal, Torunn; Endreseth, Birger Henning; Janszky, Imre; Moller, Jette			Risk for Acute Myocardial Infarction After Ophthalmologic Procedures	ANNALS OF INTERNAL MEDICINE			English	Article							TRIGGERS	Background: Preoperative cardiovascular evaluations are frequently done before ambulatory ophthalmologic procedures. However, whether these procedures can trigger an acute myocardial infarction (AMI) is unknown. Objective: To assess the short-term risk for AMI associated with ophthalmologic procedures. Design: Case-crossover design. Setting: Population-based nationwide study from Norway and Sweden. Participants: First-time patients with AMI, aged 40 years and older, identified via inpatient registries and linked to outpatient surgical procedures in Norway (2008 to 2014) and Sweden (2001 to 2014), respectively. Measurements: Using self-matching, for each participant, exposure to ophthalmologic procedures in the 0 to 7 days before AMI diagnosis (hazard period) was compared with an 8-day period 30 days earlier, that is, days 29 to 36 before AMI (control period) to estimate the relative risk for an AMI the week after an ophthalmologic procedure. The odds ratios (ORs) with 95% CIs were calculated, using conditional logistic regression. Only patients who had a procedure of interest during either the hazard or control period were included. Results: For the 806 patients with AMI included in this study, there was a lower likelihood of AMI in the week after an ophthalmologic procedure than during the control week (OR, 0.83; 95% CI, 0.75 to 0.91). Furthermore, there was no evidence of increased risk for AMI when analyses were stratified by surgery subtype, anesthesia (local or general), duration, invasiveness (low, intermediate, or high), patient's age (<65 years or >= 65 years), or comorbidity (none vs. any). Limitation: Potential bias from time-varying confounders between the hazard and the control periods. Conclusion: Ophthalmologic procedures done in an outpatient setting did not seem to be associated with an increased risk for AMI.	[Sen, Abhijit; Janszky, Imre] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Hakon Jarls Gate 11 & Mauritz Hanssens Gate 2, Trondheim, Norway; [Sen, Abhijit] Ctr Oral Hlth Serv & Res TkMidt, Trondheim, Norway; [Sen, Abhijit; Endreseth, Birger Henning; Janszky, Imre] St Olavs Univ Hosp, Clin Surg, Trondheim, Norway; [Gemes, Katalin] Karolinska Inst, Inst Environm Med, Dept Global Publ Hlth, Stockholm, Sweden; [Gemes, Katalin; Stalhammar, Gustav] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Stalhammar, Gustav] St Erik Eye Hosp, Stockholm, Sweden; [Svensen, Christer; Tornvall, Per] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Jonsson, Magnus] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Jonsson, Magnus] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden; [Varmdal, Torunn] St Olavs Univ Hosp, Dept Res & Dev, Trondheim, Norway; [Varmdal, Torunn] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Janszky, Imre] St Olavs Univ Hosp, Reg Ctr Hlth Care Improvement, Trondheim, Norway; [Moller, Jette] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet	Sen, A (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Hakon Jarls Gate 11 & Mauritz Hanssens Gate 2, Trondheim, Norway.	abhijit.sen@ntnu.no	Stålhammar, Gustav/AAF-4653-2021	Stalhammar, Gustav/0000-0001-9401-8911; Sen, Abhijit/0000-0001-9560-4226	Central Norway Regional Health Authority; Swedish Research Council	Central Norway Regional Health Authority; Swedish Research Council(Swedish Research CouncilEuropean Commission)	0 Central Norway Regional Health Authority and the Swedish Research Council.	Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Chen CL, 2021, OPHTHALMOLOGY, V128, P208, DOI 10.1016/j.ophtha.2020.09.013; Chen CL, 2015, NEW ENGL J MED, V372, P1530, DOI 10.1056/NEJMsa1410846; Chen YF, 2021, BRIT J OPHTHALMOL, DOI 10.1136/bjophthalmol-2021-319678; Culic V, 2005, INT J CARDIOL, V99, P1, DOI 10.1016/j.ijcar.2004.01.008; Govatsmark RES, 2020, SCAND J PUBLIC HEALT, V48, P5, DOI 10.1177/1403494818803256; Hallas J, 2014, J INTERN MED, V275, P581, DOI 10.1111/joim.12186; Hallqvist L, 2020, BRIT J ANAESTH, V125, P47, DOI 10.1016/j.bja.2020.03.015; Hammoudeh AJ, 2009, CARDIOL REV, V17, P270, DOI 10.1097/CRD.0b013e3181bdba75; Janszky I, 2018, J AM COLL CARDIOL, V71, P2744, DOI 10.1016/j.jacc.2018.03.532; Keay L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007293.pub4; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; National Board of Health and Welfare National Patient Register (NPR), 2020, KLASS KIR ATG 1997 C; Nordic Medico-Statistical Committee, 2010, NOMESCO CLASS SURG P; Priebe HJ, 2005, BRIT J ANAESTH, V95, P3, DOI 10.1093/bja/aei063; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189	22	2	2	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					628	+		10.7326/M20-6618	http://dx.doi.org/10.7326/M20-6618		MAR 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35313112				2022-12-28	WOS:000805220000002
J	[Anonymous]				[Anonymous]			Summary for Patients: Risk for Heart Attack After Eye Procedures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					I22	I22		10.7326/P22-0001	http://dx.doi.org/10.7326/P22-0001		MAR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2U5RH	35313117				2022-12-28	WOS:000779639300001
J	Taylor, L				Taylor, Luke			Covid-19: Hong Kong reports world's highest death rate as zero covid strategy fails	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, REUTERS 0312; Government of Hong Kong, HONG KONG VACC DASHB; National Health Commission of the People's Republic of China, 2022, DAILY BRIEFING NOVEL; Perez-Then E, 2022, NAT MED, V28, P481, DOI 10.1038/s41591-022-01705-6; Silver A, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o420; Stevenson A., 2022, NEW YORK TIMES	6	21	20	4	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o707	10.1136/bmj.o707	http://dx.doi.org/10.1136/bmj.o707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35302043	Bronze			2022-12-28	WOS:000796719200008
J	Tita, AT; Szychowski, JM; Boggess, K; Dugoff, L; Sibai, B; Lawrence, K; Hughes, BL; Bell, J; Aagaard, K; Edwards, RK; Gibson, K; Haas, DM; Plante, L; Metz, T; Casey, B; Esplin, S; Longo, S; Hoffman, M; Saade, GR; Hoppe, KK; Foroutan, J; Tuuli, M; Owens, MY; Simhan, HN; Frey, H; Rosen, T; Palatnik, A; Baker, S; August, P; Reddy, UM; Kinzler, W; Su, E; Krishna, I; Nguyen, N; Norton, ME; Skupski, D; El-Sayed, YY; Ogunyemi, D; Galis, ZS; Harper, L; Ambalavanan, N; Geller, NL; Oparil, S; Cutter, GR; Andrews, WW				Tita, Alan T.; Szychowski, Jeff M.; Boggess, Kim; Dugoff, Lorraine; Sibai, Baha; Lawrence, Kirsten; Hughes, Brenna L.; Bell, Joseph; Aagaard, Kjersti; Edwards, Rodney K.; Gibson, Kelly; Haas, David M.; Plante, Lauren; Metz, Torri; Casey, Brian; Esplin, Sean; Longo, Sherri; Hoffman, Matthew; Saade, George R.; Hoppe, Kara K.; Foroutan, Janelle; Tuuli, Methodius; Owens, Michelle Y.; Simhan, Hyagriv N.; Frey, Heather; Rosen, Todd; Palatnik, Anna; Baker, Susan; August, Phyllis; Reddy, Uma M.; Kinzler, Wendy; Su, Emily; Krishna, Iris; Nguyen, Nicki; Norton, Mary E.; Skupski, Daniel; El-Sayed, Yasser Y.; Ogunyemi, Dotum; Galis, Zorina S.; Harper, Lorie; Ambalavanan, Namasivayam; Geller, Nancy L.; Oparil, Suzanne; Cutter, Gary R.; Andrews, William W.		Chronic Hypertension Pregnancy	Treatment for Mild Chronic Hypertension During Pregnancy	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material								Chronic hypertension affects >2% of pregnancies in the United States and disproportionately affects Black women. The condition is also associated with an increased risk of adverse neonatal outcomes, including preeclampsia, placental abruption, pretermbirth, small for gestational age (SGA), or perinatal death, andmaternal outcomes, includingmaternal death, heart failure, stroke, pulmonary edema, or acute kidney injury. Although antihypertensive therapy is the standard of care for nonpregnant people, clinical recommendations for pregnant peoplewith hypertension vary. This is because antihypertensive treatment during pregnancy has not demonstrated improvement in maternal and neonatal outcomes, despite reducing the risk of severe hypertension. Although there is consensus to treat pregnant people with severe hypertension, it is unclear whether to provide antihypertensive therapy to those with mild chronic hypertension until the condition is severe (=160-105mmHg). The aimof this study was to assess whether antihypertension therapy for pregnant women with mild chronic hypertension would improve maternal and perinatal outcomes compared with reserving treatment until their blood pressure reached severe levels. The Chronic Hypertension and Pregnancy project was a randomized controlled trial, conducted at >70 recruiting sites across the United States. Included were women with viable singleton pregnancies and a known or new diagnosis of chronic hypertension (=140/90 mm Hg) before 23 weeks of gestation. Excluded were those with severe hypertension or the need for >1 antihypertensive medication, known secondary hypertension, high-risk coexisting illnesses, complications that warrant treatment at a lower blood-pressure level, obstetric conditions with increased fetal risk, and contraindications to antihypertensive therapy during pregnancy. Patients were randomized into 2 groups: the active treatment group, which received antihypertension therapy with a blood-pressure goal of <140/90 mm Hg, and the control group, which did not receive antihypertension therapy unless severe hypertension developed. The primary outcome was a composite of preeclampsia with severe features, medically indicated preterm birth at <35 weeks of gestation, placental abruption, or fetal or neonatal death. The safety outcome was SGA below the 10th percentile for gestational age. Secondary outcomes included composites of serious neonatal and maternal complications, preeclampsia, and preterm birth. A total of 2408 pregnant womenwithmild chronic hypertension were included in the analysis, with 1208 in the active treatment group and 1200 in the control group. The primary composite outcome was lower in the active treatment group versus the control group (30.2% vs 37.0%, respectively; adjusted risk ratio [RR], 0.82; 95% confidence interval [CI], 0.74-0.92; P < 0.001). There were fewer women in the active treatment group than control group to experience preeclampsia with severe features (23.3% vs 29.1%; adjusted RR, 0.80; 95% CI, 0.70-0.92) and preterm birth at <35 weeks (12.2% vs 16.7%; adjusted RR, 0.73; 95% CI, 0.60-0.89). To prevent one event of the primary composite outcome, 14.7 patients would need to be treated (95% CI, 9.4-33.7). The safety, SGA outcome was also higher in the active treatment group versus the control group, but the difference was not significant (11.2% vs 10.4%, respectively; adjusted RR, 1.04; 95% CI, 0.82-1.31; P = 0.76). The incidence of serious maternal complications was low in both the active treatment group and control group (2.1% vs 2.8%, respectively; RR, 0.75; 95% CI, 0.45-1.26). Fewer women in the active group experienced preeclampsia, with or without severe features, than in the control group (24.4% vs 31.1%). The incidence of severe neonatal complications was also low in both groups (2.0% vs 2.6%; RR, 0.77; 95% CI, 0.45-1.30). Fewer women in the active group experienced preterm birth at <37 weeks (27.5% vs 31.4%; RR, 0.87; 95% CI, 0.77-0.99) and birth weight <2500 g (19.2% vs 23.1%; RR, 0.83; 95% CI, 0.71-0.79) than in those in the control group. In this study, women with mild chronic hypertension who received antihypertension therapy had improved pregnancy outcomes compared with those whose antihypertensive therapy was reserved until severe hypertension developed.	[Tita, Alan T.; Andrews, William W.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL USA; [Tita, Alan T.; Szychowski, Jeff M.; Ambalavanan, Namasivayam; Oparil, Suzanne; Cutter, Gary R.; Andrews, William W.] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL USA; [Szychowski, Jeff M.; Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA; [Ambalavanan, Namasivayam] Univ Alabama Birmingham, Div Neonatol, Dept Pediat, Birmingham, AL USA; [Oparil, Suzanne] Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, Birmingham, AL USA; [Boggess, Kim] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hughes, Brenna L.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Dugoff, Lorraine] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA USA; [Plante, Lauren] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA USA; [Bell, Joseph] St Lukes Univ Hlth Network, Fountain Hill, PA USA; [Simhan, Hyagriv N.] Univ Pittsburgh, Magee Womens Hosp, Dept Obstet & Gynecol, Pittsburgh, PA USA; [Sibai, Baha] Univ Texas Houston, Dept Obstet & Gynecol, Houston, TX USA; [Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX USA; [Aagaard, Kjersti] Texas Childrens Hosp, Houston, TX USA; [Casey, Brian] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX USA; [Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA; [Harper, Lorie] Univ Texas Austin, Dept Womens Hlth, Austin, TX USA; [Lawrence, Kirsten] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [August, Phyllis] Weill Cornell Univ, New York, NY USA; [Skupski, Daniel] New York Presbyterian Queens Hosp, Dept Obstet & Gynecol, New York, NY USA; [Kinzler, Wendy] Winthrop Univ Hosp, Dept Obstet & Gynecol, Mineola, NY USA; [Edwards, Rodney K.] Univ Oklahoma Hlth Sci, Dept Obstet & Gynecol, Oklahoma City, OK USA; [Gibson, Kelly] MetroHlth Syst, Cleveland, OH USA; [Haas, David M.] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN USA; [Metz, Torri] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Esplin, Sean] Intermt Healthcare, Salt Lake City, UT USA; [Longo, Sherri] Ochsner Baptist Med Ctr, New Orleans, LA USA; [Hoffman, Matthew] Christiana Care Hlth Syst, Newark, DE USA; [Hoppe, Kara K.] UnityPoint Hlth Meriter Hosp, Marshfield Clin, Dept Obstet & Gynecol, Madison, WI USA; [Palatnik, Anna] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI USA; [Foroutan, Janelle] St Peters Univ Hosp, New Brunswick, NJ USA; [Rosen, Todd] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA; [Tuuli, Methodius] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Owens, Michelle Y.] Univ Mississippi, Dept Obstet & Gynecol, Med Ctr, Jackson, MS USA; [Frey, Heather] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH USA; [Baker, Susan] Univ S Alabama, Dept Obstet & Gynecol, Mobile, AL USA; [Reddy, Uma M.] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA; [Su, Emily] Univ Colorado, Dept Obstet & Gynecol, Boulder, CO USA; [Nguyen, Nicki] Denver Hlth, Dept Obstet & Gynecol, Denver, CO USA; [Krishna, Iris] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA USA; [Norton, Mary E.] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA USA; [Norton, Mary E.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [El-Sayed, Yasser Y.] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA USA; [Ogunyemi, Dotum] Arrowhead Reg Med Ctr, Dept Obstet & Gynecol, Colton, CA USA; [Ogunyemi, Dotum] Beaumont Hosp, Southfield, MI USA; [Geller, Nancy L.] Natl Heart Lung & Blood Inst, Div Cardiovasc Sci, Bethesda, MD USA; [Geller, Nancy L.] Natl Heart Lung & Blood Inst, Off Biostat Res, Bethesda, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Pennsylvania; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Austin; Columbia University; Cornell University; Winthrop University Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; MetroHealth System; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Ochsner Health System; Christiana Care Health System; Marshfield Clinic; Medical College of Wisconsin; Saint Peter's University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL); University of Mississippi; University of Mississippi Medical Center; University System of Ohio; Ohio State University; University of South Alabama; Yale University; University of Colorado System; University of Colorado Boulder; Denver Health Medical Center; Emory University; University of California System; University of California San Francisco; Stanford University; Beaumont Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tita, AT (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL USA.; Tita, AT (corresponding author), Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL USA.			Foroutan, Janelle/0000-0002-4758-0028; Hughes, Brenna/0000-0001-8950-1204					0	39	39	9	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	NOV	2022	77	11					634	636		10.1097/01.ogx.0000899456.24100.71	http://dx.doi.org/10.1097/01.ogx.0000899456.24100.71			3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	5Q8ML	35363951				2022-12-28	WOS:000874079000004
J	Nattino, G; Castiglioni, S; Cereda, D; Della Valle, PG; Pellegrinelli, L; Bertolini, G; Pariani, E				Nattino, Giovanni; Castiglioni, Sara; Cereda, Danilo; Della Valle, Petra Giulia; Pellegrinelli, Laura; Bertolini, Guido; Pariani, Elena			Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter; Early Access								This study evaluates the association between SARS-CoV-2 load in urban wastewater and surveillance indicators of infection prevalence and severity in Milan, Italy.	[Nattino, Giovanni; Bertolini, Guido] Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Ranica, Italy; [Castiglioni, Sara] Ist Ric Farmacol Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy; [Cereda, Danilo] Directorate Gen Hlth, Milan, Lombardy Region, Italy; [Della Valle, Petra Giulia] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy; [Pellegrinelli, Laura; Pariani, Elena] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia; University of Milan	Bertolini, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Lab Clin Epidemiol, Dept Publ Hlth, Via GB Camozzi 3, I-24020 Ranica, BG, Italy.	guido.bertolini@marionegri.it	Nattino, Giovanni/T-7306-2019; PARIANI, ELENA/M-3491-2016	Nattino, Giovanni/0000-0002-3034-6251; PARIANI, ELENA/0000-0001-5681-3455; Bertolini, Guido/0000-0002-3101-4259				Bivins A, 2020, ENVIRON SCI TECHNOL, V54, P7754, DOI 10.1021/acs.est.0c02388; Hart OE, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138875; Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357; Thompson JR, 2020, WATER RES, V184, DOI 10.1016/j.watres.2020.116181; UK Health Security Agency, SARS COV 2 VAR CONC	5	4	4	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.4908	http://dx.doi.org/10.1001/jama.2022.4908		APR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E5QR	35363259	Green Published, Bronze			2022-12-28	WOS:000776736500001
J	Vollger, MR; Guitart, X; Dishuck, PC; Mercuri, L; Harvey, WT; Gershman, A; Diekhans, M; Sulovari, A; Munson, KM; Lewis, AP; Hoekzema, K; Porubsky, D; Li, RY; Nurk, S; Koren, S; Miga, KH; Phillippy, AM; Timp, W; Ventura, M; Eichler, EE				Vollger, Mitchell R.; Guitart, Xavi; Dishuck, Philip C.; Mercuri, Ludovica; Harvey, William T.; Gershman, Ariel; Diekhans, Mark; Sulovari, Arvis; Munson, Katherine M.; Lewis, Alexandra P.; Hoekzema, Kendra; Porubsky, David; Li, Ruiyang; Nurk, Sergey; Koren, Sergey; Miga, Karen H.; Phillippy, Adam M.; Timp, Winston; Ventura, Mario; Eichler, Evan E.			Segmental duplications and their variation in a complete human genome	SCIENCE			English	Article							COPY NUMBER VARIATION; POLYMORPHIC VARIANTS; STRUCTURAL VARIATION; DNA-SEQUENCE; CYP2D6 GENE; METABOLISM; ALIGNMENT; IMPACT; HETEROCHROMATIN; LIPOPROTEIN(A)	Despite their importance in disease and evolution, highly identical segmental duplications (SDs) are among the last regions of the human reference genome (GRCh38) to be fully sequenced. Using a complete telomere-to-telomere human genome (T2T-CHM13), we present a comprehensive view of human SD organization. SDs account for nearly one-third of the additional sequence, increasing the genome-wide estimate from 5.4 to 7.0% [218 million base pairs (Mbp)]. An analysis of 268 human genomes shows that 91% of the previously unresolved T2T-CHM13 SD sequence (68.3 Mbp) better represents human copy number variation. Comparing long-read assemblies from human (n = 12) and nonhuman primate (n = 5) genomes, we systematically reconstruct the evolution and structural haplotype diversity of biomedically relevant and duplicated genes. This analysis reveals patterns of structural heterozygosity and evolutionary differences in SD organization between humans and other primates.	[Vollger, Mitchell R.; Guitart, Xavi; Dishuck, Philip C.; Harvey, William T.; Sulovari, Arvis; Munson, Katherine M.; Lewis, Alexandra P.; Hoekzema, Kendra; Porubsky, David; Li, Ruiyang; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Mercuri, Ludovica; Ventura, Mario] Univ Bari Aldo Moro, Dept Biol, I-70125 Bari, Italy; [Gershman, Ariel; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Dept Mol Biol & Genet, Baltimore, MD USA; [Diekhans, Mark; Miga, Karen H.] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Nurk, Sergey; Koren, Sergey; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Johns Hopkins University; University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	eee@gs.washington.edu	; Phillippy, Adam/U-5731-2018	Guitart, Xavi/0000-0002-4128-4375; Gershman, Ariel/0000-0001-8899-8781; Vollger, Mitchell/0000-0002-8651-1615; Mercuri, Ludovica/0000-0002-3688-4501; Harvey, William/0000-0003-0646-7528; Munson, Katherine/0000-0001-8413-6498; Sulovari, Arvis/0000-0003-4354-9020; Diekhans, Mark/0000-0002-0430-0989; Phillippy, Adam/0000-0003-2983-8934	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; U.S. National Institutes of Health (NIH) [5R01HG002385, 5U01HG010971, 1U01HG010973, 1R01HG011274, 5R01HG009190, U41HG007234]; Futuro in Ricerca [2010-RBFR103CE3]	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Futuro in Ricerca	This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (S.N., S.K., and A.M.P.), grants from the U.S. National Institutes of Health (NIH grants 5R01HG002385, 5U01HG010971, and 1U01HG010973 to E.E.E.; 1R01HG011274 to K.H.M.; 5R01HG009190 to W.T.; and U41HG007234 to M.D.), and a grant from Futuro in Ricerca (2010-RBFR103CE3 to M.V.). E.E.E. is an investigator of Howard Hughes Medical Institute.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; ALEXANDERSON B, 1969, BMJ-BRIT MED J, V4, P764, DOI 10.1136/bmj.4.5686.764; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1987, AM J MED GENET, V26, P95, DOI 10.1002/; Arnheim N., 1983, P38; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barber JCK, 2006, CYTOGENET GENOME RES, V114, P351, DOI 10.1159/000094225; BARBER JCK, 1994, PRENATAL DIAG, V14, P323, DOI 10.1002/pd.1970140418; Bebee TW, 2010, FRONT BIOSCI-LANDMRK, V15, P1191, DOI 10.2741/3670; Bell AD, 2018, METHODS MOL BIOL, V1768, P143, DOI 10.1007/978-1-4939-7778-9_9; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479; Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x; Bhasin M. K., 2005, International Journal of Human Genetics, V5, P83; Butchbach MER, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00007; Caglayan AO, 2010, J OBSTET GYNAECOL RE, V36, P774, DOI 10.1111/j.1447-0756.2010.01207.x; Cantsilieris S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02074-4; Cardone MF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r91; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Cheng HY, 2021, NAT METHODS, V18, P170, DOI 10.1038/s41592-020-01056-5; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coassin S, 2019, J LIPID RES, V60, P186, DOI 10.1194/jlr.M090381; Codina-Pascual M, 2006, HUM REPROD, V21, P1490, DOI 10.1093/humrep/del028; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; DAHL ML, 1992, CLIN PHARMACOL THER, V51, P12, DOI 10.1038/clpt.1992.2; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dougherty ML, 2018, GENOME RES, V28, P1566, DOI 10.1101/gr.237610.118; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Ebler J, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.11.11.378133, DOI 10.1101/2020.11.11.378133]; Eichler EE., 2002, PROPOSAL CONSTRUCTIO; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; GAEDIGK A, 1991, AM J HUM GENET, V48, P943; Gel B, 2017, BIOINFORMATICS, V33, P3088, DOI 10.1093/bioinformatics/btx346; Gershman A, 2022, SCIENCE, V376, P58, DOI 10.1126/science.abj5089; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; GOTOH O, 1993, COMPUT APPL BIOSCI, V9, P361; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; HAMMER WOLFGANG, 1967, LIFE SCI, V6, P1895, DOI 10.1016/0024-3205(67)90218-4; Hong Y, 2011, HUM REPROD, V26, P933, DOI 10.1093/humrep/deq333; Hsieh P, 2019, SCIENCE, V366, P324, DOI 10.1126/science.aax2083; HSU LYF, 1987, AM J MED GENET, V26, P95, DOI 10.1002/ajmg.1320260116; Jain C, 2020, BIOINFORMATICS, V36, P111, DOI 10.1093/bioinformatics/btaa435; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Ju XC, 2016, ELIFE, V5, DOI 10.7554/eLife.18197; Kalantari P, 2001, Tsitol Genet, V35, P50; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Killick H., 2016, CHANGEPOINT R PACKAG; Kim JH, 2018, NUCLEIC ACIDS RES, V46, P6712, DOI 10.1093/nar/gky442; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; Krasheninnikova K, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa047; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Kronenberg F, 2016, CARDIOVASC DRUG THER, V30, P87, DOI 10.1007/s10557-016-6648-3; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02168-z; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Logsdon GA, 2021, NATURE, V593, P101, DOI 10.1038/s41586-021-03420-7; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; LUKE S, 1992, J CELL SCI, V103, P919; Lyle R, 2007, GENOME RES, V17, P1690, DOI 10.1101/gr.6675307; Madon PF, 2005, REPROD BIOMED ONLINE, V11, P726, DOI 10.1016/S1472-6483(10)61691-4; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Marques-Bonet T, 2009, COLD SH Q B, V74, P355, DOI 10.1101/sqb.2009.74.011; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Minocherhomji S, 2009, FERTIL STERIL, V92, P88, DOI 10.1016/j.fertnstert.2008.05.071; Molder Felix, 2021, F1000Res, V10, P33, DOI 10.12688/f1000research.29032.1; Numanagic I, 2018, BIOINFORMATICS, V34, P706, DOI 10.1093/bioinformatics/bty586; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; Nurk S, 2020, GENOME RES, V30, P1291, DOI 10.1101/gr.263566.120; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, P1; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Porubsky D, 2020, NAT GENET, V52, P849, DOI 10.1038/s41588-020-0646-x; Pratt WS, 2000, BIOCHEM BIOPH RES CO, V275, P916, DOI 10.1006/bbrc.2000.3406; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sahin FI, 2008, J ASSIST REPROD GEN, V25, P191, DOI 10.1007/s10815-008-9216-3; Sanders AD, 2017, NAT PROTOC, V12, P1151, DOI 10.1038/nprot.2017.029; Sanders AD, 2016, GENOME RES, V26, P1575, DOI 10.1101/gr.201160.115; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt K, 2016, J LIPID RES, V57, P1339, DOI 10.1194/jlr.R067314; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shumate A, 2021, BIOINFORMATICS, V37, P1639, DOI 10.1093/bioinformatics/btaa1016; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; Smit AF., 2018, REPEATMASKER; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Standing Committee on Human Cytogenetic Nomenclature, 1995, ISCN 1995 INT SYSTEM; Stergachis AB, 2020, SCIENCE, V368, P1449, DOI 10.1126/science.aaz1646; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067; Venter JC, 2001, SCIENCE, V292, P1838; Vollger M. R., 2021, ZENODO; Vollger M. R., 2021, ASSEMBLIES DATA GENE; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [DOI 10.21105/JOSS.01686, 10.21105/joss.01686]; Wilch ES, 2018, ADV EXP MED BIOL, V1044, P1, DOI 10.1007/978-981-13-0593-1_1	117	16	16	13	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		55	+	eabj6965	10.1126/science.abj6965	http://dx.doi.org/10.1126/science.abj6965			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357917	Green Accepted, Green Submitted			2022-12-28	WOS:000780195200023
J	Abdel-Fattah, M; Cooper, D; Davidson, T; Kilonzo, M; Hossain, M; Boyers, D; Bhal, K; Wardle, J; N'Dow, J; MacLennan, G; Norrie, J				Abdel-Fattah, Mohamed; Cooper, David; Davidson, Tracey; Kilonzo, Mary; Hossain, Md; Boyers, Dwayne; Bhal, Kiron; Wardle, Judith; N'Dow, James; MacLennan, Graeme; Norrie, John			Single-Incision Mini-Slings for Stress Urinary Incontinence in Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STANDARD MIDURETHRAL SLINGS; SURGICAL-MANAGEMENT; RANDOMIZED-TRIAL; METAANALYSIS; EFFICACY; OUTCOMES; SYSTEMS	BACKGROUND Until recently, synthetic midurethral slings (made of mesh or tape) were the standard surgical treatment worldwide for female stress urinary incontinence, if conservative management failed. Data comparing the effectiveness and safety of newer single-incision mini-slings with those of standard midurethral slings are limited. METHODS We performed a pragmatic, noninferiority, randomized trial comparing mini-slings with midurethral slings among women at 21 U.K. hospitals during 36 months of follow-up. The primary outcome was patient-reported success (defined as a response of very much or much improved on the Patient Global Impression of Improvement questionnaire) at 15 months after randomization (approximately 1 year after surgery). The noninferiority margin was 10 percentage points. RESULTS A total of 298 women were assigned to receive mini-slings and 298 were assigned to receive midurethral slings. At 15 months, success was reported by 212 of 268 patients (79.1%) in the mini-sling group and by 189 of 250 patients (75.6%) in the midurethral-sling group (adjusted risk difference, 4.6 percentage points; 95% confidence interval [CI], -2.7 to 11.8; P<0.001 for noninferiority). At the 36-month follow-up, success was reported by 177 of 246 patients (72.0%) and by 157 of 235 patients (66.8%) in the respective groups (adjusted risk difference, 5.7 percentage points; 95% CI, -1.3 to 12.8). At 36 months, the percentage of patients with groin or thigh pain was 14.1% with mini-slings and 14.9% with midurethral slings. Over the 36-month follow-up period, the percentage of patients with tape or mesh exposure was 3.3% with mini-slings and 1.9% with midurethral slings, and the percentage who underwent further surgery for stress urinary incontinence was 2.5% and 1.1%, respectively. Outcomes with respect to quality of life and sexual function were similar in the two groups, with the exception of dyspareunia; among 290 women responding to a validated questionnaire, dyspareunia was reported by 11.7% in the mini-sling group and 4.8% in the midurethral-sling group. CONCLUSIONS Single-incision mini-slings were noninferior to standard midurethral slings with respect to patient-reported success at 15 months, and the percentage of patients reporting success remained similar in the two groups at the 36-month follow-up.	[Abdel-Fattah, Mohamed; Cooper, David; Davidson, Tracey; Kilonzo, Mary; Hossain, Md; Boyers, Dwayne; N'Dow, James; MacLennan, Graeme] Univ Aberdeen, Aberdeen, Scotland; [Bhal, Kiron] Univ Hosp Wales, Cardiff, Wales; [Wardle, Judith] Univ Hosp Wales, Oxford, England; [Norrie, John] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Aberdeen; Cardiff University; University of Edinburgh	Abdel-Fattah, M (corresponding author), Aberdeen Matern Hosp, 2nd Fl,Foresterhill Campus, Aberdeen AB25 2ZD, Scotland.	m.abdelfattah@abdn.ac.uk		MacLennan, Graeme/0000-0002-1039-5646	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research.	Abdel-Fattah M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015111; Abdel-fattah M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000206; Abdel-Fattah M, 2011, EUR UROL, V60, P468, DOI 10.1016/j.eururo.2011.05.003; Abdel-fattah M, 2010, EUR J OBSTET GYN R B, V149, P106, DOI 10.1016/j.ejogrb.2009.11.023; Alexandridis V, 2019, INT UROGYNECOL J, V30, P1465, DOI 10.1007/s00192-019-04004-w; Cornu JN, 2012, INT UROGYNECOL J, V23, P1265, DOI 10.1007/s00192-012-1740-0; de Leval J, 2003, EUR UROL, V44, P724, DOI 10.1016/j.eururo.2003.09.003; Delorme E, 2001, PROG UROL, V11, P1306; Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3045; Karmakar D, 2017, BJOG-INT J OBSTET GY, V124, P973, DOI 10.1111/1471-0528.14561; Kim A, 2019, BJU INT, V123, P566, DOI 10.1111/bju.14447; Lee S., 2018, P ABSTRACTS 43 ANN M, V29, P266; Masata J, 2012, INT UROGYNECOL J, V23, P1403, DOI 10.1007/s00192-012-1662-x; Moldovan CP, 2015, INT J WOMENS HEALTH, V7, P227, DOI 10.2147/IJWH.S59265; Mostafa A, 2014, EUR UROL, V65, P402, DOI 10.1016/j.eururo.2013.08.032; Nambiar A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008709.pub2; NHS Digital, 2018, STAT SMOK ENGL 2018; Ogah J, 2011, NEUROUROL URODYNAM, V30, P284, DOI 10.1002/nau.20980; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; Sabadell J, 2017, INT UROGYNECOL J, V28, P1041, DOI 10.1007/s00192-016-3221-3; Schellart RP, 2018, INT UROGYNECOL J, V29, P37, DOI 10.1007/s00192-017-3362-z; Shah HN, 2012, INDIAN J UROL, V28, P129, DOI 10.4103/0970-1591.98453; Statacorp, 2017, STATA STAT SOFTWARE, DOI DOI 10.2307/2234838; Tincello DG, 2002, INT UROGYNECOL J PEL, V13, P96, DOI 10.1007/s001920200022; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Xin X, 2016, ARCH GYNECOL OBSTET, V293, P457, DOI 10.1007/s00404-015-3949-x; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	28	2	2	4	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1230	1243		10.1056/NEJMoa2111815	http://dx.doi.org/10.1056/NEJMoa2111815			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353961	Green Published			2022-12-28	WOS:000820666300007
J	Bollyky, TJ; Nuzzo, J; Huhn, N; Kiernan, S; Pond, E				Bollyky, Thomas J.; Nuzzo, Jennifer; Huhn, Noelle; Kiernan, Samantha; Pond, Emily			Global vaccination must be swifter	NATURE			English	Editorial Material						SARS-CoV-2; Vaccines; Diseases; Health care		Speeding up development of new vaccines won't help much in the next pandemic, unless world leaders work faster to roll out vaccination globally. Speeding up development of new vaccines won't help much in the next pandemic, unless world leaders work faster to roll out vaccination globally.	[Bollyky, Thomas J.] Council Foreign Relat, Global Hlth Program, Washington, DC 20006 USA; [Nuzzo, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Huhn, Noelle] Johns Hopkins Ctr Hlth Secur, Baltimore, MD USA; [Kiernan, Samantha] Council Foreign Relat, Washington, DC USA; [Pond, Emily] Johns Hopkins Coronavirus Resource Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bollyky, TJ (corresponding author), Council Foreign Relat, Global Hlth Program, Washington, DC 20006 USA.	tbollyky@cfr.org; jnuzzo1@jhu.edu						Andrews N, 2022, NEW ENGL J MED, V386, P340, DOI 10.1056/NEJMoa2115481; Barnes O, 2022, FINANC TIMES; Bollyky T.J., 2021, NAVIGATING WORLD COV; Center for Countering Digital Hate, 2020, ANT PLAYB; Center for Countering Digital Hate, 2021, DIS DOZ; Mancini D P, 2022, FINANC TIMES; Pandemic Preparedness Partnership, 2021, 100 DAYS MISS RESP F; US National Institute of Allergy and Infectious Diseases, 2021, NIAID PAND PREP PLAN	8	0	0	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					788	792		10.1038/d41586-022-00809-w	http://dx.doi.org/10.1038/d41586-022-00809-w			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0A4QE	35347298	Bronze			2022-12-28	WOS:000773940000002
J	Rearte, A; Castelli, JM; Rearte, R; Fuentes, N; Pennini, V; Pesce, M; Barbeira, PB; Iummato, LE; Laurora, M; Bartolomeu, ML; Galligani, G; Juarez, MD; Giovacchini, CM; Santoro, A; Esperatti, M; Tarragona, S; Vizzotti, C				Rearte, Analia; Manuel Castelli, Juan; Rearte, Ramiro; Fuentes, Nora; Pennini, Velen; Pesce, Martina; Barcena Barbeira, Pilar; Eva Iummato, Luciana; Laurora, Melisa; Lucia Bartolomeu, Maria; Galligani, Guido; Del Valle Juarez, Maria; Maria Giovacchini, Carlos; Santoro, Adrian; Esperatti, Mariano; Tarragona, Sonia; Vizzotti, Carla			Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study	LANCET			English	Article							EFFICACY	Background In January, 2021, a vaccination campaign against COVID-19 was initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina. The objective of this study was to estimate vaccine effectiveness at reducing risk of SARS-CoV-2 infection and COVID-19 deaths in people older than 60 years. Methods In this test-negative, case-control, and retrospective longitudinal study done in Argentina, we evaluated the effectiveness of three vaccines (rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV) on SARS-CoV-2 infection and risk of death in people with RT-PCR confirmed COVID-19, using data from the National Surveillance System (SNVS 2.0). All individuals aged 60 years or older reported to SNVS 2.0 as being suspected to have COVID-19 who had disease status confirmed with RT-PCR were included in the study. Unvaccinated individuals could participate in any of the analyses. People with suspected COVI D-19 who developed symptoms before the start of the implementation of the vaccination programme for their age group or district were excluded from the study. The odds ratio of SARS-CoV-2 infection was evaluated by logistic regression and the risk of death in individuals with RT-PCR confirmed COVID-19 was evaluated by proportional hazard regression models, adjusted for possible confounders: age at the time of the symptom onset date, sex, district of residence, epidemiological week corresponding to the symptom onset date, and history of COVID-19. The estimation of vaccine effectiveness to prevent death due to COVID-19 was done indirectly by combining infection and death estimates. In addition, we evaluated the effect of the first dose of viral vector vaccines across time. Findings From Jan 31, to Sept 14, 2021,1282928 individuals were induded, of whom 687167 (53.6%) were in the rAd26-rAd5 analysis, 358431 (27.6%) in the ChAdOx1 nCoV-19 analysis, and 237330 (18.5%) in the BBIBP-CorV analysis. Vaccine effectiveness after two doses was high for all three vaccines, adjusted odds ratio 0.36 (95% CI 0.35-0.37) for rAd26-rAd5, 0.32 (0.31-0.33) for ChAdOxi nCoV-19, and 0.56 (0.55-0.58) for BBIBP-CorV. After two doses, the effect on deaths was higher than that on risk of infection: adjusted hazard ratio 0.19 (95% CI 0.18-0.21) for rAd26-rAd5, 0.20 (0.18-0.22) for ChAdOxl nCoV-19, and 0.27 (0.25-0.29) for BBIBP-CorV. The indirectly estimated effectiveness on deaths was 93.1% (95% CI 92.6-93.5) for rAd26-rAd5, 93.7% (93.2-94.3) for ChAdOxi nCoV-19, and 85.0% (84-0-86.0) for BBIBP-CorV following two doses. First dose effect of viral vector vaccines remained stable over time. Interpretation The vaccines used in Argentina showed effectiveness in reducing infection and death by SARS-CoV-2 and COVID-19. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Rearte, Analia; Manuel Castelli, Juan; Pennini, Velen; Pesce, Martina; Barcena Barbeira, Pilar; Eva Iummato, Luciana; Laurora, Melisa; Lucia Bartolomeu, Maria; Galligani, Guido; Del Valle Juarez, Maria; Maria Giovacchini, Carlos; Santoro, Adrian; Tarragona, Sonia; Vizzotti, Carla] Minist Salud Nacion Argentina, C1073ABA, Buenos Aires, DF, Argentina; [Rearte, Ramiro] Univ Nacl La Plata, Fac Ciencias Vet, Buenos Aires, DF, Argentina; [Fuentes, Nora; Esperatti, Mariano] Univ Nacl Mar del Plata, Hosp Privado Comunidad, Escuela Super Med, Buenos Aires, DF, Argentina	National University of La Plata; National University of Mar del Plata	Rearte, A (corresponding author), Minist Salud Nacion Argentina, C1073ABA, Buenos Aires, DF, Argentina.	arearte@msal.gov.ar						Alencar CH, 2021, TROP MED INFECT DIS, V6, DOI 10.3390/tropicalmed6030129; AlHosani FI, 2022, VACCINE, V40, P2003, DOI 10.1016/j.vaccine.2022.02.039; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Bunn A, 2014, CROSSDATING DPLR; De Serres G, 2013, Euro Surveill, V18; Dean NE, 2021, NEW ENGL J MED, V385, P1431, DOI 10.1056/NEJMe2113151; Dean NE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat0360; Gonzalez S, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101126; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Lewnard JA, 2018, AM J EPIDEMIOL, V187, P2686, DOI 10.1093/aje/kwy163; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Masina L, 2021, MAL ADDS MOR COVID 1; McGill University, 2021, COVID 19 VACC TRACK; Ministerio-de-Salud, 2020, REC EQ SAL LAB; Ministerio-de-Salud, 2011, GUIA INV SAL HUM; Olliaro P, 2021, LANCET MICROBE, V2, pE279, DOI 10.1016/S2666-5247(21)00069-0; Ontario Ministry of Health, 2021, COVID 19 VACC STOR H; Paris C, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.06.043; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; VanderWeele TJ, 2008, EPIDEMIOLOGY, V19, P720, DOI 10.1097/EDE.0b013e3181810e29; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Voko Z, 2022, CLIN MICROBIOL INFEC, V28, P398, DOI 10.1016/j.cmi.2021.11.011; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	31	9	9	10	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1254	1264		10.1016/S0140-6736(22)00011-3	http://dx.doi.org/10.1016/S0140-6736(22)00011-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I5XZ	35303473	Green Published, Bronze			2022-12-28	WOS:000779495000022
J	Adhikari, EH; MacDonald, L; SoRelle, JA; Morse, J; Pruszynski, J; Spong, CY				Adhikari, Emily H.; MacDonald, Lorre; SoRelle, Jeffrey A.; Morse, Jessica; Pruszynski, Jessica; Spong, Catherine Y.			COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter; Early Access								This study examines infections, illness severity, vaccinations, and early neonatal infections among obstetric patients during the pre-Delta, Delta, and Omicron periods of the COVID-19 pandemic.	[Adhikari, Emily H.; Pruszynski, Jessica; Spong, Catherine Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [MacDonald, Lorre] Parkland Hlth, Dallas, TX USA; [SoRelle, Jeffrey A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Morse, Jessica] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Adhikari, EH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	emily.adhikari@utsouthwestern.edu			American Heart Association; Doris Duke Charitable Foundation; Harry S. Moss Heart Trust; Once Upon a Time Foundation Next Generation Sequencing Lab; Centers for Disease Control and Prevention [NU50CK000501]	American Heart Association(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Harry S. Moss Heart Trust; Once Upon a Time Foundation Next Generation Sequencing Lab; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for investigator and statistical effort, infrastructure, and sequencing effort was provided by the American Heart Association, the Doris Duke Charitable Foundation, the Harry S. Moss Heart Trust, the Once Upon a Time Foundation Next Generation Sequencing Lab, and the Centers for Disease Control and Prevention (grant NU50CK000501).	Addetia A, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02226-20; Adhikari EH, 2022, AM J OBSTET GYNECOL, V226, P149, DOI 10.1016/j.ajog.2021.09.008; Gale C, 2021, LANCET CHILD ADOLESC, V5, P113, DOI 10.1016/S2352-4642(20)30342-4; Hui KPY, 2022, NATURE, V603, P715, DOI 10.1038/s41586-022-04479-6; Iuliano AD, 2022, MMWR-MORBID MORTAL W, V71, P146, DOI [10.1101/2021.12.30.21268560v2, 10.15585/mmwr.mm7104e4]; Society for Maternal-Fetal Medicine, MAN CONS PREG PAT CO	6	13	14	10	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.4356	http://dx.doi.org/10.1001/jama.2022.4356		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ0TD	35325015	Green Published, Bronze			2022-12-28	WOS:000772988500002
J	Guan, XN; Polesso, F; Wang, CJ; Sehrawat, A; Hawkins, RM; Murray, SE; Thomas, GV; Caruso, B; Thompson, RF; Wood, MA; Hipfinger, C; Hammond, SA; Graff, JN; Xia, Z; Moran, AE				Guan, Xiangnan; Polesso, Fanny; Wang, Chaojie; Sehrawat, Archana; Hawkins, Reed M.; Murray, Susan E.; Thomas, George, V; Caruso, Breanna; Thompson, Reid F.; Wood, Mary A.; Hipfinger, Christina; Hammond, Scott A.; Graff, Julie N.; Xia, Zheng; Moran, Amy E.			Androgen receptor activity in T cells limits checkpoint blockade efficacy	NATURE			English	Article							RESISTANT PROSTATE-CANCER; CTLA-4 BLOCKADE; PD-1 BLOCKADE; DOUBLE-BLIND; SEX; EXPRESSION; IPILIMUMAB; IMMUNOTHERAPY; MAINTAINS; RESPONSES	Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-tumour immunity in solid tumours. In patients with advanced prostate cancer, immunotherapy treatments have largely failed(1-5). Androgen deprivation therapy is classically administered in these patients to inhibit tumour cell growth, and we postulated that this therapy also affects tumour-associated T cells. Here we demonstrate that androgen receptor (AR) blockade sensitizes tumour-bearing hosts to effective checkpoint blockade by directly enhancing CD8 T cell function. Inhibition of AR activity in CD8 T cells prevented T cell exhaustion and improved responsiveness to PD-1 targeted therapy via increased IFN gamma expression. AR bound directly to Ifng and eviction of AR with a small molecule significantly increased cytokine production in CD8 T cells. Together, our findings establish that T cell intrinsic AR activity represses IFN gamma expression and represents a novel mechanism of immunotherapy resistance.	[Guan, Xiangnan; Thompson, Reid F.; Xia, Zheng] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR USA; [Guan, Xiangnan; Murray, Susan E.; Xia, Zheng] Oregon Hlth & Sci Univ, Mol Microbiol & Immunol, Portland, OR USA; [Polesso, Fanny; Wang, Chaojie; Sehrawat, Archana; Hawkins, Reed M.; Caruso, Breanna; Hipfinger, Christina; Moran, Amy E.] Oregon Hlth & Sci Univ, Cell Dev & Canc Biol, Portland, OR 97201 USA; [Murray, Susan E.] Univ Portland, Dept Biol, Portland, OR USA; [Thomas, George, V; Thompson, Reid F.; Graff, Julie N.; Xia, Zheng; Moran, Amy E.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Thomas, George, V] Oregon Hlth & Sci Univ, Dept Pathol & Lab Med, Portland, OR USA; [Thompson, Reid F.] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR USA; [Thompson, Reid F.; Wood, Mary A.; Graff, Julie N.] VA Portland Hlth Care Syst, Portland, OR USA; [Hammond, Scott A.] AstraZeneca, Oncol R&D, Crin IO Discovery, Gaithersburg, MD USA; [Guan, Xiangnan] Genentech Inc, San Francisco, CA 94080 USA; [Wang, Chaojie] Bristol Myers Squibb, New Brunswick, NJ USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Portland; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; AstraZeneca; Roche Holding; Genentech; Bristol-Myers Squibb	Moran, AE (corresponding author), Oregon Hlth & Sci Univ, Cell Dev & Canc Biol, Portland, OR 97201 USA.; Moran, AE (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	moranam@ohsu.edu		Caruso, Breanna/0000-0002-1519-8131; Murray, Susan/0000-0002-6470-3827; Thomas, George V/0000-0001-7416-8840	Collins Medical Trust; OHSU Foundation; Prostate Cancer Foundation; Pacific Northwest Prostate Cancer SPORE NCI [5P50CA097186]; NIH [1R37 CA263592-01, 5K01LM012877, 1R21HL145426]; M.J. Murdock Charitable Trust [NS-201812034]; MedImmune; Medical Research Foundation at Oregon; Massively Parallel Sequencing Shared Resource (MPSSR)	Collins Medical Trust; OHSU Foundation; Prostate Cancer Foundation; Pacific Northwest Prostate Cancer SPORE NCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust; MedImmune(AstraZenecaMedimmune); Medical Research Foundation at Oregon; Massively Parallel Sequencing Shared Resource (MPSSR)	We thank A. Adey and R. Searle for sharing expertise as we developed protocols for single-cell RNA-seq. We are grateful to the OHSU Department of Comparative Medicine for outstanding animal husbandry, the Massively Parallel Sequencing Shared Resource (MPSSR) for their support, and the Knight Cancer Institute Prostate Programs outstanding clinical research team. This work is funded in part by the Collins Medical Trust, OHSU Foundation, Prostate Cancer Foundation, Pacific Northwest Prostate Cancer SPORE NCI 5P50CA097186, NIH 1R37 CA263592-01 (to A.E.M.), M.J. Murdock Charitable Trust NS-201812034 (to S.E.M.), and a sponsored research agreement with MedImmune (to A.E.M.). This work is also supported by Medical Research Foundation at Oregon, NIH 5K01LM012877 and NIH 1R21HL145426 (to Z.X.). The resources of the Exacloud high performance computing environment developed jointly by OHSU and Intel and the technical support of the OHSU Advanced Computing Center are gratefully acknowledged. BioRender.com software was used for the creation of some figures.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Antonarakis ES, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01638; ASHLEY DJB, 1969, BRIT J CANCER, V23, P313, DOI 10.1038/bjc.1969.41; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bebo BF, 1999, J IMMUNOL, V162, P35; Beer TM, 2017, J CLIN ONCOL, V35, P40, DOI 10.1200/JCO.2016.69.1584; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Bishop JL, 2015, ONCOTARGET, V6, P234, DOI 10.18632/oncotarget.2703; Bupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01269; Cartwright RA, 2002, BRIT J HAEMATOL, V118, P1071, DOI 10.1046/j.1365-2141.2002.03750.x; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; FONG PCC, 2019, J CLIN ONCOL, V37; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Graff JN, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000642; Graff JN, 2016, ONCOTARGET, V7, P52810, DOI 10.18632/oncotarget.10547; Gruner BM, 2016, NAT METHODS, V13, P883, DOI 10.1038/nmeth.3992; He MX, 2021, NAT MED, V27, P426, DOI 10.1038/s41591-021-01244-6; Higano CS, 2019, CANCER-AM CANCER SOC, V125, P4172, DOI 10.1002/cncr.32445; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hwang SS, 2020, SCIENCE, V367, P1255, DOI 10.1126/science.aax0194; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin AA, 2010, J NEUROIMMUNOL, V226, P8, DOI 10.1016/j.jneuroim.2010.05.026; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Moran AE, 2016, J IMMUNOL, V197, P2509, DOI 10.4049/jimmunol.1502659; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Murray SE, 2017, J EXP MED, V214, P1889, DOI 10.1084/jem.20161988; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Nussing S, 2020, J IMMUNOL, V204, P2308, DOI 10.4049/jimmunol.1901396; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pavese J, 2013, JOVE-J VIS EXP, DOI 10.3791/50873; Pernigoni N, 2021, SCIENCE, V374, P216, DOI 10.1126/science.abf8403; Polesso F, 2021, EUR J IMMUNOL, V51, P1473, DOI 10.1002/eji.202048960; Polesso F, 2019, J IMMUNOL, V203, P2011, DOI 10.4049/jimmunol.1900696; Polesso F, 2019, CANCER IMMUNOL RES, V7, P269, DOI 10.1158/2326-6066.CIR-18-0222; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Rayford W, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02140-y; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schofield DJ, 2021, MABS-AUSTIN, V13, DOI 10.1080/19420862.2020.1857100; Sharma P, 2020, CANCER CELL, V38, P489, DOI 10.1016/j.ccell.2020.08.007; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valkenburg KC, 2016, JOVE-J VIS EXP, DOI 10.3791/53984; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Walecki M, 2015, MOL BIOL CELL, V26, P2845, DOI 10.1091/mbc.E14-08-1323; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Zediak VP, 2011, J IMMUNOL, V186, P2705, DOI 10.4049/jimmunol.1003741	69	29	29	39	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2022	606	7915					791	+		10.1038/s41586-022-04522-6	http://dx.doi.org/10.1038/s41586-022-04522-6		MAR 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J7WG	35322234				2022-12-28	WOS:000772363100002
J	Larkin, H				Larkin, Howard			Medical News & Perspectives Treating Epilepsy With Antiseizure Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2022	327	16					1537	1537		10.1001/jama.2022.4599	http://dx.doi.org/10.1001/jama.2022.4599			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0W7TZ	35380577				2022-12-28	WOS:000789226500010
J	Liang, CS; Tseng, PT; Su, KP				Liang, Chih-Sung; Tseng, Ping-Tao; Su, Kuan-Pin			Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Liang, Chih-Sung] Triserv Gen Hosp, Beitou Branch, Taipei, Taiwan; [Tseng, Ping-Tao] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Su, Kuan-Pin] China Med Univ, An Nan Hosp, Tainan, Taiwan	Tri-Service General Hospital; National Sun Yat Sen University; China Medical University Taiwan	Tseng, PT (corresponding author), Prospect Clin Otorhinolaryngol & Neurol, 252 Nanzixin Rd, Kaohsiung 81166, Taiwan.	ducktseng@gmail.com	Su, Kuan-Pin/P-5284-2015	Su, Kuan-Pin/0000-0002-4501-2502				Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; Guu TW, 2019, PSYCHOTHER PSYCHOSOM, V88, P263, DOI [10.1159/000502652, 10.1159/000504232]; Lin PY, 2012, MOL PSYCHIATR, V17, P1161, DOI 10.1038/mp.2012.111; Okereke OI, 2021, JAMA-J AM MED ASSOC, V326, P2385, DOI 10.1001/jama.2021.21187; Zenebe Y, 2021, ANN GEN PSYCHIATR, V20, DOI 10.1186/s12991-021-00375-x	5	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13								10.1001/jama.2022.2030	http://dx.doi.org/10.1001/jama.2022.2030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380588				2022-12-28	WOS:000783965500026
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Hospital admissions continue to climb amid record infection rates	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, CORONAVIRUS COVID 19; NHS England, 2022, WEEKL ADM BEDS 1 OCT; NHS England, 2022, CRIT CARE GEN AC BED; Office for National Statistics, 2022, COR COV 19 INF SURV	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								o882	10.1136/bmj.o882	http://dx.doi.org/10.1136/bmj.o882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N8UW	35379674	Bronze			2022-12-28	WOS:000783107700004
J	Balbus, JM; McCannon, CJ; Mataka, A; Levine, RL				Balbus, John M.; McCannon, C. Joseph; Mataka, Arsenio; Levine, Rachel L.			After COP26-Putting Health and Equity at the Center of the Climate Movement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								After COP26The Department of Health and Human Services has made commitments to climate-change resilience in U.S. communities and decarbonization in our health systems, but myriad public and private organizations will have to be mobilized to achieve these goals.	[Balbus, John M.] Off Climate Change & Hlth Equ, Washington, DC 20201 USA; [Mataka, Arsenio; Levine, Rachel L.] Off Assistant Secretary Hlth, Dept Hlth & Human Serv, Washington, DC USA; [McCannon, C. Joseph] Agcy Healthcare Res & Qual, Rockville, MD 20857 USA	Agency for Healthcare Research & Quality	Balbus, JM (corresponding author), Off Climate Change & Hlth Equ, Washington, DC 20201 USA.							Atwoli L, 2021, LANCET, V398, P939, DOI 10.1016/S0140-6736(21)01915-2; Eckelman MJ, 2020, HEALTH AFFAIR, V39, P2071, DOI 10.1377/hlthaff.2020.01247; Office of the Press Secretary, 2021, PRES BID SIGNS EX OR; World Health Organization (WHO), 2021, COUNTR COMM DEV CLIM	4	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2118259	http://dx.doi.org/10.1056/NEJMp2118259		APR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0V1GZ	35363451	Bronze			2022-12-28	WOS:000788094900001
J	Howard, S				Howard, Sally			Poland's buckling healthcare system nevertheless welcomes Ukraine refugees with open arms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						Harlan C, 2022, WASHINGTON POST 0309; Kosc W., 2021, POLISH HOSP SHUTTING; Ministry of the Interior and Administration, 2022, PROC ASS PESEL NUMB; OECD European Observatory on Health Systems and Policies, 2017, STAT HLTH EU POL; Philippine Senate, 2022, LEN KIK FIGHT PH TER; UNHCR/The UN Refugee Agency, 2022, POL WELC MOR 2 MILL	6	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o844	10.1136/bmj.o844	http://dx.doi.org/10.1136/bmj.o844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365477	Bronze			2022-12-28	WOS:000783141700013
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... jet pack paramedics	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Great North Air Ambulance Service, 2022, GNAAS PARTN REN EN L	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o876	10.1136/bmj.o876	http://dx.doi.org/10.1136/bmj.o876			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365479				2022-12-28	WOS:000783141700005
J	Kohno, K; Shirasaka, R; Yoshihara, K; Mikuriya, S; Tanaka, K; Takanami, K; Inoue, K; Sakamoto, H; Ohkawa, Y; Masuda, T; Tsuda, M				Kohno, Keita; Shirasaka, Ryoji; Yoshihara, Kohei; Mikuriya, Satsuki; Tanaka, Kaori; Takanami, Keiko; Inoue, Kazuhide; Sakamoto, Hirotaka; Ohkawa, Yasuyuki; Masuda, Takahiro; Tsuda, Makoto			A spinal microglia population involved in remitting and relapsing neuropathic pain	SCIENCE			English	Article							GROWTH-FACTOR-I; DENDRITIC CELLS; CHOROID-PLEXUS; BRAIN; MICE; MENINGES; SYSTEM	Neuropathic pain is often caused by injury and diseases that affect the somatosensory system. Although pain development has been well studied, pain recovery mechanisms remain largely unknown. Here, we found that CD11c-expressing spinal microglia appear after the development of behavioral pain hypersensitivity following nerve injury. Nerve-injured mice with spinal CD11c(+) microglial depletion failed to recover spontaneously from this hypersensitivity. CD11c(+) microglia expressed insulin-like growth factor-1 (IGF1), and interference with IGF1 signaling recapitulated the impairment in pain recovery. In pain-recovered mice, the depletion of CD11c(+) microglia or the interruption of IGF1 signaling resulted in a relapse in pain hypersensitivity. Our findings reveal a mechanism for the remission and recurrence of neuropathic pain, providing potential targets for therapeutic strategies.	[Kohno, Keita; Mikuriya, Satsuki; Masuda, Takahiro; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Japan; [Kohno, Keita; Shirasaka, Ryoji; Yoshihara, Kohei; Masuda, Takahiro; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka, Japan; [Tanaka, Kaori; Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Takanami, Keiko; Sakamoto, Hirotaka] Okayama Univ, Grad Sch Nat Sci & Technol, Ushimado Marine Inst, Setouchi, Japan; [Takanami, Keiko] Natl Inst Genet, Mouse Genom Resources Lab, Shizuoka, Japan; [Inoue, Kazuhide] Kyushu Univ, Inst Adv Study, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Okayama University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyushu University	Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Japan.; Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka, Japan.	tsuda@phar.kyushu-u.ac.jp	Masuda, Takahiro/AAY-6719-2021; Ohkawa, Yasuyuki/C-4087-2016	Masuda, Takahiro/0000-0003-3687-452X; Sakamoto, Hirotaka/0000-0002-6224-4591; Kohno, Keita/0000-0001-5038-5680; Mikuriya, Satsuki/0000-0003-4980-968X; Takanami, Keiko/0000-0002-5462-1182; Shirasaka, Ryoji/0000-0002-6139-3587; Ohkawa, Yasuyuki/0000-0001-6440-9954	Japanese Society for the Promotion of Science (JSPS KAKENHI) [JP19H05658, JP20H05900, JP20K22687, JP21H02752, JP21H00204, JP16H06280]; Japan Science and Technology Agency [JST Moonshot RD] [JPMJMS2024, JP21gm0910006]; AMED [JP20gm6310016 AMED-PRIME JP21wm0425001]; Platform Project for Supporting Drug Discovery and Life Science Research (BINDS AMED) [JP21am0101091]; Shionogi Co., Ltd.	Japanese Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency [JST Moonshot RD]; AMED; Platform Project for Supporting Drug Discovery and Life Science Research (BINDS AMED); Shionogi Co., Ltd.	This work was supported by the Japanese Society for the Promotion of Science (JSPS KAKENHI grants JP19H05658 and JP20H05900 to M.T.; JP20K22687, JP21H02752, and JP21H00204 to T.M.; and JP16H06280 to H.S.); the Japan Science and Technology Agency [JST Moonshot R&D grant JPMJMS2024 to M.T. and a Grant-in-Aid for Scientific Research on Innovative Areas -Platforms for Advanced Technologies and Research Resources "Advanced Bioimaging Support (ABiS)" to H.S.]; CREST (AMED grant JP21gm0910006 to M.T.; AMED grant JP20gm6310016 AMED-PRIME JP21wm0425001 to T.M.); the Platform Project for Supporting Drug Discovery and Life Science Research (BINDS AMED grant JP21am0101091 to M.T.); and by an academic research grant from Shionogi & Co., Ltd.	Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Benmamar-Badel A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00430; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2018, NEURON, V100, P1292, DOI 10.1016/j.neuron.2018.11.009; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Hwang DH, 2014, J NEUROSCI, V34, P12788, DOI 10.1523/JNEUROSCI.5359-13.2014; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Inoue K, 2018, NAT REV NEUROSCI, V19, P138, DOI 10.1038/nrn.2018.2; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kohno K, 2018, BIOL PHARM BULL, V41, P1096, DOI 10.1248/bpb.b18-00278; Kohro Y, 2020, NAT NEUROSCI, V23, P1376, DOI 10.1038/s41593-020-00713-4; Kohro Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14306; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00365; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Liu YY, 2017, NEURON, V95, P817, DOI 10.1016/j.neuron.2017.07.037; Llewellyn-Smith IJ, 2000, J NEUROSCI METH, V103, P83, DOI 10.1016/S0165-0270(00)00298-3; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; Masuda T, 2020, NAT IMMUNOL, V21, P802, DOI 10.1038/s41590-020-0707-4; Masuda T, 2020, CELL REP, V30, P1271, DOI 10.1016/j.celrep.2020.01.010; Masuda T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12529; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peng JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12029; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Pristera A, 2019, P NATL ACAD SCI USA, V116, P3817, DOI 10.1073/pnas.1806820116; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; SHEADS LD, 1977, J NEUROBIOL, V8, P67, DOI 10.1002/neu.480080106; Shiraishi Y, 2021, MOL BRAIN, V14, DOI 10.1186/s13041-021-00768-9; Stratoulias V, 2019, EMBO J, V38, DOI 10.15252/embj.2019101997; Tarpley JW, 2004, BRAIN RES, V1029, P65, DOI 10.1016/j.brainres.2004.09.027; Tashima R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23701; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Wlodarczyk A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00463	43	14	14	19	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		86	+		10.1126/science.abf6805	http://dx.doi.org/10.1126/science.abf6805			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357926				2022-12-28	WOS:000780195200032
J	Saul, H; Gursul, D; Cassidy, S; Hinks, T				Saul, Helen; Gursul, Deniz; Cassidy, Samantha; Hinks, Timothy			Combination inhaler is effective in mild asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								as required for adults or children with mild asthma: Why was the study needed? Between 45% and 70% of people with asthma have mild disease, such as wheezing, breathlessness, coughing, and a tight feeling in the chest. To relieve symptoms, most people use inhalers that contain fast acting beta agonists. They are also prescribed a second inhaler containing a steroid which, when taken regularly, reduces inflammation in the airways. Inhaled steroids are associated with side effects such as an increased risk of osteoporosis, diabetes, and mood or sleep disorders. People may be reluctant to take the steroids, and many are tempted to rely on just their reliever medication. However, their symptoms can get worse when they don't use steroid inhalers regularly. This increases their risk of asthma attacks.	[Saul, Helen; Gursul, Deniz; Cassidy, Samantha] NIHR Ctr Engagement & Disseminat, Twickenham, England; [Hinks, Timothy] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						Global Strategy for Asthma Management and Prevention, 2021 UPDATE GLOBAL I; Royal College of Physicians, WHY ASTHMA STILL KIL	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o663	10.1136/bmj.o663	http://dx.doi.org/10.1136/bmj.o663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346973				2022-12-28	WOS:000778641000003
J	Chen, X; Qin, HC; Qian, XS; Zhu, WY; Li, B; Zhang, B; Lu, WC; Li, RP; Zhang, SH; Zhu, L; Dos Santos, FD; Bernholc, J; Zhang, QM				Chen, Xin; Qin, Hancheng; Qian, Xiaoshi; Zhu, Wenyi; Li, Bo; Zhang, Bing; Lu, Wenchang; Li, Ruipeng; Zhang, Shihai; Zhu, Lei; Dos Santos, Fabrice Domingues; Bernholc, J.; Zhang, Q. M.			Relaxor ferroelectric polymer exhibits ultrahigh electromechanical coupling at low electric field	SCIENCE			English	Article							VINYLIDENE FLUORIDE; PIEZOELECTRIC PROPERTIES; BEHAVIOR; ELECTROSTRICTION; DEPENDENCE; FILMS	Electromechanical (EM) coupling-the conversion of energy between electric and mechanical forms-in ferroelectrics has been used for a broad range of applications. Ferroelectric polymers have weak EM coupling that severely limits their usefulness for applications. We introduced a small amount of fluorinated alkyne (FA) monomers (<2 mol %) in relaxor ferroelectric poly(vinylidene fluoridetrifluoroethylene-chlorofluoroethylene) (PVDF-TrFE-CFE) terpolymer that markedly enhances the polarization change with strong EM coupling while suppressing other polarization changes that do not contribute to it. Under a low-dc bias field of 40 megavolts per meter, the relaxor tetrapolymer has an EM coupling factor (k(33)) of 88% and a piezoelectric coefficient (d(33)) >1000 picometers per volt. These values make this solution-processed polymer competitive with ceramic oxide piezoelectrics, with the potential for use in distinct applications.	[Chen, Xin; Zhang, Q. M.] Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Qin, Hancheng; Zhang, Bing; Lu, Wenchang; Bernholc, J.] North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Qian, Xiaoshi] Shanghai Jiao Tong Univ, Interdisciplinary Res Ctr Metamat & Intelligent S, State Key Lab Mech Syst & Vibrat, Shanghai, Peoples R China; [Qian, Xiaoshi] Shanghai Jiao Tong Univ, MOE Key Lab Power Machinery & Engn, Sch Mech Engn, Shanghai, Peoples R China; [Zhu, Wenyi; Zhang, Q. M.] Penn State Univ, Sch Elect Engn & Comp Sci, Mat Res Inst, University Pk, PA 16802 USA; [Li, Bo; Zhang, Shihai] PolyK Technol, State Coll, PA 16801 USA; [Li, Ruipeng] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Zhu, Lei] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Dos Santos, Fabrice Domingues] Arkema Piezotech, F-92700 Colombes, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; North Carolina State University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Brookhaven National Laboratory; Case Western Reserve University	Zhang, QM (corresponding author), Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, University Pk, PA 16802 USA.; Zhang, QM (corresponding author), Penn State Univ, Sch Elect Engn & Comp Sci, Mat Res Inst, University Pk, PA 16802 USA.	qxz1@psu.edu	Zhu, Lei/C-8754-2013; Chen, Xin/H-1238-2013	Zhu, Lei/0000-0001-6570-9123; Lu, Wenchang/0000-0002-3105-0014; Qin, Hancheng/0000-0003-0146-8206; Chen, Xin/0000-0001-8213-4704; Bernholc, Jerzy/0000-0002-9981-8851; zhu, wenyi/0000-0003-2356-3159; Li, Bo/0000-0002-4890-8435	US Office of Naval Research [N00014-19-1-2028]; NCSU [N00014-19-1-2033]; National Science Foundation [DMR-2103196]; National Natural Science Foundation of China [52076127]; DOE [DE-AC05-00OR22725]; US DOE User Facility operated by BNL [DE-SC0012704]	US Office of Naval Research(Office of Naval Research); NCSU; National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DOE(United States Department of Energy (DOE)); US DOE User Facility operated by BNL(United States Department of Energy (DOE))	This research is supported by the US Office of Naval Research under award no. N00014-19-1-2028 at Penn State (X.C., W.Z. and Q.M.Z.) and by N00014-19-1-2033 at NCSU (H.Q., B.Z., W.L., and J.B.). L.Z. acknowledges financial support from the National Science Foundation (DMR-2103196). X.Q. acknowledges financial support from National Natural Science Foundation of China (52076127). The calculations were performed at Oak Ridge Leadership Computing Facility, supported by DOE contract DE-AC05-00OR22725. The SAXS used the 11-BM CMS beamline of National Synchrotron Light Source II (NSLS-II), Brookhaven National Laboratory (BNL), a US DOE User Facility operated by BNL under contract DE-SC0012704.	[Anonymous], 1988, 1761987 ANSIIEEE, DOI 10.1109/IEEESTD.1988.796380_1.1988; Bengtsson L, 1999, PHYS REV B, V59, P12301, DOI 10.1103/PhysRevB.59.12301; Bobnar V, 1999, EUROPHYS LETT, V48, P326, DOI 10.1209/epl/i1999-00549-4; Chen X, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5048599; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Damjanovic D., 1992, Journal of Intelligent Material Systems and Structures, V3, P190, DOI 10.1177/1045389X9200300201; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Full R.J., 2004, ELECTROACTIVE POLYM, P74, DOI [10.1117/3.547465., DOI 10.1117/3.547465]; FURUKAWA T, 1990, JPN J APPL PHYS 1, V29, P675, DOI 10.1143/JJAP.29.675; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; GUY IL, 1988, APPL PHYS LETT, V52, P532, DOI 10.1063/1.99407; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Katsouras I, 2016, NAT MATER, V15, P78, DOI [10.1038/NMAT4423, 10.1038/nmat4423]; KEPLER RG, 1982, PHYS REV LETT, V48, P1274, DOI 10.1103/PhysRevLett.48.1274; Klein RJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1882769; Li F, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4861260; Liu Y, 2020, NAT MATER, V19, P1169, DOI 10.1038/s41563-020-0724-6; Liu Y, 2018, NATURE, V562, P96, DOI 10.1038/s41586-018-0550-z; LOVINGER AJ, 1982, MACROMOLECULES, V15, P323, DOI 10.1021/ma00230a024; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Ma RJ, 2017, SCIENCE, V357, P1130, DOI 10.1126/science.aan5980; Nalwa H.S., 1995, FERROELECTRIC POLYM; Omote K, 1997, J APPL PHYS, V81, P2760, DOI 10.1063/1.364300; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Prandini G, 2018, NPJ COMPUT MATER, V4, DOI 10.1038/s41524-018-0127-2; Ranjan V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087802; Su J, 1998, REV SCI INSTRUM, V69, P2480, DOI 10.1063/1.1148947; Thonhauser T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125112; Uchino K., 2018, FERROELECTRIC DEVICE; WANG H, 1993, J APPL PHYS, V74, P3394, DOI 10.1063/1.354566; Wongwirat T, 2020, MACROMOLECULES, V53, P10942, DOI 10.1021/acs.macromol.0c02083; Wu YC, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aax1594; Xia F, 2002, ADV MATER, V14, P1574, DOI 10.1002/1521-4095(20021104)14:21<1574::AID-ADMA1574>3.0.CO;2-#; Yang LY, 2013, POLYMER, V54, P1709, DOI 10.1016/j.polymer.2013.01.035; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; Zhang ZC, 2019, J MATER CHEM A, V7, P5201, DOI 10.1039/c8ta11938d	37	14	14	113	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1418	+		10.1126/science.abn0936	http://dx.doi.org/10.1126/science.abn0936			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324308				2022-12-28	WOS:000778894800045
J	Finn, CA; Bedrosian, PA; Holbrook, WS; Auken, E; Bloss, BR; Crosbie, J				Finn, Carol A.; Bedrosian, Paul A.; Holbrook, W. Steven; Auken, Esben; Bloss, Benjamin R.; Crosbie, Jade			Geophysical imaging of the Yellowstone hydrothermal plumbing system	NATURE			English	Article							TAUPO VOLCANIC ZONE; LATERALLY CONSTRAINED INVERSION; NATIONAL-PARK; ELECTRICAL-RESISTIVITY; MAGNETIC-ANOMALIES; GEOTHERMAL SYSTEM; GEYSER BASIN; TEMPERATURE; RESOLUTION; SURFACE	The nature of Yellowstone National Park's plumbing system linking deep thermal fluids to its legendary thermal features is virtually unknown. The prevailing concepts of Yellowstone hydrology and chemistry are that fluids reside in reservoirs with unknown geometries, flow laterally from distal sources and emerge at the edges of lava flows(1-)(4). Here we present a high-resolution synoptic view of pathways of the Yellowstone hydrothermal system derived from electrical resistivity and magnetic susceptibility models of airborne geophysical data(5,6). Groundwater and thermal fluids containing appreciable total dissolved solids significantly reduce resistivities of porous volcanic rocks and are differentiated by their resistivity signatures(7). Clay sequences mapped in thermal areas(8,9) and boreholes(10) typically form at depths of less than 1,000 metres over fault-controlled thermal fluid and/orgas conduits(11,14). We showthat most thermal features are located above high-flux conduits along buried faults capped with clay that has low resistivity and low susceptibility. Shallow subhorizontal pathways feed groundwater into basins that mixes with thermal fluids from vertical conduits. These mixed fluids emerge at the surface, controlled by surficial permeability, and flow outwards along deeper brecciated layers. These outflows, continuing between the geyser basins, mix with local groundwater and thermal fluids to produce the observed geochemical signatures. Our high-fidelity images inform geochemical and groundwater models for hydrothermal systems worldwide.	[Finn, Carol A.; Bedrosian, Paul A.; Bloss, Benjamin R.; Crosbie, Jade] US Geol Survey, Box 25046, Denver, CO 80225 USA; [Holbrook, W. Steven] Virginia Tech, Blacksburg, VA USA; [Auken, Esben] Aarhus Univ, Aarhus, Denmark	United States Department of the Interior; United States Geological Survey; Virginia Polytechnic Institute & State University; Aarhus University	Finn, CA (corresponding author), US Geol Survey, Box 25046, Denver, CO 80225 USA.	cfinn@usgs.gov	Auken, Esben/G-8036-2012	Auken, Esben/0000-0002-5397-4832; Crosbie, Jade/0000-0002-2724-1264; Finn, Carol/0000-0002-6178-0405	University of Wyoming Office of Research and Economic Development; NSF [EPS-1208909]; US Geological Survey Mineral and Energy Resources Program; US Geological Survey Volcanic Hazards Program	University of Wyoming Office of Research and Economic Development; NSF(National Science Foundation (NSF)); US Geological Survey Mineral and Energy Resources Program; US Geological Survey Volcanic Hazards Program	We thank B. Minsley for generating Extended Data Fig. 1 and S. Hurwitz and P. Gardner for suggestions that improved this paper. This work was supported by the US Geological Survey Mineral and Energy Resources and Volcanic Hazards Programs, NSF grant no. EPS-1208909 and the University of Wyoming Office of Research and Economic Development. This work was carried out when one of the co-authors, E.A., was a professor in geophysics at Aarhus University. Any use of trade, firm or product names is for descriptive purposes and does not imply endorsement by the US Government.	ALLIS RG, 1990, J GEOCHEM EXPLOR, V36, P339, DOI 10.1016/0375-6742(90)90060-N; Archie GE, 1942, T AM I MIN MET ENG, V146, P54, DOI 10.2118/942054-G; Auken E, 2005, GEOPHYS PROSPECT, V53, P497, DOI 10.1111/j.1365-2478.2005.00486.x; Auken E, 2008, J APPL GEOPHYS, V65, P10, DOI 10.1016/j.jappgeo.2008.03.003; Auken E, 2015, EXPLOR GEOPHYS, V46, P223, DOI 10.1071/EG13097; BARGAR KE, 1981, AM MINERAL, V66, P473; Bargar KE., 1984, GEOL SURV PROF PAPER, V1054-B, pB1; Bedrosian P, 2016, AIRBORNE ELECTROMAGN, DOI [10.5066/P9LVAU7W (2021, DOI 10.5066/P9LVAU7W(2021]; BHATTACHARYYA BK, 1975, J GEOPHYS RES, V80, P4461, DOI 10.1029/JB080i032p04461; Bibby H. M., 1992, Geothermics, V21, P43, DOI 10.1016/0375-6505(92)90067-J; BIBBY HM, 1995, J VOLCANOL GEOTH RES, V68, P29, DOI 10.1016/0377-0273(95)00007-H; Bouligand C, 2020, J GEOPHYS RES-SOL EA, V125, DOI 10.1029/2020JB019743; Bouligand C, 2019, J GEOPHYS RES-SOL EA, V124, P291, DOI 10.1029/2018JB016202; Bouligand C, 2014, J GEOPHYS RES-SOL EA, V119, P2595, DOI 10.1002/2013JB010802; Christensen NB, 2014, GEOPHYSICS, V79, pE167, DOI 10.1190/GEO2013-0364.1; Christiansen AV, 2012, GEOPHYSICS, V77, pWB171, DOI [10.1190/geo2011-0393.1, 10.1190/GEO2011-0393.1]; Christiansen RL, 2001, GEOL SURV PROF PAPER, V729-G, pG1; Cordell L., 1985, UTILITY REGIONAL GRA, P181, DOI [10.1190/1.0931830346.ch16, DOI 10.1190/1.0931830346.CH16]; Dickey K. A., 2018, GEOPHYS INVESTIGATIO; Dobson PF, 2003, J VOLCANOL GEOTH RES, V123, P313, DOI 10.1016/S0377-0273(03)00039-8; Farrell J, 2014, GEOPHYS RES LETT, V41, P3068, DOI 10.1002/2014GL059588; Farrell J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044605; Farrell J, 2009, J VOLCANOL GEOTH RES, V188, P260, DOI 10.1016/j.jvolgeores.2009.08.008; Finn C. A., AIRBORNE ELECTROMAGN, DOI [10.5066/P9MCJ9B6 (2021, DOI 10.5066/P9MCJ9B6(2021]; Finn CA, 2002, J VOLCANOL GEOTH RES, V115, P207, DOI 10.1016/S0377-0273(01)00317-1; Finn CA, 2018, J VOLCANOL GEOTH RES, V357, P261, DOI 10.1016/j.jvolgeores.2018.04.013; FOURNIER RO, 1989, ANNU REV EARTH PL SC, V17, P13, DOI 10.1146/annurev.ea.17.050189.000305; Gardner WP, 2013, J GEOPHYS RES-SOL EA, V118, P2777, DOI 10.1002/jgrb.50210; Gardner WP, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003353; HEDENQUIST JW, 1990, J GEOPHYS RES-SOLID, V95, P19365, DOI 10.1029/JB095iB12p19365; Hersir G. P., 2014, SHORT COURSE 9 EXPLO, P1; Hochstein MP, 1997, GEOTHERMICS, V26, P1, DOI 10.1016/S0375-6505(96)00028-4; Hurwitz S, 2014, REV GEOPHYS, V52, P375, DOI 10.1002/2014RG000452; Jaworowski C, 2016, USGS OPEN-FILE REP, V2016-1029, P1; Jaworowski C., 2006, YELLOWSTONE SCI, V14, P13; Livo K. E., 2007, GEOL SURV PROF PAPER, V1717, P493; LLERA FJ, 1990, GEOPHYSICS, V55, P576, DOI 10.1190/1.1442869; McCleskey R., 2014, US. Geolog. Surv. Water Resources, DOI 10.5066/F7M043FS; Morgan LA, 2009, GEOL SOC AM SPEC PAP, V459, P1, DOI 10.1130/2009.2459; Munoz G, 2014, SURV GEOPHYS, V35, P101, DOI 10.1007/s10712-013-9236-0; Nordstrom DK, 2009, APPL GEOCHEM, V24, P191, DOI 10.1016/j.apgeochem.2008.11.019; Phillips J., 2014, SEG TECHN PROGR EXP, P1339, DOI [10.1190/segam2014-0226.1, DOI 10.1190/SEGAM2014-0226.1]; PHILLIPS JD, 2001, ASEG EXT ABSTR, V2001, P1, DOI DOI 10.1071/ASEG2001AB110; Revil A, 2017, GEOPHYS J INT, V208, P826, DOI 10.1093/gji/ggw444; Rowland JV, 2004, GEOFLUIDS, V4, P259, DOI 10.1111/j.1468-8123.2004.00091.x; Schamper C, 2014, GEOPHYS PROSPECT, V62, P658, DOI 10.1111/1365-2478.12104; Shelly DR, 2019, GEOPHYS RES LETT, V46, P2544, DOI 10.1029/2018GL081607; Simmons S.F., 2005, EC GEOLOGY 100 ANNIV, V100, P485, DOI DOI 10.2113/gsecongeo.100.5.1052; TRUESDELL AH, 1977, J GEOPHYS RES, V82, P3694, DOI 10.1029/JB082i026p03694; US Geological Survey, 2000, US GEOL SURV OPEN FI; Vaughan R.G., 2014, 20145137 US GEOL SUR, P1, DOI 10.3133/sir20145137; Waite GP, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000586; White D.E., 1988, US GEOL SURV PROF PA, P1, DOI 10.3133/pp1456; White DE., 1975, GEOL SURV PROF PAPER, V892, P70	54	5	5	8	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					643	+		10.1038/s41586-021-04379-1	http://dx.doi.org/10.1038/s41586-021-04379-1			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322248	Green Published, Green Submitted			2022-12-28	WOS:000772661800020
J	Schmitz, MT; Sandoval, K; Chen, CP; Mostajo-Radji, MA; Seeley, WW; Nowakowski, TJ; Ye, CJ; Paredes, MF; Pollen, AA				Schmitz, Matthew T.; Sandoval, Kadellyn; Chen, Christopher P.; Mostajo-Radji, Mohammed A.; Seeley, William W.; Nowakowski, Tomasz J.; Ye, Chun Jimmie; Paredes, Mercedes F.; Pollen, Alex A.			The development and evolution of inhibitory neurons in primate cerebrum	NATURE			English	Article							GANGLIONIC EMINENCE; RNA-SEQ; CELLS; REVEALS; BRAIN; NEUROGENESIS; INTERNEURONS; ARCHITECTURE; EXPRESSION; DIVERSITY	Neuroanatomists have long speculated that expanded primate brains contain an increased morphological diversity of inhibitory neurons (INs)(1), and recent studies have identified primate-specific neuronal populations at the molecular level(2). However, we know little about the developmental mechanisms that specify evolutionarily novel cell types in the brain. Here, we reconstructgene expression trajectories specifying INs generated throughout the neurogenic period in macaques and mice by analysing the transcriptomes of 250,181 cells. We find that the initial classes of INs generated prenatally are largely conserved among mammals. Nonetheless, we identify two contrasting developmental mechanisms for specifying evolutionarily novel cell types during prenatal development. First, we show that recently identified primate-specific TAC3 striatal INs are specified by a unique transcriptional programme in progenitors followed by induction of a distinct suite of neuropeptides and neurotransmitter receptors in new-born neurons. Second, we find that multiple classes of transcriptionally conserved olfactory bulb (OB)-bound precursors are redirected to expanded primate white matter and striatum. These classes include a novel peristriatal class of striatum laureatum neuronsthat resemble dopaminergic periglomerular cells ofthe OB. We propose an evolutionary model in which conserved initial classes of neurons supplying the smaller primate OB are reused in the enlarged striatum and cortex. Together, our results provide a unified developmental taxonomy of initial classes of mammalian INs and reveal multiple developmental mechanisms for neural cell type evolution.	[Schmitz, Matthew T.; Chen, Christopher P.; Mostajo-Radji, Mohammed A.; Pollen, Alex A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Schmitz, Matthew T.; Sandoval, Kadellyn; Chen, Christopher P.; Mostajo-Radji, Mohammed A.; Seeley, William W.; Paredes, Mercedes F.; Pollen, Alex A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Sandoval, Kadellyn; Nowakowski, Tomasz J.; Paredes, Mercedes F.; Pollen, Alex A.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.; Ye, Chun Jimmie; Pollen, Alex A.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Ye, Chun Jimmie] Parker Inst Canc Immunotherapy, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollen, AA (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Pollen, AA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Pollen, AA (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Pollen, AA (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	alex.pollen@ucsf.edu		Pollen, Alex/0000-0003-3263-8634	NIH [F31NS124333, DP2MH122400-01, U01MH114825, R01AI136972, DP2NS122550-01]; Roberta and Oscar Gregory Endowment; Schmidt Futures Foundation; Shurl and Kay Curci Foundation; Chan Zuckerberg Biohub	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roberta and Oscar Gregory Endowment; Schmidt Futures Foundation; Shurl and Kay Curci Foundation; Chan Zuckerberg Biohub	We thank A. Bhaduri, A. Alvarez-Buylla, J. Rubenstein, C. Harwell, M. Turrero Garcia, M. Andrews, S. Nolbrant, J. Wallace, S. Salama, I. Fiddes and members of the Pollen and Ye laboratories for helpful discussion and A. Li, S. Gaus, S. Wang, B. Alvarado, A. Tarantal and A. Fox for providing samples for genomic and histological analyses, and K. Probst for drawing the artwork in Fig. 4g. This study was supported by NIH awards F31NS124333 (M.T.S.), DP2MH122400-01 (A.A.P.), U01MH114825 (A.A.P., T.J.N.), R01AI136972 (C.J.Y.) and DP2NS122550-01 (M.F.P.); the Roberta and Oscar Gregory Endowment (M.F.P.); the Schmidt Futures Foundation (A.A.P., T.J.N.); the Chan Zuckerberg Biohub (C.J.Y., A.A.P., T.J.N.); and a grant from the Shurl and Kay Curci Foundation to the Innovative Genomics Institute (A.A.P.). A.A.P is a New York Stem Cell Foundation Robertson Investigator and member of the UCSF Kavli Institute for Fundamental Neuroscience.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Alzu'bi A, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.00061; Anderson AG, 2020, CELL REP, V30, P3051, DOI 10.1016/j.celrep.2020.02.030; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Betarbet R, 1997, J NEUROSCI, V17, P6761; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cave JW, 2010, J NEUROSCI, V30, P4717, DOI 10.1523/JNEUROSCI.0419-10.2010; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Diederich NJ, 2019, MOVEMENT DISORD, V34, P453, DOI 10.1002/mds.27628; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; Duchatel RJ, 2019, NPJ SCHIZOPHR, V5, DOI 10.1038/s41537-019-0078-8; Fiddes IT, 2018, GENOME RES, V28, P1029, DOI 10.1101/gr.233460.117; Fishell G, 2020, ANNU REV NEUROSCI, V43, P1, DOI 10.1146/annurev-neuro-070918-050421; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Frazer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14219; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Krienen FM, 2020, NATURE, V586, P262, DOI 10.1038/s41586-020-2781-z; Kuerbitz J, 2021, CEREB CORTEX, V31, P1744, DOI 10.1093/cercor/bhaa323; Kuerbitz X, 2018, J NEUROSCI, V38, P1160, DOI 10.1523/JNEUROSCI.1412-17.2017; La Manno G, 2021, NATURE, V596, P92, DOI 10.1038/s41586-021-03775-x; Lange M, 2022, NAT METHODS, V19, P159, DOI 10.1038/s41592-021-01346-6; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Loo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08079-9; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Martin A, 2019, CELL REP, V29, P4320, DOI 10.1016/j.celrep.2019.11.096; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; McGinnis CS, 2019, NAT METHODS, V16, P619, DOI 10.1038/s41592-019-0433-8; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Miller JA, 2020, ELIFE, V9, DOI 10.7554/eLife.59928; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Munoz-Manchado AB, 2018, CELL REP, V24, P2179, DOI 10.1016/j.celrep.2018.07.053; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Paredes MF, 2016, J COMP NEUROL, V524, P646, DOI 10.1002/cne.23896; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Polanski K, 2020, BIOINFORMATICS, V36, P964, DOI 10.1093/bioinformatics/btz625; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Sousa AMM, 2017, SCIENCE, V358, P1027, DOI 10.1126/science.aan3456; Speir ML, 2021, BIOINFORMATICS, V37, P4578, DOI 10.1093/bioinformatics/btab503; Stenman J, 2003, J NEUROSCI, V23, P167; STEPHAN H, 1969, ANN NY ACAD SCI, V167, P370, DOI 10.1111/j.1749-6632.1969.tb20457.x; Sun YL, 2017, JOVE-J VIS EXP, DOI 10.3791/56188; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tepe B, 2018, CELL REP, V25, P2689, DOI 10.1016/j.celrep.2018.11.034; Valero M, 2021, NAT NEUROSCI, V24, P401, DOI 10.1038/s41593-021-00797-6; Wagner DE, 2020, NAT REV GENET, V21, P410, DOI 10.1038/s41576-020-0223-2; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhu Y, 2018, SCIENCE, V362, P1267, DOI 10.1126/science.aat8077	59	10	10	17	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					871	+		10.1038/s41586-022-04510-w	http://dx.doi.org/10.1038/s41586-022-04510-w		MAR 2022	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35322231	hybrid, Green Published			2022-12-28	WOS:000772363100005
J	Shepherd, A				Shepherd, Alison			BMA expresses gratitude and grief for doctors who died from covid	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o752	10.1136/bmj.o752	http://dx.doi.org/10.1136/bmj.o752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321872	Bronze			2022-12-28	WOS:000790072700008
J	Connors, JM; Ridker, PM				Connors, Jean M.; Ridker, Paul M.			Thromboinflammation and Antithrombotics in COVID-19 Accumulating Evidence and Current Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OPEN-LABEL; ANTICOAGULATION; MULTICENTER		[Connors, Jean M.] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Connors, JM (corresponding author), Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA.	jconnors@bwh.harvard.edu						Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Berger JS, 2022, JAMA-J AM MED ASSOC, V327, P227, DOI 10.1001/jama.2021.23605; Bikdeli B, 2022, THROMB HAEMOSTASIS, V122, P131, DOI 10.1055/a-1485-2372; Connors JM, 2021, JAMA-J AM MED ASSOC, V326, P1703, DOI 10.1001/jama.2021.17272; Connors JM, 2020, J THROMB HAEMOST, V18, P1559, DOI 10.1111/jth.14849; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; Lown B, 2013, LOWN C 2013 AVOIDABL; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008; Ramacciotti E, 2022, LANCET, V399, P50, DOI 10.1016/S0140-6736(21)02392-8; REMAP-CAP Investigators, 2022, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2022.2910, DOI 10.1001/JAMA.2022.2910]; Sholzberg M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2400; Spyropoulos AC, 2021, JAMA INTERN MED, V181, P1612, DOI 10.1001/jamainternmed.2021.6203; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768	18	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1234	1235		10.1001/jama.2022.2361	http://dx.doi.org/10.1001/jama.2022.2361		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35315488	Bronze			2022-12-28	WOS:000772989300001
J	Kuehn, BM				Kuehn, Bridget M.			High-Volume Prescribers Drive Antibiotic Use in Medicare Part D	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1119	1119		10.1001/jama.2022.3503	http://dx.doi.org/10.1001/jama.2022.3503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315877				2022-12-28	WOS:000775589900012
J	Morgan, M				Morgan, Matt			Matt Morgan: Learning from all creatures great and small	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								o723	10.1136/bmj.o723	http://dx.doi.org/10.1136/bmj.o723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9XK	35318210	Bronze			2022-12-28	WOS:000777024700006
J	James, CA; Wachter, RM; Woolliscroft, JO				James, Cornelius A.; Wachter, Robert M.; Woolliscroft, James O.			Preparing Clinicians for a Clinical World Influenced by Artificial Intelligence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[James, Cornelius A.] Univ Michigan, Dept Internal Med & Pediat, Ann Arbor, MI 48109 USA; [Wachter, Robert M.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Woolliscroft, James O.] Univ Michigan, Dept Internal Med & Learning Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	James, CA (corresponding author), Univ Michigan, Div Gen Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	jamesca@med.umich.edu						Alvarado R, 2022, BIOETHICS, V36, P121, DOI 10.1111/bioe.12959; Emanuel EJ, 2019, JAMA-J AM MED ASSOC, V321, P2281, DOI 10.1001/jama.2019.4914; Liu Y, 2019, JAMA-J AM MED ASSOC, V322, P1806, DOI 10.1001/jama.2019.16489; Matheny M., 2019, ARTIF INTELL; Melnick ER, 2020, MAYO CLIN PROC, V95, P476, DOI 10.1016/j.mayocp.2019.09.024; Wong A, 2021, JAMA INTERN MED, V181, P1065, DOI 10.1001/jamainternmed.2021.2626	6	6	6	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2022	327	14					1333	1334		10.1001/jama.2022.3580	http://dx.doi.org/10.1001/jama.2022.3580		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1FH	35311917				2022-12-28	WOS:000772991200001
J	Zhang, P; Chen, L				Zhang, Peng; Chen, Lian			Melanoma of the Palpebral Conjunctiva and Eyelid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Melanoma of the Palpebral Conjunctiva and Eyelid A 47-year-old woman presented with eyelid itching and the sensation of a foreign body in her right eye. A pigmented mass was observed on the eyelid, and a large, pigmented lesion was observed on the palpebral conjunctiva on eyelid eversion. Excisional biopsy was performed, and a malignant melanoma was detected.	[Zhang, Peng; Chen, Lian] Xian No 3 Hosp, Xian, Peoples R China		Zhang, P (corresponding author), Xian No 3 Hosp, Xian, Peoples R China.	zhangpengfmmu@163.com							0	0	0	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2022	386	12								10.1056/NEJMicm2115699	http://dx.doi.org/10.1056/NEJMicm2115699		MAR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2C2ZT	35302723				2022-12-28	WOS:000779064600001
J	Bekker, LG; Garrett, N; Goga, A; Fairall, L; Reddy, T; Yende-Zuma, N; Kassanjee, R; Collie, S; Sanne, I; Boulle, A; Seocharan, I; Engelbrecht, I; Davies, MA; Champion, J; Chen, T; Bennett, S; Mametja, S; Semenya, M; Moultrie, H; de Oliveira, T; Lessells, RJ; Cohen, C; Jassat, W; Groome, M; Von Gottberg, A; Le Roux, E; Khuto, K; Barouch, D; Mahomed, H; Wolmarans, M; Rousseau, P; Bradshaw, D; Mulder, M; Opie, J; Louw, V; Jacobson, B; Rowji, P; Peter, JG; Takalani, A; Odhiambo, J; Mayat, F; Takuva, S; Corey, L; Gray, GE				Bekker, Linda-Gail; Garrett, Nigel; Goga, Ameena; Fairall, Lara; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Kassanjee, Reshma; Collie, Shirley; Sanne, Ian; Boulle, Andrew; Seocharan, Ishen; Engelbrecht, Imke; Davies, Mary-Ann; Champion, Jared; Chen, Tommy; Bennett, Sarah; Mametja, Selaelo; Semenya, Mabatlo; Moultrie, Harry; de Oliveira, Tulio; Lessells, Richard John; Cohen, Cheryl; Jassat, Waasila; Groome, Michelle; Von Gottberg, Anne; Le Roux, Engelbert; Khuto, Kentse; Barouch, Dan; Mahomed, Hassan; Wolmarans, Milani; Rousseau, Petro; Bradshaw, Debbie; Mulder, Michelle; Opie, Jessica; Louw, Vernon; Jacobson, Barry; Rowji, Pradeep; Peter, Jonny G.; Takalani, Azwi; Odhiambo, Jackline; Mayat, Fatima; Takuva, Simbarashe; Corey, Lawrence; Gray, Glenda E.		Sisonke Protocol Team; Sisonke Study Team	Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study	LANCET			English	Article							COVID-19 VACCINES; ADULTS; STATES; WAVES; 1ST	Background We aimed to assess the effectiveness of a single dose of the Ad26.COV2.S vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the South African COVID-19 epidemic. Methods In the single-arm, open-label, phase 3B implementation Sisonke study, health-care workers aged 18 years and older were invited for vaccination at one of 122 vaccination sites nationally. Participants received a single dose of 5 x 10(10) viral particles of the Ad26.COV2.S vaccine. Vaccinated participants were linked with their person-level data from one of two national medical insurance schemes (scheme A and scheme B) and matched for COVID-19 risk with an unvaccinated member of the general population. The primary outcome was vaccine effectiveness against severe COVID-19, defined as COVID-19-related admission to hospital, hospitalisation requiring critical or intensive care, or death, in health-care workers compared with the general population, ascertained 28 days or more after vaccination or matching, up to data cutoff. This study is registered with the South African National Clinical Trial Registry, DOH-27-022021-6844, ClinicalTrials.gov, NCT04838795, and the Pan African Clinical Trials Registry, PACTR202102855526180, and is closed to accrual. Findings Between Feb 17 and May 17, 2021, 477 102 health-care workers were enrolled and vaccinated, of whom 357 401 (74.9%) were female and 119 701 (25.1%) were male, with a median age of 42.0 years (33.0-51.0). 215813 vaccinated individuals were matched with 215 813 unvaccinated individuals. As of data cutoff (July 17, 2021), vaccine effectiveness derived from the total matched cohort was 83% (95% CI 75-89) to prevent COVID-19-related deaths, 75% (69-82) to prevent COVID-19-related hospital admissions requiring critical or intensive care, and 67% (62-71) to prevent COVID-19-related hospitalisations. The vaccine effectiveness for all three outcomes were consistent across scheme A and scheme B. The vaccine effectiveness was maintained in older health-care workers and those with comorbidities including HIV infection. During the course of the study, the beta (B.1.351) and then the delta (B.1.617.2) SARS-CoV-2 variants of concerns were dominant, and vaccine effectiveness remained consistent (for scheme A plus B vaccine effectiveness against COVID-19-related hospital admission during beta wave was 62% [95% CI 42-76] and during delta wave was 67% [62-71], and vaccine effectiveness against COVID-19-related death during beta wave was 86% [57-100] and during delta wave was 82% [74-89]). Interpretation The single-dose Ad26.COV2.S vaccine shows effectiveness against severe COVID-19 disease and COVID-19-related death after vaccination, and against both beta and delta variants, providing real-world evidence for its use globally. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Bekker, Linda-Gail; Fairall, Lara] Desmond Tutu HIV Ctr, Cape Town, South Africa; [Peter, Jonny G.] Univ Cape Town, Div Allergy & Clin Immunol, Cape Town, South Africa; [Kassanjee, Reshma; Boulle, Andrew; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Von Gottberg, Anne] Univ Cape Town, Dept Pathol, Cape Town, South Africa; [Louw, Vernon] Univ Cape Town, Dept Med, Div Clin Haematol, Cape Town, South Africa; [Jacobson, Barry] Univ Cape Town, Fac Hlth Sci, Cape Town, South Africa; [Jacobson, Barry] Univ Cape Town, Allergy & Immunol Unit, Cape Town, South Africa; [Bekker, Linda-Gail; Opie, Jessica] Univ Cape Town, Cape Town, South Africa; [Garrett, Nigel] Univ KwaZulu Natal, Doris Duke Med Res Inst, Durban, South Africa; [Yende-Zuma, Nonhlanhla] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa, Durban, South Africa; [de Oliveira, Tulio; Lessells, Richard John] Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat, Durban, South Africa; [Goga, Ameena] South Africa Med Res Council, HIV Prevent Res Unit, Cape Town, South Africa; [Mulder, Michelle; Gray, Glenda E.] South Africa Med Res Council, Cape Town, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat & Child Hlth, Pretoria, South Africa; [Takuva, Simbarashe] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Fairall, Lara] Kings Coll London, Kings Global Hlth Inst, London, England; [Reddy, Tarylee; Seocharan, Ishen] South African Med Res Council, Biostat Res Unit, Durban, South Africa; [Collie, Shirley; Champion, Jared; Chen, Tommy] Discovery Hlth, Sandton, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Groome, Michelle; Von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Sanne, Ian] Right Care, Houghton, South Africa; [Boulle, Andrew] Western Cape Govt Hlth, Cape Town, South Africa; [Boulle, Andrew] Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Engelbrecht, Imke] Right Care, Centurion, South Africa; [Davies, Mary-Ann] Western Cape Govt, Hlth Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Bennett, Sarah] Medscheme, Cape Town, South Africa; [Mametja, Selaelo; Semenya, Mabatlo] Govt Employees Med Scheme, Pretoria, South Africa; [Moultrie, Harry] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr TB, Johannesburg, South Africa; [Cohen, Cheryl; Von Gottberg, Anne] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Jassat, Waasila] Natl Inst Communicable Dis, Johannesburg, South Africa; [Groome, Michelle] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Le Roux, Engelbert; Khuto, Kentse; Takalani, Azwi; Odhiambo, Jackline] Chris Hani Baragwanath Acad Hosp, Hutchinson Ctr Res Inst South Africa HCRISA, Soweto, South Africa; [Barouch, Dan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Mahomed, Hassan] Western Cape Govt Hlth, Metro Hlth Serv, Cape Town, South Africa; [Mahomed, Hassan] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Global Hlth, Div Hlth Syst & Publ Hlth, Cape Town, South Africa; [Wolmarans, Milani; Rousseau, Petro] Natl Dept Hlth, Pretoria, South Africa; [Bradshaw, Debbie] South African Med Res Council, Tygerberg, South Africa; [Opie, Jessica] Natl Hlth Lab Serv, Cape Town, South Africa; [Louw, Vernon] Groote Schuur Hosp, Cape Town, South Africa; [Rowji, Pradeep] Southern African Soc Thrombosis & Haemostasis, Neurol Assoc South Afric, Johannesburg, South Africa; [Mayat, Fatima] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Perinatal HIV Res Unit PHRU, Johannesburg, South Africa; [Takuva, Simbarashe; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Pretoria; University of Pretoria; University of London; King's College London; South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Stellenbosch University; South African Medical Research Council; University of Cape Town; University of Witwatersrand; Fred Hutchinson Cancer Center	Gray, GE (corresponding author), South Africa Med Res Council, ZA-7505 Tygerberg, South Africa.	glenda.gray@mrc.ac.za	Takuva, Simba/G-7735-2012; Groome, Michelle Jennifer/AAI-9967-2021; Jassat, Waasila/GZM-9860-2022; Moultrie, Harry/H-1842-2014	Takuva, Simba/0000-0001-6030-2359; Groome, Michelle Jennifer/0000-0001-5893-3725; Jassat, Waasila/0000-0003-4279-3056; Fairall, Lara/0000-0002-7460-4670; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Moultrie, Harry/0000-0001-9722-0699; von Gottberg, Anne/0000-0002-0243-7455; Spooner, Elizabeth/0000-0002-1498-8131; de Oliveira, Tulio/0000-0002-3027-5254; Reddy, Tarylee/0000-0002-9521-2692; Meintjes, Graeme/0000-0003-1196-4414; Brumskine, William/0000-0002-1092-9919; Opie, Jessica/0000-0002-1408-2604	National Treasury of South Africa; National Department of Health; Solidarity Response Fund NPC; Michael & Susan Dell Foundation; Elma Vaccines and Immunization Foundation; Bill & Melinda Gates Foundation	National Treasury of South Africa; National Department of Health; Solidarity Response Fund NPC; Michael & Susan Dell Foundation; Elma Vaccines and Immunization Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	National Treasury of South Africa, the National Department of Health, Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation, and the Bill & Melinda Gates Foundation.	Bekker LG, 2021, LANCET GLOB HEALTH, V9, pE1177, DOI 10.1016/S2214-109X(21)00313-2; Corchado-Garcia J, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.32540; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; de Gier B, 2021, MEDRXIV, DOI [10.1101/2021.09.15.21263613, DOI 10.1101/2021.09.15.21263613]; Goga AE, 2022, S AFR MED J, V112, P13486; Grannis SJ, 2021, MMWR-MORBID MORTAL W, V70, P1291, DOI 10.15585/mmwr.mm7037e2; Jassat W, 2021, LANCET GLOB HEALTH, V9, pE1216, DOI 10.1016/S2214-109X(21)00289-8; Katz IT, 2021, NEW ENGL J MED, V384, P1281, DOI 10.1056/NEJMp2103614; Khan K, 2022, CLIN INFECT DIS, V75, pE857, DOI 10.1093/cid/ciab1008; Moline HL, 2021, MMWR-MORBID MORTAL W, V70, P1088, DOI 10.15585/mmwr.mm7032e3; Parikh PM, 2021, SOUTH ASIAN J CANCER, V10, P28, DOI 10.1055/s-0041-1733320; Polinski JM., 2021, EFFECTIVENESS SINGLE, DOI [10.1101/2021.09.10.21263385, DOI 10.1101/2021.09.10.21263385]; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Shaw JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247852; Shinde V, 2021, NEW ENGL J MED, V384, P1899, DOI 10.1056/NEJMoa2103055; Sykes Wendy, 2021, Res Sq, DOI 10.21203/rs.3.rs-233375/v1; Takuva S, 2021, NEW ENGL J MED, V385, P570, DOI 10.1056/NEJMc2107920; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Thompson MG, 2021, NEW ENGL J MED, V385, P1355, DOI 10.1056/NEJMoa2110362; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Tlotleng N, 2021, NATL COVID 19 HOSP A; US Centers for Disease Control and Prevention, 2021, COVID 19 PEOPL CERT; Yassi A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254920	24	17	17	4	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1141	1153						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZV8ZO	35305740	hybrid, Green Published			2022-12-28	WOS:000770814300022
J	Jaffe, S				Jaffe, Susan			Califf takes the helm at the US FDA, again	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1105	1106						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305729				2022-12-28	WOS:000770814300009
J	Slomski, A				Slomski, Anita			Air Quality and Brain Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1430	1430						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35319730				2022-12-28	WOS:000793035800001
J	Larkin, H				Larkin, Howard			Treating Epilepsy With Antiseizure Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item; Early Access								This Medical News article summarizes a recent Clinical Reviews interview with Dr Andres M. Kanner, MD, of the University of Miami Miller School of Medicine in Miami, Florida about the management of epilepsy in adults using antiseizure drugs.											0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.4599	http://dx.doi.org/10.1001/jama.2022.4599		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I5LH	35380577				2022-12-28	WOS:000779461800001
J	Ott, SM				Ott, Susan M.			In osteoporosis or osteopenia, exercise interventions improve BMD; effects vary by exercise type and BMD site	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FRACTURE; RISK		[Ott, Susan M.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ott, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.							CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Kistler-Fischbacher M, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115696; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Shojaa M, 2020, OSTEOPOROSIS INT, V31, P1427, DOI 10.1007/s00198-020-05441-w; Zhou Y, 2021, EVID-BASED COMPL ALT	5	1	1	6	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC46	JC46		10.7326/J22-0014	http://dx.doi.org/10.7326/J22-0014		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377720				2022-12-28	WOS:000799170800013
J	Slomski, A				Slomski, Anita			Maternal COVID-19 Vaccine Safe for Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1218	1218		10.1001/jama.2022.4371	http://dx.doi.org/10.1001/jama.2022.4371			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380595				2022-12-28	WOS:000783965500004
J	Slomski, A				Slomski, Anita			At-home COVID-19 Test Instructions Frequently Misinterpreted	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1218	1218		10.1001/jama.2022.4370	http://dx.doi.org/10.1001/jama.2022.4370			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380596				2022-12-28	WOS:000783965500005
J	Avery, N; McNeilage, AG; Stanaway, F; Ashton-James, CE; Blyth, FM; Martin, R; Gholamrezaei, A; Glare, P				Avery, Nicholas; McNeilage, Amy G.; Stanaway, Fiona; Ashton-James, Claire E.; Blyth, Fiona M.; Martin, Rebecca; Gholamrezaei, Ali; Glare, Paul			Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPINAL-CORD STIMULATION; LOW-BACK-PAIN; BILATERAL THORACOSCOPIC SPLANCHNICECTOMY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; TREATMENT OUTCOMES; PRIMARY-CARE; MULTIDISCIPLINARY PAIN; NEUROPATHIC PAIN; USE DISORDER	OBjECTIVE To review interventions to reduce long term opioid treatment in people with chronic non-cancer pain, considering efficacy on dose reduction and discontinuation, pain, function, quality of life, withdrawal symptoms, substance use, and adverse events. DESIGN Systematic review and meta-analysis of randomised controlled trials and non-randomised studies of interventions. DATA SOURCES Medline, Embase, PsycINFO, CINAHL, and the Cochrane Library searched from inception to July 2021. Reference lists and previous reviews were also searched and experts were contacted. ELIGIBILITY CRITERIA FOR STUDY SELECTION Original research in English. Case reports and cross sectional studies were excluded. DATA ExTRACTION AND SYNTHESIS Two authors independently selected studies, extracted data, and used the Cochrane risk-of-bias tools for randomised and non-randomised studies (RoB 2 and ROBINS-I). Authors grouped interventions into five categories (pain self-management, complementary and alternative medicine, pharmacological and biomedical devices and interventions, opioid replacement treatment, and deprescription methods), estimated pooled effects using random effects meta-analytical models, and appraised the certainty of evidence using GRADE (grading of recommendations, assessment, development, and evaluation). RESULTS Of 166 studies meeting inclusion criteria, 130 (78%) were considered at critical risk of bias and were excluded from the evidence synthesis. Of the 36 included studies, few had comparable treatment arms and sample sizes were generally small. Consequently, the certainty of the evidence was low or very low for more than 90% (41/44) of GRADE outcomes, including for all non-opioid patient outcomes. Despite these limitations, evidence of moderate certainty indicated that interventions to support prescribers' adherence to guidelines increased the likelihood of patients discontinuing opioid treatment (adjusted odds ratio 1.5, 95% confidence interval 1.0 to 2.1), and that these prescriber interventions as well as pain self-management programmes reduced opioid dose more than controls (intervention v control, mean difference -6.8 mg (standard error 1.6) daily oral morphine equivalent, P<0.001; pain programme v control, -14.31 mg daily oral morphine equivalent, 95% confidence interval-21.57 to-7.05). CONCLUSIONS as 10.1136/bmj-2021-066375 on 4 April 2022. Downloaded from CONCLUSIONS Evidence on the reduction of long term opioid treatment for chronic pain continues to be constrained by poor study methodology. Of particular concern is the lack of evidence relating to possible harms. Agreed standards for designing and reporting studies on the reduction of opioid treatment are urgently needed. REVIEw REGISTRATION PROSPERO CRD42020140943.	[Avery, Nicholas; McNeilage, Amy G.; Ashton-James, Claire E.; Gholamrezaei, Ali] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Avery, Nicholas; McNeilage, Amy G.; Ashton-James, Claire E.; Blyth, Fiona M.] Univ Sydney, Pain Management Res Inst, Kolling Inst, Sydney, NSW, Australia; [Stanaway, Fiona; Blyth, Fiona M.] Univ Sydney, Fac Med & Hlth, Sch Publ Hlth, Sydney, NSW, Australia; [Martin, Rebecca] Royal North Shore Hosp, Michael J Cousins Pain Management & Res Ctr, Sydney, NSW, Australia	University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital		paul.glare@sydney.edu.au	Gholamrezaei, Ali/M-7308-2015	Gholamrezaei, Ali/0000-0001-8674-450X; McNeilage, Amy/0000-0001-7112-042X; Glare, Paul/0000-0001-6850-7025; Avery, Nicholas/0000-0002-2060-312X; Blyth, Fiona/0000-0003-1128-6756; Stanaway, Fiona/0000-0003-2104-3010				Agnoli A, 2021, JAMA-J AM MED ASSOC, V326, P411, DOI 10.1001/jama.2021.11013; Al-Kaisy A, 2018, PAIN MED, V19, P1219, DOI 10.1093/pm/pnx237; Amirdelfan K, 2020, NEUROSURGERY, V87, P176, DOI 10.1093/neuros/nyz495; Aviram J, 2021, EUR J PAIN, V25, P359, DOI 10.1002/ejp.1675; Baron Michael J, 2006, J Opioid Manag, V2, P277; Barry AR, 2020, CAN PHARM J, V153, P52, DOI 10.1177/1715163519887766; Basinski A, 2005, WORLD J GASTROENTERO, V11, P5010, DOI 10.3748/wjg.v11.i32.5010; Becker WC, 2020, ANN INTERN MED, V173, P70, DOI 10.7326/L19-0725; Bellnier Terrance, 2018, Ment Health Clin, V8, P110, DOI 10.9740/mhc.2018.05.110; Bennett DS, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014745; Berger A, 2003, CLIN THER, V25, P2809, DOI 10.1016/S0149-2918(03)80335-1; Berland DW, 2013, AM J THER, V20, P316, DOI 10.1097/MJT.0b013e31827ab599; Berna C, 2015, MAYO CLIN PROC, V90, P828, DOI 10.1016/j.mayocp.2015.04.003; Bhutiani N, 2017, J AM COLL SURGEONS, V224, P566, DOI 10.1016/j.jamcollsurg.2016.12.048; Bienek N, 2019, PAIN MED, V20, P2438, DOI 10.1093/pm/pny320; Binswanger IA, 2020, DRUG ALCOHOL DEPEN, V217, DOI 10.1016/j.drugalcdep.2020.108248; Blondell RD, 2010, J ADDICT MED, V4, P140, DOI 10.1097/ADM.0b013e3181ba895d; Blyth FM, 2007, PAIN, V129, P8, DOI 10.1016/j.pain.2007.03.009; Bohnert ASB, 2018, ANN INTERN MED, V169, P367, DOI 10.7326/M18-1243; Bolash RB, 2018, PAIN PRACT, V18, P305, DOI 10.1111/papr.12602; Bonnie RJ, 2017, PAIN MANAGEMENT AND THE OPIOID EPIDEMIC: BALANCING SOCIETAL AND INDIVIDUAL BENEFITS AND RISKS OF PRESCRIPTION OPIOID USE, P1, DOI 10.17226/24781; Bordacahar B, 2018, SURGERY, V164, P1064, DOI 10.1016/j.surg.2018.05.025; BUCKLEY FP, 1986, PAIN, V26, P153, DOI 10.1016/0304-3959(86)90071-0; Buono FD, 2020, J PAIN RES, V13, P1515, DOI 10.2147/JPR.S250568; Buscher HCJL, 2007, EUR J PAIN, V11, P437, DOI 10.1016/j.ejpain.2006.06.001; Caraway D, 2015, NEUROMODULATION, V18, P508, DOI 10.1111/ner.12318; Chaudhary MA, 2021, MIL MED, V186, P587, DOI 10.1093/milmed/usaa573; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Chen CK, 2013, KOREAN J PAIN, V26, P401, DOI 10.3344/kjp.2013.26.4.401; Cherian JJ, 2016, J KNEE SURG, V29, P497, DOI 10.1055/s-0035-1566735; Chevlen E, 2000, J PAIN SYMPTOM MANAG, V19, pS42; Chong J, 2020, AUST J GEN PRACT, V49, P339, DOI 10.31128/AJGP-07-19-4994; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Coffin PO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232538; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cowan DT, 2005, PAIN MED, V6, P113, DOI 10.1111/j.1526-4637.2005.05020.x; Cowan DT, 2003, PAIN MED, V4, P340, DOI 10.1111/j.1526-4637.2003.03038.x; Craner JR, 2020, PAIN PRACT, V20, P44, DOI 10.1111/papr.12824; Crisostomo RA, 2008, AM J PHYS MED REHAB, V87, P527, DOI 10.1097/PHM.0b013e31817c124f; Crowley M., 2020, APPROACH MANAGEMENT; Cunningham JL, 2016, PAIN MED, V17, P1676, DOI 10.1093/pm/pnv079; D'Souza RS, 2021, NEUROMODULATION, V24, P135, DOI 10.1111/ner.13273; Daitch D, 2014, PAIN MED, V15, P2087, DOI 10.1111/pme.12520; Daitch J, 2012, PAIN PHYSICIAN, V15, pES59; Darchuk KM, 2010, PAIN MED, V11, P1352, DOI 10.1111/j.1526-4637.2010.00937.x; Darnall BD, 2019, PAIN MED, V20, P429, DOI 10.1093/pm/pny228; Darnall BD, 2018, JAMA INTERN MED, V178, P707, DOI 10.1001/jamainternmed.2017.8709; Darnall BD, 2017, PAIN MED, V18, P1413, DOI 10.1093/pm/pnw166; de Vos CC, 2014, PAIN, V155, P2426, DOI 10.1016/j.pain.2014.08.031; Dear BF, 2015, PAIN, V156, P1920, DOI 10.1097/j.pain.0000000000000251; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Deeks J.J., 2020, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604.CH10; Dematteis M, 2017, EXPERT OPIN PHARMACO, V18, P1987, DOI 10.1080/14656566.2017.1409722; Demidenko MI, 2017, GEN HOSP PSYCHIAT, V47, P29, DOI 10.1016/j.genhosppsych.2017.04.011; Dengler J, 2019, J BONE JOINT SURG AM, V101, P400, DOI 10.2106/JBJS.18.00022; Dersh J, 2008, SPINE, V33, P2219, DOI 10.1097/BRS.0b013e31818096d1; Deyo RA, 2018, PAIN, V159, P1147, DOI 10.1097/j.pain.0000000000001202; DiBenedetto DJ, 2018, J PAIN RES, V11, P2929, DOI 10.2147/JPR.S188795; Dimitrova A, 2017, MED ACUPUNCT, V29, P352, DOI 10.1089/acu.2017.1242; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Drossman DA, 2012, AM J GASTROENTEROL, V107, P1426, DOI 10.1038/ajg.2012.142; Eccleston C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010323.pub3; Eldridge S., 2021, REVISED COCHRANE RIS; EVANS PJD, 1981, ANAESTHESIA, V36, P597, DOI 10.1111/j.1365-2044.1981.tb10323.x; Fenton JJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16271; Fernstrum C, 2020, JSLS-J SOC LAPAROEND, V24, DOI 10.4293/JSLS.2020.00014; Fishbain DA, 2019, PAIN MED, V20, P2179, DOI 10.1093/pm/pny231; Frank JW, 2020, J GEN INTERN MED, V35, P910, DOI 10.1007/s11606-020-06294-z; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Franklin PD, 2010, J ARTHROPLASTY, V25, P12, DOI 10.1016/j.arth.2010.05.003; Garland EL, 2020, AM PSYCHOL, V75, P840, DOI 10.1037/amp0000638; Garland EL, 2019, J CONSULT CLIN PSYCH, V87, P927, DOI 10.1037/ccp0000390; Gee L, 2019, NEUROSURGERY, V84, P217, DOI 10.1093/neuros/nyy065; Gewandter JS, 2021, PAIN, V162, P2669, DOI 10.1097/j.pain.0000000000002283; Gilliam WP, 2018, J PAIN, V19, P678, DOI 10.1016/j.jpain.2018.02.010; Glare PA, 2017, NEW ENGL J MED, V377, P1797; Gowing L., 2014, NATL GUIDELINES MEDI; Gudin JA, 2018, POSTGRAD MED, V130, P42, DOI 10.1080/00325481.2018.1414551; Guildford BJ, 2018, BRIT J PAIN, V12, P72, DOI 10.1177/2049463717734016; Hammond B, 2004, AM SURGEON, V70, P546; Hansen CA, 2017, J ARTHROPLASTY, V32, P811, DOI 10.1016/j.arth.2016.09.040; Hanson KA, 2009, INFLAMM BOWEL DIS, V15, P772, DOI 10.1002/ibd.20847; Harden P, 2015, PAIN MED, V16, P1975, DOI 10.1111/pme.12812; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Hassamal S, 2016, SCAND J PAIN, V13, P27, DOI 10.1016/j.sjpain.2016.06.007; Hatheway JA, 2020, NEUROMODULATION, V23, P961, DOI 10.1111/ner.13053; Hayes CJ, 2022, ADDICTION, V117, P946, DOI 10.1111/add.15689; Heiwe S, 2011, EUR J PAIN, V15, P966, DOI 10.1016/j.ejpain.2011.03.006; Henry SG, 2019, J PAIN, V20, P181, DOI 10.1016/j.jpain.2018.09.001; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins J., 2021, REVISED COCHRANE RIS; Hooten WM, 2007, PAIN MED, V8, P624, DOI 10.1111/j.1526-4637.2006.00202.x; Hooten WM, 2007, PAIN MED, V8, P8, DOI 10.1111/j.1526-4637.2007.00253.x; Hooten WM, 2015, ADDICT BEHAV, V42, P69, DOI 10.1016/j.addbeh.2014.11.007; Hooten WM, 2010, PAIN MED, V11, P1587, DOI 10.1111/j.1526-4637.2010.00962.x; Hooten WM, 2009, ANESTH ANALG, V108, P308, DOI 10.1213/ane.0b013e31818c7b99; Hudak J, 2021, NEUROPSYCHOPHARMACOL, V46, P836, DOI 10.1038/s41386-020-00831-4; Huffman KL, 2017, PAIN, V158, P1380, DOI 10.1097/j.pain.0000000000000907; Huffman KL, 2013, PAIN MED, V14, P1908, DOI 10.1111/pme.12201; Hundley Lauren, 2018, J Opioid Manag, V14, P89, DOI 10.5055/jom.2018.0436; Hwang R, 2019, NEUROMODULATION, V22, P341, DOI 10.1111/ner.12886; Jackson HJ, 2021, MED ACUPUNCT, V33, P153, DOI 10.1089/acu.2020.1450; Jacobs SC, 2016, SUBST ABUS, V37, P15, DOI 10.1080/08897077.2015.1129527; James JR, 2019, J GEN INTERN MED, V34, P2749, DOI 10.1007/s11606-019-05301-2; Johnson B., 2013, NEUROPSYCHOANALYSIS, V2013, P145, DOI [10.1080/152 94145.2013.10799827, DOI 10.1080/15294145.2013.10799827]; Johnson JL, 2015, HEADACHE, V55, P1192, DOI 10.1111/head.12655; Kamper SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h444; Kapural L, 2010, PAIN PHYSICIAN, V13, P389; Kidner CL, 2009, J BONE JOINT SURG AM, V91A, P919, DOI 10.2106/JBJS.H.00286; KROENING RJ, 1985, INT J ADDICT, V20, P1347, DOI 10.3109/10826088509047771; Krumova EK, 2013, CLIN J PAIN, V29, P760, DOI 10.1097/AJP.0b013e31827c7cf6; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Kuntz JL, 2021, J AM PHARM ASSOC, V61, P248, DOI 10.1016/j.japh.2020.12.019; Kurita GP, 2018, EUR J PAIN, V22, P1528, DOI 10.1002/ejp.1241; Laigaard J, 2020, J PAIN RES, V13, P3385, DOI 10.2147/JPR.S273025; Lake AE, 2009, HEADACHE, V49, P555, DOI 10.1111/j.1526-4610.2009.01364.x; Lee DW, 2018, PAIN PHYSICIAN, V21, pE661; Levenick JM, 2012, DIGEST DIS SCI, V57, P1954, DOI 10.1007/s10620-012-2214-4; Levine AB, 2017, PAIN PHYSICIAN, V20, P95; Liebschutz JM, 2017, JAMA INTERN MED, V177, P1265, DOI 10.1001/jamainternmed.2017.2468; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; LIPCHIK GL, 1993, CLIN J PAIN, V9, P49, DOI 10.1097/00002508-199303000-00007; Lucas P, 2021, PAIN MED, V22, P727, DOI 10.1093/pm/pnaa396; Maani CV, 2011, J TRAUMA, V71, pS114, DOI 10.1097/TA.0b013e3182219209; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mackey K, 2020, J GEN INTERN MED, V35, P935, DOI 10.1007/s11606-020-06253-8; MacLaren JE, 2006, CLIN J PAIN, V22, P392, DOI 10.1097/01.ajp.0000208250.15572.01; Malinoff Herbert L, 2005, Am J Ther, V12, P379, DOI 10.1097/01.mjt.0000160935.62883.ff; Manhapra A, 2020, J GEN INTERN MED, V35, P964, DOI 10.1007/s11606-020-06251-w; Marchetti F, 2015, EUR J PAIN, V19, P984, DOI 10.1002/ejp.624; Mathieson S, 2020, DRUGS, V80, P1563, DOI 10.1007/s40265-020-01368-y; Matthias MS, 2020, J GEN INTERN MED, V35, P3525, DOI 10.1007/s11606-020-06007-6; Mazza M, 2021, J CANNABIS RES, V3, DOI 10.1186/s42238-021-00060-6; McNeilage AG, 2022, PAIN, V163, pE246, DOI 10.1097/j.pain.0000000000002336; Mehl-Madrona L, 2016, J ALTERN COMPLEM MED, V22, P621, DOI 10.1089/acm.2015.0212; Miller Norman S, 2006, Am J Ther, V13, P436, DOI 10.1097/01.mjt.0000212894.35705.90; Moran RA, 2017, PANCREATOLOGY, V17, P732, DOI 10.1016/j.pan.2017.07.005; Muriel J, 2018, ANN NY ACAD SCI, V1425, P82, DOI 10.1111/nyas.13735; Murphy JL, 2016, J REHABIL RES DEV, V53, P83, DOI 10.1682/JRRD.2014.10.0250; Murphy JL, 2013, CLIN J PAIN, V29, P109, DOI 10.1097/AJP.0b013e3182579935; National Center for Complementary and Integrative Health, 2018, COMPLEMENTARY ALTERN; Naylor MR, 2010, J PAIN, V11, P1410, DOI 10.1016/j.jpain.2010.03.019; Neumann AM, 2020, J ADDICT DIS, V38, P33, DOI 10.1080/10550887.2019.1690929; Nicholas MK, 2020, PAIN, V161, P509, DOI 10.1097/j.pain.0000000000001763; Nielssen O, 2019, J CONSULT CLIN PSYCH, V87, P904, DOI 10.1037/ccp0000407; Nilsen HK, 2010, ACTA ANAESTH SCAND, V54, P571, DOI 10.1111/j.1399-6576.2009.02164.x; Nissen LM, 2001, BRIT J CLIN PHARMACO, V52, P693, DOI 10.1046/j.0306-5251.2001.01502.x; Nordmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176288; O'Mara B., 2020, EVID BASE J EVID REV, V2, P79, DOI [DOI 10.21307/EB-2020-004, 10.21307/eb-2020-004]; Olason Magnus, 2004, Work, V22, P9; Oliva EM, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m283; Oohata M, 2017, JA CLIN REP, V3, P1, DOI 10.1186/s40981-017-0130-5; Opperman Charles P, 2018, J Opioid Manag, V14, P117, DOI 10.5055/jom.2018.0438; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160; Parker CM, 2019, NEW ENGL J MED, V380, P1, DOI 10.1056/NEJMp1813836; Patel KV, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000784; Patel V, 2020, MED DEVICES-EVID RES, V13, P173, DOI 10.2147/MDER.S253741; Pearson JS, 2014, THER ADV GASTROENTER, V7, P232, DOI 10.1177/1756283X14540028; Peterson K, 2016, VA EVIDENCE SYNTHESI; Pollard EM, 2019, J PAIN RES, V12, P1311, DOI 10.2147/JPR.S186662; Pope JE, 2015, NEUROMODULATION, V18, P414, DOI 10.1111/ner.12274; Powell VD, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.24152; Prusik J, 2017, NEUROMODULATION, V20, P386, DOI 10.1111/ner.12486; Przekop P, 2018, J BODYW MOV THER, V22, P685, DOI 10.1016/j.jbmt.2017.08.009; Quinlan J, 2012, PAIN MED, V13, P1524, DOI 10.1111/j.1526-4637.2012.01486.x; Raiszadeh K, 2021, J MED INTERNET RES, V23, DOI 10.2196/22548; RALPHS JA, 1994, PAIN, V56, P279, DOI 10.1016/0304-3959(94)90166-X; Raphael JH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003061; Robb LP, 2017, IRISH J MED SCI, V186, P767, DOI 10.1007/s11845-017-1565-4; Robbins JL, 2021, J AM BOARD FAM MED, V34, pS141, DOI 10.3122/jabfm.2021.S1.200236; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Rosenblum Andrew, 2012, J Opioid Manag, V8, P369, DOI 10.5055/jom.2012.0137; Roux P, 2013, PAIN, V154, P1442, DOI 10.1016/j.pain.2013.05.004; Ryan R, 2016, DESCRIBING RESULTS; Saal JS, 2000, SPINE, V25, P382, DOI 10.1097/00007632-200002010-00021; Salmon J, 2019, POSTGRAD MED, V131, P230, DOI 10.1080/00325481.2019.1587564; Sandhu H, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2990; Sch_unemann H, 2013, GRADE HDB; Scherrer JF, 2018, BRIT J PSYCHIAT, V212, P103, DOI 10.1192/bjp.2017.25; Schneider Jennifer P, 2010, J Opioid Manag, V6, P385; Schumann Matthew E, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P276, DOI 10.1016/j.mayocpiqo.2020.01.004; Schwarzer A, 2015, PAIN, V156, P2167, DOI 10.1097/j.pain.0000000000000279; Scott LJ, 2020, BRIT J GEN PRACT, V70, pE111, DOI 10.3399/bjgp19X707237; Sharan AD, 2018, PAIN MED, V19, P699, DOI 10.1093/pm/pnx262; Simopoulos T, 2019, PAIN PRACT, V19, P794, DOI 10.1111/papr.12807; Stein BD, 2022, J GEN INTERN MED, V37, P1603, DOI 10.1007/s11606-021-07119-3; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Streltzer J, 2015, AM J ADDICTION, V24, P357, DOI 10.1111/ajad.12198; Sturgeon JA, 2020, PAIN MED, V21, P3635, DOI 10.1093/pm/pnaa029; Sullivan MD, 2017, J PAIN, V18, P308, DOI 10.1016/j.jpain.2016.11.003; Sutherland DER, 2012, J AM COLL SURGEONS, V214, P409, DOI 10.1016/j.jamcollsurg.2011.12.040; Takakuwa KM, 2020, CANNABIS CANNABINOID, V5, P263, DOI 10.1089/can.2019.0039; Tang VM, 2020, AM J ADDICTION, V29, P73, DOI 10.1111/ajad.12964; Tardif H, 2021, MED J AUSTRALIA, V214, P430, DOI 10.5694/mja2.51031; Tauben D, 2020, PHARMACOLOGIC MANAGE; TAYLOR CB, 1980, PAIN, V8, P319, DOI 10.1016/0304-3959(80)90077-9; TENNANT FS, 1982, ARCH INTERN MED, V142, P1845, DOI 10.1001/archinte.142.10.1845; The Opioid Therapy for Chronic Pain Work Group, 2017, VA DOD CLIN PRACT GU; The Royal Australian College of General Practitioners, 2017, PRESCR DRUGS DEP GEN; Thieme K, 2003, ARTHRIT RHEUM-ARTHR, V49, P314, DOI 10.1002/art.11124; Thorlund JB, 2021, BRIT J SPORT MED, V55, P670, DOI 10.1136/bjsports-2019-101265; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; Vigil JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187795; Vines S W, 1996, Rehabil Nurs, V21, P25; Walker MJ, 2013, J PAIN MANAG, V6, P257; Wang HL, 2011, PAIN MED, V12, P1720, DOI 10.1111/j.1526-4637.2011.01276.x; Weber J, 2009, ANESTHESIOL RES PRAC, V2009, DOI 10.1155/2009/827290; Webster L, 2016, PAIN MED, V17, P899, DOI 10.1093/pm/pnv110; Weimer MB, 2016, SUBST ABUS, V37, P141, DOI 10.1080/08897077.2015.1129526; Weiss A, 2021, CORE STANDARDS PAIN, V2nd; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; White PF, 2017, J CLIN ANESTH, V40, P51, DOI 10.1016/j.jclinane.2017.03.046; Whitten SK, 2013, J AM ASSOC NURSE PRA, V25, P368, DOI 10.1111/j.1745-7599.2012.00800.x; Williams ACD, 1996, PAIN, V66, P13, DOI 10.1016/0304-3959(96)02996-X; Williams ACD, 2021, PAIN, V162, P2149, DOI 10.1097/j.pain.0000000000002273; Williams DR, 2003, CEPHALALGIA, V23, P963, DOI 10.1046/j.1468-2982.2003.00623.x; Windmill J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010323.pub2; Worley MJ, 2017, ADDICTION, V112, P1202, DOI 10.1111/add.13782; Worley MJ, 2015, EXP CLIN PSYCHOPHARM, V23, P428, DOI 10.1037/pha0000039; YOUNG RF, 1985, J NEUROSURG, V62, P389, DOI 10.3171/jns.1985.62.3.0389; Younger J, 2008, PAIN MED, V9, P1158, DOI 10.1111/j.1526-4637.2008.00475.x; Zaman T, 2018, SUBST ABUS, V39, P441, DOI 10.1080/08897077.2018.1455163; Zekry O, 2016, J PAIN PALLIAT CARE, V30, P91, DOI 10.3109/15360288.2016.1161690; Zgierska AE, 2016, J ALTERN COMPLEM MED, V22, P610, DOI 10.1089/acm.2015.0314; Zhao Y, 2010, CURR MED RES OPIN, V26, P2147, DOI 10.1185/03007995.2010.503140; Zheng Z, 2008, EUR J PAIN, V12, P671, DOI 10.1016/j.ejpain.2007.10.003; Zheng Z, 2019, PAIN MED, V20, P397, DOI 10.1093/pm/pny113; Zhou KH, 2017, SCAND J PAIN, V17, P167, DOI 10.1016/j.sjpain.2017.09.005	229	2	2	6	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								e066375	10.1136/bmj-2021-066375	http://dx.doi.org/10.1136/bmj-2021-066375			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0N8UW	35379650	Green Published, hybrid			2022-12-28	WOS:000783107700007
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word .... Remembrance of things past	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				[Anonymous], 1941, COLLECTED PAPERS MEM, V18, P28; Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o804; Aronson JK, 2020, ANAMNESIS; Chan KH, 2007, CLIN VACCINE IMMUNOL, V14, P1433, DOI 10.1128/CVI.00056-07; Luk HKH, 2019, INFECT GENET EVOL, V71, P21, DOI 10.1016/j.meegid.2019.03.001	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o873	10.1136/bmj.o873	http://dx.doi.org/10.1136/bmj.o873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365482	Bronze			2022-12-28	WOS:000783141700008
J	Sideris-Lampretsas, G; Malcangio, M				Sideris-Lampretsas, George; Malcangio, Marzia			Pain-resolving microglia	SCIENCE			English	Editorial Material									[Sideris-Lampretsas, George; Malcangio, Marzia] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	University of London; King's College London	Sideris-Lampretsas, G (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	george.sideris@kcl.ac.uk; marzia.malcangio@kcl.ac.uk		Sideris-Lampretsas, George/0000-0002-9165-0900	European Union [764860]	European Union(European Commission)	We acknowledge funds from the European Union Horizon 2020 research and innovation programme "TOBeATPAIN" under Marie Sklodowska-Curie grant agreement 764860.	Benmamar-Badel A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00430; Chen G, 2018, NEURON, V100, P1292, DOI 10.1016/j.neuron.2018.11.009; Costigan M, 2009, ANN REV NEUROSCI, V32; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kohno K, 2022, SCIENCE, V86; Santos EN, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abk1131; Sideris-Lampretsas G, 2021, BRAIN BEHAV IMMUN, V96, P279, DOI 10.1016/j.bbi.2021.06.005; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Tansley S, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28473-8	10	1	1	7	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		33	34		10.1126/science.abo5592	http://dx.doi.org/10.1126/science.abo5592			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357920				2022-12-28	WOS:000780195200014
J	DeGrace, MM; Ghedin, E; Frieman, MB; Krammer, F; Grifoni, A; Alisoltani, A; Alter, G; Amara, RR; Baric, RS; Barouch, DH; Bloom, JD; Bloyet, LM; Bonenfant, G; Boon, ACM; Boritz, EA; Bratt, DL; Bricker, TL; Brown, L; Buchser, WJ; Carreno, JM; Cohen-Lavi, L; Darling, TL; Davis-Gardner, ME; Dearlove, BL; Di, H; Dittmann, M; Doria-Rose, NA; Douek, DC; Drosten, C; Edara, VV; Ellebedy, A; Fabrizio, TP; Ferrari, G; Fischer, WM; Florence, WC; Fouchier, RAM; Franks, J; Garcia-Sastre, A; Godzik, A; Gonzalez-Reiche, AS; Gordon, A; Haagmans, BL; Halfmann, PJ; Ho, DD; Holbrook, MR; Huang, YX; James, SL; Jaroszewski, L; Jeevan, T; Johnson, RM; Jones, TC; Joshi, A; Kawaoka, Y; Kercher, L; Koopmans, MPG; Korber, B; Koren, E; Koup, RA; LeGresley, EB; Lemieux, JE; Liebeskind, MJ; Liu, ZM; Livingston, B; Logue, JP; Luo, Y; McDermott, AB; McElrath, MJ; Meliopoulos, VA; Menachery, VD; Montefiori, DC; Muhlemann, B; Munster, VJ; Munt, JE; Nair, MS; Netzl, A; Niewiadomska, AM; O'Dell, S; Pekosz, A; Perlman, S; Pontelli, MC; Rockx, B; Rolland, M; Rothlauf, PW; Sacharen, S; Scheuermann, RH; Schmidt, SD; Schotsaert, M; Schultz-Cherry, S; Seder, RA; Sedova, M; Sette, A; Shabman, RS; Shen, XY; Shi, PY; Shukla, M; Simon, V; Stumpf, S; Sullivan, NJ; Thackray, LB; Theiler, J; Thomas, PG; Trifkovic, S; Tureli, S; Turner, SA; Vakaki, MA; van Bakel, H; VanBlargan, LA; Vincent, LR; Wallace, ZS; Wang, L; Wang, M; Wang, PF; Wang, W; Weaver, SC; Webby, RJ; Weiss, CD; Wentworth, DE; Weston, SM; Whelan, SPJ; Whitener, BM; Wilks, SH; Xie, XP; Ying, BL; Yoon, H; Zhou, B; Hertz, T; Smith, DJ; Diamond, MS; Post, DJ; Suthar, MS				DeGrace, Marciela M.; Ghedin, Elodie; Frieman, Matthew B.; Krammer, Florian; Grifoni, Alba; Alisoltani, Arghavan; Alter, Galit; Amara, Rama R.; Baric, Ralph S.; Barouch, Dan H.; Bloom, Jesse D.; Bloyet, Louis-Marie; Bonenfant, Gaston; Boon, Adrianus C. M.; Boritz, Eli A.; Bratt, Debbie L.; Bricker, Traci L.; Brown, Liliana; Buchser, William J.; Carreno, Juan Manuel; Cohen-Lavi, Liel; Darling, Tamarand L.; Davis-Gardner, Meredith E.; Dearlove, Bethany L.; Di, Han; Dittmann, Meike; Doria-Rose, Nicole A.; Douek, Daniel C.; Drosten, Christian; Edara, Venkata-Viswanadh; Ellebedy, Ali; Fabrizio, Thomas P.; Ferrari, Guido; Fischer, Will M.; Florence, William C.; Fouchier, Ron A. M.; Franks, John; Garcia-Sastre, Adolfo; Godzik, Adam; Gonzalez-Reiche, Ana Silvia; Gordon, Aubree; Haagmans, Bart L.; Halfmann, Peter J.; Ho, David D.; Holbrook, Michael R.; Huang, Yaoxing; James, Sarah L.; Jaroszewski, Lukasz; Jeevan, Trushar; Johnson, Robert M.; Jones, Terry C.; Joshi, Astha; Kawaoka, Yoshihiro; Kercher, Lisa; Koopmans, Marion P. G.; Korber, Bette; Koren, Eilay; Koup, Richard A.; LeGresley, Eric B.; Lemieux, Jacob E.; Liebeskind, Mariel J.; Liu, Zhuoming; Livingston, Brandi; Logue, James P.; Luo, Yang; McDermott, Adrian B.; McElrath, Margaret J.; Meliopoulos, Victoria A.; Menachery, Vineet D.; Montefiori, David C.; Muehlemann, Barbara; Munster, Vincent J.; Munt, Jenny E.; Nair, Manoj S.; Netzl, Antonia; Niewiadomska, Anna M.; O'Dell, Sijy; Pekosz, Andrew; Perlman, Stanley; Pontelli, Marjorie C.; Rockx, Barry; Rolland, Morgane; Rothlauf, Paul W.; Sacharen, Sinai; Scheuermann, Richard H.; Schmidt, Stephen D.; Schotsaert, Michael; Schultz-Cherry, Stacey; Seder, Robert A.; Sedova, Mayya; Sette, Alessandro; Shabman, Reed S.; Shen, Xiaoying; Shi, Pei-Yong; Shukla, Maulik; Simon, Viviana; Stumpf, Spencer; Sullivan, Nancy J.; Thackray, Larissa B.; Theiler, James; Thomas, Paul G.; Trifkovic, Sanja; Tureli, Sina; Turner, Samuel A.; Vakaki, Maria A.; van Bakel, Harm; VanBlargan, Laura A.; Vincent, Leah R.; Wallace, Zachary S.; Wang, Li; Wang, Maple; Wang, Pengfei; Wang, Wei; Weaver, Scott C.; Webby, Richard J.; Weiss, Carol D.; Wentworth, David E.; Weston, Stuart M.; Whelan, Sean P. J.; Whitener, Bradley M.; Wilks, Samuel H.; Xie, Xuping; Ying, Baoling; Yoon, Hyejin; Zhou, Bin; Hertz, Tomer; Smith, Derek J.; Diamond, Michael S.; Post, Diane J.; Suthar, Mehul S.			Defining the risk of SARS-CoV-2 variants on immune protection	NATURE			English	Article							INFLUENZA-VIRUS INFECTION; RECEPTOR-BINDING DOMAIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; EFFECTOR FUNCTIONS; VACCINE; EVOLUTION; HIV-1; MUTATIONS; EFFICACY	The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures. The SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme provides a real-time risk assessment of SARS-CoV-2 variants with the potential to affect transmission, virulence and resistance to infection- and vaccine-induced immunity.	[DeGrace, Marciela M.; Ghedin, Elodie; Boritz, Eli A.; Bratt, Debbie L.; Brown, Liliana; Doria-Rose, Nicole A.; Douek, Daniel C.; Florence, William C.; Koup, Richard A.; McDermott, Adrian B.; O'Dell, Sijy; Schmidt, Stephen D.; Seder, Robert A.; Shabman, Reed S.; Sullivan, Nancy J.; Vincent, Leah R.; Post, Diane J.] NIAID, NIH, Rockville, MD 20852 USA; [DeGrace, Marciela M.; Boritz, Eli A.; Bratt, Debbie L.; Brown, Liliana; Florence, William C.; Shabman, Reed S.; Vincent, Leah R.; Post, Diane J.] Natl Inst Hlth, Div Microbiol & Infect Dis, Rockville, MD USA; [Ghedin, Elodie] Natl Inst Hlth, Lab Parasit Dis, Syst Genom Sect, Rockville, MD USA; [Frieman, Matthew B.; Johnson, Robert M.; Logue, James P.; Weston, Stuart M.] Univ Maryland, Ctr Pathogen Res, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Krammer, Florian; Carreno, Juan Manuel; Garcia-Sastre, Adolfo; Schotsaert, Michael; Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Krammer, Florian; Garcia-Sastre, Adolfo; Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Grifoni, Alba; Sette, Alessandro] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA; [Alisoltani, Arghavan; Godzik, Adam; Jaroszewski, Lukasz; Sedova, Mayya] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Alter, Galit] MIT, Ragon Inst MGH, Boston, MA USA; [Amara, Rama R.] Emory Univ, Sch Med, Div Microbiol & Immunol,Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr,Dept Microbiol & Immu, Atlanta, GA USA; [Baric, Ralph S.; Munt, Jenny E.] Univ N Carolina Chapel Hill, Dept Epidmiol, Chapel Hill, NC USA; [Baric, Ralph S.] Univ N Carolina Chapel Hill, Dept Microbiol, Chapel Hill, NC USA; [Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Bloom, Jesse D.] Howard Hughes Med Inst, Fred Hutch Canc Ctr, Seattle, WA USA; [Bloyet, Louis-Marie; Liu, Zhuoming; Pontelli, Marjorie C.; Rothlauf, Paul W.; Stumpf, Spencer; Whelan, Sean P. J.] Washington Univ, Sch Med, Dept Mol Microbiol, St. Louis, MO USA; [Bonenfant, Gaston; Di, Han; Wang, Li; Wentworth, David E.; Zhou, Bin] CDC COVID 19 Emergency Response, Ctr Dis Control & Prevent, Atlanta, GA USA; [Boon, Adrianus C. M.; Bricker, Traci L.; Darling, Tamarand L.; Joshi, Astha; Thackray, Larissa B.; VanBlargan, Laura A.; Whitener, Bradley M.; Ying, Baoling; Diamond, Michael S.] Washington Univ St Louis, Dept Med, St. Louis, MO USA; [Boritz, Eli A.; Doria-Rose, Nicole A.; Douek, Daniel C.; Koup, Richard A.; McDermott, Adrian B.; O'Dell, Sijy; Schmidt, Stephen D.; Seder, Robert A.; Sullivan, Nancy J.] Vaccine Res Ctr, Bethesda, MD USA; [Bratt, Debbie L.] NIAID, CAMRIS, Bethesda, MD USA; [Buchser, William J.; Liebeskind, Mariel J.; Vakaki, Maria A.] Washington Univ, High Throughput Screening Ctr, Sch Med, St. Louis, MO USA; [Cohen-Lavi, Liel; Koren, Eilay; Sacharen, Sinai] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Dept Ind Engn & Management, Beer Sheva, Israel; [Davis-Gardner, Meredith E.; Edara, Venkata-Viswanadh; Suthar, Mehul S.] Emory Univ Sch Med, Ctr Childhood Infections & Vaccines Childrens Hlt, Emory Vaccine Ctr, Dept Pediat, Atlanta, GA USA; [Dearlove, Bethany L.; Rolland, Morgane] Jackson Fdn Advancement Mil Med, Walter Reed Army Inst Res, US Mil HIV Res Program, Henry M, Silver Spring, MD USA; [Dittmann, Meike] NYU, Grossman Sch Med, Microbiol Dept, New York, NY 10003 USA; [Drosten, Christian; Jones, Terry C.; Muehlemann, Barbara] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Drosten, Christian; Jones, Terry C.; Muehlemann, Barbara] German Ctr Infect Res DZIF, Berlin, Germany; [Ellebedy, Ali] Washington Univ, Sch Med, Dept Pathol & Immunol, St. Louis, MO USA; [Fabrizio, Thomas P.; Franks, John; Jeevan, Trushar; Kercher, Lisa; Livingston, Brandi; Meliopoulos, Victoria A.; Schultz-Cherry, Stacey; Trifkovic, Sanja; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA; [Ferrari, Guido; Shen, Xiaoying] Duke Univ Med Ctr, Dept Surg, Durham, NC USA; [Fouchier, Ron A. M.; Haagmans, Bart L.; Koopmans, Marion P. G.; Rockx, Barry] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia-Sastre, Adolfo; Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA; [Garcia-Sastre, Adolfo; Schotsaert, Michael; Simon, Viviana] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Gonzalez-Reiche, Ana Silvia; van Bakel, Harm] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Gen Technol, Dept Genet & Gen Sci, New York, NY 10029 USA; [Gordon, Aubree] Univ Michigan, Dept Epidmiol, Ann Arbor, MI USA; [Halfmann, Peter J.; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Sch Vet Med, Dept Pathobiol Sci, Madison, WI USA; [Ho, David D.; Huang, Yaoxing; Luo, Yang; Nair, Manoj S.; Wang, Maple; Wang, Pengfei] Columbia Univ, Aaron Diamond AIDS Res Ctr, Vagelos Coll Phys & Surg, New York, NY USA; [Holbrook, Michael R.] Natl Inst Allergy & Infect Dis Integrated Res Fac, Frederick, MD USA; [James, Sarah L.; Jones, Terry C.; LeGresley, Eric B.; Muehlemann, Barbara; Netzl, Antonia; Tureli, Sina; Turner, Samuel A.; Wilks, Samuel H.; Smith, Derek J.] Univ Cambridge, Ctr Pathogen Evolution, Dept Zool, Cambridge, England; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Natl Ctr Global Hlth & Med Hosp, Dis Control & Prevent Ctr, Tokyo, Japan; [Fischer, Will M.; Korber, Bette; Theiler, James; Yoon, Hyejin] Los Alamos Natl Lab, New Mexico Consortium, Los Alamos, NM USA; [Koren, Eilay; Sacharen, Sinai] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Lemieux, Jacob E.] Broad Inst MIT & Harvard, Boston, MA USA; [McElrath, Margaret J.] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Menachery, Vineet D.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, World Ref Ctr Emerging Viruses, Dept Microbiol & Immunol, Galveston, TX USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Munster, Vincent J.] Natl Inst Allergy & Infect Dis, Div Intramural Res, Lab Virol, Natl Inst Hlth, Hamilton, MT USA; [Niewiadomska, Anna M.; Scheuermann, Richard H.; Wallace, Zachary S.] J Craig Venter Inst, Dept Informat, La Jolla, CA USA; [Pekosz, Andrew] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Sette, Alessandro] Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA USA; [Shi, Pei-Yong; Xie, Xuping] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Shukla, Maulik] Univ Chicago, Univ Chicago Consortium Adv Sci & Engn, Chicago, IL USA; [Shukla, Maulik] Argonne Natl Lab, Data Sci & Learning Div, Argonne, IL USA; [Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN USA; [Wallace, Zachary S.] Univ Calif, Dept Comp Sci & Engn, San Diego, CA USA; [Wang, Wei; Weiss, Carol D.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Hertz, Tomer] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St. Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St. Louis, MO USA; [Zhou, Bin; Diamond, Michael S.] Washington Univ, Bursky Ctr Human Immunol & Immunotherapy Programs, Sch Med, St. Louis, MO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; La Jolla Institute for Immunology; University of California System; University of California Riverside; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Washington University (WUSTL); Centers for Disease Control & Prevention - USA; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Ben Gurion University; Emory University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); New York University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Washington University (WUSTL); St Jude Children's Research Hospital; Duke University; Erasmus University Rotterdam; Erasmus MC; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University of Cambridge; University of Tokyo; National Center for Global Health & Medicine - Japan; United States Department of Energy (DOE); Los Alamos National Laboratory; Ben Gurion University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); J. Craig Venter Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Iowa; University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; St Jude Children's Research Hospital; University of California System; University of California San Diego; US Food & Drug Administration (FDA); Ben Gurion University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Post, DJ (corresponding author), NIAID, NIH, Rockville, MD 20852 USA.; Post, DJ (corresponding author), Natl Inst Hlth, Div Microbiol & Infect Dis, Rockville, MD USA.; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA.; Diamond, MS (corresponding author), Washington Univ St Louis, Dept Med, St. Louis, MO USA.; Suthar, MS (corresponding author), Emory Univ Sch Med, Ctr Childhood Infections & Vaccines Childrens Hlt, Emory Vaccine Ctr, Dept Pediat, Atlanta, GA USA.; Smith, DJ (corresponding author), Univ Cambridge, Ctr Pathogen Evolution, Dept Zool, Cambridge, England.; Krammer, F; Hertz, T; Suthar, MS (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	florian.krammer@mssm.edu; thertz@bgu.ac.il; djs200@cam.ac.uk; mdiamond@wustl.edu; postd@niaid.nih.gov; mehul.s.suthar@emory.edu	Nair, Manoj/B-4389-2009; Joshi, Astha/U-9014-2019; Haagmans, Bart/E-9791-2015; Sette, Alessandro/AFO-8916-2022; Krammer, Florian/H-3237-2019; Bonenfant, Gaston/ABG-3349-2021; Ferrari, Guido/Z-2137-2019; Bloyet, Louis-Marie/AAB-6244-2022; Munster, Vincent/I-7607-2018	Nair, Manoj/0000-0002-5994-3957; Joshi, Astha/0000-0003-4914-8228; Haagmans, Bart/0000-0001-6221-2015; Krammer, Florian/0000-0003-4121-776X; Bonenfant, Gaston/0000-0002-0081-7470; Bloyet, Louis-Marie/0000-0002-5648-3190; Alisoltani, Arghavan/0000-0003-3638-2218; Whitener, Bradley/0000-0001-6652-0701; Smith, Derek/0000-0002-2393-1890; Munster, Vincent/0000-0002-2288-3196; Wang, Pengfei/0000-0003-2454-7652; Weiss, Carol D./0000-0002-9965-1289; Pontelli, Marjorie/0000-0003-3173-5977; Vakaki, Maria/0000-0001-7519-5170; Johnson, Robert/0000-0002-1976-7688; Netzl, Antonia/0000-0001-8034-2382; Cohen-Lavi, Liel/0000-0001-6909-4779; Wallace, Zachary/0000-0003-0237-501X; Liebeskind, Mariel/0000-0003-4595-0651; Baric, Ralph/0000-0001-6827-8701; Ghedin, Elodie/0000-0002-1515-725X; Buchser, William/0000-0002-6675-6359	Institute of MGH,; MIT; Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); National Institutes of Health (NIH) [3R37AI080289-11S1, R01AI146785, U19AI42790-01, U19AI135995-02, AI134907]; Gates Foundation Global Health Vaccine Accelerator Platform funding [OPP1146996, INV-001650]; Musk Foundation; National Institute of Allergy and Infectious Diseases (NIAID)/NIH Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00050]; Duke University; NIH/NIAID CIVIC [75N93019C00051]; Icahn School of Medicine at Mount Sinai; NIH/NIAID Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) CIVIC [75N93019C0052]; University of Georgia; NIH/NIAID Centers of Excellence for Influenza Research and Response (CEIRR) [75N93021C00014]; NIH\NIAID CEIRR [75N9302100016]; St Jude Children's Research Hospital; NIH/NIAID CEIRR [75N93021C00017]; Emory University; NIH/NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400006C]; NIH/NIAID CEIRS [HHS N2772201400007C, HHSN272201400008C]; Johns Hopkins University; Investigator of the Howard Hughes Medical Institute; Intramural NIH Research Program project [ZIA AI005156-02]; NIH/NIAID [75N93019D0025]; Intramural Research Program of the NIAID, NIH; Henry M. Jackson Foundation for the Advancement of Military Medicine; US Department of the Army [W81XWH-18-2-0040]; Intramural Research Program of the Vaccine Research Center, NIAID and NIH; German Ministry of research under project codes DZIF; MolTrax; PREPARED; NIAID [U01AI141990, 1U01AI150747, HHSN272201800013C]; NIH\NIAID [P51OD011132, 3U19AI057266-17S1]; Emory Executive Vice President for Health Affairs Synergy Fund award; Woodruff Health Sciences Center 2020 COVID-19 CURE Award, Agod; VEO, versatile emerging infectious disease observatory: forecasting, nowcasting and tracking in a changing world; European Union's Horizon 2020 research and innovation programme [874735]; ZonMw [10150062010005, APW 202645827]; WHO [APW 202605269]; Los Alamos National Laboratory; Gates Foundation [OPP1169339]; Sealy Smith Foundation; Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gillson Longenbaugh Foundation; Summerfield Robert Foundation; NIH/NCI: Serological Sciences Network (SeroNet) [75N91019D00024]; NIH, NIAID [75N93019C00076]; US Food and Drug Administration institutional research funds; NIH [R24 AI120942]; Sealy and Smith Foundation;  [HHSN272201700060C];  [3R01AI148378-01S1];  [R01AI141707];  [U01AI151810];  [R01AI157155];  [1R01AI143639];  [R01AI20997];  [UM1AI068618];  [R01AI153602];  [P01AI060699];  [R01AI129269];  [U01AI144616];  [U01AI150747];  [R01AI136514];  [R01AI154470]	Institute of MGH,; MIT; Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation Global Health Vaccine Accelerator Platform funding; Musk Foundation; National Institute of Allergy and Infectious Diseases (NIAID)/NIH Collaborative Influenza Vaccine Innovation Centers (CIVIC); Duke University; NIH/NIAID CIVIC; Icahn School of Medicine at Mount Sinai; NIH/NIAID Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) CIVIC; University of Georgia; NIH/NIAID Centers of Excellence for Influenza Research and Response (CEIRR); NIH\NIAID CEIRR; St Jude Children's Research Hospital; NIH/NIAID CEIRR; Emory University; NIH/NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); NIH/NIAID CEIRS; Johns Hopkins University(Johns Hopkins University); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH Research Program project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine; US Department of the Army; Intramural Research Program of the Vaccine Research Center, NIAID and NIH; German Ministry of research under project codes DZIF; MolTrax; PREPARED; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH\NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory Executive Vice President for Health Affairs Synergy Fund award; Woodruff Health Sciences Center 2020 COVID-19 CURE Award, Agod; VEO, versatile emerging infectious disease observatory: forecasting, nowcasting and tracking in a changing world; European Union's Horizon 2020 research and innovation programme; ZonMw(Netherlands Organization for Health Research and Development); WHO(World Health Organization); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gates Foundation(Bill & Melinda Gates Foundation); Sealy Smith Foundation; Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gillson Longenbaugh Foundation; Summerfield Robert Foundation; NIH/NCI: Serological Sciences Network (SeroNet)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Food and Drug Administration institutional research funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy and Smith Foundation; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	A.A. is funded by HHSN272201700060C; G.A. is funded by the Ragon Institute of MGH, MIT and Harvard, the Massachusetts Consortium on Pathogen Readiness (MassCPR), the National Institutes of Health (NIH) (3R37AI080289-11S1, R01AI146785, U19AI42790-01, U19AI135995-02, U19AI42790-01, 1U01CA260476-01), the Gates Foundation Global Health Vaccine Accelerator Platform funding (OPP1146996 and INV-001650) and the Musk Foundation; D.C.M. and X.S. are supported in part by the National Institute of Allergy and Infectious Diseases (NIAID)/NIH Collaborative Influenza Vaccine Innovation Centers (CIVIC) under contract 75N93019C00050, Duke University; A.E., A. Gordon, J.M.C., F.K. and V.S. are funded in part by NIH/NIAID CIVIC under contract 75N93019C00051, Icahn School of Medicine at Mount Sinai; G.A., B.L., V.A.M., S.S.-C. and P.G.T. are funded in part by the NIH/NIAID Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) CIVIC under contract 75N93019C0052, University of Georgia; M.S.D., V.S., L.B.T., H.v.B., L.A.V., R.A.M.F., A.G.-S., M.B.F., R.M.J., J.P.L., S.M.W., B.L.H., D.D.H., Y.H., Y.L., M.S.N., P.W., M.W., D.J.S., A.N., E.B.L., S.L.J., S. Tureli, S.M.W., S.A.T., J.M.C., F.K., B.M.W., B.R. and B.Y. are supported by the NIH/NIAID Centers of Excellence for Influenza Research and Response (CEIRR) under contract 75N93021C00014, Icahn School of Medicine at Mount Sinai; T.P.F., G.F., J.F., T.J., L.K., B.L., V.A.M., S.S.-C., A.S., S.T., P.G.T., E.K., L.C.-L., T.H., S. Sacharen and R.J.W. are funded in part by the NIH\NIAID CEIRR under contract 75N9302100016, St Jude Children's Research Hospital; R.R.A., V.-V.E., M.E.D.-G. and M.S.S. are funded in part by the NIH/NIAID CEIRR under contract 75N93021C00017, Emory University; A.E., T.P.F., J.F., T.J., L.K., B.L., V.A.M., S.S.-C., S.T. S.P.J.W., Z.L., L.-M.B., P.W.R., M.C.P., S. Stumpf, A.G., A.S. and R.J.W. are funded in part by the NIH/NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) under contract HHSN272201400006C, St Jude Children's Research Hospital; A.P. is supported in part by the NIH/NIAID CEIRS under contract HHS N2772201400007C, Johns Hopkins University; A.E., M.B.F., R.M.J., A.G.-S., J.P.L., S.M.W., P.J.H., Y.K., J.M.C., F.K., M. Schotsaert and V.S. are funded in part by the NIH/NIAID CEIRS under contract HHSN272201400008C, Icahn School of Medicine at Mount Sinai; R.R.A. is funded by 3R01AI148378-01S1; J.D.B. is supported in part by R01AI141707 and is an Investigator of the Howard Hughes Medical Institute; A.C.M.B. is funded by U01AI151810; E.A.B. is supported by an Intramural NIH Research Program project ZIA AI005156-02; D.L.B. is supported by NIH/NIAID under contract 75N93019D0025 to CAMRIS International; E.G. and V.J.M. are supported by the Intramural Research Program of the NIAID, NIH; B.L.D. and M.R. are supported by a cooperative agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine and the US Department of the Army (W81XWH-18-2-0040); M.S.D. is supported in part by R01AI157155; M.D. is supported by 1R01AI143639; N.A.D.-R., D.C.D., A.B.M., N.J.S., R.A.K., S.O., S.D.S. and R.A.S. are supported by the Intramural Research Program of the Vaccine Research Center, NIAID and NIH; C.D., B.A.M. and T.C.J. are funded in part by the German Ministry of research under project codes DZIF, MolTrax and PREPARED; A.E. is supported by NIAID grants U01AI141990 and 1U01AI150747; V.-V.E., M.E.D.-G. and M.S.S.; are supported in part by the NIH\NIAID (P51OD011132 and 3U19AI057266-17S1), Emory Executive Vice President for Health Affairs Synergy Fund award, and Woodruff Health Sciences Center 2020 COVID-19 CURE Award, Agod; L.J. and M. Sedova are supported by HHSN272201700060C; A. Gordon is supported by R01AI20997; M.R.H. is supported by NIAID contract HHSN272201800013C; M.P.G.K. is supported by VEO, versatile emerging infectious disease observatory: forecasting, nowcasting and tracking in a changing world. VEO has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 874735, COVID-19 vaccination in kidney patients (RECOVAC), ZonMw 10430072010002 monitoring the evolution, spread and transmission of SARS-CoV-2 through whole-genome sequencing to enable fast genotype to phenotype prediction' funded by ZonMw (project 10150062010005, APW 202645827); to support the structured evaluation of SARS-CoV-2 evolution funded by the WHO (APW 202605269); to gain in-depth understanding of the evolution, spread and transmission of SARS-CoV-2 during the coming phase of the pandemic funded by the WHO. B.K., J.T. and H.Y. are funded by the Los Alamos National Laboratory and the Gates Foundation OPP1169339; R.A.K. is funded by Intramural NIH funding; M.J.M. is supported by UM1AI068618; V.D.M. is supported by R01AI153602; S.P. is supported by P01AI060699 and R01AI129269; P.-Y.S. is supported by NIH grants AI134907 and awards from the Sealy Smith Foundation, the Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Gillson Longenbaugh Foundation and the Summerfield Robert Foundation; V.S. is supported by the NIH/NCI: Serological Sciences Network (SeroNet) 75N91019D00024; P.G.T. is supported by U01AI144616, U01AI150747, R01AI136514, R01AI154470; Z.S.W., R.H.S., A.M.N. and M. Shukla are supported by NIH, NIAID Contract 75N93019C00076; W.W. and C.D.W. are supported by US Food and Drug Administration institutional research funds; and S.C.W. is supported by NIH grant R24 AI120942 and by the Sealy and Smith Foundation. The findings and conclusions in this Review are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the US Centers for Disease Control and Prevention or the US Department of Health and Human Services.	Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; Amanat Fatima, 2021, Cell, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Anand Sai Priya, 2021, bioRxiv, DOI [10.1016/j.xcrm.2021.100290, 10.1101/2021.01.25.428097]; [Anonymous], 2021, SARS COV 2 VAR CLASS; Arunkumar GA, 2019, J VIROL, V93, DOI 10.1128/JVI.01696-18; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Bartsch YC, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abn9243; Begin P, 2021, NAT MED, V27, P2012, DOI 10.1038/s41591-021-01488-2; Bewley KR, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg7996; Boras B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26239-2; Bricker Traci L, 2021, Cell Rep, V36, P109400, DOI [10.1101/2020.12.02.408823, 10.1016/j.celrep.2021.109400]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Carreno JM, 2022, NATURE, V602, P682, DOI 10.1038/s41586-022-04399-5; Carreno JM, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103626; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Corbett KS, 2021, SCIENCE, V374, P1343, DOI 10.1126/science.abl8912; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; Corbett KS, 2021, NAT IMMUNOL, V22, P1306, DOI 10.1038/s41590-021-01021-0; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1101/2020.06.11.145920, 10.1038/s41586-020-2622-0]; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davis JJ, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.01803-21; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Edara Venkata-Viswanadh, 2021, bioRxiv, DOI 10.1101/2021.12.20.473557; Escalera A, 2022, CELL HOST MICROBE, V30, P373, DOI 10.1016/j.chom.2022.01.006; Fischer RJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26178-y; Fischer W, 2021, CELL HOST MICROBE, V29, P1093, DOI 10.1016/j.chom.2021.05.012; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francica JR, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi4547; Gagne M, 2022, CELL, V185, P113, DOI 10.1016/j.cell.2021.12.002; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Golden JW, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142032; Gorman MJ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100405; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guebre-Xabier M, 2020, VACCINE, V38, P7892, DOI 10.1016/j.vaccine.2020.10.064; Halfmann PJ, 2022, NATURE, V603, P687, DOI 10.1038/s41586-022-04441-6; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; He X, 2021, CELL, V184, P3467, DOI 10.1016/j.cell.2021.05.040; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; Hirose R, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00159-21; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Imai M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106535118; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; JANSEN JE, 1988, ACTA CHIR SCAND, V154, P323; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Kaplonek P, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abm2311; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Knezevic I, 2022, LANCET MICROBE, V3, pE235, DOI 10.1016/S2666-5247(21)00266-4; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Liu LJ, 2022, NUTR NEUROSCI, V25, P2302, DOI 10.1080/1028415X.2021.1959099; Liu Y, 2022, NATURE, V602, P294, DOI 10.1038/s41586-021-04245-0; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Lusvarghi S, 2022, J VIROL, V96, DOI 10.1128/JVI.01110-21; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Moreau GB, 2020, AM J TROP MED HYG, V103, P1215, DOI 10.4269/ajtmh.20-0762; Mullen J.L., 2020, OUTBREAK INFO; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Muruato A, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001284; Muruato Antonio E, 2020, bioRxiv, DOI 10.1101/2020.05.21.109546; Neerukonda SN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248348; Obermeyer F., MEDRXIV, DOI 10.1101/2021.09.07.21263228(2022; Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Pajon R, 2022, NEW ENGL J MED, V386, P1088, DOI 10.1056/NEJMc2119912; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Pino M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh3634; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Pruijssers Andrea J, 2020, bioRxiv, DOI 10.1101/2020.04.27.064279; Rathnasinghe R., 2021, MEDRXIV, DOI 10.1101/2021.01.19.21249592; Roubidoux EK, 2021, MBIO, V12, DOI 10.1128/mBio.03617-20; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Schmitz AJ, 2021, IMMUNITY, V54, P2159, DOI [10.1016/j.immuni.2021.08.013, 10.1101/2021.03.24.436864]; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Starr Tyler N, 2021, Cell Rep Med, V2, P100255, DOI [10.1101/2021.02.17.431683, 10.1016/j.xcrm.2021.100255]; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Sun CP, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009758; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tian JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20653-8; Tso FY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247640; Valanparambil R. M., 2022, MEDRXIV, DOI 10.1101/2022.01.03.22268599; van Doremalen N, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh0755; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Vanderheiden A, 2021, MBIO, V12, DOI 10.1128/mBio.02749-21; Vanderheiden Abigail, 2020, Curr Protoc Immunol, V131, pe116, DOI 10.1002/cpim.116; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Walensky RP, 2021, JAMA-J AM MED ASSOC, V325, P1037, DOI 10.1001/jama.2021.2294; Wang Pengfei, 2021, bioRxiv, DOI [10.1016/j.chom.2021.04.007, 10.1101/2021.03.01.433466]; Wang YZ, 2022, CELL RES, V32, P953, DOI 10.1038/s41422-022-00666-2; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yamin R, 2021, NATURE, V599, P465, DOI 10.1038/s41586-021-04017-w; Ying BL, 2022, SCI TRANSL MED, V14, DOI [10.1101/2021.08.25.457693, 10.1126/scitranslmed.abm3302]; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zhou J, 2005, VACCINE, V23, P3202, DOI 10.1016/j.vaccine.2004.11.075; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052	120	15	15	33	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 26	2022	605	7911					640	652		10.1038/s41586-022-04690-5	http://dx.doi.org/10.1038/s41586-022-04690-5		MAR 2022	13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P5ES	35361968	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000797787500001
J	Dyer, C				Dyer, Clare			Failure to work collaboratively and learn from incidents led to deaths of babies and mothers at Shrewsbury and Telford trust, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4797; O'Dowd A, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1712; Ockenden Maternity Review, 2022, FINAL REPORT FINDING; Wilkinson E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o446	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o858	10.1136/bmj.o858	http://dx.doi.org/10.1136/bmj.o858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361686				2022-12-28	WOS:000779990000015
J	Lombarts, KMJ; Verghese, A				Lombarts, Kiki M. J.; Verghese, Abraham			Medicine Is Not Gender-Neutral - She Is Male	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIAN GENDER; WOMEN		[Lombarts, Kiki M. J.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Lombarts, Kiki M. J.] Stanford Univ, Sch Med, Ctr Adv Study Behav Sci, Stanford, CA 94305 USA; [Lombarts, Kiki M. J.; Verghese, Abraham] Stanford Univ, Sch Med, Presence Ctr, Dept Med, Stanford, CA 94305 USA; [Verghese, Abraham] Stanford Univ, Sch Med, Dept Internal Med, Stanford, CA 94305 USA	University of Amsterdam; Stanford University; Stanford University; Stanford University	Lombarts, KMJ (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.; Lombarts, KMJ (corresponding author), Stanford Univ, Sch Med, Ctr Adv Study Behav Sci, Stanford, CA 94305 USA.; Lombarts, KMJ (corresponding author), Stanford Univ, Sch Med, Presence Ctr, Dept Med, Stanford, CA 94305 USA.			Lombarts, Kiki/0000-0001-6167-0620				American Medical Association, 2021, COMP RVS UPD COMM; BERG M, 1995, SOC STUD SCI, V25, P437, DOI 10.1177/030631295025003002; Bertakis Klea D, 2003, J Am Med Womens Assoc (1972), V58, P69; Berthold HK, 2008, J INTERN MED, V264, P340, DOI 10.1111/j.1365-2796.2008.01967.x; Bravender T, 2021, JAMA PEDIATR, V175, P524, DOI 10.1001/jamapediatrics.2020.5683; Chen YW, 2021, ANN SURG, V273, P197, DOI 10.1097/SLA.0000000000004497; Childers CP, 2020, JAMA SURG, V155, P493, DOI 10.1001/jamasurg.2020.0422; Firth-Cozens J, 2008, BRIT MED J, V336, P731, DOI 10.1136/bmj.39526.359630.BE; Greenwood BN, 2018, P NATL ACAD SCI USA, V115, P8569, DOI 10.1073/pnas.1800097115; Hall JA, 2014, PATIENT EDUC COUNS, V95, P313, DOI 10.1016/j.pec.2014.03.015; Hall S., 2001, DISCOURSE THEORY PRA, P72; Israni ST, 2019, JAMA-J AM MED ASSOC, V321, P29, DOI 10.1001/jama.2018.19398; Jones Kathleen W., 1999, TAMING TROUBLESOME C; Kang SK, 2019, LANCET, V393, P579, DOI 10.1016/S0140-6736(18)33138-6; Koven S., 2021, LETT YOUNG FEMALE PH; Laver KE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020380; Lombarts KMJMH., 2019, PHYSICIANS PROFESSIO; Lyons NB, 2021, AM J MED SCI, V361, P151, DOI 10.1016/j.amjms.2020.10.017; Mello MM, 2020, NEW ENGL J MED, V382, P1385, DOI 10.1056/NEJMp1915351; Morantz-Sanchez Regina, 2000, SYMPATHY SCI WOMEN P; Onumah C, 2021, J GEN INTERN MED, V36, P2039, DOI 10.1007/s11606-021-06771-z; Organisation for Economic Cooperation and Development, 2020, HLTH GLANC 2019 OECD; Richter KP, 2020, NEW ENGL J MED, V383, P2148, DOI 10.1056/NEJMsa1916935; Risman B., 2018, MILLENNIALS WILL TAK; Rogers EA, 2021, J GEN INTERN MED, V36, P1448, DOI 10.1007/s11606-020-05772-8; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Silver JK., 2018, BEETHICAL CALL HEALT; Sprow HN, 2021, WORLD J SURG, V45, P1409, DOI 10.1007/s00268-021-05974-z; Stern DT, 2006, NEW ENGL J MED, V355, P1794, DOI 10.1056/NEJMra054783; Sudol NT, 2021, JAMA SURG, V156, DOI 10.1001/jamasurg.2021.0265; Torres MB, 2019, JAMA SURG, V154, P868, DOI 10.1001/jamasurg.2019.1648; Trinh LN, 2021, J SURG EDUC, V78, P836, DOI 10.1016/j.jsurg.2020.08.050; Trzeciak S, 2017, MED HYPOTHESES, V107, P92, DOI 10.1016/j.mehy.2017.08.015; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Verghese A, 2011, ANN INTERN MED, V155, P550, DOI 10.7326/0003-4819-155-8-201110180-00013; Wallis CJD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4366; Westendorp J, 2021, PATIENT EDUC COUNS, V104, P1109, DOI 10.1016/j.pec.2020.10.025; Woolf V, 1938, 3 GUINEAS; Yanagisako S, 1995, NATURALIZING POWER, P1	39	0	0	3	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1284	1287		10.1056/NEJMms2116556	http://dx.doi.org/10.1056/NEJMms2116556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353969				2022-12-28	WOS:000820666300015
J	Maloney, FP; Kuklewicz, J; Corey, RA; Bi, YC; Ho, RY; Mateusiak, L; Pardon, E; Steyaert, J; Stansfeld, PJ; Zimmer, J				Maloney, Finn P.; Kuklewicz, Jeremi; Corey, Robin A.; Bi, Yunchen; Ho, Ruoya; Mateusiak, Lukasz; Pardon, Els; Steyaert, Jan; Stansfeld, Phillip J.; Zimmer, Jochen			Structure, substrate recognition and initiation of hyaluronan synthase	NATURE			English	Article							MEMBRANE TRANSLOCATION; SOFTWARE NEWS; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; PREDICTION	Hyaluronan is an acidic heteropolysaccharide comprising alternating N-acetylglucosamine and glucuronic acid sugars that is ubiquitously expressed in the vertebrate extracellular matrix(1). The high-molecular-mass polymer modulates essential physiological processes in health and disease, including cell differentiation, tissue homeostasis and angiogenesis(2). Hyaluronan is synthesized by a membrane-embedded processive glycosyltransferase, hyaluronan synthase (HAS), which catalyses the synthesis and membrane translocation of hyaluronan from uridine diphosphate-activated precursors(3,4). Here we describe five cryo-electron microscopy structures of a viral HAS homologue at different states during substrate binding and initiation of polymer synthesis. Combined with biochemical analyses and molecular dynamics simulations, our data reveal how HAS selects its substrates, hydrolyses the first substrate to prime the synthesis reaction, opens a hyaluronan-conducting transmembrane channel, ensures alternating substrate polymerization and coordinates hyaluronan inside its transmembrane pore. Our research suggests a detailed model for the formation of an acidic extracellular heteropolysaccharide and provides insights into the biosynthesis of one of the most abundant and essential glycosaminoglycans in the human body.	[Maloney, Finn P.; Kuklewicz, Jeremi; Ho, Ruoya; Zimmer, Jochen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Corey, Robin A.] Univ Oxford, Dept Biochem, Oxford, England; [Bi, Yunchen] Pilot Natl Lab Marine Sci & Technol Qingdao, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Mateusiak, Lukasz] Vrije Univ Brussel, Lab Vivo Cellular & Mol Imaging, ICMI BEFY, Brussels, Belgium; [Pardon, Els; Steyaert, Jan] VIB, VIB VUB Ctr Struct Biol, Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Stansfeld, Phillip J.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Stansfeld, Phillip J.] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Bi, Yunchen] Chinese Acad Sci, Ctr Ocean Megasci, Inst Oceanol, CAS & Shandong Prov Key Lab Expt Marine Biol, Qingdao, Peoples R China	University of Virginia; University of Oxford; Qingdao National Laboratory for Marine Science & Technology; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Warwick; University of Warwick; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zimmer, J (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu	steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Corey, Robin A/AAI-7251-2020; Stansfeld, Phill/C-6213-2011	Steyaert, Jan/0000-0002-3825-874X; Corey, Robin A/0000-0003-1820-7993; Pardon, Els/0000-0002-2466-0172; Mateusiak, Lukasz/0000-0002-2837-8342; Zimmer, Jochen/0000-0002-8423-2882; Kuklewicz, Jeremi/0000-0002-2204-8844; Stansfeld, Phill/0000-0001-8800-7669	Instruct-ERIC, part of the European Strategy Forum on Research Infrastructures (ESFRI); Research Foundation-Flanders (FWO); NIH [R21AI148853, R01GM101001]; Wellcome [208361/Z/17/Z]; BBSRC [BB/P01948X/1, BB/R002517/1, BB/S003339/1]; MRC [MR/S009213/1]	Instruct-ERIC, part of the European Strategy Forum on Research Infrastructures (ESFRI); Research Foundation-Flanders (FWO)(FWO); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Dryden and M. Purdy from the MEMC at the University of Virginia as well as A. Wier and the support staff at the NCI-NCEF. E.P. and J.S. acknowledge the support of Instruct-ERIC, part of the European Strategy Forum on Research Infrastructures (ESFRI), and the Research Foundation-Flanders (FWO) for supporting the nanobody discovery and thank E. Beke for technical assistance. J.Z. and F.P.M. were supported by NIH grant R21AI148853. R.H. was supported by NIH grant R01GM101001 (awarded to J.Z.). R.A.C. and P.J.S. are supported by Wellcome (208361/Z/17/Z). P.J.S.'s laboratory is supported by awards from the BBSRC (BB/P01948X/1, BB/R002517/1 and BB/S003339/1) and the MRC (MR/S009213/1). P.J.S. acknowledges the University of Warwick Scientific Computing Research Technology Platform for computational access.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2021, PYMOL PYMOL MOL GRAP; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Blackburn MR, 2018, GLYCOBIOLOGY, V28, P108, DOI 10.1093/glycob/cwx096; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Cowman MK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00261; Cyphert Jaime M, 2015, Int J Cell Biol, V2015, P563818, DOI 10.1155/2015/563818; DeAngelis PL, 1999, CELL MOL LIFE SCI, V56, P670, DOI 10.1007/s000180050461; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kelly SJ, 2001, GLYCOBIOLOGY, V11, P297, DOI 10.1093/glycob/11.4.297; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; McManus JB, 2018, ACS OMEGA, V3, P2690, DOI 10.1021/acsomega.7b01808; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Orlean Peter, 2019, Cell Surf, V5, P100017, DOI 10.1016/j.tcsw.2018.100017; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Purushotham P, 2020, SCIENCE, V369, P1089, DOI 10.1126/science.abb2978; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wu Q, 2020, BIOINFORMATICS, V36, P41, DOI 10.1093/bioinformatics/btz477; Yang J, 2017, BIOMACROMOLECULES, V18, P1064, DOI 10.1021/acs.biomac.6b01239	50	7	7	19	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					195	+		10.1038/s41586-022-04534-2	http://dx.doi.org/10.1038/s41586-022-04534-2		MAR 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355017	Green Accepted, Green Published			2022-12-28	WOS:000776020400006
J	Cao, JJ; Belousoff, MJ; Liang, YL; Johnson, RM; Josephs, TM; Fletcher, MM; Christopoulos, A; Hay, DL; Danev, R; Wootten, D; Sexton, PM				Cao, Jianjun; Belousoff, Matthew J.; Liang, Yi-Lynn; Johnson, Rachel M.; Josephs, Tracy M.; Fletcher, Madeleine M.; Christopoulos, Arthur; Hay, Debbie L.; Danev, Radostin; Wootten, Denise; Sexton, Patrick M.			A structural basis for amylin receptor phenotype	SCIENCE			English	Article							GENE-RELATED PEPTIDE; CRYO-EM STRUCTURE; CALCITONIN RECEPTOR; SALMON-CALCITONIN; DUAL AMYLIN; BODY-WEIGHT; DIFFERENTIALLY MODULATE; PROTEIN-INTERACTION; BINDING; PRAMLINTIDE	Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMY(1)R, AMY(2)R, and AMY(3)R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY(1)R with salmon CT (sCT), AMY(2)R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.	[Cao, Jianjun; Belousoff, Matthew J.; Liang, Yi-Lynn; Johnson, Rachel M.; Josephs, Tracy M.; Fletcher, Madeleine M.; Christopoulos, Arthur; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia; [Cao, Jianjun; Belousoff, Matthew J.; Johnson, Rachel M.; Josephs, Tracy M.; Christopoulos, Arthur; Wootten, Denise; Sexton, Patrick M.] Monash Univ, ARC Ctr Cryo Electron Microscopy Membrane Prot, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Hay, Debbie L.] Univ Otago, Dept Pharmacol & Toxicol, Dunedin 9054, New Zealand; [Danev, Radostin] Univ Tokyo, Grad Sch Med, Bunkyo Ku, N415,7-3-1 Hongo, Tokyo 1130033, Japan; [Belousoff, Matthew J.] Confo Therapeut, B-9052 Ghent, Belgium; [Fletcher, Madeleine M.] GlaxoSmithKline, Abbotsford, Vic 3067, Australia	Monash University; Monash University; University of Otago; University of Tokyo; GlaxoSmithKline	Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia.; Wootten, D; Sexton, PM (corresponding author), Monash Univ, ARC Ctr Cryo Electron Microscopy Membrane Prot, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.	denise.wootten@monash.edu; patrick.sexton@monash.edu	Christopoulos, Arthur/B-6207-2013; Belousoff, Matthew/N-4066-2017	Christopoulos, Arthur/0000-0003-4442-3294; Cao, Jianjun/0000-0001-9160-0228; Josephs, Tracy/0000-0002-7799-3683; Wootten, Denise/0000-0003-4563-1642; Hay, Debbie/0000-0002-9558-5122; Danev, Radostin/0000-0001-6406-8993; Liang, Yi-Lynn/0000-0001-6948-5550; Belousoff, Matthew/0000-0002-3229-474X	Monash University Ramaciotti Centre for Cryo-Electron Microscopy; Monash MASSIVE high-performance; National Institutes of Health [R01-GM129325]; Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases; Australian Research Council (ARC) [IC200100052]; National Health and Medical Research Council of Australia (NHMRC) [1120919, 1159006, 1154434, 1155302]; Victoria Endowment for Science Knowledge and Innovation; Takeda Science Foundation; Japan Science and Technology Agency (PRESTO) [18069571]	Monash University Ramaciotti Centre for Cryo-Electron Microscopy; Monash MASSIVE high-performance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victoria Endowment for Science Knowledge and Innovation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST))	This work was supported by the Monash University Ramaciotti Centre for Cryo-Electron Microscopy and the Monash MASSIVE high-performance computing facility. Figures were created with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from National Institutes of Health grant R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases. This work was also funded by the Australian Research Council (ARC Centre grant IC200100052 to P.M.S. and D.W.); the National Health and Medical Research Council of Australia (NHMRC project grant 1120919 to P.M.S.; NHMRC project grant 1159006 to D.W.; NHMRC program grant 1150083 to P.M.S. and A.C.; NHMRC senior principal research fellowship 1154434 to P.M.S.; and NHMRC senior research fellowship 1155302 to D.W.); the Victoria Endowment for Science Knowledge and Innovation (fellowship to T.M.J.); the Takeda Science Foundation (2019 Medical Research Grant to R.D.); and the Japan Science and Technology Agency (PRESTO grant 18069571 to R.D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014; Aronne L, 2007, J CLIN ENDOCR METAB, V92, P2977, DOI 10.1210/jc.2006-2003; Aronne LJ, 2010, OBESITY, V18, P1739, DOI 10.1038/oby.2009.478; Binkley N, 2012, J BONE MINER RES, V27, P1821, DOI 10.1002/jbmr.1602; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Bower RL, 2018, ACS PHARMACOL TRANSL, V1, P32, DOI 10.1021/acsptsci.8b00002; Chan KY, 2012, BIOPOLYMERS, V97, P678, DOI 10.1002/bip.22042; Chelikani PK, 2007, AM J PHYSIOL-REG I, V293, pR1798, DOI 10.1152/ajpregu.00386.2007; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; dal Maso E, 2019, ACS PHARMACOL TRANSL, V2, P31, DOI 10.1021/acsptsci.8b00056; Dal Maso E, 2018, BIOCHEM PHARMACOL, V150, P212, DOI 10.1016/j.bcp.2018.02.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enebo LB, 2021, LANCET, V397, P1736, DOI 10.1016/S0140-6736(21)00845-X; EPAND RM, 1990, EUR J BIOCHEM, V188, P633, DOI 10.1111/j.1432-1033.1990.tb15444.x; Feigh M, 2011, DIABETES OBES METAB, V13, P911, DOI 10.1111/j.1463-1326.2011.01425.x; Fletcher MM, 2021, J PHARMACOL EXP THER, V377, DOI 10.1124/jpet.121.000567; Furness SGB, 2016, CELL, V167, P739, DOI 10.1016/j.cell.2016.09.021; Garelja ML, 2020, ACS PHARMACOL TRANSL, V3, P246, DOI 10.1021/acsptsci.9b00083; Gingell JJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.12; Gingell JJ, 2014, ENDOCRINOLOGY, V155, P21, DOI 10.1210/en.2013-1658; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Guo H, 2020, IUCRJ, V7, P860, DOI 10.1107/S205225252000929X; Gydesen S, 2017, AM J PHYSIOL-ENDOC M, V313, pE598, DOI 10.1152/ajpendo.00419.2016; Gydesen S, 2016, AM J PHYSIOL-ENDOC M, V310, pE821, DOI 10.1152/ajpendo.00514.2015; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hay DL, 2014, BRIT J PHARMACOL, V171, P415, DOI 10.1111/bph.12464; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; HOUSSAMI S, 1995, MOL PHARMACOL, V47, P798; Johansson E, 2016, J BIOL CHEM, V291, P13689, DOI 10.1074/jbc.M116.726034; Kruse T, 2021, J MED CHEM, V64, P11183, DOI 10.1021/acs.jmedchem.1c00565; Larsen AT, 2020, J PHARMACOL EXP THER, V374, P74, DOI 10.1124/jpet.119.263392; Larsen AT, 2020, J PHARMACOL EXP THER, V373, P269, DOI 10.1124/jpet.119.263400; Larsen AT, 2019, J PHARMACOL EXP THER, V370, P35, DOI 10.1124/jpet.119.257576; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SM, 2020, J MOL BIOL, V432, P1996, DOI 10.1016/j.jmb.2020.01.028; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Lee SM, 2020, BIOPHYS CHEM, V267, DOI 10.1016/j.bpc.2020.106477; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Liang YL, 2020, MOL CELL, V77, P656, DOI 10.1016/j.molcel.2020.01.012; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lutz TA, 2000, PEPTIDES, V21, P233, DOI 10.1016/S0196-9781(99)00208-9; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Mack CM, 2011, DIABETES OBES METAB, V13, P1105, DOI 10.1111/j.1463-1326.2011.01465.x; MAIER R, 1976, CLIN ENDOCRINOL, V5, pS327, DOI 10.1111/j.1365-2265.1976.tb03841.x; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mathiesen DS, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.617400; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Musa H, 2019, BIOCHEMISTRY-US, V58, P3468, DOI 10.1021/acs.biochem.9b00571; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; ORLOWSKI RC, 1987, EUR J BIOCHEM, V162, P399, DOI 10.1111/j.1432-1033.1987.tb10615.x; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qi T, 2008, MOL PHARMACOL, V74, P1059, DOI 10.1124/mol.108.047142; Udawela M, 2006, MOL PHARMACOL, V70, P1750, DOI 10.1124/mol.106.024257; Udawela M, 2006, MOL PHARMACOL, V69, P1984, DOI 10.1124/mol.105.021915; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wells G, 2016, OSTEOPOROSIS INT, V27, P13, DOI 10.1007/s00198-015-3339-z; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yen HY, 2018, NATURE, V559, P424, DOI 10.1038/s41586-018-0325-6; Zakariassen HL, 2020, BASIC CLIN PHARMACOL, V127, P163, DOI 10.1111/bcpt.13427; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	71	5	5	6	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1371	+	eabm9609	10.1126/science.abm9609	http://dx.doi.org/10.1126/science.abm9609			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324283				2022-12-28	WOS:000778894800034
J	Fletcher, RJ; Zwierlein, M				Fletcher, Richard J.; Zwierlein, Martin			Photons think inside the box	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; LONG-RANGE ORDER		[Fletcher, Richard J.; Zwierlein, Martin] MIT, Harvard Ctr Ultracold Atoms, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fletcher, Richard J.; Zwierlein, Martin] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fletcher, RJ (corresponding author), MIT, Harvard Ctr Ultracold Atoms, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Fletcher, RJ (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	rfletch@mit.edu			National Science Foundation through the Center for UltracoldAtoms,Air Force Office of Scientific Research; Vannevar Bush Faculty Fellowship	National Science Foundation through the Center for UltracoldAtoms,Air Force Office of Scientific Research; Vannevar Bush Faculty Fellowship	The authors acknowledge support from the National Science Foundation through the Center for UltracoldAtoms,Air Force Office of Scientific Research, and M.Z. acknowledges support through the Vannevar Bush Faculty Fellowship.	BAGNATO V, 1991, PHYS REV A, V44, P7439, DOI 10.1103/PhysRevA.44.7439; BEREZINSKII VL, 1972, SOV PHYS JETP-USSR, V34, P610; Busley E, 2022, SCIENCE, V375, P1403, DOI 10.1126/science.abm2543; Clark LW, 2020, NATURE, V582, P41, DOI 10.1038/s41586-020-2318-5; Fletcher RJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255302; HOHENBERG PC, 1967, PHYS REV, V158, P383, DOI 10.1103/PhysRev.158.383; Klaers J, 2010, NATURE, V468, P545, DOI 10.1038/nature09567; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Navon N, 2021, NAT PHYS, V17, P1334, DOI 10.1038/s41567-021-01403-z; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361	10	0	0	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1355	1356		10.1126/science.abo2856	http://dx.doi.org/10.1126/science.abo2856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324311				2022-12-28	WOS:000778894800025
J	Kucharski, AJ; Cohen, C				Kucharski, Adam J.; Cohen, Cheryl			Effective surveillance of variants	SCIENCE			English	Editorial Material							SOUTH-AFRICA; COHORT		[Kucharski, Adam J.] London Sch Hyg & Trop Med, Ctr Epidem Preparedness & Response, London, England; [Cohen, Cheryl] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Kucharski, AJ (corresponding author), London Sch Hyg & Trop Med, Ctr Epidem Preparedness & Response, London, England.	adam.kucharski@lshtm.ac.uk						Chapman LAC, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.1.2101038; Cohen C, 2021, LANCET GLOB HEALTH, V9, pE863, DOI 10.1016/S2214-109X(21)00141-8; Elliott P, 2022, SCIENCE, V375, P1406, DOI 10.1126/science.abn8347; European Centre for Disease Prevention and Control (ECDC), 2021, THREATASSESSMENT BRI; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Houlihan C. F, 2020, LANCET; Kissler SM, 2021, NEW ENGL J MED, V385, P2489, DOI 10.1056/NEJMc2102507; Kleynhans J, 2021, EMERG INFECT DIS, V27, P3020, DOI 10.3201/eid2712.211465; Koopmans M, 2019, LANCET INFECT DIS, V19, pE59, DOI 10.1016/S1473-3099(18)30497-3; Kucharski A.J., 2021, CMMID COVID 19WORKIN; Munafo MR, 2018, NATURE, V553, P399, DOI 10.1038/d41586-018-01023-3; Public Health England, INVESTIGATION SARS C; RadioNew Zealand (RNZ), RNZ3JANUARY 2021; Riley S, 2021, WORKING PAPER; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4	15	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1349	1350		10.1126/science.abo4257	http://dx.doi.org/10.1126/science.abo4257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324314	Green Submitted			2022-12-28	WOS:000778894800021
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government left "inadequate" paper trail when awarding testing contracts, says watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, 2022, INV GOV CONTR RAND L	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o789	10.1136/bmj.o789	http://dx.doi.org/10.1136/bmj.o789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331990	Bronze			2022-12-28	WOS:000778460100020
J	Cluver, L; Perks, B; Rakotomalala, S; Maalouf, W				Cluver, Lucie; Perks, Ben; Rakotomalala, Sabine; Maalouf, Wadih			Ukraine's children: Use evidence to support child protection in emergencies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cluver, Lucie] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Cluver, Lucie] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Perks, Ben] UNICEF HQ, New York, NY USA; [Perks, Ben] Univ Birmingham, Jubilee Ctr, Birmingham, W Midlands, England; [Rakotomalala, Sabine] WHO, Violence Prevent Unit, Geneva, Switzerland; [Maalouf, Wadih] UN Off Drugs & Crime, Vienna, Austria	University of Oxford; University of Cape Town; UNICEF; University of Birmingham; World Health Organization	Cluver, L (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford, England.; Cluver, L (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa.			Perks, Benjamin/0000-0002-4098-5372				[Anonymous], 2020, GUIDANCE ALTERNATIVE; [Anonymous], 2022, UNACCOMPANIED SEPARA; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Cappa C, 2021, CHILD ABUSE NEGLECT, V116, DOI 10.1016/j.chiabu.2021.105053; Dhaliwal M, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2021-068123; Gardner F, 2021, GLOBAL REV EVIDENCE; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; UNHCR. UNICEF UNDP UNFPA, 2022, UKR RESP PROT SNAPSH; UNICEF. WHO Parenting for Lifelong Health ECDAN., 2021, GLOB PARTN END VIOL; Unwin HJT, 2022, LANCET CHILD ADOLESC, V6, P249, DOI 10.1016/S2352-4642(22)00005-0; World Health Organisation, 2018, INSPIRE HDB ACT IMPL	12	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o781	10.1136/bmj.o781	http://dx.doi.org/10.1136/bmj.o781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321861	Bronze			2022-12-28	WOS:000790072700007
J	Slomski, A				Slomski, Anita			Trial Suggests Starting Peanut Oral Immunotherapy Early	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1118	1118		10.1001/jama.2022.2442	http://dx.doi.org/10.1001/jama.2022.2442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315890				2022-12-28	WOS:000775589900010
J	Wang, W; Zhang, MJ; Inciardi, RM; Norby, FL; Johansen, MC; Parikh, R; Van't Hof, JR; Alonso, A; Soliman, EZ; Mosley, TH; Gottesman, RF; Shah, AM; Solomon, SD; Chen, LY				Wang, Wendy; Zhang, Michael J.; Inciardi, Riccardo M.; Norby, Faye L.; Johansen, Michelle C.; Parikh, Romil; Van't Hof, Jeremy R.; Alonso, Alvaro; Soliman, Elsayed Z.; Mosley, Thomas H.; Gottesman, Rebecca F.; Shah, Amil M.; Solomon, Scott D.; Chen, Lin Yee			Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; RESERVOIR FUNCTION; COMMUNITIES; VOLUME; FIBRILLATION; PREDICTION; ABNORMALITIES; SURVIVAL; OUTCOMES	Question Are lower (worse) left atrial (LA) function and greater LA size associated with increased risk of subsequent dementia? Findings In this retrospective cohort study that included 4096 participants, there were statistically significant associations between measures of lower LA function and incident dementia comparing the lowest vs highest quintile for LA reservoir strain (HR, 1.98), conduit strain (HR, 1.50), contractile strain (HR, 1.57), emptying fraction (HR, 1.87), and active emptying fraction (HR, 1.43). Measures of LA size were not significantly associated with incident dementia. Meaning The findings suggest that impaired LA function may be a risk factor associated with dementia. This exploratory retrospective analysis evaluated the association of echocardiographic measures of left atrial function and size with incident dementia in a large community-based cohort. Importance Atrial myopathy-characterized by alterations in left atrial (LA) function and size-is associated with ischemic stroke, independent of atrial fibrillation (AF). Electrocardiographic markers of atrial myopathy are associated with dementia, but it is unclear whether 2-dimensional echocardiographic (2DE)-defined LA function and size are associated with dementia. Objective To examine the association of LA function and size with incident dementia. Design, Setting, and Participants The Atherosclerosis Risk in Communities (ARIC) study is a community-based prospective cohort. An exploratory, retrospective analysis was conducted. ARIC centers are located in Forsyth County, North Carolina; Jackson, Mississippi; Washington County, Maryland; and suburban Minneapolis, Minnesota. For this analysis, visit 5 (2011-2013) served as the baseline. Participants without prevalent AF and stroke and who had 2DEs in 2011-2013 were included and surveilled through December 31, 2019. Exposures LA function (reservoir strain, conduit strain, contractile strain, emptying fraction, passive emptying fraction, and active emptying fraction), and LA size (maximal and minimal volume index) as evaluated by 2DE. Main Outcomes and Measures Dementia cases were identified using in-person and phone cognitive assessments, hospitalization codes, and death certificates. Cox proportional hazards models were used. Results Among 4096 participants (mean [SD] age, 75 [5] years; 60% women; 22% Black individuals), 531 dementia cases were ascertained over a median follow-up of 6 years. Dementia incidence for the lowest LA quintile was 4.80 for reservoir strain, 3.94 for conduit strain, 3.29 for contractile strain, 4.20 for emptying fraction, 3.67 for passive emptying fraction, and 3.27 for active emptying fraction per 100 person-years. After full-model adjustments, there were statistically significant associations between measures of LA function and dementia; the hazard ratios (HRs) from the lowest vs highest quintile for reservoir strain were 1.98 (95% CI, 1.42-2.75); for conduit strain, 1.50 (95% CI, 1.09-2.06); for contractile strain, 1.57 (95% CI, 1.16-2.14); for emptying fraction, 1.87 (95% CI, 1.31-2.65); and for active emptying fraction, 1.43 (95% CI, 1.04-1.96). LA passive emptying fraction was not significantly associated with dementia (HR, 1.26 [95% CI, 0.93-1.71]). Dementia incidence for the highest LA maximal volume index quintile was 3.18 per 100 person-years (HR for highest vs lowest quintile, 0.77 [95% CI, 0.58-1.02]) and for the highest minimal volume index quintile was 3.50 per 100 person-years (HR for the highest vs lowest quintile, 0.95 [95% CI, 0.71-1.28]). Both measures were not significantly associated with dementia. These findings were robust to sensitivity analyses that excluded participants with incident AF or stroke. Conclusions and Relevance In this exploratory analysis of a US community-based cohort, several echocardiographic measures of lower LA function were significantly associated with an increased risk of subsequent dementia. Measures of LA size were not significantly associated with dementia risk. These findings suggest that impaired LA function may be a risk factor associated with dementia.	[Wang, Wendy; Parikh, Romil] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S Second St,Ste 300, Minneapolis, MN 55454 USA; [Zhang, Michael J.; Van't Hof, Jeremy R.; Chen, Lin Yee] Univ Minnesota, Med Sch, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA; [Inciardi, Riccardo M.] Univ Brescia, Inst Cardiol, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy; [Norby, Faye L.] Cedars Sinai Smidt Heart Inst, Ctr Cardiac Arrest Prevent, Dept Cardiol, Los Angeles, CA USA; [Johansen, Michelle C.; Gottesman, Rebecca F.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Alonso, Alvaro] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr, Dept Internal Med, Cardiovasc Med Sect, Winston Salem, NC 27101 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, MIND Ctr, Jackson, MS 39216 USA; [Gottesman, Rebecca F.] NINDS, Stroke Branch, Intramural Res Program, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Shah, Amil M.; Solomon, Scott D.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Brescia; Cedars Sinai Medical Center; Johns Hopkins University; Emory University; Rollins School Public Health; Wake Forest University; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Brigham & Women's Hospital	Wang, W (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S Second St,Ste 300, Minneapolis, MN 55454 USA.	wang5694@umn.edu	Norby, Faye/FNA-7255-2022; Van't Hof, Jeremy/AAQ-2005-2020	Norby, Faye/0000-0002-1975-0405; Van't Hof, Jeremy/0000-0002-9982-3685; Johansen, Michelle C./0000-0003-0393-3589; Parikh, Romil/0000-0001-6087-0583; Zhang, Michael/0000-0003-2537-2831; Wang, Wendy/0000-0001-6025-0173	NHLBI [K24HL148521, R01HL126637, R01HL141288, K24HL155813, HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I, U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, 2U01HL096917]; NINDS; National Institute on Aging (NIA); National Institute on Deafness and Other Communication Disorders; National Institute of General Medical Sciences [T32GM132063]; NIA [P30AG066511]; The NHLBI [R01-HL70825, R01HL135008, R01HL143224, R01HL150342, R01HL148218, K24HL152008]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The NHLBI	The Atherosclerosis Risk in Communities study has been funded in whole or in part by grants HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I from the NHLBI; neurocognitive data collection by grants U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, and 2U01HL096917 from the NHLBI, NINDS, National Institute on Aging (NIA), and National Institute on Deafness and Other Communication Disorders; R01-HL70825 for previous brain magnetic resonance imaging examinations from the NHLBI; T32GM132063 from the National Institute of General Medical Sciences (Wang); P30AG066511 from the NIA and K24HL148521 from the NHLBI (Alonso); R01HL126637, R01HL141288, and K24HL155813 from the NHLBI (Chen); and R01HL135008, R01HL143224, R01HL150342, R01HL148218, K24HL152008 from the NHLBI (Shah).	Abhayaratna Walter P, 2008, Am J Cardiol, V101, P1626, DOI 10.1016/j.amjcard.2008.01.051; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Alonso A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006014; Chen Cynthia, 2018, Alzheimers Dement (N Y), V4, P510, DOI 10.1016/j.trci.2018.08.009; Chen LY, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007301; Edwards JD, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013227; Fatema K, 2009, EUR J ECHOCARDIOGR, V10, P282, DOI 10.1093/ejechocard/jen235; Gan GCH, 2020, ECHOCARDIOGR-J CARD, V37, P2018, DOI 10.1111/echo.14922; Gottesman RF, 2017, JAMA NEUROL, V74, P1246, DOI 10.1001/jamaneurol.2017.1658; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Gupta S, 2013, EUR HEART J, V34, P278, DOI 10.1093/eurheartj/ehs188; Gutierrez A, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.014553; Habibi M, 2019, JACC-CARDIOVASC IMAG, V12, P2417, DOI 10.1016/j.jcmg.2019.02.021; Hedberg P, 2017, HEART, V103, P687, DOI 10.1136/heartjnl-2016-310242; Hedberg P, 2016, INT J CARDIOVAS IMAG, V32, P417, DOI 10.1007/s10554-015-0800-1; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Inciardi RM, 2019, EUR J HEART FAIL, V21, P1571, DOI 10.1002/ejhf.1606; Karadag B, 2013, J CLIN NEUROSCI, V20, P1074, DOI 10.1016/j.jocn.2012.10.021; Knopman David S, 2016, Alzheimers Dement (Amst), V2, P1; Knopman DS, 2015, STROKE, V46, P433, DOI 10.1161/STROKEAHA.114.007847; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Martinez-Selles M, 2020, INT J CARDIOL, V321, P95, DOI 10.1016/j.ijcard.2020.08.006; Power MC, 2021, JAMA NEUROL, V78, P275, DOI 10.1001/jamaneurol.2020.4471; Rooney MR, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007390; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Russo C, 2013, JACC-CARDIOVASC IMAG, V6, P313, DOI 10.1016/j.jcmg.2012.10.019; Shah AM, 2014, CIRC-CARDIOVASC IMAG, V7, P173, DOI 10.1161/CIRCIMAGING.113.000736; Shin SH, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019545; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Sorrentino R, 2020, J AM SOC ECHOCARDIOG, V33, P171, DOI 10.1016/j.echo.2019.08.013; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2003, J AM COLL CARDIOL, V42, P1199, DOI 10.1016/S0735-1097(03)00943-4; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wright JD, 2021, J AM COLL CARDIOL, V77, P2939, DOI 10.1016/j.jacc.2021.04.035; Zhang MHJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013197	39	10	10	3	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1138	1148		10.1001/jama.2022.2518	http://dx.doi.org/10.1001/jama.2022.2518			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315884	Green Published			2022-12-28	WOS:000775589900020
J	Atkin, B; Dupley, L; Chakravorty, P; Zafar, K; Boden, R				Atkin, B.; Dupley, L.; Chakravorty, P.; Zafar, K.; Boden, R.			Approach to patients with a potential prosthetic joint infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; MARKERS		[Atkin, B.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Dupley, L.; Chakravorty, P.; Boden, R.] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England; [Zafar, K.] New Collegiate Med Ctr, Cheetham Hill & Crumpsall Primary Care Network, Manchester, Lancs, England	University of Birmingham	Atkin, B (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	bmlatkin@gmail.com						Aresti N, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4431; Barretto João Maurício, 2017, Rev. bras. ortop., V52, P176, DOI 10.1016/j.rboe.2016.05.009; Berbari E, 2010, J BONE JOINT SURG AM, V92A, P2102, DOI 10.2106/JBJS.I.01199; British Orthopaedic Association, INVESTIGATION MANAGE; Cyteval Catherine, 2012, Diagn Interv Imaging, V93, P547, DOI 10.1016/j.diii.2012.03.004; Daniels R, 2018, SEPSIS MANUAL; Deirmengian C, 2015, CLIN ORTHOP RELAT R, V473, P198, DOI 10.1007/s11999-014-3722-7; Drago L, 2011, INT J IMMUNOPATH PH, V24, P433, DOI 10.1177/039463201102400216; Escudero-Sanchez R, 2020, CLIN MICROBIOL INFEC, V26, P499, DOI 10.1016/j.cmi.2019.09.007; Fischbacher Arnaud, 2019, J Bone Jt Infect, V4, P198, DOI 10.7150/jbji.35428; Garfield K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01803-7; Iqbal F, 2020, CLIN ORTHOP SURG, V12, P470, DOI 10.4055/cios20037; Izakovicova P, 2019, EFORT OPEN REV, V4, P482, DOI 10.1302/2058-5241.4.180092; Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0; Kunutsor SK, 2018, J INFECTION, V77, P479, DOI 10.1016/j.jinf.2018.08.017; Kunutsor SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150866, 10.1371/journal.pone.0151537]; Lee Hee Dong, 2015, Hip Pelvis, V27, P63, DOI 10.5371/hp.2015.27.2.63; Lenguerrand E, 2019, LANCET INFECT DIS, V19, P589, DOI 10.1016/S1473-3099(18)30755-2; McNally M, 2021, BONE JOINT J, V103B, P18, DOI 10.1302/0301-620X.103B1.BJJ-2020-1381.R1; Moran E, 2007, J INFECTION, V55, P1, DOI 10.1016/j.jinf.2007.01.007; Osmon DR, 2013, CLIN INFECT DIS, V56, P1, DOI [10.1093/cid/cis966, 10.1093/cid/cis803]; Parvizi J, 2018, J ARTHROPLASTY, V33, P1309, DOI 10.1016/j.arth.2018.02.078; Ren XL, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04647-1; Tan Timothy L, 2018, JB JS Open Access, V3, pe0060, DOI 10.2106/JBJS.OA.17.00060; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Visuri T, 2006, J ARTHROPLASTY, V21, P311, DOI 10.1016/j.arth.2005.03.046; Watanabe S, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02450-1; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	29	0	0	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								e069502	10.1136/bmj-2021-069502	http://dx.doi.org/10.1136/bmj-2021-069502			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314426				2022-12-28	WOS:000773915700008
J	Mahase, E				Mahase, Elisabeth			Study questions relationship between statins and cardiovascular outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Byrne P, 2022, JAMA INTERN MED, V182, P474, DOI 10.1001/jamainternmed.2022.0134; Byrne P, 2019, BRIT J GEN PRACT, V69, pE373, DOI 10.3399/bjgp19X702701	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o712	10.1136/bmj.o712	http://dx.doi.org/10.1136/bmj.o712			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301189				2022-12-28	WOS:000796719200014
J	Tangye, SG; Burnett, DL; Bull, RA				Tangye, Stuart G.; Burnett, Deborah L.; Bull, Rowena A.			Getting to the (germinal) center of humoral immune responses to SARS-CoV-2	CELL			English	Article								Long-term protection against SARS-CoV-2 requires effective and durable immunity. In this issue of Cell, two papers closely examine germinal centers, the physiological birthplace of adaptive immunity, to quantify the specificity, breadth, magnitude, and persistence of systemic and local humoral immune responses following natural infection with, or vaccination against, SARS-CoV-2.	[Tangye, Stuart G.; Burnett, Deborah L.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Tangye, Stuart G.; Burnett, Deborah L.] UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Bull, Rowena A.] UNSW Sydney, Sch Med Sci, Fac Med & Hlth, Kensington, NSW, Australia; [Bull, Rowena A.] UNSW Sydney, Kirby Inst, Kensington, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute	Tangye, SG (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW, Australia.; Tangye, SG (corresponding author), UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW, Australia.	s.tangye@garvan.org.au						Bok K, 2021, IMMUNITY, V54, P1636, DOI 10.1016/j.immuni.2021.07.017; Burnett DL, 2021, IMMUNITY, V54, P2908, DOI 10.1016/j.immuni.2021.10.019; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Laidlaw BJ, 2022, NAT REV IMMUNOL, V22, P7, DOI 10.1038/s41577-021-00657-1; Lederer K, 2022, CELL, V185, P1008, DOI 10.1016/j.cell.2022.01.027; Roltgen K, 2022, CELL, V185, P1025, DOI 10.1016/j.cell.2022.01.018; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Slifka MK, 2014, VACCINE, V32, P2948, DOI 10.1016/j.vaccine.2014.03.078; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Wheatley AK, 2021, TRENDS IMMUNOL, V42, P956, DOI 10.1016/j.it.2021.09.001	12	2	2	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2022	185	6					945	948		10.1016/j.cell.2022.02.018	http://dx.doi.org/10.1016/j.cell.2022.02.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZZ6CW	35303427	Bronze, Green Published			2022-12-28	WOS:000773355400004
J	Thornton, J				Thornton, Jacqui			Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], ANTICOV CLIN TRIAL; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2713; Mazaherpour H., 2022, BIOMED RES INT, V2022, DOI [10.1155/2022/1522426, DOI 10.1155/2022/1522426]	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o721	10.1136/bmj.o721	http://dx.doi.org/10.1136/bmj.o721			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301222	Bronze			2022-12-28	WOS:000796719200009
J	Watts, G				Watts, Geoff			Alberto Garcia-Basteiro: seeking better TB control in Mozambique	LANCET			English	Editorial Material															Steve Lawn Memorial Fund; International Union Against Tuberculosis and Lung Disease; Lancet; London School of Hygiene & Tropical Medicine; University of Cape Town	Steve Lawn Memorial Fund; International Union Against Tuberculosis and Lung Disease; Lancet; London School of Hygiene & Tropical Medicine; University of Cape Town	The Stephen Lawn TB-HIV Research Leadership Prize is funded by the Steve Lawn Memorial Fund and awarded annually by The International Union Against Tuberculosis and Lung Disease, with the London School of Hygiene & Tropical Medicine, the University of Cape Town, and The Lancet.		0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1109	1109						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305731				2022-12-28	WOS:000770814300011
J	Yakovenko, V; Brauner, R; Votinov, E; Goldfarb, Y; Zimhony, O				Yakovenko, Victoria; Brauner, Ron; Votinov, Ekaterina; Goldfarb, Yigal; Zimhony, Oren			Infective endocarditis and thromboses due to antiphospholipid syndrome following acute Q fever	LANCET			English	Editorial Material									[Yakovenko, Victoria; Zimhony, Oren] Kaplan Med Ctr, Infect Dis Unit, POB 1, Rehovot, Israel; [Brauner, Ron] Kaplan Med Ctr, Dept Cardiothorac Surg, Rehovot, Israel; [Votinov, Ekaterina] Kaplan Med Ctr, Haematol Inst, Rehovot, Israel; [Goldfarb, Yigal] Kaplan Med Ctr, Dept Radiol, Rehovot, Israel; [Yakovenko, Victoria; Brauner, Ron; Votinov, Ekaterina; Goldfarb, Yigal; Zimhony, Oren] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem	Zimhony, O (corresponding author), Kaplan Med Ctr, Infect Dis Unit, POB 1, Rehovot, Israel.	oren_z@clalit.org.il							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1154	1154						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305741				2022-12-28	WOS:000770814300023
J	Patel, JR; Oh, J; Wang, SQ; Crawford, JM; Isaacs, FJ				Patel, Jaymin R.; Oh, Joonseok; Wang, Shenqi; Crawford, Jason M.; Isaacs, Farren J.			Cross-kingdom expression of synthetic genetic elements promotes discovery of metabolites in the human microbiome	CELL			English	Article							CHROMOBACTERIUM-VIOLACEUM; FUNCTIONAL METAGENOMICS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; TN5 TRANSPOSASE; IN-VITRO; DESIGN; TRANSCRIPTION; OPTIMIZATION; CLUSTERS	Small molecules encoded by biosynthetic pathways mediate cross-species interactions and harbor untapped potential, which has provided valuable compounds for medicine and biotechnology. Since studying biosynthetic gene clusters in their native context is often difficult, alternative efforts rely on heterologous expression, which is limited by host-specific metabolic capacity and regulation. Here, we describe a computational-experimental technology to redesign genes and their regulatory regions with hybrid elements for cross-species expression in Gram-negative and -positive bacteria and eukaryotes, decoupling biosynthetic capacity from host-range constraints to activate silenced pathways. These synthetic genetic elements enabled the discovery of a class of microbiome-derived nucleotide metabolites-tyrocitabines-from Lactobacillus iners. Tyrocitabines feature a remarkable orthoester-phosphate, inhibit translational activity, and invoke unexpected biosynthetic machinery, including a class of "Amadori synthases" and "abortive" tRNA synthetases. Our approach establishes a general strategy for the redesign, expression, mobilization, and characterization of genetic elements in diverse organisms and communities.	[Patel, Jaymin R.; Wang, Shenqi; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Patel, Jaymin R.; Wang, Shenqi; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06520 USA; [Patel, Jaymin R.; Oh, Joonseok; Crawford, Jason M.] Yale Univ, Inst Biomol Design & Discovery, West Haven, CT 06520 USA; [Oh, Joonseok; Crawford, Jason M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Crawford, Jason M.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Isaacs, Farren J.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Isaacs, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Isaacs, FJ (corresponding author), Yale Univ, Syst Biol Inst, West Haven, CT 06520 USA.; Crawford, JM (corresponding author), Yale Univ, Inst Biomol Design & Discovery, West Haven, CT 06520 USA.; Crawford, JM (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Crawford, JM (corresponding author), Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA.; Isaacs, FJ (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	jason.crawford@yale.edu; farren.isaacs@yale.edu		Patel, Jaymin/0000-0002-4380-4805; Isaacs, Farren/0000-0001-8615-8236	National Institutes of Health Chemical Biology Training Grant [5T32GM06754]; Yale University; US Department of Energy, Office of Science, Office of Biological and Environmental Research (BER), Secure Biosystems Design Initiative; National Science Foundation [IOS-1923321]; National Institutes of Health [R01CA215553]; Burroughs Wellcome Fund [1016720]; Camille & Henry Dreyfus Foundation [TC-17-011]	National Institutes of Health Chemical Biology Training Grant; Yale University; US Department of Energy, Office of Science, Office of Biological and Environmental Research (BER), Secure Biosystems Design Initiative(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Camille & Henry Dreyfus Foundation	We thank members of the Crawford and Isaacs labs for helpful feedback on this study and Terence Wu for his assistance with chemical instrumentation. J.R.P. acknowledges support from the National Institutes of Health Chemical Biology Training Grant (5T32GM06754). S.W. gratefully acknowledges support from Yale University. F.J.I. gratefully acknowledges support from the US Department of Energy, Office of Science, Office of Biological and Environmental Research (BER), Secure Biosystems Design Initiative and the National Science Foundation (IOS-1923321). J.M.C. gratefully acknowledges support from National Institutes of Health (R01CA215553), the Burroughs Wellcome Fund (1016720), and the Camille & Henry Dreyfus Foundation (TC-17-011).	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Amos GCA, 2017, P NATL ACAD SCI USA, V114, pE11121, DOI 10.1073/pnas.1714381115; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; Arranz-Gibertt P, 2018, CURR OPIN CHEM BIOL, V46, P203, DOI 10.1016/j.cbpa.2018.07.020; Austin MJ, 2019, BIOMATER SCI-UK, V7, P490, DOI 10.1039/c8bm01215f; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bennion BJ, 2017, J PHYS CHEM B, V121, P5228, DOI 10.1021/acs.jpcb.7b02914; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Bishe B, 2019, ISCIENCE, V20, P216, DOI 10.1016/j.isci.2019.09.002; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; Bodor A, 2020, REV ENVIRON SCI BIO, V19, P1, DOI 10.1007/s11157-020-09522-4; Borkowski A, 2016, ECOTOX ENVIRON SAFE, V130, P54, DOI 10.1016/j.ecoenv.2016.04.004; Borujeni AE, 2016, NUCLEIC ACIDS RES, V44, P1, DOI 10.1093/nar/gkv1289; Brophy JAN, 2018, NAT MICROBIOL, V3, P1043, DOI 10.1038/s41564-018-0216-5; BRUAND C, 1993, P NATL ACAD SCI USA, V90, P11668, DOI 10.1073/pnas.90.24.11668; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Casini A, 2018, J AM CHEM SOC, V140, P4302, DOI 10.1021/jacs.7b13292; Cetnar DP, 2021, ACS SYNTH BIOL, V10, P318, DOI 10.1021/acssynbio.0c00471; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chanda D, 2018, TETRAHEDRON LETT, V59, P2983, DOI 10.1016/j.tetlet.2018.06.050; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Colloms SD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1101; Covington BC, 2021, ANNU REV BIOCHEM, V90, P763, DOI 10.1146/annurev-biochem-081420-102432; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; Cravens A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09848-w; Cuperus JT, 2017, GENOME RES, V27, P2015, DOI 10.1101/gr.224964.117; Curran KA, 2015, ACS SYNTH BIOL, V4, P824, DOI 10.1021/sb5003357; Davison EK, 2019, CURR OPIN CHEM BIOL, V52, P1, DOI [10.1016/j.cbpa.2018.12.007, 10.1016/j.cbpa.2018.12.07]; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DELACRUZ NB, 1993, J BACTERIOL, V175, P6932, DOI 10.1128/jb.175.21.6932-6938.1993; Dempwolff F, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02893-19; Der BS, 2017, ACS SYNTH BIOL, V6, P1115, DOI 10.1021/acssynbio.6b00252; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Du DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08740; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; Ghoneim DH, 2019, NUCLEIC ACIDS RES, V47, P1164, DOI 10.1093/nar/gky1262; Gilchrist CLM., 2021, BIOINFORMATICS ADV, V1, DOI [10.1093/bioadv/vbab016, DOI 10.1093/BIOADV/VBAB016]; Glasner ME, 2020, FEBS J, V287, P1323, DOI 10.1111/febs.15185; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Ichikawa Y, 2016, BIOCHEM BIOPH RES CO, V476, P57, DOI 10.1016/j.bbrc.2016.05.063; Inda ME, 2019, TRENDS IMMUNOL, V40, P952, DOI 10.1016/j.it.2019.08.007; Iqbal HA, 2016, J AM CHEM SOC, V138, P9341, DOI 10.1021/jacs.6b02921; Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222; Jain A, 2013, FEMS MICROBIOL LETT, V348, P87, DOI 10.1111/1574-6968.12241; Jin M, 2019, EXP MOL MED, V51, DOI [10.1038/s12276-018-0190-2, 10.1038/s12276-018-0196-9]; Jones JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11301; Kaishima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35932; Kautsar SA, 2020, NUCLEIC ACIDS RES, V48, pD454, DOI 10.1093/nar/gkz882; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kim CS, 2020, ACS CENTRAL SCI, V6, P197, DOI 10.1021/acscentsci.9b01076; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kumar M Ravish, 2012, Int J Appl Basic Med Res, V2, P70, DOI 10.4103/2229-516X.96814; Kushwaha M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8832; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1998, GENETICS, V149, P179; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; LESKIW BK, 1991, P NATL ACAD SCI USA, V88, P2461, DOI 10.1073/pnas.88.6.2461; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; Leventhal DS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16602-0; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li SC, 2018, ACS CHEM BIOL, V13, P2203, DOI 10.1021/acschembio.8b00375; Li YX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09383; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopatkin AJ, 2020, NAT REV MICROBIOL, V18, P507, DOI 10.1038/s41579-020-0372-5; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; MacPherson M, 2017, ACS SYNTH BIOL, V6, P130, DOI 10.1021/acssynbio.6b00165; Martinez-Garcia E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-38; Matsuda Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04983-2; Mauro VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/j.molmed.2014.09.003; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Monteiro PT, 2020, NUCLEIC ACIDS RES, V48, pD642, DOI 10.1093/nar/gkz859; Morse NJ, 2017, ACS SYNTH BIOL, V6, P2086, DOI 10.1021/acssynbio.7b00138; Moutiez M, 2017, CHEM REV, V117, P5578, DOI 10.1021/acs.chemrev.6b00523; Navarro-Munoz JC, 2020, NAT CHEM BIOL, V16, P60, DOI 10.1038/s41589-019-0400-9; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; OSULLIVAN DJ, 1993, GENE, V137, P227, DOI 10.1016/0378-1119(93)90011-Q; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Palaniappan K, 2020, NUCLEIC ACIDS RES, V48, pD422, DOI 10.1093/nar/gkz932; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Puigbo P, 2008, NUCLEIC ACIDS RES, V36, pD524, DOI 10.1093/nar/gkm831; Puri AW, 2015, APPL ENVIRON MICROB, V81, P1766, DOI 10.1128/AEM.03795-14; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Ren HQ, 2017, CURR OPIN BIOTECH, V48, P21, DOI 10.1016/j.copbio.2017.02.008; Ronda C, 2019, NAT METHODS, V16, P167, DOI 10.1038/s41592-018-0301-y; Ross AC, 2015, ACS SYNTH BIOL, V4, P414, DOI 10.1021/sb500280q; Rubin BE, 2022, NAT MICROBIOL, V7, P34, DOI 10.1038/s41564-021-01014-7; Saito K, 2020, ELIFE, V9, DOI 10.7554/eLife.55002; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Santos CNS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3503; Scherlach K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24133-5; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Segall-Shapiro TH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145299; Seyedsayamdost MR, 2014, P NATL ACAD SCI USA, V111, P7266, DOI 10.1073/pnas.1400019111; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shine EE, 2021, ANNU REV BIOCHEM, V90, P789, DOI 10.1146/annurev-biochem-080320-115307; Sidda JD, 2014, CHEM SCI, V5, P86, DOI 10.1039/c3sc52536h; Skinnider MA, 2017, NUCLEIC ACIDS RES, V45, pW49, DOI 10.1093/nar/gkx320; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Sugimoto Y, 2019, SCIENCE, V366, P1332, DOI 10.1126/science.aax9176; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; THOMAS CM, 1987, ANNU REV MICROBIOL, V41, P77, DOI 10.1146/annurev.mi.41.100187.000453; Tian J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10546-0; Tobias NJ, 2019, J MOL BIOL, V431, P4589, DOI 10.1016/j.jmb.2019.04.042; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; TRIEUCUOT P, 1985, EMBO J, V4, P3583, DOI 10.1002/j.1460-2075.1985.tb04120.x; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Vizcaino MI, 2014, J IND MICROBIOL BIOT, V41, P285, DOI 10.1007/s10295-013-1356-5; Wachsmuth M, 2013, NUCLEIC ACIDS RES, V41, P2541, DOI 10.1093/nar/gks1330; Wang GY, 2019, NAT MICROBIOL, V4, P2498, DOI 10.1038/s41564-019-0573-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang YJ, 2007, CHEM RES TOXICOL, V20, P609, DOI 10.1021/tx6003437; Wang ZX, 2019, CHEMBIOCHEM, V20, P2383, DOI 10.1002/cbic.201900163; Wannier T.M., 2021, NAT REV METHODS PRIM, V1, P8; WEINREICH MD, 1994, J BACTERIOL, V176, P5494, DOI 10.1128/JB.176.17.5494-5504.1994; Wu S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh4048; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zhang MZM, 2017, NAT CHEM BIOL, V13, P607, DOI 10.1038/nchembio.2341; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095; Zhou Z, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01318-z	141	2	2	18	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2022	185	9					1487	+		10.1016/j.cell.2022.03.008	http://dx.doi.org/10.1016/j.cell.2022.03.008			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	3G0DH	35366417				2022-12-28	WOS:000831027800006
J	Cousins, S				Cousins, Sophie			Afghanistan's health crisis deepens under the Taliban	LANCET			English	Editorial Material								Health agencies say acute hunger has increased in Afghanistan and many people have lost access to water, shelter, and health care since the Taliban regained power. Sophie Cousins reports.											0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1290	1291						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35366997				2022-12-28	WOS:000812828300012
J	Hamilton, I				Hamilton, Ian			Should families do more to help with addiction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, Ian] Univ York, York, N Yorkshire, England	University of York - UK	Hamilton, I (corresponding author), Univ York, York, N Yorkshire, England.							Adfam, US ORG; Campbell D., 2019, GUARDIAN 1105; Ewald D Rose, 2019, Glob Pediatr Health, V6, p2333794X18821943, DOI 10.1177/2333794X18821943; Javid S., 2022, HLTH SOCIAL CARE SEC; Kerr DCR, 2020, PSYCHOL ADDICT BEHAV, V34, P811, DOI 10.1037/adb0000652; Levin Y, 2021, ADDICT BEHAV, V118, DOI 10.1016/j.addbeh.2021.106889; O'Shay-Wallace S, 2020, HEALTH COMMUN, V35, P465, DOI 10.1080/10410236.2019.1567443	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o855	10.1136/bmj.o855	http://dx.doi.org/10.1136/bmj.o855			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0J3FG	35361698	Bronze			2022-12-28	WOS:000779990000012
J	Iacobucci, G				Iacobucci, Gareth			Medical schools should include climate change in their curriculum, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Tamilia F, 2022, CLIMATE CRISIS ITS H	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o845	10.1136/bmj.o845	http://dx.doi.org/10.1136/bmj.o845			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354591	Bronze			2022-12-28	WOS:000779561800009
J	Oliver, D				Oliver, David			David Oliver: Is Sajid Javid putting political ideology before prevention?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Barclay S, 2022, WE NO 10 KNOW CUTTIN; Finch D., 2021, PUBLIC HLTH GRANT AL; Griffith A., 2022, CONSERVATIVE HO 0207; Health Foundation, 2022, ADDR LEAD RISK FACT; House of Commons Housing Communities and Local Government Committee, 2019, LOC GOV FIN 2019 SPE; Javid S., 2022, HLTH SOCIAL CARE SEC; Marmot M., 2020, PANDEMIC SOCIOECONOM; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Mason P, NEW STATESMAN, V2021; Oliver D, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4712; Oliver D, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k583; Therrien A., BBC NEWS 0725, V2021	12	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o797	10.1136/bmj.o797	http://dx.doi.org/10.1136/bmj.o797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354595	Bronze			2022-12-28	WOS:000779561800011
J	Reis, G; Silva, EASM; Silva, DCM; Thabane, L; Milagres, AC; Ferreira, TS; dos Santos, CVQ; Campos, VHS; Nogueira, AMR; de Almeida, APFG; Callegari, ED; Neto, ADF; Savassi, LCM; Simplicio, MIC; Ribeiro, LB; Oliveira, R; Harari, O; Forrest, JI; Ruton, H; Sprague, S; McKay, P; Guo, CM; Rowland-Yeo, K; Guyatt, GH; Boulware, DR; Rayner, CR; Mills, EJ				Reis, G.; Silva, E. A. S. M.; Silva, D. C. M.; Thabane, L.; Milagres, A. C.; Ferreira, T. S.; dos Santos, C. V. Q.; Campos, V. H. S.; Nogueira, A. M. R.; de Almeida, A. P. F. G.; Callegari, E. D.; Neto, A. D. F.; Savassi, L. C. M.; Simplicio, M. I. C.; Ribeiro, L. B.; Oliveira, R.; Harari, O.; Forrest, J., I; Ruton, H.; Sprague, S.; McKay, P.; Guo, C. M.; Rowland-Yeo, K.; Guyatt, G. H.; Boulware, D. R.; Rayner, C. R.; Mills, E. J.		TOGETHER Investigators	Effect of Early Treatment with Ivermectin among Patients with Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Early Access								Background: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. Methods: We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2-positive adults recruited from 12 public health clinics in Brazil. Patients who had had symptoms of Covid-19 for up to 7 days and had at least one risk factor for disease progression were randomly assigned to receive ivermectin (400 mu g per kilogram of body weight) once daily for 3 days or placebo. (The trial also involved other interventions that are not reported here.) The primary composite outcome was hospitalization due to Covid-19 within 28 days after randomization or an emergency department visit due to clinical worsening of Covid-19 (defined as the participant remaining under observation for > 6 hours) within 28 days after randomization. Results: A total of 3515 patients were randomly assigned to receive ivermectin (679 patients), placebo (679), or another intervention (2157). Overall, 100 patients (14.7%) in the ivermectin group had a primary-outcome event, as compared with 111 (16.3%) in the placebo group (relative risk, 0.90; 95% Bayesian credible interval, 0.70 to 1.16). Of the 211 primary-outcome events, 171 (81.0%) were hospital admissions. Findings were similar to the primary analysis in a modified intention-to-treat analysis that included only patients who received at least one dose of ivermectin or placebo (relative risk, 0.89; 95% Bayesian credible interval, 0.69 to 1.15) and in a per-protocol analysis that included only patients who reported 100% adherence to the assigned regimen (relative risk, 0.94; 95% Bayesian credible interval, 0.67 to 1.35). There were no significant effects of ivermectin use on secondary outcomes or adverse events. Conclusions: Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19. (Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER ClinicalTrials.gov number, NCT04727424).	[Reis, G.; Silva, E. A. S. M.; Silva, D. C. M.; Ferreira, T. S.; dos Santos, C. V. Q.; Simplicio, M. I. C.; Ribeiro, L. B.; Oliveira, R.] Cardres Cardiol Assistencial & Pesquisa, Res Div, Rua Domingos Vieira 300,Sala 606, BR-30150242 Belo Horizonte, MG, Brazil; [Reis, G.; Silva, E. A. S. M.; Silva, D. C. M.; dos Santos, C. V. Q.; Campos, V. H. S.] Pontificia Univ Catolica Minas Gerais, Dept Med, Belo Horizonte, MG, Brazil; [Milagres, A. C.; Savassi, L. C. M.] Univ Fed Ouro Preto, Dept Publ Hlth & Mental & Family Med, Ouro Preto, Brazil; [Milagres, A. C.] Publ Hlth Care Div, Ibirite, Brazil; [Nogueira, A. M. R.; de Almeida, A. P. F. G.] UNIFIPMoc, Dept Publ Hlth, Montes Claros, MG, Brazil; [Nogueira, A. M. R.; de Almeida, A. P. F. G.] UNIFIPMoc, Family Med Fellowship Program, Montes Claros, MG, Brazil; [Callegari, E. D.] Publ Hlth Care Div, Brumadinho, Brazil; [Neto, A. D. F.] Governador Valadares Publ Hlth Author, Publ Hlth Fellowship Program, Governador Valadares, Brazil; [Thabane, L.; Sprague, S.; McKay, P.; Guyatt, G. H.; Mills, E. J.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Harari, O.; Ruton, H.; Mills, E. J.] Cytel, Vancouver, BC, Canada; [Forrest, J., I; Guo, C. M.; Mills, E. J.] Platform Life Sci, Vancouver, BC, Canada; [Rowland-Yeo, K.; Rayner, C. R.] Certara, Princeton, NJ USA; [Boulware, D. R.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN USA; [Rayner, C. R.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia	Pontificia Universidade Catolica de Minas Gerais; Universidade Federal de Ouro Preto; McMaster University; University of Minnesota System; University of Minnesota Twin Cities; Monash University	Reis, G (corresponding author), Cardres Cardiol Assistencial & Pesquisa, Res Div, Rua Domingos Vieira 300,Sala 606, BR-30150242 Belo Horizonte, MG, Brazil.; Rayner, CR (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Melbourne, Vic 3052, Australia.	thetogethertrial@gmail.com	Boulware, David R/GRS-0999-2022; SAVASSI, LEONARDO CANCADO MONTEIRO/Z-4310-2019; Savassi, Leonardo CM/I-4733-2013; Reis, Gilmar/I-4500-2013	Boulware, David R/0000-0002-4715-0060; SAVASSI, LEONARDO CANCADO MONTEIRO/0000-0001-6780-0377; Savassi, Leonardo CM/0000-0001-6780-0377; Reis, Gilmar/0000-0002-4847-1034				Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bryant A, 2021, AM J THER, V28, pE434, DOI 10.1097/MJT.0000000000001402; Chua KP, 2022, JAMA-J AM MED ASSOC, V327, P584, DOI 10.1001/jama.2021.24352; Department of Health and Human Services, 2017, DIV AIDS DAIDS TABL; Forrester SG, 2002, BIOCHEM PHARMACOL, V63, P1061, DOI 10.1016/S0006-2952(02)00852-3; Heidary F, 2020, J ANTIBIOT, V73, P593, DOI 10.1038/s41429-020-0336-z; Hill A, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofab645; Kim MS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003501; Kow CS, 2021, PHARMACOL REP, V73, P1473, DOI 10.1007/s43440-021-00245-z; Lee K, 2009, GLOB INST, P1; Mahani AS, 2019, J STAT SOFTW, V89, DOI 10.18637/jss.v089.i09; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Rayner CR, 2020, AM J TROP MED HYG, V103, P1364, DOI 10.4269/ajtmh.20-0995; Reardon S, 2021, NATURE, V596, P173, DOI 10.1038/d41586-021-02081-w; Reis G., 2021, GATES OPEN RESE, V5, P117; Reis G, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6468; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; Thorlund K, 2020, LANCET DIGIT HEALTH, V2, pE286, DOI 10.1016/S2589-7500(20)30086-8; Torres I, 2020, LANCET GLOB HEALTH, V8, pE1355, DOI 10.1016/S2214-109X(20)30415-0; Zein AFMZ, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102186	22	41	41	3	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMoa2115869	http://dx.doi.org/10.1056/NEJMoa2115869		MAR 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L2BH	35353979	Bronze, Green Published			2022-12-28	WOS:000799096500001
J	Smith, MA; Sherrah, M; Sultana, F; Castle, PE; Arbyn, M; Gertig, D; Caruana, M; Wrede, CD; Saville, M; Canfell, K				Smith, Megan A.; Sherrah, Maddison; Sultana, Farhana; Castle, Philip E.; Arbyn, Marc; Gertig, Dorota; Caruana, Michael; Wrede, C. David; Saville, Marion; Canfell, Karen			National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXTENDED FOLLOW-UP; INTRAEPITHELIAL NEOPLASIA; CANCER; WOMEN; CYTOLOGY; RISK; ELIMINATION; PROGRAM	OBJECTIVE To review the first two years of the primary human papillomavirus (HPV) cervical screening programme in an HPV vaccinated population. DESIGN Observational study. SETTING Australia. PARTICIPANTS 3 745 318 women with a primary HPV test between 1 December 2017 and 31 December 2019; most women aged <40 years had previously been offered vaccination against HPV16 and HPV18. INTERVENTIONS Primary HPV screening with referral if HPV16 or HPV18 (HPV16/18) positive and triage with liquid based cytology testing (threshold atypical squamous cells cannot exclude high grade squamous intraepithelial lesion) for women who were positive for high risk HPV types other than 16/18. A 12 month follow-up HPV test was recommended in triaged women with a negative or low grade cytology result, with referral if they tested positive for any high risk HPV type at follow-up. MAIN OUTCOME MEASURES Proportion of women who had attended for their first HPV screening test, tested positive, and were referred for colposcopy; and short term risk of detecting cervical intraepithelial neoplasia (CIN) grade 2 or worse, CIN grade 3 or worse, or cancer. RESULTS 54.6% (n=3 507 281) of an estimated 6 428 677 eligible women aged 25-69 had undergone their first HPV test by the end of 2019. Among those attending for routine screening, positivity for HPV16/18 and for HPV types not 16/18 was, respectively, 2.0% and 6.6% in women aged 25-69 (n=3 045 844) and 2.2% and 13.3% in highly vaccinated cohorts of women aged 25-34 (n=768 362). Colposcopy referral (ages 25-69 years) was 3.5%, increasing to an estimated 6.2% after accounting for women who had not yet had a 12 month repeat test. Cervical cancer was detected in 0.98% (456/46 330) of women positive for HPV16/18 at baseline, including 0.32% (89/28 003) of women with HPV16/18 and negative cytology. Women with HPV types not 16/18 and negative or low grade cytology at both baseline and 12 months were at low risk of serious disease (3.4% CIN grade 3 or worse; 0.02% cancer; n=20 019) but estimated to account for 62.0% of referrals for this screening algorithm. CONCLUSIONS Colposcopy referral thresholds need to consider underlying cancer risk; on this basis, women with HPV16/18 in the first round of HPV screening were found to be at higher risk regardless of cytology result, even in a previously well screened population. Women with HPV types not 16/18 and negative or low grade cytology showed a low risk of serious abnormalities but constitute most referrals and could be managed safely with two rounds of repeat HPV testing rather than one. HPV16/18 driven referrals were low in HPV vaccinated cohorts.	[Smith, Megan A.; Sherrah, Maddison; Caruana, Michael; Canfell, Karen] Univ Sydney, Daffodil Ctr, Sydney, NSW 2011, Australia; [Sultana, Farhana; Gertig, Dorota] Telstra Hlth, Natl Canc Screening Register, Melbourne, Vic, Australia; [Sultana, Farhana; Gertig, Dorota] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Castle, Philip E.] Us Natl Canc Inst, Div Canc Prevent, NIH, Rockville, MD USA; [Castle, Philip E.] Us Natl Canc Inst, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Arbyn, Marc] Sciensano, Unit Canc Epidemiol, Belgian Canc Ctr, Brussels, Belgium; [Arbyn, Marc] Univ Ghent, Fac Med & Hlth Sci, Dept Human Struct & Repair, Ghent, Belgium; [Wrede, C. David] Royal Womens Hosp, Oncol & Dysplasia Unit, Melbourne, Vic, Australia; [Wrede, C. David; Saville, Marion] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Saville, Marion] Australian Ctr Prevent Cerv Canc, Melbourne, Vic, Australia; [Canfell, Karen] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sciensano; Ghent University; University of Melbourne; University of Sydney	Smith, MA (corresponding author), Univ Sydney, Daffodil Ctr, Sydney, NSW 2011, Australia.	megan.smith@nswcc.org.au		Smith, Megan/0000-0002-0401-2653	National Health and Medical Research Council (Australia) [APP1159491, APP1135172, APP1194679]; Cancer Institute NSW [ECF181561]; Horizon 2020 Framework Programme for Research and Innovation of the European Commission, through the Risk-based Screening for Cervical Cancer Network [847845]; Cancer Council NSW	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Horizon 2020 Framework Programme for Research and Innovation of the European Commission, through the Risk-based Screening for Cervical Cancer Network; Cancer Council NSW(Cancer Council New South Wales)	MSm, MSh, and KC receive salary support from the National Health and Medical Research Council (Australia; grant No APP1159491 to MSm; APP1135172 to KC supports MSh; APP1194679 to KC) and the Cancer Institute NSW (grant No ECF181561 to MSm) . MA was supported by the Horizon 2020 Framework Programme for Research and Innovation of the European Commission, through the Risk-based Screening for Cervical Cancer Network (grant No 847845) and Cancer Council NSW (grant to Sciensano (employer of MA) to support a meta-analysis on triage of HPV positive women) . The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Aitken CA, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1460-0; Arbyn M, 2020, BRIT J CANCER, V122, P1577, DOI 10.1038/s41416-020-0787-9; Arbyn M, 2017, ANN INTERN MED, V166, P118, DOI 10.7326/M15-2735; Armstrong B, 2017, ONCOGENIC HPV TYPES; Australian Government Department of Health, 2018, NAT CERV SCREEN PROG; Australian Institute of Health and Welfare, 2019, CANC SER, V123; Australian Institute of Health and Welfare, 2019, CANC SERIES, V125; Australian Institute of Health and Welfare, CANC SERIES, V130; Australian Institute of Health and Welfare, 2018, CERV SCREEN AUSTR 20; Bonde J, 2021, J LOW GENIT TRACT DI, V25, P27, DOI 10.1097/LGT.0000000000000573; Brisson M, 2020, LANCET, V395, P575, DOI 10.1016/S0140-6736(20)30068-4; Brotherton JML, 2019, VACCINE, V37, P412, DOI 10.1016/j.vaccine.2018.11.075; Burger EA, 2020, LANCET PUBLIC HEALTH, V5, pE213, DOI 10.1016/S2468-2667(20)30006-2; Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National Cervical Screening Program, 2017, GUIDELINES MANAGEMEN; Canfell K, 2021, MED J AUSTRALIA, V215, P347, DOI 10.5694/mja2.51262; Canfell K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016700; Canfell K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002388; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Department of Health, 2021, LANDM CHANG IMPR ACC; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Gilham C, 2020, BJOG-INT J OBSTET GY, V127, P58, DOI 10.1111/1471-0528.15957; Gultekin M, 2018, INT J CANCER, V142, P1952, DOI 10.1002/ijc.31212; Hall MT, 2019, LANCET PUBLIC HEALTH, V4, pE19, DOI 10.1016/S2468-2667(18)30183-X; Hall MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185332; Hashim D, 2020, BRIT J CANCER, V122, P1715, DOI 10.1038/s41416-020-0790-1; Isidean SD, 2016, INT J CANCER, V139, P2456, DOI 10.1002/ijc.30385; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Koliopoulos G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008587.pub2; Lew J, 2013, NATL CERVICAL SCREEN; Lew JB, 2017, LANCET PUBLIC HEALTH, V2, pE96, DOI 10.1016/S2468-2667(17)30007-5; Medical Services Advisory Committee A, 2013, NAT CERV SCREEN PROG; Obermair HM, 2021, AUST NZ J OBSTET GYN, V61, P416, DOI 10.1111/ajo.13310; Rebolj M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l240; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sand FL, 2019, INT J CANCER, V144, P1975, DOI 10.1002/ijc.31883; Simms KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0163509; Smith M., 2020, MODELLED ANAL HYPOTH; Smith M, 2020, MED J AUSTRALIA, V213, DOI 10.5694/mja2.50736; Smith M, 2019, PUBLIC HEALTH RES PR, V29, DOI 10.17061/phrp2921914; Smith MA, 2021, TUMOUR VIRUS RES, V11, DOI 10.1016/j.tvr.2021.200216; Smith MA, 2021, CANCER EPIDEM BIOMAR, V30, P268, DOI 10.1158/1055-9965.EPI-20-0998; Smith MA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1375-9; Sultana F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228042	46	4	4	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								e068582	10.1136/bmj-2021-068582	http://dx.doi.org/10.1136/bmj-2021-068582			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354610	Green Published, hybrid			2022-12-28	WOS:000779561800014
J	Hatala, A; Pervaiz, MC; Handley, R; Vijayan, T				Hatala, Andrew; Pervaiz, Maryam Chloe; Handley, Richard; Vijayan, Tara			Faith based dialogue can tackle vaccine hesitancy and build trust	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARTNERSHIPS		[Hatala, Andrew] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Pervaiz, Maryam Chloe] Wellesley Coll, Wellesley, MA 02181 USA; [Handley, Richard] Wells World Serv, Cortez, CO USA; [Vijayan, Tara] Univ Calif Los Angeles, Div Infect Dis, Los Angeles, CA USA	University of Manitoba; Wellesley College; University of California System; University of California Los Angeles	Hatala, A (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.			Vijayan, Tara/0000-0003-1141-8261				[Anonymous], 2021, IDENTITIES R RACE VI; Barmania S, 2021, GLOB HEALTH PROMOT, V28, P15, DOI 10.1177/1757975920972992; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Corbie-Smith Giselle, 2021, JAMA Health Forum, V2, pe210434, DOI 10.1001/jamahealthforum.2021.0434; Corcoran KE, 2021, VACCINE, V39, P6614, DOI 10.1016/j.vaccine.2021.09.074; Corpuz JCG, 2021, J PUBLIC HEALTH-UK, V43, pE370, DOI 10.1093/pubmed/fdab085; Duff JF, 2015, LANCET, V386, P1786, DOI 10.1016/S0140-6736(15)60250-1; Fernando C., 2021, US TODAY 21 AUGUST; Fletcher FE, 2020, HEALTH EQUITY, V4, P320, DOI 10.1089/heq.2020.0029; Gamlin J, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006132; Garcia LL, 2021, J PUBLIC HEALTH-UK, V43, pE529, DOI 10.1093/pubmed/fdab192; Idler E, 2019, AM J PUBLIC HEALTH, V109, P346, DOI 10.2105/AJPH.2018.304941; Jacobi CJ, 2021, VACCINE, V39, P6351, DOI 10.1016/j.vaccine.2021.09.005; Kasstan B, 2021, ANTHROPOL MED, V28, P411, DOI 10.1080/13648470.2020.1825618; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Marshall K, 2015, LANCET, V386, pE24, DOI 10.1016/S0140-6736(15)61082-0; McGregor L., 2021, SPIRITUAL RELIG FAIT, P38; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Olivier J, 2015, LANCET, V386, P1765, DOI 10.1016/S0140-6736(15)60251-3; Oman D, 2018, RELIG SPIRITUAL HEAL, V2, P1, DOI 10.1007/978-3-319-73966-3_1; Omer SB, 2021, LANCET, V398, P2186, DOI 10.1016/S0140-6736(21)02507-1; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n513; Watkins D, 2021, VATICAN NEWS 18 AUGU	23	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o823	10.1136/bmj.o823	http://dx.doi.org/10.1136/bmj.o823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346957	Bronze			2022-12-28	WOS:000778641000005
J	Gonzalez, PJ				Gonzalez, Pablo J.			Volcano-tectonic control of Cumbre Vieja	SCIENCE			English	Editorial Material							LA-PALMA; CANARY-ISLANDS		[Gonzalez, Pablo J.] CSIC, Inst Prod Nat & Agrobiol, Dept Life & Earth Sci, Volcanol Res Grp, San Cristobal la Laguna, Canary Islands, Spain; [Gonzalez, Pablo J.] Univ Liverpool, Sch Environm Sci, Dept Earth Ocean & Ecol Sci, COMET, Liverpool, Merseyside, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); University of Liverpool	Gonzalez, PJ (corresponding author), CSIC, Inst Prod Nat & Agrobiol, Dept Life & Earth Sci, Volcanol Res Grp, San Cristobal la Laguna, Canary Islands, Spain.; Gonzalez, PJ (corresponding author), Univ Liverpool, Sch Environm Sci, Dept Earth Ocean & Ecol Sci, COMET, Liverpool, Merseyside, England.	pabloj.gonzalez@csic.es			Spanish Ministerio de Ciencia e Innovacion research project COMPACT [PID2019-104571RA-I00, MCIN/AEI/10.13039/501100011033]; 2020 Leonardo Fellowship Grant for Researchers and Cultural Creators,BBVA Foundation	Spanish Ministerio de Ciencia e Innovacion research project COMPACT; 2020 Leonardo Fellowship Grant for Researchers and Cultural Creators,BBVA Foundation	This work was supported by the Spanish Ministerio de Ciencia e Innovacion research project COMPACT(proyecto PID2019-104571RA-I00 de investigacion financiado por MCIN/AEI/10.13039/501100011033) and a 2020 Leonardo Fellowship Grant for Researchers and Cultural Creators,BBVA Foundation.	Abadie SM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007646; Atzori S., 2021, INSAR RELOCATED SEIS; BRAVO T, 1962, B R SOC ESP HIST NAT, V60, P93; Camacho AG, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005628; Collier JS, 2001, GEOPHYS J INT, V147, P660, DOI 10.1046/j.0956-540x.2001.01506.x; Day SJ, 1999, J VOLCANOL GEOTH RES, V94, P135, DOI 10.1016/S0377-0273(99)00101-8; Garcia X, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006445; Gonzalez PJ, 2010, EARTH PLANET SC LETT, V297, P545, DOI 10.1016/j.epsl.2010.07.006; Klugel A, 2005, EARTH PLANET SC LETT, V236, P211, DOI 10.1016/j.epsl.2005.04.006; Lipman P. W., 1981, US GEOLOGICAL SURVEY; Longpre MA, 2021, SCIENCE, V374, P1197, DOI 10.1126/science.abm9423; Moore J. G, 1964, US GEOLOGICAL SURVEY, pD95; Ward SN, 2001, GEOPHYS RES LETT, V28, P3397, DOI 10.1029/2001GL013110; Ye LL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1377	14	4	4	4	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1348	1349		10.1126/science.abn5148	http://dx.doi.org/10.1126/science.abn5148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324304	Green Submitted			2022-12-28	WOS:000778894800020
J	Taylor, L				Taylor, Luke			Russian forces are increasingly targeting Ukrainian healthcare facilities, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Garfinkel N, 2022, AXIOS; Iacobucci G, BMJ, V376, po610; World Health Organization, SURV SYST ATT HLTH C	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o801	10.1136/bmj.o801	http://dx.doi.org/10.1136/bmj.o801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338043	Bronze			2022-12-28	WOS:000778396700009
J	Smith, R				Smith, Richard			Pushing back on the arguments of the Lancet Commission on the Value of Death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smith, Richard] UK Hlth Alliance Climate Change, London, England		Smith, R (corresponding author), UK Hlth Alliance Climate Change, London, England.							Ahuja A., THE FINANCIAL TIMES; Sallnow L, 2022, LANCET, DOI [10.1016/S0140-6736(21)02314-Xhttps, DOI 10.1016/S0140-6736(21)02314-XHTTPS]	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o782	10.1136/bmj.o782	http://dx.doi.org/10.1136/bmj.o782			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331978	Bronze			2022-12-28	WOS:000778460100005
J	Torjesen, I				Torjesen, Ingrid			Burnout: set up watchdog to protect NHS staff, says wellbeing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o780	10.1136/bmj.o780	http://dx.doi.org/10.1136/bmj.o780			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331979				2022-12-28	WOS:000778460100007
J	Manasseh, GSL; Amarakoon, S; Photiou, V; Arruti, N; Borman, AD				Manasseh, Gemma Susan Louise; Amarakoon, Sajeevika; Photiou, Victoria; Arruti, Natalia; Borman, Arundhati Dev			Approach to conjunctivitis in newborns	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPHTHALMIA NEONATORUM; PROPHYLAXIS		[Manasseh, Gemma Susan Louise; Amarakoon, Sajeevika; Borman, Arundhati Dev] Univ Hosp Bristol NHS Fdn Trust, Bristol Eye Hosp, Bristol, Avon, England; [Photiou, Victoria] Downend Hlth Grp, Bristol, Avon, England; [Arruti, Natalia] Hosp Univ La Paz, Madrid, Spain	Bristol Eye Hospital; University of Bristol; Hospital Universitario La Paz	Manasseh, GSL (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Bristol Eye Hosp, Bristol, Avon, England.	gslmanasseh5@gmail.com						Assadian O, PROPHYLAXIS OPHTHALM; BEEM MO, 1977, NEW ENGL J MED, V296, P306, DOI 10.1056/NEJM197702102960604; Darville Toni, 2005, Semin Pediatr Infect Dis, V16, P235, DOI 10.1053/j.spid.2005.06.004; Dharmasena A, 2015, SEX TRANSM INFECT, V91, P342, DOI 10.1136/sextrans-2014-051682; Jackson TL, 2008, MOORFIELDS MANUAL OP; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Kimberlin DWK, 2018, RED BOOK 2018 REPORT, P1046; Maqsood N, 2020, BRIT J GEN PRACT, V70, P513, DOI 10.3399/bjgp20X712973; National Institute for Health and Care Excellence,, 2018, CKS CONJ INF SCEN WH; NISHIDA H, 1975, PEDIATRICS, V56, P368; Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005; Richards A, 2010, PEDIATR REV, V31, P196, DOI 10.1542/pir.31-5-196; Sathiamoorthi S, 2019, BRIT J OPHTHALMOL, V103, P527, DOI 10.1136/bjophthalmol-2018-312074; Schaller UC, 2001, B WORLD HEALTH ORGAN, V79, P262; Tang XJ, 2022, INT OPHTHALMOL, V42, P2185, DOI 10.1007/s10792-022-02218-4; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Zloto O, 2016, GRAEF ARCH CLIN EXP, V254, P577, DOI 10.1007/s00417-016-3274-5; Zuppa AA, 2011, J MATERN-FETAL NEO M, V24, P769, DOI 10.3109/14767058.2010.531326	18	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								e068023	10.1136/bmj-2021-068023	http://dx.doi.org/10.1136/bmj-2021-068023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321902				2022-12-28	WOS:000790072700006
J	Bradbury, CA; Lawler, PR; Stanworth, SJ; McVerry, BJ; McQuilten, Z; Higgins, AM; Mouncey, PR; Al-Beidh, F; Rowan, KM; Berry, LR; Lorenzi, E; Zarychanski, R; Arabi, YM; Annane, D; Beane, A; Van Bentum-Puijk, W; Bhimani, Z; Bihari, S; Bonten, MJM; Brunkhorst, FM; Buzgau, A; Buxton, M; Carrier, M; Cheng, AC; Cove, M; Detry, MA; Estcourt, LJ; Fitzgerald, M; Girard, TD; Goligher, EC; Goossens, H; Haniffa, R; Hills, T; Huang, DT; Horvat, CM; Hunt, BJ; Ichihara, N; Lamontagne, F; Leavis, HL; Linstrum, KM; Litton, E; Marshall, JC; McAuley, DF; McGlothlin, A; McGuinness, SP; Middeldorp, S; Montgomery, SK; Morpeth, SC; Murthy, S; Neal, MD; Nichol, AD; Parke, RL; Parker, JC; Reyes, L; Saito, H; Santos, MS; Saunders, CT; Serpa-Neto, A; Seymour, CW; Shankar-Hari, M; Singh, V; Tolppa, T; Turgeon, AF; Turner, AM; van de Veerdonk, FL; Green, C; Lewis, RJ; Angus, DC; McArthur, CJ; Berry, S; Derde, LPG; Webb, SA; Gordon, AC				Bradbury, Charlotte A.; Lawler, Patrick R.; Stanworth, Simon J.; McVerry, Bryan J.; McQuilten, Zoe; Higgins, Alisa M.; Mouncey, Paul R.; Al-Beidh, Farah; Rowan, Kathryn M.; Berry, Lindsay R.; Lorenzi, Elizabeth; Zarychanski, Ryan; Arabi, Yaseen M.; Annane, Djillali; Beane, Abi; Van Bentum-Puijk, Wilma; Bhimani, Zahra; Bihari, Shailesh; Bonten, Marc J. M.; Brunkhorst, Frank M.; Buzgau, Adrian; Buxton, Meredith; Carrier, Marc; Cheng, Allen C.; Cove, Matthew; Detry, Michelle A.; Estcourt, Lise J.; Fitzgerald, Mark; Girard, Timothy D.; Goligher, Ewan C.; Goossens, Herman; Haniffa, Rashan; Hills, Thomas; Huang, David T.; Horvat, Christopher M.; Hunt, Beverley J.; Ichihara, Nao; Lamontagne, Francois; Leavis, Helen L.; Linstrum, Kelsey M.; Litton, Edward; Marshall, John C.; McAuley, Daniel F.; McGlothlin, Anna; McGuinness, Shay P.; Middeldorp, Saskia; Montgomery, Stephanie K.; Morpeth, Susan C.; Murthy, Srinivas; Neal, Matthew D.; Nichol, Alistair D.; Parke, Rachael L.; Parker, Jane C.; Reyes, Luis; Saito, Hiroki; Santos, Marlene S.; Saunders, Christina T.; Serpa-Neto, Ary; Seymour, Christopher W.; Shankar-Hari, Manu; Singh, Vanessa; Tolppa, Timo; Turgeon, Alexis F.; Turner, Anne M.; van de Veerdonk, Frank L.; Green, Cameron; Lewis, Roger J.; Angus, Derek C.; McArthur, Colin J.; Berry, Scott; Derde, Lennie P. G.; Webb, Steve A.; Gordon, Anthony C.		REMAP-CAP Investigators	Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COAGULOPATHY; INFECTION	IMPORTANCE The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain. OBJECTIVE To determine whether antiplatelet therapy improves outcomes for critically ill adults with COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing adaptive platform trial (RE MAP-CAP) testing multiple interventions within multiple therapeutic domains, 1557 critically ill adult patients with COVID-19 were enrolled between October 30, 2020, and June 23, 2021, from 105 sites in 8 countries and followed up for 90 days (final follow-up date: July 26, 2021). INTERVENTIONS Patients were randomized to receive either open-label aspirin (n = 565). a P2Y12 inhibitor (n = 455), or no antiplatelet therapy (control; n = 529). Interventions were continued in the hospital for a maximum of 14 days and were in addition to anticoagulation thromboprophylaxis. MAIN OUTCOMES AND MEASURES The primary end point was organ support-free days (days alive and free of intensive care unit-based respiratory or cardiovascular organ support) within 21 days, ranging from -1 for any death in hospital (censored at 90 days) to 22 for survivors with no organ support. There were 13 secondary outcomes, including survival to discharge and major bleeding to 14 days. The primary analysis was a bayesian cumulative logistic model. An odds ratio (OR) greater than 1 represented improved survival, more organ support-free days, or both. Efficacy was defined as greater than 99% posterior probability of an OR greater than 1. Futility was defined as greater than 95% posterior probability of an OR less than 1.2 vs control. Intervention equivalence was defined as greater than 90% probability that the OR (compared with each other) was between 1/1.2 and 1.2 for 2 noncontrol interventions. RESULTS The aspirin and P2Y12 inhibitor groups met the predefined criteria for equivalence at an adaptive analysis and were statistically pooled for further analysis. Enrollment was discontinued after the prespecified criterion for futility was met for the pooled antiplatelet group compared with control. Among the 1557 critically ill patients randomized, 8 patients withdrew consent and 1549 completed the trial (median age. 57 years; 521 [33.6%] female). The median for organ support-free days was 7 (IQR. -1 to 16) in both the antiplatelet and control groups (median-adjusted OR, 1.02 [95% credible interval {Crl}, 0.86-1.23]; 95.7% posterior probability of futility). The proportions of patients surviving to hospital discharge were 71.5% (723/1011) and 67.9% (354/521) in the antiplatelet and control groups, respectively (median-adjusted OR, 1.27 [95% Crl, 0.99-1.62]; adjusted absolute difference, 5% [95% Crl, -0.2% to 9.5%]; 97% posterior probability of efficacy). Among survivors, the median for organ support-free days was 14 in both groups. Major bleeding occurred in 2.1% and 0.4% of patients in the antiplatelet and control groups (adjusted OR, 2.97 [95% Crl, 1.23-8.28]; adjusted absolute risk increase, 0.8% [95% Crl, 0.1%-2.7%]: 99.4% probability of harm). CONCLUSIONS AND RELEVANCE Among critically ill patients with COVID-19, treatment with an antiplatelet agent, compared with no antiplatelet agent, had a low likelihood of providing improvement in the number of organ support-free days within 21 days. (C) 2022 American Medical Association. All rights reserved.	[Bradbury, Charlotte A.] Univ Bristol, Bristol, Avon, England; [Lawler, Patrick R.; Goligher, Ewan C.] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Lawler, Patrick R.; Goligher, Ewan C.] Univ Toronto, Toronto, ON, Canada; [Stanworth, Simon J.; Beane, Abi] Univ Oxford, Oxford, England; [Stanworth, Simon J.; Estcourt, Lise J.] NHS Blood & Transplant, Oxford, England; [McVerry, Bryan J.; Girard, Timothy D.; Huang, David T.; Linstrum, Kelsey M.; Montgomery, Stephanie K.; Neal, Matthew D.; Seymour, Christopher W.; Angus, Derek C.] Univ Pittsburgh, Pittsburgh, PA USA; [McQuilten, Zoe; Higgins, Alisa M.; Buzgau, Adrian; Cheng, Allen C.; McGuinness, Shay P.; Nichol, Alistair D.; Parker, Jane C.; Serpa-Neto, Ary; Singh, Vanessa; Green, Cameron; Webb, Steve A.] Monash Univ, Melbourne, Vic, Australia; [McQuilten, Zoe] Monash Hlth, Melbourne, Vic, Australia; [Mouncey, Paul R.; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr ICNARC, London, England; [Al-Beidh, Farah; Gordon, Anthony C.] Imperial Coll London, London, England; [Berry, Lindsay R.; Lorenzi, Elizabeth; Detry, Michelle A.; Fitzgerald, Mark; McGlothlin, Anna; Saunders, Christina T.; Lewis, Roger J.; Berry, Scott] Berry Consultants, Austin, TX USA; [Zarychanski, Ryan] Univ Manitoba, Winnipeg, MB, Canada; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Arabi, Yaseen M.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Annane, Djillali] Hop Raymond Poincare, Assistance Publ Hop Paris, Garches, France; [Annane, Djillali] Univ Versailles SQY Univ Paris Saclay, Montigny Le Bretonneux, France; [Van Bentum-Puijk, Wilma; Bonten, Marc J. M.; Leavis, Helen L.; Derde, Lennie P. G.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Bhimani, Zahra; Marshall, John C.; Santos, Marlene S.] St Michaels Hosp Unity Hlth, Toronto, ON, Canada; [Bihari, Shailesh] Flinders Univ S Australia, Bedford Pk, SA, Australia; [Brunkhorst, Frank M.] Jena Univ Hosp, Jena, Germany; [Buxton, Meredith] Global Coalit Adapt Res, Los Angeles, CA USA; [Carrier, Marc] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Carrier, Marc] Inst Savoir Montfort, Ottawa, ON, Canada; [Cheng, Allen C.] Alfred Hlth, Melbourne, Vic, Australia; [Cove, Matthew] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Goossens, Herman] Univ Antwerp, Antwerp, Belgium; [Haniffa, Rashan] Univ Oxford, Bangkok, Thailand; [Haniffa, Rashan; Tolppa, Timo] Natl Intens Care Surveillance NICST, Colombo, Sri Lanka; [Hills, Thomas; Turner, Anne M.] Med Res Inst New Zealand MRINZ, Wellington, New Zealand; [Horvat, Christopher M.] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Hunt, Beverley J.] Kings Healthcare Partners, London, England; [Ichihara, Nao] Univ Tokyo, Tokyo, Japan; [Lamontagne, Francois] Univ Sherbrooke, Sherbrooke, PQ, Canada; [Litton, Edward] Fiona Stanley Hosp, Perth, WA, Australia; [Litton, Edward] Univ Western Australia, Perth, WA, Australia; [McAuley, Daniel F.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Royal Victoria Hosp, Belfast, Antrim, North Ireland; [McGuinness, Shay P.; Parke, Rachael L.; McArthur, Colin J.] Auckland City Hosp, Auckland, New Zealand; [Middeldorp, Saskia; van de Veerdonk, Frank L.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Morpeth, Susan C.] Middlemore Hosp, Auckland, New Zealand; [Murthy, Srinivas] Univ British Columbia, Vancouver, BC, Canada; [Nichol, Alistair D.] Univ Coll Dublin, Dublin, Ireland; [Parke, Rachael L.] Univ Auckland, Auckland, New Zealand; [Reyes, Luis] Univ La Sabana, Chia, Colombia; [Reyes, Luis] Clin Univ La Sabana, Chia, Colombia; [Saito, Hiroki] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Yokohama, Kanagawa, Japan; [Serpa-Neto, Ary] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Shankar-Hari, Manu] Kings Coll London, London, England; [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, London, England; [Turgeon, Alexis F.] Univ Laval, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval Res Ctr, CHU Quebec, Quebec City, PQ, Canada; [Berry, Lindsay R.; Lorenzi, Elizabeth; Detry, Michelle A.; Fitzgerald, Mark; McGlothlin, Anna; Saunders, Christina T.; Lewis, Roger J.; Berry, Scott] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Webb, Steve A.] St John God Hosp, Subiaco, WA, Australia; [Gordon, Anthony C.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England	University of Bristol; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University; Intensive Care National Audit & Research Centre; Imperial College London; University of Manitoba; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Utrecht University; Utrecht University Medical Center; Flinders University South Australia; Friedrich Schiller University of Jena; University of Ottawa; Ottawa Hospital Research Institute; National University of Singapore; University of Antwerp; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tokyo; University of Sherbrooke; University of Western Australia; Queens University Belfast; Auckland City Hospital; Radboud University Nijmegen; University of British Columbia; University College Dublin; University of Auckland; Universidad de La Sabana; Universidad de La Sabana; Saint Marianna University; Hospital Israelita Albert Einstein; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Laval University; Laval University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; St John of God Health Care; Imperial College London	Bradbury, CA (corresponding author), Bristol Haematol & Oncol Ctr, Horfield Rd, Bristol BS2 8ED, Avon, England.	c.bradbury@bristol.ac.uk	Gordon, Anthony/A-3472-2012; Veenith, Tonny/A-9948-2010; Middeldorp, Saskia/ABI-8197-2020; Neal, Matthew/GMW-5601-2022; Dushianthan, Ahilanandan/T-8390-2019; Leaf, David/AAO-8977-2021; Derde, Lennie/AAF-2725-2021; Presneill, Jeffrey/B-4894-2012; litton, edward/C-5384-2017; Summers, Charlotte/A-6973-2012	Gordon, Anthony/0000-0002-0419-547X; Veenith, Tonny/0000-0002-4125-8804; Middeldorp, Saskia/0000-0002-1006-6420; Neal, Matthew/0000-0001-8931-6236; Dushianthan, Ahilanandan/0000-0002-0165-3359; Leaf, David/0000-0001-7875-090X; Derde, Lennie/0000-0002-3577-5629; Presneill, Jeffrey/0000-0001-7177-7667; Ustianowski, Andrew/0000-0002-6134-7855; Vodovar, Dominique/0000-0002-8196-5511; Dark, Paul/0000-0003-3309-0164; Murthy, Srinivas/0000-0002-9476-839X; Nichol, Alistair/0000-0002-4689-1238; Hills, Thomas/0000-0003-0322-5822; Hormis, Anil/0000-0001-5510-7639; Binnie, Alexandra/0000-0003-2969-8177; Ichihara, Nao/0000-0002-6902-2342; Beane, Abigail/0000-0001-7046-1580; Jayakumar, Devachandran/0000-0001-7134-3746; Waite, Alicia/0000-0001-8734-994X; litton, edward/0000-0002-5125-6829; Hunt, Beverley Jane/0000-0002-4709-0774; Acquah, Ronald/0000-0002-5375-6106; Mouncey, Paul/0000-0002-8510-8517; Jhanji, Shaman/0000-0002-1116-628X; Rowan, Kathryn/0000-0001-8217-5602; Malley, Brian/0000-0002-1731-1046; Young, Paul/0000-0002-3428-3083; Lamontagne, Francois/0000-0002-0360-3427; Summers, Charlotte/0000-0002-7269-2873; Duffy, Eamon/0000-0002-4515-5116	Platform for European Preparedness Against (Re-)Emerging Epidemics (PREPARE) consortium of the European Union, FP7-HEALTH-2013-INNOVATION-1 [602525]; Rapid European COVID-19 Emergency Research Response (RECOVER) consortium of the European Union's Horizon 2020 Research and Innovation Programme [101003589]; Australian National Health and Medical Research Council [APP1101719]; Health Research Council of New Zealand [16/631]; Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program [158584]; NIHR; NIHR Imperial Biomedical Research Centre; Health Research Board of Ireland [CTN 2014-012]; University of Pittsburgh Medical Center (UPMC) Learning While Doing Program; Translational Breast Cancer Research Consortium; French Ministry of Health [PHRC-20-0147]; Minderoo Foundation; Wellcome Trust Innovations Project [215522]; NIHR clinician scientist fellowship [CS-2016-16-011]; NIHR [RP-2015-06-18]	Platform for European Preparedness Against (Re-)Emerging Epidemics (PREPARE) consortium of the European Union, FP7-HEALTH-2013-INNOVATION-1; Rapid European COVID-19 Emergency Research Response (RECOVER) consortium of the European Union's Horizon 2020 Research and Innovation Programme; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program(Canadian Institutes of Health Research (CIHR)); NIHR(National Institute for Health Research (NIHR)); NIHR Imperial Biomedical Research Centre; Health Research Board of Ireland; University of Pittsburgh Medical Center (UPMC) Learning While Doing Program; Translational Breast Cancer Research Consortium; French Ministry of Health; Minderoo Foundation; Wellcome Trust Innovations Project(Wellcome Trust); NIHR clinician scientist fellowship; NIHR(National Institute for Health Research (NIHR))	This study was funded by the following: the Platform for European Preparedness Against (Re-)Emerging Epidemics (PREPARE) consortium of the European Union, FP7-HEALTH-2013-INNOVATION-1 (grant 602525), the Rapid European COVID-19 Emergency Research Response (RECOVER) consortium of the European Union's Horizon 2020 Research and Innovation Programme (grant 101003589), the Australian National Health and Medical Research Council (grant APP1101719), the Health Research Council of New Zealand (grant 16/631), the Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program (grant 158584), the NIHR and the NIHR Imperial Biomedical Research Centre, the Health Research Board of Ireland (grant CTN 2014-012), the University of Pittsburgh Medical Center (UPMC) Learning While Doing Program, the Translational Breast Cancer Research Consortium, the French Ministry of Health (grant PHRC-20-0147), the Minderoo Foundation, and theWellcome Trust Innovations Project (grant 215522). Dr Shankar-Hari is funded by an NIHR clinician scientist fellowship (grant CS-2016-16-011) and Dr Gordon is funded by an NIHR research professorship (grant RP-2015-06-18).	Akinosoglou K, 2014, THROMB RES, V133, P131, DOI 10.1016/j.thromres.2013.07.002; Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Angus DC, 2020, ANN AM THORAC SOC, V17, P879, DOI 10.1513/AnnalsATS.202003-192SD; Arabi YM, 2021, INTENS CARE MED, V47, P867, DOI 10.1007/s00134-021-06448-5; Berger JS, 2022, JAMA-J AM MED ASSOC, V327, P227, DOI 10.1001/jama.2021.23605; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Chow JH, 2021, ANESTH ANALG, V132, P930, DOI 10.1213/ANE.0000000000005292; Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014; Estcourt LJ, 2021, JAMA-J AM MED ASSOC, V326, P1690, DOI 10.1001/jama.2021.18178; Frantzeskaki F, 2017, RESPIRATION, V93, P212, DOI 10.1159/000453002; Godoy LC, 2020, CAN MED ASSOC J, V192, pE1156, DOI 10.1503/cmaj.201240; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Gomez K, 2021, BRIT J HAEMATOL, V192, P459, DOI 10.1111/bjh.17241; Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911; Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008; Morris G, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118617; O'Sullivan JM, 2020, LANCET HAEMATOL, V7, pE553, DOI 10.1016/S2352-3026(20)30215-5; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Shah A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03260-3; Shaw RJ, 2021, BRIT J HAEMATOL, V194, P518, DOI 10.1111/bjh.17664; Sholzberg M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2400; Spaetgens B, 2022, JAMA-J AM MED ASSOC, V327, P223, DOI 10.1001/jama.2021.23866; Spyropoulos AC, 2021, JAMA INTERN MED, V181, P1612, DOI 10.1001/jamainternmed.2021.6203; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zaid Y, 2020, CIRC RES, V127, P1404, DOI 10.1161/CIRCRESAHA.120.317703	42	26	26	5	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1247	1259		10.1001/jama.2022.2910	http://dx.doi.org/10.1001/jama.2022.2910		MAR 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35315874	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000772989300002
J	Traeger, AC; Underwood, M; Ivers, R; Buchbinder, R				Traeger, Adrian C.; Underwood, Martin; Ivers, Rowena; Buchbinder, Rachelle			Low back pain in people aged 60 years and over	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-ADULTS; FACET JOINT; CARE; PREVALENCE; MANAGEMENT; ASSOCIATIONS; DIAGNOSIS; SYMPTOMS; OUTCOMES; THERAPY	A 63 year old woman presents with a three day history of severe low back pain. She has a 20-year history of intermittent back trouble, but this episode is more severe than previous episodes and came on without provocation. She is physically active and usually swims most days but is unable to do so with the current pain. Previously, over-the counter ibuprofen provided some relief, but this time it has had little effect. She asks about investigations, possible causes, and pain management options.	[Traeger, Adrian C.] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Underwood, Martin] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Underwood, Martin] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England; [Ivers, Rowena] Univ Wollongong, Grad Med, Wollongong, NSW, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Cabrini Hlth, Monash Cabrini Dept Musculoskeletal Hlth & Clin E, Melbourne, Vic, Australia	University of Sydney; University of Warwick; University of Warwick; University of Wollongong; Monash University; Cabrini Health	Traeger, AC (corresponding author), Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia.	adrian.traeger@sydney.edu.au	; Underwood, Martin/D-6364-2015	Ivers, Rowena/0000-0001-7847-9734; Underwood, Martin/0000-0002-0309-1708				Amaral LKB, 2020, ARCH GERONTOL GERIAT, V90, DOI 10.1016/j.archger.2020.104177; [Anonymous], 2020, ECONOMIST, V434, P17; Atlas SJ, 2001, J GEN INTERN MED, V16, P120, DOI 10.1111/j.1525-1497.2001.91141.x; Ballin M, 2021, J INTERN MED, V290, P1112, DOI 10.1111/joim.13353; de Souza IMB, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e789; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Bowen E, 2020, PAIN MED, V21, P951, DOI 10.1093/pm/pnz280; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Bunn F, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0853-9; Cashin AG, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1446; Chen Q, 2011, J AM GERIATR SOC, V59, P1385, DOI 10.1111/j.1532-5415.2011.03544.x; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Day RO, 2019, LANCET RHEUMATOL, V1, pE140, DOI 10.1016/S2665-9913(19)30041-4; de Zoete A, 2021, SPINE, V46, pE505, DOI 10.1097/BRS.0000000000003814; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Enke O, 2018, CAN MED ASSOC J, V190, pE786, DOI 10.1503/cmaj.171333; Enthoven WTM, 2016, PHYS THER, V96, P305, DOI 10.2522/ptj.20140525; Ferreira GE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4825; Hall AM, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n291; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; Harris IA, 2018, INTERN MED J, V48, P1430, DOI 10.1111/imj.14120; Hebert JJ, 2015, J MANIP PHYSIOL THER, V38, P677, DOI 10.1016/j.jmpt.2013.05.009; Henschke N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008686.pub2; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Hicks GE, 2008, ARTHRIT RHEUM-ARTHR, V59, P1306, DOI 10.1002/art.24006; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hoeritzauer I, 2021, NEUROLOGY, V96, pE433, DOI 10.1212/WNL.0000000000011154; Hoffmann TC, 2021, BMJ EVID-BASED MED, V26, DOI 10.1136/bmjebm-2020-111521; Institute for Health Metrics and Evaluation, 2022, GBD COMP VIZ HUB; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Jensen RK, 2020, EUR SPINE J, V29, P2143, DOI 10.1007/s00586-020-06339-1; Kamper SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h444; Kent P, 2005, SPINE, V30, P1433, DOI 10.1097/01.brs.0000166523.84016.4b; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Maas ET, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008572.pub2; Macfarlane GJ, 2012, PAIN, V153, P27, DOI 10.1016/j.pain.2011.08.005; Machado GC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n104; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Makris UE, 2017, PAIN MED, V18, P1225, DOI 10.1093/pm/pnw196; Marshall LM, 2017, J GERONTOL A-BIOL, V72, P1264, DOI 10.1093/gerona/glw227; McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x; Megale RZ., 2018, J PAIN, V19, pe471, DOI DOI 10.1016/J.JPAIN.2017.12.001; Mu JL, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013814; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2008, METASTATIC SPINAL CO; National Institute for Health and Care Excellence, 2016, LOW BACK PAIN SCIATI; Proetzel S, 2021, EUR J PHYS REHAB MED, V57, P783, DOI 10.23736/S1973-9087.21.06553-9; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Reid MC, 2003, J AM GERIATR SOC, V51, P1710, DOI 10.1046/j.1532-5415.2003.51554.x; Rubinstein SM, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l689; Sciubba DM, 2010, J NEUROSURG-SPINE, V13, P94, DOI 10.3171/2010.3.SPINE09202; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Steinman MA, 2021, JAMA-J AM MED ASSOC, V326, P475, DOI 10.1001/jama.2021.12134; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Swain TA, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116671703; The Patients Association, 2022, SHARED DECISION MAKI; Tousignant-Laflamme Y, 2017, J MAN MANIP THER, V25, P144, DOI 10.1080/10669817.2017.1323607; Traeger AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002019; Underwood M, BMJ, V372; Underwood M, 2008, BMJ-BRIT MED J, V336, P138, DOI 10.1136/bmj.39399.656331.25; Vekaria R, 2016, EUR SPINE J, V25, P1266, DOI 10.1007/s00586-016-4455-y; Walumbe J, 2021, SCAND J PAIN, V21, P32, DOI 10.1515/sjpain-2020-0112; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; Williams CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008643.pub2; Wu AM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.175; Zaina F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010264.pub2	71	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								e066928	10.1136/bmj-2021-066928.r1	http://dx.doi.org/10.1136/bmj-2021-066928.r1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0E9XK	35318211				2022-12-28	WOS:000777024700003
J	Dyer, C				Dyer, Clare			Judge approves "highly invasive" medical procedure to try to keep patient with OCD alive	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, PENNINE CARE NHS FDN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o758	10.1136/bmj.o758	http://dx.doi.org/10.1136/bmj.o758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314439				2022-12-28	WOS:000773915700004
J	Bernath, P; Boone, C; Crouse, J				Bernath, Peter; Boone, Chris; Crouse, Jeff			Wildfire smoke destroys stratospheric ozone	SCIENCE			English	Article							N2O5	Large wildfires inject smoke and biomass-burning products into the mid-latitude stratosphere, where they destroy ozone, which protects us from ultraviolet radiation. The infrared spectrometer on the Atmospheric Chemistry Experiment satellite measured the spectra of smoke particles from the "Black Summer" fires in Australia in late 2019 and early 2020, revealing that they contain oxygenated organic functional groups and water adsorption on the surfaces. These injected smoke particles have produced unexpected and extreme perturbations in stratospheric gases beyond any seen in the previous 15 years of measurements, including increases in formaldehyde, chlorine nitrate, chlorine monoxide, and hypochlorous acid and decreases in ozone, nitrogen dioxide, and hydrochloric acid. These perturbations in stratospheric composition have the potential to affect ozone chemistry in unexpected ways.	[Bernath, Peter] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA; [Bernath, Peter; Boone, Chris; Crouse, Jeff] Univ Waterloo, Dept Chem, Waterloo, ON, Canada; [Bernath, Peter] Old Dominion Univ, Dept Phys, Norfolk, VA 23529 USA	Old Dominion University; University of Waterloo; Old Dominion University	Bernath, P (corresponding author), Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA.; Bernath, P (corresponding author), Univ Waterloo, Dept Chem, Waterloo, ON, Canada.; Bernath, P (corresponding author), Old Dominion Univ, Dept Phys, Norfolk, VA 23529 USA.	pbernath@odu.edu	Bernath, Peter/B-6567-2012	Bernath, Peter/0000-0002-1255-396X; Crouse, Jeff/0000-0002-8368-7367; Boone, Chris/0000-0001-9041-8299	Canadian Space Agency [9F045-200575/001/SA]	Canadian Space Agency(Canadian Space Agency)	Canadian Space Agency contract 9F045-200575/001/SA (P.B., C.B., and J.C.)	Amos M., 2020, ATMOS CHEM PHYS, V20, P9961, DOI [10.5194/acp-20-9961-2020, DOI 10.5194/acp-20-9961-2020]; Bernath PF, 2021, J QUANT SPECTROSC RA, V264, DOI 10.1016/j.jqsrt.2021.107559; Bernath PF, 2020, J QUANT SPECTROSC RA, V253, DOI 10.1016/j.jqsrt.2020.107178; Bernath PF, 2017, J QUANT SPECTROSC RA, V186, P3, DOI 10.1016/j.jqsrt.2016.04.006; Bernath P, 2018, J QUANT SPECTROSC RA, V217, P126, DOI 10.1016/j.jqsrt.2018.05.027; Bertram TH, 2009, ATMOS CHEM PHYS, V9, P8351, DOI 10.5194/acp-9-8351-2009; Boone CD, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL088442; Boone CD, 2020, J QUANT SPECTROSC RA, V247, DOI 10.1016/j.jqsrt.2020.106939; Di Virgilio G, 2019, GEOPHYS RES LETT, V46, P8517, DOI 10.1029/2019GL083699; Finlayson-Pitts B.J., 1980, CHEM UPPER LOWER ATM; Fromm M, 2010, B AM METEOROL SOC, V91, P1193, DOI 10.1175/2010BAMS3004.1; Galib M, 2021, SCIENCE, V371, P921, DOI 10.1126/science.abd7716; Glatthor N, 2013, ATMOS CHEM PHYS, V13, P1637, DOI 10.5194/acp-13-1637-2013; Gordon IE, 2017, J QUANT SPECTROSC RA, V203, P3, DOI 10.1016/j.jqsrt.2017.06.038; IPCC, 2021, CONTRIBUTION WORKING, DOI DOI 10.1007/S10584-021-03233-7; Khaykin SM, 2018, GEOPHYS RES LETT, V45, P1639, DOI 10.1002/2017GL076763; Masson-Delmotte V., 2021, CLIMATE CHANGE 2021; Peterson DA, 2021, NPJ CLIM ATMOS SCI, V4, DOI 10.1038/s41612-021-00192-9; Peterson DA, 2018, NPJ CLIM ATMOS SCI, V1, DOI 10.1038/s41612-018-0039-3; PRATHER M, 1992, J GEOPHYS RES-ATMOS, V97, P10187, DOI 10.1029/92JD00845; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Solomon S., P NATL ACAD SCI US, V119; UN Environment Programme, 1987, MONTREAL PROTOCOL SU; United Nations, 1987, MONTR PROT SUBST DEP; von Clarmann T, 2012, ATMOS CHEM PHYS, V12, P1965, DOI 10.5194/acp-12-1965-2012; Wang PD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021528118; WMO (World Meteorological Organization), 2018, 58 WMO, P588; Yu PF, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2021GL092609	28	11	11	44	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2022	375	6586					1292	+		10.1126/science.abm5611	http://dx.doi.org/10.1126/science.abm5611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZV2SY	35298277				2022-12-28	WOS:000770386600040
J	Wang, FB; Cvirkaite-Krupovic, V; Vos, M; Beltran, L; Liu, J; Krupovic, M; Egelman, EH				Wang, Fengbin; Cvirkaite-Krupovic, Virginija; Vos, Matthijn; Beltran, Leticia; Liu, Jun; Krupovic, Mart; Egelman, Edward H.			Spindle-shaped archaeal viruses evolved from rod-shaped ancestors to package a larger genome	BIOPHYSICAL JOURNAL			English	Meeting Abstract	66th Annual Meeting of the Biophysical-Society	FEB 19-23, 2022	San Francisco, CA	Biophys Soc					[Wang, Fengbin; Beltran, Leticia] Univ Virginia, Charlottesville, VA USA; [Cvirkaite-Krupovic, Virginija; Vos, Matthijn; Krupovic, Mart] Inst Pasteur, Paris, France; [Liu, Jun] Yale Univ, New Haven, CT USA; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA	University of Virginia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; University of Virginia			Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Wang, Fengbin/0000-0003-1008-663X; Cvirkaite-Krupovic, Virginija/0000-0002-0876-9397					0	4	4	5	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	FEB 11	2022	121	3		1		725-Plat	148	149						2	Biophysics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics	ZF4EM	35325592	Green Published, Green Submitted			2022-12-28	WOS:000759523000719
J	Mudzingwa, EK; Parker, IK				Mudzingwa, Emily Krogstad; Parker, Ivana K.			Long-acting injections for HIV prevention among women in sub-Saharan Africa Comment	LANCET			English	Editorial Material							PREEXPOSURE PROPHYLAXIS; INFECTION; SAFETY; MEN		[Mudzingwa, Emily Krogstad] Univ Connecticut, Inst Collaborat Hlth Intervent, Storrs, CT 06269 USA; [Parker, Ivana K.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA	University of Connecticut; State University System of Florida; University of Florida	Mudzingwa, EK (corresponding author), Univ Connecticut, Inst Collaborat Hlth Intervent, Storrs, CT 06269 USA.	emily.krogstad@uconn.edu		Mudzingwa, Emily/0000-0003-2736-8350				[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Delany-Moretlwe S, 2022, LANCET, V399, P1779, DOI 10.1016/S0140-6736(22)00538-4; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2021, UNAIDS DAT 2021; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2019, JAIDS-J ACQ IMM DEF, V80, P542, DOI 10.1097/QAI.0000000000001960; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2022	399	10337					1754	1755		10.1016/S0140-6736(22)00613-4	http://dx.doi.org/10.1016/S0140-6736(22)00613-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1W5PO	35378079				2022-12-28	WOS:000806825600002
J	Wang, FB; Cvirkaite-Krupovic, V; Vos, M; Beltran, LC; Kreutzberger, MAB; Winter, JM; Su, ZL; Liu, J; Schouten, S; Krupovic, M; Egelman, EH				Wang, Fengbin; Cvirkaite-Krupovic, Virginija; Vos, Matthijn; Beltran, Leticia C.; Kreutzberger, Mark A. B.; Winter, Jean-Marie; Su, Zhangli; Liu, Jun; Schouten, Stefan; Krupovic, Mart; Egelman, Edward H.			Spindle-shaped archaeal viruses evolved from rod-shaped ancestors to package a larger genome	CELL			English	Article							GAS VESICLE FORMATION; CRYO-EM; CAPSID PROTEINS; MODEL; RECONSTRUCTION; EVOLUTIONARY; REFINEMENT; PRINCIPLES; DIVERSITY; PARADIGM	Spindle- or lemon-shaped viruses infect archaea in diverse environments. Due to the highly pleomorphic nature of these virions, which can be found with cylindrical tails emanating from the spindle-shaped body, structural studies of these capsids have been challenging. We have determined the atomic structure of the capsid of Sulfolobus monocaudavirus 1, a virus that infects hosts living in nearly boiling acid. A highly hydrophobic protein, likely integrated into the host membrane before the virions assemble, forms 7 strands that slide past each other in both the tails and the spindle body. We observe the discrete steps that occur as the tail tubes expand, and these are due to highly conserved quasiequivalent interactions with neighboring sub-units maintained despite significant diameter changes. Our results show how helical assemblies can vary their diameters, becoming nearly spherical to package a larger genome and suggest how all spindle-shaped viruses have evolved from archaeal rod-like viruses.	[Wang, Fengbin; Beltran, Leticia C.; Kreutzberger, Mark A. B.; Su, Zhangli; Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Cvirkaite-Krupovic, Virginija; Krupovic, Mart] Univ Paris, CNRS, Inst Pasteur, Archaeal Virol Unit,UMR 6047, F-75015 Paris, France; [Vos, Matthijn; Winter, Jean-Marie] Inst Pasteur, Ctr Ressources & Recherches Technol C2RT, NanoImaging Core Facil, F-75015 Paris, France; [Liu, Jun] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Liu, Jun] Yale Univ, Sch Med, Microbial Sci Inst, New Haven, CT 06510 USA; [Schouten, Stefan] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Texel, Netherlands	University of Virginia; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; Yale University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Egelman, EH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.; Krupovic, M (corresponding author), Univ Paris, CNRS, Inst Pasteur, Archaeal Virol Unit,UMR 6047, F-75015 Paris, France.	mart.krupovic@pasteur.fr; egelman@virginia.edu	Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Wang, Fengbin/0000-0003-1008-663X; Cvirkaite-Krupovic, Virginija/0000-0002-0876-9397	School of Medicine; French Government?s Investissements d?avenir program [ANR-11-EQPX-0008]; NIH [GM122510, K99GM138756]; lAgence Natio-nale de la Recherche [ANR-17-CE15-0005-01, ANR-20-CE20-009-02, ANR-21-CE11-0001-01]; Ville de Paris (Emergence (s) project MEM-REMA)	School of Medicine; French Government?s Investissements d?avenir program(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); lAgence Natio-nale de la Recherche(French National Research Agency (ANR)); Ville de Paris (Emergence (s) project MEM-REMA)	We are grateful to Dr. Xu Peng (University of Copenhagen) for the kind gift of SMV1 and its host, Saccharolobus islandicus DC1C2. Part of the cry o-EM imaging of SMV1 was done at the Molecular Electron Microscopy Core Facility at the University of Virginia, which is supported by the School of Medicine. Part of the Cryo-EM and the cryo-ET imaging were done at the Nano-Imaging Core Facility at Institut Pasteur, created with the help of a grant from the French Government?s Investissements davenir program (EQUIPEX CACSICE-Centre d?analyse de syst?mes complexes dans les environnements complexes, ANR-11-EQPX-0008) . This work was sup-ported by NIH grant GM122510 (E.H.E.) and K99GM138756 (F.W.) . The work in the M.K. laboratory was supported by grants from lAgence Natio-nale de la Recherche (ANR-17-CE15-0005-01, ANR-20-CE20-009-02, and ANR-21-CE11-0001-01) and Ville de Paris (Emergence (s) project MEM-REMA) . We are grateful to Youssef Ghorbal for the help with data transfer, to Caglar Yildiz for support in the lipid analysis, and to the Ultrastructural BioImaging unit of Institut Pasteur for access to electron microscopes.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Baquero DP, 2020, ADV VIRUS RES, V108, P127, DOI 10.1016/bs.aivir.2020.09.004; Besseling MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57035-0; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Costa TRD, 2016, CELL, V166, P1436, DOI 10.1016/j.cell.2016.08.025; CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Damodaran KV, 2002, J MOL BIOL, V324, P723, DOI 10.1016/S0022-2836(02)01138-5; Dellas N, 2014, ANNU REV VIROL, V1, P399, DOI 10.1146/annurev-virology-031413-085357; DiMaio F, 2015, SCIENCE, V348, P914, DOI 10.1126/science.aaa4181; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann S, 2014, EXTREMOPHILES, V18, P51, DOI 10.1007/s00792-013-0591-z; Forterre P, 2014, TRENDS MICROBIOL, V22, P554, DOI 10.1016/j.tim.2014.07.004; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Goulet A, 2010, ACTA CRYSTALLOGR D, V66, P304, DOI 10.1107/S0907444909051798; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hay ID, 2019, EMBO REP, V20, DOI 10.15252/embr.201847427; Hillyer MB, 2016, ANNU REV PHYS CHEM, V67, P307, DOI 10.1146/annurev-physchem-040215-112316; Hochstein R, 2018, P NATL ACAD SCI USA, V115, P2120, DOI 10.1073/pnas.1719180115; Hochstein RA, 2016, J VIROL, V90, P3458, DOI 10.1128/JVI.03098-15; Hong C, 2015, P NATL ACAD SCI USA, V112, P2449, DOI 10.1073/pnas.1425008112; Iranzo J, 2016, J VIROL, V90, P11043, DOI 10.1128/JVI.01622-16; Iverson EA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120373; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Johnson JE, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100554; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kim JG, 2019, P NATL ACAD SCI USA, V116, P15645, DOI 10.1073/pnas.1905682116; Knitsch R, 2017, MOL MICROBIOL, V106, P530, DOI 10.1111/mmi.13833; Krupovic M, 2020, NAT REV MICROBIOL, V18, P661, DOI 10.1038/s41579-020-0408-x; Krupovic M, 2019, NAT REV MICROBIOL, V17, P449, DOI 10.1038/s41579-019-0205-6; Krupovic M, 2017, P NATL ACAD SCI USA, V114, pE2401, DOI 10.1073/pnas.1621061114; Krupovic M, 2014, J VIROL, V88, P2354, DOI 10.1128/JVI.02941-13; Li N, 1998, J BACTERIOL, V180, P2450, DOI 10.1128/JB.180.9.2450-2458.1998; Li ZW, 2020, NUCLEIC ACIDS RES, V48, pW60, DOI 10.1093/nar/gkaa443; Liu JF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022578118; Mochizuki T, 2010, VIROLOGY, V402, P347, DOI 10.1016/j.virol.2010.03.046; Newberry RW, 2019, ACS CHEM BIOL, V14, P1677, DOI 10.1021/acschembio.9b00339; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Perotti LE, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.012404; Perotti LE, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.022413; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfab J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017525118; Pfeifer F, 2002, J MOL MICROB BIOTECH, V4, P175; Pfitzner AK, 2021, TRENDS CELL BIOL, V31, P856, DOI 10.1016/j.tcb.2021.04.005; Pietila MK, 2013, ENVIRON MICROBIOL, V15, P1674, DOI 10.1111/1462-2920.12030; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; Prangishvili D, 2017, NAT REV MICROBIOL, V15, P724, DOI 10.1038/nrmicro.2017.125; Ptchelkine D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01668-0; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Quemin ERJ, 2016, MBIO, V7, DOI 10.1128/mBio.01439-16; Quemin ERJ, 2015, J VIROL, V89, P11681, DOI 10.1128/JVI.02270-15; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; RAYMENT I, 1982, NATURE, V295, P110, DOI 10.1038/295110a0; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Medvedeva S, 2021, bioRxiv, DOI 10.1101/2021.07.29.453957; Scheele U, 2011, J VIROL, V85, P4812, DOI 10.1128/JVI.00072-11; Sevvana M., 2021, ENCY VIROLOGY, P257, DOI [10.1016/B978-0-12-814515-9.00033-3, DOI 10.1016/B978-0-12-814515-9.00033-3]; Sheppard C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13595; SOJAR HT, 1987, METHOD ENZYMOL, V138, P341; Stedman KM, 2015, VIROLOGY, V474, P105, DOI 10.1016/j.virol.2014.10.014; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Strunk T, 2011, MOL MICROBIOL, V81, P56, DOI 10.1111/j.1365-2958.2011.07669.x; Uldahl KB, 2016, J VIROL, V90, P5693, DOI 10.1128/JVI.00075-16; Wang FB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17268-4; Wang FB, 2019, NAT MICROBIOL, V4, P1401, DOI 10.1038/s41564-019-0458-x; Weber MS, 2021, ELIFE, V10, DOI 10.7554/eLife.70307; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Xiang XY, 2005, J VIROL, V79, P8677, DOI 10.1128/JVI.79.14.8677-8686.2005; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng WL, 2020, STRUCTURE, V28, P1321, DOI 10.1016/j.str.2020.08.010; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	78	4	4	5	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1297	+		10.1016/j.cell.2022.02.019	http://dx.doi.org/10.1016/j.cell.2022.02.019			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	1V8JR	35325592	Green Submitted, Green Published			2022-12-28	WOS:000806331300011
J	Larkin, HD				Larkin, Howard D.			FDA Expands Empagliflozin Heart Failure Indication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1219	1219		10.1001/jama.2022.4556	http://dx.doi.org/10.1001/jama.2022.4556			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380600				2022-12-28	WOS:000783965500009
J	Liu, SS; Lin, CC; Wei, JCC				Liu, Shu-Tsen; Lin, Chieh-Chung; Wei, James Cheng-Chung			Mediterranean Diet or Mindfulness-Based Stress Reduction and Prevention of Small-for-Gestational-Age Birth Weights in Newborns-Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Liu, Shu-Tsen] China Med Univ, Dept Child & Adolescent Psychiat, Childrens Hosp, Taichung, Taiwan; [Lin, Chieh-Chung] Taichung Vet Gen Hosp, Childrens Med Ctr, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Taichung, Taiwan	China Medical University Taiwan; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Dept Med, 110 Jianguo N Rd,Sect 1, Taichung 40201, Taiwan.	jccwei@gmail.com			Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras; Hospital Clinic/Institut d'Investigacions Biomediques August Pi i Sunyer La Caixa Foundation; Cerebra Foundation; Agencia de Gestio d'Ajudes Universitaries i de Investigacio (AGAUR) [LCF/PR/GN18/10310003]; Cerebra Foundation for the Brain Injured Child; AGAUR Catalonian government [1531]; Editorial Medica Panamericana; Roche Diagnostics International	Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras; Hospital Clinic/Institut d'Investigacions Biomediques August Pi i Sunyer La Caixa Foundation; Cerebra Foundation; Agencia de Gestio d'Ajudes Universitaries i de Investigacio (AGAUR); Cerebra Foundation for the Brain Injured Child; AGAUR Catalonian government; Editorial Medica Panamericana; Roche Diagnostics International	Dr Crovetto reported receiving personal fees from the Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras for support for investigation (until July 2019) during the conduct of the study. Dr Crispi reported receiving grants from the Hospital Clinic/Institut d'Investigacions Biomediques August Pi i Sunyer La Caixa Foundation, Cerebra Foundation, and Agencia de Gestio d'Ajudes Universitaries i de Investigacio (AGAUR) during the conduct of the study. Dr Gratacos reported receiving grants from CaixaResearch (LCF/PR/GN18/10310003), the Cerebra Foundation for the Brain Injured Child, and AGAUR Catalonian government (2017 SGR No. 1531) during the conduct of the study and book royalties from Columna Edicions and Editorial Medica Panamericana and grants from Roche Diagnostics International (paid to his institution).	[Anonymous], 2018, PREGN MON PROT CAT, V3rd; Crovetto F, 2021, JAMA-J AM MED ASSOC, V326, P2150, DOI 10.1001/jama.2021.20178; Sevild CH, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09111-8	3	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13								10.1001/jama.2022.2167	http://dx.doi.org/10.1001/jama.2022.2167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380584				2022-12-28	WOS:000783965500030
J	Song, ZR; Zubizarreta, JR; Giuriato, M; Paulos, E; Koh, KA				Song, Zirui; Zubizarreta, Jos R.; Giuriato, Mia; Paulos, Erica; Koh, Katherine A.			Changes in Health Care Spending, Use, and Clinical Outcomes After Nonfatal Firearm Injuries Among Survivors and Family Members A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; VIOLENCE; DESIGN; COSTS; SENSITIVITY	Background: Despite increasing awareness of firearm-related deaths, evidence on the clinical and economic implications of nonfatal firearm injuries is limited. Objective: To measure changes in clinical and economic outcomes after nonfatal firearm injuries among survivors and their family members. Design: Cohort study. Setting: MarketScan Medicare and commercial claims data, 2008 to 2018. Participants: 6498 survivors of firearm injuries matched to 32490 control participants and 12489 family members of survivors matched to 62445 control participants. Intervention: Exposure to nonfatal firearm injury as a survivor or family member of a survivor. Measurements: Changes in health care spending, use, and morbidity from preinjury through 1 year postinjury relative to control participants, on average and by type and severity of firearm injury. Results: After nonfatal firearm injury, medical spending increased $2495 per person per month (402%) and cost sharing increased $102 per person per month (176%) among survivors relative to control participants (P < 0.001) in the first year after injury, driven by an increase in the first month of $25554 (4122%) in spending and $1112 (1917%) in cost sharing per survivor (P < 0.001). All categories of health care use increased relative to the control group. Survivors had a 40% increase in pain diagnoses, a 51% increase in psychiatric disorders, and an 85% increase in substance use disorders after firearm injury relative to control participants (P < 0.001), accompanied by increased pain and psychiatric medications. Family members had a 12% increase in psychiatric disorders relative to their control participants (P = 0.003). These overall clinical and economic changes were driven by intentional firearm injuries and more severe firearm injuries. Limitation: Precision of diagnostic codes and generalizability to other patient populations, including Medicaid and uninsured patients. Conclusion: In survivors, nonfatal firearm injuries led to increases in psychiatric disorders, substance use disorders, and pain diagnoses, alongside substantial increases in health care spending and use. In addition, mental health worsened among family members.	[Song, Zirui] Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA; [Song, Zirui] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zubizarreta, Jos R.] Harvard Med Sch, Dept Hlth Care Policy, Dept Biostat, Boston, MA 02115 USA; [Zubizarreta, Jos R.] Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, CAUSALab, Boston, MA 02115 USA; [Zubizarreta, Jos R.] Harvard Med Sch, Dept Stat, Fac Arts & Sci, Boston, MA 02115 USA; [Giuriato, Mia] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Paulos, Erica] Univ Michigan, Ann Arbor, MI 48109 USA; [Koh, Katherine A.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Koh, Katherine A.] Massachusetts Gen Hosp, Boston Hlth Care Homeless Program, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Song, ZR (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA.	song@hcp.med.harvard.edu			National Institutes of Health (NIH Director's Early Independence Award) [DP5-OD024564]	National Institutes of Health (NIH Director's Early Independence Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grant DP5-OD024564 from the Office of the Director, National Institutes of Health (NIH Director's Early Independence Award [Dr. Song]) for a portion of investigator time and data costs.	Alcorn T, 2017, JAMA INTERN MED, V177, P124, DOI 10.1001/jamainternmed.2016.7076; American Psychiatric Association, 2016, PRACTICE GUIDELINES; Barber C, 2021, JAMA INTERN MED, V181, P1132, DOI 10.1001/jamainternmed.2021.0382; Centers for Disease Control and Prevention, CDC WOND UND CAUS DE; Cook PJ, 1999, JAMA-J AM MED ASSOC, V282, P447, DOI 10.1001/jama.282.5.447; Cunningham RM, 2015, JAMA PEDIATR, V169, P63, DOI 10.1001/jamapediatrics.2014.1900; Educational Fund to Stop Gun Violence, PREV FIR SUIC; Fitzpatrick V, 2019, J COMMUN HEALTH, V44, P866, DOI 10.1007/s10900-018-00603-8; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Gani F, 2018, JAMA PEDIATR, V172, P1195, DOI 10.1001/jamapediatrics.2018.3091; Gani F, 2017, HEALTH AFFAIR, V36, P1729, DOI 10.1377/hlthaff.2017.0625; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Gramlich John., 2019, WHAT DATA SAYS GUN D; Guo S.Y., 2014, PROPENSITY SCORE ANA; IBM Watson Health, 2018, IBM MARKETSCAN RES D; Institute for Womens Policy Research (IWPR), 2021, BRIEF PAP; Kalesan B, 2017, AM J EPIDEMIOL, V185, P546, DOI 10.1093/aje/kww147; Kaufman EJ, 2021, JAMA INTERN MED, V181, P237, DOI 10.1001/jamainternmed.2020.6696; Lee J, 2014, SURGERY, V155, P894, DOI 10.1016/j.surg.2014.02.011; Li YFP, 2001, J AM STAT ASSOC, V96, P870, DOI 10.1198/016214501753208573; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; NELSON CL, 1987, CLIN ORTHOP RELAT R, P114; Niknam BA, 2022, JAMA-J AM MED ASSOC, V327, P173, DOI 10.1001/jama.2021.20555; Pallin R, 2019, ANN INTERN MED, V170, pITC81, DOI 10.7326/AITC201906040; Peek-Asa Corinne, 2017, Inj Epidemiol, V4, P20, DOI 10.1186/s40621-017-0120-0; Ranney ML, 2020, ANN INTERN MED, V173, P949, DOI 10.7326/M20-0323; Rosenbaum P ., 2002, OBSERVATIONAL STUDIE; Rosenbaum PR, 2013, BIOMETRICS, V69, P118, DOI 10.1111/j.1541-0420.2012.01821.x; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2006, MATCHED SAMPLING FOR CAUSAL EFFECTS, P1, DOI 10.2277/ 0521674360; Spitzer SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209896; Spitzer SA, 2017, AM J PUBLIC HEALTH, V107, P770, DOI 10.2105/AJPH.2017.303684; Strong BL, 2016, J TRAUMA ACUTE CARE, V81, P961, DOI 10.1097/TA.0000000000001222; U.S. Government Accountability Office, 2021, FIR INJ HLTH CAR SER; Vella MA, 2020, JAMA SURG, V155, P51, DOI 10.1001/jamasurg.2019.4533; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; Zubizarreta JR, 2014, ANN APPL STAT, V8, P204, DOI 10.1214/13-AOAS713; Zubizarreta JR, 2012, J AM STAT ASSOC, V107, P1360, DOI 10.1080/01621459.2012.703874	41	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2022	175	6					795	+		10.7326/M21-2812	http://dx.doi.org/10.7326/M21-2812		APR 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Z8GP	35377713				2022-12-28	WOS:000815172700001
J	Takahashi, H; Strittmatter, SM				Takahashi, Hideyuki; Strittmatter, Stephen M.			Mining protein fibrils using structural biology	NATURE			English	Editorial Material						Neurodegeneration; Structural biology		Protein fibrils accumulate in the brain during neurodegeneration. Cryo-electron microscopy has now uncovered fibrils of a protein not previously thought to accumulate. High-resolution structures of TMEM106B fibrils.	[Takahashi, Hideyuki; Strittmatter, Stephen M.] Yale Sch Med, Dept Neurosci, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Takahashi, Hideyuki; Strittmatter, Stephen M.] Yale Sch Med, Dept Neurol, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Sch Med, Dept Neurosci, Kavli Inst Neurosci, New Haven, CT 06510 USA.; Strittmatter, SM (corresponding author), Yale Sch Med, Dept Neurol, Kavli Inst Neurosci, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu						Arseni D, 2022, NATURE, V601, P139, DOI 10.1038/s41586-021-04199-3; Busch JI, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-36; Chang A, 2022, CELL, V185, P1346, DOI 10.1016/j.cell.2022.02.026; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jiang YX, 2022, NATURE, V605, P304, DOI 10.1038/s41586-022-04670-9; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Klein ZA, 2017, NEURON, V95, P281, DOI 10.1016/j.neuron.2017.06.026; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Schweighauser M, 2022, NATURE, V605, P310, DOI 10.1038/s41586-022-04650-z; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Wightman DP, 2021, NAT GENET, V53, P1276, DOI 10.1038/s41588-021-00921-z	12	0	0	4	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2022	605	7909					227	228		10.1038/d41586-022-00873-2	http://dx.doi.org/10.1038/d41586-022-00873-2		APR 2022	2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1B8IF	35379977				2022-12-28	WOS:000778095900001
J	Blakney, AK; Bekker, LG				Blakney, Anna K.; Bekker, Linda-Gail			DNA vaccines join the fight against COVID-19	LANCET			English	Editorial Material									[Blakney, Anna K.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6S0K3, Canada; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Cape Town, South Africa	University of British Columbia; University of Cape Town	Blakney, AK (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6S0K3, Canada.	anna.blakney@msl.ubc.ca	Blakney, Anna/GWC-0911-2022					Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Khobragade A, 2022, LANCET, V399, P1313, DOI 10.1016/S0140-6736(22)00151-9; Lee J, 2018, ACTA BIOMATER, V80, P31, DOI 10.1016/j.actbio.2018.08.033; Lee K, 2009, GLOB INST, P1; Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X; Sheridan C, 2021, NAT BIOTECHNOL, V39, P1479, DOI [10.1038/d41587-021-00023-5, 10.1038/s41587-021-01166-1]; Tebas P, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100689; UN Development Programme, VACC ACC	8	2	2	4	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1281	1282						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35366995	Green Published, Bronze			2022-12-28	WOS:000812828300007
J	Devereaux, PJ; Marcucci, M; Painter, TW; Conen, D; Lomivorotov, V; Sessler, DI; Chan, MTV; Borges, FK; Martinez-Zapata, MJ; Wang, CY; Xavier, D; Ofori, SN; Wang, MK; Efremov, S; Landoni, G; Kleinlugtenbelt, YV; Szczeklik, W; Schmartz, D; Garg, AX; Short, TG; Wittmann, M; Meyhoff, CS; Amir, M; Torres, D; Patel, A; Duceppe, E; Ruetzler, K; Parlow, JL; Tandon, V; Fleischmann, E; Polanczyk, CA; Lamy, A; Astrakov, SV; Rao, M; Wu, WKK; Bhatt, K; de Nadal, M; Likhvantsev, VV; Paniagua, P; Aguado, HJ; Whitlock, RP; McGillion, MH; Prystajecky, M; Vincent, J; Eikelboom, J; Copland, I; Balasubramanian, K; Turan, A; Bangdiwala, SI; Stillo, D; Gross, PL; Cafaro, T; Alfonsi, P; Roshanov, PS; Belley-Cote, EP; Spence, J; Richards, T; VanHelder, T; McIntyre, W; Guyatt, G; Yusuf, S; Leslie, K				Devereaux, P. J.; Marcucci, M.; Painter, T. W.; Conen, D.; Lomivorotov, V; Sessler, D., I; Chan, M. T., V; Borges, F. K.; Martinez-Zapata, M. J.; Wang, C-Y; Xavier, D.; Ofori, S. N.; Wang, M. K.; Efremov, S.; Landoni, G.; Kleinlugtenbelt, Y., V; Szczeklik, W.; Schmartz, D.; Garg, A. X.; Short, T. G.; Wittmann, M.; Meyhoff, C. S.; Amir, M.; Torres, D.; Patel, A.; Duceppe, E.; Ruetzler, K.; Parlow, J. L.; Tandon, V; Fleischmann, E.; Polanczyk, C. A.; Lamy, A.; Astrakov, S., V; Rao, M.; Wu, W. K. K.; Bhatt, K.; de Nadal, M.; Likhvantsev, V. V.; Paniagua, P.; Aguado, H. J.; Whitlock, R. P.; McGillion, M. H.; Prystajecky, M.; Vincent, J.; Eikelboom, J.; Copland, I; Balasubramanian, K.; Turan, A.; Bangdiwala, S., I; Stillo, D.; Gross, P. L.; Cafaro, T.; Alfonsi, P.; Roshanov, P. S.; Belley-Cote, E. P.; Spence, J.; Richards, T.; VanHelder, T.; McIntyre, W.; Guyatt, G.; Yusuf, S.; Leslie, K.		POISE-3 Investigators	Tranexamic Acid in Patients Undergoing Noncardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-TRANSFUSION; HEMORRHAGE; MORTALITY; BIMS	BACKGROUND & nbsp;Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding.& nbsp;METHODS & nbsp;We conducted a trial involving patients undergoing noncardiac surgery. Patients were randomly assigned to receive tranexamic acid (1-g intravenous bolus) or placebo at the start and end of surgery (reported here) and, with the use of a partial factorial design, a hypotension-avoidance or hypertension-avoidance strategy (not reported here). The primary efficacy outcome was life-threatening bleeding, major bleeding, or bleeding into a critical organ (composite bleeding outcome) at 30 days. The primary safety outcome was myocardial injury after noncardiac surgery, nonhemorrhagic stroke, peripheral arterial thrombosis, or symptomatic proximal venous thromboembolism (composite cardiovascular outcome) at 30 days. To establish the noninferiority of tranexamic acid to placebo for the composite cardiovascular outcome, the upper boundary of the one-sided 97.5% confidence interval for the hazard ratio had to be below 1.125, and the one-sided P value had to be less than 0.025.& nbsp;RESULTS & nbsp;A total of 9535 patients underwent randomization. A composite bleeding outcome event occurred in 433 of 4757 patients (9.1%) in the tranexamic acid group and in 561 of 4778 patients (11.7%) in the placebo group (hazard ratio, 0.76; 95% confidence interval [CI], 0.67 to 0.87; absolute difference, -2.6 percentage points; 95% CI, -3.8 to -1.4; two-sided P < 0.001 for superiority). A composite cardiovascular outcome event occurred in 649 of 4581 patients (14.2%) in the tranexamic acid group and in 639 of 4601 patients (13.9%) in the placebo group (hazard ratio, 1.02; 95% CI, 0.92 to 1.14; upper boundary of the one-sided 97.5% CI, 1.14; absolute difference, 0.3 percentage points; 95% CI, -1.1 to 1.7; one-sided P=0.04 for noninferiority).& nbsp;CONCLUSIONSAmong patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. Although the between-group difference in the composite cardiovascular outcome was small, the noninferiority of tranexamic acid was not established.& nbsp;	[Devereaux, P. J.; Marcucci, M.; Conen, D.; Borges, F. K.; Ofori, S. N.; Wang, M. K.; Lamy, A.; Whitlock, R. P.; McGillion, M. H.; Vincent, J.; Eikelboom, J.; Copland, I; Balasubramanian, K.; Bangdiwala, S., I; Stillo, D.; Cafaro, T.; Roshanov, P. S.; McIntyre, W.; Yusuf, S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Devereaux, P. J.; Marcucci, M.; Conen, D.; Borges, F. K.; Ofori, S. N.; Wang, M. K.; Garg, A. X.; Bangdiwala, S., I; Spence, J.; Guyatt, G.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Devereaux, P. J.; Marcucci, M.; Conen, D.; Borges, F. K.; Wang, M. K.; Patel, A.; Tandon, V; Eikelboom, J.; Gross, P. L.; Belley-Cote, E. P.; McIntyre, W.; Guyatt, G.; Yusuf, S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lamy, A.; Whitlock, R. P.] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Spence, J.; VanHelder, T.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [McGillion, M. H.] McMaster Univ, Sch Nursing, Hamilton, ON, Canada; [Garg, A. X.; Whitlock, R. P.] Western Univ, Dept Med, London, ON, Canada; [Garg, A. X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Parlow, J. L.] Queens Univ, Dept Anesthesiol & Perioperat Med, Kingston, ON, Canada; [Parlow, J. L.] Kingston Hlth Sci Ctr, Kingston, ON, Canada; [Duceppe, E.] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada; [Cafaro, T.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada; [Prystajecky, M.] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Painter, T. W.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Painter, T. W.] Royal Adelaide Hosp, Dept Anaesthesia, Adelaide, SA, Australia; [Richards, T.] Monash Univ, Dept Anaesthesia & Perioperat Med, Melbourne, Vic, Australia; [Leslie, K.] Univ Melbourne, Melbourne Med Sch, Dept Crit Care Med, Melbourne, Vic, Australia; [Lomivorotov, V] Novosibirsk State Univ, Dept Anesthesiol & Intens Care, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia; [Lomivorotov, V] Novosibirsk State Univ, V Zelman Inst Med & Psychol, Dept Anesthesiol & Intens Care, Novosibirsk, Russia; [Astrakov, S., V] Novosibirsk State Univ, V Zelman Inst Med & Psychol, Dept Anesthesiol, Novosibirsk, Russia; [Efremov, S.] St Petersburg State Univ Hosp, St Petersburg, Russia; [Likhvantsev, V. V.] First Moscow State Med Univ Sechenov Univ, Anesthesia & Intens Care Dept, V Negovsky Reanimatol Res Inst, Moscow, Russia; [Sessler, D., I; Ruetzler, K.; Turan, A.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [Ruetzler, K.; Turan, A.] Cleveland Clin, Dept Gen Anesthesia, Cleveland, OH 44106 USA; [Sessler, D., I; Ruetzler, K.; Turan, A.] Cleveland Clin, Anesthesiol Inst, Cleveland, OH 44106 USA; [Chan, M. T., V; Wu, W. K. K.] Chinese Univ Hong Kong, Shatin, Peoples R China; [Martinez-Zapata, M. J.] Ctr Invest Biomed Red Epidemiol & Salud Publ, Inst Invest Biomed St Pau, Publ Hlth & Clin Epidemiol Serv, Iberoamer Cochrane Ctr, Barcelona, Spain; [de Nadal, M.] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Anesthesiol & Intens Care, Barcelona, Spain; [Paniagua, P.] Santa Creu & St Pau Univ Hosp, Anesthesiol Dept, Barcelona, Spain; [Aguado, H. J.] Hosp Clin Univ Valladolid, Trauma & Orthoped Surg Dept, Valladolid, Spain; [Wang, C-Y] Univ Malaya, Fac Med, Dept Anesthesiol, Kuala Lumpur, Malaysia; [Xavier, D.; Rao, M.] St Johns Med Coll, Bangalore, Karnataka, India; [Bhatt, K.] Surat Inst Digest Sci & Lospital & Res Ctr, Dept Gastrointestinal Surg, Surat, India; [Landoni, G.] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Dept Anesthesiol & Intens Care, Milan, Italy; [Kleinlugtenbelt, Y., V] Deventer Ziekenhuis, Dept Orthoped & Trauma Surg, Deventer, Netherlands; [Szczeklik, W.] Jagiellonian Univ Med Coll, Ctr Intens Care & Perioperat Med, Krakow, Poland; [Schmartz, D.] Univ Libre Bruxelles, Ctr Hosp Univ Brugmann, Brussels, Belgium; [Short, T. G.] Univ Auckland, Auckland City Hosp, Dept Anesthesia, Auckland, New Zealand; [Short, T. G.] Univ Auckland, Sch Hlth Sci, Auckland, New Zealand; [Wittmann, M.] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Meyhoff, C. S.] Univ Copenhagen, Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Anesthesia & Intens Care, Copenhagen, Denmark; [Meyhoff, C. S.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Amir, M.] Shifa Int Hosp, Islamabad, Pakistan; [Torres, D.] Univ Los Andes, Dept Epidemiol & Estudios Salud, Santiago, Chile; [Torres, D.] Clin Santa Maria, Serv Anestesiol, Santiago, Chile; [Fleischmann, E.] Med Univ Vienna, Dept Anesthesia Gen Intens Care Med & Pain Med, Vienna, Austria; [Polanczyk, C. A.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Natl Inst Hlth Technol Assessment, Porto Alegre, RS, Brazil; [Polanczyk, C. A.] Hosp Moinhos de Vento, Porto Alegre, RS, Brazil; [Alfonsi, P.] Univ Paris, Hosp Paris St Joseph, Dept Anesthesia, Paris, France	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada; Universite de Montreal; McGill University; University of Saskatchewan; University of Adelaide; Royal Adelaide Hospital; Monash University; University of Melbourne; Meshalkin National Medical Research Center; Novosibirsk State University; Novosibirsk State University; Novosibirsk State University; Federal Research & Clinical Center of Intensive Care Medicine & Rehabilitology; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chinese University of Hong Kong; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universiti Malaya; St. John's National Academy of Health Sciences; St. John's Medical College; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Deventer Hospital; Jagiellonian University; Collegium Medicum Jagiellonian University; Universite Libre de Bruxelles; Auckland City Hospital; University of Auckland; University of Auckland; University of Bonn; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Universidad de los Andes - Chile; Medical University of Vienna; Universidade Federal do Rio Grande do Sul; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite	Devereaux, PJ (corresponding author), Hamilton Gen Hosp, David Braley Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	pj.devereaux@phri.ca	Wu, William K.K./A-3277-2009; Ng, Tyng Yan/CAG-3286-2022; Chee, Kok Han/I-2138-2013; Szczeklik, Wojciech/N-8096-2014; Berikashvili, Levan/ADO-4089-2022; Velten, Markus/P-3078-2018; Fot, Eugenia/AAF-2660-2019; Hussain, Ayyaz/O-8342-2016; Wang, Chew Yin/F-7573-2010; Kuzkov, Vsevolod/R-6331-2016; Schandelmaier, Stefan/GLV-3722-2022; Sokolova, Maria/L-5814-2015; López-Baamonde, Manuel/AAF-9721-2021; wu, william/HII-5817-2022; Yadgarov, Mikhail/AAX-6748-2020; Kirov, Mikhail/R-2320-2016; Ruetzler, Kurt/W-2596-2017; EGOM, EMMANUEL EROUME-A/ABG-1708-2021; Chan, Matthew/J-2884-2013; Azawi, Nessn/T-6147-2018	Wu, William K.K./0000-0002-5662-5240; Ng, Tyng Yan/0000-0002-3150-6923; Chee, Kok Han/0000-0002-4485-0504; Szczeklik, Wojciech/0000-0002-1349-1123; Berikashvili, Levan/0000-0001-9267-3664; Velten, Markus/0000-0001-5439-4648; Fot, Eugenia/0000-0003-0052-8086; Hussain, Ayyaz/0000-0003-1476-3693; Kuzkov, Vsevolod/0000-0002-8191-1185; Schandelmaier, Stefan/0000-0002-8429-0337; Sokolova, Maria/0000-0002-6705-5124; López-Baamonde, Manuel/0000-0001-5537-1755; Yadgarov, Mikhail/0000-0003-3792-1682; Kirov, Mikhail/0000-0002-4375-3374; Ruetzler, Kurt/0000-0003-0467-1736; EGOM, EMMANUEL EROUME-A/0000-0001-7142-5477; Araujo Duran, Jorge Andres/0000-0002-4126-9554; Beltran, Joan/0000-0002-6225-5223; Ziemann, Sebastian/0000-0003-4485-6030; Yusuf, Salim/0000-0003-4776-5601; Meyhoff, Christian/0000-0002-4885-4609; Chan, Matthew/0000-0002-3574-7855; KLIMOV, Andrei/0000-0001-7633-6852; Garcia-Virto, Virginia/0000-0002-7609-7991; Zahid, Jawad Ahmad/0000-0001-7078-8591; LANDONI, Giovanni/0000-0002-8594-5980; Wang, Michael Ke/0000-0002-4949-3235; Roshanov, Pavel/0000-0003-3908-1955; Dieu, Audrey/0000-0002-6026-1734; Echeverria-Villalobos, Marco/0000-0001-5770-754X; Martinez-Zapata/0000-0002-5836-1138; Kadantseva, Kristina/0000-0002-6593-8580; Azawi, Nessn/0000-0001-7519-8654; Rivas, Eva/0000-0002-5816-998X; Nadler, Naomi/0000-0002-1416-2153; Zamudio Penko, Diana/0000-0002-5367-5525	Canadian Institutes of Health Research [FDN-143302]; Australian National Health and Medical Research Council [14104419]; General Research Fund; Research Grant Council, Hong Kong; Population Health Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); General Research Fund; Research Grant Council, Hong Kong(Hong Kong Research Grants Council); Population Health Research Institute	Supported by a Foundation Grant (FDN-143302, to Dr. De-vereaux) from the Canadian Institutes of Health Research, a Project Grant (1162362) from the Australian National Health and Medical Research Council, and a grant from General Research Fund 14104419, Research Grant Council, Hong Kong, and by the Population Health Research Institute.	Borges Flavia K, 2020, CJC Open, V2, P577, DOI 10.1016/j.cjco.2020.07.009; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Houston BL, 2021, TRANSFUSION MED, V31, P236, DOI 10.1111/tme.12780; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Kamel H, 2012, CIRCULATION, V126, P207, DOI 10.1161/CIRCULATIONAHA.112.094326; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Marcucci M, 2022, TRIALS, V23, DOI 10.1186/s13063-021-05992-1; Murao S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03799-9; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Oberweis BS, 2013, AM HEART J, V165, P427, DOI 10.1016/j.ahj.2012.11.005; Roberts N, 2019, LANCET HAEMATOL, V6, pE606, DOI 10.1016/S2352-3026(19)30200-5; Roshanov PS, 2021, BRIT J ANAESTH, V126, P163, DOI 10.1016/j.bja.2020.06.051; Roshanov PS, 2021, BRIT J ANAESTH, V126, P172, DOI 10.1016/j.bja.2020.02.028; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Sentilhes L, 2021, NEW ENGL J MED, V384, P1623, DOI 10.1056/NEJMoa2028788; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shehata N, 2014, TRANSFUSION, V54, P2631, DOI 10.1111/trf.12644; Spence J, 2019, CAN MED ASSOC J, V191, pE830, DOI 10.1503/cmaj.190221; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; Taeuber I, 2021, JAMA SURG, V156, DOI 10.1001/jamasurg.2021.0884; Vetter TR, 2014, ANESTH ANALG, V118, P1301, DOI 10.1213/ANE.0000000000000131; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Wells AW, 2002, BRIT MED J, V325, P803, DOI 10.1136/bmj.325.7368.803	26	24	24	17	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2022	386	21					1986	1997		10.1056/NEJMoa2201171	http://dx.doi.org/10.1056/NEJMoa2201171		APR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1T5MB	35363452	Bronze, Green Accepted			2022-12-28	WOS:000788123500001
J	Dolgin, E				Dolgin, Elie			Closing in on a cure	NATURE			English	News Item						Diseases; Drug discovery; Therapeutics; Medical research		Finite courses of treatment could get the virus under control - with the right combination of drugs.										Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Revill P, 2016, NAT REV GASTRO HEPAT, V13, P239, DOI 10.1038/nrgastro.2016.7; Revill PA, 2019, LANCET GASTROENTEROL, V4, P545, DOI 10.1016/S2468-1253(19)30119-0; Tu T, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050515; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yang YC, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14010004; Yuen MF, 2021, NAT MED, V27, P1725, DOI 10.1038/s41591-021-01513-4	7	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S46	S48		10.1038/d41586-022-00812-1	http://dx.doi.org/10.1038/d41586-022-00812-1			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354992	Bronze			2022-12-28	WOS:000776361600009
J	Iacobucci, G				Iacobucci, Gareth			All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G., 2019, BMJ, V367, pl5895; Iacobucci G, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4812; National Institute for Health and Care Excellence, NICE GUID DIAB TYP 1; National Institute for Health and Care Excellence, NICE GUID TYP 1 DIAB	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o834	10.1136/bmj.o834	http://dx.doi.org/10.1136/bmj.o834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361579				2022-12-28	WOS:000779990000006
J	Iacobucci, G				Iacobucci, Gareth			MPs vote to retain provision for women in England to take abortion pills at home	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o869	10.1136/bmj.o869	http://dx.doi.org/10.1136/bmj.o869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361681				2022-12-28	WOS:000779990000001
J	Jehanno, C; Alty, JW; Roosen, M; De Meester, S; Dove, AP; Chen, EYX; Leibfarth, FA; Sardon, H				Jehanno, Coralie; Alty, Jill W.; Roosen, Martijn; De Meester, Steven; Dove, Andrew P.; Chen, Eugene Y-X; Leibfarth, Frank A.; Sardon, Haritz			Critical advances and future opportunities in upcycling commodity polymers	NATURE			English	Article							HIGH-DENSITY POLYETHYLENE; CONSEQUENTIAL LCA; REACTIVE COMPATIBILIZATION; WASTE; PLASTICS; BLENDS; POLY(ETHYLENE-TEREPHTHALATE); DEPOLYMERIZATION; POLYPROPYLENE; CONVERSION	The vast majority of commodity plastics do not degrade and therefore they permanently pollute the environment. At present, less than 20% of post-consumer plastic waste in developed countries is recycled, predominately for energy recovery or repurposing as lower-value materials by mechanical recycling. Chemical recycling offers an opportunity to revert plastics back to monomers for repolymerization to virgin materials without altering the properties of the material or the economic value of the polymer. For plastic waste that is either cost prohibitive or infeasible to mechanically or chemically recycle, the nascent field of chemical upcycling promises to use chemical or engineering approaches to place plastic waste at the beginning of a new value chain. Here state-of-the-art methods are highlighted for upcycling plastic waste into value-added performance materials, fine chemicals and specialty polymers. By identifying common conceptual approaches, we critically discuss how the advantages and challenges of each approach contribute to the goal of realizing a sustainable plastics economy.	[Jehanno, Coralie; Sardon, Haritz] Univ Basque Country UPV EHU, POLYMAT, Donostia San Sebastian, Spain; [Alty, Jill W.; Leibfarth, Frank A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Roosen, Martijn; De Meester, Steven] Univ Ghent, Lab Circular Proc Engn, Kortrijk, Belgium; [Dove, Andrew P.] Univ Birmingham, Sch Chem, Birmingham, W Midlands, England; [Chen, Eugene Y-X] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Jehanno, Coralie] POLYKEY, Donostia San Sebastian, Spain	University of Basque Country; POLYMAT; University of North Carolina; University of North Carolina Chapel Hill; Ghent University; University of Birmingham; Colorado State University	Sardon, H (corresponding author), Univ Basque Country UPV EHU, POLYMAT, Donostia San Sebastian, Spain.; Leibfarth, FA (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.; De Meester, S (corresponding author), Univ Ghent, Lab Circular Proc Engn, Kortrijk, Belgium.	Steven.DeMeester@UGent.be; FrankL@email.unc.edu; haritz.sardon@ehu.es	Sardon, Haritz/C-4044-2015	Sardon, Haritz/0000-0002-6268-0916; Alty, Jill/0000-0002-9780-1343	Spanish Ministry for the excellence Grant POLYCE; Basque University; Air Force Office of Scientific Research award [17RT0487]; VLAIO; Catalisti Moonshot programme through the PREFER project [HBC20202609]; European Regional Development Fund (ERDF) via the PSYCHE project (Interreg France-Wallonie-Vlaanderen); province of East-Flanders; province of West-Flanders; US Department of Energy, Office of Energy Efficiency and Renewable Energy, Advanced Manufacturing Office and Bioenergy Technologies Office [DE-AC36-08GO28308]; National Renewable Energy Laboratory; University of Birmingham	Spanish Ministry for the excellence Grant POLYCE; Basque University; Air Force Office of Scientific Research award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); VLAIO; Catalisti Moonshot programme through the PREFER project; European Regional Development Fund (ERDF) via the PSYCHE project (Interreg France-Wallonie-Vlaanderen); province of East-Flanders; province of West-Flanders; US Department of Energy, Office of Energy Efficiency and Renewable Energy, Advanced Manufacturing Office and Bioenergy Technologies Office(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); University of Birmingham	C.J. and H.S. thank the Spanish Ministry for the excellence Grant POLYCE and the Basque University for the EHUrOPE grant. F.A.L. and J.W.A. acknowledge support from the Air Force Office of Scientific Research award number 17RT0487 under the Young Investigator Program. S.D.M. and M.R. acknowledge support from VLAIO and the Catalisti Moonshot programme through the PREFER project (The plastics refinery: No more waste - HBC20202609) and the European Regional Development Fund (ERDF) via the PSYCHE project (Interreg France-Wallonie-Vlaanderen) with co-financing from the provinces of East-Flanders and West-Flanders. E.Y.-X.C. acknowledges support from the BOTTLE Consortium funded by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Advanced Manufacturing Office and Bioenergy Technologies Office under contract number DE-AC36-08GO28308 with the National Renewable Energy Laboratory, operated by Alliance for Sustainable Energy. A.P.D. acknowledges the financial support from theT University of Birmingham.	Anastas P.T., 1998, GREEN CHEM THEORY PR; Anastas PT, 2003, ENVIRON SCI TECHNOL, V37, p94A, DOI 10.1021/es032373g; [Anonymous], 2019, NAT CATAL, V2, P945, DOI 10.1038/s41929-019-0391-7; [Anonymous], 2019, PLAST THE FACTS 2019; [Anonymous], 2021, ADDITIVE MANUFACTURI; [Anonymous], 2020, SCI ENABLE SUSTAINAB; [Anonymous], 2012, WHAT WASTE GLOBAL RE; [Anonymous], 2017, NAT OV FACTS FIG MAT; Antelava A, 2019, ENVIRON MANAGE, V64, P230, DOI 10.1007/s00267-019-01178-3; Backstrom E, 2017, IND ENG CHEM RES, V56, P14814, DOI 10.1021/acs.iecr.7b04091; Backstrorn E, 2019, ACS SUSTAIN CHEM ENG, V7, P11004, DOI 10.1021/acssuschemeng.9b02092; Bae C, 2005, J AM CHEM SOC, V127, P767, DOI 10.1021/ja044440s; Bae CS, 2005, ANGEW CHEM INT EDIT, V44, P6410, DOI 10.1002/anie.200501837; Britt P.F., 2019, REPORT BASIC ENERGY; Buyle M, 2019, J CLEAN PROD, V218, P141, DOI 10.1016/j.jclepro.2019.01.306; Chen LY, 2021, CHEM-US, V7, P137, DOI 10.1016/j.chempr.2020.11.020; Christensen PR, 2019, NAT CHEM, V11, P442, DOI 10.1038/s41557-019-0249-2; Civancik-Uslu D, 2021, RESOUR CONSERV RECY, V171, DOI 10.1016/j.resconrec.2021.105633; Coates GW, 2020, NAT REV MATER, V5, P501, DOI 10.1038/s41578-020-0190-4; De Meester S, 2019, RESOUR CONSERV RECY, V142, P1, DOI 10.1016/j.resconrec.2018.10.015; Demarteau J, 2020, CHEMSUSCHEM, V13, P3122, DOI 10.1002/cssc.202000505; Do T, 2018, POLYMER, V143, P106, DOI 10.1016/j.polymer.2018.04.015; Eagan JM, 2017, SCIENCE, V355, P814, DOI 10.1126/science.aah5744; Easterling CP, 2017, CHEM SCI, V8, P7705, DOI 10.1039/c7sc02574b; Ellen Macarthur Foundation, 2018, NEW PLAST EC CAT ACT; Ellis LD, 2021, NAT CATAL, V4, P539, DOI 10.1038/s41929-021-00648-4; Ellis LD, 2021, ACS SUSTAIN CHEM ENG, V9, P623, DOI 10.1021/acssuschemeng.0c07612; Equiza N, 2007, MACROMOL MATER ENG, V292, P1001, DOI 10.1002/mame.200700148; Eriksen MK, 2019, J IND ECOL, V23, P156, DOI 10.1111/jiec.12822; Fazekas TJ, 2022, SCIENCE, V375, P545, DOI 10.1126/science.abh4308; Feldman D, 2005, J MACROMOL SCI PURE, VA42, P587, DOI 10.1081/MA-200056331; Fukushima K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3861; Fukushima K, 2013, POLYM CHEM-UK, V4, P1610, DOI 10.1039/c2py20793a; Fukushima K, 2012, ACS NANO, V6, P9191, DOI 10.1021/nn3035217; Galloway JA, 2005, POLYMER, V46, P183, DOI 10.1016/j.polymer.2004.10.061; Geyer B, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.39786, 10.1002/app.39786]; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Ghose A, 2017, J CLEAN PROD, V165, P119, DOI 10.1016/j.jclepro.2017.07.099; Gong J, 2019, PROG POLYM SCI, V94, P1, DOI 10.1016/j.progpolymsci.2019.04.001; Gong J, 2014, APPL CATAL B-ENVIRON, V152, P289, DOI 10.1016/j.apcatb.2014.01.051; Gong J, 2014, IND ENG CHEM RES, V53, P4173, DOI 10.1021/ie4043246; Hettema R, 2002, POLYM ENG SCI, V42, P665, DOI 10.1002/pen.10980; Hlavata D, 2001, MACROMOL SYMP, V176, P93, DOI 10.1002/1521-3900(200112)176:1<93::AID-MASY93>3.0.CO;2-L; Hong M, 2017, GREEN CHEM, V19, P3692, DOI 10.1039/c7gc01496a; Iannone F, 2017, J MOL CATAL A-CHEM, V426, P107, DOI 10.1016/j.molcata.2016.11.006; Jehanno C, 2020, ACS MACRO LETT, V9, P443, DOI 10.1021/acsmacrolett.0c00164; Jehanno C, 2019, POLYM CHEM-UK, V10, P172, DOI 10.1039/c8py01284a; Jones GO, 2016, P NATL ACAD SCI USA, V113, P7722, DOI 10.1073/pnas.1600924113; Kammakakam I, 2019, POLYM INT, V68, P1123, DOI 10.1002/pi.5802; Kathalewar M, 2013, PROG ORG COAT, V76, P147, DOI 10.1016/j.porgcoat.2012.08.023; Kenny ST, 2008, ENVIRON SCI TECHNOL, V42, P7696, DOI 10.1021/es801010e; Kenny ST, 2012, APPL MICROBIOL BIOT, V95, P623, DOI 10.1007/s00253-012-4058-4; Kim HT, 2019, ACS SUSTAIN CHEM ENG, V7, P19396, DOI 10.1021/acssuschemeng.9b03908; Kim JG, 2020, POLYM CHEM-UK, V11, P4830, DOI 10.1039/c9py01927h; Kim PJ, 2018, ACS APPL MATER INTER, V10, P14827, DOI 10.1021/acsami.8b03959; Ko S, 2020, J IND ENG CHEM, V83, P449, DOI 10.1016/j.jiec.2019.12.018; Kondo Y, 2002, J AM CHEM SOC, V124, P1164, DOI 10.1021/ja016763j; Koning C, 1998, PROG POLYM SCI, V23, P707, DOI 10.1016/S0079-6700(97)00054-3; Lazarevic D, 2010, RESOUR CONSERV RECY, V55, P246, DOI 10.1016/j.resconrec.2010.09.014; Lewis SE, 2020, POLYM CHEM-UK, V11, P4914, DOI 10.1039/c9py01884k; Lewis SE, 2019, CHEM SCI, V10, P6270, DOI 10.1039/c9sc01425j; Liu X, 2019, MACROMOLECULES, V52, P4570, DOI 10.1021/acs.macromol.9b00817; Macosko CW, 2005, PROG POLYM SCI, V30, P939, DOI 10.1016/j.progpolymsci.2005.06.003; Mohamed HH, 2019, ENVIRON SCI POLLUT R, V26, P12288, DOI 10.1007/s11356-019-04684-3; Monsigny L, 2018, ACS SUSTAIN CHEM ENG, V6, P10481, DOI 10.1021/acssuschemeng.8b01842; Moraga G, 2019, RESOUR CONSERV RECY, V146, P452, DOI 10.1016/j.resconrec.2019.03.045; Mouawia A, 2017, ACS SUSTAIN CHEM ENG, V5, P696, DOI 10.1021/acssuschemeng.6b01777; Nechifor M, 2018, INT J POLYM ANAL CH, V23, P740, DOI 10.1080/1023666X.2018.1509493; Nicholson SR, 2021, JOULE, V5, P673, DOI 10.1016/j.joule.2020.12.027; Pang CC, 2018, ACS SUSTAIN CHEM ENG, V6, P17059, DOI 10.1021/acssuschemeng.8b04421; Pauli G., 1999, UPCYCLING; Pawlak A, 2002, J APPL POLYM SCI, V86, P1473, DOI 10.1002/app.11307; Plummer CM, 2020, POLYM CHEM-UK, V11, P6862, DOI 10.1039/d0py01279c; Pracella M, 2002, MACROMOL CHEM PHYSIC, V203, P1473, DOI 10.1002/1521-3935(200207)203:10/11<1473::AID-MACP1473>3.0.CO;2-4; Prosman EJ, 2018, J CLEAN PROD, V172, P2782, DOI 10.1016/j.jclepro.2017.11.134; Ragaert K, 2017, WASTE MANAGE, V69, P24, DOI 10.1016/j.wasman.2017.07.044; Rahimi A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0046; Rottger M, 2017, SCIENCE, V356, P62, DOI 10.1126/science.aah5281; Rorrer NA, 2019, JOULE, V3, P1006, DOI 10.1016/j.joule.2019.01.018; Roy PK, 2013, J ENVIRON CHEM ENG, V1, P1062, DOI 10.1016/j.jece.2013.08.019; Saito K, 2020, J MATER CHEM A, V8, P13921, DOI 10.1039/d0ta03374j; SALEEM M, 1990, J APPL POLYM SCI, V39, P655, DOI 10.1002/app.1990.070390316; Santana RMC, 2003, J APPL POLYM SCI, V87, P747, DOI 10.1002/app.11404; Sardon H, 2015, MACROMOLECULES, V48, P3153, DOI 10.1021/acs.macromol.5b00384; Schneiderman DK, 2017, MACROMOLECULES, V50, P3733, DOI 10.1021/acs.macromol.7b00293; Sharma P, 2016, ACS SUSTAIN CHEM ENG, V4, P1085, DOI 10.1021/acssuschemeng.5b01153; Shi CX, 2021, CHEM-US, V7, P2896, DOI 10.1016/j.chempr.2021.10.004; Sohn YJ, 2020, BIOTECHNOL J, V15, DOI 10.1002/biot.201900489; SUNDARARAJ U, 1995, MACROMOLECULES, V28, P2647, DOI 10.1021/ma00112a009; Tan JPK, 2019, MACROMOLECULES, V52, P7878, DOI 10.1021/acs.macromol.9b01333; Tempelaar S, 2013, CHEM SOC REV, V42, P1312, DOI 10.1039/c2cs35268k; Tiso T, 2021, METAB ENG, V66, P167, DOI 10.1016/j.ymben.2021.03.011; Tournier V, 2020, NATURE, V580, P216, DOI 10.1038/s41586-020-2149-4; Ugduler S, 2020, WASTE MANAGE, V104, P148, DOI 10.1016/j.wasman.2020.01.003; Vadenbo C, 2017, J IND ECOL, V21, P1078, DOI 10.1111/jiec.12519; Villagomez-Salas S, 2018, ACS OMEGA, V3, P17520, DOI 10.1021/acsomega.8b02290; Vollmer I, 2020, ANGEW CHEM INT EDIT, V59, P15402, DOI 10.1002/anie.201915651; Ward PG, 2006, ENVIRON SCI TECHNOL, V40, P2433, DOI 10.1021/es0517668; WASHIYAMA J, 1993, MACROMOLECULES, V26, P2928, DOI 10.1021/ma00063a043; Wei R, 2020, NAT CATAL, V3, P867, DOI 10.1038/s41929-020-00521-w; Westhues S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat9669; Williamson JB, 2019, J AM CHEM SOC, V141, P12815, DOI 10.1021/jacs.9b05799; Williamson JB, 2019, ANGEW CHEM INT EDIT, V58, P8654, DOI 10.1002/anie.201810970; Williamson JB, 2018, ANGEW CHEM INT EDIT, V57, P6261, DOI 10.1002/anie.201803020; Wu CH, 2018, ACS SUSTAIN CHEM ENG, V6, P8964, DOI 10.1021/acssuschemeng.8b01326; Xu J, 2018, MACROMOLECULES, V51, P8585, DOI 10.1021/acs.macromol.8b01907; Yang RX, 2015, ENERG FUEL, V29, P8178, DOI 10.1021/acs.energyfuels.5b01866; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zhang F, 2020, SCIENCE, V370, P437, DOI 10.1126/science.abc5441; Zhang JH, 2013, IND ENG CHEM RES, V52, P5708, DOI 10.1021/ie4004392; Zhao DT, 2020, CHEMSUSCHEM, V13, P1764, DOI 10.1002/cssc.201903434; Zhuo CW, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39931	112	45	47	227	328	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					803	814		10.1038/s41586-021-04350-0	http://dx.doi.org/10.1038/s41586-021-04350-0			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354997				2022-12-28	WOS:000776361600024
J	Maxmen, A				Maxmen, Amy			SCIENTISTS STRUGGLE TO PROBE COVID'S ORIGINS AMID SPARSE DATA FROM CHINA	NATURE			English	News Item						SARS-CoV-2; Politics; Virology; Public health		Origin investigations typically take years, but some researchers say China is delaying the process for political reasons as international tensions rise.										Gao G, RES SQUARE, DOI [10.21203/rs.3.rs-1370392/v1 (2022), DOI 10.21203/RS.3.RS-1370392/V1(2022)]; He WT, 2022, CELL, V185, P1117, DOI 10.1016/j.cell.2022.02.014; Pekar J. E, ZENODO, DOI [10.5281/zenodo.6291628 (2022, DOI 10.5281/ZENODO.6291628(2022]; Worobey M., 2022, ZENODO, DOI [10.5281/zenodo.6299600, DOI 10.5281/ZENODO.6299600]; Xiao X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91470-2; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	6	0	0	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					773	775		10.1038/d41586-022-00732-0	http://dx.doi.org/10.1038/d41586-022-00732-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0B9EM	35304880	Bronze			2022-12-28	WOS:000774929100011
J	Wadhwani, SI; Lai, JC; Gottlieb, LM				Wadhwani, Sharad I.; Lai, Jennifer C.; Gottlieb, Laura M.			Medical Need, Financial Resources, and Transplant Accessibility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wadhwani, Sharad I.; Lai, Jennifer C.; Gottlieb, Laura M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wadhwani, SI (corresponding author), Univ Calif San Francisco, Sch Med, 744 52nd St, Oakland, CA 94609 USA.	sharad.wadhwani@ucsf.edu						[Anonymous], 2022, NAT DAT; Bently TS., 2020, 2020 US ORGAN TISSUE; Dakhoul L, 2019, HEPATOL COMMUN, V3, P52, DOI 10.1002/hep4.1277; Ebel NH, 2022, LIVER TRANSPLANT, V28, P1520, DOI 10.1002/lt.26437; Jesse MT, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13714; Ku E, 2020, TRANSPLANTATION, V104, P1437, DOI 10.1097/TP.0000000000002962; Ng YH, 2020, TRANSPLANTATION, V104, P1445, DOI 10.1097/TP.0000000000003002; Patzer RE, 2012, AM J TRANSPLANT, V12, P358, DOI 10.1111/j.1600-6143.2011.03927.x	8	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1445	1446		10.1001/jama.2022.5283	http://dx.doi.org/10.1001/jama.2022.5283		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35357415				2022-12-28	WOS:000776736300001
J	Gemble, S; Wardenaar, R; Keuper, K; Srivastava, N; Nano, M; Mace, AS; Tijhuis, AE; Bernhard, SV; Spierings, DCJ; Simon, A; Goundiam, O; Hochegger, H; Piel, M; Foijer, F; Storchova, Z; Basto, R				Gemble, Simon; Wardenaar, Rene; Keuper, Kristina; Srivastava, Nishit; Nano, Maddalena; Mace, Anne-Sophie; Tijhuis, Andrea E.; Bernhard, Sara Vanessa; Spierings, Diana C. J.; Simon, Anthony; Goundiam, Oumou; Hochegger, Helfrid; Piel, Matthieu; Foijer, Floris; Storchova, Zuzana; Basto, Renata			Genetic instability from a single S phase after whole-genome duplication	NATURE			English	Article							DNA-REPLICATION; CYCLE; CYTOKINESIS; TRANSCRIPTION; POLYPLOIDY; EXPRESSION; DYNAMICS; E2F; G1	Diploid and stable karyotypes are associated with health and fitness in animals. By contrast, whole-genome duplications-doublings of the entire complement of chromosomes-are linked to genetic instability and frequently found in human cancers(1-3). It has been established that whole-genome duplications fuel chromosome instability through abnormal mitosis(4-8); however, the immediate consequences of tetraploidy in the first interphase are not known. This is a key question because single whole-genome duplication events such as cytokinesis failure can promote tumorigenesis(9). Here we find that human cells undergo high rates of DNA damage during DNA replication in the first S phase following induction of tetraploidy. Using DNA combing and single-cell sequencing, we show that DNA replication dynamics is perturbed, generating under- and over-replicated regions. Mechanistically, we find that these defects result from a shortage of proteins during the G1/S transition, which impairs the fidelity of DNA replication. This work shows that within a single interphase, unscheduled tetraploid cells can acquire highly abnormal karyotypes. These findings provide an explanation for the genetic instability landscape that favours tumorigenesis after tetraploidization.	[Gemble, Simon; Nano, Maddalena; Simon, Anthony; Goundiam, Oumou; Basto, Renata] PSL Res Univ, Inst Curie, CNRS, UMR144,Biol Centrosomes & Genet Instabil Lab, Paris, France; [Wardenaar, Rene; Tijhuis, Andrea E.; Spierings, Diana C. J.; Foijer, Floris] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Keuper, Kristina; Bernhard, Sara Vanessa; Storchova, Zuzana] TU Kaiserslautern, Dept Mol Genet, Kaiserslautern, Germany; [Srivastava, Nishit; Piel, Matthieu] Inst Curie, Paris, France; [Srivastava, Nishit; Piel, Matthieu] PSL Res Univ, Inst Pierre Gilles Gennes, CNRS, UMR144,Syst Biol Cell Polar & Cell Div, Paris, France; [Mace, Anne-Sophie] PSL Res Univ, CNRS, Inst Curie, Cell & Tissue Imaging Facil PICT IBiSA, Paris, France; [Hochegger, Helfrid] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton, E Sussex, England; [Nano, Maddalena] Univ Calif Santa Barbara, Mol Cellular & Dev Biol Dept, Santa Barbara, CA 93106 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Groningen; University of Kaiserslautern; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Sussex; University of California System; University of California Santa Barbara	Gemble, S; Basto, R (corresponding author), PSL Res Univ, Inst Curie, CNRS, UMR144,Biol Centrosomes & Genet Instabil Lab, Paris, France.	simon.gemble@curie.fr; renata.basto@curie.fr		Srivastava, Nishit/0000-0003-4177-6123; Nano, Maddalena/0000-0002-8369-6466; Tijhuis, Andrea/0000-0001-8150-3061; Foijer, Floris/0000-0003-0989-3127; Storchova, Zuzana/0000-0003-2376-7047; GOUNDIAM, Oumou/0000-0002-0714-7860; MACE, Anne-Sophie/0000-0003-3072-3819; Spierings, Diana/0000-0001-8403-474X	Cell and Tissue Imaging platform (PICT-IBiSA), member of the French National Research Infrastructure France-BioImaging [ANR10-INBS-04]; ERC CoG [725907]; Institut Curie; CNRS;  [FOR2800/STO918-7]	Cell and Tissue Imaging platform (PICT-IBiSA), member of the French National Research Infrastructure France-BioImaging; ERC CoG; Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); 	We authors acknowledge the Cell and Tissue Imaging platform (PICT-IBiSA), member of the French National Research Infrastructure France-BioImaging (ANR10-INBS-04) and the Nikon Imaging center from Institut Curie for microscopy. We thank L. Guyonnet, A. Chipont, C. Guerrin and C. Roulin from the Cytometry and RADEXP platforms of Institut Curie; and V. Marthiens, S. Lambert, E. Schwob, W. Marshall, G. Almouzni, J. S. Hoffmann, D. Fachinetti, M. Budzyk, F. Edwards, G. Fantozzi, R. Salame, A. Goupil, C. Chen, F. Perez and N. Ganem for helpful discussions and/or comments on the manuscript. This work was supported by FOR2800/STO918-7 to Z.S., ERC CoG (ChromoNumber-725907) to R.B., Institut Curie and the CNRS. The Basto laboratory is a member of the Cell(n)Scale Labex.	Aknoun S, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.12.126009; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bielski CM, 2018, NAT GENET, V50, P1189, DOI 10.1038/s41588-018-0165-1; Bon P, 2009, OPT EXPRESS, V17, P13080, DOI 10.1364/OE.17.013080; Burgess A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045726; Cadart C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05393-0; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Fox DT, 2010, GENE DEV, V24, P2294, DOI 10.1101/gad.1952710; Frawley LE, 2015, CURR BIOL, V25, pR353, DOI 10.1016/j.cub.2015.03.037; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gemble S, 2020, BIOESSAYS, V42, DOI 10.1002/bies.202000105; Gemble S, 2019, CURR BIOL, V29, P3072, DOI 10.1016/j.cub.2019.07.052; Goupil A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201908006; Hegarat N, 2020, EMBO J, V39, DOI 10.15252/embj.2020104419; Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Koh SB, 2017, J CELL SCI, V130, P512, DOI 10.1242/jcs.195164; Koundrioukoff S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003643; KS Y. RH K. M L. R G. R W., 2015, SCI REP-UK, V5; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lopez S, 2020, NAT GENET, V52, P283, DOI 10.1038/s41588-020-0584-7; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nano M, 2019, CURR BIOL, V29, P3937, DOI 10.1016/j.cub.2019.09.041; Orr-Weaver TL, 2015, TRENDS GENET, V31, P307, DOI 10.1016/j.tig.2015.03.011; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; van den Bos H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0976-2; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao BL, 2020, NAT REV MOL CELL BIO, V21, P765, DOI 10.1038/s41580-020-00297-8; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	50	8	8	8	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					146	+		10.1038/s41586-022-04578-4	http://dx.doi.org/10.1038/s41586-022-04578-4		MAR 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355016	Green Published, hybrid			2022-12-28	WOS:000776020400007
J	Howard, S; Krishna, G				Howard, Sally; Krishna, Geetanjali			The world's refugees remain last in line for covid-19 vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Holder J, 2022, NEW YORK TIMES; Oxfam, 2021, PEOPL VACC REF; UNHCR, 2021, UNHCR COVID 19 VACC; WHO, 2020, WHO SAG ROADM PRIOR	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o703	10.1136/bmj.o703	http://dx.doi.org/10.1136/bmj.o703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351691	Bronze			2022-12-28	WOS:000779544800012
J	Davies, M				Davies, Madlen			Why hospital bombings remain difficult to prosecute as war crimes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												madlen.davies@bmj.com						[Anonymous], 2022, LITH INT ALL 100 000; [Anonymous], 2022, UKR RUSS CLUST MUN H; Coalition for the International Criminal Court, SUFF BUDG; International Criminal Court, PROP BUDG 2022; World Health Organization, SURV SYST ATT HLTH C	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o771	10.1136/bmj.o771	http://dx.doi.org/10.1136/bmj.o771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346949	Bronze			2022-12-28	WOS:000778641000004
J	Mills, EJ; Reis, G				Mills, Edward J.; Reis, Gilmar			Evaluating COVID-19 vaccines in the real world	LANCET			English	Editorial Material									[Mills, Edward J.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada; [Reis, Gilmar] Pontificia Univ Catolica Minas Gerais, Dept Med, Belo Horizonte, MG, Brazil	McMaster University; Pontificia Universidade Catolica de Minas Gerais	Mills, EJ (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada.	millsej@mcmaster.ca						Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Center for Systems Science and Engineering, 2022, J HOPKINS U COVID 19; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rearte A, 2022, LANCET, V399, P1254, DOI 10.1016/S0140-6736(22)00011-3; Thompson Mark G, 2022, MMWR Morb Mortal Wkly Rep, V71, P139, DOI 10.15585/mmwr.mm7104e3; Vandenbroucke JP, 2019, EPIDEMIOLOGY, V30, P838, DOI 10.1097/EDE.0000000000001088; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	9	0	0	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1205	1206		10.1016/S0140-6736(22)00194-5	http://dx.doi.org/10.1016/S0140-6736(22)00194-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35303472	Bronze, Green Published			2022-12-28	WOS:000779495000004
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word ... . Memory, semantic and episodic ...	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o747; Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o646; Bartolomei F, 2017, CORTEX, V90, P173, DOI 10.1016/j.cortex.2016.12.005; Baudry M, 2020, NEUROBIOL LEARN MEM, V171, DOI 10.1016/j.nlm.2020.107191; Buss C, 2004, PSYCHONEUROENDOCRINO, V29, P1093, DOI 10.1016/j.psyneuen.2003.09.006; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Clayton NS, 2007, CURR BIOL, V17, pR189, DOI 10.1016/j.cub.2007.01.011; Delvecchio M, 2020, DIABETES THER, V11, P1667, DOI 10.1007/s13300-020-00864-4; El Haj M, 2022, ARCH CLIN NEUROPSYCH, V37, P513, DOI 10.1093/arclin/acab074; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; Proust M, 1959, COMMUNICATION 1010	11	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o804	10.1136/bmj.o804	http://dx.doi.org/10.1136/bmj.o804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0G9YB	35338051	Bronze			2022-12-28	WOS:000778396700007
J	Chumachenko, D; Chumachenko, T				Chumachenko, Dmytro; Chumachenko, Tetyana			Ukraine war: The humanitarian crisis in Kharkiv	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chumachenko, Dmytro] Natl Aerosp Univ, Dept Math Modelling & Artificial Intelligence, Kharkiv, Ukraine; [Chumachenko, Tetyana] Kharkiv Natl Med Univ, Dept Epidemiol, Kharkiv, Ukraine	Ministry of Education & Science of Ukraine; National Aerospace University - Kharkiv Aviation Institute; Kharkiv National Medical University	Chumachenko, D (corresponding author), Natl Aerosp Univ, Dept Math Modelling & Artificial Intelligence, Kharkiv, Ukraine.		Chumachenko, Tetyana/AAS-2094-2020; Chumachenko, Dmytro/I-8520-2018	Chumachenko, Tetyana/0000-0002-4175-2941; Chumachenko, Dmytro/0000-0003-2623-3294				[Anonymous], 2022, GUARDIAN; [Anonymous], 2022, ALM 6 5 MILL PEOPL I; [Anonymous], MEDSCAPE MED NEWS, P2022; Mohammadi A, RADIOELECTRONIC COMP, V3, P5; Operational data portal, 2022, UKR REF SIT	5	4	4	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o796	10.1136/bmj.o796	http://dx.doi.org/10.1136/bmj.o796			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338030	Bronze			2022-12-28	WOS:000778396700004
J	Hong, J; Bae, JH; Jo, H; Park, HY; Lee, S; Hong, SJ; Chun, H; Cho, MK; Kim, J; Kim, J; Son, Y; Jin, H; Suh, JY; Kim, SC; Roh, HK; Lee, KH; Kim, HS; Chung, KY; Yoon, CW; Lee, K; Kim, SH; Ahn, JP; Baik, H; Kim, GH; Han, B; Jin, S; Hyeon, T; Park, J; Son, CY; Yang, Y; Lee, YS; Yoo, SJ; Chun, DW				Hong, Jaeyoung; Bae, Jee-Hwan; Jo, Hyesung; Park, Hee-Young; Lee, Sehyun; Hong, Sung Jun; Chun, Hoje; Cho, Min Kyung; Kim, Juyoung; Kim, Joodeok; Son, Yongju; Jin, Haneul; Suh, Jin-Yoo; Kim, Sung-Chul; Roh, Ha-Kyung; Lee, Kyu Hyoung; Kim, Hyung-Seok; Chung, Kyung Yoon; Yoon, Chang Won; Lee, Kiryeong; Kim, Seo Hee; Ahn, Jae-Pyoung; Baik, Hionsuck; Kim, Gyeung Ho; Han, Byungchan; Jin, Sungho; Hyeon, Taeghwan; Park, Jungwon; Son, Chang Yun; Yang, Yongsoo; Lee, Young-Su; Yoo, Sung Jong; Chun, Dong Won			Metastable hexagonal close-packed palladium hydride in liquid cell TEM	NATURE			English	Article							ELECTRON TOMOGRAPHY; NANOCRYSTALS; NUCLEATION; NANOPARTICLE; MECHANISMS; GRAPHENE; GROWTH; CONSTANTS; PDHX	Metastable phases-kinetically favoured structures-are ubiquitous in nature(1,2). Rather than forming thermodynamically stable ground-state structures, crystals grown from high-energy precursors often initially adopt metastable structures depending on the initial conditions, such as temperature, pressure or crystal size(1,3,4). As the crystals grow further, they typically undergo a series of transformations from metastable phases to lower-energy and ultimately energetically stable phases(1,3,4). Metastable phases sometimes exhibit superior physicochemical properties and, hence, the discovery and synthesis of new metastable phases are promising avenues for innovations in materials science(1,5). However, the search for metastable materials has mainly been heuristic, performed on the basis of experiences, intuition or even speculative predictions, namely 'rules of thumb'. This limitation necessitates the advent of a new paradigm to discover new metastable phases based on rational design. Such a design rule is embodied in the discovery of a metastable hexagonal close-packed (hcp) palladium hydride (PdHx) synthesized in a liquid cell transmission electron microscope. The metastable hcp structure is stabilized through a unique interplay between the precursor concentrations in the solution: a sufficient supply of hydrogen (H) favours the hcp structure on the subnanometre scale, and an insufficient supply of Pd inhibits further growth and subsequent transition towards the thermodynamically stable face-centred cubic structure. These findings provide thermodynamic insights into metastability engineering strategies that can be deployed to discover new metastable phases.	[Hong, Jaeyoung; Bae, Jee-Hwan; Cho, Min Kyung; Kim, Juyoung; Kim, Sung-Chul; Lee, Kiryeong; Kim, Seo Hee; Ahn, Jae-Pyoung; Kim, Gyeung Ho; Chun, Dong Won] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea; [Jo, Hyesung; Yang, Yongsoo] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Park, Hee-Young; Lee, Sehyun; Jin, Haneul; Yoon, Chang Won; Yoo, Sung Jong] Korea Inst Sci & Technol, Ctr Hydrogen Fuel Cell Res, Seoul, South Korea; [Hong, Sung Jun] Yonsei Univ, Integrated Sci & Engn Div, UIC, Seoul, South Korea; [Hong, Sung Jun; Chun, Hoje; Han, Byungchan] Yonsei Univ, Chem & Biomol Engn Dept, Seoul, South Korea; [Kim, Joodeok; Son, Yongju; Hyeon, Taeghwan; Park, Jungwon] Inst Basic Sci IBS, Ctr Nanoparticle Res, Seoul, South Korea; [Kim, Joodeok; Son, Yongju; Hyeon, Taeghwan; Park, Jungwon] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Kim, Joodeok; Son, Yongju; Hyeon, Taeghwan; Park, Jungwon] Seoul Natl Univ, Inst Chem Proc, Seoul, South Korea; [Suh, Jin-Yoo; Lee, Young-Su; Chun, Dong Won] Korea Inst Sci & Technol, Ctr Energy Mat Res, Seoul, South Korea; [Roh, Ha-Kyung; Kim, Hyung-Seok; Chung, Kyung Yoon] Korea Inst Sci & Technol, Ctr Energy Storage Res, Seoul, South Korea; [Lee, Kyu Hyoung] Yonsei Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Chung, Kyung Yoon; Yoon, Chang Won; Yoo, Sung Jong] Korea Univ Sci & Technol, KIST Sch, Div Energy & Environm Technol, Seoul, South Korea; [Yoon, Chang Won; Yoo, Sung Jong] Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea; [Baik, Hionsuck] Korea Basic Sci Inst, Seoul, South Korea; [Jin, Sungho] Univ Calif San Diego, Dept Mech & Aerosp Engn, Mat Sci & Engn Program, La Jolla, CA USA; [Park, Jungwon] Seoul Natl Univ, Inst Engn Res, Seoul, South Korea; [Son, Chang Yun] Pohang Univ Sci & Technol, Dept Chem, Pohang, South Korea; [Son, Chang Yun] Pohang Univ Sci & Technol, Div Adv Mat Sci, Pohang, South Korea	Korea Institute of Science & Technology (KIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Institute of Science & Technology (KIST); Yonsei University; Yonsei University; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Yonsei University; Korea Institute of Science & Technology (KIST); Kyung Hee University; Korea Basic Science Institute (KBSI); University of California System; University of California San Diego; Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Chun, DW (corresponding author), Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea.; Yang, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea.; Yoo, SJ (corresponding author), Korea Inst Sci & Technol, Ctr Hydrogen Fuel Cell Res, Seoul, South Korea.; Lee, YS; Chun, DW (corresponding author), Korea Inst Sci & Technol, Ctr Energy Mat Res, Seoul, South Korea.; Yoo, SJ (corresponding author), Korea Univ Sci & Technol, KIST Sch, Div Energy & Environm Technol, Seoul, South Korea.; Yoo, SJ (corresponding author), Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea.; Son, CY (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Pohang, South Korea.; Son, CY (corresponding author), Pohang Univ Sci & Technol, Div Adv Mat Sci, Pohang, South Korea.	changyunson@postech.ac.kr; yongsoo.yang@kaist.ac.kr; lee0su@kist.re.kr; ysj@kist.re.kr; chundream98@kist.re.kr	Lee, Young-Su/C-3834-2012; Yang, Yongsoo/P-7716-2014; Jin, Haneul/HDL-7981-2022; Han, Byungchan/G-2615-2018; Yoo, Sung Jong/A-1405-2009; Chung, Kyung Yoon/E-4646-2011	Lee, Young-Su/0000-0002-3160-6633; Yang, Yongsoo/0000-0001-8654-302X; Jin, Haneul/0000-0002-2428-6790; Han, Byungchan/0000-0002-2325-6733; Yoo, Sung Jong/0000-0003-0238-5971; Chung, Kyung Yoon/0000-0002-1273-746X; Chun, Hoje/0000-0003-0624-536X; Hong, Jaeyoung/0000-0001-9605-8888	National Research Foundation [2018M3D1A1058793, 2015M1A2A2074688, 2018M1A2A2061975, 2021M3H4A1A02042948, 2019R1F1A1058236, 2020R1C1C1006239, 2020R1F1A1060331, 2019M3E6A1064877]; Korea Institute of Science and Technology [2E30201]; Institute for Basic Science [IBS-R006-D1]; KAIST [M3I3]	National Research Foundation; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); Institute for Basic Science; KAIST	This research was supported by the National Research Foundation (grant nos. 2018M3D1A1058793, 2015M1A2A2074688, 2018M1A2A2061975, 2021M3H4A1A02042948, 2019R1F1A1058236, 2020R1C1C1006239, 2020R1F1A1060331 and 2019M3E6A1064877), the Korea Institute of Science and Technology (grant no. 2E30201), the KAIST-funded Global Singularity Research Program (M3I3) and the Institute for Basic Science (grant no. IBS-R006-D1).	Algara-Siller G, 2015, NATURE, V519, P443, DOI 10.1038/nature14295; Arblaster JW, 2012, PLATIN MET REV, V56, P181, DOI 10.1595/147106712X646113; Aykol M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0148; Bakalis E, 2020, J PHYS CHEM C, V124, P14881, DOI 10.1021/acs.jpcc.0c03203; Baldi A, 2014, NAT MATER, V13, P1143, DOI [10.1038/NMAT4086, 10.1038/nmat4086]; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bruker AXS,, 2014, TOPAS V5 GEN PROF ST; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Chen BR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04917-y; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Chen L, 2019, ENERG ENVIRON SCI, V12, P3099, DOI 10.1039/c9ee01564g; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Dal Corso A, 2014, COMP MATER SCI, V95, P337, DOI 10.1016/j.commatsci.2014.07.043; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Errea I, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.177002; Giannozzi P, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa8f79; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; GOPALAKRISHNAN J, 1995, CHEM MATER, V7, P1265, DOI 10.1021/cm00055a001; Griessen R, 2016, NAT MATER, V15, P311, DOI [10.1038/NMAT4480, 10.1038/nmat4480]; Guo C, 2016, J PHYS CHEM LETT, V7, P5008, DOI 10.1021/acs.jpclett.6b02276; Hammond C, 2001, BASICS CRYSTALLOGRAP, V214; Houari A, 2014, J APPL PHYS, V116, DOI 10.1063/1.4901004; Jung HJ, 2013, NANO LETT, V13, P716, DOI 10.1021/nl304400c; Kim BH, 2020, SCIENCE, V368, P60, DOI 10.1126/science.aax3233; Kobayashi K, 2017, ANGEW CHEM INT EDIT, V56, P6578, DOI 10.1002/anie.201703209; Kwon SG, 2011, SMALL, V7, P2685, DOI 10.1002/smll.201002022; Lange AP, 2016, ACTA MATER, V120, P364, DOI 10.1016/j.actamat.2016.08.061; LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Lee J, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.34; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Lim B, 2007, ANGEW CHEM INT EDIT, V46, P9279, DOI 10.1002/anie.200703755; Loh ND, 2017, NAT CHEM, V9, P77, DOI [10.1038/NCHEM.2618, 10.1038/nchem.2618]; Long DB, 2018, INT J HYDROGEN ENERG, V43, P18372, DOI 10.1016/j.ijhydene.2018.08.030; Martinolich AJ, 2017, CHEM MATER, V29, P479, DOI 10.1021/acs.chemmater.6b04861; Marzari N, 1999, PHYS REV LETT, V82, P3296, DOI 10.1103/PhysRevLett.82.3296; Moore Jr W.J., 1941, J AM CHEM SOC, V63, P1392, DOI 10.1021/ja01850a074; Nielsen MH, 2014, SCIENCE, V345, P1158, DOI 10.1126/science.1254051; Park JH, 2015, NANO LETT, V15, P5314, DOI 10.1021/acs.nanolett.5b01677; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Politano A, 2017, MAT SCI SEMICON PROC, V65, P88, DOI 10.1016/j.mssp.2016.05.002; Pryor A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09847-1; Ross F.M., 2017, LIQUID CELL ELECT MI; Sachs C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075408; SCHIRBER JE, 1975, PHYS REV B, V12, P117, DOI 10.1103/PhysRevB.12.117; Schneider N. M., 2015, RADIOLYSIS; Schneider NM, 2014, J PHYS CHEM C, V118, P22373, DOI 10.1021/jp507400n; Sun WH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600225; Tian XZ, 2020, NAT MATER, V19, P867, DOI 10.1038/s41563-020-0636-5; Walter J, 2000, J CATAL, V189, P449, DOI 10.1006/jcat.1999.2710; Woehl TJ, 2012, ACS NANO, V6, P8599, DOI 10.1021/nn303371y; Yang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02617-z; Yang YS, 2017, NATURE, V542, P75, DOI 10.1038/nature21042; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zhang TH, 2007, J AM CHEM SOC, V129, P13520, DOI 10.1021/ja073598k; Zhou JH, 2020, MRS BULL, V45, P290, DOI 10.1557/mrs.2020.88; Zhou XW, 2008, J MATER RES, V23, P704, DOI 10.1557/JMR.2008.0090	59	6	6	29	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					631	+		10.1038/s41586-021-04391-5	http://dx.doi.org/10.1038/s41586-021-04391-5			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322249	Green Submitted			2022-12-28	WOS:000772661800018
J	Robinson, A				Robinson, Ann			Ann Robinson's research reviews-24 March 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o748	10.1136/bmj.o748	http://dx.doi.org/10.1136/bmj.o748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35332031	Bronze			2022-12-28	WOS:000778460100013
J	Jain, R; Simcox, J				Jain, Raghav; Simcox, Judith			Igniting adipocyte thermogenesis	CELL			English	Editorial Material							ENERGY-EXPENDITURE; ADIPOSE-TISSUE; MICE	Maintenance of body temperature is intimately tied to energy expenditure and body weight regulation. In this issue of Cell, Li, Wang, et al. discovered that localized hyperthermia induces the thermogenic program to increase energy expenditure and decrease body weight in mice and humans.	[Jain, Raghav; Simcox, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Simcox, J (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	jsimcox@wisc.edu		Jain, Raghav/0000-0002-1284-6762				Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Cohen P, 2021, NAT REV MOL CELL BIO, V22, P393, DOI 10.1038/s41580-021-00350-0; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Li Y, 2022, CELL, V185, P949, DOI 10.1016/j.cell.2022.02.004; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Patsouris D, 2015, CELL REP, V13, P1538, DOI 10.1016/j.celrep.2015.10.028; Shao ML, 2019, DIABETES, V68, P1874, DOI 10.2337/db19-0308; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555	10	0	0	15	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2022	185	6					941	943		10.1016/j.cell.2022.02.024	http://dx.doi.org/10.1016/j.cell.2022.02.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZZ6CW	35303425				2022-12-28	WOS:000773355400002
J	Yen, M; Ren, JM; Liu, QX; Glassman, CR; Sheahan, TP; Picton, LK; Moreira, FR; Rustagi, A; Jude, KM; Zhao, X; Blish, CA; Baric, RS; Su, LL; Garcia, KC				Yen, Michelle; Ren, Junming; Liu, Qingxiang; Glassman, Caleb R.; Sheahan, Timothy P.; Picton, Lora K.; Moreira, Fernando R.; Rustagi, Arjun; Jude, Kevin M.; Zhao, Xiang; Blish, Catherine A.; Baric, Ralph S.; Su, Leon L.; Garcia, K. Christopher			Facile discovery of surrogate cytokine agonists	CELL			English	Article							IL-2 RECEPTOR; STAT5 PROTEINS; T-CELLS; INTERLEUKIN-2; ALPHA; ASSOCIATION; LYMPHOCYTES; ACTIVATION; INFECTION; BIOLOGY	Cytokines are powerful immune modulators that initiate signaling through receptor dimerization, but natural cytokines have structural limitations as therapeutics. We present a strategy to discover cytokine surrogate agonists by using modular ligands that exploit induced proximity and receptor dimer geometry as pharmacological metrics amenable to high-throughput screening. Using VHH and scFv to human interleukin-2/15, type-I interferon, and interleukin-10 receptors, we generated combinatorial matrices of single-chain bispecific ligands that exhibited diverse spectrums of functional activities, including potent inhibition of SARS-CoV-2 by surrogate interferons. Crystal structures of IL-2R:VHH complexes revealed that variation in receptor dimer geometries resulted in functionally diverse signaling outputs. This modular platform enabled engineering of surrogate ligands that compelled assembly of an IL-2R/IL-10R heterodimer, which does not naturally exist, that signaled through pSTAT5 on T and natural killer (NK) cells. This "cytokine med-chem'' approach, rooted in principles of induced proximity, is generalizable for discovery of diversified agonists for many ligand-receptor systems.	[Yen, Michelle; Ren, Junming; Liu, Qingxiang; Glassman, Caleb R.; Picton, Lora K.; Jude, Kevin M.; Zhao, Xiang; Su, Leon L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Yen, Michelle; Ren, Junming; Liu, Qingxiang; Glassman, Caleb R.; Picton, Lora K.; Jude, Kevin M.; Zhao, Xiang; Su, Leon L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Yen, Michelle; Ren, Junming; Liu, Qingxiang; Glassman, Caleb R.; Picton, Lora K.; Jude, Kevin M.; Zhao, Xiang; Su, Leon L.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Sheahan, Timothy P.; Moreira, Fernando R.; Baric, Ralph S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Rustagi, Arjun; Blish, Catherine A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Blish, Catherine A.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Ren, Junming/AAN-2968-2020	Ren, Junming/0000-0002-0764-0882; Picton, Lora/0000-0002-0482-5187; Jude, Kevin/0000-0002-3675-5136; Blish, Catherine/0000-0001-6946-7627; Liu, Qingxiang/0000-0002-9333-5648; Rustagi, Arjun/0000-0002-6921-1012	National Institute of Allergy and Infectious Diseases (NIAID) [R37-AI051321]; Mathers Charitable Foundation; NIAID [R01 AI132178, R01 AI132178-04S1]; Bill & Melinda Gates Foundation [OPP1113682]; North Carolina Policy Collaboratory at University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund by the North Carolina General Assembly; Stanford Immunology Program Training Grant [5T32AI07290-33]; Stanford Immunology and Rheumatology Training Grant [5T32AR050942-15]; NIH grant [T32 AI007502-23]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P30GM133894]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mathers Charitable Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); North Carolina Policy Collaboratory at University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund by the North Carolina General Assembly; Stanford Immunology Program Training Grant; Stanford Immunology and Rheumatology Training Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Yakun Wan for sharing of VHH reagents. This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R37-AI051321 to K.C.G., the Mathers Charitable Foundation, NIAID grants R01 AI132178 and R01 AI132178-04S1 to R.S.B. and T.P.S., and the Bill & Melinda Gates Foundation grant OPP1113682 to C.A.B. This project was supported in part by the North Carolina Policy Collaboratory at University of North Carolina at Chapel Hill, with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly to R.S.B. K.C.G. is an investigator of the Howard Hughes Medical Institute. M.Y.'s training was supported by the Stanford Immunology Program Training Grant (5T32AI07290-33) and the Stanford Immunology and Rheumatology Training Grant (5T32AR050942-15). A.R.'s training was supported by NIH grant T32 AI007502-23. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894). Portions of schematics in Figures 1C and S4A were generated using BioRender.com.	Berraondo P, 2019, BRIT J CANCER, V120, P6, DOI 10.1038/s41416-018-0328-y; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cardarelli J.M., 2010, US Patent, Patent No. [7662381B2, 7662381]; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corman SL, 2010, ANN PHARMACOTHER, V44, P1072, DOI 10.1345/aph.1P042; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Delespine-Carmagnat M, 2000, EUR J IMMUNOL, V30, P59, DOI 10.1002/1521-4141(200001)30:1<59::AID-IMMU59>3.0.CO;2-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelowski E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04454-8; Fairhead M., 2015, METHODS MOL BIOL, P171; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Glassman CR, 2021, ELIFE, V10, DOI 10.7554/eLife.65777; Glassman CR, 2021, CELL, V184, P983, DOI 10.1016/j.cell.2021.01.018; Harris KE, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90096-8; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Janda CY, 2017, NATURE, V545, P234, DOI 10.1038/nature22306; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kromann-Hansen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03457-7; KUZIEL WA, 1993, J IMMUNOL, V150, P3357; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Lerner RA, 2015, Q REV BIOPHYS, V48, P389, DOI 10.1017/S0033583515000049; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin JX, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028449; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mansurov A, 2021, AM J PHYSIOL-CELL PH, V321, pC369, DOI 10.1152/ajpcell.00515.2020; Mendoza JL, 2019, NATURE, V567, P56, DOI 10.1038/s41586-019-0988-7; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Mohan K, 2019, SCIENCE, V364, P750, DOI 10.1126/science.aav7532; Moraga I, 2017, ELIFE, V6, DOI 10.7554/eLife.22882; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; Ng J, 1997, J BIOL CHEM, V272, P24542, DOI 10.1074/jbc.272.39.24542; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; Overwijk WW, 2021, ANNU REV MED, V72, P281, DOI 10.1146/annurev-med-073118-011031; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Quigley M, 2008, J IMMUNOL, V180, P2158, DOI 10.4049/jimmunol.180.4.2158; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Saxton RA, 2021, SCIENCE, V371, P1222, DOI 10.1126/science.abc8433; Sharma N, 2016, J BIOL CHEM, V291, P3371, DOI 10.1074/jbc.M115.686071; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Shourian M, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101307; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang C. -I., 2016, U.S. Patent, Patent No. [20160367664A1, 20160367664]; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wu Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00930; Xue HH, 2002, INT IMMUNOL, V14, P1263, DOI 10.1093/intimm/dxf101; Zhang HK, 2013, CHEM BIOL, V20, P734, DOI 10.1016/j.chembiol.2013.04.012	65	6	6	10	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1414	+		10.1016/j.cell.2022.02.025	http://dx.doi.org/10.1016/j.cell.2022.02.025			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	3F9YN	35325595				2022-12-28	WOS:000831015400004
J	Hipp, HS; Crawford, S; Boulet, S; Toner, J; Sparks, AAE; Kawwass, JF				Hipp, Heather S.; Crawford, Sara; Boulet, Sheree; Toner, James; Sparks, Amy A. E.; Kawwass, Jennifer F.			Trends and Outcomes for Preimplantation Genetic Testing in the United States, 2014-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							IN-VITRO FERTILIZATION		[Hipp, Heather S.; Toner, James; Kawwass, Jennifer F.] Emory Univ, Div Reprod Endocrinol & Infertil, Atlanta, GA 30305 USA; [Crawford, Sara] Univ Mt Union, Dept Math, Alliance, OH USA; [Boulet, Sheree] Emory Univ, Div Gynecol Specialties, Atlanta, GA 30305 USA; [Sparks, Amy A. E.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	Emory University; University of Mount Union; Emory University; University of Iowa	Hipp, HS (corresponding author), Emory Univ, 550 Peachtree St,Ste 1800, Atlanta, GA 30305 USA.	hhipp@emory.edu	Sparks, Amy/GQH-8512-2022	Hipp, Heather/0000-0002-1089-3928; Toner, James/0000-0002-1401-7722				Amer Soc Reprod Med, 2018, FERTIL STERIL, V109, P429, DOI 10.1016/j.fertnstert.2018.01.002; Chang J, 2016, FERTIL STERIL, V105, P394, DOI 10.1016/j.fertnstert.2015.10.018; Hipp H, 2017, J ASSIST REPROD GEN, V34, P885, DOI 10.1007/s10815-017-0926-2; Munne S, 2019, FERTIL STERIL, V112, P1071, DOI 10.1016/j.fertnstert.2019.07.1346; Paulson RJ, 2020, HUM REPROD, V35, P490, DOI 10.1093/humrep/dez280; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035	6	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1288	1290		10.1001/jama.2022.1892	http://dx.doi.org/10.1001/jama.2022.1892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380591	Green Published			2022-12-28	WOS:000783965500023
J	Zong, WJ; Obenhaus, HA; Skytoen, ER; Eneqvist, H; de Jong, NL; Vale, R; Jorge, MR; Moser, MB; Moser, EI				Zong, Weijian; Obenhaus, Horst A.; Skytoen, Emilie R.; Eneqvist, Hanna; de Jong, Nienke L.; Vale, Ruben; Jorge, Marina R.; Moser, May-Britt; Moser, Edvard, I			Large-scale two-photon calcium imaging in freely moving mice	CELL			English	Article							FIELD-OF-VIEW; LONG-TERM; SPATIAL REPRESENTATION; NEURONAL-ACTIVITY; MICROSCOPY; SYSTEM; COMPRESSION; HIPPOCAMPUS; DYNAMICS; ACCESS	We developed a miniaturized two-photon microscope (MINI2P) for fast, high-resolution, multiplane calcium imaging of over 1,000 neurons at a time in freely moving mice. With a microscope weight below 3 g and a highly flexible connection cable, MINI2P allowed stable imaging with no impediment of behavior in a variety of assays compared to untethered, unimplanted animals. The improved cell yield was achieved through a optical system design featuring an enlarged field of view (FOV) and a microtunable lens with increased z-scanning range and speed that allows fast and stable imaging of multiple interleaved planes, as well as 3D functional imaging. Successive imaging across multiple, adjacent FOVs enabled recordings from more than 10,000 neurons in the same animal. Large-scale proof-of-principle data were obtained from cell populations in visual cortex, medial entorhinal cortex, and hippocampus, revealing spatial tuning of cells in all areas.	[Zong, Weijian; Obenhaus, Horst A.; Skytoen, Emilie R.; Eneqvist, Hanna; de Jong, Nienke L.; Vale, Ruben; Jorge, Marina R.; Moser, May-Britt; Moser, Edvard, I] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, NO-7491 Trondheim, Norway; [Zong, Weijian; Obenhaus, Horst A.; Skytoen, Emilie R.; Eneqvist, Hanna; de Jong, Nienke L.; Vale, Ruben; Jorge, Marina R.; Moser, May-Britt; Moser, Edvard, I] Norwegian Univ Sci & Technol NTNU, Ctr Neural Computat, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Zong, WJ; Moser, EI (corresponding author), Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, NO-7491 Trondheim, Norway.; Zong, WJ; Moser, EI (corresponding author), Norwegian Univ Sci & Technol NTNU, Ctr Neural Computat, NO-7491 Trondheim, Norway.	weijian.zong@ntnu.no; edvard.moser@ntnu.no	; Rodrigues Jorge, Marina/K-6855-2014	Obenhaus, Horst A./0000-0002-7670-4827; Eneqvist, Hanna/0000-0003-0696-8365; Rodrigues Jorge, Marina/0000-0002-3237-8548	European Research Council [951319]; Research Council of Norway (RCN) FRIPRO grants [286225, 300394]; RCN Centre of Excellence grant [223262, 295721]; RCN National Infrastructure grant [223262, 295721]; Ministry of Education and Research of Norway; Kavli Foundation; European Union's Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie grant) [842006]; EMBO postdoctoral fellowship [EMBO ALTF 1078-2020]	European Research Council(European Research Council (ERC)European Commission); Research Council of Norway (RCN) FRIPRO grants(Research Council of Norway); RCN Centre of Excellence grant; RCN National Infrastructure grant; Ministry of Education and Research of Norway; Kavli Foundation; European Union's Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie grant); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO))	We thank A.M. Amundsga degrees rd, K. Haugen, K.J. Jenssen, E. Kra degrees kvik, and H. Waade for technical assistance; I. Ulsaker-Janke, R.I. Jacobsen, T. Rose, J. Sugar, A.Z. Vollan, T. Waaga, and M.M. Bolton for discussion of analysis; T. Slettmoen and F. Donato for suggestions on MEC implantation; R.I. Jacobsen and T. Rose for suggestions on visual cortex imaging; M.P. Witter for help with anatomy and recording positions; R.N. Raveendran and the Viral Vector Core Facility of the Kavli Institute for Systems Neuroscience (NTNU) for viral reagents; H.-K. Yddal for support with development of the Tlens; S. Eggen and I. Ulsaker-Janke for help with animal surgery; M. Nyga degrees rd for building the ladder; and L. Descamps for suggestions on 1P data processing. The work was supported by a Synergy grant from the European Research Council to E.I.M. (`KILONEURONS', grant agreement no. 951319), Research Council of Norway (RCN) FRIPRO grants to E.I.M. (grant number 286225) and M.-B.M. (grant number 300394), an RCN Centre of Excellence grant and an RCN National Infrastructure grant to E.I.M. and M.-B.M. (Centre of Neural Computation, grant number 223262; NORBRAIN, grant number 295721), a contribution to M.-B.M. and E.I.M. from the Ministry of Education and Research of Norway, the Kavli Foundation, the European Union's Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie grant agreement to W.Z.: ANATMEC no. 842006), and an EMBO postdoctoral fellowship to R.V. (EMBO ALTF 1078-2020).	Aharoni D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00141; Aharoni D, 2019, NAT METHODS, V16, P11, DOI 10.1038/s41592-018-0266-x; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Bocarsly ME, 2015, BIOMED OPT EXPRESS, V6, P4546, DOI 10.1364/BOE.6.004546; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H, 2019, NAT METHODS, V16, P649, DOI 10.1038/s41592-019-0435-6; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Diamanti EM, 2021, ELIFE, V10, DOI 10.7554/eLife.63705; Farghaly MA, 2016, OPT EXPRESS, V24, P28890, DOI 10.1364/OE.24.028889; Fiser A, 2016, NAT NEUROSCI, V19, P1658, DOI 10.1038/nn.4385; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gilman JP, 2017, CEREB CORTEX, V27, P2078, DOI 10.1093/cercor/bhw062; Ginosar G, 2021, NATURE, V596, P404, DOI 10.1038/s41586-021-03783-x; Glas A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214954; Grieves RM, 2021, NAT NEUROSCI, V24, P1567, DOI 10.1038/s41593-021-00907-4; Guitchounts G, 2020, NEURON, V108, P512, DOI 10.1016/j.neuron.2020.07.014; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Haggerty DC, 2015, ELIFE, V4, DOI 10.7554/eLife.08902; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Helmchen Fritjof, 2013, Cold Spring Harb Protoc, V2013, P904, DOI 10.1101/pdb.top078147; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kane S, 1997, J OPT SOC AM B, V14, P661, DOI 10.1364/JOSAB.14.000661; Klioutchnikov A, 2020, NAT METHODS, V17, P509, DOI 10.1038/s41592-020-0817-9; Kong LJ, 2016, BIOMED OPT EXPRESS, V7, P3686, DOI 10.1364/BOE.7.003686; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Li A, 2021, OPTICA, V8, P870, DOI 10.1364/OPTICA.422657; Liberti WA, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6806; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Milanovic V, 2004, IEEE J SEL TOP QUANT, V10, P462, DOI 10.1109/JSTQE.2004.829205; Minderer M, 2016, NATURE, V533, P324, DOI 10.1038/nature17899; Nath T, 2019, NAT PROTOC, V14, P2152, DOI 10.1038/s41596-019-0176-0; Obenhaus HA, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2121655119; Ozbay BN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26326-3; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pachitariu M, 2018, J NEUROSCI, V38, P7976, DOI 10.1523/JNEUROSCI.3339-17.2018; Pavillon N, 2016, OPT EXPRESS, V24, P30038, DOI 10.1364/OE.24.030038; Pervak V, 2008, OPT EXPRESS, V16, P10220, DOI 10.1364/OE.16.010220; Piyawattanametha W, 2009, OPT LETT, V34, P2309, DOI 10.1364/OL.34.002309; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rubin A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12724-2; Saleem AB, 2018, NATURE, V562, P124, DOI 10.1038/s41586-018-0516-1; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen Y, 2020, NEUROSCI RES, V152, P3, DOI 10.1016/j.neures.2020.01.011; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Stringer C, 2019, CURR OPIN NEUROBIOL, V55, P22, DOI 10.1016/j.conb.2018.11.005; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Vale R., 2020, BIORXIV; Vale R, 2017, CURR BIOL, V27, P1342, DOI 10.1016/j.cub.2017.03.031; Velasco MGM, 2014, BIOMED OPT EXPRESS, V5, P1700, DOI 10.1364/BOE.5.001700; Velez-Fort M, 2018, NEURON, V98, P179, DOI 10.1016/j.neuron.2018.02.023; Wallace DJ, 2019, NAT METHODS, V16, P9, DOI 10.1038/s41592-018-0275-9; Wekselblatt JB, 2016, J NEUROPHYSIOL, V115, P2852, DOI 10.1152/jn.01056.2015; Xue YJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb7508; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Zeytunyan A, 2013, APPL OPTICS, V52, P7755, DOI 10.1364/AO.52.007755; Zhang J, 2017, ELIFE, V6, DOI 10.7554/eLife.18372; Zhang Y., 2021, BIORXIV; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong WJ, 2021, NAT METHODS, V18, P46, DOI 10.1038/s41592-020-01024-z; Zong WJ, 2017, NAT METHODS, V14, P713, DOI 10.1038/nmeth.4305	72	15	15	15	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1240	+		10.1016/j.cell.2022.02.017	http://dx.doi.org/10.1016/j.cell.2022.02.017			48	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J3JC	35305313	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000780000700001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Taxpayers are still liable for 2.7bn pound risk from government PPE contracts, say auditors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o837	10.1136/bmj.o837	http://dx.doi.org/10.1136/bmj.o837			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354587	Bronze			2022-12-28	WOS:000779561800001
J	Kamal-Yanni, M; Cueni, T				Kamal-Yanni, Mohga; Cueni, Thomas			Should covid-19 vaccines and drugs be "not for profit"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Inequality in access to medicines and vaccines has been prevalent in developing countries for decades. The HIV epidemic of the 1980s revealed massive faults in the global system of biomedical research-primarily a reliance on market incentives to dictate research and development (R&D) of pharmaceuticals through intellectual property rights. Millions of people died of AIDS, mainly in Africa, for lack of access to the highly priced medicines that could have saved their lives. And when Ebola hit west Africa in 2014, the world discovered that there was no medicine or vaccines because the virus primarily affected poor countries. Then came covid-19. While over 60% of people in rich countries are vaccinated, less than 20% are vaccinated in Africa. Yet governments maintained the same system, leaving three vital decisions in the hands of drug companies: production, distribution, and price. This allows companies to maximise their profit by supplying countries that could pay the highest price while ignoring poorer ones. For most of 2021 the major problem facing the global Covax initiative was the lack of doses available for supply to low and middle income countries: Covax was able to deliver only the Oxford-AstraZeneca vaccine despite agreements with other companies.1 Under the banner of "profit being necessary for innovation," drug companies fight hard to maintain the current monopoly based system. The situation presented by covid-19 vaccines dismantles this approach and instead calls for a system of manufacturing and distribution of tests, medicines, and vaccines at affordable prices. Global actions are needed to expand manufacturing sites to ensure universal access to vaccines, medicines, and tests. This in turn requires maximising and diversifying production by sharing technology and know-how and waiving intellectual property drug companies' focus on maximising profit.				MohgaKY@access2healthcare.net; t.cueni@ifpma.org						Airfinity, 2021, SEPT 2021 SNAPSH COV; Airfinity, 2022, ON BILL COV 19 VACC; [Anonymous], 2022, PHARMAPHORUM; [Anonymous], 2021, BUSINESSWIRE, DOI DOI 11005963/EN/JASPER-THERAPEUTICS-ANNOUNCES-LAUNCH-OF-NEW-CLINICAL-TRIAL-WITH-NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE-TO-EVALUATE-JSP191-IN-SICKLE-CELL-DISEASE; [Anonymous], 2022, GAVI VACCINE ALLIANC; Cross S., 2021, WHO FUNDED RES OXFOR, DOI [10.1101/2021.04.08.21255103v1, DOI 10.1101/2021.04.08.21255103V1]; International Federation of Pharmaceutical Manufacturers and Associations, 2022, 3 PRIOR URG INCR ACC; Lee K, 2009, GLOB INST, P1; Marriott, 2021, ST REG SAAD ISL RES; McCarthy N., 2021, FORBES 0506; Pearce O, 2018, OXFAM SEP; Teicher C, 2021, STAT 1104; World Health Organization, 2020, COV ANN ADD DEALS AC; World Trade Organization, 2021, INT ORG DISC IMPR AC	14	0	0	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o755	10.1136/bmj.o755	http://dx.doi.org/10.1136/bmj.o755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354558	Bronze			2022-12-28	WOS:000779561800005
J	Price, AM; Olson, SM; Newhams, MM; Halasa, NB; Boom, JA; Sahni, LC; Pannaraj, PS; Irby, K; Bline, KE; Maddux, AB; Nofziger, RA; Cameron, MA; Walker, TC; Schwartz, SP; Mack, EH; Smallcomb, L; Schuster, JE; Hobbs, CV; Kamidani, S; Tarquinio, KM; Bradford, TT; Levy, ER; Chiotos, K; Bhumbra, SS; Cvijanovich, NZ; Heidemann, SM; Cullimore, ML; Gertz, SJ; Coates, BM; Staat, MA; Zinter, MS; Kong, M; Chatani, BM; Hume, JR; Typpo, KV; Maamari, M; Flori, HR; Tenforde, MW; Zambrano, LD; Campbell, AP; Patel, MM; Randolph, AG				Price, A. M.; Olson, S. M.; Newhams, M. M.; Halasa, N. B.; Boom, J. A.; Sahni, L. C.; Pannaraj, P. S.; Irby, K.; Bline, K. E.; Maddux, A. B.; Nofziger, R. A.; Cameron, M. A.; Walker, T. C.; Schwartz, S. P.; Mack, E. H.; Smallcomb, L.; Schuster, J. E.; Hobbs, C., V; Kamidani, S.; Tarquinio, K. M.; Bradford, T. T.; Levy, E. R.; Chiotos, K.; Bhumbra, S. S.; Cvijanovich, N. Z.; Heidemann, S. M.; Cullimore, M. L.; Gertz, S. J.; Coates, B. M.; Staat, M. A.; Zinter, M. S.; Kong, M.; Chatani, B. M.; Hume, J. R.; Typpo, K., V; Maamari, M.; Flori, H. R.; Tenforde, M. W.; Zambrano, L. D.; Campbell, A. P.; Patel, M. M.; Randolph, A. G.		Overcoming Covid-19 Investigators	BNT162b2 Protection against the Omicron Variant in Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MESSENGER-RNA VACCINATION; COVID-19 VACCINE; STATES	BackgroundSpread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (omicron) variant, which led to increased U.S. hospitalizations for coronavirus disease 2019 (Covid-19), generated concern about immune evasion and the duration of protection from vaccines in children and adolescents. MethodsUsing a case-control, test-negative design, we assessed vaccine effectiveness against laboratory-confirmed Covid-19 leading to hospitalization and against critical Covid-19 (i.e., leading to receipt of life support or to death). From July 1, 2021, to February 17, 2022, we enrolled case patients with Covid-19 and controls without Covid-19 at 31 hospitals in 23 states. We estimated vaccine effectiveness by comparing the odds of antecedent full vaccination (two doses of BNT162b2 messenger RNA vaccine) at least 14 days before illness among case patients and controls, according to time since vaccination for patients 12 to 18 years of age and in periods coinciding with circulation of B.1.617.2 (delta) (July 1, 2021, to December 18, 2021) and omicron (December 19, 2021, to February 17, 2022) among patients 5 to 11 and 12 to 18 years of age. ResultsWe enrolled 1185 case patients (1043 [88%] of whom were unvaccinated, 291 [25%] of whom received life support, and 14 of whom died) and 1627 controls. During the delta-predominant period, vaccine effectiveness against hospitalization for Covid-19 among adolescents 12 to 18 years of age was 93% (95% confidence interval [CI], 89 to 95) 2 to 22 weeks after vaccination and was 92% (95% CI, 80 to 97) at 23 to 44 weeks. Among adolescents 12 to 18 years of age (median interval since vaccination, 162 days) during the omicron-predominant period, vaccine effectiveness was 40% (95% CI, 9 to 60) against hospitalization for Covid-19, 79% (95% CI, 51 to 91) against critical Covid-19, and 20% (95% CI, -25 to 49) against noncritical Covid-19. During the omicron period, vaccine effectiveness against hospitalization among children 5 to 11 years of age was 68% (95% CI, 42 to 82; median interval since vaccination, 34 days). ConclusionsBNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age. Although two doses provided lower protection against omicron-associated hospitalization than against delta-associated hospitalization among adolescents 12 to 18 years of age, vaccination prevented critical illness caused by either variant. (Funded by the Centers for Disease Control and Prevention.) Vaccine Effectiveness against Omicron in Children and AdolescentsIn this study evaluating BNT162b2, vaccine effectiveness against hospitalization for Covid-19 in the delta-predominant period among adolescents 12 to 18 years of age was more than 90%; during the omicron period, vaccine effectiveness was 40% against hospitalization and 79% against critical illness. Vaccine effectiveness against hospitalization was 68% among children 5 to 11 years of age.	[Price, A. M.; Olson, S. M.; Newhams, M. M.; Tenforde, M. W.; Zambrano, L. D.; Campbell, A. P.; Patel, M. M.] Ctr Dis Control & Prevent, Covid 19 Response Team, Atlanta, GA 30329 USA; [Kamidani, S.] Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA USA; [Kamidani, S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Tarquinio, K. M.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Div Crit Care Med,Dept Pediat, Atlanta, GA USA; [Newhams, M. M.; Randolph, A. G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Randolph, A. G.] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Randolph, A. G.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Halasa, N. B.] Vanderbilt Univ Sch Med, Dept Pediat, Div Pediat Infect Dis, Nashville, TN USA; [Boom, J. A.; Sahni, L. C.] Texas Childrens Hosp, Immunizat Project, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA; [Maamari, M.] Univ Texas Southwestern, Childrens Med Ctr, Div Crit Care Med, Dept Pediat, Dallas, TX USA; [Pannaraj, P. S.] Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA; [Pannaraj, P. S.] Univ Southern Calif, Dept Pediat, Los Angeles, CA USA; [Pannaraj, P. S.] Univ Southern Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Cameron, M. A.] UC San Diego Rady Childrens Hosp, Div Pediat Hosp Med, San Diego, CA USA; [Cvijanovich, N. Z.] UCSF Benioff Childrens Hosp, Div Crit Care Med, Oakland, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Crit Care Med, San Francisco, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Immunol, San Francisco, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Bone Marrow Transplant, San Francisco, CA USA; [Irby, K.] Arkansas Childrens Hosp, Sect Pediat Crit Care, Dept Pediat, Little Rock, AR 72202 USA; [Bline, K. E.] Nationwide Childrens Hosp Columbus, Div Pediat Crit Care Med, Akron, OH USA; [Nofziger, R. A.] Akron Childrens Hosp, Dept Pediat, Div Crit Care Med, Akron, OH 44308 USA; [Staat, M. A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Maddux, A. B.] Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO USA; [Maddux, A. B.] Childrens Hosp Colorado, Aurora, CO USA; [Walker, T. C.; Schwartz, S. P.] Univ North Carolina Chapel Hill, Childrens Hosp, Dept Pediat, Chapel Hill, NC USA; [Mack, E. H.] Med Univ South Carolina, Div Pediat Crit Care Med, Charleston, SC 29425 USA; [Smallcomb, L.] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA; [Schuster, J. E.] Childrens Mercy Kansas City, Dept Pediat, Div Pediat Infect Dis, Kansas City, MO USA; [Hobbs, C., V] Univ Mississippi Med Ctr, Div Infect Dis, Dept Pediat, Jackson, MS USA; [Hobbs, C., V] Univ Mississippi Med Ctr, Div Infect Dis, Dept Microbiol, Jackson, MS USA; [Bradford, T. T.] Louisiana State Univ, Hlth Sci Ctr, Div Cardiol, Dept Pediat, New Orleans, LA USA; [Bradford, T. T.] Childrens Hosp New Orleans, New Orleans, LA USA; [Levy, E. R.] Mayo Clin, Div Pediat Infect Dis, Dept Pediat & Adolescent Med, Rochester, NY USA; [Levy, E. R.] Mayo Clin, Div Pediat Crit Care Med, Dept Pediat & Adolescent Med, Rochester, NY USA; [Hume, J. R.] Univ Minnesota, Masonic Childrens Hosp, Div Pediat Crit Care, Minneapolis, MN USA; [Chiotos, K.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Div Crit Care Med, Philadelphia, PA 19104 USA; [Bhumbra, S. S.] Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Heidemann, S. M.] Cent Michigan Univ, Childrens Hosp Michigan, Div Pediat Crit Care Med, Detroit, MI USA; [Flori, H. R.] Mott Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Ann Arbor, MI USA; [Flori, H. R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Cullimore, M. L.] Childrens Hosp & Med Ctr, Dept Pediat, Div Pediat Crit Care, Omaha, NE USA; [Gertz, S. J.] Cooperman Barnabas Med Ctr, Dept Pediat, Div Pediat Crit Care, Livingston, NJ USA; [Coates, B. M.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Crit Care Med,Dept Pediat, Chicago, IL 60611 USA; [Kong, M.] Univ Alabama Birmingham, Dept Pediat, Div Pediat Crit Care Med, Birmingham, AL USA; [Chatani, B. M.] UHlth Holtz Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Miami, FL USA; [Typpo, K., V] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Typpo, K., V] Univ Arizona, Banner Childrens, Diamond Childrens Med Ctr, Tucson, AZ USA	Centers for Disease Control & Prevention - USA; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vanderbilt University; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Rady Childrens Hospital San Diego; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Arkansas Children's Hospital; Akron Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Medical University of South Carolina; Medical University of South Carolina; Children's Mercy Hospital; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Indiana University System; Indiana University Bloomington; Central Michigan University; Children's Hospital of Michigan; University of Michigan System; University of Michigan; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; University of Arizona; University of Arizona	Patel, MM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd NE,H24-7, Atlanta, GA 30329 USA.	aul3@cdc.gov	Bhumbra, Samina/AAX-8266-2020	Bhumbra, Samina/0000-0002-4036-0479; Hobbs, Charlotte/0000-0003-4829-0791; Olson, Samantha/0000-0003-0589-5766	Centers for Disease Control and Prevention (CDC); Boston Childrens Hospital	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Boston Childrens Hospital	Supported by the Centers for Disease Control and Prevention (CDC) under a contract with Boston Childrens Hospital.	Chua HY, 2020, EPIDEMIOLOGY, V31, P43, DOI 10.1097/EDE.0000000000001116; Collie S, 2022, NEW ENGL J MED, V386, P494, DOI 10.1056/NEJMc2119270; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dean NE, 2021, NEW ENGL J MED, V385, P1431, DOI 10.1056/NEJMe2113151; Feng S, 2018, LANCET RESP MED, V6, P925, DOI 10.1016/S2213-2600(18)30419-3; Ferdinands JM, 2021, CLIN INFECT DIS, V73, P726, DOI 10.1093/cid/ciab045; Food and Drug Administration, 2021, VACC REL BIOL PROD A; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033]; Glatman-Freedman A, 2021, EMERG INFECT DIS, V27, P2919, DOI 10.3201/eid2711.211886; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Israeli E, 2022, ISR MED ASSOC J, V24, P257, DOI 10.1056/NEJMoa2117995; Klein NP., 2022, MMWR MORB MORTAL WKL, V71, P352; Lauring AS., 2022, BMJ, V376; Lipsitch M, 2022, NAT REV IMMUNOL, V22, P57, DOI 10.1038/s41577-021-00662-4; Liu J., 2022, SAE TECHNICAL PAPER; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Nemet I, 2022, NEW ENGL J MED, V386, P492, DOI 10.1056/NEJMc2119358; Office of the Federal Register, 2022, COD FED REG POINT TI; Olson SM, 2021, MMWR-MORBID MORTAL W, V70, P1483; Olson SM., 2022, CLIN INFECT DIS; Patel MM, 2021, LANCET MICROBE, V2, pE715, DOI 10.1016/S2666-5247(21)00180-4; Patel MK, 2021, VACCINE, V39, P4013, DOI 10.1016/j.vaccine.2021.05.099; Reis B, 2021, NEW ENGL J MED, V385, P2101, DOI 10.1056/NEJMc2114290; Son MBF, 2021, NEW ENGL J MED, V385, P23, DOI 10.1056/NEJMoa2102605; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Tenforde MW, 2021, JAMA-J AM MED ASSOC, V326, P2043, DOI 10.1001/jama.2021.19499; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Tenforde MW., 2021, CLIN INFECT DIS; Thompson Mark G, 2022, MMWR Morb Mortal Wkly Rep, V71, P139, DOI 10.15585/mmwr.mm7104e3; Treanor JJ, 2016, NEW ENGL J MED, V375, P1261, DOI 10.1056/NEJMcp1512870; Walter EB, 2022, NEW ENGL J MED, V386, P35, DOI 10.1056/NEJMoa2116298	31	41	42	10	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2022	386	20					1899	1909		10.1056/NEJMoa2202826	http://dx.doi.org/10.1056/NEJMoa2202826		MAR 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1J8UI	35353976	Green Published, Bronze			2022-12-28	WOS:000784328700001
J	Limb, M				Limb, Matthew			Are fewer people living in poverty in the UK than 10 years ago?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, BBC SUNDAY MORNING; Baseley E, 2020, TROUBLE MEASURING PO; Department for Work and Pensions, HOUSEHOLDS AVERAGE I; Institute for Fiscal Studies, 2021, LIVING STANDARDS POV; Joseph Rowntree Foundation, 2022, UK POVERTY 202021; Legatum Institute, 2020, POVERTY COVID 19 CRI; Social Metrics Commission, 2020, MEASURING POVERTY 20; Social Mobility Commission, 2021, STATE NATION 2021 SO; UK Government, 2018, ONE MILLION PEOPLE L	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o814	10.1136/bmj.o814	http://dx.doi.org/10.1136/bmj.o814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346948				2022-12-28	WOS:000778641000001
J	Lai, HWH; Benedetti, FM; Ahn, JM; Robinson, AM; Wang, YG; Pinnau, I; Smith, ZP; Xia, Y				Lai, Holden W. H.; Benedetti, Francesco M.; Ahn, Jun Myun; Robinson, Ashley M.; Wang, Yingge; Pinnau, Ingo; Smith, Zachary P.; Xia, Yan			Hydrocarbon ladder polymers with ultrahigh permselectivity for membrane gas separations	SCIENCE			English	Article							INTRINSIC MICROPOROSITY; CHAIN-PACKING; UPPER-BOUNDS; PLASTICIZATION; PERMEATION; TRANSPORT; CO2/CH4; MODEL; DIFFUSION	Membranes have the potential to substantially reduce energy consumption of industrial chemical separations, but their implementation has been limited owing to a performance upper bound-the trade-off between permeability and selectivity. Although recent developments of highly permeable polymer membranes have advanced the upper bounds for various gas pairs, these polymers typically exhibit limited selectivity. We report a class of hydrocarbon ladder polymers that can achieve both high selectivity and high permeability in membrane separations for many industrially relevant gas mixtures. Additionally, their corresponding films exhibit desirable mechanical and thermal properties. Tuning of the ladder polymer backbone configuration was found to have a profound effect on separation performance and aging behavior.	[Lai, Holden W. H.; Ahn, Jun Myun; Robinson, Ashley M.; Xia, Yan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Benedetti, Francesco M.; Smith, Zachary P.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Wang, Yingge; Pinnau, Ingo] King Abdullah Univ Sci & Technol KAUST, Adv Membranes & Porous Mat Ctr, Div Phys Sci & Engn, Chem Engn Program, Thuwal 23955-6900, Thuwal 239556900, Saudi Arabia; [Benedetti, Francesco M.; Ahn, Jun Myun] Osmoses Inc, 501 Massachusetts Ave, Cambridge, MA 02139 USA; [Robinson, Ashley M.] Vertex Pharmaceut Inc, 50 Northern Ave, Boston, MA 02210 USA	Stanford University; Massachusetts Institute of Technology (MIT); King Abdullah University of Science & Technology; Vertex Pharmaceuticals	Xia, Y (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Smith, ZP (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	zpsmith@mit.edu; yanx@stanford.edu		Benedetti, Francesco Maria/0000-0002-2621-6649; Ahn, Jun Myun/0000-0002-8181-908X; Lai, Holden/0000-0002-0090-9594; Xia, Yan/0000-0002-5298-748X; Pinnau, Ingo/0000-0003-3040-9088	Stanford Natural Gas Initiative; Sloan Research Foundation; US Department of Energy, Office of Science, Office of Basic Energy Sciences, Separation Science program [DE-SC0019087]; NSF-GRFP [DGE-156518]; MRSEC Program of the National Science Foundation [DMR-1419807]; KAUST [BAS/1/1323-01-01]	Stanford Natural Gas Initiative; Sloan Research Foundation; US Department of Energy, Office of Science, Office of Basic Energy Sciences, Separation Science program(United States Department of Energy (DOE)); NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); KAUST(King Abdullah University of Science & Technology)	Y.X. acknowledges the Stanford Natural Gas Initiative for seed funding and the Sloan Research Foundation for a Sloan Research Fellowship. Z.P.S. and F.M.B. acknowledge support from the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Separation Science program (DE-SC0019087). H.W.H.L. was supported by NSF-GRFP (DGE-156518). This work made use of the Shared Experimental Facilities supported in part by the MRSEC Program of the National Science Foundation under award DMR-1419807. I.P. was supported by KAUST baseline funding (BAS/1/1323-01-01).	Bezzu CG, 2018, J MATER CHEM A, V6, P10507, DOI 10.1039/c8ta02601g; Bezzu CG, 2012, ADV MATER, V24, P5930, DOI 10.1002/adma.201202393; Bos A, 1999, J MEMBRANE SCI, V155, P67, DOI 10.1016/S0376-7388(98)00299-3; BRANDT WW, 1959, J PHYS CHEM-US, V63, P1080, DOI 10.1021/j150577a012; Brown AS, 2004, J CHROMATOGR A, V1040, P215, DOI 10.1016/j.chroma.2004.04.007; Carta M, 2014, ADV MATER, V26, P3526, DOI 10.1002/adma.201305783; Carta M, 2013, SCIENCE, V339, P303, DOI 10.1126/science.1228032; Comesana-Gandara B, 2019, ENERG ENVIRON SCI, V12, P2733, DOI 10.1039/c9ee01384a; Doghieri F, 1996, MACROMOLECULES, V29, P7885, DOI 10.1021/ma951366c; Du NY, 2011, NAT MATER, V10, P372, DOI [10.1038/NMAT2989, 10.1038/nmat2989]; Fuoco A, 2019, J MATER CHEM A, V7, P20121, DOI 10.1039/c9ta07159h; Fuoco A, 2018, ACS APPL MATER INTER, V10, P36475, DOI 10.1021/acsami.8b13634; Geng ZM, 2016, SYNTHETIC MET, V213, P57, DOI 10.1016/j.synthmet.2016.01.001; Ghanem BS, 2014, ADV MATER, V26, P6696, DOI 10.1002/adma.201401328; Gleason KL, 2015, J MEMBRANE SCI, V475, P204, DOI 10.1016/j.memsci.2014.10.014; Grisorio R, 2005, MACROMOL CHEM PHYS, V206, P448, DOI 10.1002/macp.200400306; Gu ZB, 2015, MONATSH CHEM, V146, P1519, DOI 10.1007/s00706-015-1432-9; Kim HW, 2013, SCIENCE, V342, P91, DOI 10.1126/science.1236098; Lai HWH, 2019, MACROMOLECULES, V52, P6294, DOI 10.1021/acs.macromol.9b01155; Lai HWH, 2017, ACS MACRO LETT, V6, P1357, DOI 10.1021/acsmacrolett.7b00806; Liu S, 2014, J AM CHEM SOC, V136, P17434, DOI 10.1021/ja5110415; Low ZX, 2018, CHEM REV, V118, P5871, DOI 10.1021/acs.chemrev.7b00629; MICHAELS AS, 1963, J APPL PHYS, V34, P1, DOI 10.1063/1.1729066; Park HJ, 1999, TRENDS FOOD SCI TECH, V10, P254, DOI 10.1016/S0924-2244(00)00003-0; Patel HA, 2012, CHEM COMMUN, V48, P9989, DOI 10.1039/c2cc35392j; Ricci E, 2020, J MEMBRANE SCI, V612, DOI 10.1016/j.memsci.2020.118374; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Sanders DE, 2013, POLYMER, V54, P4729, DOI 10.1016/j.polymer.2013.05.075; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; Swaidan R, 2015, MACROMOLECULES, V48, P6553, DOI 10.1021/acs.macromol.5b01581; Swaidan R, 2015, ACS MACRO LETT, V4, P947, DOI 10.1021/acsmacrolett.5b00512; Swaidan R, 2014, MACROMOLECULES, V47, P7453, DOI 10.1021/ma501798v; Swaidan R, 2014, J MEMBRANE SCI, V457, P95, DOI 10.1016/j.memsci.2014.01.055; Wang Y, 2018, MATER TODAY NANO, V3, P69, DOI 10.1016/j.mtnano.2018.11.003; WIJMANS JG, 1995, J MEMBRANE SCI, V107, P1, DOI 10.1016/0376-7388(95)00102-I; Williams R, 2018, J MATER CHEM A, V6, P5661, DOI 10.1039/c8ta00509e	36	18	18	115	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1390	+		10.1126/science.abl7163	http://dx.doi.org/10.1126/science.abl7163			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324307	Green Submitted			2022-12-28	WOS:000778894800039
J	Zhang, ZT; Wang, WC; Jiang, YW; Wang, YX; Wu, YL; Lai, JC; Niu, SM; Xu, CY; Shih, CC; Wang, C; Yan, HP; Galuska, L; Prine, N; Wu, HC; Zhong, DL; Chen, G; Matsuhisa, N; Zheng, Y; Yu, ZA; Wang, Y; Dauskardt, R; Gu, XD; Tok, JBH; Bao, ZN				Zhang, Zhitao; Wang, Weichen; Jiang, Yuanwen; Wang, Yi-Xuan; Wu, Yilei; Lai, Jian-Cheng; Niu, Simiao; Xu, Chengyi; Shih, Chien-Chung; Wang, Cheng; Yan, Hongping; Galuska, Luke; Prine, Nathaniel; Wu, Hung-Chin; Zhong, Donglai; Chen, Gan; Matsuhisa, Naoji; Zheng, Yu; Yu, Zhiao; Wang, Yang; Dauskardt, Reinhold; Gu, Xiaodan; Tok, Jeffrey B-H; Bao, Zhenan			High-brightness all-polymer stretchable LED with charge-trapping dilution	NATURE			English	Article							LIGHT-EMITTING DEVICES; DIODES; FILMS	Next-generation light-emitting displays on skin should be soft, stretchable and bright(1-)(7). Previously reported stretchable light-emitting devices were mostly based on inorganic nanomaterials, such as light-emitting capacitors, quantum dots or perovskites(6-11). They either require high operating voltage or have limited stretchability and brightness, resolution or robustness under strain. On the other hand, intrinsically stretchable polymer materials hold the promise of good strain tolerance(12,13). However, realizing high brightness remains a grand challenge for intrinsically stretchable light-emitting diodes. Here we report a material design strategy and fabrication processes to achieve stretchable all-polymer-based light-emitting diodes with high brightness (about 7,450 candela per square metre), current efficiency (about 5.3 candela per ampere) and stretchability (about 100 per cent strain). We fabricate stretchable all-polymer light-emitting diodes coloured red, green and blue, achieving both on-skin wireless powering and real-time displaying of pulse signals. This work signifies a considerable advancement towards high-performance stretchable displays.	[Zhang, Zhitao; Wang, Weichen; Jiang, Yuanwen; Wang, Yi-Xuan; Wu, Yilei; Lai, Jian-Cheng; Niu, Simiao; Xu, Chengyi; Shih, Chien-Chung; Yan, Hongping; Wu, Hung-Chin; Zhong, Donglai; Matsuhisa, Naoji; Zheng, Yu; Yu, Zhiao; Tok, Jeffrey B-H; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Wang, Weichen; Chen, Gan; Wang, Yang; Dauskardt, Reinhold] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Wang, Yi-Xuan] Tianjin Univ, Sch Sci, Dept Chem, Tianjin Key Lab Mol Optoelect Sci, Tianjin, Peoples R China; [Lai, Jian-Cheng] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing, Peoples R China; [Wang, Cheng] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA USA; [Galuska, Luke; Prine, Nathaniel; Gu, Xiaodan] Univ Southern Mississippi, Sch Polymer Sci & Engn, Hattiesburg, MS 39406 USA; [Zheng, Yu; Yu, Zhiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University; Tianjin University; Nanjing University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Southern Mississippi; Stanford University	Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	zbao@stanford.edu	Yu, Zhiao/R-6736-2017; Chen, Gan/AAU-8425-2020; Wu, Yilei/O-5404-2014; Niu, Simiao/D-3019-2012; Zheng, Yu/GMW-6814-2022; Zhong, Donglai/GQP-7894-2022; Lai, Jiancheng/J-3490-2013	Yu, Zhiao/0000-0001-8746-1640; Chen, Gan/0000-0001-5541-6212; Wu, Yilei/0000-0001-6756-1855; Niu, Simiao/0000-0003-1973-2204; Zheng, Yu/0000-0001-9854-7378; Zhong, Donglai/0000-0002-0876-414X; Shih, Chien-Chung/0000-0001-9179-937X; Bao, Zhenan/0000-0002-0972-1715; Lai, Jiancheng/0000-0001-9290-678X; Wang, Cheng/0000-0001-7192-5471; Xu, Chengyi/0000-0002-7491-6295	National Science Foundation [ECCS-1542152]; China Scholarship Council [201806255002]; Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowship; U.S. Department of Energy Office of Science User Facility [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE))	Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152. We thank Agfa-Gevaert N.V. for providing PEDOT:PSS, Daikin Co. for providing PVDF-HFP and Kaneka Co. for providing SIBS. Y.-X.W. was supported by a visiting scholar funding (201806255002) from the China Scholarship Council. N.M. was supported by a Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowship. This research used resources of the Advanced Light Source, a U.S. Department of Energy Office of Science User Facility under contract no. DE-AC02-05CH11231.	Abbaszadeh D, 2016, NAT MATER, V15, P628, DOI [10.1038/nmat4626, 10.1038/NMAT4626]; Abbaszadeh D, 2016, ADV ELECTRON MATER, V2, DOI 10.1002/aelm.201500406; Bade SGR, 2017, ADV MATER, V29, DOI 10.1002/adma.201607053; Bolink HJ, 2009, ADV MATER, V21, P79, DOI 10.1002/adma.200802155; Chen Y, 2003, NATURE, V423, P136, DOI 10.1038/423136a; Choi S., 2020, P INT C DISPLAY TECH, V52, P279; Choong CL, 2014, ADV MATER, V26, P3451, DOI 10.1002/adma.201305182; Collins BA, 2012, NAT MATER, V11, P536, DOI [10.1038/nmat3310, 10.1038/NMAT3310]; de Pauli M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873118; Fong HH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2369545; Gann E, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3701831; Jiang DH, 2020, ACS APPL MATER INTER, V12, P14408, DOI 10.1021/acsami.9b23291; Jiang Y., 2022, PREPRINT, DOI [10.1101/2022.01.16.476423, DOI 10.1101/2022.01.16.476423]; Kee S, 2018, ADV MATER, V30, DOI 10.1002/adma.201703437; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim D, 2020, P NATL ACAD SCI USA, V117, P21138, DOI 10.1073/pnas.2007395117; Kim JH, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd9715; Kim Y, 2018, SCIENCE, V360, P998, DOI 10.1126/science.aao0098; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Larson C, 2016, SCIENCE, V351, P1071, DOI 10.1126/science.aac5082; Li YF, 2019, ADV MATER, V31, DOI 10.1002/adma.201807516; Liang JJ, 2014, ACS NANO, V8, P1590, DOI 10.1021/nn405887k; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI [10.1038/NPHOTON.2013.242, 10.1038/nphoton.2013.242]; Mengistie DA, 2013, J MATER CHEM A, V1, P9907, DOI 10.1039/c3ta11726j; Ohisa S, 2018, ACS APPL MATER INTER, V10, P17318, DOI 10.1021/acsami.8b00752; Park J, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902412; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Park S, 2018, NATURE, V561, P516, DOI 10.1038/s41586-018-0536-x; Rein M, 2018, NATURE, V560, P214, DOI 10.1038/s41586-018-0390-x; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Someya T, 2016, NATURE, V540, P379, DOI 10.1038/nature21004; Steude A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600061; Urquhart SG, 1999, J PHYS CHEM B, V103, P4603, DOI 10.1021/jp990059w; Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]; Xu J, 2017, SCIENCE, V355, P59, DOI 10.1126/science.aah4496; Yin D, 2016, ACS APPL MATER INTER, V8, P31166, DOI 10.1021/acsami.6b10328; Yu H, 2020, ACS APPL MATER INTER, V12, P36409, DOI 10.1021/acsami.0c05615; Zhang ZT, 2018, ADV MATER, V30, DOI 10.1002/adma.201800323; Zhang ZT, 2015, NAT PHOTONICS, V9, P233, DOI 10.1038/NPHOTON.2015.37; Zheng YQ, 2021, SCIENCE, V373, P88, DOI 10.1126/science.abh3551; Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829	42	24	24	142	312	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					624	+		10.1038/s41586-022-04400-1	http://dx.doi.org/10.1038/s41586-022-04400-1			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322250				2022-12-28	WOS:000772661800017
J	Davidson, KW; Mangione, CM; Barry, MJ; Nicholson, WK; Cabana, MD; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Mangione, Carol M.; Barry, Michael J.; Nicholson, Wanda K.; Cabana, Michael D.; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INFORMED-CONSENT; AIDS	This methods report from the US Preventive Services Task Force reviews the ethical and scientific principles behind shared decision-making, highlights the value of ensuring that patients are informed and involved in their care, and reaffirms the role of shared decision-making in making patient-centered decisions about prevention. The US Preventive Services Task Force (USPSTF) works to improve the health of people nationwide by making evidence-based recommendations for preventive services. Patient-centered care is a core value in US health care. Shared decision-making (SDM), in which patients and clinicians make health decisions together, ensures patients' rights to be informed and involved in preventive care decisions and that these decisions are patient-centered. SDM has a role across the spectrum of USPSTF recommendations. For A or B recommendations (judged by the USPSTF to have high or moderate certainty of a moderate or substantial net benefit at the population level), SDM allows individual patients to decide whether to accept such services based on their personal values and preferences. For C recommendations (indicating at least moderate certainty of a small net benefit at the population level), SDM is critical for individual patients to decide whether the net benefit for them is worthwhile. For D recommendations (reflecting at least moderate certainty of a zero or negative net benefit) or I statements (low certainty of net benefit), clinicians should be prepared to discuss these services if patients ask. More evidence is needed to determine if, in addition to promoting patient-centeredness, SDM reduces inequities in preventive care, as well as to define new strategies to find time for discussion of preventive services in primary care.	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, New York, NY USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Nicholson, Wanda K.; Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Cabana, Michael D.] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU Grossman Sch Med, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Med Sch, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Stevermer, James] Univ Missouri, Columbia, MO 65211 USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Northwell Health; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; George Mason University; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Gen Internal Med Div, 100 Cambridge St,16th Floor, Boston, MA 02114 USA.	mbarry@mgh.harvard.edu	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				American Medical Association, CPT EV MAN; [Anonymous], US PREV SERV TASK FO; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Barry MJ, 2008, J LAW MED ETHICS, V36, P396, DOI 10.1111/j.1748-720X.2008.00283.x; DeRosa AP, 2022, PATIENT EDUC COUNS, V105, P1057, DOI 10.1016/j.pec.2021.09.012; Eder Michelle, 2021, MDM Policy Pract, V6, p23814683211067522, DOI 10.1177/23814683211067522; Fagerlin A, 2011, BREAST CANCER RES TR, V127, P681, DOI 10.1007/s10549-011-1450-1; Grabinski VF, 2018, HEALTH EQUITY, V2, P234, DOI 10.1089/heq.2018.0020; Horn DM, 2020, NEW ENGL J MED, V383, P1505, DOI 10.1056/NEJMp2018749; Hsu C, 2013, MED DECIS MAKING, V33, P85, DOI 10.1177/0272989X12468615; Ibrahim SA, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.4225; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jolles MP, 2019, PATIENT EDUC COUNS, V102, P1251, DOI 10.1016/j.pec.2019.02.003; Joseph-Williams N, 2014, MED DECIS MAKING, V34, P699, DOI 10.1177/0272989X13501721; Langford AT, 2019, ETHNIC DIS, V29, P97, DOI 10.18865/ed.29.S1.97; Lee CN, 2010, ANN PLAS SURG, V64, P563, DOI 10.1097/SAP.0b013e3181c01279; Manta CJ, 2021, J PATIENT SAF, V17, pE149, DOI 10.1097/PTS.0000000000000310; Meyers K, 2021, AIDS PATIENT CARE ST, V35, P195, DOI 10.1089/apc.2021.0066; Moin T, 2019, J GEN INTERN MED, V34, P2652, DOI 10.1007/s11606-019-05238-6; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Ottawa Hospital Research Institute, A Z INV DEC AIDS; Peek ME, 2013, HEALTH COMMUN, V28, P616, DOI 10.1080/10410236.2012.710873; Pope TM, 2019, AM J BIOETHICS, V19, P90, DOI [10.1080/15265161.2018.1544309, 10.1080/15265161.2019.1587549]; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAK HLTH CAR DEC REP; Privett N, 2021, AM J PUBLIC HEALTH, V111, P145, DOI 10.2105/AJPH.2020.305967; QUILL TE, 1993, HUM MED, V9, P109; Sepucha KR, 2016, HEALTH AFFAIR, V35, P630, DOI 10.1377/hlthaff.2015.1376; Sheridan SL, 2004, AM J PREV MED, V26, P56, DOI 10.1016/j.amepre.2003.09.011; Spatz ES, 2016, JAMA-J AM MED ASSOC, V315, P2063, DOI 10.1001/jama.2016.3070; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; King JS, 2006, AM J LAW MED, V32, P429, DOI 10.1177/009885880603200401; Tan NQP, 2022, BMJ QUAL SAF, V31, P75, DOI 10.1136/bmjqs-2021-013533; Trenaman L, 2021, MED DECIS MAKING, V41, P954, DOI 10.1177/0272989X211011120; Turkson-Ocran RAN, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018183; U.S. Preventive Services Task Force, 2018, IS PROST CANC SCREEN; US Preventive Services Task Force, MED HELP PREV BREAST; US Preventive Services Task Force, PREP HIV PREV LETS T; Valentine KD, 2021, MED DECIS MAKING, V41, P108, DOI 10.1177/0272989X20977878; Washington State Healthcare Authority, PAT DEC AIDS PDAS; Wexler RM, 2015, INT J PERSON CTR MED, V5, P105; Yen RW, 2021, MED DECIS MAKING, V41, P870, DOI 10.1177/0272989X211020317	41	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1171	1176		10.1001/jama.2022.3267	http://dx.doi.org/10.1001/jama.2022.3267			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0C8XO	35315879	Bronze			2022-12-28	WOS:000775589900023
J	Abbasi, J				Abbasi, Jennifer			Pushed to Their Limits, 1 in 5 Physicians Intends to Leave Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1435	1436						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35353134				2022-12-28	WOS:000793035800012
J	Sacks, HS				Sacks, Henry S.			In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Gandhi RT, 2022, JAMA-J AM MED ASSOC, V327, P617, DOI 10.1001/jama.2022.0335; National Institutes of Health, THER MAN NONH AD COV; National Institutes of Health, COVID 19 TREATM GUID	3	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC40	JC40		10.7326/J22-0017	http://dx.doi.org/10.7326/J22-0017		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377719				2022-12-28	WOS:000799170800006
J	Aganezov, S; Yan, SM; Soto, DC; Kirsche, M; Zarate, S; Avdeyev, P; Taylor, DJ; Shafin, K; Shumate, A; Xiao, CL; Wagner, J; McDaniel, J; Olson, ND; Sauria, MEG; Vollger, MR; Rhie, A; Meredith, M; Martin, S; Lee, J; Koren, S; Rosenfeld, JA; Paten, B; Layer, R; Chin, CS; Sedlazeck, FJ; Hansen, NF; Miller, DE; Phillippy, AM; Miga, KH; McCoy, RC; Dennis, MY; Zook, JM; Schatz, MC				Aganezov, Sergey; Yan, Stephanie M.; Soto, Daniela C.; Kirsche, Melanie; Zarate, Samantha; Avdeyev, Pavel; Taylor, Dylan J.; Shafin, Kishwar; Shumate, Alaina; Xiao, Chunlin; Wagner, Justin; McDaniel, Jennifer; Olson, Nathan D.; Sauria, Michael E. G.; Vollger, Mitchell R.; Rhie, Arang; Meredith, Melissa; Martin, Skylar; Lee, Joyce; Koren, Sergey; Rosenfeld, Jeffrey A.; Paten, Benedict; Layer, Ryan; Chin, Chen-Shan; Sedlazeck, Fritz J.; Hansen, Nancy F.; Miller, Danny E.; Phillippy, Adam M.; Miga, Karen H.; McCoy, Rajiv C.; Dennis, Megan Y.; Zook, Justin M.; Schatz, Michael C.			A complete reference genome improves analysis of human genetic variation	SCIENCE			English	Article							SEGMENTAL DUPLICATIONS; MUTATIONS; SEQUENCE; DIVERSITY; ANCESTRY; MAP	Compared to its predecessors, the Telomere-to-Telomere CHM13 genome adds nearly 200 million base pairs of sequence, corrects thousands of structural errors, and unlocks the most complex regions of the human genome for clinical and functional study. We show how this reference universally improves read mapping and variant calling for 3202 and 17 globally diverse samples sequenced with short and long reads, respectively. We identify hundreds of thousands of variants per sample in previously unresolved regions, showcasing the promise of the T2T-CHM13 reference for evolutionary and biomedical discovery. Simultaneously, this reference eliminates tens of thousands of spurious variants per sample, including reduction of false positives in 269 medically relevant genes by up to a factor of 12. Because of these improvements in variant discovery coupled with population and functional genomic resources, T2T-CHM13 is positioned to replace GRCh38 as the prevailing reference for human genetics.	[Aganezov, Sergey; Kirsche, Melanie; Zarate, Samantha; Schatz, Michael C.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Yan, Stephanie M.; Taylor, Dylan J.; Sauria, Michael E. G.; McCoy, Rajiv C.; Schatz, Michael C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Soto, Daniela C.; Dennis, Megan Y.] Univ Calif Davis, Dept Biochem & Mol Med, Genome Ctr, MIND Inst, Davis, CA 95616 USA; [Avdeyev, Pavel; Rhie, Arang; Koren, Sergey; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Bethesda, MD 20892 USA; [Shafin, Kishwar; Meredith, Melissa; Paten, Benedict; Miga, Karen H.] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Shumate, Alaina] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Xiao, Chunlin] Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA; [Wagner, Justin; McDaniel, Jennifer; Olson, Nathan D.; Zook, Justin M.] NIST, Gaithersburg, MD 20899 USA; [Vollger, Mitchell R.; Miller, Danny E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Martin, Skylar; Layer, Ryan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Martin, Skylar; Layer, Ryan] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Lee, Joyce] Bionano Genom, San Diego, CA USA; [Rosenfeld, Jeffrey A.] Canc Inst New Jersey, New Brunswick, NJ USA; [Chin, Chen-Shan] DNAnexus, Mountain View, CA USA; [Sedlazeck, Fritz J.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Hansen, Nancy F.] NHGRI, Comparat Genom Anal Unit, Rockville, MD USA; [Miller, Danny E.] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA; [Miller, Danny E.] Seattle Childrens Hosp, Seattle, WA USA; [Schatz, Michael C.] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, POB 100, Cold Spring Harbor, NY 11724 USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institute of Standards & Technology (NIST) - USA; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; Seattle Children's Hospital; Cold Spring Harbor Laboratory	Schatz, MC (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.; McCoy, RC; Schatz, MC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Dennis, MY (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Genome Ctr, MIND Inst, Davis, CA 95616 USA.; Zook, JM (corresponding author), NIST, Gaithersburg, MD 20899 USA.; Schatz, MC (corresponding author), Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, POB 100, Cold Spring Harbor, NY 11724 USA.	rajtv.mccoy@jhu.edu; mydennis@ucdavis.edu; justin.zook@nist.gov; mschatz@cs.jhu.edu	Sedlazeck, Fritz J/E-4548-2018; Phillippy, Adam/U-5731-2018	Sedlazeck, Fritz J/0000-0001-6040-2691; Taylor, Dylan/0000-0001-5806-4494; Zarate, Samantha/0000-0001-5570-2059; Shafin, Kishwar/0000-0001-5252-3434; Avdeyev, Pavel/0000-0002-7953-6259; Kirsche, Melanie/0000-0002-6631-4761; Vollger, Mitchell/0000-0002-8651-1615; Phillippy, Adam/0000-0003-2983-8934; Soto, Daniela/0000-0002-6292-655X; Shumate, Alaina/0000-0002-4450-1857	NIH [R35GM133747, DP2MH119424, R01HG006677, R01HG010485, U41HG010972, U01HG010961, U24HG011853, OT2OD026682, UM1HG008898, 1R01HG011274-01, 1R21HG010548-01, 1U01HG010971, U24HG010263, U24HG006620, U01CA253481, R24DK106766-01A1, R00HG009532]; NSF [DBI-1627442, IOS-1732253, IOS-1758800]; Intramural Research Program of the National Human Genome Research Institute; Intramural Program of the National Institute of Standards and Technology; Mark Foundation for Cancer Research [19-033-ASP]; Fulbright fellowship; Intramural Research Program of the National Library of Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Program of the National Institute of Standards and Technology; Mark Foundation for Cancer Research; Fulbright fellowship; Intramural Research Program of the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by NIH grants R35GM133747 (R.C.M.), DP2MH119424 (M.Y.D.), R01HG006677 (A.S.), R01HG010485 (B.P.), U41HG010972 (B.P.), U01HG010961 (B.P., U24HG011853 (B.P.), OT2OD026682 (B.P.), UM1HG008898 (F.J.S.), 1R01HG011274-01 (K.H.M.), 1R21HG010548-01 (K.H.M.), 1U01HG010971 (K.H.M.), U24HG010263 (M.C.S.), U24HG006620 (M.C.S.), U01CA253481 (M.C.S.), R24DK106766-01A1 (M.C.S.), and R00HG009532 (R.M.L.); NSF grants DBI-1627442, IOS-1732253, and IOS-1758800 (M.C.S.); the Intramural Research Program of the National Human Genome Research Institute (P.A., A.R., S.K., A.M.P.); the Intramural Program of the National Institute of Standards and Technology (N.D.O., J.M., J.W., J.M.Z.); the Intramural Research Program of the National Library of Medicine (C.X.); the Mark Foundation for Cancer Research (19-033-ASP) (M.C.S.); and a Fulbright fellowship (D.C.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altemose N, 2022, SCIENCE, V376, P56, DOI 10.1126/science.abl4178; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Ballouz S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1774-4; Beyter D, 2021, NAT GENET, V53, P779, DOI 10.1038/s41588-021-00865-4; Bonfield JK, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab007; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Byrska-Bishop M., HIGH COVERAGE WHOLE, DOI [10.1101/2021.02.06.430068, DOI 10.1101/2021.02.06.430068, 10.1101/ 2021.02.06.430068]; Cartney AMM, 2022, NAT METHODS, V19, P687, DOI 10.1038/s41592-022-01440-3; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen L, 2020, CELL, V180, P677, DOI 10.1016/j.cell.2020.01.012; Cheng HY, 2021, NAT METHODS, V18, P170, DOI 10.1038/s41592-020-01056-5; Cheng JY, 2022, MOL BIOL EVOL, V39, DOI 10.1093/molbev/msab294; Cheng JY, 2017, BIOINFORMATICS, V33, P2148, DOI 10.1093/bioinformatics/btx098; Church DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0587-3; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Dennis MY, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0069; Eizenga JM, 2020, ANNU REV GENOM HUM G, V21, P139, DOI 10.1146/annurev-genom-120219-080406; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez JN, 2021, NUCLEIC ACIDS RES, V49, pD1046, DOI 10.1093/nar/gkaa1070; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gurunluoglu K, 2020, CLIN EXP HEPATOL, V6, P347, DOI 10.5114/ceh.2020.102156; Hartasanchez DA, 2018, GENOME BIOL EVOL, V10, P2899, DOI 10.1093/gbe/evy223; Hoyt SJ, 2022, SCIENCE, V376, P57, DOI 10.1126/science.abk3112; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jain C, 2020, BIOINFORMATICS, V36, P111, DOI 10.1093/bioinformatics/btaa435; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Khalilipour N, 2018, CANCER GENET-NY, V221, P46, DOI 10.1016/j.cancergen.2017.11.011; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirsche M., 2021, JASMINE POPULATIONSC; Kirsche M., 2021, IRIS STRUCTURAL VARI; Kirsche M., 2021, BIORXIV, V2021, DOI [10.1101/2021.05.27.445886, DOI 10.1101/2021.05.27.445886]; Kirsche M, 2021, BIOINFORMATICS, V37, P744, DOI 10.1093/bioinformatics/btaa911; Krusche P, 2019, NAT BIOTECHNOL, V37, P555, DOI 10.1038/s41587-019-0054-x; Lalrohlui F, 2021, GENE, V769, DOI 10.1016/j.gene.2020.145229; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Langley SA, 2019, ELIFE, V8, DOI 10.7554/eLife.42989; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2018, NAT METHODS, V15, P595, DOI 10.1038/s41592-018-0054-7; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; McCoy R., 2021, MCCOY LAB T2T VARIAN; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miga KH, 2021, ANNU REV GENOM HUM G, V22, P81, DOI 10.1146/annurev-genom-120120-081921; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Miller CA, 2022, J MOL DIAGN, V24, P219, DOI 10.1016/j.jmoldx.2021.10.013; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Munchel S, 2015, ONCOTARGET, V6, P25943, DOI 10.18632/oncotarget.4671; Numanagic I, 2018, BIOINFORMATICS, V34, P706, DOI 10.1093/bioinformatics/bty586; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; O'Bleness M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-387; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Pedersen BS, 2018, BIOINFORMATICS, V34, P867, DOI 10.1093/bioinformatics/btx699; Pertea M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1590-2; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178, DOI 10.1101/201178]; Pritt J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1595-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rentzsch P, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00835-9; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sauria M., 2021, MSAURIA T2T MUK ANAL; Schatz M., 2021, SCHATZLAB T2T VARIAN; Schatz Michael C, 2022, Cell Genom, V2, DOI 10.1016/j.xgen.2021.100085; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Shafin K, 2021, NAT METHODS, V18, P1322, DOI 10.1038/s41592-021-01299-w; Shafin K, 2020, NAT BIOTECHNOL, V38, P1044, DOI 10.1038/s41587-020-0503-6; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Sherman RM, 2019, NAT GENET, V51, P30, DOI 10.1038/s41588-018-0273-y; Sherry ST, 1999, GENOME RES, V9, P677; Soto D. C., 2021, MYDENNISLAB T2T VARI; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; Steinegger M, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02023-1; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Van der Auwera G.A., 2020, GENOMICS CLOUD USING; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vollger MR, 2022, SCIENCE, V376, P55, DOI 10.1126/science.abj6965; Vollger MR, 2020, ANN HUM GENET, V84, P125, DOI 10.1111/ahg.12364; Wagner J., NIST PUBLIC DATA REP, V2021, DOI [10.18434/MDS2-2475, DOI 10.18434/MDS2-2475]; Wagner J, 2022, NAT BIOTECHNOL, V40, P672, DOI 10.1038/s41587-021-01158-1; Yan SM, 2021, ELIFE, V10, DOI [10.7554/eLife.67615, 10.7554/eLife.67615.sa1, 10.7554/eLife.67615.sa2]; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Zerbino DR, 2020, ANNU REV GENOM HUM G, V21, P55, DOI 10.1146/annurev-genom-121119-083418; Zook JM, 2020, NAT BIOTECHNOL, V38, P1347, DOI 10.1038/s41587-020-0538-8	105	16	16	26	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		54	+	eabl3533	10.1126/science.abl3533	http://dx.doi.org/10.1126/science.abl3533			113	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357935	Green Accepted, Green Submitted			2022-12-28	WOS:000780195200022
J	Burnett, NP; Hernandez, AM; King, EE; Tanner, RL; Wilsterman, K				Burnett, Nicholas P.; Hernandez, Alyssa M.; King, Emily E.; Tanner, Richelle L.; Wilsterman, Kathryn			A push for inclusive data collection in STEM organizations Professional societies could better survey, and thus better serve, underrepresented groups	SCIENCE			English	Article							SCIENCE		[Burnett, Nicholas P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Hernandez, Alyssa M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [King, Emily E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Tanner, Richelle L.] Chapman Univ, Environm Sci & Policy Program, Orange, CA USA; [Wilsterman, Kathryn] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Wilsterman, Kathryn] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Harvard University; University of California System; University of California Berkeley; Chapman University System; Chapman University; University of Montana System; University of Montana; Colorado State University	Burnett, NP (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	burnettnp@gmail.com		Burnett, Nicholas/0000-0003-4438-8062				Armstrong M. A., 2015, J WOMEN MINORITIES S, V21, P141, DOI [10.1615/jwomenminorscieneng.2015011275, DOI 10.1615/JWOMENMINORSCIENENG.2015011275]; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Burnett NP, 2020, NAT ECOL EVOL, V4, P1283, DOI 10.1038/s41559-020-1276-5; Freeman JB, 2021, SCIENCE, V374, P1333, DOI 10.1126/science.abn1103; NationalCenter forScience and Engineering Statistics, 2021, NATIONALSCIENCE FDN; NationalScience Board, 2020, 20201 NSB; Nguyen KH., 2022, B ECOLOGIC SOC AM, V103, DOI [10.1002/bes2.1939, DOI 10.1002/BES2.1939]; Roth PL, 1998, J MANAGE, V24, P97, DOI 10.1016/S0149-2063(99)80055-5; Rushworth CA, 2021, EVOLUTION, V75, P208, DOI 10.1111/evo.14168; Scott JM, 2008, BIOSCIENCE, V58, P865, DOI 10.1641/B580914; Sellami N, 2021, CBE-LIFE SCI EDUC, V20, DOI 10.1187/cbe.20-09-0224; Sills SJ, 2002, SOC SCI COMPUT REV, V20, P22, DOI 10.1177/089443930202000103; Snipp CM, 2003, ANNU REV SOCIOL, V29, P563, DOI 10.1146/annurev.soc.29.010202.100006; Yoder JB, 2016, J HOMOSEXUAL, V63, P1, DOI 10.1080/00918369.2015.1078632	14	3	3	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		37	39		10.1126/science.abo1599	http://dx.doi.org/10.1126/science.abo1599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357921	Green Submitted			2022-12-28	WOS:000780195200017
J	Kumar, V; Wang, WJ; Zhang, J; Wang, YQ; Ruan, QR; Yu, JJ; Wu, XH; Hu, XJ; Wu, XH; Guo, W; Wang, B; Niyazi, A; Lv, EG; Tang, ZH; Cao, P; Liu, F; Dai, QY; Yang, RW; Feng, XT; Ping, WJ; Zhang, LZ; Zhang, M; Hou, WH; Liu, YC; Bennett, EA; Fu, QM				Kumar, Vikas; Wang, Wenjun; Zhang, Jie; Wang, Yongqiang; Ruan, Qiurong; Yu, Jianjun; Wu, Xiaohong; Hu, Xingjun; Wu, Xinhua; Guo, Wu; Wang, Bo; Niyazi, Alipujiang; Lv, Enguo; Tang, Zihua; Cao, Peng; Liu, Feng; Dai, Qingyan; Yang, Ruowei; Feng, Xiaotian; Ping, Wanjing; Zhang, Lizhao; Zhang, Ming; Hou, Weihong; Liu, Yichen; Bennett, E. Andrew; Fu, Qiaomei			Bronze and Iron Age population movements underlie Xinjiang population history	SCIENCE			English	Article							INDO-EUROPEAN LANGUAGES; ANCIENT HUMAN GENOMES; LATE PLEISTOCENE; DNA; SEQUENCE; DIVERSITY; ADMIXTURE; NEANDERTHAL; INSIGHTS; ORIGIN	The Xinjiang region in northwest China is a historically important geographical passage between East and West Eurasia. By sequencing 201 ancient genomes from 39 archaeological sites, we clarify the complex demographic history of this region. Bronze Age Xinjiang populations are characterized by four major ancestries related to Early Bronze Age cultures from the central and eastern Steppe, Central Asian, and Tarim Basin regions. Admixtures between Middle and Late Bronze Age Steppe cultures continued during the Late Bronze and Iron Ages, along with an inflow of East and Central Asian ancestry. Historical era populations show similar admixed and diverse ancestries as those of present-day Xinjiang populations. These results document the influence that East and West Eurasian populations have had over time in the different regions of Xinjiang.	[Kumar, Vikas; Wang, Wenjun; Cao, Peng; Liu, Feng; Dai, Qingyan; Yang, Ruowei; Feng, Xiaotian; Ping, Wanjing; Zhang, Lizhao; Zhang, Ming; Hou, Weihong; Liu, Yichen; Bennett, E. Andrew; Fu, Qiaomei] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Kumar, Vikas; Liu, Yichen; Fu, Qiaomei] Shanghai Qi Zhi Inst, Shanghai 200232, Peoples R China; [Wang, Wenjun] Natl Ctr Archaeol, Beijing 100013, Peoples R China; [Zhang, Jie; Wang, Yongqiang; Ruan, Qiurong; Yu, Jianjun; Hu, Xingjun; Niyazi, Alipujiang; Lv, Enguo] Inst Cultural Rel & Archaeol Xinjiang, Urumqi 830011, Peoples R China; [Wu, Xiaohong] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Wu, Xinhua; Guo, Wu] Chinese Acad Social Sci, Inst Archaeol, Beijing 100710, Peoples R China; [Wang, Bo] Xinjiang Uygur Autonomous Reg Museum, Urumqi 830002, Peoples R China; [Tang, Zihua] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100020, Peoples R China; [Fu, Qiaomei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YC; Bennett, EA; Fu, QM (corresponding author), Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.; Liu, YC; Fu, QM (corresponding author), Shanghai Qi Zhi Inst, Shanghai 200232, Peoples R China.; Fu, QM (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	yichen.liu@ivpp.ac.cn; eabennett@gmail.com; fuqiaomei@ivpp.ac.cn	hou, wei/GWM-4800-2022; liu, yichen/GVT-6262-2022	Wang, Yongqiang/0000-0003-4909-2965; Kumar, Vikas/0000-0002-5263-9303	National Key R&D Program of China [2016YFE0203700]; Chinese Academy of Sciences (CAS); Ministry of Finance of the People's Republic of China [YSBR-019, XDB26000000]; National Natural Science Foundation of China [41925009]; Tencent Foundation through the XPLORER PRIZE; Howard Hughes Medical Institute [55008731]; Key National Social Science Foundation of China [16ZDA144]; "Research on the roots of Chinese civilization" of Zhengzhou University [XKZDJC202006]	National Key R&D Program of China; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Ministry of Finance of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tencent Foundation through the XPLORER PRIZE; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Key National Social Science Foundation of China; "Research on the roots of Chinese civilization" of Zhengzhou University	This work was supported by the National Key R&D Program of China (2016YFE0203700), the Chinese Academy of Sciences (CAS) and the Ministry of Finance of the People's Republic of China (YSBR-019 and XDB26000000), the National Natural Science Foundation of China (41925009), "Research on the roots of Chinese civilization" of Zhengzhou University (XKZDJC202006), the Tencent Foundation through the XPLORER PRIZE, and the Howard Hughes Medical Institute (grant no. 55008731). Xia.W. was supported by the Key National Social Science Foundation of China (no. 16ZDA144).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bailey H. W, 1970, IRAN, V8, P65; BAILEY Harold Walter, 1970, IRAN, V8, P65; Betts A, 2019, ARCHAEOL RES ASIA, V17, P204, DOI 10.1016/j.ara.2018.04.001; Betts A. V. G., 2020, CULTURES ANCIENT XIN; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Caspari G, 2017, J ARCHAEOL SCI-REP, V14, P12, DOI 10.1016/j.jasrep.2017.05.036; Chaitanya L, 2018, FORENSIC SCI INT-GEN, V35, P123, DOI 10.1016/j.fsigen.2018.04.004; Chen A., 2012, RES TURPAN, V2, P105; Cong D., 2017, W REG STUD, V4, P15; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Eddisford D., EARLY BRONZE AGE EXC; Feng QD, 2017, MOL BIOL EVOL, V34, P2572, DOI 10.1093/molbev/msx177; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gnecchi-Ruscone GA, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4414; Guan B., 2018, W REG STUD, V3, P137; Guo W, 2016, W REG STUD, V1, P135; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Han J.Y., 2007, CULTURES XINJIANG BR; HARTLEY PA, 1985, POWDER TECHNOL, V42, P35, DOI 10.1016/0032-5910(85)80036-X; Hemphill BE, 2004, AM J PHYS ANTHROPOL, V124, P199, DOI 10.1002/ajpa.10354; Institute of Archaeology Chinese Academy of Social Science, 2012, ACTA ARCHAEOL SIN, V2, P229; Institute of Archaeology Chinese Academy of Social Science., 2016, ARCHAEOLOGY, P19; Institute of Archaeology Xinjiang Academy of Social Sciences, 1981, CULT RELICS, V1, P23; Institute of Cultural Relics and Archaeology in Xinjiang, 2018, XINJIANG CULT RELICS, V1; Institute of Cultural Relics and Archaeology in Xinjiang, 2017, XINJIANG CULT RELICS, V2, P19; Institute of Cultural Relics and Archaeology in Xinjiang, 2014, CULT RELICS, V12, P18; Institute of Cultural Relics and Archaeology in Xinjiang, 2012, CULT RELICS, V5, P13; Institute of Cultural Relics and Archaeology in Xinjiang, 2006, CULT RELICS, P32; Institute of Cultural Relics and Archaeology in Xinjiang, 2012, ARCHAEOLOGY, V9, P3; Institute of Cultural Relics and Archaeology in Xinjiang, 2020, ARCHAEOLOGY, V12; Institute of Cultural Relics and Archaeology in Xinjiang, 2012, XINJIANG CULT RELICS, V2; Institute of Cultural Relics and Archaeology in Xinjiang, 2013, CULT RELICS, V3, P4; Jeong C, 2020, CELL, V183, P890, DOI 10.1016/j.cell.2020.10.015; Jeong C, 2016, P NATL ACAD SCI USA, V113, P7485, DOI 10.1073/pnas.1520844113; Jia PW, 2017, ANTIQUITY, V91, P621, DOI 10.15184/aqy.2017.67; Jixieliefu C. B, 1981, ANCIENT HIST SO SIBE; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Kassian AS, 2021, LINGUISTICS, V59, P949, DOI 10.1515/ling-2020-0060; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li CX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0237-5; Li JW, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1082-0; Li KK, 2018, SCI CHINA EARTH SCI, V61, P1659, DOI 10.1007/s11430-017-9257-3; Li S., 2018, CULT RELICS XINJIANG, V1, P105; Li YQ, 2021, VEG HIST ARCHAEOBOT, V30, P287, DOI 10.1007/s00334-020-00774-2; Lipson M, 2018, CURR BIOL, V28, P1157, DOI 10.1016/j.cub.2018.02.051; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mao XW, 2021, CELL, V184, P3256, DOI 10.1016/j.cell.2021.04.040; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mei J, 2000, METALLURGICAL STUDY; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Millward James, 2021, EURASIAN CROSSROADS, V2nd; Museum X., 2003, ACTA ARCHAEOL SIN, V1, P89; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Ning C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16557-2; Ning C, 2019, CURR BIOL, V29, P2526, DOI 10.1016/j.cub.2019.06.044; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peyrot M., 2019, INDO EUROPEAN LINGUI, V7, P72; Peyrot M, 2019, LINGUIST, V7, P72; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Posth C, 2018, NAT ECOL EVOL, V2, P731, DOI 10.1038/s41559-018-0498-2; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragettli S, 2021, HYDROL RES, V52, P4, DOI 10.2166/nh.2019.118; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralf A, 2018, MOL BIOL EVOL, V35, P1291, DOI 10.1093/molbev/msy032; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Ruan Q., 2012, CULT RELICS, V5, P13; Ruan Q., 2014, CULT RELICS, V12, P50; Shao H, 2008, RES CHINAS FRONT ARC, V7, P170; Shinde V, 2019, CELL, V179, P729, DOI 10.1016/j.cell.2019.08.048; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Tian G., 1980, ARCHAEOLOGY, V4, P333; Wang B, 1995, W REG STUD, V4, P67; Wang CC, 2021, NATURE, V591, P413, DOI 10.1038/s41586-021-03336-2; Wang L, 2019, ARCHAEOL ANTHROP SCI, V11, P2407, DOI 10.1007/s12520-018-0679-6; Wang WJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6690; Wang Y, 2016, W REGIONS STUDIES, V1, P132; Wang Y., 2019, W REGIONS STUD, V1, P133; Wang Y., 2017, PUBLIC ARCHAEOL, V7, P57; Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Wu X., 2014, W REG STUD, V1, P124; Xie CZ, 2007, PROG NAT SCI, V17, P927; Xu XJ, 2018, NUCLEIC ACIDS RES, V46, pD14, DOI 10.1093/nar/gkx897; Yang MA, 2020, SCIENCE, V369, P282, DOI 10.1126/science.aba0909; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Ye S., 2018, INN MONG SOC SCI, V4, P137; Yu J, 2013, POP ARCHAEOL, V6, P75; Yu J., 2014, CULT RELICS, V4, P4; Yu J., 2013, CULT RELICS, V3, P53; Zhang F, 2021, NATURE, V599, P256, DOI 10.1038/s41586-021-04052-7; Zhang Y., 2002, ARCHAEOLOGY, V6, P3; Zhou XY, 2020, NAT PLANTS, V6, P78, DOI 10.1038/s41477-019-0581-y	115	2	2	15	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		62	+		10.1126/science.abk1534	http://dx.doi.org/10.1126/science.abk1534			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357918				2022-12-28	WOS:000780195200027
J	Coutrot, A; Manley, E; Goodroe, S; Gahnstrom, C; Filomena, G; Yesiltepe, D; Dalton, RC; Wiener, JM; Holscher, C; Hornberger, M; Spiers, HJ				Coutrot, A.; Manley, E.; Goodroe, S.; Gahnstrom, C.; Filomena, G.; Yesiltepe, D.; Dalton, R. C.; Wiener, J. M.; Hoelscher, C.; Hornberger, M.; Spiers, H. J.			Entropy of city street networks linked to future spatial navigation ability	NATURE			English	Article							ENVIRONMENT; COGNITION; MEMORY; MODEL; MICE	The cultural and geographical properties of the environment have been shown to deeply influence cognition and mental health(1-6). Living near green spaces has been found to be strongly beneficial(7-11), and urban residence has been associated with a higher risk of some psychiatric disorders(12-14)-although some studies suggest that dense socioeconomic networks found in larger cities provide a buffer against depression(15). However, how the environment in which one grew up affects later cognitive abilities remains poorly understood. Here we used a cognitive task embedded in a video game(16) to measure non-verbal spatial navigation ability in 397,162 people from 38 countries across the world. Overall, we found that people who grew up outside cities were better at navigation. More specifically, people were better at navigating in environments that were topologically similar to where they grew up. Growing up in cities with a low street network entropy (for example, Chicago) led to better results at video game levels with a regular layout, whereas growing up outside cities or in cities with a higher street network entropy (for example, Prague) led to better results at more entropic video game levels. This provides evidence of the effect of the environment on human cognition on a global scale, and highlights the importance of urban design in human cognition and brain function.	[Coutrot, A.] Univ Lyon, LIRIS, CNRS, Lyon, France; [Manley, E.] UCL, Ctr Adv Spatial Anal, London, England; [Manley, E.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Goodroe, S.; Gahnstrom, C.; Spiers, H. J.] UCL, Inst Behav Neurosci, Dept Expt Psychol, Div Psychol & Language Sci, London, England; [Filomena, G.] Univ Munster, Inst Geoinformat, Munster, Germany; [Yesiltepe, D.; Dalton, R. C.] Northumbria Univ, Dept Architecture & Built Environm, Newcastle Upon Tyne, Tyne & Wear, England; [Wiener, J. M.] Bournemouth Univ, Ageing & Dementia Res Ctr, Dept Psychol, Poole, Dorset, England; [Hoelscher, C.] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Zurich, Switzerland; [Hornberger, M.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of London; University College London; University of Leeds; University of London; University College London; University of Munster; Northumbria University; Bournemouth University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of East Anglia	Coutrot, A (corresponding author), Univ Lyon, LIRIS, CNRS, Lyon, France.; Spiers, HJ (corresponding author), UCL, Inst Behav Neurosci, Dept Expt Psychol, Div Psychol & Language Sci, London, England.	antoine.coutrot@cnrs.fr; h.spiers@ucl.ac.uk	Filomena, Gabriele/ABF-8146-2020; Wiener, Jan/H-4657-2013	Filomena, Gabriele/0000-0001-6380-7264; Manley, Ed/0000-0002-8904-0513; Wiener, Jan/0000-0002-9583-298X; Gahnstrom, Christoffer J./0000-0002-9989-5136; Goodroe, Sarah/0000-0003-1468-8304; Dalton, Ruth/0000-0001-9594-1724; Yesiltepe, Demet/0000-0003-2409-6687	Deutsche Telekom; Alzheimer's Research UK [ARUK-DT2016-1]	Deutsche Telekom; Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	This research is part of the Sea Hero Quest initiative funded and supported by Deutsche Telekom. Alzheimer's Research UK (ARUK-DT2016-1) funded the analysis; Glitchers designed and produced the game; and Saatchi and Saatchi London managed the creation of the game. The geographical information used in this study has been made available by OSM contributors under the Open Database License (https://www.openstreetmap.org/copyright).	Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2014, J GEOGR SYST, V16, P363, DOI 10.1007/s10109-014-0202-2; Berman MG, 2019, AM PSYCHOL, V74, P1039, DOI 10.1037/amp0000583; Boeing G, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0189-1; Boeing G, 2020, ENVIRON PLAN B-URBAN, V47, P590, DOI 10.1177/2399808318784595; Boeing G, 2017, COMPUT ENVIRON URBAN, V65, P126, DOI 10.1016/j.compenvurbsys.2017.05.004; Bongiorno C, 2021, NAT COMPUT SCI, V1, P678, DOI 10.1038/s43588-021-00130-y; Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903; Bruny?, 2015, PLOS ONE, V10; Carey IM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022404; Clemenson GD, 2015, CURR OPIN BEHAV SCI, V4, P56, DOI 10.1016/j.cobeha.2015.02.005; Coughlan G, 2019, P NATL ACAD SCI USA, V116, P9285, DOI 10.1073/pnas.1901600116; Coutrot A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213272; Dadvand P, 2015, P NATL ACAD SCI USA, V112, P7937, DOI 10.1073/pnas.1503402112; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Ekstrom A.D., 2018, HUMAN SPATIAL NAVIGA; Engemann K, 2019, P NATL ACAD SCI USA, V116, P5188, DOI 10.1073/pnas.1807504116; Epstein RA, 2017, NAT NEUROSCI, V20, P1504, DOI 10.1038/nn.4656; Filomena G, 2019, CITIES, V89, P14, DOI 10.1016/j.cities.2019.01.006; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Fuchs F, 2016, BEHAV BRAIN RES, V299, P1, DOI 10.1016/j.bbr.2015.11.019; Giacomin DJ, 2015, ENVIRON PLANN B, V42, P1040, DOI 10.1068/b130131p; Gudmundsson A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03324; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Javadi AH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14652; Jiang B, 2004, GEOINFORMATICA, V8, P157, DOI 10.1023/B:GEIN.0000017746.44824.70; Jiang B, 2004, ENVIRON PLANN B, V31, P151, DOI 10.1068/b306; Kardan O, 2015, SCI REP-UK, V5, DOI 10.1038/srep11610; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; Koohsari MJ, 2019, AM J ALZHEIMERS DIS, V34, P381, DOI 10.1177/1533317519844046; Kuhn S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12046-7; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lester AW, 2017, NEURON, V95, P1019, DOI 10.1016/j.neuron.2017.06.037; Lynch K., 1960, IMAGEN CITY; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Malanchini M, 2020, NPJ SCI LEARN, V5, DOI 10.1038/s41539-020-0067-8; Marshall S., 2005, STREETS AND PATTERNS, DOI DOI 10.4324/9780203589397; Masucci AP, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0763; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; McNamee, 2016, ADV NEURAL INF PROCE, P4511; Montello DR, 2009, LECT NOTES COMPUT SC, V5756, P1; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; Nazareth A, 2019, PSYCHON B REV, V26, P1503, DOI 10.3758/s13423-019-01633-6; Nazareth A, 2018, J EXP CHILD PSYCHOL, V170, P86, DOI 10.1016/j.jecp.2018.01.009; Porta S, 2009, ENVIRON PLANN B, V36, P450, DOI 10.1068/b34098; Ritchie SJ, 2018, PSYCHOL SCI, V29, P1358, DOI 10.1177/0956797618774253; SADALLA EK, 1980, ENVIRON BEHAV, V12, P65, DOI 10.1177/0013916580121005; Salon D, 2015, RES TRANSP ECON, V52, P34, DOI 10.1016/j.retrec.2015.10.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Spiers H. J., 2021, TOP COGN SCI, DOI [10.1111/tops.12590, DOI 10.1111/TOPS.12590]; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Spiers HJ, 2015, CURR OPIN BEHAV SCI, V1, P47, DOI 10.1016/j.cobeha.2014.08.005; Stier, 2020, RETHINKING DEPRESSIO, DOI [10.1101/2020.08.20.20179036, DOI 10.1101/2020.08.20.20179036]; Sutherland RJ, 2004, NEUROSCI BIOBEHAV R, V28, P687, DOI 10.1016/j.neubiorev.2004.09.012; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Ulrich S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0204781; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Watts Amber, 2015, Gerontol Geriatr Med, V1; Wiener JM, 2004, J ENVIRON PSYCHOL, V24, P475, DOI 10.1016/j.jenvp.2004.09.006; Xu, NAT HUM BEHAV, DOI [10.1038/s41562-021-01204-7 (2021), DOI 10.1038/S41562-021-01204-7(2021), 10.1038/s41562-021-01204-7, DOI 10.1038/S41562-021-01204-7]	66	11	11	22	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					104	+		10.1038/s41586-022-04486-7	http://dx.doi.org/10.1038/s41586-022-04486-7		MAR 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0I0EB	35355009	Green Accepted, Green Submitted			2022-12-28	WOS:000775757700003
J	Samarasekera, U				Samarasekera, Udani			Martin Landray: harnessing the power of good clinical trials	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1217	1217						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339216	Green Published, Bronze			2022-12-28	WOS:000779495000011
J	Slomski, A				Slomski, Anita			Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1118	1118		10.1001/jama.2022.3755	http://dx.doi.org/10.1001/jama.2022.3755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315887				2022-12-28	WOS:000775589900008
J	Dyer, O				Dyer, Owen			Essential medicines keep flowing to Russia, but sanctions could severely effect health	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Duranti, Tommaso/0000-0003-3649-5183					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o745	10.1136/bmj.o745	http://dx.doi.org/10.1136/bmj.o745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314466				2022-12-28	WOS:000773915700002
J	Bose, M; Lampe, M; Mahamid, J; Ephrussi, A				Bose, Mainak; Lampe, Marko; Mahamid, Julia; Ephrussi, Anne			Liquid-to-solid phase transition of oskar ribonucleoprotein granules is essential for their function in Drosophila embryonic development	CELL			English	Article							MESSENGER-RNA LOCALIZATION; RESTRICTS POLE PLASM; CELL-FORMATION; HNRNPA/B HOMOLOG; GERM PLASM; P GRANULES; KINESIN I; PROTEIN; TRANSLATION; POSTERIOR	Asymmetric localization of oskar ribonucleoprotein (RNP) granules to the oocyte posterior is crucial for abdominal patterning and germline formation in the Drosophila embryo. We show that oskar RNP granules in the oocyte are condensates with solid-like physical properties. Using purified oskar RNA and scaffold proteins Bruno and Hrp48, we confirm in vitro that oskar granules undergo a liquid-to-solid phase transition. Whereas the liquid phase allows RNA incorporation, the solid phase precludes incorporation of additional RNA while allowing RNA-dependent partitioning of client proteins. Genetic modification of scaffold granule proteins or tethering the intrinsically disordered region of human fused in sarcoma (FUS) to oskar mRNA allowed modulation of granule material properties in vivo. The resulting liquid-like properties impaired oskar localization and translation with severe consequences on embryonic development. Our study reflects how physiological phase transitions shape RNA-protein condensates to regulate the localization and expression of a maternal RNA that instructs germline formation.	[Bose, Mainak; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Lampe, Marko] European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany; [Mahamid, Julia] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.; Mahamid, J (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.	julia.mahamid@embl.de; anne.ephrussi@embl.org	Bose, Mainak/GMW-6428-2022	Bose, Mainak/0000-0001-5464-3851; Mahamid, Julia/0000-0001-6968-041X	EMBL Interdisciplinary Postdoctoral (EIPOD) Program under Marie Sk1odowska-Curie Actions COFUND [EI3POD]; EMBL; European Research Council [ERC 3DCellPhase-760067]	EMBL Interdisciplinary Postdoctoral (EIPOD) Program under Marie Sk1odowska-Curie Actions COFUND; EMBL; European Research Council(European Research Council (ERC)European Commission)	We acknowledge the EMBL Advanced Light Microscopy Facility, especially Aliaksandr Halavatyi, for help with FRAP analysis, the EMBL cryo-EM platform, Anna Cyrklaff for embryo collection, Alessandra Reversi for transgenesis, and the EMBL Protein Expression and Purification Core Facility for expression vectors and TEV protease. We thank Xiaojie Zhang and Anthony Hyman for the FUS plasmid, purified hFUS protein, and help with Electron Microscopy Data Bank (EMDB) depositions; Bernhard Hampoelz and Martin Beck for the RFP-Nup107 fly line; Justin Crocker for Even-skipped antibody; Tse-Bin Chou and Elizabeth Gavis for the oskar6xMS2 fly line; and Imre Gaspar and Frank Wippich for the RNA copy number calculation R-script. We thank Simon Alberti, Florence Besse, and Jeff Woodruff for their critical comments on the manuscript. M.B. was supported by a fellowship from the EMBL Interdisciplinary Postdoctoral (EIPOD) Program under Marie Sk1odowska-Curie Actions COFUND (EI3POD). A.E. and J.M. acknowledge funding from the EMBL and J.M. from the European Research Council (ERC 3DCellPhase-760067).	Alberti S, 2021, NAT REV MOL CELL BIO, V22, P196, DOI 10.1038/s41580-020-00326-6; Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Audas TE, 2016, DEV CELL, V39, P155, DOI 10.1016/j.devcel.2016.09.002; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Beydoun T, 2015, J OCUL PHARMACOL TH, V31, P93, DOI 10.1089/jop.2013.0247; Boeynaems S, 2019, P NATL ACAD SCI USA, V116, P7889, DOI 10.1073/pnas.1821038116; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Daetwyler S, 2020, BIOL OPEN, V9, DOI 10.1242/bio.056200; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; Dold A, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008581; Eichler CE, 2020, ELIFE, V9, DOI 10.7554/eLife.49988; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Filardo P, 2003, MECH DEVELOP, V120, P289, DOI 10.1016/S0925-4773(02)00454-9; Folkmann AW, 2021, SCIENCE, V373, P1218, DOI 10.1126/science.abg7071; Fujioka Y, 2020, NATURE, V578, P301, DOI 10.1038/s41586-020-1977-6; Gaspar I., BIORXIV; Gaspar I, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2380; Gaspar I, 2018, ACS CHEM BIOL, V13, P742, DOI 10.1021/acschembio.7b01007; Gaspar I, 2017, RNA, V23, P1582, DOI 10.1261/rna.061184.117; Gaspar I, 2017, EMBO J, V36, P319, DOI 10.15252/embj.201696038; Gaspar I, 2014, J CELL BIOL, V206, P199, DOI 10.1083/jcb.201310010; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Halavatyi A., 2017, STANDARD SUPER RESOL, P99; Hampoelz B, 2019, CELL, V179, P671, DOI 10.1016/j.cell.2019.09.022; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Holehouse AS, 2018, BIOCHEMISTRY-US, V57, P2415, DOI 10.1021/acs.biochem.7b01136; Hurd TR, 2016, DEV CELL, V39, P560, DOI 10.1016/j.devcel.2016.11.004; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jambor H, 2014, RNA, V20, P429, DOI 10.1261/rna.041566.113; Jambor H, 2011, RNA, V17, P2049, DOI 10.1261/rna.2686411; Jawerth L, 2020, SCIENCE, V370, P1317, DOI 10.1126/science.aaw4951; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kim G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004992; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lafontaine DLJ, 2021, NAT REV MOL CELL BIO, V22, P165, DOI 10.1038/s41580-020-0272-6; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin MD, 2008, DEV BIOL, V322, P276, DOI 10.1016/j.ydbio.2008.07.033; Little SC, 2015, NAT CELL BIOL, V17, P558, DOI 10.1038/ncb3143; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mittasch M, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201912036; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Protter DSW, 2018, CELL REP, V22, P1401, DOI 10.1016/j.celrep.2018.01.036; Putnam A, 2019, NAT STRUCT MOL BIOL, V26, P220, DOI 10.1038/s41594-019-0193-2; Quiroz FG, 2020, SCIENCE, V367, P1210, DOI 10.1126/science.aax9554; Ranganathan S, 2020, ELIFE, V9, DOI 10.7554/eLife.56159; Rhoads SN, 2018, MOL BIOL CELL, V29, P1786, DOI 10.1091/mbc.E17-12-0735; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Shimobayashi SF, 2021, NATURE, V599, P503, DOI 10.1038/s41586-021-03905-5; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Shorter J, 2017, EMBO J, V36, P2925, DOI 10.15252/embj.201798078; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Snee M, 2008, RNA BIOL, V5, P49, DOI 10.4161/rna.5.1.5735; Tanaka Tsubasa, 2011, Bioarchitecture, V1, P122; Tauber D, 2020, TRENDS BIOCHEM SCI, V45, P764, DOI 10.1016/j.tibs.2020.05.002; Theodoridis PR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014457118; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Tsang B, 2019, P NATL ACAD SCI USA, V116, P4218, DOI 10.1073/pnas.1814385116; Van Treeck B, 2018, CELL, V174, P791, DOI 10.1016/j.cell.2018.07.023; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Vanzo N, 2007, DEV CELL, V12, P543, DOI 10.1016/j.devcel.2007.03.002; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Vijayakumar J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10554-w; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; WIDOM B, 1988, J STAT PHYS, V52, P1343, DOI 10.1007/BF01011651; Wiegand T, 2020, EMERG TOP LIFE SCI, V4, P247, DOI 10.1042/ETLS20190174; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Xing WM, 2020, ELIFE, V9, DOI 10.7554/eLife.56525; Yamazaki Tomohiro, 2019, Cold Spring Harb Symp Quant Biol, V84, P227, DOI 10.1101/sqb.2019.84.039404; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Yoshida S, 2004, DEVELOPMENT, V131, P1401, DOI 10.1242/dev.01034; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	119	8	8	21	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1308	+		10.1016/j.cell.2022.02.022	http://dx.doi.org/10.1016/j.cell.2022.02.022			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	1V8JR	35325593	Green Published, hybrid			2022-12-28	WOS:000806331300012
J	Tita, AT; Szychowski, JM; Boggess, K; Dugoff, L; Sibai, B; Lawrence, K; Hughes, BL; Bell, J; Aagaard, K; Edwards, RK; Gibson, K; Haas, DM; Plante, L; Metz, T; Casey, B; Esplin, S; Longo, S; Hoffman, M; Saade, GR; Hoppe, KK; Foroutan, J; Tuuli, M; Owens, MY; Simhan, HN; Frey, H; Rosen, T; Palatnik, A; Baker, S; August, P; Reddy, UM; Kinzler, W; Su, E; Krishna, I; Nguyen, N; Norton, ME; Skupski, D; El-Sayed, YY; Ogunyemi, D; Galis, ZS; Harper, L; Ambalavanan, N; Geller, NL; Oparil, S; Cutter, GR; Andrews, WW				Tita, A. T.; Szychowski, J. M.; Boggess, K.; Dugoff, L.; Sibai, B.; Lawrence, K.; Hughes, B. L.; Bell, J.; Aagaard, K.; Edwards, R. K.; Gibson, K.; Haas, D. M.; Plante, L.; Metz, T.; Casey, B.; Esplin, S.; Longo, S.; Hoffman, M.; Saade, G. R.; Hoppe, K. K.; Foroutan, J.; Tuuli, M.; Owens, M. Y.; Simhan, H. N.; Frey, H.; Rosen, T.; Palatnik, A.; Baker, S.; August, P.; Reddy, U. M.; Kinzler, W.; Su, E.; Krishna, I; Nguyen, N.; Norton, M. E.; Skupski, D.; El-Sayed, Y. Y.; Ogunyemi, D.; Galis, Z. S.; Harper, L.; Ambalavanan, N.; Geller, N. L.; Oparil, S.; Cutter, G. R.; Andrews, W. W.		Chronic Hypertension Pregnancy CHA	Treatment for Mild Chronic Hypertension during Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Early Access							BLOOD-PRESSURE; AMERICAN-COLLEGE; TASK-FORCE; MANAGEMENT	BackgroundThe benefits and safety of the treatment of mild chronic hypertension (blood pressure, < 160/100 mm Hg) during pregnancy are uncertain. Data are needed on whether a strategy of targeting a blood pressure of less than 140/90 mm Hg reduces the incidence of adverse pregnancy outcomes without compromising fetal growth.MethodsIn this open-label, multicenter, randomized trial, we assigned pregnant women with mild chronic hypertension and singleton fetuses at a gestational age of less than 23 weeks to receive antihypertensive medications recommended for use in pregnancy (active-treatment group) or to receive no such treatment unless severe hypertension (systolic pressure, >= 160 mm Hg; or diastolic pressure, >= 105 mm Hg) developed (control group). The primary outcome was a composite of preeclampsia with severe features, medically indicated preterm birth at less than 35 weeks' gestation, placental abruption, or fetal or neonatal death. The safety outcome was small-for-gestational-age birth weight below the 10th percentile for gestational age. Secondary outcomes included composites of serious neonatal or maternal complications, preeclampsia, and preterm birth.ResultsA total of 2408 women were enrolled in the trial. The incidence of a primary-outcome event was lower in the active-treatment group than in the control group (30.2% vs. 37.0%), for an adjusted risk ratio of 0.82 (95% confidence interval [CI], 0.74 to 0.92; P < 0.001). The percentage of small-for-gestational-age birth weights below the 10th percentile was 11.2% in the active-treatment group and 10.4% in the control group (adjusted risk ratio, 1.04; 0.82 to 1.31; P=0.76). The incidence of serious maternal complications was 2.1% and 2.8%, respectively (risk ratio, 0.75; 95% CI, 0.45 to 1.26), and the incidence of severe neonatal complications was 2.0% and 2.6% (risk ratio, 0.77; 95% CI, 0.45 to 1.30). The incidence of any preeclampsia in the two groups was 24.4% and 31.1%, respectively (risk ratio, 0.79; 95% CI, 0.69 to 0.89), and the incidence of preterm birth was 27.5% and 31.4% (risk ratio, 0.87; 95% CI, 0.77 to 0.99).ConclusionsIn pregnant women with mild chronic hypertension, a strategy of targeting a blood pressure of less than 140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension, with no increase in the risk of small-for-gestational-age birth weight. (Funded by the National Heart, Lung, and Blood Institute; CHAP ClinicalTrials.gov number, .)	[Tita, A. T.; Andrews, W. W.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35249 USA; [Tita, A. T.; Szychowski, J. M.; Ambalavanan, N.; Oparil, S.; Cutter, G. R.; Andrews, W. W.] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL 35249 USA; [Szychowski, J. M.; Cutter, G. R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35249 USA; [Ambalavanan, N.] Univ Alabama Birmingham, Div Neonatol, Dept Pediat, Birmingham, AL 35249 USA; [Oparil, S.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35249 USA; [Boggess, K.] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hughes, B. L.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Dugoff, L.] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Plante, L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Bell, J.] St Lukes Univ Hlth Network, Fountain Hill, PA USA; [Simhan, H. N.] Univ Pittsburgh, Magee Womens Hosp, Dept Obstet & Gynecol, Pittsburgh, PA 15213 USA; [Sibai, B.] Univ Texas Houston, Dept Obstet & Gynecol, Houston, TX USA; [Aagaard, K.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, K.] Texas Childrens Hosp, Houston, TX 77030 USA; [Casey, B.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX USA; [Saade, G. R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Harper, L.] Univ Texas Austin, Dept Womens Hlth, Austin, TX 78712 USA; [Lawrence, K.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [August, P.] Weill Cornell Univ, New York, NY USA; [Skupski, D.] New York Presbyterian Queens Hosp, Dept Obstet & Gynecol, New York, NY USA; [Kinzler, W.] Winthrop Univ Hosp, Dept Obstet & Gynecol, Mineola, NY 11501 USA; [Edwards, R. K.] Univ Oklahoma Hlth Sci, Dept Obstet & Gynecol, Oklahoma City, OK USA; [Gibson, K.] MetroHlth Syst, Cleveland, OH USA; [Haas, D. M.] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46204 USA; [Metz, T.] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Esplin, S.] Intermt Healthcare, Salt Lake City, UT USA; [Longo, S.] Ochsner Baptist Med Ctr, New Orleans, LA USA; [Hoffman, M.] Christiana Care Hlth Syst, Newark, DE USA; [Hoppe, K. K.] UnityPoint Hlth Meriter Hosp, Marshfield Clin, Dept Obstet & Gynecol, Madison, WI USA; [Palatnik, A.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Foroutan, J.] St Peters Univ Hosp, New Brunswick, NJ USA; [Rosen, T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA; [Tuuli, M.] Washington Univ, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Owens, M. Y.] Univ Mississippi, Med Ctr, Dept Obstet & Gynecol, Jackson, MS 39216 USA; [Frey, H.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Baker, S.] Univ S Alabama, Dept Obstet & Gynecol, Mobile, AL USA; [Reddy, U. M.] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA; [Su, E.] Univ Colorado, Dept Obstet & Gynecol, Boulder, CO 80309 USA; [Nguyen, N.] Denver Hlth, Dept Obstet & Gynecol, Denver, CO USA; [Krishna, I] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA 30322 USA; [Norton, M. E.] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Norton, M. E.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [El-Sayed, Y. Y.] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Ogunyemi, D.] Arrowhead Reg Med Ctr, Dept Obstet & Gynecol, Colton, CA USA; [Ogunyemi, D.] Beaumont Hosp, Southfield, MI USA; [Galis, Z. S.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Geller, N. L.] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; University of Pennsylvania; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Austin; Columbia University; Cornell University; Winthrop University Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; MetroHealth System; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Ochsner Health System; Christiana Care Health System; Marshfield Clinic; Medical College of Wisconsin; Saint Peter's University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL); University of Mississippi; University of Mississippi Medical Center; University System of Ohio; Ohio State University; University of South Alabama; Yale University; University of Colorado System; University of Colorado Boulder; Denver Health Medical Center; Emory University; University of California System; University of California San Francisco; Stanford University; Beaumont Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tita, AT (corresponding author), Univ Alabama Birmingham, Marnix E Heersink Sch Med, Ctr Womens Reprod Hlth, Dept Obstet & Gynecol, 619 19th St S, Birmingham, AL 35249 USA.	atita@uab.edu		Foroutan, Janelle/0000-0002-4758-0028; Hughes, Brenna/0000-0001-8950-1204				Abalos E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub4; American College of Obstetricians and Gynecologists' Committee on Practice BulletinsObstetrics, 2019, Obstet Gynecol, V133, pe26, DOI 10.1097/AOG.0000000000003020; Ananth CV, 2019, HYPERTENSION, V74, P1089, DOI 10.1161/HYPERTENSIONAHA.119.12968; Ankumah NA, 2014, OBSTET GYNECOL, V123, P966, DOI 10.1097/AOG.0000000000000205; [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be; Bateman BT, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2012.02.039, 10.1016/j.ajog.2011.07.030, 10.1016/j.ajog.2011.10.878]; Blackwell S, 2015, AM J OBSTET GYNECOL, V213, P3, DOI 10.1016/j.ajog.2015.04.013; Duryea EL, 2014, OBSTET GYNECOL, V124, P16, DOI 10.1097/AOG.0000000000000345; Garovic VD, 2022, HYPERTENSION, V79, pE21, DOI 10.1161/HYP.0000000000000208; Grover S, 2022, BJOG-INT J OBSTET GY, V129, P572, DOI 10.1111/1471-0528.16932; Hardy ST, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002276; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; Magee LA, 2000, EUR J OBSTET GYN R B, V88, P15, DOI 10.1016/S0301-2115(99)00113-X; Magee LA, 2015, NEW ENGL J MED, V372, P407, DOI 10.1056/NEJMoa1404595; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P960, DOI 10.1016/0002-9378(90)91297-P; Sinkey RG, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01082-w; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Thomopoulos C, 2014, J HYPERTENS, V32, P2285, DOI 10.1097/HJH.0000000000000378; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006	22	39	39	9	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMoa2201295	http://dx.doi.org/10.1056/NEJMoa2201295		APR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1T5ED	35363951	Green Accepted			2022-12-28	WOS:000804750700001
J	Altemose, N; Logsdon, GA; Bzikadze, AV; Sidhwani, P; Langley, SA; Caldas, GV; Hoyt, SJ; Uralsky, L; Ryabov, FD; Shew, CJ; Sauria, MEG; Borchers, M; Gershman, A; Mikheenko, A; Shepelev, VA; Dvorkina, T; Kunyavskaya, O; Vollger, MR; Rhie, A; McCartney, AM; Asri, M; Lorig-Roach, R; Shafin, K; Lucas, JK; Aganezov, S; Olson, D; de Lima, LG; Potapova, T; Hartley, GA; Haukness, M; Kerpedjiev, P; Gusev, F; Tigyi, K; Brooks, S; Young, A; Nurk, S; Koren, S; Salama, SR; Paten, B; Rogaev, EI; Streets, A; Karpen, GH; Dernburg, AF; Sullivan, BA; Straight, AF; Wheeler, TJ; Gerton, JL; Eichler, EE; Phillippy, AM; Timp, W; Dennis, MY; O'Neill, RJ; Zook, JM; Schatz, MC; Pevzner, PA; Diekhans, M; Langley, CH; Alexandrov, IA; Miga, KH				Altemose, Nicolas; Logsdon, Glennis A.; Bzikadze, Andrey, V; Sidhwani, Pragya; Langley, Sasha A.; Caldas, Gina, V; Hoyt, Savannah J.; Uralsky, Lev; Ryabov, Fedor D.; Shew, Colin J.; Sauria, Michael E. G.; Borchers, Matthew; Gershman, Ariel; Mikheenko, Alla; Shepelev, Valery A.; Dvorkina, Tatiana; Kunyavskaya, Olga; Vollger, Mitchell R.; Rhie, Arang; McCartney, Ann M.; Asri, Mobin; Lorig-Roach, Ryan; Shafin, Kishwar; Lucas, Julian K.; Aganezov, Sergey; Olson, Daniel; de Lima, Leonardo Gomes; Potapova, Tamara; Hartley, Gabrielle A.; Haukness, Marina; Kerpedjiev, Peter; Gusev, Fedor; Tigyi, Kristof; Brooks, Shelise; Young, Alice; Nurk, Sergey; Koren, Sergey; Salama, Sofie R.; Paten, Benedict; Rogaev, Evgeny, I; Streets, Aaron; Karpen, Gary H.; Dernburg, Abby F.; Sullivan, Beth A.; Straight, Aaron F.; Wheeler, Travis J.; Gerton, Jennifer L.; Eichler, Evan E.; Phillippy, Adam M.; Timp, Winston; Dennis, Megan Y.; O'Neill, Rachel J.; Zook, Justin M.; Schatz, Michael C.; Pevzner, Pavel A.; Diekhans, Mark; Langley, Charles H.; Alexandrov, Ivan A.; Miga, Karen H.			Complete genomic and epigenetic maps of human centromeres	SCIENCE			English	Article							TANDEMLY REPEATED DNA; ALPHA-SATELLITE DNA; HIGHER-ORDER REPEATS; CENP-A NUCLEOSOMES; HUMAN X-CHROMOSOME; SEQUENCE VARIATION; MEIOTIC DRIVE; ARRAY SIZE; ORGANIZATION; EVOLUTION	Existing human genome assemblies have almost entirely excluded repetitive sequences within and near centromeres, limiting our understanding of their organization, evolution, and functions, which include facilitating proper chromosome segregation. Now, a complete, telomere-to-telomere human genome assembly (T2T-CHM13) has enabled us to comprehensively characterize pericentromeric and centromeric repeats, which constitute 6.2% of the genome (189.9 megabases). Detailed maps of these regions revealed multimegabase structural rearrangements, including in active centromeric repeat arrays. Analysis of centromere-associated sequences uncovered a strong relationship between the position of the centromere and the evolution of the surrounding DNA through layered repeat expansions. Furthermore, comparisons of chromosome X centromeres across a diverse panel of individuals illuminated high degrees of structural, epigenetic, and sequence variation in these complex and rapidly evolving regions.	[Altemose, Nicolas; Langley, Sasha A.; Caldas, Gina, V; Karpen, Gary H.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Logsdon, Glennis A.; Vollger, Mitchell R.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Bzikadze, Andrey, V] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Sidhwani, Pragya; Straight, Aaron F.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Hoyt, Savannah J.; Hartley, Gabrielle A.; O'Neill, Rachel J.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA; [Hoyt, Savannah J.; Hartley, Gabrielle A.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Uralsky, Lev; Rogaev, Evgeny, I] Sirius Univ Sci & Technol, Soci, Russia; [Uralsky, Lev; Shepelev, Valery A.; Gusev, Fedor; Rogaev, Evgeny, I; Alexandrov, Ivan A.] Vavilov Inst Gen Genet, Moscow, Russia; [Ryabov, Fedor D.] Moscow Polytech Univ, Moscow, Russia; [Shew, Colin J.; Dennis, Megan Y.] Univ Calif Davis, Sch Med, Genome Ctr, MIND Inst, Davis, CA 95616 USA; [Shew, Colin J.; Dennis, Megan Y.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Sauria, Michael E. G.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Borchers, Matthew; de Lima, Leonardo Gomes; Potapova, Tamara; Gerton, Jennifer L.] Stowers Inst Med Res, Kansas City, MO USA; [Gershman, Ariel; Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA; [Mikheenko, Alla; Dvorkina, Tatiana; Kunyavskaya, Olga; Alexandrov, Ivan A.] St Petersburg State Univ, Inst Translat Biomed, Ctr Algorithm Biotechnol, St Petersburg, Russia; [Rhie, Arang; McCartney, Ann M.; Nurk, Sergey; Koren, Sergey; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Asri, Mobin; Lorig-Roach, Ryan; Shafin, Kishwar; Lucas, Julian K.; Haukness, Marina; Tigyi, Kristof; Salama, Sofie R.; Paten, Benedict; Diekhans, Mark; Miga, Karen H.] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Aganezov, Sergey; Schatz, Michael C.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Olson, Daniel; Wheeler, Travis J.] Univ Montana, Dept Comp Sci, Missoula, MT USA; [Kerpedjiev, Peter] Reservoir Genom, Oakland, CA USA; [Tigyi, Kristof; Salama, Sofie R.; Dernburg, Abby F.; Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Brooks, Shelise; Young, Alice] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Paten, Benedict; Miga, Karen H.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Rogaev, Evgeny, I] Univ Massachusetts Med Sch, Dept Psychiat, Worcester, MA USA; [Rogaev, Evgeny, I] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Streets, Aaron] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Streets, Aaron] Chan Zuckerberg Biohub, San Francisco, CA USA; [Karpen, Gary H.] Lawrence Berkeley Natl Lab, Bioengn & BioMed Sci Dept, Berkeley, CA USA; [Dernburg, Abby F.] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Sullivan, Beth A.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA; [Gerton, Jennifer L.] Univ Kansas, Univ Kansas Med Sch, Dept Biochem & Mol Biol, Kansas City, KS USA; [Gerton, Jennifer L.] Univ Kansas, Canc Ctr, Kansas City, KS USA; [Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Zook, Justin M.] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA; [Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA USA; [Langley, Charles H.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Alexandrov, Ivan A.] Russian Acad Sci, Res Ctr Biotechnol, Moscow, Russia	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Stanford University; University of Connecticut; University of Connecticut; Russian Academy of Sciences; Vavilov Institute of General Genetics; Moscow Polytechnic University; University of California System; University of California Davis; University of California System; University of California Davis; Johns Hopkins University; Stowers Institute for Medical Research; Johns Hopkins University; Saint Petersburg State University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; Johns Hopkins University; University of Montana System; University of Montana; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; University of Massachusetts System; University of Massachusetts Worcester; Lomonosov Moscow State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Duke University; University of Kansas; University of Kansas Medical Center; University of Kansas; Johns Hopkins University; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California San Diego; University of California System; University of California Davis; Research Center of Biotechnology RAS; Russian Academy of Sciences	Alexandrov, IA (corresponding author), Vavilov Inst Gen Genet, Moscow, Russia.; Alexandrov, IA (corresponding author), St Petersburg State Univ, Inst Translat Biomed, Ctr Algorithm Biotechnol, St Petersburg, Russia.; Miga, KH (corresponding author), Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA.; Miga, KH (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.; Alexandrov, IA (corresponding author), Russian Acad Sci, Res Ctr Biotechnol, Moscow, Russia.	ivanalx@hotmail.com; khmiga@ucsc.edu	Altemose, Nicolas/EIR-2712-2022; Phillippy, Adam/U-5731-2018	Altemose, Nicolas/0000-0002-7231-6026; Vollger, Mitchell/0000-0002-8651-1615; Ryabov, Fedor/0000-0001-8728-9465; Wheeler, Travis/0000-0003-2004-1785; Sidhwani, Pragya/0000-0002-5292-6740; Hartley, Gabrielle/0000-0002-5672-2171; Phillippy, Adam/0000-0003-2983-8934	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; National Institute of Standards and Technology; HHMI Hanna H. Gray Fellowship; Damon Runyon Postdoctoral Fellowship; Pew Latin American Fellowship; US National Institutes of Health [NIH/NIGMS F32 GM134558, NIH/NHGRI R01 GM074728, NIH R01GM123312-02, NIH R21CA240199, NIH/NIGMS R01GM132600, P20GM103546, NIH/NHGRI U24HG010136, NIH/NHGRI R01HG010329, NIH/NHGRI R01HG010485, U41HG010972]; National Science Foundation [NSF 1613806, NSF 1643825, NSF DBI-1627442, NSF IOS-1732253, NSF IOS-1758800]; Mark Foundation for Cancer Research [19-033ASP]; Russian Science Foundation [RSF 19-75-30039]; St. Petersburg State University [PURE 73023573, PURE 51555639]; Sirius University; Ministry of Science and Higher Education of the Russian Federation [075-10-2020-116 (13.1902.21.0023)]; Connecticut Innovations; Stowers Institute for Medical Research; The US National Institutes of Health [NIH R01GM124041, R01GM129263, R21CA238758, NIH/NHGRI R01HG010169, U01HG010971, NIH/NHGRI R21HG010548-01, R01GM117420]; A US National Institutes of Health [U01HG010961, U24HG011853, OT2OD026682, NIH/GM R35GM139653, NIH R01AG054712, NIH/OD/NIMH DP2MH119424, NIH/NHGRI U24HG010263, NHGRI U24HG006620, NCI U01CA253481, NIDDK R24DK106766-01A1, NIH/NHGRI U41HG007234, NIH/NHGRI R01HG011274-01]	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); HHMI Hanna H. Gray Fellowship; Damon Runyon Postdoctoral Fellowship; Pew Latin American Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mark Foundation for Cancer Research; Russian Science Foundation(Russian Science Foundation (RSF)); St. Petersburg State University; Sirius University; Ministry of Science and Higher Education of the Russian Federation; Connecticut Innovations; Stowers Institute for Medical Research; The US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	. This work was supported, in part, by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (S.N., S.K., A.R., A.M.M., S.B., A.Y., and A.M.P.), the Intramural funding at the National Institute of Standards and Technology (J.M.Z.), HHMI Hanna H. Gray Fellowship (N.A.), Damon Runyon Postdoctoral Fellowship, and Pew Latin American Fellowship (G.V.C.). Grants supporting this work are from the US National Institutes of Health (NIH/NIGMS F32 GM134558 to G.A.L.; NIH/NHGRI R01 GM074728 to P.S. and A.F.S.; NIH R01GM123312-02 to S.J.H., G.A.H., and R.J.O.; NIH R21CA240199 to R.J.O.; NIH/NHGRI F31HG011205 to C.J.S.; NIH/NHGRI R01HG009190 to A.G. and W.T.; NIH/NHGRI R01HG010485, U41HG010972, and U01HG010961 to K.S.; NIH/NIGMS R01GM132600, P20GM103546, and NIH/NHGRI U24HG010136 to D.O. and T.J.W.; NIH/NHGRI R01HG010329 to S.R.S.; NIH/NHGRI R01HG010485, U41HG010972, U01HG010961, U24HG011853, and OT2OD026682 to B. P.; NIH R01AG054712 to E.I.R.; NIH/GM R35GM139653 and R01GM117420 to G.H.K.; NIH R01GM124041, R01GM129263, and R21CA238758 to B.A.S.; NIH/NHGRI R01HG010169 and U01HG010971 to E.E.E.; NIH/OD/NIMH DP2MH119424 to M.Y.D.; NIH/NHGRI U24HG010263; NHGRI U24HG006620; NCI U01CA253481; NIDDK R24DK106766-01A1 to M.C.S.; NIH/NHGRI U41HG007234 to M.D.; NIH/NHGRI R01HG011274-01 and NIH/NHGRI R21HG010548-01 to K.H.M.), National Science Foundation (NSF 1613806 to S.J.H., G.A.H., and R.J.O.; NSF 1643825 to R.J.O.; NSF DBI-1627442, NSF IOS-1732253, and NSF IOS-1758800 to M.C.S.); Mark Foundation for Cancer Research to SA and MCS (19-033ASP); Russian Science Foundation RSF 19-75-30039 (analysis of genomic repeats) (I.A.A.); St. Petersburg State University (grant ID PURE 73023573 to A.M., T.D., and I.A.A. and grant ID PURE 51555639 to O.K.); Supported by the Sirius University (L.U.); Ministry of Science and Higher Education of the Russian Federation [075-10-2020-116 (13.1902.21.0023)] (F.G.); Connecticut Innovations to R.J.O.; and Stowers Institute for Medical Research to J.L.G.; A.S. is a Chan Zuckerberg Biohub Investigator. E.E.E. and A.F.D. are investigators of the Howard Hughes Medical Institute.	Aganezov S., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.07.12.452063, DOI 10.1101/2021.07.12.452063]; Aganezov S, 2022, SCIENCE, V376, P54, DOI 10.1126/science.abl3533; AGRESTI A, 1989, J MOL BIOL, V205, P625, DOI 10.1016/0022-2836(89)90308-2; Aldrup-MacDonald ME, 2016, GENOME RES, V26, P1301, DOI 10.1101/gr.206706.116; Alexandrov I, 2001, CHROMOSOMA, V110, P253, DOI 10.1007/s004120100146; ALEXANDROV IA, 1988, CHROMOSOMA, V96, P443, DOI 10.1007/BF00303039; Alkan C, 2007, PLOS COMPUT BIOL, V3, P1807, DOI 10.1371/journal.pcbi.0030181; Altemose N., 2022, CLASSICAL REVIVAL HU, DOI [10.20944/preprints202202.0009.v1, DOI 10.20944/PREPRINTS202202.0009.V1]; Altemose N., 2021, DIMELO SEQ LONG READ, DOI [DOI 10.1038/NMETH.4035, 10.1101/2021.07.06.451383, DOI 10.1101/2021.07.06.451383]; Altemose N., 2021, altemose/NTRprism: NTRprism-v1.0.0. Zenodo, DOI 10.5281/zenodo.5715473; Altemose N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003628; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Babcock M, 2007, GENOME RES, V17, P451, DOI 10.1101/gr.5651507; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P223, DOI 10.1023/A:1016648404388; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Black EM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120615; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Byrska-Bishop M., HIGH COVERAGE WHOLE, DOI [10.1101/2021.02.06.430068, DOI 10.1101/2021.02.06.430068, 10.1101/ 2021.02.06.430068]; Bzikadze AV, 2020, NAT BIOTECHNOL, V38, P1309, DOI 10.1038/s41587-020-0582-4; Capozzi O, 2009, GENOME RES, V19, P778, DOI 10.1101/gr.085688.108; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cheng HY, 2021, NAT METHODS, V18, P170, DOI 10.1038/s41592-020-01056-5; Chmatal L, 2014, CURR BIOL, V24, P2295, DOI 10.1016/j.cub.2014.08.017; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; CRAIGHOLMES AP, 1971, SCIENCE, V174, P702, DOI 10.1126/science.174.4010.702; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Dubois ML, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15090-6; Dumont M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102924; DURFY SJ, 1989, GENOMICS, V5, P810, DOI 10.1016/0888-7543(89)90123-7; Dvorkina T, 2021, BIOINFORMATICS, V37, pI196, DOI 10.1093/bioinformatics/btab265; Dvorkina T, 2020, BIOINFORMATICS, V36, P93, DOI 10.1093/bioinformatics/btaa454; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fishman L, 2015, EVOLUTION, V69, P1208, DOI 10.1111/evo.12661; FROMMER M, 1984, NUCLEIC ACIDS RES, V12, P2887, DOI 10.1093/nar/12.6.2887; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gershman A, 2022, SCIENCE, V376, P58, DOI 10.1126/science.abj5089; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Henikoff JG, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400234; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hoyt SJ, 2022, SCIENCE, V376, P57, DOI 10.1126/science.abk3112; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; JACKSON MS, 1993, NUCLEIC ACIDS RES, V21, P5865, DOI 10.1093/nar/21.25.5865; Jain C, 2020, BIOINFORMATICS, V36, P111, DOI 10.1093/bioinformatics/btaa435; Jain M, 2018, NAT BIOTECHNOL, V36, P321, DOI 10.1038/nbt.4109; JEANPIERRE M, 1985, HUM GENET, V70, P302, DOI 10.1007/BF00295365; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kazakov AE, 2003, GENOMICS, V82, P619, DOI 10.1016/S0888-7543(03)00182-4; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kokot M, 2017, BIOINFORMATICS, V33, P2759, DOI 10.1093/bioinformatics/btx304; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kunyavskaya O., 2021, HORMON AUTOMATED ANN, DOI [10.1101/2021.10.12.464028, DOI 10.1101/2021.10.12.464028]; Kursel LE, 2018, CURR OPIN CELL BIOL, V52, P58, DOI 10.1016/j.ceb.2018.01.011; Langley SA, 2019, ELIFE, V8, DOI 10.7554/eLife.42989; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; LEE C, 1995, CHROMOSOMA, V104, P103, DOI 10.1007/BF00347692; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H.-D., 2018, GTFTOOLS PYTHON PACK, DOI [10.1101/263517, DOI 10.1101/263517, 10.1101/263517.]; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIN CC, 1993, CHROMOSOMA, V102, P333, DOI 10.1007/BF00661276; Lo AWI, 1999, GENOME RES, V9, P895, DOI 10.1101/gr.9.10.895; Logsdon GA, 2021, NATURE, V593, P101, DOI 10.1038/s41586-021-03420-7; Lucas J., 2021, Zenodo, DOI 10.5281/zenodo.5715444; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; Maloney KA, 2012, P NATL ACAD SCI USA, V109, P13704, DOI 10.1073/pnas.1203126109; MANUELIDIS L, 1976, NUCLEIC ACIDS RES, V3, P3063, DOI 10.1093/nar/3.11.3063; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McCartney A. M., 2021, CHASING PERFECTION V, DOI [10.1101/2021.07.02.450803, DOI 10.1101/2021.07.02.450803]; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; McNulty SM, 2018, CHROMOSOME RES, V26, P115, DOI 10.1007/s10577-018-9582-3; MENEVERI R, 1993, GENE, V123, P227, DOI 10.1016/0378-1119(93)90128-P; METZDORF R, 1988, CHROMOSOMA, V97, P154, DOI 10.1007/BF00327372; Miga KH, 2021, ANNU REV GENET, V55, P583, DOI 10.1146/annurev-genet-071719-020519; Miga KH, 2021, ANNU REV GENOM HUM G, V22, P81, DOI 10.1146/annurev-genom-120120-081921; Miga KH, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112127; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Miga KH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050352; Miga KH, 2015, CHROMOSOME RES, V23, P421, DOI 10.1007/s10577-015-9488-2; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Mikheenko A, 2020, BIOINFORMATICS, V36, P75, DOI 10.1093/bioinformatics/btaa440; MUSICH PR, 1980, CHROMOSOMA, V80, P331, DOI 10.1007/BF00292688; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Naish M, 2021, SCIENCE, V374, P840, DOI 10.1126/science.abi7489; Nambiar M, 2016, SEMIN CELL DEV BIOL, V54, P188, DOI [10.1016/j.semsdb.2016.01.042, 10.1016/j.semcdb.2016.01.042]; Nechemia-Arbely Y, 2019, NAT CELL BIOL, V21, P743, DOI 10.1038/s41556-019-0331-4; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng BL, 2006, CYTOM PART A, V69A, P1028, DOI 10.1002/cyto.a.20330; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; Olson D, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P37, DOI 10.1145/3233547.3233604; Paar V, 2007, CURR GENOMICS, V8, P93, DOI 10.2174/138920207780368169; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Rice W. R, 2019, A GAME THRONES HUMAN, DOI [10.1101/731471, DOI 10.1101/731471]; Rosandic M, 2006, CHROMOSOME RES, V14, P735, DOI 10.1007/s10577-006-1078-x; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sevim V, 2016, BIOINFORMATICS, V32, P1921, DOI 10.1093/bioinformatics/btw101; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shepelev VA, 2015, GENOM DATA, V5, P139, DOI 10.1016/j.gdata.2015.05.035; Shepelev VA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000641; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Smit A, 1996, REPEATMASKER OPEN 30; Smith OK, 2021, GENOME RES, V31, P958, DOI 10.1101/gr.267781.120; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan LL, 2011, CHROMOSOME RES, V19, P457, DOI 10.1007/s10577-011-9208-5; Sun P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku201; Suzuki Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd9230; TAGARRO I, 1994, HUM GENET, V93, P383; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakur J, 2018, GENE DEV, V32, P20, DOI 10.1101/gad.307736.117; Thakur J, 2016, GENOME RES, V26, P1178, DOI 10.1101/gr.204784.116; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; TYLERSMITH C, 1987, DEVELOPMENT, V101, P93; Uralsky L., 2022, FigShare, DOI 10.6084/m9. figshare.19299857.v1; Uralsky LI, 2019, DATA BRIEF, V24, DOI 10.1016/j.dib.2019.103708; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Vollger M. R., 2022, SCIENCE, V376; Vollger MR, 2022, BIOINFORMATICS, V38, P2049, DOI 10.1093/bioinformatics/btac018; Warburton P E, 1992, Methods Mol Biol, V12, P299, DOI 10.1385/0-89603-229-9:299; Warburton PE, 1995, J MOL EVOL, V41, P1006; WARBURTON PE, 1990, J MOL BIOL, V216, P3, DOI 10.1016/S0022-2836(05)80056-7; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WAYE JS, 1985, NUCLEIC ACIDS RES, V13, P2731, DOI 10.1093/nar/13.8.2731; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; WILLARD HF, 1985, AM J HUM GENET, V37, P524; WILLARD HF, 1989, GENOME, V31, P737, DOI 10.1139/g89-132; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILLARD HF, 1987, J MOL EVOL, V25, P207, DOI 10.1007/BF02100014; WU JC, 1980, J MOL BIOL, V142, P363, DOI 10.1016/0022-2836(80)90277-6; Ziccardi W, 2016, CHROMOSOME RES, V24, P421, DOI 10.1007/s10577-016-9530-z	155	33	33	23	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		56	+	eabl4178	10.1126/science.abl4178	http://dx.doi.org/10.1126/science.abl4178			167	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357911	Green Submitted, Green Accepted			2022-12-28	WOS:000780195200024
J	Zahn, LM				Zahn, Laura M.			FILLING THE GAPS	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		43	43						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357909				2022-12-28	WOS:000780195200020
J	Iacobucci, G				Iacobucci, Gareth			Seven days in medicine: 23-29 March 2022	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ANA Enterprise,, 2022, COR COVID 19 INF SUR; Heinrich M, 2022, NAT MED, V28, P852, DOI 10.1038/s41591-022-01745-y; Kojima R, 2022, OCCUP ENVIRON MED, V79, P521, DOI 10.1136/oemed-2021-108034; Leite FHM, 2022, BMJ GLOB HEALTH, V7, DOI 10.1136/bmjgh-2021-008269; Majeed H, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-056806	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o820	10.1136/bmj.o820	http://dx.doi.org/10.1136/bmj.o820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361615				2022-12-28	WOS:000779990000007
J	Ruiz-Barrio, I; Guisado-Alonso, D; Bulnes-Gonzalez, V; Green, BT				Ruiz-Barrio, Inigo; Guisado-Alonso, Daniel; Bulnes-Gonzalez, Victoria; Green, Benedict T.			Isolated dilated pupil	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ruiz-Barrio, Inigo; Guisado-Alonso, Daniel] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain; [Bulnes-Gonzalez, Victoria] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Ophthalmol, Barcelona, Spain; [Green, Benedict T.] USA Poisonous Plant Res Lab, Dept Pharmacol, Logan, UT USA	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Guisado-Alonso, D (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain.	dguisado@santpau.cat		Ruiz Barrio, Inigo/0000-0002-2015-5857					0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								e069133	10.1136/bmj-2021-069133	http://dx.doi.org/10.1136/bmj-2021-069133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361677				2022-12-28	WOS:000779990000016
J	Ahsan, S				Ahsan, Saleyha			Seeking accountablity for Ukraine health-care attacks	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1215	1216						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339215				2022-12-28	WOS:000779495000010
J	Goumeniouk, N; Lang, E				Goumeniouk, Natasha; Lang, Eddy			In suspected PE, YEARS rule plus D-dimer was noninferior to D-dimer alone to rule out PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Goumeniouk, Natasha; Lang, Eddy] Univ Calgary, Calgary, AB, Canada	University of Calgary	Goumeniouk, N (corresponding author), Univ Calgary, Calgary, AB, Canada.							Levi M, 2021, JAMA-J AM MED ASSOC, V326, P2135, DOI 10.1001/jama.2021.19282	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC43	JC43		10.7326/J22-0013	http://dx.doi.org/10.7326/J22-0013		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377723				2022-12-28	WOS:000799170800008
J	Okereke, OI; Mischoulon, D; Manson, JE				Okereke, Olivia, I; Mischoulon, David; Manson, JoAnn E.			Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Okereke, Olivia, I; Mischoulon, David] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Okereke, OI (corresponding author), Massachusetts Gen Hosp, One Bowdoin Sq,Seventh Floor, Boston, MA 02114 USA.	olivia.okereke@mgh.harvard.edu						Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Okereke OI, 2021, JAMA-J AM MED ASSOC, V326, P2385, DOI 10.1001/jama.2021.21187; Okereke OI, 2020, JAMA-J AM MED ASSOC, V324, P471, DOI 10.1001/jama.2020.10224; Zenebe Y, 2021, ANN GEN PSYCHIATR, V20, DOI 10.1186/s12991-021-00375-x	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1292	1292						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380585				2022-12-28	WOS:000783965500037
J	Drew, L				Drew, Liam			Halting mother-to-baby transmission	NATURE			English	News Item						Diseases; Health care; Therapeutics; Developing world	HEPATITIS-B; INFANT TRANSMISSION; GLOBAL ELIMINATION; EFFICACY	The global effort to eliminate the disease depends heavily on blocking the most common mode of viral infection.										BEASLEY RP, 1983, HEPATOLOGY, V3, P135; Boucheron P, 2021, LANCET INFECT DIS, V21, P85, DOI 10.1016/S1473-3099(20)30593-4; Chen HL, 2015, HEPATOLOGY, V62, P375, DOI 10.1002/hep.27837; de Villiers MJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26475-6; Funk AL, 2021, LANCET INFECT DIS, V21, P70, DOI 10.1016/S1473-3099(20)30586-7; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Jourdain G, 2018, NEW ENGL J MED, V378, P911, DOI 10.1056/NEJMoa1708131; Lu FT, 2020, PEDIATR GASTROENTERO, V23, P311, DOI 10.5223/pghn.2020.23.4.311; Nayagam S, 2020, J VIRAL HEPATITIS, V27, P342, DOI 10.1111/jvh.13231; Nayagam S, 2016, LANCET INFECT DIS, V16, P1399, DOI 10.1016/S1473-3099(16)30204-3; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; WONG VCW, 1984, LANCET, V1, P921	13	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S50	S52		10.1038/d41586-022-00814-z	http://dx.doi.org/10.1038/d41586-022-00814-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354989	Bronze			2022-12-28	WOS:000776361600011
J	Potter, AL; Rosenstein, AL; Kiang, MV; Shah, SA; Gaissert, HA; Chang, DC; Fintelmann, FJ; Yang, CFJ				Potter, Alexandra L.; Rosenstein, Allison L.; Kiang, Mathew, V; Shah, Shivani A.; Gaissert, Henning A.; Chang, David C.; Fintelmann, Florian J.; Yang, Chi-Fu Jeffrey			Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE	OBJECTIVE To determine the effect of the introduction of low dose computed tomography screening in 2013 on lung cancer stage shift, survival, and disparities in the stage of lung cancer diagnosed in the United States. DESIGN Quasi-experimental study using Joinpoint modeling, multivariable ordinal logistic regression, and multivariable Cox proportional hazards modeling. SETTING US National Cancer Database and Surveillance Epidemiology End Results program database. PARTICIPANTS Patients aged 45-80 years diagnosed as having non small cell lung cancer (NSCLC) between 1 January 2010 and 31 December 2018. MAIN OUTCOME MEASURES Annual per cent change in percentage of stage I NSCLC diagnosed among patients aged 45-54 (ineligible for screening) and 55-80 (potentially eligible for screening), median all cause survival, and incidence of NSCLC; multivariable adjusted odds ratios for yearto-year changes in likelihood of having earlier stages of disease at diagnosis and multivariable adjusted hazard ratios for changes in hazard of death before versus after introduction of screening. RESULTS The percentage of stage I NSCLC diagnosed among patients aged 55-80 did not significantly increase from 2010 to 2013 (from 27.8% to 29.4%) and then increased at 3.9% (95% confidence interval 3.0% to 4.8%) per year from 2014 to 2018 (from 30.2% to 35.5%). In multivariable adjusted analysis, the increase in the odds per year of a patient having one lung cancer stage lower at diagnosis during the time period from 2014 to 2018 was 6.2% (multivariable adjusted odds ratio 1.062, 95% confidence interval 1.048 to 1.077; P(0.001) higher than the increase in the odds per year from 2010 to 2013. Similarly, the median all cause survival of patients aged 55-80 did not significantly increase from 2010 to 2013 (from 15.8 to 18.1 months), and then increased at 11.9% (8.9% to 15.0%) per year from 2014 to 2018 (from 19.7 to 28.2 months). In multivariable adjusted analysis, the hazard of death decreased significantly faster after 2014 compared with before 2014 (P(0.001). By 2018, stage I NSCLC was the predominant diagnosis among non-Hispanic white people and people living in the highest income or best educated regions. Non-white people and those living in lower income or less educated regions remained more likely to have stage IV disease at diagnosis. Increases in the detection of early stage disease in the US from 2014 to 2018 led to an estimated 10 100 averted deaths. CONCLUSIONS A recent stage shift toward stage I NSCLC coincides with improved survival and the introduction of lung cancer screening. Non-white patients and those living in areas of greater deprivation had lower rates of stage I disease identified, highlighting the need for efforts to increase access to screening in the US.	[Potter, Alexandra L.; Rosenstein, Allison L.; Shah, Shivani A.; Gaissert, Henning A.; Yang, Chi-Fu Jeffrey] Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA; [Kiang, Mathew, V] Dept Epidemiol & Populat Hlth, Stanford, CA USA; [Chang, David C.] Massachusetts Gen Hosp, Codman Ctr Clin Effectiveness Surg, Boston, MA 02114 USA; [Chang, David C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Fintelmann, Florian J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Yang, Chi-Fu Jeffrey] Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Yang, CFJ (corresponding author), Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA.	cjyang@mgh.harvard.edu	Yang, Chi-Fu/AFN-9841-2022	Kiang, Mathew/0000-0001-9198-150X				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aldrich MC, 2019, JAMA ONCOL, V5, P1318, DOI 10.1001/jamaoncol.2019.1402; American Academy of Family Physicians, 2013, CLIN PREV SERV REC L; American Academy of Family Physicians, 2021, AAFP UPD REC LUNG CA; American Lung Association, 2021, LUNG CANC KEY FIND; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Blumenthal D, 2015, NEW ENGL J MED, V372, P2451, DOI 10.1056/NEJMhpr1503614; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Centers for Disease Control and Prevention National Center for Health Statistics, NATL HLTH INTERVIEW; Chung JH, 2019, J AM COLL RADIOL, V16, P674, DOI 10.1016/j.jacr.2018.11.011; Cornelius ME, 2020, MMWR-MORBID MORTAL W, V69, P1736, DOI 10.15585/mmwr.mm6946a4; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Detterbeck FC, 2017, CHEST, V151, P193, DOI 10.1016/j.chest.2016.10.010; Flores R, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.37508; Fritz AG., 2000, INT CLASSIFICATION D, Vvii, P240; Ganti AK, 2021, JAMA ONCOL, V7, P1824, DOI 10.1001/jamaoncol.2021.4932; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Haddad DN, 2020, ANN AM THORAC SOC, V17, P399, DOI 10.1513/AnnalsATS.201907-556CME; Hovanec J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192999; Howlader N, 2020, NEW ENGL J MED, V383, P640, DOI 10.1056/NEJMoa1916623; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Jemal A, 2017, JAMA ONCOL, V3, P1278, DOI 10.1001/jamaoncol.2016.6416; Katki HA, 2020, JNCI-J NATL CANCER I, V112, P429, DOI 10.1093/jnci/djz165; Landy R, 2021, JNCI-J NATL CANCER I, V113, P1590, DOI 10.1093/jnci/djaa211; Mallin K, 2019, ANN SURG ONCOL, V26, P1604, DOI 10.1245/s10434-019-07213-1; Marrer E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3029-z; Mishra SI, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160093; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Potter AL, 2022, JAMA ONCOL, V8, P163, DOI 10.1001/jamaoncol.2021.5790; Randhawa S, 2018, AM SURGEON, V84, P1415; Ranscombe P, 2020, LANCET INFECT DIS, V20, P545, DOI 10.1016/S1473-3099(20)30301-7; Richards TB, 2019, AM J PREV MED, V56, P66, DOI 10.1016/j.amepre.2018.07.030; Tailor TD, 2019, J AM COLL RADIOL, V16, P15, DOI 10.1016/j.jacr.2018.07.007; Wang GX, 2019, RADIOLOGY, V290, P278, DOI 10.1148/radiol.2018180212	34	7	7	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								e069008	10.1136/bmj-2021-069008	http://dx.doi.org/10.1136/bmj-2021-069008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354556	hybrid, Green Published			2022-12-28	WOS:000779561800019
J	Baumer, EPS				Baumer, Eric P. S.			A House Between Earth and the Moon	SCIENCE			English	Book Review									[Baumer, Eric P. S.] Lehigh Univ, Dept Comp Sci & Engn, Bethlehem, PA 18015 USA	Lehigh University	Baumer, EPS (corresponding author), Lehigh Univ, Dept Comp Sci & Engn, Bethlehem, PA 18015 USA.	ericpsb@lehigh.edu						SCHERM R, 2022, HOUSE EARTH MOON	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1360	1360		10.1126/science.abo1738	http://dx.doi.org/10.1126/science.abo1738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324279				2022-12-28	WOS:000778894800027
J	de Waal, FBM; Andrews, K				de Waal, Frans B. M.; Andrews, Kristin			The question of animal emotions	SCIENCE			English	Editorial Material							WELFARE		[de Waal, Frans B. M.] Emory Univ, Psychol Dept, Atlanta, GA 30322 USA; [Andrews, Kristin] York Univ, Philosophy Dept, Toronto, ON, Canada	Emory University; York University - Canada	de Waal, FBM (corresponding author), Emory Univ, Psychol Dept, Atlanta, GA 30322 USA.	dewaal@emory.edu; andrewsk@yorku.ca						Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Ando H., 2021, HDB HORMONES COMP EN, V2; Andrews K., 2020, STUDY ANIMAL MINDS; Appel M, 2009, APPL ANIM BEHAV SCI, V119, P120, DOI 10.1016/j.applanim.2009.03.013; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Crump A., 2022, ANIMAL SENTIENCE, V32, DOI [https://doi.org/10.51291/2377-7478.1691, DOI 10.51291/2377-7478.1691]; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2017, NAT REV NEUROSCI, V18, P498, DOI 10.1038/nrn.2017.72; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Monso Susana, 2018, J Ethics, V22, P283, DOI 10.1007/s10892-018-9275-3; Rodkey EN, 2013, J PAIN, V14, P338, DOI 10.1016/j.jpain.2012.12.017; Webb CE, 2020, BIOESSAYS, V42, DOI 10.1002/bies.202000030	15	3	3	7	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1351	1352		10.1126/science.abo2378	http://dx.doi.org/10.1126/science.abo2378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324315				2022-12-28	WOS:000778894800022
J	Torjesen, I				Torjesen, Ingrid			NHS pensions: offer doctors same scheme as judges to keep them in the workforce, urges BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Moberly T, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1594	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o806	10.1136/bmj.o806	http://dx.doi.org/10.1136/bmj.o806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338042				2022-12-28	WOS:000778396700013
J	McMahon, DE; Thomas, C; Singh, R; Freeman, EE				McMahon, Devon E.; Thomas, Cristina; Singh, Rhea; Freeman, Esther E.			Nodules in a sporotrichoid (lymphangitic) distribution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MYCOBACTERIA; INFECTIONS		[McMahon, Devon E.; Thomas, Cristina; Freeman, Esther E.] Harvard Med Sch, Dept Dermatol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Singh, Rhea] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Virginia Commonwealth University	Freeman, EE (corresponding author), Harvard Med Sch, Dept Dermatol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	efreeman@mgh.harvard.edu						Castillo NE, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofz550; Barros MBD, 2011, CLIN MICROBIOL REV, V24, P633, DOI 10.1128/CMR.00007-11; Franco-Paredes C, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00069-18; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Henkle E, 2015, CLIN CHEST MED, V36, P91, DOI 10.1016/j.ccm.2014.11.002; Johnson MG, 2015, INFECTION, V43, P655, DOI 10.1007/s15010-015-0776-8; Keyal U, 2018, DISCOV MED, V25, P225; Rallis E, 2007, EXPERT OPIN PHARMACO, V8, P2965, DOI 10.1517/14656566.8.17.2965; Sia TY, 2016, CLIN INFECT DIS, V62, P590, DOI 10.1093/cid/civ937	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								e067649	10.1136/bmj-2021-067649	http://dx.doi.org/10.1136/bmj-2021-067649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331991				2022-12-28	WOS:000778460100022
J	Reiling, J				Reiling, Jennifer			A Remedy for Professional Unrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1190	1190		10.1001/jama.2021.16904	http://dx.doi.org/10.1001/jama.2021.16904			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315900				2022-12-28	WOS:000775589900039
J	Adhikari, EH; MacDonald, L; SoRelle, JA; Morse, J; Pruszynski, J; Spong, CY				Adhikari, Emily H.; MacDonald, Lorre; SoRelle, Jeffrey A.; Morse, Jessica; Pruszynski, Jessica; Spong, Catherine Y.			COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity AssociatedWith Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Adhikari, Emily H.; Pruszynski, Jessica; Spong, Catherine Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [MacDonald, Lorre] Parkland Hlth, Dallas, TX USA; [SoRelle, Jeffrey A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Morse, Jessica] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Adhikari, EH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	emily.adhikari@utsouthwestern.edu			American Heart Association; Doris Duke Charitable Foundation; Harry S. Moss Heart Trust; Once Upon a Time Foundation Next Generation Sequencing Lab; Centers for Disease Control and Prevention [NU50CK000501]	American Heart Association(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Harry S. Moss Heart Trust; Once Upon a Time Foundation Next Generation Sequencing Lab; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for investigator and statistical effort, infrastructure, and sequencing effort was provided by the American Heart Association, the Doris Duke Charitable Foundation, the Harry S. Moss Heart Trust, the Once Upon a Time Foundation Next Generation Sequencing Lab, and the Centers for Disease Control and Prevention (grant NU50CK000501).	Addetia A, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02226-20; Adhikari EH, 2022, AM J OBSTET GYNECOL, V226, P149, DOI 10.1016/j.ajog.2021.09.008; Gale Chris, 2021, Lancet Child Adolesc Health, V5, P113, DOI 10.1016/S2352-4642(20)30342-4; Hui KPY, 2022, NATURE, V603, P715, DOI 10.1038/s41586-022-04479-6; Iuliano AD, 2022, MMWR-MORBID MORTAL W, V71, P146, DOI [10.1101/2021.12.30.21268560v2, 10.15585/mmwr.mm7104e4]; Society for Maternal-Fetal Medicine, MAN CONS PREGN PAT C	6	13	14	10	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1500	1502		10.1001/jama.2022.4356	http://dx.doi.org/10.1001/jama.2022.4356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35325015	Bronze, Green Published			2022-12-28	WOS:000793035800034
J	Ferry, G				Ferry, Georgina			Gillian Hanson: UK innovator in intensive care medicine	LANCET			English	Editorial Material												mgf@georginaferry.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1295	1295						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35367000	Bronze, Green Published			2022-12-28	WOS:000812828300015
J	Centuori, SM; Bhattacharya, D				Centuori, Sara M.; Bhattacharya, Deepta			Locally produced autoantibodies in cancer	CELL			English	Editorial Material							B-CELLS; IMMUNOTHERAPY; SURVIVAL	The function and antigen-specificities of tumor-infiltrating B cells are mostly unknown. In a new study by Mazor et al., matrix metalloproteinase 14 (MMP14), a self-antigen that is overexpressed by ovarian cancers, is shown to drive B cell activation and autoantibody production in tertiary lymphoid structures (Mazor et al., 2022).	[Centuori, Sara M.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA; [Centuori, Sara M.; Bhattacharya, Deepta] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Centuori, Sara M.] Univ Arizona Canc Ctr, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Bhattacharya, D (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.	deeptab@arizona.edu			National Institutes of Health [R01AI099108, P30CA023074, UG1CA242596]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (R01AI099108 to D.B. and P30CA023074 and UG1CA242596 to S.M.C.)	Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Centuori SM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1404-z; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Mazor RD, 2022, CELL, V185, P1208, DOI 10.1016/j.cell.2022.02.012; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Sakata K, 2000, INT J ONCOL, V17, P673; Sato S, 2003, J INVEST DERMATOL, V120, P542, DOI 10.1046/j.1523-1747.2003.12097.x; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Wieland A, 2021, NATURE, V597, P274, DOI 10.1038/s41586-020-2931-3	10	0	0	5	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1110	1111		10.1016/j.cell.2022.03.006	http://dx.doi.org/10.1016/j.cell.2022.03.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J7WH	35364029				2022-12-28	WOS:000780311600003
J	Kamdar, S; Shin, S; Leishangthem, P; Francis, LF; Xu, XL; Cheng, X				Kamdar, Shashank; Shin, Seunghwan; Leishangthem, Premkumar; Francis, Lorraine F.; Xu, Xinliang; Cheng, Xiang			The colloidal nature of complex fluids enhances bacterial motility	NATURE			English	Article							MICROORGANISMS; TRAJECTORIES; LOCOMOTION; VISCOSITY; MOTION	The natural habitats of microorganisms in the human microbiome, ocean and soil ecosystems are full of colloids and macromolecules. Such environments exhibit non-Newtonian flow properties, drastically affecting the locomotion of microorganisms(1-5). Although the low-Reynolds-number hydrodynamics of swimming flagellated bacteria in simple Newtonian fluids has been well developed(6-9), our understanding of bacterial motility in complex non-Newtonian fluids is less mature(10,11). Even after six decades of research, fundamental questions about the nature and origin of bacterial motility enhancement in polymer solutions are still under debate(12-)(23). Here we show that flagellated bacteria in dilute colloidal suspensions display quantitatively similar motile behaviours to those in dilute polymer solutions, in particular a universal particle-size-dependent motility enhancement up to 80% accompanied by a strong suppression of bacterial wobbling(18)(,)(24). By virtue of the hard-sphere nature of colloids, whose size and volume fraction we vary across experiments, our results shed light on the long-standing controversy over bacterial motility enhancement in complex fluids and suggest that polymer dynamics may not be essential for capturing the phenomenon(12-)(23). A physical model that incorporates the colloidal nature of complex fluids quantitatively explains bacterial wobbling dynamics and mobility enhancement in both colloidal and polymeric fluids. Our findings contribute to the understanding of motile behaviours of bacteria in complex fluids, which are relevant for a wide range of microbiological processes' and for engineering bacterial swimming in complex environments(26,27).	[Kamdar, Shashank; Shin, Seunghwan; Francis, Lorraine F.; Cheng, Xiang] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA; [Leishangthem, Premkumar; Xu, Xinliang] Beijing ComputationalSci Res Ctr, CompLex Syst Div, Beijing, Peoples R China; [Xu, Xinliang] Beijing Normal Univ, Dept Phys, Beijing, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Beijing Normal University	Cheng, X (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.; Xu, XL (corresponding author), Beijing ComputationalSci Res Ctr, CompLex Syst Div, Beijing, Peoples R China.; Xu, XL (corresponding author), Beijing Normal Univ, Dept Phys, Beijing, Peoples R China.	xinliang@csrc.ac.cn; xcheng@umn.edu		Francis, Lorraine/0000-0003-2516-2957; Shin, Seunghwan/0000-0001-6581-1523; Kamdar, Shashank/0000-0003-2455-692X; Xu, Xinliang/0000-0003-4940-3612; Cheng, Xiang/0000-0002-2759-764X	IPRIME program of University of Minnesota; US National Science Foundation [CBET-1702352, 2028652]; National Natural Science Foundation of China [11974038, U1930402]; US National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) [ECCS-2025124]	IPRIME program of University of Minnesota; US National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI)	We thank P. Agrawal, S. Ghosh, Y. Kim, Z. Liu, R. Patel and G. Pradipta for help with experiments and data analysis and S. Guo, P. Kolliopoulos, E. Lauga, Y. Man and Z. Qu for fruitful discussions. We would also like to acknowledge the late Professor Howard Berg, who answered our questions on E. coli mutant strains. This research is supported by the IPRIME program of University of Minnesota, and by the US National Science Foundation CBET-1702352 and 2028652. X.X. acknowledges the financial support from National Natural Science Foundation of China no. 11974038 and no. U1930402. Portions of this work were conducted in the Minnesota Nano Center, which is supported by the US National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) under award number ECCS-2025124.	Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bechinger C, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.045006; Berg H. C., 2004, COLI MOTION; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Binagia JP, 2020, J FLUID MECH, V900, DOI 10.1017/jfm.2020.456; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Childress S., 1981, MECH SWIMMING FLYING; Cortese D, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.088003; Crenshaw HC, 1996, AM ZOOL, V36, P608; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Elfring GJ, 2015, BIOL MED PHYS BIOMED, P283, DOI 10.1007/978-1-4939-2065-5_8; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hyon Y, 2012, J FLUID MECH, V705, P58, DOI 10.1017/jfm.2012.217; JEFFREY DJ, 1984, J FLUID MECH, V139, P261, DOI 10.1017/S0022112084000355; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lauga E, 2016, ANNU REV FLUID MECH, V48, P105, DOI 10.1146/annurev-fluid-122414-034606; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Li GL, 2008, P NATL ACAD SCI USA, V105, P18355, DOI 10.1073/pnas.0807305105; Lodge T. P., 2007, POLYM CHEM-UK; Macosko C. W., 1994, RHEOLOGY PRINCIPLES; Magariyama Y, 2002, BIOPHYS J, V83, P733, DOI 10.1016/S0006-3495(02)75204-1; Man Y, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.023004; Martinez VA, 2014, P NATL ACAD SCI USA, V111, P17771, DOI 10.1073/pnas.1415460111; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Patteson AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15761; Patteson AE, 2016, CURR OPIN COLLOID IN, V21, P86, DOI 10.1016/j.cocis.2016.01.001; Peng Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd1240; Poon WCK, 2012, SOFT MATTER, V8, P21, DOI 10.1039/c1sm06083j; Qu ZJ, 2020, PHYS REV FLUIDS, V5, DOI 10.1103/PhysRevFluids.5.073103; Qu ZJ, 2018, P NATL ACAD SCI USA, V115, P1707, DOI 10.1073/pnas.1714187115; Rossi M, 2017, P NATL ACAD SCI USA, V114, P13085, DOI 10.1073/pnas.1708064114; SCHNEIDER WR, 1974, J BACTERIOL, V117, P696, DOI 10.1128/JB.117.2.696-701.1974; Shimogonya Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18488; SHOESMITH JG, 1960, J GEN MICROBIOL, V22, P528, DOI 10.1099/00221287-22-2-528; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; WELLS ML, 1991, NATURE, V353, P342, DOI 10.1038/353342a0; Zhang BK, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100145118; Zhang YC, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.023101; Zottl A, 2019, NAT PHYS, V15, P554, DOI 10.1038/s41567-019-0454-3	44	16	16	14	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					819	+		10.1038/s41586-022-04509-3	http://dx.doi.org/10.1038/s41586-022-04509-3			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35355005	Green Submitted			2022-12-28	WOS:000776361600026
J	Torjesen, I				Torjesen, Ingrid			"Demeaning" junior doctor title should be abandoned, report says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McNally S, 2022, WHAT SHOULD WE CALL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o854	10.1136/bmj.o854	http://dx.doi.org/10.1136/bmj.o854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361689				2022-12-28	WOS:000779990000003
J	Wang, W; Cai, JF				Wang, Wei; Cai, Jifu			Cholesterol Embolization Syndrome after Carotid-Artery Stenting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, Wei; Cai, Jifu] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China	University of Hong Kong	Cai, JF (corresponding author), Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China.	caijf@hku-szh.org		Cai, Ji-Fu/0000-0002-0717-6127					0	0	0	3	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1265	1265		10.1056/NEJMicm2114022	http://dx.doi.org/10.1056/NEJMicm2114022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353964				2022-12-28	WOS:000820666300010
J	Weiss, JM; Hunter, MV; Cruz, NM; Baggiolini, A; Tagore, M; Ma, YL; Misale, S; Marasco, M; Simon-Vermot, T; Campbell, NR; Newell, F; Wilmott, JS; Johansson, PA; Thompson, JF; Long, GV; Pearson, JV; Mann, GJ; Scolyer, RA; Waddell, N; Montal, ED; Huang, TH; Jonsson, P; Donoghue, MTA; Harris, CC; Taylor, BS; Xu, TH; Chaligne, R; Shliaha, PV; Hendrickson, R; Jungbluth, AA; Lezcano, C; Koche, R; Studer, L; Ariyan, CE; Solit, DB; Wolchok, JD; Merghoub, T; Rosen, N; Hayward, NK; White, RM				Weiss, Joshua M.; Hunter, Miranda, V; Cruz, Nelly M.; Baggiolini, Arianna; Tagore, Mohita; Ma, Yilun; Misale, Sandra; Marasco, Michelangelo; Simon-Vermot, Theresa; Campbell, Nathaniel R.; Newell, Felicity; Wilmott, James S.; Johansson, Peter A.; Thompson, John F.; Long, Georgina, V; Pearson, John, V; Mann, Graham J.; Scolyer, Richard A.; Waddell, Nicola; Montal, Emily D.; Huang, Ting-Hsiang; Jonsson, Philip; Donoghue, Mark T. A.; Harris, Christopher C.; Taylor, Barry S.; Xu, Tianhao; Chaligne, Ronan; Shliaha, Pavel, V; Hendrickson, Ronald; Jungbluth, Achim A.; Lezcano, Cecilia; Koche, Richard; Studer, Lorenz; Ariyan, Charlotte E.; Solit, David B.; Wolchok, Jedd D.; Merghoub, Taha; Rosen, Neal; Hayward, Nicholas K.; White, Richard M.			Anatomic position determines oncogenic specificity in melanoma	NATURE			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; SOMATIC GENOMIC LANDSCAPE; READ ALIGNMENT; CUTANEOUS MELANOMA; CANCER; FIN; CLASSIFICATION; PORTRAITS; PLATFORM; GENES	Oncogenic alterations to DNA are not transforming in all cellular contexts(1,2). This may be due to pre-existing transcriptional programmes in the cell of origin. Here we define anatomic position as a major determinant of why cells respond to specific oncogenes. Cutaneous melanoma arises throughout the body, whereas the acral subtype arises on the palms of the hands, soles of the feet or under the nails(3). We sequenced the DNA of cutaneous and acral melanomas from a large cohort of human patients and found a specific enrichment for BRAF mutations in cutaneous melanoma and enrichment for CRKL amplifications in acral melanoma. We modelled these changes in transgenic zebrafish models and found that CRKL-driven tumours formed predominantly in the fins of the fish. The fins are the evolutionary precursors to tetrapod limbs, indicating that melanocytes in these acral locations may be uniquely susceptible to CRKL. RNA profiling of these fin and limb melanocytes, when compared with body melanocytes, revealed a positional identity gene programme typified by posterior HOX13 genes. This positional gene programme synergized with CRKL to amplify insulin-like growth factor (IGF) signalling and drive tumours at acral sites. Abrogation of this CRKL-driven programme eliminated the anatomic specificity of acral melanoma. These data suggest that the anatomic position of the cell of origin endows it with a unique transcriptional state that makes it susceptible to only certain oncogenic insults.	[Weiss, Joshua M.; Ma, Yilun; Campbell, Nathaniel R.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Weiss, Joshua M.; Hunter, Miranda, V; Cruz, Nelly M.; Tagore, Mohita; Ma, Yilun; Simon-Vermot, Theresa; Campbell, Nathaniel R.; Montal, Emily D.; Huang, Ting-Hsiang; White, Richard M.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA; [Weiss, Joshua M.; Ma, Yilun] Weill Cornell Grad Sch Med Sci, Cell & Dev Biol Program, New York, NY USA; [Baggiolini, Arianna; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10021 USA; [Misale, Sandra; Marasco, Michelangelo; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Campbell, Nathaniel R.; Xu, Tianhao; Chaligne, Ronan] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol, 1275 York Ave, New York, NY 10021 USA; [Campbell, Nathaniel R.] Weill Cornell Grad Sch Med Sci, Physiol Biophys & Syst Biol Grad Program, New York, NY USA; [Newell, Felicity; Johansson, Peter A.; Pearson, John, V; Waddell, Nicola; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Wilmott, James S.; Thompson, John F.; Long, Georgina, V; Mann, Graham J.; Scolyer, Richard A.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Thompson, John F.; Long, Georgina, V; Scolyer, Richard A.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Thompson, John F.; Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Long, Georgina, V] Royal North Shore Hosp, Sydney, NSW, Australia; [Mann, Graham J.] Australian Natl Univ, John Curtin Sch Med Res, Acton, ACT, Australia; [Mann, Graham J.] Univ Sydney, Ctr Canc Res, Westmead Inst Med Res, Sydney, NSW, Australia; [Scolyer, Richard A.] New South Wales Hlth Pathol, Sydney, NSW, Australia; [Waddell, Nicola] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Jonsson, Philip; Donoghue, Mark T. A.; Harris, Christopher C.; Taylor, Barry S.; Solit, David B.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Jonsson, Philip; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Jonsson, Philip; Taylor, Barry S.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Shliaha, Pavel, V] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, Odense, Denmark; [Shliaha, Pavel, V; Hendrickson, Ronald] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Facil, 1275 York Ave, New York, NY 10021 USA; [Jungbluth, Achim A.; Lezcano, Cecilia] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Koche, Richard] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Ariyan, Charlotte E.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Solit, David B.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Wolchok, Jedd D.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Wolchok, Jedd D.; Merghoub, Taha] Weill Cornell Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; QIMR Berghofer Medical Research Institute; Melanoma Institute Australia; University of Sydney; University of Sydney; University of Sydney; Royal North Shore Hospital; Australian National University; John Curtin School of Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Queensland; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Southern Denmark; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	White, RM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.		Scolyer, Richard/AAE-8511-2019; Long, Georgina/C-1771-2013	Scolyer, Richard/0000-0002-8991-0013; Campbell, Nathaniel/0000-0002-0355-0708; Hunter, Miranda/0000-0002-6971-1738; Tagore, Mohita/0000-0002-2586-1427; Long, Georgina/0000-0001-8894-3545; Baggiolini, Arianna/0000-0002-2476-561X; Shliaha, Pavel/0000-0003-3092-0724; Cruz, Nelly/0000-0002-9040-6957; Ma, Yilun/0000-0002-2297-9980	NIH [F30CA236442, F30CA220954, T32GM007739, K00CA223016, R01CA229215, R01CA238317, DP2CA186572]; Cell and Developmental Biology Program at Weill Cornell Graduate School by the NIH [T32GM008539]; Swiss National Science Foundation [P2ZHP3_171967, P400PB_180672]; Marie-Josee Kravis Women in Science Endeavor Postdoctoral Fellowship; Australian National Health and Medical Research Council; Cameron Family; Ainsworth Foundation; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Ludwig Collaborative; Swim Across America Laboratory; Memorial Sloan Kettering Cancer Center; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center; Department of Medicine, Memorial Sloan Kettering Cancer Center; Weill Cornell Medicine; Melanoma Research Alliance; Debra and Leon Black Family Foundation; Pershing Square Sohn Foundation; Mark Foundation for Cancer Research; American Cancer Society; Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center; Harry J. Lloyd Foundation; Starr Cancer Consortium; Consano; NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Developmental Biology Program at Weill Cornell Graduate School by the NIH; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie-Josee Kravis Women in Science Endeavor Postdoctoral Fellowship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cameron Family; Ainsworth Foundation; NIH/NCI Cancer Center Support Grant; Ludwig Collaborative; Swim Across America Laboratory; Memorial Sloan Kettering Cancer Center; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center; Department of Medicine, Memorial Sloan Kettering Cancer Center; Weill Cornell Medicine; Melanoma Research Alliance; Debra and Leon Black Family Foundation; Pershing Square Sohn Foundation(Pershing Square Sohn Cancer Research Alliance); Mark Foundation for Cancer Research; American Cancer Society(American Cancer Society); Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center; Harry J. Lloyd Foundation; Starr Cancer Consortium; Consano; NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	M.W. was supported by the Kirschstein-NRSA predoctoral fellowship (F30) from the NIH under award number F30CA236442 and by a predoctoral fellowship (T32) by the Cell and Developmental Biology Program at Weill Cornell Graduate School supported by the NIH under award number T32GM008539. N.R.C. was supported by the Kirschstein-NRSA predoctoral fellowship (F30) from the NIH under award number F30CA220954. J.M.W., Y.M. and N.R.C were supported by a Medical Scientist Training Program grant from the NIH under award number T32GM007739. A.B. was supported by the Swiss National Science Foundation Postdoc mobility fellowships P2ZHP3_171967 and P400PB_180672. M.T. was supported by the Marie-Josee Kravis Women in Science Endeavor Postdoctoral Fellowship. E.D.M. was supported by the Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) from the NIH under award number K00CA223016. R.A.S., G.V.L., J.F.T., G.J.M. and N.K.H. are supported by an Australian National Health and Medical Research Council Program Grant. R.A.S., N.K.H. and G.V.L. are supported by the Australian National Health and Medical Research Council Fellowship programme. The authors acknowledge support from colleagues at their respective institutions and support from the Cameron Family and the Ainsworth Foundation. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center; Department of Medicine, Memorial Sloan Kettering Cancer Center; and Weill Cornell Medicine. This work was supported by awards from the Melanoma Research Alliance, The Debra and Leon Black Family Foundation, NIH Research Program Grants R01CA229215 and R01CA238317, NIH Director's New Innovator Award DP2CA186572, The Pershing Square Sohn Foundation, The Mark Foundation for Cancer Research, The American Cancer Society, The Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center, The Harry J. Lloyd Foundation, Consano and the Starr Cancer Consortium (all to R.M.W.). We thank L. T. Koufariotis for technical assistance with the alignment of human RNA-seq data. We acknowledge the use of the Integrated Genomics Operation Core, funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Baggiolini A, 2021, SCIENCE, V373, P1104, DOI 10.1126/science.abc1048; Baron M, 2020, CELL SYST, V11, P536, DOI 10.1016/j.cels.2020.08.018; Belote RL, 2021, NAT CELL BIOL, V23, P1035, DOI 10.1038/s41556-021-00740-8; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Caravagna G, 2018, NAT METHODS, V15, P707, DOI 10.1038/s41592-018-0108-x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dhupkar Pooja, 2016, Biochem Biophys Rep, V8, P382, DOI 10.1016/j.bbrep.2016.10.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eshiba S, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109492; Farshidfar F, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28566-4; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Fowler JC, 2021, CANCER DISCOV, V11, P340, DOI 10.1158/2159-8290.CD-20-1092; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Hunter MV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26614-z; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim K, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0949-5; Kiselev VY, 2019, NAT REV GENET, V20, P273, DOI 10.1038/s41576-018-0088-9; Klemen ND, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000341; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohler C, 2017, CELL STEM CELL, V21, P679, DOI 10.1016/j.stem.2017.08.003; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li SJ, 2019, NUCLEIC ACIDS RES, V47, pW206, DOI 10.1093/nar/gkz332; Liang WS, 2017, GENOME RES, V27, P524, DOI 10.1101/gr.213348.116; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Luo LY, 2015, J GENET GENOMICS, V42, P521, DOI 10.1016/j.jgg.2015.09.001; Moon H, 2017, CELL STEM CELL, V21, P665, DOI 10.1016/j.stem.2017.09.001; Nakamura T, 2016, NATURE, V537, P225, DOI 10.1038/nature19322; Newell F., 2020, NAT COMMUN, V11; Petit F, 2017, NAT REV GENET, V18, P245, DOI 10.1038/nrg.2016.167; Petrelli F, 2017, JAMA ONCOL, V3, P211, DOI 10.1001/jamaoncol.2016.4227; Rabbie R, 2019, J PATHOL, V247, P539, DOI 10.1002/path.5213; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Reed RJ, 1976, NEW CONCEPTS SURG PA, P89; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Sheth R, 2016, CELL REP, V17, P2913, DOI 10.1016/j.celrep.2016.11.039; Shoushtari AN, 2016, CANCER-AM CANCER SOC, V122, P3354, DOI 10.1002/cncr.30259; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Tang J, 2020, NATURE, V586, P600, DOI 10.1038/s41586-020-2785-8; Tang QS, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0961-8; Tanna CE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020442; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Tothova Z, 2017, CELL STEM CELL, V21, P547, DOI 10.1016/j.stem.2017.07.015; van den Heuvel CNAM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00117; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Xu B, 2010, DEV BIOL, V348, P3, DOI 10.1016/j.ydbio.2010.08.018; Ye LH, 2016, DEV BIOL, V409, P354, DOI 10.1016/j.ydbio.2015.12.003; Yeh I, 2019, JNCI-J NATL CANCER I, V111, P1068, DOI 10.1093/jnci/djz005; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang J, 2017, CELL REP, V20, P549, DOI 10.1016/j.celrep.2017.06.054; Zhang YM, 2018, DEV CELL, V45, P580, DOI 10.1016/j.devcel.2018.04.025; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	100	9	9	4	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 14	2022	604	7905					354	+		10.1038/s41586-022-04584-6	http://dx.doi.org/10.1038/s41586-022-04584-6		MAR 2022	35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0M9OF	35355015	Green Submitted, Green Accepted			2022-12-28	WOS:000776020400005
J	Block, J				Block, Jennifer			Covid-19: US tracker overestimated deaths among children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention, COVID DAT TRACK; Krohnert K., 2022, TWITTER; National Center for Health Statistics, SEX AG; Scheiber M, 2022, GUARDIAN 0311; Twitter, 2022, VERIFIED ACCOUNTS; Woodhouse E, 2021, TWITTER	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o831	10.1136/bmj.o831	http://dx.doi.org/10.1136/bmj.o831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351678	Bronze			2022-12-28	WOS:000779544800002
J	Holt, E				Holt, Ed			Growing concern over Ukrainian refugee health	LANCET			English	Editorial Material																			0	3	3	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1213	1214						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339214				2022-12-28	WOS:000779495000009
J	Grubbs, V; Cerdena, JP; Non, AL				Grubbs, Vanessa; Cerdena, Jessica P.; Non, Amy L.			The art of medicine The misuse of race in the search for disease-causing alleles	LANCET			English	Editorial Material									[Grubbs, Vanessa] Alameda Hlth Syst, Dept Ambulatory & Prevent Med, Oakland, CA 94602 USA; [Cerdena, Jessica P.] Yale Univ, Yale Sch Med, New Haven, CT USA; [Cerdena, Jessica P.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Non, Amy L.] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA	Yale University; Yale University; University of California System; University of California San Diego	Grubbs, V (corresponding author), Alameda Hlth Syst, Dept Ambulatory & Prevent Med, Oakland, CA 94602 USA.	drvanessa@thenephrologist.com		Cerdena, Jessica/0000-0003-1317-116X					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1110	1111		10.1377/hblog20210415.30548	http://dx.doi.org/10.1377/hblog20210415.30548			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305732				2022-12-28	WOS:000770814300012
J	Mazid, MA; Ward, C; Luo, ZW; Liu, CY; Li, YP; Lai, YW; Wu, L; Li, JX; Jia, WQ; Jiang, Y; Liu, H; Fu, LX; Yang, YL; Ibanez, DP; Lai, JJ; Wei, XY; An, J; Guo, PC; Yuan, Y; Deng, QT; Wang, Y; Liu, Y; Gao, F; Wang, JW; Zaman, S; Qin, BM; Wu, GM; Maxwell, PH; Xu, X; Liu, LQ; Li, WJ; Esteban, MA				Mazid, Md. Abdul; Ward, Carl; Luo, Zhiwei; Liu, Chuanyu; Li, Yunpan; Lai, Yiwei; Wu, Liang; Li, Jinxiu; Jia, Wenqi; Jiang, Yu; Liu, Hao; Fu, Lixin; Yang, Yueli; Ibanez, David P.; Lai, Junjian; Wei, Xiaoyu; An, Juan; Guo, Pengcheng; Yuan, Yue; Deng, Qiuting; Wang, Yang; Liu, Ying; Gao, Fei; Wang, Junwen; Zaman, Shahriar; Qin, Baoming; Wu, Guangming; Maxwell, Patrick H.; Xu, Xun; Liu, Longqi; Li, Wenjuan; Esteban, Miguel A.			Rolling back human pluripotent stem cells to an eight-cell embryo-like stage	NATURE			English	Article							RNA-SEQ; METHYLATION LANDSCAPE; TRANSCRIPTION; TROPHOBLAST; ACTIVATION; DERIVATION; INDUCTION; CRITERIA; STELLA	After fertilization, the quiescent zygote experiences a burst of genome activation that initiates a short-lived totipotent state. Understanding the process of totipotency in human cells would have broad applications. However, in contrast to in mice(1,2), demonstration of the time of zygotic genome activation or the eight-cell (8C) stage in in vitro cultured human cells has not yet been reported, and the study of embryos is limited by ethical and practical considerations. Here we describe a transgene-free, rapid and controllable method for producing 8C-like cells (8CLCs) from human pluripotent stem cells. Single-cell analysis identified key molecular events and gene networks associated with this conversion. Loss-of-function experiments identified fundamental roles for DPPA3, a master regulator of DNA methylation in oocytes(3), and TPRX1, a eutherian totipotent cell homeobox (ETCHbox) family transcription factor that is absent in mice(4). DPPA3 induces DNA demethylation throughout the 8CLC conversion process, whereas TPRX1 is a key executor of 8CLC gene networks. We further demonstrate that 8CLCs can produce embryonic and extraembryonic lineages in vitro or in vivo in the form of blastoids 5 and complex teratomas. Our approach provides a resource to uncover the molecular process of early human embryogenesis.	[Mazid, Md. Abdul; Ward, Carl; Luo, Zhiwei; Li, Yunpan; Lai, Yiwei; Jia, Wenqi; Liu, Hao; Fu, Lixin; Ibanez, David P.; Lai, Junjian; An, Juan; Li, Wenjuan; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Integrat Biol, Guangzhou, Peoples R China; [Mazid, Md. Abdul; Wu, Liang; Li, Jinxiu; Jia, Wenqi; Fu, Lixin; Ibanez, David P.; Wei, Xiaoyu; Yuan, Yue; Deng, Qiuting] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Chuanyu; Lai, Yiwei; Wu, Liang; Li, Jinxiu; Wei, Xiaoyu; Yuan, Yue; Deng, Qiuting; Wang, Yang; Liu, Ying; Xu, Xun; Liu, Longqi; Esteban, Miguel A.] BGI Shenzhen, Shenzhen, Peoples R China; [Jiang, Yu; Yang, Yueli; Guo, Pengcheng; Esteban, Miguel A.] Jilin Univ, Coll Vet Med, Jilin Prov Key Lab Anim Embryo Engn, Key Lab Zoonoses Res,Minist Educ, Changchun, Peoples R China; [An, Juan] Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei, Peoples R China; [Gao, Fei] Chinese Acad Agr Sci, Genome Anal Lab, Minist Agr, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Wang, Junwen] E GENE, Shenzhen, Peoples R China; [Zaman, Shahriar] Rajshahi Univ, Fac Life & Earth Sci, Dept Genet Engn & Biotechnol, Rajshahi, Bangladesh; [Qin, Baoming] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Metab & Cell Fate, Guangzhou, Peoples R China; [Wu, Guangming] Guangzhou Lab, Guangzhou, Peoples R China; [Maxwell, Patrick H.] Univ Cambridge, Inst Med Res, Dept Med, Cambridge, England; [Xu, Xun] Guangdong Prov Key Lab Genome Read & Write, Shenzhen, Peoples R China; [Esteban, Miguel A.] Chinese Acad Sci, Inst Stem Cells & Regenerat, Beijing, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Jilin University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; University of Rajshahi; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Cambridge; Chinese Academy of Sciences	Mazid, MA; Li, WJ; Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Integrat Biol, Guangzhou, Peoples R China.; Mazid, MA (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Liu, LQ; Esteban, MA (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.; Esteban, MA (corresponding author), Jilin Univ, Coll Vet Med, Jilin Prov Key Lab Anim Embryo Engn, Key Lab Zoonoses Res,Minist Educ, Changchun, Peoples R China.; Esteban, MA (corresponding author), Chinese Acad Sci, Inst Stem Cells & Regenerat, Beijing, Peoples R China.	mazid@gibh.ac.cn; liulongqi@genomics.cn; li_wenjuan@gibh.ac.cn; miguel@gibh.ac.cn	Esteban, MA/D-6709-2011; Maxwell, Patrick H/C-5557-2008; Ward, Carl RJ/G-3779-2017	Esteban, MA/0000-0002-6264-1458; Maxwell, Patrick H/0000-0002-0338-2679; Ward, Carl RJ/0000-0003-0889-9025; Liu, Chuanyu/0000-0003-2258-0897; Mazid, Md. Abdul/0000-0001-7909-4422; Lai, Yiwei/0000-0003-0733-812X	National Key Research and Development Program of China [2018YFA0106903, 2016YFA0100102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030502]; National Natural Science Foundation of China [U20A2015, 31900466, 32150410348, 32070861, 31950410553]; Guangdong Provincial Key Laboratory of Genome Read and Write [2017B030301011]; Guangdong Basic and Applied Basic Research Foundation [2021A1515110180]; Guangzhou Science and Technology Foundation [2021000122]; CAS-TWAS President's PhD Fellowship; CAS President's International Fellowship Initiative (PIFI) [2020FSB0002]	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Genome Read and Write; Guangdong Basic and Applied Basic Research Foundation; Guangzhou Science and Technology Foundation; CAS-TWAS President's PhD Fellowship; CAS President's International Fellowship Initiative (PIFI)	We thank all members of our laboratories for their support; L. Lai and G. Pan (Guangzhou Institutes of Biomedicine and Health) for their helpful comments during the execution of this project; X. Quan (the Experimental Animal Center of Guangzhou Institutes of Biomedicine and Health) for technical help with the chimera experiments; staff at the CNGB for providing technical support; and staff at the instrument platforms of the Guangzhou Institutes of Biomedicine and Health and the Bioland Laboratory for their technical support. This work was supported by the National Key Research and Development Program of China (2018YFA0106903 and 2016YFA0100102 to M.A.E.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030502 to M.A.E.), the National Natural Science Foundation of China (U20A2015 to M.A.E., 31900466 to L.L., 32150410348 to M.A.M., 32070861 to B.Q. and 31950410553 to C.W.), the Guangdong Provincial Key Laboratory of Genome Read and Write (2017B030301011 to X.X.), the Guangdong Basic and Applied Basic Research Foundation (2021A1515110180 to Y.L.), and the Guangzhou Science and Technology Foundation (2021000122 to W.L.). M.A.M. was funded by CAS-TWAS President's PhD Fellowship and CAS President's International Fellowship Initiative (PIFI) for special experts (2020FSB0002).	A.Chen, 2019, bioRxiv, DOI 10.1101/818450; Bayerl J, 2021, CELL STEM CELL, V28, P1549, DOI 10.1016/j.stem.2021.04.001; Bredenkamp N, 2019, STEM CELL REP, V13, P1083, DOI 10.1016/j.stemcr.2019.10.009; Castel G, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108419; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Di Stefano B, 2018, NAT METHODS, V15, P732, DOI 10.1038/s41592-018-0104-1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong C, 2020, ELIFE, V9, DOI 10.7554/eLife.52504; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Guo G, 2021, CELL STEM CELL, V28, P1040, DOI 10.1016/j.stem.2021.02.025; Guo G, 2017, DEVELOPMENT, V144, P2748, DOI 10.1242/dev.146811; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07098-w; Lee CQE, 2016, STEM CELL REP, V6, P257, DOI 10.1016/j.stemcr.2016.01.006; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YF, 2018, NATURE, V564, P136, DOI 10.1038/s41586-018-0751-5; Liu LQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08244-0; Liu XD, 2020, NATURE, V586, P101, DOI 10.1038/s41586-020-2734-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macnair W, 2019, BIORXIV, DOI [10.1101/622001, DOI 10.1101/622001]; Maeso I, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0267-0; Manor YS, 2015, CURR OPIN GENET DEV, V34, P35, DOI 10.1016/j.gde.2015.07.005; McDonald D, 2020, CELL, V183, P1402, DOI 10.1016/j.cell.2020.10.018; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morabito S, 2021, NAT GENET, V53, P1143, DOI 10.1038/s41588-021-00894-z; Mulholland CB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19603-1; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Pastor WA, 2018, NAT CELL BIOL, V20, P553, DOI 10.1038/s41556-018-0089-0; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Posfai E, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00609-2; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rodriguez-Terrones D, 2020, EMBO REP, V21, DOI 10.15252/embr.201948354; Sang H, 2019, J MOL CELL BIOL, V11, P474, DOI 10.1093/jmcb/mjy069; Shakiba N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8329; Shen H, 2021, CELL, V184, P2843, DOI 10.1016/j.cell.2021.04.020; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Stirparo GG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158501; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Velychko S, 2019, CELL STEM CELL, V25, P737, DOI 10.1016/j.stem.2019.10.002; Wang LY, 2017, J GENET GENOMICS, V44, P363, DOI 10.1016/j.jgg.2017.06.001; Wang Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21409-8; Wang YX, 2018, ELIFE, V7, DOI 10.7554/eLife.29518; Wu JY, 2018, NATURE, V557, P256, DOI 10.1038/s41586-018-0080-8; Xia WK, 2019, SCIENCE, V365, P353, DOI 10.1126/science.aaw5118; Xu XB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7008; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yanagida A, 2021, CELL STEM CELL, V28, P1016, DOI 10.1016/j.stem.2021.04.031; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu LQ, 2021, NATURE, V591, P620, DOI 10.1038/s41586-021-03356-y; Yu YY, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.651355; Zhang M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1593	71	13	13	68	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2022	605	7909					315	+		10.1038/s41586-022-04625-0	http://dx.doi.org/10.1038/s41586-022-04625-0			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D7UZ	35314832				2022-12-28	WOS:000794004500027
J	Zhou, TQ; Wang, LS; Misasi, J; Pegu, A; Zhang, Y; Harris, DR; Olia, AS; Talana, CA; Yang, ES; Chen, M; Choe, M; Shi, W; Teng, IT; Creanga, A; Jenkins, C; Leung, K; Liu, T; Stancofski, ESD; Stephens, T; Zhang, BS; Tsybovsky, Y; Graham, BS; Mascola, JR; Sullivan, NJ; Kwong, PD				Zhou, Tongqing; Wang, Lingshu; Misasi, John; Pegu, Amarendra; Zhang, Yi; Harris, Darcy R.; Olia, Adam S.; Talana, Chloe Adrienna; Yang, Eun Sung; Chen, Man; Choe, Misook; Shi, Wei; Teng, I-Ting; Creanga, Adrian; Jenkins, Claudia; Leung, Kwanyee; Liu, Tracy; Stancofski, Erik-Stephane D.; Stephens, Tyler; Zhang, Baoshan; Tsybovsky, Yaroslav; Graham, Barney S.; Mascola, John R.; Sullivan, Nancy J.; Kwong, Peter D.			Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529	SCIENCE			English	Article							RECEPTOR-BINDING DOMAIN	The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent sera are driving a search for monoclonal antibodies with potent neutralization. To provide insight into effective neutralization, we determined cryo-electron microscopy structures and evaluated receptor binding domain (RBD) antibodies for their ability to bind and neutralize B.1.1.529. Mutations altered 16% of the B.1.1.529 RBD surface, clustered on an RBD ridge overlapping the angiotensin-converting enzyme 2 (ACE2)-binding surface and reduced binding of most antibodies. Substantial inhibitory activity was retained by select monoclonal antibodies-including A23-58.1, B1-182.1, COV2-2196, S2E12, A19-46.1, S309, and LY-CoV1404-that accommodated these changes and neutralized B.1.1.529. We identified combinations of antibodies with synergistic neutralization. The analysis revealed structural mechanisms for maintenance of potent neutralization against emerging variants.	[Zhou, Tongqing; Wang, Lingshu; Misasi, John; Pegu, Amarendra; Zhang, Yi; Harris, Darcy R.; Olia, Adam S.; Talana, Chloe Adrienna; Yang, Eun Sung; Chen, Man; Choe, Misook; Shi, Wei; Teng, I-Ting; Creanga, Adrian; Leung, Kwanyee; Liu, Tracy; Stancofski, Erik-Stephane D.; Zhang, Baoshan; Graham, Barney S.; Mascola, John R.; Sullivan, Nancy J.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Jenkins, Claudia; Stephens, Tyler; Tsybovsky, Yaroslav] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Leidos Biomed Res, Canc Res Technol Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhou, TQ; Misasi, J; Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	tzhou@nih.gov; john.misasi@nih.gov; pdkwong@nih.gov	; Zhou, Tongqing/A-6880-2010	Yang, Eun Sung/0000-0003-3161-1624; Talana, Chloe Adrienna/0000-0002-0313-8502; Pegu, Amarendra/0000-0003-3564-6453; Misasi, John/0000-0001-7169-2639; Harris, Darcy/0000-0002-3671-6452; Olia, Adam/0000-0003-0805-1331; Zhou, Tongqing/0000-0002-3935-4637	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research [HSSN261200800001E]	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. This research was, in part, supported by the National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research under contract HSSN261200800001E.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Center for Systems Science and Engineering at Johns Hopkins University, 2021, J HOPK U COVID 19 DA; Cerutti G, 2021, CELL REP, V37, DOI [10.1016/j.celrep.2021.109928, 10.1101/2021.06.29.450397]; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Corbett KS, 2021, SCIENCE, V374, P1343, DOI 10.1126/science.abl8912; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Dong Jinhui, 2021, bioRxiv, DOI 10.1101/2021.01.27.428529; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Gallaher W. R., 2021, OMICRON IS MULTIPLY; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Han PC, 2022, CELL, V185, P630, DOI 10.1016/j.cell.2022.01.001; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Howell KA, 2017, CELL REP, V19, P413, DOI 10.1016/j.celrep.2017.03.049; Iketani S, 2022, ANTIBODY EVASION PRO, DOI [10.1101/2022.02.07.479306, DOI 10.1101/2022.02.07.479306, 10.1101/ 2022.02.07. 479306]; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Kim C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20602-5; Ko SH, 2021, PLOS PATHOG, V17, DOI [10.1371/journal.ppat.1009431, 10.1101/2021.02.21.432184]; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Mannar D, 2022, SCIENCE, V375, P760, DOI 10.1126/science.abn7760; McCallum M, 2022, SCIENCE, V375, P864, DOI 10.1126/science.abn8652; Nabel KG, 2022, SCIENCE, V375, P282, DOI 10.1126/science.abl6251; Naveca F, 2021, SARS COV 2 REINFECTI; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rambaut A., 2020, PRELIMINARY GENOMIC; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rosa A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg7607; Ryu DK, 2021, BIOCHEM BIOPH RES CO, V578, P91, DOI 10.1016/j.bbrc.2021.09.023; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shi W., 2022, STRUCTURE, DOI [10.1016/j.str.2022.06.004, DOI 10.1016/J.STR.2022.06.004]; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wang PF, 2021, CELL HOST MICROBE, V29, P747, DOI 10.1016/j.chom.2021.04.007; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Westendorf Kathryn, 2022, bioRxiv, DOI 10.1101/2021.04.30.442182; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; World Health Organization, 2021, COVID19 WEEKL EP UPD, P1; World Health Organization (WHO), 2021, TECHN BRIEF PRIOR AC; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102; Yin WC, 2022, SCIENCE, V375, P1048, DOI 10.1126/science.abn8863; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhou TQ, 2020, CELL REP, V33, DOI [10.1101/2020.06.22.166033, 10.1016/j.celrep.2020.108322]; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	64	29	29	20	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2022	376	6591					369	+		10.1126/science.abn8897	http://dx.doi.org/10.1126/science.abn8897			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V7XJ	35324257	Green Submitted, Green Published			2022-12-28	WOS:000788553700033
J	Gostin, LO; Klock, KA; Clark, H; Diop, FZ; Jayasuriya, D; Mahmood, J; Waris, A				Gostin, Lawrence O.; Klock, Kevin A.; Clark, Helen; Diop, Fatimatou Zahra; Jayasuriya, Dayanath; Mahmood, Jemilah; Waris, Attiya			Financing the future of WHO	LANCET			English	Editorial Material									[Gostin, Lawrence O.; Klock, Kevin A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Klock, Kevin A.] Fdn Natl Inst Hlth, North Bethesda, MD USA; [Clark, Helen] Helen Clark Fdn, Auckland, New Zealand; [Clark, Helen] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Diop, Fatimatou Zahra] Fdn Afrivac, Dakar, Senegal; [Jayasuriya, Dayanath] Int Advisory Council Round Table, Colombo, Sri Lanka; [Mahmood, Jemilah] Sunway Univ, Sunway Ctr Planetary Hlth, Subang Jaya, Selangor, Malaysia; [Waris, Attiya] Univ Nairobi, Sch Law, Nairobi, Kenya	Georgetown University; Sunway University; University of Nairobi	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Klock, Kevin A./0000-0002-5281-2022				Daugirdas K, 2019, INT ORGAN LAW REV, V16, P299, DOI 10.1163/15723747-01602005; Dolgin E, 2019, NAT REV DRUG DISCOV, V18, P240; https://www.who.int/news-room/events/ detail/2021/11/29/default-calendar/second-special-session-of-the-world- health-assembly WHO, 2021, SPEC SESS WORLD HLTH; Humanitarian Finance Forum, 2022, WHAT WE AIM; Kellerman M, 2019, REV INT ORGAN, V14, P107, DOI 10.1007/s11558-018-9302-y; Waris A., 2013, TAX DEV SOLVING KENY; WHO, 2021, MRNA VACC TECHN TRAN; WHO, 1948, 1 WORLD HLTH ASS; WHO, 2016, PROP INCR ASS CONTR; WHO, 2019, CONTR; WHO. 34th World Health Assembly, 1981, 34 WORLD HLTH ASS PR; WHO Executive Board, 2022, WORK GROUP SUST FIN; WHO Executive Board, 2022, IT 19 3 SUST FIN REP; WHO Executive Board, 2022, SUSTAINABLE FINANCIN; World Health Organization (WHO), 2018, WHO LAUNCH 1 INV CAS	15	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2022	399	10334					1445	1447		10.1016/S0140-6736(22)00533-5	http://dx.doi.org/10.1016/S0140-6736(22)00533-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JN	35338858	Green Published, Bronze			2022-12-28	WOS:000795611300005
J	Ainsworth, C				Ainsworth, Claire			Mark of resistance	NATURE			English	News Item						Diseases; Health care; Public health; Society	HEPATITIS-B; VIRUS	Chronic hepatitis B infection is heavily stigmatized around the world. Now, patients are finding a voice to push back and demand an end to discrimination and isolation. By Claire Ainsworth										Gerlich WH, 2014, INTERVIROLOGY, V57, P202, DOI 10.1159/000360949; Kan QC, 2015, LANCET, V386, P245, DOI 10.1016/S0140-6736(15)61276-4; Mokaya Jolynne, 2018, Wellcome Open Res, V3, P29, DOI [10.12688/wellcomeopenres.14273.2, 10.12688/wellcomeopenres.14273.1]; Moraras K, 2020, PUBLIC HEALTH REP, V135, p13S, DOI 10.1177/0033354920921252; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Wallace J, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0637-4	6	0	0	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S54	S56		10.1038/d41586-022-00816-x	http://dx.doi.org/10.1038/d41586-022-00816-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354985	Bronze			2022-12-28	WOS:000776361600013
J	Calafat, FM; Wahl, T; Tadesse, MG; Sparrow, SN				Calafat, Francisco M.; Wahl, Thomas; Tadesse, Michael Getachew; Sparrow, Sarah N.			Trends in Europe storm surge extremes match the rate of sea-level rise	NATURE			English	Article							NORTH-ATLANTIC; PROJECTIONS; ADAPTATION; REANALYSIS; WEATHER; MODEL; CMIP5; POWER	Coastal communities acrossthe world are already feelingthe disastrous impacts of climate changethrough variations in extreme sea levels(1). Thesevariations reflect the combined effect of sea-level rise and changes in storm surge activity. Understanding the relative importance ofthesetwo factors in altering the likelihood of extreme events is crucial to the success of coastal adaptation measures. Existing analyses oftide gauge records(2-10) agreethat sea-level rise has been a considerable driver oftrends in sea-level extremes since at least1960. However, the contribution from changes in storminess remains unclear, owing tothe difficulty of inferring this contribution from sparse data and the consequent inconclusive resultsthat have accumulated in the literature(11,12). Here we analyse tide gauge observations using spatial Bayesian methods(13) to showthat, contrary to current thought, trends in surge extremes and sea-level rise both made comparable contributionstothe overall change in extreme sea levels in Europe since1960. We determine that the trend pattern of surge extremes reflectsthe contributions from a dominant north-south dipole associated with internal climate variability and a single-sign positive pattern related to anthropogenic forcing. Our results demonstrate that both external and internal influences can considerably affect the likelihood of surge extremes over periods as long as 60 years, suggesting that the current coastal planning practice of assuming stationary surge extremes(1,14) might be inadequate.	[Calafat, Francisco M.] Natl Oceanog Ctr, Liverpool, Merseyside, England; [Wahl, Thomas; Tadesse, Michael Getachew] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL USA; [Wahl, Thomas; Tadesse, Michael Getachew] Univ Cent Florida, Natl Ctr Integrated Coastal Res, Orlando, FL USA; [Sparrow, Sarah N.] Univ Oxford, Oxford E Res Ctr, Dept Engn Sci, Oxford, England	NERC National Oceanography Centre; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; University of Oxford	Calafat, FM (corresponding author), Natl Oceanog Ctr, Liverpool, Merseyside, England.	francisco.calafat@noc.ac.uk	; Sparrow, Sarah/D-7905-2016	Calafat, Francisco/0000-0002-7474-135X; Sparrow, Sarah/0000-0002-1802-6909	Natural Environment Research Council (NERC) National Capability funding; National Aeronautics and Space Administration (NASA) under the New (Early Career) Investigator Program (NIP) in Earth Science [80NSSC18K0743]; NASA Sea Level Science Team [80NSSC20K1241]; National Science Foundation [ICER-1854896]	Natural Environment Research Council (NERC) National Capability funding(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Aeronautics and Space Administration (NASA) under the New (Early Career) Investigator Program (NIP) in Earth Science; NASA Sea Level Science Team; National Science Foundation(National Science Foundation (NSF))	We acknowledge the GESLA project for assembling and making the tide gauge data available. F.M.C. was supported by the Natural Environment Research Council (NERC) National Capability funding. M.G.T. and T.W. were supported by the National Aeronautics and Space Administration (NASA) under the New (Early Career) Investigator Program (NIP) in Earth Science (grant number 80NSSC18K0743) and the NASA Sea Level Science Team (grant number 80NSSC20K1241). T.W. also acknowledges support from the National Science Foundation (under grant ICER-1854896). We acknowledge conversations with M. Marcos and also thank her for providing the tide gauge data (from the British Oceanographic Data Centre and the Copernicus Marine Environment Monitoring Service) for the period 2014-2018.	Barcikowska MJ, 2018, EARTH SYST DYNAM, V9, P679, DOI 10.5194/esd-9-679-2018; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Calafat FM, 2020, P NATL ACAD SCI USA, V117, P1877, DOI 10.1073/pnas.1913049117; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Coles S, 2001, INTRO STAT MODELLING; Conte D, 2013, GLOBAL PLANET CHANGE, V111, P159, DOI 10.1016/j.gloplacha.2013.09.006; Dangendorf S, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/5/054001; Faulkner D., 2020, FRS18087REAR2 ENV AG; Feser F, 2015, Q J ROY METEOR SOC, V141, P350, DOI 10.1002/qj.2364; Frederikse T, 2020, NATURE, V584, P393, DOI 10.1038/s41586-020-2591-3; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guillod BP, 2018, HYDROL EARTH SYST SC, V22, P611, DOI 10.5194/hess-22-611-2018; Guillod BP, 2017, GEOSCI MODEL DEV, V10, P1849, DOI 10.5194/gmd-10-1849-2017; Haigh I, 2010, CONT SHELF RES, V30, P1042, DOI 10.1016/j.csr.2010.02.002; Hersbach H, 2020, Q J ROY METEOR SOC, V146, P1999, DOI 10.1002/qj.3803; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Holgate SJ, 2013, J COASTAL RES, V29, P493, DOI 10.2112/JCOASTRES-D-12-00175.1; Howard T, 2019, ENVIRON RES COMMUN, V1, DOI 10.1088/2515-7620/ab42d7; Jevrejeva S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacc76; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Kulp SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12808-z; Little CM, 2015, NAT CLIM CHANGE, V5, P1114, DOI [10.1038/NCLIMATE2801, 10.1038/nclimate2801]; Marcos M, 2017, J GEOPHYS RES-OCEANS, V122, P7031, DOI 10.1002/2017JC013065; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; Marcos M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004912; McFadden Daniel, 1978, SPATIAL INTERACTION, V673, P72; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Muis S, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00263; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reich BJ, 2012, ANN APPL STAT, V6, P1430, DOI 10.1214/12-AOAS591; Rohmer J, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf0cd; Schlather M., 2002, EXTREMES, V5, P33, DOI [https://doi.org/10.1023/A:1020977924878, DOI 10.1023/A:1020977924878]; Stephenson AG, 2015, J APPL METEOROL CLIM, V54, P395, DOI 10.1175/JAMC-D-14-0041.1; Stocker T. F., 2013, PHYS SCI BASIS CONTR; Stott PA, 2016, WIRES CLIM CHANGE, V7, P23, DOI 10.1002/wcc.380; Tadesse M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00260; Tadesse MG, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00906-x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tiggeloven T, 2020, NAT HAZARD EARTH SYS, V20, P1025, DOI 10.5194/nhess-20-1025-2020; Vousdoukas MI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04692-w; Vousdoukas MI, 2016, CLIM DYNAM, V47, P3171, DOI 10.1007/s00382-016-3019-5; Vousdoukas MI, 2017, EARTHS FUTURE, V5, P304, DOI 10.1002/2016EF000505; Wahl T, 2015, J GEOPHYS RES-OCEANS, V120, P1527, DOI 10.1002/2014JC010443; Weisse R, 2014, COAST ENG, V87, P4, DOI 10.1016/j.coastaleng.2013.10.017; Woodworth PL, 2016, GEOSCI DATA J, V3, P50, DOI 10.1002/gdj3.42; Woodworth PL, 2004, J CLIMATE, V17, P1190, DOI 10.1175/1520-0442(2004)017&lt;1190:EFSCIE&gt;2.0.CO;2; Zappa G, 2013, J CLIMATE, V26, P5846, DOI 10.1175/JCLI-D-12-00573.1; Zhang KQ, 2000, J CLIMATE, V13, P1748, DOI 10.1175/1520-0442(2000)013<1748:TCSAAT>2.0.CO;2	51	7	7	21	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					841	+		10.1038/s41586-022-04426-5	http://dx.doi.org/10.1038/s41586-022-04426-5			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35355000	Green Accepted, Green Submitted			2022-12-28	WOS:000776361600030
J	Aguilar, R; Spencer, KB; Kesner, B; Rizvi, NF; Badmalia, MD; Mrozowich, T; Mortison, JD; Rivera, C; Smith, GF; Burchard, J; Dandliker, PJ; Patel, TR; Nickbarg, EB; Lee, JT				Aguilar, Rodrigo; Spencer, Kerrie B.; Kesner, Barry; Rizvi, Noreen F.; Badmalia, Maulik D.; Mrozowich, Tyler; Mortison, Jonathan D.; Rivera, Carlos; Smith, Graham F.; Burchard, Julja; Dandliker, Peter J.; Patel, Trushar R.; Nickbarg, Elliott B.; Lee, Jeannie T.			Targeting Xist with compounds that disrupt RNA structure and X inactivation	NATURE			English	Article							SMALL MOLECULES; IDENTIFICATION; DISCOVERY; DOMAINS; GENOME	Although more than 98% of the human genome is non-coding(1), nearly all of the drugs on the market target one of about 700 disease-related proteins. The historical reluctance to invest in non-coding RNA stems partly from requirements for drug targets to adopt a single stable conformation(2). Most RNAs can adopt several conformations of similar stabilities. RNA structures also remain challenging to determine(3). Nonetheless, an increasing number of diseases are now being attributed to non-coding RNA(4) and the ability to target them would vastly expand the chemical space for drug development. Here we devise a screening strategy and identify small molecules that bind the non-coding RNA prototype Xist(5). The X1 compound has drug-like properties and binds specifically the RepA motif(6) of Xist in vitro and in vivo. Small-angle X-ray scattering analysis reveals that RepA can adopt multiple conformations but favours one structure in solution. X1 binding reduces the conformational space of RepA, displaces cognate interacting protein factors (PRC2 and SPEN), suppresses histone H3K27 trimethylation, and blocks initiation of X-chromosome inactivation. X1 inhibits cell differentiation and growth in a female-specific manner. Thus, RNA can be systematically targeted by drug-like compounds that disrupt RNA structure and epigenetic function.	[Aguilar, Rodrigo; Kesner, Barry; Rivera, Carlos; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Aguilar, Rodrigo; Kesner, Barry; Rivera, Carlos; Lee, Jeannie T.] Harvard Med Sch, Dept Genet, Blavatnik Inst, Boston, MA 02115 USA; [Spencer, Kerrie B.; Rizvi, Noreen F.; Mortison, Jonathan D.; Smith, Graham F.; Burchard, Julja; Dandliker, Peter J.; Nickbarg, Elliott B.] Merck & Co Inc, Boston, MA USA; [Badmalia, Maulik D.; Mrozowich, Tyler; Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada; [Aguilar, Rodrigo] Univ Andres Bello, Inst Biomed Sci ICB, Fac Med, Santiago, Chile; [Aguilar, Rodrigo] Univ Andres Bello, Fac Life Sci, Santiago, Chile	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; University of Lethbridge; Universidad Andres Bello; Universidad Andres Bello	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Lee, JT (corresponding author), Harvard Med Sch, Dept Genet, Blavatnik Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu	Patel, Trushar/F-2776-2011	Patel, Trushar/0000-0003-0627-2923; Aguilar, Rodrigo/0000-0003-0410-5478	Merck MINt Award; US National Institutes of Health [R01-HD097665]; Howard Hughes Medical Institute; Pew Charitable Trust Latin American Fellows Program; MGH Fund for Medical Discovery; MITACS fellowship; NSERC PGS-D fellowship	Merck MINt Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Charitable Trust Latin American Fellows Program; MGH Fund for Medical Discovery; MITACS fellowship; NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank all members of the Lee and Patel laboratories, Charles Lesberg and other Merck team members for stimulating scientific discussions. We acknowledge the Merck MINt Award, a grant from the US National Institutes of Health (R01-HD097665), and funding from the Howard Hughes Medical Institute to J.T.L.; the Pew Charitable Trust Latin American Fellows Program to R.A. and C.R.; and the MGH Fund for Medical Discovery to R.A. M.D.B. and T.M. acknowledge MITACS and NSERC PGS-D fellowships respectively. T.R.P. is Canada Research Chair in RNA and Protein Biophysics. We thank DIAMOND Light Source B21 beamline staff for their help with data collection (BAG SM22113).	Annis DA, 2004, INT J MASS SPECTROM, V238, P77, DOI 10.1016/j.ijms.2003.11.022; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carrette LLG, 2018, P NATL ACAD SCI USA, V115, pE668, DOI 10.1073/pnas.1715124115; Chillon I, 2015, METHOD ENZYMOL, V558, P3, DOI 10.1016/bs.mie.2015.01.008; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Colognori D, 2019, MOL CELL, V74, P101, DOI 10.1016/j.molcel.2019.01.015; Disney MD, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a034769; Disney MD, 2016, ACS CHEM BIOL, V11, P1720, DOI 10.1021/acschembio.6b00001; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Kim DN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13942-4; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee MK, 2014, CHEM COMMUN, V50, P368, DOI 10.1039/c3cc46973e; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Liu F, 2017, NAT CHEM BIOL, V13, P282, DOI [10.1038/NCHEMBIO.2272, 10.1038/nchembio.2272]; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Rizvi NF, 2020, SLAS DISCOV, V25, P384, DOI 10.1177/2472555219885373; Rizvi NF, 2018, ACS CHEM BIOL, V13, P820, DOI 10.1021/acschembio.7b01013; Rizvi NF, 2017, BIOORG MED CHEM LETT, V27, P5083, DOI 10.1016/j.bmcl.2017.10.052; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Sunwoo H, 2017, P NATL ACAD SCI USA, V114, P10654, DOI 10.1073/pnas.1711206114; Warner KD, 2018, NAT REV DRUG DISCOV, V17, P547, DOI 10.1038/nrd.2018.93; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	30	12	13	12	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					160	+		10.1038/s41586-022-04537-z	http://dx.doi.org/10.1038/s41586-022-04537-z		MAR 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355011				2022-12-28	WOS:000776020400011
J	Bapat, SP; Whitty, C; Mowery, CT; Liang, YQ; Yoo, A; Jiang, ZW; Peters, MC; Zhang, LJ; Vogel, I; Zhou, C; Nguyen, VQ; Li, ZM; Chang, C; Zhu, WS; Hastie, AT; He, HE; Ren, X; Qiu, WL; Gayer, SG; Liu, C; Choi, EJ; Fassett, M; Cohen, JN; Sturgill, JL; Alexander, LEC; Suh, JM; Liddle, C; Atkins, AR; Yu, RT; Downes, M; Liu, SH; Nikolajczyk, BS; Lee, IK; Guttman-Yassky, E; Ansel, KM; Woodruff, PG; Fahy, JV; Sheppard, D; Gallo, RL; Ye, CJ; Evans, RM; Zheng, Y; Marson, A				Bapat, Sagar P.; Whitty, Caroline; Mowery, Cody T.; Liang, Yuqiong; Yoo, Arum; Jiang, Zewen; Peters, Michael C.; Zhang, Ling-juan; Vogel, Ian; Zhou, Carmen; Nguyen, Vinh Q.; Li, Zhongmei; Chang, Christina; Zhu, Wandi S.; Hastie, Annette T.; He, Helen; Ren, Xin; Qiu, Wenli; Gayer, Sarah G.; Liu, Chang; Choi, Eun Jung; Fassett, Marlys; Cohen, Jarish N.; Sturgill, Jamie L.; Alexander, Laura E. Crotty; Suh, Jae Myoung; Liddle, Christopher; Atkins, Annette R.; Yu, Ruth T.; Downes, Michael; Liu, Sihao; Nikolajczyk, Barbara S.; Lee, In-Kyu; Guttman-Yassky, Emma; Ansel, K. Mark; Woodruff, Prescott G.; Fahy, John, V; Sheppard, Dean; Gallo, Richard L.; Ye, Chun Jimmie; Evans, Ronald M.; Zheng, Ye; Marson, Alexander			Obesity alters pathology and treatment response in inflammatory disease	NATURE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; AIRWAY INFLAMMATION; ASTHMA PHENOTYPES; ATOPIC-DERMATITIS; DENDRITIC CELLS; T-CELLS; METABOLISM; DIFFERENTIATION; FAT	Decades of work have elucidated cytokine signalling and transcriptional pathways that control T cell differentiation and have led the way to targeted biologic therapies that are effective in a range of autoimmune, allergic and inflammatory diseases. Recent evidence indicates that obesity and metabolic disease can also influence the immune system(1-7), although the mechanisms and effects on immunotherapy outcomes remain largely unknown. Here, using two models of atopic dermatitis, we show that lean and obese mice mount markedly different immune responses. Obesity converted the classical type 2 T helper (T(H)2)-predominant disease associated with atopic dermatitis to a more severe disease with prominent T(H)17 inflammation. We also observed divergent responses to biologic therapies targeting T(H)2 cytokines, which robustly protected lean mice but exacerbated disease in obese mice. Single-cell RNA sequencing coupled with genome-wide binding analyses revealed decreased activity of nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR gamma) in T(H)2 cells from obese mice relative to lean mice. Conditional ablation of PPAR gamma in T cells revealed that PPAR gamma is required to focus the in vivo T-H response towards a T(H)2-predominant state and prevent aberrant non-T(H)2 inflammation. Treatment of obese mice with a small-molecule PPAR gamma agonist limited development of T(H)17 pathology and unlocked therapeutic responsiveness to targeted anti-T(H)2 biologic therapies. These studies reveal the effects of obesity on immunological disease and suggest a precision medicine approach to target the immune dysregulation caused by obesity.	[Bapat, Sagar P.; Liang, Yuqiong; Zhou, Carmen; Chang, Christina; Zheng, Ye] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Bapat, Sagar P.; Liddle, Christopher; Atkins, Annette R.; Yu, Ruth T.; Downes, Michael; Liu, Sihao; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Bapat, Sagar P.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Bapat, Sagar P.; Whitty, Caroline; Yoo, Arum; Jiang, Zewen; Vogel, Ian; Gayer, Sarah G.; Liu, Chang] Univ Calif San Diego, Dept Lab Med, La Jolla, CA 92093 USA; [Bapat, Sagar P.; Whitty, Caroline; Yoo, Arum; Jiang, Zewen; Vogel, Ian; Gayer, Sarah G.; Liu, Chang] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Bapat, Sagar P.; Whitty, Caroline; Mowery, Cody T.; Vogel, Ian; Zhu, Wandi S.; Fassett, Marlys; Ansel, K. Mark; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Bapat, Sagar P.; Mowery, Cody T.; Yoo, Arum; Jiang, Zewen; Gayer, Sarah G.; Liu, Chang; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Mowery, Cody T.; Woodruff, Prescott G.; Fahy, John, V; Sheppard, Dean] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Peters, Michael C.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep, San Francisco, CA 94143 USA; [Zhang, Ling-juan; Gallo, Richard L.] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Zhang, Ling-juan] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Nguyen, Vinh Q.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Li, Zhongmei; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Zhu, Wandi S.; Fassett, Marlys; Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Hastie, Annette T.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [He, Helen; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Ren, Xin; Qiu, Wenli; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Choi, Eun Jung] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Grad Sch, Dept Biomed Sci, Daegu, South Korea; [Fassett, Marlys; Cohen, Jarish N.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Cohen, Jarish N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Sturgill, Jamie L.] Univ Kentucky, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Lexington, KY USA; [Alexander, Laura E. Crotty] Vet Affairs San Diego Healthcare Syst, Dept Med, Pulm Crit Care Sect, San Diego, CA USA; [Alexander, Laura E. Crotty] Univ Calif San Diego, Dept Med, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA; [Suh, Jae Myoung] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Suh, Jae Myoung] Univ Sydney, Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia; [Suh, Jae Myoung] Univ Sydney, Westmead Hosp, Sydney Med Sch, Westmead, NSW, Australia; [Nikolajczyk, Barbara S.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Nikolajczyk, Barbara S.] Univ Kentucky, Barnstable Brown Diabet & Obes Res Ctr, Lexington, KY USA; [Lee, In-Kyu] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; [Ye, Chun Jimmie; Marson, Alexander] Univ Calif San Francisco, Inst Human Genet IHG, San Francisco, CA 94143 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Marson, Alexander] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Whitty, Caroline; Mowery, Cody T.; Liang, Yuqiong; Marson, Alexander] Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94158 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Xiamen University; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Kyungpook National University; Kyungpook National University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Korea Advanced Institute of Science & Technology (KAIST); University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Kentucky; University of Kentucky; Kyungpook National University; Kyungpook National University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bapat, SP; Zheng, Y (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Bapat, SP; Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Bapat, SP (corresponding author), Univ Calif San Diego, Dept Lab Med, La Jolla, CA 92093 USA.; Bapat, SP (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Bapat, SP; Marson, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Bapat, SP; Marson, A (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Inst Human Genet IHG, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Marson, A (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Marson, A (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94158 USA.	sagar.bapat@ucsf.edu; evans@salk.edu; yzheng@salk.edu; alexander.marson@ucsf.edu	Zhang, Ling-juan/V-6141-2019; Gallo, Richard L/A-8931-2009; Suh, Jae Myoung/B-3268-2015	Zhang, Ling-juan/0000-0001-6937-4578; Gallo, Richard L/0000-0002-1401-7861; Jiang, Zewen/0000-0002-3852-8666; Suh, Jae Myoung/0000-0001-8097-4662; Vogel, Ian/0000-0001-6593-3598; Bapat, Sagar/0000-0002-4402-1511	U.S. National Institutes of Health (NIH) [F30 DK096828, T32 GM007198, R38 HL143581, K38 HL154202, P30GM127211, HL147835, HL105278, CA014195]; KAIST [N11210257]; National Research Foundation of Korea [2017K1A1A2013124, 2021R1A2C200757311]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017R1A2B3006406]; NIH [U01AI52038, R01AI53185, R01AR076082, R01DK121760, R37AI052453]; American Heart Association grant [16BGIA27790079]; VA BLR&D Career Development Award [1IK2BX001313]; NOMIS Foundation-Science of Health; HHMI; Foundation Leducq; Don and Lorraine Freeberg Foundation; Larry L. Hillblom foundation; David C. Copley Foundation; NOMIS Foundation; Crohn's and Colitis Foundation; Leona M. and Harry B. Helmsley Charitable Trust; National Institute of Health [R01-AI107027, R01-AI1511123, R21-AI154919, S10-OD023689, NCI CCSG P30-014195]; Cancer Research Institute (CRI) Lloyd J. Old STAR grant; Innovative Genomics Institute (IGI); Simons Foundation; Parker Institute for Cancer Immunotherapy (PICI); National Cancer Institute [CA014195]; James B. Pendleton Charitable Trust; UCSF Parnassus Flow Cytometry Core by the Diabetes Research Center grant from the National Institutes of Health [P30 DK063720]; National Institute of Environmental Health Sciences of the National Institutes of Health [P42ES010337]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK057978, R01DK120480]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAIST; National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); VA BLR&D Career Development Award; NOMIS Foundation-Science of Health; HHMI(Howard Hughes Medical Institute); Foundation Leducq(Leducq Foundation); Don and Lorraine Freeberg Foundation; Larry L. Hillblom foundation; David C. Copley Foundation; NOMIS Foundation; Crohn's and Colitis Foundation; Leona M. and Harry B. Helmsley Charitable Trust; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute (CRI) Lloyd J. Old STAR grant; Innovative Genomics Institute (IGI); Simons Foundation; Parker Institute for Cancer Immunotherapy (PICI); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James B. Pendleton Charitable Trust; UCSF Parnassus Flow Cytometry Core by the Diabetes Research Center grant from the National Institutes of Health; National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Levine for advice and critical review of the manuscript; E. Marsh, B. Shy, S. Dodgson and B. Schaar for review of the manuscript; S. Pyle for scientific graphic illustration; Y. Dai, J. Alvarez, A. Cheng and Y. Zhang for technical assistance; and L. Ong, C. Brondos, J. Woo, J. Okano and J. Sawin for administrative assistance. We thank the Severe Asthma Research Program (SARP) for access to their patient data. S.P.B. was supported by U.S. National Institutes of Health (NIH) grants F30 DK096828, T32 GM007198, R38 HL143581 and K38 HL154202. J.L.S. and B.S.N. were supported by U.S. NIH grant P30GM127211. J.M.S. was supported by KAIST (N11210257) and the National Research Foundation of Korea (2017K1A1A2013124 and 2021R1A2C200757311). I.-K.L was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1A2B3006406). R.L.G. is supported by NIH grants U01AI52038, R01AI53185, R01AR076082, R01DK121760 and R37AI052453. L.E.C.A. was supported by an American Heart Association grant 16BGIA27790079 and a VA BLR&D Career Development Award 1IK2BX001313. R.M.E. holds the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute, a SWCRF Investigator Award, and is supported by the NOMIS Foundation-Science of Health, and by U.S. NIH grants HL147835, HL105278, and CA014195. This research was made possible by funding from HHMI, the Foundation Leducq, the Don and Lorraine Freeberg Foundation, the Larry L. Hillblom foundation, and David C. Copley Foundation. Y.Z. was supported by the NOMIS Foundation, the Crohn's and Colitis Foundation, the Leona M. and Harry B. Helmsley Charitable Trust and the National Institute of Health (R01-AI107027, R01-AI1511123, R21-AI154919, S10-OD023689 and NCI CCSG P30-014195). A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, is an investigator at the Chan Zuckerberg Biohub, and is a recipient of the Cancer Research Institute (CRI) Lloyd J. Old STAR grant. The Marson laboratory has received funds from the Innovative Genomics Institute (IGI), the Simons Foundation, and the Parker Institute for Cancer Immunotherapy (PICI). The Marson laboratory has received gifts from the Byers family, B. Bakar, K. Jordan, and E. Radutzky. This work was also supported by National Cancer Institute funded Salk Institute Cancer Center core facilities (CA014195) and the James B. Pendleton Charitable Trust as well as the UCSF Parnassus Flow Cytometry Core funded in part by the Diabetes Research Center grant from the National Institutes of Health (P30 DK063720). Research reported in this publication was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number P42ES010337 and by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Numbers R01DK057978 and R01DK120480 (all to R.M.E.). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chen T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5196; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eckert L, 2018, J AM ACAD DERMATOL, V78, P54, DOI 10.1016/j.jaad.2017.08.002; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Gooderham MJ, 2018, J AM ACAD DERMATOL, V78, pS28, DOI 10.1016/j.jaad.2017.12.022; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Hastie AT, 2021, AM J RESP CRIT CARE, V203, P882, DOI 10.1164/rccm.202009-3713OC; Hastie AT, 2020, J ALLERGY CLIN IMMUN, V146, P222, DOI 10.1016/j.jaci.2020.01.039; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hearn AP, 2020, CURR OPIN IMMUNOL, V66, P151, DOI 10.1016/j.coi.2020.10.004; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laidlaw TM, 2021, ANN ALLERG ASTHMA IM, V126, P584, DOI 10.1016/j.anai.2021.01.012; Lazar MA, 2017, J CLIN INVEST, V127, P1123, DOI 10.1172/JCI92949; Lee KS, 2006, J IMMUNOL, V177, P5248, DOI 10.4049/jimmunol.177.8.5248; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Man K, 2017, CELL METAB, V25, P11, DOI 10.1016/j.cmet.2016.08.016; McInnes L., 2018, ARXIV180203426, DOI [10.48550/arXiv.1802.03426, DOI 10.48550/ARXIV.1802.03426]; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Nicholas DA, 2019, CELL METAB, V30, P447, DOI 10.1016/j.cmet.2019.07.004; Nobs SP, 2017, J EXP MED, V214, P3015, DOI 10.1084/jem.20162069; Ringel AE, 2020, CELL, V183, P1848, DOI 10.1016/j.cell.2020.11.009; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Stark JM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02318; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034594; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tubau C, 2021, EXPERT REV CLIN IMMU, V17, P15, DOI 10.1080/1744666X.2020.1858802; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zhang A, 2015, J AM ACAD DERMATOL, V72, P606, DOI 10.1016/j.jaad.2014.12.013; Zhang CY, 2020, CELL METAB, V31, P148, DOI 10.1016/j.cmet.2019.10.013	58	13	13	43	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 14	2022	604	7905					337	+		10.1038/s41586-022-04536-0	http://dx.doi.org/10.1038/s41586-022-04536-0		MAR 2022	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0M9OF	35355021	Green Accepted			2022-12-28	WOS:000776020400012
J	Basil, MC; Cardenas-Diaz, FL; Kathiriya, JJ; Morley, MP; Carl, J; Brumwell, AN; Katzen, J; Slovik, KJ; Babu, A; Zhou, S; Kremp, MM; McCauley, KB; Li, SR; Planer, JD; Hussain, SS; Liu, XM; Windmueller, R; Ying, Y; Stewart, KM; Oyster, M; Christie, JD; Diamond, JM; Engelhardt, JF; Cantu, E; Rowe, SM; Kotton, DN; Chapman, HA; Morrisey, EE				Basil, Maria C.; Cardenas-Diaz, Fabian L.; Kathiriya, Jaymin J.; Morley, Michael P.; Carl, Justine; Brumwell, Alexis N.; Katzen, Jeremy; Slovik, Katherine J.; Babu, Apoorva; Zhou, Su; Kremp, Madison M.; McCauley, Katherine B.; Li, Shanru; Planer, Joseph D.; Hussain, Shah S.; Liu, Xiaoming; Windmueller, Rebecca; Ying, Yun; Stewart, Kathleen M.; Oyster, Michelle; Christie, Jason D.; Diamond, Joshua M.; Engelhardt, John F.; Cantu, Edward; Rowe, Steven M.; Kotton, Darrell N.; Chapman, Harold A.; Morrisey, Edward E.			Human distal airways contain a multipotent secretory cell that can regenerate alveoli	NATURE			English	Article							EPITHELIAL SELF-RENEWAL; PLURIPOTENT STEM-CELLS; BRONCHIOLITIS OBLITERANS; IN-VIVO; LUNG; DIFFERENTIATION; OBSTRUCTION; PHENOTYPE; FEATURES; FERRET	Human respiratory bronchioles contain a unique population of secretory cells called respiratory airway secretory cells that are distinct from the cells in the larger proximal airways, and act as unidirectional progenitors for alveolar type 2 cells. The human lung differs substantially from its mouse counterpart, resulting in a distinct distal airway architecture affected by disease pathology in chronic obstructive pulmonary disease. In humans, the distal branches of the airway interweave with the alveolar gas-exchange niche, forming an anatomical structure known as the respiratory bronchioles. Owing to the lack of a counterpart in mouse, the cellular and molecular mechanisms that govern respiratory bronchioles in the human lung remain uncharacterized. Here we show that human respiratory bronchioles contain a unique secretory cell population that is distinct from cells in larger proximal airways. Organoid modelling reveals that these respiratory airway secretory (RAS) cells act as unidirectional progenitors for alveolar type 2 cells, which are essential for maintaining and regenerating the alveolar niche. RAS cell lineage differentiation into alveolar type 2 cells is regulated by Notch and Wnt signalling. In chronic obstructive pulmonary disease, RAS cells are altered transcriptionally, corresponding to abnormal alveolar type 2 cell states, which are associated with smoking exposure in both humans and ferrets. These data identify a distinct progenitor in a region of the human lung that is not found in mouse that has a critical role in maintaining the gas-exchange compartment and is altered in chronic lung disease.	[Basil, Maria C.; Cardenas-Diaz, Fabian L.; Morley, Michael P.; Carl, Justine; Katzen, Jeremy; Slovik, Katherine J.; Babu, Apoorva; Zhou, Su; Kremp, Madison M.; Li, Shanru; Planer, Joseph D.; Ying, Yun; Stewart, Kathleen M.; Oyster, Michelle; Christie, Jason D.; Diamond, Joshua M.; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Basil, Maria C.; Cardenas-Diaz, Fabian L.; Morley, Michael P.; Carl, Justine; Katzen, Jeremy; Slovik, Katherine J.; Babu, Apoorva; Zhou, Su; Kremp, Madison M.; Li, Shanru; Planer, Joseph D.; Windmueller, Rebecca; Ying, Yun; Stewart, Kathleen M.; Cantu, Edward; Morrisey, Edward E.] Univ Penn, Penn Chop Lung Biol Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kathiriya, Jaymin J.; Brumwell, Alexis N.; Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chapman, Harold A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Morley, Michael P.; Slovik, Katherine J.; Babu, Apoorva] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [McCauley, Katherine B.; Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02215 USA; [McCauley, Katherine B.; Kotton, Darrell N.] Boston Med Ctr, Boston, MA USA; [Hussain, Shah S.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Hussain, Shah S.; Rowe, Steven M.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Liu, Xiaoming; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Cantu, Edward] Univ Penn, Perelman Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Kotton, Darrell N.] Boston Univ, Pulm Ctr, Boston, MA 02215 USA; [Kotton, Darrell N.] Boston Univ, Dept Med, Boston, MA 02215 USA; [Windmueller, Rebecca; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Cell & DeveLopmentalBioL, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Boston University; Boston Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Boston University; Boston University; University of Pennsylvania; Pennsylvania Medicine	Morrisey, EE (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Chop Lung Biol Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & DeveLopmentalBioL, Philadelphia, PA 19104 USA.	emorrise@pennmedicine.upenn.edu	Hussain, Shah/ABH-1550-2021	Hussain, Shah/0000-0002-6830-2924; Morley, Michael/0000-0002-0958-7376; Babu, Apoorva/0000-0003-3661-5261; McCauley, Katherine/0000-0002-8817-7120	National Institutes of Health [HL148857, HL087825, HL134745, HL132999, 5T32HL007586-35, 5R03HL135227-02, K23 HL121406, K08 HL150226, DK047967, HL152960, 75N92019R0014, R35HL135816, P30DK072482, U01HL152978, R35HL150767, U01HL134766, F32HL143931-01A1, K99HL155785-01]; BREATH Consortium/Longfunds of the Netherlands; Parker B. Francis Foundation; GSK [RA3000034436]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BREATH Consortium/Longfunds of the Netherlands; Parker B. Francis Foundation; GSK(GlaxoSmithKline)	We thank the patients who contributed to our study, without their willingness to participate in research, these studies would not be possible; the staff at the Cell and Developmental Microscopy Core at the University of Pennsylvania, the Flow Cytometry Core at The Children's Hospital of Philadelphia and the Animal Model Core of the Cystic Fibrosis Research Center of the University of Alabama at Birmingham for assistance in these studies; and M. Beers, V. Krymskya, S. Millar, A. Vaughan and S. Albelda for their critiques and insights throughout the development of the project. This work was supported by grants from the National Institutes of Health including HL148857, HL087825, HL134745 and HL132999 (to E.E.M.); 5T32HL007586-35 (to M.C.B.); 5R03HL135227-02 (to E.C.); K23 HL121406 (to J.M.D.); K08 HL150226 (to J.K.); DK047967, HL152960 and Federal Contract 75N92019R0014 (to J.F.E.); R35HL135816, P30DK072482, and U01HL152978 (to S.M.R.), R35HL150767 and U01HL134766 (to H.A.C.); and F32HL143931-01A1 and K99HL155785-01 (to J.J.K.). E.E.M. was also supported by the BREATH Consortium/Longfunds of the Netherlands. J.K. was supported by the Parker B. Francis Foundation. F.L.C.-D. was supported by a postdoctoral fellowship from GSK (RA3000034436). The embryonic stem cell experiments in this manuscript were not funded as part of the research agreement between University of Pennsylvania and GSK.	BAL HS, 1988, LAB ANIM, V22, P76, DOI 10.1258/002367788780746539; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Basil MC, 2020, CELL STEM CELL, V26, P482, DOI 10.1016/j.stem.2020.03.009; Burney PGJ, 2015, EUR RESPIR J, V45, P1239, DOI 10.1183/09031936.00142414; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calabrese DR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133083; Chapin C, 2012, AM J PHYSIOL-LUNG C, V302, pL216, DOI 10.1152/ajplung.00055.2011; Choi J, 2021, NAT CELL BIOL, V23, P953, DOI 10.1038/s41556-021-00742-6; Diamond JM, 2013, AM J RESP CRIT CARE, V187, P527, DOI 10.1164/rccm.201210-1865OC; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Fretzayas A, 2017, WORLD J PEDIATR, V13, P293, DOI 10.1007/s12519-017-0031-8; Ganguly K, 2014, AM J RESP CELL MOL, V51, P637, DOI 10.1165/rcmb.2013-0471OC; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Ghorani V, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0130-2; Gomez R, 2004, ANN ALLERG ASTHMA IM, V93, P447, DOI 10.1016/S1081-1206(10)61411-1; Gotoh S, 2014, STEM CELL REP, V3, P394, DOI 10.1016/j.stemcr.2014.07.005; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hawkins F, 2017, J CLIN INVEST, V127, P2277, DOI 10.1172/JCI89950; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; HYDE D M, 1979, Scanning Electron Microscopy, P891; Jacob A, 2019, NAT PROTOC, V14, P3303, DOI 10.1038/s41596-019-0220-0; Jacob A, 2017, CELL STEM CELL, V21, P472, DOI 10.1016/j.stem.2017.08.014; Kathiriya JJ, 2022, NAT CELL BIOL, V24, P10, DOI 10.1038/s41556-021-00809-4; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Koo HK, 2018, LANCET RESP MED, V6, P591, DOI 10.1016/S2213-2600(18)30196-6; Lin SE, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12657; Lin VY, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00419-2019; McCauley KB, 2018, STEM CELL REP, V10, P1579, DOI 10.1016/j.stemcr.2018.03.013; McCauley KB, 2017, CELL STEM CELL, V20, P844, DOI 10.1016/j.stem.2017.03.001; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; Miller AJ, 2020, DEV CELL, V53, P117, DOI 10.1016/j.devcel.2020.01.033; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Raju SV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87536; Regeling A, 2016, BBA-MOL BASIS DIS, V1862, P788, DOI 10.1016/j.bbadis.2016.01.020; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Shikotra A, 2017, J IMMUNOL, V198, P3307, DOI 10.4049/jimmunol.1600606; Stanford D, 2020, AM J PHYSIOL-LUNG C, V319, pL11, DOI 10.1152/ajplung.00328.2019; Sterner-Kock A, 2000, AM J RESP CRIT CARE, V162, P1152, DOI 10.1164/ajrccm.162.3.9812153; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stupnikov MR, 2019, ELIFE, V8, DOI 10.7554/eLife.50487; TENHAVEOPBROEK AAW, 1991, ANAT REC, V229, P339; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Van den Berge K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14766-3; Verleden SE, 2021, LANCET RESP MED, V9, P167, DOI 10.1016/S2213-2600(20)30324-6; Verleden SE, 2016, CHEST, V150, P219, DOI 10.1016/j.chest.2016.04.014; Verleden SE, 2014, AM J RESP CRIT CARE, V189, P292, DOI 10.1164/rccm.201310-1894OC; VINEGAR A, 1985, LAB ANIM SCI, V35, P246; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P41, DOI 10.1513/pats.200512-124JH; Weibel ER, 2005, RESP PHYSIOL NEUROBI, V148, P3, DOI 10.1016/j.resp.2005.03.005; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zappia L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy083; Zepp JA, 2019, NAT REV MOL CELL BIO, V20, P551, DOI 10.1038/s41580-019-0141-3; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034	65	14	14	23	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					120	+		10.1038/s41586-022-04552-0	http://dx.doi.org/10.1038/s41586-022-04552-0		MAR 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355013				2022-12-28	WOS:000776020400003
J	[Anonymous]				[Anonymous]			Summary for Patients: Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					I26	I26		10.7326/P22-0003	http://dx.doi.org/10.7326/P22-0003		MAR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2U5RH	35344375				2022-12-28	WOS:000779639700001
J	Wise, J				Wise, Jacqui			Covid-19: Researchers call for routine flu testing of hospital inpatients with SARS-CoV-2 infection	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Swets MC, 2022, LANCET, V399, P1463, DOI 10.1016/S0140-6736(22)00383-X	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o809	10.1136/bmj.o809	http://dx.doi.org/10.1136/bmj.o809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346952	Bronze			2022-12-28	WOS:000778641000007
J	Watkins, DA; Msemburi, WT; Pickersgill, SJ; Kawakatsu, Y; Gheorghe, A; Dain, K; Johansson, KA; Said, S; Renshaw, N; Tolla, MT; Twea, PD; Varghese, C; Chalkidou, K; Ezzati, M; Norheim, OF				Watkins, David A.; Msemburi, William T.; Pickersgill, Sarah J.; Kawakatsu, Yoshito; Gheorghe, Adrian; Dain, Katie; Johansson, Kjell Arne; Said, Sanaa; Renshaw, Nina; Tolla, Mieraf T.; Twea, Pakwanja D.; Varghese, Cherian; Chalkidou, Kalipso; Ezzati, Majid; Norheim, Ole F.		NCD Countdown 2030 Collaborators	NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries	LANCET			English	Article							DISEASE-CONTROL-PRIORITIES; UNIVERSAL HEALTH COVERAGE; KEY MESSAGES; NONCOMMUNICABLE DISEASES; COST-EFFECTIVENESS; GLOBAL HEALTH; CANCER; IMPLEMENTATION; INTERVENTIONS; INTEGRATION	Most countries have made little progress in achieving the Sustainable Development Goal (SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable diseases (NCDs) by a third from 2015 to 2030. In this Health Policy paper, we synthesise the evidence related to interventions that can reduce premature mortality from the major NCDs over the next decade and that are feasible to implement in countries at all levels of income. Our recommendations are intended as generic guidance to help 123 low-income and middle-income countries meet SDG target 3.4; country-level applications require additional analyses and consideration of the local implementation and utilisation context. Protecting current investments and scaling up these interventions is especially crucial in the context of COVID-19-related health system disruptions. We show how cost-effectiveness data and other information can be used to define locally tailored packages of interventions to accelerate rates of decline in NCD mortality. Under realistic implementation constraints, most countries could achieve (or almost achieve) the NCD target using a combination of these interventions; the greatest gains would be for cardiovascular disease mortality. Implementing the most efficient package of interventions in each world region would require, on average, an additional US$18 billion annually over 2023-30; this investment could avert 39 million deaths and generate an average net economic benefit of $2.7 trillion, or $390 per capita. Although specific clinical intervention pathways would vary across countries and regions, policies to reduce behavioural risks, such as tobacco smoking, harmful use of alcohol, and excess sodium intake, would be relevant in nearly every country, accounting for nearly two-thirds of the health gains of any locally tailored NCD package. By 2030, ministries of health would need to contribute about 20% of their budgets to high-priority NCD interventions. Our report concludes with a discussion of financing and health system implementation considerations and reflections on the NCD agenda beyond the SDG target 3A and beyond the SDG period.	[Watkins, David A.] Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA; [Watkins, David A.; Pickersgill, Sarah J.; Kawakatsu, Yoshito] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Msemburi, William T.] WHO, Div Data Analyt & Delivery Impact, Geneva, Switzerland; [Gheorghe, Adrian; Chalkidou, Kalipso; Ezzati, Majid] Imperial Coll London, Sch Publ Hlth, London, England; [Dain, Katie; Renshaw, Nina] NCD Alliance, London, England; [Johansson, Kjell Arne; Norheim, Ole F.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Johansson, Kjell Arne] Haukeland Hosp, Dept Addict Med, Bergen, Norway; [Said, Sanaa] State Univ Zanzibar, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Tolla, Mieraf T.] Addis Ababa Univ, Addis Ctr Eth & Prior Setting, Addis Ababa, Ethiopia; [Twea, Pakwanja D.] Minist Hlth, Dept Planning & Policy Dev, Lilongwe, Malawi; [Varghese, Cherian] WHO, Dept Noncommunicable Dis, Geneva, Switzerland; [Ezzati, Majid] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Norheim, Ole F.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; World Health Organization; Imperial College London; University of Bergen; University of Bergen; Haukeland University Hospital; Addis Ababa University; World Health Organization; University of Ghana; Harvard University; Harvard T.H. Chan School of Public Health	Watkins, DA (corresponding author), Univ Washington, Hans Rosling Ctr Populat Hlth, Dept Global Hlth, Seattle, WA 98195 USA.	davidaw@uw.edu	Norheim, Ole Frithjof/AAC-8771-2020	Norheim, Ole Frithjof/0000-0002-5748-5956	Trond Mohn Foundation; Norwegian Agency for Development Cooperation; University of Bergen through the Bergen Centre for Ethics [813596]; UK Research and Innovation's Medical Research Council [MR/V034057/1]	Trond Mohn Foundation; Norwegian Agency for Development Cooperation; University of Bergen through the Bergen Centre for Ethics; UK Research and Innovation's Medical Research Council	The authors wish to thank James Bennett for contributing epidemiological data used in this Health Policy and Robert Beaglehole for providing important comments on an earlier draft of the manuscript. This Health Policy was supported by the Trond Mohn Foundation, the Norwegian Agency for Development Cooperation, the University of Bergen through the Bergen Centre for Ethics and Priority Setting (project number 813596) , and the UK Research and Innovation's Medical Research Council (grant number MR/V034057/1) . The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility to submit for publication.	Allen LN, 2020, LANCET GLOB HEALTH, V8, pE50, DOI 10.1016/S2214-109X(19)30446-2; Barroy H, 2018, HEALTH SYST REFORM, V4, P214, DOI 10.1080/23288604.2018.1441620; Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Bertram M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1648; Bertram MY, 2018, LANCET, V391, P2071, DOI [10.1016/S0140-6736(18)30665-2, 10.1016/s0140-6736(18)30665-2]; Bukhman G, 2020, LANCET, V396, P991, DOI 10.1016/S0140-6736(20)31907-3; Chan JCN, 2020, LANCET, V396, P2019, DOI 10.1016/S0140-6736(20)32374-6; Chang AY, 2017, DIS CONTROL PRIORITI, V9, P167; Coady D, 2017, WORLD DEV, V91, P11, DOI 10.1016/j.worlddev.2016.10.004; Collins TE, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4499; Curti D, 2019, TOB CONTROL, V28, pS53, DOI 10.1136/tobaccocontrol-2017-054218; Delobelle P, 2019, INT J HEALTH POLICY, V8, P727, DOI 10.15171/ijhpm.2019.74; Ebrahim S, 2020, B WORLD HEALTH ORGAN, V98, P438, DOI 10.2471/BLT.20.254110; Eregata GT, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1829313; Ethiopian Public Health Institute, 2016, ETH STEPS REP RISK F; Ethiopian Public Health Institute, 2016, ETH SERV AV READ ASS; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Federal Ministry of Health, 2019, ETH HLTH ACC 2016 17; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Gerayeli FV, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100789; Gospodarowicz M, 2015, CANC DIS CONTROL PRI, V3, P195; Government of Malawi, 2018, HLTH SECT RES MAPP F; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Harrison SL, 2021, EUR HEART J-QUAL CAR, V7, P330, DOI 10.1093/ehjqcco/qcab029; Hensher M, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1229; Hoffer-Hawlik MA, 2020, GLOB HEART, V15, DOI 10.5334/gh.852; Horton S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182951; Isaranuwatchai W, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m141; Jailobaeva K, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00713-4; Jamison DT, 2018, LANCET, V391, P1108, DOI 10.1016/S0140-6736(17)32906-9; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4; Kemp CG, 2018, AIDS, V32, pS93, DOI 10.1097/QAD.0000000000001897; Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9; Kontis V, 2022, WELLCOME OPEN RES, V6, P279; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Kostova D, 2021, HEALTH SECUR, V19, P288, DOI 10.1089/hs.2020.0121; Lane C, 2020, MEASURING EFFECTIVEN; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Ministry of Health of Ethiopia, 2019, ESS HLTH SERV PACK E; Norwegian Ministry of Foreign Affairs Norwegian Ministry of Health and Care Services, 2019, PNP CHIEF WANTS BETT; Nugent R, 2018, AIDS, V32, pS83, DOI 10.1097/QAD.0000000000001884; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; Ochalek J, 2015, COST DALY AVERTED TH; Oroxom R, 2018, CGD POLICY PAPER; Prabhakaran D, 2018, LANCET, V391, P1224, DOI 10.1016/S0140-6736(17)32471-6; Robinson L. A., 2019, REFERENCE CASE GUIDE; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Ruiz R, 2017, CANCER-AM CANCER SOC, V123, P1313, DOI 10.1002/cncr.30549; Sankoh O, 2020, LANCET GLOB HEALTH, V8, pE33, DOI 10.1016/S2214-109X(19)30442-5; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Tolla MT, 2017, BMJ GLOB HEALTH, V2, DOI [10.1136/bmjgh-2016-000216, 10.1136/bmjgh-2016-000280]; UN Interagency Task Force on NCDs, 2020, CAT FUND NONC DIS ME; UN Sustainable Development Goals, 2016, GOAL 3 ENS HLTH LIV; Van Biesen W, 2020, KIDNEY INT SUPPL, V10, pE63, DOI 10.1016/j.kisu.2019.11.004; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE288, DOI 10.1016/S2214-109X(14)70346-8; Watkins DA, 2018, COSTING UNIVERSAL HL; Watkins D, 2019, B WORLD HEALTH ORGAN, V97, P442, DOI 10.2471/BLT.19.236356; Watkins D, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001335; Watkins DA, 2020, LANCET GLOB HEALTH, V8, pE829, DOI 10.1016/S2214-109X(20)30121-2; Watkins DA, 2018, LANCET, V392, P1434, DOI 10.1016/S0140-6736(18)32389-4; WHO, 2014, HEALTH OF THE PEOPLE: WHAT WORKS, P1; WHO, 2011, INT ACT HLTH PATH PO; WHO, 2016, GLOBAL REPORT DIABET; WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases, 2015, FIN REP REC WORK GRO; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2020, GLOB HLTH EST LIF EX; World Health Organization, 2020, RAP ASS SERV DEL NCD; World Health Organization, 2017, REP GLOB TOB EP 2017; World Health Organization, 2017, TECHN ANN UPD APP 3; Yang LD, 2021, CANCER BIOL MED, V18, P298, DOI 10.20892/j.issn.2095-3941.2020.0559	74	6	6	5	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1266	1278						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I5XZ	35339227	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000779495000024
J	Busley, E; Miranda, LE; Redmann, A; Kurtscheid, C; Umesh, KK; Vewinger, F; Weitz, M; Schmitt, J				Busley, Erik; Miranda, Leon Espert; Redmann, Andreas; Kurtscheid, Christian; Umesh, Kirankumar Karkihalli; Vewinger, Frank; Weitz, Martin; Schmitt, Julian			Compressibility and the equation of state of an optical quantum gas in a box	SCIENCE			English	Article							POTENTIALS; SYSTEMS; PHYSICS; LIGHT	The compressibility of a medium, quantifying its response to mechanical perturbations, is a fundamental property determined by the equation of state. For gases of material particles, studies of the mechanical response are well established, in fields from classical thermodynamics to cold atomic quantum gases. We demonstrate a measurement of the compressibility of a two-dimensional quantum gas of light in a box potential and obtain the equation of state for the optical medium. The experiment was carried out in a nanostructured dye-filled optical microcavity. We observed signatures of Bose-Einstein condensation at high phase-space densities in the finite-size system. Upon entering the quantum degenerate regime, the measured density response to an external force sharply increases, hinting at the peculiar prediction of an infinite compressibility of the deeply degenerate Bose gas.	[Busley, Erik; Miranda, Leon Espert; Redmann, Andreas; Kurtscheid, Christian; Umesh, Kirankumar Karkihalli; Vewinger, Frank; Weitz, Martin; Schmitt, Julian] Univ Bonn, Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany	University of Bonn	Schmitt, J (corresponding author), Univ Bonn, Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany.	schmitt@iap.uni-bonn.de		Karkihalli Umesh, Kirankumar/0000-0002-3644-1233; Busley, Erik/0000-0003-2050-5316; Vewinger, Frank/0000-0001-7818-2981; Kurtscheid, Christian/0000-0002-9171-285X; Schmitt, Julian/0000-0002-0002-3777; Espert Miranda, Leon/0000-0002-7460-3387; Redmann, Andreas/0000-0002-6825-2875	DFG [SFB/TR 185 (277625399), EXC 2004/1-390534769]; EU within the Quantum Flagship project PhoQuS [820392]; ML4Q Independence grant	DFG(German Research Foundation (DFG)); EU within the Quantum Flagship project PhoQuS; ML4Q Independence grant	This work was supported by the DFG within SFB/TR 185 (277625399) and the Cluster of Excellence ML4Q (EXC 2004/1-390534769) and by the EU within the Quantum Flagship project PhoQuS (820392). J.S. acknowledges support from an ML4Q Independence grant.	Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bohlen M, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.240403; Busley E.., 2021, ZENODO, DOI [10.5281/zenodo.5775757, DOI 10.5281/ZENODO.5775757]; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Christodoulou P, 2021, NATURE, V594, P191, DOI 10.1038/s41586-021-03537-9; Comaron P, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.095302; Damm T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11340; Diehl S, 2008, NAT PHYS, V4, P878, DOI 10.1038/nphys1073; Dung D, 2017, NAT PHOTONICS, V11, P565, DOI 10.1038/NPHOTON.2017.139; Estrecho E, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.075301; Fletcher RJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255302; Ghosh A, 2019, EUR PHYS J-SPEC TOP, V227, P2043, DOI 10.1140/epjst/e2019-800060-7; Gioia G, 1997, ADV APPL MECH, V33, P119, DOI 10.1016/S0065-2156(08)70386-7; Gladilin VN, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.215301; Greveling S, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.013810; Hadzibabic Z, 2011, RIV NUOVO CIMENTO, V34, P389, DOI 10.1393/ncr/i2011-10066-3; Ho TL, 2010, NAT PHYS, V6, P131, DOI 10.1038/NPHYS1477; Hung CL, 2011, NATURE, V470, P236, DOI 10.1038/nature09722; Klaers J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.160403; Klaers J, 2010, NATURE, V468, P545, DOI 10.1038/nature09567; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Kurtscheid C, 2020, EPL-EUROPHYS LETT, V130, DOI 10.1209/0295-5075/130/54001; Marelic J, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033813; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Mordini C, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.150404; Navon N, 2010, SCIENCE, V328, P729, DOI 10.1126/science.1187582; Pitaevskii L., 2016, BOSE EINSTEIN CONDEN, DOI DOI 10.1093/ACPROF:OSO/9780198758884.001.0001; Schmitt J, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aad409; Schmitt J, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.011602; Stepanov B.I., 1971, J APPL SPECTROSC+, V14, P596, DOI 10.1007/BF00605796; Tammuz N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230401; Ville JL, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.145301; Walker BT, 2021, OPT EXPRESS, V29, P10800, DOI 10.1364/OE.422127; Yefsah T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.130401; Zamora A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041006	35	3	3	4	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1403	+		10.1126/science.abm2543	http://dx.doi.org/10.1126/science.abm2543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324306	Green Submitted			2022-12-28	WOS:000778894800042
J	Jeon, S; Hwang, SY; Ciston, J; Bustillo, KC; Reed, BW; Hong, S; Zettl, A; Kim, WY; Ercius, P; Park, J; Lee, WC				Jeon, Sungho; Hwang, Sang-Yeon; Ciston, Jim; Bustillo, Karen C.; Reed, Bryan W.; Hong, Sukjoon; Zettl, Alex; Kim, Woo Youn; Ercius, Peter; Park, Jungwon; Lee, Won Chul			Response to Comment on "Reversible disorder-order transitions in atomic crystal nucleation"	SCIENCE			English	Editorial Material							NANOPARTICLES; CLUSTERS	Yu et al. suggested calculating precisely the size ranges of the three parts of our figure 3A, adjusting the free-energy levels in figure 3B, and considering the shape effect in the first-principles calculation. The first and second suggestions raise strong concerns for misinterpretation and overinterpretation of our experiments. The original calculation is sufficient to support our claim about crystalline-to-disordered transformations.	[Jeon, Sungho; Hong, Sukjoon; Lee, Won Chul] Hanyang Univ, BK21FOUR ERICA ACE Ctr, Dept Mech Engn, Ansan 15588, Gyeonggi, South Korea; [Hwang, Sang-Yeon; Kim, Woo Youn] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon 34141, South Korea; [Ciston, Jim; Bustillo, Karen C.; Ercius, Peter] Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Reed, Bryan W.] Integrated Dynam Electron Solut Inc, Pleasanton, CA 94588 USA; [Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Zettl, Alex] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Zettl, Alex] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Park, Jungwon] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 08826, South Korea; [Park, Jungwon] Seoul Natl Univ, Inst Chem Proc, Seoul 08826, South Korea; [Park, Jungwon] Inst for Basic Sci Korea, Ctr Nanoparticle Res, Seoul 08826, South Korea; [Jeon, Sungho] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Hwang, Sang-Yeon] HITS Inc, Seoul 06234, South Korea	Hanyang University; Korea Advanced Institute of Science & Technology (KAIST); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); University of Pennsylvania	Lee, WC (corresponding author), Hanyang Univ, BK21FOUR ERICA ACE Ctr, Dept Mech Engn, Ansan 15588, Gyeonggi, South Korea.; Ercius, P (corresponding author), Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA.; Park, J (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 08826, South Korea.; Park, J (corresponding author), Seoul Natl Univ, Inst Chem Proc, Seoul 08826, South Korea.; Park, J (corresponding author), Inst for Basic Sci Korea, Ctr Nanoparticle Res, Seoul 08826, South Korea.	percius@lbl.gov; jungwonpark@snu.ac.kr; wonchullee@hanyang.ac.kr			National Research Foundation of Korea - Korea government (MSIT) [2021R1A2C1011797]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Institutes for Basic Science [IBS-R006-D1]	National Research Foundation of Korea - Korea government (MSIT); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Institutes for Basic Science	Supported by a National Research Foundation of Korea grant funded by the Korea government (MSIT) under contract 2021R1A2C1011797. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract DE-AC02-05CH11231. J.P. acknowledges financial support from Institutes for Basic Science (IBS-R006-D1).	Aiken JD, 1999, J MOL CATAL A-CHEM, V145, P1, DOI 10.1016/S1381-1169(99)00098-9; Azubel M, 2014, SCIENCE, V345, P909, DOI 10.1126/science.1251959; Barnard AS, 2009, ACS NANO, V3, P1431, DOI 10.1021/nn900220k; Chakraborty I, 2017, CHEM REV, V117, P8208, DOI 10.1021/acs.chemrev.6b00769; Garzon IL, 1998, PHYS REV LETT, V81, P1600, DOI 10.1103/PhysRevLett.81.1600; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Jeon S, 2021, SCIENCE, V371, P498, DOI 10.1126/science.aaz7555; Li L, 2013, J AM CHEM SOC, V135, P13062, DOI 10.1021/ja405497p; Petkov V, 2008, J PHYS CHEM C, V112, P8907, DOI 10.1021/jp801195c; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Stevens S., 2019, INTRO STAT THINK DO; Sun Y, 2007, J AM CHEM SOC, V129, P15465, DOI 10.1021/ja076177b; Wang ZW, 2012, NANO LETT, V12, P5510, DOI 10.1021/nl303429z; Yu C.-L., 2022, SCIENCE, V375	14	0	0	6	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI					10.1126/science.abj3683	http://dx.doi.org/10.1126/science.abj3683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0H7EO	35324302	Green Submitted			2022-12-28	WOS:000778894800002
J	Wang, S; Sears, JD; Moore, CE; Rheingold, AL; Neidig, ML; Figueroa, JS				Wang, Shuai; Sears, Jeffrey D.; Moore, Curtis E.; Rheingold, Arnold L.; Neidig, Michael L.; Figueroa, Joshua S.			Side-on coordination of diphosphorus to a mononuclear iron center	SCIENCE			English	Article							NMR SHIELDING CONSTANTS; CORRELATION-ENERGY; BASIS-SETS; AB-INITIO; P-2; PHOSPHORUS; COMPLEXES; CHEMISTRY; ACTIVATION; VALENCE	The diagonal relationship in the periodic table between phosphorus and carbon has set an expectation that the triple-bonded diatomic diphosphorus molecule (P-2) should more closely mimic the attributes of acetylene (HC CH) rather than its group 15 congener dinitrogen (N-2). Although acetylene has well-documented coordination chemistry with mononuclear transition metals, coordination complexes that feature P-2 bound to a single metal center have remained elusive. We report the isolation and x-ray crystallographic characterization of a mononuclear iron complex featuring P-2 coordination in a side-on, eta(2)-binding mode. An analogous eta(2)-bound bis-timethylsilylacetylene iron complex is reported for comparison. Nuclear magnetic resonance, infrared, and Mossbauer spectroscopic analysis-in conjunction with density functional theory calculations-demonstrate that eta(2)-P-2 and eta(2)-acetylene ligands exert a similar electronic demand on mononuclear iron centers but exhibit different reactivity profiles.	[Wang, Shuai; Rheingold, Arnold L.; Figueroa, Joshua S.] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Mail Code 0358, La Jolla, CA 92093 USA; [Sears, Jeffrey D.; Neidig, Michael L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Moore, Curtis E.] Ohio State Univ, Dept Chem, 88 West 18th Ave, Columbus, OH 43210 USA	University of California System; University of California San Diego; University of Rochester; University System of Ohio; Ohio State University	Figueroa, JS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Mail Code 0358, La Jolla, CA 92093 USA.	jsfig@ucsd.edu	Figueroa, Joshua/GSO-0962-2022	Wang, Shuai/0000-0001-9464-6758; Moore, Curtis/0000-0002-3311-7155; Sears, Jeffrey/0000-0002-9444-351X				[Anonymous], 2021, C S DAT CSD VERS 201; Antusek A, 2011, COMPUT THEOR CHEM, V970, P54, DOI 10.1016/j.comptc.2011.05.026; Armarego W.L.F., 2003, PURIFICATION LAB CHE; BARR ME, 1991, J AM CHEM SOC, V113, P3052, DOI 10.1021/ja00008a038; BECKE AD, 1986, J CHEM PHYS, V84, P4524, DOI 10.1063/1.450025; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENSON SW, 1965, J CHEM EDUC, V42, P502, DOI 10.1021/ed042p502; Caporali M, 2010, CHEM REV, V110, P4178, DOI 10.1021/cr900349u; Carpenter AE, 2015, INORG CHEM, V54, P2936, DOI 10.1021/ic5030845; CHATT J, 1953, J CHEM SOC, P2939, DOI 10.1039/jr9530002939; CHATT J, 1957, P CHEM SOC LONDON, P208; Cossairt BM, 2010, CHEM REV, V110, P4164, DOI 10.1021/cr9003709; Dillon K. B., 1998, PHOSPHORUS CARBON CO; Ditri TB, 2018, INORG SYN, V37, P109; Ditri TB, 2009, INORG CHEM, V48, P8362, DOI 10.1021/ic9010828; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Dransfeld A, 1998, CHEM PHYS, V234, P69, DOI 10.1016/S0301-0104(98)00163-3; Esterhuysen C, 2003, CHEM-EUR J, V9, P3518, DOI 10.1002/chem.200304723; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; Glendening E., 2013, NBO VERSION 3 1; GOLDBERG KI, 1982, INORG CHEM, V21, P3863, DOI 10.1021/ic00141a001; Greenwood N.N., 1997, CHEM ELEMENTS; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; Huber K.P., 1979, MOL SPECTRA MOL STRU, DOI DOI 10.1007/978-1-4757-0961-2; Kraus F, 2003, ANGEW CHEM INT EDIT, V42, P4030, DOI 10.1002/anie.200351776; KUTZELNIGG W, 1984, ANGEW CHEM INT EDIT, V23, P272, DOI 10.1002/anie.198402721; LAZZERETTI P, 1987, J PHYS CHEM-US, V91, P800, DOI 10.1021/j100288a010; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu L, 2016, CHEM SCI, V7, P2335, DOI 10.1039/c5sc04504e; Mandla KA, 2019, ANGEW CHEM INT EDIT, V58, P1779, DOI 10.1002/anie.201809042; Maxwell LR, 1935, J CHEM PHYS, V3, P699, DOI 10.1063/1.1749580; Melville HW, 1936, T FARADAY SOC, V32, P0271, DOI 10.1039/tf9363200271; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Nixon JF, 1995, COORDIN CHEM REV, V145, P201; Olkowska-Oetzel J, 2003, APPL ORGANOMET CHEM, V17, P28, DOI 10.1002/aoc.387; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; PERDEW JP, 1986, PHYS REV B, V34, P7406, DOI 10.1103/PhysRevB.34.7406; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peresypkina E, 2021, COORDIN CHEM REV, V446, DOI 10.1016/j.ccr.2021.213995; Piro NA, 2008, J AM CHEM SOC, V130, P9524, DOI 10.1021/ja802080m; Piro NA, 2006, SCIENCE, V313, P1276, DOI 10.1126/science.1129630; Popov IA, 2014, CHEMICAL BOND: CHEMICAL BONDING ACROSS THE PERIODIC TABLE, P421; Rayner-Canham G., 2011, FOUND CHEM, V13, P121, DOI DOI 10.1007/s10698-011-9108-y; Rottschafer D, 2019, CHEM-EUR J, V25, P8127, DOI 10.1002/chem.201901204; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Spek AL, 2015, ACTA CRYSTALLOGR C, V71, P9, DOI 10.1107/S2053229614024929; Stevenson DP, 1941, J CHEM PHYS, V9, P403, DOI 10.1063/1.1750923; Sun J, 2021, CHEM-US, V7, P1952, DOI 10.1016/j.chempr.2021.06.006; TEMPLETON JL, 1989, ADV ORGANOMET CHEM, V29, P1, DOI 10.1016/S0065-3055(08)60352-4; Tofan D, 2010, ANGEW CHEM INT EDIT, V49, P7516, DOI 10.1002/anie.201004385; Transue WJ, 2017, J AM CHEM SOC, V139, P10822, DOI 10.1021/jacs.7b05464; Velian A, 2014, J AM CHEM SOC, V136, P13586, DOI 10.1021/ja507922x; Velian A, 2012, CHEM SCI, V3, P1003, DOI 10.1039/c2sc00931e; VIZIOROS.A, 1973, J ORGANOMET CHEM, V60, pC25, DOI 10.1016/S0022-328X(00)85423-6; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Xu LT, 2015, J CHEM THEORY COMPUT, V11, P2496, DOI 10.1021/acs.jctc.5b00104; Zhurko G.A., 2014, CHEMCRAFT VERSION 1	60	0	0	14	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1393	+		10.1126/science.abn7100	http://dx.doi.org/10.1126/science.abn7100			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324298				2022-12-28	WOS:000778894800040
J	Dyer, C				Dyer, Clare			Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o787	10.1136/bmj.o787	http://dx.doi.org/10.1136/bmj.o787			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35332030				2022-12-28	WOS:000778460100015
J	Fralick, M; Colacci, M; Munshi, L; Venus, K; Fidler, L; Hussein, H; Britto, K; Fowler, R; da Costa, BR; Dhalla, I; Dunbar-Yaffe, R; Day, LB; MacMillan, TE; Zipursky, J; Carpenter, T; Tang, T; Cooke, A; Hensel, R; Bregger, M; Gordon, A; Worndl, E; Go, S; Mandelzweig, K; Castellucci, LA; Tamming, D; Razak, F; Verma, AA				Fralick, Michael; Colacci, Michael; Munshi, Laveena; Venus, Kevin; Fidler, Lee; Hussein, Haseena; Britto, Karen; Fowler, Rob; da Costa, Bruno R.; Dhalla, Irfan; Dunbar-Yaffe, Richard; Day, Leora Branfield; MacMillan, Thomas E.; Zipursky, Jonathan; Carpenter, Travis; Tang, Terence; Cooke, Amanda; Hensel, Rachel; Bregger, Melissa; Gordon, Alexis; Worndl, Erin; Go, Stephanie; Mandelzweig, Keren; Castellucci, Lana A.; Tamming, Daniel; Razak, Fahad; Verma, Amol A.		COVID Prone Study Investigators	Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To assess the effectiveness of prone positioning to reduce the risk of death or respiratory failure in non-critically ill patients admitted to hospital with covid-19. DESIGN Multicentre pragmatic randomised clinical trial. SETTING 15 hospitals in Canada and the United States from May 2020 until May 2021. PARTICIPANTS Eligible patients had a laboratory confirmed or a clinically highly suspected diagnosis of covid-19, needed supplemental oxygen (up to 50% fraction of inspired oxygen), and were able to independently lie prone with verbal instruction. Of the 570 patients who were assessed for eligibility, 257 were randomised and 248 were included in the analysis. INTERVENTION Patients were randomised 1:1 to prone positioning (that is, instructing a patient to lie on their stomach while they are in bed) or standard of care (that is, no instruction to adopt prone position). MAIN OUTCOME MEASURES The primary outcome was a composite of in-hospital death, mechanical ventilation, or worsening respiratory failure defined as needing at least 60% fraction of inspired oxygen for at least 24 hours. Secondary outcomes included the change in the ratio of oxygen saturation to fraction of inspired oxygen. RESULTS The trial was stopped early on the basis of futility for the pre-specified primary outcome. The median time from hospital admission until randomisation was 1 day, the median age of patients was 56 (interquartile range 45-65) years, 89 (36%) patients were female, and 222 (90%) were receiving oxygen via nasal prongs at the time of randomisation. The median time spent prone in the first 72 hours was 6 (1.5-12.8) hours in total for the prone arm compared with 0 (0-2) hours in the control arm. The risk of the primary outcome was similar between the prone group (18 (14%) events) and the standard care group (17 (14%) events) (odds ratio 0.92, 95% confidence interval 0.44 to 1.92). The change in the ratio of oxygen saturation to fraction of inspired oxygen after 72 hours was similar for patients randomised to prone positioning and standard of care. CONCLUSION Among non-critically ill patients with hypoxaemia who were admitted to hospital with covid-19, a multifaceted intervention to increase prone positioning did not improve outcomes. However, wide confidence intervals preclude definitively ruling out benefit or harm. Adherence to prone positioning was poor, despite multiple efforts to increase it. Subsequent trials of prone positioning should aim to develop strategies to improve adherence to awake prone positioning. STUDY REGISTRATION ClinicalTrials.gov NCT04383613.	[Fralick, Michael] Sinai Hlth, Div Gen Internal Med, Toronto, ON, Canada; [Colacci, Michael; Day, Leora Branfield] Univ Toronto, Dept Med, Gen Internal Med, Toronto, ON, Canada; [Munshi, Laveena] Mt Sinai Hosp, Interdept Div Crit Care Med, Toronto, ON, Canada; [Venus, Kevin; MacMillan, Thomas E.] Univ Hlth Network, Div Gen Internal Med & Geriatr, Toronto, ON, Canada; [Fidler, Lee] Sunnybrook Hlth Sci Ctr, Div Respirol, Toronto, ON, Canada; [Hussein, Haseena; Britto, Karen] William Osler Hlth Syst, Dept Med, Brampton, ON, Canada; [Fowler, Rob] Univ Hlth Network, Interdept Div Crit Care Med, Toronto, ON, Canada; [da Costa, Bruno R.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr AHRC, Toronto, ON, Canada; [Dhalla, Irfan; Razak, Fahad; Verma, Amol A.] St Michaels Hosp, Unity Hlth Toronto, Div Gen Internal Med, Toronto, ON, Canada; [Dunbar-Yaffe, Richard] Sinai Hlth Syst, Div Gen Internal Med & Geriatr, Toronto, ON, Canada; [Dunbar-Yaffe, Richard] Univ Hlth Network, Toronto, ON, Canada; [Zipursky, Jonathan] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Carpenter, Travis] Unity Hlth Toronto, Div Gen Internal Med, St Josephs Hlth Ctr, Toronto, ON, Canada; [Carpenter, Travis] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tang, Terence] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada; [Cooke, Amanda; Hensel, Rachel] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Bregger, Melissa] Northwestern Univ, Div Hosp Med, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Gordon, Alexis; Worndl, Erin] Scarborough Hlth Network, Dept Med, Scarborough, ON, Canada; [Go, Stephanie; Mandelzweig, Keren] Humber River Hosp, Dept Med, Toronto, ON, Canada; [Castellucci, Lana A.] Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Tamming, Daniel] Unity Hlth Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Toronto; University of Toronto; Trillium Health Partners; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; Feinberg School of Medicine; University of Ottawa; Ottawa Hospital Research Institute	Fralick, M (corresponding author), Sinai Hlth, Div Gen Internal Med, Toronto, ON, Canada.	mike.fralick@mail.utoronto.ca	Bregger, Melissa/HDM-9770-2022	MacMillan, Thomas/0000-0002-1964-678X; Bregger, Melissa/0000-0002-4437-7622	St Michael's Hospital Innovation Fund; Sinai Health Research Fund; Sunnybrook Health Sciences Centre Alternate Funding Plan Innovation Fund	St Michael's Hospital Innovation Fund; Sinai Health Research Fund; Sunnybrook Health Sciences Centre Alternate Funding Plan Innovation Fund	This study was funded by St Michael's Hospital Innovation Fund, the Sinai Health Research Fund, and Sunnybrook Health Sciences Centre Alternate Funding Plan Innovation Fund. The funders had no role in considering the study design or in the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the article for publication.	Bloomfield R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008095.pub2; C.chen, 2020, medRxiv, DOI 10.1101/2020.03.11.20030957; Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994; Ehrmann S, 2021, LANCET RESP MED, V9, P1387, DOI 10.1016/S2213-2600(21)00356-8; Elharrar X, 2020, JAMA-J AM MED ASSOC, V323, P2336, DOI 10.1001/jama.2020.8255; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Johnson SA, 2021, ANN AM THORAC SOC, V18, P1423, DOI 10.1513/AnnalsATS.202011-1466RL; Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT; Perez-Nieto OR, 2022, EUR RESPIR J, V59, DOI 10.1183/13993003.00265-2021; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Sun Q, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00650-2; Venus K, 2020, CAN MED ASSOC J, V192, pE1532, DOI 10.1503/cmaj.201201; Verma AA, 2021, CAN MED ASSOC J, V193, pE410, DOI 10.1503/cmaj.202795; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	14	7	7	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								e068585	10.1136/bmj-2021-068585	http://dx.doi.org/10.1136/bmj-2021-068585			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321918	Green Published, hybrid			2022-12-28	WOS:000790072700009
J	Jacobs, DR; Woo, JG; Sinaiko, AR; Daniels, SR; Ikonen, J; Juonala, M; Kartiosuo, N; Lehtimaki, T; Magnussen, CG; Viikari, JSA; Zhang, NH; Bazzano, LA; Burns, TL; Prineas, RJ; Steinberger, J; Urbina, EM; Venn, AJ; Raitakari, OT; Dwyer, T				Jacobs, David R., Jr.; Woo, Jessica G.; Sinaiko, Alan R.; Daniels, Stephen R.; Ikonen, Johanna; Juonala, Markus; Kartiosuo, Noora; Lehtimaki, Terho; Magnussen, Costan G.; Viikari, Jorma S. A.; Zhang, Nanhua; Bazzano, Lydia A.; Burns, Trudy L.; Prineas, Ronald J.; Steinberger, Julia; Urbina, Elaine M.; Venn, Alison J.; Raitakari, Olli T.; Dwyer, Terence			Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; HEART-DISEASE; NORTH KARELIA; CHILDREN; ATHEROSCLEROSIS	BackgroundChildhood cardiovascular risk factors predict subclinical adult cardiovascular disease, but links to clinical events are unclear. MethodsIn a prospective cohort study involving participants in the International Childhood Cardiovascular Cohorts (i3C) Consortium, we evaluated whether childhood risk factors (at the ages of 3 to 19 years) were associated with cardiovascular events in adulthood after a mean follow-up of 35 years. Body-mass index, systolic blood pressure, total cholesterol level, triglyceride level, and youth smoking were analyzed with the use of i3C-derived age- and sex-specific z scores and with a combined-risk z score that was calculated as the unweighted mean of the five risk z scores. An algebraically comparable adult combined-risk z score (before any cardiovascular event) was analyzed jointly with the childhood risk factors. Study outcomes were fatal cardiovascular events and fatal or nonfatal cardiovascular events, and analyses were performed after multiple imputation with the use of proportional-hazards regression. ResultsIn the analysis of 319 fatal cardiovascular events that occurred among 38,589 participants (49.7% male and 15.0% Black; mean [+/- SD] age at childhood visits, 11.8 +/- 3.1 years), the hazard ratios for a fatal cardiovascular event in adulthood ranged from 1.30 (95% confidence interval [CI], 1.14 to 1.47) per unit increase in the z score for total cholesterol level to 1.61 (95% CI, 1.21 to 2.13) for youth smoking (yes vs. no). The hazard ratio for a fatal cardiovascular event with respect to the combined-risk z score was 2.71 (95% CI, 2.23 to 3.29) per unit increase. The hazard ratios and their 95% confidence intervals in the analyses of fatal cardiovascular events were similar to those in the analyses of 779 fatal or nonfatal cardiovascular events that occurred among 20,656 participants who could be evaluated for this outcome. In the analysis of 115 fatal cardiovascular events that occurred in a subgroup of 13,401 participants (31.0 +/- 5.6 years of age at the adult measurement) who had data on adult risk factors, the adjusted hazard ratio with respect to the childhood combined-risk z score was 3.54 (95% CI, 2.57 to 4.87) per unit increase, and the mutually adjusted hazard ratio with respect to the change in the combined-risk z score from childhood to adulthood was 2.88 (95% CI, 2.06 to 4.05) per unit increase. The results were similar in the analysis of 524 fatal or nonfatal cardiovascular events. ConclusionsIn this prospective cohort study, childhood risk factors and the change in the combined-risk z score between childhood and adulthood were associated with cardiovascular events in midlife. (Funded by the National Institutes of Health.) Childhood Risk Factors and Adult Cardiovascular EventsIn this study, childhood cardiovascular risk factors including BMI, systolic blood pressure, lipid levels, and smoking were correlated with cardiovascular events in adulthood after a mean follow-up of 35 years. Childhood risk factors and the change in risk score between childhood and adulthood were associated with midlife cardiovascular events.	[Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sinaiko, Alan R.; Steinberger, Julia] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Woo, Jessica G.; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Urbina, Elaine M.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA; [Woo, Jessica G.; Zhang, Nanhua; Urbina, Elaine M.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Daniels, Stephen R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Daniels, Stephen R.] Childrens Hosp Colorado, Anschutz Med Campus, Aurora, CO USA; [Ikonen, Johanna; Kartiosuo, Noora; Magnussen, Costan G.; Raitakari, Olli T.] Univ Turku, Ctr Populat Hlth Res, Turku, Finland; [Ikonen, Johanna; Kartiosuo, Noora; Magnussen, Costan G.; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Juonala, Markus; Viikari, Jorma S. A.] Univ Turku, Dept Med, Turku, Finland; [Kartiosuo, Noora] Univ Turku, Dept Math & Stat, Turku, Finland; [Ikonen, Johanna; Kartiosuo, Noora; Magnussen, Costan G.; Raitakari, Olli T.] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland; [Juonala, Markus; Viikari, Jorma S. A.] Turku Univ Hosp, Div Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Lehtimaki, Terho] Tampere Univ, Dept Clin Chem, Fimlab Labs, Tampere, Finland; [Lehtimaki, Terho] Tampere Univ, Finnish Cardiovasc Res Ctr, Tampere, Finland; [Lehtimaki, Terho] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Magnussen, Costan G.; Venn, Alison J.; Dwyer, Terence] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Dwyer, Terence] Murdoch Childrens Res Inst, Heart Res Grp, Melbourne, Vic, Australia; [Bazzano, Lydia A.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Burns, Trudy L.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Prineas, Ronald J.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27101 USA; [Dwyer, Terence] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University; University of Tasmania; Menzies Institute for Medical Research; Murdoch Children's Research Institute; Tulane University; University of Iowa; Wake Forest University; University of Oxford	Woo, JG (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 5041, Cincinnati, OH 45229 USA.	jessica.woo@cchmc.org		Jacobs, David/0000-0002-7232-0543; Kartiosuo, Noora/0000-0001-7859-0483; Juonala, Markus/0000-0001-9498-364X	National Institutes of Health [NIH HL121230]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a grant (NIH HL121230) from the National Institutes of Health. Historical funding sources for cohorts in the i3C Consortium are listed in Table S31.	Armstrong AC, 2014, INT J CARDIOL, V172, P350, DOI 10.1016/j.ijcard.2014.01.003; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; de Ferranti SD, 2019, CIRCULATION, V139, pE603, DOI 10.1161/CIR.0000000000000618; De Stavola BL, 2006, AM J EPIDEMIOL, V163, P84, DOI 10.1093/aje/kwj003; Dwyer T, 2013, INT J EPIDEMIOL, V42, P86, DOI 10.1093/ije/dys004; Ference BA, 2019, JAMA-J AM MED ASSOC, V322, P1381, DOI 10.1001/jama.2019.14120; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flynn JT, 2017, HYPERTENSION, V70, P683, DOI 10.1161/HYPERTENSIONAHA.117.10050; Hu T, 2020, DIABETES CARE, V43, P2821, DOI 10.2337/dc20-0822; Hu T, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014381; Krist AH, 2020, JAMA-J AM MED ASSOC, V324, P1878, DOI 10.1001/jama.2020.20122; LAUER RM, 1992, PEDIATRICS, V89, P495; McGill HC, 2008, CIRCULATION, V117, P1216, DOI 10.1161/CIRCULATIONAHA.107.717033; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Pahkala K, 2020, LANCET CHILD ADOLESC, V4, P359, DOI 10.1016/S2352-4642(20)30059-6; Pool LR, 2021, J PEDIATR-US, V232, P118, DOI 10.1016/j.jpeds.2021.01.053; Puska P, 2009, ANN NUTR METAB, V54, P33, DOI 10.1159/000220825; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Raitakari O, 2022, NAT REV CARDIOL, V19, P543, DOI 10.1038/s41569-021-00647-9; Salomaa V, 2016, GLOB HEART, V11, P201, DOI 10.1016/j.gheart.2016.04.005; Sinaiko AR, 2018, CONTEMP CLIN TRIALS, V69, P55, DOI 10.1016/j.cct.2018.04.009; Urbina EM, 2019, HYPERTENSION, V73, P1224, DOI 10.1161/HYPERTENSIONAHA.118.12334; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; World Health Organization, BEST BUYS OTH REC IN; Zhang NH, 2016, J OFF STAT, V32, P769, DOI 10.1515/JOS-2016-0039	25	23	23	20	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2022	386	20					1877	1888		10.1056/NEJMoa2109191	http://dx.doi.org/10.1056/NEJMoa2109191		APR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1J8UI	35373933	Bronze, Green Accepted			2022-12-28	WOS:000780201600001
J	Prasad, A				Prasad, Aarathi			Profile Angela Migowa: advocating for children with rheumatic diseases	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1294	1294						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35366999				2022-12-28	WOS:000812828300014
J	Bibby, J				Bibby, Jo			The spring statement shows the chancellor hasn't grasped that health and wealth are fundamentally intertwined	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bibby, Jo] Hlth Fdn, London, England		Bibby, J (corresponding author), Hlth Fdn, London, England.							Department of Health, IMPR LIV WORK HLTH D; Office for Budget Responsibility, EC FISC OUTL MARCH 2; Office for National Statistics, IND PRIV HOUS RENT P; Resolution Foundation, CHANC PRIOR HIS TAX; The Health Foundation, ADDR LEAD RISK FACT; The Health Foundation, LIV POV WAS BAD YOUR	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o866	10.1136/bmj.o866	http://dx.doi.org/10.1136/bmj.o866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361616	Bronze			2022-12-28	WOS:000779990000005
J	Campbell, K				Campbell, Kristina			The liver cancer endgame	NATURE			English	News Item						Diseases; Microbiome; Microbiology; Medical research	HEPATITIS-B	Detecting and treating hepatitis B infection could help to reverse the increase in fatal liver cancer worldwide. By Kristina Campbell										Behary J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20422-7; George ES, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010172; Lee WY, 2019, BIOL REV, V94, P353, DOI 10.1111/brv.12457; Liu QS, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-018-0281-6; lvarez E.G., 2021, NATURE COMMUN, V12, P6910, DOI [10.1038/s41467-021-26805-8, DOI 10.1038/S41467-021-26805-8]; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Toy M, 2022, CLIN INFECT DIS, V74, P210, DOI 10.1093/cid/ciab405; Zeng YB, 2020, J VIRAL HEPATITIS, V27, P143, DOI 10.1111/jvh.13216	8	1	1	5	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S64	S65		10.1038/d41586-022-00821-0	http://dx.doi.org/10.1038/d41586-022-00821-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354988	Bronze			2022-12-28	WOS:000776361600018
J	Iannacone, M; Guidotti, LG				Iannacone, Matteo; Guidotti, Luca G.			Time to rethink lifelong therapies	NATURE			English	News Item						Diseases; Drug discovery; Therapeutics; Medical research		The search for a cure for chronic hepatitis B requires new treatments based on the immune system, say Matteo Iannacone and Luca G. Guidotti.	[Iannacone, Matteo; Guidotti, Luca G.] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University	Iannacone, M (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.		Guidotti, Luca G./I-8542-2018	Guidotti, Luca G./0000-0002-0205-2678				Aliabadi E, 2022, GUT, V71, P2300, DOI 10.1136/gutjnl-2021-324646; Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005; Fumagalli V, 2020, J EXP MED, V217, DOI 10.1084/jem.20200298; Iannacone M, 2022, NAT REV IMMUNOL, V22, P19, DOI 10.1038/s41577-021-00549-4; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Le Bert N, 2020, GASTROENTEROLOGY, V159, P652, DOI 10.1053/j.gastro.2020.04.019; Michler T, 2020, GASTROENTEROLOGY, V158, P1762, DOI 10.1053/j.gastro.2020.01.032; Naggie S, 2021, ANNU REV MED, V72, P93, DOI 10.1146/annurev-med-080119-103356	9	0	0	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S49	S49		10.1038/d41586-022-00813-0	http://dx.doi.org/10.1038/d41586-022-00813-0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354983	Bronze			2022-12-28	WOS:000776361600010
J	Onate-Ocana, LF; Perez-Diaz, L				Onate-Ocana, Luis F.; Perez-Diaz, Lizeth			Intestinal Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Onate-Ocana, Luis F.] Inst Nacl Cancerol, Mexico City, DF, Mexico; [Perez-Diaz, Lizeth] Fdn Clin Med Sur, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN)	Onate-Ocana, LF (corresponding author), Inst Nacl Cancerol, Mexico City, DF, Mexico.	lfonate@gmail.com							0	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					E30	E30		10.1056/NEJMicm2114345	http://dx.doi.org/10.1056/NEJMicm2114345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35333483				2022-12-28	WOS:000820666300002
J	Yao, YK; Kim, G; Shafer, S; Chen, ZJ; Kubo, S; Ji, YL; Luo, JL; Yang, WM; Perner, SP; Kanellopoulou, C; Park, AY; Jiang, P; Li, J; Baris, S; Aydiner, EK; Ertem, D; Mulder, DJ; Warner, N; Griffiths, AM; Topf-Olivestone, C; Kori, M; Werner, L; Ouahed, J; Field, M; Liu, CY; Schwarz, B; Bosio, CM; Ganesan, S; Song, J; Urlaub, H; Oellerich, T; Malaker, SA; Zheng, LX; Bertozzi, CR; Zhang, Y; Matthews, H; Montgomery, W; Shih, HY; Jiang, JS; Jones, M; Baras, A; Shuldiner, A; Gonzaga-Jauregui, C; Snapper, SB; Muise, AM; Shouval, DS; Ozen, A; Pan, KT; Wu, C; Lenardo, MJ				Yao, Yikun; Kim, Girak; Shafer, Samantha; Chen, Zuojia; Kubo, Satoshi; Ji, Yanlong; Luo, Jialie; Yang, Weiming; Perner, Sebastian P.; Kanellopoulou, Chrysi; Park, Ann Y.; Jiang, Ping; Li, Jian; Baris, Safa; Aydiner, Elif Karakoc; Ertem, Deniz; Mulder, Daniel J.; Warner, Neil; Griffiths, Anne M.; Topf-Olivestone, Chani; Kori, Michal; Werner, Lael; Ouahed, Jodie; Field, Michael; Liu, Chengyu; Schwarz, Benjamin; Bosio, Catharine M.; Ganesan, Sundar; Song, Jian; Urlaub, Henning; Oellerich, Thomas; Malaker, Stacy A.; Zheng, Lixin; Bertozzi, Carolyn R.; Zhang, Yu; Matthews, Helen; Montgomery, Will; Shih, Han-Yu; Jiang, Jiansheng; Jones, Marcus; Baras, Aris; Shuldiner, Alan; Gonzaga-Jauregui, Claudia; Snapper, Scott B.; Muise, Aleixo M.; Shouval, Dror S.; Ozen, Ahmet; Pan, Kuan-Ting; Wu, Chuan; Lenardo, Michael J.			Mucus sialylation determines intestinal host-commensal homeostasis	CELL			English	Article							CHAIN FATTY-ACIDS; INFLAMMATORY BOWEL DISEASES; ULCERATIVE-COLITIS; N-GLYCOSYLATION; HUMAN COLON; O-GLYCANS; EXPRESSION; MUCIN; CELLS; TN	Intestinal mucus forms the first line of defense against bacterial invasion while providing nutrition to support microbial symbiosis. How the host controls mucus barrier integrity and commensalism is unclear. We show that terminal sialylation of glycans on intestinal mucus by ST6GALNAC1 (ST6), the dominant sialyltransferase specifically expressed in goblet cells and induced by microbial pathogen-associated molecular patterns, is essential for mucus integrity and protecting against excessive bacterial proteolytic degradation. Glycoproteomic profiling and biochemical analysis of ST6 mutations identified in patients show that decreased sialylation causes defective mucus proteins and congenital inflammatory bowel disease (IBD). Mice harboring a patient ST6 mutation have compromised mucus barriers, dysbiosis, and susceptibility to intestinal inflammation. Based on our understanding of the ST6 regulatory network, we show that treatment with sialylated mucin or a Foxo3 inhibitor can ameliorate IBD.	[Yao, Yikun; Shafer, Samantha; Kubo, Satoshi; Kanellopoulou, Chrysi; Park, Ann Y.; Jiang, Ping; Zheng, Lixin; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Lab Immune Syst Biol & Clin Genom Program, NIH, Bethesda, MD 20892 USA; [Kim, Girak; Chen, Zuojia; Luo, Jialie; Li, Jian; Wu, Chuan] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ji, Yanlong; Perner, Sebastian P.; Oellerich, Thomas; Pan, Kuan-Ting] Goethe Univ Frankfurt, Dept Med 2, Hematol Oncol, D-60590 Frankfurt, Germany; [Ji, Yanlong; Perner, Sebastian P.; Oellerich, Thomas; Pan, Kuan-Ting] Goethe Univ, Frankfurt Canc Inst, D-60596 Frankfurt, Germany; [Ji, Yanlong; Urlaub, Henning] Max Planck Inst Multidisciplinary Sci, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Yang, Weiming] Natl Inst Dent & Craniofacial Res NIDCR, Sect Biol Chem, NIH, Bethesda, MD 20892 USA; [Baris, Safa; Aydiner, Elif Karakoc] Marmara Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, TR-34722 Istanbul, Turkey; [Baris, Safa; Aydiner, Elif Karakoc; Ozen, Ahmet] Marmara Univ, Isil Berat Barlan Ctr Translat Med, TR-34722 Istanbul, Turkey; [Ertem, Deniz; Ozen, Ahmet] Marmara Univ, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey; [Mulder, Daniel J.] Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; [Mulder, Daniel J.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Mulder, Daniel J.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Warner, Neil; Griffiths, Anne M.; Muise, Aleixo M.] Hosp Sick Children, Res Inst, SickKids Inflammatory Bowel Dis Ctr, Toronto, ON M5G 1X8, Canada; [Warner, Neil; Griffiths, Anne M.; Muise, Aleixo M.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Topf-Olivestone, Chani; Kori, Michal] Kaplan Med Ctr, Pediat Gastroenterol, Pasternak St,POB 1, IL-76100 Rehovot, Israel; [Werner, Lael; Shouval, Dror S.] Schneider Childrens Med Ctr Israel, Inst Gastroenterol Nutr & Liver Dis, IL-4920235 Petah Tiqwa, Israel; [Ouahed, Jodie; Field, Michael; Snapper, Scott B.] Boston Childrens Hosp, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, Bethesda, MD 20892 USA; [Schwarz, Benjamin; Bosio, Catharine M.] NIAID, Immun Pulm Pathogens Sect, Lab Bacteriol, NIH, Hamilton, MT 59840 USA; [Ganesan, Sundar] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Song, Jian] NIAID, Lab Immune Syst Biol, Bethesda, MD 20892 USA; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, D-37075 Gottingen, Germany; [Oellerich, Thomas] German Canc Res Ctr, German Canc Consortium, D-69120 Heidelberg, Germany; [Malaker, Stacy A.] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Zhang, Yu; Matthews, Helen] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD 20892 USA; [Montgomery, Will; Shih, Han-Yu] NEI, Neuro Immune Regulome Unit, NIH, Bethesda, MD 20892 USA; [Jiang, Jiansheng] NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Jones, Marcus; Baras, Aris; Shuldiner, Alan; Gonzaga-Jauregui, Claudia] Regeneron Genet Ctr, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Gonzaga-Jauregui, Claudia] Univ Nacl Autonoma Mexico, Lab Int Invest El Genoma Humano, Internatl Lab Human Genome Res, Juriquilla 04510, Queretaro, Mexico; [Muise, Aleixo M.] Univ Toronto, Dept Pediat IMS & Biochem, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Marmara University; Marmara University; Marmara University; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hebrew University of Jerusalem; Kaplan Medical Center; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gottingen; Helmholtz Association; German Cancer Research Center (DKFZ); Yale University; Stanford University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Regeneron; Universidad Nacional Autonoma de Mexico; University of Toronto	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Lab Immune Syst Biol & Clin Genom Program, NIH, Bethesda, MD 20892 USA.; Wu, C (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	chuan.wu@nih.gov; lenardo@nih.gov	Yao, Yikun/AAH-9197-2021; Li, Jian/AGV-0996-2022	Li, Jian/0000-0002-7076-3332; Shafer, Sam/0000-0001-9429-414X; Ji, Yanlong/0000-0002-9741-5119; Pan, Kuan-Ting/0000-0001-6974-5324; Kubo, Satoshi/0000-0001-9693-9263	Regeneron Genetics Center, United States; Intramural Research Program of the NIAID, NIH, United States; National Cancer Institute (NCI, United States) [R01CA200423]; National Eye Institute (NEI, United States) Intramural Research Program [ZIAEY000569-01]; LOEWE Center Frankfurt Cancer Institute (FCI), Hessen State Ministry for Higher Education, Research, and the Arts, Germany [III L 5-519/03/03.001- [0015]]; Division of Intramural Research, NIDCR/NIH, United States [ZIA DE000751]; Intramural Research Program of the NIDCR, NIH, United States [ZIA-DE000739-05]; National Multiple Sclerosis Society Career Transition Award, United States [TA 3059-A-2]; Leona M. and Harry B. Helmsley Charitable Trust, United States; NIH, United States [RC2DK122532, RC2DK118640]; Canada Research Chair (Tier 1) in Pediatric IBD; CIHR Foundation Grant, Canada	Regeneron Genetics Center, United States; Intramural Research Program of the NIAID, NIH, United States; National Cancer Institute (NCI, United States); National Eye Institute (NEI, United States) Intramural Research Program; LOEWE Center Frankfurt Cancer Institute (FCI), Hessen State Ministry for Higher Education, Research, and the Arts, Germany; Division of Intramural Research, NIDCR/NIH, United States; Intramural Research Program of the NIDCR, NIH, United States; National Multiple Sclerosis Society Career Transition Award, United States; Leona M. and Harry B. Helmsley Charitable Trust, United States; NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair (Tier 1) in Pediatric IBD; CIHR Foundation Grant, Canada(Canadian Institutes of Health Research (CIHR))	We thank the participating physicians and families. We thank Jizhong Zou from the National Heart, Lung, and Blood Institute (NHLBI) for iPSC cell generation. We thank Ronald Germain and Jeff Zhu for critically reading the manuscript; Ryan Kissinger, NIAID for illustrations; and acknowledge support from the Regeneron Genetics Center, United States. This research was supported by the Intramural Research Program of the NIAID, NIH, United States. C.R.B. was funded by National Cancer Institute (NCI, United States) grant (R01CA200423) , H.-Y.S. by the National Eye Institute (NEI, United States) Intramural Research Program (ZIAEY000569-01) , and K.-T.P. by the LOEWE Center Frankfurt Cancer Institute (FCI), Hessen State Ministry for Higher Education, Research, and the Arts (III L 5-519/03/03.001- [0015] ) , Germany. We thank Dr. Yan Wang of NIDCR Mass Spectrometry Facility for mass spectrom-etry of S-Tn carrying proteins. The work with NIDCR Mass Spectrometry Facility is supported by the Division of Intramural Research, NIDCR/NIH (ZIA DE000751) , United States and the Intramural Research Program of the NIDCR, NIH (ZIA-DE000739-05) , United States with thanks to Lawrence A. Tabak. This work was supported by National Multiple Sclerosis Society Career Transition Award, United States (TA 3059-A-2 to C.W.) . This work utilized the NIH HPC Biowulf cluster. A.M.M. and C.K. were funded by the Leona M. and Harry B. Helmsley Charitable Trust, United States and NIH, United States (RC2DK122532) and A.M.M. by a Canada Research Chair (Tier 1) in Pediatric IBD, CIHR Foundation Grant, Canada, and NIH, United States (RC2DK118640) .	Alipour M, 2016, J CROHNS COLITIS, V10, P462, DOI 10.1093/ecco-jcc/jjv223; Amaya E, 2007, AQUACULTURE, V262, P419, DOI 10.1016/j.aquaculture.2006.11.001; Arike L, 2017, GLYCOBIOLOGY, V27, P318, DOI 10.1093/glycob/cww134; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Banerjee A, 2020, GASTROENTEROLOGY, V159, DOI 10.1053/j.gastro.2020.08.029; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Bergstrom K, 2020, SCIENCE, V370, P467, DOI 10.1126/science.aay7367; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Campbell BJ, 2001, GLYCOCONJUGATE J, V18, P851, DOI 10.1023/A:1022240107040; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen ZJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20210324; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Fang P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19052-w; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Guzman-Aranguez A, 2010, OCUL SURF, V8, P8, DOI 10.1016/S1542-0124(12)70213-6; Habowski AN, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01181-z; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Han J, 2015, ANAL CHIM ACTA, V854, P86, DOI 10.1016/j.aca.2014.11.015; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Ikehara Y, 1999, GLYCOBIOLOGY, V9, P1213, DOI 10.1093/glycob/9.11.1213; InanlooRahatloo K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03595; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jeong YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001163; Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2012, METHODS MOL BIOL, V842, P109, DOI 10.1007/978-1-61779-513-8_6; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Julien S, 2012, BIOMOLECULES, V2, P435, DOI 10.3390/biom2040435; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim K, 2019, MOL MED REP, V20, P1569, DOI 10.3892/mmr.2019.10431; Ko SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12692-x; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kudelka MR, 2020, NAT REV GASTRO HEPAT, V17, P597, DOI 10.1038/s41575-020-0331-7; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kvorjak M, 2020, CANCER IMMUNOL RES, V8, P167, DOI 10.1158/2326-6066.CIR-19-0514; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liso M, 2020, INFLAMM BOWEL DIS, V26, P546, DOI 10.1093/ibd/izz279; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Long PM, 2015, J CELL PHYSIOL, V230, P1929, DOI 10.1002/jcp.24927; Loureiro LR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30421-w; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Mayne CG, 2013, INFLAMM BOWEL DIS, V19, P1772, DOI 10.1097/MIB.0b013e318281f5a3; Moehle C, 2006, J MOL MED, V84, P1055, DOI 10.1007/s00109-006-0100-2; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Munkley J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030275; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; Nason R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24366-4; Patel RY, 2006, GLYCOBIOLOGY, V16, P108, DOI 10.1093/glycob/cwj046; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Prendergast JM, 2017, MABS-AUSTIN, V9, P615, DOI 10.1080/19420862.2017.1290752; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Robbe-Masselot C, 2009, GLYCOCONJUGATE J, V26, P397, DOI 10.1007/s10719-008-9186-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudresh, 2002, PROTEIN ENG, V15, P627, DOI 10.1093/protein/15.8.627; Sahuri-Arisoylu M, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.588466; Salcher S, 2020, ONCOGENE, V39, P1080, DOI 10.1038/s41388-019-1044-7; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shauchuk A, 2020, GLYCOCONJUGATE J, V37, P577, DOI 10.1007/s10719-020-09941-z; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stark RM, 2000, METH MOL B, V125, P385; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Takayama N, 2007, CLIN IMMUNOL, V123, P199, DOI 10.1016/j.clim.2007.01.007; Tarrerias AL, 2002, PAIN, V100, P91, DOI 10.1016/S0304-3959(02)00234-8; Theodoratou E, 2014, NAT REV GASTRO HEPAT, V11, P588, DOI 10.1038/nrgastro.2014.78; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18696-y; Tytgat KMAJ, 1996, GUT, V38, P554, DOI 10.1136/gut.38.4.554; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Visschedijk MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159609; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu MN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092809; Wu ZL, 2019, GLYCOBIOLOGY, V29, P750, DOI 10.1093/glycob/cwz058; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737	96	9	10	19	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1172	+		10.1016/j.cell.2022.02.013	http://dx.doi.org/10.1016/j.cell.2022.02.013			46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0K3YO	35303419	Bronze			2022-12-28	WOS:000780727500002
J	Arora, VM; Bloomgarden, E; Jain, S				Arora, Vineet M.; Bloomgarden, Eve; Jain, Shikha			Supporting Health Care Workers to Address Misinformation on Social Media	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Addressing Misinformation on Social MediaClinicians who respond to misinformation on social media face obstacles. It's important to train clinicians in dispelling harmful myths, to support those who are attacked, and to ensure that people who spread disinformation are held accountable for the harm they cause.	[Arora, Vineet M.] Univ Chicago Med, Chicago, IL USA; [Bloomgarden, Eve] NorthShore Univ Hlth Syst, Chicago, IL USA; [Jain, Shikha] Univ Illinois, Coll Med, Chicago, IL USA	NorthShore University Health System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Arora, VM (corresponding author), Univ Chicago Med, Chicago, IL USA.			Bloomgarden, Eve/0000-0003-1124-2569; Jain, Shikha/0000-0002-5684-7898				Arora VM, 2020, JAMA-J AM MED ASSOC, V324, P2367, DOI 10.1001/jama.2020.4263; Nersessian Anahid, KEATSS ODES LOVERS D, P83; Nogrady B, 2021, NATURE, V598, P250, DOI 10.1038/d41586-021-02741-x; Pendergrast TR, 2021, JAMA INTERN MED, V181, P550, DOI 10.1001/jamainternmed.2020.7235; Schwarz N., 2016, BEHAV SCI POLICY, V2, P85, DOI DOI 10.1353/BSP.2016.0009	5	3	3	4	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2022	386	18					1683	1685		10.1056/NEJMp2117180	http://dx.doi.org/10.1056/NEJMp2117180		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D5AM	35353977				2022-12-28	WOS:000784443800001
J	Jodie, L				Jodie, L.			The US shouldn't settle for its current number of covid deaths or vaccination rates	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jodie, L.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Jodie, L (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.							Bollyky TJ, 2022, LANCET, V399, P1489, DOI 10.1016/S0140-6736(22)00172-6; CDC, COVID 19 COMM LEV; CDC, COVID DAT TRACK; Michie S., 2020, BMJ OPINION; Our World in Data, COR COVID 19 HOSP; Our World in Data, CORN COVID 19 DEATHS; The Center for Systems Science and Engineering at Johns Hopkins University, COV 19 DASHB; US Department of Health and Human Services Centers for Disease Control and Prevention, 2006, PRINC EP, V3rd	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								o763	10.1136/bmj.o763	http://dx.doi.org/10.1136/bmj.o763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9XK	35318215	Bronze			2022-12-28	WOS:000777024700001
J	Peterson, DM; Damsky, WE; Vesely, MD				Peterson, Danielle M.; Damsky, William E.; Vesely, Matthew D.			Fever, Hypotension, and a Worsening Necrotic Wound	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PYODERMA-GANGRENOSUM		[Peterson, Danielle M.; Damsky, William E.; Vesely, Matthew D.] Yale Sch Med, Dept Dermatol, 333 Cedar St,POB 208059, New Haven, CT 06510 USA; [Damsky, William E.] Yale Sch Med, Dept Pathol, New Haven, CT USA	Yale University; Yale University	Vesely, MD (corresponding author), Yale Sch Med, Dept Dermatol, 333 Cedar St,POB 208059, New Haven, CT 06510 USA.	matthew.vesely@yale.edu		Vesely, Matthew/0000-0001-9363-945X	Dermatology Foundation Career Development Award; Melanoma Research Alliance; National Center for Advancing Translational Sciences [KL2 TR001862]; National Institute of Allergy and Infectious Diseases [K08AI159229]	Dermatology Foundation Career Development Award; Melanoma Research Alliance; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr Vesely is supported by a Dermatology Foundation Career Development Award, the Melanoma Research Alliance, and the National Center for Advancing Translational Sciences (KL2 TR001862). Dr Damsky is supported by the National Institute of Allergy and Infectious Diseases (K08AI159229).	Ashchyan HJ, 2018, J AM ACAD DERMATOL, V79, P1009, DOI 10.1016/j.jaad.2017.11.063; Ashchyan HJ, 2018, JAMA DERMATOL, V154, P409, DOI 10.1001/jamadermatol.2017.5978; Jockenhofer F, 2019, BRIT J DERMATOL, V180, P615, DOI 10.1111/bjd.16401; Kroshinsky D, 2012, J AM ACAD DERMATOL, V67, P945, DOI 10.1016/j.jaad.2012.02.024; Maverakis E, 2018, JAMA DERMATOL, V154, P461, DOI 10.1001/jamadermatol.2017.5980; Nelson CA, 2018, J AM ACAD DERMATOL, V79, P987, DOI 10.1016/j.jaad.2017.11.064; Ormerod AD, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2958; Sanchez IM, 2019, JAMA DERMATOL, V155, P79, DOI 10.1001/jamadermatol.2018.3890; Tolkachjov SN, 2016, MAYO CLIN PROC, V91, P1267, DOI 10.1016/j.mayocp.2016.05.001; Xu A, 2020, J AM ACAD DERMATOL, V83, P425, DOI 10.1016/j.jaad.2019.08.001	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1496	1497		10.1001/jama.2022.2806	http://dx.doi.org/10.1001/jama.2022.2806		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35311923				2022-12-28	WOS:000772991200002
J	Usher, AD				Usher, Ann Danaiya			CEPI launches 100-day vaccine "moonshot"	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1107	1108						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305730	Green Published			2022-12-28	WOS:000770814300010
J	Hua, FY; Bruijnzeel, LA; Meli, P; Martin, PA; Zhang, J; Nakagawa, S; Miao, XR; Wang, WY; McEvoy, C; Pena-Arancibia, JL; Brancalion, PHS; Smith, P; Edwards, DP; Balmford, A				Hua, Fangyuan; Bruijnzeel, L. Adrian; Meli, Paula; Martin, Philip A.; Zhang, Jun; Nakagawa, Shinichi; Miao, Xinran; Wang, Weiyi; McEvoy, Christopher; Pena-Arancibia, Jorge Luis; Brancalion, Pedro H. S.; Smith, Pete; Edwards, David P.; Balmford, Andrew			The biodiversity and ecosystem service contributions and trade-offs of forest restoration approaches	SCIENCE			English	Article							HYDROLOGICAL OBSERVATION REPORTS; RED SOIL REGION; BEETLES COLEOPTERA STAPHYLINIDAE; PONDEROSA PINE PLANTATIONS; SOUTHEASTERN UNITED-STATES; FRUIT-FEEDING BUTTERFLIES; NATURAL SECONDARY FOREST; SOUTHERN ATLANTIC FOREST; SEMI-DECIDUOUS FORESTS; EXOTIC TREE PLANTATION	Forest restoration is being scaled up globally to deliver critical ecosystem services and biodiversity benefits; however, there is a lack of rigorous comparison of cobenefit delivery across different restoration approaches. Through global synthesis, we used 25,950 matched data pairs from 264 studies in 53 countries to assess how delivery of climate, soil, water, and wood production services, in addition to biodiversity, compares across a range of tree plantations and native forests. Benefits of aboveground carbon storage, water provisioning, and especially soil erosion control and biodiversity are better delivered by native forests, with compositionally simpler, younger plantations in drier regions performing particularly poorly. However, plantations exhibit an advantage in wood production. These results underscore important trade-offs among environmental and production goals that policy-makers must navigate in meeting forest restoration commitments.	[Hua, Fangyuan; Miao, Xinran; Wang, Weiyi; Edwards, David P.] Peking Univ, Coll Urban & Environm Sci, Inst Ecol, Minist Educ, Beijing 100871, Peoples R China; [Hua, Fangyuan; Miao, Xinran; Wang, Weiyi; Edwards, David P.] Peking Univ, Coll Urban & Environm Sci, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China; [Hua, Fangyuan; Martin, Philip A.; McEvoy, Christopher; Edwards, David P.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Bruijnzeel, L. Adrian] Kings Coll London, Dept Geog, Bush House, London WC2B 4BG, England; [Bruijnzeel, L. Adrian; Zhang, Jun] Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming 650091, Yunnan, Peoples R China; [Meli, Paula; Brancalion, Pedro H. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil; [Meli, Paula] Univ La Frontera, Dept Ciencias Forestales, Av Francisco Salazar 01145, Temuco, Chile; [Martin, Philip A.] Basque Ctr Climate Change BC3, Edificio Sede 1,Planta 1,Parque Cient UPV EHU, Leioa 48940, Bizkaia, Spain; [Zhang, Jun] TNO, Environm Modelling Sensing & Anal, NL-1755 LE Petten, Netherlands; [Nakagawa, Shinichi] Univ New South Wales, Evolut & Ecol Res Ctr, Sydney, NSW 2052, Australia; [Nakagawa, Shinichi] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Pena-Arancibia, Jorge Luis] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland	Peking University; Peking University; University of Cambridge; University of London; King's College London; Yunnan University; Universidade de Sao Paulo; Universidad de La Frontera; Basque Centre for Climate Change (BC3); Netherlands Organization Applied Science Research; University of New South Wales Sydney; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Aberdeen	Hua, FY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Inst Ecol, Minist Educ, Beijing 100871, Peoples R China.; Hua, FY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China.; Hua, FY (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England.; Bruijnzeel, LA (corresponding author), Kings Coll London, Dept Geog, Bush House, London WC2B 4BG, England.; Bruijnzeel, LA (corresponding author), Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming 650091, Yunnan, Peoples R China.	fhua@pku.edu.cn; sampurno.bruijnzeel@kcl.ac.uk	Edwards, David/AAC-5091-2019; Wang, Weiyi/GZN-0408-2022; Hua, Fangyuan/CAA-3871-2022; Martin, Philip Anthony/R-5843-2019; Smith, Pete/G-1041-2010; Nakagawa, Shinichi/B-5571-2011	Edwards, David/0000-0001-8562-3853; Hua, Fangyuan/0000-0001-8514-8757; Martin, Philip Anthony/0000-0002-5346-8868; Smith, Pete/0000-0002-3784-1124; Nakagawa, Shinichi/0000-0002-7765-5182; Wang, Weiyi/0000-0002-1329-2837; /0000-0001-5390-7552; ZHANG, JUN/0000-0003-1846-8915; Miao, Xinran/0000-0001-5449-1093	Royal Society Newton International Fellowship [NF160839]; National Natural Science Foundation of China [32122057, 31988102]; Sao Paulo Research Foundation [2016/00052-9]	Royal Society Newton International Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Royal Society Newton International Fellowship NF160839 and National Natural Science Foundation of China Grants 32122057 and 31988102 (to F.H.), as well as and Sao Paulo Research Foundation Postdoctoral Grant 2016/00052-9 (to P.M.).	Adams M. B., 2014, LONG TERM RESPONSE F, P194; Adams M. B., 1994, GEN TECHNICAL REPORT; Aguilos M, 2021, AGR FOREST METEOROL, V303, DOI 10.1016/j.agrformet.2021.108381; Maglianesi MA, 2010, ORNITOL NEOTROP, V21, P339; Alem Shiferaw, 2009, Journal of Forestry Research (Harbin), V20, P31, DOI 10.1007/s11676-009-0006-2; Almeida Auro Campi de, 2003, Rev. Árvore, V27, P159, DOI 10.1590/S0100-67622003000200006; Aloe AM, 2010, RES SYNTH METHODS, V1, P272, DOI 10.1002/jrsm.23; Amatya DM, 2016, FOREST HYDROLOGY: PROCESSES, MANAGEMENT AND ASSESSMENT, P219, DOI 10.1079/9781780646602.0219; Amatya DM, 2011, T ASABE, V54, P2087, DOI 10.13031/2013.40667; Anache JAA, 2017, CATENA, V152, P29, DOI 10.1016/j.catena.2017.01.003; Anderson CJ, 2011, SOUTH J APPL FOR, V35, P170, DOI 10.1093/sjaf/35.4.170; Anderson J. M., 1991, 7 MAB DIGEST; Anderson-Teixeira KJ, 2016, GLOBAL CHANGE BIOL, V22, P1690, DOI 10.1111/gcb.13226; Andreassian V, 2004, J HYDROL, V291, P1, DOI 10.1016/j.jhydrol.2003.12.015; Araujo PI, 2020, FOREST ECOL MANAG, V460, DOI 10.1016/j.foreco.2020.117902; Rios AIA, 2015, BIODIVERS CONSERV, V24, P1239, DOI 10.1007/s10531-014-0855-7; Arevalo CBM, 2009, FOREST ECOL MANAG, V257, P1776, DOI 10.1016/j.foreco.2009.01.034; Atkinson EE, 2015, FOREST ECOL MANAG, V335, P270, DOI 10.1016/j.foreco.2014.09.033; Aubinet M., 2016, FORET NATURE, V139, P17; AUSSENAC G, 1980, ANN SCI FOREST, V37, P91, DOI 10.1051/forest:19800201; Bailly C., 1974, CAHIERS SCIENTIFIQUE, V4, P1; Baishya R, 2009, TROP ECOL, V50, P295; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Barton K., 2020, MUMIN MULTIMODEL INF; Baruch Z, 2019, REV BIOL TROP, V67, P24, DOI 10.15517/rbt.v67i1.33445; Beaulieu E, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0244-1; BEEHLER BM, 1987, IBIS, V129, P197, DOI 10.1111/j.1474-919X.1987.tb03201.x; Beets P. N., 2007, New Zealand Journal of Forestry Science, V37, P306; Behera SK, 2017, ECOL ENG, V99, P513, DOI 10.1016/j.ecoleng.2016.11.046; Bekessy SA, 2008, CONSERV BIOL, V22, P510, DOI 10.1111/j.1523-1739.2008.00943.x; Benecke P., 1984, SCHRIFTEN FORSTL FAK, V77, P1; Bentley JM, 2000, CONSERV BIOL, V14, P1075, DOI 10.1046/j.1523-1739.2000.98531.x; Bentley L, 2020, GLOBAL CHANGE BIOL, V26, P1458, DOI 10.1111/gcb.14954; Berger TW, 2009, PLANT SOIL, V322, P317, DOI 10.1007/s11104-009-9918-z; Bergkvit Folkeson, 1995, ECOL BULL, V44, P90; Bernal B, 2018, CARBON BAL MANAGE, V13, DOI 10.1186/s13021-018-0110-8; Berndt LA, 2008, BIODIVERS CONSERV, V17, P1171, DOI 10.1007/s10531-008-9379-3; Berndt LA, 2019, NZ J FORESTRY SCI, V49, DOI 10.33494/nzjfs492019x54x; Besseau P., 2018, RESTORING FORESTS LA; Betts MG, 2021, BIOL REV, V96, P1301, DOI 10.1111/brv.12703; Bigelow S, 2001, HYDROL PROCESS, V15, P2779, DOI 10.1002/hyp.268; Bivand R.R., 2020, RGEOS INTERFACE GEOM, P5; Blackie J. R., 1979, E AFR AGR FORESTRY J, V43, P155, DOI [10.1080/00128325.1979.11662952, DOI 10.1080/00128325.1979.11662952]; BONELL M, 1993, J HYDROL, V150, P217, DOI 10.1016/0022-1694(93)90112-M; Bonham KJ, 2002, FOREST ECOL MANAG, V158, P237, DOI 10.1016/S0378-1127(00)00717-9; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; Bonnesoeur V, 2019, FOREST ECOL MANAG, V433, P569, DOI 10.1016/j.foreco.2018.11.033; Boonrotpong Singtoe, 2004, ScienceAsia, V30, P59, DOI 10.2306/scienceasia1513-1874.2004.30.059; Borenstein M., 2009, INTROD MAGN MAT, P277, DOI [DOI 10.1002/9780470743386.CH30, 10.1002/9780470743386.ch30, DOI 10.1002/9780470386323.FMATTER]; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; BOUTEN W, 1995, ECOL MODEL, V83, P245, DOI 10.1016/0304-3800(95)00102-2; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bradshaw CJA, 2013, BIOL CONSERV, V161, P71, DOI 10.1016/j.biocon.2013.02.012; Brancalion PHS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3223; Brancalion PHS, 2020, J APPL ECOL, V57, P55, DOI 10.1111/1365-2664.13513; BREN LJ, 1991, WATER RESOUR RES, V27, P2421, DOI 10.1029/91WR01491; Brien L, 2007, J HYDROL, V336, P416, DOI 10.1016/j.jhydrol.2007.01.018; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Brown AE, 2013, J HYDROL, V483, P39, DOI 10.1016/j.jhydrol.2012.12.031; Brown HCA, 2020, FOREST ECOL MANAG, V472, DOI 10.1016/j.foreco.2020.118236; Bruijnzeel LA, 2011, HYDROL PROCESS, V25, P465, DOI 10.1002/hyp.7974; Bruijnzeel L. A., 1997, Management of soil, nutrients and water in tropical plantation forests., P125; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Buckland ST, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00186.1; Buttle JM, 2012, J HYDROL, V466, P103, DOI 10.1016/j.jhydrol.2012.08.021; Caballero-Gini A, 2019, S AM J HERPETOL, V14, P48, DOI 10.2994/SAJH-D-17-00050.1; Cai HY, 2016, CAN J FOREST RES, V46, P143, DOI 10.1139/cjfr-2015-0038; CALDER IR, 1986, AGR WATER MANAGE, V11, P333, DOI 10.1016/0378-3774(86)90049-1; Calvo de Anta R, 2002, EDAFOLOGIA, V9, P49; CARBON BA, 1982, J HYDROL, V55, P53, DOI 10.1016/0022-1694(82)90120-2; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; Castro-Diez P, 2019, BIOL REV, V94, P1477, DOI 10.1111/brv.12511; Ceia R, 2009, ARDEOLA, V56, P25; Cesar RG, 2018, ECOL APPL, V28, P373, DOI 10.1002/eap.1653; Chanasyk DS, 2003, J ENVIRON ENG SCI, V2, pS51, DOI [10.1139/s03-034, 10.1139/S03-034]; Chauhan D. S., 2008, Tropical Ecology, V49, P53; Chazdon R, 2019, SCIENCE, V365, P24, DOI 10.1126/science.aax9539; Chazdon RL, 2021, RESTOR ECOL, DOI 10.1111/rec.13535; Chazdon RL, 2016, BIOTROPICA, V48, P709, DOI 10.1111/btp.12409; Chen GS, 2005, ANN FOREST SCI, V62, P659, DOI 10.1051/forest:2005073; Cheng JD, 2002, FOREST ECOL MANAG, V165, P11, DOI 10.1016/S0378-1127(01)00626-0; Cheng Saisai, 2018, Acta Ecologica Sinica, V38, P3097; Chiawo DO, 2018, EMU, V118, P281, DOI 10.1080/01584197.2018.1431052; Christian DP, 1998, BIOMASS BIOENERG, V14, P395, DOI 10.1016/S0961-9534(97)10076-9; Silva BPC, 2016, CIENC AGROTEC, V40, P432, DOI 10.1590/1413-70542016404013216; CLOUT MN, 1984, J APPL ECOL, V21, P795, DOI 10.2307/2405048; Coble AA, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138926; Coleman EA, 2021, NAT SUSTAIN, V4, P997, DOI 10.1038/s41893-021-00761-z; COP26, 2021, GLASG LEAD DECL FOR; Cornish P. M., 1989, 49 FOR COMM NEW S WA; Cornish PM, 2001, J HYDROL, V242, P43, DOI 10.1016/S0022-1694(00)00384-X; Cosandey C, 2005, J HYDROL, V301, P235, DOI 10.1016/j.jhydrol.2004.06.040; Creed I.F., 2018, GLOBAL ASSESSMENT RE, V38; Creed IF, 2014, GLOBAL CHANGE BIOL, V20, P3191, DOI 10.1111/gcb.12615; Crouzeilles R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701345; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Cubbage F, 2007, NEW FOREST, V33, P237, DOI 10.1007/s11056-006-9025-4; CUEVAS E, 1991, PLANT SOIL, V135, P257, DOI 10.1007/BF00010914; Curran M, 2014, ECOL APPL, V24, P617, DOI 10.1890/13-0243.1; da Silva LP, 2019, EUR J FOREST RES, V138, P461, DOI 10.1007/s10342-019-01183-5; da Silva MA, 2011, CIENC FLOREST, V21, P765, DOI 10.5902/198050984520; Daimaru H., 1999, BULL FOR FOR PROD R, V376, P1; Dambrine E, 2000, ANN FOREST SCI, V57, P23; Dave R., 2019, 2 BONN CHALLENGE PRO, DOI DOI 10.2305/IUCN.CH.2019.06.EN; Davis AJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P281, DOI 10.1046/j.1365-2699.2000.00189.x; Daz S., 2019, GLOBAL ASSESSMENT RE; Daz S, 2019, GLOBAL ASSESSMENT RE; De Schrijver A, 2008, ENVIRON POLLUT, V153, P295, DOI 10.1016/j.envpol.2007.08.025; De Schrijver A, 2004, ENVIRON POLLUT, V131, P93, DOI 10.1016/j.envpol.2004.01.019; Deharveng L, 1996, CONSERV BIOL, V10, P74, DOI 10.1046/j.1523-1739.1996.10010074.x; Delang C.O., 2015, CHINAS GRAIN GREEN P; Devagiri GM, 2020, J FORESTRY RES, V31, P1005, DOI 10.1007/s11676-019-00885-1; [邸月宝 Di YueBao], 2012, [科学通报, Chinese Science Bulletin], V57, P1553; Dinerstein E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2869; Do Y, 2013, APPL ECOL ENV RES, V11, P451, DOI 10.15666/aeer/1103_451461; Dolman A. J., 2000, WATER USE FORESTS 25; Dotterweich M, 2013, GEOMORPHOLOGY, V201, P1, DOI 10.1016/j.geomorph.2013.07.021; Douglas I, 1999, PHILOS T R SOC B, V354, P1725, DOI 10.1098/rstb.1999.0516; Duan X., 2014, J LIAONING SCI TECHN, V1, P10; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Echeverría Cristian, 2007, Bosque (Valdivia), V28, P271; Edwards DP, 2021, CURR BIOL, V31, pR1326, DOI 10.1016/j.cub.2021.08.058; Einsele V. G., 1983, FORSTWISS CENTRALBL, V102, P281; Einzmann HJR, 2016, TROP CONSERV SCI, V9, P629, DOI 10.1177/194008291600900205; Munoz-Villers LE, 2015, BOSQUE, V36, P395, DOI 10.4067/S0717-92002015000300007; Elliott JA, 1998, CAN J SOIL SCI, V78, P17, DOI 10.4141/S97-021; Evans J. S., SPATIALECO SPATIAL A; Fahey B, 1997, AGR FOREST METEOROL, V84, P69, DOI 10.1016/S0168-1923(96)02376-3; Fahy O, 1998, FOREST ECOL MANAG, V110, P263, DOI 10.1016/S0378-1127(98)00285-0; Fan JL, 2014, J HYDROL, V519, P1120, DOI 10.1016/j.jhydrol.2014.08.039; Fan SH, 2016, FORESTS, V7, DOI 10.3390/f7070142; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; Farwig N, 2008, FOREST ECOL MANAG, V255, P3885, DOI 10.1016/j.foreco.2008.03.042; Feng XM, 2016, NAT CLIM CHANGE, V6, P1019, DOI [10.1038/nclimate3092, 10.1038/NCLIMATE3092]; Fernandez-Moya J, 2014, CATENA, V123, P236, DOI 10.1016/j.catena.2014.08.010; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fierro A, 2019, ECOL INDIC, V96, P532, DOI 10.1016/j.ecolind.2018.09.018; Fierro A, 2017, FOREST ECOL MANAG, V405, P246, DOI 10.1016/j.foreco.2017.09.026; Filoso S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183210; Fleming TL, 1998, ECOSCIENCE, V5, P213, DOI 10.1080/11956860.1998.11682467; Fonturbel FE, 2016, REV MEX BIODIVERS, V87, P1402, DOI 10.1016/j.rmb.2016.09.011; Food and Agriculture Organization, 2020, Global Forest Resources Assessment (FRA) 2020: main report, DOI 10.4060/ca9825en; Ford CR, 2011, ECOL APPL, V21, P2049, DOI 10.1890/10-2246.1; FRITSCH JM, 1993, IAHS-AISH P, P53; Fu DG, 2009, ARCH BIOL SCI, V61, P741, DOI 10.2298/ABS0904741F; Fuhrer H. W, 1990, FORSTLICHE FORSCHUNG; Fuller RJ, 2008, INSECT CONSERV DIVER, V1, P242, DOI 10.1111/j.1752-4598.2008.00032.x; Furey PR, 2001, WATER RESOUR RES, V37, P2709, DOI 10.1029/2001WR000243; Gahagan A, 2015, FOREST ECOL MANAG, V337, P88, DOI 10.1016/j.foreco.2014.10.037; Gangenova E, 2018, FOREST ECOL MANAG, V424, P529, DOI 10.1016/j.foreco.2018.03.038; Gann GD, 2019, RESTOR ECOL, V27, pS3, DOI 10.1111/rec.13035; Garcia-Ruiz JM, 2011, AGR ECOSYST ENVIRON, V140, P317, DOI 10.1016/j.agee.2011.01.003; Garcia-Ruiz JM, 2015, GEOMORPHOLOGY, V239, P160, DOI 10.1016/j.geomorph.2015.03.008; Garcia-Ruiz JM, 2010, GEOMORPHOLOGY, V120, P248, DOI 10.1016/j.geomorph.2010.03.038; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Ghimire CP, 2014, HYDROL EARTH SYST SC, V18, P4933, DOI 10.5194/hess-18-4933-2014; Gholz HL, 2002, AGR FOREST METEOROL, V112, P87, DOI 10.1016/S0168-1923(02)00059-X; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gomez VCG, 2018, INSECT CONSERV DIVER, V11, P554, DOI 10.1111/icad.12299; Goded S, 2019, GLOB ECOL CONSERV, V19, DOI 10.1016/j.gecco.2019.e00690; Gomez-Cifuentes A, 2017, J INSECT CONSERV, V21, P147, DOI 10.1007/s10841-017-9964-4; Gomi T, 2005, J AM WATER RESOUR AS, V41, P877, DOI 10.1111/j.1752-1688.2005.tb03775.x; Gonzalez A. P., 1985, ANN EDAFOL AGROBIOL, V44, P1081; Gonzalez-Vainer P, 2012, NEOTROP ENTOMOL, V41, P366, DOI 10.1007/s13744-012-0062-8; Granier A, 2000, AGR FOREST METEOROL, V100, P291, DOI [10.1016/S0168-1923(99)00151-3, 10.1016/0168-1923(95)02252-X]; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Gu Wei, 2015, Acta Ecologica Sinica, V35, P7387; Guedes BS, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00414; Guertin D. P, 1990, AN ASS P WORKSH; Guimar D. V., 2015, THESIS U FED LAVRAS; Guo QK, 2015, CATENA, V124, P68, DOI 10.1016/j.catena.2014.08.013; Gupta A, 1996, IAHS-AISH P, P215; Gush M. B., 2002, TT17302 WAT RES COMM; Gyenge J. E., 2010, AM J PLANT SCI BIOTE, V3, P9; Gyenge J, 2009, NEW FOREST, V38, P67, DOI 10.1007/s11056-009-9132-0; Gyenge Javier E, 2011, Ecol. austral, V21, P271; Habel J.C., 2018, Animal Conservation, V21, P405, DOI 10.1111/acv.12408; Haggar J, 2013, ENVIRON MANAGE, V51, P811, DOI 10.1007/s00267-013-0019-7; Hagger V, 2019, ECOL EVOL, V9, P14379, DOI 10.1002/ece3.5874; Hamilton LS, 1983, TROPICAL FORESTED WA; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; HASE H, 1983, FOREST ECOL MANAG, V6, P33, DOI 10.1016/0378-1127(83)90004-X; Hawes J, 2009, J TROP ECOL, V25, P281, DOI 10.1017/S0266467409006038; Heil G. W., 2007, ENV EFFECTS AFFOREST; Herbst M, 2008, AGR FOREST METEOROL, V148, P1655, DOI 10.1016/j.agrformet.2008.05.011; Herbst M, 2015, FOREST ECOL MANAG, V355, P101, DOI 10.1016/j.foreco.2015.05.034; Herrmann A., 2010, STATUS PERSPECTIVES; Herve-Fernandez P, 2016, HYDROL PROCESS, V30, P4944, DOI 10.1002/hyp.11001; Hewlett JD, 1967, FOREST HYDROLOGY, P275; Hibbert A., 1967, INT S FOR HYDR PERG, P527; Hirata T., 1963, COMMONWEALTH BUREAU, V53; Hobbs R, 2003, AGROFOREST SYST, V58, P195, DOI 10.1023/A:1026073906512; Hodge S, 2010, NZ ENTOMOL, V33, P43, DOI 10.1080/00779962.2010.9722191; Holbech LH, 2009, BIRD CONSERV INT, V19, P287, DOI 10.1017/S0959270909007126; Holdridge L. R., 1967, Life zone ecology.; Holz DJ, 2015, J CONTEMP WAT RES ED, V154, P48, DOI 10.1111/j.1936-704X.2015.03187.x; HORNBECK JW, 1993, J HYDROL, V150, P323, DOI 10.1016/0022-1694(93)90115-P; Hosoda Ikuhiro, 2019, Bulletin of the Forestry and Forest Products Research Institute, V18, P111; Hosoda Ikuhiro, 2009, Bulletin of the Forestry and Forest Products Research Institute, V8, P51; Hosoda Ikuhiro, 2006, Bulletin of the Forestry and Forest Products Research Institute, V5, P99; Hou XL, 2010, ECOL RES, V25, P139, DOI 10.1007/s11284-009-0645-y; Hua FY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12717; Huang ZG, 2010, J ENVIRON SCI, V22, P1765, DOI 10.1016/S1001-0742(09)60317-X; Huber A, 2001, J HYDROL, V248, P78, DOI 10.1016/S0022-1694(01)00394-8; HUBER J ANTON, 2004, Bosque (Valdivia), V25, P33; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hwong JeenLian, 2002, Journal of the Experimental Forest of National Taiwan University, V16, P95; Iezzi ME, 2020, FOREST ECOL MANAG, V473, DOI 10.1016/j.foreco.2020.118303; IUCN International Union for Conservation of Nature, BONN CHALLENGE; Jaafar O., 2011, GEOGRAFIA MALAYS J S, V7, P1; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jacoboski LI, 2016, BRAZ J BIOL, V76, P583, DOI 10.1590/1519-6984.18614; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; Ji Ying, 2015, Journal of Beijing Forestry University, V37, P41; Jirasuktaveekul W., 1998, SOIL WATER LOSSES RE; Jones JA, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002952; Jones J, 2017, HYDROL PROCESS, V31, P972, DOI 10.1002/hyp.11035; Jones JA, 2012, BIOSCIENCE, V62, P390, DOI 10.1525/bio.2012.62.4.10; JORDAN CF, 1982, ENVIRON MANAGE, V6, P485, DOI 10.1007/BF01868377; Juez C, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.142610; Kanowski J, 2005, FOREST ECOL MANAG, V208, P359, DOI 10.1016/j.foreco.2005.01.018; Kanowski JJ, 2006, RESTOR ECOL, V14, P67, DOI 10.1111/j.1526-100X.2006.00106.x; Kanowski John, 2010, Ecological Management & Restoration, V11, P119, DOI 10.1111/j.1442-8903.2010.00529.x; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kattan GH, 2010, TROP CONSERV SCI, V3, P334, DOI 10.1177/194008291000300307; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Kawahara T., 1981, Journal of the Japanese Forestry Society, V63, P320; Komatsu H, 2008, J HYDROL, V348, P330, DOI 10.1016/j.jhydrol.2007.10.006; Komatsu H, 2007, J HYDROL, V336, P361, DOI 10.1016/j.jhydrol.2007.01.009; Krishnaswamy J, 2012, J HYDROL, V472, P216, DOI 10.1016/j.jhydrol.2012.09.016; Kumar JIN, 2010, MITIG ADAPT STRAT GL, V15, P811, DOI 10.1007/s11027-010-9240-3; Kwok HK, 2000, FOREST ECOL MANAG, V130, P227, DOI 10.1016/S0378-1127(99)00178-4; Labriere N, 2015, AGR ECOSYST ENVIRON, V203, P127, DOI 10.1016/j.agee.2015.01.027; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Ladekarl UL, 2005, J HYDROL, V300, P76, DOI 10.1016/j.jhydrol.2004.05.003; Lamb D, 1998, RESTOR ECOL, V6, P271, DOI 10.1046/j.1526-100X.1998.00632.x; Lane PNJ, 2005, J HYDROL, V310, P253, DOI 10.1016/j.jhydrol.2005.01.006; Lantschner Maria V., 2007, Ecologia Austral, V17, P99; Lantschner MV, 2008, BIODIVERS CONSERV, V17, P969, DOI 10.1007/s10531-007-9243-x; Lara A, 2009, FOREST ECOL MANAG, V258, P415, DOI 10.1016/j.foreco.2009.01.004; Lasco RD, 2002, SCI CHINA SER C, V45, P55; Lasco RD, 2009, J ENVIRON SCI MANAG, V12, P1; Laudon H, 2011, FORESTS, V2, P243, DOI 10.3390/f2010243; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Silva AKL, 2011, PLANT SOIL, V347, P377, DOI 10.1007/s11104-011-0857-0; Leclere D, 2020, NATURE, V585, P551, DOI 10.1038/s41586-020-2705-y; Leemans R, 1989, GLOBAL HOLDRIDGE LIF; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; Legout A, 2016, FOREST ECOL MANAG, V378, P244, DOI 10.1016/j.foreco.2016.07.003; Lewis SL, 2019, NATURE, V568, P25, DOI 10.1038/d41586-019-01026-8; Lewis T, 2016, FOREST ECOL MANAG, V370, P65, DOI 10.1016/j.foreco.2016.03.058; Li JJ, 2013, J SOIL SEDIMENT, V13, P760, DOI 10.1007/s11368-013-0652-z; Li Q, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1838; Li Q, 2017, J INSECT CONSERV, V21, P621, DOI 10.1007/s10841-017-0005-0; Li SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135946; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Licata JA, 2008, FOREST ECOL MANAG, V255, P753, DOI 10.1016/j.foreco.2007.09.061; Lima W. de P, 1987, REFORESTATION EUCALY; Lima W. de P, 1993, ENV EFFECTS EUCALYPT; Lin DM, 2015, EUR J FOREST RES, V134, P769, DOI 10.1007/s10342-015-0888-9; Lin KM, 2017, NEW FOREST, V48, P115, DOI 10.1007/s11056-016-9559-z; Lindenmayer DB, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1362; Lindenmayer DB, 2004, BIOL CONSERV, V119, P151, DOI 10.1016/j.biocon.2003.10.028; Liu X, 2018, AGR FOREST METEOROL, V262, P14, DOI 10.1016/j.agrformet.2018.06.025; Liu XD, 2015, ECOHYDROLOGY, V8, P1037, DOI 10.1002/eco.1561; Llorens P, 2007, J HYDROL, V335, P37, DOI 10.1016/j.jhydrol.2006.10.032; Locatelli B, 2017, FRONT ECOL ENVIRON, V15, P150, DOI 10.1002/fee.1470; Locatelli B, 2009, FOREST ECOL MANAG, V258, P1864, DOI 10.1016/j.foreco.2009.01.015; Loescher HW, 2005, J HYDROL, V315, P274, DOI 10.1016/j.jhydrol.2005.03.040; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Longworth JB, 2018, TROP CONSERV SCI, V11, P1, DOI 10.1177/1940082918773298; Lozano-Baez SE, 2018, WATER-SUI, V10, DOI 10.3390/w10040453; Lu Zhi-xing, 2016, Forest Research, V29, P576; Lu YH, 2008, PROG PHYS GEOG, V32, P491, DOI 10.1177/0309133308098942; LUGO AE, 1992, ECOL MONOGR, V62, P1, DOI 10.2307/2937169; Lugo AE, 1997, FOREST ECOL MANAG, V99, P9, DOI 10.1016/S0378-1127(97)00191-6; Luo TH, 2013, ENVIRON ENTOMOL, V42, P7, DOI 10.1603/EN11298; Ma L, 2014, ECOHYDROLOGY, V7, P612, DOI 10.1002/eco.1382; Maetens W, 2012, PROG PHYS GEOG, V36, P599, DOI 10.1177/0309133312451303; Magnano AL, 2019, EMU, V119, P346, DOI 10.1080/01584197.2019.1581032; MALMER A, 1992, J HYDROL, V134, P77, DOI 10.1016/0022-1694(92)90029-U; Malmer A., 2005, EFFECTS SHIFTING CUL, P533; Mandal J, 2016, CONDOR, V118, P345, DOI 10.1650/CONDOR-15-163.1; Mang SL, 2015, BIODIVERS CONSERV, V24, P3431, DOI 10.1007/s10531-015-1022-5; Marques R, 1997, FOREST ECOL MANAG, V92, P167, DOI 10.1016/S0378-1127(96)03913-8; Martens B, 2017, GEOSCI MODEL DEV, V10, P1903, DOI 10.5194/gmd-10-1903-2017; Martin C., 2003, ETUDES GEOGRAPHIE PH, V30, P3; Martinez A, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009003; Martins S. G., 2005, THESIS U FED LAVRAS; Mascaro J, 2012, FOREST ECOL MANAG, V276, P62, DOI 10.1016/j.foreco.2012.03.032; Matsumoto K, 2008, AGR FOREST METEOROL, V148, P1978, DOI 10.1016/j.agrformet.2008.09.008; Mead D. J., 2001, FP1 FAO; Medina CA, 2002, BIOTROPICA, V34, P181, DOI 10.1111/j.1744-7429.2002.tb00255.x; Meli P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171368; Melo FPL, 2021, NAT SUSTAIN, V4, P85, DOI 10.1038/s41893-020-00608-z; Merheb M, 2016, HYDROLOG SCI J, V61, P2520, DOI 10.1080/02626667.2016.1140174; Merino-Sainz I, 2018, J INSECT CONSERV, V22, P363, DOI 10.1007/s10841-018-0066-8; Milheiras SG, 2020, PEERJ, V8, DOI 10.7717/peerj.8486; Minor MA, 2008, NEW ZEAL J ZOOL, V35, P271, DOI 10.1080/03014220809510124; MITRA SS, 1993, AUK, V110, P529, DOI 10.2307/4088417; Molchanov A. A, 1971, PRODUCTIVITY FOREST, V54, P49; Moreira-Arce D, 2015, BIOL CONSERV, V192, P258, DOI 10.1016/j.biocon.2015.09.015; Moreno-Mateos D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14163; Mott B, 2010, FOREST ECOL MANAG, V259, P916, DOI 10.1016/j.foreco.2009.11.031; Munro Nicola T., 2007, Ecological Management & Restoration, V8, P199, DOI 10.1111/j.1442-8903.2007.00368.x; Murakami S, 2000, J HYDROL, V227, P114, DOI 10.1016/S0022-1694(99)00175-4; N'dri JK, 2013, CURR ZOOL, V59, P633, DOI 10.1093/czoolo/59.5.633; N'Gbala FN, 2017, AGR ECOSYST ENVIRON, V239, P30, DOI 10.1016/j.agee.2017.01.015; Nadal-Romero E, 2016, HYDROL PROCESS, V30, P2717, DOI 10.1002/hyp.10820; Naime J, 2020, FOREST ECOL MANAG, V473, DOI 10.1016/j.foreco.2020.118294; Nakagawa S, 2022, METHODS ECOL EVOL, V13, P4, DOI 10.1111/2041-210X.13724; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Nakano H., 1967, INT S FOREST HYDROLO, P551; NEAL C, 1993, J HYDROL, V146, P221, DOI 10.1016/0022-1694(93)90277-G; NFGA (National Forestry and Grassland Administration), 2020, 20 YEARS CHIN GRAIN; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nicolas V, 2009, BIODIVERS CONSERV, V18, P2043, DOI 10.1007/s10531-008-9572-4; NIHLGARD B, 1972, OIKOS, V23, P69, DOI 10.2307/3543928; Niu X, 2013, J FOOD AGRIC ENVIRON, V11, P1008; Norfolk O, 2017, BIOTROPICA, V49, P346, DOI 10.1111/btp.12421; Norton David A., 1998, New Zealand Forestry, V43, P34; NUMMELIN M, 1989, J TROP ECOL, V5, P349, DOI 10.1017/S0266467400003758; Nurinsiyah AS, 2016, ECOL INDIC, V70, P557, DOI 10.1016/j.ecolind.2016.05.013; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; Ogai T, 2016, ECOL RES, V31, P177, DOI 10.1007/s11284-015-1325-8; Ohwaki A, 2017, EUR J ENTOMOL, V114, P533, DOI 10.14411/eje.2017.068; Oishi AC, 2010, ECOSYSTEMS, V13, P421, DOI 10.1007/s10021-010-9328-3; Oliveira A. H., 2011, THESIS U FED LAVRAS; Oliveira AH, 2013, CIENC AGROTEC, V37, P159, DOI 10.1590/S1413-70542013000200007; Omoro LMA, 2013, SILVA FENN, V47, DOI 10.14214/sf.935; Osuri AM, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab5f75; Otuoma J, 2016, FOREST ECOL MANAG, V365, P61, DOI 10.1016/j.foreco.2016.01.028; Oyarzun C. E., 1999, Terra, V17, P35; Oyarzun C. E., 2012, FOREST MANAGEMENT, P79; OYARZUN CE, 1995, MT RES DEV, V15, P331, DOI 10.2307/3673809; Oyebande L., 1988, FORESTS CLIMATE HYDR, P16; Palladini JD, 2007, FOREST ECOL MANAG, V242, P619, DOI 10.1016/j.foreco.2007.01.074; Pandey CB, 2010, INDIAN J AGR SCI, V80, P399; Pangle L, 2009, FOREST ECOL MANAG, V257, P1034, DOI 10.1016/j.foreco.2008.11.004; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Pardini G, 2003, SCI TOTAL ENVIRON, V309, P213, DOI 10.1016/S0048-9697(03)00007-X; Paritsis J, 2008, FOREST ECOL MANAG, V255, P1575, DOI 10.1016/j.foreco.2007.11.015; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Pawson SM, 2008, BIODIVERS CONSERV, V17, P1127, DOI 10.1007/s10531-008-9363-y; Paz CP, 2015, BIOTROPICA, V47, P616, DOI 10.1111/btp.12240; Peck A. K, 2004, HYDROMETEOROLOGICAL; Pedley SM, 2014, FOREST ECOL MANAG, V314, P172, DOI 10.1016/j.foreco.2013.12.010; Penman H. L, 1963, 49 FOR COMM NEW S WA; Penteado M, 2016, BIODIVERSITY IN AGRICULTURAL LANDSCAPES OF SOUTHEASTERN BRAZIL, P243; Pibumrung P., 2008, Journal of Forestry Research (Harbin), V19, P11, DOI 10.1007/s11676-008-0002-y; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Piotto D, 2010, NEW FOREST, V39, P369, DOI 10.1007/s11056-009-9177-0; Pomeroy J. W., 1997, NHRI CONTRIBUTION SE; Powers JS, 1997, FOREST ECOL MANAG, V99, P43, DOI 10.1016/S0378-1127(97)00193-X; Preece ND, 2012, FOREST ECOL MANAG, V264, P228, DOI 10.1016/j.foreco.2011.10.016; Price K, 2011, PROG PHYS GEOG, V35, P465, DOI 10.1177/0309133311402714; PUNTTILA P, 1991, OIKOS, V61, P250, DOI 10.2307/3545343; Qi L., 2008, SOURCES SCI, V30, P709; R Core Team, 2020, R LANG ENV STAT COMP; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Ramirez PA, 2011, J NAT CONSERV, V19, P351, DOI 10.1016/j.jnc.2011.06.003; Ratsirarson H, 2002, AFR ENTOMOL, V10, P93; Razafindrabe BHN, 2010, ENVIRON MONIT ASSESS, V160, P337, DOI 10.1007/s10661-008-0699-2; Reid JL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9143; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; RIEKERK H, 1989, WATER RESOUR RES, V25, P713, DOI 10.1029/WR025i004p00713; Ringgaard R, 2014, J HYDROL, V517, P677, DOI 10.1016/j.jhydrol.2014.06.007; Rizzo J.R., 2022, ZENODO, DOI [10.5281/zenodo.7046117, DOI 10.5281/ZENODO.7046117, 10.5281/zenodo.6103053, DOI 10.5281/ZENODO.6103053]; Roberts J, 2005, HYDROL EARTH SYST SC, V9, P596, DOI 10.5194/hess-9-596-2005; Roberts J, 1999, ROUT PHYS E, P181; Robinson M, 1992, 120 I HYDR; Rodrigues PES, 2017, J INSECT CONSERV, V21, P297, DOI 10.1007/s10841-017-9976-0; Rodriguez-Suarez JA, 2011, J HYDROL, V396, P321, DOI 10.1016/j.jhydrol.2010.11.027; Roll A, 2019, AGR FOREST METEOROL, V274, P160, DOI 10.1016/j.agrformet.2019.04.017; Romijn E, 2019, FORESTS, V10, DOI 10.3390/f10060510; Rosenqvist L, 2010, AGR FOREST METEOROL, V150, P196, DOI 10.1016/j.agrformet.2009.10.004; Rowe L. K., 2003, 6 LANDC RES; Rowe L. K., 2002, 5 LAND CAR RES; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Saavedra B, 2005, MAMMALIA, V69, P337, DOI 10.1515/mamm.2005.027; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Sakchoowong W, 2008, ENTOMOL SCI, V11, P301, DOI 10.1111/j.1479-8298.2008.00281.x; Santini L, 2017, BIOL CONSERV, V213, P341, DOI 10.1016/j.biocon.2016.08.024; Sarrionandia E, 2015, CAN J FOREST RES, V45, P667, DOI 10.1139/cjfr-2014-0317; Scheurer K, 2009, ENVIRON SCI POLLUT R, V16, P232, DOI 10.1007/s11356-008-0075-3; Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434; Schmalz B, 2015, HYDROL WASSERBEWIRTS, V59, P184; Scott D.F., 2005, HYDROLOGICAL SOIL IM, P622, DOI DOI 10.1017/CBO9780511535666; Sekercioglu CH, 2002, BIOL CONSERV, V107, P229, DOI 10.1016/S0006-3207(02)00097-6; Senior AM, 2016, ECOLOGY, V97, P3293, DOI 10.1002/ecy.1591; Sheldon FH, 2011, RAFFLES B ZOOL, V59, P295; Sheldon FH, 2010, BIOL CONSERV, V143, P399, DOI 10.1016/j.biocon.2009.11.004; [盛后财 Sheng Houcai], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P101; Shiklomanov I. A., 1988, FORESTS CLIMATE HYDR, P78; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Soares JV, 2001, J HYDROL, V253, P130, DOI 10.1016/S0022-1694(01)00477-2; Soares SD, 2010, REV BRAS ENTOMOL, V54, P76, DOI 10.1590/S0085-56262010000100009; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Sopper W. E., 1967, INT S FOR HYDR; Soto-Schonherr S, 2016, HYDROL PROCESS, V30, P4674, DOI 10.1002/hyp.10946; Soubie R, 2016, AGR FOREST METEOROL, V228, P191, DOI 10.1016/j.agrformet.2016.07.001; Spake R, 2015, CONSERV BIOL, V29, P1695, DOI 10.1111/cobi.12548; Station K. B, 1979, BULL FOR FOR PROD R, V308, P133; Stednick JD, 1996, J HYDROL, V176, P79, DOI 10.1016/0022-1694(95)02780-7; Stephens SS, 2007, J FOREST, V105, P307; Stott T, 2004, PROG PHYS GEOG, V28, P197, DOI 10.1191/0309133304pp410ra; Strassburg BBN, 2020, NATURE, V586, P724, DOI 10.1038/s41586-020-2784-9; STUEBING RB, 1989, J TROP ECOL, V5, P203, DOI 10.1017/S0266467400003485; Styring AR, 2011, FOREST ECOL MANAG, V261, P531, DOI 10.1016/j.foreco.2010.11.003; Sun G, 2008, AGR FOREST METEOROL, V148, P257, DOI 10.1016/j.agrformet.2007.08.010; Sun G, 2002, J HYDROL, V263, P92, DOI 10.1016/S0022-1694(02)00064-1; Sung YH, 2012, FOREST ECOL MANAG, V270, P71, DOI 10.1016/j.foreco.2012.01.011; Sutmoller J, 2018, HYDROL WASSERBEWIRTS, V62, P184, DOI 10.5675/HyWa_2018,3_5; Taboada A, 2008, BASIC APPL ECOL, V9, P161, DOI 10.1016/j.baae.2007.01.004; Tamai K., 2008, Bulletin of the Forestry and Forest Products Research Institute, Ibaraki, P125; Tan ZH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050006; Tang CQ, 2007, MT RES DEV, V27, P242, DOI 10.1659/mrd.0732; Thapa RB, 2015, IEEE J-STARS, V8, P661, DOI 10.1109/JSTARS.2014.2328656; Thompson ME, 2018, COPEIA, V106, P10, DOI 10.1643/CH-17-654; Tian DL, 2008, HYDROL PROCESS, V22, P4870, DOI 10.1002/hyp.7105; Tikoca Siteri, 2016, Journal of Research on the Lepidoptera, V49, P69; TIKTAK A, 1994, J HYDROL, V156, P265, DOI 10.1016/0022-1694(94)90081-7; Tondoh JE, 2011, BIODIVERS CONSERV, V20, P169, DOI 10.1007/s10531-010-9953-3; Trimble MJ, 2014, ANIM CONSERV, V17, P441, DOI 10.1111/acv.12111; Tummers B., 2006, DATATHIEF 3; Twedt DJ, 1999, FOREST ECOL MANAG, V123, P261, DOI 10.1016/S0378-1127(99)00043-2; Udayana C, 2020, J SUSTAIN FOREST, V39, P494, DOI 10.1080/10549811.2019.1686029; Ueda A, 2015, J INSECT CONSERV, V19, P765, DOI 10.1007/s10841-015-9798-x; UN Environment Programme FAO, UN DEC EC REST; Upadhaya K, 2015, TROP ECOL, V56, P257; Urbano AR, 2017, FOREST ECOL MANAG, V392, P21, DOI 10.1016/j.foreco.2017.02.037; Vadell E, 2016, LAND USE POLICY, V55, P37, DOI 10.1016/j.landusepol.2016.03.017; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Van Lanen H. A. J., 1997, 971 UNESCO IHP OHP; Vanmaercke M, 2011, GEOMORPHOLOGY, V130, P142, DOI 10.1016/j.geomorph.2011.03.010; Vasconcelos RN, 2019, FOREST ECOL MANAG, V432, P115, DOI 10.1016/j.foreco.2018.09.017; Venkatesh B, 2014, J FORESTRY RES, V25, P37, DOI 10.1007/s11676-014-0431-8; Vergara PM, 2004, ORYX, V38, P383, DOI 10.1017/S0030605304000742; VERRY E S, 1977, Canadian Journal of Forest Research, V7, P112, DOI 10.1139/x77-016; Verstraeten W. W, 2001, 9906 VLINA; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volpato GH, 2010, FOREST ECOL MANAG, V260, P1156, DOI 10.1016/j.foreco.2010.07.006; Vonesh JR, 2001, BIOTROPICA, V33, P502, DOI 10.1111/j.1744-7429.2001.tb00204.x; Wakiyama Y, 2010, GEODERMA, V159, P39, DOI 10.1016/j.geoderma.2010.06.012; Waldick RC, 1999, CAN FIELD NAT, V113, P408; Walling DE, 1996, IAHS-AISH P, P3; Wallis G., 1994, LOGGING IND RES ORGA, V19, P1; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang Jun, 2008, Yingyong Shengtai Xuebao, V19, P25; Wang SP, 2020, J HYDROL, V590, DOI 10.1016/j.jhydrol.2020.125387; WARD RC, 1984, J HYDROL, V74, P171, DOI 10.1016/0022-1694(84)90147-1; Warren-Thomas E, 2014, FOREST ECOL MANAG, V334, P369, DOI 10.1016/j.foreco.2014.09.022; Webb AA, 2012, J HYDROL, V464, P412, DOI 10.1016/j.jhydrol.2012.07.034; Webb EL, 2003, FOREST ECOL MANAG, V176, P337, DOI 10.1016/S0378-1127(02)00272-4; Wei X, 2005, HYDROL PROCESS, V19, P63, DOI 10.1002/hyp.5777; Wei XH, 2008, J AM WATER RESOUR AS, V44, P1076, DOI 10.1111/j.1752-1688.2008.00237.x; WHITEHEAD PG, 1993, J HYDROL, V145, P217, DOI 10.1016/0022-1694(93)90055-E; Wiersum K. F., 1984, Symposium on effects of forest land use on erosion and slope stability, P231; Wilson SJ, 2017, ECOL SOC, V22, DOI 10.5751/ES-09615-220438; Wondzell SM, 2001, NORTHWEST SCI, V75, P128; World Economic Forum, 1 TRILL TREES CAMP; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; Wu Jia-ming, 2015, Journal of South China University of Technology (Natural Science Edition), V43, P141, DOI 10.3969/j.issn.1000-565X.2015.12.020; Xie JS, 2013, FOREST ECOL MANAG, V300, P53, DOI 10.1016/j.foreco.2012.06.038; Yamamoto S, 2014, ENTOMOL SCI, V17, P52, DOI 10.1111/ens.12036; Yamaura Y, 2011, ENTOMOL SCI, V14, P56, DOI 10.1111/j.1479-8298.2010.00415.x; [颜廷武 YAN Ting-wu], 2009, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V40, P449; [颜廷武 Yan Tingwu], 2015, [生态学报, Acta Ecologica Sinica], V35, P172; [杨一松 Yang Yisong], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P84; Yang YS, 2005, FOREST ECOL MANAG, V216, P216, DOI 10.1016/j.foreco.2005.05.030; Yang YS, 2007, PLANT ECOL, V193, P71, DOI 10.1007/s11258-006-9249-6; Yang YS, 2018, J GEOPHYS RES-BIOGEO, V123, P676, DOI 10.1002/2017JG004267; Yang ZB, 2010, ENVIRON MONIT ASSESS, V164, P357, DOI 10.1007/s10661-009-0898-5; Yao Y. F, 2011, THESIS NE FORESTRY U; Yoshikura S, 2011, MAMM STUDY, V36, P189, DOI 10.3106/041.036.0402; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Yu XD, 2004, ENTOMOL FENNICA, V15, P129; Yu XD, 2008, FOREST ECOL MANAG, V255, P2617, DOI 10.1016/j.foreco.2008.01.019; Yu XD, 2006, FOREST ECOL MANAG, V231, P169, DOI 10.1016/j.foreco.2006.05.043; Yu XD, 2010, J INSECT CONSERV, V14, P617, DOI 10.1007/s10841-010-9290-6; Zahawi RA, 2014, RESTOR ECOL, V22, P284, DOI 10.1111/rec.12098; Zhang J, 2020, EUR J SOIL BIOL, V96, DOI 10.1016/j.ejsobi.2019.103149; Zhang MF, 2017, J HYDROL, V546, P44, DOI 10.1016/j.jhydrol.2016.12.040; Zhang Q, 2011, FOREST ECOL MANAG, V261, P1738, DOI 10.1016/j.foreco.2011.01.025; Zhao Jing-wen, 2017, Forest Research, V30, P823, DOI 10.13275/j.cnki.lykxyj.2017.05.016; Zheng H, 2008, J HYDROL, V356, P174, DOI 10.1016/j.jhydrol.2008.04.007; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015; Zhou BZ, 2012, ADV MATER RES-SWITZ, V518-523, P4827, DOI 10.4028/www.scientific.net/AMR.518-523.4827; Zhou GY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6918; Zhou H, 2019, J FORESTRY RES, V30, P1679, DOI 10.1007/s11676-018-0761-z; [周璟 Zhou Jing], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P18; [朱建佳 Zhu Jianjia], 2016, [自然资源学报, Journal of Natural Resources], V31, P1871; Cain MD, 1996, FOREST ECOL MANAG, V81, P227, DOI 10.1016/0378-1127(95)03605-9; Doua-Bi GYA, 2021, FOREST ECOL MANAG, V493, DOI 10.1016/j.foreco.2021.119240; Fantini AC, 2019, FLORESTA AMBIENTE, V26, DOI 10.1590/2179-8087.069017; Gomyo M., 2013, Journal of the Japanese Forest Society, V95, P109, DOI 10.4005/jjfs.95.109; Hallsby G, 2015, FORESTRY, V88, P441, DOI 10.1093/forestry/cpv010; Julin KR, 2003, WEST J APPL FOR, V18, P30, DOI 10.1093/wjaf/18.1.30; Kuraji K., 2019, DEVELOPING NETWORK L, P81; Nandakumar N., 1993, AUSTR NATL C PUBLICA, V93/14, P87; Ogden FL, 2013, WATER RESOUR RES, V49, P8443, DOI 10.1002/2013WR013956; Pilgrim D. H., 1982, First national symposium on forest hydrology, P103; Pitt DG, 2013, FOREST CHRON, V89, P446, DOI 10.5558/tfc2013-086; Putuhena WM, 2000, AGR FOREST METEOROL, V100, P59, DOI 10.1016/S0168-1923(99)00086-6; Richardson J. H., 1982, Zeitschrift fur Geomorphologie, Supplementband, P107; Rothe A, 2002, PLANT SOIL, V240, P33, DOI 10.1023/A:1015846906956; ROWE LK, 1994, HYDROL PROCESS, V8, P263, DOI 10.1002/hyp.3360080307; ROWE LK, 1994, HYDROL PROCESS, V8, P281, DOI 10.1002/hyp.3360080402; Salemi LF, 2013, J HYDROL, V499, P100, DOI 10.1016/j.jhydrol.2013.06.049; Schafer KVR, 2002, GLOBAL CHANGE BIOL, V8, P895, DOI 10.1046/j.1365-2486.2002.00513.x; Scott DF, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006781; Scott DF, 1997, WATER SA, V23, P135; Shoo LP, 2016, CONSERV BIOL, V30, P121, DOI 10.1111/cobi.12606; Tsykin E., 1982, First national symposium on forest hydrology, P124; Voigtlaender M., 2007, THESIS U SAO PAULO; Vsquez-Velsquez G. L., 2016, THESIS U NACL COLOMB; Wang X., 2015, THESIS BEIJING FOR U; Wolf S, 2011, ECOSYSTEMS, V14, P1264, DOI 10.1007/s10021-011-9478-y; Wu ZL, 2018, FORESTS, V9, DOI 10.3390/f9010040; Yang H, 2019, WATER-SUI, V11, DOI 10.3390/w11112301; Zambiazi DC, 2021, FOREST ECOL MANAG, V495, DOI 10.1016/j.foreco.2021.119352; [张建军 ZHANG JianJun], 2008, [生态学报, Acta Ecologica Sinica], V28, P3597; Zhang SY, 2006, CAN J FOREST RES, V36, P945, DOI 10.1139/X05-307; Zhang Xi, 2015, Journal of Beijing Forestry University, V37, P19; Zhou Guoyi, 1999, Journal of Tropical and Subtropical Botany, V7, P93; Zhou GY, 2002, FOREST ECOL MANAG, V167, P209, DOI 10.1016/S0378-1127(01)00694-6; [邹志谨 Zou Zhijin], 2017, [生态环境学报, Ecology and Environmental Sciences], V26, P770	535	29	31	318	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2022	376	6595					839	+		10.1126/science.abl4649	http://dx.doi.org/10.1126/science.abl4649			106	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1K3GZ	35298279	Green Submitted, Green Accepted			2022-12-28	WOS:000798495000033
J	Rosa, WE; Grant, L; Knaul, FM; Marston, J; Arreola-Ornelas, H; Riga, O; Marabyan, R; Penkov, A; Sallnow, L; Rajagopal, MR				Rosa, William E.; Grant, Liz; Knaul, Felicia Marie; Marston, Joan; Arreola-Ornelas, Hector; Riga, Olena; Marabyan, Roman; Penkov, Andriy; Sallnow, Libby; Rajagopal, M. R.			The value of alleviating suffering and dignifying death in war and humanitarian crises	LANCET			English	Editorial Material									[Rosa, William E.] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10022 USA; [Grant, Liz] Univ Edinburgh, Global Hlth Acad, Edinburgh, Midlothian, Scotland; [Knaul, Felicia Marie; Arreola-Ornelas, Hector] Univ Miami, Inst Adv Study Amer, Coral Gables, FL 33124 USA; [Knaul, Felicia Marie] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Knaul, Felicia Marie; Arreola-Ornelas, Hector] Tomatelo Pecho, Mexico City, DF, Mexico; [Knaul, Felicia Marie; Arreola-Ornelas, Hector] Fdn Mexicana Salud, Mexico City, DF, Mexico; [Marston, Joan] Univ Edinburgh, Palliat Care Humanitarian Aid Situat & Emergencie, Edinburgh, Midlothian, Scotland; [Marston, Joan] Palliat Care Children Bloemfontein, Bloemfontein, Free State, South Africa; [Riga, Olena] Natl Med Univ Kharkiv, Kharkiv, Ukraine; [Marabyan, Roman] Reg Clin Ctr Med Rehabil & Palliat Care Children, Kharkiv, Ukraine; [Penkov, Andriy] Eastern Ukrainian Acad Pediat, Kharkiv, Ukraine; [Sallnow, Libby] St Christophers Hospice, London, England; [Sallnow, Libby] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Rajagopal, M. R.] WHO Collaborating Ctr Training & Policy Access Pa, Trivandrum Inst Palliat Serv, Trivandrum, Kerala, India; [Rajagopal, M. R.] Pallium India, Trivandrum, Kerala, India	Memorial Sloan Kettering Cancer Center; University of Edinburgh; University of Miami; University of Miami; University of Edinburgh; Kharkiv National Medical University; Vrije Universiteit Brussel	Rosa, WE (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10022 USA.	rosaw@mskcc.org	Sallnow, Libby/ABF-2995-2021	Sallnow, Libby/0000-0001-7079-9637; Knaul, Felicia/0000-0002-0512-4788				[Anonymous], 2015, AUST J EMERG MANAG, V30, P9; [Anonymous], 2022, REUTERS; Bone RM, 2021, FOREIGN POLICY 1202; Council on Foreign Relations, 2022, GLOB CONFL TRACK VIO; Devi S, 2022, LANCET, V399, P1037, DOI 10.1016/S0140-6736(22)00474-3; ehospice Worldwide Hospice Palliative Care Alliance, 2022, PALL CAR HUM AID SIT; Farge E, 2022, REUTERS 0308; Farmer P., 2003, PATHOLOGIES POWER HL; Grant L, 2022, LANCET, V399, P775, DOI 10.1016/S0140-6736(22)00162-3; HAP International People in Aid The Sphere Project, 2014, COR HUM STAND QUAL A; Human Rights Watch, 2011, UNC PAIN UKR OBL ENS; International Committee of the Red Cross International Federation of Red Cross., 1994, COD COND INT RED CRO; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Pavadia Jagjit, 2022, 65 SESS COMM NARC DR; Powell RA, 2017, LANCET, V389, P1498, DOI 10.1016/S0140-6736(17)30978-9; Refugees International, 2021, ADV LETT MEM IMP US; Sallnow L, 2022, LANCET, V399, P837, DOI 10.1016/S0140-6736(21)02314-X; Schneider Martin, 2017, Med Confl Surviv, V33, P263, DOI 10.1080/13623699.2017.1409167; Sivaram M., 2018, INT J HUMANITARIAN A, V3, P5, DOI DOI 10.1186/S41018-018-0033-8; Sphere A., 2018, SPHERE HDB HUMANITAR, DOI [10.3362/9781908176738, DOI 10.3362/9781908176738]; The Lancet, LANCET, V399, P1023; UN General Assembly, 2004, STRENGTH COORD EM HU; UN Refugee Agency, 2015, EM HDB; United Nations High Commissioner for Refugees, 2022, OP DAT PORT SYR REG; Waldman E, 2020, FIELD MANUAL PALLIAT; WHO, 2013, ES MED PALL CAR PREP; World Health Organization, 2018, INT PALL CAR SYMPT R	27	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2022	399	10334					1447	1450		10.1016/S0140-6736(22)00534-7	http://dx.doi.org/10.1016/S0140-6736(22)00534-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JN	35325605	Green Accepted			2022-12-28	WOS:000795611300006
J	Brophy, JM				Brophy, James M.			After DES implantation, DAPT for 1 y vs. <= 6 mo increased major bleeding in patients with high baseline bleeding risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MULTIVARIABLE PREDICTION MODEL; INDIVIDUAL PROGNOSIS		[Brophy, James M.] McGill Univ, Montreal, PQ, Canada	McGill University	Brophy, JM (corresponding author), McGill Univ, Montreal, PQ, Canada.							Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376	3	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC45	JC45		10.7326/J22-0012	http://dx.doi.org/10.7326/J22-0012		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377722				2022-12-28	WOS:000799170800011
J	Larkin, HD				Larkin, Howard D.			New Cancer Clinical Trial Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1219	1219		10.1001/jama.2022.3970	http://dx.doi.org/10.1001/jama.2022.3970			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380598				2022-12-28	WOS:000783965500010
J	Larkin, HD				Larkin, Howard D.			First Condom Authorized Specifically for Anal Intercourse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1219	1219		10.1001/jama.2022.4561	http://dx.doi.org/10.1001/jama.2022.4561			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380599				2022-12-28	WOS:000783965500008
J	Lin, K; Lang, E				Lin, Katie; Lang, Eddy			In ischemic stroke upon wakening, IV thrombolysis or EVT improves functional outcome at 90 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lin, Katie; Lang, Eddy] Univ Calgary, Calgary, AB, Canada	University of Calgary	Lin, K (corresponding author), Univ Calgary, Calgary, AB, Canada.							Bassetti C, 1999, J NEUROL NEUROSUR PS, V67, P463, DOI 10.1136/jnnp.67.4.463; Boulanger JM, 2018, INT J STROKE, V13, P949, DOI 10.1177/1747493018786616	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC41	JC41		10.7326/J22-0020	http://dx.doi.org/10.7326/J22-0020		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377725				2022-12-28	WOS:000799170800007
J	Waters, A				Waters, Adele			NHS staff survey underlines need for national workforce strategy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Health Service Staff Survey, 2022, NHS STAFF SURV RES A; Waters Adele, 2022, BMJ, V376, po554, DOI 10.1136/bmj.o554	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o871	10.1136/bmj.o871	http://dx.doi.org/10.1136/bmj.o871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365492				2022-12-28	WOS:000783141700006
J	Sullivan, DJ; Gebo, KA; Shoham, S; Bloch, EM; Lau, B; Shenoy, AG; Mosnaim, GS; Gniadek, TJ; Fukuta, Y; Patel, B; Heath, SL; Levine, AC; Meisenberg, BR; Spivak, ES; Anjan, S; Huaman, MA; Blair, JE; Currier, JS; Paxton, JH; Gerber, JM; Petrini, JR; Broderick, PB; Rausch, W; Cordisco, ME; Hammel, J; Greenblatt, B; Cluzet, VC; Cruser, D; Oei, K; Abinante, M; Hammitt, LL; Sutcliffe, CG; Forthal, DN; Zand, MS; Cachay, ER; Raval, JS; Kassaye, SG; Foster, EC; Roth, M; Marshall, CE; Yarava, A; Lane, K; McBee, NA; Gawad, AL; Karlen, N; Singh, A; Ford, DE; Jabs, DA; Appel, LJ; Shade, DM; Ehrhardt, S; Baksh, SN; Laeyendecker, O; Pekosz, A; Klein, SL; Casadevall, A; Tobian, AAR; Hanley, DF				Sullivan, D. J.; Gebo, K. A.; Shoham, S.; Bloch, E. M.; Lau, B.; Shenoy, A. G.; Mosnaim, G. S.; Gniadek, T. J.; Fukuta, Y.; Patel, B.; Heath, S. L.; Levine, A. C.; Meisenberg, B. R.; Spivak, E. S.; Anjan, S.; Huaman, M. A.; Blair, J. E.; Currier, J. S.; Paxton, J. H.; Gerber, J. M.; Petrini, J. R.; Broderick, P. B.; Rausch, W.; Cordisco, M-E; Hammel, J.; Greenblatt, B.; Cluzet, V. C.; Cruser, D.; Oei, K.; Abinante, M.; Hammitt, L. L.; Sutcliffe, C. G.; Forthal, D. N.; Zand, M. S.; Cachay, E. R.; Raval, J. S.; Kassaye, S. G.; Foster, E. C.; Roth, M.; Marshall, C. E.; Yarava, A.; Lane, K.; McBee, N. A.; Gawad, A. L.; Karlen, N.; Singh, A.; Ford, D. E.; Jabs, D. A.; Appel, L. J.; Shade, D. M.; Ehrhardt, S.; Baksh, S. N.; Laeyendecker, O.; Pekosz, A.; Klein, S. L.; Casadevall, A.; Tobian, A. A. R.; Hanley, D. F.			Early Outpatient Treatment for Covid-19 with Convalescent Plasma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BackgroundPolyclonal convalescent plasma may be obtained from donors who have recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing serious complications in outpatients with recent-onset Covid-19 is uncertain.MethodsIn this multicenter, double-blind, randomized, controlled trial, we evaluated the efficacy and safety of Covid-19 convalescent plasma, as compared with control plasma, in symptomatic adults (>= 18 years of age) who had tested positive for severe acute respiratory syndrome coronavirus 2, regardless of their risk factors for disease progression or vaccination status. Participants were enrolled within 8 days after symptom onset and received a transfusion within 1 day after randomization. The primary outcome was Covid-19-related hospitalization within 28 days after transfusion.ResultsParticipants were enrolled from June 3, 2020, through October 1, 2021. A total of 1225 participants underwent randomization, and 1181 received a transfusion. In the prespecified modified intention-to-treat analysis that included only participants who received a transfusion, the primary outcome occurred in 17 of 592 participants (2.9%) who received convalescent plasma and 37 of 589 participants (6.3%) who received control plasma (absolute risk reduction, 3.4 percentage points; 95% confidence interval, 1.0 to 5.8; P & nbsp;-& nbsp;& nbsp;0.005), which corresponded to a relative risk reduction of 54%. Evidence of efficacy in vaccinated participants cannot be inferred from these data because 53 of the 54 participants with Covid-19 who were hospitalized were unvaccinated and 1 participant was partially vaccinated. A total of 16 grade 3 or 4 adverse events (7 in the convalescent-plasma group and 9 in the control-plasma group) occurred in participants who were not hospitalized.ConclusionsIn participants with Covid-19, most of whom were unvaccinated, the administration of convalescent plasma within 9 days after the onset of symptoms reduced the risk of disease progression leading to hospitalization. (Funded by the Department of Defense and others; CSSC-004 ClinicalTrials.gov number, NCT04373460.)	[Gebo, K. A.; Shoham, S.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Bloch, E. M.; Marshall, C. E.; Tobian, A. A. R.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Yarava, A.; Lane, K.; McBee, N. A.; Gawad, A. L.; Karlen, N.; Hanley, D. F.] Johns Hopkins Sch Med, Dept Neurol, Brain Injury Outcomes Div, Baltimore, MD USA; [Jabs, D. A.] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD USA; [Appel, L. J.] Johns Hopkins Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Ford, D. E.] Johns Hopkins Sch Med, Inst Clin & Translat Res, Baltimore, MD USA; [Sullivan, D. J.; Singh, A.; Pekosz, A.; Klein, S. L.; Casadevall, A.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Hammitt, L. L.; Sutcliffe, C. G.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Lau, B.; Shade, D. M.; Ehrhardt, S.; Baksh, S. N.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Laeyendecker, O.] NIAID, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Meisenberg, B. R.] Luminis Hlth, Annapolis, MD USA; [Shenoy, A. G.] MedStar Washington Hosp Ctr, Div Hematol & Oncol, Dept Med, Washington, DC USA; [Kassaye, S. G.] Georgetown Univ Med Ctr, Div Infect Dis, Dept Med, Washington, DC USA; [Mosnaim, G. S.] North Shore Univ Hlth Syst, Div Allergy & Immunol, Dept Med, Evanston, IL USA; [Gniadek, T. J.] North Shore Univ Hlth Syst, Dept Pathol, Evanston, IL USA; [Fukuta, Y.] Baylor Coll Med, Sect Infect Dis, Houston, TX 77030 USA; [Patel, B.] Univ Texas Hlth Sci Ctr Houston, Div Pulm & Crit Care Med, Dept Med, Houston, TX 77030 USA; [Foster, E. C.] Next Practices Grp, Austin, TX USA; [Heath, S. L.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL USA; [Levine, A. C.] Brown Univ, Rhode Isl Hosp, Dept Emergency Med, Providence, RI 02903 USA; [Spivak, E. S.] Univ Utah, Sch Med, Dept Med, Div Infect Dis, Salt Lake City, UT USA; [Anjan, S.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Huaman, M. A.] Univ Cincinnati, Dept Med, Div Infect Dis, Cincinnati, OH USA; [Blair, J. E.] Mayo Clin Hosp, Div Infect Dis, Dept Med, Phoenix, AZ USA; [Currier, J. S.] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Oei, K.; Abinante, M.] Ascada Res, Irvine, CA USA; [Forthal, D. N.] Univ Calif Irvine, Div Infect Dis, Dept Med, Irvine, CA USA; [Cachay, E. R.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Paxton, J. H.] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Gerber, J. M.] Univ Massachusetts, Chan Med Sch, Div Hematol & Oncol, Dept Med, Worcester, MA 01605 USA; [Petrini, J. R.; Rausch, W.; Cordisco, M-E] Nuvance Hlth, Danbury, CT USA; [Broderick, P. B.] Nuvance Hlth Danbury Hosp, Danbury, CT USA; [Hammel, J.; Greenblatt, B.] Nuvance Hlth Norwalk Hosp, Norwalk, CT USA; [Cluzet, V. C.; Cruser, D.] Nuvance Hlth Vassar Bros Med Ctr, Poughkeepsie, NY USA; [Zand, M. S.] Univ Rochester, Dept Med, Med Ctr, Rochester, NY USA; [Roth, M.] Bliss Grp, New York, NY USA; [Raval, J. S.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MedStar Washington Hospital Center; Georgetown University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Utah System of Higher Education; University of Utah; University of Miami; University System of Ohio; University of Cincinnati; Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California San Diego; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; University of Rochester; University of New Mexico	Sullivan, DJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Rm W4606,615 N Wolfe St, Baltimore, MD 21205 USA.	dsulliv7@jhmi.edu	Appel, Larry/GLT-2608-2022	Huaman, Moises/0000-0002-6839-5809; Sutcliffe, Catherine/0000-0001-8512-8326; Esmail, MD, Abdullah/0000-0002-2337-8351				Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; Begin P, 2021, NAT MED, V27, P2012, DOI 10.1038/s41591-021-01488-2; Bloch EM, 2021, TRANSFUS APHER SCI, V60, DOI 10.1016/j.transci.2020.102957; Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745; Casadevall A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148832; Casadevall A, 2021, MBIO, V12, DOI 10.1128/mBio.03372-20; Diaz I, 2019, LIFETIME DATA ANAL, V25, P439, DOI 10.1007/s10985-018-9428-5; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Joyner MJ, 2020, MAYO CLIN PROC, V95, P1888, DOI 10.1016/j.mayocp.2020.06.028; Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]; Klein S, 2020, J CLIN INVEST, V130, P6141, DOI 10.1172/JCI142004; Korley FK, 2021, NEW ENGL J MED, V385, P1951, DOI 10.1056/NEJMoa2103784; Kunze KL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25113-5; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Natarajan H, 2021, MBIO, V12, DOI 10.1128/mBio.00765-21; O'Donnell MR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150646; Pommeret F, 2021, ANN ONCOL, V32, P1445, DOI 10.1016/j.annonc.2021.07.015; Rasheed Anwar M, 2020, Infez Med, V28, P357; Tobian A., 2021, BLOOD; Valk SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600; Verdun N., 2021, 26382 EUA FOOD DRUG; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002	26	45	45	5	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2022	386	18					1700	1711		10.1056/NEJMoa2119657	http://dx.doi.org/10.1056/NEJMoa2119657		MAR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D5AM	35353960	Green Published, Bronze			2022-12-28	WOS:000786453200001
J	Jiang, YW; Zhang, ZT; Wang, YX; Li, DL; Coen, CT; Hwaun, E; Chen, G; Wu, HC; Zhong, DL; Niu, SM; Wang, WC; Saberi, A; Lai, JC; Wu, YL; Wang, Y; Trotsyuk, AA; Loh, KY; Shih, CC; Xu, WH; Liang, K; Zhang, KL; Bai, YH; Gurusankar, G; Hu, WP; Jia, W; Cheng, Z; Dauskardt, RH; Gurtner, GC; Tok, JBH; Deisseroth, K; Soltesz, I; Bao, ZN				Jiang, Yuanwen; Zhang, Zhitao; Wang, Yi-Xuan; Li, Deling; Coen, Charles-Theophile; Hwaun, Ernie; Chen, Gan; Wu, Hung-Chin; Zhong, Donglai; Niu, Simiao; Wang, Weichen; Saberi, Aref; Lai, Jian-Cheng; Wu, Yilei; Wang, Yang; Trotsyuk, Artem A.; Loh, Kang Yong; Shih, Chien-Chung; Xu, Wenhui; Liang, Kui; Zhang, Kailiang; Bai, Yihong; Gurusankar, Gurupranav; Hu, Wenping; Jia, Wang; Cheng, Zhen; Dauskardt, Reinhold H.; Gurtner, Geoffrey C.; Tok, Jeffrey B-H; Deisseroth, Karl; Soltesz, Ivan; Bao, Zhenan			Topological supramolecular network enabled high-conductivity, stretchable organic bioelectronics	SCIENCE			English	Article							PEDOT-PSS; ELECTRODE ARRAY; TRANSPARENT; FILMS; FABRICATION; INTERFACES; ADDITIVES; COMPOSITE; SENSORS; SURFACE	Intrinsically stretchable bioelectronic devices based on soft and conducting organic materials have been regarded as the ideal interface for seamless and biocompatible integration with the human body. A remaining challenge is to combine high mechanical robustness with good electrical conduction, especially when patterned at small feature sizes. We develop a molecular engineering strategy based on a topological supramolecular network, which allows for the decoupling of competing effects from multiple molecular building blocks to meet complex requirements. We obtained simultaneously high conductivity and crack-onset strain in a physiological environment, with direct photopatternability down to the cellular scale. We further collected stable electromyography signals on soft and malleable octopus and performed localized neuromodulation down to single-nucleus precision for controlling organ-specific activities through the delicate brainstem.	[Jiang, Yuanwen; Zhang, Zhitao; Wang, Yi-Xuan; Coen, Charles-Theophile; Wu, Hung-Chin; Zhong, Donglai; Niu, Simiao; Saberi, Aref; Lai, Jian-Cheng; Wu, Yilei; Shih, Chien-Chung; Gurusankar, Gurupranav; Tok, Jeffrey B-H; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Wang, Yi-Xuan; Bai, Yihong; Hu, Wenping] Tianjin Univ, Sch Sci, Dept Chem, Tianjin Key Lab Mol Optoelect Sci, Tianjin 300072, Peoples R China; [Li, Deling; Cheng, Zhen] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford MIPS, Stanford, CA 94305 USA; [Li, Deling; Jia, Wang] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Neurosurg, Beijing 100070, Peoples R China; [Hwaun, Ernie; Soltesz, Ivan] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Chen, Gan; Wang, Weichen; Wang, Yang; Xu, Wenhui; Dauskardt, Reinhold H.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Lai, Jian-Cheng] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Peoples R China; [Trotsyuk, Artem A.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Trotsyuk, Artem A.; Gurtner, Geoffrey C.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Loh, Kang Yong] Stanford Univ, Dept Chem, Stanford Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Liang, Kui; Zhang, Kailiang] BOE Technol Grp Co Ltd, BOE Technol Ctr, Beijing 100176, Peoples R China; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Tianjin University; Stanford University; Capital Medical University; Stanford University; Stanford University; Nanjing University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wang, YX; Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Wang, YX (corresponding author), Tianjin Univ, Sch Sci, Dept Chem, Tianjin Key Lab Mol Optoelect Sci, Tianjin 300072, Peoples R China.	yx_wang@tju.edu.cn; zbao@stanford.edu	Niu, Simiao/D-3019-2012; Zhong, Donglai/GQP-7894-2022; Chen, Gan/AAU-8425-2020; Wu, Yilei/O-5404-2014; Lai, Jiancheng/J-3490-2013; Jiang, Yuanwen/B-6584-2018	Niu, Simiao/0000-0003-1973-2204; Zhong, Donglai/0000-0002-0876-414X; Chen, Gan/0000-0001-5541-6212; Wu, Yilei/0000-0001-6756-1855; Xu, Wenhui/0000-0002-6853-0548; Lai, Jiancheng/0000-0001-9290-678X; Wang, Yi-Xuan/0000-0003-4462-9532; Jiang, Yuanwen/0000-0002-2056-2639; Saberi, Aref/0000-0002-2021-8491; Coen, Charles-Theophile/0000-0002-2496-4248; Bao, Zhenan/0000-0002-0972-1715; Trotsyuk, Artem/0000-0001-8886-5583	BOE Technology Group Co., Ltd.; Stanford Wu Tsai Neurosciences Institute Big Idea project on Brain Organogenesis; National Science Foundation [ECCS-1542152]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC0276SF00515]; ONR MURI grant [N0014-19-1-2373]; Tsai Neurosciences Institute Interdisciplinary Scholarship Award on the octopus-related work; National Natural Science Foundation of China Projects [81971668]; China Scholarship Council [201806255002]	BOE Technology Group Co., Ltd.; Stanford Wu Tsai Neurosciences Institute Big Idea project on Brain Organogenesis; National Science Foundation(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); ONR MURI grant; Tsai Neurosciences Institute Interdisciplinary Scholarship Award on the octopus-related work; National Natural Science Foundation of China Projects(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was partly supported by BOE Technology Group Co., Ltd., and the Stanford Wu Tsai Neurosciences Institute Big Idea project on Brain Organogenesis. Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152. The GIXD measurements were performed at Beamline 11-3 of the Stanford Synchrotron Radiation Light (SSRL) source, supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract no. DE-AC0276SF00515. E.H. and I.S. acknowledge support from an ONR MURI grant (N0014-19-1-2373) and a Wu Tsai Neurosciences Institute Interdisciplinary Scholarship Award on the octopus-related work. D.L. acknowledges support from the National Natural Science Foundation of China Projects (81971668). Y.-X.W. acknowledges financial support from the China Scholarship Council (201806255002) for visiting scholar funding.	Afanasenkau D, 2020, NAT BIOMED ENG, V4, P1010, DOI 10.1038/s41551-020-00615-7; Afsharipour B, 2019, BIOMED SIGNAL PROCES, V49, P298, DOI 10.1016/j.bspc.2018.12.001; Alemu D, 2012, ENERG ENVIRON SCI, V5, P9662, DOI 10.1039/c2ee22595f; Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; Biessmann L, 2019, ADV ELECTRON MATER, V5, DOI 10.1002/aelm.201800654; Butler-Struben HM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00109; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Chang SH, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2331254; Chen ZX, 2013, LANGMUIR, V29, P13836, DOI 10.1021/la4033282; Choi S, 2018, NAT NANOTECHNOL, V13, P1048, DOI 10.1038/s41565-018-0226-8; Choi YS, 2021, NAT BIOTECHNOL, V39, P1228, DOI 10.1038/s41587-021-00948-x; Choong CL, 2014, ADV MATER, V26, P3451, DOI 10.1002/adma.201305182; Deep NL, 2019, J NEUROL SURG PART B, V80, P203, DOI 10.1055/s-0039-1679891; Douglas Jennifer E, 2021, World J Otorhinolaryngol Head Neck Surg, V7, P291, DOI 10.1016/j.wjorl.2020.10.003; Funda S, 2016, J APPL PHYS, V120, DOI 10.1063/1.4958845; Gonzales DL, 2017, NAT NANOTECHNOL, V12, P684, DOI [10.1038/NNANO.2017.55, 10.1038/nnano.2017.55]; Gotoh H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7629; Graudejus O, 2012, ADV FUNCT MATER, V22, P640, DOI 10.1002/adfm.201102290; Greczynski G, 1999, THIN SOLID FILMS, V354, P129, DOI 10.1016/S0040-6090(99)00422-8; Gu YW, 2018, NATURE, V560, P65, DOI 10.1038/s41586-018-0339-0; Guex AA, 2015, J MATER CHEM B, V3, P5021, DOI 10.1039/c5tb00099h; Guo L, 2014, ADV MATER, V26, P1427, DOI 10.1002/adma.201304140; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Haines D, 2011, NEUROANATOMY ATLAS S; He H, 2021, MACROMOLECULES, V54, P1234, DOI 10.1021/acs.macromol.0c02309; He H, 2019, ACS APPL MATER INTER, V11, P26185, DOI 10.1021/acsami.9b07325; Hecht DS, 2009, J SOC INF DISPLAY, V17, P941, DOI 10.1889/JSID17.11.941; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Hwaun E., 2022, ERNIE7334066 EMG ANA, DOI [10.5281/zenodo.6236224, DOI 10.5281/ZENODO.6236224]; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Kim DH, 2011, NAT MATER, V10, P316, DOI 10.1038/NMAT2971; Kim N, 2014, ADV MATER, V26, P2268, DOI 10.1002/adma.201304611; Kim SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06084-6; Lacour SP, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.63; Lee JH, 2018, ACS APPL MATER INTER, V10, P28027, DOI 10.1021/acsami.8b07287; Lee S, 2019, NAT NANOTECHNOL, V14, P156, DOI 10.1038/s41565-018-0331-8; Li PC, 2015, ACS APPL MATER INTER, V7, P18415, DOI 10.1021/acsami.5b04492; Liu J, 2020, P NATL ACAD SCI USA, V117, P14769, DOI 10.1073/pnas.2000207117; Liu YX, 2019, NAT BIOMED ENG, V3, P58, DOI 10.1038/s41551-018-0335-6; Mathieson K, 2012, NAT PHOTONICS, V6, P391, DOI [10.1038/NPHOTON.2012.104, 10.1038/nphoton.2012.104]; Matsuhisa N, 2019, ADV ELECTRON MATER, V5, DOI 10.1002/aelm.201900347; Mengistie DA, 2013, J MATER CHEM A, V1, P9907, DOI 10.1039/c3ta11726j; Metallo C, 2015, BRAIN BEHAV EVOLUT, V85, P47, DOI 10.1159/000369372; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Oh JY, 2016, ADV MATER, V28, P4455, DOI [10.1002/adma.201502947, 10.1002/adma.201670155]; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Paulsen BD, 2020, NAT MATER, V19, P13, DOI 10.1038/s41563-019-0435-z; Qi DP, 2017, ADV MATER, V29, DOI 10.1002/adma.201702800; Salatino JW, 2017, NAT BIOMED ENG, V1, P862, DOI 10.1038/s41551-017-0154-1; Savagatrup S, 2015, ADV FUNCT MATER, V25, P427, DOI 10.1002/adfm.201401758; Someya T, 2016, NATURE, V540, P379, DOI 10.1038/nature21004; Song EM, 2020, NAT MATER, V19, P590, DOI 10.1038/s41563-020-0679-7; Teo MY, 2017, ACS APPL MATER INTER, V9, P819, DOI 10.1021/acsami.6b11988; Tybrandt K, 2018, ADV MATER, V30, DOI 10.1002/adma.201706520; Vachicouras N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax9487; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Wang SH, 2018, NATURE, V555, P83, DOI 10.1038/nature25494; Wang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602076; Worfolk BJ, 2015, P NATL ACAD SCI USA, V112, P14138, DOI 10.1073/pnas.1509958112; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329; Yeon C, 2017, RSC ADV, V7, P5888, DOI 10.1039/c6ra24749k; Yu XG, 2019, NATURE, V575, P473, DOI 10.1038/s41586-019-1687-0; Yu ZM, 2016, ACS APPL MATER INTER, V8, P11629, DOI 10.1021/acsami.6b00317; Yuk H, 2019, CHEM SOC REV, V48, P1642, DOI 10.1039/c8cs00595h; Zhang S, 2015, APL MATER, V3, DOI 10.1063/1.4905154	68	27	27	206	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1411	+		10.1126/science.abj7564	http://dx.doi.org/10.1126/science.abj7564			78	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324282				2022-12-28	WOS:000778894800044
J	Berkley, S				Berkley, Seth			Ending the covid-19 pandemic means helping countries to catch-up with vaccination, not giving up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berkley, Seth] Gavi Vaccine Alliance, Geneva, Switzerland		Berkley, S (corresponding author), Gavi Vaccine Alliance, Geneva, Switzerland.								0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o786	10.1136/bmj.o786	http://dx.doi.org/10.1136/bmj.o786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331983	Bronze			2022-12-28	WOS:000778460100004
J	Hopkins, J; Narasimhan, M				Hopkins, Jon; Narasimhan, Manjulaa			Access to self-care interventions can improve health outcomes for people experiencing homelessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hopkins, Jon] U Turn, Cape Town, South Africa; [Narasimhan, Manjulaa] WHO, Dept Sexual & Reprod Hlth & Res, UNDP UNFPA Unicef WHO World Bank Special Programm, Geneva, Switzerland	The World Bank; United Nations Population Fund; World Health Organization	Hopkins, J (corresponding author), U Turn, Cape Town, South Africa.	jon@homeless.org.za		Narasimhan, Manjulaa/0000-0003-0598-6887				Aldridge Robert W, 2019, Wellcome Open Res, V4, P49, DOI 10.12688/wellcomeopenres.15151.1; Allen J, 2008, ADAPTING YOUR PRACTI; Anderson I, 2006, CHANGING ROLE SERVIC; Barker SL, 2017, COMMUNITY MENT HLT J, V53, P598, DOI 10.1007/s10597-017-0102-2; Bring C, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05358-4; BrisDoc Healthcare Services, HOM HLTH SERV PRIM H; Burridge S, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4669; Campbell DJT, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0361-3; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; Gaetz S., 2012, SIERRA MAGAZINE; Goodman L., 2006, NO SAFE PLACE SEXUAL; Hopkins J, 2020, COST HOMELESSNESS CA; Hulton LJ, 2015, GSTF J NURS HLTH CAR, V3, P4; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Keene DE, 2018, CITYSCAPE, V20, P107, DOI 10.2307/26472170; Lewer D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025192; Mathieu E, 2017, TORONTO STAR; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Narasimhan M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l688; Narasimhan M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1403; National Alliance to End Homelessness, 2020, CHRON HOM; O'Campo P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010581; Omerov P, 2020, HEALTH SOC CARE COMM, V28, P1, DOI 10.1111/hsc.12857; Pathway, 2019, HEALTHC HOM PEOPL WH; Pendyal A, 2021, HEART LUNG, V50, P80, DOI 10.1016/j.hrtlng.2020.08.001; Purkey E, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1004-4; Rice B, CITY VOICES LEARNING; Salhi BA, 2018, ACAD EMERG MED, V25, P577, DOI 10.1111/acem.13358; Schenck R, 2017, SOC WORK-MAATSK WERK, V53, P266, DOI [10.15270/52-2-568, 10.15270/53-2-568]; Seager JR, 2010, DEV SO AFR, V27, P63, DOI 10.1080/03768350903519358; Ungpakorn R, 2020, J ADV NURS, V76, P253, DOI 10.1111/jan.14225; Wenzel SL, 2000, J GEN INTERN MED, V15, P265, DOI 10.1111/j.1525-1497.2000.04269.x; WHO, ADV PUBL COR DIS COV, P2021; WHO, 2021, WHO GUID SELF CAR IN; WHO, CLASS SELF CAR INT H, P2021; WHO, 2021, SELF CAR INT HLTH	37	2	2	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								e068700	10.1136/bmj-2021-068700	http://dx.doi.org/10.1136/bmj-2021-068700			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0H0WE	35331989	Green Published, hybrid			2022-12-28	WOS:000778460100011
J	Shitara, K; Ajani, JA; Moehler, M; Garrido, M; Gallardo, C; Shen, L; Yamaguchi, K; Wyrwicz, L; Skoczylas, T; Bragagnoli, AC; Liu, TS; Tehfe, M; Elimova, E; Bruges, R; Zander, T; de Azevedo, S; Kowalyszyn, R; Pazo-Cid, R; Schenker, M; Cleary, JM; Yanez, P; Feeney, K; Karamouzis, MV; Poulart, V; Lei, M; Xiao, H; Kondo, K; Li, MS; Janjigian, YY				Shitara, Kohei; Ajani, Jaffer A.; Moehler, Markus; Garrido, Marcelo; Gallardo, Carlos; Shen, Lin; Yamaguchi, Kensei; Wyrwicz, Lucjan; Skoczylas, Tomasz; Bragagnoli, Arinilda Campos; Liu, Tianshu; Tehfe, Mustapha; Elimova, Elena; Bruges, Ricardo; Zander, Thomas; de Azevedo, Sergio; Kowalyszyn, Ruben; Pazo-Cid, Roberto; Schenker, Michael; Cleary, James M.; Yanez, Patricio; Feeney, Kynan; Karamouzis, Michalis, V; Poulart, Valerie; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Janjigian, Yelena Y.			Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer	NATURE			English	Article							OPEN-LABEL; COMBINATION THERAPY; SOLID TUMORS; JUNCTION; CAPECITABINE; CISPLATIN	Standard first-line chemotherapy results in disease progression and death within one year in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-oesophageal adenocarcinoma(1-4). Nivolumab plus chemotherapy demonstrated superior overall survival versus chemotherapy at 12-month follow-up in gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in the randomized, global CheckMate 649 phase 3 trial(5) (programmed death ligand-1 (PD-L1) combined positive score >= 5 and all randomized patients). On the basis of these results, nivolumab plus chemotherapy is now approved as a first-line treatment for these patients in many countries(6). Nivolumab and the cytotoxic T-lymphocyte antigen-4 (CTLA-4) inhibitor ipilimumab have distinct but complementary mechanisms of action that contribute to the restoration of anti-tumour T-cell function and induction of de novo anti-tumour T-cell responses, respectively(7-)(11). Treatment combining 1 mg kg(-1) nivolumab with 3 mg kg(-1) ipilimumab demonstrated clinically meaningful anti-tumour activity with a manageable safety profile in heavily pre-treated patients with advanced gastro-oesophageal cancer(12). Here we report both long-term follow-up results comparing nivolumab plus chemotherapyversus chemotherapy alone and the first results comparing nivolumab plus ipilimumab versus chemotherapy alone from CheckMate 649. After the 24.0-month minimum follow-up, nivolumab plus chemotherapy continued to demonstrate improvement in overall survival versus chemotherapy alone in patients with PD-L1 combined positive >= 5 score (hazard ratio 0.70; 95% confidence interval 0.61, 0.81) and all randomized patients (hazard ratio 0.79; 95% confidence interval 0.71, 0.88). Overall survival in patients with PD-L1 combined positive score >= 5 for nivolumab plus ipilimumab versus chemotherapy alone did not meet the prespecified boundary for significance. No new safety signals were identified. Our results support the continued use of nivolumab plus chemotherapy as standard first-line treatment for advanced gastro-oesophageal adenocarcinoma.	[Shitara, Kohei] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Moehler, Markus] Johannes Gutenberg Univ Clin, Mainz, Germany; [Garrido, Marcelo] Pontificia Univ Catolica, Unica San Carlos Apoquindo, Santiago, Chile; [Gallardo, Carlos] Fdn Arturo Lopez Perez, Providencia, Chile; [Shen, Lin] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China; [Yamaguchi, Kensei] Canc Inst Hosp JFCR, Tokyo, Japan; [Wyrwicz, Lucjan] Narodowy Inst Onkol, Klin Onkol & Radioterapii, Warsaw, Poland; [Skoczylas, Tomasz] Med Univ Lublin, Klin Chirurgii Ogolnej Gastroenterol & Nowotworow, Lublin, Poland; [Bragagnoli, Arinilda Campos] Fundacao Pio Xii Hosp Canc Barretos, Barretos, Brazil; [Liu, Tianshu] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Tehfe, Mustapha] Ctr Hosp Univ Montreal, Oncol Ctr, Montreal, PQ, Canada; [Elimova, Elena] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Bruges, Ricardo] Inst Nacl Cancerol ESE, Bogota, Colombia; [Zander, Thomas] Univ Cologne, Dept Internal Med, Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Cologne, Germany; [Zander, Thomas] Gastrointestinal Canc Grp Cologne GCGC, Cologne, Germany; [de Azevedo, Sergio] Hos Clin Porto Alegre, Porto Alegre, RS, Brazil; [Kowalyszyn, Ruben] Clin Viedma SA, Inst Multidisciplinario Oncol, Viedma, Argentina; [Pazo-Cid, Roberto] Hosp Univ Rio Miguel Servet, Zaragoza, Spain; [Schenker, Michael] SF Nectarie Oncol Ctr, Craiova, Romania; [Cleary, James M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Yanez, Patricio] Univ La Frontera, James Lind Canc Res Ctr, Temuco, Chile; [Feeney, Kynan] St John God Murdoch Hosp, Murdoch, WA, Australia; [Karamouzis, Michalis, V] Laiko Gen Hosp Athens, Athens, Greece; [Poulart, Valerie; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun] Bristol Myers Squibb, Princeton, NJ USA; [Janjigian, Yelena Y.] Mem Hosp Canc & Allied Dis, 1275 York Ave, New York, NY 10021 USA; [Janjigian, Yelena Y.] Weill Cornea Med Coll, New York, NY 10021 USA	National Cancer Center - Japan; University of Texas System; UTMD Anderson Cancer Center; Johannes Gutenberg University of Mainz; Pontificia Universidad Catolica de Chile; Japanese Foundation for Cancer Research; Medical University of Lublin; Hospital de Cancer de Barretos; Fudan University; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Universidad de La Frontera; St John of God Health Care; Laiko General Hospital; Bristol-Myers Squibb; Memorial Sloan Kettering Cancer Center	Janjigian, YY (corresponding author), Mem Hosp Canc & Allied Dis, 1275 York Ave, New York, NY 10021 USA.; Janjigian, YY (corresponding author), Weill Cornea Med Coll, New York, NY 10021 USA.	janjigiy@mskcc.org	Schenker, Michael/AAD-6920-2022; Shitara, Kohei/AAA-3877-2021	Schenker, Michael/0000-0003-2645-6391; Skoczylas, Tomasz/0000-0002-1276-3828; Pazo-Cid, Roberto A./0000-0002-8026-7391	Bristol Myers Squibb; Ono Pharmaceutical Co., Ltd.	Bristol Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd)	This study was supported by Bristol Myers Squibb and Ono Pharmaceutical Co., Ltd. We thank the patients and their families who made this study possible, the investigators and the clinical study teams at Bristol Myers Squibb and Ono Pharmaceutical Co., Ltd. for CheckMate 649 study support. Analysis of patient-reported outcomes was supported by S. Blum (Bristol Myers Squibb), and S. Hunter, E. Davenport and J. Wang (RTI Health Solutions). We thank Dako (an Agilent Technologies company) for collaborative development of the PD-L1 IHC 28-8 pharmDx assay. Professional medical writing and editorial assistance were provided by P. Dang (Parexel), funded by Bristol Myers Squibb.	Angell HK, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1544442; Baas P, 2021, LANCET, V397, P375, DOI 10.1016/S0140-6736(20)32714-8; Bang YJ, 2018, ANN ONCOL, V29, P2052, DOI 10.1093/annonc/mdy264; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Catenacci DVT, 2017, LANCET ONCOL, V18, P1467, DOI 10.1016/S1470-2045(17)30566-1; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Doki Y, 2022, NEW ENGL J MED, V386, P449, DOI 10.1056/NEJMoa2111380; Fassan M, 2020, VIRCHOWS ARCH, V477, P151, DOI 10.1007/s00428-019-02693-8; Fuchs CS, 2019, LANCET ONCOL, V20, P420, DOI 10.1016/S1470-2045(18)30791-5; Garland SN, 2011, CANCER-AM CANCER SOC, V117, P1302, DOI 10.1002/cncr.25556; Hagi T, 2020, BRIT J CANCER, V123, P965, DOI 10.1038/s41416-020-0975-7; Hellmann MD, 2019, NEW ENGL J MED, V381, P2020, DOI 10.1056/NEJMoa1910231; Janjigian YY, 2021, LANCET, V398, P27, DOI 10.1016/S0140-6736(21)00797-2; Janjigian YY, 2018, J CLIN ONCOL, V36, P2836, DOI 10.1200/JCO.2017.76.6212; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kulangara K, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4065; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lei M, 2021, CLIN CANCER RES, V27, P3926, DOI 10.1158/1078-0432.CCR-20-2790; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; OPDIVO (Nivolumab) Injection for Intravenous Use, 2021, PRESCRIBING INFORM; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Shah MA, 2017, JAMA ONCOL, V3, P620, DOI 10.1001/jamaoncol.2016.5580; Shitara K, 2020, JAMA ONCOL, V6, P1571, DOI 10.1001/jamaoncol.2020.3370; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Xu J., 2021, ANN ONCOL, V32, P1283, DOI [10.1016/j.annonc.2020.10.600, DOI 10.1016/J.ANNONC.2020.10.600]; Xu JM, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT213; Zhou KI, 2020, CLIN CANCER RES, V26, P6453, DOI 10.1158/1078-0432.CCR-20-2085	32	22	22	13	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					942	+		10.1038/s41586-022-04508-4	http://dx.doi.org/10.1038/s41586-022-04508-4		MAR 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35322232	Green Published, hybrid			2022-12-28	WOS:000772363100008
J	Shah, R; Dai, DWT; Alsweiler, JM; Brown, GTL; Chase, JG; Gamble, GD; Harris, DL; Keegan, P; Nivins, S; Wouldes, TA; Thompson, B; Turuwhenua, J; Harding, JE; McKinlay, CJD				Shah, Rajesh; Dai, Darren W. T.; Alsweiler, Jane M.; Brown, Gavin T. L.; Chase, J. Geoffrey; Gamble, Gregory D.; Harris, Deborah L.; Keegan, Peter; Nivins, Samson; Wouldes, Trecia A.; Thompson, Benjamin; Turuwhenua, Jason; Harding, Jane E.; McKinlay, Christopher J. D.		Children Hypoglycaemia Their Lat	Association of Neonatal Hypoglycemia With Academic Performance in Mid-Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOBAL MOTION PERCEPTION; NEURODEVELOPMENTAL OUTCOMES; CHILDREN; BABIES; GLYCEMIA; PRETERM; RISK	Question Among children born at risk of neonatal hypoglycemia, do those who experience hypoglycemia have worse academic performance in mid-childhood? Findings In this prospective cohort study that included 480 participants at risk of neonatal hypoglycemia who were screened and treated if needed to maintain blood glucose concentration of at least 47 mg/dL (2.6 mmol/L), children who were and were not exposed to neonatal hypoglycemia did not significantly differ in rates of low educational performance at 9 to 10 years' corrected age, based on standardized tests of reading comprehension or mathematics (47% vs 48%). Meaning Among participants at risk of neonatal hypoglycemia who were screened and treated if needed, the occurrence of neonatal hypoglycemia compared with no such exposure was not significantly associated with lower educational achievement in mid-childhood. Importance Neonatal hypoglycemia is associated with increased risk of poor executive and visual-motor function, but implications for later learning are uncertain. Objective To test the hypothesis that neonatal hypoglycemia is associated with educational performance at age 9 to 10 years. Design, Setting, and Participants Prospective cohort study of moderate to late preterm and term infants born at risk of hypoglycemia. Blood and masked interstitial sensor glucose concentrations were measured for up to 7 days. Infants with hypoglycemic episodes (blood glucose concentration <47 mg/dL [2.6 mmol/L]) were treated to maintain a blood glucose concentration of at least 47 mg/dL. Six hundred fourteen infants were recruited at Waikato Hospital, Hamilton, New Zealand, in 2006-2010; 480 were assessed at age 9 to 10 years in 2016-2020. Exposures Hypoglycemia was defined as at least 1 hypoglycemic event, representing the sum of nonconcurrent hypoglycemic and interstitial episodes (sensor glucose concentration <47 mg/dL for >= 10 minutes) more than 20 minutes apart. Main Outcomes and Measures The primary outcome was low educational achievement, defined as performing below or well below the normative curriculum level in standardized tests of reading comprehension or mathematics. There were 47 secondary outcomes related to executive function, visual-motor function, psychosocial adaptation, and general health. Results Of 587 eligible children (230 [48%] female), 480 (82%) were assessed at a mean age of 9.4 (SD, 0.3) years. Children who were and were not exposed to neonatal hypoglycemia did not significantly differ on rates of low educational achievement (138/304 [47%] vs 82/176 [48%], respectively; adjusted risk difference, -2% [95% CI, -11% to 8%]; adjusted relative risk, 0.95 [95% CI, 0.78-1.15]). Children who were exposed to neonatal hypoglycemia, compared with those not exposed, were significantly less likely to be rated by teachers as being below or well below the curriculum level for reading (68/281 [24%] vs 49/157 [31%], respectively; adjusted risk difference, -9% [95% CI, -17% to -1%]; adjusted relative risk, 0.72 [95% CI, 0.53-0.99; P = .04]). Groups were not significantly different for other secondary end points. Conclusions and Relevance Among participants at risk of neonatal hypoglycemia who were screened and treated if needed, exposure to neonatal hypoglycemia compared with no such exposure was not significantly associated with lower educational achievement in mid-childhood. This study assesses the association of neonatal hypoglycemia with low educational achievement at age 9 to 10 years among a prospective cohort of moderate to late preterm and term infants.	[Shah, Rajesh; Dai, Darren W. T.; Gamble, Gregory D.; Harris, Deborah L.; Nivins, Samson; Harding, Jane E.; McKinlay, Christopher J. D.] Univ Auckland, Liggins Inst, Private Bag 92019,Victoria St West, Auckland 1142, New Zealand; [Alsweiler, Jane M.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Brown, Gavin T. L.] Univ Auckland, Fac Educ & Social Work, Auckland, New Zealand; [Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand; [Harris, Deborah L.] Victoria Univ Wellington, Sch Nursing Midwifery & Hlth Practice, Wellington, New Zealand; [Keegan, Peter] Univ Auckland, Te Puna Wananga, Auckland, New Zealand; [Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Auckland, New Zealand; [Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Thompson, Benjamin; Turuwhenua, Jason] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand; [Thompson, Benjamin] Ctr Eye & Vis Res, Hong Kong, Peoples R China; [Turuwhenua, Jason] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Canterbury; Victoria University Wellington; University of Auckland; University of Auckland; University of Waterloo; University of Auckland; University of Auckland	McKinlay, CJD (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019,Victoria St West, Auckland 1142, New Zealand.	c.mckinlay@auckland.ac.nz	Brown, Gavin Thomas Lumsden/G-8674-2011; McKinlay, Christopher JD/E-6263-2018; Nivins, Samson/D-9418-2019; Keegan, Peter/D-7047-2016	Brown, Gavin Thomas Lumsden/0000-0002-8352-2351; McKinlay, Christopher JD/0000-0003-1088-9467; Nivins, Samson/0000-0002-6777-9333; Dai, Darren W.T./0000-0003-2422-7448; Keegan, Peter/0000-0002-3663-2814; Shah, Rajesh/0000-0002-3175-7845	Health Research Council of New Zealand [17/240]; Maurice and Phyllis Paykel Trust	Health Research Council of New Zealand(Health Research Council of New Zealand); Maurice and Phyllis Paykel Trust	This work is funded by the Health Research Council of New Zealand (17/240) and the Maurice and Phyllis Paykel Trust.	Adane AA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4234; Alsweiler JM, 2021, LANCET CHILD ADOLESC, V5, P513, DOI 10.1016/S2352-4642(20)30387-4; [Anonymous], 2004, ETHN DAT PROT HLTH D; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Bakken L, 2017, J RES CHILD EDUC, V31, P255, DOI 10.1080/02568543.2016.1273285; Beery K., 2010, BEERY BUKTENICA DEVE; Brand PLP, 2005, ARCH DIS CHILD, V90, P78, DOI 10.1136/adc.2003.039412; Burakevych N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44609-1; Burakevych N, 2016, J PAEDIATR CHILD H, V52, P600, DOI 10.1111/jpc.13169; Chakraborty A, 2015, VISION RES, V115, P83, DOI 10.1016/j.visres.2015.08.007; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Griffith R, 2021, ARCH DIS CHILD-FETAL, V106, pF278, DOI 10.1136/archdischild-2020-320305; Harding JE, 2017, EARLY HUM DEV, V104, P51, DOI 10.1016/j.earlhumdev.2016.12.009; Harris DL, 2013, LANCET, V382, P2077, DOI 10.1016/S0140-6736(13)61645-1; Harris DL, 2011, J PEDIATR-US, V159, P755, DOI 10.1016/j.jpeds.2011.04.026; Harris DL, 2010, J PEDIATR-US, V157, P198, DOI 10.1016/j.jpeds.2010.02.003; Hattie John A. C., 2007, Journal of Educational Technology Systems, V36, P189, DOI 10.2190/ET.36.2.g; Hayes L, 2007, AUST NZ J PSYCHIAT, V41, P231, DOI 10.1080/00048670601172715; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631; Levine TA, 2015, PEDIATRICS, V135, P126, DOI 10.1542/peds.2014-1143; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; McKinlay CJD, 2021, J PERINATOL, V41, P1205, DOI 10.1038/s41372-021-01058-x; McKinlay CJD, 2017, JAMA PEDIATR, V171, P972, DOI 10.1001/jamapediatrics.2017.1579; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; Shah R, 2020, J PAEDIATR CHILD H, V56, P1090, DOI 10.1111/jpc.14824; Shah R, 2019, NEONATOLOGY, V115, P116, DOI 10.1159/000492859; Signal M, 2012, DIABETES TECHNOL THE, V14, P883, DOI 10.1089/dia.2012.0111; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Tin W, 2012, PEDIATRICS, V130, pE1497, DOI 10.1542/peds.2012-0776; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Yu TY, 2013, INVEST OPHTH VIS SCI, V54, P8408, DOI 10.1167/iovs.13-13051	37	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1158	1170		10.1001/jama.2022.0992	http://dx.doi.org/10.1001/jama.2022.0992			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0C8XO	35315886	Green Published			2022-12-28	WOS:000775589900022
J	Zheng, CY; Duffy, J; Liu, ILA; Sy, LS; Chen, WS; Qian, L; Navarro, RA; Ryan, DS; Kim, SS; Mercado, C; Jacobsen, SJ				Zheng, Chengyi; Duffy, Jonathan; Liu, In-Lu Amy; Sy, Lina S.; Chen, Wansu; Qian, Lei; Navarro, Ronald A.; Ryan, Denison S.; Kim, Sunhea S.; Mercado, Cheryl; Jacobsen, Steven J.			Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data	ANNALS OF INTERNAL MEDICINE			English	Article							SKELETAL-MUSCLE MASS; SEASONAL INFLUENZA; SEX-DIFFERENCES; BURSITIS; PREVENTION; ARTHRITIS	Background: Although shoulder conditions have been reported as an adverse event after intramuscular vaccination in the deltoid muscle, epidemiologic data on shoulder conditions after vaccination are limited. Objective: To estimate the risk for shoulder conditions after vaccination and assess possible risk factors. Design: Retrospective cohort study. Setting: Kaiser Permanente Southern California, a large integrated health care organization. Participants: Kaiser Permanente Southern California members aged 3 years or older who had an intramuscular vaccination administered in the deltoid muscle between 1 April 2016 and 31 December 2017. Measurements: A natural language processing (NLP) algorithm was used to identify potential shoulder conditions among vaccinated persons with shoulder disorder diagnosis codes. All NLP-identified cases were manually chart confirmed on the basis of our case definition. The characteristics of vaccinated persons with and without shoulder conditions were compared. Results: Among 3 758 764 administered vaccinations, 371 cases of shoulder condition were identified, with an estimated incidence of 0.99 (95% CI, 0.89 to 1.09) per 10000 vaccinations. The incidence was 1.22 (CI, 1.10 to 1.35) for the adult (aged >= 18 years) and 0.05 (CI, 0.02 to 0.14) for the pediatric (aged 3 to 17 years) vaccinated populations. In the adult vaccinated population, advanced age, female sex, an increased number of outpatient visits in the 6 months before vaccination, lower Charlson Comorbidity Index, and pneumococcal conjugate vaccine were associated with a higher risk for shoulder conditions. Among influenza vaccines, quadrivalent vaccines were associated with an increased risk for shoulder conditions. Simultaneous administration of vaccines was associated with a higher risk for shoulder conditions among elderly persons. Limitation: Generalizability to other health care settings, use of administrative data, and residual confounding. Conclusion: These population-based data suggest a small absolute risk for shoulder conditions after vaccination. Given the high burden of shoulder conditions, clinicians should pay attention to any factors that may further increase risks. Primary Funding Source: Centers for Disease Control and Prevention. Ann Intern Med. doi:10.7326/M21-3023 Annals.org For author, article, and disclosure information, see end of text. This article was published at Annals.org on 22 March 2022.	[Zheng, Chengyi; Liu, In-Lu Amy; Sy, Lina S.; Chen, Wansu; Qian, Lei; Ryan, Denison S.; Kim, Sunhea S.; Mercado, Cheryl; Jacobsen, Steven J.] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Duffy, Jonathan] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA; [Navarro, Ronald A.] Kaiser Permanente South Bay Med Ctr, Harbor City, CA USA	Kaiser Permanente; Centers for Disease Control & Prevention - USA; Kaiser Permanente	Zheng, CY (corresponding author), Kaiser Permanente Southern Calif, 100 South Los Robles Ave, Pasadena, CA 91101 USA.	Chengyi.X.Zheng@kp.org; Amy.L.Liu@kp.org	zheng, chengyi/AAC-6284-2022; Navarro, Ronald A/AAE-1422-2019; Sy, Lina/AFM-9458-2022	Navarro, Ronald A/0000-0003-1869-6440; Duffy, Jonathan/0000-0002-8060-0940; Sy, Lina/0000-0003-2762-9266; Zheng, Chengyi/0000-0002-4194-0029	CDC [200-2012-53580]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Through the Vaccine Safety Datalink under contract 200-2012-53580 from the CDC.	Abe T, 2003, BRIT J SPORT MED, V37, P436, DOI 10.1136/bjsm.37.5.436; Atanasoff S, 2010, VACCINE, V28, P8049, DOI 10.1016/j.vaccine.2010.10.005; Barnes MG, 2012, J AM BOARD FAM MED, V25, P919, DOI 10.3122/jabfm.2012.06.110334; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Bodor M, 2007, VACCINE, V25, P585, DOI 10.1016/j.vaccine.2006.08.034; Burroughs K, SHOULDER PAIN 25 YEA; Centers for Disease Control and Prevention, POSS SID EFF VACC; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cook IF, 2011, HUM VACCINES, V7, P845, DOI 10.4161/hv.7.8.16271; Cross GB, 2016, AUST FAM PHYSICIAN, V45, P303; DeRogatis Michael J, 2018, HSS J, V14, P299, DOI 10.1007/s11420-018-9613-9; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Domnich A, 2017, VACCINE, V35, P513, DOI 10.1016/j.vaccine.2016.12.011; DUMONDE DC, 1962, BRIT J EXP PATHOL, V43, P373; Edwards KM, 2012, VACCINE, V30, P6389, DOI 10.1016/j.vaccine.2012.08.022; Erickson Brandon J, 2019, JBJS Case Connect, V9, pe0248, DOI 10.2106/JBJS.CC.18.00248; Floyd MW, 2012, ORTHOPEDICS, V35, pE101, DOI 10.3928/01477447-20111122-31; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Hamborsky Jennifer, 2015, EPIDEMIOLOGY PREVENT; Health Resources and Services Administration Health and Human Services Administration, NAT VACC INJ COMP PR; Health Resources & Services Administration, 2020, VACC INJ TABL; Hesse EM, 2020, ANN INTERN MED, V173, P253, DOI 10.7326/M19-3176; Hesse EM, 2020, VACCINE, V38, P1076, DOI 10.1016/j.vaccine.2019.11.032; Institute of Medicine, 2012, NAT AC PR; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kroger AT, 2017, BEST PRACTICES GUIDA; Kwetkat A, 2020, INTERD T GERONT GERI, V43, P73, DOI 10.1159/000504491; Lamb YN, 2019, DRUGS, V79, P1337, DOI [10.1007/s40265-019-01176-z, 10.1007/s40265-019-01237-3]; Macomb CV, 2020, MIL MED, V185, pE298, DOI 10.1093/milmed/usz269; Arias LHM, 2017, VACCINE, V35, P4870, DOI 10.1016/j.vaccine.2017.07.055; Messerschmitt PJ, 2012, ORTHOPEDICS, V35, pE283, DOI 10.3928/01477447-20120123-26; Nakajima Y, 2017, HUM VACC IMMUNOTHER, V13, P2123, DOI 10.1080/21645515.2017.1334747; Natanzi Naveed, 2020, Radiol Case Rep, V15, P552, DOI 10.1016/j.radcr.2020.02.009; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Rudzki JR, 2008, J SHOULDER ELB SURG, V17, p96S, DOI 10.1016/j.jse.2007.07.004; Saleh ZM, 2015, J CHIROPR MED, V14, P285, DOI 10.1016/j.jcm.2015.05.005; Salmon JH, 2015, VACCINE, V33, P6152, DOI 10.1016/j.vaccine.2015.09.090; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Shahbaz M, 2019, WORKPLACE HEALTH SAF, V67, P501, DOI 10.1177/2165079919875161; Shankar Nachiket, 2014, Med J Armed Forces India, V70, P338, DOI 10.1016/j.mjafi.2014.08.005; Terreri MT, 2008, PEDIATR RADIOL, V38, P481, DOI 10.1007/s00247-007-0711-y; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TROLLMO C, 1990, CLIN EXP IMMUNOL, V82, P384; Uchida S, 2012, VACCINE, V31, P27, DOI 10.1016/j.vaccine.2012.10.075; Walston JD, 2012, CURR OPIN RHEUMATOL, V24, P623, DOI 10.1097/BOR.0b013e328358d59b; Wright A, 2019, J RADIOL CASE REP, V13, P24, DOI 10.3941/jrcr.v13i6.3656; Yang D, P SAS GLOB FOR 2012; Yu W, 2020, PHARMACOEPIDEM DR S, V29, P182, DOI 10.1002/pds.4919; Zheng C, MEDRXIV, DOI [10.1101/2021.05.05.21256555, DOI 10.1101/2021.05.05.21256555]; Zheng CY, 2019, INT J MED INFORM, V127, P27, DOI 10.1016/j.ijmedinf.2019.04.009	52	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					634	+		10.7326/M21-3023	http://dx.doi.org/10.7326/M21-3023		MAR 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35313110	Green Accepted			2022-12-28	WOS:000779640800001
J	Wong, LYR; Zheng, J; Wilhelmsen, K; Li, K; Ortiz, ME; Schnicker, NJ; Thurman, A; Pezzulo, AA; Szachowicz, PJ; Li, PF; Pan, RG; Klumpp, K; Aswad, F; Rebo, J; Narumiya, S; Murakami, M; Zuniga, S; Sola, I; Enjuanes, L; Meyerholz, DK; Fortney, K; McCray, PB; Perlman, S				Wong, Lok-Yin Roy; Zheng, Jian; Wilhelmsen, Kevin; Li, Kun; Ortiz, Miguel E.; Schnicker, Nicholas J.; Thurman, Andrew; Pezzulo, Alejandro A.; Szachowicz, Peter J.; Li, Pengfei; Pan, Ruangang; Klumpp, Klaus; Aswad, Fred; Rebo, Justin; Narumiya, Shuh; Murakami, Makoto; Zuniga, Sonia; Sola, Isabel; Enjuanes, Luis; Meyerholz, David K.; Fortney, Kristen; McCray, Paul B., Jr.; Perlman, Stanley			Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19	NATURE			English	Article							PROSTANOID DP RECEPTOR; PHOSPHOLIPASE A(2); ANTAGONISTS; POTENT; PGD(2)	Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective, but vaccine efficacy is partly compromised by the emergence of SARS-CoV-2 variants with enhanced transmissibility(2). The emergence of these variants emphasizes the need for further development of anti-SARS-CoV-2 therapies, especially for aged populations. Here we describe the isolation of highly virulent mouse-adapted viruses and use them to test a new therapeutic drug in infected aged animals. Many of the alterations observed in SARS-CoV-2 during mouse adaptation (positions 417, 484, 493, 498 and 501 of the spike protein) also arise in humans in variants of concern(2). Their appearance during mouse adaptation indicates that immune pressure is not required for selection. For murine SARS, for which severity is also age dependent, elevated levels of an eicosanoid (prostaglandin D-2 (PGD(2))) and a phospholipase (phospholipase A2 group 2D (PLA(2)G2D)) contributed to poor outcomes in aged mice(3,4). mRNA expression of PLA(2)G2D and prostaglandin D-2 receptor (PTGDR), and production of PGD2 also increase with ageing and after SARS-CoV-2 infection in dendritic cells derived from human peripheral blood mononuclear cells. Using our mouse-adapted SARS-CoV-2, we show that middle-aged mice lacking expression of PTGDR or PLA2G2D are protected from severe disease. Furthermore, treatment with a PTGDR antagonist, asapiprant, protected aged mice from lethal infection. PTGDR antagonism is one of the first interventions in SARS-CoV2-infected animals that specifically protects aged animals, suggesting that the PLA(2)G2D-PGD(2)/PTGDR pathway is a useful target for therapeutic interventions.	[Wong, Lok-Yin Roy; Zheng, Jian; Li, Pengfei; Pan, Ruangang; McCray, Paul B., Jr.; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Wilhelmsen, Kevin; Klumpp, Klaus; Aswad, Fred; Rebo, Justin; Fortney, Kristen] BIOAGE Labs, Richmond, CA USA; [Li, Kun; Ortiz, Miguel E.; McCray, Paul B., Jr.; Perlman, Stanley] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Schnicker, Nicholas J.] Univ Iowa, Prot & Crystallog Facil, Iowa City, IA USA; [Thurman, Andrew; Pezzulo, Alejandro A.; Szachowicz, Peter J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Narumiya, Shuh] Kyoto Univ, Dept Drug Discovery Med, Kyoto, Japan; [Murakami, Makoto] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Tokyo, Japan; [Zuniga, Sonia; Sola, Isabel; Enjuanes, Luis] Campus Univ Autonoma Madrid, Dept Mol & Cell Biol, Natl Ctr Biotechnol CNB CSIC, Madrid, Spain; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Kyoto University; University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Iowa	McCray, PB; Perlman, S (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; McCray, PB; Perlman, S (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	paul-mccray@uiowa.edu; stanley-perlman@uiowa.edu	Meyerholz, David/J-8131-2019; Zúñiga, Sonia/O-8548-2016	Meyerholz, David/0000-0003-1552-3253; Zúñiga, Sonia/0000-0003-2549-6826; Pezzulo, Alejandro/0000-0001-7544-5109; Wong, Lok Yin Roy/0000-0002-0727-8289; Schnicker, Nicholas/0000-0002-5189-4943	National Institutes of Health USA (NIH) [P01 AI060699, R01 AI129269]; Center for Gene Therapy for Cystic Fibrosis (NIH) [P30 DK-54759]; Cystic Fibrosis Foundation; Roy J. Carver Charitable Trust; Mechanism of Parasitism Training Grant [T32 AI007511]	National Institutes of Health USA (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gene Therapy for Cystic Fibrosis (NIH); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Roy J. Carver Charitable Trust; Mechanism of Parasitism Training Grant	This work is supported in part by grants from the National Institutes of Health USA (NIH; P01 AI060699 (S.P. and P.B.M.) and R01 AI129269 (S.P.)) and BIOAGE Labs (S.P.). The Pathology Core is partially supported by the Center for Gene Therapy for Cystic Fibrosis (NIH grant P30 DK-54759) and the Cystic Fibrosis Foundation. P.B.M. is supported by the Roy J. Carver Charitable Trust. L.-Y.R.W. is supported by Mechanism of Parasitism Training Grant (T32 AI007511). We thank M. Gelb (University of Washington) for Pla2g2d<SUP>-/-</SUP> mice.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13; [Anonymous], 2021, LANCET RHEUMATOL, V3, pE465, DOI 10.1016/S2665-9913(21)00144-2; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P307, DOI 10.1089/bio.2015.29031.hmm; Channappanavar R, 2020, J CLIN INVEST, V130, P6204, DOI 10.1172/JCI144115; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Drake Thomas M, 2021, Lancet Rheumatol, V3, pe498, DOI 10.1016/S2665-9913(21)00104-1; Fehr AR, 2020, METHODS MOL BIOL, V2099, P53, DOI 10.1007/978-1-0716-0211-9_5; Furusawa H, 2020, AM J RESP CRIT CARE, V202, P1430, DOI 10.1164/rccm.202001-0134OC; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hirano Y, 2007, EUR J PHARMACOL, V560, P81, DOI 10.1016/j.ejphar.2007.01.003; Hirano Y, 2011, EUR J PHARMACOL, V666, P233, DOI 10.1016/j.ejphar.2011.05.003; Huang K, 2021, EBIOMEDICINE, V67, DOI 10.1016/j.ebiom.2021.103381; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499; Li QQ, 2021, CELL, V184, P2362, DOI 10.1016/j.cell.2021.02.042; Marone G, 2019, EXPERT OPIN INV DRUG, V28, P73, DOI 10.1080/13543784.2019.1555237; Meyerholz DK, 2018, LAB INVEST, V98, P844, DOI 10.1038/s41374-018-0057-0; Miki Y, 2016, J BIOL CHEM, V291, P15588, DOI 10.1074/jbc.M116.734624; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; RECOVERY Collaborative Group, 2022, Lancet, V399, P143, DOI 10.1016/S0140-6736(21)01825-0; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Santoro F, 2022, HEART, V108, P130, DOI [10.1136/heartjnl-2021-319552, 10.1136/heartjnl-2021-320255]; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Sun SH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25903-x; Takahashi G, 2015, EUR J PHARMACOL, V765, P15, DOI 10.1016/j.ejphar.2015.08.003; Ullah MA, 2021, MUCOSAL IMMUNOL, V14, P963, DOI 10.1038/s41385-021-00405-7; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; Voruganti D, 2022, HEART, V108, P88, DOI 10.1136/heartjnl-2021-320255; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang JL, 2020, PROTEIN CELL, V11, P776, DOI 10.1007/s13238-020-00767-x; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhang YF, 2021, J VIROL, V95, DOI 10.1128/JVI.02477-20; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777; Zheng J, 2021, J INFECT DIS, V223, P785, DOI 10.1093/infdis/jiaa753; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z	48	13	13	10	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 5	2022	605	7908					146	+		10.1038/s41586-022-04630-3	http://dx.doi.org/10.1038/s41586-022-04630-3		MAR 2022	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z3DT	35314834	Bronze			2022-12-28	WOS:000790204800001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: NHS staff absences rise again as cases increase	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, URGENT EMERGENCY CAR	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o737	10.1136/bmj.o737	http://dx.doi.org/10.1136/bmj.o737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304415	Bronze			2022-12-28	WOS:000773507900008
J	Milligan, JC; Davis, CW; Yu, XY; Ilinykh, PA; Huang, K; Halfmann, PJ; Cross, RW; Borisevich, V; Agans, KN; Geisbert, JB; Chennareddy, C; Goff, AJ; Piper, AE; Hui, SA; Shaffer, KCL; Buck, T; Heinrich, ML; Branco, LM; Crozier, I; Holbrook, MR; Kuhn, JH; Kawaoka, Y; Glass, PJ; Bukreyev, A; Geisbert, TW; Worwa, G; Ahmed, R; Saphire, EO				Milligan, Jacob C.; Davis, Carl W.; Yu, Xiaoying; Ilinykh, Philipp A.; Huang, Kai; Halfmann, Peter J.; Cross, Robert W.; Borisevich, Viktoriya; Agans, Krystle N.; Geisbert, Joan B.; Chennareddy, Chakravarthy; Goff, Arthur J.; Piper, Ashley E.; Hui, Sean; Shaffer, Kelly C. L.; Buck, Tierra; Heinrich, Megan L.; Branco, Luis M.; Crozier, Ian; Holbrook, Michael R.; Kuhn, Jens H.; Kawaoka, Yoshihiro; Glass, Pamela J.; Bukreyev, Alexander; Geisbert, Thomas W.; Worwa, Gabriella; Ahmed, Rafi; Saphire, Erica Ollmann			Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses	CELL			English	Article							MONOCLONAL-ANTIBODIES; VIRUS NEUTRALIZATION; STRUCTURAL BASIS; MOUSE MODEL; EBOLA; INFECTION; QUANTIFICATION; GENERATION; FEATURES; THERAPY	Several ebolaviruses cause outbreaks of severe disease. Vaccines and monoclonal antibody cocktails are available to treat Ebola virus (EBOV) infections, but not Sudan virus (SUDV) or other ebolaviruses. Current cocktails contain antibodies that cross-react with the secreted soluble glycoprotein (sGP) that absorbs virus-neutralizing antibodies. By sorting memory B cells from EBOV infection survivors, we isolated two broadly reactive anti-GP monoclonal antibodies, 1C3 and 1C11, that potently neutralize, protect rodents from disease, and lack sGP cross-reactivity. Both antibodies recognize quaternary epitopes in trimeric ebolavirus GP. 1C11 bridges adjacent protomers via the fusion loop. 1C3 has a tripartite epitope in the center of the trimer apex. One 1C3 antigen-binding fragment anchors simultaneously to the three receptor-binding sites in the GP trimer, and separate 1C3 paratope regions interact differently with identical residues on the three protomers. A cocktail of both antibodies completely protected nonhuman primates from EBOV and SUDV infections, indicating their potential clinical value.	[Milligan, Jacob C.; Yu, Xiaoying; Hui, Sean; Shaffer, Kelly C. L.; Buck, Tierra; Saphire, Erica Ollmann] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Discovery, La Jolla, CA 92037 USA; [Davis, Carl W.; Chennareddy, Chakravarthy; Ahmed, Rafi] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Davis, Carl W.; Chennareddy, Chakravarthy; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yu, Xiaoying] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Ilinykh, Philipp A.; Huang, Kai; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Huang, Kai; Cross, Robert W.; Borisevich, Viktoriya; Agans, Krystle N.; Geisbert, Joan B.; Bukreyev, Alexander; Geisbert, Thomas W.] Galveston Natl Lab, Galveston, TX 77550 USA; [Halfmann, Peter J.; Kawaoka, Yoshihiro] Univ Wisconsin, Div Pathobiol Sci, Madison, WI 53706 USA; [Cross, Robert W.; Borisevich, Viktoriya; Agans, Krystle N.; Geisbert, Joan B.; Bukreyev, Alexander; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Goff, Arthur J.; Piper, Ashley E.; Glass, Pamela J.] US Army Res Inst Infect Dis, Virol Div, Frederick, MD 21702 USA; [Heinrich, Megan L.; Branco, Luis M.] Zalgen Labs, Germantown, MD 20876 USA; [Crozier, Ian] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD 21702 USA; [Holbrook, Michael R.; Kuhn, Jens H.; Worwa, Gabriella] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Dept Microbiol & Immunol, Dept Special Pathogens,Div Virol, Tokyo, Japan; [Saphire, Erica Ollmann] Univ Calif La Jolla, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; Emory University; Emory University; Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; United States Army Medical Research Institute of Infectious Diseases; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Tokyo; University of California System; University of California San Diego	Saphire, EO (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Discovery, La Jolla, CA 92037 USA.; Ahmed, R (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Worwa, G (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA.; Saphire, EO (corresponding author), Univ Calif La Jolla, Dept Med, La Jolla, CA 92093 USA.	gabriella.worwa@nih.gov; rahmed@emory.edu; erica@lji.org	Kuhn, Jens H./B-7615-2011; Yu, Xiaoying/J-2424-2015	Kuhn, Jens H./0000-0002-7800-6045; Yu, Xiaoying/0000-0002-6778-5004; Chennareddy, Chakravarthy/0000-0002-3937-5788; Davis, Carl/0000-0002-6049-0684; Agans, Krystle/0000-0002-7319-6935; Hui, Sean/0000-0002-9870-6823	National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI142790]; Consortium for Immunotherapeutics against Emerging Viral Threats; DARPA [W31P4Q-14-1-0010, U19AI109762]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sci-ences [P30GM133894]; Laulima Government Solutions, LLC; Battelle Memorial Institute; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201800013C, HHSN272200700016I]; Laulima Government Solutions, LLC [HHSN272201800013C]; National Cancer Institute, National In-stitutes of Health [HHSN261201500003I, HHSN26100043, 75N91019D00024, 75N91019F00130]; U.S. Department of Health and Human Services, NIH [UC7AI094660]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consortium for Immunotherapeutics against Emerging Viral Threats; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sci-ences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laulima Government Solutions, LLC; Battelle Memorial Institute; U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laulima Government Solutions, LLC; National Cancer Institute, National In-stitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Health and Human Services, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sharon Schendel for editing the manuscript, and Dawid Zyla and Haoyang Li for help with model validation. We gratefully acknowledge our funding from National Institute of Allergy and Infectious Diseases (NIAID) U19 AI142790, Consortium for Immunotherapeutics against Emerging Viral Threats (E.O.S., C.W.D.) , DARPA contract W31P4Q-14-1-0010 (C.W.D.) , and U19AI109762 (T.W.G) . Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sci-ences (P30GM133894) . The contents of this publication are solely the respon-sibility of the authors and do not necessarily represent the official views of NIGMS or NIH. We thank all the staff of the National Institutes of Health (NIH) NIAID Division of Clinical Research (DCR) Integrated Research Facility at Fort Detrick (IRF-Freder-ick) , Frederick, MD, USA, who supported this study-in particular, Kaleb Sharer, Russel Byrum, Jennifer Jackson, Sarah Klim, Danny Ragland, Marisa St. Claire, and Lisa Hensley. This work was supported in part through Laulima Government Solutions, LLC, prime contract and Battelle Memorial Institute prime contract with the U.S. National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272201800013C and No. HHSN272200700016I, respec-tively (M.R.H., G.W.,) . J.H.K. performed this work as an employee of Tunnell Gov-ernment Services (TGS) , a subcontractor of Laulima Government Solutions, LLC under Contract No. HHSN272201800013C. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National In-stitutes of Health, under Contract No. HHSN261201500003I, Task Order No. HHSN26100043 and Contract No. 75N91019D00024, Task Order No. 75N91019F00130 (I.C.) . The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Health and Human Services or of the institutions and companies affiliated with the au-thors. The study protocol was reviewed and approved by the NIH NIAID DCR IRF-Frederick Animal Care and Use Committee in compliance with all applicable federal regulations governing the protection of animals and research. We thank Anya Crane (NIH NIAID DCR IRF-Frederick) for critically editing the manuscript and Jiro Wada (NIH NIAID DCR IRF-Frederick) for helping with figure preparation.We thank the University of Texas Medical Branch (UTMB) Animal Resource Center for husbandry support of laboratory animals and Daniel Deer and Kevin Melody for assistance with the animal studies. This study was supported in part by the U.S. Department of Health and Human Services, NIH grant UC7AI094660 to the UTMB for BSL-4 operations in support of the Galveston National Laboratory. Opinions, interpretations, conclusions, and recommen-dations are those of the authors and are not necessarily endorsed by the UTMB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; CDC, 2021, HIST EB VIR DIS EVD; CDC, 2021, EB VIR DIS DISTR MAP; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cohen-Dvashi H, 2020, CELL HOST MICROBE, V27, P418, DOI 10.1016/j.chom.2020.01.007; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Cross RW, 2015, J INFECT DIS, V212, pS305, DOI 10.1093/infdis/jiv237; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI 10.1177/0271678X20943823; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; European Commission, 2020, VACC EB COMM GRANTS; Food and Drug Administration, 2020, FDA APPR 1 TREATM EB; Food and Drug Administration, 2020, FDA APPR TREATM EB V; Fujii R, 2006, NAT PROTOC, V1, P2493, DOI 10.1038/nprot.2006.403; Gilchuk P, 2021, CELL, V184, P5593, DOI 10.1016/j.cell.2021.09.035; Gilchuk P, 2020, IMMUNITY, V52, P388, DOI 10.1016/j.immuni.2020.01.001; Gilchuk P, 2018, IMMUNITY, V49, P363, DOI 10.1016/j.immuni.2018.06.018; Gorman J, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.052; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Honnold SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104708; Howell KA, 2016, CELL REP, V15, P1514, DOI 10.1016/j.celrep.2016.04.026; Ilinykh PA, 2020, CELL HOST MICROBE, V27, P976, DOI 10.1016/j.chom.2020.03.025; Ilinykh PA, 2018, J INFECT DIS, V218, pS418, DOI 10.1093/infdis/jiy423; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Keita AK, 2021, NATURE, V597, P539, DOI 10.1038/s41586-021-03901-9; Kuhn JH, 2020, FIELDS VIROLOGY, V1; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Milligan JC, 2019, J INFECT DIS, V219, P415, DOI 10.1093/infdis/jiy532; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; National Research Council Division on Earth and Life Studies Institute for Laboratory Animal Research and Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2010, GUIDE CARE USE LAB A, VEighth; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; Pascal KE, 2018, J INFECT DIS, V218, pS612, DOI 10.1093/infdis/jiy285; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu XG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9875; Saphire EO, 2020, CELL, V181, P6, DOI 10.1016/j.cell.2020.03.011; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Shurtleff AC, 2012, VIRUSES-BASEL, V4, P3511, DOI 10.3390/v4123511; Stewart-Jones GBE, 2018, P NATL ACAD SCI USA, V115, P12265, DOI 10.1073/pnas.1811980115; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; West BR, 2018, MBIO, V9, DOI [10.1128/mBio.01674-18, 10.1128/mbio.01674-18]; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wong G, 2016, J VIROL, V90, P392, DOI 10.1128/JVI.02331-15; World Health Organization, 2021, EB OUTBR 2021 N KIV; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	60	8	8	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2022	185	6					995	+		10.1016/j.cell.2022.02.023	http://dx.doi.org/10.1016/j.cell.2022.02.023			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZZ6CW	35303429	hybrid			2022-12-28	WOS:000773355400008
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Pfizer asks US regulator to authorise fourth vaccine dose for over 65s	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, BOSTON GLOBE; Pfizer, 2022, PFIZ BIONTECH SUBM U; Regev-Yochay G, 2022, NEW ENGL J MED, V386, P1377, DOI 10.1056/NEJMc2202542; Visser N, HUFFINGTON POST; Y. M. Bar-On, 2022, medRxiv, DOI 10.1101/2022.02.01.22270232	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o711	10.1136/bmj.o711	http://dx.doi.org/10.1136/bmj.o711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301233	Bronze			2022-12-28	WOS:000796719200010
J	Ma, XY; Lu, CJ; Chen, YT; Li, SL; Ma, NJ; Tao, X; Li, Y; Wang, J; Zhou, M; Yan, YB; Li, PL; Heydari, K; Deng, HT; Zhang, M; Yi, C; Ge, L				Ma, Xinyu; Lu, Caijing; Chen, Yuting; Li, Shulin; Ma, Ningjia; Tao, Xuan; Li, Ying; Wang, Jing; Zhou, Min; Yan, Yong-Bin; Li, Pilong; Heydari, Kartoosh; Deng, Haiteng; Zhang, Min; Yi, Cong; Ge, Liang			CCT2 is an aggrephagy receptor for clearance of solid protein aggregates	CELL			English	Article							LIQUID PHASE-SEPARATION; ENDOPLASMIC-RETICULUM; SELECTIVE AUTOPHAGY; MOLECULAR CHAPERONE; TAU FIBRILS; DEGRADATION; POLYGLUTAMINE; MECHANISM; HUNTINGTIN; TOXICITY	Protein aggregation is a hallmark of multiple human pathologies. Autophagy selectively degrades protein aggregates via aggrephagy. How selectivity is achieved has been elusive. Here, we identify the chaperonin subunit CCT2 as an autophagy receptor regulating the clearance of aggregation-prone proteins in the cell and the mouse brain. CCT2 associates with aggregation-prone proteins independent of cargo ubiquitination and interacts with autophagosome marker ATG8s through a non-classical VLIR motif. In addition, CCT2 regulates aggrephagy independently of the ubiquitin-binding receptors (P62, NBR1, and TAX1 BP1) or chaperone-mediated autophagy. Unlike P62, NBR1, and TAX1 BP1, which facilitate the clearance of protein condensates with liquidity, CCT2 specifically promotes the autophagic degradation of protein aggregates with little liquidity (solid aggregates). Furthermore, aggregation-prone protein accumulation induces the functional switch of CCT2 from a chaperone subunit to an autophagy receptor by promoting CCT2 monomer formation, which exposes the VLIR to ATG8s interaction and, therefore, enables the autophagic function.	[Ma, Xinyu; Lu, Caijing; Li, Shulin; Ma, Ningjia; Tao, Xuan; Li, Ying; Wang, Jing; Yan, Yong-Bin; Ge, Liang] State Key Lab Membrane Biol, Beijing, Peoples R China; [Ma, Xinyu; Lu, Caijing; Li, Shulin; Ma, Ningjia; Tao, Xuan; Li, Ying; Zhou, Min; Li, Pilong; Ge, Liang] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ma, Xinyu; Lu, Caijing; Li, Shulin; Ma, Ningjia; Tao, Xuan; Li, Ying; Wang, Jing; Zhou, Min; Yan, Yong-Bin; Li, Pilong; Deng, Haiteng; Ge, Liang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chen, Yuting; Yi, Cong] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Dept Biochem, Affiliated Hosp 1,Sch Med, Hangzhou, Peoples R China; [Zhou, Min; Li, Pilong; Deng, Haiteng] Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Zhou, Min; Li, Pilong; Deng, Haiteng] Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China; [Heydari, Kartoosh] Univ Calif Berkeley, Canc Res Lab, FACS Core Facil, Berkeley, CA 94720 USA; [Deng, Haiteng] MOE Key Lab Bioinformat, Beijing, Peoples R China; [Zhang, Min] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Zhejiang University; University of California System; University of California Berkeley; Tsinghua University	Ge, L (corresponding author), State Key Lab Membrane Biol, Beijing, Peoples R China.; Ge, L (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Ge, L (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Yi, C (corresponding author), Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Dept Biochem, Affiliated Hosp 1,Sch Med, Hangzhou, Peoples R China.; Zhang, M (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.	zhangmin143@mail.tsinghua.edu.cn; yiconglab@zju.edu.cn; liangge@mail.tsinghua.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022; Yan, Yong-Bin/A-4282-2008	Chen, Yu ting/0000-0002-0595-5717; Yan, Yong-Bin/0000-0002-8565-3558	Ministry of Science and Technology of the People's Republic of China [2019YFA0508602]; National Natural Science Foundation of China [91854114, 32061143009, 31872832, 32130023, 31872826, 32122028, 91754107]; Beijing Natural Science Foundation [JQ20028]; Tsinghua Independent Research Program [2019Z06QCX02]; Tsinghua University COVID-19 Emergency Aid Fund [2020Z99CFZ024]; Zhejiang Provincial Natural Science Foundation of China [LR21C070001]; Tsinghua-Peking Center for Life Sciences	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Tsinghua Independent Research Program; Tsinghua University COVID-19 Emergency Aid Fund; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Tsinghua-Peking Center for Life Sciences	We thank Dr. Nukina Nobuyuki (RIKEN Brain Science Institute, Japan) , Dr. Franz-Ulrich Hartl (Max Planck Institute of Biochemistry, Germany) , Dr. Kirill Bersuker (previously in Dr. Ron Kopito's lab at Stanford and now in Calico, USA) , Dr. Boxun Lu (Fudan University, China) , Dr. Bao-Liang Song (Wuhan University, China) , and Dr. Bing Zhou (Tsinghua University, China) for reagents. We thank Dr. Li Yu, Dr. Yi Lin (Tsinghua University, China) , Dr. Hong Zhang (Institute of Biophysics, CAS, China) , Dr. Cong Liu (Interdisciplinary Research Center on Biology and Chemistry, CAS, China) , Dr. Zhenyu Yue (Mount Sinai, USA) , Dr. Wei Liu, Dr. Qiming Sun (Zhejiang University, China) , Dr. Quan Chen (Nankai University, China) , Dr. Yao Cong (Center for Excellence in Molecular Cell Science, CAS, China) , and Dr. Qing Zhong (Shanghai Jiao Tong University, China) for helpful suggestions on the study. The work is funded by Ministry of Science and Technology of the People's Republic of China (2019YFA0508602) , National Natural Science Foundation of China (91854114, 32061143009, 31872832, 32130023, 31872826, 32122028, 91754107) , Beijing Natural Science Foundation (JQ20028) , Tsinghua Indepen-dent Research Program (2019Z06QCX02) , Tsinghua University COVID-19 Emergency Aid Fund (2020Z99CFZ024) , Zhejiang Provincial Natural Science Foundation of China (no. LR21C070001) , and Tsinghua-Peking Center for Life Sciences.	Agudo-Canalejo J, 2021, NATURE, V591, P142, DOI 10.1038/s41586-020-2992-3; Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; An H, 2019, MOL CELL, V74, P891, DOI 10.1016/j.molcel.2019.03.034; Babinchak WM, 2020, J MOL BIOL, V432, P1910, DOI 10.1016/j.jmb.2020.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bersuker K, 2016, J CELL BIOL, V213, P229, DOI 10.1083/jcb.201511024; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Briner A, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108045; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Chino H, 2020, TRENDS CELL BIOL, V30, P384, DOI 10.1016/j.tcb.2020.02.001; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dengjel J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014035; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Gestaut D, 2019, CURR OPIN STRUC BIOL, V55, P50, DOI 10.1016/j.sbi.2019.03.002; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Gu JG, 2020, P NATL ACAD SCI USA, V117, P31123, DOI 10.1073/pnas.2002437117; Gubas A, 2022, FEBS J, V289, P75, DOI 10.1111/febs.15824; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Horwich AL, 2020, Q REV BIOPHYS, V53, DOI 10.1017/S0033583519000143; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jin ML, 2019, SUBCELL BIOCHEM, V93, P625, DOI 10.1007/978-3-030-28151-9_19; Johansen T, 2020, J MOL BIOL, V432, P80, DOI 10.1016/j.jmb.2019.07.016; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knowlton JJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018127118; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Li D, 2022, TRENDS CELL BIOL, V32, P1, DOI 10.1016/j.tcb.2021.08.004; Li ZY, 2019, NATURE, V575, P203, DOI 10.1038/s41586-019-1722-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin L, 2013, J CELL BIOL, V201, P113, DOI 10.1083/jcb.201209098; Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu ZY, 2020, NAT STRUCT MOL BIOL, V27, P363, DOI 10.1038/s41594-020-0399-3; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mathieu C, 2020, SCIENCE, V370, P56, DOI 10.1126/science.abb8032; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Minegishi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33742; Mitsui K, 2002, J NEUROSCI, V22, P9267; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Noda NN, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202004062; Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pavel M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13821; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Qi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046834; Ramdzan Yasmin M, 2013, Methods Mol Biol, V1017, P85, DOI 10.1007/978-1-62703-438-8_6; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Ray S, 2020, NAT CHEM, V12, DOI 10.1038/s41557-020-0465-9; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Sarraf SA, 2020, MOL CELL, V80, DOI 10.1016/j.molcel.2020.10.041; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Sin O, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3042; Sun DX, 2020, J MOL BIOL, V432, P160, DOI 10.1016/j.jmb.2019.06.026; Sun DX, 2018, CELL RES, V28, P405, DOI 10.1038/s41422-018-0017-7; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turco E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25572-w; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; Vaquer-Alicea J, 2019, ANNU REV BIOCHEM, V88, P785, DOI 10.1146/annurev-biochem-061516-045049; Vendruscolo M, 2012, CURR OPIN STRUC BIOL, V22, P138, DOI 10.1016/j.sbi.2012.01.005; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wetzel L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16689-5; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Xiao GR, 2013, P NATL ACAD SCI USA, V110, P14995, DOI 10.1073/pnas.1308535110; Xiao J, 2019, SCI CHINA LIFE SCI, V62, P1117, DOI 10.1007/s11427-019-9569-9; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yamasaki A, 2020, MOL CELL, V77, P1163, DOI 10.1016/j.molcel.2019.12.026; Yan ZH, 2021, ANAL CHEM, V93, P2988, DOI 10.1021/acs.analchem.0c05011; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zaffagnini G, 2018, EMBO J, V37, DOI 10.15252/embj.201798308; Zang YX, 2016, NAT STRUCT MOL BIOL, V23, P1083, DOI 10.1038/nsmb.3309; Zellner S, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2021.01.009; Zhang GM, 2018, CELL, V174, P1492, DOI 10.1016/j.cell.2018.08.006; Zhang M, 2020, CELL, V181, P637, DOI 10.1016/j.cell.2020.03.031; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang T, 2016, CELL REP, V14, P2426, DOI 10.1016/j.celrep.2016.02.040; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	126	18	18	38	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1325	+		10.1016/j.cell.2022.03.005	http://dx.doi.org/10.1016/j.cell.2022.03.005			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	1M4GC	35366418				2022-12-28	WOS:000799928600001
J	Nissen, SE; Wolski, K; Balog, C; Swerdlow, DI; Scrimgeour, AC; Rambaran, C; Wilson, RJ; Boyce, M; Ray, KK; Cho, L; Watts, GF; Koren, M; Turner, T; Stroes, ES; Melgaard, C; Campion, GV				Nissen, Steven E.; Wolski, Kathy; Balog, Craig; Swerdlow, Daniel, I; Scrimgeour, Alison C.; Rambaran, Curtis; Wilson, Rosamund J.; Boyce, Malcom; Ray, Kausik K.; Cho, Leslie; Watts, Gerald F.; Koren, Michael; Turner, Traci; Stroes, Erik S.; Melgaard, Carrie; Campion, Giles, V			Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OXIDIZED PHOSPHOLIPIDS; RISK	IMPORTANCE Lipoprotein(a) (Lp[a]) is an important risk factor for atherothrombotic cardiovascular disease and aortic stenosis, for which there are no treatments approved by regulatory authorities. OBJECTIVES To assess adverse events and tolerability of a short interfering RNA (siRNA) designed to reduce hepatic production of apolipoprotein(a) and to assess associated changes in plasma concentrations of Lp(a) at different doses. DESIGN, SETTING, AND PARTICIPANTS A single ascending dose study of SLN360, an siRNA targeting apolipoprotein(a) synthesis conducted at 5 clinical research unit sites located in the US, United Kingdom, and Australia. The study enrolled adults with Lp(a) plasma concentrations of 150 nmol/L or greater at screening and no known clinically overt cardiovascular disease. Participants were enrolled between November 18, 2020, and July 21, 2021, with last follow-up on December 29, 2021. INTERVENTIONS Participants were randomized to receive placebo (n = 8) or single doses of SLN360 at 30 mg (n = 6), 100 mg (n = 6), 300 mg (n = 6), or 600 mg (n = 6), administered subcutaneously. MAIN OUTCOMES AND MEASURES The primary outcome was evaluation of safety and tolerability. Secondary outcomes included change in plasma concentrations of Lp(a) to a maximum follow-up of 150 days. RESULTS Among 32 participants who were randomized and received the study intervention (mean age, 50 [SD, 13.5] years; 17 women [53%]), 32 (100%) completed the trial. One participant experienced 2 serious adverse event episodes: admission to the hospital for headache following SARS-CoV-2 vaccination and later for complications of cholecystitis, both of which were judged to be unrelated to study drug. Median baseline Lp(a) concentrations were as follows: placebo, 238 (IQR, 203-308) nmol/L; 30-mg SLN360, 171 (IQR, 142-219) nmol/L; 100-mg SLN360, 217 (IQR, 202-274) nmol/L; 300-mg SLN360, 285 (IQR, 195-338) nmol/L; and 600-mg SLN360, 231 (IQR, 179-276) nmol/L. Maximal median changes in Lp(a) were -20 (IQR, -61 to 3) nmol/L, -89 (IQR, -119 to -61) nmol/L, -185 (IQR, -226 to -163) nmol/L, -268 (IQR, -292 to -189) nmol/L, and -227 (IQR, -270 to -174) nmol/L, with maximal median percentage changes of -10% (IQR, -16% to 1%), -46%(IQR, -64% to -40%), -86%(IQR, -92% to -82%), -96%(IQR, -98% to -89%), and -98%(IQR, -98% to -97%), for the placebo group and the 30-mg, 100-mg, 300-mg, and 600-mg SLN360 groups, respectively. The duration of Lp(a) lowering was dose dependent, persisting for at least 150 days after administration. CONCLUSIONS AND RELEVANCE In this phase 1 study of 32 participants with elevated Lp(a) levels and no known cardiovascular disease, the siRNA SLN360 was well tolerated, and a dose-dependent lowering of plasma Lp(a) concentrations was observed. The findings support further study to determine the safety and efficacy of this siRNA.	[Nissen, Steven E.; Wolski, Kathy; Balog, Craig; Cho, Leslie; Melgaard, Carrie] Cleveland Clin Ctr Clin Res, Cleveland, OH USA; [Swerdlow, Daniel, I; Scrimgeour, Alison C.; Rambaran, Curtis; Campion, Giles, V] Silence Therapeut PLC, London, England; [Wilson, Rosamund J.] Spica Consultants Ltd, Marlborough, England; [Boyce, Malcom] UK Hammersmith Med Res, London, England; [Ray, Kausik K.] Imperial Coll London, London, England; [Watts, Gerald F.] Univ Western Australia, Royal Perth Hosp, Perth, WA, Australia; [Watts, Gerald F.] Univ Western Australia, Sch Med, Dept Cardiol, Perth, WA, Australia; [Watts, Gerald F.] Univ Western Australia, Sch Med, Dept Internal Med, Perth, WA, Australia; [Koren, Michael] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Turner, Traci] Medpace, Cincinnati, OH USA; [Stroes, Erik S.] Univ Amsterdam, Fac Med, Amsterdam, Netherlands	Imperial College London; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Amsterdam	Nissen, SE (corresponding author), Cleveland Clin, JB 820,9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org			Silence Therapeutics PLC; Medpace; National Institute for Health Research Biomedical Research Centre at Imperial College London	Silence Therapeutics PLC; Medpace; National Institute for Health Research Biomedical Research Centre at Imperial College London	The trial was funded by Silence Therapeutics PLC and coordinated by Silence Therapeutics, Medpace (a contract research organization), and C5Research. Dr Ray received support from the National Institute for Health Research Biomedical Research Centre at Imperial College London.	BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470; Capoulade R, 2015, J AM COLL CARDIOL, V66, P1236, DOI 10.1016/j.jacc.2015.07.020; Cybulska B, 2020, PROG CARDIOVASC DIS, V63, P219, DOI 10.1016/j.pcad.2020.04.004; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2014, J AM COLL CARDIOL, V63, P470, DOI 10.1016/j.jacc.2013.09.038; Koren MJ, 2022, NAT MED, V28, P96, DOI 10.1038/s41591-021-01634-w; Koschinsky ML, 1997, CLIN GENET, V52, P338; Mann R, 2021, CUREUS, V13, DOI 10.7759/cureus.16491; National Cancer Institute, 2017, COMMON TERMINOLOGY C; Sewing S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187574; Springer AD, 2018, NUCLEIC ACID THER, V28, P109, DOI 10.1089/nat.2018.0736; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Tsimikas S, 2020, NEW ENGL J MED, V382, P244, DOI 10.1056/NEJMoa1905239; US Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND TOX GRAD SC; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yeang C, 2021, J LIPID RES, V62, DOI 10.1016/j.jlr.2021.100053	17	29	29	5	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2022	327	17					1679	1687		10.1001/jama.2022.5050	http://dx.doi.org/10.1001/jama.2022.5050		APR 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D3AC	35368052	Green Published			2022-12-28	WOS:000779463700002
J	Rourke, EJ				Rourke, Elizabeth J.			Ten Years of Choosing Wisely to Reduce Low-Value Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								Ten Years of Choosing Wisely to Reduce Low-Value Care The Choosing Wisely initiative was a public relations win for the medical profession in 2012: doctors were stepping up to address low value and high costs in medicine. Today, it's clear that making lists and publicizing them are not sufficient to reduce low-value care.	[Rourke, Elizabeth J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Rourke, Elizabeth J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rourke, EJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Rourke, EJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Admon AJ, 2018, J HOSP MED, V13, P688, DOI 10.12788/jhm.2964; Cliff BQ, 2021, MILBANK Q, V99, P1024, DOI 10.1111/1468-0009.12531; Schlesinger M, 2017, MILBANK Q, V95, P70, DOI 10.1111/1468-0009.12246; Shrank WH, 2019, JAMA-J AM MED ASSOC, V322, P1501, DOI 10.1001/jama.2019.13978; Zadro JR, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4576-1	5	5	5	3	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2200422	http://dx.doi.org/10.1056/NEJMp2200422		APR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0V1HA	35363450				2022-12-28	WOS:000788095000001
J	Hellard, M; Howell, J				Hellard, Margaret; Howell, Jessica			Simplify, simplify	NATURE			English	News Item						Diseases; Health care; Public health		Overhauling the guidelines for who has access to testing and treatment would lower costs and improve patient outcomes.	[Hellard, Margaret; Howell, Jessica] Burnet Inst, Melbourne, Vic, Australia; [Hellard, Margaret] Alfred Hosp, Melbourne, Vic, Australia; [Howell, Jessica] St Vincents Hosp, Melbourne, Vic, Australia	Burnet Institute; Florey Institute of Neuroscience & Mental Health; St Vincent's Hospital Melbourne	Hellard, M (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Hellard, M (corresponding author), Alfred Hosp, Melbourne, Vic, Australia.	margaret.hellard@burnet.edu.au						Howell J, 2021, J HEPATOL, V74, P535, DOI 10.1016/j.jhep.2020.09.013; Kennedy PTF, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050096; Kim HL, 2021, GUT, V70, P2172, DOI 10.1136/gutjnl-2020-321309; Pan CQ, 2016, NEW ENGL J MED, V374, P2324, DOI 10.1056/NEJMoa1508660; WHO, 2017, WHO PUBLISHES LIST B	5	0	0	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S53	S53		10.1038/d41586-022-00815-y	http://dx.doi.org/10.1038/d41586-022-00815-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354984	Bronze			2022-12-28	WOS:000776361600012
J	Looi, MK				Looi, Mun-Keat			Disincentives for vaccine refusal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o865	10.1136/bmj.o865	http://dx.doi.org/10.1136/bmj.o865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361694	Bronze			2022-12-28	WOS:000779990000002
J	Nordling, L				Nordling, Linda			African hotspot	NATURE			English	News Item						Diseases; Health care; Public health; Developing world		The viral disease is widespread on the continent, but many countries lack the resources to heighten awareness and treat patients.											0	0	0	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S60	S61		10.1038/d41586-022-00819-8	http://dx.doi.org/10.1038/d41586-022-00819-8			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354993	Bronze			2022-12-28	WOS:000776361600016
J	Sohn, E				Sohn, Emily			FALLING SHORT	NATURE			English	News Item						Diseases; Health care; Public health; Developing world		Uneven access to health-care resources is complicating the drive to eliminate this viral infection.										Kane MA, 2013, VACCINE, V31, pJ15, DOI 10.1016/j.vaccine.2013.03.045; Shen KL, 2020, WORLD J PEDIATR, V16, P219, DOI 10.1007/s12519-020-00344-6; Stockdale AJ, 2022, J INFECT DIS, V226, P871, DOI 10.1093/infdis/jiab562; Tordrup D, 2020, VALUE HEALTH, V23, P1552, DOI 10.1016/j.jval.2020.06.015; Tordrup D, 2019, LANCET GLOB HEALTH, V7, pE1180, DOI 10.1016/S2214-109X(19)30272-4; Toy M, 2022, CLIN INFECT DIS, V74, P210, DOI 10.1093/cid/ciab405; Toy M, 2018, HEALTH AFFAIR, V37, P1033, DOI 10.1377/hlthaff.2018.0035	7	0	0	3	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S58	S59		10.1038/d41586-022-00818-9	http://dx.doi.org/10.1038/d41586-022-00818-9			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354994	Bronze			2022-12-28	WOS:000776361600015
J	Ho, E; Ferreira, M; Chen, LX; Simic, M; Ashton-James, C; Comachio, J; Hayden, J; Ferreira, P; Wang, DXM; Ferreira, PH				Ho, Emma; Ferreira, Manuela; Chen, Lingxiao; Simic, Milena; Ashton-James, Claire; Comachio, Josielli; Hayden, Jill; Ferreira, Paulo; Wang, Daniel Xin Mo; Ferreira, Paulo Henrique			Psychological interventions for chronic, non-specific low back pain: systematic review with network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BEHAVIORAL GROUP-THERAPY; QUALITY-OF-LIFE; GRADED ACTIVITY; FOLLOW-UP; PRACTICE GUIDELINES; CLINICAL-PRACTICE; INFORMED PRACTICE; COMBINED EXERCISE; IN-VIVO; DISABILITY	OBJECTIVE To determine the comparative effectiveness and safety of psychological interventions for chronic low back pain. DESIGN Systematic review with network meta-analysis. DATA SOURCES Medline, Embase, PsycINFO, Cochrane Central Register of Controlled Trials, Web of Science, SCOPUS, and CINAHL from database inception to 31 January 2021. ELIGIBILITY CRITERIA FOR STUDY SELECTION Randomised controlled trials comparing psychological interventions with any comparison intervention in adults with chronic, non-specific low back pain. Two reviewers independently screened studies, extracted data, and assessed risk of bias and confidence in the evidence. Primary outcomes were physical function and pain intensity. A random effects network meta analysis using a frequentist approach was performed at post-intervention (from the end of treatment to <2 months post-intervention); and at short term (s2 to <6 months post-intervention), mid-term (s6 to <12 months post-intervention), and long term follow-up (s12 months post-intervention). Physiotherapy care was the reference comparison intervention. The design-by-treatment interaction model was used to assess global inconsistency and the Bucher method was used to assess local inconsistency. RESULTS 97 randomised controlled trials involving 13 136 participants and 17 treatment nodes were included. Inconsistency was detected at short term and midterm follow-up for physical function, and short term follow-up for pain intensity, and were resolved through sensitivity analyses. For physical function, cognitive behavioural therapy (standardised mean difference 1.01, 95% confidence interval 0.58 to 1.44), and pain education (0.62, 0.08 to 1.17), delivered with physiotherapy care, resulted in clinically important improvements at post-intervention (moderate quality evidence). The most sustainable effects of treatment for improving physical function were reported with pain education delivered with physiotherapy care, at least until mid-term follow-up (0.63, 0.25 to 1.00; low quality evidence). No studies investigated the long term effectiveness of pain education delivered with physiotherapy care. For pain intensity, behavioural therapy (1.08, 0.22 to 1.94), cognitive behavioural therapy (0.92, 0.43 to 1.42), and pain education (0.91, 0.37 to 1.45), delivered with physiotherapy care, resulted in clinically important effects at post intervention (low to moderate quality evidence). Only behavioural therapy delivered with physiotherapy care maintained clinically important effects on reducing pain intensity until mid-term follow-up (1.01, 0.41 to 1.60; high quality evidence). CONCLUSIONS For people with chronic, non-specific low back pain, psychological interventions are most effective when delivered in conjunction with physiotherapy care (mainly structured exercise). Pain education programmes (low to moderate quality evidence) and behavioural therapy (low to high quality evidence) result in the most sustainable effects of treatment; however, uncertainty remains as to their long term effectiveness. Although inconsistency was detected, potential sources were identified and resolved. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42019138074.	[Ho, Emma; Simic, Milena; Comachio, Josielli; Wang, Daniel Xin Mo; Ferreira, Paulo Henrique] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney Musculoskeletal Hlth,Sch Hlth Sci, Sydney, NSW, Australia; [Ho, Emma; Chen, Lingxiao; Ferreira, Paulo] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Kolling Inst,Sydney Musculoskeletal Hlth, Sydney, NSW, Australia; [Ashton-James, Claire] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Ashton-James, Claire] Univ Sydney, Pain Management Res Inst, Kolling Inst, Sydney, NSW, Australia; [Hayden, Jill] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Dalhousie University	Ho, E (corresponding author), Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney Musculoskeletal Hlth,Sch Hlth Sci, Sydney, NSW, Australia.; Ho, E; Chen, LX (corresponding author), Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Kolling Inst,Sydney Musculoskeletal Hlth, Sydney, NSW, Australia.	emma.ho@sydney.edu.au; lche4036@uni.sydney.edu.au	Comachio, Josielli/J-3353-2016; Simic, Milena/K-6309-2014	Comachio, Josielli/0000-0002-3286-6998; Ho, Emma/0000-0002-2479-0081; Chen, Lingxiao/0000-0001-7721-0493; Simic, Milena/0000-0002-5387-3986; Wang, Daniel/0000-0001-5921-0262; Hayden, Jill Alison/0000-0001-7026-144X	Australian Government Research Training Programme Scholarship; National Health and Medical Research Council of Australia Research Fellowships; Sydney University SOAR fellowship; Northern Clinical School Higher Degree Research Support Scholarship	Australian Government Research Training Programme Scholarship(Australian Government); National Health and Medical Research Council of Australia Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Sydney University SOAR fellowship; Northern Clinical School Higher Degree Research Support Scholarship	: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. EK-YH is funded by an Australian Government Research Training Programme Scholarship. PHF and MLF are funded by National Health and Medical Research Council of Australia Research Fellowships. MS is funded by a Sydney University SOAR fellowship. LC is funded by Northern Clinical School Higher Degree Research Support Scholarship.	Ahern M, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000756; Alnaqbi A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253155; Galan-Martin MA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041201; Anheyer D, 2017, ANN INTERN MED, V166, P799, DOI 10.7326/M16-1997; [Anonymous], 2021, LANCET, V397, P2023, DOI 10.1016/S0140-6736(21)01194-6; [Anonymous], 2015, STAT STAT SOFTW REL; [Anonymous], 2020, ANALYTICS C ENDNOTE; Bendix A E, 1998, Eur Spine J, V7, P111, DOI 10.1007/s005860050040; Bendix AF, 1998, SPINE, V23, P717, DOI 10.1097/00007632-199803150-00013; Boehmer KR, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0316-3; Brunner E, 2013, DISABIL REHABIL, V35, P1, DOI 10.3109/09638288.2012.683848; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Bury TJ, 2013, PHYSIOTHERAPY, V99, P285, DOI 10.1016/j.physio.2012.12.011; Caldwell DM, 2016, EVID-BASED MENT HEAL, V19, P16, DOI 10.1136/eb-2015-102275; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Chiarotto A, 2018, J CLIN EPIDEMIOL, V102, P23, DOI 10.1016/j.jclinepi.2018.05.006; Chiarotto A, 2018, PAIN, V159, P481, DOI 10.1097/j.pain.0000000000001117; Chiarotto A, 2015, EUR SPINE J, V24, P1127, DOI 10.1007/s00586-015-3892-3; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Christiansen S, 2010, PAIN, V149, P444, DOI 10.1016/j.pain.2009.12.015; CINeMA, 2017, CINEMA CONF NETW MET; Clement RC, 2015, ACTA ORTHOP, V86, P523, DOI 10.3109/17453674.2015.1036696; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; covidence, COV SYST REV SOFTW V; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; de Campos TF, 2017, J PHYSIOTHER, V63, P120, DOI 10.1016/j.jphys.2017.02.012; Dufour N, 2010, SPINE, V35, P469, DOI 10.1097/BRS.0b013e3181b8db2e; Duggan C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-335; Friedrich M, 2005, SPINE, V30, P995, DOI 10.1097/01.brs.0000160844.71551.af; Friedrich M, 1998, ARCH PHYS MED REHAB, V79, P475, DOI 10.1016/S0003-9993(98)90059-4; Gannon J, 2019, CLIN J PAIN, V35, P295, DOI 10.1097/AJP.0000000000000678; Gardner T, 2019, BRIT J SPORT MED, V53, P1424, DOI 10.1136/bjsports-2018-100080; George SZ, 2010, J ORTHOP SPORT PHYS, V40, P197, DOI 10.2519/jospt.2010.3298; Gibbs BB, 2018, OCCUP ENVIRON MED, V75, P321, DOI 10.1136/oemed-2017-104732; Godfrey E, 2020, J PAIN, V21, P71, DOI 10.1016/j.jpain.2019.05.012; Gould HM, 2020, PAIN, V161, P1341, DOI 10.1097/j.pain.0000000000001834; Guevara-Lopez U, 2011, CIR CIR, V79, P264; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Hall A, 2018, DISABIL REHABIL, V40, P1, DOI 10.1080/09638288.2016.1236155; Harris A, 2017, EUR J PAIN, V21, P1397, DOI 10.1002/ejp.1041; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hayden JA, 2021, J PHYSIOTHER, V67, P252, DOI 10.1016/j.jphys.2021.09.004; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Ho E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034996; Ho EK, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04479-z; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Holden J, 2014, INT J CLIN PRACT, V68, P950, DOI 10.1111/ijcp.12444; Holopainen R, 2020, PAIN, V161, P1150, DOI 10.1097/j.pain.0000000000001809; Hutton B, 2016, MED CLIN-BARCELONA, V147, P262, DOI 10.1016/j.medcli.2016.02.025; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kamper SJ, 2020, PAIN, V161, P694, DOI 10.1097/j.pain.0000000000001751; Keefe FJ, 2018, PHYS THER, V98, P398, DOI 10.1093/ptj/pzy024; Keeley P, 2008, PAIN, V135, P142, DOI 10.1016/j.pain.2007.05.015; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Krein SL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2605; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lambeek LC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1035; Lee H, 2015, PAIN, V156, P988, DOI 10.1097/j.pain.0000000000000146; Leeuw M, 2008, PAIN, V138, P192, DOI 10.1016/j.pain.2007.12.009; Lorig KR, 2002, ARCH INTERN MED, V162, P792, DOI 10.1001/archinte.162.7.792; Louw A, 2014, SPINE, V39, P1449, DOI 10.1097/BRS.0000000000000444; Lovschall C, 2010, SUNDHEDSSTYRELSEN M, V12; Lysne PE, 2021, PILOT FEASIBILITY ST, V7, DOI 10.1186/s40814-021-00923-y; Macedo LG, 2012, PHYS THER, V92, P363, DOI 10.2522/ptj.20110290; Magalhaes MO, 2018, BRAZ J PHYS THER, V22, P82, DOI 10.1016/j.bjpt.2017.07.002; Magnussen L, 2007, J REHABIL MED, V39, P81, DOI 10.2340/16501977-0004; Main CJ, 2011, PHYS THER, V91, P820, DOI 10.2522/ptj.20110060; Mehling WE, 2005, ALTERN THER HEALTH M, V11, P44, DOI 10.1111/j.1365-263X.2005.00605.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Monticone M, 2016, EUR J PAIN, V20, P541, DOI 10.1002/ejp.756; Monticone M, 2013, CLIN J PAIN, V29, P929, DOI 10.1097/AJP.0b013e31827fef7e; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Morone NE, 2016, JAMA INTERN MED, V176, P329, DOI 10.1001/jamainternmed.2015.8033; Murad MH, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4817; Nguyen C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18311-z; NICHOLAS MK, 1991, BEHAV RES THER, V29, P225, DOI 10.1016/0005-7967(91)90112-G; Nielsen M, 2014, PHYS THER, V94, P197, DOI 10.2522/ptj.20130047; Nielson WR, 2001, CLIN J PAIN, V17, pS114, DOI 10.1097/00002508-200112001-00020; O'Keeffe M, 2020, BRIT J SPORT MED, V54, P782, DOI 10.1136/bjsports-2019-100780; O'Keeffe M, 2019, BRIT J SPORT MED, V53, P793, DOI 10.1136/bjsports-2018-099816; Oliveira CB, 2018, EUR SPINE J, V27, P2791, DOI 10.1007/s00586-018-5673-2; Paolucci T, 2017, DISABIL REHABIL, V39, P994, DOI 10.1080/09638288.2016.1175035; Petersen L, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4952-x; Petrozzi MJ, 2019, CHIROPR MAN THER, V27, DOI 10.1186/s12998-019-0277-4; Phillips R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024537; Pinheiro MB, 2016, SPINE J, V16, P105, DOI 10.1016/j.spinee.2015.10.037; Pires D, 2015, CLIN REHABIL, V29, P538, DOI 10.1177/0269215514549033; Poole H, 2007, EUR J PAIN, V11, P878, DOI 10.1016/j.ejpain.2007.01.006; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Rabiei P, 2021, PAIN PRACT, V21, P333, DOI 10.1111/papr.12963; Rizzo RRN, 2018, J PAIN, V19, P1103; Saracoglu I, 2020, EUR J INTEGR MED, V33, DOI 10.1016/j.eujim.2019.101046; Savigny P, 2009, NATL COLLABORATING C, P14; Schaller A, 2016, CLIN REHABIL, V30, P865, DOI 10.1177/0269215515618730; Semple Randye J., 2010, MINDFULNESS, V1, P121, DOI DOI 10.1007/S12671-010-0017-2; Shariat A, 2019, J EXERC REHABIL, V15, P703, DOI 10.12965/jer.1938490.245; Siemonsma PC, 2013, PHYS THER, V93, P435, DOI 10.2522/ptj.20110150; Simon ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub3; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; Sorensen PH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-212; Sturgeon JA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0317-4; Suzuki H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229228; Synnott A, 2015, J PHYSIOTHER, V61, P68, DOI 10.1016/j.jphys.2015.02.016; Tan G, 2015, EUR J PAIN, V19, P271, DOI 10.1002/ejp.545; Tavafian SS, 2017, INT J RHEUM DIS, V20, P1910, DOI 10.1111/1756-185X.12540; Tekur P, 2008, J ALTERN COMPLEM MED, V14, P637, DOI 10.1089/acm.2007.0815; Toward Optimized Practice (TOP) and Low Back Pain Working Group, EV INF PRIM CAR MAN, V3rd; Traeger AC, 2019, B WORLD HEALTH ORGAN, V97, P423, DOI 10.2471/BLT.18.226050; TURNER JA, 1990, J CONSULT CLIN PSYCH, V58, P573, DOI 10.1037/0022-006X.58.5.573; TURNER JA, 1982, J CONSULT CLIN PSYCH, V50, P757, DOI 10.1037/0022-006X.50.5.757; TURNER JA, 1993, PAIN, V52, P169, DOI 10.1016/0304-3959(93)90128-C; Unal M, 2020, J BODYW MOV THER, V24, P188, DOI 10.1016/j.jbmt.2020.07.014; Van Tulder M, 2010, CLIN CARE GUIDELINE; van Tulder MW, 2000, SPINE, V25, P2688, DOI 10.1097/00007632-200010150-00024; Van Wambeke P., 2017, LOW BACK PAIN RADICU; Vitoula K, 2018, PAIN THER, V7, P1, DOI 10.1007/s40122-018-0099-4; Vong SK, 2011, ARCH PHYS MED REHAB, V92, P176, DOI 10.1016/j.apmr.2010.10.016; Wertli MM, 2014, SPINE J, V14, P2658, DOI 10.1016/j.spinee.2014.02.033; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Wood L, 2021, PHYSIOTHERAPY, V112, P78, DOI 10.1016/j.physio.2021.03.005; Woods MP, 2008, PAIN, V136, P271, DOI 10.1016/j.pain.2007.06.037; Yao CJ, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/1428246	124	8	8	8	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								e067718	10.1136/bmj-2021-067718	http://dx.doi.org/10.1136/bmj-2021-067718			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I6XR	35354560	hybrid, Green Published			2022-12-28	WOS:000779561800013
J	Dalbye, R; Johannessen, HH				Dalbye, Rebecka; Johannessen, Hege Holmo			Two midwives during the second stage of labour to reduce severe perineal trauma	LANCET			English	Editorial Material							OASIS		[Dalbye, Rebecka] Oslo Metropolitan Univ, Ostfold Hosp Trust, Dept Obstet & Gynecol, N-0130 Oslo, Norway; [Dalbye, Rebecka] Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, N-0130 Oslo, Norway; [Johannessen, Hege Holmo] Ostfold Univ Coll, Fac Nursing Hlth & Lab Sci, Halden, Norway	Oslo Metropolitan University (OsloMet); Oslo Metropolitan University (OsloMet); Ostfold University College	Dalbye, R (corresponding author), Oslo Metropolitan Univ, Ostfold Hosp Trust, Dept Obstet & Gynecol, N-0130 Oslo, Norway.; Dalbye, R (corresponding author), Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, N-0130 Oslo, Norway.	rebecka.dalbye@oslomet.no						Andrews V, 2009, INT UROGYNECOL J, V20, P193, DOI 10.1007/s00192-008-0756-y; Edqvist M, 2022, LANCET, V399, P1242, DOI 10.1016/S0140-6736(22)00188-X; Gommesen D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032368; Gurol-Urganci I, 2021, BJOG-INT J OBSTET GY, V128, P584, DOI 10.1111/1471-0528.16396; Johannessen HH, 2020, BJOG-INT J OBSTET GY, V127, P1499, DOI 10.1111/1471-0528.16322; Lindqvist M, 2019, SEX REPROD HEALTHC, V19, P36, DOI 10.1016/j.srhc.2018.11.002; Milsom I., 2017, INCONTINENCE, V6th ed., P61, DOI DOI 10.1159/000335134; NHS Litigation Authority, 10 YEARS MAT CLAIMS, DOI [10.1177/1356262213486434#, DOI 10.1177/1356262213486434#]; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Roper JC, 2020, INT UROGYNECOL J, V31, P2247, DOI 10.1007/s00192-020-04464-5; WHO, 2015, INT CLASSIFICATION D; Xu X, 2012, DIS COLON RECTUM, V55, P586, DOI 10.1097/DCR.0b013e31823dfd6d	12	1	1	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1203	+						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35303471				2022-12-28	WOS:000779495000003
J	Liu, CL; Cai, XT; Ritzau-Jost, A; Kramer, PF; Li, YL; Khaliq, ZM; Hallermann, S; Kaeser, PS				Liu, Changliang; Cai, Xintong; Ritzau-Jost, Andreas; Kramer, Paul F.; Li, Yulong; Khaliq, Zayd M.; Hallermann, Stefan; Kaeser, Pascal S.			An action potential initiation mechanism in distal axons for the control of dopamine release	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHOLINERGIC INTERNEURONS; MIDBRAIN DOPAMINE; NEURONS; ACTIVATION; SUBUNIT; REWARD; TERMINALS; STRIATUM; CHANNELS	Information flow in neurons proceeds by integrating inputs in dendrites, generating action potentials near the soma, and releasing neurotransmitters from nerve terminals in the axon. We found that in the striatum, acetylcholine-releasing neurons induce action potential firing in distal dopamine axons. Spontaneous activity of cholinergic neurons produced dopamine release that extended beyond acetylcholine-signaling domains, and traveling action potentials were readily recorded from dopamine axons in response to cholinergic activation. In freely moving mice, dopamine and acetylcholine covaried with movement direction. Local inhibition of nicotinic acetylcholine receptors impaired dopamine dynamics and affected movement. Our findings uncover an endogenous mechanism for action potential initiation independent of somatodendritic integration and establish that this mechanism segregates the control of dopamine signaling between axons and somata.	[Liu, Changliang; Cai, Xintong; Kaeser, Pascal S.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Ritzau-Jost, Andreas; Hallermann, Stefan] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany; [Kramer, Paul F.; Khaliq, Zayd M.] NINDS, Cellular Neurophysiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Li, Yulong] Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Beijing, Peoples R China	Harvard University; Harvard Medical School; Leipzig University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Peking University	Liu, CL; Kaeser, PS (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	changliang_liu@hms.harvard.edu; kaeser@hms.harvard.edu	Liu, Changliang/H-6531-2017	Liu, Changliang/0000-0002-0915-8408; Hallermann, Stefan/0000-0001-9376-7048; Kramer, Paul/0000-0002-0095-3712; Ritzau-Jost, Andreas/0000-0002-3922-949X; cai, xintong/0000-0001-7903-2416	NIH [R01NS103484, R01NS083898]; NINDS Intramural Research Program [NS003135]; European Research Council [ERC CoG 865634]; German Research Foundation (DFG) [HA6386/10-1]; Dean's Initiative Award for Innovation; Harvard-MIT Joint Research Grant; Gordon family fellowship; Xi'an Jiaotong University/China Scholarship Council	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); European Research Council(European Research Council (ERC)European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Dean's Initiative Award for Innovation; Harvard-MIT Joint Research Grant; Gordon family fellowship; Xi'an Jiaotong University/China Scholarship Council	This work was supported by the NIH (R01NS103484 and R01NS083898 to P.S.K. and NINDS Intramural Research Program Grant NS003135 to Z.M.K.), the European Research Council (ERC CoG 865634 to S.H.), the German Research Foundation (DFG; HA6386/10-1 to S.H.), the Dean's Initiative Award for Innovation (to P.S.K.), a Harvard-MIT Joint Research Grant (to P.S.K.), and a Gordon family fellowship (to C.L.). X.C. is a visiting graduate student and received a PhD Mobility National Grants fellowship from Xi'an Jiaotong University/China Scholarship Council.	Arosio C., 2022, ZENODO, DOI [10.5281/zenodo.7197774, DOI 10.5281/ZENODO.7197774, 10.5281/zenodo.6342367, DOI 10.5281/ZENODO.6342367]; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Berke JD, 2018, NAT NEUROSCI, V21, P787, DOI 10.1038/s41593-018-0152-y; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cai Y, 2018, CELL REP, V25, P3148, DOI 10.1016/j.celrep.2018.11.053; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DECKER ER, 1990, J NEUROSCI, V10, P3413; Dodson PD, 2016, P NATL ACAD SCI USA, V113, pE2180, DOI 10.1073/pnas.1515941113; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Gentet LJ, 2007, J NEUROSCI, V27, P1892, DOI 10.1523/JNEUROSCI.5234-06.2007; GIORGUIEFF MF, 1977, J PHARMACOL EXP THER, V200, P535; GRACE AA, 1980, SCIENCE, V210, P654, DOI 10.1126/science.7433992; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Held RG, 2020, NEURON, V107, P667, DOI 10.1016/j.neuron.2020.05.032; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Howe M, 2019, ELIFE, V8, DOI 10.7554/eLife.44903; Jing M, 2020, NAT METHODS, V17, P1139, DOI 10.1038/s41592-020-0953-2; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Liu C., 2022, ZENODO, DOI [10.5281/zenodo.6342359, DOI 10.5281/ZENODO.6342359]; Liu CL, 2021, NAT REV NEUROSCI, V22, P345, DOI 10.1038/s41583-021-00455-7; Liu CL, 2018, CELL, V172, P706, DOI 10.1016/j.cell.2018.01.008; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mamaligas AA, 2016, NEURON, V91, P574, DOI 10.1016/j.neuron.2016.06.021; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Pereira DB, 2016, NAT NEUROSCI, V19, P578, DOI 10.1038/nn.4252; Pereverzev A, 2002, MOL ENDOCRINOL, V16, P884, DOI 10.1210/me.16.4.884; Ritzau-Jost A, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108612; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; Straub C, 2014, J NEUROSCI, V34, P8557, DOI 10.1523/JNEUROSCI.0589-14.2014; Sun FM, 2020, NAT METHODS, V17, P1156, DOI 10.1038/s41592-020-00981-9; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Todorov B, 2006, GENESIS, V44, P589, DOI 10.1002/dvg.20255; Wang L, 2014, J PHYSIOL-LONDON, V592, P3559, DOI 10.1113/jphysiol.2014.271825; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Yang J, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00317; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	48	8	8	12	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1378	+		10.1126/science.abn0532	http://dx.doi.org/10.1126/science.abn0532			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324301				2022-12-28	WOS:000778894800037
J	Fell, DB; Dhinsa, T; Alton, GD; Torok, E; Dimanlig-Cruz, S; Regan, AK; Sprague, AE; Buchan, SA; Kwong, JC; Wilson, SE; Haberg, SE; Gravel, CA; Wilson, K; El-Chaar, D; Walker, MC; Barrett, J; MacDonald, SE; Okun, N; Shah, PS; Dougan, SD; Dunn, S; Bisnaire, L				Fell, Deshayne B.; Dhinsa, Tavleen; Alton, Gillian D.; Torok, Eszter; Dimanlig-Cruz, Sheryll; Regan, Annette K.; Sprague, Ann E.; Buchan, Sarah A.; Kwong, Jeffrey C.; Wilson, Sarah E.; Haberg, Siri E.; Gravel, Christopher A.; Wilson, Kumanan; El-Chaar, Darine; Walker, Mark C.; Barrett, Jon; MacDonald, Shannon E.; Okun, Nannette; Shah, Prakesh S.; Dougan, Shelley D.; Dunn, Sandra; Bisnaire, Lise			Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZA VACCINATION; SPONTANEOUS-ABORTION; ACELLULAR PERTUSSIS; SAFETY; BIRTH	IMPORTANCE There is limited comparative epidemiological evidence on outcomes associated with COVID-19 vaccination during pregnancy; monitoring pregnancy outcomes in large populations is required. OBJECTIVE To evaluate peripartum outcomes following COVID-19 vaccination during pregnancy. DESIGN, SETTING, AND PARTICIPANTS Population-based retrospective cohort study in Ontario, Canada, using a birth registry linked with the provincial COVID-19 immunization database. All births between December 14, 2020, and September 30, 2021, were included. EXPOSURES COVID-19 vaccination during pregnancy, COVID-19 vaccination after pregnancy, and no vaccination. MAIN OUTCOMES AND MEASURES Postpartum hemorrhage, chorioamnionitis, cesarean delivery (overall and emergency cesarean delivery), admission to neonatal intensive care unit (NICU), and low newborn 5-minute Apgar score (<7). Linear and robust Poisson regression was used to generate adjusted risk differences (aRDs) and risk ratios (aRRs), respectively, comparing cumulative incidence of outcomes in those who received COVID-19 vaccination during pregnancy with those vaccinated after pregnancy and those with no record of COVID-19 vaccination at any point. Inverse probability of treatment weights were used to adjust for confounding. RESULTS Among 97 590 individuals (mean [SD] age, 31.9 [4.9] years), 22 660 (23%) received at least 1 dose of COVID-19 vaccine during pregnancy (63.6% received dose 1 in the third trimester; 99.8% received an mRNA vaccine). Comparing those vaccinated during vs after pregnancy (n = 44 815), there were no significantly increased risks of postpartum hemorrhage (incidence: 3.0% vs 3.0%; aRD, -0.28 per 100 individuals [95% CI, -0.59 to 0.03]; aRR, 0.91 [95% CI, 0.82-1.02]), chorioamnionitis (0.5% vs 0.5%; aRD, -0.04 per 100 individuals [95% CI, -0.17 to 0.09]; aRR, 0.92 [95% CI, 0.70-1.21]), cesarean delivery (30.8% vs 32.2%; aRD, -2.73 per 100 individuals [95% CI, -3.59 to -1.88]; aRR, 0.92 [95% CI, 0.89-0.95]), NICU admission (11.0% vs 13.3%; aRD, -1.89 per 100 newborns [95% CI, -2.49 to -1.30]; aRR, 0.85 [95% CI, 0.80-0.90]), or low Apgar score (1.8% vs 2.0%; aRD, -0.31 per 100 newborns [95% CI, -0.56 to -0.06]; aRR, 0.84 [95% CI, 0.73-0.97]). Findings were qualitatively similar when compared with individuals who did not receive COVID-19 vaccination at any point (n = 30 115). CONCLUSIONS AND RELEVANCE In this population-based cohort study in Ontario, Canada, COVID-19 vaccination during pregnancy, compared with vaccination after pregnancy and with no vaccination, was not significantly associated with increased risk of adverse peripartum outcomes. Study interpretation should consider that the vaccinations received during pregnancy were primarily mRNA vaccines administered in the second and third trimester.	[Fell, Deshayne B.; Dimanlig-Cruz, Sheryll; Gravel, Christopher A.; El-Chaar, Darine; Walker, Mark C.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Fell, Deshayne B.; Dhinsa, Tavleen; Alton, Gillian D.; Torok, Eszter; Dimanlig-Cruz, Sheryll; Sprague, Ann E.; Walker, Mark C.; Dougan, Shelley D.; Dunn, Sandra; Bisnaire, Lise] Childrens Hosp Eastern Ontario CHEO Res Inst, Ottawa, ON, Canada; [Dhinsa, Tavleen; Alton, Gillian D.; Torok, Eszter; Dimanlig-Cruz, Sheryll; Sprague, Ann E.; Walker, Mark C.; Dougan, Shelley D.; Dunn, Sandra; Bisnaire, Lise] Better Outcomes Registry Network BORN Ontario, Ottawa, ON, Canada; [Regan, Annette K.] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA USA; [Regan, Annette K.] UCLA, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Buchan, Sarah A.; Kwong, Jeffrey C.; Wilson, Sarah E.] Publ Hlth Ontario, Toronto, ON, Canada; [Buchan, Sarah A.; Kwong, Jeffrey C.; Wilson, Sarah E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] ICES, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Haberg, Siri E.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, Oslo, Norway; [Gravel, Christopher A.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wilson, Kumanan; El-Chaar, Darine; Walker, Mark C.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Wilson, Kumanan] Bruyere Res Inst, Ottawa, ON, Canada; [El-Chaar, Darine; Walker, Mark C.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Barrett, Jon] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [MacDonald, Shannon E.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [MacDonald, Shannon E.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Okun, Nannette] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Shah, Prakesh S.] Mt Sinai Hosp, Dept Pediat, Toronto, ON, Canada; [Shah, Prakesh S.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Shah, Prakesh S.] Mt Sinai Hosp, Dept Pediat, Maternal infant Care Res Ctr, Toronto, ON, Canada; [Shah, Prakesh S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dunn, Sandra] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of San Francisco; University of California System; University of California Los Angeles; University of Toronto; University of Toronto; University of Toronto; Norwegian Institute of Public Health (NIPH); McGill University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; McMaster University; University of Alberta; University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Ottawa	Fell, DB (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Childrens Hosp Eastern Ontario CHEO Res Inst, Ctr Practice Changing Res, 401 Smyth Rd,Room L1154, Ottawa, ON K1H 8L1, Canada.	dfell@cheo.on.ca	Regan, Annette/Q-9159-2016	Regan, Annette/0000-0002-3879-6193	Public Health Agency of Canada, through the Vaccine Surveillance Reference Group; Norwegian Research Council [324312, 262700]; COVID-19 Immunity Task Force	Public Health Agency of Canada, through the Vaccine Surveillance Reference Group; Norwegian Research Council(Research Council of NorwayEuropean Commission); COVID-19 Immunity Task Force	This study was supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force. Dr Haberg was partly funded by the Norwegian Research Council (project numbers 324312 and 262700).	Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Baxter R, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4091; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Berman Institute of Bioethics Center for Immunization Research, COVID 19 MAT IMM TRA; Centers for Disease Control and Prevention, POP PEOPL CERT MED C; Dagan N, 2021, NAT MED, V27, P1693, DOI 10.1038/s41591-021-01490-8; Dunn S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4825-3; Fakhraei Romina, 2021, CMAJ Open, V9, pE349, DOI 10.9778/cmajo.20200239; Giles ML, 2019, HUM VACC IMMUNOTHER, V15, P687, DOI 10.1080/21645515.2018.1540807; Goldshtein I, 2022, JAMA PEDIATR, V176, P470, DOI 10.1001/jamapediatrics.2022.0001; Goldshtein I, 2021, JAMA-J AM MED ASSOC, V326, P728, DOI 10.1001/jama.2021.11035; Gray KJ, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.023; Griffin JB, 2018, VACCINE, V36, P5173, DOI 10.1016/j.vaccine.2018.07.011; Health Canada, APPR COVID 19 VACC; Karasek D., 2021, LANCET REG HLTH AM, V2; Kharbanda EO, 2021, JAMA-J AM MED ASSOC, V326, P1629, DOI 10.1001/jama.2021.15494; Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a; Lipkind HS, 2022, MMWR-MORBID MORTAL W, V7, P26, DOI 10.15585/mmwr.mm7101e1; Magnus MC, 2021, NEW ENGL J MED, V385, P2008, DOI 10.1056/NEJMc2114466; McMillan M, 2015, VACCINE, V33, P2108, DOI 10.1016/j.vaccine.2015.02.068; Murphy Malia S Q, 2021, Int J Epidemiol, V50, P1416, DOI 10.1093/ije/dyab033; National Advisory Committee on Immunization, RECOMMENDATIONS USE; National Advisory Committee on Immunization, NACI RAP RESP EXT DO; Neophytou AM, 2021, INT J EPIDEMIOL, V50, P337, DOI 10.1093/ije/dyaa252; Office of the Premier of Ontario, ONT DEL 1 COVID 19 V; Omer SB, 2017, NEW ENGL J MED, V376, P2497, DOI 10.1056/NEJMc1705482; Ontario Ministry of Health, PROT ONT ENH CAS CON; Ontario Ministry of Health, ONT COVID 19 VACC PL; Ontario Ministry of Health, COVID 19 GUID PRIOR; Public Health Ontario, ONT MARG IND; Regan AK, 2021, EXPERT REV VACCINES, V20, P649, DOI 10.1080/14760584.2021.1915138; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P139; Savitz DA, 2015, VACCINE, V33, P6430, DOI 10.1016/j.vaccine.2015.08.041; Sukumaran L, 2015, OBSTET GYNECOL, V126, P1069, DOI 10.1097/AOG.0000000000001066; Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050; Vygen-Bonnet S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4824-3; Walsh LK, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4151; World Health Organization Department of Reproductive Health and Research, US COVID 19 MRNA VAC	39	23	25	13	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1478	1487		10.1001/jama.2022.4255	http://dx.doi.org/10.1001/jama.2022.4255		MAR 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35323842	Green Published, Bronze			2022-12-28	WOS:000772988500004
J	Kuehn, BM				Kuehn, Bridget M.			A New Resource in CDC's Campaign to Reduce Maternal Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1119	1119		10.1001/jama.2022.2804	http://dx.doi.org/10.1001/jama.2022.2804			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315878				2022-12-28	WOS:000775589900013
J	Suran, M				Suran, Melissa			COVID-19 Booster Shot Data Now Available From Nursing Homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1117	1117		10.1001/jama.2022.3709	http://dx.doi.org/10.1001/jama.2022.3709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315902	Bronze			2022-12-28	WOS:000775589900006
J	Uhl, S; Bloschichak, A; Moran, A; McShea, K; Nunemaker, MS; McKay, JR; D'Anci, KE				Uhl, Stacey; Bloschichak, Aaron; Moran, Amber; McShea, Kristina; Nunemaker, Megan S.; McKay, James R.; D'Anci, Kristen E.			Telehealth for Substance Use Disorders: A Rapid Review for the 2021 US Department of Veterans Affairs and US Department of Defense Guidelines for Management of Substance Use Disorders	ANNALS OF INTERNAL MEDICINE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; ALCOHOL-USE DISORDER; CONTINUING CARE; FEASIBILITY; PROGRAM	Background: Approximately 20.4 million Americans met criteria for a substance use disorder (SUD) in 2019; however, only about 12.2% of persons with an SUD receive specialty care. Telehealth offers alternatives to traditional forms of substance use treatment. Purpose: To synthesize recent findings on the efficacy of telehealth for SUDs. Data Sources: MEDLINE, Embase, PubMed, and the Cochrane Library from January 2015 through August 2021 (English language only). Study Selection: Randomized controlled trials (RCTs) of adults with a diagnosis of SUD based on the Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases. Data Extraction: One investigator abstracted data and assessed study quality, and a second checked for accuracy. Data Synthesis: This rapid review synthesized evidence from 17 RCTs. Evidence is very uncertain that telehealth provided as videoconference therapy (1 RCT) or web-based cognitive behavioral therapy (CBT) (3 RCTs) has similar effects to in-person therapy for improving abstinence from alcohol or cannabis. Low-strength evidence suggests that web-based CBT has similar effects for improving abstinence in multiple SUDs (2 RCTs). Low-strength evidence suggests that adding supportive text messaging to follow-up care improves abstinence and amount of alcohol per day (2 RCTs) but does not improve emergency department visits or frequency of consumption (2 RCTs). Enhanced telephone monitoring likely reduces readmissions for SUD detoxification compared with usual follow-up alone (1 RCT) but does not reduce days of substance use (low-strength evidence). Limitation: Narrative synthesis, heterogeneity of telehealth interventions, no assessment of publication bias, and study methodology. Conclusion: Evidence is very uncertain that telehealth is similar to in-person care for SUD outcomes. Limited evidence suggests some benefit of adding telehealth to usual SUD care. Ann Intern Med. 2022;175:691-700. doi:10.7326/M21-3931 Annals.org For author, article, and disclosure information, see end of text. This article was published at Annals.org on 22 March 2022.	[Uhl, Stacey; Bloschichak, Aaron; Moran, Amber; McShea, Kristina; Nunemaker, Megan S.; D'Anci, Kristen E.] ECRI, Ctr Clin Excellence, Plymouth Meeting, PA USA; [McKay, James R.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Uhl, S (corresponding author), ECRI, ECRI Ctr Clin Evidence & Guidelines, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	suhl@ecri.org		Bloschichak, Aaron/0000-0002-9356-1274; Nunemaker, Megan/0000-0001-9347-4085	Veterans Health Administration of the VA	Veterans Health Administration of the VA	By the Veterans Health Administration of the VA.	Abramson A, 2021, MONITOR PSYCHOL, V52, P22; Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10; Agyapong VIO, 2018, J SUBST ABUSE TREAT, V94, P74, DOI 10.1016/j.jsat.2018.08.014; Baca CT, 2007, ALCOHOL TREAT Q, V25, P31, DOI 10.1300/J020v25n04_03; Budney AJ, 2015, PSYCHOL ADDICT BEHAV, V29, P501, DOI 10.1037/adb0000078; Clay JM, 2020, LANCET PUBLIC HEALTH, V5, pE259, DOI 10.1016/S2468-2667(20)30088-8; Farren C. K., 2015, Irish Journal of Psychological Medicine, V32, P237, DOI 10.1017/ipm.2014.64; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Grossman ER, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249189; Gustafson DH, 2014, JAMA PSYCHIAT, V71, P566, DOI 10.1001/jamapsychiatry.2013.4642; Haug S, 2015, ALCOHOL ALCOHOLISM, V50, P188, DOI 10.1093/alcalc/agu107; Kiluk BD, 2018, AM J PSYCHIAT, V175, P853, DOI 10.1176/appi.ajp.2018.17090978; Kiluk BD, 2016, ALCOHOL CLIN EXP RES, V40, DOI 10.1111/acer.13162; Lucht M, 2021, ADDICTION, V116, P1431, DOI 10.1111/add.15313; McKay JR, 2010, J CONSULT CLIN PSYCH, V78, P912, DOI 10.1037/a0020700; Murphy SM, 2016, DRUG ALCOHOL DEPEN, V161, P119, DOI 10.1016/j.drugalcdep.2016.01.021; O'Reilly H, 2019, ALCOHOL ALCOHOLISM, V54, P551, DOI 10.1093/alcalc/agz060; Robinson KA, 2016, J CLIN EPIDEMIOL, V70, P38, DOI 10.1016/j.jclinepi.2015.05.035; Rose GL, 2015, ADDICT BEHAV, V41, P223, DOI 10.1016/j.addbeh.2014.10.022; Schunemann H., 2013, GRADE HDB HANDBOOK G; Shi JM, 2019, SUBST ABUS, V40, P132, DOI 10.1080/08897077.2019.1569192; Stoner SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124613; Substance Abuse and Mental Health Services Administration, 2018, HHS PUBL; Sundstrom C, 2020, ADDICTION, V115, P863, DOI 10.1111/add.14871; Takano A, 2020, J SUBST ABUSE TREAT, V111, P37, DOI 10.1016/j.jsat.2019.12.001; Tarp K, 2017, JMIR MENT HEALTH, V4, DOI 10.2196/mental.6713; Tetrault JM, 2020, J ADDICT MED, V14, pE303, DOI 10.1097/ADM.0000000000000663; Timko C, 2019, J SUBST ABUSE TREAT, V99, P24, DOI 10.1016/j.jsat.2018.12.008; Timko C, 2019, DRUG ALCOHOL DEPEN, V194, P230, DOI 10.1016/j.drugalcdep.2018.09.010; U.S. Department of Veteran Affairs, 2013, GUID GUID; U.S. Preventive Services Task Force, 2015, PROC MAN	31	1	1	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					691	+		10.7326/M21-3931	http://dx.doi.org/10.7326/M21-3931		MAR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35313116				2022-12-28	WOS:000805220000009
J	Limb, M				Limb, Matthew			Covid-19: Updated PPE guidance puts NHS staff at risk of infection, say medics	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gov.uk, 2022, INFECT PREVENTION CO	1	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o733	10.1136/bmj.o733	http://dx.doi.org/10.1136/bmj.o733			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304389	Bronze			2022-12-28	WOS:000773507900012
J	Mahase, E				Mahase, Elisabeth			Covid-19: Is the UK heading for another omicron wave?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ANA Enterprise,, 2022, COR COVID 19 INF SUR; [Anonymous], 2022, WEEKLY STAT NHS TEST; [Anonymous], COVID-19 daily situation report: COVID-19 admissions estimates in England,01 October 2021 to 13 March 2022; [Anonymous], VACCINATIONS UK; Kall M., 2022, TWITTER; Karaian J., 2022, NEW YORK TIMES; Limb M, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o515; Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o358; Tapper J., 2022, GUARDIAN 0312; Taylor L, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o707	10	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o738	10.1136/bmj.o738	http://dx.doi.org/10.1136/bmj.o738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304409	Bronze			2022-12-28	WOS:000773507900013
J	Anthony, SM; Hensley, LE				Anthony, Scott M.; Hensley, Lisa E.			Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection	CELL			English	Editorial Material								Recent outbreaks of Ebola have brought to the forefront the need for focused therapeutic treatments. In this issue of Cell, Milligan and colleagues build on previous studies of antibody treatments for Ebola virus disease, uncovering broad synergistic protective immunity when administered in combination (as antibody cocktails).	[Anthony, Scott M.; Hensley, Lisa E.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Anthony, SM; Hensley, LE (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA.	scott.anthony@nih.gov; lisa.hensley@nih.gov		Hensley, Lisa/0000-0003-1188-4342	U.S. National Institute of Allergy and Infectious Diseases; Laulima Government Solutions [HHSN272201800013C]	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laulima Government Solutions	This work was supported in part through a U.S. National Institute of Allergy and Infectious Diseases contract with Laulima Government Solutions (HHSN272201800013C) . We thank Anya Crane (NIH NIAID IRF-Frederick) for criti-cally editing the manuscript and Jiro Wada (NIH NIAID IRF-Frederick) for helping with figure prep-aration.	August A, 2021, NAT MED, V27, P2224, DOI 10.1038/s41591-021-01573-6; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Gilchuk P, 2021, CELL, V184, P5593, DOI 10.1016/j.cell.2021.09.035; Keita AK, 2021, NATURE, V597, P539, DOI 10.1038/s41586-021-03901-9; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Milligan J.C., 2022, CELL; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113	9	0	0	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2022	185	6					943	945		10.1016/j.cell.2022.01.025	http://dx.doi.org/10.1016/j.cell.2022.01.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZZ6CW	35303426				2022-12-28	WOS:000773355400003
J	Tita, AT; Szychowski, JM; Boggess, K; Dugoff, L; Sibai, B; Lawrence, K; Hughes, BL; Bell, J; Aagaard, K; Edwards, RK; Gibson, K; Haas, DM; Plante, L; Metz, T; Casey, B; Esplin, S; Longo, S; Hoffman, M; Saade, GR; Hoppe, KK; Foroutan, J; Tuuli, M; Owens, MY; Simhan, HN; Frey, H; Rosen, T; Palatnik, A; Baker, S; August, P; Reddy, UM; Kinzler, W; Su, E; Krishna, I; Nguyen, N; Norton, ME; Skupski, D; El-Sayed, YY; Ogunyemi, D; Galis, ZS; Harper, L; Ambalavanan, N; Geller, NL; Oparil, S; Cutter, GR; Andrews, WW				Tita, Alan T.; Szychowski, Jeff M.; Boggess, Kim; Dugoff, Lorraine; Sibai, Baha; Lawrence, Kirsten; Hughes, Brenna L.; Bell, Joseph; Aagaard, Kjersti; Edwards, Rodney K.; Gibson, Kelly; Haas, David M.; Plante, Lauren; Metz, Torri; Casey, Brian; Esplin, Sean; Longo, Sherri; Hoffman, Matthew; Saade, George R.; Hoppe, Kara K.; Foroutan, Janelle; Tuuli, Methodius; Owens, Michelle Y.; Simhan, Hyagriv N.; Frey, Heather; Rosen, Todd; Palatnik, Anna; Baker, Susan; August, Phyllis; Reddy, Uma M.; Kinzler, Wendy; Su, Emily; Krishna, Iris; Nguyen, Nicki; Norton, Mary E.; Skupski, Daniel; El-Sayed, Yasser Y.; Ogunyemi, Dotum; Galis, Zorina S.; Harper, Lorie; Ambalavanan, Namasivayam; Geller, Nancy L.; Oparil, Suzanne; Cutter, Gary R.; Andrews, William W.		Chronic Hypertension Pregnancy CHA	Treatment for Mild Chronic Hypertension During Pregnancy	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Article								(Abstracted from N Engl J Med 2022;386:1781-1792) Chronic hypertension develops in 2% of pregnancies in the United States. As this condition disproportionately affects Black women and is associated with 3 to 5 times the risk of placental abruption, preeclampsia, preterm birth (PTB), small-for-gestational-age (SGA) birthweight, and perinatal death, optimizing treatment is critical to possibly preventing these associated complications.	[Tita, Alan T.; Andrews, William W.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Tita, Alan T.; Szychowski, Jeff M.; Ambalavanan, Namasivayam; Oparil, Suzanne; Cutter, Gary R.; Andrews, William W.] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL 35294 USA; [Szychowski, Jeff M.; Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Div Neonatol, Birmingham, AL USA; [Oparil, Suzanne] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Boggess, Kim] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hughes, Brenna L.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Dugoff, Lorraine] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Plante, Lauren] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Bell, Joseph] St Lukes Univ Hlth Network, Fountain Hill, PA USA; [Simhan, Hyagriv N.] Univ Pittsburgh, Magee Womens Hosp, Dept Obstet & Gynecol, Pittsburgh, PA 15213 USA; [Sibai, Baha] Univ Texas Houston, Dept Obstet & Gynecol, Houston, TX USA; [Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti] Texas Childrens Hosp, Houston, TX 77030 USA; [Casey, Brian] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX USA; [Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Harper, Lorie] Univ Texas Austin, Dept Womens Hlth, Austin, TX 78712 USA; [Lawrence, Kirsten] Columbia Univ, Dept Obstet & Gynecol, New York, NY 10027 USA; [August, Phyllis] Weill Cornell Univ, New York, NY USA; [Skupski, Daniel] New York Presbyterian Queens Hosp, Dept Obstet & Gynecol, New York, NY USA; [Kinzler, Wendy] Winthrop Univ Hosp, Dept Obstet & Gynecol, Mineola, NY 11501 USA; [Edwards, Rodney K.] Univ Oklahoma Hlth Sci, Dept Obstet & Gynecol, Oklahoma City, OK USA; [Gibson, Kelly] MetroHlth Syst, Cleveland, OH USA; [Haas, David M.] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46204 USA; [Metz, Torri] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Esplin, Sean] Intermt Healthcare, Salt Lake City, UT USA; [Longo, Sherri] Ochsner Baptist Med Ctr, New Orleans, LA USA; [Hoffman, Matthew] Christiana Care Hlth Syst, Newark, DE USA; [Hoppe, Kara K.] UnityPoint Hlth Meriter Hosp, Marshfield Clin, Dept Obstet & Gynecol, Madison, WI USA; [Palatnik, Anna] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Foroutan, Janelle] St Peters Univ Hosp, New Brunswick, NJ USA; [Rosen, Todd] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA; [Tuuli, Methodius] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Owens, Michelle Y.] Univ Mississippi Med Ctr, Dept Obstet & Gynecol, Jackson, MS USA; [Frey, Heather] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Baker, Susan] Univ S Alabama, Dept Obstet & Gynecol, Mobile, AL USA; [Reddy, Uma M.] Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA; [Su, Emily] Univ Colorado, Dept Obstet & Gynecol, Boulder, CO USA; [Nguyen, Nicki] Denver Hlth, Dept Obstet & Gynecol, Denver, CO USA; [Krishna, Iris] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA USA; [Norton, Mary E.] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Norton, Mary E.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [El-Sayed, Yasser Y.] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Ogunyemi, Dotum] Arrowhead Reg Med Ctr, Dept Obstet & Gynecol, Colton, CA USA; [Ogunyemi, Dotum] Beaumont Hosp, Southfield, MI USA; [Galis, Zorina S.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Geller, Nancy L.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Pennsylvania; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Austin; Columbia University; Cornell University; Winthrop University Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; MetroHealth System; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Ochsner Health System; Christiana Care Health System; Marshfield Clinic; Medical College of Wisconsin; Saint Peter's University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL); University of Mississippi; University of Mississippi Medical Center; University System of Ohio; Ohio State University; University of South Alabama; Yale University; University of Colorado System; University of Colorado Boulder; Denver Health Medical Center; Emory University; University of California System; University of California San Francisco; Stanford University; Beaumont Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tita, AT (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA.; Tita, AT (corresponding author), Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL 35294 USA.			Foroutan, Janelle/0000-0002-4758-0028; Hughes, Brenna/0000-0001-8950-1204					0	39	39	9	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	AUG	2022	77	8					460	462		10.1097/01.ogx.0000852888.79526.c3	http://dx.doi.org/10.1097/01.ogx.0000852888.79526.c3			3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	3I0UT	35363951				2022-12-28	WOS:000832442600006
J	Zaliska, O; Oleshchuk, O; Forman, R; Mossialos, E				Zaliska, Olha; Oleshchuk, Oleksandra; Forman, Rebecca; Mossialos, Elias			Health impacts of the Russian invasion in Ukraine: need for global health action	LANCET			English	Editorial Material									[Zaliska, Olha] Danylo Halytsky Lviv Natl Med Univ, Dept Management & Econ Pharm, Med Technol & Pharmacoecon, Lvov, Ukraine; [Oleshchuk, Oleksandra] Horbachevsky Ternopil Natl Med Univ, Dept Pharmacol Clin Pharmacol, Ternopol, Ukraine; [Forman, Rebecca; Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Mossialos, Elias] Imperial Coll London, Inst Global Hlth Innovat, London, England	Danylo Halytsky Lviv National Medical University; I. Horbachevsky Ternopil State Medical University; University of London; London School Economics & Political Science; Imperial College London	Mossialos, E (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.; Mossialos, E (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, London, England.	e.a.mossialos@lse.ac.uk	Mossialos, Elias/ABE-1301-2021	Forman, Rebecca/0000-0002-0124-9997				Health Cluster Ukraine, 2022, UKR PUBL HLTH SIT AN, P2022; McKee M, 2022, BMJ, V376; Murray CJL, 2002, BRIT MED J, V324, P346, DOI 10.1136/bmj.324.7333.346; Provan S., 2022, FINANC TIMES; Roborgh S, 2022, LANCET, V399, P1365, DOI 10.1016/S0140-6736(22)00485-8; Sheather J, 2022, BMJ-BRIT MED J, V376, DOI [10.1136/bmj.324.7333.346, 10.1136/bmj.o499]; Southall DP, 2022, LANCET, V399, P1301, DOI 10.1016/S0140-6736(22)00526-8; Ukrinform, 2022, 15000 BAB BORN UKR F; UN Office of the High Commissioner for Human Rights, UKR CIV CAS; UN Sustainable Development Group, 2022, GUARDIAN 0314; UNAIDS, 2020, GLOB AIDS MON 2019 U; UNICEF,, 2022, WAR UKR CONT MILL CH; WHO Regional Office for Europe, 2022, EM UKR EXT SIT REP 4; Yamey G, 2022, LANCET, V399, P1284, DOI 10.1016/S0140-6736(22)00571-2	14	9	9	7	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2022	399	10334					1450	1452		10.1016/S0140-6736(22)00615-8	http://dx.doi.org/10.1016/S0140-6736(22)00615-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JN	35367006				2022-12-28	WOS:000795611300007
J	Yamey, G; Arya, AN; Bhutta, ZA; Causevic, S; Chisadza, C; Fewer, S; Friberg, P; Gloppen, S; Guha-Sapir, D; Halonen, T; Hoffman, SJ; Langer, A; Lyytikainen, M; Oppenheim, B; Ottersen, OP; Percival, V; Mohamed, IS; Thoms, OT				Yamey, Gavin; Arya, Akshaya Neil; Bhutta, Zulfiqar A.; Causevic, Sara; Chisadza, Carolyn; Fewer, Sara; Friberg, Peter; Gloppen, Siri; Guha-Sapir, Debarati; Halonen, Tarja; Hoffman, Steven J.; Langer, Ana; Lyytikainen, Minna; Oppenheim, Ben; Ottersen, Ole Petter; Percival, Valerie; Mohamed, Idil Shekh; Thoms, Oskar Timo		Lancet SIGHT Comm Peaceful Socie	A call for an immediate ceasefire and peaceful end to the Russian aggression against Ukraine	LANCET			English	Editorial Material									[Yamey, Gavin] Duke Global Hlth Inst, Duke Ctr Policy Impact Global Hlth, Durham, NC 27710 USA; [Arya, Akshaya Neil] Wilfrid Laurier Univ, Int Migrat Res Ctr, Waterloo, ON, Canada; [Arya, Akshaya Neil] Wilfrid Laurier Univ, Balsillie Sch Int Affairs, Waterloo, ON, Canada; [Arya, Akshaya Neil] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Aga Khan Univ, Inst Global Hlth & Dev, Karachi, Pakistan; [Bhutta, Zulfiqar A.] SickKids Ctr Global Child Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Causevic, Sara; Fewer, Sara; Friberg, Peter; Mohamed, Idil Shekh] Royal Swedish Acad Sci, Swedish Inst Global Hlth Transformat, Stockholm, Sweden; [Causevic, Sara; Ottersen, Ole Petter] Karolinska Inst, Stockholm, Sweden; [Chisadza, Carolyn] Univ Pretoria, Dept Econ, Pretoria, South Africa; [Friberg, Peter] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Gloppen, Siri] Univ Bergen, Bergen, Norway; [Guha-Sapir, Debarati] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Johns Hopkins Ctr Humanitarian Hlth, Baltimore, MD USA; [Halonen, Tarja] Off President Halonen, Helsinki, Finland; [Hoffman, Steven J.] York Univ, Sch Global Hlth & Osgoode Hall Law Sch, Global Strategy Lab, Toronto, ON, Canada; [Langer, Ana] Harvard TH Chan Sch Publ Hlth, Global Hlth & Populat Dept, Women & Hlth Initiat, Boston, MA USA; [Lyytikainen, Minna] Univ Helsinki, Helsinki, Finland; [Oppenheim, Ben] New York Univ, Ctr Int Cooperat, New York, NY USA; [Percival, Valerie] Carleton Univ, Norman Paterson Sch Int Affairs, Ottawa, ON, Canada; [Thoms, Oskar Timo] Carleton Univ, Montreal, PQ, Canada	Duke University; Wilfrid Laurier University; University of Waterloo; Wilfrid Laurier University; McMaster University; Aga Khan University; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Royal Swedish Academy of Sciences; Karolinska Institutet; University of Pretoria; University of Gothenburg; University of Bergen; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; York University - Canada; Harvard University; Harvard T.H. Chan School of Public Health; University of Helsinki; New York University; Carleton University; Carleton University	Yamey, G (corresponding author), Duke Global Hlth Inst, Duke Ctr Policy Impact Global Hlth, Durham, NC 27710 USA.	gavin.yamey@duke.edu		Causevic, Sara/0000-0003-0271-8000; Shekh Mohamed, Idil/0000-0001-8793-601X	Swedish Ministry for Foreign Affairs (MFA); Susan Thompson Buffett Foundation (STBF); Ministry of Social Affairs and Health in Finland; Canada's International Development Research Centre (IDRC); Swedish MFA; STBF; IDRC; Social Sciences and Humanities Research Council; WHO	Swedish Ministry for Foreign Affairs (MFA); Susan Thompson Buffett Foundation (STBF); Ministry of Social Affairs and Health in Finland; Canada's International Development Research Centre (IDRC); Swedish MFA; STBF; IDRC; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); WHO(World Health Organization)	The work of the Lancet-SIGHT Commission on Peaceful Societies through Health and Gender Equality has been funded by the Swedish Ministry for Foreign Affairs (MFA), the Susan Thompson Buffett Foundation (STBF), the Ministry of Social Affairs and Health in Finland, and Canada's International Development Research Centre (IDRC). The coauthors did not receive any funding to support the writing of this Comment. TH is former President of Finland (2000-12). ANA declares a consultation with Interpeace on a scoping review of peace through health. SC, SF, PF, and ISM declare funding from the Swedish MFA to support the Commission Secretariat. SF, PF, and ISM declare funding from the STBF to support the Commission Secretariat.VP declares grants from the IDRC and the Social Sciences and Humanities Research Council to support Commission-related research, and a contract from the Canadian Federation ofthe Red Cross on sexual and reproductive health in humanitarian settings. GY declares a grant from WHO to study pandemic preparedness and response in fragile, conflict-affected, and vulnerable countries in the Eastern Mediterranean region. The opinions expressed here do not necessarily reflect those of the funders or authors' institutions. We declare no other competing interests.	Al Jazeera, 2022, JAZEERA 0303; Bachega H, 2022, BBC NEWS 0317; Baier J, 2021, BROOKINGS 0419; Broad WJ, 2022, NEW YORK TIMES; Council on Foreign Relations, 2020, WOMENS PARTICIPATION; Cueto I, 2022, STAT-US; Dobson J, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o634; Gerzon Mahler D, 2021, WORLD BANK BLOG 0208; International Crisis Group, 2021, 10 CONFL WATCH 2022; International Rescue Committee, 2022, 15 MILL FLEE UKR WOM; Koeze E, 2022, NEW YORK TIMES; Krause J, 2018, INT INTERACT, V44, P985, DOI 10.1080/03050629.2018.1492386; Peksen D, 2011, FOREIGN POL ANAL-US, V7, P237, DOI 10.1111/j.1743-8594.2011.00136.x; Putka S, 2022, MEDPAGE TODAY; Reuters, 2022, REUTERS 0306; UN Office of the High Commissioner for Human Rights, UKR CIV CAS UPD 22 M; UNHCR, 2022, OP DAT PORT UKR REF; WHO, WHO DIR GEN OP REM W; World Food Program, WFP AFGH SIT REP 17	19	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1284	1287		10.1016/S0140-6736(22)00571-2	http://dx.doi.org/10.1016/S0140-6736(22)00571-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35339228				2022-12-28	WOS:000812828300009
J	Fontanarosa, PB; Flanagin, A; Golub, RM				Fontanarosa, Phil B.; Flanagin, Annette; Golub, Robert M.			Catastrophic Health Consequences of the War in Ukraine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REFUGEES		[Fontanarosa, Phil B.; Flanagin, Annette; Golub, Robert M.] JAMA Network, Chicago, IL USA; [Fontanarosa, Phil B.; Flanagin, Annette; Golub, Robert M.] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA		Fontanarosa, PB (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	Phil.Fontanarosa@jamanetwork.org						[Anonymous], 2022, NATURE, V603, P201, DOI 10.1038/d41586-022-00647-w; [Anonymous], 2022, JAMA-J AM MED ASSOC; European Commission, SANCTIONS ADOPTED FO; Galea S, 2022, JAMA-HEALTH FORUM, V3, DOI 10.1001/jamahealthforum.2022.0845; Gostin LO, 2022, JAMA-J AM MED ASSOC, V327, P1541, DOI 10.1001/jama.2022.6045; Guterres A, 2012, JAMA-J AM MED ASSOC, V308, P673, DOI 10.1001/2012.jama.10161; Iacopino V, 1999, JAMA-J AM MED ASSOC, V282, P479, DOI 10.1001/jama.282.5.479; McKee M, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o548; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Research4Life, 2022, ENSURING CONTINUED S; Rubin R, 2022, JAMA-J AM MED ASSOC, V327, P1318, DOI 10.1001/jama.2022.4680; Stephenson J, 2022, JAMA-HEALTH FORUM, V3, DOI 10.1001/jamahealthforum.2022.0838; United Nations High Commissioner for Refugees, OPERATIONAL DATA POR; United Nations Office of the High Commissioner for Human Rights, UKRAINE CIVILIAN CAS; Warburton M., 2022, REUTERS; Wren SM, 2020, JAMA SURG, V155, P114, DOI 10.1001/jamasurg.2019.4547; Yamey G, 2022, LANCET, V399, P1284, DOI 10.1016/S0140-6736(22)00571-2	17	4	4	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2022	327	16					1549	1550		10.1001/jama.2022.6046	http://dx.doi.org/10.1001/jama.2022.6046		APR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0W7TZ	35363251	Bronze			2022-12-28	WOS:000776736500003
J	Chamma-Siqueira, NN; Negreiros, SC; Ballard, SB; Farias, S; Silva, SP; Chenet, SM; Santos, EJM; de Sena, LWP; da Costa, FP; Cardoso-Mello, AGN; Marchesini, PB; Peterka, CRL; Viana, GMR; de Oliveira, AM				Chamma-Siqueira, Nathalia N.; Negreiros, Suiane C.; Ballard, Sarah-Blythe; Farias, Samela; Silva, Sandro P.; Chenet, Stella M.; Santos, Eduardo J. M.; de Sena, Luann W. Pereira; da Costa, Flavia Povoa; Cardoso-Mello, Amanda G. N.; Marchesini, Paola B.; Peterka, Cassio R. L.; Viana, Giselle M. R.; de Oliveira, Alexandre Macedo			Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TAFENOQUINE; EFFICACY; GENOTYPE	BACKGROUND In most of the Americas, the recommended treatment to prevent relapse of Plasmodium vivax malaria is primaquine at a total dose of 3.5 mg per kilogram of body weight, despite evidence of only moderate efficacy. METHODS In this trial conducted in Brazil, we evaluated three primaquine regimens to prevent relapse of P. vivax malaria in children at least 5 years of age and in adults with microscopy-confirmed P. vivax monoinfection. All the patients received directly observed chloroquine for 3 days (total dose, 25 mg per kilogram). Group 1 received a total primaquine dose of 3.5 mg per kilogram (0.5 mg per kilogram per day) over 7 days with unobserved administration; group 2 received the same regimen as group 1 but with observed administration; and group 3 received a total primaquine dose of 7.0 mg per kilogram over 14 days (also 0.5 mg per kilogram per day) with observed administration. We monitored the patients for 168 days. RESULTS We enrolled 63 patients in group 1, 96 in group 2, and 95 in group 3. The median age of the patients was 22.4 years (range, 5.4 to 79.8). By day 28, three P. vivax recurrences were observed: 2 in group 1 and 1 in group 2. By day 168, a total of 70 recurrences had occurred: 24 in group 1, 34 in group 2, and 12 in group 3. No serious adverse events were noted. On day 168, the percentage of patients without recurrence was 58% (95% confidence interval [CI], 44 to 70) in group 1, 59% (95% CI, 47 to 69) in group 2, and 86% (95% CI, 76 to 92) in group 3. Survival analysis showed a difference in the day 168 recurrence-free percentage of 27 percentage points (97.5% CI, 10 to 44; P<0.001) between group 1 and group 3 and a difference of 27 percentage points (97.5% CI, 12 to 42; P<0.001) between group 2 and group 3. CONCLUSIONS The administration of primaquine at a total dose of 7.0 mg per kilogram had higher efficacy in preventing relapse of P. vivax malaria than a total dose of 3.5 mg per kilogram through day 168.	[Chamma-Siqueira, Nathalia N.; Silva, Sandro P.; Viana, Giselle M. R.] Minist Saude Brasil, Inst Evandro Chagas, Rodovia BR 316,Km 07 S-N, BR-67030000 Ananindeua, PA, Brazil; [Chamma-Siqueira, Nathalia N.; Santos, Eduardo J. M.; da Costa, Flavia Povoa; Viana, Giselle M. R.] Univ Fed Para, Programa Posgrad Biol Agentes Infecciosos & Paras, Inst Ciencias Biol, Belem, Para, Brazil; [Santos, Eduardo J. M.; da Costa, Flavia Povoa] Univ Fed Para, Lab Genet Doencas Complexas, Inst Ciencias Biol, Belem, Para, Brazil; [de Sena, Luann W. Pereira; Cardoso-Mello, Amanda G. N.] Univ Fed Para, Lab Farmacocinet Drogas Antimalar, Inst Ciencias Saude, Belem, Para, Brazil; [Negreiros, Suiane C.; Farias, Samela] Secretaria Saude Estado Acre, Cruzeiro Do Sul, Brazil; [Marchesini, Paola B.] Minist Saude, Grp Tecn Malaria, Coordenacao Geral Vigilancia Zoonoses & Doencas T, Dept Imunizacao & Doencas Transmissiveis,Secretar, Brasilia, DF, Brazil; [Peterka, Cassio R. L.] Secretaria Estadual Saude Dist Fed, Subsecretaria Vigilancia Saude, Diretoria Vigilancia Epidemiol, Brasilia, DF, Brazil; [Ballard, Sarah-Blythe] Ctr Surveillance Epidemiol & Lab Serv, Epidem Intelligence Serv, Atlanta, GA USA; [Ballard, Sarah-Blythe; de Oliveira, Alexandre Macedo] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Chenet, Stella M.] Univ Ricardo Palma, Inst Invest Ciencias Biomed, Lima, Peru; [Chenet, Stella M.] Univ Nacl Toribio Rodriguez de Mendoza Amazonas, Inst Enfermedades Trop, Chachapoyas, Peru	Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Centers for Disease Control & Prevention - USA; Universidad Ricardo Palma; Universidad Nacional Toribio Rodriguez De Mendoza De Amazonas	Chamma-Siqueira, NN (corresponding author), Minist Saude Brasil, Inst Evandro Chagas, Rodovia BR 316,Km 07 S-N, BR-67030000 Ananindeua, PA, Brazil.	nathaliachamma@iec.gov.br	Pereira de Sena, Luann Wendel/AAV-8510-2021; Chenet, Stella/H-6001-2018	Pereira de Sena, Luann Wendel/0000-0001-9363-5766; Chenet, Stella/0000-0002-5305-0664	U.S. Agency for International Development	U.S. Agency for International Development(United States Agency for International Development (USAID))	Supported by the U.S. Agency for International Development	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2020, GUIA TRATAMENTO MALA; Avalos S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2564-2; Baird JK, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1449; Baird JK, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2190-z; Beck HP, 2016, J INFECT DIS, V213, P794, DOI 10.1093/infdis/jiv508; Bennett JW, 2013, NEW ENGL J MED, V369, P1381, DOI 10.1056/NEJMc1301936; Brito-Sousa JD, 2019, CLIN INFECT DIS, V69, P1440, DOI 10.1093/cid/ciz122; Caudle KE, 2020, CTS-CLIN TRANSL SCI, V13, P116, DOI 10.1111/cts.12692; Centers for Disease:Control and Prevention, 2020, MAL TREATM US; Collins WE, 1996, AM J TROP MED HYG, V55, P243, DOI 10.4269/ajtmh.1996.55.243; Daher A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2950-4; Durand S, 2014, AM J TROP MED HYG, V91, P18, DOI 10.4269/ajtmh.13-0053; Ebstie YA, 2016, DRUG DES DEV THER, V10, P2387, DOI 10.2147/DDDT.S61443; Friedrich DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110691; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Imwong M, 2006, MOL BIOL EVOL, V23, P1016, DOI 10.1093/molbev/msj116; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Lacerda MVG, 2019, NEW ENGL J MED, V380, P215, DOI 10.1056/NEJMoa1710775; Llanos-Cuentas A, 2019, NEW ENGL J MED, V380, P229, DOI 10.1056/NEJMoa1802537; Ministerio da Saude, DAD CID MAL BRAS SIV; Miranda TA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0570-1; Monteiro WM, 2016, CLIN INFECT DIS, V62, DOI 10.1093/cid/ciw039; Negreiros S, 2016, AM J TROP MED HYG, V95, P1061, DOI 10.4269/ajtmh.16-0075; Rueangweerayut R, 2017, AM J TROP MED HYG, V97, P702, DOI 10.4269/ajtmh.16-0779; St Jean PL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1145-5; Taylor WRJ, 2019, LANCET, V394, P929, DOI 10.1016/S0140-6736(19)31285-1; WHO, 2015, GUID TREATM MAL; World Health Organization, 2009, METH SURV ANT DRUG E	31	6	7	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1244	1253		10.1056/NEJMoa2104226	http://dx.doi.org/10.1056/NEJMoa2104226			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353962	Bronze			2022-12-28	WOS:000820666300008
J	Zhou, HN; Stein, CB; Shafiq, TA; Shipkovenska, G; Kalocsay, M; Paulo, JA; Zhang, JC; Luo, ZH; Gygi, SP; Adelman, K; Moazed, D				Zhou, Haining; Stein, Chad B.; Shafiq, Tiasha A.; Shipkovenska, Gergana; Kalocsay, Marian; Paulo, Joao A.; Zhang, Jiuchun; Luo, Zhenhua; Gygi, Steven P.; Adelman, Karen; Moazed, Danesh			Rixosomal RNA degradation contributes to silencing of Polycomb target genes	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CHROMATIN-STRUCTURE; PRC2 RECRUITMENT; COMPLEX; PROTEINS; TRANSCRIPTION; H2A; METHYLATION; PROMOTERS; UBIQUITYLATION	Polycomb repressive complexes 1 and 2 (PRC1 and PRC2) are histone-modifying and -binding complexes that mediate the formation of facultative heterochromatin and are required for silencing of developmental genes and maintenance of cell fate(1-3). Multiple pathways of RNA decay work together to establish and maintain heterochromatin in fission yeast, including a recently identified role for a conserved RNA-degradation complex known as the rixosome or RIX1 complex(4-6). Whether RNA degradation also has a role in the stability of mammalian heterochromatin remains unknown. Here we show that the rixosome contributes to silencing of many Polycomb targets in human cells. The rixosome associates with human PRC complexes and is enriched at promoters of Polycomb target genes. Depletion of either the rixosome or Polycomb results in accumulation of paused and elongating RNA polymerase at Polycomb target genes. We identify point mutations in the RING1B subunit of PRC1 that disrupt the interaction between PRC1 and the rixosome and result in diminished silencing, suggesting that direct recruitment of the rixosome to chromatin is required for silencing. Finally, we show that the RNA endonuclease and kinase activities of the rixosome and the downstream XRN2 exoribonuclease, which degrades RNAs with 5 ' monophosphate groups generated by the rixosome, are required for silencing. Our findings suggest that rixosomal degradation of nascent RNA is conserved from fission yeast to human, with a primary role in RNA degradation at facultative heterochromatin in human cells.	[Zhou, Haining; Shafiq, Tiasha A.; Shipkovenska, Gergana; Moazed, Danesh] Harvard Med Sch, Howard Hughes Med Inst, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Stein, Chad B.; Adelman, Karen] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kalocsay, Marian; Paulo, Joao A.; Gygi, Steven P.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Jiuchun] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Initiat Genome Editing & Neurodegenerat, Boston, MA 02115 USA; [Luo, Zhenhua] Sun Yat Sen Univ, Affiliated Hosp 1, Precis Med Inst, Guangzhou, Peoples R China	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Sun Yat Sen University	Moazed, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu		Stein, Chad/0000-0003-4711-3611; Kalocsay, Marian/0000-0002-4187-5829; Adelman, Karen/0000-0001-5364-334X	National Institutes of Health [R01GM134539, RO1GM072805]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Nikon Imaging Center at the Department of Cell Biology at Harvard Medical School for access to microscopes and advice, the HMS Nascent Transcriptomics Core for PRO-seq, members of the Moazed laboratory for helpful discussions, and K. D'Orazio, S. Parhad, H. Saini, A. Tatarakis and J. Yu for comments on the manuscript. This work was supported by the National Institutes of Health, grants R01GM134539 to K.A. and RO1GM072805 to D.M. D.M. is an investigator of the Howard Hughes Medical Institute.	Beltran M, 2016, GENOME RES, V26, P896, DOI 10.1101/gr.197632.115; Blackledge NP, 2020, MOL CELL, V77, P857, DOI 10.1016/j.molcel.2019.12.001; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheutin T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002465; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fromm L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01786-9; Fursova NA, 2019, MOL CELL, V74, P1020, DOI 10.1016/j.molcel.2019.03.024; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gasse L, 2015, MOL CELL, V60, P808, DOI 10.1016/j.molcel.2015.10.021; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Healy E, 2019, MOL CELL, V76, P437, DOI 10.1016/j.molcel.2019.08.012; Heindl K, 2010, EMBO J, V29, P4161, DOI 10.1038/emboj.2010.275; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Huttlin EL, 2021, CELL, V184, P3022, DOI 10.1016/j.cell.2021.04.011; Iglesias N, 2020, MOL CELL, V77, P51, DOI 10.1016/j.molcel.2019.10.018; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kasinath V, 2021, SCIENCE, V371, P362, DOI 10.1126/science.abc3393; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lau MS, 2017, SCIENCE, V355, DOI 10.1126/science.aah5403; Long YC, 2020, NAT GENET, V52, P931, DOI 10.1038/s41588-020-0662-x; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mattout A, 2020, NAT CELL BIOL, V22, P579, DOI 10.1038/s41556-020-0504-1; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Navarrete-Perea J, 2018, J PROTEOME RES, V17, P2226, DOI 10.1021/acs.jproteome.8b00217; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Pillon MC, 2017, P NATL ACAD SCI USA, V114, pE5530, DOI 10.1073/pnas.1703133114; Plys AJ, 2019, GENE DEV, V33, P799, DOI 10.1101/gad.326488.119; Reimer KA, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.018; Sanso M, 2016, GENE DEV, V30, P117, DOI 10.1101/gad.269589.115; Scelfo A, 2019, MOL CELL, V74, P1037, DOI 10.1016/j.molcel.2019.04.002; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shipkovenska G, 2020, ELIFE, V9, DOI 10.7554/eLife.54341; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tatavosian R, 2019, J BIOL CHEM, V294, P1451, DOI 10.1074/jbc.RA118.006620; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang XY, 2017, NAT STRUCT MOL BIOL, V24, P1028, DOI 10.1038/nsmb.3487; Zhao JC, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0484-1; Zhao WK, 2017, J BIOL CHEM, V292, P21527, DOI 10.1074/jbc.M117.804054	57	2	2	12	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					167	+		10.1038/s41586-022-04598-0	http://dx.doi.org/10.1038/s41586-022-04598-0		MAR 2022	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355014	Green Published, hybrid			2022-12-28	WOS:000776020400009
J	Mahase, E				Mahase, Elisabeth			Global health boards remain dominated by men from high income countries, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o835	10.1136/bmj.o835	http://dx.doi.org/10.1136/bmj.o835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351677				2022-12-28	WOS:000779544800015
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Are antivirals a covid-19 game changer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						[Anonymous], 2022, REUTERS 0322; NHS, TREATM COR COVID 19	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o810	10.1136/bmj.o810	http://dx.doi.org/10.1136/bmj.o810			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351682	Bronze			2022-12-28	WOS:000779544800007
J	Wensink, MJ; Lu, Y; Tian, L; Shaw, GM; Rizzi, S; Jensen, TK; Mathiesen, ER; Skakkebaek, NE; Lindahl-Jacobsen, R; Eisenberg, ML				Wensink, Maarten J.; Lu, Ying; Tian, Lu; Shaw, Gary M.; Rizzi, Silvia; Jensen, Tina Kold; Mathiesen, Elisabeth R.; Skakkebaek, Niels E.; Lindahl-Jacobsen, Rune; Eisenberg, Michael L.			Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GESTATIONAL DIABETES-MELLITUS; METFORMIN; ENVIRONMENT; FERTILITY; EXPOSURE; CANCER; TRENDS	Background: Diabetes reduces semen quality and increasingly occurs during reproductive years. Diabetes medications, such as metformin, have glucose-independent effects on the male reproductive system. Associations with birth defects in offspring are unknown. Objective: To evaluate whether the risk for birth defects in offspring varies with preconceptional pharmacologic treatment of fathers with diabetes. Design: Nationwide prospective registry-based cohort study. Setting: Denmark from 1997 to 2016. Participants: All liveborn singletons from mothers without histories of diabetes or essential hypertension. Measurements: Offspring were considered exposed if their father filled 1 or more prescriptions for a diabetes drug during the development of fertilizing sperm. Sex and frequencies of major birth defects were compared across drugs, times of exposure, and siblings. Results: Of 1116779 offspring included, 3.3% had 1 or more major birth defects (reference). Insulin-exposed offspring (n = 5298) had the reference birth defect frequency (adjusted odds ratio [aOR], 0.98 [95% CI, 0.85 to 1.14]). Metformin-exposed offspring (n = 1451) had an elevated birth defect frequency (aOR, 1.40 [CI, 1.08 to 1.82]). For sulfonylurea-exposed offspring (n = 647), the aOR was 1.34 (CI, 0.94 to 1.92). Offspring whose fathers filled a metformin prescription in the year before (n = 1751) or after (n = 2484) sperm development had reference birth defect frequencies (aORs, 0.88 [CI, 0.59 to 1.31] and 0.92 [CI, 0.68 to 1.26], respectively), as did unexposed siblings of exposed offspring (3.2%; exposed vs. unexposed OR, 1.54 [CI, 0.94 to 2.53]). Among metformin-exposed offspring, genital birth defects, all in boys, were more common (aOR, 3.39 [CI, 1.82 to 6.30]), while the proportion of male offspring was lower (49.4% vs. 51.4%, P= 0.073). Limitation: Information on underlying disease status was limited. Conclusion: Preconception paternal metformin treatment is associated with major birth defects, particularly genital birth defects in boys. Further research should replicate these findings and clarify the causation. Primary Funding Source: National Institutes of Health.	[Wensink, Maarten J.; Rizzi, Silvia; Lindahl-Jacobsen, Rune] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Odense C, Denmark; [Wensink, Maarten J.; Rizzi, Silvia; Lindahl-Jacobsen, Rune] Univ Southern Denmark, Interdisciplinary Ctr Populat Dynam, Odense C, Denmark; [Lu, Ying; Tian, Lu] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Shaw, Gary M.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Jensen, Tina Kold] Univ Southern Denmark, Dept Environm Med, Odense C, Denmark; [Mathiesen, Elisabeth R.] Univ Copenhagen, Rigshosp, Ctr Pregnant Women Diabet, Copenhagen, Denmark; [Skakkebaek, Niels E.] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Growth & Reprod, Copenhagen, Denmark; [Eisenberg, Michael L.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Dept Urol,Male Reprod Med & Surg, Stanford, CA 94305 USA	University of Southern Denmark; University of Southern Denmark; Stanford University; Stanford University; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Stanford University	Wensink, MJ (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Winsloewsvej 9B, DK-5000 Odense C, Denmark.	mwensink@health.sdu.dk	Lindahl-Jacobsen, Rune/J-2985-2012	Lindahl-Jacobsen, Rune/0000-0002-4622-9826; Rizzi, Silvia/0000-0002-3512-2361; Shaw, Gary/0000-0001-7438-4914; tian, lu/0000-0002-5893-0169; Jensen, Tina Kold/0000-0003-2311-5778	National Institutes of Health [HD096468, 1UL1TR003142]; Centers for Disease Control and Prevention [U01DD001226]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Acknowledgment: The authors thank Matthew Keys for comments. Grant Support: By grants HD096468 (MJW, YL, SR, TKJ, NES, RL, and MLE) and 1UL1TR003142 (LT and YL) from the National Institutes of Health and grant U01DD001226 (GMS) from the Centers for Disease Control and Prevention.	Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Alla LNR, 2021, CHEMOSPHERE, V271, DOI 10.1016/j.chemosphere.2020.129442; Bednar F, 2012, CANCER PREV RES, V5, P351, DOI 10.1158/1940-6207.CAPR-12-0026; Bliddal M, 2018, EUR J EPIDEMIOL, V33, P27, DOI 10.1007/s10654-018-0356-1; Bruckner TA, 2018, SSM-POPUL HLTH, V5, P101, DOI 10.1016/j.ssmph.2018.05.010; Cadarette SM, 2021, PHARMACOEPIDEM DR S, V30, P671, DOI 10.1002/pds.5227; Carstensen B, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2019-001071; Christensen DH, 2016, CLIN EPIDEMIOL, V8, P381, DOI 10.2147/CLEP.S113211; Condorelli RA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00268; Eisenberg ML, 2016, HUM REPROD, V31, P2369, DOI 10.1093/humrep/dew200; Eisenberg ML, 2015, FERTIL STERIL, V103, P1271, DOI 10.1016/j.fertnstert.2015.02.010; Eisenberg ML, 2015, FERTIL STERIL, V103, P66, DOI 10.1016/j.fertnstert.2014.10.017; Eisenberg ML, 2012, ASIAN J ANDROL, V14, P683, DOI 10.1038/aja.2012.58; EUROCAT Central Registry, EUROPEAN SURVEILLANC; Faure M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00675; Forcato S, 2017, REPROD TOXICOL, V74, P48, DOI 10.1016/j.reprotox.2017.08.023; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gabbay-Benziv R, 2015, WORLD J DIABETES, V6, P481, DOI 10.4239/wjd.v6.i3.481; Ghasemnejad-Berenji M, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12846; Guo D, 2017, WORLD J MENS HEALTH, V35, P59, DOI 10.5534/wjmh.2017.35.2.59; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Harris BS, 2017, OBSTET GYNECOL SURV, V72, P123, DOI 10.1097/OGX.0000000000000405; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS173, DOI [10.1016/S0020-7292(15)30033-3, 10.1016/S0020-7292(15)30007-2]; Hu Y, 2021, DIABETES CARE, V44, P1059, DOI 10.2337/dc20-1558; Immler S, 2018, HEREDITY, V121, P239, DOI 10.1038/s41437-018-0111-0; Ludvigsson JF, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2638; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009; Persson Frederik, 2018, Endocrinol Diabetes Metab, V1, pe00036, DOI 10.1002/edm2.36; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; R Development Core Team, 2009, R LANG ENV STAT COMP; Romero R, 2017, AM J OBSTET GYNECOL, V217, P282, DOI 10.1016/j.ajog.2017.06.003; Rynn L, 2008, JAMA-J AM MED ASSOC, V299, P756; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Tartarin P, 2012, HUM REPROD, V27, P3304, DOI 10.1093/humrep/des264; Temidayo S.O., 2018, ASIAN PACIFIC J REPR, V7, P6, DOI [10.4103/2305-0500.220978, DOI 10.4103/2305-0500.220978]; van Buuren S, 2011, J STAT SOFTW, V45, P1; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wasserman CR, 1998, AM J PUBLIC HEALTH, V88, P1674, DOI 10.2105/AJPH.88.11.1674; Wensink MJ, 2021, SCAND J PUBLIC HEALT, V49, P884, DOI 10.1177/1403494820987468; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn	44	10	10	6	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					665	+		10.7326/M21-4389	http://dx.doi.org/10.7326/M21-4389		MAR 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35344380				2022-12-28	WOS:000779640700001
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Moderna will ask for authorisation for vaccine for infants and children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Facts USA, US COR VACC TRACK NA; investors.modernatx.com, 2022, MOD ANN ITS COVID 19; LaFraniere S, 2022, NEW YORK TIMES; WHO, 2022, GEN ACC DEM COVID 19	4	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o798	10.1136/bmj.o798	http://dx.doi.org/10.1136/bmj.o798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338047	Bronze			2022-12-28	WOS:000778396700005
J	Hodkinson, A; Tsimpida, D; Kontopantelis, E; Rutter, MK; Mamas, MA; Panagioti, M				Hodkinson, Alexander; Tsimpida, Dialechti; Kontopantelis, Evangelos; Rutter, Martin K.; Mamas, Mamas A.; Panagioti, Maria			Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							REDUCES ADIPONECTIN LEVELS; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; LDL-CHOLESTEROL; INSULIN SENSITIVITY; ATORVASTATIN THERAPY; SIMVASTATIN THERAPY; PRIMARY PREVENTION; HDL-CHOLESTEROL	OBJECTIVE To compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes. DESIGN Systematic review and network meta-analysis. DATA SOURCES Medline, Cochrane Central Register of Controlled Trials, and Embase from inception to 1 December 2021. REVIEW METHODS Randomised controlled trials comparing different types and intensities of statins, including placebo, in adults with type 1 or type 2 diabetes mellitus were included. The primary outcome was changes in levels of non-HDL-C, calculated from measures of total cholesterol and HDL-C. Secondary outcomes were changes in levels of low density lipoprotein cholesterol (LDL-C) and total cholesterol, three point major cardiovascular events (non-fatal stroke, non-fatal myocardial infarction, and death related to cardiovascular disease), and discontinuations because of adverse events. A bayesian network meta analysis of statin intensity (low, moderate, or high) with random effects evaluated the treatment effect on non-HDL-C by mean differences and 95% credible intervals. Subgroup analysis of patients at greater risk of major cardiovascular events was compared with patients at low or moderate risk. The confidence in network meta-analysis (CINeMA) framework was applied to determine the certainty of evidence. RESULTS In 42 randomised controlled trials involving 20 193 adults, 11 698 were included in the meta-analysis. Compared with placebo, the greatest reductions in levels of non-HDL-C were seen with rosuvastatin at high (-2.31 mmol/L, 95% credible interval-3.39 to-1.21) and moderate (-2.27,-3.00 to-1.49) intensities, and simvastatin (-2.26,-2.99 to-1.51) and atorvastatin (-2.20,-2.69 to-1.70) at high intensity. Atorvastatin and simvastatin at any intensity and pravastatin at low intensity were also effective in reducing levels of non-HDL-C. In 4670 patients at greater risk of a major cardiovascular events, atorvastatin at high intensity showed the largest reduction in levels of non-HDL-C (-1.98,-4.16 to 0.26, surface under the cumulative ranking curve 64%). Simvastatin (-1.93,-2.63 to-1.21) and rosuvastatin (-1.76,-2.37 to-1.15) at high intensity were the most effective treatment options for reducing LDL-C. Significant reductions in non-fatal myocardial infarction were found for atorvastatin at moderate intensity compared with placebo (relative risk=0.57, confidence interval 0.43 to 0.76, n=4 studies). No significant differences were found for discontinuations, non-fatal stroke, and cardiovascular deaths. CONCLUSIONS This network meta-analysis indicated that rosuvastatin, at moderate and high intensity doses, and simvastatin and atorvastatin, at high intensity doses, were most effective at moderately reducing levels of non-HDL-C in patients with diabetes. Given the potential improvement in accuracy in predicting cardiovascular disease when reduction in levels of non-HDL-C is used as the primary target, these findings provide guidance on which statin types and intensities are most effective by reducing non-HDL-C in patients with diabetes. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42021258819.	[Hodkinson, Alexander; Tsimpida, Dialechti; Kontopantelis, Evangelos; Mamas, Mamas A.; Panagioti, Maria] Univ Manchester, Natl Inst Hlth Res Sch Primary Care Res, Sch Hlth Sci,Div Populat Hlth Hlth Serv Res & Pri, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Tsimpida, Dialechti; Kontopantelis, Evangelos] Univ Manchester, Inst Hlth Policy & Org, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Tsimpida, Dialechti] Univ Manchester, Div Med Educ, Sch Med Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Div Informat Imaging & Data Sci, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Rutter, Martin K.] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Sch Med Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Rutter, Martin K.] Manchester Univ NHS Fdn Trust, Diabet Endocrinol & Metab Ctr, Manchester, Lancs, England; [Mamas, Mamas A.] Keele Univ, Ctr Prognosis Res, Keele Cardiovasc Res Grp, Keele, Staffs, England; [Mamas, Mamas A.] Royal Stoke Univ Hosp, Dept Cardiol, Stoke On Trent, Staffs, England; [Hodkinson, Alexander; Panagioti, Maria] Univ Manchester, Natl Inst Hlth Res Greater Manchester Safety Tran, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; Keele University; Royal Stoke University Hospital; University of Manchester	Hodkinson, A (corresponding author), Univ Manchester, Natl Inst Hlth Res Sch Primary Care Res, Sch Hlth Sci,Div Populat Hlth Hlth Serv Res & Pri, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Hodkinson, A (corresponding author), Univ Manchester, Natl Inst Hlth Res Greater Manchester Safety Tran, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England.	alexander.hodkinson@manchester.ac.uk		Mamas, Mamas/0000-0001-9241-8890; Rutter, Martin/0000-0001-6380-539X; Tsimpida, Dr Dialechti/0000-0002-3709-5651; Panagioti, Maria/0000-0002-7153-5745; Kontopantelis, Evangelos/0000-0001-6450-5815	National Institute for Health Research (NIHR) School for Primary Care Research [461]	National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (461) and was supported by a presidential fellowship held by AH. The research team members were independent from the funding agencies. The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript.	Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741; BEHOUNEK BD, 1994, CLIN CARDIOL, V17, P558, DOI 10.1002/clc.4960171009; Berberoglu Z, 2009, ENDOCRINOLOGIST, V19, P271, DOI 10.1097/TEN.0b013e3181c052fa; Berkplanken I, 2001, DIABETES CARE, V24, P1335; Betteridge DJ, 2007, AM J CARDIOL, V100, P1245, DOI 10.1016/j.amjcard.2007.05.044; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cai T, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1537; Caldwell DM, 2016, EVID-BASED MENT HEAL, V19, P16, DOI 10.1136/eb-2015-102275; Campbell RT, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002842; Ferrer-Garcia JC, 2008, J CARDIOVASC PHARM T, V13, P183, DOI 10.1177/1074248408321461; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chang Yu-Hung, 2013, Rev Diabet Stud, V10, P213, DOI 10.1900/RDS.2013.10.213; Cheung RC, 2005, INT J CARDIOL, V100, P309, DOI 10.1016/j.ijcard.2004.12.011; Chu CH, 2008, J ENDOCRINOL INVEST, V31, P42, DOI 10.1007/BF03345565; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Dalla Nora E, 2003, J ENDOCRINOL INVEST, V26, P73, DOI 10.1007/BF03345126; Dallinga-Thie GM, 2009, BBA-MOL CELL BIOL L, V1791, P714, DOI 10.1016/j.bbalip.2009.03.008; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2014, NICE DSU TECHNICAL S; Eliasson B, 2014, EUR J PREV CARDIOL, V21, P1420, DOI 10.1177/2047487313494292; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Frost PH, 1998, AM J CARDIOL, V81, p26B, DOI 10.1016/S0002-9149(98)00034-4; Gentile S, 2000, DIABETES OBES METAB, V2, P355, DOI 10.1046/j.1463-1326.2000.00106.x; Goldberg RB, 2006, MAYO CLIN PROC, V81, P1579, DOI 10.4065/81.12.1579; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Gunhan BK, 2020, RES SYNTH METHODS, V11, P74, DOI 10.1002/jrsm.1370; Hadjibabaie M, 2006, THERAPY, V3, P759, DOI [10.2217/14750708.3.6.759, DOI 10.2217/14750708.3.6.759]; Herrett E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n135; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hodkinson A, 2021, STAT METHODS MED RES, V30, P1589, DOI 10.1177/09622802211022385; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Ichihara A, 2002, NEPHROL DIAL TRANSPL, V17, P1513, DOI 10.1093/ndt/17.8.1513; Insull W, 2001, AM J CARDIOL, V87, P554, DOI 10.1016/S0002-9149(00)01430-2; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Ishigaki Y, 2014, J ATHEROSCLER THROMB, V21, P1055, DOI 10.5551/jat.22095; Janatuinen T, 2004, ARTERIOSCL THROM VAS, V24, P1303, DOI 10.1161/01.ATV.0000132409.87124.60; Jia PL, 2021, J CLIN EPIDEMIOL, V131, P113, DOI 10.1016/j.jclinepi.2020.11.017; Jialal I, 2007, CURR OPIN LIPIDOL, V18, P610, DOI 10.1097/MOL.0b013e3282efa566; Kim JM, 2016, DIABETES METAB J, V40, P70, DOI 10.4093/dmj.2016.40.1.70; Kim JH, 2013, ATHEROSCLEROSIS, V227, P355, DOI 10.1016/j.atherosclerosis.2013.01.045; Kip KE, 2008, J AM COLL CARDIOL, V51, P701, DOI 10.1016/j.jacc.2007.10.034; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Koh KK, 2008, DIABETES CARE, V31, P776, DOI 10.2337/dc07-2199; Koh KK, 2016, INT J CARDIOL, V223, P488, DOI 10.1016/j.ijcard.2016.08.051; Koh KK, 2009, ATHEROSCLEROSIS, V204, P483, DOI 10.1016/j.atherosclerosis.2008.09.021; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawrence JM, 2004, ATHEROSCLEROSIS, V174, P141, DOI 10.1016/j.atherosclerosis.2004.01.016; Lewin AJ, 2004, CLIN THER, V26, P379, DOI 10.1016/S0149-2918(04)90033-1; Liu PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076298; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Miller M, 2004, CURR MED RES OPIN, V20, P1087, DOI 10.1185/030079904125004105; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; Mori H, 2013, DIABETOL INT, V4, P117, DOI 10.1007/s13340-012-0103-x; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; National Institute for Health and Care Excellence,, 2021, CKS LIP MOD CVD PREV; National Institute for Health and Care Excellence (NICE), 2016, NICE GUID CARD DIS R; Nikolakopoulou A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003082; Office of National Statistics, ETHN GROUP NAT ID RE; PAOLISSO G, 1991, EUR J CLIN PHARMACOL, V40, P27, DOI 10.1007/BF00315135; Papakonstantinou T, 2020, CAMPBELL SYST REV, V16, DOI 10.1002/cl2.1080; Pedder Hugo, MBNMADOSE DOSE RESPO; Reiter-Brennan C, 2020, CLEV CLIN J MED, V87, P231, DOI 10.3949/ccjm.87a.19078; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schneider JG, 2004, ATHEROSCLEROSIS, V175, P325, DOI 10.1016/j.atherosclerosis.2004.04.003; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sever PS, 2005, AM J CARDIOL, V96, p39F, DOI 10.1016/j.amjcard.2005.06.025; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Sharma A, 2020, CIRCULATION, V141, P843, DOI 10.1161/CIRCULATIONAHA.119.041022; Sindhu S, 2011, J PHARMACOL PHARMACO, V2, P261, DOI 10.4103/0976-500X.85954; Son JW, 2013, J DIABETES INVEST, V4, P466, DOI 10.1111/jdi.12074; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Tekin A, 2008, CORONARY ARTERY DIS, V19, P513, DOI 10.1097/MCA.0b013e32830d27d2; Tekin A, 2008, PHARMACOL RES, V57, P393, DOI 10.1016/j.phrs.2008.04.001; Thongtang N, 2020, DIABET METAB SYND OB, V13, P423, DOI 10.2147/DMSO.S219496; Thorlund K, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-41; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; van Valkenhoef G, 2012, STAT COMPUT, V22, P1099, DOI 10.1007/s11222-011-9281-9; Visseren FLJ, 2001, CLIN DRUG INVEST, V21, P671, DOI 10.2165/00044011-200121100-00001; Winkler K, 2002, J CLIN ENDOCR METAB, V87, P5485, DOI 10.1210/jc.2002-020370; Wolffenbuttel BHR, 2005, J INTERN MED, V257, P531, DOI 10.1111/j.1365-2796.2005.01499.x; Wright AK, 2020, DIABETOLOGIA, V63, P1542, DOI 10.1007/s00125-020-05169-6; Xu Kai, 2007, Exp Clin Cardiol, V12, P48; ZHANG A, 1995, DIABETES RES CLIN PR, V29, P189, DOI 10.1016/0168-8227(95)01138-2; Zhang XD, 2020, CARDIOVASC THER, V2020, DOI 10.1155/2020/3987065	94	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								e067731	10.1136/bmj-2021-067731	http://dx.doi.org/10.1136/bmj-2021-067731			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331984	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000778460100003
J	Mahase, E				Mahase, Elisabeth			Covid-19: What do we know about the delta omicron recombinant variant?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item								How does a recombinant emerge? Recombinants can emerge when multiple variants infect the same person at the same time, allowing the variants to interact during replication, mix up their genetic material, and form new combinations. These events become more likely when cases are higher-an important consideration, as covid-19 cases worldwide have once again started to rise after several weeks of decline.2 covid-19 technical lead, said in a post on social media,3 "[This is] what happens when we allow the virus to circulate at such an intense level. The virus continues to evolve and more variants are expected. Recombinants are also expected . .. as we have been explaining for a very long time." She emphasised that vaccines alone could not be used to control the SARS-CoV-2 pandemic but that other measures were also needed, while testing and sequencing around the world were vital. What do we know about "deltacron"? So far, very little. The literature on deltacron is sparse, although a perspective published by the Chinese Center for Disease Control and Prevention has provided some insight.4 The researchers have reported that the recombinant is very similar to the delta (AY.4) variant except when it comes to the region encoding the spike gene, which is similar to BA.1. Of the 36 amino acid mutations found in the spike protein, 27 were found in BA.1 and five in AY.4, while four were found in both.										Bolze A., 2022, MEDRXIV, V2022, DOI [10.1101/2022.03.09.22272113, DOI 10.1101/2022.03.09.22272113]; Mahase E., BMJ, V376, po738; Robert Koch Institute, 2022, CORONAVIRUS SARS COV; Van Kerkhove M, TWITTER; Wang L., 2022, CHINA CDC WEEKLY	5	7	7	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o792	10.1136/bmj.o792	http://dx.doi.org/10.1136/bmj.o792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331986	Bronze			2022-12-28	WOS:000778460100018
J	Yates, K				Yates, Kit			Was lockdown necessary?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yates, Kit] Univ Bath, Dept Math Sci, Bath, Avon, England	University of Bath	Yates, K (corresponding author), Univ Bath, Dept Math Sci, Bath, Avon, England.		Yates, Christian/A-8863-2014	Yates, Christian/0000-0003-0461-7297				[Anonymous], 2020, BBC NEWS 0610; [Anonymous], 2022, PREV ONG SYMPT FOLL; [Anonymous], 2016, REPORT EC; [Anonymous], 2020, PRIM MIN STAT COR CO; [Anonymous], CORONAVIRUS COVID19; Elliott L, 2021, GUARDIAN 0322; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fetzer T, 2022, 607 CAGE; Hasell J., 2020, OUR WORLD DATA; Jones G., REUTERS; Orange R, 2022, TELEGRAPH; Quinn B, 2020, GUARDIAN 0830; SAGE, 2020, UK GOV MESS ITS ASS; Siddique H., 2021, GUARDIAN 0602; The Independent Scientific Advisory Group for Emergencies (SAGE), 2020, STAT MAN NHS TEST TR; Tondo L., 2020, GUARDIAN 0309; Triggle N, 2022, BBC NEWS 0310; Yates K., 2021, HUFFINGTON POST	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o776	10.1136/bmj.o776	http://dx.doi.org/10.1136/bmj.o776			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321862	Bronze			2022-12-28	WOS:000790072700014
J	Suran, M				Suran, Melissa			Melanoma Immunotherapy Responses to Dietary Fiber and Probiotics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1117	1117		10.1001/jama.2022.3708	http://dx.doi.org/10.1001/jama.2022.3708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315903				2022-12-28	WOS:000775589900007
J	Razai, MS; Playdon, Z				Razai, Mohammad S.; Playdon, Zoe			What is wrong with playing doctor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Razai, Mohammad S.] St Georges Univ London, London, England; [Playdon, Zoe] Birkbeck Univ London, London, England	St Georges University London; University of London; Birkbeck University London	Razai, MS (corresponding author), St Georges Univ London, London, England.			Razai, Mohammad Sharif/0000-0002-6671-5557				[Anonymous], 2022, THIS IS GOING HURT B; Cronin AJ., 2013, CITADEL PAN MACMILLA; Kay A., 2017, THIS IS GOING HURT S; Lowe V, 2007, FILM HIST, V19, P73, DOI 10.2979/FIL.2007.19.1.73; Sontag Susan., 1977, PHOTOGRAPHY; Turow J, 2010, PLAYING DOCTOR: TELEVISION, STORYTELLING, AND MEDICAL POWER, P1, DOI 10.3998/mpub.354930	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o739	10.1136/bmj.o739	http://dx.doi.org/10.1136/bmj.o739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304869	Bronze			2022-12-28	WOS:000773507900014
J	Kuehn, BM				Kuehn, Bridget M.			Medical Groups Defend Patient-Physician Relationship and Access to Adolescent Gender-Affirming Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1432	1433						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35353160				2022-12-28	WOS:000793035800009
J	Tollefson, J; Kozlov, M; Maxmen, A; Witze, A				Tollefson, Jeff; Kozlov, Max; Maxmen, Amy; Witze, Alexandra			BIDEN BIDS AGAIN TO BOOST SCIENCE SPENDING - BUT FACES LONG ODDS	NATURE			English	News Item						Funding; Government; Policy; SARS-CoV-2; Climate change		But the president faces a divided Congress, which might not go along with the plan.											0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					18	19		10.1038/d41586-022-00897-8	http://dx.doi.org/10.1038/d41586-022-00897-8			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7XK	35347311	Bronze			2022-12-28	WOS:000781003700011
J	Auron, M				Auron, Moises			PICC vs. midline catheter use for short-term indications was linked to major complications at <= 30 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Auron, Moises] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Auron, M (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.				Blue Cross Blue Shield of Michigan; Blue Care Network	Blue Cross Blue Shield of Michigan; Blue Care Network	Blue Cross Blue Shield of Michigan and Blue Care Network.	Bahl A, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619839150; Tripathi S, 2021, CRIT CARE MED, V49, pE140, DOI 10.1097/CCM.0000000000004764	2	0	0	5	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC47	JC47		10.7326/J22-0015	http://dx.doi.org/10.7326/J22-0015		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377721				2022-12-28	WOS:000799170800015
J	Carpenter, CR; Steel, PAD				Carpenter, Christopher R.; Steel, Peter A. D.			In severe COVID-19, high-flow vs. conventional oxygen therapy reduced intubation and time to clinical recovery at 28 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NASAL CANNULA		[Carpenter, Christopher R.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Steel, Peter A. D.] New York Presbyterian Hosp Weill Cornell, New York, NY USA	Washington University (WUSTL); NewYork-Presbyterian Hospital	Carpenter, CR (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.				Centro de Investigaciones Clinicas, Colombia	Centro de Investigaciones Clinicas, Colombia	Centro de Investigaciones Clinicas, Colombia.	Li J, 2020, RESP CARE, V65, P545, DOI 10.4187/respcare.07663; Long B, 2021, AM J EMERG MED, V49, P352, DOI 10.1016/j.ajem.2021.06.074; Rochwerg B, 2019, INTENS CARE MED, V45, P563, DOI 10.1007/s00134-019-05590-5	3	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					E1	E1		10.7326/J22-0011	http://dx.doi.org/10.7326/J22-0011		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377724				2022-12-28	WOS:000799170800002
J	Zarocostas, J				Zarocostas, John			Mixed response to COVID-19 intellectual property waiver	LANCET			English	Editorial Material								The global health community says the draft outcome-between the EU, the USA, India, and South Africa-falls short of expectations. John Zarocostas reports from Geneva.											0	3	3	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1292	1293						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35366998	Green Published, Bronze			2022-12-28	WOS:000812828300013
J	Maurice, S; Chide, B; Murdoch, N; Lorenz, RD; Mimoun, D; Wiens, RC; Stott, A; Jacob, X; Bertrand, T; Montmessin, F; Lanza, NL; Alvarez-Llamas, C; Angel, SM; Aung, M; Balaram, J; Beyssac, O; Cousin, A; Delory, G; Forni, O; Fouchet, T; Gasnault, O; Grip, H; Hecht, M; Hoffman, J; Laserna, J; Lasue, J; Maki, J; McClean, J; Meslin, PY; Le Mouelic, S; Munguira, A; Newman, CE; Manfredi, JAR; Moros, J; Ollila, A; Pilleri, P; Schroder, S; Juarez, MD; Tzanetos, T; Stack, KM; Farley, K; Williford, K				Maurice, S.; Chide, B.; Murdoch, N.; Lorenz, R. D.; Mimoun, D.; Wiens, R. C.; Stott, A.; Jacob, X.; Bertrand, T.; Montmessin, F.; Lanza, N. L.; Alvarez-Llamas, C.; Angel, S. M.; Aung, M.; Balaram, J.; Beyssac, O.; Cousin, A.; Delory, G.; Forni, O.; Fouchet, T.; Gasnault, O.; Grip, H.; Hecht, M.; Hoffman, J.; Laserna, J.; Lasue, J.; Maki, J.; McClean, J.; Meslin, P. -y.; Le Mouelic, S.; Munguira, A.; Newman, C. E.; Rodriguez Manfredi, J. A.; Moros, J.; Ollila, A.; Pilleri, P.; Schroder, S.; de la Torre Juarez, M.; Tzanetos, T.; Stack, K. M.; Farley, K.; Williford, K.		SuperCam Team	In situ recording of Mars soundscape	NATURE			English	Article							ATMOSPHERE; SURFACE; PROPAGATION; ABSORPTION; ACOUSTICS	Before the Perseverance rover landing, the acoustic environment of Mars was unknown. Models predicted that: (1) atmospheric turbulence changes at centimetre scales or smaller at the point where molecular viscosity converts kinetic energy into heat(1), (2) the speed of sound varies at the surface with frequency(2,3) and (3) high-frequency waves are strongly attenuated with distance in CO2 (refs. (2-4)). However, theoretical models were uncertain because of a lack of experimental data at low pressure and the difficulty to characterize turbulence or attenuation in a closed environment. Here, using Perseverance microphone recordings, we present the first characterization of the acoustic environment on Mars and pressure fluctuations in the audible range and beyond, from 20 Hz to 50 kHz. We find that atmospheric sounds extend measurements of pressure variations down to 1,000 times smaller scales than ever observed before, showing a dissipative regime extending over five orders of magnitude in energy. Using point sources of sound (Ingenuity rotorcraft, laser-induced sparks), we highlight two distinct values for the speed of sound that are about 10 m s(-1) apart below and above 240 Hz, a unique characteristic of low-pressure CO2-dominated atmosphere. We also provide the acoustic attenuation with distance above 2 kHz, allowing us to explain the large contribution of the CO2 vibrational relaxation in the audible range. These results establish a ground truth for the modelling of acoustic processes, which is critical for studies in atmospheres such as those of Mars and Venus.	[Maurice, S.; Cousin, A.; Forni, O.; Gasnault, O.; Lasue, J.; Meslin, P. -y.; Pilleri, P.] Univ Toulouse 3 Paul Sabatier, CNRS, Inst Rech Astrophys & Planetol, CNES, Toulouse, France; [Chide, B.; Wiens, R. C.; Lanza, N. L.; Ollila, A.] Los Alamos Natl Lab, Space & Planetary Explorat Team, Los Alamos, NM 87545 USA; [Murdoch, N.; Mimoun, D.; Stott, A.] Univ Toulouse, Inst Super Aeronaut & Espace ISAE SUPAERO, Toulouse, France; [Lorenz, R. D.] Johns Hopkins Appl Phys Lab, Space Explorat Sect, Laurel, MD USA; [Wiens, R. C.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Jacob, X.] Univ Toulouse 3 Paul Sabatier, CNRS, Inst Mecan Fluides, INP, Toulouse, France; [Bertrand, T.; Fouchet, T.] Univ Paris Diderot, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris, CNRS,Sorbonne Univ, Meudon, France; [Montmessin, F.] Sorbonne Univ, Univ St Quentin En Yvelines, CNRS, Lab Atmospheres Milieux,Observ Spatiales, Guyancourt, France; [Alvarez-Llamas, C.; Laserna, J.; Moros, J.] Univ Malaga, Malaga, Spain; [Angel, S. M.] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Aung, M.; Balaram, J.; Grip, H.; Maki, J.; de la Torre Juarez, M.; Tzanetos, T.; Stack, K. M.; Farley, K.; Williford, K.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Beyssac, O.] Sorbonne Univ, MNHN, CNRS, Inst Mineral Phys Mat & Cosmochim, Paris, France; [Delory, G.] Heliospace Corp, Berkeley, CA USA; [Hecht, M.; McClean, J.] MIT, Haystack Observ, Westford, MA 01886 USA; [Hoffman, J.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Le Mouelic, S.] Univ Angers, Nantes Univ, CNRS, Lab Planetol & Geosci, Nantes, France; [Munguira, A.] Univ Pais Vasco UPV EHU, Escuela Ingn Bilbao, Bilbao, Spain; [Newman, C. E.] Aeolis Corp, Sierra Madre, CA USA; [Rodriguez Manfredi, J. A.] Ctr Astrobiol INTA CSIC, Madrid, Spain; [Schroder, S.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Opt Sensor Syst, Berlin, Germany; [Williford, K.] Blue Marble Space Inst Sci, Seattle, WA USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; United States Department of Energy (DOE); Los Alamos National Laboratory; Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Universidad de Malaga; University of South Carolina System; University of South Carolina Columbia; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Universite d'Angers; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Helmholtz Association; German Aerospace Centre (DLR)	Maurice, S (corresponding author), Univ Toulouse 3 Paul Sabatier, CNRS, Inst Rech Astrophys & Planetol, CNES, Toulouse, France.; Chide, B (corresponding author), Los Alamos Natl Lab, Space & Planetary Explorat Team, Los Alamos, NM 87545 USA.	sylvestre.maurice@irap.omp.eu; bchide@lanl.gov	Rodriguez-Manfredi, Jose/L-8001-2014; Castro, Kepa/A-8336-2017; MIMOUN, DAVID/HHM-9197-2022; Alvarez-Llamas, Cesar/H-9821-2016; Frydenvang, Jens/D-4781-2013; IMPMC, ROCKS @/U-8478-2017; FABRE, Cécile/B-5827-2012; Castro, Kepa/AAI-7842-2020; Chide, Baptiste/AAJ-1843-2020; Murdoch, Naomi/AAD-7502-2021; Jacob, Xavier/M-9625-2016; Lorenz, Ralph/B-8759-2016; Wiens, Roger/S-3078-2017	Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Castro, Kepa/0000-0002-9931-7889; MIMOUN, DAVID/0000-0002-3427-2974; Alvarez-Llamas, Cesar/0000-0001-7793-7000; Frydenvang, Jens/0000-0001-9294-1227; FABRE, Cécile/0000-0001-8627-4050; Castro, Kepa/0000-0002-9931-7889; Chide, Baptiste/0000-0002-5124-9119; Murdoch, Naomi/0000-0002-9701-4075; Mandon, Lucia/0000-0002-9310-0742; Manrique, Jose Antonio/0000-0002-2053-2819; udry, Stephane/0000-0001-7576-6236; Knutsen, Elise Wright/0000-0002-7702-2844; Pilleri, Paolo/0000-0003-4861-0476; Jacob, Xavier/0000-0001-6718-4981; Lorenz, Ralph/0000-0001-8528-4644; Rapin, William/0000-0003-4660-8006; Wiens, Roger/0000-0002-3409-7344; Munguira, Asier/0000-0002-1677-6327; Gibbons, Erin/0000-0002-4789-4772	NASA's Mars Exploration Program;  [PID2019-109467GB-I00];  [MCIN/AEI/10.13039/501100011033]	NASA's Mars Exploration Program; ; 	Many people helped with this project in addition to the co-authors, including hardware and operation teams, and we are most grateful for their support. This project was supported in the USA by NASA's Mars Exploration Program and in France is conducted under the authority of CNES. The work of A. Munguira is supported by grant PID2019-109467GB-I00 funded by MCIN/AEI/10.13039/501100011033.	Balaram J, 2021, SPACE SCI REV, V217, DOI 10.1007/s11214-021-00815-w; Banfield D, 2019, SPACE SCI REV, V215, DOI 10.1007/s11214-018-0570-x; Banfield D, 2020, NAT GEOSCI, V13, P190, DOI 10.1038/s41561-020-0534-0; Bass H., 1984, PHYS ACOUSTICS PRINC, V17; Bass HE, 2001, J ACOUST SOC AM, V109, P3069, DOI 10.1121/1.1365424; Bass HE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007806; Berengier MC, 2003, ACTA ACUST UNITED AC, V89, P980; Chatain A, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2021GL095453; Chen W, 2016, J GEOPHYS RES-ATMOS, V121, P11968, DOI 10.1002/2016JD025211; Chiba R, 2017, PHYS PLASMAS, V24, DOI 10.1063/1.4986085; Chide B, 2020, SPECTROCHIM ACTA B, V174, DOI 10.1016/j.sab.2020.106000; Chide B, 2021, ICARUS, V354, DOI 10.1016/j.icarus.2020.114060; Colaitis A, 2013, J GEOPHYS RES-PLANET, V118, P1468, DOI 10.1002/jgre.20104; Delory G.T., 2007, J ACOUST SOC AM, V121, P3116, DOI [10.1121/1.4782072, DOI 10.1121/1.4782072]; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Garcia R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023558; Garcia RF, 2017, SPACE SCI REV, V211, P547, DOI 10.1007/s11214-016-0324-6; Hanford AD, 2009, J ACOUST SOC AM, V125, P640, DOI 10.1121/1.3050279; Hecht M, 2021, SPACE SCI REV, V217, DOI 10.1007/s11214-020-00782-8; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Larsen SE, 2002, BOUND-LAY METEOROL, V105, P451, DOI 10.1023/A:1020338016753; Maki JN, 2020, SPACE SCI REV, V216, DOI 10.1007/s11214-020-00765-9; Manrique JA, 2020, SPACE SCI REV, V216, DOI 10.1007/s11214-020-00764-w; Martinez GM, 2017, SPACE SCI REV, V212, P295, DOI 10.1007/s11214-017-0360-x; Maurice S, 2021, SPACE SCI REV, V217, DOI 10.1007/s11214-021-00807-w; Millour E., 2018, TECHNICAL PAPER SERI, V2; MORGAN S, 1992, J ACOUST SOC AM, V92, P1180, DOI 10.1121/1.404049; Murdoch N, 2019, PLANET SPACE SCI, V165, P260, DOI 10.1016/j.pss.2018.09.009; NASA, MARS DESC IM MARDI; Noble J. M., 1995, ARLTR565; Ostashev V. E., 2002, SOUND FLOW INTERACTI; Petculescu A, 2007, ICARUS, V186, P413, DOI 10.1016/j.icarus.2006.09.014; Petrosyan A, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000351; Qin Q, 2004, APPL ACOUST, V65, P325, DOI 10.1016/j.apacoust.2003.11.003; Rodriguez-Manfredi JA, 2021, SPACE SCI REV, V217, DOI 10.1007/s11214-021-00816-9; Russo RE, 2006, LASER-INDUCED BREAKDOWN SPECTROSCOPY (LIBS): FUNDAMENTALS AND APPLICATIONS, pXV; Savijarvi H., 1991, Contributions to Atmospheric Physics, V64, P219; Seel F., 2021, THESIS TU BERLIN; Spiga A, 2021, J GEOPHYS RES-PLANET, V126, DOI 10.1029/2020JE006511; Sutherland LC, 2004, J ACOUST SOC AM, V115, P1012, DOI 10.1121/1.1631937; TCHEN CM, 1953, J RES NAT BUR STAND, V50, P51, DOI 10.6028/jres.050.009; Temel O, 2021, ATMOS RES, V250, DOI 10.1016/j.atmosres.2020.105381; TILLMAN JE, 1994, J ATMOS SCI, V51, P1709, DOI 10.1175/1520-0469(1994)051<1709:TBLOMF>2.0.CO;2; Ullan A, 2017, ICARUS, V288, P78, DOI 10.1016/j.icarus.2017.01.020; Wiens RC, 2021, SPACE SCI REV, V217, DOI 10.1007/s11214-020-00777-5; Williams JP, 2001, J GEOPHYS RES-PLANET, V106, P5033, DOI 10.1029/1999JE001174; Zhang XQ, 2020, MEAS SCI TECHNOL, V31, DOI 10.1088/1361-6501/ab9375	47	7	7	19	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 26	2022	605	7911					653	+		10.1038/s41586-022-04679-0	http://dx.doi.org/10.1038/s41586-022-04679-0		APR 2022	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P5ES	35364602	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000797332200001
J	Sibley, M				Sibley, Miles			Ockenden report: the refusal of our healthcare service to take patient experience seriously	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Sibley, Miles/0000-0002-9320-3477				[Anonymous], 2018, INQ HYP REL DEATHS; Broderick C, 2019, LISTENING WOMEN FAMI; Cumberlege J., 2020, REPORT INDEPENDENT M; Francis R., 2013, REPORT MID STAFFORDS; Gosport War Memorial Hospital, 2018, REPORT GOSPORT INDEP; Kirkup B., 2015, REPORT MORECAMBE BAY; Ockenden D., 2022, FINDINGS CONCLUSIONS	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o875	10.1136/bmj.o875	http://dx.doi.org/10.1136/bmj.o875			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365462	Bronze			2022-12-28	WOS:000783141700016
J	Li, H; Burgie, ES; Gannam, ZTK; Li, HL; Vierstra, RD				Li, Hua; Burgie, E. Sethe; Gannam, Zachary T. K.; Li, Huilin; Vierstra, Richard D.			Plant phytochrome B is an asymmetric dimer with unique signalling potential	NATURE			English	Article							HISTIDINE KINASE; CRYSTAL-STRUCTURE; LIGHT; MODULE; DOMAIN; MECHANISM	Many aspects of plant photoperception are mediated by the phytochrome (Phy) family of bilin-containing photoreceptors that reversibly interconvert between inactive Pr and active Pfr conformers(1,2). Despite extensive biochemical studies, full understanding of plant Phy signalling has remained unclear due to the absence of relevant 3D models. Here we report a cryo-electron microscopy structure of Arabidopsis PhyB in the Pr state that reveals a topologically complex dimeric organization that is substantially distinct from its prokaryotic relatives. Instead of an anticipated parallel architecture, the C-terminal histidine-kinase-related domains (HKRDs) associate head-to-head, whereas the N-terminal photosensory regions associate head-to-tail to form a parallelogram-shaped platform with near two-fold symmetry. The platform is internally linked by the second of two internal Per/Arnt/Sim domains that binds to the photosensory module of the opposing protomer and a preceding 'modulator' loop that assembles tightly with the photosensory module of its own protomer. Both connections accelerate the thermal reversion of Pfr back to Pr, consistent with an inverse relationship between dimer assembly and Pfr stability. Lopsided contacts between the HKRDs and the platform create profound asymmetry to PhyB that might imbue distinct signalling potentials to the protomers. We propose that this unique structural dynamism creates an extensive photostate-sensitive surface for conformation-dependent interactions between plant Phy photoreceptors and their signalling partners.	[Li, Hua; Li, Huilin] Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA; [Burgie, E. Sethe; Gannam, Zachary T. K.; Vierstra, Richard D.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Van Andel Institute; Washington University (WUSTL)	Li, HL (corresponding author), Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA.; Vierstra, RD (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	Huilin.Li@vai.org; rdvierstra@wustl.edu		Vierstra, Richard/0000-0003-0210-3516; Li, Huilin/0000-0001-8085-8928	US National Institutes of Health [GM127892, GM131754]; Van Andel Institute; Washington University in St Louis	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Institute; Washington University in St Louis	Cryo-EM data were collected using the Titan Krios system at the David Van Andel Cryo-Electron Microscopy Suite at the Van Andel Institute. We thank G. Zhao and X. Meng for help with data collection; J. Zhang for the mass spectrometry analysis; H. Zaher for help with the kinase assays; and C. Sherman and K. McLoughlin for technical assistance. This work was funded by the US National Institutes of Health R01 grants GM127892 (to R.D.V.) and GM131754 (to Huilin Li), and funds provided by the Van Andel Institute (to Huilin Li) and Washington University in St Louis (to R.D.V.).	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Boylan MT, 1996, PROTOPLASMA, V195, P12, DOI 10.1007/BF01279182; Buckley CE, 2016, DEV CELL, V36, P117, DOI 10.1016/j.devcel.2015.12.011; Burgie ES, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2105649118, 10.1073/pnas.21056491181]; Burgie ES, 2020, P NATL ACAD SCI USA, V117, P300, DOI 10.1073/pnas.1912041116; Burgie ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14037-0; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Cai YF, 2017, ACTA CRYSTALLOGR D, V73, P793, DOI 10.1107/S2059798317013043; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chernov KG, 2017, CHEM REV, V117, P6423, DOI 10.1021/acs.chemrev.6b00700; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Elich TD, 1997, CELL, V91, P713, DOI 10.1016/S0092-8674(00)80458-4; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Etzl S, 2018, J BIOL CHEM, V293, P9078, DOI 10.1074/jbc.RA118.003069; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Isaksson L, 2021, STRUCTURE, V29, P151, DOI 10.1016/j.str.2020.08.009; JONES AM, 1985, PLANTA, V164, P501, DOI 10.1007/BF00395966; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; Kikis EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000352; Klose C, 2020, MOL PLANT, V13, P386, DOI 10.1016/j.molp.2019.12.004; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2015.90, 10.1038/NPLANTS.2015.90]; Krall L, 2000, P NATL ACAD SCI USA, V97, P8169, DOI 10.1073/pnas.140520097; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Legris M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13045-0; Legris M, 2016, SCIENCE, V354, P897, DOI 10.1126/science.aaf5656; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li FW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8852; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Nagano S, 2020, NAT PLANTS, V6, DOI 10.1038/s41477-020-0638-y; Ni WM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15236; Ni WM, 2014, SCIENCE, V344, P1160, DOI 10.1126/science.1250778; Rensing SA, 2016, TRENDS PLANT SCI, V21, P543, DOI 10.1016/j.tplants.2016.05.009; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2020, NEW PHYTOL, V225, P2283, DOI 10.1111/nph.16240; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shin AY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11545; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	49	4	4	12	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					127	+		10.1038/s41586-022-04529-z	http://dx.doi.org/10.1038/s41586-022-04529-z		MAR 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355010				2022-12-28	WOS:000776020400013
J	Shapira, T; Monreal, IA; Dion, SP; Buchholz, DW; Imbiakha, B; Olmstead, AD; Jager, M; Desilets, A; Gao, G; Martins, M; Vandal, T; Thompson, CAH; Chin, A; Rees, WD; Steiner, T; Nabi, IR; Marsault, E; Sahler, J; Diel, DG; Van de Walle, GR; August, A; Whittaker, GR; Boudreault, PL; Leduc, R; Aguilar, HC; Jean, F				Shapira, Tirosh; Monreal, I. Abrrey; Dion, Sebastien P.; Buchholz, David W.; Imbiakha, Brian; Olmstead, Andrea D.; Jager, Mason; Desilets, Antoine; Gao, Guang; Martins, Mathias; Vandal, Thierry; Thompson, Connor A. H.; Chin, Aaleigha; Rees, William D.; Steiner, Theodore; Nabi, Ivan Robert; Marsault, Eric; Sahler, Julie; Diel, Diego G.; Van de Walle, Gerlinde R.; August, Avery; Whittaker, Gary R.; Boudreault, Pierre-Luc; Leduc, Richard; Aguilar, Hector C.; Jean, Francois			A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic	NATURE			English	Article							SARS-COV-2; MATRIPTASE; INFLUENZA; INFECTION; PROTEASES; EFFICACY; PROTEIN; POTENT; VIRUS	The COVID-19 pandemic caused by the SARS-CoV-2 virus remains a global public health crisis. Although widespread vaccination campaigns are underway, their efficacy is reduced owing to emerging variants of concern(1,2). Development of host-directed therapeutics and prophylactics could limit such resistance and offer urgently needed protection against variants of concern(3,4). Attractive pharmacological targets to impede viral entry include type-II transmembrane serine proteases (TTSPs) such as TMPRSS2; these proteases cleave the viral spike protein to expose the fusion peptide for cell entry, and thus have an essential role in the virus lifecycle(5,6). Here we identify and characterize a small-molecule compound, N-0385, which exhibits low nanomolar potency and a selectivity index of higher than 10(6) in inhibiting SARS-CoV-2 infection in human lung cells and in donor-derived colonoids(7). In Calu-3 cells it inhibits the entry of the SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta). Notably, in the K18-human ACE2 transgenic mouse model of severe COVID-19, we found that N-0385 affords a high level of prophylactic and therapeutic benefit after multiple administrations or even after a single administration. Together, our findings show that TTSP-mediated proteolytic maturation of the spike protein is critical for SARS-CoV-2 infection in vivo, and suggest that N-0385 provides an effective early treatment option against COVID-19 and emerging SARS-CoV-2 variants of concern.	[Shapira, Tirosh; Olmstead, Andrea D.; Gao, Guang; Thompson, Connor A. H.; Chin, Aaleigha; Jean, Francois] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Monreal, I. Abrrey; Buchholz, David W.; Imbiakha, Brian; Jager, Mason; Sahler, Julie; Van de Walle, Gerlinde R.; August, Avery; Whittaker, Gary R.; Aguilar, Hector C.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Dion, Sebastien P.; Desilets, Antoine; Vandal, Thierry; Marsault, Eric; Boudreault, Pierre-Luc; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Inst Pharmacol Sherbrooke, Dept Pharmacol Physiol, Sherbrooke, PQ, Canada; [Gao, Guang; Nabi, Ivan Robert] Univ British Columbia, Life Sci Inst, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Martins, Mathias; Diel, Diego G.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Rees, William D.; Steiner, Theodore] Univ British Columbia, BC Childrens Hosp, Res Inst, Dept Med, Vancouver, BC, Canada	University of British Columbia; Cornell University; University of Sherbrooke; University of British Columbia; Cornell University; BC Childrens Hospital; University of British Columbia	Jean, F (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Aguilar, HC (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.; Leduc, R (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Inst Pharmacol Sherbrooke, Dept Pharmacol Physiol, Sherbrooke, PQ, Canada.	richard.leduc@usherbrooke.ca; ha363@cornerll.edu; fjean@mail.ubc.ca	Nabi, Ivan/GWZ-5144-2022; Martins, Mathias/M-7284-2016	Nabi, Ivan/0000-0002-0670-0513; Steiner, Ted/0000-0002-3136-6668; Jager, Mason/0000-0001-6036-9895; Shapira, Tirosh/0000-0002-9790-4860; Martins, Mathias/0000-0002-8290-5756; Desilets, Antoine/0000-0001-5081-5564; Monreal, Isaac/0000-0003-0521-9063	CL-3 facility (Facility for Infectious Disease and Epidemic Research (FINDER) of the Life Sciences Institute of the University of British Columbia; Canadian Foundation of Innovation; BC Knowledge Development Fund; Strategic Investment Fund (Faculty of Medicine, University of British Columbia); Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding program of the Canadian Institutes of Health Research (CIHR) [UBR 322812, VR3-172639, OV3-170342]; Genome British Columbia/COVID-19 Rapid Response Funding Initiative [COV011]; Coronavirus Variants Rapid Response Network (CoVaRR-Net) [175622]; Cornell University Seed Grant; Cornell University start-up funds; George Mason University; Mercatus Center; Emergent Ventures-Fast Grant; National Institutes of Health [R01AI35270]; MITACS Accelerate Fellowship [IT18555]; NIH [T32EB023860, R25GM125597, AI138570]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Award [167018]; PROTEO graduate scholarship; MITACS Inc. [IT18585]	CL-3 facility (Facility for Infectious Disease and Epidemic Research (FINDER) of the Life Sciences Institute of the University of British Columbia; Canadian Foundation of Innovation(Canada Foundation for Innovation); BC Knowledge Development Fund(General Electric); Strategic Investment Fund (Faculty of Medicine, University of British Columbia); Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding program of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome British Columbia/COVID-19 Rapid Response Funding Initiative; Coronavirus Variants Rapid Response Network (CoVaRR-Net); Cornell University Seed Grant; Cornell University start-up funds; George Mason University; Mercatus Center; Emergent Ventures-Fast Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MITACS Accelerate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Award(Canadian Institutes of Health Research (CIHR)); PROTEO graduate scholarship; MITACS Inc.	We acknowledge the support of the CL-3 facility (Facility for Infectious Disease and Epidemic Research (FINDER) of the Life Sciences Institute of the University of British Columbia, which was founded by F.J.; and its biosafety support staff, including B. Ahidjo and T. Dean Airey. We thank the LSI imaging facility of the Life Sciences Institute of the University of British Columbia, funded by the Canadian Foundation of Innovation and BC Knowledge Development Fund, as well as a Strategic Investment Fund (Faculty of Medicine, University of British Columbia). We also thank A. Ball for supplying the SARS-CoV-2 (COVID-19) nucleocapsid antibody (HL344) (GTX635679); S. Mubareka for providing the original SARS-CoV-2 strain (SARS-COV-2/Canada/VIDO-01/2020); and M. Petric, S. Kaweski, P. Levett and M. Krajden for isolating and providing the SARS-CoV-2 VOCs (B.1.1.7, B.1.351, P.1 and B.1.617.2). We acknowledge a donation towards the purchase of the CellInsight CX7 HCS system provided by the Vancouver General Hospital Foundation to F.J. We thank N. Durso for CX7 expertise and support; the Cornell BSL-3, animal and biosafety support staff and members of the laboratory of A.A. for their support in setting up the animal studies, including but not limited to A. L. Redko, N. Kushner, P. Jennette, J. Turse, B. Singh, D. Miller, D. G. Collins and T. L. Van Deusen; NEOMED/adMare in the early phases of developing host-based antivirals; E. Tan for help growing and preparing cells for plaque assays; E. Colombo and B. Plancq for the synthesis of some intermediates, analogues and warhead; J. Kelly for proofreading the manuscript; N. Zachos from John Hopkins University for providing human colonoids; and the patients who donated these samples for research. We recognize the help of the RNomics Platform of the Universite de Sherbrooke. We dedicate this work to the memory of Professor Eric Marsault67. This work was supported by operating grants from the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding program of the Canadian Institutes of Health Research (CIHR) (UBR 322812; VR3-172639 (R.L., P.L.B. and F.J.) and OV3-170342 (F.J.)); by a Genome British Columbia/COVID-19 Rapid Response Funding Initiative (COV011 (F.J.)); by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) (175622 (F.J. and A.D.O.)); by a Cornell University Seed Grant, Cornell University start-up funds and a George Mason University, Mercatus Center; Emergent Ventures-Fast Grant (H.A.C.); by a National Institutes of Health research grant (R01AI35270 (G.W.)); by a MITACS Accelerate Fellowship (IT18555 (W.R.)); an NIH training grant (T32EB023860 (A.A. to support D.W.B.) and R25GM125597 (A.A. to support B.I.)); by an NIH R01 (AI138570 (A.A.)); by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Award (167018 (S.P.D.)); by a PROTEO graduate scholarship (T.V.); and by a MITACS Inc. Accelerate fellowship COVID-19 Award (IT18585 (T.S.)).	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Beliveau F, 2019, CELL CHEM BIOL, V26, P1559, DOI 10.1016/j.chembiol.2019.09.004; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Beumer J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25729-7; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Caceres CJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89013-w; Callaway E, 2021, NATURE, V600, P204, DOI 10.1038/d41586-021-03619-8; Chitalia VC, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02476-9; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Dampalla CS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101555118; de Vries RD, 2021, SCIENCE, V371, P1379, DOI 10.1126/science.abf4896; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Erdo F, 2018, BRAIN RES BULL, V143, P155, DOI 10.1016/j.brainresbull.2018.10.009; Gallo O, 2021, MUCOSAL IMMUNOL, V14, P305, DOI 10.1038/s41385-020-00359-2; Gunst JD, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100849; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Higgins TS, 2020, OTOLARYNG HEAD NECK, V163, P682, DOI 10.1177/0194599820933170; Hoffmann M, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103255; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Jackson CB, 2022, NAT REV MOL CELL BIO, V23, P3, DOI 10.1038/s41580-021-00418-x; Johansen MD, 2020, MUCOSAL IMMUNOL, V13, P877, DOI 10.1038/s41385-020-00340-z; Klingenstein M, 2021, CELLS TISSUES ORGANS, V209, P155, DOI 10.1159/000513040; Kokic G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20542-0; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Laporte M, 2017, CURR OPIN VIROL, V24, P16, DOI 10.1016/j.coviro.2017.03.018; Long RKM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77170-3; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; Lutz C, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00272-6; Mahoney M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2108728118; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Meyerholz DK, 2020, METHODS MOL BIOL, V2099, P205, DOI 10.1007/978-1-0716-0211-9_16; Murgolo N, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009225; Murza A, 2020, EXPERT OPIN THER PAT, V30, P807, DOI 10.1080/13543776.2020.1817390; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Owen DR, 2021, SCIENCE, V374, P1586, DOI 10.1126/science.abl4784; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Rathnasinghe Raveen, 2020, bioRxiv, DOI 10.1101/2020.07.06.190066; Rees WD, 2020, J CROHNS COLITIS, V14, P948, DOI 10.1093/ecco-jcc/jjz194; Sarret P, 2021, J MED CHEM, V64, P5221, DOI 10.1021/acs.jmedchem.1c00481; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shapira T, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.553962; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Shrimp JH., 2020, PHARM TRANSL SCI, V3, DOI [10.1021/acsptsci.0c00106, DOI 10.1021/ACSPTSCI.0C00106]; Sievers BL, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abn7842; Soldatov VO, 2020, RES RESULTS PHARM, V6, P1, DOI [DOI 10.3897/RRPHARMACOLOGY.6.53633, 10.3897/rrpharmacology.6.53633]; St-Georges C, 2017, EUR J MED CHEM, V129, P110, DOI 10.1016/j.ejmech.2017.02.006; Staab Janet F, 2020, Curr Protoc Immunol, V131, pe113, DOI 10.1002/cpim.113; Sun YJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147973; Tang T, 2021, ACS INFECT DIS, V7, P264, DOI 10.1021/acsinfecdis.0c00701; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w; White KM, 2021, SCIENCE, V371, P926, DOI 10.1126/science.abf4058; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wong JP, 2021, SCIENCE, V371, P884, DOI 10.1126/science.abg6837; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	66	26	26	21	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2022	605	7909					340	+		10.1038/s41586-022-04661-w	http://dx.doi.org/10.1038/s41586-022-04661-w		MAR 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D7UZ	35344983	hybrid, Green Published			2022-12-28	WOS:000790749300002
J	Coropceanu, I; Janke, EM; Portner, J; Haubold, D; Nguyen, TD; Das, A; Tanner, CPN; Utterback, JK; Teitelbaum, SW; Hudson, MH; Sarma, NA; Hinkle, AM; Tassone, CJ; Eychmuller, A; Limmer, DT; de la Cruz, MO; Ginsberg, NS; Talapin, DV				Coropceanu, Igor; Janke, Eric M.; Portner, Joshua; Haubold, Danny; Nguyen, Trung Dac; Das, Avishek; Tanner, Christian P. N.; Utterback, James K.; Teitelbaum, Samuel W.; Hudson, Margaret H.; Sarma, Nivedina A.; Hinkle, Alex M.; Tassone, Christopher J.; Eychmuller, Alexander; Limmer, David T.; de la Cruz, Monica Olvera; Ginsberg, Naomi S.; Talapin, Dmitri, V			Self-assembly of nanocrystals into strongly electronically coupled all-inorganic supercrystals	SCIENCE			English	Article							COLLOIDAL NANOCRYSTALS; CHARGE-TRANSPORT; LIGAND-EXCHANGE; FREE-ENERGY; BINARY; PHASE; SUPERLATTICES; CRYSTALLIZATION; NANOPARTICLES; AGGREGATION	Colloidal nanocrystals of metals, semiconductors, and other functional materials can self-assemble into long-range ordered crystalline and quasicrystalline phases, but insulating organic surface ligands prevent the development of collective electronic states in ordered nanocrystal assemblies. We reversibly self-assembled colloidal nanocrystals of gold. platinum, nickel, lead sulfide, and lead selenide with conductive inorganic ligands into supercrystals exhibiting optical and electronic properties consistent with strong electronic coupling between the constituent nanocrystals. The phase behavior of charge-stabilized nanocrystals can be rationalized and navigated with phase diagrams computed for particles interacting through short-range attractive potentials. By finely tuning interparticle interactions, the assembly was directed either through one-step nucleation or nonclassical two-step nucleation pathways. In the latter case, the nucleation was preceded by the formation of two metastable colloidal fluids.	[Coropceanu, Igor; Janke, Eric M.; Portner, Joshua; Haubold, Danny; Hudson, Margaret H.; Sarma, Nivedina A.; Hinkle, Alex M.; Talapin, Dmitri, V] Univ Chicago, James Franck Inst, Dept Chem, Chicago, IL 60637 USA; [Coropceanu, Igor; Janke, Eric M.; Portner, Joshua; Haubold, Danny; Hudson, Margaret H.; Sarma, Nivedina A.; Hinkle, Alex M.; Talapin, Dmitri, V] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Haubold, Danny; Eychmuller, Alexander] Tech Univ Dresden, Phys Chem, Dresden, Germany; [Nguyen, Trung Dac; de la Cruz, Monica Olvera] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Das, Avishek; Tanner, Christian P. N.; Utterback, James K.; Limmer, David T.; Ginsberg, Naomi S.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Teitelbaum, Samuel W.] Arizona State Univ, Biodesign Inst, Dept Phys, Tempe, AZ 85287 USA; [Teitelbaum, Samuel W.] Arizona State Univ, Biodesign Inst, Beus CXFEL Labs, Tempe, AZ 85287 USA; [Tassone, Christopher J.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Limmer, David T.] Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA; [Limmer, David T.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Limmer, David T.; Ginsberg, Naomi S.] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [de la Cruz, Monica Olvera] Northwestern Univ, Dept Mat Sci & Engn, Dept Chem, Evanston, IL 60208 USA; [de la Cruz, Monica Olvera] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Ginsberg, Naomi S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ginsberg, Naomi S.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Mat Sci Div, Berkeley, CA 94720 USA; [Talapin, Dmitri, V] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60517 USA	University of Chicago; University of Chicago; Technische Universitat Dresden; Northwestern University; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Northwestern University; Northwestern University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60517 USA.	dvtalapin@uchicago.edu	Utterback, James K/GVT-2912-2022; Hudson, Maggie/HHC-3479-2022	Utterback, James K/0000-0002-2926-841X; Portner, Joshua/0000-0002-5926-6503; Das, Avishek/0000-0003-0269-7721; Haubold, Danny/0000-0003-4793-2465; Hinkle, Alex/0000-0002-6185-4478; Hudson, Margaret/0000-0002-8977-8139; Coropceanu, Igor/0000-0001-8057-1134	Office of Basic Energy Sciences (BES), US Department of Energy (DOE) [DE-SC0019375]; Advanced Materials for Energy-Water Systems (AMEWS) Center, an Energy Frontier Research Center - DOE, Office of Science, BES; DOE, Office of Science, BES, Materials Sciences and Engineering Division [5J-30161-0010A]; Department of Defense Air Force Office of Scientific Research [FA9550-18-1-0099]; Deutsche Forschungsgemeinschaft [DFG1401/02]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; NSF [DGE1106400]; Arnold O. Beckman Postdoctoral Fellowship in Chemical Sciences from the Arnold and Mabel Beckman Foundation; Alfred P. Sloan Research Fellowship; David and Lucile Packard Foundation Fellowship for Science and Engineering; Camille and Henry Dreyfus Teacher-Scholar Awards	Office of Basic Energy Sciences (BES), US Department of Energy (DOE)(United States Department of Energy (DOE)); Advanced Materials for Energy-Water Systems (AMEWS) Center, an Energy Frontier Research Center - DOE, Office of Science, BES(United States Department of Energy (DOE)); DOE, Office of Science, BES, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Department of Defense Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Arnold O. Beckman Postdoctoral Fellowship in Chemical Sciences from the Arnold and Mabel Beckman Foundation; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); David and Lucile Packard Foundation Fellowship for Science and Engineering(The David & Lucile Packard Foundation); Camille and Henry Dreyfus Teacher-Scholar Awards	Self-assembly experiments, in situ x-ray scattering studies, and associated data interpretations were supported by the Office of Basic Energy Sciences (BES), US Department of Energy (DOE) (award no. DE-SC0019375). Nanomaterials synthesis and surface functionalization studies were supported by the Advanced Materials for Energy-Water Systems (AMEWS) Center, an Energy Frontier Research Center funded by the DOE, Office of Science, BES. Modeling and simulations of pair potentials were supported by the Midwest Integrated Center for Computational Materials (MICCoM) as part of the Computational Materials Sciences Program funded by the DOE, Office of Science, BES, Materials Sciences and Engineering Division (award no. 5J-30161-0010A). Spectroscopic and charge transport studies were supported by the Department of Defense Air Force Office of Scientific Research (grant no. FA9550-18-1-0099). D.H. and A.E. were supported by the Deutsche Forschungsgemeinschaft (award no. DFG1401/02). M.H. was supported by the University of Chicago Materials Research Science and Engineering Center, which is funded by the National Science Foundation (NSF) (award no. DMR-2011854). The work used resources of the Center for Nanoscale Materials, a U.S. DOE (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (contract no. DE-AC02-06CH11357). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the DOE, Office of Science, Office of Basic Energy Sciences (contract no. DE-AC02-76SF00515). C.P.N.T. was supported by the NSF (Graduate Research Fellowship no. DGE1106400). J.K.U. was supported by an Arnold O. Beckman Postdoctoral Fellowship in Chemical Sciences from the Arnold and Mabel Beckman Foundation. N.S.G. and D.V.T. were supported by an Alfred P. Sloan Research Fellowship, a David and Lucile Packard Foundation Fellowship for Science and Engineering, and a Camille and Henry Dreyfus Teacher-Scholar Awards. M.-O.C. thanks the Sherman Fairchild Foundation for computational support.	Abelson A, 2020, NAT MATER, V19, P49, DOI 10.1038/s41563-019-0485-2; Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Balazs DM, 2015, ACS NANO, V9, P11951, DOI 10.1021/acsnano.5b04547; Bardeen J, 1940, J APPL PHYS, V11, P88, DOI 10.1063/1.1712751; Bian T, 2021, NAT CHEM, V13, P940, DOI 10.1038/s41557-021-00752-9; BIGGS S, 1994, J CHEM PHYS, V100, P8501, DOI 10.1063/1.466748; Bodnarchuk MI, 2010, J AM CHEM SOC, V132, P11967, DOI 10.1021/ja103083q; Boles MA, 2016, CHEM REV, V116, P11220, DOI 10.1021/acs.chemrev.6b00196; Boles MA, 2015, J AM CHEM SOC, V137, P4494, DOI 10.1021/jacs.5b00839; Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Carey GH, 2013, MRS COMMUN, V3, P83, DOI 10.1557/mrc.2013.17; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Chelikowsky J R, 1996, QUANTUM THEORY REAL, V348; Chen J, 2010, NANO LETT, V10, P5103, DOI 10.1021/nl103568q; Chen O, 2008, ANGEW CHEM INT EDIT, V47, P8638, DOI 10.1002/anie.200804266; Chipot C., 2007, SPRINGER SERIES CHEM, V86, P1; Choi JH, 2016, SCIENCE, V352, P205, DOI 10.1126/science.aad0371; CLARK AF, 1970, CRYOGENICS, V10, P295, DOI 10.1016/0011-2275(70)90056-1; Dong AG, 2013, ACS NANO, V7, P10978, DOI 10.1021/nn404566b; Fortini A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041402; Frenkel D, 1999, PHYSICA A, V263, P26, DOI 10.1016/S0378-4371(98)00501-9; Frenkel D.D., 1996, UNDERSTANDING MOL SI, DOI DOI 10.1016/B978-012267351-1/50003-; Garcia GIG, 2014, J PHYS CHEM B, V118, P8854, DOI 10.1021/jp5045173; Gliko O, 2005, J AM CHEM SOC, V127, P3433, DOI 10.1021/ja043218k; Guerrero-Garcia GI, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656763; Guyot-Sionnest P, 2012, J PHYS CHEM LETT, V3, P1169, DOI 10.1021/jz300048y; HAGEN MHJ, 1994, J CHEM PHYS, V101, P4093, DOI 10.1063/1.467526; Haxton TK, 2015, SOFT MATTER, V11, P9307, DOI 10.1039/c5sm01833a; Henrichs S, 2000, J AM CHEM SOC, V122, P4077, DOI 10.1021/ja991543f; Israelachvili JN, 1985, INTERMOLECULAR SURFA; Jimenez-Angeles F, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.043244; Jing YF, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4935704; Jungblut S, 2019, PHYS CHEM CHEM PHYS, V21, P5723, DOI 10.1039/c9cp00549h; Kallay N, 2002, J COLLOID INTERF SCI, V253, P70, DOI 10.1006/jcis.2002.8476; Klotsa D, 2011, SOFT MATTER, V7, P6294, DOI 10.1039/c1sm05456b; Kovalenko MV, 2010, J AM CHEM SOC, V132, P10085, DOI 10.1021/ja1024832; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lan XZ, 2020, NAT MATER, V19, P323, DOI 10.1038/s41563-019-0582-2; Lee JS, 2011, NAT NANOTECHNOL, V6, P348, DOI [10.1038/nnano.2011.46, 10.1038/NNANO.2011.46]; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Li YH, 2017, P NATL ACAD SCI USA, V114, P11838, DOI 10.1073/pnas.1713168114; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Liu H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871682; Liu HJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2085051; Liu Y, 2010, NANO LETT, V10, P1960, DOI 10.1021/nl101284k; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Malossi RM, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0012073; Mamode M, 2017, J PHYS COMMUN, V1, DOI 10.1088/2399-6528/aa8ab6; MEAKIN P, 1988, PHYS REV A, V38, P2110, DOI 10.1103/PhysRevA.38.2110; Mueller NS, 2020, NATURE, V583, P780, DOI 10.1038/s41586-020-2508-1; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Muschol M, 1997, J CHEM PHYS, V107, P1953, DOI 10.1063/1.474547; Noro MG, 2000, J CHEM PHYS, V113, P2941, DOI 10.1063/1.1288684; Paik T, 2015, J AM CHEM SOC, V137, P6662, DOI 10.1021/jacs.5b03234; Peng S, 2008, NANO RES, V1, P229, DOI 10.1007/s12274-008-8026-3; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Poon WCK, 1999, PHYS REV LETT, V83, P1239, DOI 10.1103/PhysRevLett.83.1239; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Quan ZW, 2014, P NATL ACAD SCI USA, V111, P9054, DOI 10.1073/pnas.1408835111; Saunders AE, 2004, J PHYS CHEM B, V108, P16732, DOI 10.1021/jp047153j; Sauter A, 2015, FARADAY DISCUSS, V179, P41, DOI 10.1039/c4fd00225c; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Tao P, 2014, J CHEM THEORY COMPUT, V10, P4198, DOI 10.1021/ct500342h; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Nguyen TD, 2019, COMPUT PHYS COMMUN, V241, P80, DOI 10.1016/j.cpc.2019.03.006; Vanmaekelbergh D, 2011, NANO TODAY, V6, P419, DOI 10.1016/j.nantod.2011.06.005; Wang PP, 2018, J AM CHEM SOC, V140, P9095, DOI 10.1021/jacs.8b05643; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Weidman MC, 2015, CHEM MATER, V27, P474, DOI 10.1021/cm503626s; Whitham K, 2016, NAT MATER, V15, P557, DOI [10.1038/NMAT4576, 10.1038/nmat4576]; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wu LH, 2017, NATURE, V548, P197, DOI 10.1038/nature23308; YAMANOUCHI C, 1967, J PHYS SOC JPN, V22, P859, DOI 10.1143/JPSJ.22.859; Ye XC, 2017, NAT MATER, V16, P214, DOI [10.1038/NMAT4759, 10.1038/nmat4759]; Yu YX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06734-9; Zabet-Khosousi A, 2008, CHEM REV, V108, P4072, DOI 10.1021/cr0680134; Zhang JB, 2015, J PHYS CHEM LETT, V6, P1830, DOI 10.1021/acs.jpclett.5b00689; Zwanikken JW, 2013, P NATL ACAD SCI USA, V110, P5301, DOI 10.1073/pnas.1302406110	82	10	10	63	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1422	+		10.1126/science.abm6753	http://dx.doi.org/10.1126/science.abm6753			73	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324292				2022-12-28	WOS:000778894800046
J	Jaeger, ACH				Jaeger, Astrid C. H.			No shame in my pain	SCIENCE			English	Editorial Material									[Jaeger, Astrid C. H.] Swiss Fed Inst Technol, Zurich, Switzerland	ETH Zurich	Jaeger, ACH (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1430	1430						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324285				2022-12-28	WOS:000778894800047
J	Marciniak, CD; Feldker, T; Pogorelov, I; Kaubruegger, R; Vasilyev, DV; van Bijnen, R; Schindler, P; Zoller, P; Blatt, R; Monz, T				Marciniak, Christian D.; Feldker, Thomas; Pogorelov, Ivan; Kaubruegger, Raphael; Vasilyev, Denis V.; van Bijnen, Rick; Schindler, Philipp; Zoller, Peter; Blatt, Rainer; Monz, Thomas			Optimal metrology with programmable quantum sensors	NATURE			English	Article							ENTANGLEMENT; GENERATION; SIMULATION; HUNDREDS; STATES; NOISE	Quantum sensors are an established technology that has created new opportunities for precision sensing across the breadth of science. Using entanglement for quantum enhancement will allow us to construct the next generation of sensors that can approach the fundamental limits of precision allowed by quantum physics. However, determining how state-of-the-art sensing platforms may be used to converge to these ultimate limits is an outstanding challenge. Here we merge concepts from the field of quantum information processing with metrology, and successfully implement experimentally a programmable quantum sensor operating close to the fundamental limits imposed by the laws of quantum mechanics. We achieve this by using low-depth, parametrized quantum circuits implementing optimal input states and measurement operators for a sensing task on a trapped-ion experiment. With 26 ions, we approach the fundamental sensing limit up to a factor of 1.45 +/- 0.01, outperforming conventional spin-squeezing with a factor of 1.87 +/- 0.03. Our approach reduces the number of averages to reach a given Allan deviation by a factor of 1.59 +/- 0.06 compared with traditional methods not using entanglement-enabled protocols. We further perform on-device quantum-classical feedback optimization to 'self-calibrate' the programmable quantum sensor with comparable performance. This ability illustrates that this next generation of quantum sensor can be used without previous knowledge of the device or its noise environment.	[Marciniak, Christian D.; Feldker, Thomas; Pogorelov, Ivan; Schindler, Philipp; Blatt, Rainer; Monz, Thomas] Inst Expt Phys, Innsbruck, Austria; [Kaubruegger, Raphael; Vasilyev, Denis V.; van Bijnen, Rick; Zoller, Peter; Blatt, Rainer] Inst Quantum Opt & Quantum Informat, Innsbruck, Austria; [Kaubruegger, Raphael; Vasilyev, Denis V.; van Bijnen, Rick; Zoller, Peter] Ctr Quantum Phys, Innsbruck, Austria; [Monz, Thomas] Alpine Quantum Technol, Innsbruck, Austria		Monz, T (corresponding author), Inst Expt Phys, Innsbruck, Austria.; Monz, T (corresponding author), Alpine Quantum Technol, Innsbruck, Austria.	thomas.monz@uibk.ac.at	Marciniak, Christian/GMX-2959-2022; Schindler, Philipp/AAB-4803-2019	Schindler, Philipp/0000-0002-9461-9650; van Bijnen, Rick/0000-0002-0979-2521; Kaubruegger, Raphael/0000-0003-0846-2333; Marciniak, Christian/0000-0001-8401-3981; Monz, Thomas/0000-0001-7410-4804	EU [820495]; Austrian Science Fund (FWF), through the SFB BeyondC (FWF) [F7109]; IQI GmbH; Austrian Research Promotion Agency (FFG) [872766, 884471]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through US ARO [W911NF-16-1-0070, W911NF-20-1-0007]; US Air Force Office of Scientific Research (AFOSR) via IOE grant [FA9550-19-1-7044 LASCEM]; US Air Force Office of Scientific Research (AFOSR) through IOE grant [FA9550-19-1-7044 LASCEM]; FWF [I04426]; European Union's Horizon 2020 research and innovation programme [817482]; Simons Collaboration on Ultra-Quantum Matter, Simons Foundation [651440]	EU(European Commission); Austrian Science Fund (FWF), through the SFB BeyondC (FWF)(Austrian Science Fund (FWF)); IQI GmbH; Austrian Research Promotion Agency (FFG); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through US ARO; US Air Force Office of Scientific Research (AFOSR) via IOE grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Air Force Office of Scientific Research (AFOSR) through IOE grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); FWF(Austrian Science Fund (FWF)); European Union's Horizon 2020 research and innovation programme; Simons Collaboration on Ultra-Quantum Matter, Simons Foundation	We acknowledge funding from the EU H2020-FETFLAG-2018-03 under grant agreement no. 820495. We also acknowledge support by the Austrian Science Fund (FWF), through the SFB BeyondC (FWF Project No. F7109), and the IQI GmbH. P.S. acknowledges support from the Austrian Research Promotion Agency (FFG) contract 872766. P.S., T.M. and R.B. acknowledge funding by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through US ARO grant no. W911NF-16-1-0070 and W911NF-20-1-0007, and the US Air Force Office of Scientific Research (AFOSR) via IOE grant no. FA9550-19-1-7044 LASCEM. R.K., D.V.V. and P.Z. are supported by the US Air Force Office of Scientific Research (AFOSR) through IOE grant no. FA9550-19-1-7044 LASCEM, D.V.V by a joint-project grant from the FWF (grant no. I04426, RSF/Russia 2019), R.v.B and P.Z. by the European Union's Horizon 2020 research and innovation programme under grant agreement no. 817482 (PASQuanS) and R.v.B by the Austrian Research Promotion Agency (FFG) contract 884471 (ELQO). P.Z. acknowledges funding by the the European Union's Horizon 2020 research and innovation programme under grant agreement no. 731473 (QuantERA through QTFLAG), and by the Simons Collaboration on Ultra-Quantum Matter, which is a grant from the Simons Foundation (651440). Innsbruck theory is a member of the NSF Quantum Leap Challenge Institute Q-Sense. The computational results presented here have been achieved (in part) using the LEO HPC infrastructure of the University of Innsbruck. All statements of fact, opinions or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of the funding agencies.	Ahn J, 2020, NAT NANOTECHNOL, V15, P89, DOI 10.1038/s41565-019-0605-9; Andre A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230801; Bohnet JG, 2016, SCIENCE, V352, P1297, DOI 10.1126/science.aad9958; Bollinger, 1996, Phys Rev A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; Borde CJ, 2002, METROLOGIA, V39, P435, DOI 10.1088/0026-1394/39/5/5; Borregaard J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090801; Casacio CA, 2021, NATURE, V594, P201, DOI 10.1038/s41586-021-03528-w; Cerezo M, 2021, NAT REV PHYS, V3, P625, DOI 10.1038/s42254-021-00348-9; Chaste J, 2012, NAT NANOTECHNOL, V7, P300, DOI [10.1038/nnano.2012.42, 10.1038/NNANO.2012.42]; Chen YJ, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014019; Davis E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.053601; Degen CL, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.035002; Demkowicz-Dobrzanski R, 2020, J PHYS A-MATH THEOR, V53, DOI 10.1088/1751-8121/ab8ef3; Demkowicz-Dobrzanski R, 2015, PROG OPTICS, V60, P345, DOI 10.1016/bs.po.2015.02.003; Ebadi S, 2021, NATURE, V595, P227, DOI 10.1038/s41586-021-03582-4; Frasco MF, 2009, SENSORS-BASEL, V9, P7266, DOI 10.3390/s90907266; Gilmore KA, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.263602; Gilmore KA, 2021, SCIENCE, V373, P673, DOI 10.1126/science.abi5226; Gorecki W, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.030501; Hosten O, 2016, SCIENCE, V352, P1552, DOI 10.1126/science.aaf3397; Jones JA, 2009, SCIENCE, V324, P1166, DOI 10.1126/science.1170730; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Kaubruegger R, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.041045; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Leroux ID, 2017, METROLOGIA, V54, DOI 10.1088/1681-7575/aa66e9; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Macieszczak K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113002; Moser J, 2013, NAT NANOTECHNOL, V8, P493, DOI [10.1038/nnano.2013.97, 10.1038/NNANO.2013.97]; Omran A, 2019, SCIENCE, V365, P570, DOI 10.1126/science.aax9743; Pedrozo-Penafiel E, 2020, NATURE, V588, P414, DOI 10.1038/s41586-020-3006-1; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Pezze L, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.035005; Pogorelov I, 2021, PRX QUANTUM, V2, DOI 10.1103/PRXQuantum.2.020343; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Rej E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9459; Scholl P, 2021, NATURE, V595, P233, DOI 10.1038/s41586-021-03585-1; Semeghini G, 2021, SCIENCE, V374, P1242, DOI 10.1126/science.abi8794; Taylor MA, 2016, PHYS REP, V615, P1, DOI 10.1016/j.physrep.2015.12.002; TREES HLV, 1968, DETECTION ESTIMATION; Tse M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.231107; Wineland, 1992, Phys Rev A, V46, pR6797, DOI 10.1103/PhysRevA.46.R6797; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; Wu YZ, 2016, ANGEW CHEM INT EDIT, V55, P6586, DOI 10.1002/anie.201506556	46	6	6	7	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					604	+		10.1038/s41586-022-04435-4	http://dx.doi.org/10.1038/s41586-022-04435-4			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322252	Green Submitted			2022-12-28	WOS:000772661800014
J	Mahase, E				Mahase, Elisabeth			Water fluoridation can significantly reduce tooth decay in children, report confirms	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, WATER FLUORIDATION H	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o774	10.1136/bmj.o774	http://dx.doi.org/10.1136/bmj.o774			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321866				2022-12-28	WOS:000790072700002
J	Oliver, D				Oliver, David			David Oliver: Can the recovery plan for elective care in England deliver?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Abuelsamid, 2022, FORBES; BMA, 2022, NHS BACKL DAT AN; King's Fund, 2021, NHS HOSP BED NUMB; Kings Fund, 2019, CLOSING GAP; McLellan A., HEALTH SERV J, V2022; Neville S, FINANC TIMES, V2022; NHS England, 2022, DEL PLAN TACKL COV 1; Reed S, 2022, HLTH SYSTEM RECOVERY; Stoye G, 2021, ARE ALL MISSING HOSP	9	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o724	10.1136/bmj.o724	http://dx.doi.org/10.1136/bmj.o724			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321864	Bronze			2022-12-28	WOS:000790072700004
J	Smyth, L				Smyth, Lisa			Northern Ireland's surgeons force action on hospital reform	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												l.smyth@belfasttelegraph.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o643	10.1136/bmj.o643	http://dx.doi.org/10.1136/bmj.o643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304411				2022-12-28	WOS:000773507900005
J	Nattino, G; Castiglioni, S; Cereda, D; Della Valle, PG; Pellegrinelli, L; Bertolini, G; Pariani, E				Nattino, Giovanni; Castiglioni, Sara; Cereda, Danilo; Della Valle, Petra Giulia; Pellegrinelli, Laura; Bertolini, Guido; Pariani, Elena			Association Between SARS-CoV-2 Viral Load inWastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Nattino, Giovanni; Bertolini, Guido] Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Ranica, Italy; [Castiglioni, Sara] Ist Ric Farmacol Mario Negri IRCCS, Dept Environm Hlth Sci, Milan, Italy; [Cereda, Danilo] Directorate Gen Hlth, Lombardy Region, Milan, Italy; [Della Valle, Petra Giulia] Univ Pavia, Dept Publ Hlth, Expt & Forens Med, Pavia, Italy; [Bertolini, Guido; Pariani, Elena] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia; University of Milan	Bertolini, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Lab Clin Epidemiol, Via GB Camozzi 3, I-24020 Ranica, Italy.	guido.bertolini@marionegri.it	Nattino, Giovanni/T-7306-2019; PARIANI, ELENA/M-3491-2016	Nattino, Giovanni/0000-0002-3034-6251; PARIANI, ELENA/0000-0001-5681-3455; Bertolini, Guido/0000-0002-3101-4259				Bivins A, 2020, ENVIRON SCI TECHNOL, V54, P7754, DOI 10.1021/acs.est.0c02388; Hart OE, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138875; Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357; Public Health England, 2021, SARS COV 2 VAR VAR I; Thompson JR, 2020, WATER RES, V184, DOI 10.1016/j.watres.2020.116181	5	4	4	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2022	327	19					1922	1924		10.1001/jama.2022.4908	http://dx.doi.org/10.1001/jama.2022.4908			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3V2BU	35363259	Bronze, Green Published			2022-12-28	WOS:000841466900004
J	Broedersz, CP; Ronceray, P				Broedersz, Chase P.; Ronceray, Pierre			Twenty-five years of nanoscale thermodynamics	NATURE			English	Editorial Material						Biophysics; Physics		How the Jarzynski equality updated the second law of thermodynamics. A paper published in 1997 brought the thermodynamics of the nineteenth century into the twenty-first century - expanding the physics of transformations involved in the operation of steam engines to the realm of molecular motors.	[Broedersz, Chase P.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Broedersz, Chase P.] Ludwig Maximilian Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Ronceray, Pierre] Aix Marseille Univ, Interdisciplinary Ctr Nanosci Marseille, French Natl Ctr Sci Res, F-13009 Marseille, France; [Ronceray, Pierre] Aix Marseille Univ, Turing Ctr Living Syst, F-13009 Marseille, France	Vrije Universiteit Amsterdam; University of Munich; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Broedersz, CP (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.; Broedersz, CP (corresponding author), Ludwig Maximilian Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany.	c.p.broedersz@vu.nl; pierre.ronceray@univ-amu.fr	Ronceray, Pierre/R-9770-2016	Ronceray, Pierre/0000-0002-9012-7544				Barato AC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.158101; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; EVANS DJ, 1993, PHYS REV LETT, V71, P2401, DOI 10.1103/PhysRevLett.71.2401; GALLAVOTTI G, 1995, PHYS REV LETT, V74, P2694, DOI 10.1103/PhysRevLett.74.2694; Gingrich TR, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.120601; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Saira OP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.180601; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001	11	1	1	15	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					46	47		10.1038/d41586-022-00869-y	http://dx.doi.org/10.1038/d41586-022-00869-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0G4FO	35379991				2022-12-28	WOS:000778003200006
J	Eskin, B				Eskin, Barnet			In acute ischemic stroke, EVT alone vs. IV alteplase plus EVT did not differ for functional outcome at 90 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Eskin, Barnet] Morristown Med Ctr, Morristown, NJ 07960 USA	Atlantic Health System	Eskin, B (corresponding author), Morristown Med Ctr, Morristown, NJ 07960 USA.							Katsanos AH, 2021, NEUROLOGY, V97, pE777, DOI 10.1212/WNL.0000000000012390	1	0	0	4	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC42	JC42	e77784	10.7326/J22-0016	http://dx.doi.org/10.7326/J22-0016		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377718				2022-12-28	WOS:000799170800001
J	[Anonymous]				[Anonymous]			Summary for Patients: Homicide Deaths Among Adults Living With Handgun Owners in California	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2022	175	6					I28	I28		10.7326/P22-0004	http://dx.doi.org/10.7326/P22-0004		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3J5DE	35377711				2022-12-28	WOS:000833414400004
J	Raber, L; Ueki, Y; Otsuka, T; Losdat, S; Haner, JD; Lonborg, J; Fahrni, G; Iglesias, JF; van Geuns, RJ; Ondracek, AS; Jensen, MRJD; Zanchin, C; Stortecky, S; Spirk, D; Siontis, GCM; Saleh, L; Matter, CM; Daemen, J; Mach, F; Heg, D; Windecker, S; Engstrom, T; Lang, IEM; Koskinas, KC				Raber, Lorenz; Ueki, Yasushi; Otsuka, Tatsuhiko; Losdat, Sylvain; Haner, Jonas D.; Lonborg, Jacob; Fahrni, Gregor; Iglesias, Juan F.; van Geuns, Robert-Jan; Ondracek, Anna S.; Radu Juul Jensen, Maria D.; Zanchin, Christian; Stortecky, Stefan; Spirk, David; Siontis, George C. M.; Saleh, Lanja; Matter, Christian M.; Daemen, Joost; Mach, Francois; Heg, Dik; Windecker, Stephan; Engstrom, Thomas; Lang, Irene M.; Koskinas, Konstantinos C.		PACMAN-AMI Collaborators	Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction The PACMAN-AMI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; FIBROUS CAP THICKNESS; INTRAVASCULAR ULTRASOUND; COLLAGEN CONTENT; LIPID-CONTENT; PLAQUE; ATORVASTATIN; PROGRESSION; EVOLOCUMAB	IMPORTANCE Coronary plaques that are prone to rupture and cause adverse cardiac events are characterized by large plaque burden, large lipid content, and thin fibrous caps. Statins can halt the progression of coronary atherosclerosis; however, the effect of the proprotein convertase subtilisin kexin type 9 inhibitor alirocumab added to statin therapy on plaque burden and composition remains largely unknown. OBJECTIVE To determine the effects of alirocumab on coronary atherosclerosis using serial multimodality intracoronary imaging in patients with acute myocardial infarction. DESIGN, SETTING, AND PARTICIPANTS The PACMAN-AMI double-blind, placebo-controlled, randomized clinical trial (enrollment: May 9, 2017, through October 7, 2020; final follow-up: October 13, 2021) enrolled 300 patients undergoing percutaneous coronary intervention for acute myocardial infarction at 9 academic European hospitals. INTERVENTIONS Patients were randomized to receive biweekly subcutaneous alirocumab (150 mg; n = 148) or placebo (n = 152), initiated less than 24 hours after urgent percutaneous coronary intervention of the culprit lesion, for 52 weeks in addition to high-intensity statin therapy (rosuvastatin, 20 mg). MAIN OUTCOMES AND MEASURES Intravascular ultrasonography (IVUS), near-infrared spectroscopy, and optical coherence tomography were serially performed in the 2 non-infarct-related coronary arteries at baseline and after 52 weeks. The primary efficacy end point was the change in IVUS-derived percent atheroma volume from baseline to week 52. Two powered secondary end points were changes in near-infrared spectroscopy-derived maximum lipid core burden index within 4 mm (higher values indicating greater lipid content) and optical coherence tomography-derived minimal fibrous cap thickness (smaller values indicating thin-capped, vulnerable plaques) from baseline to week 52. RESULTS Among 300 randomized patients (mean [SD] age, 58.5 [9.7] years; 56 [18.7%) women; mean [SD] low-density lipoprotein cholesterol level, 152.4 [33.8] mg/dL), 265 (88.3%) underwent serial IVUS imaging in 537 arteries. At 52 weeks, mean change in percent atheroma volume was -2.13% with alirocumab vs -0.92% with placebo (difference, -1.21% [95% CI, -1.78% to -0.65%], P < .001). Mean change in maximum lipid core burden index within 4 mm was -79.42 with alirocumab vs -37.60 with placebo (difference, -41.24 [95% CI, -70.71 to -11.77]; P = .006). Mean change in minimal fibrous cap thickness was 62.67 mu m with alirocumab vs 33.19 mu m with placebo (difference, 29.65 mu m [95% Cl, 11.75-47.55]; P = .001). Adverse events occurred in 70.7% of patients treated with alirocumab vs 72.8% of patients receiving placebo. CONCLUSIONS AND RELEVANCE Among patients with acute myocardial infarction, the addition of subcutaneous biweekly alirocumab, compared with placebo, to high-intensity statin therapy resulted in significantly greater coronary plaque regression in non-infarct-related arteries after 52 weeks. Further research is needed to understand whether alirocumab improves clinical outcomes in this population.	[Raber, Lorenz; Ueki, Yasushi; Otsuka, Tatsuhiko; Haner, Jonas D.; Zanchin, Christian; Stortecky, Stefan; Siontis, George C. M.; Windecker, Stephan; Koskinas, Konstantinos C.] Univ Bern, Bern Univ Hosp, Dept Cardiol, Bern, Switzerland; [Losdat, Sylvain; Heg, Dik] Univ Bern, CTU Bern, Bern, Switzerland; [Lonborg, Jacob; Radu Juul Jensen, Maria D.; Engstrom, Thomas] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Fahrni, Gregor] Univl Hosp Base, Dept Cardiol, Basel, Switzerland; [Iglesias, Juan F.; Mach, Francois] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [van Geuns, Robert-Jan] Radboud UMC, Dept Cardiol, Nijmegen, Netherlands; [Ondracek, Anna S.; Lang, Irene M.] Med Univ Vienna, Dept Cardiol, Vienna, Austria; [Spirk, David] Bern Univ Hosp, Dept Pharmacol, Bern, Switzerland; [Spirk, David] Sanofi, Vernier, Switzerland; [Saleh, Lanja] Zurich Univ Hosp, Inst Clin Chem, Zurich, Switzerland; [Matter, Christian M.] Zurich Univ Hosp, Dept Cardiol, Zurich, Switzerland; [Daemen, Joost] Erasmus Univ, Med Ctr, Dept Cardiol, Rotterdam, Netherlands	University of Bern; University Hospital of Bern; University of Bern; Rigshospitalet; University of Copenhagen; University of Geneva; Radboud University Nijmegen; Medical University of Vienna; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Erasmus University Rotterdam; Erasmus MC	Raber, L (corresponding author), Bern Univ Hosp, Dept Cardiol, Freiburgstr 18, CH-3010 Bern, Switzerland.	lorenz.raeber@insel.ch	Iglesias, Juan F./ABB-1115-2020; Häner, Jonas Dominik/H-7662-2019	Iglesias, Juan F./0000-0002-1669-6036; Häner, Jonas Dominik/0000-0002-1420-8967; Heg, Dik/0000-0002-8766-7945	Sanofi; Regeneron; Infraredx	Sanofi; Regeneron(Regeneron); Infraredx	y This study was funded by Sanofi, Regeneron, and Infraredx. Regeneron provided alirocumab and placebo free of charge.	Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Erlinge D, 2021, LANCET, V397, P985, DOI 10.1016/S0140-6736(21)00249-X; Fukumoto Y, 2001, CIRCULATION, V103, P993; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Honda S, 2022, JACC-CARDIOVASC IMAG, V15, P709, DOI 10.1016/j.jcmg.2021.11.014; Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Johnson TW, 2019, EUR HEART J, V40, P2566, DOI 10.1093/eurheartj/ehz332; Kini AS, 2013, J AM COLL CARDIOL, V62, P21, DOI 10.1016/j.jacc.2013.03.058; Komukai K, 2014, J AM COLL CARDIOL, V64, P2207, DOI 10.1016/j.jacc.2014.08.045; Koskinas KC, 2019, J AM COLL CARDIOL, V74, P2452, DOI 10.1016/j.jacc.2019.08.010; Koskinas KC, 2018, EUR HEART J, V39, P1172, DOI 10.1093/eurheartj/ehx566; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Nicholls SJ, 2022, JACC-CARDIOVASC IMAG, V15, P1308, DOI 10.1016/j.jcmg.2022.03.002; Nicholls SJ, 2018, J AM COLL CARDIOL, V72, P2012, DOI 10.1016/j.jacc.2018.06.078; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Prati F, 2020, EUR HEART J, V41, P383, DOI 10.1093/eurheartj/ehz520; Puri R, 2013, EUR HEART J, V34, P1818, DOI 10.1093/eurheartj/eht084; Radu MD, 2016, EUROINTERVENTION, V12, pE987, DOI 10.4244/EIJV12I8A162; Raber L, 2019, JACC-CARDIOVASC IMAG, V12, P1518, DOI 10.1016/j.jcmg.2018.08.024; Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Waksman R, 2019, LANCET, V394, P1629, DOI 10.1016/S0140-6736(19)31794-5; Zanchin C, 2021, AM HEART J, V238, P33, DOI 10.1016/j.ahj.2021.04.006	32	29	29	10	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2022	327	18					1771	1781		10.1001/jama.2022.5218	http://dx.doi.org/10.1001/jama.2022.5218		APR 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1P8WO	35368058	Green Published			2022-12-28	WOS:000779463700001
J	Post, LA; Lorenzo-Redondo, R				Post, Lori Ann; Lorenzo-Redondo, Ramon			Omicron: fewer adverse outcomes come with new dangers	LANCET			English	Editorial Material							SARS-COV-2		[Post, Lori Ann] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Post, Lori Ann] Northwestern Univ, Feinberg Sch Med, Buehler Ctr Hlth Policy & Econ, Inst Global Hlth, Chicago, IL 60611 USA; [Lorenzo-Redondo, Ramon] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Dept Med, Chicago, IL 60611 USA; [Lorenzo-Redondo, Ramon] Northwestern Univ, Feinberg Sch Med, Ctr Pathogen Genom & Microbial Evolut, Inst Global Hlth, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Post, LA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA.; Post, LA (corresponding author), Northwestern Univ, Feinberg Sch Med, Buehler Ctr Hlth Policy & Econ, Inst Global Hlth, Chicago, IL 60611 USA.	lori.post@northwestern.edu						Andrews N., 2021, EFFECTIVENESS COVID1, DOI [10.1101/2021.12.14.21267615, DOI 10.1101/2021.12.14.21267615]; Bager P, 2022, SSRN; Centers for Disease Control and Prevention, COVID DAT TRACK; Dhawan M, 2022, ANN MED SURG, V73, DOI 10.1016/j.amsu.2021.103186; Lundberg Alexander L, 2022, JMIR Public Health Surveill, V8, pe35763, DOI 10.2196/35763; Nyberg T, 2022, LANCET, V399, P1303, DOI 10.1016/S0140-6736(22)00462-7; Sheikh A., 2021, SEVERITY OMICRON VAR; Tangcharoensathien V, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n83; Townsend JP, 2021, LANCET MICROBE, V2, pE666, DOI 10.1016/S2666-5247(21)00219-6; Veneti L, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.4.2200077; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4	12	2	2	5	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1280	1281		10.1016/S0140-6736(22)00514-1	http://dx.doi.org/10.1016/S0140-6736(22)00514-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35305298	Bronze, Green Published			2022-12-28	WOS:000812828300006
J	Winter, AK; Moss, WJ				Winter, Amy K.; Moss, William J.			Rubella	LANCET			English	Article							CONGENITAL-RUBELLA; SYNDROME CRS; MEASLES; MUMPS; EPIDEMIOLOGY; VIRUS; PERSISTENCE; VACCINE; BURDEN; IMMUNIZATION	Rubella is an acute illness caused by rubella virus and characterised by fever and rash. Although rubella is a clinically mild illness, primary rubella virus infection in early pregnancy can result in congenital rubella syndrome, which has serious medical and public health consequences. WHO estimates that approximately 100 000 congenital rubella syndrome cases occur per year. Rubella virus is transmitted through respiratory droplets and direct contact. 25-50% of people infected with rubella virus are asymptomatic. Clinical disease often results in mild, self-limited illness characterised by fever, a generalised erythematous maculopapular rash, and lymphadenopathy. Complications include arthralgia, arthritis, thrombocytopenic purpura, and encephalitis. Common presenting signs and symptoms of congenital rubella syndrome include cataracts, sensorineural hearing impairment, congenital heart disease, jaundice, purpura, hepatosplenomegaly, and microcephaly. Rubella and congenital rubella syndrome can be prevented by rubella-containing vaccines, which are commonly administered in combination with measles vaccine. Although global rubella vaccine coverage reached only 70% in 2020 global rubella eradiation remains an ambitious but achievable goal.	[Winter, Amy K.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Moss, William J.] Int Vaccine Access Ctr, Dept Int Hlth, New York, NY 10017 USA; [Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	University System of Georgia; University of Georgia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	wmoss1@jhu.edu		Winter, Amy/0000-0003-2737-7003				[Anonymous], 2013, VACCINES; Bankamp B, 2019, CURR OPIN VIROL, V34, P110, DOI 10.1016/j.coviro.2019.01.002; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Bennett AJ, 2020, NATURE, V586, P424, DOI 10.1038/s41586-020-2812-9; Bento RF, 2005, ACTA OTO-LARYNGOL, V125, P492, DOI 10.1080/00016480510036420; Best JM, 2008, IMMUNIZATION VACCINE; Bouthry E, 2021, J CLIN VIROL, V134, DOI 10.1016/j.jcv.2020.104708; Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467; Brown KE, 2019, MMWR-MORBID MORTAL W, V68, P587, DOI 10.15585/mmwr.mm6826a3; CDC, 2020, RUB GERM MEASL 3 DAY; Centers for Disease Control and Prevention, 1978, PUBL HLTH MAG ID 712; Chimhuya S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1642-4; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; COOPER LZ, 1965, AM J DIS CHILD, V110, P416, DOI 10.1001/archpedi.1965.02090030436011; COOPER LZ, 1985, REV INFECT DIS, V7, pS2; Crooke SN, 2019, VACCINE, V37, P3876, DOI 10.1016/j.vaccine.2019.05.049; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; Das PK, 2021, J VIROL, V95, DOI 10.1128/JVI.02349-20; Datta SS, 2018, VACCINE, V36, P5408, DOI 10.1016/j.vaccine.2017.06.042; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; Durowade KA, 2021, INDIAN J HLTH SCI BI, V14, P31; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Getahun M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3841-z; Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35; Hahne S, 2009, PEDIATR INFECT DIS J, V28, P795, DOI 10.1097/INF.0b013e3181a3e2d5; Haralambieva IH, 2020, VACCINE, V38, P1249, DOI 10.1016/j.vaccine.2019.11.004; Hess AF, 1914, ARCH INTERN MED, V13, P913; Hiro Y, 1938, MSCHR KINDERHEILK, V76, P328; Jimenez G, 2007, PEDIATR INFECT DIS J, V26, P382, DOI 10.1097/01.inf.0000260000.84792.9e; JOHNSON RT, 1975, NEW ENGL J MED, V292, P1023, DOI 10.1056/NEJM197505082921909; Kirby T, 2015, LANCET INFECT DIS, V15, P768, DOI 10.1016/S1473-3099(15)00102-4; Lambert ND, 2015, J INFECT DIS, V211, P898, DOI 10.1093/infdis/jiu553; Lebrun AJ, 1978, PUBLIC HLTH IMAGE ID; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Leuridan E, 2011, VACCINE, V29, P2222, DOI 10.1016/j.vaccine.2010.06.004; Ma SJ, 2015, VACCINE, V33, P3636, DOI 10.1016/j.vaccine.2015.06.009; Mangtani P, 2020, VACCINE, V38, P963, DOI 10.1016/j.vaccine.2019.11.070; Mantadakis E, 2010, J PEDIATR-US, V156, P623, DOI 10.1016/j.jpeds.2009.10.015; Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131; Metcalf CJE, 2011, EPIDEMIOL INFECT, V139, P1029, DOI 10.1017/S0950268810002165; Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320; MILLER E, 1982, LANCET, V2, P781; Moss WJ, 2021, VACCINE, V39, P3544, DOI 10.1016/j.vaccine.2021.04.027; Noorbakhsh F, 2008, NEUROL CLIN, V26, P759, DOI 10.1016/j.ncl.2008.03.009; O'Connor D, 2019, CELL REP, V27, P3241, DOI 10.1016/j.celrep.2019.05.053; Oishi K, 2020, YAKUGAKU ZASSHI, V140, P901, DOI 10.1248/yakushi.19-00255-3; Oster ME, 2010, BIRTH DEFECTS RES A, V88, P1, DOI 10.1002/bdra.20621; Ovsyannikova IG, 2015, IMMUNOGENETICS, V67, P547, DOI 10.1007/s00251-015-0864-z; Ovsyannikova IG, 2014, VACCINE, V32, P4206, DOI 10.1016/j.vaccine.2014.04.091; Pan American Health Organization, 2018, MEASL RUB WEEKL B ME, P24; Panagiotopoulos T, 2004, Euro Surveill, V9, P17; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; Patel MK, 2020, LANCET GLOB HEALTH, V8, pE1399, DOI 10.1016/S2214-109X(20)30320-X; Patel MK, 2018, VACCINE, V36, P7385, DOI 10.1016/j.vaccine.2018.10.007; PLOTKIN SA, 1968, LANCET, V2, P934; PLOTKIN SA, 1969, AM J DIS CHILD, V118, P178, DOI 10.1001/archpedi.1969.02100040180004; Plotkin SA, 2017, VACCINES; POLK BF, 1982, AM J EPIDEMIOL, V115, P19, DOI 10.1093/oxfordjournals.aje.a113276; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928; Richardson LC, 2020, PAN AFR MED J, V35, P7, DOI 10.11604/pamj.supp.2020.35.1.19753; Rios-Doria D, 2009, MATH STAT ESTIMATION, P325; Rozhnova G, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0643; SALONEN EM, 1985, J MED VIROL, V16, P1, DOI 10.1002/jmv.1890160102; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Schenk J, 2021, LANCET INFECT DIS, V21, P286, DOI 10.1016/S1473-3099(20)30442-4; Seagle EE, 2018, VACCINE, V36, P818, DOI 10.1016/j.vaccine.2017.12.075; SOUTH MA, 1985, TERATOLOGY, V31, P297, DOI 10.1002/tera.1420310216; Stratton K, 2012, ADVERSE EFFECTS VACC, P103; Sugishita Y, 2015, JPN J INFECT DIS, V68, P159, DOI 10.7883/yoken.JJID.2014.195; THOMAS HIJ, 1993, J MED VIROL, V41, P196, DOI 10.1002/jmv.1890410305; Thompson KM, 2016, RISK ANAL, V36, P1315, DOI 10.1111/risa.12264; Toizumi M, 2014, PEDIATRICS, V134, pE519, DOI 10.1542/peds.2013-4184; Toor J, 2021, ELIFE, V10, DOI 10.7554/eLife.67635; Tushabe P, 2020, J MED VIROL, V92, P279, DOI 10.1002/jmv.25604; Ueda K, 2016, VACCINE, V34, P1971, DOI 10.1016/j.vaccine.2015.10.010; US Centers for Disease Control and Prevention, 2021, RUB INF HEALTHC PROF; van den Boogaard J, 2021, VACCINE, V39, P889, DOI 10.1016/j.vaccine.2020.12.079; Voigt EA, 2018, J INFECT DIS, V217, P560, DOI 10.1093/infdis/jix538; Vynnycky E, 2003, VACCINE, V21, P2708, DOI 10.1016/S0264-410X(03)00229-9; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; WHO, CONG RUB SYNDR CRS R, P2021; WHO, 2021, IMM COV FACT SHEET; WHO, 2021, RUB REP CAS INC; WHO, 2020, WEEKLY EPIDEMIOLOGIC, V95, P306; WHO, 2018, CONG RUB SYNDR; WHO, 2017, JRF SUPPL QUEST SURV; Winter AK, 2018, J INFECT DIS, V218, P355, DOI 10.1093/infdis/jiy137; WITTE JJ, 1969, AM J DIS CHILD, V118, P107, DOI 10.1001/archpedi.1969.02100040109018; World Health Organization, 2012, M DEV GLOB CONS PREC; World Health Organization, 2020, IMM AG 2030 GLOB STR; World Health Organization, 2011, GLOB VACC ACT PLAN 2; World Health Organization, 2018, VACC PREV DIS SURV S; Xu H, 2013, VACCINE, V32, P85, DOI 10.1016/j.vaccine.2013.10.070; Young MK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010586.pub2; Zimmerman LA, 2022, MMWR MORB MORTAL WKL, V71, P196	95	3	4	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1336	1346						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35367004				2022-12-28	WOS:000812828300025
J	Mahase, E				Mahase, Elisabeth			Improving public health: five minutes with ... Chris Whitty	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chris Whitty, 2022, ROYAL COLL PHYS ANN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o877	10.1136/bmj.o877	http://dx.doi.org/10.1136/bmj.o877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365493				2022-12-28	WOS:000783141700001
J	Kmietowicz, Z				Kmietowicz, Zosia			Postnatal care: WHO highlights urgency of physical and mental support	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2022, WHO REC MAT NEWB CAR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o846	10.1136/bmj.o846	http://dx.doi.org/10.1136/bmj.o846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354579				2022-12-28	WOS:000779561800003
J	Mahase, E				Mahase, Elisabeth			Covid-19: Oxygen shortages two years into pandemic highlight pre-covid failures, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o829	10.1136/bmj.o829	http://dx.doi.org/10.1136/bmj.o829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351685	Bronze			2022-12-28	WOS:000779544800009
J	Yu, CL; Cheng, H; Qi, Y; Song, J; Yang, CG; Wen, Y; Wang, XF				Yu, Cheng-Long; Cheng, Hang; Qi, Yong; Song, Jie; Yang, Chen-Guang; Wen, Yu; Wang, Xiu-Feng			Comment on "Reversible disorder-order transitions in atomic crystal nucleation"	SCIENCE			English	Editorial Material							TEMPERATURE; SIZE	Jeon et al. (Reports, 29 January 2021, p. 498) reported reversible fluctuations between disordered and crystalline states during nucleation. We argue that the adoption of "magic numbers" for separation of the size range into three parts is misleading when using the sigmoid functions and that their figure 3B was wrongly illustrated. The crystal shape effect was neglected during theoretical analysis.	[Yu, Cheng-Long; Cheng, Hang; Song, Jie; Yang, Chen-Guang; Wen, Yu; Wang, Xiu-Feng] Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China; [Qi, Yong] Shaanxi Univ Sci & Technol, Sch Elect Informat & Artificial Intelligence, Xian 710021, Peoples R China	Shaanxi University of Science & Technology; Shaanxi University of Science & Technology	Yu, CL (corresponding author), Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China.	johnyucl@aliyun.com	Qi, Yong/GRY-4011-2022	Qi, Yong/0000-0002-4930-5978; YU, Cheng-Long/0000-0001-7672-6009; Wang, Xiufeng/0000-0003-3629-1738				CHALLA MSS, 1986, PHYS REV B, V34, P1841, DOI 10.1103/PhysRevB.34.1841; Chen JJ, 2018, SCIENCE, V362, P1135, DOI 10.1126/science.aau4146; Garzon IL, 1998, PHYS REV LETT, V81, P1600, DOI 10.1103/PhysRevLett.81.1600; Jeon S, 2021, SCIENCE, V371, P498, DOI 10.1126/science.aaz7555; Kamiya S., 2012, Japanese Patent, Patent No. [P2012-254359, 2012254359]; PosadaAmarillas A, 1996, PHYS REV B, V53, P8363, DOI 10.1103/PhysRevB.53.8363; Qi WH, 2004, MATER CHEM PHYS, V88, P280, DOI 10.1016/j.matchemphys.2004.04.026; Song M, 2020, SCIENCE, V367, P40, DOI 10.1126/science.aax6511; Vandeginste B.G.M., 1998, DATA HANDLING SCI TE, V20, P649, DOI [10.1016/S0922-3487(98)80054-3, DOI 10.1016/S0922-3487(98)80054-3]; Yu C. L., 2020, SCI ELETTER, DOI [10.1126/science.aax6511#, DOI 10.1126/SCIENCE.AAX6511#]; Zheng HM, 2011, SCIENCE, V333, P206, DOI 10.1126/science.1204713	11	0	0	15	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI					10.1126/science.abj1711	http://dx.doi.org/10.1126/science.abj1711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324280				2022-12-28	WOS:000778894800001
J	Kazatchkine, M				Kazatchkine, Michel			Ukrainian war: an economic crisis in Eastern Europe and Central Asia will lead to a health crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kazatchkine, Michel] Grad Inst Int Affairs & Dev, Geneva, Switzerland		Kazatchkine, M (corresponding author), Grad Inst Int Affairs & Dev, Geneva, Switzerland.							Aids UN, AIDS INFO; European Centre for Disease Prevention and Control, TUB SURV MON EUR 202; Our world in data, COR PAND	3	1	1	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o793	10.1136/bmj.o793	http://dx.doi.org/10.1136/bmj.o793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35332029	Bronze			2022-12-28	WOS:000778460100021
J	O'Meara, S; Ye, Y				O'Meara, Sarah; Ye, Yvaine			FOUR RESEARCH TEAMS POWERING CHINA'S NET-ZERO ENERGY GOAL	NATURE			English	News Item																			0	4	4	6	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					S41	S43						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322257	Bronze			2022-12-28	WOS:000772661800005
J	Baraniuk, C				Baraniuk, Chris			Airborne transmission: Are CO2 monitors a long term solution or "pandemic hack?"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						[Anonymous], WASHINGTON OPEN AIR; [Anonymous], 2021, BUNKA ONLINE NE 1210; [Anonymous], COSCHOOLS; Ashworth S, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3050; Baraniuk C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1030; Brogan C, 2022, CURING COVID 19 SCH; Di Gilio A, 2021, ENVIRON RES, V202, DOI 10.1016/j.envres.2021.111560; Eykelbosh A., 2021, INDOOR CO2 SENSORS C; Jiminez Jose-uis, 2021, TWITTER; Laurent MR, 2022, SCI TOTAL ENVIRON, V806, DOI 10.1016/j.scitotenv.2021.151349; NOG, 2021, TWITTER; Scientific Advisory Group for Emergencies, 2020, SARS COV 2 TRANSM; UK Health Security Agency HNS England Pulic Health Wales Public Health Agency. (Northern Ireland), 2022, COV 19 INF PREV CONT	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o736	10.1136/bmj.o736	http://dx.doi.org/10.1136/bmj.o736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321870	Bronze			2022-12-28	WOS:000790072700003
J	Alnahhas, H; Mishori, R; Heisler, M				Alnahhas, Houssam; Mishori, Ranit; Heisler, Michele			Hospitals and healthcare workers must be protected from the waging of war	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Alnahhas, Houssam; Mishori, Ranit; Heisler, Michele] Phys Human Rights, New York, NY 10018 USA; [Mishori, Ranit] Georgetown Sch Med, Dept Family Med, Washington, DC USA; [Heisler, Michele] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Heisler, Michele] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Alnahhas, H (corresponding author), Phys Human Rights, New York, NY 10018 USA.		Heisler, Michele/B-5774-2015	Heisler, Michele/0000-0002-6889-2063				[Anonymous], BBC NEWS; Fouad FM, 2017, LANCET, V390, P2516, DOI 10.1016/S0140-6736(17)30741-9; International Committee of the Red Cross, TREAT STAT PART COMM; Physicians for Human Rights, MORE 4000 ATTACKS HL; United Nations, HUM RIGHTS COUNC EST	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								o764	10.1136/bmj.o764	http://dx.doi.org/10.1136/bmj.o764			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9XK	35318266	Bronze			2022-12-28	WOS:000777024700009
J	Maciejewski, ML; Dowd, BE; Norton, EC				Maciejewski, Matthew L.; Dowd, Bryan E.; Norton, Edward C.			Instrumental Variables and Heterogeneous Treatment Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MODELS	This JAMA Guide to Statistics and Methods discusses instrumental variable analysis, a method designed to reduce or eliminate unobserved confounding in observational studies, with the goal of achieving unbiased estimation of treatment effects.	[Maciejewski, Matthew L.] Durham Vet Affairs Med Ctr, Ctr Innovat Accelerate Discovery & Practice Trans, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Populat Hlth Sci, 508 Fulton St,Ste 600, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27705 USA; [Dowd, Bryan E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Norton, Edward C.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Univ Michigan, Dept Econ, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Natl Bur Econ Res, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Bureau of Economic Research	Maciejewski, ML (corresponding author), Duke Univ, Sch Med, Dept Populat Hlth Sci, 508 Fulton St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov			US Department of Veterans Affairs Health Services Research Development [RCS 10-391]	US Department of Veterans Affairs Health Services Research Development(US Department of Veterans Affairs)	Dr Maciejewski reported receiving grants from US Department of Veterans Affairs Health Services Research & Development (RCS 10-391) and that he owns Amgen stock through his spouse's employment. No other disclosures were reported.	Angus DC, 2021, JAMA-J AM MED ASSOC, V326, P2312, DOI 10.1001/jama.2021.20552; Baiocchi M, 2014, STAT MED, V33, P2297, DOI 10.1002/sim.6128; Bhattacharya J, 2006, STAT MED, V25, P389, DOI 10.1002/sim.2226; Kent DM, 2012, JAMA-J AM MED ASSOC, V307, P1585, DOI 10.1001/jama.2012.469; Lee DS, VALID T RATIO INFERE; Maciejewski ML, 2019, JAMA-J AM MED ASSOC, V321, P2124, DOI 10.1001/jama.2019.5646; Mogstad M, 2021, AM ECON REV, V111, P3663, DOI 10.1257/aer.20190221; Werner RM, 2019, JAMA INTERN MED, V179, P617, DOI 10.1001/jamainternmed.2018.7998	8	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1177	1178		10.1001/jama.2022.2505	http://dx.doi.org/10.1001/jama.2022.2505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315905				2022-12-28	WOS:000775589900024
J	Dyer, C				Dyer, Clare			Covid-19: Parliament was denied power to scrutinise pandemic laws, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabinet Office, UK COV 19 INQ DRAFT; House of Commons Public Administration and Constitutional Affairs Committee, 2022, COR ACT 2020 2 YEARS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o730	10.1136/bmj.o730	http://dx.doi.org/10.1136/bmj.o730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304363	Bronze			2022-12-28	WOS:000773507900020
J	O'Dowd, A				O'Dowd, Adrian			Government promises action on NHS's ethnic pay gaps and health inequalities in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Appleby J, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3586; HM Government, 2022, 625 CP HM GOVT; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n911; Sewell T., 2021, COMMISSION RACE ETHN	4	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o735	10.1136/bmj.o735	http://dx.doi.org/10.1136/bmj.o735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304406				2022-12-28	WOS:000773507900011
J	Kanner, AM; Bicchi, MM				Kanner, Andres M.; Bicchi, Manuel Melo			Antiseizure Medications for Adults With Epilepsy A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY STANDARDS SUBCOMMITTEE; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; CONTROLLED-RELEASE CARBAMAZEPINE; CONTROLLED CLINICAL-TRIAL; NEWLY-DIAGNOSED EPILEPSY; SOCIETY GUIDELINE DEVELOPMENT; UPDATE MANAGEMENT ISSUES; VAGUS NERVE-STIMULATION; ANTIEPILEPTIC DRUGS II; NEW-ONSET EPILEPSY	IMPORTANCE Epilepsy affects approximately 65 million people worldwide. Persistent seizures are associated with a 20% to 40% risk of bodily injuries (eg, fractures, burns, concussions) over 12-month follow-up. The primary goal of epilepsy treatment is to eliminate seizures while minimizing adverse effects of antiseizure drugs (ASDs). OBSERVATIONS An epileptic seizure is defined as a sudden occurrence of transient signs and symptoms caused by abnormal and excessive or synchronous neuronal activity in the brain. Focal and generalized epilepsy are the 2 most frequent types of epilepsy; diagnosis is based on the type of seizures. There are 26 US Food and Drug Administration-approved medications for epilepsy, of which 24 have similar antiseizure efficacy for focal epilepsy and 9 have similar efficacy for generalized epilepsy. The decision to initiate an ASD should be individualized, but should be strongly considered after 2 unprovoked seizures or after 1 unprovoked seizure that occurred during sleep and/or in the presence of epileptiform activity on an electroencephalogram and/or in the presence of a structural lesion on the brain magnetic resonance imaging. The ASDs must be selected based on the seizure and epilepsy types, the epilepsy syndrome, and the adverse effects associated with the drug. For focal epilepsy, oxcarbazepine and lamotrigine are first-line therapy, while levetiracetam can be also considered if there is no history of psychiatric disorder. For generalized epilepsy, the selection of the ASD is based on the type of epilepsy syndrome and the patient's sex, age, and psychiatric history. Seizure freedom is achieved in approximately 60% to 70% of all patients. A total of 25% to 50% of patients also experience neurologic, psychiatric, cognitive, or medical disorders, such as mood, anxiety, and attention deficit disorders and migraines. For these patients, selecting an ASD should consider the presence of these disorders and concomitant use of medications to treat them. ASDs with cytochrome P450 enzyme-inducing properties (eg, carbamazepine, phenytoin) may worsen comorbid coronary and cerebrovascular disease by causing hyperlipidemia and accelerating the metabolism of concomitant drugs used for their treatment. They can also facilitate the development of osteopenia and osteoporosis. CONCLUSIONS AND RELEVANCE Epilepsy affects approximately 65 million people worldwide and is associated with increased rates of bodily injuries and mortality when not optimally treated. For focal and generalized epilepsy, selection of ASDs should consider the seizure and epilepsy types and epilepsy syndrome, as well as the patient's age and sex, comorbidities, and potential drug interactions.	[Kanner, Andres M.] Univ Miami, Comprehens Epilepsy Ctr, Miller Sch Med, Dept Neurol, 1120 NW 14th St,Room 1324, Miami, FL 33136 USA; Univ Miami, Epilepsy Div, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami	Kanner, AM (corresponding author), Univ Miami, Comprehens Epilepsy Ctr, Miller Sch Med, Dept Neurol, 1120 NW 14th St,Room 1324, Miami, FL 33136 USA.	a.kanner@med.miami.edu						Aicua-Rapun I, 2020, ANN NEUROL, V87, P22, DOI 10.1002/ana.25641; Anderson J, 2011, EPILEPSY RES, V94, P127, DOI 10.1016/j.eplepsyres.2011.03.008; [Anonymous], 1991, Lancet, V337, P1175; [Anonymous], 2021, EP DIAGN MAN; Badry R, 2013, INT J NEUROSCI, V123, P646, DOI 10.3109/00207454.2013.785543; Baulac M, 2017, LANCET NEUROL, V16, P43, DOI 10.1016/S1474-4422(16)30292-7; Baulac M, 2014, EPILEPSIA, V55, P1534, DOI 10.1111/epi.12749; Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Beerhorst K, 2013, J NEUROL SCI, V331, P19, DOI 10.1016/j.jns.2013.05.005; Beghi E., 2013, EPILEPTOLOGY, V1, P17, DOI [10.1016/j.epilep.2012.07.001, DOI 10.1016/J.EPILEP.2012.07.001]; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Ben-Menachem E, 2007, EPILEPSIA, V48, P42, DOI 10.1111/j.1528-1167.2007.01402.x; BERG AT, 1994, NEUROLOGY, V44, P601, DOI 10.1212/WNL.44.4.601; Bermeo-Ovalle A, 2019, EPILEPSY CURR, V19, P96, DOI 10.1177/1535759719835672; Bill PA, 1997, EPILEPSY RES, V27, P195, DOI 10.1016/S0920-1211(97)00024-7; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; BRODIE MJ, 1995, LANCET, V345, P476, DOI 10.1016/S0140-6736(95)90581-2; Brodie MJ, 1999, EPILEPSY RES, V37, P81, DOI 10.1016/S0920-1211(99)00039-X; Brodie MJ, 2002, EPILEPSIA, V43, P993, DOI 10.1046/j.1528-1157.2002.45401.x; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Camfield P, 2010, EPILEPSY BEHAV, V18, P61, DOI 10.1016/j.yebeh.2010.02.014; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Carbone LD, 2010, J BONE MINER RES, V25, P873, DOI 10.1359/jbmr.091027; Chang CS, 2014, SEIZURE-EUR J EPILEP, V23, P377, DOI 10.1016/j.seizure.2014.02.007; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Christe W, 1997, EPILEPSY RES, V26, P451, DOI 10.1016/S0920-1211(96)01013-3; DAM M, 1989, EPILEPSY RES, V3, P70; Devinsky O, 2016, LANCET NEUROL, V15, P1075, DOI 10.1016/S1474-4422(16)30158-2; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; Farhat G, 2002, NEUROLOGY, V58, P1348, DOI 10.1212/WNL.58.9.1348; Fields MC, 2013, JAMA NEUROL, V70, P360, DOI 10.1001/2013.jamaneurol.337; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; Gidal BE, 2021, EPILEPSY BEHAV, V120, DOI 10.1016/j.yebeh.2021.107993; Gidal BE, 2009, NEUROLOGY, V72, P419, DOI 10.1212/01.wnl.0000341789.77291.8d; Giordano F, 2017, EPILEPSIA, V58, P85, DOI 10.1111/epi.13678; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; Guerreiro MM, 1997, EPILEPSY RES, V27, P205, DOI 10.1016/S0920-1211(97)00025-9; Harden CL, 2009, NEUROLOGY, V73, P142, DOI 10.1212/WNL.0b013e3181a6b325; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; Harden CL, 2009, EPILEPSIA, V50, P1247, DOI 10.1111/j.1528-1167.2009.02130.x; Haut SR, 2015, CURR OPIN NEUROL, V28, P143, DOI 10.1097/WCO.0000000000000177; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hirsch LJ, 2006, EPILEPSIA, V47, P318, DOI 10.1111/j.1528-1167.2006.00423.x; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Josephson CB, 2021, JAMA NEUROL, V78, P1367, DOI 10.1001/jamaneurol.2021.3424; Kanner AM, 2018, EPILEPSY CURR, V18, P269, DOI 10.5698/1535-7597.18.4.269; Kanner AM, 2018, EPILEPSY CURR, V18, P260, DOI 10.5698/1535-7597.18.4.260; Kanner AM, 2016, NAT REV NEUROL, V12, P106, DOI 10.1038/nrneurol.2015.243; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; Krumholz A, 2015, NEUROLOGY, V84, P1705, DOI 10.1212/WNL.0000000000001487; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2011, LANCET NEUROL, V10, P881, DOI 10.1016/S1474-4422(11)70154-5; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lamberink HJ, 2017, LANCET NEUROL, V16, P523, DOI 10.1016/S1474-4422(17)30114-X; Lattanzi S, 2019, ACTA NEUROL SCAND, V139, P33, DOI 10.1111/ane.13025; Leach JP, 2005, SEIZURE-EUR J EPILEP, V14, P514, DOI 10.1016/j.seizure.2005.08.008; Lee-Lane E, 2021, EPILEPSIA, V62, P1604, DOI 10.1111/epi.16930; Loiseau J, 1999, EPILEPSIA, V40, P1388, DOI 10.1111/j.1528-1157.1999.tb02010.x; LOISEAU P, 1995, EPILEPSIA, V36, P1182, DOI 10.1111/j.1528-1157.1995.tb01060.x; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; Marson A, 2021, LANCET, V397, P1375, DOI 10.1016/S0140-6736(21)00246-4; Marson A, 2021, LANCET, V397, P1363, DOI 10.1016/S0140-6736(21)00247-6; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1990, SEMIN NEUROL, V10, P406, DOI 10.1055/s-2008-1063985; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mintzer S, 2009, ANN NEUROL, V65, P448, DOI 10.1002/ana.21615; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; Mula M, 2007, EPILEPSIA, V48, P2322; Mula M, 2017, CNS DRUGS, V31, P11, DOI 10.1007/s40263-016-0398-4; Olafsson E, 1998, EPILEPSIA, V39, P89, DOI 10.1111/j.1528-1157.1998.tb01279.x; Pennell PB, 2018, JAMA NEUROL, V75, P962, DOI 10.1001/jamaneurol.2018.0646; Pennell PB, 2016, NEUROTHERAPEUTICS, V13, P811, DOI 10.1007/s13311-016-0464-0; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Ranta A, 2004, EPILEPSIA, V45, P879, DOI 10.1111/j.0013-9580.2004.00604.x; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Seneviratne U, 2012, EPILEPSIA, V53, P2079, DOI 10.1111/j.1528-1167.2012.03723.x; Senf P, 2013, NEUROLOGY, V81, P2128, DOI 10.1212/01.wnl.0000437303.36064.f8; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Specchio LM, 2002, J NEUROL NEUROSUR PS, V72, P22, DOI 10.1136/jnnp.72.1.22; Steiner TJ, 1999, EPILEPSIA, V40, P601, DOI 10.1111/j.1528-1157.1999.tb05562.x; Tatum WO, 2020, JAMA NEUROL, V77, P593, DOI 10.1001/jamaneurol.2019.4785; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; Theodore WH, 2006, EPILEPSIA, V47, P1700, DOI 10.1111/j.1528-1167.2006.00633.x; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Trinka E, 2004, J NEUROL, V251, P1235, DOI 10.1007/s00415-004-0521-1; Veiby G, 2013, JAMA NEUROL, V70, P1367, DOI 10.1001/jamaneurol.2013.4290; Wiggs KK, 2020, NEUROLOGY, V95, pE3232, DOI 10.1212/WNL.0000000000010993; Xu Y, 2016, SEIZURE-EUR J EPILEP, V41, P167, DOI 10.1016/j.seizure.2016.08.005	104	13	13	15	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1269	1281		10.1001/jama.2022.3880	http://dx.doi.org/10.1001/jama.2022.3880			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380580				2022-12-28	WOS:000783965500019
J	Slomski, A				Slomski, Anita			Few Black Individuals Are Becoming Surgeons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1218	1218		10.1001/jama.2022.4372	http://dx.doi.org/10.1001/jama.2022.4372			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380593				2022-12-28	WOS:000783965500007
J	Tanner, M				Tanner, Michael			Antihypertensive drugs reduced risk for new-onset type 2 diabetes; effect varies by antihypertensive class	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Tanner, Michael] NYU, Grossman Sch Med, New York, NY 10003 USA	New York University	Tanner, M (corresponding author), NYU, Grossman Sch Med, New York, NY 10003 USA.							Centers for Disease Control and Prevention, PREV PRED AD; Centers for Disease Control and Prevention, FACTS HYP; Eleftheriadou I, 2011, CURR VASC PHARMACOL, V9, P715, DOI 10.2174/157016111797484099; New York State Department of Health, PRED; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC44	JC44		10.7326/J22-0018	http://dx.doi.org/10.7326/J22-0018		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377716				2022-12-28	WOS:000799170800010
J	Kmietowicz, Z				Kmietowicz, Zosia			Artificial pancreas is piloted in nearly 1000 people in England to gather real world data	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o834	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o874	10.1136/bmj.o874	http://dx.doi.org/10.1136/bmj.o874			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365478				2022-12-28	WOS:000783141700012
J	Rae, M; Carruthers, J				Rae, Maggie; Carruthers, Jamie			Childhood poverty is rising in the UK, but the government continue to ignore it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Carruthers, Jamie/0000-0003-3949-2711				Department For Work And Pensions, 2021, HOUS BEL AV INC 1994; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Gupta RPS, 2007, PAED CHILD HEALT-CAN, V12, P667, DOI 10.1093/pch/12.8.667; Sharma V, 2019, OBES REV, V20, P1341, DOI 10.1111/obr.12904; Simmonds M, 2016, OBES REV, V17, P95, DOI 10.1111/obr.12334; Survivors UK, 2022, GROOM	6	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o872	10.1136/bmj.o872	http://dx.doi.org/10.1136/bmj.o872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365459	Bronze			2022-12-28	WOS:000783141700020
J	He, WT; Hou, X; Zhao, J; Sun, JM; He, HJ; Si, W; Wang, J; Jiang, ZW; Yan, ZQ; Xing, G; Lu, M; Suchard, MA; Ji, X; Gong, WJ; He, B; Li, J; Lemey, P; Guo, DY; Tu, CC; Holmes, EC; Shi, M; Su, S				He, Wan-Ting; Hou, Xin; Zhao, Jin; Sun, Jiumeng; He, Haijian; Si, Wei; Wang, Jing; Jiang, Zhiwen; Yan, Ziqing; Xing, Gang; Lu, Meng; Suchard, Marc A.; Ji, Xiang; Gong, Wenjie; He, Biao; Li, Jun; Lemey, Philippe; Guo, Deyin; Tu, Changchun; Holmes, Edward C.; Shi, Mang; Su, Shuo			Virome characterization of game animals in China reveals a spectrum of emerging pathogens	CELL			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MOSAIC STRUCTURE; VIRUS; SEQUENCE; TRANSMISSION; INFECTION; EVOLUTION; ALIGNMENT; IDENTIFICATION; SARS-COV-2	Game animals are wildlife species traded and consumed as food and are potential reservoirs for SARS-CoV and SARS-CoV-2. We performed a meta-transcriptomic analysis of 1,941 game animals, representing 18 species and five mammalian orders, sampled across China. From this, we identified 102 mammalian-infecting viruses, with 65 described for the first time. Twenty-one viruses were considered as potentially high risk to humans and domestic animals. Civets (Paguma larvata) carried the highest number of potentially high-risk viruses. We inferred the transmission of bat-associated coronavirus from bats to civets, as well as cross -species jumps of coronaviruses from bats to hedgehogs, from birds to porcupines, and from dogs to raccoon dogs. Of note, we identified avian Influenza A virus H9N2 in civets and Asian badgers, with the latter displaying respiratory symptoms, as well as cases of likely human-to-wildlife virus transmission. These data highlight the importance of game animals as potential drivers of disease emergence.	[He, Wan-Ting; Zhao, Jin; Sun, Jiumeng; Jiang, Zhiwen; Yan, Ziqing; Lu, Meng; Su, Shuo] Nanjing Agr Univ, Acad Adv Interdisciplinary Studies, Coll Vet Med, Inst Immunol,Jiangsu Engn Lab Anim Immunol, Nanjing 210095, Peoples R China; [Hou, Xin; Wang, Jing; Guo, Deyin; Shi, Mang] Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen Campus, Shenzhen 518107, Peoples R China; [Gong, Wenjie; He, Biao; Tu, Changchun] Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun 130062, Jilin, Peoples R China; [Si, Wei; Xing, Gang] Zhejiang Univ, MOA Key Lab Anim Virol, Hangzhou 310058, Peoples R China; [Suchard, Marc A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA; [Ji, Xiang] Tulane Univ, Sch Sci & Engn, Dept Math, New Orleans, LA 70118 USA; [He, Haijian] Jinhua Polytech, Agr Coll, Jinhua 320017, Zhejiang, Peoples R China; [Li, Jun] City Univ Hong Kong, Jockey Club Coll Vet Med & Life Sci, Dept Infect Dis & Publ Hlth, Hong Kong 999077, Peoples R China; [Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Lab Clin & Epidemiol Virol, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium; [Holmes, Edward C.] Univ Sydney, Sydney Inst Infect Dis, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia	Nanjing Agricultural University; Sun Yat Sen University; Academy of Military Medical Sciences - China; Zhejiang University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tulane University; Jinhua Polytechnic; City University of Hong Kong; KU Leuven; University of Sydney; University of Sydney	Su, S (corresponding author), Nanjing Agr Univ, Acad Adv Interdisciplinary Studies, Coll Vet Med, Inst Immunol,Jiangsu Engn Lab Anim Immunol, Nanjing 210095, Peoples R China.; Shi, M (corresponding author), Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen Campus, Shenzhen 518107, Peoples R China.; Holmes, EC (corresponding author), Univ Sydney, Sydney Inst Infect Dis, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.; Holmes, EC (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	edward.holmes@sydney.edu.au; shim23@mail.sysu.edu.cn; shuosu@njau.edu.cn	Holmes, Edward/GVR-9499-2022	Sun, Jiumeng/0000-0003-2549-4812; Shi, Mang/0000-0002-6154-4437; Li, Jun/0000-0001-7218-429X	National Natural Science Foundation of Outstanding Youth Fund in China (NSFC) [31922081]; Fundamental Research Funds for the Central Universities [Y0201900459]; Bioinformatics Center (BIC) of Nanjing Agricultural University; National Key Research and Development Program of China [2021YFD1801101]; Shenzhen Science and Technology Program [KQTD20200820145822023]; Guangdong Province "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project [2019ZT08Y464]; Health and Medical Research Fund [COVID190206]; Australian Research Council Australia Laureate Fellowship [FL170100022]; Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen) [G051322N, G0D5117N, G0B9317N]; European Research Council under the European Union [725422-ReservoirDOCS]; Wellcome Trust [206298/Z/17/Z]; NIH [R01 AI153044]	National Natural Science Foundation of Outstanding Youth Fund in China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Bioinformatics Center (BIC) of Nanjing Agricultural University; National Key Research and Development Program of China; Shenzhen Science and Technology Program; Guangdong Province "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project; Health and Medical Research Fund; Australian Research Council Australia Laureate Fellowship(Australian Research Council); Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen)(FWO); European Research Council under the European Union(European Research Council (ERC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of Outstanding Youth Fund in China (NSFC grant no. 31922081) , the Fundamental Research Funds for the Central Universities (grant No. Y0201900459) , and the Bioinformatics Center (BIC) of Nanjing Agricultural University. The genomic epidemiology of novel raccoon dog coronavirus was supported by the National Key Research and Development Program of China (grant No. 2021YFD1801101) . M.S. was supported by the National Key Research and Development Program of China, the Shenzhen Science and Technology Program (KQTD20200820145822023) , the Guangdong Province "Pearl River Talent Plan"Innovation and Entrepreneurship Team Project (2019ZT08Y464) , and the Health and Medical Research Fund (COVID190206) . E.C.H. was supported by an Australian Research Council Australia Laureate Fellowship (FL170100022) . P.L. acknowledges support from the Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen,"G051322N, G0D5117N, and G0B9317N) . P.L. and M.A.S. acknowledge funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement no. 725422-ReservoirDOCS) , from the Wellcome Trust through project 206298/Z/17/Z (Artic Network) and from the NIH grant R01 AI153044. We give special thanks to Alibaba Cloud Computing Co. Ltd. for providing the computational resources for rapid data processing. We thank Professor Jiyong Zhou, Zhejiang University, for his guidance and help.	Abe M, 2010, VET MICROBIOL, V146, P253, DOI 10.1016/j.vetmic.2010.05.019; Aditya V, 2021, BIOL CONSERV, V257, DOI 10.1016/j.biocon.2021.109136; Aghokeng AF, 2010, INFECT GENET EVOL, V10, P386, DOI 10.1016/j.meegid.2009.04.014; Ao YY, 2017, SCI CHINA LIFE SCI, V60, P1348, DOI 10.1007/s11427-017-9231-4; Arnaboldi S, 2021, FOOD ENVIRON VIROL, V13, P146, DOI 10.1007/s12560-021-09467-z; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Banks M, 2002, J GEN VIROL, V83, P1325, DOI 10.1099/0022-1317-83-6-1325; Bi YH, 2016, CELL HOST MICROBE, V20, P810, DOI 10.1016/j.chom.2016.10.022; Bodewes R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-89; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buchfink B, 2021, NAT METHODS, V18, P366, DOI 10.1038/s41592-021-01101-x; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen JP, 2008, BIOCHEM GENET, V46, P392, DOI 10.1007/s10528-008-9157-7; CLEWLEY JP, 1995, MOL BIOTECHNOL, V3, P221, DOI 10.1007/BF02789332; Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13; Crossley BM, 2012, VIRUSES-BASEL, V4, P3689, DOI 10.3390/v4123689; Dai XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0081-6; Doro R, 2015, EXPERT REV ANTI-INFE, V13, P1337, DOI 10.1586/14787210.2015.1089171; Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/eLife.37324, 10.7554/elife.37324]; Gao WH, 2019, J GEN VIROL, V100, P1273, DOI 10.1099/jgv.0.001294; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Guillen-Servent A, 2006, ACTA CHIROPTEROL, V8, P39, DOI 10.3161/1733-5329(2006)8[39:ANSOBO]2.0.CO;2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holmes EC, 2021, CELL, V184, P4848, DOI 10.1016/j.cell.2021.08.017; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kent A, 2018, J WILDLIFE DIS, V54, P133, DOI 10.7589/2016-12-274; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau SKP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11110980; Lednicky JA, 2021, NATURE, V600, P133, DOI 10.1038/s41586-021-04111-z; Lednicky JA, 2022, CLIN INFECT DIS, V75, pE1184, DOI 10.1093/cid/ciab924; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178328; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Liu D, 2014, LANCET, V383, P869, DOI 10.1016/S0140-6736(14)60386-X; Liu P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11110979; Locatelli S, 2012, AIDS, V26, P659, DOI 10.1097/QAD.0b013e328350fb68; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luo XL, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0020-6; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Huong NQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237129; Nimgaonkar I, 2018, NAT REV GASTRO HEPAT, V15, P96, DOI 10.1038/nrgastro.2017.150; Ntumvi N.F., 2021, WILDLIFE CAMEROON HA, DOI [10.1101/2021.09.03.458874, DOI 10.1101/2021.09.03.458874]; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Philavong C, 2020, ZOONOSES PUBLIC HLTH, V67, P794, DOI 10.1111/zph.12759; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ran ZG, 2015, J VIROL, V89, P4818, DOI 10.1128/JVI.00059-15; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sayers EW, 2021, NUCLEIC ACIDS RES, V49, pD10, DOI 10.1093/nar/gkaa892; Shao Yu-hao, 2008, Chinese Journal of Virology, V24, P376; Shivaprakash KN, 2021, CURR BIOL, V31, P3671, DOI 10.1016/j.cub.2021.06.006; Skowronski DA, 2005, ANNU REV MED, V56, P357, DOI 10.1146/annurev.med.56.091103.134135; SMITH JM, 1992, J MOL EVOL, V34, P126; Song WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6509; Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008; Sun XJ, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050541; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Techangamsuwan S, 2015, VET PATHOL, V52, P724, DOI 10.1177/0300985814551580; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Villabruna N, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050478; Vlasova AN, 2022, CLIN INFECT DIS, V74, P446, DOI 10.1093/cid/ciab456; Wang JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143601; Wang SL, 2020, TRANSBOUND EMERG DIS, V67, P1074, DOI 10.1111/tbed.13469; Wang XH, 2019, J WILDLIFE DIS, V55, P947, DOI 10.7589/2018-09-211; Worobey M, 2021, SCIENCE, V374, P1202, DOI 10.1126/science.abm4454; Wu DL, 2005, J VIROL, V79, P2620, DOI 10.1128/JVI.79.4.2620-2625.2005; Xiao X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91470-2; Xu GL, 2016, J VIROL, V90, P8105, DOI 10.1128/JVI.00883-16; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou H, 2021, CELL, V184, P4380, DOI 10.1016/j.cell.2021.06.008; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	90	31	33	49	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1117	+		10.1016/j.cell.2022.02.014	http://dx.doi.org/10.1016/j.cell.2022.02.014			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J7WH	35298912	Green Accepted, Bronze			2022-12-28	WOS:000780311600006
J	Dyer, C				Dyer, Clare			Whistleblowing: nephrologist who reported colleagues to GMC was unfairly dismissed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o828	10.1136/bmj.o828	http://dx.doi.org/10.1136/bmj.o828			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351679				2022-12-28	WOS:000779544800011
J	Kariuki, S; Kamau, L				Kariuki, Simon; Kamau, Luna			A new generation of long-lasting insecticidal nets	LANCET			English	Editorial Material									[Kariuki, Simon; Kamau, Luna] Kenya Govt Med Res Ctr, POB 1578-40100, Kisumu, Kenya	Kenya Medical Research Institute	Kariuki, S (corresponding author), Kenya Govt Med Res Ctr, POB 1578-40100, Kisumu, Kenya.	skariuk1578@gmail.com						Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Hancock PA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000633; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Mosha JF, 2022, LANCET, V399, P1227, DOI 10.1016/S0140-6736(21)02499-5; Moyes CL, 2020, P NATL ACAD SCI USA, V117, P22042, DOI 10.1073/pnas.2006781117; Staedke SG, 2020, LANCET, V395, P1292, DOI 10.1016/S0140-6736(20)30214-2; Tiono AB, 2018, LANCET, V392, P569, DOI 10.1016/S0140-6736(18)31711-2; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, GLOB PLAN INS RES MA	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1202	+		10.1016/S0140-6736(22)00381-6	http://dx.doi.org/10.1016/S0140-6736(22)00381-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339212				2022-12-28	WOS:000779495000002
J	Thomson, R; Vrinten, C				Thomson, Rachel; Vrinten, Charlotte		UK Public Hlth Sci Conf Organising	UK Public Health Science 2022: a call for abstracts	LANCET			English	Editorial Material								The Public Health Science: A National Conference Dedicated to New Research in UK Public Health, will be held in Glasgow, UK, on Nov 25, 2022, and we are delighted to invite abstract submissions. This year marks a decade since the inaugural conference, which celebrated the talent and creativity of the public health research community in the UK and Ireland. This vision remains at the heart of the conference, which provides a platform to highlight excellence in public health science and enable discussion of important public health issues; the latest public health perspectives and science; and their implications for public health practice, policy, health services, and research. COVID-19 has brought new challenges for those working in public health to design, deliver, commission, or evaluate public health services. The impacts of the COVID-19 pandemic have amplified many of the inequalities that are pervasive in our communities.1,2 but also on wellbeing, equity, inclusiveness, and sustainability.	[Vrinten, Charlotte] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Thomson, Rachel] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	Imperial College London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Vrinten, C (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England.	c.vrinten@imperial.ac.uk		Ashman, Annie/0000-0002-3181-4168				Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Mellor, 2021, FORTUNE	2	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1210	1211		10.1016/S0140-6736(22)00476-7	http://dx.doi.org/10.1016/S0140-6736(22)00476-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35298904	Green Published			2022-12-28	WOS:000779495000007
J	Su, LZ; Wang, DY; Wang, SN; Qin, BC; Wang, YP; Qin, YX; Jin, Y; Chang, C; Zhao, LD				Su, Lizhong; Wang, Dongyang; Wang, Sining; Qin, Bingchao; Wang, Yuping; Qin, Yongxin; Jin, Yang; Chang, Cheng; Zhao, Li-Dong			High thermoelectric performance realized through manipulating layered phonon-electron decoupling	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; CARRIER MOBILITY; ENHANCEMENT	Thermoelectric materials allow for direct conversion between heat and electricity, offering the potential for power generation. The average dimensionless figure of merit ZT(ave) determines device efficiency. N-type tin selenide crystals exhibit outstanding three-dimensional charge and two-dimensional phonon transport along the out-of-plane direction, contributing to a high maximum figure of merit Z(max)of similar to 3.6 x 10(-3 )per kelvin but a moderate ZT(ave) of similar to 1.1. We found an attractive high Z(max) of similar to 4.1 x 10(-3 )per kelvin at 748 kelvin and a ZT(ave) of similar to 1.7 at 300 to 773 kelvin in chlorine-doped and lead-alloyed tin selenide crystals by phonon-electron decoupling. The chlorine-induced low deformation potential improved the carrier mobility. The lead-induced mass and strain fluctuations reduced the lattice thermal conductivity. Phonon-electron decoupling plays a critical role to achieve high-performance thermoelectrics.	[Su, Lizhong; Wang, Dongyang; Wang, Sining; Qin, Bingchao; Wang, Yuping; Qin, Yongxin; Jin, Yang] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Chang, Cheng; Zhao, Li-Dong] IST Austria, A-3400 Klosterneuburg, Austria	Beihang University; Institute of Science & Technology - Austria	Chang, C; Zhao, LD (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	cheng.chang@ist.ac.at; zhaolidong@buaa.edu.cn	Lizhong, Su/GSD-9524-2022; Qin, Bingchao/B-8438-2017; Zhao, Lidong/B-1045-2019	Lizhong, Su/0000-0002-3313-0886; Qin, Bingchao/0000-0003-2720-5922; Zhao, Lidong/0000-0003-1247-4345; Wang, Sining/0000-0001-7630-4041; Wang, Yuping/0000-0001-8080-7338; Chang, Cheng/0000-0002-9515-4277; Qin, Yongxin/0000-0002-1699-1369	Basic Science Center Project of the National Natural Science Foundation of China [51788104]; National Key Research and Development Program of China [2018YFB0703600]; National Science Fund for Distinguished Young Scholars [51925101]; 111 Project [B17002]; Lise Meitner Project [M2889-N]; National Postdoctoral Program for Innovative Talents [BX20200028]	Basic Science Center Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 Project(Ministry of Education, China - 111 Project); Lise Meitner Project(Austrian Science Fund (FWF)); National Postdoctoral Program for Innovative Talents	This work was supported by the Basic Science Center Project of the National Natural Science Foundation of China (51788104), the National Key Research and Development Program of China (2018YFA0702100), the National Science Fund for Distinguished Young Scholars (51925101), the 111 Project (B17002), the Lise Meitner Project (M2889-N), and the National Key Research and Development Program of China (2018YFB0703600). This work is also supported by the National Postdoctoral Program for Innovative Talents (BX20200028). L.-D.Z. is thankful for the high-performance computing resources at Beihang University.	Agne MT, 2019, ADV MATER, V31, DOI 10.1002/adma.201902980; Duong AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13713; BARDEEN J, 1950, PHYS REV, V80, P72, DOI 10.1103/PhysRev.80.72; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; Chang C, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201901334; Chang C, 2018, CHEM MATER, V30, P7355, DOI 10.1021/acs.chemmater.8b03732; Chang C, 2018, SCIENCE, V360, P778, DOI 10.1126/science.aaq1479; Chen HY, 2019, ADV MATER, V31, DOI 10.1002/adma.201806518; Chen ZG, 2018, PROG MATER SCI, V97, P283, DOI 10.1016/j.pmatsci.2018.04.005; Dewandre A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.276601; Fischetti MV, 1996, J APPL PHYS, V80, P2234, DOI 10.1063/1.363052; He JQ, 2010, ADV FUNCT MATER, V20, P764, DOI 10.1002/adfm.200901905; He WK, 2019, SCIENCE, V365, P1418, DOI 10.1126/science.aax5123; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; HERRING C, 1956, PHYS REV, V101, P944, DOI 10.1103/PhysRev.101.944; Jiang BB, 2021, SCIENCE, V371, P830, DOI 10.1126/science.abe1292; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kutorasinski K, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.205201; Liu WS, 2017, MATER TODAY PHYS, V1, P50, DOI 10.1016/j.mtphys.2017.06.001; Liu XH, 2013, ADV ENERGY MATER, V3, P1238, DOI 10.1002/aenm.201300174; Ma JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22541-1; Mao J, 2019, SCIENCE, V365, P495, DOI 10.1126/science.aax7792; Mao LS, 2020, ENERG ENVIRON SCI, V13, P616, DOI 10.1039/c9ee03897c; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Qin BC, 2021, SCIENCE, V373, P556, DOI 10.1126/science.abi8668; Qin BC, 2021, INFOMAT, V3, P755, DOI 10.1002/inf2.12217; Qin BC, 2019, J AM CHEM SOC, V141, P1141, DOI 10.1021/jacs.8b12450; Roychowdhury S, 2021, SCIENCE, V371, P722, DOI 10.1126/science.abb3517; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shi X, 2016, NAT MATER, V15, P691, DOI 10.1038/nmat4643; Snyder GJ, 2020, ADV MATER, V32, DOI 10.1002/adma.202001537; Tan GJ, 2016, CHEM REV, V116, P12123, DOI 10.1021/acs.chemrev.6b00255; Tang X.F., 2022, INTERDISCIP MAT, V1, P88, DOI DOI 10.1002/IDM2.12009; Volykhov AA, 2008, INORG MATER+, V44, P345, DOI 10.1134/S0020168508040043; Wang H, 2022, MATER ADV, V3, P734, DOI 10.1039/d1ma00780g; Wang H, 2012, P NATL ACAD SCI USA, V109, P9705, DOI 10.1073/pnas.1111419109; Wei TR, 2018, J MATERIOMICS, V4, P304, DOI 10.1016/j.jmat.2018.07.001; Xiao Y, 2020, SCIENCE, V367, P1196, DOI 10.1126/science.aaz9426; Xiao Y, 2020, J AM CHEM SOC, V142, P4051, DOI 10.1021/jacs.0c00306; Xie HH, 2013, ADV FUNCT MATER, V23, P5123, DOI 10.1002/adfm.201300663; Xin JZ, 2018, NPJ QUANTUM MATER, V3, DOI 10.1038/s41535-018-0083-6; Yan QY, 2022, NAT MATER, V21, P503, DOI 10.1038/s41563-021-01109-w; Yang J, 2016, NPJ COMPUT MATER, V2, DOI 10.1038/npjcompumats.2015.15; Yang TY, 2015, NUCL SCI TECH, V26, DOI [10.13538/j.1001-8042/nst.26.020101, 10.13538/j.1001-8042/nst.26.20101]; Zhao DL, 2016, J ELECTRON PACKAGING, V138, DOI 10.1115/1.4034605; Zhao LD, 2021, ACTA METALL SIN, V57, P1171, DOI 10.11900/0412.1961.2021.00130; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Zhao WY, 2017, NATURE, V549, P247, DOI 10.1038/nature23667; Zhou CJ, 2021, NAT MATER, V20, P1378, DOI 10.1038/s41563-021-01064-6; Zhou JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03866-w	54	34	34	142	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1385	+		10.1126/science.abn8997	http://dx.doi.org/10.1126/science.abn8997			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324303				2022-12-28	WOS:000778894800038
J	Fabbri, M; Navalon, G; Benson, RBJ; Pol, D; O'Connor, J; Bhullar, BAS; Erickson, GM; Norell, MA; Orkney, A; Lamanna, MC; Zouhri, S; Becker, J; Emke, A; Dal Sasso, C; Bindellini, G; Maganuco, S; Auditore, M; Ibrahim, N				Fabbri, Matteo; Navalon, Guillermo; Benson, Roger B. J.; Pol, Diego; O'Connor, Jingmai; Bhullar, Bhart-Anjan S.; Erickson, Gregory M.; Norell, Mark A.; Orkney, Andrew; Lamanna, Matthew C.; Zouhri, Samir; Becker, Justine; Emke, Amanda; Dal Sasso, Cristiano; Bindellini, Gabriele; Maganuco, Simone; Auditore, Marco; Ibrahim, Nizar			Subaqueous foraging among carnivorous dinosaurs	NATURE			English	Article							SEMIAQUATIC ADAPTATIONS; EVOLUTION; BIRD; MICROANATOMY; PHYLOGENY; SPINOSAUR; PATTERNS	Secondary aquatic adaptations evolved independently more than 30 times from terrestrial vertebrate ancestors(1,2). For decades, non-avian dinosaurs were believed to be an exception to this pattern. Only a few species have been hypothesized to be partly or predominantly aquatic(3-11). However, these hypotheses remain controversial(12,13), largely owing to the difficulty of identifying unambiguous anatomical adaptations for aquatic habits in extinct animals. Here we demonstrate that the relationship between bone density and aquatic ecologies across extant amniotes provides a reliable inference of aquatic habits in extinct species. We use this approach to evaluate the distribution of aquatic adaptations among non-avian dinosaurs. We find strong support for aquatic habits in spinosaurids, associated with a marked increase in bone density, which precedesthe evolution of more conspicuous anatomical modifications, a pattern also observed in other aquatic reptiles and mammals(14-16). Spinosaurids are revealed to be aquatic specialists with surprising ecological disparity, including subaqueous foraging behaviour in Spinosaurus and Baryonyx, and non-diving habits in Suchomimus. Adaptation to aquatic environments appeared in spinosaurids during the Early Cretaceous, following their divergence from other tetanu ran theropods during the Early Jurassic(17).	[Fabbri, Matteo; O'Connor, Jingmai] Field Museum Nat Hist, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA; [Navalon, Guillermo] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Navalon, Guillermo; Benson, Roger B. J.; Orkney, Andrew] Univ Oxford, Dept Earth Sci, Oxford, England; [Navalon, Guillermo] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain; [Pol, Diego] Museo Paleontol Egidio Feruglio, CONICET, Trelew, Argentina; [Bhullar, Bhart-Anjan S.] Yale Univ, Museum Nat Hist, Dept Earth & Planetary Sci & Peabody, New Haven, CT USA; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Vertebrate Paleontol, New York, NY 10024 USA; [Lamanna, Matthew C.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA USA; [Zouhri, Samir] Hassan II Univ Casablanca, Dept Geol, Casablanca, Morocco; [Zouhri, Samir] Hassan II Univ Casablanca, Hlth & Environm Lab, Casablanca, Morocco; [Becker, Justine; Emke, Amanda] Univ Detroit Mercy, Dept Biol, Detroit, MI 48221 USA; [Emke, Amanda] Wayne State Univ, Dept Phys Assistant Studies, Detroit, MI USA; [Dal Sasso, Cristiano; Bindellini, Gabriele; Maganuco, Simone; Auditore, Marco] Museo Storia Nat Milano, Sez Pareontol Vertebrati, Milan, Italy; [Bindellini, Gabriele] Univ Milan, Dipartimento Sci Terra A Desio, Milan, Italy; [Maganuco, Simone] Assoc Pareontol Pareoartist Itariana, Parma, Italy; [Ibrahim, Nizar] Univ Portsmouth, Sch Environm Geog & Geosci, Portsmouth, Hants, England	Field Museum of Natural History (Chicago); University of Cambridge; University of Oxford; Autonomous University of Madrid; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Yale University; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Hassan II University of Casablanca; Hassan II University of Casablanca; University of Detroit Mercy; Wayne State University; University of Milan; University of Portsmouth	Fabbri, M (corresponding author), Field Museum Nat Hist, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA.; Navalon, G (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge, England.; Navalon, G; Benson, RBJ (corresponding author), Univ Oxford, Dept Earth Sci, Oxford, England.; Navalon, G (corresponding author), Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain.	mfabbri@fieldmuseum.org; gn315@cam.ac.uk; roger.benson@earth.ox.ac.uk	Pol, Diego/A-8007-2008; Lamanna, Matthew/E-6045-2019	Pol, Diego/0000-0002-9690-7517; Lamanna, Matthew/0000-0001-9845-0728; Benson, Roger/0000-0001-8244-6177; Fabbri, Matteo/0000-0002-1257-1594; Zouhri, Samir/0000-0002-3811-9977; Navalon, Guillermo/0000-0002-2447-1275; Orkney, Andrew/0000-0003-4972-2541	European Union [677774]; National Geographic Society [CP-143R-170]; National Geographic Emerging Explorer Grant; Jurassic Foundation; Paleontological Society grant; Explorers Club; Lokschuppen (Rosenheim, Germany)	European Union(European Commission); National Geographic Society(National Geographic Society); National Geographic Emerging Explorer Grant(National Geographic Society); Jurassic Foundation; Paleontological Society grant; Explorers Club; Lokschuppen (Rosenheim, Germany)	We acknowledge P. Barrett and S. Chapman for access to the holotype of Baryonyx at the Natural History Museum, London, J. Scannella for access to thin sections of Tyrannosaurus housed at the Museum of the Rockies, and M. Fox and J. Gauthier for access to Poposaurus at the Yale Peabody Museum. The Moroccan Ministry of Energy, Mines, and the Environment is thanked for providing fieldwork permits to N. I. Members of the 2015-2019 expedition seasons are thanked for their assistance in the field. We thank J. Choiniere, P. Falkingham, S. Nesbitt and the other, anonymous, reviewer for constructive comments that improved the manuscript. Funding was received from the European Union's Horizon 2020 research and innovation program 2014-2018, starting grant (R. B. J. B., 677774); a National Geographic Society grant (N.I., CP-143R-170); a National Geographic Emerging Explorer Grant (N.I.); the Jurassic Foundation (M.F.); the Paleontological Society grant (M.F.), as well as the Explorers Club (grant awarded to M.F.). The Lokschuppen (Rosenheim, Germany) and J. Pfauntsch provided additional financial support for fieldwork led by N.I. in Morocco.	Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Amson E, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01016-1; Amson E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0192; Aureliano T, 2018, CRETACEOUS RES, V90, P283, DOI 10.1016/j.cretres.2018.04.024; Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Barker CT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97870-8; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bidar A., 1972, Annales Mus Hist nat Nice, V1, P9; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Canoville A, 2016, BIOL J LINN SOC, V118, P706, DOI 10.1111/bij.12779; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Cau A, 2017, NATURE, V552, P395, DOI 10.1038/nature24679; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Cope E., 1883, P NATL ACAD NAT SCI, V35, P97; De Ricqles AJ, 2003, J VERTEBR PALEONTOL, V23, P373, DOI 10.1671/0272-4634(2003)023[0373:OOCSTA]2.0.CO;2; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Griffin CT, 2021, BIOL REV, V96, P470, DOI 10.1111/brv.12666; Gutarra S, 2022, BIOL REV, V97, P67, DOI 10.1111/brv.12790; Hassler A, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0197; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Henderson DM, 2018, PEERJ, V6, DOI 10.7717/peerj.5409; Hone D, 2021, PALAEONTOL ELECTRON, V24, pa03, DOI [10.26879/1110, DOI 10.26879/1110]; Houssaye A, 2021, J MAMM EVOL, V28, P847, DOI 10.1007/s10914-021-09536-x; Houssaye A, 2016, INTEGR COMP BIOL, V56, P1349, DOI 10.1093/icb/icw120; Houssaye A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118409; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Ibrahim N, 2020, NATURE, V581, P67, DOI 10.1038/s41586-020-2190-3; Ibrahim N, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.928.47517; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kelley NP, 2015, SCIENCE, V348, DOI 10.1126/science.aaa3716; Langer MC, 2017, NATURE, V551, pE1, DOI 10.1038/nature24011; Larramendi A, 2021, ANAT REC, V304, P1833, DOI 10.1002/ar.24574; Lee YN, 2014, NATURE, V515, P257, DOI 10.1038/nature13874; LIEM KF, 1980, AM ZOOL, V20, P295; Maddison WP, 2008, MESQUITE MODULAR SYS; Malafaia E, 2020, CRETACEOUS RES, V106, DOI 10.1016/j.cretres.2019.104221; Motani R, 2015, NATURE, V517, P485, DOI 10.1038/nature13866; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; Nesbitt SJ, 2017, NATURE, V544, P484, DOI 10.1038/nature22037; Norell MA, 2001, NATURE, V412, P873, DOI 10.1038/35091139; Owen R., 1841, P GEOLOGICAL SOC LON, V3, P457; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Quemeneur S, 2013, BIOL J LINN SOC, V109, P644, DOI 10.1111/bij.12066; Rauhut OWM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53672-7; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Reid R.E.H., 1990, Modern Geology, V15, P19; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Simoes TR, 2018, NATURE, V557, P706, DOI 10.1038/s41586-018-0093-3; Smyth RSH, 2020, CRETACEOUS RES, V114, DOI 10.1016/j.cretres.2020.104520; Straehl FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069275; Taquet P., 1976, GEOLOGIE PALEONTOLOG; Tereschenko VS, 2008, PALEONTOL J+, V42, P273, DOI 10.1134/S003103010803009X; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Upham NS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000494; Voeten DFAE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03296-8; Wilson LE, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140245; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377	66	4	4	11	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					852	+		10.1038/s41586-022-04528-0	http://dx.doi.org/10.1038/s41586-022-04528-0		MAR 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35322229	Green Submitted			2022-12-28	WOS:000772363100006
J	Teshome, BG; Desai, MM; Gross, CP; Hill, KA; Li, FY; Samuels, EA; Wong, AH; Xu, YS; Boatright, DH				Teshome, Bethelehem G.; Desai, Mayur M.; Gross, Cary P.; Hill, Katherine A.; Li, Fangyong; Samuels, Elizabeth A.; Wong, Ambrose H.; Xu, Yunshan; Boatright, Dowin H.			Marginalized identities, mistreatment, discrimination, and burnout among US medical students: cross sectional survey and retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; INTERSECTIONALITY; ASSOCIATION; HARASSMENT; EXPERIENCES; DIVERSITY; EDUCATION; FACULTY; GENDER; WOMEN	OBJECTIVE To describe the association between mistreatment, burnout, and having multiple marginalized identities during undergraduate medical education. DESIGN Cross sectional survey and retrospective cohort study. SETTING 140 US medical schools accredited by the Association of American Medical Colleges. PARTICIPANTS 30 651 graduating medical students in 2016 and 2017. MAIN OUTCOME MEASURES Self-reported sex, race or ethnicity, and sexual orientation groups were considered, based on the unique combinations of historically marginalized identities held by students. Multivariable linear regression was used to determine the association between unique identity groups and burnout along two dimensions (exhaustion and disengagement) as measured by the Oldenburg Burnout Inventory for Medical Students while accounting for mistreatment and discrimination. RESULTS Students with three marginalized identities (female; non-white; lesbian, gay, or bisexual (LGB)) had the largest proportion reporting recurrent experiences of multiple types of mistreatment (88/299, P<0.001) and discrimination (92/299, P<0.001). Students with a higher number of marginalized identities also had higher average scores for exhaustion. Female, non-white, and LGB students had the largest difference in average exhaustion score compared with male, white, and heterosexual students (adjusted mean difference 1.96, 95% confidence interval 1.47 to 2.44). Mistreatment and discrimination mediated exhaustion scores for all identity groups but did not fully explain the association between unique identity group and burnout. Non-white and LGB students had higher average disengagement scores than their white and heterosexual counterparts (0.28, 0.19 to 0.37; and 0.73, 0.52 to 0.94; respectively). Female students, in contrast, had lower average disengagement scores irrespective of the other identities they held. After adjusting for mistreatment and discrimination among female students, the effect among female students became larger, indicating a negative confounding association. CONCLUSION In this study population of US medical students, those with multiple marginalized identities reported more mistreatment and discrimination during medical school, which appeared to be associated with burnout.	[Teshome, Bethelehem G.] Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA; [Teshome, Bethelehem G.] Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA 91101 USA; [Desai, Mayur M.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, Divers Equ & Inclus, New Haven, CT USA; [Gross, Cary P.] Yale Sch Med, Dept Internal Med, Natl Clinician Scholars Program, New Haven, CT USA; [Hill, Katherine A.] Yale Sch Med, New Haven, CT USA; [Li, Fangyong; Xu, Yunshan] Yale Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT USA; [Samuels, Elizabeth A.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Wong, Ambrose H.; Boatright, Dowin H.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA	Yale University; Kaiser Permanente; Yale University; Yale University; Yale University; Yale University; Brown University; Yale University	Teshome, BG (corresponding author), Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA.; Teshome, BG (corresponding author), Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA 91101 USA.	bgteshome@aya.yale.edu	Samuels, Elizabeth/E-6302-2018	Samuels, Elizabeth/0000-0003-2414-110X; Teshome, Bethelehem/0000-0002-4913-2421	National Institute of General Medical Sciences [RO1GM137411]; Josiah Macy Jr Foundation; Society for Academic Emergency Medicine Foundation/Academy for Diversity and Inclusion in Emergency Medicine; Association of American Medical Colleges' Northeast Group on Educational Affairs; US National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases [T35DK10468]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Josiah Macy Jr Foundation; Society for Academic Emergency Medicine Foundation/Academy for Diversity and Inclusion in Emergency Medicine; Association of American Medical Colleges' Northeast Group on Educational Affairs; US National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases	This study was supported by the National Institute of General Medical Sciences (award RO1GM137411 for DHB) , Josiah Macy Jr Foundation, Society for Academic Emergency Medicine Foundation/Academy for Diversity and Inclusion in Emergency Medicine, Association of American Medical Colleges' Northeast Group on Educational Affairs, and US National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (award T35DK10468 for KAH) . The funders had no role in the study design, analysis, interpretation of results, or writing and dissemination of the article and its findings.	Acosta D, 2018, ACAD MED, V93, P354, DOI 10.1097/ACM.0000000000002037; Anderson N, 2022, J GEN INTERN MED, V37, P298, DOI 10.1007/s11606-021-06786-6; Association of American Medical Colleges, 2017, CREATING WELCOMING C; Association of American Medical Colleges, UND MED DEF; Association of American Medical Colleges, 2020, MED STUD; Association of American Medical Colleges, GRAD QUEST 2019; Babaria P, 2012, SOC SCI MED, V74, P1013, DOI 10.1016/j.socscimed.2011.11.043; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Beagan BL, 2003, MED EDUC, V37, P852, DOI 10.1046/j.1365-2923.2003.01622.x; Behel JM, 2018, HEALING HEALERS; Berg DavidN., 2002, J APPL BEHAV SCI, V38, P397, DOI [10.1177/002188602237789, DOI 10.1177/002188602237789]; Boatright DH, 2018, JAMA-J AM MED ASSOC, V320, P2267, DOI 10.1001/jama.2018.13705; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Brand JPL., 1999, DEV IMPLEMENTATION E; Bright CM, 1998, J NATL MED ASSOC, V90, P681; Brogan DJ, 1999, JAMA-J AM MED ASSOC, V282, P1290, DOI 10.1001/jama.282.13.1290; Campbell KM, 2019, ACAD MED, V94, P1854, DOI 10.1097/ACM.0000000000002839; Cook AF, 2014, ACAD MED, V89, P749, DOI 10.1097/ACM.0000000000000204; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [10.2307/1229039, DOI 10.2307/1229039]; Cyrus KD, 2017, JAMA-J AM MED ASSOC, V317, P1833, DOI 10.1001/jama.2017.0196; Demerouti E., 2008, HDB STRESS BURNOUT H, P65; Dyrbye LN, 2015, ACAD MED, V90, P961, DOI 10.1097/ACM.0000000000000655; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Eckstrand KL, 2016, ACAD MED, V91, P904, DOI 10.1097/ACM.0000000000001231; Ellinas EH, 2018, J WOMENS HEALTH, V27, P324, DOI 10.1089/jwh.2017.6457; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Franklin JD, 2019, RACE ETHNIC EDUC-UK, V22, P589, DOI 10.1080/13613324.2019.1579178; Halbesleben JRB, 2005, WORK STRESS, V19, P208, DOI 10.1080/02678370500340728; Hill KA, 2020, JAMA INTERN MED, V180, P653, DOI 10.1001/jamainternmed.2020.0030; Hu YY, 2019, NEW ENGL J MED, V381, P1741, DOI 10.1056/NEJMsa1903759; Hwang J, 2017, AM J PHYS MED REHAB, V96, P593, DOI 10.1097/PHM.0000000000000716; Lapinski J, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-171; Lett LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207274; Madera JM, 2012, CULT DIVERS ETHN MIN, V18, P165, DOI 10.1037/a0027724; Mansh Matthew, 2015, Mo Med, V112, P266; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Nunez-Smith M, 2009, J NATL MED ASSOC, V101, P1274, DOI 10.1016/S0027-9684(15)31139-1; Nunez-Smith M, 2009, J GEN INTERN MED, V24, P1198, DOI 10.1007/s11606-009-1103-9; Pololi LH, 2013, ACAD MED, V88, P1308, DOI 10.1097/ACM.0b013e31829eefff; Powers BW, 2016, ACAD MED, V91, P913, DOI 10.1097/ACM.0000000000001074; Reed DA, 2011, ACAD MED, V86, P1367, DOI 10.1097/ACM.0b013e3182305d81; Samuels EA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.36136; Sanchez NF, 2015, LGBT HEALTH, V2, P346, DOI 10.1089/lgbt.2015.0024; Sinval J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00338; Tipa Raluca Oana, 2019, J Med Life, V12, P354, DOI 10.25122/jml-2019-0089; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van Ryn M, 2015, J GEN INTERN MED, V30, P1748, DOI 10.1007/s11606-015-3447-7; Viehl C., 2017, PSYCHOL SEX ORIENTAT, V4, P354, DOI [DOI 10.1037/SGD0000236, 10.1037/sgd0000236]; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Zelin NS, 2018, MED EDUC ONLINE, V23, DOI 10.1080/10872981.2018.1461513	52	5	5	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								e065984	10.1136/bmj-2021-065984	http://dx.doi.org/10.1136/bmj-2021-065984			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0E9XK	35318190	hybrid, Green Published			2022-12-28	WOS:000777024700004
J	Wise, J				Wise, Jacqui			Health of people in England did not improve in the years before the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Office for National Statistics, 2022, HLTH ENGL 2015 2019	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o744	10.1136/bmj.o744	http://dx.doi.org/10.1136/bmj.o744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314437				2022-12-28	WOS:000773915700005
J	Kennedy, AG				Kennedy, Ashley Graham			Evaluating the Effectiveness of Diagnostic Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kennedy, Ashley Graham] Florida Atlantic Univ, Honors Coll, 5353 Parkside Dr, Jupiter, FL 33458 USA	State University System of Florida; Florida Atlantic University	Kennedy, AG (corresponding author), Florida Atlantic Univ, Honors Coll, 5353 Parkside Dr, Jupiter, FL 33458 USA.	kennedya@fau.edu						Kennedy AG., 2021, DIAGNOSIS GUIDE MED; Kennedy AG, 2016, J EVAL CLIN PRACT, V22, P575, DOI 10.1111/jep.12541; Sox H., 2013, MED DECIS MAKING, V2nd ed, DOI [10.1002/9781118341544, DOI 10.1002/9781118341544]	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2022	327	14					1335	1336		10.1001/jama.2022.4463	http://dx.doi.org/10.1001/jama.2022.4463		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1FH	35302590				2022-12-28	WOS:000770396900002
J	Luo, JH; Yang, Q; Zhang, XF; Zhang, YY; Wan, L; Zhan, XC; Zhou, Y; He, LQ; Li, DY; Jin, DZ; Zhen, Y; Huang, J; Li, YY; Tao, L				Luo, Jianhua; Yang, Qi; Zhang, Xiaofeng; Zhang, Yuanyuan; Wan, Li; Zhan, Xiechao; Zhou, Yao; He, Liuqing; Li, Danyang; Jin, Dazhi; Zhen, Ying; Huang, Jing; Li, Yanyan; Tao, Liang			TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile	CELL			English	Article							FACTOR PATHWAY INHIBITOR; CLOSTRIDIUM-DIFFICILE INFECTION; UDP-GLUCOSE DEFICIENCY; TOXIN-B; FRIZZLED PROTEINS; KUNITZ-3 DOMAIN; LETHAL TOXIN; FACTOR XA; ALPHA; SPECIFICITY	The emergence of hypervirulent clade 2 Clostridioides difficile is associated with severe symptoms and accounts for >20% of global infections. TcdB is a dominant virulence factor of C. difficile, and clade 2 strains exclusively express two TcdB variants (TcdB2 and TcdB4) that use unknown receptors distinct from the classic TcdB. Here, we performed CRISPR/Cas9 screens for TcdB4 and identified tissue factor pathway inhibitor (TFPI) as its receptor. Using cryo-EM, we determined a complex structure of the full-length TcdB4 with TFPI, defining a common receptor-binding region for TcdB. Residue variations within this region divide major TcdB variants into 2 classes: one recognizes Frizzled (FZD), and the other recognizes TFPI. TFPI is highly expressed in the intestinal glands, and recombinant TFPI protects the colonic epithelium from TcdB2/4. These findings establish TFPI as a colonic crypt receptor for TcdB from clade 2 C. difficile and reveal new mechanisms for CDI pathogenesis.	[Luo, Jianhua; Yang, Qi; Zhang, Xiaofeng; Zhang, Yuanyuan; Wan, Li; Zhan, Xiechao; Zhou, Yao; He, Liuqing; Li, Danyang; Zhen, Ying; Huang, Jing; Li, Yanyan; Tao, Liang] Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China; [Luo, Jianhua; Yang, Qi; Zhang, Xiaofeng; Zhang, Yuanyuan; Wan, Li; Zhan, Xiechao; Zhou, Yao; He, Liuqing; Li, Danyang; Zhen, Ying; Huang, Jing; Li, Yanyan; Tao, Liang] Westlake Lab Life Sci & Biomed, Ctr Infect Dis Res, Hangzhou 310024, Zhejiang, Peoples R China; [Luo, Jianhua; Yang, Qi; Zhang, Yuanyuan; Zhou, Yao; He, Liuqing; Li, Danyang; Tao, Liang] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou 310024, Zhejiang, Peoples R China; [Zhang, Xiaofeng; Wan, Li; Zhan, Xiechao; Zhen, Ying; Huang, Jing; Li, Yanyan] Westlake Inst Adv Study, Inst Biol, Hangzhou 310024, Zhejiang, Peoples R China; [Zhang, Yuanyuan] Zhejiang Gongshang Univ, Sch Food Sci & Biotechnol Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Jin, Dazhi] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Ctr Lab Med, Hangzhou 310014, Zhejiang, Peoples R China; [Jin, Dazhi] Hangzhou Med Coll, Sch Lab Med, Hangzhou 310014, Zhejiang, Peoples R China	Westlake University; Westlake University; Westlake University; Zhejiang Gongshang University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College	Li, YY; Tao, L (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Zhejiang, Peoples R China.; Li, YY; Tao, L (corresponding author), Westlake Lab Life Sci & Biomed, Ctr Infect Dis Res, Hangzhou 310024, Zhejiang, Peoples R China.; Tao, L (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou 310024, Zhejiang, Peoples R China.; Li, YY (corresponding author), Westlake Inst Adv Study, Inst Biol, Hangzhou 310024, Zhejiang, Peoples R China.	liyanyan@westlake.edu.cn; taoliang@westlake.edu.cn	Tao, Liang/O-4590-2019; wan, li/GRY-7634-2022; li, danyang/HHS-3319-2022; Luo, jian/HGE-7331-2022; Zhang, Yuanyuan/GOJ-9271-2022; Zhan, Xiechao/GLQ-9287-2022	Tao, Liang/0000-0003-3441-698X; /0000-0003-3589-115X; He, Liuqing/0000-0003-0213-3213; Zhan, Xiechao/0000-0001-5198-6461; Zhang, Xiaofeng/0000-0002-9658-5917	National Natural Science Foundation of China [31970129, 31800128, 32171205]; Zhejiang Provincial Natural Science Foundation of China [LR20C010001, LR20C050001]; Westlake Education Foundation; Westlake Laboratory of Life Sciences and Biomedicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Westlake Education Foundation; Westlake Laboratory of Life Sciences and Biomedicine	We thank Drs. Min Dong (Boston Children's Hospital), Hongtao Yu (Westlake University), and Dangsheng Li (Westlake University) for discussion. We also appreciate the technical support from the Biomedical Research Core Facilities and Laboratory Animal Resources Center of Westlake University. This study was partially supported by the National Natural Science Foundation of China (grant nos. 31970129 and 31800128 to L.T. and grant no. 32171205 to Y.L.) and Zhejiang Provincial Natural Science Foundation of China (grant no. LR20C010001 to L.T. and grant no. LR20C050001 to Y.L.). L.T. and Y.L. acknowledge support from Westlake Education Foundation and Westlake Laboratory of Life Sciences and Biomedicine.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Badilla-Lobo A, 2021, ANAEROBE, V69, DOI 10.1016/j.anaerobe.2021.102355; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Chandrasekaran R, 2017, FEMS MICROBIOL REV, V41, P723, DOI 10.1093/femsre/fux048; Charilaou P, 2018, J GASTROEN HEPATOL, V33, P1227, DOI 10.1111/jgh.14064; ChavesOlarte E, 1996, J BIOL CHEM, V271, P6925, DOI 10.1074/jbc.271.12.6925; Chen P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23878-3; Chen P, 2019, NAT STRUCT MOL BIOL, V26, P712, DOI 10.1038/s41594-019-0268-0; Chen P, 2019, FEBS J, V286, P874, DOI 10.1111/febs.14681; Chen P, 2018, SCIENCE, V360, P664, DOI 10.1126/science.aar1999; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chowdary P, 2020, INT J HEMATOL, V111, P42, DOI 10.1007/s12185-018-2548-6; Chung SY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02314; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Cowardin CA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.108, 10.1038/nmicrobiol.2016.108]; Donahue BS, 2006, J THROMB HAEMOST, V4, P1011, DOI 10.1111/j.1538-7836.2006.01896.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher JR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20746-4; FloresDiaz M, 1997, J BIOL CHEM, V272, P23784, DOI 10.1074/jbc.272.38.23784; Genth H, 2014, CELL MICROBIOL, V16, P1706, DOI 10.1111/cmi.12321; Girard TJ, 2018, J THROMB HAEMOST, V16, P2246, DOI 10.1111/jth.14288; Girard TJ, 2012, BLOOD, V119, P1256, DOI 10.1182/blood-2011-10-388512; Guh AY, 2020, NEW ENGL J MED, V382, P1320, DOI 10.1056/NEJMoa1910215; Gupta P, 2017, J BIOL CHEM, V292, P17290, DOI 10.1074/jbc.M117.806687; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Henkel D, 2020, TOXINS, V12, DOI 10.3390/toxins12120736; Huang ZF, 1997, BLOOD, V90, P944, DOI 10.1182/blood.V90.3.944.944_944_951; Hunt JJ, 2013, MICROBIOL MOL BIOL R, V77, P567, DOI 10.1128/MMBR.00017-13; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Knight DR, 2021, ELIFE, V10, DOI 10.7554/eLife.64325; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Lee HS, 2020, CELL, V182, P345, DOI 10.1016/j.cell.2020.06.005; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lopez-Urena D, 2019, TOXINS BASEL, V11, pE348; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mansfield MJ, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009181; Maroney SA, 2015, J THROMB HAEMOST, V13, pS200, DOI 10.1111/jth.12897; Maroney SA, 2010, THROMB RES, V125, pS52, DOI 10.1016/j.thromres.2010.01.038; Mast AE, 2016, ARTERIOSCL THROM VAS, V36, P9, DOI 10.1161/ATVBAHA.115.305996; Mileto SJ, 2020, P NATL ACAD SCI USA, V117, P8064, DOI 10.1073/pnas.1915255117; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NOVOTNY WF, 1989, J BIOL CHEM, V264, P18832; Pan ZR, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009197; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piro O, 2005, J THROMB HAEMOST, V3, P2677, DOI 10.1111/j.1538-7836.2005.01636.x; Piro O, 2004, CIRCULATION, V110, P3567, DOI 10.1161/01.CIR.0000148778.76917.89; Pruss KM, 2021, NATURE, V593, P261, DOI 10.1038/s41586-021-03502-6; Quesada-Gomez C, 2016, INFECT IMMUN, V84, P856, DOI 10.1128/IAI.01291-15; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SANDSET PM, 1988, THROMB RES, V50, P803, DOI 10.1016/0049-3848(88)90340-4; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Shen EH, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1078-y; Sidonio RF, 2019, BLOOD, V134, P1885, DOI 10.1182/blood.2019002900; Simeon R, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000311; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Tao L, 2019, NAT MICROBIOL, V4, P1760, DOI 10.1038/s41564-019-0464-z; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VanInsberghe D, 2020, NAT MICROBIOL, V5, P642, DOI 10.1038/s41564-020-0668-2; VONEICHELSTREIBER C, 1995, MOL MICROBIOL, V17, P313, DOI 10.1111/j.1365-2958.1995.mmi_17020313.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang J, 2003, CIRCULATION, V108, P623, DOI 10.1161/01.CIR.0000078642.45127.7B; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou Y, 2021, CELL RES, V31, P935, DOI 10.1038/s41422-021-00510-z; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	86	6	6	12	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2022	185	6					980	+		10.1016/j.cell.2022.02.010	http://dx.doi.org/10.1016/j.cell.2022.02.010			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZZ6CW	35303428				2022-12-28	WOS:000773355400007
J	Nolan, T				Nolan, Tom			Tom Nolan's research reviews-17 March 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o670	10.1136/bmj.o670	http://dx.doi.org/10.1136/bmj.o670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301196	Bronze			2022-12-28	WOS:000796719200005
J	Delany-Moretlwe, S; Hughes, JP; Bock, P; Ouma, SG; Hunidzarira, P; Kalonji, D; Kayange, N; Makhema, J; Mandima, P; Mathew, C; Spooner, E; Mpendo, J; Mukwekwerere, P; Mgodi, N; Ntege, PN; Nair, G; Nakabiito, C; Nuwagaba-Biribonwoha, H; Panchia, R; Singh, N; Siziba, B; Farrior, J; Rose, S; Anderson, PL; Eshleman, SH; Marzinke, MA; Hendrix, CW; Beigel-Orme, S; Hosek, S; Tolley, E; Sista, N; Adeyeye, A; Rooney, JF; Rinehart, A; Spreen, WR; Smith, K; Hanscom, B; Cohen, MS; Hosseinipour, MC				Delany-Moretlwe, Sinead; Hughes, James P.; Bock, Peter; Ouma, Samuel Gurrion; Hunidzarira, Portia; Kalonji, Dishiki; Kayange, Noel; Makhema, Joseph; Mandima, Patricia; Mathew, Carrie; Spooner, Elizabeth; Mpendo, Juliet; Mukwekwerere, Pamela; Mgodi, Nyaradzo; Ntege, Patricia Nahirya; Nair, Gonasagrie; Nakabiito, Clemensia; Nuwagaba-Biribonwoha, Harriet; Panchia, Ravindre; Singh, Nishanta; Siziba, Bekezela; Farrior, Jennifer; Rose, Scott; Anderson, Peter L.; Eshleman, Susan H.; Marzinke, Mark A.; Hendrix, Craig W.; Beigel-Orme, Stephanie; Hosek, Sybil; Tolley, Elizabeth; Sista, Nirupama; Adeyeye, Adeola; Rooney, James F.; Rinehart, Alex; Spreen, William R.; Smith, Kimberly; Hanscom, Brett; Cohen, Myron S.; Hosseinipour, Mina C.		HPTN 084 study group	Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial	LANCET			English	Article							PREEXPOSURE PROPHYLAXIS; CISGENDER MEN; TENOFOVIR; EMTRICITABINE; INFECTION	Background Oral pre-exposure prophylaxis has been introduced in more than 70 countries, including many in sub-Saharan Africa, but women experience considerable barriers to daily pill-taking, such as stigma, judgement, and the fear of violence. Safe and effective long-acting agents for HIV prevention are needed for women. We aimed to evaluate the safety and efficacy of injectable cabotegravir compared with daily oral tenofovir diphosphate plus emtricitabine (TDF-FTC) for HIV prevention in HIV-uninfected women. Methods HPTN 084 was a phase 3, randomised, double-blind, double-dummy, active-controlled, superiority trial in 20 clinical research sites in seven countries in sub-Saharan Africa. Participants were eligible for enrolment if they were assigned female sex at birth, were aged 18-45 years, reported at least two episodes of vaginal intercourse in the previous 30 days, were at risk of HIV infection based on an HIV risk score, and agreed to use a long-acting reversible contraceptive method. Participants were randomly assigned (1:1) to either active cabotegravir with TDF-FTC placebo (cabotegravir group) or active TDF-FTC with cabotegravir placebo (TDF-FTC group). Study staff and participants were masked to study group allocation, with the exception of the site pharmacist who was responsible for study product preparation. Participants were prescribed 5 weeks of daily oral product followed by intramuscular injections every 8 weeks after an initial 4-week interval load, alongside daily oral pills. Participants who discontinued injections were offered open-label daily TDF-FTC for 48 weeks. The primary endpoints of the study were incident HIV infection in the intention-to-treat population, and clinical and laboratory events that were grade 2 or higher in all women who had received at least one dose of study product. This study is registered with ClinicalTrials.gov, NCT03164564. Findings From Nov 27, 2017, to Nov 4, 2020, we enrolled 3224 participants (1614 in the cabotegravir group and 1610 in the TDF-FTC group). Median age was 25 years (IQR 22-30); 1755 (54middot7%) of 3209 had two or more partners in the preceding month. 40 incident infections were observed over 3898 person-years (HIV incidence 1middot0% [95% CI 0middot73-1middot40]); four in the cabotegravir group (HIV incidence 0middot2 cases per 100 person-years [0middot06-0middot52]) and 36 in the TDF-FTC group (1middot85 cases per 100 person-years [1middot3-2middot57]; hazard ratio 0middot12 [0middot05-0middot31]; p<0middot0001; risk difference -1middot6% [-1middot0% to -2middot3%]. In a random subset of 405 TDF-FTC participants, 812 (42middot1%) of 1929 plasma samples had tenofovir concentrations consistent with daily use. Injection coverage was 93% of the total number of person-years. Adverse event rates were similar across both groups, apart from injection site reactions, which were more frequent in the cabotegravir group than in the TDF-FTC group (577 [38middot0%] of 1519 vs 162 [10middot7%] of 1516]) but did not result in injection discontinuation. Confirmed pregnancy incidence was 1middot3 per 100 person-years (0middot9-1middot7); no congenital birth anomalies were reported. Interpretation Although both products for HIV prevention were generally safe, well tolerated, and effective, cabotegravir was superior to TDF-FTC in preventing HIV infection in women. Funding National Institute of Allergy and Infectious Diseases, ViiV Healthcare, and the Bill & Melinda Gates Foundation. Additional support was provided through the National Institute of Mental Health, the National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. ViiV Healthcare and Gilead Sciences provided pharmaceutical support. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Delany-Moretlwe, Sinead; Mathew, Carrie] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Hughes, James P.; Beigel-Orme, Stephanie; Hanscom, Brett] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Bock, Peter] Univ Stellenbosch, Desmond Tutu TB Ctr, Stellenbosch, South Africa; [Ouma, Samuel Gurrion] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu Clin Res Site, Kisumu, Kenya; [Hunidzarira, Portia; Mandima, Patricia; Mukwekwerere, Pamela; Mgodi, Nyaradzo; Siziba, Bekezela] Univ Zimbabwe, Clin Trials Res Ctr, Harare, Zimbabwe; [Kalonji, Dishiki; Spooner, Elizabeth; Singh, Nishanta] South African Med Res Council, HIV & Other Infect Dis Res Unit, Durban, South Africa; [Kayange, Noel] Univ Malawi, Blantyre Clin Res Site, Coll Med, Blantyre, Malawi; [Makhema, Joseph] Botswana Harvard AIDS Inst Partnership BHP, Gaborone, Botswana; [Mpendo, Juliet] Uganda Virus Res Inst, Int AIDS Vaccine Initiat, Entebbe, Uganda; [Ntege, Patricia Nahirya] Baylor Coll Med, Childrens Fdn Uganda, Kampala, Uganda; [Nair, Gonasagrie] Univ Cape Town, DesmondTutu Hlth Fdn, Cape Town, South Africa; [Nakabiito, Clemensia] Makerere Univ, Johns Hopkins Univ, Res Collaborat, Kampala, Uganda; [Nuwagaba-Biribonwoha, Harriet] Columbia Univ, Mailman Sch Publ Hlth, Eswatini Prevent Ctr, Int Ctr AIDS Care & Treatment Program, New York, NY USA; [Farrior, Jennifer; Rose, Scott; Tolley, Elizabeth; Sista, Nirupama] FHI 360, Durham, NC USA; [Anderson, Peter L.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Eshleman, Susan H.; Marzinke, Mark A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA; [Marzinke, Mark A.; Hendrix, Craig W.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hosek, Sybil] John H Stroger Jr Hosp Cook Cty, Dept Psychiat, Chicago, IL USA; [Adeyeye, Adeola] Natl Inst Allergy & Infect Dis, Div AIDS, Rockville, MD USA; [Rooney, James F.] Gilead Sci, Foster City, CA USA; [Rinehart, Alex; Spreen, William R.; Smith, Kimberly] ViiV Healthcare, Durham, NC USA; [Cohen, Myron S.; Hosseinipour, Mina C.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Hosseinipour, Mina C.] UNC Project Malawi, Lilongwe, Malawi	University of Witwatersrand; University of Witwatersrand; Fred Hutchinson Cancer Center; Stellenbosch University; Kenya Medical Research Institute; University of Zimbabwe; South African Medical Research Council; University of Malawi; Botswana-Harvard AIDS Institute Partnership; International AIDS Vaccine Initiative; Uganda Virus Research Institute; Baylor College of Medicine; University of Cape Town; Makerere University; Columbia University; FHI 360; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Gilead Sciences; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill	Delany-Moretlwe, S (corresponding author), Wits Reprod Hlth & HIV Inst, ZA-2001 Johannesburg, South Africa.	sdelany@wrhi.ac.za		Spooner, Elizabeth/0000-0002-1498-8131	National Institute of Allergy and Infectious Diseases; ViiV Healthcare; Bill & Melinda Gates Foundation; National Institute of Mental Health; National Institute on Drug Abuse; Eunice Kennedy Shriver National Institute of Child Health and Human Development	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ViiV Healthcare; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institute of Allergy and Infectious Diseases, ViiV Healthcare, and the Bill & Melinda Gates Foundation. Additional support was provided through the National Institute of Mental Health, the National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. ViiV Healthcare and Gilead Sciences provided pharmaceutical support.	Anderson PL, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01710-17; Andrews CD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010298; Baeten JM, 2017, NEW ENGL J MED, V376, P995, DOI 10.1056/NEJMc1616546; Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Barnighausen K, 2021, CULT HEALTH SEX, V23, P1198, DOI 10.1080/13691058.2020.1770333; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; Celum CL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25298; Corey L, 2021, NEW ENGL J MED, V384, P1003, DOI 10.1056/NEJMoa2031738; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; EMERSON SS, 1990, BIOMETRIKA, V77, P875, DOI 10.2307/2337110; Eshleman S, 2022, 29 C RETROVIRUSES OP; Eshleman SH, J INFECT DIS; Gray GE, 2021, NEW ENGL J MED, V384, P1089, DOI 10.1056/NEJMoa2031499; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Laher F, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09785-0; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Landovitz RJ, 2020, CLIN INFECT DIS, V70, P319, DOI 10.1093/cid/ciz439; Landovitz RJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002690; Markowitz M, 2017, LANCET HIV, V4, pE331, DOI 10.1016/S2352-3018(17)30068-1; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Marzinke MA, 2021, J INFECT DIS, V224, P1581, DOI 10.1093/infdis/jiab152; Minnis AM, 2019, JAIDS-J ACQ IMM DEF, V80, P394, DOI [10.1097/QAI.0000000000001945, 10.1097/qai.0000000000001945]; National Institute of Allergy and Infectious Diseases, 2017, DIV AIDS DAIDS TABL; Palanee-Phillips T, 2019, 10 INT AIDS SOC C HI; Pillay D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228620; Quaife M, 2018, MED DECIS MAKING, V38, P120, DOI 10.1177/0272989X17729376; Radzio J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010297; UNAIDS, 2021, CONFR IN LESS PAND R; Velloza J, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25463; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; World Health Organization, 2015, POL BRIEF PREEXP PRO	32	31	31	11	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2022	399	10337					1779	1789		10.1016/S0140-6736(22)00538-4	http://dx.doi.org/10.1016/S0140-6736(22)00538-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1W5PO	35378077	hybrid, Green Published			2022-12-28	WOS:000806825600020
J	Abbasi, J				Abbasi, Jennifer			Medical News & Perspectives Even Mild COVID-19 May Change the Brain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2022	327	14					1321	1322		10.1001/jama.2022.4507	http://dx.doi.org/10.1001/jama.2022.4507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1FH	35319732	Bronze			2022-12-28	WOS:000783967600002
J	Urquhart, A; Lucey, B				Urquhart, Andrew; Lucey, Brian			Crypto and digital currencies - nine research priorities	NATURE			English	Editorial Material						Economics; Policy; Information technology; Mathematics and computing	BITCOIN	To avert privacy breaches, scams and environmental damage, governments and central banks need to know how best to regulate this financial frontier. To avert privacy breaches, scams and environmental damage, governments and central banks need to know how best to regulate this financial frontier.	[Urquhart, Andrew] Univ Reading, Henley Business Sch, Finance & Financial Technol, ICMA Ctr, Reading, Berks, England; [Lucey, Brian] Trinity Coll Dublin, Trinity Business Sch, Int Finance & Commod, Dublin, Ireland; [Lucey, Brian] Univ Econ, Inst Business Res, Ho Chi Minh City, Vietnam; [Lucey, Brian] Jiangxi Univ Econ & Finance, Inst Ind Econ, Nanchang, Jiangxi, Peoples R China	University of Reading; Trinity College Dublin; Ho Chi Minh City University Economics; Jiangxi University of Finance & Economics	Urquhart, A (corresponding author), Univ Reading, Henley Business Sch, Finance & Financial Technol, ICMA Ctr, Reading, Berks, England.	a.j.urquhart@icmacentre.ac.uk; blucey@tcd.ie						AGUR I., 2022, J MONETARY ECON, V125, P62; Baur DG, 2018, J INT FINANC MARK I, V54, P177, DOI 10.1016/j.intfin.2017.12.004; Corbet S, 2019, INT REV FINANC ANAL, V62, P182, DOI 10.1016/j.irfa.2018.09.003; Corbet S, 2018, ECON LETT, V172, P23, DOI 10.1016/j.econlet.2018.07.031; Easley D, 2019, J FINANC ECON, V134, P91, DOI 10.1016/j.jfineco.2019.03.004; Foley S, 2019, REV FINANC STUD, V32, P1798, DOI 10.1093/rfs/hhz015; Lucey BM, 2022, FINANC RES LETT, V45, DOI 10.1016/j.frl.2021.102147; Nakamoto S., 2008, CONSULTED, V2008, P21260; Shen DH, 2020, EUR FINANC MANAG, V26, P1294, DOI 10.1111/eufm.12254; Teichmann FMJ, 2021, J MONEY LAUND CONTRO, V24, P775, DOI 10.1108/JMLC-05-2020-0060	10	1	1	9	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					36	39		10.1038/d41586-022-00927-5	http://dx.doi.org/10.1038/d41586-022-00927-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0G4FO	35379988	Bronze, Green Accepted			2022-12-28	WOS:000778003200003
J	Saul, H; Gursul, D; Cassidy, S; Sharpe, D				Saul, Helen; Gursul, Deniz; Cassidy, Samantha; Sharpe, Darren			Why don't children and young people engage with diabetes services?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Cassidy, Samantha] NIHR Ctr Engagement & Disseminat, Twickenham, England; [Sharpe, Darren] Univ East London, London, England	University of East London	Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						NIHR, YOUNG COMM MOD CO DE; Sharpe D, 2018, RES ALL, P289	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								o750	10.1136/bmj.o750	http://dx.doi.org/10.1136/bmj.o750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N8UW	35379673				2022-12-28	WOS:000783107700005
J	Bertrand, OC; Shelley, SL; Williamson, TE; Wible, JR; Chester, SGB; Flynn, JJ; Holbrook, LT; Lyson, TR; Meng, J; Miller, IM; Puschel, HP; Smith, T; Spaulding, M; Tseng, ZJ; Brusatte, SL				Bertrand, Ornella C.; Shelley, Sarah L.; Williamson, Thomas E.; Wible, John R.; Chester, Stephen G. B.; Flynn, John J.; Holbrook, Luke T.; Lyson, Tyler R.; Meng, Jin; Miller, Ian M.; Puschel, Hans P.; Smith, Thierry; Spaulding, Michelle; Tseng, Z. Jack; Brusatte, Stephen L.			Brawn before brains in placental mammals after the end-Cretaceous extinction	SCIENCE			English	Article							VINTANA-SERTICHI MAMMALIA; DIGITAL CRANIAL ENDOCAST; LATE MIDDLE EOCENE; GREEN RIVER-BASIN; SAN-JUAN BASIN; BODY-SIZE; EARLY PALEOCENE; NEW-MEXICO; R PACKAGE; ENCEPHALIZATION QUOTIENT	Mammals are the most encephalized vertebrates, with the largest brains relative to body size. Placental mammals have particularly enlarged brains, with expanded neocortices for sensory integration, the origins of which are unclear. We used computed tomography scans of newly discovered Paleocene fossils to show that contrary to the convention that mammal brains have steadily enlarged over time, early placentals initially decreased their relative brain sizes because body mass increased at a faster rate. Later in the Eocene, multiple crown lineages independently acquired highly encephalized brains through marked growth in sensory regions. We argue that the placental radiation initially emphasized increases in body size as extinction survivors filled vacant niches. Brains eventually became larger as ecosystems saturated and competition intensified.	[Bertrand, Ornella C.; Shelley, Sarah L.; Puschel, Hans P.; Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Grant Inst, Edinburgh EH9 3FE, Midlothian, Scotland; [Shelley, Sarah L.; Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA USA; [Williamson, Thomas E.; Brusatte, Stephen L.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [Chester, Stephen G. B.] CUNY Brooklyn Coll, Dept Anthropol, Brooklyn, NY 11210 USA; [Chester, Stephen G. B.] CUNY, Grad Ctr, Dept Anthropol, New York, NY USA; [Chester, Stephen G. B.] New York Consortium Evolutionary Primatol, New York, NY USA; [Flynn, John J.; Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Flynn, John J.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA; [Flynn, John J.] CUNY, Grad Ctr, PhD Program Biol, Ecol Evolutionary Biol & Behav Subprogram, New York, NY USA; [Flynn, John J.] CUNY, Grad Ctr, PhD Program Earth & Environm Sci, New York, NY USA; [Holbrook, Luke T.] Rowan Univ, Dept Biol Sci, Glassboro, NJ USA; [Lyson, Tyler R.; Miller, Ian M.] Denver Museum Nat & Sci, Denver, CO USA; [Miller, Ian M.] Natl Geog Soc, Washington, DC USA; [Smith, Thierry] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Spaulding, Michelle] Purdue Univ Northwest, Dept Biol Sci, Westville, IN USA; [Tseng, Z. Jack] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Tseng, Z. Jack] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of Edinburgh; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; American Museum of Natural History (AMNH); Columbia University; City University of New York (CUNY) System; City University of New York (CUNY) System; Rowan University; National Geographic Society; Royal Belgian Institute of Natural Sciences; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bertrand, OC; Brusatte, SL (corresponding author), Univ Edinburgh, Sch GeoSci, Grant Inst, Edinburgh EH9 3FE, Midlothian, Scotland.; Brusatte, SL (corresponding author), New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA.	ornella.bertrand@ed.ac.uk; stephen.brusatte@ed.ac.uk	Bertrand, Ornella/I-7063-2019	Bertrand, Ornella/0000-0003-3461-3908; Wible, John/0000-0002-0721-1228; Shelley, Sarah/0000-0001-6628-0226; Miller, Ian/0000-0001-6783-8105; Flynn, John/0000-0003-4705-3591; Chester, Stephen/0000-0002-6479-5741; Holbrook, Luke/0000-0001-5179-3053; Puschel, Hans P./0000-0002-6130-9322; meng, jin/0000-0002-3385-8383; Williamson, Thomas/0000-0002-2856-9632	Marie Sklodowska-Curie Actions: Individual Fellowship, H2020-MSCA-IF2018-2020 [792611]; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [756226]; Philip Leverhulme Prize; NSF [DEB1456826, DEB 1654952, DEB 1654949]; Belgian Science Policy Office project BRAIN [BR/121/A3/PalEurAfrica]; Lisa Levin Appel Family Foundation; M. Cleworth, Lyda Hill Philanthropies; David B. Jones Foundation; National Agency for Research and Development (ANID)/PFCHA/Doctorado en el extranjero Becas Chile/2018 [72190003]; American Museum of Natural History Frick Fund, Division of Paleontology, American Museum of Natural History; US National Science Foundation [DEB-1257572]	Marie Sklodowska-Curie Actions: Individual Fellowship, H2020-MSCA-IF2018-2020; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC)); Philip Leverhulme Prize; NSF(National Science Foundation (NSF)); Belgian Science Policy Office project BRAIN; Lisa Levin Appel Family Foundation; M. Cleworth, Lyda Hill Philanthropies; David B. Jones Foundation; National Agency for Research and Development (ANID)/PFCHA/Doctorado en el extranjero Becas Chile/2018; American Museum of Natural History Frick Fund, Division of Paleontology, American Museum of Natural History; US National Science Foundation(National Science Foundation (NSF))	This work was supported by Marie Sklodowska-Curie Actions: Individual Fellowship, H2020-MSCA-IF2018-2020, no. 792611 (O.C.B.); European Research Council (ERC) Starting Grant 756226 under the European Union's Horizon 2020 Research and Innovation Programme (S.L.B.); Philip Leverhulme Prize (S.L.B.); NSF DEB 1654952 (T.E.W. and S.L.B.); NSF DEB 1654949 (J.R.W. and S.L.S.); NSF DEB1456826 (L.T.H. and S.G.B.C.); Belgian Science Policy Office project BRAIN BR/121/A3/PalEurAfrica (T.S.); Lisa Levin Appel Family Foundation, M. Cleworth, Lyda Hill Philanthropies, David B. Jones Foundation, M. L. and S. R. Kneller, T. and K. Ryan, and J. R. Tucker as part of the Denver Museum of Nature & Science No Walls Community Initiative (T.R.L. and I.M.M.); and National Agency for Research and Development (ANID)/PFCHA/Doctorado en el extranjero Becas Chile/2018-72190003 (H.P.P.). Funding to J.J.F. and for scanning American Museum specimens was provided by the Microscopy and Imaging Facility, American Museum of Natural History Frick Fund, Division of Paleontology, American Museum of Natural History, and US National Science Foundation (DEB-1257572).	Ahrens H. E, 2017, THESIS J HOPKINS U; Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Anan T, 2014, J AFR EARTH SCI, V100, P614, DOI 10.1016/j.jafrearsci.2014.08.015; Anderson D, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P311; [Anonymous], 1966, VERTEBRATE PALEONTOL; Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Archibald J. David, 1998, P292; Argot C, 2013, J MAMM EVOL, V20, P83, DOI 10.1007/s10914-012-9198-x; Armstrong SD, 2011, ANAT REC, V294, P263, DOI 10.1002/ar.21298; Asher RJ, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190387; Astruc JG, 2000, GEODIN ACTA, V13, P271, DOI 10.1016/S0985-3111(00)01047-0; Averianov AO, 1997, ACTA PALAEONTOL POL, V42, P243; Bai B, 2017, B AM MUS NAT HIST, P1; Baker J, 2016, BIOL J LINN SOC, V118, P95, DOI 10.1111/bij.12649; Bapst D.W., 2014, MODERN PHYLOGENETIC, P515, DOI [10.1007/978-3-662-43550-2_22, DOI 10.1007/978-3-662-43550-2_22]; Bapst DW, 2013, METHODS ECOL EVOL, V4, P724, DOI 10.1111/2041-210X.12081; Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Benoit J, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.991021; Benoit J, 2013, BRAIN BEHAV EVOLUT, V81, P154, DOI 10.1159/000348481; Benson-Amram S, 2016, P NATL ACAD SCI USA, V113, P2532, DOI 10.1073/pnas.1505913113; Bertrand O. C., 2022, ZENODO; Bertrand OC, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01887-8; Bertrand OC, 2020, J ANAT, V236, P21, DOI 10.1111/joa.13084; Bertrand OC, 2019, J MAMM EVOL, V26, P345, DOI 10.1007/s10914-017-9425-6; Bertrand OC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2316; Bertrand OC, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1014905; Billet G, 2009, PALAEOGEOGR PALAEOCL, V274, P114, DOI 10.1016/j.palaeo.2009.01.004; BiochroM'97, 1997, MEMOIRES TRAVAUX ECO, P769; Bloch JI, 1998, J MAMMAL, V79, P804, DOI 10.2307/1383090; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; BOWN TM, 1981, J PALEONTOL, V55, P257; Boyer D. M, 2009, GRADUATE SCH; Boyer D. M., 2019, PAP PALAEONTOL, V38, P10; Boyer Doug M., 2008, P233, DOI 10.1007/978-1-4020-6997-0_11; Burger JR, 2019, J MAMMAL, V100, P276, DOI 10.1093/jmammal/gyz043; Burgin CJ, 2018, J MAMMAL, V99, P1, DOI 10.1093/jmammal/gyx147; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clyde WC, 2016, EARTH PLANET SC LETT, V452, P272, DOI 10.1016/j.epsl.2016.07.041; COOMBS M C, 1982, Journal of Vertebrate Paleontology, V2, P219; Cope E. D., 1877, P AM PHILOS SOC, V16, P616; Crochet J.Y., 1981, B MUSEUM NATL HIST N, V4, P255; Croft D., 2000, THESIS U CHICAGO; Croft DA, 2020, ANNU REV EARTH PL SC, V48, P259, DOI 10.1146/annurev-earth-072619-060126; Csiki-Sava Z, 2018, P NATL ACAD SCI USA, V115, P4857, DOI 10.1073/pnas.1801143115; Dag O, 2018, R J, V10, P175; DAGOSTO M, 1992, INT J PRIMATOL, V13, P307, DOI 10.1007/BF02547818; Damuth J., 1990, P229; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; De Bast E, 2013, J VERTEBR PALEONTOL, V33, P964, DOI 10.1080/02724634.2013.747531; de Muizon C, 2015, GEODIVERSITAS, V37, P397, DOI 10.5252/g2015n4a1; Domning D. P., 2018, ENCY MARINE MAMMALS, V3, P856; Edinger T., 1956, ANN PALEONTOL, V62, P97; Edinger T., 1966, EVOLUTION FOREBRAIN, P153; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; Elissamburu A, 2012, ESTUD GEOL-MADRID, V68, P91, DOI 10.3989/egeol.40336.133; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez-Monescillo M, 2019, J MAMM EVOL, V26, P85, DOI 10.1007/s10914-017-9416-7; Finlay BL., 2009, ENCY NEUROSCIENCE, P337, DOI [10.1016/B978-008045046-9.00939-6, DOI 10.1016/B978-008045046-9.00939-6]; Flynn AG, 2020, GEOL SOC AM BULL, V132, P2154, DOI 10.1130/B35481.1; Flynn AG, 2019, PALEOBIOLOGY, V45, P612, DOI 10.1017/pab.2019.24; Flynn J. J., 1998, EVOLUTION TERTIARY M, V1, P110; Flynn J. J., 1991, AM MUS NOVIT, V3007, P1; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; Gasin C. L., 1936, Proceedings of the American Philosophical Society, V76, P597; Gaudin Timothy J., 2019, Fossil Imprint, V75, P484, DOI 10.2478/if-2019-0029; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Gazin C. L., 1962, Smithsonian Miscellaneous Collections, V144, P1; Gazin C. L., 1968, Smithsonian Miscellaneous Collections, V153, P1; Gazin CL., 1953, SMITHSONIAN MISCELLA, V121, P1; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Gheerbrant Emmanuel, 2005, P84; Gidley J. W, 1917, NOTICE NEW PALEOCENE, V52; Gidley J. W, 1909, NOTES FOSSIL MAMMALI, V293; GINGERICH P D, 1989, Contributions from the Museum of Paleontology University of Michigan, V27, P327; GINGERICH P D, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P141; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Gingerich P. D., 1995, NEW ARCHAEOCETES MAM; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Gingerich Philip D., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P185; Gingerich PD, 2016, J MAMM EVOL, V23, P17, DOI 10.1007/s10914-015-9304-y; Gingerich Philip D., 1998, P423; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grossnickle DM, 2019, TRENDS ECOL EVOL, V34, P936, DOI 10.1016/j.tree.2019.05.008; Gunnell GF, 2000, J VERTEBR PALEONTOL, V20, P349, DOI 10.1671/0272-4634(2000)020[0349:BPFTLE]2.0.CO;2; Gunnell Gregg F., 1998, Contributions from the Museum of Paleontology University of Michigan, V30, P83; Halliday TJD, 2017, BIOL REV, V92, P521, DOI 10.1111/brv.12242; Hand Suzanne J., 2016, PALAEOVERTEBRATA, V40, pe2, DOI 10.18563/pv.40.2.e2; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Harrington A., 2020, PALAEOVERTEBRATA, V43, pe1; Harrington AR, 2016, J HUM EVOL, V99, P52, DOI 10.1016/j.jhevol.2016.06.005; Herculano-Houzel S, 2017, CURR OPIN BEHAV SCI, V16, P1, DOI 10.1016/j.cobeha.2017.02.004; Herculano-Houzel S, 2015, BRAIN BEHAV EVOLUT, V86, P145, DOI 10.1159/000437413; Hoffmann S, 2014, J VERTEBR PALEONTOL, V34, P110, DOI 10.1080/02724634.2014.956878; Holbrook LT, 2014, J VERTEBR PALEONTOL, V34, P1203, DOI 10.1080/02724634.2014.854249; Holroyd Patricia A., 1996, Palaeovertebrata (Montpellier), V25, P175; Hooker J. J, 2010, MAMMAL FAUNA EARLY E; Hooker JJ, 2012, AUSTRIAN J EARTH SCI, V105, P17; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hurum Jorn H., 1998, Journal of Mammalian Evolution, V5, P65, DOI 10.1023/A:1020571003901; Janis C.M., 1990, P255; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Janis CM., 1998, EVOLUTION TERTIARY M, V1; Jerison HJ, 2012, BIOLINGUISTICS, V6, P383; JERISON HJ, 1961, SCIENCE, V133, P1012, DOI 10.1126/science.133.3457.1012; JERISON HJ, 1970, SCIENCE, V170, P1224, DOI 10.1126/science.170.3963.1224; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kassambara, 2020, PACKAGE GGPUBR; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; KAY RF, 1992, AM J PHYS ANTHROPOL, V89, P477, DOI 10.1002/ajpa.1330890409; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; KAY RF, 1990, NATURE, V345, P342, DOI 10.1038/345342a0; KERMACK KA, 1963, PHILOS T ROY SOC B, V246, P87; Kielan-Jaworowska Z, 2004, ACTA PALAEONTOL POL, V49, P177; KIELAN-JAWOROWSKA Z, 1978, Acta Palaeontologica Polonica, V23, P115; Kielan-Jaworowska Z., 1983, Palaeovertebrata (Montpellier), V13, P1; Kielan-Jaworowska Z, 1984, PALAEONTOLOGIA POLON, V46, P157; Kirk EC, 2014, J VERTEBR PALEONTOL, V34, P203, DOI 10.1080/02724634.2014.963232; Kirk EC, 2014, J HUM EVOL, V74, P82, DOI 10.1016/j.jhevol.2014.03.007; KITTS DAVID B., 1956, BULL AMER MUS NAT HIST, V110, P1; Kondrashov PE, 2012, J PALEONTOL, V86, P25, DOI 10.1666/11-009.1; Korth W.W., 1994, TERTIARY RECORD RODE; Krause DW, 2020, NATURE, V581, P421, DOI 10.1038/s41586-020-2234-8; Krause David W., 1993, Palaeovertebrata (Montpellier), V22, P99; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Laduke TC, 2010, J VERTEBR PALEONTOL, V30, P109, DOI 10.1080/02724630903409188; Larramendi A, 2015, HYSTRIX, V26, P102, DOI 10.4404/hystrix-26.2-11478; Lartet E., 1868, CR HEBD ACAD SCI, V66, P1119; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Leslie C, 2018, AM J SCI, V318, P300, DOI 10.2475/03.2018.02; Lofgren D, 2014, AM MUS NOVIT, P1; Long A, 2015, AM J PHYS ANTHROPOL, V157, P363, DOI 10.1002/ajpa.22724; Lorente M, 2019, LETHAIA, V52, P244, DOI 10.1111/let.12310; Lucas S., 1998, EVOLUTION TERTIARY M, V1, P274; Lucas S., 1998, EVOLUTION TERTIARY M, V1, P260; Lucas S. G, 1984, THESIS YALE U; Lucas S. G., 2004, NEW MEXICO MUSEUM NA, V26, P33; Luo Zhexi, 1993, Journal of Vertebrate Paleontology, V13, P477; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Lyras George A., 2009, Scripta Geologica (Leiden), V139, P1; Lyson TR, 2019, SCIENCE, V366, P977, DOI 10.1126/science.aay2268; Macrini TE, 2006, THESIS U TEXAS AUSTI; Macrini TE, 2007, ANAT REC, V290, P875, DOI 10.1002/ar.20551; Macrini TE, 2007, J VERTEBR PALEONTOL, V27, P99, DOI 10.1671/0272-4634(2007)27[99:DCEOPA]2.0.CO;2; Macrini TE, 2010, J ANAT, V216, P600, DOI 10.1111/j.1469-7580.2010.01224.x; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; Mader BJ, 2010, ZOOTAXA, P1; Maitre Elodie, 2014, Swiss Journal of Palaeontology, V133, P141, DOI 10.1007/s13358-014-0069-3; Mangiafico S, 2016, rcompanion: Functions to support extension education program evaluation [R statistical package]; Marino L, 2004, ANAT REC PART A, V281A, P1247, DOI 10.1002/ar.a.20128; Marsh O.C., 1876, American Journal of Science (3), Vxi, P425; Marsh O. C, 1886, DINOCERATA MONOGRAPH, V10; Marsh O. C., 1872, AM J SCI, V3, P202, DOI DOI 10.2475/AJS.S3-4.21.202; Marsh O. C, 1874, ANN MAG NAT HIST, V14, P167; Matthew W.D., 1909, MEM AM MUS NAT HIST, V9, P291; Matthews WD, 1915, B AM MUS NAT HIST, V34, P329; Maugoust J, 2021, J MAMM EVOL, V28, P679, DOI 10.1007/s10914-020-09522-9; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Meehan TJ, 2010, NEUES JAHRB GEOL P-A, V256, P99, DOI 10.1127/0077-7749/2010/0035; Meng J., 1990, AM MUS NOVIT, V2972, P1; Middleton M. D, 1983, U COL BOULD; Mihlbachler M. C., 2005, THESIS COLUMBIA U AN; Mihlbachler MC, 2008, B AM MUS NAT HIST, P1; Miyata K, 2007, J VERTEBR PALEONTOL, V27, P661, DOI 10.1671/0272-4634(2007)27[661:NSOTTM]2.0.CO;2; Miyata K, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1089878; Montgomery SH, 2013, EVOLUTION, V67, P3339, DOI 10.1111/evo.12197; Morlo M, 1999, GEOBIOS-LYON, V32, P297, DOI 10.1016/S0016-6995(99)80043-6; Morlo Michael, 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P43; Morlo M, 2014, PALAEONTOLOGY, V57, P111, DOI 10.1111/pala.12052; Muchlinski M. N, 2008, U TEXAS AUSTIN; Murphey PC, 2018, PALAEONTOL ELECTRON, V21, DOI 10.26879/804; Napoli JG, 2018, J MAMM EVOL, V25, P179, DOI 10.1007/s10914-017-9381-1; Nascimento FF, 2017, NAT ECOL EVOL, V1, P1446, DOI 10.1038/s41559-017-0280-x; Ni XJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7913; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Orliac MJ, 2014, J MAMM EVOL, V21, P299, DOI 10.1007/s10914-014-9254-9; Orliac MJ, 2013, J SYST PALAEONTOL, V11, P925, DOI 10.1080/14772019.2012.704409; Orliac MJ, 2012, P ROY SOC B-BIOL SCI, V279, P3670, DOI 10.1098/rspb.2012.1156; Orliac MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2792; Orliac MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030000; Osborn H. F, 1908, B AM MUS NAT HIST, V24, P1; Osborn H. F, 1898, B AMNH, V10, P1; Osborn H. F, 1929, TITANOTHERES ANCIENT, V55; OSBORN HENRY FAIRFIELD, 1936, AMER MUS NOVITATES, V859, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Patterson B., 1958, Breviora, VNo. 93, P1; Pinheiro J, R PACKAGE VERSION; Piveteau J, 1961, TRAITE PALEONTOLOGIE, V1; Piveteau J, 1935, ANN PALEONTOL, V24, P73; Piveteau J, 1958, TRAITE PALEONTOLOGIE, V2; Piveteau J., 1961, TRAITE PALEONTOLOGIE, V6, P806; Prothero D., 1988, PHYLOGENY CLASSIFICA, P201; Prothero D. R., 2005, TERRESTRIAL EOCENE O; QUIROGA JC, 1980, J HIRNFORSCH, V21, P299; RADINSKY L, 1977, PALEOBIOLOGY, V3, P333, DOI 10.1017/S0094837300005509; RADINSKY L, 1978, AM NAT, V112, P815, DOI 10.1086/283325; RADINSKY L, 1976, Fieldiana Geology, V33, P323; RADINSKY L, 1981, BRAIN BEHAV EVOLUT, V18, P169, DOI 10.1159/000121785; RADINSKY L, 1976, SCIENCE, V194, P626, DOI 10.1126/science.790567; RADINSKY LB, 1982, PALEOBIOLOGY, V8, P177, DOI 10.1017/S0094837300006928; Radinsky LB., 1967, AM MUS NOVIT, V2316, P1; RADINSKY LEONARD B., 1965, BULL MUS COMP ZOOL HARVARD UNIV, V134, P69; Rambaut A., 2018, FIGTREE V1 4 4 2006; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambold H, 2002, J NEUROPHYSIOL, V87, P912, DOI 10.1152/jn.00768.2000; Ramdarshan A, 2016, AM J PHYS ANTHROPOL, V159, P5, DOI 10.1002/ajpa.22868; Ratcliffe JM, 2006, BRAIN BEHAV EVOLUT, V67, P165, DOI 10.1159/000090980; Ravel A, 2015, HIST BIOL, V27, P957, DOI 10.1080/08912963.2014.915823; Reguero Marcelo A., 2010, P152; RENSBERGER JM, 1986, PALEOBIOLOGY, V12, P474, DOI 10.1017/S0094837300003183; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rook DL, 2014, J MAMM EVOL, V21, P75, DOI 10.1007/s10914-013-9230-9; ROSE KD, 2006, BEGINNING AGE MAMMAL; Rose KD, 2019, J VERTEBR PALEONTOL, V39, P1, DOI 10.1080/02724634.2020.1761370; Rose KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6570; Rougier G.W., 1993, THESIS U NACL BUENOS; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; RUNESTAD JA, 1995, AM J PHYS ANTHROPOL, V98, P101, DOI 10.1002/ajpa.1330980202; RUSSELL DONALD E., 1964, MEM MUS NAT HIST NATUR NOW SER SER C SCI TERRE, V13, P1; Sarko DK, 2010, MAR MAMMAL SCI, V26, P937, DOI 10.1111/j.1748-7692.2010.00384.x; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Schoch R. M, 1983, THESIS YALE U; Schuler M., 1992, CAHIERS MICROPALEONT, V7, P29; Scott W. B., 1887, P AM PHILOS SOC, V24, P255; Scott W. B., 1890, T AM PHILOS SOC, V16, P461; Scott W. B, 1888, SOME NEW LITTLE KNOW; Seiffert Erik R., 2010, P19; Shelley SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200132; Silcox MT, 2020, J PALEONTOL, V94, P979, DOI 10.1017/jpa.2020.24; Silcox MT, 2011, J VERTEBR PALEONTOL, V31, P1314, DOI 10.1080/02724634.2011.609574; Silcox MT, 2010, ZOOL J LINN SOC-LOND, V160, P773, DOI 10.1111/j.1096-3642.2009.00614.x; Silcox MT, 2010, J HUM EVOL, V58, P505, DOI 10.1016/j.jhevol.2010.03.008; Silcox MT, 2009, P NATL ACAD SCI USA, V106, P10987, DOI 10.1073/pnas.0812140106; SILVA M, 1995, CRC HDB MAMMALIAN BO; Simons EL., 1960, T AM PHILOS SOC, V50, P3, DOI [10.2307/1005810, DOI 10.2307/1005810]; SIMPSON GEORGE GAYLORD, 1932, AMER MUS NOVITATES [NEW YORK], V578, P1; Simpson GG, 1937, B AM MUS NAT HIST, V73, P727; Simpson GG, 1937, BIOL REV CAMB PHILOS, V12, P1, DOI 10.1111/j.1469-185X.1937.tb01220.x; Simpson GG, 1927, AM J SCI, V14, P259; Smaers JB, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe2101; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; Sol F., 2020, BIOLOGICAL CONSEQUEN, P279; Sole F, 2014, J VERTEBR PALEONTOL, V34, P1, DOI 10.1080/02724634.2013.793195; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Springer MS, 2018, MOL PHYLOGENET EVOL, V121, P158, DOI 10.1016/j.ympev.2018.01.007; Sudre J., 1977, GEOBIOS, V10, P213; Tabuce R, 2008, MAMMALIA, V72, P2, DOI 10.1515/MAMM.2008.004; Thewissen J.G.M., 1989, Journal of Vertebrate Paleontology, V9, P459; THEWISSEN JGM, 1991, GEOBIOS-LYON, V24, P483, DOI 10.1016/S0016-6995(06)80249-4; Thorpe MR, 1923, AM J SCI, V5, P23, DOI 10.2475/ajs.s5-5.25.23; Tilney F, 1933, B NEUROL I NEW YORK, P430; Tsagkogeorga G, 2013, CURR BIOL, V23, P2262, DOI 10.1016/j.cub.2013.09.014; Tsuboi M, 2018, NAT ECOL EVOL, V2, P1492, DOI 10.1038/s41559-018-0632-1; Turnbull W. D., 2002, FIELDIANA GEOLOGY, V47, P1, DOI DOI 10.5962/BHL.TITLE.3567; Uhen Mark D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P259; Uhen Mark D., 2013, Bulletin Alabama Museum of Natural History, V31, P1; Upham NS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000494; Van Valen L., 1978, EVOL THEORY REV, V4, P46; van Valkenburgh Blaire, 1994, Historical Biology, V8, P129; van Woerden JT, 2012, EVOLUTION, V66, P191, DOI 10.1111/j.1558-5646.2011.01434.x; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Visualization Sciences Group, 2011, AVIZO 7 0 0; Wahlert JH, 2006, PALAEONTOGR ABT A, V277, P39; WALL WP, 1982, J PALEONTOL, V56, P434; Wang Xiaoming, 1994, American Museum Novitates, V3092, P1; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; West R. M, 1976, N AM PHEN MAMM COND; Wheeler W. H, 1961, REVISION UINTATHERES; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Williamson T. E, 1996, BEGINNING AGE MAMMAL, V8; Wilson J. A, 1977, STRATIGRAPHIC OCCURR; Wilson J. A, 1971, B TEX MEM MUS, V18, P1; Wood AR, 2011, J MAMM EVOL, V18, P1, DOI 10.1007/s10914-010-9145-7; WOOD ALBERT E., 1962, TRANS AMER PHIL SOC, V52, P1; Woodburne M. O., 2004, LATE CRETACEOUS CENO; Woodburne MO, 2014, J S AM EARTH SCI, V54, P109, DOI 10.1016/j.jsames.2014.05.003; Wortman JL, 1901, AM J SCI, V12, P143	292	5	5	4	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		80	+		10.1126/science.abl5584	http://dx.doi.org/10.1126/science.abl5584			142	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357913	Green Accepted			2022-12-28	WOS:000780195200031
J	Gates, B				Gates, Bill			Paul Farmer (1959-2022)	SCIENCE			English	Editorial Material									[Gates, Bill] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	info@gatesfoundation.org							0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		36	36		10.1126/science.abq0061	http://dx.doi.org/10.1126/science.abq0061			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357940				2022-12-28	WOS:000780195200016
J	Lucas, G				Lucas, George			War in an automated, data-driven world	SCIENCE			English	Editorial Material									[Lucas, George] US Naval Acad, Annapolis, MD 21402 USA	United States Department of Defense; United States Navy; United States Naval Academy	Lucas, G (corresponding author), US Naval Acad, Annapolis, MD 21402 USA.	george.r.lucas.jr@gmail.com						Scharre P, 2018, ARMY NONE AUTONOMOUS; Sharkey N., 2014, MILITARYETHICS EMERG, P132	2	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		41	41		10.1126/science.abo4591	http://dx.doi.org/10.1126/science.abo4591			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357939				2022-12-28	WOS:000780195200019
J	Dyer, O				Dyer, Owen			Covid-19: Lockdowns spread in China as omicron tests "zero covid" strategy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dutton J, 2022, NEWSWEEK	1	10	10	8	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o859	10.1136/bmj.o859	http://dx.doi.org/10.1136/bmj.o859			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361680	Bronze			2022-12-28	WOS:000779990000018
J	Zhang, YQ; Jiao, RM; Witt, CM; Lao, LX; Liu, JP; Thabane, L; Sherman, KJ; Cummings, M; Richards, DP; Kim, EKA; Kim, TH; Lee, MS; Wechsler, ME; Brinkhaus, B; Mao, JJ; Smith, CA; Gang, WJ; Liu, BY; Liu, ZS; Liu, Y; Zheng, H; Wu, JN; Carrasco-Labra, A; Bhandari, M; Devereaux, PJ; Jing, XH; Guyatt, G				Zhang, Yu-Qing; Jiao, Rui-Min; Witt, Claudia M.; Lao, Lixing; Liu, Jian-Ping; Thabane, Lehana; Sherman, Karen J.; Cummings, Mike; Richards, Dawn P.; Kim, Eun-Kyung Anna; Kim, Tae-Hun; Lee, Myeong Soo; Wechsler, Michael E.; Brinkhaus, Benno; Mao, Jun J.; Smith, Caroline A.; Gang, Wei-Juan; Liu, Bao-Yan; Liu, Zhi-Shun; Liu, Yan; Zheng, Hui; Wu, Jia-Ni; Carrasco-Labra, Alonso; Bhandari, Mohit; Devereaux, Philip J.; Jing, Xiang-Hong; Guyatt, Gordon			How to design high quality acupuncture trials-a consensus informed by evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; LOW-BACK-PAIN; RECOVERY EXPECTATIONS; PATIENT EXPECTATIONS; PUBLIC INVOLVEMENT; SHAM ACUPUNCTURE; CLINICAL-TRIALS; KNEE; OSTEOARTHRITIS; VALIDATION	An international panel including patients, clinicians, researchers, acupuncture and surgery trialists, statisticians, and experts in clinical epidemiology and methodology have developed new guidance for randomised controlled trials in acupuncture. It addresses the most prevalent and critical concerns of current acupuncture trials and will help funding agencies, trial registers, and journal editors to evaluate the relevance, importance, and quality of submitted trial proposals and completed trials	[Zhang, Yu-Qing; Jiao, Rui-Min; Gang, Wei-Juan; Jing, Xiang-Hong] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China; [Zhang, Yu-Qing] China Acad Chinese Med Sci, Guanganmen Hosp, CEBIM Ctr Evidence Based Integrat Med Clar Collab, Beijing, Peoples R China; [Zhang, Yu-Qing; Guyatt, Gordon] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Zhang, Yu-Qing] Univ Nottingham Ningbo, Nottingham Ningbo GRADE Ctr, Ningbo, Peoples R China; [Jiao, Rui-Min; Gang, Wei-Juan; Jing, Xiang-Hong] China Acad Chinese Med Sci, China Ctr Evidence Based Tradit Chinese Med, Beijing, Peoples R China; [Witt, Claudia M.] Univ Hosp Zurich, Inst Complementary & Integrat Med, Zurich, Switzerland; [Witt, Claudia M.] Univ Zurich, Zurich, Switzerland; [Lao, Lixing] Virginia Univ Integrat Med, Fairfax, VA USA; [Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Liu, Jian-Ping] Beijing Univ Chinese Med, Inst Excellence Evidence Based Chinese Med, Beijing, Peoples R China; [Thabane, Lehana; Bhandari, Mohit; Devereaux, Philip J.; Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON, Canada; [Sherman, Karen J.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Sherman, Karen J.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cummings, Mike] British Med Acupuncture Soc, London, England; [Richards, Dawn P.] Clin Trials Ontario, Patient & Publ Engagement, Toronto, ON, Canada; [Kim, Eun-Kyung Anna] Virginia Univ Integrat Med, Dept Western Med, Fairfax, VA USA; [Kim, Tae-Hun] Korean Med Clin Trial Ctr, Seoul, South Korea; [Kim, Tae-Hun] Korean Med Hosp, Seoul, South Korea; [Kim, Tae-Hun] Kyung Hee Univ, Seoul, South Korea; [Lee, Myeong Soo] Korea Inst Oriental Med, Clin Med Div, Daejeon, South Korea; [Lee, Myeong Soo] Univ Sci & Technol, Korean Convergence Med, Daejeon, South Korea; [Wechsler, Michael E.] Natl Jewish Hlth, Denver, CO USA; [Brinkhaus, Benno] Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Brinkhaus, Benno] Free Univ Berlin, Berlin, Germany; [Brinkhaus, Benno] Humboldt Univ, Berlin, Germany; [Mao, Jun J.] Mem Sloan Kettering Canc Ctr, Bendheim Integrat Med Ctr, Integrat Med Serv, 1275 York Ave, New York, NY 10021 USA; [Smith, Caroline A.] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Liu, Bao-Yan] China Acad Chinese Med Sci, Beijing, Peoples R China; [Liu, Zhi-Shun; Wu, Jia-Ni] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Yan] Beijing Univ Chinese Med, Dongzhimen Hosp, Key Lab Chinese Internal Med, Minist Educ, Beijing, Peoples R China; [Zheng, Hui] Chengdu Univ Tradit Chinese Med, Sch Acupuncture Moxibust & Tuina, Affiliated Hosp 3, Chengdu, Sichuan, Peoples R China; [Carrasco-Labra, Alonso] Univ Penn, Ctr Integrat Global Oral Hlth, Sch Dent Med, Philadelphia, PA 19104 USA	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; McMaster University; University of Nottingham Ningbo China; China Academy of Chinese Medical Sciences; University of Zurich; University Zurich Hospital; University of Zurich; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; McMaster University; Kaiser Permanente; University of Washington; University of Washington Seattle; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); University of Science & Technology (UST); National Jewish Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Memorial Sloan Kettering Cancer Center; Western Sydney University; China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Beijing University of Chinese Medicine; Chengdu University of Traditional Chinese Medicine; University of Pennsylvania	Jing, XH (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China.; Jing, XH (corresponding author), China Acad Chinese Med Sci, China Ctr Evidence Based Tradit Chinese Med, Beijing, Peoples R China.	xhjingt66@163.com	Witt, Claudia M./AAX-2370-2021; Jing, Xianghong/HHS-4003-2022	Witt, Claudia M./0000-0002-5440-7805; 	China Academy of Chinese Medical Sciences (CACMS) Innovation Fund [CI 2021A03503, CI2021B011]; "Belt and Road" Traditional Chinese Medicine Cooperation Project of China Academy of Chinese Medical Sciences [GH201901]	China Academy of Chinese Medical Sciences (CACMS) Innovation Fund; "Belt and Road" Traditional Chinese Medicine Cooperation Project of China Academy of Chinese Medical Sciences	Funding: The China Academy of Chinese Medical Sciences (CACMS) Innovation Fund (CI 2021A03503 and CI2021B011) and " The Belt and Road" Traditional Chinese Medicine Cooperation Project of China Academy of Chinese Medical Sciences (GH201901) supported this work. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Avis NE, 2016, MENOPAUSE, V23, P626, DOI 10.1097/GME.0000000000000597; Barth J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026712; Bednarska E, 2008, CLIN ORTHOP RELAT R, V466, P1734, DOI 10.1007/s11999-008-0273-9; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Bialosky JE, 2010, PHYS THER, V90, P1345, DOI 10.2522/ptj.20090306; Brett J, 2014, HEALTH EXPECT, V17, P637, DOI 10.1111/j.1369-7625.2012.00795.x; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chen HY, 2019, AM J CHINESE MED, V47, P1, DOI 10.1142/S0192415X19500010; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Constantino MJ, 2012, PSYCHOTHERAPY, V49, P557, DOI 10.1037/a0029440; Crocker JC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4738; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; DeVore AD, 2020, AM HEART J, V220, P41, DOI 10.1016/j.ahj.2019.09.012; Deyo RA, 2014, PAIN MED, V15, P1249, DOI 10.1111/pme.12538; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Du Y., 2000, ZHONGGUO ZHENJIU, V20, P312; Evaniew N, 2016, JAMA SURG, V151, P657, DOI 10.1001/jamasurg.2016.0072; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; FUNG KP, 1986, LANCET, V2, P1419; Gang WJ, BMJ OPEN; Glasziou P, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4645; Goldfarb D. S, 2004, ACP J CLUB; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Haynes RB, 2006, J CLIN EPIDEMIOL, V59, P873, DOI 10.1016/j.jclinepi.2006.06.005; Hershman DL, 2018, JAMA-J AM MED ASSOC, V320, P167, DOI 10.1001/jama.2018.8907; Hinman RS, 2014, JAMA-J AM MED ASSOC, V312, P1313, DOI 10.1001/jama.2014.12660; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Johnston BC, 2008, SPINE, V33, P914, DOI 10.1097/BRS.0b013e31816b4be4; Jones SMW, 2016, J ALTERN COMPLEM MED, V22, P936, DOI 10.1089/acm.2016.0242; Karanicolas PJ, 2009, J CLIN EPIDEMIOL, V62, P479, DOI 10.1016/j.jclinepi.2008.02.009; Kim TH, 2020, ACUPUNCT MED, V38, P37, DOI 10.1136/acupmed-2018-011671; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Li J, 2015, KEY POINT IMPLEMENTA; Li Z.Q., 2014, ACAD FORUM, V37, P99; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Luo S.P, 2016, CLIN APPL GUIDE CHIN; Ma Peifeng, 2016, Zhongguo Zhen Jiu, V36, P1027, DOI 10.13703/j.0255-2930.2016.10.006; MacPherson Hugh, 2002, Acupunct Med, V20, P22; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; Mao JJ, 2010, ALTERN THER HEALTH M, V16, P22; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Moura CD, 2019, REV ESC ENFERM USP, V53, DOI [10.1590/s1980-220x2018009003418, 10.1590/S1980-220X2018009003418]; Moustgaard H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6802; Nielsen Arya, 2021, Glob Adv Health Med, V10, p21649561211007091, DOI 10.1177/21649561211007091; Oxman AD, 2009, J CLIN EPIDEMIOL, V62, P485, DOI 10.1016/j.jclinepi.2008.08.015; Pach D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/125937; Paterson C, 2004, J ALTERN COMPLEM MED, V10, P791; Price A, 2018, J EVAL CLIN PRACT, V24, P240, DOI 10.1111/jep.12805; Riddle DL, 2010, J CLIN EPIDEMIOL, V63, P1271, DOI 10.1016/j.jclinepi.2010.03.006; Santosa KB, 2018, JAMA SURG, V153, P891, DOI 10.1001/jamasurg.2018.1677; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Schlaeger Judith M, 2018, Pilot Feasibility Stud, V4, P72, DOI 10.1186/s40814-018-0265-9; Scholtes Vanessa A, 2012, J Bone Joint Surg Am, V94 Suppl 1, P24, DOI 10.2106/JBJS.K.01626; Shuai P, 2012, STAT MED, V31, P606, DOI 10.1002/sim.4034; Skovlund Pernille Christiansen, 2020, Res Involv Engagem, V6, P43, DOI 10.1186/s40900-020-00214-5; Smith CA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1986-4; Smith TO, 2019, J RHEUMATOL, V46, P981, DOI 10.3899/jrheum.181194; Su CX, 2015, EVALUATION BIAS ACUP; Takakura N, 2008, ACUPUNCT MED, V26, P224, DOI 10.1136/aim.26.4.224; Takakura Nobuari, 2007, BMC Complement Altern Med, V7, P31, DOI 10.1186/1472-6882-7-31; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Tu JF, 2021, ARTHRITIS RHEUMATOL, V73, P448, DOI 10.1002/art.41584; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; Vas J, 2019, ACTA OBSTET GYN SCAN, V98, P1307, DOI 10.1111/aogs.13635; Vickers AJ, 2021, ACUPUNCT MED, V39, P309, DOI 10.1177/0964528420959089; Wasan AD, 2010, J PAIN, V11, P555, DOI 10.1016/j.jpain.2009.09.013; Wayne PM, 2005, ARCH PHYS MED REHAB, V86, P2248, DOI 10.1016/j.apmr.2005.07.287; Wenden AJ, 2018, MED J AUSTRALIA, V208, DOI 10.5694/mja17.00623; White AR, 2001, COMPLEMENT THER MED, V9, P237, DOI 10.1054/ctim.2001.0489; Witt CM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-169; Witt CM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-148; Witt CM, 2010, J PAIN, V11, P431, DOI 10.1016/j.jpain.2009.08.010; Xu Ze-Gong, 2020, Zhongguo Zhen Jiu, V40, P538, DOI 10.13703/j.0255-2930.20190514-0001; Zhuang Y, 2013, INT REV NEUROBIOL, V111, P1, DOI 10.1016/B978-0-12-411545-3.00001-8; Zucker NA, 2017, PAIN MED, V18, P1582, DOI 10.1093/pm/pnx001	77	7	7	7	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								e067476	10.1136/bmj-2021-067476	http://dx.doi.org/10.1136/bmj-2021-067476			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354583	Green Published, hybrid			2022-12-28	WOS:000779561800010
J	Mayer, KH; Allan-Blitz, LT				Mayer, Kenneth H.; Allan-Blitz, Lao-Tzu			Enhancing HIV Prevention With New Modalities and Routine Sexual History Discussions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEN		[Mayer, Kenneth H.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Allan-Blitz, Lao-Tzu] Harvard Med Sch, Boston, MA 02115 USA; [Allan-Blitz, Lao-Tzu] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Fenway Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Mayer, KH (corresponding author), Fenway Hlth, 1340 Boylston St, Boston, MA 02215 USA.	kmayer@fenwayhealth.org						CDC, NAT STRAT PLAN ROADM; Centers for Disease Control and Prevention (CDC), PREEXP PROPH PREV HI; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Mayer KH, 2020, ADV THER, V37, P1778, DOI 10.1007/s12325-020-01295-0; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Neilan AM, 2022, ANN INTERN MED, V175, P479, DOI 10.7326/M21-1548; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Sharfstein JM, 2022, JAMA-J AM MED ASSOC, V327, P921, DOI 10.1001/jama.2022.0420; Traeger MW, 2019, JAMA-J AM MED ASSOC, V321, P1380, DOI 10.1001/jama.2019.2947	9	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1447	1448		10.1001/jama.2022.3848	http://dx.doi.org/10.1001/jama.2022.3848		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35344025				2022-12-28	WOS:000776736700002
J	Bentley, A				Bentley, Alison			Avert global wheat crisis due to invasion of Ukraine	NATURE			English	Editorial Material						Sustainability; Policy; Agriculture		Russia's war highlights the fragility of the global food supply - sustained investment is needed to feed the world in a changing climate.	[Bentley, Alison] Int Maize & Wheat Improvement Ctr, Global Wheat Program, Texcoco, Mexico	CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Bentley, A (corresponding author), Int Maize & Wheat Improvement Ctr, Global Wheat Program, Texcoco, Mexico.	a.bentley@cgiar.org							0	9	9	24	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					551	551		10.1038/d41586-022-00789-x	http://dx.doi.org/10.1038/d41586-022-00789-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZX7IY	35318475	Bronze			2022-12-28	WOS:000772068800001
J	Edwards, T; Alsweiler, JM; Crowther, CA; Edlin, R; Gamble, GD; Hegarty, JE; Lin, LL; McKinlay, CJD; Rogers, JA; Thompson, B; Wouldes, TA; Harding, JE				Edwards, Taygen; Alsweiler, Jane M.; Crowther, Caroline A.; Edlin, Richard; Gamble, Greg D.; Hegarty, Joanne E.; Lin, Luling; McKinlay, Christopher J. D.; Rogers, Jenny A.; Thompson, Benjamin; Wouldes, Trecia A.; Harding, Jane E.			Prophylactic Oral Dextrose Gel and Neurosensory Impairment at 2-Year Follow-up of Participants in the hPOD Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							III MOTOR SCALE; NEONATAL HYPOGLYCEMIA; NEURODEVELOPMENTAL OUTCOMES; GLYCEMIA; PRETERM; ASSOCIATION	IMPORTANCE Prophylactic oral dextrose gel reduces neonatal hypoglycemia, but later benefits or harms remain unclear. OBJECTIVE To assess the effects on later development of prophylactic dextrose gel for infants born at risk of neonatal hypoglycemia. DESIGN, SETTING, AND PARTICIPANTS Prospective follow-up of a multicenter randomized clinical trial conducted in 18 Australian and New Zealand hospitals from January 2015 to May 2019. Participants were late preterm or term at-risk infants; those randomized in 9 New Zealand centers (n = 1359) were included and followed up between January 2017 and July 2021. INTERVENTIONS Infants were randomized to prophylactic 40% dextrose (n = 681) or placebo (n = 678) gel, 0.5 mL/kg, massaged into the buccal mucosa 1 hour after birth. MAIN OUTCOMES AND MEASURES The primary outcome of this follow-up study was neurosensory impairment at 2 years' corrected age. There were 44 secondary outcomes, including cognitive, language, and motor composite Bayley-III scores (mean [SD], 100 [15]; higher scores indicate better performance). RESULTS Of eligible infants, 1197 (91%) were assessed (581 females [49%]). Neurosensory impairment was not significantly different between the dextrose and placebo gel groups (20.8% vs 18.7%; unadjusted risk difference [RD], 2.09% [95% CI, -2.43% to 6.60%]; adjusted risk ratio [aRR], 1.13 [95% CI, 0.90 to 1.41]). The risk of cognitive and language delay was not significantly different between the dextrose and placebo groups (cognitive: 7.6% vs 5.3%; RD, 2.32% [95% CI, -0.46% to 5.11%]; aRR, 1.40 [95% CI, 0.91 to 2.17]; language: 17.0% vs 14.7%; RD, 2.35% [95% CI, -1.80% to 6.50%]; aRR, 1.19 [95% CI, 0.92 to 1.54]). However, the dextrose gel group had a significantly higher risk of motor delay (2.5% vs 0.7%; RD, 1.81% [95% CI, 0.40% to 3.23%]; aRR, 3.79 [95% CI, 1.27 to 11.32]) and significantly lower composite scores for cognitive (adjusted mean difference [aMD], -1.30 [95% CI, -2.55 to -0.05]), language (aMD, -2.16 [95% CI, -3.86 to -0.46]), and motor (aMD, -1.40 [95% CI, -2.60 to -0.20]) performance. There were no significant differences between groups in the other 27 secondary outcomes. CONCLUSIONS AND RELEVANCE Among late preterm and term infants born at risk of neonatal hypoglycemia, prophylactic oral 40% dextrose gel at 1 hour of age, compared with placebo, resulted in no significant difference in the risk of neurosensory impairment at 2 years' corrected age. However, the study may have been underpowered to detect a small but potentially clinically important increase in risk, and further research including longer-term follow-up is required. Question Among late preterm and term infants born at risk of neonatal hypoglycemia, does prophylactic oral 40% dextrose gel 1 hour after birth alter the risk of neurosensory impairment at 2 years' corrected age? Findings In this prospective follow-up of a subset of 1321 participants enrolled in a randomized clinical trial, the prevalence of neurosensory impairment was 21% among those randomized to prophylactic oral dextrose gel and 19% among those randomized to placebo gel, a difference that was not statistically significant. Meaning Administration of prophylactic oral dextrose gel to at-risk late preterm and term infants, compared with placebo, resulted in no significant difference in the risk of neurosensory impairment at 2 years' corrected age, although the study may have been underpowered to detect a small but potentially clinically important difference in risk. This follow-up of a multicenter randomized clinical trial assesses the effects on later development of prophylactic dextrose gel vs placebo for infants born at risk of neonatal hypoglycemia.	[Edwards, Taygen; Crowther, Caroline A.; Gamble, Greg D.; Lin, Luling; McKinlay, Christopher J. D.; Rogers, Jenny A.; Harding, Jane E.] Univ Auckland, Liggins Inst, Private Bag 92019,Victoria St W, Auckland 1142, New Zealand; [Alsweiler, Jane M.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Alsweiler, Jane M.; Hegarty, Joanne E.] Auckland City Hosp, Newborn Serv, Auckland, New Zealand; [Edlin, Richard] Univ Auckland, Sch Populat Hlth, Hlth Syst, Auckland, New Zealand; [McKinlay, Christopher J. D.] Counties Manukau Hlth, Kidz First Neonatal Care, Auckland, New Zealand; [Thompson, Benjamin] Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Thompson, Benjamin] Ctr Eye & Vis Res, Hong Kong, Peoples R China; [Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland City Hospital; University of Auckland; University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019,Victoria St W, Auckland 1142, New Zealand.	j.harding@auckland.ac.nz	McKinlay, Christopher JD/E-6263-2018	McKinlay, Christopher JD/0000-0003-1088-9467; Edwards, Taygen/0000-0001-7619-0398	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [R01HD091075]; HRC [15/216]	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HRC	This trial was funded by grants from the HRC (grant 15/216) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH; grant R01HD091075).	Adamkin DH, 2011, PEDIATRICS, V127, P575, DOI 10.1542/peds.2010-3851; Ansell JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188158; Atkinson J., 2020, NZDEP2018 INDEX DEPR; Bayley N, 1993, BAYLEY SCALES INFANT; British Association of Perinatal Medicine, ID MAN NEON HYP FULL; Burakevych N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44609-1; Burakevych N, 2017, DEV MED CHILD NEUROL, V59, P216, DOI 10.1111/dmcn.13232; Gioia GA, 2000, BEHAV RATING INVENTO; Griffith R, 2021, ARCH DIS CHILD-FETAL, V106, pF278, DOI 10.1136/archdischild-2020-320305; Harding JE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003411; Harding JE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0440-6; Harris DL, 2016, J PEDIATR-US, V170, P54, DOI 10.1016/j.jpeds.2015.10.066; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Hay WW, 2009, J PEDIATR-US, V155, P612, DOI 10.1016/j.jpeds.2009.06.044; Hegarty JE, 2021, J PEDIATR-US, V235, P107, DOI 10.1016/j.jpeds.2021.03.057; Hegarty JE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002155; Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631; McKinlay CJD, 2017, JAMA PEDIATR, V171, P972, DOI 10.1001/jamapediatrics.2017.1579; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; SAS Institute Inc, 2018, SAS STAT 15 1 US GUI; Spencer-Smith MM, 2015, PEDIATRICS, V135, pE1258, DOI 10.1542/peds.2014-3039; Spittle AJ, 2013, DEV MED CHILD NEUROL, V55, P448, DOI 10.1111/dmcn.12049; Statistics New Zealand, ETHN NZ STAND CLASS; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Thornton PS, 2015, J PEDIATR-US, V167, P238, DOI 10.1016/j.jpeds.2015.03.057; University of Auckland, OR DEXTR GEL TREAT N; Wackernagel D, 2020, ACTA PAEDIATR, V109, P31, DOI 10.1111/apa.14955; Wight NE, 2021, BREASTFEED MED, V16, P353, DOI 10.1089/bfm.2021.29178.new; World Health Organization, 2010, WHO ANTHR PERS COMP; Yu TY, 2013, INVEST OPHTH VIS SCI, V54, P8408, DOI 10.1167/iovs.13-13051	30	4	4	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1149	1157		10.1001/jama.2022.2363	http://dx.doi.org/10.1001/jama.2022.2363			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315885	Green Published			2022-12-28	WOS:000775589900021
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: The persistence of covid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Aiyegbusi OL, 2021, J ROY SOC MED, V114, P428, DOI 10.1177/01410768211032850; Department for Education, 2022, TWITTER; Office for National Statistics, 2022, INF RIS FURTH WEEK; Pagel C., 2022, TWITTER; Zhao SJ, 2022, BRAIN COMMUN, V4, DOI 10.1093/braincomms/fcab295	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								o740	10.1136/bmj.o740	http://dx.doi.org/10.1136/bmj.o740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9XK	35318220	Bronze			2022-12-28	WOS:000777024700007
J	Slomski, A				Slomski, Anita			Intensive Glycemic Treatment Reduces Diabetic Foot Ulcers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	5	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1118	1118		10.1001/jama.2022.3754	http://dx.doi.org/10.1001/jama.2022.3754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315888				2022-12-28	WOS:000775589900009
J	Iacobucci, G				Iacobucci, Gareth			Government inaction on child mental health recommendations is "unacceptable," say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, GOVT RESPONSE HLTH S; Wise J, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3053	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o734	10.1136/bmj.o734	http://dx.doi.org/10.1136/bmj.o734			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304390				2022-12-28	WOS:000773507900023
J	Eisenstein, M				Eisenstein, Michael			In pursuit of data immortality	NATURE			English	Editorial Material						Software; Computer science; Information technology; Research data		Data sharing can save important scientific work from extinction, but only if researchers take care to ensure that resources are easy to find and reuse. Data sharing can save important scientific work from extinction, but only if researchers take care to ensure that resources are easy to find and reuse.										Roche DG, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002295; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18	3	1	1	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					207	208		10.1038/d41586-022-00929-3	http://dx.doi.org/10.1038/d41586-022-00929-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0G4FO	35379989	Bronze			2022-12-28	WOS:000778003200007
J	Ference, BA				Ference, Brian A.			The Potential Clinical Benefit of Lowering Lipoprotein(a)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; VARIANTS		[Ference, Brian A.] Univ Cambridge, Ctr Naturally Randomized Trials, 2 Worts Causeway, Cambridge CB1 8RN, England	University of Cambridge	Ference, BA (corresponding author), Univ Cambridge, Ctr Naturally Randomized Trials, 2 Worts Causeway, Cambridge CB1 8RN, England.	baf29@medschl.cam.ac.uk						Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Ference BA, 2020, JAMA-J AM MED ASSOC, V324, P595, DOI 10.1001/jama.2020.5685; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Koren MJ, 2022, NAT MED, V28, P96, DOI 10.1038/s41591-021-01634-w; Koschinsky ML, 1997, CLIN GENET, V52, P338; Nissen SE, 2022, JAMA-J AM MED ASSOC, V327, P1679, DOI 10.1001/jama.2022.5050; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Tsimikas S, 2020, NEW ENGL J MED, V382, P244, DOI 10.1056/NEJMoa1905239	15	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2022	327	17					1653	1655		10.1001/jama.2022.5333	http://dx.doi.org/10.1001/jama.2022.5333		APR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D3AC	35368050				2022-12-28	WOS:000779463700003
J	Barbour, MA; Kliebenstein, DJ; Bascompte, J				Barbour, Matthew A.; Kliebenstein, Daniel J.; Bascompte, Jordi			A keystone gene underlies the persistence of an experimental food web	SCIENCE			English	Article							BREVICORYNE-BRASSICAE; ARABIDOPSIS-THALIANA; COMMUNITY STRUCTURE; INSECT RESISTANCE; MEAN TEMPERATURE; GLUCOSINOLATE; DIVERSITY; COMPLEXITY; APHIDIDAE; DYNAMICS	Genes encode information that determines an organism's fitness. Yet we know little about whether genes of one species influence the persistence of interacting species in an ecological community. Here, we experimentally tested the effect of three plant defense genes on the persistence of an insect food web and found that a single allele at a single gene promoted coexistence by increasing plant growth rate, which in turn increased the intrinsic growth rates of species across multiple trophic levels. Our discovery of a "keystone gene" illustrates the need to bridge between biological scales, from genes to ecosystems, to understand community persistence.	[Barbour, Matthew A.; Bascompte, Jordi] Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of Zurich; University of California System; University of California Davis	Barbour, MA (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland.	matthew.barbour@ieu.uzh.ch	Barbour, Matthew/D-5875-2012; Bascompte, Jordi/B-7596-2008	Barbour, Matthew/0000-0001-7686-0400; Kliebenstein, Daniel/0000-0001-5759-3175; Bascompte, Jordi/0000-0002-0108-6411	Swiss National Science Foundation [31003A_160671, 310030_197201]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation grants 31003A_160671 and 310030_197201 to J.B.	[Anonymous], MAT METHODS SUPPLEME; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barker HL, 2019, MOL ECOL, V28, P4404, DOI 10.1111/mec.15158; Barrett RDH, 2019, SCIENCE, V363, P499, DOI 10.1126/science.aav3824; Bascompte J, 2020, THEORETICAL ECOLOGY: CONCEPTS AND APPLICATIONS, P93, DOI 10.1093/oso/9780198824282.003.0007; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bates D., 2018, ARXIV150604967STAT; Begert M, 2018, INT J CLIMATOL, V38, P2792, DOI 10.1002/joc.5460; Brachi B, 2015, P NATL ACAD SCI USA, V112, P4032, DOI 10.1073/pnas.1421416112; Buenafe KCV., 2022, ZENODO; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burow M, 2015, MOL PLANT, V8, P1201, DOI 10.1016/j.molp.2015.03.001; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Detto M, 2019, ECOL LETT, V22, P1923, DOI 10.1111/ele.13372; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; FRITZ RS, 1988, ECOLOGY, V69, P845, DOI 10.2307/1941034; Gelman A, 2019, AM STAT, V73, P307, DOI 10.1080/00031305.2018.1549100; Grimaldi David, 2005, pi; Hampton SE, 2013, ECOLOGY, V94, P2663, DOI 10.1890/13-0996.1; Hansen BG, 2008, PLANT PHYSIOL, V148, P2096, DOI 10.1104/pp.108.129981; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jahan F, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu146; Karami A, 2018, ARTHROPOD-PLANT INTE, V12, P291, DOI 10.1007/s11829-017-9576-7; Katz E, 2021, ELIFE, V10, DOI 10.7554/eLife.67784; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kerwin R, 2015, ELIFE, V4, DOI 10.7554/eLife.05604; Kerwin RE, 2011, PLANT CELL, V23, P471, DOI 10.1105/tpc.110.082065; Kliebenstein DJ, 2016, ADV BOT RES, V80, P31, DOI 10.1016/bs.abr.2016.06.002; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kostenko O, 2015, ECOL ENTOMOL, V40, P748, DOI 10.1111/een.12251; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Leigh DM, 2019, EVOL APPL, V12, P1505, DOI 10.1111/eva.12810; Lever JJ, 2020, ECOL LETT, V23, P2, DOI 10.1111/ele.13401; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; Liu TX, 2000, SOUTHWEST ENTOMOL, V25, P91; Matuschek H, 2017, J MEM LANG, V94, P305, DOI 10.1016/j.jml.2017.01.001; McCann K.S., 2011, FOOD WEBS; Moayeri HRS, 2013, EUR J ENTOMOL, V110, P109, DOI 10.14411/eje.2013.015; Molenberghs G., 2005, MODELS DISCRETE LONG, P297; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; R Core Team, 2015, R LANGUAGE ENV STAT; Rivero L, 2014, METHODS MOL BIOL, V1062, P3, DOI 10.1007/978-1-62703-580-4_1; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Saavedra S, 2017, ECOL MONOGR, V87, P470, DOI 10.1002/ecm.1263; Satar Serdar, 2005, Turkish Journal of Agriculture and Forestry, V29, P341; Sato Y, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1705-2; Skovmand LH, 2018, TRENDS ECOL EVOL, V33, P689, DOI 10.1016/j.tree.2018.07.002; Song CL, 2018, J THEOR BIOL, V450, P30, DOI 10.1016/j.jtbi.2018.04.030; Stan Development Team, STAN MOD LANG US GUI; Stange M, 2021, NAT REV GENET, V22, P89, DOI 10.1038/s41576-020-00288-7; Taghizadeh R, 2019, J AGR SCI TECH-IRAN, V21, P627; Therneau T.M., 2020, PACKAGE SURVIVAL SUR, DOI DOI 10.1198/TECH.2004.S740; Therneau T.M., 2020, COXME MIXED EFFECTS; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Zubler EM, 2014, CLIMATIC CHANGE, V125, P237, DOI 10.1007/s10584-014-1144-x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	65	6	6	27	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		70	+		10.1126/science.abf2232	http://dx.doi.org/10.1126/science.abf2232			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357912	Green Published			2022-12-28	WOS:000780195200028
J	Sandru, M; Sandru, EM; Ingram, WF; Deng, J; Stenstad, PM; Deng, LY; Spontak, RJ				Sandru, Marius; Sandru, Eugenia M.; Ingram, Wade F.; Deng, Jing; Stenstad, Per M.; Deng, Liyuan; Spontak, Richard J.			An integrated materials approach to ultrapermeable and ultraselective CO2 polymer membranes	SCIENCE			English	Article							FACILITATED TRANSPORT MEMBRANES; GRAPHENE OXIDE NANOSHEETS; GAS SEPARATION; COMPOSITE MEMBRANE; HYDROGEN-SULFIDE; CAPTURE; PERMEABILITY; PERFORMANCE; PERMEATION; WATER	Advances in membrane technologies that combine greatly improved carbon dioxide (CO2) separation efficacy with low costs, facile fabrication, feasible upscaling, and mechanical robustness are needed to help mitigate global climate change. We introduce a hybrid-integrated membrane strategy wherein a high-permeability thin film is chemically functionalized with a patchy CO2-philic grafted chain surface layer. A high-solubility mechanism enriches the concentration of CO2 in the surface layer hydrated by water vapor naturally present in target gas streams, followed by fast CO2 transport through a highly permeable (but low-selectivity) polymer substrate. Analytical methods confirm the existence of an amine surface layer. Integrated multilayer membranes prepared in this way are not diffusion limited and retain much of their high CO2 permeability, and their CO2 selectivity is concurrently increased in some cases by more than similar to 150-fold.	[Sandru, Marius; Sandru, Eugenia M.; Stenstad, Per M.] SINTEF Ind, Dept Biotechnol & Nanomed, N-7034 Trondheim, Norway; [Ingram, Wade F.; Spontak, Richard J.] North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA; [Deng, Jing; Deng, Liyuan] Norwegian Univ Sci & Technol, Dept Chem Engn, N-7491 Trondheim, Norway; [Spontak, Richard J.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	SINTEF; University of North Carolina; North Carolina State University; Norwegian University of Science & Technology (NTNU); University of North Carolina; North Carolina State University	Sandru, M (corresponding author), SINTEF Ind, Dept Biotechnol & Nanomed, N-7034 Trondheim, Norway.; Spontak, RJ (corresponding author), North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.; Spontak, RJ (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	marius.sandru@sintef.no; rich_spontak@ncsu.edu	Deng, Jing/AAK-5800-2020	Deng, Jing/0000-0003-3680-3799; Sandru, Marius/0000-0003-2120-5032; Ingram, Wade/0000-0002-9473-4130; Sandru, Eugenia Mariana/0000-0002-6343-5891; Deng, Liyuan/0000-0003-4785-4620	Research Council of Norway through the POLYMEM project in the CLIMIT program [254791]; UEFSCDI Romania through the CO2Hybrid project [13/2020]; National Science Foundation through the North Carolina Research Triangle Nanotechnology Network, National Nanotechnology Coordinated Infrastructure [ECCS2025064]; Kraton Corporation	Research Council of Norway through the POLYMEM project in the CLIMIT program(Research Council of Norway); UEFSCDI Romania through the CO2Hybrid project; National Science Foundation through the North Carolina Research Triangle Nanotechnology Network, National Nanotechnology Coordinated Infrastructure; Kraton Corporation	This study was supported by the Research Council of Norway through the POLYMEM project (grant no. 254791) in the CLIMIT program; UEFSCDI Romania through the CO2Hybrid project (grant no. 13/2020); the National Science Foundation through the North Carolina Research Triangle Nanotechnology Network (grant no. ECCS2025064), which is part of the National Nanotechnology Coordinated Infrastructure; and the Kraton Corporation.	Baker RW, 2014, MACROMOLECULES, V47, P6999, DOI 10.1021/ma501488s; Boot-Handford ME, 2014, ENERG ENVIRON SCI, V7, P130, DOI 10.1039/c3ee42350f; Brinkmann T, 2017, ENGINEERING-PRC, V3, P485, DOI 10.1016/J.ENG.2017.04.004; Chen MM, 2018, J IND ENG CHEM, V63, P296, DOI 10.1016/j.jiec.2018.02.030; Comesana-Gandara B, 2019, ENERG ENVIRON SCI, V12, P2733, DOI 10.1039/c9ee01384a; CUSSLER EL, 1989, J MEMBRANE SCI, V43, P149, DOI 10.1016/S0376-7388(00)85094-2; Dai ZD, 2019, NPG ASIA MATER, V11, DOI 10.1038/s41427-019-0155-5; Dai ZD, 2018, GREEN CHEM, V20, P1391, DOI 10.1039/c7gc03727a; Deng JP, 2009, PROG POLYM SCI, V34, P156, DOI 10.1016/j.progpolymsci.2008.06.002; Deng J, 2019, J MEMBRANE SCI, V570, P455, DOI 10.1016/j.memsci.2018.10.031; Deng LY, 2010, J MEMBRANE SCI, V363, P295, DOI 10.1016/j.memsci.2010.07.043; Deng LY, 2009, J MEMBRANE SCI, V340, P154, DOI 10.1016/j.memsci.2009.05.019; Dragan ES, 2010, BIOMACROMOLECULES, V11, P787, DOI 10.1021/bm9014057; Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m; Engelhard MH, 2020, J VAC SCI TECHNOL A, V38, DOI 10.1116/6.0000359; Galizia M, 2017, MACROMOLECULES, V50, P7809, DOI 10.1021/acs.macromol.7b01718; Gokaltun A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43625-5; Guiver MD, 2013, SCIENCE, V339, P284, DOI 10.1126/science.1232714; Hagg MB, 2017, ENRGY PROCED, V114, P6150, DOI 10.1016/j.egypro.2017.03.1752; Han Y, 2020, MEMBRANES-BASEL, V10, DOI 10.3390/membranes10110365; Han Y, 2019, J MEMBRANE SCI, V575, P242, DOI 10.1016/j.memsci.2019.01.024; He XZ, 2021, ENGINEERING-PRC, V7, P124, DOI 10.1016/j.eng.2020.11.001; HENIS JMS, 1983, SCIENCE, V220, P11, DOI 10.1126/science.220.4592.11; Ismail AF, 2002, SEP PURIF TECHNOL, V27, P173, DOI 10.1016/S1383-5866(01)00211-8; Janakiram S, 2020, GREEN CHEM, V22, P3546, DOI 10.1039/d0gc00544d; Kim MJ, 2004, J MEMBRANE SCI, V245, P79, DOI 10.1016/j.memsci.2004.07.019; Kim TJ, 2013, J MEMBRANE SCI, V428, P218, DOI 10.1016/j.memsci.2012.10.009; Koros WJ, 2017, NAT MATER, V16, P289, DOI [10.1038/NMAT4805, 10.1038/nmat4805]; Koros WJ, 2000, J MEMBRANE SCI, V175, P181, DOI 10.1016/S0376-7388(00)00418-X; KOROS WJ, 1981, J POLYM SCI POL PHYS, V19, P1513, DOI 10.1002/pol.1981.180191004; Kraftschik B, 2013, J MEMBRANE SCI, V428, P608, DOI 10.1016/j.memsci.2012.10.025; Li X, 2017, SEP PURIF TECHNOL, V181, P223, DOI 10.1016/j.seppur.2017.02.051; Li XQ, 2015, ACS APPL MATER INTER, V7, P5528, DOI 10.1021/acsami.5b00106; Liao JY, 2014, CHEM SCI, V5, P2843, DOI 10.1039/c3sc53334d; Lin HQ, 2006, SCIENCE, V311, P639, DOI 10.1126/science.1118079; Liu JY, 2019, JOULE, V3, P1881, DOI 10.1016/j.joule.2019.07.003; Low ZX, 2018, CHEM REV, V118, P5871, DOI 10.1021/acs.chemrev.7b00629; Merkel TC, 2006, MACROMOLECULES, V39, P7591, DOI 10.1021/ma061072z; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; Merkel TC, 2010, J MEMBRANE SCI, V359, P126, DOI 10.1016/j.memsci.2009.10.041; NOBLE RD, 1990, J MEMBRANE SCI, V50, P207, DOI 10.1016/S0376-7388(00)80316-6; Park HB, 2017, SCIENCE, V356, DOI 10.1126/science.aab0530; Patel NP, 2003, ADV MATER, V15, P729, DOI 10.1002/adma.200304712; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Robeson LM, 2014, J MEMBRANE SCI, V453, P71, DOI 10.1016/j.memsci.2013.10.066; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Sandru M., 2016, ENCY MEMBRANES, P776; Sandru M, 2013, ENRGY PROCED, V37, P6473, DOI 10.1016/j.egypro.2013.06.577; Sandru M, 2010, J MEMBRANE SCI, V346, P172, DOI 10.1016/j.memsci.2009.09.039; Scholes CA, 2010, J MEMBRANE SCI, V350, P189, DOI 10.1016/j.memsci.2009.12.027; Shamsabadi AA, 2021, PROG ENERG COMBUST, V84, DOI 10.1016/j.pecs.2021.100903; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; STERN SA, 1987, J POLYM SCI POL PHYS, V25, P1263, DOI 10.1002/polb.1987.090250607; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]; Tong Z, 2015, REACT FUNCT POLYM, V86, P111, DOI 10.1016/j.reactfunctpolym.2014.09.010; Wang B, 2020, ADV MATER, V32, DOI 10.1002/adma.201907701; Wang SF, 2016, ENERG ENVIRON SCI, V9, P1863, DOI 10.1039/c6ee00811a; Wang Z, 2020, SUSTAIN ENERG FUELS, V4, P1191, DOI 10.1039/c9se00857h; Werber JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.18; White LS, 2017, J MEMBRANE SCI, V542, P217, DOI 10.1016/j.memsci.2017.08.017; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xin QP, 2015, J MATER CHEM A, V3, P6629, DOI 10.1039/c5ta00506j; Yegani R, 2007, J MEMBRANE SCI, V291, P157, DOI 10.1016/j.memsci.2007.01.011; Zhao YA, 2013, IND ENG CHEM RES, V52, P8774, DOI 10.1021/ie301397m	64	12	12	115	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		90	+		10.1126/science.abj9351	http://dx.doi.org/10.1126/science.abj9351			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357934				2022-12-28	WOS:000780195200033
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Americans who are over 50 or immunocompromised are advised to have second booster	BMJ-BRITISH MEDICAL JOURNAL			English	News Item								The new recommendations from the Food and Drug omicron variant spreads rapidly in the US and is responsible for about 55% of new infections. The variant seems to be more contagious but does not cause more severe infections.3 Evaluation and Research, said on 29 March, "Current evidence suggests some waning of protection over time against serious outcomes from covid-19 in older and immunocompromised individuals. Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna covid-19 vaccine could help increase protection levels for these high risk individuals. "Additionally, the data show that an individual booster dose is critical in helping to protect all adults from the potentially severe outcomes of covid-19. So, those who have not received their initial booster dose are strongly encouraged to do so." Marks said that another covid-19 booster might be needed in the autumn. The FDA will hold an advisory committee meeting on 6 April to consider boosters and possible updates to the existing vaccines.4 The FDA recommended the second booster to be given to over 50s at least four months after the first booster. Thus it will be the fourth vaccine dose for people who have already received the two dose Pfizer-BioNTech and Moderna vaccines plus a booster.										Arbel A, RES SQUARE; Centers for Disease Control and Prevention, 2022, CDC REC ADD BOOST CE; Ferdinands JM, 2022, MMWR-MORBID MORTAL W, V71, P255, DOI 10.15585/mmwr.mm7107e2; Kimball S., 2022, CNBC 0329; Prevention CfDCa, 2022, COVID DAT TRACK MON; U.S. Food and Drug Administration, 2022, COR COVID 19 UPD FDA	6	1	1	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o842	10.1136/bmj.o842	http://dx.doi.org/10.1136/bmj.o842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354586	Bronze			2022-12-28	WOS:000779561800017
J	Waters, A				Waters, Adele			Government is to blame for lowest NHS satisfaction rating in 25 years, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kings Fund and the Nuffield Trust, 2022, PUBL SAT NHS SOC CAR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o836	10.1136/bmj.o836	http://dx.doi.org/10.1136/bmj.o836			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354557				2022-12-28	WOS:000779561800004
J	Michalopoulou, M; Ferrey, AE; Harmer, G; Goddard, L; Kebbe, M; Theodoulou, A; Jebb, SA; Aveyard, P				Michalopoulou, Moscho; Ferrey, Anne E.; Harmer, Georgina; Goddard, Lucy; Kebbe, Maryam; Theodoulou, Annika; Jebb, Susan A.; Aveyard, Paul			Effectiveness of Motivational Interviewing in Managing Overweight and Obesity A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS MAINTENANCE; PERCEIVED BARRIERS; BRIEF INTERVENTION; DIETARY-INTAKE; LOSS PROGRAMS; SELF-HELP; WOMEN; CARE; ADULTS	Background: Motivational interviewing (MI) is potentially useful in management of overweight and obesity, but staff training and increased delivery time are barriers, and its effectiveness independent of other behavioral components is unclear. Purpose: To assess the independent contribution of MI as part of a behavioral weight management program (BWMP) in controlling weight and improving psychological well-being. Data Sources: 6 electronic databases and 2 trial registries, searched from database inception through 24 September 2021. Study Selection: Randomized controlled trials in adults or adolescents aimed at weight loss or maintenance and comparing programs incorporating MI versus interventions without MI. Data Extraction: Two reviewers independently screened studies, extracted data, and assessed risk of bias. Outcomes included weight, anxiety, depression, quality of life, and other aspects of psychological well-being. Pooled mean differences or standardized mean differences were obtained using random- and fixed-effects meta-analyses. Data Synthesis: Forty-six studies involving 11 077 participants, predominantly with obesity, were included. At 6 months, BWMPs using MI were more effective than no/minimal intervention (-0.88 [95% CI, -1.27 to -0.48] kg; I-2 = 0%) but were not statistically significantly more effective than lower-intensity (-0.88 [CI, -2.39 to 0.62] kg; /2 = 55.8%) or similar-intensity (-1.36 [CI, -2.80 to 0.07] kg; I-2 = 18.8%) BWMPs. At 1 year, data were too sparse to pool comparisons with no/minimal intervention, but MI did not produce statistically significantly greater weight change compared with lower-intensity (-1.16 [CI, -2.49 to 0.17] kg; I-2 = 88.7%) or similar-intensity (-0.18 [CI, -2.40 to 2.04] kg; I-2 = 72.7%) BWMPs without MI. Studies with 18-month follow-up were also sparse; MI did not produce statistically significant benefit in any of the comparator categories. There was no evidence of subgroup differences based on study, participant, or intervention characteristics. Too few studies assessed effects on psychological well-being to pool, but data did not suggest that MI was independently effective. Limitations: High statistical heterogeneity among studies, largely unexplained by sensitivity and subgroup analyses; stratification by comparator intensity and follow-up duration resulted in pooling of few studies. Conclusion: There is no evidence that MI increases effectiveness of BWMPs in controlling weight. Given the intensive training required for its delivery, MI may not be a worthwhile addition to BWMPs.	[Michalopoulou, Moscho; Ferrey, Anne E.; Harmer, Georgina; Goddard, Lucy; Kebbe, Maryam; Theodoulou, Annika; Jebb, Susan A.; Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford, England; [Michalopoulou, Moscho; Ferrey, Anne E.; Jebb, Susan A.; Aveyard, Paul] Oxford Univ Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford	Michalopoulou, M (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Woodstock Rd, Oxford OX2 6GG, England.	moscho.michalopoulou@phc.ox.ac.uk		Goddard, Lucy/0000-0003-3505-2399	Primary Funding Source: National Institute for Health Res-earch Biomedical Research Centre [PROSPERO: CRD42020177259]	Primary Funding Source: National Institute for Health Res-earch Biomedical Research Centre	Primary Funding Source: National Institute for Health Res-earch Biomedical Research Centre. (PROSPERO: CRD42020177259)	Ahern AL, 2017, LANCET, V389, P2214, DOI 10.1016/S0140-6736(17)30647-5; Allen JK, 2013, J OBES, V2013, DOI 10.1155/2013/151597; Amiri P, 2022, INT J BEHAV MED, V29, P78, DOI 10.1007/s12529-021-09994-w; Andre N, 2015, EAT WEIGHT DISORD-ST, V20, P519, DOI 10.1007/s40519-015-0219-7; Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Azami S, 2020, CRESCENT J MED BIOL, V7, P260; Ball GDC, 2011, PAED CHILD HEALT-CAN, V16, P345, DOI 10.1093/pch/16.6.345; Barnes RD, 2015, OBES REV, V16, P304, DOI 10.1111/obr.12264; Barnes RD, 2014, OBESITY, V22, P2508, DOI 10.1002/oby.20889; Beeken RJ, 2017, INT J OBESITY, V41, P246, DOI 10.1038/ijo.2016.206; Befort CA, 2008, J BEHAV MED, V31, P367, DOI 10.1007/s10865-008-9161-8; Boveda-Fontan J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0370-2; Burrows T, 2021, APPETITE, V156, DOI 10.1016/j.appet.2020.104974; Buscemi J, 2011, CLIN OBES, V1, P131, DOI 10.1111/j.1758-8111.2011.00030.x; Butler CC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1191; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Carels RA, 2007, HEALTH PSYCHOL, V26, P369, DOI 10.1037/0278-6133.26.3.369; Chapman A, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00252; Chee WSS, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000384; Christie D, 2017, ARCH DIS CHILD, V102, P695, DOI 10.1136/archdischild-2016-311586; Currie Jessica, 2017, Int J Adolesc Med Health, V30, DOI 10.1515/ijamh-2016-0121; Davis JN, 2011, MED SCI SPORT EXER, V43, P2195, DOI 10.1249/MSS.0b013e31821f5d4e; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; DiMarco ID, 2009, EAT BEHAV, V10, P134, DOI 10.1016/j.eatbeh.2009.02.001; Drevenhorn E, 2012, BLOOD PRESSURE, V21, P293, DOI 10.3109/08037051.2012.680734; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Elliot DL, 2007, J OCCUP ENVIRON MED, V49, P204, DOI 10.1097/JOM.0b013e3180329a8d; Everett B, 2021, CONTEMP NURSE, V57, P80, DOI 10.1080/10376178.2021.1927774; Ferrara A, 2016, DIABETES CARE, V39, P65, DOI 10.2337/dc15-1254; Freira S, 2018, EUR J PEDIATR, V177, P1121, DOI 10.1007/s00431-018-3158-2; Espinoza PG, 2019, ATEN PRIM, V51, P548, DOI 10.1016/j.aprim.2018.04.006; Hardcastle SJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-40; Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220; Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165; Hartmann-Boyce J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1840; Hartmann-Boyce J, 2015, AM J PUBLIC HEALTH, V105, pE43, DOI 10.2105/AJPH.2014.302389; Heinrich E, 2010, DIABETES RES CLIN PR, V90, P270, DOI 10.1016/j.diabres.2010.09.012; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Jones RA, 2021, OBES REV, V22, DOI 10.1111/obr.13150; Rodriguez-Cristobal JJ, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0644-y; Joseph CLM, 2021, PILOT FEASIBILITY ST, V7, DOI 10.1186/s40814-021-00848-6; Langan D, 2019, RES SYNTH METHODS, V10, P83, DOI 10.1002/jrsm.1316; LaRose JG, 2020, OBES SCI PRACT, V6, P460, DOI 10.1002/osp4.435; Lewis E, 2019, INT J BEHAV MED, V26, P580, DOI 10.1007/s12529-019-09815-1; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacDonell K, 2012, J ADOLESCENT HEALTH, V50, P201, DOI 10.1016/j.jadohealth.2011.04.018; Makin H, 2021, CLIN OBES, V11, DOI 10.1111/cob.12457; Martin PD, 2006, OBESITY, V14, P1412, DOI 10.1038/oby.2006.160; Mash RJ, 2014, DIABETIC MED, V31, P987, DOI 10.1111/dme.12475; Mead E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012651; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Mirkarimi K, 2017, IRAN RED CRESCENT ME, V19, DOI 10.5812/ircmj.29504; Moeller LV, 2019, GYNECOL ENDOCRINOL, V35, P76, DOI 10.1080/09513590.2018.1498832; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moss EL, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2094-1; Oliver I, 2012, IEEE IC COMP COM NET; Pakpour AH, 2015, PEDIATRICS, V135, pE644, DOI 10.1542/peds.2014-1987; Patel ML, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.05.026; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Quintiliani LM, 2021, PREV MED REP, V22, DOI 10.1016/j.pmedr.2021.101360; Rand K, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2017.1306421; Sabinsky MS, 2007, EUR J CLIN NUTR, V61, P526, DOI 10.1038/sj.ejcn.1602537; Saffari M, 2014, HEALTH PROMOT PERSPE, V4, P206, DOI 10.5681/hpp.2014.027; Sawyer AT, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720922714; Sharifi N, 2013, HEALTH PROMOT PERSPE, V3, P11, DOI 10.5681/hpp.2013.002; Simpson SA, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19500; Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52; Solbrig L, 2017, INTERNET INTERV, V7, P23, DOI 10.1016/j.invent.2016.12.003; Staite E, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15448; Suire KB, 2021, INT J BEHAV MED, V28, P403, DOI 10.1007/s12529-020-09934-0; Sun XH, 2020, WORLD J CLIN CASES, V8, P3209, DOI 10.12998/wjcc.v8.i15.3209; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Walls HL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-136; Webber KH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-4; West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966; West DS, 2016, OBESITY, V24, P2334, DOI 10.1002/oby.21645; Williams LT, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.12; WOOLLARD J, 1995, CLIN EXP PHARMACOL P, V22, P466, DOI 10.1111/j.1440-1681.1995.tb02046.x; World Health Organization, OB OV	80	1	1	5	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2022	175	6					838	+		10.7326/M21-3128	http://dx.doi.org/10.7326/M21-3128		MAR 2022	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Z8GP	35344379				2022-12-28	WOS:000779640300001
J	King, B; Ohyama, M; Kwon, O; Zlotogorski, A; Ko, JS; Mesinkovska, NA; Hordinsky, M; Dutronc, Y; Wu, WS; McCollam, J; Chiasserini, C; Yu, GL; Stanley, S; Holzwarth, K; DeLozier, AM; Sinclair, R				King, Brett; Ohyama, Manabu; Kwon, Ohsang; Zlotogorski, Abraham; Ko, Justin; Mesinkovska, Natasha A.; Hordinsky, Maria; Dutronc, Yves; Wu, Wen-Shuo; McCollam, Jill; Chiasserini, Chiara; Yu, Guanglei; Stanley, Sarah; Holzwarth, Katrin; DeLozier, Amy M.; Sinclair, Rodney		Investigators, BA	Two Phase 3 Trials of Baricitinib for Alopecia Areata	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; LYMPHOCYTES; EFFICACY; SAFETY; ADULTS	BACKGROUND & nbsp;Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited. Baricitinib, an oral, selective, reversible inhibitor of Janus kinases 1 and 2, may interrupt cytokine signaling implicated in the pathogenesis of alopecia areata.& nbsp;METHODS & nbsp;We conducted two randomized, placebo-controlled, phase 3 trials (BRAVE-AA1 and BRAVE-AA2) involving adults with severe alopecia areata with a Severity of Alopecia Tool (SALT) score of 50 or higher (range, 0 [no scalp hair loss] to 100 [complete scalp hair loss]). Patients were randomly assigned in a 3:2:2 ratio to receive once-daily baricitinib at a dose of 4 mg, baricitinib at a dose of 2 mg, or placebo. The primary outcome was a SALT score of 20 or less at week 36.& nbsp;RESULTS & nbsp;We enrolled 654 patients in the BRAVE-AA1 trial and 546 in the BRAVE-AA2 trial. The estimated percentage of patients with a SALT score of 20 or less at week 36 was 38.8% with 4-mg baricitinib, 22.8% with 2-mg baricitinib, and 6.2% with placebo in BRAVE-AA1 and 35.9%, 19.4%, and 3.3%, respectively, in BRAVE-AA2. In BRAVE-AA1, the difference between 4-mg baricitinib and placebo was 32.6 percentage points (95% confidence interval [CI], 25.6 to 39.5), and the difference between 2-mg baricitinib and placebo was 16.6 percentage points (95% CI, 9.5 to 23.8) (P < 0.001 for each dose vs. placebo). In BRAVE-AA2, the corresponding values were 32.6 percentage points (95% CI, 25.6 to 39.6) and 16.1 percentage points (95% CI, 9.1 to 23.2) (P < 0.001 for each dose vs. placebo). Secondary outcomes for baricitinib at a dose of 4 mg but not at a dose of 2 mg generally favored baricitinib over placebo. Acne, elevated levels of creatine kinase, and increased levels of low- and high-density lipoprotein cholesterol were more common with baricitinib than with placebo.& nbsp;CONCLUSIONS & nbsp;In two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks. Longer trials are required to assess the efficacy and safety of baricitinib for alopecia areata. (Funded by Eli Lilly under license from Incyte; BRAVE-AA1 and BRAVE-AA2 .	[King, Brett] Yale Sch Med, New Haven, CT USA; [Ohyama, Manabu] Kyorin Univ, Dept Dermatol, Fac Med, Tokyo, Japan; [Kwon, Ohsang] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Zlotogorski, Abraham] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Ctr, Dept Dermatol, Jerusalem, Israel; [Ko, Justin] Stanford Univ, Sch Med, Stanford, CA USA; [Mesinkovska, Natasha A.] Univ Calif Irvine, Irvine, CA USA; [Mesinkovska, Natasha A.] Univ Minnesota, Dept Dermatol, Med Sch, Minneapolis, MN USA; [Dutronc, Yves; Wu, Wen-Shuo; McCollam, Jill; Chiasserini, Chiara; Yu, Guanglei; Stanley, Sarah; Holzwarth, Katrin; DeLozier, Amy M.] Eli Lilly, Indianapolis, IN USA; [Sinclair, Rodney] Sinclair Dermatol, Melbourne, Vic, Australia	Yale University; Kyorin University; Seoul National University (SNU); Hebrew University of Jerusalem; Hadassah University Medical Center; Stanford University; University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities; Eli Lilly	King, B (corresponding author), Yale Sch Med, Dept Dermatol, POB 208059,333 Cedar St, LCI 501, New Haven, CT 06510 USA.	brett.-king@-yale.-edu	KWON, OHSANG/J-2733-2012	KWON, OHSANG/0000-0003-0464-5124	Eli Lilly under license from Incyte	Eli Lilly under license from Incyte	Supported by Eli Lilly under license from Incyte	Aldhouse NVJ, 2020, J PATIENT-REP OUTCOM, V4, DOI 10.1186/s41687-020-00240-7; Blume-Peytavi U, 2011, BRIT J DERMATOL, V164, P5, DOI 10.1111/j.1365-2133.2010.10011.x; Bretz F, 2011, BIOMETRICAL J, V53, P894, DOI 10.1002/bimj.201000239; Cranwel WC, 2019, AUSTRALAS J DERMATOL, V60, P163, DOI 10.1111/ajd.12941; Crispin MK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89776; Damsky W, 2017, J AM ACAD DERMATOL, V76, P736, DOI 10.1016/j.jaad.2016.12.005; de Oliveira AB, 2019, DERMATOL THER, V32, DOI 10.1111/dth.13053; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Jabbari A, 2018, J INVEST DERMATOL, V138, P1539, DOI 10.1016/j.jid.2018.01.032; Jabbari A, 2015, EBIOMEDICINE, V2, P351, DOI 10.1016/j.ebiom.2015.02.015; King B, 2021, J AM ACAD DERMATOL, V85, P847, DOI 10.1016/j.jaad.2021.05.050; King B, 2021, J AM ACAD DERMATOL, V85, P379, DOI 10.1016/j.jaad.2021.03.050; Liu LY, 2018, J AM ACAD DERMATOL, V79, P556, DOI 10.1016/j.jaad.2018.01.048; Liu LY, 2016, J AM ACAD DERMATOL, V75, P806, DOI 10.1016/j.jaad.2016.04.035; Mackay-Wiggan J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89790; Meah N, 2020, J AM ACAD DERMATOL, V83, P123, DOI 10.1016/j.jaad.2020.03.004; Olamiju Brianna, 2019, JAAD Case Rep, V5, P892, DOI 10.1016/j.jdcr.2019.07.005; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Phan K, 2019, J EUR ACAD DERMATOL, V33, P850, DOI 10.1111/jdv.15489; Pratt CH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.11; Strazzulla LC, 2018, J AM ACAD DERMATOL, V78, P15, DOI 10.1016/j.jaad.2017.04.1142; Wang EHC, 2018, J INVEST DERMATOL, V138, P1911, DOI 10.1016/j.jid.2018.05.027; Wyrwich KW, 2020, BRIT J DERMATOL, V183, P702, DOI 10.1111/bjd.18883; Wyrwich KW, 2020, AM J CLIN DERMATOL, V21, P725, DOI 10.1007/s40257-020-00545-9; Wyrwich K, 2020, BRIT J DERMATOL, V183, P1065, DOI 10.1111/bjd.19024; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645	28	19	19	13	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2022	386	18					1687	1699		10.1056/NEJMoa2110343	http://dx.doi.org/10.1056/NEJMoa2110343		MAR 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D5AM	35334197				2022-12-28	WOS:000782564000001
J	Chen, WK; Chen, L; Zhang, X; Yang, N; Guo, JH; Wang, M; Ji, SH; Zhao, XY; Yin, PF; Cai, LC; Xu, J; Zhang, LL; Han, YJ; Xiao, YN; Xu, G; Wang, YB; Wang, SH; Wu, S; Yang, F; Jackson, D; Cheng, JK; Chen, SH; Sun, CQ; Qin, F; Tian, F; Fernie, AR; Li, JS; Yan, JB; Yang, XH				Chen, Wenkang; Chen, Lu; Zhang, Xuan; Yang, Ning; Guo, Jianghua; Wang, Min; Ji, Shenghui; Zhao, Xiangyu; Yin, Pengfei; Cai, Lichun; Xu, Jing; Zhang, Lili; Han, Yingjia; Xiao, Yingni; Xu, Gen; Wang, Yuebin; Wang, Shuhui; Wu, Sheng; Yang, Fang; Jackson, David; Cheng, Jinkui; Chen, Saihua; Sun, Chuanqing; Qin, Feng; Tian, Feng; Fernie, Alisdair R.; Li, Jiansheng; Yan, Jianbing; Yang, Xiaohong			Convergent selection of a WD40 protein that enhances grain yield in maize and rice	SCIENCE			English	Article							PLANT ARCHITECTURE; READ ALIGNMENT; DOMESTICATION; GENOME; POPULATION; GENE; IDENTIFICATION; ASSOCIATION; TRAITS; MODEL	A better understanding of the extent of convergent selection among crops could greatly improve breeding programs. We found that the quantitative trait locus KRN2 in maize and its rice ortholog, OsKRN2, experienced convergent selection. These orthologs encode WD40 proteins and interact with a gene of unknown function, DUF1644, to negatively regulate grain number in both crops. Knockout of KRN2 in maize or OsKRN2 in rice increased grain yield by similar to 10% and similar to 8%, respectively, with no apparent trade-offs in other agronomic traits. Furthermore, genome-wide scans identified 490 pairs of orthologous genes that underwent convergent selection during maize and rice evolution, and these were enriched for two shared molecular pathways. KRN2, together with other convergently selected genes, provides an excellent target for future crop improvement.	[Chen, Wenkang; Zhang, Xuan; Guo, Jianghua; Wang, Min; Ji, Shenghui; Zhao, Xiangyu; Yin, Pengfei; Cai, Lichun; Xu, Jing; Zhang, Lili; Han, Yingjia; Xiao, Yingni; Xu, Gen; Wang, Shuhui; Wu, Sheng; Cheng, Jinkui; Sun, Chuanqing; Qin, Feng; Tian, Feng; Li, Jiansheng; Yang, Xiaohong] China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100193, Peoples R China; [Chen, Wenkang; Zhang, Xuan; Guo, Jianghua; Wang, Min; Ji, Shenghui; Zhao, Xiangyu; Yin, Pengfei; Cai, Lichun; Xu, Jing; Zhang, Lili; Han, Yingjia; Xiao, Yingni; Xu, Gen; Wang, Shuhui; Wu, Sheng; Cheng, Jinkui; Sun, Chuanqing; Qin, Feng; Tian, Feng; Li, Jiansheng; Yang, Xiaohong] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100193, Peoples R China; [Chen, Lu; Yang, Ning; Wang, Yuebin; Yang, Fang; Jackson, David; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yang, Ning; Yang, Fang; Yan, Jianbing] Hubei Hongshan Lab, Wuhan 430070, Peoples R China; [Jackson, David] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Cheng, Jinkui; Qin, Feng; Tian, Feng; Li, Jiansheng; Yang, Xiaohong] China Agr Univ, Ctr Crop Funct Genom & Mol Breeding, Beijing 100193, Peoples R China; [Chen, Saihua] Yangzhou Univ, Minist Educ, Key Lab Plant Funct Genom, Yangzhou 225009, Jiangsu, Peoples R China; [Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, D-14476 Potsdam, Germany; [Chen, Lu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Chen, Lu] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	China Agricultural University; China Agricultural University; Huazhong Agricultural University; Cold Spring Harbor Laboratory; China Agricultural University; Yangzhou University; Max Planck Society; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Li, JS; Yang, XH (corresponding author), China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100193, Peoples R China.; Li, JS; Yang, XH (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100193, Peoples R China.; Yan, JB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.; Yan, JB (corresponding author), Hubei Hongshan Lab, Wuhan 430070, Peoples R China.; Li, JS; Yang, XH (corresponding author), China Agr Univ, Ctr Crop Funct Genom & Mol Breeding, Beijing 100193, Peoples R China.	lijiansheng@cau.edu.cn; yjianbing@mail.hzau.edu.cn; yxiaohong@cau.edu.cn		Yang, Ning/0000-0002-6354-3534; yan, peng fei/0000-0002-7556-9635; Wang, Min/0000-0001-6874-4282				Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2013, PREPRINTS; Bai XF, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0115; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai LC, 2014, MOL BREEDING, V34, P1087, DOI 10.1007/s11032-014-0101-8; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen L., 2021, BIORXIV, DOI [10.1101/2021.04.07.438828, DOI 10.1101/2021.04.07.438828]; Chen QY, 2021, MOL PLANT, V14, P9, DOI 10.1016/j.molp.2020.12.006; Chen W, 2022, FIGSHARE, DOI [10.6084/ m9. figshare.18104336, DOI 10.6084/M9.FIGSHARE.18104336]; Chen W., FIGSHARE 2022; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernie AR, 2019, MOL PLANT, V12, P615, DOI 10.1016/j.molp.2019.03.016; Fichtner F, 2021, ANNU REV PLANT BIOL, V72, P737, DOI 10.1146/annurev-arplant-050718-095929; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gaut BS, 2015, MOL BIOL EVOL, V32, P1661, DOI 10.1093/molbev/msv105; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAMMER K, 1984, Kulturpflanze, V32, P11; Huang C, 2018, P NATL ACAD SCI USA, V115, pE334, DOI 10.1073/pnas.1718058115; Huang LC, 2021, PLANT COMMUN, V2, DOI 10.1016/j.xplc.2021.100237; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Ishii T, 2013, NAT GENET, V45, P462, DOI 10.1038/ng.2567; Jain BP, 2018, PROTEIN J, V37, P391, DOI 10.1007/s10930-018-9785-7; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER ES, 1989, GENETICS, V121, P185; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2021, MOL BIOL EVOL, V38, P3567, DOI 10.1093/molbev/msab119; Liang YM, 2021, ANNU REV PLANT BIOL, V72, P357, DOI 10.1146/annurev-arplant-080720-090632; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Liu Z, PLANT GENOME-US; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Pankin A, 2017, CURR OPIN PLANT BIOL, V36, P15, DOI 10.1016/j.pbi.2016.12.001; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tang HB, 2013, P NATL ACAD SCI USA, V110, P15824, DOI 10.1073/pnas.1305213110; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Tian JG, 2019, SCIENCE, V365, P658, DOI 10.1126/science.aax5482; Tsuda K, 2011, PLANT CELL, V23, P4368, DOI 10.1105/tpc.111.090050; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang M, 2018, NAT GENET, V50, P1435, DOI 10.1038/s41588-018-0229-2; Wang WS, 2018, NATURE, V557, P43, DOI 10.1038/s41586-018-0063-9; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Woodhouse MR, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0245; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu QY, 2020, P NATL ACAD SCI USA, V117, P1799, DOI 10.1073/pnas.1917577116; Wu Y., P NATL ACAD SCI; Wu YY, 2012, P NATL ACAD SCI USA, V109, P10281, DOI 10.1073/pnas.1201700109; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang ZY, 2015, PLANT CELL, V27, P1162, DOI 10.1105/tpc.15.00035; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zheng XM, 2022, PLANT BIOTECHNOL J, V20, P16, DOI 10.1111/pbi.13730; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	88	21	23	101	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1372	+	eabg7985	10.1126/science.abg7985	http://dx.doi.org/10.1126/science.abg7985			79	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324310				2022-12-28	WOS:000778894800035
J	Suran, M				Suran, Melissa			Federal Government Buys Thousands of Bebtelovimab Doses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1117	1117		10.1001/jama.2022.3520	http://dx.doi.org/10.1001/jama.2022.3520			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315904				2022-12-28	WOS:000775589900005
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word .... Diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o646; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Brown P, 2015, SOC SCI MED, V146, P164, DOI 10.1016/j.socscimed.2015.10.047; Dyrbus K, 2021, ATHEROSCLEROSIS, V333, P16, DOI 10.1016/j.atherosclerosis.2021.08.024; Gelbard MK, 2021, ENDOCRIN DIAB METAB, V4, DOI 10.1002/edm2.195; Launer J, 2022, POSTGRAD MED J, V98, P236, DOI 10.1136/postgradmedj-2022-141516; Mathieu S, 2020, JOINT BONE SPINE, V87, P203, DOI 10.1016/j.jbspin.2020.02.001; Osler W., 1903, MED NEWS NEW YORK, V82, P49	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o747	10.1136/bmj.o747	http://dx.doi.org/10.1136/bmj.o747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314432	Bronze			2022-12-28	WOS:000773915700010
J	Rodriguez, JA; Shachar, C; Bates, DW				Rodriguez, Jorge A.; Shachar, Carmel; Bates, David W.			Digital Inclusion as Health Care - Supporting Health Care Equity with Digital-Infrastructure Initiatives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								Digital inclusion is becoming intertwined with health care equity. The Infrastructure Investment and Jobs Act addresses drivers of digital health disparities, offers opportunities for community-based digital inclusion, and could be a lever for improving access to care.	[Rodriguez, Jorge A.; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA USA; [Rodriguez, Jorge A.; Bates, David W.] Harvard Med Sch, Boston, MA USA; [Bates, David W.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Shachar, Carmel] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Rodriguez, JA (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA USA.; Rodriguez, JA (corresponding author), Harvard Med Sch, Boston, MA USA.							Benda NC, 2020, AM J PUBLIC HEALTH, V110, P1123, DOI 10.2105/AJPH.2020.305784; Clark CR, 2021, J AM MED INFORM ASSN, V28, P2013, DOI 10.1093/jamia/ocab103; Grossman LV, 2019, J AM MED INFORM ASSN, V26, P855, DOI 10.1093/jamia/ocz023; Horrigan J., 2021, EMERGENCY BROADBAND; National Digital Inclusion Alliance, DEF	5	7	7	18	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.									1101	1103		10.1056/NEJMp2115646	http://dx.doi.org/10.1056/NEJMp2115646		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H9RE	35302722	Bronze			2022-12-28	WOS:000779064900001
J	Abbasi, J				Abbasi, Jennifer			Pushed to Their Limits, 1 in 5 Physicians Intends to Leave Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1435	1435						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35353134				2022-12-28	WOS:000793035800008
J	Mariano, VJ; Mylonakis, E				Mariano, Vincent J.; Mylonakis, Eleftherios			In inpatients with COVID-19 who need supplemental oxygen lenzilumab increased ventilation-free survival	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mariano, Vincent J.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mariano, VJ (corresponding author), Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA.							COVID-19 Treatment Guidelines Panel, COR DIS 2019 COVID 1	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					JC39	JC39		10.7326/J22-0019	http://dx.doi.org/10.7326/J22-0019		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1L3DC	35377717				2022-12-28	WOS:000799170800005
J	Gostin, LO; Rubenstein, LS				Gostin, Lawrence O.; Rubenstein, Leonard S.			Attacks on Health Care in the War in Ukraine International Law and the Need for Accountability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, O Neill Inst Natl & Global Hlth Law, 500 First St NW,Off 810, Washington, DC 20001 USA; [Rubenstein, Leonard S.] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD 21218 USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, O Neill Inst Natl & Global Hlth Law, 500 First St NW,Off 810, Washington, DC 20001 USA.	gostin@georgetown.edu						Bachega H., 2022, BBC NEWS 0315; Disability Rights International, UKR EM ACT DRI SEEKS; Rubenstein L., 2021, PERILOUS MED STRUGGL; Safeguarding Health in Conflict Coalition (SHCC) and Insecurity Insight, 2021, IN UNC FUT UN SEC C; The United Nations High Commissioner for Refugees, 2022, MONTH START WAR ALM; Tiefenthaler A., 2022, NEW YORK TIMES; United Nations General Assembly, ARESES112 UN GEN ASS; United Nations High Commissioner for Refugees, OP DAT PORT UKR REF; WHO, SURV SYST ATT HEALTH; World Health Organization, 2022, COMMUNICATION 0317	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2022	327	16					1541	1542		10.1001/jama.2022.6045	http://dx.doi.org/10.1001/jama.2022.6045		APR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0W7TZ	35363248				2022-12-28	WOS:000776736500002
J	Hoyt, SJ; Storer, JM; Hartley, GA; Grady, PGS; Gershman, A; de Lima, LG; Limouse, C; Halabian, R; Wojenski, L; Rodriguez, M; Altemose, N; Rhie, A; Core, LJ; Gerton, JL; Makalowski, W; Olson, D; Rosen, J; Smit, AFA; Straight, AF; Vollger, MR; Wheeler, TJ; Schatz, MC; Eichler, EE; Phillippy, AM; Timp, W; Miga, KH; O'Neill, RJ				Hoyt, Savannah J.; Storer, Jessica M.; Hartley, Gabrielle A.; Grady, Patrick G. S.; Gershman, Ariel; de Lima, Leonardo G.; Limouse, Charles; Halabian, Reza; Wojenski, Luke; Rodriguez, Matias; Altemose, Nicolas; Rhie, Arang; Core, Leighton J.; Gerton, Jennifer L.; Makalowski, Wojciech; Olson, Daniel; Rosen, Jeb; Smit, Arian F. A.; Straight, Aaron F.; Vollger, Mitchell R.; Wheeler, Travis J.; Schatz, Michael C.; Eichler, Evan E.; Phillippy, Adam M.; Timp, Winston; Miga, Karen H.; O'Neill, Rachel J.			From telomere to telomere: The transcriptional and epigenetic state of human repeat elements	SCIENCE			English	Article							X-CHROMOSOME INACTIVATION; CENP-A; TRANSPOSABLE ELEMENTS; CENTROMERIC CHROMATIN; STRUCTURAL VARIATION; SVA ELEMENTS; XIST RNA; DNA; SEQUENCE; EVOLUTION	Mobile elements and repetitive genomic regions are sources of lineage-specific genomic innovation and uniquely fingerprint individual genomes. Comprehensive analyses of such repeat elements, including those found in more complex regions of the genome, require a complete, linear genome assembly. We present a de novo repeat discovery and annotation of the T2T-CHM13 human reference genome. We identified previously unknown satellite arrays, expanded the catalog of variants and families for repeats and mobile elements, characterized classes of complex composite repeats, and located retroelement transduction events. We detected nascent transcription and delineated CpG methylation profiles to define the structure of transcriptionally active retroelements in humans, including those in centromeres. These data expand our insight into the diversity, distribution, and evolution of repetitive regions that have shaped the human genome.	[Hoyt, Savannah J.; Hartley, Gabrielle A.; Grady, Patrick G. S.; Wojenski, Luke; Core, Leighton J.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Storer, Jessica M.; Rosen, Jeb; Smit, Arian F. A.] Inst Syst Biol, Seattle, WA USA; [Gershman, Ariel; Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA; [de Lima, Leonardo G.; Gerton, Jennifer L.] Stowers Inst Med Res, Kansas City, MO USA; [Limouse, Charles; Straight, Aaron F.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Halabian, Reza; Rodriguez, Matias; Makalowski, Wojciech] Univ Munster, Fac Med, Inst Bioinformat, Munster, Germany; [Altemose, Nicolas] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Rhie, Arang; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Core, Leighton J.; O'Neill, Rachel J.] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Olson, Daniel; Wheeler, Travis J.] Univ Montana, Dept Comp Sci, Missoula, MT 59812 USA; [Vollger, Mitchell R.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Schatz, Michael C.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Schatz, Michael C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Miga, Karen H.] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [O'Neill, Rachel J.] UConn Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA	University of Connecticut; Institute for Systems Biology (ISB); Johns Hopkins University; Stowers Institute for Medical Research; Stanford University; University of Munster; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Connecticut; University of Montana System; University of Montana; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Johns Hopkins University; University of California System; University of California Santa Cruz	O'Neill, RJ (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.; O'Neill, RJ (corresponding author), Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA.; O'Neill, RJ (corresponding author), UConn Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA.	rachel.oneill@uconn.edu	Altemose, Nicolas/EIR-2712-2022; Phillippy, Adam/U-5731-2018	Altemose, Nicolas/0000-0002-7231-6026; Wojenski, Luke/0000-0003-4822-5017; Halabian, Reza/0000-0002-0360-4171; Vollger, Mitchell/0000-0002-8651-1615; de Lima, Leonardo/0000-0001-6340-6065; Grady, Patrick/0000-0003-0180-7810; Rosen, Jeb/0000-0002-8832-1276; Hartley, Gabrielle/0000-0002-5672-2171; Wheeler, Travis/0000-0003-2004-1785; Phillippy, Adam/0000-0003-2983-8934; Rodriguez, Matias/0000-0002-2698-6686; Gershman, Ariel/0000-0001-8899-8781	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (AMP); US National Institutes of Health [R01GM123312-02, R21CA240199, R01HG002939, U24HG010136, R01HG009190, R01HG00990905, R35GM128857, R01GM132600, P20GM103546, U24HG010263, U24HG006620, U01CA253481, R24DK106766-01A1, R01HG002385, R01HG010169, U01HG010971, 1ZIAHG200398R01, 1R01HG011274-01, R21HG010548-01]; National Science Foundation [NSF 1613806, NSF 1643825]; NSF [DBI-1627442, IOS-1732253, IOS-1758800]; Connecticut Innovations grant [20190200]; Mark Foundation for Cancer Research grant [19-033-ASP]; Stowers Institute for Medical Research grant; Howard Hughes Medical Institute Hanna H. Gray Fellowship	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (AMP); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Connecticut Innovations grant; Mark Foundation for Cancer Research grant; Stowers Institute for Medical Research grant; Howard Hughes Medical Institute Hanna H. Gray Fellowship	This work was supported, in part, by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (AMP). Grants from the US National Institutes of Health: R01GM123312-02 and R21CA240199 to S.J.H., G.A.H., P.G.S.G., and R.J.O.; R01HG002939 and U24HG010136 to J.M.S., J.R., A.F.A.S.; R01HG009190 to A.G. and W.T.; R01HG00990905 to C.L. and A.F.S.; R35GM128857 to L.W. and L.J.C.; R01GM132600, P20GM103546, and U24HG010136 to D.O. and T.J.W.; U24HG010263, U24HG006620, U01CA253481, and R24DK106766-01A1 to M.C.S.; R01HG002385, R01HG010169, and U01HG010971 to M.R.V. and E.E.E.; 1ZIAHG200398R01 to A.R. and A.M.P.; 1R01HG011274-01, R21HG010548-01, and U01HG010971 to K.H.M. Grants from the National Science Foundation: NSF 1613806 and NSF 1643825 to R.J. O.; NSF DBI-1627442, NSF IOS-1732253, and NSF IOS-1758800 to M.C.S. Connecticut Innovations grant 20190200 to R.J.O. Mark Foundation for Cancer Research grant 19-033-ASP to M.C.S. Stowers Institute for Medical Research grant to L.G.d.L. and J.L.G. Howard Hughes Medical Institute Hanna H. Gray Fellowship to N.A. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Altemose N, 2022, SCIENCE, V376, P56, DOI 10.1126/science.abl4178; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Baaj S., 2014, REPBASE REP, V14, P2086; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P223, DOI 10.1023/A:1016648404388; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bobkov GOM, 2018, J CELL BIOL, V217, P1957, DOI 10.1083/jcb.201611087; Brazda V, 2019, BIOINFORMATICS, V35, P3493, DOI 10.1093/bioinformatics/btz087; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Carlevaro-Fita J, 2019, GENOME RES, V29, P208, DOI 10.1101/gr.229922.117; Carone DM, 2013, CHROMOSOME RES, V21, P49, DOI 10.1007/s10577-013-9337-0; Catania S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004986; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen CC, 2015, DEV CELL, V34, P73, DOI 10.1016/j.devcel.2015.05.012; Chen LL, 2017, TRENDS CELL BIOL, V27, P480, DOI 10.1016/j.tcb.2017.01.002; Chen XJ, 2021, INT J GYNECOL PATHOL, V40, P333, DOI 10.1097/PGP.0000000000000697; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Chu Tinyi, 2019, Curr Protoc Bioinformatics, V66, pe70, DOI 10.1002/cpbi.70; Chueh AC, 2005, HUM MOL GENET, V14, P85, DOI 10.1093/hmg/ddi008; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dfam, TRANSPOSABLE ELEMENT; Dumbovic G, 2018, NUCLEIC ACIDS RES, V46, P5504, DOI 10.1093/nar/gky263; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Fastx-toolkit, FASTQ A SHORT READS; Fatyol K, 2000, MOL GEN GENET, V262, P931, DOI 10.1007/PL00008661; Fernandes JD, 2020, MOBILE DNA-UK, V11, DOI 10.1186/s13100-020-00208-w; Flynn JM, 2020, P NATL ACAD SCI USA, V117, P9451, DOI 10.1073/pnas.1921046117; Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; Frattini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15377; Freimanis G. L., 2008, THESIS; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gardner EJ, 2017, GENOME RES, V27, P1916, DOI 10.1101/gr.218032.116; Gershman A, 2022, SCIENCE, V376, P58, DOI 10.1126/science.abj5089; Gondo Y, 1998, GENOMICS, V54, P39, DOI 10.1006/geno.1998.5545; Gonzalez B, 2021, CANCERS, V13, DOI 10.3390/cancers13215353; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Guiblet WM, 2021, GENOME RES, V31, P1136, DOI 10.1101/gr.269589.120; Hallast P, 2021, ELIFE, V10, DOI 10.7554/eLife.65420; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Hao ZD, 2020, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.251; Hartley GA, 2021, MOL BIOL EVOL, V38, P3972, DOI 10.1093/molbev/msab148; He YX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12174-w; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoyt S. J., 2022, TELOMERE TELOMERE TR; Hubley R., 2013, REPEATMASKER OPEN 40; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Hung YH, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1204; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jayakumar V, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6657-2; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; Johnson WL, 2017, ELIFE, V6, DOI 10.7554/eLife.25299; Judd J., 2020, 20200518102277 BIORX, P1, DOI DOI 10.1101/2020.05.18.102277; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein SJ, 2018, CHROMOSOME RES, V26, P5, DOI 10.1007/s10577-017-9569-5; Koga A, 2017, GENOME BIOL EVOL, V9, P1963, DOI 10.1093/gbe/evx142; Kokot M, 2017, BIOINFORMATICS, V33, P2759, DOI 10.1093/bioinformatics/btx304; Konkel MK, 2010, EVOL ANTHROPOL, V19, P236, DOI 10.1002/evan.20283; Koonin EV, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0442; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kronenberg ZN, 2018, SCIENCE, V360, P1085, DOI 10.1126/science.aar6343; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen PA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0439-6; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Lewin HA, 2018, P NATL ACAD SCI USA, V115, P4325, DOI 10.1073/pnas.1720115115; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Logsdon GA, 2021, NATURE, V593, P101, DOI 10.1038/s41586-021-03420-7; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; McCartney A. M., 2021, CHASING PERFECTION V, DOI [10.1101/2021.07.02.450803, DOI 10.1101/2021.07.02.450803]; McNulty SM, 2017, DEV CELL, V42, P226, DOI 10.1016/j.devcel.2017.07.001; MENEVERI R, 1993, GENE, V123, P227, DOI 10.1016/0378-1119(93)90128-P; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Nagai H, 1999, GENE, V237, P15, DOI 10.1016/S0378-1119(99)00322-4; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishiyama R, 2005, CANCER BIOL THER, V4, P440; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Olson D, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P37, DOI 10.1145/3233547.3233604; Pajic P, 2019, ELIFE, V8, DOI 10.7554/eLife.44628; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Piegu B, 2015, MOL PHYLOGENET EVOL, V86, P90, DOI 10.1016/j.ympev.2015.03.009; Pontis J, 2019, CELL STEM CELL, V24, P724, DOI 10.1016/j.stem.2019.03.012; Pradhan B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15076-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rhie A, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02134-9; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Roden C, 2021, NAT REV MOL CELL BIO, V22, P183, DOI 10.1038/s41580-020-0264-6; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Samuelsson JK, 2017, EPIGENOMES, V1, DOI 10.3390/epigenomes1010002; SAS Institute Inc, JMP; Scrucca L, 2016, R J, V8, P289; Seibt KM, 2018, BIOINFORMATICS, V34, P3575, DOI 10.1093/bioinformatics/bty395; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Sokolowski M, 2017, NUCLEIC ACIDS RES, V45, P5294, DOI 10.1093/nar/gkx211; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Stecher G, 2020, MOL BIOL EVOL, V37, P1237, DOI 10.1093/molbev/msz312; Storer J, 2021, MOBILE DNA-UK, V12, DOI 10.1186/s13100-020-00230-y; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Szak ST, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r30; Thompson PJ, 2016, MOL CELL, V62, P766, DOI 10.1016/j.molcel.2016.03.029; Thoraval D, 1996, GENE CHROMOSOME CANC, V17, P234, DOI 10.1002/(SICI)1098-2264(199612)17:4<234::AID-GCC5>3.0.CO;2-4; Tica J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2670-x; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; van Bemmel JG, 2019, NAT GENET, V51, P1024, DOI 10.1038/s41588-019-0412-0; Vollger M. R., 2022, SCIENCE, V376; Vollger MR, 2022, BIOINFORMATICS, V38, P2049, DOI 10.1093/bioinformatics/btac018; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang L, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz098; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wissink EM, 2019, NAT REV GENET, V20, P705, DOI 10.1038/s41576-019-0159-6; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262	151	25	25	30	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		57	+	eabk3112	10.1126/science.abk3112	http://dx.doi.org/10.1126/science.abk3112			130	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357925	Green Accepted, Green Submitted			2022-12-28	WOS:000780195200025
J	Kim, KH				Kim, Kyra H.			Bucking tradition	SCIENCE			English	Editorial Material									[Kim, Kyra H.] CALTECH, Jet Prop Lab, NASA, 4800 Oak Grove Dr, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Kim, KH (corresponding author), CALTECH, Jet Prop Lab, NASA, 4800 Oak Grove Dr, Pasadena, CA 91125 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		102	102						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357941				2022-12-28	WOS:000780195200035
J	Nosil, P; Gompert, Z				Nosil, Patrik; Gompert, Zach			Eco-evolutionary effects of keystone genes	SCIENCE			English	Editorial Material							COMMUNITY; GENETICS		[Nosil, Patrik] Univ Paul Valery Montpellier 3, CEFE, Univ Montpellier, CNRS,EPHE,IRD, Montpellier, France; [Gompert, Zach] Utah State Univ, Dept Biol, Logan, UT 84322 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Utah System of Higher Education; Utah State University	Nosil, P (corresponding author), Univ Paul Valery Montpellier 3, CEFE, Univ Montpellier, CNRS,EPHE,IRD, Montpellier, France.	patrik.nosil@cele.crns.fr			European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [770826]; US National Science Foundation [DEB-1638768]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); US National Science Foundation(National Science Foundation (NSF))	This work is part of a project that has received funding from the European Research Council (ERC) to P.N., under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 770826 EE-Dynamics). Z.G. is supported by the US National Science Foundation (DEB-1638768).	Barbour MA, 2022, SCIENCE, V376, P70, DOI 10.1126/science.abf2232; Becks L, 2012, ECOL LETT, V15, P492, DOI 10.1111/j.1461-0248.2012.01763.x; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; Ford EB, 1971, ECOLOGICAL GENETICS; Hendry A.P., 2017, ECO EVOLUTIONARY DYN; Hyman SE, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0031; Levine JM, 2017, NATURE, V546, P56, DOI 10.1038/nature22898; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Skovmand LH, 2018, TRENDS ECOL EVOL, V33, P689, DOI 10.1016/j.tree.2018.07.002; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Wellenreuther M, 2018, TRENDS ECOL EVOL, V33, P427, DOI 10.1016/j.tree.2018.04.002; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2	15	0	0	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		30	31		10.1126/science.abo3575	http://dx.doi.org/10.1126/science.abo3575			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357923				2022-12-28	WOS:000780195200012
J	Mazor, RD; Nathan, N; Gilboa, A; Stoler-Barak, L; Moss, L; Solomonov, I; Hanuna, A; Divinsky, Y; Shmueli, MD; Hezroni, H; Zaretsky, I; Mor, M; Golani, O; Sabah, G; Jakobson-Setton, A; Yanichkin, N; Feinmesser, M; Tsoref, D; Salman, L; Yeoshoua, E; Peretz, E; Erlich, I; Cohen, NM; Gershoni, JM; Freund, N; Merbl, Y; Yaari, G; Eitan, R; Sagi, I; Shulman, Z				Mazor, Roei D.; Nathan, Nachum; Gilboa, Amit; Stoler-Barak, Liat; Moss, Lihee; Solomonov, Inna; Hanuna, Assaf; Divinsky, Yalin; Shmueli, Merav D.; Hezroni, Hadas; Zaretsky, Irina; Mor, Michael; Golani, Ofra; Sabah, Gad; Jakobson-Setton, Ariella; Yanichkin, Natalia; Feinmesser, Meora; Tsoref, Daliah; Salman, Lina; Yeoshoua, Effi; Peretz, Eyal; Erlich, Inna; Cohen, Netta Mendelson; Gershoni, Jonathan M.; Freund, Natalia; Merbl, Yifat; Yaari, Gur; Eitan, Ram; Sagi, Irit; Shulman, Ziv			Tumor-reactive antibodies evolve from non-binding and autoreactive precursors	CELL			English	Article							TERTIARY LYMPHOID STRUCTURES; FAST INTERACTION REFINEMENT; B-CELLS; AUTOANTIBODY PRODUCTION; BOUND IMMUNOGLOBULINS; SOMATIC HYPERMUTATION; OVARIAN-CANCER; MEMORY; IMMUNOTHERAPY; GENERATION	The tumor microenvironment hosts antibody-secreting cells (ASCs) associated with a favorable prognosis in several types of cancer. Patient-derived antibodies have diagnostic and therapeutic potential; yet, it remains unclear how antibodies gain autoreactivity and target tumors. Here, we found that somatic hypermutations (SHMs) promote antibody antitumor reactivity against surface autoantigens in high-grade serous ovarian carcinoma (HGSOC). Patient-derived tumor cells were frequently coated with IgGs. Intratumoral ASCs in HGSOC were both mutated and clonally expanded and produced tumor-reactive antibodies that targeted MMP14, which is abundantly expressed on the tumor cell surface. The reversion of monoclonal antibodies to their germline configuration revealed two types of classes: one dependent on SHMs for tumor binding and a second with germline-encoded autoreactivity. Thus, tumor-reactive autoantibodies are either naturally occurring or evolve through an antigen-driven selection process. These findings highlight the origin and potential applicability of autoantibodies directed at surface antigens for tumor targeting in cancer patients.	[Mazor, Roei D.; Nathan, Nachum; Stoler-Barak, Liat; Moss, Lihee; Divinsky, Yalin; Shmueli, Merav D.; Hezroni, Hadas; Zaretsky, Irina; Merbl, Yifat; Shulman, Ziv] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Mazor, Roei D.; Solomonov, Inna; Hanuna, Assaf; Sagi, Irit] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel; [Gilboa, Amit; Yaari, Gur] Bar Ilan Univ, Fac Engn, IL-52900 Ramat Gan, Israel; [Zaretsky, Irina; Golani, Ofra] Weizmann Inst Sci, Dept Life Sci & Core Facil, IL-7610001 Rehovot, Israel; [Mor, Michael; Freund, Natalia] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Sabah, Gad; Jakobson-Setton, Ariella; Salman, Lina; Yeoshoua, Effi; Peretz, Eyal; Erlich, Inna; Eitan, Ram] Helen Schneider Hosp Women, Rabin Med Ctr, Gynecol Oncol Div, Petah Tiqwa, Israel; [Yanichkin, Natalia; Feinmesser, Meora] Rabin Med Ctr, Dept Pathol, Petah Tiqwa, Israel; [Tsoref, Daliah] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel; [Sabah, Gad; Jakobson-Setton, Ariella; Yanichkin, Natalia; Feinmesser, Meora; Tsoref, Daliah; Salman, Lina; Yeoshoua, Effi; Eitan, Ram] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Cohen, Netta Mendelson] Weizmann Inst Sci, Dept Math & Comp Sci, IL-7610001 Rehovot, Israel; [Gershoni, Jonathan M.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Bar Ilan University; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Tel Aviv University	Shulman, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.; Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel.	irit.sagi@weizmann.ac.il; ziv.shulman@weizmann.ac.il	Shmueli, Merav/HDM-9859-2022	Shmueli, Merav/0000-0002-9196-7633; Moss, Lihee/0000-0003-1111-8699; Mor, Michael/0000-0003-1361-4151; Divinsky, Yalin/0000-0001-5275-4312; Mazor, Roei/0000-0002-4784-9808	Morris Kahn Institute for Human Immunology; Human Frontiers of Science Program [CDA-00023/2016]; Azrieli Foundation; Moross Integrated Cancer Center; Rising Tide Foundation; Israel Science Foundation [1090/18, 1800/19]; RCDA [18-703-R]; Beverley Lubrach Abshez initiative for ovarian and female reproductive sys-tem cancers (Israel Cancer Research Fund); European Union [801126]; European Research Council (ERC) under the European Union [695437]; Thompson Family Foundation; Marie Sklodowska-Curie individual fellowship [GAP-845066]	Morris Kahn Institute for Human Immunology; Human Frontiers of Science Program(Human Frontier Science Program); Azrieli Foundation; Moross Integrated Cancer Center; Rising Tide Foundation; Israel Science Foundation(Israel Science Foundation); RCDA; Beverley Lubrach Abshez initiative for ovarian and female reproductive sys-tem cancers (Israel Cancer Research Fund); European Union(European Commission); European Research Council (ERC) under the European Union(European Research Council (ERC)); Thompson Family Foundation; Marie Sklodowska-Curie individual fellowship	Z.S. is supported by the Morris Kahn Institute for Human Immunology, Human Frontiers of Science Program (CDA-00023/2016) , Azrieli Foundation, Moross Integrated Cancer Center, Rising Tide Foundation, and Israel Science Foundation (1090/18) . This study was also supported by RCDA (18-703-R) and Beverley Lubrach Abshez initiative for ovarian and female reproductive sys-tem cancers (Israel Cancer Research Fund) . Z.S. is a member of the European Molecular Biology Organization (EMBO) Young Investigator Program. I.S. is an incumbent of the Maurizio Pontecorvo Professorial Chair and has received funding from the European Union's Horizon 2020 research and innovation program (grant agreement no. 801126) , European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 695437) , Israel Science Foundation (1800/19) , and the Thompson Family Foundation. M.D.S. is supported by Marie Sklodowska-Curie individual fellowship (Horizon, 2020 grant no. GAP-845066).	Anderson KS, 2015, J PROTEOME RES, V14, P578, DOI 10.1021/pr500908n; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ashkenazy H, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167071; Auersperg N, 2013, GYNECOL ONCOL, V130, P246, DOI 10.1016/j.ygyno.2013.03.021; Balicer RD, 2017, LANCET, V389, P2451, DOI 10.1016/S0140-6736(17)30876-0; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Biram A, 2019, IMMUNOL REV, V288, P37, DOI 10.1111/imr.12737; Biswas S, 2021, NATURE, V591, P464, DOI 10.1038/s41586-020-03144-0; Boland JL, 2019, GYNECOL ONCOL, V152, P251, DOI 10.1016/j.ygyno.2018.11.025; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Cathcart JM, 2016, ONCOTARGET, V7, P61107, DOI 10.18632/oncotarget.11243; Cho A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00245; Cornaby C, 2015, IMMUNOL LETT, V163, P56, DOI 10.1016/j.imlet.2014.11.001; Crowley JT, 2016, J AUTOIMMUN, V69, P24, DOI 10.1016/j.jaut.2016.02.005; Cui C, 2021, CELL, V184, P6101, DOI 10.1016/j.cell.2021.11.007; Degn SE, 2017, CELL, V170, P913, DOI 10.1016/j.cell.2017.07.026; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; DeWeerdt S, 2021, NATURE, V600, pS42, DOI 10.1038/d41586-021-03717-7; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; DiLillo DJ, 2015, CANCER IMMUNOL RES, V3, P704, DOI 10.1158/2326-6066.CIR-15-0120; Doo DW, 2019, GYNECOL ONCOL REP, V29, P48, DOI 10.1016/j.gore.2019.06.003; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Freund, 2009, CURR PROTOC IMMUNOL, V9, P8; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hu XH, 2019, NAT GENET, V51, P560, DOI 10.1038/s41588-018-0339-x; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kaimal R, 2013, CANCER RES, V73, P2457, DOI 10.1158/0008-5472.CAN-12-1426; Kamel H, 2010, J OBSTET GYNAECOL CA, V32, P580, DOI 10.1016/S1701-2163(16)34527-3; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Labidi-Galy SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00962-1; Ma Y, 2021, CANCER SCI, V112, P537, DOI 10.1111/cas.14732; Mahmood RD, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00933-8; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032639; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Milne K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003409; Mirdita Milot, 2021, GOLABFOLD MAKING PRO, DOI [10.21203/rs.3.rs-1032816/v1, DOI 10.21203/RS.3.RS-1032816/V1]; Montfort A, 2017, CLIN CANCER RES, V23, P250, DOI 10.1158/1078-0432.CCR-16-0081; Mose LE, 2016, BIOINFORMATICS, V32, P3729, DOI 10.1093/bioinformatics/btw526; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nishijima C, 2004, CLIN EXP IMMUNOL, V138, P357, DOI 10.1111/j.1365-2249.2004.02615.x; Nzula S, 2003, CANCER RES, V63, P3275; ODonnell RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090604; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Prigent J, 2016, EUR J IMMUNOL, V46, P2340, DOI 10.1002/eji.201646446; Ramalingam P, 2016, ONCOLOGY-NY, V30, P166; RAN M, 1976, INT J CANCER, V17, P90, DOI 10.1002/ijc.2910170113; RAO GS, 1988, AM J OBSTET GYNECOL, V159, P94, DOI 10.1016/0002-9378(88)90500-5; Sakata K, 2000, INT J ONCOL, V17, P673; Sato S, 2003, J INVEST DERMATOL, V120, P542, DOI 10.1046/j.1523-1747.2003.12097.x; Saul L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29736; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Sharonov GV, 2020, NAT REV IMMUNOL, V20, P294, DOI 10.1038/s41577-019-0257-x; SILBURN PA, 1984, DIAGN CLIN IMMUNOL, V2, P30; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Udi Y, 2013, J MOL BIOL, V425, P2330, DOI 10.1016/j.jmb.2013.04.009; Uppendahl LD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01825; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vos MC, 2021, J OVARIAN RES, V14, DOI 10.1186/s13048-021-00852-7; Vos MC, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0262-7; Wang EY, 2021, NATURE, V595, P283, DOI [10.1101/2020.12.10.20247205, 10.1038/s41586-021-03631-y]; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Webb NE, 2021, CURR OPIN VIROL, V47, P52, DOI 10.1016/j.coviro.2021.01.001; Wieland A, 2021, NATURE, V597, P274, DOI 10.1038/s41586-020-2931-3; Wieland A, 2019, CURR TOP MICROBIOL, V423, P119, DOI 10.1007/82_2019_154; Witz I P, 1977, Adv Cancer Res, V25, P95, DOI 10.1016/S0065-230X(08)60633-8; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yang F, 2021, SCIENCE, V372, P738, DOI 10.1126/science.abf6648; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zaenker P, 2016, AUTOIMMUN REV, V15, P477, DOI 10.1016/j.autrev.2016.01.017	83	15	15	8	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1208	+		10.1016/j.cell.2022.02.012	http://dx.doi.org/10.1016/j.cell.2022.02.012			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0N2DP	35305314				2022-12-28	WOS:000782655200001
J	Oberlander, J				Oberlander, Jonathan			Health Care Reform under the Biden Administration - Broad Ambitions, Narrow Majorities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Health Care Reform under the Biden Administration The Biden administration has made important incremental progress in expanding access to affordable health insurance. But its struggles to enact a broader reform agenda reflect the daunting political constraints that limit U.S. health policy.	[Oberlander, Jonathan] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA; [Oberlander, Jonathan] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Dept Social Med, Chapel Hill, NC USA.; Oberlander, J (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA.							Park E, 2021, AM RESCUE PLAN ACT H; Perreira KM, 2021, ANN AM ACAD POLIT SS, V696, P223, DOI 10.1177/00027162211050007; Sommers BD, 2020, HEALTH AFFAIR, V39, P1522, DOI 10.1377/hlthaff.2020.00538	3	0	0	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2022	386	19					1773	1775		10.1056/NEJMp2202813	http://dx.doi.org/10.1056/NEJMp2202813		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1H2QJ	35353978				2022-12-28	WOS:000784445300001
J	Wade, C; Malhotra, AM; McGuire, P; Vincent, C; Fowler, A				Wade, Cian; Malhotra, Akanksha Mimi; McGuire, Priscilla; Vincent, Charles; Fowler, Aidan			Action on patient safety can reduce health inequalities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; DISPARITIES; AMERICAN; RISKS; CALL; CARE; RACE	Health inequalities are widening in many high income countries and have been thrown into focus by the covid-19 pandemic.1-4 Not only have black, Hispanic, Asian, and other marginalised ethnic groups in many high income countries had disproportionate death rates from covid-19, but non-covid health outcomes have also worsened.5 -7 These unfair and avoidable differences in health between population groups are driven by a range of social determinants such as education, poor housing, and unemployment that contribute to social exclusion and disadvantage.1 When people already negatively affected by unfavourable social determinants of health seek care, healthcare itself may exacerbate health inequalities rather than mitigate them.8 One way in which this occurs is when patients experience disproportionate levels of harm from the healthcare they receive. For example, a 2022 review in the UK found that ethnic minority women's experiences of poor communication and discrimination during interactions with healthcare staff may explain some of the stark inequalities observed in maternal health outcomes.9 Healthcare may therefore be less safe for some patients than others. Patient safety is the science and practice of minimising harm and error experienced by patients while receiving healthcare.10 Harm typically centres on a "patient safety incident" in which a failure in healthcare causes physical or psychological injury to a patient.11 12 Most clinicians would recognise patient safety incidents such as administering a drug to the wrong patient as potentially extremely harmful and preventable (box 1), but it is less clear whether the concept of harm should encompass population level health inequities such as more severe diabetic complications in one group compared with another. We focus here on patient safety incidents to emphasise that the responsibility for their avoidance lies directly with the healthcare system and its workforce.	[Wade, Cian; McGuire, Priscilla; Fowler, Aidan] NHS England & NHS Improvement, London, England; [Wade, Cian] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Malhotra, Akanksha Mimi] Hlth Fdn, London, England; [Vincent, Charles] Univ Oxford, Dept Expt Psychol, Oxford, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford	Wade, C (corresponding author), NHS England & NHS Improvement, London, England.; Wade, C (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	cianwade@hsph.harvard.edu						Agerstrom J, 2021, EUR HEART J, V42, P861, DOI 10.1093/eurheartj/ehaa954; Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; [Anonymous], 2005, CIRC J, V112, P3564; [Anonymous], 2020, IHI CEO EMPHASIZES N; Armstrong K, 2007, AM J PUBLIC HEALTH, V97, P1283, DOI 10.2105/AJPH.2005.080762; Attridge M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub3; Barnett P, 2019, LANCET PSYCHIAT, V6, P305, DOI 10.1016/S2215-0366(19)30027-6; Bowen Matthew D, 2015, JUST MED CURE RACIAL; Cerdena JP, 2020, LANCET, V396, P1125, DOI 10.1016/S0140-6736(20)32076-6; Chauhan A, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01223-2; Churchwell K, 2020, CIRCULATION, V142, pE454, DOI 10.1161/CIR.0000000000000936; Davis P, 2006, LANCET, V367, P1920, DOI 10.1016/S0140-6736(06)68847-8; Department of Health and Social Care, 2021, PRESS REL NEW ERA PU; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Entwistle VA, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.039743; FitzPatrick Michael Eb, 2021, Future Healthc J, V8, P12, DOI 10.7861/fhj.2020-0242; Gangopadhyaya A, 2021, BLACK WHITE PATIENTS; Grubbs V, 2020, CLIN J AM SOC NEPHRO, V15, P1201, DOI 10.2215/CJN.00690120; Hayre J, 2021, ECLINICALMEDICINE, V37, DOI 10.1016/j.eclinm.2021.101007; Joint Commission, 2020, SPEAK SAF SURG; Kapadia D, 2022, ETHNIC INEQUALITIES; Kapur N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6347; Liu B, 2022, BJOG-INT J OBSTET GY, DOI 10.1111/1471-0528.17109; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Metersky ML, 2011, MED CARE, V49, P504, DOI 10.1097/MLR.0b013e31820fc218; Nelson A, 2002, J NATL MED ASSOC, V94, P666; NHS England, 2018, ANN REPORT; NHS England and NHS Improvement, 2021, FRAM INV PAT PAT SAF; Office for National Statistics, 2019, SOC IN AV MORT ENGL; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Power-Hays A, 2020, NEW ENGL J MED, V383, P1902, DOI 10.1056/NEJMp2022125; Public Health England, 2020, DISP RISK OUTC COVID; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4921; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Singhal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159224; Sivashanker K, 2020, NEW ENGL J MED, V382, P301, DOI 10.1056/NEJMp1911700; Song ZR, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.4223; Suleman M, 2021, UNEQUAL PANDEMIC FAI, DOI DOI 10.37829/HF-2021-HL12; Taylor SC, 2019, JAMA DERMATOL, V155, P1109, DOI 10.1001/jamadermatol.2019.1963; Torres T, 2020, HEALTHCARE EXEC, V35, P58; van Rosse F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009052; van Rosse F, 2016, INT J NURS STUD, V54, P45, DOI 10.1016/j.ijnurstu.2015.03.012; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent CA, 2002, QUAL SAF HEALTH CARE, V11, P76, DOI 10.1136/qhc.11.1.76; Vincent C, 2014, BMJ QUAL SAF, V23, P670, DOI 10.1136/bmjqs-2013-002757; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; World Health Organization, PAT SAF FACT SHEET; Zimmerman FJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6386	51	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								e067090	10.1136/bmj-2021-067090	http://dx.doi.org/10.1136/bmj-2021-067090			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I6RD	35351684	hybrid, Green Published			2022-12-28	WOS:000779544800014
J	Jiang, YX; Cao, Q; Sawaya, MR; Abskharon, R; Ge, P; DeTure, M; Dickson, DW; Fu, JY; Loo, RRO; Loo, JA; Eisenberg, DS				Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; DeTure, Michael; Dickson, Dennis W.; Fu, Janine Y.; Loo, Rachel R. Ogorzalek; Loo, Joseph A.; Eisenberg, David S.			Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43	NATURE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; CRYO-EM; RISK-FACTOR; DISEASE; CLASSIFICATION; MOLPROBITY; PROTEINS; ONSET	Frontotemporal lobar degeneration (FTLD) is the third most common neurodegenerative condition after Alzheimer's and Parkinson's diseases(1). FTLD typically presents in 45 to 64 year olds with behavioural changes or progressive decline of language skills(2). The subtype FTLD-TDP is characterized by certain clinical symptoms and pathological neuronal inclusions with TAR DNA-binding protein (TDP-43) immunoreactivity(3). Here we extracted amyloid fibrils from brains of four patients representing four of the five FTLD-TDP subclasses, and determined their structures by cryo-electron microscopy. Unexpectedly, all amyloid fibrils examined were composed of a 135-residue carboxy-terminal fragment of transmembrane protein 106B (TMEM106B), a lysosomal membrane protein previously implicated as a genetic risk factor for FTLD-TDP4. In addition to TMEM106B fibrils, we detected abundant non-fibrillar aggregated TDP-43 by immunogold labelling. Our observations confirm that FTLD-TDP is associated with amyloid fibrils, and that the fibrils are formed by TMEM106B rather than TDP-43.	[Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; Fu, Janine Y.; Loo, Rachel R. Ogorzalek; Loo, Joseph A.; Eisenberg, David S.] UCLA, UCLA DOE Inst, Dept Chem, Los Angeles, CA 90024 USA; [Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; Fu, Janine Y.; Loo, Rachel R. Ogorzalek; Loo, Joseph A.; Eisenberg, David S.] UCLA, UCLA DOE Inst, Dept Biochem, Los Angeles, CA 90024 USA; [Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; Fu, Janine Y.; Loo, Rachel R. Ogorzalek; Loo, Joseph A.; Eisenberg, David S.] UCLA, UCLA DOE Inst, Dept Biol Chem, Los Angeles, CA 90024 USA; [Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; Fu, Janine Y.; Loo, Rachel R. Ogorzalek; Loo, Joseph A.; Eisenberg, David S.] UCLA, Mol Biol Inst, Los Angeles, CA 90024 USA; [Jiang, Yi Xiao; Cao, Qin; Sawaya, Michael R.; Abskharon, Romany; Ge, Peng; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Cao, Qin] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [DeTure, Michael; Dickson, Dennis W.] Mayo Clin, Jacksonville, FL 32224 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Shanghai Jiao Tong University; Mayo Clinic	Eisenberg, DS (corresponding author), UCLA, UCLA DOE Inst, Dept Chem, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), UCLA, UCLA DOE Inst, Dept Biochem, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), UCLA, UCLA DOE Inst, Dept Biol Chem, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), UCLA, Mol Biol Inst, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), UCLA, Howard Hughes Med Inst, Los Angeles, CA 90024 USA.	david@mbi.ucla.edu		Dickson, Dennis W/0000-0001-7189-7917; Ge, Peng/0000-0002-2661-8226; Fu, Janine Y./0000-0002-8854-041X; Loo, Rachele/0000-0002-0580-2833; Jiang, Yi Xiao/0000-0003-1433-4952; Sawaya, Michael/0000-0003-0874-9043	NIH [1S10RR23057, IS10OD018111, AG 054022, AG061847, GM007185, GM103479]; NSF [DBI-1338135, DGE-1650604]; California NanoSystems Institute at UCLA; DOE [DE-FC02-02ER63421]; ADRC [P30 AG062677]; Einstein Aging Study [P01 AG003949]; ALLFTD [U19 AG063911]; National Facility for Translational Medicine (Shanghai);  [C9ORF72 P01 (P01 NS084974)]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); California NanoSystems Institute at UCLA; DOE(United States Department of Energy (DOE)); ADRC; Einstein Aging Study; ALLFTD; National Facility for Translational Medicine (Shanghai); 	We thank Z. H. Zhou for the use of Electron Imaging Center for Nanomachines (EICN) instruments supported by the NIH (1S10RR23057 and IS10OD018111), NSF (DBI-1338135) and California NanoSystems Institute at UCLA. We thank S. Scheres and M. Goedert for discussion of TMEM106B antibodies, and L. Salwinski for evaluation of the significance of sequence matching. The authors acknowledge NIH AG 054022, NIH AG061847, DOE DE-FC02-02ER63421, NIH GM103479, NIH GM007185, NSF DGE-1650604, ADRC (P30 AG062677), Einstein Aging Study (P01 AG003949), ALLFTD (U19 AG063911), C9ORF72 P01 (P01 NS084974), and the National Facility for Translational Medicine (Shanghai) for support.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Arseni D, 2022, NATURE, V601, P139, DOI 10.1038/s41586-021-04199-3; Benson MD, 2020, AMYLOID, V27, P217, DOI 10.1080/13506129.2020.1835263; Brady OA, 2014, J BIOL CHEM, V289, P19670, DOI 10.1074/jbc.M113.515700; Cao Q, 2020, NAT STRUCT MOL BIOL, V27, P653, DOI 10.1038/s41594-020-0435-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Goldman JS, 2004, NEUROLOGIST, V10, P227, DOI 10.1097/01.nrl.0000138735.48533.26; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Laferriere F, 2019, NAT NEUROSCI, V22, P65, DOI 10.1038/s41593-018-0294-y; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P858, DOI 10.1111/nan.12250; Lee EB, 2017, ACTA NEUROPATHOL, V134, P65, DOI 10.1007/s00401-017-1679-9; Lu RC, 2014, J NEURAL TRANSM, V121, P283, DOI 10.1007/s00702-013-1106-x; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; McConnell SA, 2018, J AM CHEM SOC, V140, P8420, DOI 10.1021/jacs.8b05200; Mohandas E, 2009, Indian J Psychiatry, V51 Suppl 1, pS65; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Sawaya MR, 2021, CELL, V184, P4857, DOI 10.1016/j.cell.2021.08.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13038-z; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Shi Y, 2021, NATURE, V598, P359, DOI 10.1038/s41586-021-03911-7; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Thevis M, 2003, J PROTEOME RES, V2, P163, DOI 10.1021/pr025568g; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Wagner T, 2020, ACTA CRYSTALLOGR D, V76, P613, DOI 10.1107/S2059798320007342; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0	49	12	12	17	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2022	605	7909					304	+		10.1038/s41586-022-04670-9	http://dx.doi.org/10.1038/s41586-022-04670-9		MAR 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D7UZ	35344984				2022-12-28	WOS:000790749300003
J	Shabani, M				Shabani, Mahsa			Will the European Health Data Space change data sharing rules?	SCIENCE			English	Editorial Material									[Shabani, Mahsa] Univ Ghent, Fac Law & Criminol, Metamed, Campus Aula, Ghent, Belgium	Ghent University	Shabani, M (corresponding author), Univ Ghent, Fac Law & Criminol, Metamed, Campus Aula, Ghent, Belgium.	mahsa.shabani@ugent.be						Ahmed E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01107; Beck S, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0423-1; Bentzen HB, 2021, NAT MED, V27, P1329, DOI 10.1038/s41591-021-01460-0; Boeckhout M, 2018, EUR J HUM GENET, V26, P931, DOI 10.1038/s41431-018-0160-0; Bovenberg J, 2020, SCIENCE, V370, P40, DOI 10.1126/science.abd2499; European Commission, 2021, ASS EU MEMB STAT RUL; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mascalzoni D, 2019, ANN INTERN MED, V170, P332, DOI 10.7326/M18-2854; Murtagh Madeleine J, 2021, Wellcome Open Res, V6, P311, DOI 10.12688/wellcomeopenres.17233.1; Nicol D, 2019, SCIENCE, V364, P445, DOI 10.1126/science.aax0892; O'Doherty KC, 2021, NAT GENET, V53, P2, DOI 10.1038/s41588-020-00742-6; Peloquin D, 2020, EUR J HUM GENET, V28, P697, DOI 10.1038/s41431-020-0596-x; Shabani M, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.202110229	14	1	1	7	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1357	1359		10.1126/science.abn4874	http://dx.doi.org/10.1126/science.abn4874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324305				2022-12-28	WOS:000778894800026
J	Barba-Bon, A; Salluce, G; Lostale-Seijo, I; Assaf, KI; Hennig, A; Montenegro, J; Nau, WM				Barba-Bon, Andrea; Salluce, Giulia; Lostale-Seijo, Irene; Assaf, Khaleel, I; Hennig, Andreas; Montenegro, Javier; Nau, Werner M.			Boron clusters as broadband membrane carriers	NATURE			English	Article							CELL-PENETRATING PEPTIDES; ANTIBODY DELIVERY; RICH PEPTIDES; TRANSPORT; POLYARGININE; RECOGNITION; CALIXARENES; TECHNOLOGY; ACTIVATORS; INTERACTS	The membrane translocation of hydrophilic substances constitutes a challenge for their application astherapeutic compounds and labelling probes(1-4) . To remedy this, charged amphiphilic molecules have been classically used as carriers(3,5). However, such amphiphilic carriers may cause aggregation and non-specific membrane lysis(6,7). Here we show that globular dodecaborate clusters, and prominently B12Br122-, can function as anionic inorganic membrane carriers for a broad range of hydrophilic cargo molecules (with molecular mass of146-4,500 Da). We show that cationic and neutral peptides, amino acids, neurotransmitters, vitamins, antibiotics and drugs can be carried across liposomal membranes. Mechanistic transport studies reveal that the carrier activity is related to the superchaotropic nature of these cluster anions(8-)(12). We demonstrate that B12Br122-- affects cytosolic uptake of different small bioactive molecules, including the antineoplastic monomethyl auristatin F, the proteolysis targeting chimera dBET1 and the phalloidin toxin, which has been successfully delivered in living cells for cytoskeleton labelling. We anticipate the broad and distinct delivery spectrum of our superchaotropic carriers to be the starting point of conceptually distinct cell-biological, neurobiological, physiological and pharmaceutical studies.	[Barba-Bon, Andrea; Assaf, Khaleel, I; Hennig, Andreas; Nau, Werner M.] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany; [Salluce, Giulia; Lostale-Seijo, Irene; Montenegro, Javier] Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela, Spain; [Salluce, Giulia; Lostale-Seijo, Irene; Montenegro, Javier] Univ Santiago de Compostela, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela, Spain	Jacobs University; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CiQUS	Nau, WM (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany.; Montenegro, J (corresponding author), Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela, Spain.; Montenegro, J (corresponding author), Univ Santiago de Compostela, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela, Spain.	javier.montenegro@usc.es; w.nau@jacobs-university.de	Nau, Werner/E-6686-2011; Barba-Bon, Andrea/B-4605-2019; Montenegro, Javier/K-8895-2016; Hennig, Andreas/A-1438-2010; Assaf, Khaleel/I-8807-2017	Nau, Werner/0000-0002-7654-6232; Barba-Bon, Andrea/0000-0003-0712-4869; Montenegro, Javier/0000-0001-6503-2095; Hennig, Andreas/0000-0003-0444-5923; Assaf, Khaleel/0000-0003-4331-8492; Salluce, Giulia/0000-0002-1615-6822	Alexander von Humboldt Foundation; DFG [HE-5967/4, NA-868/8, NA-868/11, NA-868/14]; Spanish AEI [SAF2017-89890-R, PCI2019-103400, PID2020-117143RB-I00]; Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2019-2022) [ED431G 2019/03, ED431C 2017/25, 2016-AD031]; Xunta de Galicia (Oportunius Program (Gain)); ISCIII [COV20/00297]; ERC-Stg [DYNAP-677786]; ERC-PoC (TraffikGene) [838002]; HFSP [RGY0066/2017]; European Regional Development Fund (ERDF); AEI [PRE2018-085973]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); Spanish AEI(Spanish Government); Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2019-2022); Xunta de Galicia (Oportunius Program (Gain))(Xunta de Galicia); ISCIII(Instituto de Salud Carlos III); ERC-Stg; ERC-PoC (TraffikGene); HFSP(Human Frontier Science Program); European Regional Development Fund (ERDF)(European Commission); AEI	A.B.-B. thanks the Alexander von Humboldt Foundation for a fellowship for postdoctoral researchers. A.B.-B., K.I.A., A.H. and W.M.N. thank the DFG for generous financial support through projects HE-5967/4, NA-868/8, NA-868/11 and NA-868/14. J.M. thanks the Spanish AEI (SAF2017-89890-R, PCI2019-103400, PID2020-117143RB-I00), the Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2019-2022, ED431G 2019/03, ED431C 2017/25, 2016-AD031, the Oportunius Program (Gain)), the ISCIII (COV20/00297), the ERC-Stg (DYNAP-677786), the ERC-PoC (TraffikGene, 838002), the HFSP (RGY0066/2017) and the European Regional Development Fund (ERDF). G.S. thanks the AEI (PRE2018-085973).	Akishiba M, 2017, NAT CHEM, V9, P751, DOI [10.1038/nchem.2779, 10.1038/NCHEM.2779]; Assaf KI, 2019, J ORG CHEM, V84, P11790, DOI 10.1021/acs.joc.9b01688; Assaf KI, 2018, ANGEW CHEM INT EDIT, V57, P13968, DOI 10.1002/anie.201804597; Assaf KI, 2015, ANGEW CHEM INT EDIT, V54, P6852, DOI 10.1002/anie.201412485; Awad D, 2015, CHEMPLUSCHEM, V80, P656, DOI 10.1002/cplu.201402286; Behzadi S, 2017, CHEM SOC REV, V46, P4218, DOI 10.1039/c6cs00636a; de Vries WC, 2017, ANGEW CHEM INT EDIT, V56, P9603, DOI 10.1002/anie.201702620; Dhakal K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06553; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Erazo-Oliveras A, 2016, CELL CHEM BIOL, V23, P598, DOI 10.1016/j.chembiol.2016.03.016; Evans BC, 2015, ACS NANO, V9, P5893, DOI 10.1021/acsnano.5b00491; Fernandez-Alvarez R, 2018, LANGMUIR, V34, P3541, DOI 10.1021/acs.langmuir.7b03306; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Gale PA, 2017, CHEM SOC REV, V46, P2497, DOI 10.1039/c7cs00159b; Gasparini G, 2015, CHEM COMMUN, V51, P10389, DOI 10.1039/c5cc03472h; Ghale G, 2014, ANGEW CHEM INT EDIT, V53, P2762, DOI 10.1002/anie.201309583; Goszczynski TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10314-0; Hammill D., 2020, CYTOEXPLORER INTERAC; HeyHawkins E, 2018, BORON-BASED COMPOUNDS: POTENTIAL AND EMERGING APPLICATIONS IN MEDICINE, P1; Hohenschutz M, 2020, ANGEW CHEM INT EDIT, V59, P8084, DOI 10.1002/anie.201916193; John T, 2017, BBA-BIOMEMBRANES, V1859, P2242, DOI 10.1016/j.bbamem.2017.08.016; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; LaManna CM, 2012, ACCOUNTS CHEM RES, V45, P1026, DOI 10.1021/ar200228y; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Li K, 2011, CHEM MATER, V23, P2113, DOI 10.1021/cm103557h; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Lostale-Seijo I, 2018, NAT REV CHEM, V2, P258, DOI 10.1038/s41570-018-0039-1; Lostale-Seijo I, 2017, CHEM SCI, V8, P7923, DOI 10.1039/c7sc03918b; Malaspina DC, 2020, ANGEW CHEM INT EDIT, V59, P3088, DOI 10.1002/anie.201913257; Matile S, 2011, CHEM SOC REV, V40, P2453, DOI 10.1039/c0cs00209g; McKinlay CJ, 2018, P NATL ACAD SCI USA, V115, pE5859, DOI 10.1073/pnas.1805358115; Melak M, 2017, J CELL SCI, V130, P525, DOI 10.1242/jcs.189068; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Nishihara M, 2005, ORG BIOMOL CHEM, V3, P1659, DOI 10.1039/b501472g; Mellet CO, 2011, CHEM SOC REV, V40, P1586, DOI 10.1039/c0cs00019a; Pan YC, 2021, ANGEW CHEM INT EDIT, V60, P1875, DOI 10.1002/anie.202011185; Park IW, 2012, CHEM-EUR J, V18, P2514, DOI 10.1002/chem.201103239; Pazo M, 2018, CHEM COMMUN, V54, P6919, DOI 10.1039/c8cc02304b; Peng S, 2017, ANGEW CHEM INT EDIT, V56, P15742, DOI 10.1002/anie.201707979; Perret F, 2005, J AM CHEM SOC, V127, P1114, DOI 10.1021/ja043633c; Van P, 2018, BIOINFORMATICS, V34, P3951, DOI 10.1093/bioinformatics/bty441; PLESEK J, 1992, CHEM REV, V92, P269, DOI 10.1021/cr00010a005; R Core Team, 2015, R LANGUAGE ENV STAT; REBEK J, 1987, J AM CHEM SOC, V109, P2432, DOI 10.1021/ja00242a030; Robison AD, 2016, J PHYS CHEM B, V120, P9287, DOI 10.1021/acs.jpcb.6b05604; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Sachs JN, 2003, J AM CHEM SOC, V125, P8742, DOI 10.1021/ja0355729; Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l; Sansone F, 2006, J AM CHEM SOC, V128, P14528, DOI 10.1021/ja0634425; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sorochkina AI, 2013, BBA-BIOMEMBRANES, V1828, P2428, DOI 10.1016/j.bbamem.2013.06.018; Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Takeuchi T, 2009, CHEMBIOCHEM, V10, P2793, DOI 10.1002/cbic.200900512; Teng KW, 2016, ELIFE, V5, DOI 10.7554/eLife.20378; Wang FH, 2014, J CONTROL RELEASE, V174, P126, DOI 10.1016/j.jconrel.2013.11.020; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004	57	7	7	24	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					637	+		10.1038/s41586-022-04413-w	http://dx.doi.org/10.1038/s41586-022-04413-w			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322251	hybrid, Green Published			2022-12-28	WOS:000772661800019
J	Rison, SC; Carvalho, C; Rull, G; Robson, J				Rison, Stuart C. G.; Carvalho, Chris; Rull, Gurvinder; Robson, John			RATIONAL TESTING Investigating hypertension in younger patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								center dot Secondary hypertension may account for up to 30% of diagnoses of young onset hypertension center dot Thyroid dysfunction, renal parenchymal disease, and renal artery stenosis secondary to fibromuscular dysplasia are the most common causes of secondary hypertension in younger patients center dot Testing for 24 hour urinary metanephrines should be carried out only if the patient has phaeochromocytoma symptoms, clinical signs, or center dot Random (spot) serum cortisol tests are usually uninformative. Consider late evening salivary cortisol center dot If treating patients with young onset hypertension empirically, revisit a diagnosis of secondary hypertension following post-treatment blood tests, or if blood pressure control is not achieved or	[Rison, Stuart C. G.; Carvalho, Chris; Robson, John] Queen Mary Univ London, Ctr Primary Care, Wolfson Inst Populat Hlth, London, England; [Rison, Stuart C. G.] Bromley Bow Hlth Ctr, London, England; [Carvalho, Chris] De Beauvoir Surg, London, England; [Rull, Gurvinder] William Harvey Res Inst, Barts BP Ctr Excellence, London, England; [Rull, Gurvinder] NIHR Barts Cardiovasc Biomed Res Ctr, London, England; [Robson, John] UCL Partners, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London	Rison, SC (corresponding author), Queen Mary Univ London, Ctr Primary Care, Wolfson Inst Populat Hlth, London, England.; Rison, SC (corresponding author), Bromley Bow Hlth Ctr, London, England.	s.rison@qmul.ac.uk		Rison, Stuart/0000-0003-3289-6668					0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								e067924	10.1136/bmj-2021-067924	http://dx.doi.org/10.1136/bmj-2021-067924			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35332032	Green Submitted			2022-12-28	WOS:000778460100017
J	Lauzier, DC; Kansagra, AP				Lauzier, David C.; Kansagra, Akash P.			Thrombectomy in Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								Thrombectomy in Acute Ischemic StrokeA 63-year-old man presented with weakness on the left side and difficulty speaking, both of which had begun 6 hours earlier. Imaging revealed a complete occlusion of the right internal carotid artery. He received emergency endovascular therapy.	[Lauzier, David C.; Kansagra, Akash P.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Lauzier, DC (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	dlauzier@wustl.edu		Lauzier, David/0000-0003-2825-3360					0	0	0	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMicm2116727	http://dx.doi.org/10.1056/NEJMicm2116727		APR 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0V1GP	35363453				2022-12-28	WOS:000788093900001
J	O'Mahony, S				O'Mahony, Seamus			A fortunate man?	LANCET			English	Editorial Material									[O'Mahony, Seamus] Kings Coll London, Ctr Humanities & Hlth, London WC2R 2LS, England	University of London; King's College London	O'Mahony, S (corresponding author), Kings Coll London, Ctr Humanities & Hlth, London WC2R 2LS, England.	seamus.omahony@kcl.ac.uk							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1296	1297						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35367001				2022-12-28	WOS:000812828300016
J	Horne, JE; Radford, SE				Horne, Jim E.; Radford, Sheena E.			Roll out the barrel! Outer membrane tension resolves an unexpected folding intermediate	CELL			English	Editorial Material								How do bacteria assemble transmembrane 0-barrels into their outer membrane in the absence of an energy source? New structures and experiments from Doyle et al. suggest that the 0-barrel assembly machinery (BAM) co-opts the power of membrane elastic tension to help complete the folding of 0-barrel outer mem-brane proteins.	[Horne, Jim E.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Radford, SE (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039	Medical Research Council [MR/P018491/1, RSRP/RI/211057]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.E.H. and S.E.R. acknowledge support from the Medical Research Council (MR/P018491/1). S.E.R. is a Royal Society Research Professor (RSRP/RI/211057).	Doyle MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11230-9; Doyle MT, 2022, CELL, V185, P1143, DOI 10.1016/j.cell.2022.02.016; Doyle MT, 2021, MOL CELL, V81, P2000, DOI 10.1016/j.molcel.2021.02.023; Horne JE, 2020, J BIOL CHEM, V295, P10340, DOI 10.1074/jbc.REV120.011473; Iadanza MG, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01419-w; Liu JC, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008355; Storek KM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00517-18; Tomasek D, 2020, NATURE, V583, P473, DOI 10.1038/s41586-020-2370-1; White P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24432-x; Wu RR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27449-4	10	1	1	4	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1107	1109		10.1016/j.cell.2022.03.001	http://dx.doi.org/10.1016/j.cell.2022.03.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J7WH	35325591				2022-12-28	WOS:000780311600002
J	Mitchell, SJ; Bennett, MH; Moon, RE				Mitchell, Simon J.; Bennett, Michael H.; Moon, Richard E.			Decompression Sickness and Arterial Gas Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TO-LEFT SHUNT; HYPERBARIC TREATMENT; COMPRESSED-AIR; SCUBA-DIVER; ILLNESS; OXYGEN; MANAGEMENT; RISK; ASSOCIATION; ACTIVATION	DECOMPRESSION SICKNESS, IN WHICH BUBBLES FORMED FROM DISsolved gas (usually nitrogen) cause tissue and vascular injury after a reduction in environmental pressure, may occur in diving, aviation, and spaceflight. Arterial gas embolism, in which bubbles introduced into the arterial circulation cause multifocal ischemia, may occur after diving-related, iatrogenic, or accidental pulmonary barotrauma or by direct iatrogenic introduction of gas into the vasculature. Because it may be difficult to clinically differentiate decompression sickness from arterial gas embolism in divers and the treatment protocols for the two disorders are the same, the term "decompression illness" is sometimes used to indicate the presence of decompression sickness, arterial gas embolism, or both, but the separate terms are used here. Divers with nonspecific symptoms may present to clinicians who have received no specific training during medical school or residency in dealing with these disorders, which can pose challenges in the differential diagnosis and choice of appropriate treatment.	[Mitchell, Simon J.] Univ Auckland, Sch Med, Auckland, New Zealand; [Mitchell, Simon J.] Auckland City Hosp, Dept Anaesthesia, Auckland, New Zealand; [Bennett, Michael H.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Bennett, Michael H.] Prince Wales Hosp, Wales Anaesthesia, Sydney, NSW, Australia; [Moon, Richard E.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Moon, Richard E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Moon, Richard E.] Duke Univ, Ctr Hyperbar Med & Environm Physiol, Durham, NC 27710 USA	University of Auckland; Auckland City Hospital; University of New South Wales Sydney; Duke University; Duke University; Duke University	Mitchell, SJ (corresponding author), Univ Auckland, Dept Anaesthesiol, Private Bag 92019, Auckland 1142, New Zealand.	sj.mitchell@auckland.ac.nz		Moon, Richard E/0000-0003-4432-0332; Mitchell, Simon/0000-0002-5149-6371				Andre S, 2022, EMERG MED J, V39, P747, DOI 10.1136/emermed-2021-211227; Azzopardi CP, 2019, DIVING HYPERB MED, V49, P161, DOI 10.28920/dhm49.3.161-166; Bachrach WH., 1944, AVIATION PHYSIOLOGIS, V7, P2; Balldin UI, 2004, AVIAT SPACE ENVIR MD, V75, P969; Banham NDG, 2020, DIVING HYPERB MED, V50, P300, DOI 10.28920/dhm50.3.300-302; Beevor H, 2016, DIVING HYPERB MED, V46, P15; Behnke AR., 1937, NAVAL MED B, V35, P61; Bennett M, 2003, UNDERSEA HYPERBAR M, V30, P195; Bennett MH, 2012, DIVING HYPERB MED, V42, P171; BERGHAGE T E, 1976, Undersea Biomedical Research, V3, P387; Bert P., 1978, BAROMETRIC PRESSURE; Blake DF, 2020, DIVING HYPERB MED, V50, P34, DOI 10.28920/dhm50.1.34-42; Blatteau JE, 2020, DIVING HYPERB MED, V50, P181, DOI 10.28920/dhm50.2.181-184; Blick G, 1909, BRIT MED J, V1909, P1796, DOI 10.1136/bmj.2.2556.1796; Boycott AE, 1908, J HYG-CAMBRIDGE, V8, P342, DOI 10.1017/S0022172400003399; BRUNNER FP, 1964, LANCET, V1, P1071; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; Cantais E, 2003, CRIT CARE MED, V31, P84, DOI 10.1097/00003246-200301000-00013; Collins M., 1988, SMITHSONIAN, V19, P42; DAN World, DAN 24 HOUR HOTL NUM; Denoble P.J., 2019, DAN ANN DIVING REPOR; Department of the Navy, 2016, US NAVY DIVING MANUA, V5; Dick EJ, 1997, LAB ANIM SCI, V47, P50; Doolette DJ, 2018, DIVING HYPERB MED, V48, P84, DOI 10.28920/dhm48.2.84-95; Dowse MS, 2021, DIVING HYPERB MED, V51, P361, DOI 10.28920/dhm51.4.361-367; Dunford RG, 2002, UNDERSEA HYPERBAR M, V29, P247; Ferris EB., 1951, DECOMPRESSION SICKNE, P4; Fitzgerald B, 1996, SPUMS J, V26, P142; Gempp E, 2009, BRIT J SPORT MED, V43, P224, DOI 10.1136/bjsm.2007.043240; Germonpre P, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.763408; Goffinet CMJ, 2019, DIVING HYPERB MED, V49, P141, DOI 10.28920/dhm49.2.141-144; Haas RM, 2014, DIVING HYPERB MED, V44, P20; Habibi MR, 2018, EXPERT REV CLIN PHAR, V11, P361, DOI 10.1080/17512433.2018.1425614; Hampson NB, 2020, DIVING HYPERB MED, V50, P292, DOI 10.28920/dhm50.3.292-294; Hartig F, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00994; Hatling D, 2019, ACTA ANAESTH SCAND, V63, P154, DOI 10.1111/aas.13260; HELPS SC, 1991, STROKE, V22, P351, DOI 10.1161/01.STR.22.3.351; HILLS BA, 1981, UNDERSEA BIOMED RES, V8, P163; Hubbard M, 2018, DIVING HYPERB MED, V48, P218, DOI 10.28920/dhm48.4.218-223; Iadecolar C, 2020, J CLIN INVEST, V130, P2777, DOI 10.1172/JCI135530; Imbert JP, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02774; Jaminet A., 1871, PHYS EFFECTS COMPRES; Keays FL., 1909, PUBLICATIONS CORNELL, V2, P1; Lambrechts K, 2015, J APPL PHYSIOL, V118, P1234, DOI 10.1152/japplphysiol.00125.2015; Lautridou J, 2020, J APPL PHYSIOL, V129, P612, DOI 10.1152/japplphysiol.00324.2020; LEITCH DR, 1986, AVIAT SPACE ENVIR MD, V57, P931; LEVIN LL, 1981, J APPL PHYSIOL, V50, P944, DOI 10.1152/jappl.1981.50.5.944; Lindfors OH, 2021, DIVING HYPERB MED, V51, P328, DOI 10.28920/dhm51.4.328-337; Longphre JM, 2007, UNDERSEA HYPERBAR M, V34, P43; Mitchell SJ, 2018, DIVING HYPERB MED, V48, P45, DOI 10.28920/dhm48.1.45-55; Mitchell Simon J, 2015, J Extra Corpor Technol, V47, P10; Mitchell SJ, 2001, UNDERSEA HYPERBAR M, V28, P165; Mitchell SJ., 2005, MANAGEMENT MILD MARG; Moir EW., 1896, J SOC ARTS, V44, P567; Moon RE., 2003, ADJUNCTIVE THERAPY D; Moon RE, 2021, UNDERSEA HYPERBAR M, V48, P195; Moon RE, 2019, UNDERSEA HYPERBAR M, V46, P673; Nossum V, 1999, UNDERSEA HYPERBAR M, V26, P1; PHILP R B, 1974, Undersea Biomedical Research, V1, P117; Pol B., 1854, ANN HYG PUB MED LEG, V2, P241; Pontier JM, 2009, J APPL PHYSIOL, V107, P1825, DOI 10.1152/japplphysiol.91644.2008; Saadi A, 2019, NEUROHOSPITALIST, V9, P235, DOI 10.1177/1941874419828895; Smith AH., 1873, EFFECTS HIGH ATMOSPH; Snell EH., 1896, COMPRESSED AIR ILLNE; Sobolewski P, 2011, AM J PHYSIOL-CELL PH, V301, pC679, DOI 10.1152/ajpcell.00046.2011; Thalmann ED., 1996, DIVING ACCIDENT MANA, P75; Thom SR, 2019, J APPL PHYSIOL, V126, P1006, DOI 10.1152/japplphysiol.01109.2018; Thom SR, 2015, J APPL PHYSIOL, V119, P427, DOI 10.1152/japplphysiol.00380.2015; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P409; van Waart H, 2020, DIVING HYPERB MED, V50, P121, DOI 10.28920/dhm50.2.121-129; Vann RD., 2003, REPORT DECOMPRESSION, P42; von Schrotter H., 1906, SAUERSTOFF PROPHYLAX; WARD CA, 1987, J APPL PHYSIOL, V62, P1160, DOI 10.1152/jappl.1987.62.3.1160; WEIEN RW, 1990, AVIAT SPACE ENVIR MD, V61, P833; Williams STB, 2007, WILD ENVIRON MED, V18, P48, DOI 10.1580/06-WEME-BR-009R.1; WILMSHURST PT, 1989, LANCET, V1, P731; WORKMAN RD, 1968, AEROSPACE MED, V39, P1076; Xu WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050079; ZWIREWICH CV, 1987, RADIOLOGY, V163, P81, DOI 10.1148/radiology.163.1.3823462	80	7	7	7	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1254	1264		10.1056/NEJMra2116554	http://dx.doi.org/10.1056/NEJMra2116554			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353963				2022-12-28	WOS:000820666300009
J	Sap, JBI; Meyer, CF; Ford, J; Straathof, NJW; Durr, AB; Lelos, MJ; Paisey, SJ; Mollner, TA; Hell, SM; Trabanco, AA; Genicot, C; Ende, CW; Paton, RS; Tredwell, M; Gouverneur, V				Sap, Jeroen B. I.; Meyer, Claudio F.; Ford, Joseph; Straathof, Natan J. W.; Durr, Alexander B.; Lelos, Mariah J.; Paisey, Stephen J.; Mollner, Tim A.; Hell, Sandrine M.; Trabanco, Andres A.; Genicot, Christophe; Am Ende, Christopher W.; Paton, Robert S.; Tredwell, Matthew; Gouverneur, Veronique			[F-18]Difluorocarbene for positron emission tomography	NATURE			English	Article							ARYL BORONIC ACIDS; DIFLUOROMETHYLATED ARENES; MEDICINAL APPLICATIONS; ARYLBORONIC ACIDS; DIFLUOROCARBENE; F-18-DIFLUOROMETHYLARENES; IODIDES; ACCESS	The advent of total-body positron emission tomography (PET) has vastly broadened the range of research and clinical applications of this powerful molecular imaging technology(1). Such possibilities have accelerated progress in fluorine-18 (F-18) radiochemistry with numerous methods available to F-18-label (hetero)arenes and alkanes(2). However, access to F-18-difluoromethylated molecules in high molar activity is mostly an unsolved problem, despite the indispensability of the difluoromethyl group for pharmaceutical drug discovery(3). Here we report a general solution by introducing carbene chemistry to the field of nuclear imaging with a [F-18]difluorocarbene reagent capable of a myriad of F-18-difluoromethylation processes. In contrast to the tens of known difluorocarbene reagents, this F-18-reagent is carefully designed for facile accessibility, high molar activity and versatility. The issue of molar activity is solved using an assay examining the likelihood of isotopic dilution on variation of the electronics of the difluorocarbene precursor. Versatility is demonstrated with multiple [F-18]difluorocarbene-based reactions including O-H, S-H and N-H insertions, and cross-couplings that harness the reactivity of ubiquitous functional groups such as (thio)phenols, N-heteroarenes and aryl boronic acids that are easy to install. The impact is illustrated with the labelling of highly complex and functionalized biologically relevant molecules and radiotracers.	[Sap, Jeroen B. I.; Meyer, Claudio F.; Ford, Joseph; Straathof, Natan J. W.; Durr, Alexander B.; Mollner, Tim A.; Hell, Sandrine M.; Gouverneur, Veronique] Univ Oxford, Chem Res Lab, Oxford, England; [Meyer, Claudio F.; Trabanco, Andres A.] Discovery Chem Janssen Res & Dev, Toledo, Spain; [Lelos, Mariah J.] Cardiff Univ, Sch Biosci, Cardiff, Wales; [Paisey, Stephen J.] Cardiff Univ, Sch Med, Wales Res & Diagnost PET Imaging Ctr PETIC, Cardiff, Wales; [Genicot, Christophe] UCB Biopharma Sprl, Global Chem, Braine Lalleud, Belgium; [Am Ende, Christopher W.] Pfizer Inc, Med Design, Groton, CT USA; [Paton, Robert S.] Colorado State Univ, Dept Chem, Ft Collins, CO USA; [Tredwell, Matthew] Cardiff Univ, Sch Chem, Cardiff, Wales	University of Oxford; Cardiff University; Cardiff University; Pfizer; Colorado State University; Cardiff University	Gouverneur, V (corresponding author), Univ Oxford, Chem Res Lab, Oxford, England.	veronique.gouverneur@chem.ox.ac.uk	Paton, Robert/A-4564-2010	Paton, Robert/0000-0002-0104-4166; Mollner, Tim/0000-0003-2951-1368; Hell, Sandrine/0000-0002-1522-626X; Tredwell, Matthew/0000-0002-4184-5611; Lelos, Mariah/0000-0001-7102-055X; Straathof, Natan/0000-0003-0293-1530; Paisey, Stephen/0000-0002-2274-3708; Meyer, Claudio F/0000-0002-8540-7146	Engineering and Physical Sciences Research Council [EP/V013041/1]; Pfizer; Janssen; UCB; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [721902]; Centre for Doctoral Training in Synthesis for Biology and Medicine; GlaxoSmithKline; MSD; Syngenta; Vertex; EPSRC [EP/T517811/1]; National Science Foundation [NSF CHE-1955876]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); UCB(UCB Pharma SA); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); Centre for Doctoral Training in Synthesis for Biology and Medicine; GlaxoSmithKline(GlaxoSmithKline); MSD; Syngenta(Syngenta); Vertex(Vertex Pharmaceuticals); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF))	This research has received funding from the Engineering and Physical Sciences Research Council (EP/V013041/1, J.B.I.S.), Pfizer, Janssen, UCB, the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 721902 (C.F.M., S.M.H. and T.A.M.). J.F. is grateful to the Centre for Doctoral Training in Synthesis for Biology and Medicine for a studentship, generously supported by GlaxoSmithKline, MSD, Syngenta and Vertex. J.B.I.S. acknowledges financial support from an EPSRC Doctoral Prize (EP/T517811/1). R.S.P. acknowledges the RMACC Summit supercomputer at the University of Colorado Boulder and Colorado State University, the Extreme Science and Engineering Discovery Environment (XSEDE) through allocation TG-CHE180056, and support from the National Science Foundation (NSF CHE-1955876). We thank B. G. Davis, S. Verhoog and T. C. Wilson for comments, and T. Khotavivattana for preliminary experiments.	Ajenjo J, 2021, EJNMMI RADIOPHARM CH, V6, DOI 10.1186/s41181-021-00143-y; Birchall J. M., 1973, J CHEM SOC PERK T, VI; Buchner E., 1885, BER DTSCH CHEM GES, V18, P2377; Campbell MG, 2017, NAT CHEM, V9, P1, DOI 10.1038/nchem.2693; Dahl K, 2017, CLIN TRANSL IMAGING, V5, P275, DOI 10.1007/s40336-017-0223-1; Deng XY, 2016, ORG LETT, V18, P4384, DOI 10.1021/acs.orglett.6b02141; Deng XY, 2019, ANGEW CHEM INT EDIT, V58, P2580, DOI 10.1002/anie.201805501; Feng Z, 2017, NAT CHEM, V9, P918, DOI [10.1038/NCHEM.2746, 10.1038/nchem.2746]; Feng Z, 2016, ORG LETT, V18, P44, DOI 10.1021/acs.orglett.5b03206; Fier PS, 2013, ANGEW CHEM INT EDIT, V52, P2092, DOI 10.1002/anie.201209250; Fu XP, 2019, NAT CHEM, V11, P948, DOI 10.1038/s41557-019-0331-9; Geri JB, 2020, SCIENCE, V367, P1091, DOI 10.1126/science.aay4106; HINE J, 1960, J AM CHEM SOC, V82, P6178, DOI 10.1021/ja01508a050; Hopkinson MN, 2014, NATURE, V510, P485, DOI 10.1038/nature13384; Huiban M, 2013, NAT CHEM, V5, P941, DOI [10.1038/NCHEM.1756, 10.1038/nchem.1756]; ICH, 2005, INT COUNC HARM TECHN; Jia YM, 2021, ORG LETT, V23, P2670, DOI 10.1021/acs.orglett.1c00577; Keller T, 2017, MOL IMAGING BIOL, V19, P736, DOI 10.1007/s11307-016-1040-z; Khotavivattana T, 2015, ANGEW CHEM INT EDIT, V54, P9991, DOI 10.1002/anie.201504665; Kuchar M, 2015, MOLECULES, V20, P16186, DOI 10.3390/molecules200916186; Lelos M. J., 2018, GENERATING EXCITOTOX; Levin MD, 2017, SCIENCE, V356, P1272, DOI 10.1126/science.aan1411; Li SY, 2019, EUR J NUCL MED MOL I, V46, P1952, DOI 10.1007/s00259-019-04357-w; Li XJ, 2016, CHEM COMMUN, V52, P3657, DOI 10.1039/c5cc10550a; Marinelli M, 2016, CURR TOP MED CHEM, V16, P2995, DOI 10.2174/1568026616666160506145408; McCluskey SP, 2020, EUR J NUCL MED MOL I, V47, P451, DOI 10.1007/s00259-019-04488-0; Mizuta S, 2013, ORG LETT, V15, P2648, DOI 10.1021/ol4009377; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P219, DOI 10.1038/nrd.2016.63; Ni CF, 2014, SYNTHESIS-STUTTGART, V46, P842, DOI 10.1055/s-0033-1340856; Pipal RW, 2021, NATURE, V589, P542, DOI 10.1038/s41586-020-3015-0; Prakash GKS, 2014, ANGEW CHEM INT EDIT, V53, P11575, DOI 10.1002/anie.201406505; Prchalova E, 2014, FUTURE MED CHEM, V6, P1201, DOI [10.4155/FMC.14.53, 10.4155/fmc.14.53]; Reardon S, 2019, NATURE, V570, P285, DOI 10.1038/d41586-019-01833-z; Sap JBI, 2021, CHEM SOC REV, V50, P8214, DOI 10.1039/d1cs00360g; Sap JBI, 2019, CHEM SCI, V10, P3237, DOI 10.1039/c8sc05096a; Shi H, 2016, ANGEW CHEM INT EDIT, V55, P10786, DOI 10.1002/anie.201604106; SMAIL T, 1970, J PHYS CHEM-US, V74, P1866, DOI 10.1021/j100704a007; Smith CA, 2019, CHEM REV, V119, P4986, DOI 10.1021/acs.chemrev.8b00514; Staudinger H, 1912, BER DTSCH CHEM GES, V45, P501, DOI 10.1002/cber.19120450174; Trump L, 2019, ANGEW CHEM INT EDIT, V58, P13149, DOI 10.1002/anie.201907488; van der Born D, 2014, ANGEW CHEM INT EDIT, V53, P11046, DOI 10.1002/anie.201406221; Verhoog S, 2016, SYNLETT, V27, P25, DOI 10.1055/s-0035-1560592; Xie QQ, 2017, ANGEW CHEM INT EDIT, V56, P3206, DOI 10.1002/anie.201611823; Xing L, 2015, CHEMMEDCHEM, V10, P715, DOI 10.1002/cmdc.201402555; Yuan GY, 2017, CHEM COMMUN, V53, P126, DOI 10.1039/c6cc07913j; Zhao QC, 2021, CCS CHEM, V3, P1921, DOI 10.31635/ccschem.020.202000399; Zheng JZ, 2016, MOL IMAGING BIOL, V18, P127, DOI 10.1007/s11307-015-0877-x; Zhou W, 2021, CHEM COMMUN, V57, P9316, DOI 10.1039/d1cc04029d	48	4	4	21	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 2	2022	606	7912					102	+		10.1038/s41586-022-04669-2	http://dx.doi.org/10.1038/s41586-022-04669-2		MAR 2022	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T6VC	35344982	Green Accepted, Green Submitted			2022-12-28	WOS:000802324900001
J	Wang, ZX; Liao, WQ				Wang, Zhong-Xia; Liao, Wei-Qiang			Giant electromechanical effects in polymers	SCIENCE			English	Editorial Material									[Wang, Zhong-Xia; Liao, Wei-Qiang] Nanchang Univ, Ordered Matter Sci Res Ctr, Nanchang 330031, Jiangxi, Peoples R China	Nanchang University	Liao, WQ (corresponding author), Nanchang Univ, Ordered Matter Sci Res Ctr, Nanchang 330031, Jiangxi, Peoples R China.	liaowq@ncu.edu.cn	Wang, Zhong-Xia/ACJ-6056-2022	Wang, Zhong-Xia/0000-0002-9012-5653				Chen X, 2022, SCIENCE, V375, P1418, DOI 10.1126/science.abn0936; Heywang W, 2008, SPRINGER SER MATER S, V114, P1; Hines L, 2017, ADV MATER, V29, DOI 10.1002/adma.201603483; Li F, 2019, SCIENCE, V364, P264, DOI 10.1126/science.aaw2781; Liu HY, 2020, J AM CHEM SOC, V142, P15205, DOI 10.1021/jacs.0c07055; Liu Y, 2018, NATURE, V562, P96, DOI 10.1038/s41586-018-0550-z; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Martins P, 2014, PROG POLYM SCI, V39, P683, DOI 10.1016/j.progpolymsci.2013.07.006; Ramadan KS, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/3/033001; Shrout TR, 2007, J ELECTROCERAM, V19, P113, DOI 10.1007/s10832-007-9047-0; Stadlober B, 2019, CHEM SOC REV, V48, P1787, DOI 10.1039/c8cs00928g; Xia F, 2002, ADV MATER, V14, P1574, DOI 10.1002/1521-4095(20021104)14:21<1574::AID-ADMA1574>3.0.CO;2-#; Zhang SJ, 2015, PROG MATER SCI, V68, P1, DOI 10.1016/j.pmatsci.2014.10.002	13	4	4	34	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1353	1354		10.1126/science.abn7440	http://dx.doi.org/10.1126/science.abn7440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324300				2022-12-28	WOS:000778894800023
J	Limb, M				Limb, Matthew			SPRING STATEMENT Failure to protect cost of living will increase poverty and health inequalities, warn analysts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Treasury, 2022, SPRING STAT 2022 DOC; Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2207	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o794	10.1136/bmj.o794	http://dx.doi.org/10.1136/bmj.o794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331981				2022-12-28	WOS:000778460100019
J	Gardner, EJ; Neville, MDC; Samocha, KE; Barclay, K; Kolk, M; Niemi, MEK; Kirov, G; Martin, HC; Hurles, ME				Gardner, Eugene J.; Neville, Matthew D. C.; Samocha, Kaitlin E.; Barclay, Kieron; Kolk, Martin; Niemi, Mari E. K.; Kirov, George; Martin, Hilary C.; Hurles, Matthew E.			Reduced reproductive success is associated with selective constraint on human genes	NATURE			English	Article							PROTEIN-TRUNCATING VARIANTS; COPY-NUMBER VARIATION; BIRTH-DEFECTS; CHILDLESSNESS; SEX; RECURRENCE; SURVIVAL; MODEL; RISK	Genome-wide sequencing of human populations has revealed substantial variation among genes in the intensity of purifying selection acting on damaging genetic variants(1). Although genes under the strongest selective constraint are highly enriched for associations with Mendelian disorders, most of these genes are not associated with disease and therefore the nature of the selection acting on them is not known(2). Here we show that genetic variants that damage these genes are associated with markedly reduced reproductive success, primarily owing to increased childlessness, with a stronger effect in males than in females. We present evidence that increased childlessness is probably mediated by genetically associated cognitive and behavioural traits, which may mean that male carriers are less likely to find reproductive partners. This reduction in reproductive success may account for 20% of purifying selection against heterozygous variants that ablate protein-coding genes. Although this genetic association may only account for a very minor fraction of the overall likelihood of being childless (less than 1%), especially when compared to more influential sociodemographic factors, it may influence how genes evolve overtime.	[Gardner, Eugene J.; Neville, Matthew D. C.; Samocha, Kaitlin E.; Niemi, Mari E. K.; Martin, Hilary C.; Hurles, Matthew E.] Wellcome Genome Campus, Wellcome Sanger Inst, Cambridge, Hinxton, England; [Barclay, Kieron] Max Planck Inst Demog Res, Rostock, Germany; [Barclay, Kieron; Kolk, Martin] Stockholm Univ, Dept Sociol, Demog Unit, Stockholm, Sweden; [Barclay, Kieron] Swedish Coll Adv Study, Uppsala, Sweden; [Kirov, George] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, Wales; [Gardner, Eugene J.] Univ Cambridge, Sch Clin Med, Med Res Council MRC Epidemiol Unit, Inst Metab Sci,Cambridge Biomed Campus, Cambridge, England	Wellcome Trust Sanger Institute; Max Planck Society; Stockholm University; Swedish Collegium for Advanced Study (SCAS); Cardiff University; University of Cambridge	Hurles, ME (corresponding author), Wellcome Genome Campus, Wellcome Sanger Inst, Cambridge, Hinxton, England.	meh@sanger.ac.uk	Kolk, Martin/H-4716-2019	Kolk, Martin/0000-0002-7175-4040; Neville, Matthew/0000-0001-5816-7936; Gardner, Eugene/0000-0001-9671-1533; Hurles, Matthew/0000-0002-2333-7015; Samocha, Kaitlin/0000-0002-1704-3352	Wellcome [WT098051]; Medical Research Council (MRC) Centre Grant [MR/L010305/1]; Bank of Sweden Tercentenary Foundation (Riksbankens Jubileumsfond)	Wellcome; Medical Research Council (MRC) Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bank of Sweden Tercentenary Foundation (Riksbankens Jubileumsfond)	We thank L. Parts, J. Kaplanis, M. Przeworski and G. Davey-Smith for useful discussions and advice on data analysis; M. Oud and J. Veltman for helpful discussions regarding infertility; G. Kalantzis and P. F. Palamara for assistance with correcting for recent ancestry; and the INTERVAL study for sharing genotyping and exome data that enabled us to refine our CNV filtering methodology. This work has been funded by core Wellcome funding to the Wellcome Sanger Institute (grant WT098051) and as part of a Medical Research Council (MRC) Centre Grant to the MRC Centre for Neuropsychiatric Genetics and Genomics (grant MR/L010305/1). K.B. is supported by a fellowship from the Bank of Sweden Tercentenary Foundation (Riksbankens Jubileumsfond). This work has been conducted using the UK Biobank Resource under application numbers 14421 (to G.K.) and 44165 (to H.C.M.).	Allen MS, 2019, CURR DIR PSYCHOL SCI, V28, P581, DOI 10.1177/0963721419862293; Backenroth D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku345; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Barthold JA, 2012, EVOL HUM BEHAV, V33, P628, DOI 10.1016/j.evolhumbehav.2012.03.003; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berrington, 2017, DEMOGRAPHIC RES MONO, V57-76; Betzig L, 2012, EVOL HUM BEHAV, V33, P309, DOI 10.1016/j.evolhumbehav.2011.10.008; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; Buss DM, 2019, ANNU REV PSYCHOL, V70, P77, DOI 10.1146/annurev-psych-010418-103408; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carlstedt B., 2000, THESIS U GOTHENBURG; Cassa CA, 2017, NAT GENET, V49, P806, DOI 10.1038/ng.3831; Clark DW., 2019, NAT COMMUN, V10; Collins RL, 2020, NATURE, V581, P444, DOI 10.1038/s41586-020-2287-8; Costain G, 2011, J MED GENET, V48, P819, DOI 10.1136/jmedgenet-2011-100440; Crawford K, 2019, J MED GENET, V56, P131, DOI 10.1136/jmedgenet-2018-105477; Darwin C., 1871, P475; Davis KAS, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2019.100; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Dudel C, 2019, POP STUD-J DEMOG, V73, P439, DOI 10.1080/00324728.2018.1481992; Fieder M, 2007, EVOL HUM BEHAV, V28, P392, DOI 10.1016/j.evolhumbehav.2007.05.004; Fieder M, 2011, J BIOSOC SCI, V43, P619, DOI 10.1017/S002193201100023X; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Hallsten M, 2014, RES SOC STRAT MOBIL, V35, P19, DOI 10.1016/j.rssm.2013.09.002; Huguet G, 2018, JAMA PSYCHIAT, V75, P447, DOI 10.1001/jamapsychiatry.2018.0039; Jalovaara M, 2019, EUR J POPUL, V35, P563, DOI 10.1007/s10680-018-9492-2; Kaplanis J, 2020, NATURE, V586, P757, DOI 10.1038/s41586-020-2832-5; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kendall KM, 2017, BIOL PSYCHIAT, V82, P103, DOI 10.1016/j.biopsych.2016.08.014; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kolk M, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0359; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liaw A., 2002, R NEWS, V2, P285; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Mace A, 2016, BIOINFORMATICS, V32, P3298, DOI 10.1093/bioinformatics/btw477; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Mardberg B, 1998, INT J SELECT ASSESS, V6, P107, DOI 10.1111/1468-2389.00079; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Oficce for National Statistics, 2020, BIRTH SUMM TABL; Oud MS, 2019, HUM REPROD, V34, P932, DOI 10.1093/humrep/dez022; Packer JS, 2016, BIOINFORMATICS, V32, P133, DOI 10.1093/bioinformatics/btv547; Parker G.A., 2015, CURRENT PERSPECTIVES, P119, DOI DOI 10.1007/978-94-017-9585-2_7; Pawlowski B, 1999, P ROY SOC B-BIOL SCI, V266, P281, DOI 10.1098/rspb.1999.0634; Population and Welfare Department, 2017, MULT REG 2016 DESCR; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Rentzsch P, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00835-9; Ronnlund M, 2013, INTELLIGENCE, V41, P19, DOI 10.1016/j.intell.2012.10.001; Saada JN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19588-x; Samocha K. E., 2017, REGIONAL MISSENSE CO, DOI [10.1101/148353, DOI 10.1101/148353]; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; Stanley KE, 2020, NEW ENGL J MED, V383, P1107, DOI 10.1056/NEJMoa1908753; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Szustakowski JD, 2021, NAT GENET, V53, P942, DOI 10.1038/s41588-021-00885-0; Tanturri M.-L., 2015, FAMILIES SOC WORKING, V3; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tyrrell J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21073-y; Van Hout CV, 2020, NATURE, V586, P749, DOI 10.1038/s41586-020-2853-0; Verweij RM, 2017, EUR J HUM GENET, V25, P1067, DOI 10.1038/ejhg.2017.105; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0; Weghorn D, 2019, MOL BIOL EVOL, V36, P1701, DOI 10.1093/molbev/msz092; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	75	9	9	3	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					858	+		10.1038/s41586-022-04549-9	http://dx.doi.org/10.1038/s41586-022-04549-9		MAR 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35322230	Green Accepted			2022-12-28	WOS:000772363100007
J	[Anonymous]				[Anonymous]			Russia's war in Ukraine is killing cancer care in both countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Dunn C, 2022, PHILADELPHIA INQUIRE; Mingazov S., 2022, FORBES 0317; Open letter signed by 1000s of signatories calls for an end to hostilities in Ukraine, 2022, BMJ, V376, po535, DOI 10.1136/bmj.o535; Petlyanova N., 2022, NOVAYA GAZETA 0303; Pfizer, 2022, PFIZ PIP	5	0	0	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o701	10.1136/bmj.o701	http://dx.doi.org/10.1136/bmj.o701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321869	Bronze			2022-12-28	WOS:000790072700010
J	Sarkar, S				Sarkar, Sonia			Pakistan remains polio free-despite covid-19, the Afghan conflict, and a waning global eradication effort	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												26.sarkar@gmail.com						[Anonymous], 2022, BBC NEWS 0218; [Anonymous], 2019, PROTESTERS SET PESHA; Fortner R, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1818; Khan S, 2022, PAKISTAN REIGNITES P; Saifi S, THE CNN	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o617	10.1136/bmj.o617	http://dx.doi.org/10.1136/bmj.o617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301194	Bronze			2022-12-28	WOS:000796719200001
J	Kola, L; Kumar, M; Kohrt, BA; Fatodu, T; Olayemi, BA; Adefolarin, AO				Kola, Lola; Kumar, Manasi; Kohrt, Brandon A.; Fatodu, Tobi; Olayemi, Bisola A.; Adefolarin, Adeyinka O.			Strengthening public mental health during and after the acute phase of the COVID-19 pandemic Comment	LANCET			English	Editorial Material									[Kola, Lola; Fatodu, Tobi; Olayemi, Bisola A.] Univ Ibadan, Coll Med, WHO Collaborating Ctr Res & Training Mental Hlth, Neurosci & Drug & Alcohol Abuse,Dept Psychiat, Ibadan 5116, Nigeria; [Kola, Lola] Univ Washington, Dept Psychiat & Behav Sci, BRiTE Ctr, Seattle, WA 98195 USA; [Kumar, Manasi] Univ Nairobi, Dept Psychiat, Nairobi, Kenya; [Kumar, Manasi] UCL, Dept Psychol, London, England; [Kohrt, Brandon A.] George Washington Univ, Dept Psychiat & Behav Sci, Div Global Mental Hlth, Washington, DC USA; [Adefolarin, Adeyinka O.] Univ Ibadan, Dept Psychiat, Ibadan, Nigeria; [Adefolarin, Adeyinka O.] Univ Ibadan, Dept Hlth Promot & Educ, Fac Publ Hlth, Coll Med, Ibadan, Nigeria	University of Ibadan; University of Washington; University of Washington Seattle; University of Nairobi; University of London; University College London; George Washington University; University of Ibadan; University of Ibadan	Kola, L (corresponding author), Univ Ibadan, Coll Med, WHO Collaborating Ctr Res & Training Mental Hlth, Neurosci & Drug & Alcohol Abuse,Dept Psychiat, Ibadan 5116, Nigeria.; Kola, L (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, BRiTE Ctr, Seattle, WA 98195 USA.	lola_kola2004@yahoo.com		Adefolarin, Adeyinka/0000-0001-7238-2413				Douaud G, 2022, NATURE, V604, P697, DOI [10.1038/s41586-022-04569-5, 10.1101/2021.06.11.21258690]; Eaton J, 2017, EPIDEMIOL PSYCH SCI, V26, P245, DOI 10.1017/S2045796016001001; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o672; Kola L, 2021, LANCET PSYCHIAT, V8, P535, DOI 10.1016/S2215-0366(21)00025-0; Matus J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3518-7; Moutier C, 2021, JAMA PSYCHIAT, V78, P433, DOI 10.1001/jamapsychiatry.2020.3746; Pirrone I, 2021, GLOBAL HEALTH ACTION, V14, DOI 10.1080/16549716.2021.1927332; Saxena S, 2017, GLOB MENT HEALTH, V4, DOI 10.1017/gmh.2017.20; Sharifi M, 2021, ARCH ACAD EMERG MED, V9, DOI 10.22037/aaem.v9i1.1004; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; United Nations, 2020, COVID 19 RIGHTS PERS; WHO, 2022, COVID 19 PAND TRIGG; World Health Organisation, 2022, MENT HLTH COVID 19 E; World Health Organization, 2021, MENT HLTH STRAT 2021	15	3	3	8	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2022	399	10338					1851	1852						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1V8AR	35339230	Green Published, Bronze			2022-12-28	WOS:000806306700004
J	Gnecchi-Ruscone, GA; Szecsenyi-Nagy, A; Koncz, I; Csiky, G; Racz, Z; Rohrlach, AB; Brandt, G; Rohland, N; Csaky, V; Cheronet, O; Szeifert, B; Racz, TA; Benedek, A; Bernert, Z; Berta, N; Czifra, S; Dani, J; Farkas, Z; Haga, T; Hajdu, T; Jaszberenyi, M; Kisjuhasz, V; Kolozsi, B; Major, P; Marcsik, A; Kovacsoczy, BN; Balogh, C; Lezsak, GM; Odor, JG; Szelekovszky, M; Szeniczey, T; Tarnoki, J; Toth, Z; Tutkovics, EK; Mende, BG; Geary, P; Pohl, W; Vida, T; Pinhasi, R; Reich, D; Hofmanova, Z; Jeong, C; Krause, J				Gnecchi-Ruscone, Guido Alberto; Szecsenyi-Nagy, Anna; Koncz, Istvan; Csiky, Gergely; Racz, Zsofia; Rohrlach, A. B.; Brandt, Guido; Rohland, Nadin; Csaky, Veronika; Cheronet, Olivia; Szeifert, Bea; Racz, Tibor Akos; Benedek, Andras; Bernert, Zsolt; Berta, Norbert; Czifra, Szabolcs; Dani, Janos; Farkas, Zoltan; Haga, Tamara; Hajdu, Tamas; Jaszberenyi, Monika; Kisjuhasz, Viktoria; Kolozsi, Barbara; Major, Peter; Marcsik, Antonia; Kovacsoczy, Bernadett Ny; Balogh, Csilla; Lezsak, Gabriella M.; Odor, Janos Gabor; Szelekovszky, Marta; Szeniczey, Tamas; Tarnoki, Judit; Toth, Zoltan; Tutkovics, Eszter K.; Mende, Balazs G.; Geary, Patrick; Pohl, Walter; Vida, Tivadar; Pinhasi, Ron; Reich, David; Hofmanova, Zuzana; Jeong, Choongwon; Krause, Johannes			Ancient genomes reveal origin and rapid trans-Eurasian migration of 7th century Avar elites	CELL			English	Article							GENETIC HISTORY; ADMIXTURE; FRAMEWORK; PATTERNS; SEQUENCE; CAVE	The Avars settled the Carpathian Basin in 567/68 CE, establishing an empire lasting over 200 years. Who they were and where they came from is highly debated. Contemporaries have disagreed about whether they were, as they claimed, the direct successors of the Mongolian Steppe Rouran empire that was destroyed by the Turks in similar to 550 CE. Here, we analyze new genome-wide data from 66 pre-Avar and Avar-period Carpathian Basin individuals, including the 8 richest Avar-period burials and further elite sites from Avar's empire core region. Our results provide support for a rapid long-distance trans-Eurasian migration of Avar-period elites. These individuals carried Northeast Asian ancestry matching the profile of preceding Mongolian Steppe populations, particularly a genome available from the Rouran period. Some of the later elite individuals carried an additional non-local ancestry component broadly matching the steppe, which could point to a later migration or reflect greater genetic diversity within the initial migrant population.	[Gnecchi-Ruscone, Guido Alberto; Rohrlach, A. B.; Hofmanova, Zuzana; Krause, Johannes] Max Planck Inst Evolutionary Anthropol, Dept Archaeogenet, D-04103 Leipzig, Germany; [Szecsenyi-Nagy, Anna; Csaky, Veronika; Szeifert, Bea; Mende, Balazs G.] Eotvos Lorand Res Network, Res Ctr Humanities, Inst Archaeogen, H-1097 Budapest, Hungary; [Koncz, Istvan; Racz, Zsofia; Vida, Tivadar] Eotvos Lorand Univ, Inst Archaeol Sci, H-1088 Budapest, Hungary; [Csiky, Gergely] Eotvos Lorand Res Network, Res Ctr Humanities, Inst Archaeol, H-1097 Budapest, Hungary; [Rohrlach, A. B.] Univ Adelaide, ARC Ctr Excellence Math & Stat Frontiers, Sch Math Sci, Adelaide, SA 5005, Australia; [Brandt, Guido] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Rohland, Nadin; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Rohland, Nadin; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Cheronet, Olivia; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, A-1030 Vienna, Austria; [Racz, Tibor Akos; Jaszberenyi, Monika] Ferenczy Museum Ctr, H-2000 Szentendre, Hungary; [Benedek, Andras] Mora Ferenc Museum, H-6720 Szeged, Hungary; [Bernert, Zsolt; Czifra, Szabolcs] Hungarian Natl Museum, H-1113 Budapest, Hungary; [Berta, Norbert; Farkas, Zoltan; Major, Peter] Salisbury Ltd, H-1016 Budapest, Hungary; [Dani, Janos; Haga, Tamara; Kolozsi, Barbara; Szelekovszky, Marta] Deri Museum, H-4026 Debrecen, Hungary; [Hajdu, Tamas; Szeniczey, Tamas] Eotvos Lorand Univ, Dept Biol Anthropol, H-1117 Budapest, Hungary; [Kisjuhasz, Viktoria] Aquincum Museum & Archaeol Pk, H-1031 Budapest, Hungary; [Marcsik, Antonia] Szeged Univ, Dept Biol Anthropol, H-6701 Szeged, Hungary; [Kovacsoczy, Bernadett Ny] Katona Jozsef Museum, H-6000 Kecskemet, Hungary; [Balogh, Csilla] Istanbul Medeniyet Univ, Dept Art Hist, TR-34720 Istanbul, Turkey; [Lezsak, Gabriella M.] Eotvos Lorand Res Network, Res Ctr Humanities, H-1097 Budapest, Hungary; [Odor, Janos Gabor] Wosinsky Mor Museum, H-7100 Szekszard, Hungary; [Tarnoki, Judit] Damjanich Museum, H-5000 Szolnok, Hungary; [Toth, Zoltan] Dobo Istvan Museum, H-3300 Eger, Hungary; [Tutkovics, Eszter K.] Retkozi Muzeum, H-4600 Kisvarda, Hungary; [Geary, Patrick] Inst Adv Study, Princeton, NJ 08540 USA; [Pohl, Walter] Austrian Acad Sci, Inst Medieval Res, A-1020 Vienna, Austria; [Pohl, Walter] Univ Vienna, Inst Austrian Hist Res, A-1010 Vienna, Austria; [Reich, David] Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Hofmanova, Zuzana] Masaryk Univ, Fac Arts, Dept Archaeol & Museol, Brno 60200, Czech Republic; [Jeong, Choongwon] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; University of Adelaide; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Vienna; Eotvos Lorand University; Szeged University; Istanbul Medeniyet University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Institute for Advanced Study - USA; Austrian Academy of Sciences; University of Vienna; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Masaryk University Brno; Seoul National University (SNU)	Gnecchi-Ruscone, GA; Krause, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Archaeogenet, D-04103 Leipzig, Germany.; Jeong, C (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	guido_gnecchi@eva.mpg.de; cwjeong@snu.ac.kr; krause@eva.mpg.de	Rohrlach, Adam B/H-8415-2017	Rohrlach, Adam B/0000-0002-4204-5018; Cheronet, Olivia/0000-0001-6760-1204; Csiky, Gergely/0000-0003-4775-0004	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [856453 ERC-2019-SyG]; Max Planck Society; Hungarian Scientific Research Fund (OTKA-NKFI) [NN113157]; Szilagyi Family Foundation; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1C1C1003879]; Allen Discovery Center program (a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation); Czech Grant Agency [GACR 21-17092X]; John Templeton Foundation [61220]; Howard Hughes Medical Institute	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Hungarian Scientific Research Fund (OTKA-NKFI)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Szilagyi Family Foundation; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Allen Discovery Center program (a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation); Czech Grant Agency(Grant Agency of the Czech Republic); John Templeton Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 856453 ERC-2019-SyG), the Max Planck Society, the Hungarian Scientific Research Fund (OTKA-NKFI; grant number: NN113157), the Szila ' gyi Family Foundation, the Ja ' nos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to A.S.-N.), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2020R1C1C1003879), the Allen Discovery Center program (a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation), the Czech Grant Agency (GACR 21-17092X), John Templeton Foundation grant 61220, and the Howard Hughes Medical Institute. We would like to thank Ronny Barr of the Multimedia Department of the Max Planck Institute for Evolutionary Anthropology for the graphical support.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alves I, 2016, MOL BIOL EVOL, V33, P946, DOI 10.1093/molbev/msv332; Amorim CEG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06024-4; Balint C, 2019, AVARS BYZANTIUM ITAL; Breuer E, 2005, BYZANZ DONAU EINFUHR; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Csaky V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57378-8; Curta F, 2021, LONG 6 CENTURY E EUR; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Daim F, 1992, ARCHAEOLOGIA AUSTRIA; Daim F., 2003, REGNA GENTES RELATIO, P463; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobrovits M., 2003, ERAN UD ANERAN STUDI, P175; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2020, NAT PROTOC, V15, P2279, DOI 10.1038/s41596-020-0338-0; Garam E, 2005, COMARCHHUNG, P407; Gnecchi-Ruscone GA, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4414; Golden P.B., 2013, STEPPE LANDS WORLD T, P43; Gulyas B., 2016, HUNGARIAN ARCHAEOLOG; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hurbanic M., 2019, AVAR SIEGE CONSTANTI; Ilumae AM, 2016, AM J HUM GENET, V99, P163, DOI 10.1016/j.ajhg.2016.05.025; Jeong C, 2020, CELL, V183, P890, DOI 10.1016/j.cell.2020.10.015; Jeong C, 2019, NAT ECOL EVOL, V3, P966, DOI 10.1038/s41559-019-0878-2; Jeong C, 2018, P NATL ACAD SCI USA, V115, pE11248, DOI 10.1073/pnas.1813608115; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Kislinger E., 2018, MONOGRAPHIEN ROMISCH, P419; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kradin N. N., 2005, ACTA ORIENT ACAD SCI, V58, P149; Krzewinska M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4457; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Lamnidis TC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07483-5; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JW, 2018, AM J PHYS ANTHROPOL, V166, P895, DOI 10.1002/ajpa.23491; Lipatov M., 2015, BIORXIV, DOI [10.1101/023374, DOI 10.1101/023374]; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Lorinczy G., 2017, ACTA ARCHAEOL-HUNG, V68, P137; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; Nagy M., 2010, NEGLECTED BARBARIANS, P137; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Neparaczki E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53105-5; Neparaczki E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205920; Ning C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16557-2; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peltzer A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0918-z; Pohl W., 2018, AVARS STEPPE EMPIRE, P567; R Core Team, 2020, R LANG ENV STAT COMP; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralf A, 2018, MOL BIOL EVOL, V35, P1820, DOI 10.1093/molbev/msy080; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Ringbauer H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25289-w; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Salter-Townshend M, 2019, GENETICS, V212, P869, DOI 10.1534/genetics.119.302139; Savelyev A., 2020, EVOL HUM SCI, V2, P20; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Spiliopoulou A, 2017, GENETICS, V206, P91, DOI 10.1534/genetics.117.200063; Szadeczky-Kardoss S., 1990, CAMBRIDGE HIST EARLY, P206; Szenthe G., 2019, ACTA ARCHAEOL-HUNG, V70, P215; Unterlander M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14615; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Vida T., 2016, BYZANTIUM STEPPE ARC, P51; Vida T., 2008, OTHER EUROPE MIDDLE, P13	80	1	1	9	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2022	185	8					1402	+		10.1016/j.cell.2022.03.007	http://dx.doi.org/10.1016/j.cell.2022.03.007			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	3F9YN	35366416	hybrid, Green Published			2022-12-28	WOS:000831015400003
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: UK adds sore throat, headache, fatigue, and six other symptoms to official list	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3103; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1654; NHS, MAIN SYMPT COR COVID; Yates K, TWITTER	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								o892	10.1136/bmj.o892	http://dx.doi.org/10.1136/bmj.o892			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N8UW	35379691	Bronze			2022-12-28	WOS:000783107700001
J	Bernstein, RB				Bernstein, R. B.			Ken Burns, executive producer	SCIENCE			English	Book Review									[Bernstein, R. B.] CUNY City Coll, Colin Powell Sch Civ & Global Leadership, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Bernstein, RB (corresponding author), CUNY City Coll, Colin Powell Sch Civ & Global Leadership, New York, NY 10031 USA.	rbernstein@ccny.cuny.edu						Franklin B., 1793, AUTOBIOGRAPHY B FRAN; Meyer M., 2002, B FRANKLIN	2	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		40	40		10.1126/science.abo2776	http://dx.doi.org/10.1126/science.abo2776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357942				2022-12-28	WOS:000780195200018
J	Zachariou, M				Zachariou, Melina			Poetry therapy: five minutes with ... Michael Rosen	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o879	10.1136/bmj.o879	http://dx.doi.org/10.1136/bmj.o879			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365460				2022-12-28	WOS:000783141700015
J	Pellikka, PA; Dudzinski, DM; Lubitz, SA; Tsang, TSM; Tower-Rader, A; Karaa, A				Pellikka, Patricia A.; Dudzinski, David M.; Lubitz, Steven A.; Tsang, Teresa S. M.; Tower-Rader, Albree; Karaa, Amel			Case 10-2022: A 78-Year-Old Man with Marked Ventricular Wall Thickening	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FABRY-DISEASE; CARDIOMYOPATHY; DIAGNOSIS; STRAIN; HEART; MANIFESTATIONS; HYPERTROPHY; INVOLVEMENT		[Pellikka, Patricia A.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Dudzinski, David M.; Lubitz, Steven A.; Tower-Rader, Albree] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Karaa, Amel] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Dudzinski, David M.; Lubitz, Steven A.; Tower-Rader, Albree] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Karaa, Amel] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Tsang, Teresa S. M.] Univ British Columbia, Div Cardiol & Cardiovasc Surg, Vancouver, BC, Canada	Mayo Clinic; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of British Columbia	Pellikka, PA (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.							Amann K, 1998, KIDNEY INT, V54, pS78, DOI 10.1046/j.1523-1755.1998.06818.x; ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955; Bracamonte ER, 2006, AM J KIDNEY DIS, V48, P844, DOI 10.1053/j.ajkd.2006.05.034; Calcagni G, 2018, HEART FAIL CLIN, V14, P225, DOI 10.1016/j.hfc.2017.12.005; D'souza RS, 2014, CIRC-HEART FAIL, V7, P843, DOI 10.1161/CIRCHEARTFAILURE.114.001105; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Dungu JN, 2012, HEART, V98, P1546, DOI 10.1136/heartjnl-2012-301924; Eng CM, 2006, GENET MED, V8, P539, DOI 10.1097/01.gim.0000237866.70357.c6; Fagard R, 2003, HEART, V89, P1455, DOI 10.1136/heart.89.12.1455; GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V; Geske JB, 2018, JACC-HEART FAIL, V6, P364, DOI 10.1016/j.jchf.2018.02.010; Hiramitsu S, 2001, JPN CIRC J, V65, P863, DOI 10.1253/jcj.65.863; Kawano M, 2007, AM J CARDIOL, V99, P261, DOI 10.1016/j.amjcard.2006.07.088; Kittleson MM, 2020, CIRCULATION, V142, pE7, DOI 10.1161/CIR.0000000000000792; Labombarda F, 2017, ECHOCARDIOGR-J CARD, V34, P504, DOI 10.1111/echo.13496; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Linhart A, 2007, HEART, V93, P528, DOI 10.1136/hrt.2005.063818; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta A., 2002, GENEREVIEWS; Meyers DE, 2013, TEX HEART I J, V40, P385; Niemann M, 2011, JACC-CARDIOVASC IMAG, V4, P592, DOI 10.1016/j.jcmg.2011.01.020; Ommen SR, 2020, J AM COLL CARDIOL, V76, pE159, DOI 10.1016/j.jacc.2020.08.045; Ortiz A, 2018, MOL GENET METAB, V123, P416, DOI 10.1016/j.ymgme.2018.02.014; Pica S, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0099-4; Sanchorawala V, 2006, CLIN J AM SOC NEPHRO, V1, P1331, DOI 10.2215/CJN.02740806; Schiffmann Raphael, 2015, Handb Clin Neurol, V132, P231, DOI 10.1016/B978-0-444-62702-5.00017-2; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Vertilus SM, 2010, GENET MED, V12, P413, DOI 10.1097/GIM.0b013e3181e0e979; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477; Yeung DF, 2018, J AM SOC ECHOCARDIOG, V31, P639, DOI 10.1016/j.echo.2018.01.016; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Zada M, 2021, J AM SOC ECHOCARDIOG, V34, P405, DOI 10.1016/j.echo.2020.11.009	32	0	0	3	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1266	1276		10.1056/NEJMcpc2201230	http://dx.doi.org/10.1056/NEJMcpc2201230			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35353965				2022-12-28	WOS:000820666300011
J	Ramos, RN; Missolo-Koussou, Y; Gerber-Ferder, Y; Bromley, CP; Bugatti, M; Nunez, NG; Boari, JT; Richer, W; Menger, L; Denizeau, J; Sedlik, C; Caudana, P; Kotsias, F; Niborski, LL; Viel, S; Bohec, M; Lameiras, S; Baulande, S; Lesage, L; Nicolas, A; Meseure, D; Vincent-Salomon, A; Reyal, F; Dutertre, CA; Ginhoux, F; Vimeux, L; Donnadieu, E; Buttard, B; Galon, J; Zelenay, S; Vermi, W; Guermonprez, P; Piaggio, E; Helft, J				Ramos, Rodrigo Nalio; Missolo-Koussou, Yoann; Gerber-Ferder, Yohan; Bromley, Christian P.; Bugatti, Mattia; Nunez, Nicolas Gonzalo; Boari, Jimena Tosello; Richer, Wilfrid; Menger, Laurie; Denizeau, Jordan; Sedlik, Christine; Caudana, Pamela; Kotsias, Fiorella; Niborski, Leticia L.; Viel, Sophie; Bohec, Mylene; Lameiras, Sonia; Baulande, Sylvain; Lesage, Laetitia; Nicolas, Andre; Meseure, Didier; Vincent-Salomon, Anne; Reyal, Fabien; Dutertre, Charles-Antoine; Ginhoux, Florent; Vimeux, Lene; Donnadieu, Emmanuel; Buttard, Benedicte; Galon, Jerome; Zelenay, Santiago; Vermi, William; Guermonprez, Pierre; Piaggio, Eliane; Helft, Julie			Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer	CELL			English	Article							TUMOR-ASSOCIATED MACROPHAGES; GENE-EXPRESSION; DENDRITIC CELLS; R/BIOCONDUCTOR PACKAGE; INFLAMMATORY MONOCYTES; LYMPH-NODES; POLARIZATION; CYTOMETRY; ORIGIN; METASTASIS	Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration correlates with lower patient survival and resistance to therapy. Tumor-associated macrophages, however, are phenotypically and functionally heterogeneous. Specific subsets of tumor-associated macrophage might be endowed with distinct roles on cancer progression and antitumor immunity. Here, we identify a discrete population of FOLR2(+) tissue-resident macrophages in healthy mammary gland and breast cancer primary tumors. FOLR2(+) macrophages localize in perivascular areas in the tumor stroma, where they interact with CD8(+) T cells. FOLR2(+) macrophages efficiently prime effector CD8(+) T cells ex vivo. The density of FOLR2(+) macrophages in tumors positively correlates with better patient survival. This study highlights specific roles for tumor-associated macrophage subsets and paves the way for subset-targeted therapeutic interventions in macrophages-based cancer therapies.	[Ramos, Rodrigo Nalio; Missolo-Koussou, Yoann; Gerber-Ferder, Yohan; Nunez, Nicolas Gonzalo; Boari, Jimena Tosello; Richer, Wilfrid; Menger, Laurie; Denizeau, Jordan; Sedlik, Christine; Caudana, Pamela; Kotsias, Fiorella; Niborski, Leticia L.; Viel, Sophie; Vermi, William; Piaggio, Eliane; Helft, Julie] PSL Univ, Inst Curie Res Ctr, U932, INSERM, F-75005 Paris, France; [Ramos, Rodrigo Nalio; Missolo-Koussou, Yoann; Gerber-Ferder, Yohan; Nunez, Nicolas Gonzalo; Boari, Jimena Tosello; Richer, Wilfrid; Denizeau, Jordan; Sedlik, Christine; Caudana, Pamela; Kotsias, Fiorella; Niborski, Leticia L.; Viel, Sophie; Piaggio, Eliane; Helft, Julie] PSL Univ, SiRIC, Translat Immunotherapy Team, F-75005 Paris, France; [Bromley, Christian P.; Zelenay, Santiago] Univ Manchester, Canc Res UK Manchester Inst, Canc Inflammat & Immun Grp, Alderley Pk, Manchester, Lancs, England; [Bugatti, Mattia] Univ Brescia, Dept Pathol, I-25123 Brescia, Italy; [Vermi, William] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Bohec, Mylene; Lameiras, Sonia; Baulande, Sylvain] PSL Univ, Inst Curie Res Ctr, Inst Curie Genom Excellence Platform, F-75005 Paris, France; [Lesage, Laetitia; Nicolas, Andre; Meseure, Didier; Vincent-Salomon, Anne] PSL Univ, Inst Curie Hosp, Dept Pathol, F-75005 Paris, France; [Reyal, Fabien] PSL Univ, Inst Curie Hosp, Dept Surg, F-75005 Paris, France; [Dutertre, Charles-Antoine; Ginhoux, Florent] Univ Paris Saclay, Inst Gustave Roussy, INSERM, U1015, Villejuif, France; [Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Vimeux, Lene; Donnadieu, Emmanuel] Univ Paris, Inst Cochin, INSERM, CNRS,UMR 8104,U1016, F-75014 Paris, France; [Buttard, Benedicte; Galon, Jerome] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Lab Integrat Canc Immunol,INSERM, Paris, France; [Guermonprez, Pierre] Univ Paris, Ctr Inflammat Res, INSERM1149, CNRS,ERL8252, Paris, France; [Ramos, Rodrigo Nalio] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP,Dept Hematol & Cell Therapy, Lab Med Invest Pathogenesis & Directed Therapy On, Sao Paulo, Brazil; [Ramos, Rodrigo Nalio] Inst DOr Ensino & Pesquisa, Sao Paulo, Brazil; [Nunez, Nicolas Gonzalo] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Cancer Research UK; University of Manchester; University of Brescia; Washington University (WUSTL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; University of Zurich	Helft, J (corresponding author), PSL Univ, Inst Curie Res Ctr, U932, INSERM, F-75005 Paris, France.; Helft, J (corresponding author), PSL Univ, SiRIC, Translat Immunotherapy Team, F-75005 Paris, France.	julie.helft@inserm.fr	Vincent-Salomon, Anne/GXV-2625-2022; Ramos, Rodrigo N/K-3553-2012	Ramos, Rodrigo N/0000-0003-1249-4733; Tosello Boari, Jimena/0000-0003-1563-4420; LESAGE, LAETITIA/0000-0001-8592-2482; Helft, Julie/0000-0002-2733-1972; Zelenay, Santiago/0000-0002-6865-3978; Bohec, Mylene/0000-0002-6530-596X; Missolo-Koussou, Yoann-Lionel/0000-0002-3815-3980; Bromley, Christian/0000-0001-6203-6891	SiRIC-Curie Program [INCa-DGOS-12554]; Labex DCBIOL [ANR-10-IDEX-0001-02 PSL, ANR-11-LABX-0043]; Fondation ARC [PA20181207706]; Ligue Nationale contre le cancer [RS19/75-92]; Center of Clinical Investigation (CIC IGR-Curie) [1428]; ITMO-CancerAviesan (Plan Cancer III) [ANR-10-EQPX-03, ANR-10-INBS-09-08]; SiRIC-Curie program (SiRIC Grant) [INCa-DGOS-4654]; NIHR Manchester BRC; Cancer Research UK Manchester Institute Award [A19258]; IDEX [ANR-18-IDEX-0001]; INCA [PL-BIO-ICR1];  [IG23179];  [ANR-17-CE11-0001-01]	SiRIC-Curie Program; Labex DCBIOL; Fondation ARC; Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Center of Clinical Investigation (CIC IGR-Curie); ITMO-CancerAviesan (Plan Cancer III); SiRIC-Curie program (SiRIC Grant); NIHR Manchester BRC; Cancer Research UK Manchester Institute Award; IDEX; INCA(Institut National du Cancer (INCA) France); ; 	We thank A.M. Lennon-Dumenil, J. Waterfall, C. Thery, P. Sirven, and F. Benvenuti for helpful advice and reagents. E.P. team is supported by the SiRIC-Curie Program (grant INCa-DGOS-12554) , the Labex DCBIOL (ANR-10-IDEX-0001-02 PSL and ANR-11-LABX-0043) , the Fondation ARC (PA20181207706) , the Ligue Nationale contre le cancer (RS19/75-92) , and the Center of Clinical Investigation (CIC IGR-Curie 1428) . High-throughput sequencing was performed by the ICGex NGS platform of the Institut Curie supported by the grants ANR-10-EQPX-03 and ANR-10-INBS-09-08, by the ITMO-CancerAviesan (Plan Cancer III) , and by the SiRIC-Curie program (SiRIC Grant INCa-DGOS-4654) . C.P.B. and S.Z. are supported by the NIHR Man-chester BRC and by a Cancer Research UK Manchester Institute Award (A19258) . W.V. is supported by the grant IG23179, A.I.R.C. P.G. is supported by IDEX (ANR-18-IDEX-0001) , INCA (PL-BIO-ICR1) , and ANR-17-CE11-0001-01.	Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Ali HR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002194; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arwert EN, 2018, CELL REP, V23, P1239, DOI 10.1016/j.celrep.2018.04.007; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bourdely P, 2020, IMMUNITY, V53, P335, DOI 10.1016/j.immuni.2020.06.002; Brummelman J, 2019, NAT PROTOC, V14, P1946, DOI 10.1038/s41596-019-0166-2; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Casanova-Acebes M, 2021, NATURE, V595, P578, DOI 10.1038/s41586-021-03651-8; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Chow A, 2021, CANCER CELL, V39, P973, DOI 10.1016/j.ccell.2021.05.006; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Dawson CA, 2020, NAT CELL BIOL, V22, P546, DOI 10.1038/s41556-020-0505-0; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Etzerodt A, 2020, J EXP MED, V217, DOI 10.1084/jem.20191869; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Jappinen N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08065-1; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lewis CE, 2016, CANCER CELL, V30, P18, DOI 10.1016/j.ccell.2016.05.017; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Linde N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02481-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nunez NG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17046-2; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ramos RN, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1108; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Samaniego R, 2014, J LEUKOCYTE BIOL, V95, P797, DOI 10.1189/jlb.0613345; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thomas JR, 2021, J EXP MED, V218, DOI 10.1084/jem.20200891; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Utz SG, 2020, CELL, V181, P557, DOI 10.1016/j.cell.2020.03.021; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang Y, 2020, ELIFE, V9, DOI 10.7554/eLife.57438; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yuan Z. -Y., 2014, HIGH INFILTRATION TU; Zhao XX, 2017, ONCOTARGET, V8, P30576, DOI 10.18632/oncotarget.15736; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	83	24	24	31	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1189	+		10.1016/j.cell.2022.02.021	http://dx.doi.org/10.1016/j.cell.2022.02.021			45	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0V1VT	35325594				2022-12-28	WOS:000788133700001
J	Welch, B; Coe, D; Diego, JM; Zitrin, A; Zackrisson, E; Dimauro, P; Jimenez-Teja, Y; Kelly, P; Mahler, G; Oguri, M; Timmes, FX; Windhorst, R; Florian, M; de Mink, SE; Avila, RJ; Anderson, J; Bradley, L; Sharon, K; Vikaeus, A; McCandliss, S; Bradac, M; Rigby, J; Frye, B; Toft, S; Strait, V; Trenti, M; Sharma, S; Andrade-Santos, F; Broadhurst, T				Welch, Brian; Coe, Dan; Diego, Jose M.; Zitrin, Adi; Zackrisson, Erik; Dimauro, Paola; Jimenez-Teja, Yolanda; Kelly, Patrick; Mahler, Guillaume; Oguri, Masamune; Timmes, F. X.; Windhorst, Rogier; Florian, Michael; de Mink, S. E.; Avila, Roberto J.; Anderson, Jay; Bradley, Larry; Sharon, Keren; Vikaeus, Anton; McCandliss, Stephan; Bradac, Marusa; Rigby, Jane; Frye, Brenda; Toft, Sune; Strait, Victoria; Trenti, Michele; Sharma, Soniya; Andrade-Santos, Felipe; Broadhurst, Tom			A highly magnified star at redshift 6.2	NATURE			English	Article							MASS-DISTRIBUTION; GALAXIES; STELLAR; RELICS; EVOLUTION; PHOTOMETRY; SPECTRUM	Galaxy clusters magnify background objects through strong gravitational lensing. Typical magnifications for lensed galaxies are factors of a few but can also be as high as tens or hundreds, stretching galaxies into giant arcs(1,2). Individual stars can attain even higher magnifications given fortuitous alignment with the lensing cluster. Recently, several individual stars at redshifts between approximately 1 and 1.5 have been discovered, magnified by factors of thousands, temporarily boosted by microlensing(3-6). Here we report observations of a more distant and persistent magnified star at a redshift of 6.2 +/- 0.1, 900 million years after the Big Bang. This star is magnified by a factor of thousands by the foreground galaxy cluster lens WHL0137-08 (redshift 0.566), as estimated by four independent lens models. Unlike previous lensed stars, the magnification and observed brightness (AB magnitude, 27.2) have remained roughly constant over 3.5 years of imaging and follow-up. The delensed absolute UV magnitude, -10 +/- 2, is consistent with a star of mass greater than 50 times the mass of the Sun. Confirmation and spectral classification are forthcoming from approved observations with the James Webb Space Telescope.	[Welch, Brian; Coe, Dan; McCandliss, Stephan] Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; [Coe, Dan; Avila, Roberto J.; Anderson, Jay; Bradley, Larry] Space Telescope Sci Inst STScI, Baltimore, MD USA; [Coe, Dan] Assoc Univ Res Astron Aura European Space Agcy ES, STScI, Baltimore, MD USA; [Diego, Jose M.] Inst Fis Cantabria CSIC UC, Santander, Spain; [Zitrin, Adi] Ben Gurion Univ Negev, Phys Dept, Beer Sheva, Israel; [Zackrisson, Erik; Vikaeus, Anton] Uppsala Univ, Dept Phys & Astron, Observat Astrophys, Uppsala, Sweden; [Dimauro, Paola] Minist Ciencia, Tecnol, Inovacaoe Comunicacoes, Observ Nacl, Rio De Janeiro, Brazil; [Jimenez-Teja, Yolanda] Inst Astrofis Andalucia, Granada, Spain; [Kelly, Patrick] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Mahler, Guillaume; Sharon, Keren] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Mahler, Guillaume] Univ Durham, Inst Computat Cosmol, Durham, England; [Mahler, Guillaume] Univ Durham, Ctr Extragalact Astron, Durham, England; [Oguri, Masamune] Univ Tokyo, Res Ctr Early Universe, Tokyo, Japan; [Oguri, Masamune] Chiba Univ, Ctr Frontier Sci, Chiba, Japan; [Oguri, Masamune] Univ Tokyo, Kavli Inst Phys & Math Universe Kavli IPMU, WPI, Chiba, Japan; [Timmes, F. X.; Windhorst, Rogier] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Timmes, F. X.] Joint Inst Nucl Astrophys Ctr Evolut Elements, Tempe, AZ USA; [Florian, Michael; Frye, Brenda] Univ Arizona, Steward Observ, Dept Astron, Tucson, AZ USA; [de Mink, S. E.] Max Planck Inst Astrophys, Garching, Germany; [de Mink, S. E.] Univ Amsterdam, Anton Pannekoek Inst Astron, GRAPPA, Amsterdam, Netherlands; [de Mink, S. E.; Andrade-Santos, Felipe] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA USA; [Bradac, Marusa; Strait, Victoria] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Rigby, Jane; Sharma, Soniya] NASA, Observat Cosmol Lab, Goddard Space Flight Ctr, Greenbelt, MD USA; [Toft, Sune; Strait, Victoria] Cosm Dawn Ctr DAWN, Copenhagen, Denmark; [Toft, Sune; Strait, Victoria] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Trenti, Michele] Univ Melbourne, Sch Phys, Parkville, Vic, Australia; [Trenti, Michele] Univ Melbourne, ARC Ctr Excellence All Sky Astrophys 3 Dimens, Parkville, Vic, Australia; [Andrade-Santos, Felipe] Dexter Southfield, Clay Ctr Observ, Brookline, MA USA; [Broadhurst, Tom] Univ Basque Country UPV EHU, Dept Theoret Phys, Bilbao, Spain; [Broadhurst, Tom] Donostia Int Phys Ctr DIPC, Donostia San Sebastian, Spain; [Broadhurst, Tom] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Johns Hopkins University; Space Telescope Science Institute; Space Telescope Science Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); Ben Gurion University; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; Durham University; Durham University; University of Tokyo; Chiba University; University of Tokyo; Arizona State University; Arizona State University-Tempe; University of Arizona; Max Planck Society; University of Amsterdam; Smithsonian Institution; University of California System; University of California Davis; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Copenhagen; Niels Bohr Institute; University of Melbourne; University of Melbourne; University of Basque Country; Basque Foundation for Science	Welch, B (corresponding author), Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA.	bwelch7@jhu.edu	Oguri, Masamune/C-6230-2011; Diego, Jose/I-2511-2015	Dimauro, Paola/0000-0001-7399-2854; McCandliss, Stephan/0000-0003-0503-4667; Toft, Sune/0000-0003-3631-7176; Mahler, Guillaume/0000-0003-3266-2001; Diego, Jose/0000-0001-9065-3926; Bradley, Larry/0000-0002-7908-9284; Oguri, Masamune/0000-0003-3484-399X; Welch, Brian/0000-0003-1815-0114	NASA/ESA Hubble Space Telescope (HST) [GO14096, GO15842]; NASA [NAS5-26555, NAS5-32864]; MCIU/AEI/MINECO/FEDER, UE [PGC2018-101814-B-100]; Maria de Maeztu [MDM-2017-0765]; Ministry of Science and Technology, Israel; NASA JWST Interdisciplinary Scientist grants from GSFC [NNX14AN10G, 80NSSC18K0200]; World Premier International Research Center Initiative, MEXT, Japan; JSPS KAKENHI [JP20H00181, JP20H05856, JP18K03693]; European Union [MARACAS - DLV-896778, 898633]; NSF [AST-1908823]; State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa' [SEV-2017-0709]; Danish National Research Foundation [140]	NASA/ESA Hubble Space Telescope (HST)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); MCIU/AEI/MINECO/FEDER, UE; Maria de Maeztu; Ministry of Science and Technology, Israel(Ministry of Science, Technology and Space (MOST), Israel); NASA JWST Interdisciplinary Scientist grants from GSFC; World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Union(European Commission); NSF(National Science Foundation (NSF)); State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa'(Spanish Government); Danish National Research Foundation(Danmarks Grundforskningsfond)	The RELICS Hubble Treasury Program (GO14096) and follow-up programme (GO15842) consist of observations obtained by the NASA/ESA Hubble Space Telescope (HST). Data from these HST programmes were obtained from the Mikulski Archive for Space Telescopes (MAST), operated by the Space Telescope Science Institute (STScI). Both HST and STScI are operated by the Association of Universities for Research in Astronomy, Inc. (AURA), under NASA contract NAS5-26555. The HST Advanced Camera for Surveys (ACS) was developed under NASA contract NAS5-32864. J.M.D. acknowledges the support of project PGC2018-101814-B-100 (MCIU/AEI/MINECO/FEDER, UE) and Maria de Maeztu, ref. MDM-2017-0765. A.Z. acknowledges support from the Ministry of Science and Technology, Israel. R.W. acknowledges support from NASA JWST Interdisciplinary Scientist grants NAG5-12460, NNX14AN10G and 80NSSC18K0200 from GSFC. E.Z. and A.V. acknowledge funding from the Swedish National Space Board. M.O. acknowledges support from World Premier International Research Center Initiative, MEXT, Japan, and JSPS KAKENHI grant numbers JP20H00181, JP20H05856, JP18K03693. G.M. received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement no. MARACAS - DLV-896778. P.K. acknowledges support from NSF AST-1908823. Y.J.-T. acknowledges financial support from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement no. 898633, and from the State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa' award to the Instituto de Astrofisica de Andalucia (SEV-2017-0709). The Cosmic DAWN Center is funded by the Danish National Research Foundation under grant no. 140.	Abbott BP, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.101102; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525823; Alam S, 2015, ASTROPHYS J SUPPL S, V219, DOI 10.1088/0067-0049/219/1/12; Behrendt M, 2019, MON NOT R ASTRON SOC, V488, P306, DOI 10.1093/mnras/stz1717; Benitez N, 2000, ASTROPHYS J, V536, P571, DOI 10.1086/308947; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bouwens R. J., 2017, PREPRINT; Broadhurst T, 2005, ASTROPHYS J, V621, P53, DOI 10.1086/426494; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Calzetti D, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/75; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Carnall AC, 2018, MON NOT R ASTRON SOC, V480, P4379, DOI 10.1093/mnras/sty2169; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chen WL, 2019, ASTROPHYS J, V881, DOI 10.3847/1538-4357/ab297d; Coe D, 2006, ASTRON J, V132, P926, DOI 10.1086/505530; Coe D, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab412b; da Silva RL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/145; Dai L., 2021, PREPRINT; Dai L., 2021, MNRAS, V501, P5538, DOI [10.1093/mnras/stab017, DOI 10.1093/MNRAS/STAB017]; Diego JM, 2007, MON NOT R ASTRON SOC, V375, P958, DOI 10.1111/j.1365-2966.2007.11380.x; Diego JM, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201833670; Diego JM, 2005, MON NOT R ASTRON SOC, V360, P477, DOI 10.1111/j.1365-2966.2005.09021.x; Diego JM, 2018, ASTROPHYS J, V857, DOI 10.3847/1538-4357/aab617; El-Badry K, 2019, MON NOT R ASTRON SOC, V489, P5822, DOI 10.1093/mnras/stz2480; Eldridge JJ, 2017, PUBL ASTRON SOC AUST, V34, DOI 10.1017/pasa.2017.51; Eliasdottir A., 2007, PREPRINT; Ellis RS, 1997, ASTROPHYS J, V483, P582, DOI 10.1086/304261; Farrell E, 2021, MON NOT R ASTRON SOC, V502, pL40, DOI 10.1093/mnrasl/slaa196; Ferland GJ, 2017, REV MEX ASTRON ASTR, V53, P385; Figer DF, 1999, ASTROPHYS J, V514, P202, DOI 10.1086/306931; Hainline KN, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/31; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Holwerda BW, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/77; Jimenez-Teja Y, 2021, ASTROPHYS J, V922, DOI 10.3847/1538-4357/ac24a3; Johnson TL, 2017, ASTROPHYS J LETT, V843, DOI 10.3847/2041-8213/aa7516; Johnson TL, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa7756; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Jullo E, 2009, MON NOT R ASTRON SOC, V395, P1319, DOI 10.1111/j.1365-2966.2009.14654.x; Kaurov AA, 2019, ASTROPHYS J, V880, DOI 10.3847/1538-4357/ab2888; Kehrig C, 2018, MON NOT R ASTRON SOC, V480, P1081, DOI 10.1093/mnras/sty1920; Kelly PL, 2018, NAT ASTRON, V2, P334, DOI 10.1038/s41550-018-0430-3; Kinugawa T, 2021, MON NOT R ASTRON SOC, V501, pL49, DOI 10.1093/mnrasl/slaa191; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Krumholz MR, 2015, MON NOT R ASTRON SOC, V452, P1447, DOI 10.1093/mnras/stv1374; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Lejeune T, 1997, ASTRON ASTROPHYS SUP, V125, P229, DOI 10.1051/aas:1997373; Limousin M, 2005, MON NOT R ASTRON SOC, V356, P309, DOI 10.1111/j.1365-2966.2004.08449.x; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Meneghetti M, 2017, MON NOT R ASTRON SOC, V472, P3177, DOI 10.1093/mnras/stx2064; Moe M, 2017, ASTROPHYS J SUPPL S, V230, DOI 10.3847/1538-4365/aa6fb6; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Oguri M, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.023518; Oguri M, 2010, PUBL ASTRON SOC JPN, V62, P1017, DOI 10.1093/pasj/62.4.1017; Portegies Zwart S, 2010, ANNU REV ASTRON ASTR, V48, P431, DOI 10.1146/annurev-astro-081309-130834; Rivera-Thorsen TE, 2017, ASTRON ASTROPHYS, V608, DOI 10.1051/0004-6361/201732173; Rivera-Thorsen TE, 2019, SCIENCE, V366, P738, DOI 10.1126/science.aaw0978; Rodney SA, 2018, NAT ASTRON, V2, P324, DOI 10.1038/s41550-018-0405-4; Salmon B, 2020, ASTROPHYS J, V889, DOI 10.3847/1538-4357/ab5a8b; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Sana H, 2014, ASTROPHYS J SUPPL S, V215, DOI 10.1088/0067-0049/215/1/15; Sana H, 2012, SCIENCE, V337, P444, DOI 10.1126/science.1223344; Sanyal D, 2015, ASTRON ASTROPHYS, V580; Sarmento R, 2019, ASTROPHYS J, V871, DOI 10.3847/1538-4357/aafa1a; Sarmento R, 2018, ASTROPHYS J, V854, DOI 10.3847/1538-4357/aa989a; Shimizu I, 2016, MON NOT R ASTRON SOC, V461, P3563, DOI 10.1093/mnras/stw1423; Spera M, 2015, MON NOT R ASTRON SOC, V451, P4086, DOI 10.1093/mnras/stv1161; Stanford SA, 1998, ASTROPHYS J, V492, P461, DOI 10.1086/305050; Strait V, 2021, ASTROPHYS J, V910, DOI 10.3847/1538-4357/abe533; SUNYAEV RA, 1970, ASTROPHYS SPACE SCI, V7, P3; Szecsi D, 2022, ASTRON ASTROPHYS, V658, DOI 10.1051/0004-6361/202141536; Trenti M, 2009, ASTROPHYS J, V700, P1672, DOI 10.1088/0004-637X/700/2/1672; Vanzella E, 2020, MON NOT R ASTRON SOC, V494, pL81, DOI 10.1093/mnrasl/slaa041; Vanzella E, 2019, MON NOT R ASTRON SOC, V483, P3618, DOI 10.1093/mnras/sty3311; Venumadhav T, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa9575; Wen ZL, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/178; Wen ZL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/34; Windhorst RA, 2018, ASTROPHYS J SUPPL S, V234, DOI 10.3847/1538-4365/aaa760; Zdziarski AA, 2004, PROG THEOR PHYS SUPP, P99; Zitrin A, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/44; Zitrin A, 2009, MON NOT R ASTRON SOC, V396, P1985, DOI 10.1111/j.1365-2966.2009.14899.x	82	18	18	5	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					815	+		10.1038/s41586-022-04449-y	http://dx.doi.org/10.1038/s41586-022-04449-y			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354998	Green Submitted			2022-12-28	WOS:000776361600025
J	Abbasi, J				Abbasi, Jennifer			Pushed to Their Limits, 1 in 5 Physicians Intends to Leave Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item; Early Access								This Medical News article discusses burnout, financial stressors, and other factors driving physicians out of medicine during COVID-19.											0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.5074	http://dx.doi.org/10.1001/jama.2022.5074		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9DJ	35353134				2022-12-28	WOS:000776972600001
J	Jones, H				Jones, Helen			Why I ... am a DJ	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o647	10.1136/bmj.o647	http://dx.doi.org/10.1136/bmj.o647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351806	Bronze			2022-12-28	WOS:000779544800003
J	Schweighauser, M; Arseni, D; Huang, M; Lovestam, S; Shi, Y; Yang, Y; Zhang, WJ; Kotecha, A; Garringer, HJ; Vidal, R; Hallinan, GI; Newell, KL; Tarutani, A; Murayama, S; Miyazaki, M; Saito, Y; Yoshida, M; Hasegawa, K; Lashley, T; Revesz, T; Kovacs, GG; van Swieten, J; Takao, M; Hasegawa, M; Ghetti, B; Falcon, B; Murzin, AG; Goedert, M; Scheres, SHW; Spillantini, MG				Schweighauser, Manuel; Arseni, Diana; Huang, Melissa; Lovestam, Sofia; Shi, Yang; Yang, Yang; Zhang, Wenjuan; Kotecha, Abhay; Garringer, Holly J.; Vidal, Ruben; Hallinan, Grace, I; Newell, Kathy L.; Tarutani, Airi; Murayama, Shigeo; Miyazaki, Masayuki; Saito, Yuko; Yoshida, Mari; Hasegawa, Kazuko; Lashley, Tammaryn; Revesz, Tamas; Kovacs, Gabor G.; van Swieten, John; Takao, Masaki; Hasegawa, Masato; Ghetti, Bernardino; Falcon, Benjamin; Murzin, Alexey G.; Goedert, Michel; Scheres, Sjors H. W.; Spillantini, Maria Grazia			Age-dependent formation of TMEM106B amyloid filaments in human brains	NATURE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; CRYO-EM STRUCTURES; PROTEIN; ALZHEIMERS; TAU; EXPRESSION; RESOLUTION; VARIANTS; DEMENTIA; ONSET	Many age-dependent neurodegenerative diseases, such as Alzheimer's and Parkinson's, are characterized by abundant inclusions of amyloid filaments. Filamentous inclusions of the proteins tau, amyloid-beta, alpha-synuclein and transactive response DNA-binding protein (TARDBP; also known as TDP-43) are the most common(1,2). Here we used structure determination by cryogenic electron microscopy to show that residues 120-254 of the lysosomal type II transmembrane protein 106B (TMEM106B) also form amyloid filaments in human brains. We determined the structures of TMEM106B filaments from a number of brain regions of 22 individuals with abundant amyloid deposits, including those resulting from sporadic and inherited tauopathies, amyloid-beta amyloidoses, synucleinopathies and TDP-43 proteinopathies, as well as from the frontal cortex of 3 individuals with normal neurology and no or only a few amyloid deposits. We observed three TMEM106B folds, with no clear relationships between folds and diseases. TMEM106B filaments correlated with the presence of a 29-kDa sarkosyl-insoluble fragment and globular cytoplasmic inclusions, as detected by an antibody specific to the carboxy-terminal region of TMEM106B. The identification of TMEM106B filaments in the brains of older, but not younger, individuals with normal neurology indicates that they form in an age-dependent manner.	[Schweighauser, Manuel; Arseni, Diana; Lovestam, Sofia; Shi, Yang; Yang, Yang; Zhang, Wenjuan; Falcon, Benjamin; Murzin, Alexey G.; Goedert, Michel; Scheres, Sjors H. W.] MRC, Lab Mol Biol, Cambridge, England; [Huang, Melissa; Spillantini, Maria Grazia] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Kotecha, Abhay] Thermo Fisher Sci, Eindhoven, Netherlands; [Garringer, Holly J.; Vidal, Ruben; Hallinan, Grace, I; Newell, Kathy L.; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Tarutani, Airi; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Brain & Neurosci, Tokyo, Japan; [Murayama, Shigeo] Univ Osaka, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka, Japan; [Miyazaki, Masayuki] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Saito, Yuko] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo, Japan; [Saito, Yuko] Inst Gerontol, Tokyo, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Nagakute, Aichi, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Div Neurol, Sagamihara, Kanagawa, Japan; [Lashley, Tammaryn; Revesz, Tamas] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Lashley, Tammaryn; Revesz, Tamas] UCL Queen Sq Inst Neurol, Queen Sq Brain Bank Neurol Disorders, London, England; [Kovacs, Gabor G.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Kovacs, Gabor G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [van Swieten, John] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Takao, Masaki] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Clin Lab, Tokyo, Japan; [Takao, Masaki] Mihara Mem Hosp, Dept Neurol, Isesaki, Japan; [Zhang, Wenjuan] UCL, Inst Prion Dis, Prion Unit, MRC, London, England	MRC Laboratory Molecular Biology; University of Cambridge; Thermo Fisher Scientific; Indiana University System; Indiana University Bloomington; Tokyo Metropolitan Institute of Medical Science; Osaka University; National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology; Aichi Medical University; University of London; University College London; University of London; University College London; University of Toronto; University of Toronto; Medical University of Vienna; Erasmus University Rotterdam; Erasmus MC; National Center for Neurology & Psychiatry - Japan; University of London; University College London	Goedert, M; Scheres, SHW (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	mg@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk	Kovacs, Gabor/A-7468-2013; Tarutani, Airi/AAU-7462-2021	Kovacs, Gabor/0000-0003-3841-5511; Shi, Yang/0000-0003-1579-7561; Schweighauser, Manuel/0000-0002-1848-1610; Arseni, Diana/0000-0001-7585-288X; Kotecha, Abhay/0000-0002-4480-5439; Zhang, Wenjuan/0000-0002-3011-9956; Huang, Melissa/0000-0002-0698-6996; Lashley, Tammaryn/0000-0001-7389-0348; Yang, Yang/0000-0003-2238-6437; Garringer, Holly/0000-0002-1899-7676	Wellcome Trust [EM17434-75, BI23268-49]; MRC [EM17434-75, BI23268-49, MC_UP_120/25, MC_U105184291, MC_UP_A025_1013]; BBSRC [EM17434-75, BI23268-49]; EU/EFPIA/Innovative Medicines Initiative [2] Joint Undertaking IMPRiND [116060]; Japan Agency for Science and Technology (Crest) [JPMJCR18H3]; Japan Agency for Medical Research and Development (AMED) [JP20dm0207072, JP21wm0425019]; Japan Society for the Promotion of Science (JSPS, Kakenhi) [21K06417]; US National Institutes of Health [P30-AG010133, UO1-NS110437, RF1-AG071177]; Department of Pathology, Indiana University School of Medicine; Laboratory Medicine, Indiana University School of Medicine; NIHR Cambridge Biomedical Research Centre; Safra Foundation; Rossy Foundation; National Institute for Health Research Queen Square Biomedical Research Unit in Dementia; National Center of Neurology and Psychiatry; Alzheimer's Research UK Senior Fellowship; Reta Lila Weston Institute for Neurological Studies	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU/EFPIA/Innovative Medicines Initiative [2] Joint Undertaking IMPRiND; Japan Agency for Science and Technology (Crest); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS, Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Indiana University School of Medicine; Laboratory Medicine, Indiana University School of Medicine; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Safra Foundation; Rossy Foundation; National Institute for Health Research Queen Square Biomedical Research Unit in Dementia; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Alzheimer's Research UK Senior Fellowship; Reta Lila Weston Institute for Neurological Studies	We thank the patients' families for donating brain tissues; U.Kuederli, M.Jacobsen, F.Epperson and R. M.Richardson for human brain collection and technical support; E.Gelpi for preparing brain samples from the ARTAG case; T.Darling and J.Grimmett for help with high-performance computing; M. Arai, T. Katsinelos and N. Obata for help with genotyping; I.Lavenir and J.A.Macdonald for helpful discussions; the EM facility of the Medical Research Council (MRC) Laboratory of Molecular Biology for help with cryo-EM data acquisition; the Edinburgh Brain and Tissue Bank, which is supported by the MRC, for providing brain samples of controls with normal neurology. We acknowledge Diamond Light Source for access and support of the cryo-EM facilities at the UK's national Electron Bio-imaging Centre (under proposals EM17434-75 and BI23268-49), funded by the Wellcome Trust, MRC and BBSRC. This work was supported by the MRC (MC_UP_120/25 to B.R.-F., MC_U105184291 to M.G., and MC_UP_A025_1013 to S.H.W.S.), the EU/EFPIA/Innovative Medicines Initiative [2] Joint Undertaking IMPRiND (project 116060, to M.G. and M.G.S.), the Japan Agency for Science and Technology (Crest, JPMJCR18H3, to M. Hasegawa.), the Japan Agency for Medical Research and Development (AMED, JP20dm0207072, to M. Hasegawa., and AMED, JP21wm0425019, to M.T.), the Japan Society for the Promotion of Science (JSPS, Kakenhi 21K06417, to M.T.), the US National Institutes of Health (P30-AG010133, UO1-NS110437 and RF1-AG071177, to R.V. and B.G.) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (to R.V., K.L.N. and B.G.). M.G.S. was supported by the NIHR Cambridge Biomedical Research Centre. G.G.K. was supported by the Safra Foundation and the Rossy Foundation. T.R. was supported by the National Institute for Health Research Queen Square Biomedical Research Unit in Dementia. M.T. was supported by intramural funds from the National Center of Neurology and Psychiatry. T.L. holds an Alzheimer's Research UK Senior Fellowship. The Queen Square Brain Bank is supported by the Reta Lila Weston Institute for Neurological Studies. For the purpose of Open Access, the authors have applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission.	Arseni D, 2022, NATURE, V601, P139, DOI 10.1038/s41586-021-04199-3; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Busch JI, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-36; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Feng TC, 2021, ACTA NEUROPATHOL, V141, P327, DOI 10.1007/s00401-020-02246-3; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Li ZR, 2020, ACTA NEUROPATHOL, V139, P45, DOI 10.1007/s00401-019-02066-0; Nicholson AM, 2016, ACTA NEUROPATHOL, V132, P639, DOI 10.1007/s00401-016-1610-9; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Peng C, 2020, NAT REV NEUROL, V16, P199, DOI 10.1038/s41582-020-0333-7; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Satoh JI, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt247; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Shi Y, 2021, NATURE, V598, P359, DOI 10.1038/s41586-021-03911-7; Takao M, 2004, BRAIN PATHOL, V14, P137, DOI 10.1111/j.1750-3639.2004.tb00046.x; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Yang Y, 2022, SCIENCE, V375, P167, DOI 10.1126/science.abm7285; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	41	14	14	21	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2022	605	7909					310	+		10.1038/s41586-022-04650-z	http://dx.doi.org/10.1038/s41586-022-04650-z		MAR 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D7UZ	35344985	hybrid, Green Published			2022-12-28	WOS:000790749300001
J	Wise, J				Wise, Jacqui			Lasting cough could be TB, warns UK agency as cases rise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		UKHSA, 2022, TUB ENGL NATL QUART; WHO, 2022, WHO CONS GUID TUB MA	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o791	10.1136/bmj.o791	http://dx.doi.org/10.1136/bmj.o791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331985				2022-12-28	WOS:000778460100002
J	Yamey, G; Garcia, P; Hassan, F; Mao, WH; McDade, KK; Pai, M; Saha, S; Schellekens, P; Taylor, A; Udayakumar, K				Yamey, Gavin; Garcia, Patricia; Hassan, Fatima; Mao, Wenhui; McDade, Kaci Kennedy; Pai, Madhukar; Saha, Senjuti; Schellekens, Philip; Taylor, Andrea; Udayakumar, Krishna			It is not too late to achieve global covid-19 vaccine equity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yamey, Gavin; Mao, Wenhui; McDade, Kaci Kennedy] Duke Univ, Ctr Policy Impact Global Hlth, Duke Global Hlth Inst, Durham, NC 27708 USA; [Garcia, Patricia] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Hassan, Fatima] Hlth Justice Initiat, Cape Town, South Africa; [Pai, Madhukar] McGill Univ, Sch Populat & Global Hlth, Montreal, PQ, Canada; [Saha, Senjuti] Child Hlth Res Fdn, Dhaka, Bangladesh; [Schellekens, Philip] World Bank Grp IFC, Washington, DC USA; [Taylor, Andrea; Udayakumar, Krishna] Duke Univ, Duke Global Hlth Inst, Duke Global Hlth Innovat Ctr, Durham, NC USA	Duke University; Universidad Peruana Cayetano Heredia; McGill University; Duke University	Yamey, G (corresponding author), Duke Univ, Ctr Policy Impact Global Hlth, Duke Global Hlth Inst, Durham, NC 27708 USA.	gavin.yamey@duke.edu						Andersen H, 2021, GLOBAL COST VACCINE; [Anonymous], 2022, GUID ADM COVID 19 VA; [Anonymous], ELPAIS 0113; Assis R, 2021, BIORVIX, V2021, DOI [10.1101/2021.04.15.440089, DOI 10.1101/2021.04.15.440089]; Bilinski A, MODEL BASED ESTIMATE, V2022, DOI [10.1101/2022.02.08.22270465v1, DOI 10.1101/2022.02.08.22270465V1]; Boyer B, 2021, AIRPORTS ARMS NEW IN; Bozio CH., LAB CONFIRMED COVID; Burger L, 2022, REUTERS 0216; Byanyima W., 2021, GUARDIAN 0229; Cakmakli C., 2021, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w28395; Cascini F, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101113; Cavanaugh A. M., 2021, REDUCED RISK REINFEC; Chhibber A, LANCET REG HLTH AM, V2022; Counter-terrorism Committee Executive Directorate, 2021, J POLICING INTELLIGE, DOI DOI 10.1080/18335330.2021.1923786; Craven Jeff, 2022, COVID 19 VACCINE TRA; Duke Global Health Innovation Center, VACC MAN LAUNCH SCAL; Duke Global Health Innovation Center, VACC PURCH LAUNCH SC; Glassman A., 2022, COVID 19 VACCINE DEV; Goldhill O, 2021, STAT NEWS; Gopinath G, 2022, IMG BLOG 0309; Guarascio F, 2022, REUTERS 0614; Kavanagh K, INFECT CONTROL TODAY, V2021; Khandekar A., 2022, MODERNA SET MRNA VAC; Mallapaty S, 2022, NATURE, V601, P174, DOI 10.1038/d41586-021-03830-7; Mao WH, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003675; Mutombo PN, 2022, LANCET GLOB HEALTH, V10, pE320, DOI 10.1016/S2214-109X(21)00563-5; Payne D., 2022, POLITICO; Phelan AL, 2020, LANCET, V396, P800, DOI 10.1016/S0140-6736(20)31873-0; Ritchie H., CORONAVIRUS VACCINAT; Roelf W., 2022, REUTERS 0119; Roltgen K, CELL, V2022; Rosati A, 2021, BLOOMBERG; Saelee R., 2022, DISPARITIES COVID 19; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Schellekens P., 2021, COVID 19 IS DEVELOPI; Schnirring L., 2022, CIDRAP NEWS 0218; Sheel M, 2022, LANCET REG HEALTH-W, V18, DOI 10.1016/j.lanwpc.2021.100366; Sung M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101183; Tseng HF, 2022, NAT MED, V28, P1063, DOI 10.1038/s41591-022-01753-y; UNDP Data Futures Platform, IMP VACC IN EC REC; UNICEF, COV 19 VACC MARK DAS; Usher AD, 2021, LANCET, V397, P2322, DOI 10.1016/S0140-6736(21)01367-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO Strategic Advisory Group of Experts on Immunization updates recommendations on boosters, 2022, COVID 19 VACC CHILDR; World Health Organization, S AFR MRNA HUB PROGR; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Yamey G, 2021, NATURE, V590, P529, DOI 10.1038/d41586-021-00470-9	47	22	22	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								e070650	10.1136/bmj-2022-070650	http://dx.doi.org/10.1136/bmj-2022-070650			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331982	hybrid, Green Published			2022-12-28	WOS:000778460100009
J	Benard-Laribiere, A; Hucteau, E; Debette, S; Kirchgesner, J; Bezin, J; Pariente, A				Benard-Laribiere, Anne; Hucteau, Emilie; Debette, Stephanie; Kirchgesner, Julien; Bezin, Julien; Pariente, Antoine			Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIPSYCHOTICS	OBJECTIVE To estimate the risk of ischaemic stroke associated with antidopaminergic antiemetic (ADA) use. DESIGN Case-time-control study. SETTING Data from the nationwide French reimbursement healthcare system database Systeme National des Donnees de Sante (SNDS). PARTICIPANTS Eligible participants were a18 years with a first ischaemic stroke between 2012 and 2016 and at least one reimbursement for any ADA in the 70 days before stroke. Frequencies of ADA reimbursements were compared for a risk period (days-14 to-1 before stroke) and three matched reference periods (days-70 to-57,-56 to-43, and-42 to-29) for each patient. Time trend of ADA use was controlled by using a control group of 21 859 randomly selected people free of the event who were individually matched to patients with stroke according to age, sex, and risk factors of ischaemic stroke. MAIN OUTCOME MEASURES Association between ADA use and risk of ischaemic stroke was assessed by estimating the ratio of the odds ratios of exposure evaluated in patients with stroke and in controls. Analyses were adjusted for time varying confounders (anticoagulants, antiplatelets, and prothrombotic or vasoconstrictive drugs). RESULTS Among the 2612 patients identified with incident stroke, 1250 received an ADA in the risk period and 1060 in the reference periods. The comparison with the 5128 and 13 165 controls who received an ADA in the same periods yielded a ratio of adjusted odds ratios of 3.12 (95% confidence interval 2.85 to 3.42). Analyses stratified by age, sex, and history of dementia showed similar results. Ratio of adjusted odds ratios for analyses stratified by ADA was 2.51 (2.18 to 2.88) for domperidone, 3.62 (3.11 to 4.23) for metopimazine, and 3.53 (2.62 to 4.76) for metoclopramide. Sensitivity analyses suggested the risk would be higher in the first days of use. CONCLUSIONS Using French nationwide exhaustive reimbursement data, this self-controlled study reported an increased risk of ischaemic stroke with recent ADA use. The highest increase was found for metopimazine and metoclopramide.	[Benard-Laribiere, Anne; Hucteau, Emilie; Bezin, Julien; Pariente, Antoine] Univ Bordeaux, INSERM, BPH, Team Pharmacoepidemiobgy,U1219, Bordeaux, France; [Debette, Stephanie] Univ Bordeaux, Team Vasc & Neurol Dis Integrat & Genet Epidemiol, INSERM, U1219,BPH, Bordeaux, France; [Debette, Stephanie] CHU Bordeaux, Dept Neurol, Bordeaux, France; [Kirchgesner, Julien] Sorbonne Univ, Hop St Antoine, AP HP, Dept Gastroenterol,INSERM,Inst Pierre Louis Epide, Paris, France; [Bezin, Julien; Pariente, Antoine] CHU Bordeaux, Clin Pharmacol Unit, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux	Benard-Laribiere, A (corresponding author), Hop Pellegrin, Serv Pharmacol Med, Bordeaux, France.	anne.benard@u-bordeaux.fr	debette, stephanie/T-4946-2019	debette, stephanie/0000-0001-8675-7968	French Medicines Agency (Agence Nationale de Securite du Medicament et des Produits de Sante, ANSM) [2019S015]; Health Product Epidemiology Scientific Interest Group (EPI-PHARE)	French Medicines Agency (Agence Nationale de Securite du Medicament et des Produits de Sante, ANSM)(French National Research Agency (ANR)); Health Product Epidemiology Scientific Interest Group (EPI-PHARE)	This work was supported by the French Medicines Agency (Agence Nationale de Securite du Medicament et des Produits de Sante, ANSM; grant No 2019S015) in the context of a partnership with the Health Product Epidemiology Scientific Interest Group (EPI-PHARE). The present study is part of the Drugs Systematized Assessment in Real-life Environment (DRUGS-SAFER) research programme. This programme aims at providing an integrated system allowing the concomitant monitoring of drug use and safety in France. The potential impact of drugs, frailty of populations and seriousness of risks drive the research programme. The French Medicines Agency played no role in the study design, conduct, and results interpretation or discussion. This publication represents the views of the authors and does not necessarily represent the opinion of the French Medicines Agency.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; De Bandt D, 2021, PHARMACOEPIDEM DR S, V30, P418, DOI 10.1002/pds.5170; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Fernandez-Seara MA, 2011, BRIT J PHARMACOL, V163, P1639, DOI 10.1111/j.1476-5381.2010.01161.x; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Giroud M, 2015, EUR NEUROL, V74, P92, DOI 10.1159/000438859; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Paciaroni M, 2003, EUR J NEUROL, V10, P361, DOI 10.1046/j.1468-1331.2003.00646.x; Reseau Sentinelles, HISTORIQUE EPIDEMIES; Roussel V, 2013, PHARMACOEPIDEM DR S, V22, P1080, DOI 10.1002/pds.3486; Sacchetti E, 2010, J PSYCHOPHARMACOL, V24, P1131, DOI 10.1177/0269881109103202; SUISSA S, 1995, EPIDEMIOLOGY, V6, P248, DOI 10.1097/00001648-199505000-00010; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Wang S, 2012, STROKE, V43, P28, DOI 10.1161/STROKEAHA.111.617191; Wu CS, 2013, BIOL PSYCHIAT, V73, P414, DOI 10.1016/j.biopsych.2012.07.006; Zerna C, 2018, LANCET, V392, P1247, DOI 10.1016/S0140-6736(18)31874-9	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								e066192	10.1136/bmj-2021-066192	http://dx.doi.org/10.1136/bmj-2021-066192			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321876	Green Published, hybrid			2022-12-28	WOS:000790072700017
J	White, AM; Castle, IJP; Powell, PA; Hingson, RW; Koob, GF				White, Aaron M.; Castle, I-Jen P.; Powell, Patricia A.; Hingson, Ralph W.; Koob, George F.			Alcohol-Related Deaths During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[White, Aaron M.; Castle, I-Jen P.; Powell, Patricia A.; Hingson, Ralph W.; Koob, George F.] NIAAA, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	White, AM (corresponding author), NIAAA, Off Director, NIH, 6700B Rockledge Dr, Bethesda, MD 20852 USA.	whitea4@mail.nih.gov						[Anonymous], OV DEATH RAT; Castle IJP, 2014, J STUD ALCOHOL DRUGS, V75, P299, DOI 10.15288/jsad.2014.75.299; Koob GF, 2020, AM J PSYCHIAT, V177, P1031, DOI 10.1176/appi.ajp.2020.20091375; Moon AM, 2021, HEPATOL COMMUN, V5, P1616, DOI 10.1002/hep4.1747; Sharma RA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0422; White AM, 2020, ALCOHOL CLIN EXP RES, V44, P178, DOI 10.1111/acer.14239	6	29	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2022	327	17					1704	1706		10.1001/jama.2022.4308	http://dx.doi.org/10.1001/jama.2022.4308		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D3AC	35302593	Bronze, Green Published			2022-12-28	WOS:000770396900001
J	Rhodes, F; Basu, A; Welch, E				Rhodes, Freya; Basu, Ayan; Welch, Ellen			Time for change: widening participation in the UKFPO foundation programme	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rhodes, Freya] Univ Sheffield, Sheffield, S Yorkshire, England; [Basu, Ayan] Barnet, London, England; [Welch, Ellen] Doctors Assoc UK, London, England	University of Sheffield	Rhodes, F (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.							[Anonymous], MORE UNDERGRADUATE M; [Anonymous], DISADVANTAGES FACED; Lok P, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o650; NHS Digital, THIS IS LAT COMP PUB	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o715	10.1136/bmj.o715	http://dx.doi.org/10.1136/bmj.o715			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301195	Bronze			2022-12-28	WOS:000796719200011
J	Preiser, W; Fish, T				Preiser, Wolfgang; Fish, Therese			Sisonke: reaching several goals together	LANCET			English	Editorial Material							HEALTH-CARE WORKERS		[Preiser, Wolfgang; Fish, Therese] Stellenbosch Univ, Fac Med & Hlth Sci, Tygerberg Campus, ZA-7505 Cape Town, South Africa	Stellenbosch University	Preiser, W (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Tygerberg Campus, ZA-7505 Cape Town, South Africa.	preiser@sun.ac.za	Preiser, Wolfgang/J-4875-2016	Preiser, Wolfgang/0000-0002-0254-7910				Bekker LG, 2022, LANCET, V399, P1141, DOI 10.1016/S0140-6736(22)00007-1; Goga A., 2021, MEDRXIV, DOI [10.1101/2021.12.21.21268171, DOI 10.1101/2021.12.21.21268171, 10.1101/ 2021.12.21.21268171]; Gray MBBCH G.E., 2021, MEDRXIV, DOI [10.1101/2021.12.28.21268436, DOI 10.1101/2021.12.28.21268436]; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Moodley K, 2021, SAMJ S AFR MED J, V111, P554, DOI [10.7196/SAMJ.2021.v111i6.15593, 10.7196/samj.2021.v111i6.15593]; Nunes MC, 2021, CLIN INFECT DIS, V73, P1896, DOI 10.1093/cid/ciab398; Reddy DL, 2021, SAMJ S AFR MED J, V111, P610, DOI 10.7196/SAMJ.2021.v111i7.15712; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Tegally H., 2021, RAPID REPLACEMENT BE, p2021.09.23.21264018, DOI [10.1101/2021.09.23.21264018, DOI 10.1101/2021.09.23.21264018]; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Venter WDF, 2021, SAMJ S AFR MED J, V111, DOI [10.7196/SAMJ.2021.v111i5.15716, 10.7196/samj.2021.v111i5.15716]; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1095	1097						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35305727	Bronze, Green Published			2022-12-28	WOS:000770814300004
J	Zhou, L; Maldonado, M; Padavannil, A; Guo, F; Letts, JA				Zhou, Long; Maldonado, Maria; Padavannil, Abhilash; Guo, Fei; Letts, James A.			Structures of Tetrahymena's respiratory chain reveal the diversity of eukaryotic core metabolism	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; COMPLEX I; BC(1) COMPLEX; PARACOCCUS-DENITRIFICANS; COUPLING MECHANISM; ASSEMBLY FACTORS; MITOCHONDRIAL; PROTEIN	Respiration is a core biological energy-converting process whose last steps are carried out by a chain of multisubunit complexes in the inner mitochondrial membrane. To probe the functional and structural diversity of eukaryotic respiration, we examined the respiratory chain of the ciliate Tetrahymena thermophila (Tt). Using cryo-electron microscopy on a mixed sample, we solved structures of a supercomplex between Tt complex I (Tt-CI) and Tt-CIII2 (Tt-SC I+III2) and a structure of Tt-CIV2. Tt-SC I+III2 (similar to 2.3 megadaltons) is a curved assembly with structural and functional symmetry breaking. Tt-CIV2 is a similar to 2.7-megadalton dimer with more than 50 subunits per protomer, including mitochondrial carriers and a TIM8(3)-TIM13(3)-like domain. Our structural and functional study of the T. thermophila respiratory chain reveals divergence in key components of eukaryotic respiration, thereby expanding our understanding of core metabolism.	[Zhou, Long] Zhejiang Univ, Dept Biophys, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310058, Peoples R China; [Zhou, Long] Zhejiang Univ, Dept Crit Care Med, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310058, Peoples R China; [Maldonado, Maria; Padavannil, Abhilash; Letts, James A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Guo, Fei] Univ Calif Davis, BIOEM Facil, Davis, CA 95616 USA	Zhejiang University; Zhejiang University; University of California System; University of California Davis; University of California System; University of California Davis	Letts, JA (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jaletts@ucdavis.edu		Letts, James/0000-0002-9864-3586; Maldonado, Maria/0000-0002-3428-1053	National Institute of General Medical Sciences [R35GM137929]; Zhejiang University School of Medicine [ZJU100]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Zhejiang University School of Medicine	Supported by National Institute of General Medical Sciences award R35GM137929. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Also supported by a ZJU100 Young Professor award from Zhejiang University School of Medicine (L.Z.).	Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Alvarez-Paggi D, 2013, J AM CHEM SOC, V135, P4389, DOI 10.1021/ja311786b; Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Gahura O, 2022, bioRxiv, DOI 10.1101/2021.10.10.463820; Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; BERGHUIS AM, 1994, J MOL BIOL, V235, P1326, DOI 10.1006/jmbi.1994.1086; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; Blum TB, 2019, P NATL ACAD SCI USA, V116, P4250, DOI 10.1073/pnas.1816556116; Brunk CF, 2003, NUCLEIC ACIDS RES, V31, P1673, DOI 10.1093/nar/gkg270; Brzezinski P, 2021, CHEM REV, V121, P9644, DOI 10.1021/acs.chemrev.1c00140; Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y; Cianfrocco M. A., 2017, PRACTICE EXPERIENCE, P13, DOI [10.1145/3093338.3093390, DOI 10.1145/3093338.3093390]; Cramer WA, 2011, BBA-BIOENERGETICS, V1807, P788, DOI 10.1016/j.bbabio.2011.02.006; Davies KM, 2018, P NATL ACAD SCI USA, V115, P3024, DOI 10.1073/pnas.1720702115; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; EICHEL HJ, 1956, J BIOL CHEM, V222, P121; Elurbe DM, 2016, BBA-BIOENERGETICS, V1857, P971, DOI 10.1016/j.bbabio.2016.03.027; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Evers F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23919-x; Flygaard RK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18993-6; Gahura O., 2021, BIORXIV; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Ghosh A, 2016, HUM MOL GENET, V25, P660, DOI 10.1093/hmg/ddv503; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; GUTIERREZ JC, 1992, DEV GENET, V13, P160, DOI 10.1002/dvg.1020130210; Hannibal L, 2016, BIOCHEMISTRY-US, V55, P407, DOI 10.1021/acs.biochem.5b01385; Hartley AM, 2019, NAT STRUCT MOL BIOL, V26, P78, DOI 10.1038/s41594-018-0172-z; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Ho CM, 2020, NAT METHODS, V17, P79, DOI 10.1038/s41592-019-0637-y; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang G, 2017, CELL REP, V20, P923, DOI 10.1016/j.celrep.2017.06.090; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KILPATRICK L, 1977, BIOCHIM BIOPHYS ACTA, V462, P515, DOI 10.1016/0005-2728(77)90098-6; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; Klusch N, 2021, PLANT CELL, V33, P2072, DOI 10.1093/plcell/koab092; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Koyama M, 2017, PROTEIN SCI, V26, P1870, DOI 10.1002/pro.3210; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Londer YY, 2011, METHODS MOL BIOL, V705, P123, DOI 10.1007/978-1-61737-967-3_8; Lu YW, 2017, MOL BIOL CELL, V28, P1489, DOI 10.1091/mbc.E17-03-0195; Lunetti P, 2016, J BIOL CHEM, V291, P19746, DOI 10.1074/jbc.M116.736876; Maclean AE, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009301; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maldonado M, 2021, ELIFE, V10, DOI 10.7554/eLife.62047; Maldonado M, 2020, ELIFE, V9, DOI 10.7554/eLife.56664; Malone LA, 2019, NATURE, V575, P535, DOI 10.1038/s41586-019-1746-6; Marechal A, 2020, P NATL ACAD SCI USA, V117, P9349, DOI 10.1073/pnas.2001572117; MITCHELL P, 1972, J BIOENERG, V3, P5, DOI 10.1007/BF01515993; Monne M, 2013, J BIOENERG BIOMEMBR, V45, P1, DOI 10.1007/s10863-012-9475-7; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muhleip AW, 2016, P NATL ACAD SCI USA, V113, P8442, DOI 10.1073/pnas.1525430113; Muhleip A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20381-z; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; Ogunbona OB, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00003; Padavannil A, 2022, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.798353; Parey K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj3221; Parey K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9484; Parey K, 2018, ELIFE, V7, DOI 10.7554/eLife.39213; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reyes A, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008923; Rich PR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0183; Riistama S, 1996, BBA-BIOENERGETICS, V1275, P1, DOI 10.1016/0005-2728(96)00040-0; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ruprecht JJ, 2021, ANNU REV BIOCHEM, V90, P535, DOI 10.1146/annurev-biochem-072820-020508; Sanchez-Garcia R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02399-1; Schertl P, 2015, METHODS MOL BIOL, V1305, P131, DOI 10.1007/978-1-4939-2639-8_9; Shimada S, 2017, EMBO J, V36, P291, DOI 10.15252/embj.201695021; Shinzawa-Itoh K., BBA ADV, V1; Shinzawa-Itoh K., 2021, BBA ADV, V1; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Soufari H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18814-w; Sousa JS, 2016, ELIFE, V5, DOI [10.7554/eLife.21290, 10.7554/e.Life.21290]; Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; Vercellino I, 2021, NATURE, V598, P364, DOI 10.1038/s41586-021-03927-z; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Weinhaupl K, 2018, CELL, V175, P1365, DOI 10.1016/j.cell.2018.10.039; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Yoshikawa S, 2011, BBA-BIOENERGETICS, V1807, P1279, DOI 10.1016/j.bbabio.2011.06.008; Zhang YJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10081107; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zong S, 2018, CELL RES, V28, P1026, DOI 10.1038/s41422-018-0071-1	104	1	1	9	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2022	376	6595					831	+		10.1126/science.abn7747	http://dx.doi.org/10.1126/science.abn7747			74	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1K3GZ	35357889				2022-12-28	WOS:000798495000032
J	Kmietowicz, Z				Kmietowicz, Zosia			Neonatal units in Manchester roll out genetic test for gentamicin ototoxicity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McDermott JH, 2022, JAMA PEDIATR, V176, P486, DOI 10.1001/jamapediatrics.2022.0187	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2022	377								o887	10.1136/bmj.o887	http://dx.doi.org/10.1136/bmj.o887			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N8UW	35379654	Bronze			2022-12-28	WOS:000783107700003
J	Khobragade, A; Bhate, S; Ramaiah, V; Deshpande, S; Giri, K; Phophle, H; Supe, P; Godara, I; Revanna, R; Nagarkar, R; Sanmukhani, J; Dey, A; Rajanathan, TMC; Kansagra, K; Koradia, P				Khobragade, Akash; Bhate, Suresh; Ramaiah, Vijendra; Deshpande, Shrikant; Giri, Krishna; Phophle, Himanshu; Supe, Pravin; Godara, Inderjeet; Revanna, Ramesh; Nagarkar, Rajnish; Sanmukhani, Jayesh; Dey, Ayan; Rajanathan, T. M. Chozhavel; Kansagra, Kevinkumar; Koradia, Parshottam		ZyCoV D Phase Study Investigator G	Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India	LANCET			English	Article								Background ZyCoV-D, a DNA-based vaccine, showed promising safety and immunogenicity in a phase 1/2 trial. We now report the interim efficacy results of phase 3 clinical trial with ZyCoV-D vaccine in India. Methods We conducted an interim analysis of a multicentre, double-blind, randomised, placebo-controlled phase 3 trial at 49 centres in India. Healthy participants aged at least 12 years were enrolled and randomly assigned (1:1) to receive either ZyCov-D vaccine (Cadila Healthcare; 2 mg per dose) or placebo. An interactive web response system was used for randomisation (blocks of four) of participants as well as to enrol those aged 60 years and older with or without comorbid conditions, and those aged 12-17 years. It was also used to identify 600 participants for immunogenicity (blocks of six). Participants, investigators, and outcome assessors were masked to treatment assignment. Three doses of vaccine or placebo were administered intradermally via a needle-free injection system 28 days apart. The primary outcome was the number of participants with first occurrence of symptomatic RTPCR-positive COVID-19 28 days after the third dose, until the targeted number of cases (interim analysis n=79, full analysis n=158) have been achieved. The analysis was done in the per-protocol population, which consisted of all participants with negative baseline SARS-CoV-2 status who received three doses of vaccine or placebo. Assessment of safety and tolerability was based on the safety population, which consisted of all enrolled participants who were known to have received at least one dose of study vaccine or placebo. This trial is registered with Clinical Trial Registry India, CTRI/2021/01/030416, and is ongoing. Findings Between Jan 16, and June 23, 2021 (data cutoff), 33 194 individuals were screened, of whom 5241 did not meet screening criteria and 27 703 were enrolled and randomly assigned to receive ZyCoV-D (n=13 851) or placebo (n=13 852). Per-protocol, 81 cases were eligible and included in efficacy analysis (20 of 12 350 in the ZyCoV-D group and 61 of 12 320 in placebo group). The ZyCoV-D vaccine efficacy was found to be 66.6% (95% CI 47.6-80.7). The occurrence of solicited adverse events was similar between the treatment groups (623 [4.49%] in the ZyCoV-D group vs 620 [4.47%] in the placebo group). There were two deaths (one in each group) reported at the data cutoff, neither of which was considered related to the study treatments. Interpretation In this interim analysis, ZyCoV-D vaccine was found to be efficacious, safe, and immunogenic in a phase 3 trial. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Khobragade, Akash] Grant Govt Med Coll & Sir JJ Grp Hosp, Mumbai, Maharashtra, India; [Bhate, Suresh] Jeevan Rekha Hosp, Belagavi, Karnataka, India; [Ramaiah, Vijendra] Kempegowda Inst Med Sci, Hosp & Res Ctr, Bengaluru, Karnataka, India; [Deshpande, Shrikant] Ashirwad Hosp, Ulhasnagar, Maharashtra, India; [Giri, Krishna] Dhadiwal Hosp, Res Dept, Nasik, Maharashtra, India; [Supe, Pravin] Ace Hosp, Pune, Maharashtra, India; [Supe, Pravin] Supe Hosp, Nasik, Maharashtra, India; [Godara, Inderjeet; ZyCoV D Phase Study Investigator G] Marudhar Hosp, Jaipur, Rajasthan, India; [Revanna, Ramesh] NRR Hosp, Bengaluru, Karnataka, India; [Nagarkar, Rajnish] HCG Manavata Canc Ctr, Nasik, Maharashtra, India; [Sanmukhani, Jayesh] Zydus Corp Pk, Bengaluru, Karnataka, India; [Dey, Ayan; Rajanathan, T. M. Chozhavel] Vaccine Technol Ctr, Ahmadabad, Gujarat, India; [Kansagra, Kevinkumar] Zydus Res Ctr Cadila Healthcare, Ahmadabad, Gujarat, India; [Koradia, Parshottam] Cadila Healthcare, Ahmadabad, Gujarat, India; [Koradia, Parshottam] BAPS Pramukh Swami Hosp, Surat, India	Kempegowda Institute of Medical Sciences (KIMS)	Khobragade, A (corresponding author), Grant Govt Med Coll & Sir JJ Grp Hosp, Dept Pharmacol Opposite Cent Canteen, Mumbai 400008, India.	akash.khobragade@gmail.com			National Biopharma Mission, Department of Biotechnology, Government of India; Cadila Healthcare, Ahmedabad, Gujarat India	National Biopharma Mission, Department of Biotechnology, Government of India; Cadila Healthcare, Ahmedabad, Gujarat India	National Biopharma Mission, Department of Biotechnology, Government of India and Cadila Healthcare, Ahmedabad, Gujarat India.	[Anonymous], 2019, REVISING GLOBAL INDI; Dey A, 2021, VACCINE, V39, P4108, DOI 10.1016/j.vaccine.2021.05.098; FGF Industry, 2007, CONS PLASM DNA VACC; GISAID, TRACK VAR APR 26 202; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; M. P. Mammen, 2021, medRxiv, DOI 10.1101/2021.05.07.21256652; M. Salvatore, 2021, medRxiv, DOI 10.1101/2021.06.23.21259405; Momin T, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101020; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8	11	26	28	6	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1313	1321						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35367003	Bronze, Green Published			2022-12-28	WOS:000812828300023
J	Henrich, J				Henrich, Joseph			Selective cultural processes generate adaptive heuristics	SCIENCE			English	Editorial Material							EVOLUTION		[Henrich, Joseph] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Henrich, J (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	henrich@fas.harvard.edu						Atran Scott., 2008, NATIVE MIND CULTURAL; Boyd R, 2017, DIFFERENT KIND ANIMA; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Gladwin T., 2009, E IS BIG BIRD NAVIGA; Goodenough Ward, 1953, NATIVE ASTRONOMY CEN; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Henrich J, 2010, P ROY SOC B-BIOL SCI, V277, P3715, DOI 10.1098/rspb.2010.1191; Henrich Joseph, 2002, J COGN CULT, P87; Morin O, 2013, EVOL HUM BEHAV, V34, P222, DOI 10.1016/j.evolhumbehav.2013.01.004; Muthukrishna M, 2021, ANNU REV PSYCHOL, V72, P717, DOI 10.1146/annurev-psych-082820-111436; Muthukrishna M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2511; Singh M, 2021, EMOT REV, V13, P183, DOI 10.1177/17540739211022824; Thompson B, 2022, SCIENCE, V376, P95, DOI 10.1126/science.abn0915	15	1	1	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		31	32		10.1126/science.abo0713	http://dx.doi.org/10.1126/science.abo0713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357933				2022-12-28	WOS:000780195200013
J	Mullard, A				Mullard, Asher			THE LONG-TERM CONSEQUENCES OF VIRAL INFECTION	NATURE			English	News Item						Virology; Vaccines; Medical research		Researchers suspect that viral infections can trigger multiple sclerosis and other chronic conditions. Could vaccines prevent that - and how can researchers find out? By Asher Mullard										Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Cohen JI, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2014.27; Douaud G, 2022, NATURE, V604, P697, DOI [10.1038/s41586-022-04569-5, 10.1101/2021.06.11.21258690]; Lanz TV, 2022, NATURE, DOI 10.1038/s41586-022-04432-7; Lebrun-Frenay C, 2020, ANN NEUROL, V88, P407, DOI 10.1002/ana.25799; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Messick TE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5612	7	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					784	786		10.1038/d41586-022-00808-x	http://dx.doi.org/10.1038/d41586-022-00808-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354995	Bronze			2022-12-28	WOS:000776361600021
J	Wilkinson, B; Onwuzurike, C; Bartz, D				Wilkinson, Barbara; Onwuzurike, Chiamaka; Bartz, Deborah			Restrictive State Abortion Bans - A Reproductive Injustice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wilkinson, Barbara] Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wilkinson, B (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.							Addante AN, 2021, CONTRACEPTION, V104, P496, DOI 10.1016/j.contraception.2021.03.018; [Anonymous], 2007, REPROD JUSTICE BRIEF; Foster DG, 2018, AM J PUBLIC HEALTH, V108, P407, DOI [10.2105/AJPH.2017.304247, 10.2105/ajph.2017.304247]; Nash E., 2021, 26 STATES ARE CERTAI; Raymond EG, 2012, OBSTET GYNECOL, V119, P215, DOI 10.1097/AOG.0b013e31823fe923	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1197	1199		10.1056/NEJMp2119364	http://dx.doi.org/10.1056/NEJMp2119364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Q8KI	35333482	Bronze			2022-12-28	WOS:000820666300004
J	Zhan, GL; Cai, ZF; Strutynski, K; Yu, LH; Herrmann, N; Martinez-Abadia, M; Melle-Franco, M; Mateo-Alonso, A; De Feyter, S				Zhan, Gaolei; Zhen-Feng Cai; Strutynski, Karol; Yu, Lihua; Herrmann, Niklas; Martinez-Abadia, Marta; Melle-Franco, Manuel; Mateo-Alonso, Aurelio; De Feyter, Steven			Observing polymerization in 2D dynamic covalent polymers	NATURE			English	Article							ROOM-TEMPERATURE SYNTHESIS; ORGANIC FRAMEWORKS; 2-DIMENSIONAL POLYMER; BOUNDARY MIGRATION; SURFACE SYNTHESIS; GROWTH; CRYSTALLINE; NUCLEATION; INTERFACE; HYDROGEN	The quality of crystalline two-dimensional (2D) polymers(1-6) is intimately related to the elusive polymerization and crystallization processes. Understanding the mechanism of such processes at the (sub)molecular level is crucial to improve predictive synthesis and to tailor material properties for applications in catalysis(7-10) and (opto)electronics(11,12), among others(13-18). We characterize a model boroxine 2D dynamic covalent polymer, by using in situ scanning tunnelling microscopy, to unveil both qualitative and quantitative details of the nucleation-elongation processes in real time and under ambient conditions. Sequential data analysis enables observation of the amorphous-tocrystalline transition, the time-dependent evolution of nuclei, the existence of 'non-classical' crystallization pathways and, importantly, the experimental determination of essential crystallization parameters with excellent accuracy, including critical nucleus size, nucleation rate and growth rate. The experimental data have been further rationalized by atomistic computer models, which, taken together, provide a detailed picture of the dynamic on-surface polymerization process. Furthermore, we show how 2D crystal growth can be affected by abnormal grain growth. This finding provides support for the use of abnormal grain growth (a typical phenomenon in metallic and ceramic systems) to convert a polycrystalline structure into a single crystal in organic and 2D material systems.	[Zhan, Gaolei; Zhen-Feng Cai; Yu, Lihua; Herrmann, Niklas; De Feyter, Steven] Katholieke Univ Leuven, Div Mol Imaging & Photon, Dept Chem, Leuven, Belgium; [Strutynski, Karol; Melle-Franco, Manuel] Univ Aveiro, CICECO Aveiro Inst Mat, Dept Chem, Aveiro, Portugal; [Martinez-Abadia, Marta; Mateo-Alonso, Aurelio] Univ Basque Country UPV EHU, POLYMAT, Donostia San Sebastian, Spain; [Mateo-Alonso, Aurelio] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Zhan, Gaolei] Natl Univ Singapore, Dept Chem, Singapore, Singapore; [Zhen-Feng Cai] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland	KU Leuven; Universidade de Aveiro; University of Basque Country; POLYMAT; Basque Foundation for Science; National University of Singapore; Swiss Federal Institutes of Technology Domain; ETH Zurich	Cai, ZF; De Feyter, S (corresponding author), Katholieke Univ Leuven, Div Mol Imaging & Photon, Dept Chem, Leuven, Belgium.; Cai, ZF (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.	zhenfeng.cai@org.chem.ethz.ch; steven.defeyter@kuleuven.be	Mateo-Alonso, Aurelio/A-8600-2010; ZHAN, Gaolei/GRY-2739-2022; De Feyter, Steven/K-7245-2014; Strutynski, Karol/C-6170-2019; Melle-Franco, Manuel/D-3633-2011; MARTINEZ-ABADIA, MARTA/C-4541-2017	Mateo-Alonso, Aurelio/0000-0002-5316-2594; Cai, Zhen-Feng/0000-0002-1659-4291; De Feyter, Steven/0000-0002-0909-9292; Strutynski, Karol/0000-0001-8733-9012; Melle-Franco, Manuel/0000-0003-1929-0477; MARTINEZ-ABADIA, MARTA/0000-0003-2068-0296	Research Foundation -Flanders (FWO); FWO [EOS 30489208]; Marie Sklodowska Curie ETN project ULTIMATE [GA-813036]; KU Leuven [3E180504]; China Scholarship Council [201908350094]; Basque Foundation for Science (Ikerbasque); POLYMAT; University of the Basque Country (Grupo de Investigacion) [GIU17/054]; Diputacion Foral de Guipuzkoa; Gobierno de Espana (Ministerio de Economia y Competitividad) [CTQ2016-77970-R]; European funding (ERDF); European funding (ESF); European Research Council (ERC) under the European Union [722951]; European Union [664878, 899895]; Portuguese Foundation for Science and Technology I.P./MCTES [UIDB/50011/2020, UIDP/50011/2020];  [IF/00894/2015]	Research Foundation -Flanders (FWO)(FWO); FWO(FWO); Marie Sklodowska Curie ETN project ULTIMATE; KU Leuven(KU Leuven); China Scholarship Council(China Scholarship Council); Basque Foundation for Science (Ikerbasque); POLYMAT; University of the Basque Country (Grupo de Investigacion); Diputacion Foral de Guipuzkoa; Gobierno de Espana (Ministerio de Economia y Competitividad)(Spanish Government); European funding (ERDF); European funding (ESF); European Research Council (ERC) under the European Union(European Research Council (ERC)); European Union(European Commission); Portuguese Foundation for Science and Technology I.P./MCTES; 	We thank L. Verstraete and N. Bilbao for helpful discussions. We thank Y. Liao for helping with the preparation of the manuscript. We thank Y. Zhang for helping with data analysis. This work was supported by the Research Foundation -Flanders (FWO), in part by FWO under EOS 30489208, the Marie Sklodowska Curie ETN project ULTIMATE (GA-813036), and KU Leuven Internal Grant 3E180504, China Scholarship Council (201908350094), the Basque Foundation for Science (Ikerbasque), POLYMAT, the University of the Basque Country (Grupo de Investigacion GIU17/054), Diputacion Foral de Guipuzkoa, Gobierno Vasco (PIBA and BERC programmes), Gobierno de Espana (Ministerio de Economia y Competitividad CTQ2016-77970-R). Technical and human support provided by SGIker of UPV/EHU and European funding (ERDF and ESF) is acknowledged. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 722951). This project has received funding from the European Union ' s Horizon 2020 research and innovation programme under grant agreement no. 664878 and no. 899895. In addition, support through the project IF/00894/2015, the advanced computing CPCA/A2/2524/2020 granting access to the Navigator cluster at LCA-UC and within the scope of the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 & UIDP/50011/2020 funded by national funds through the Portuguese Foundation for Science and Technology I.P./MCTES is gratefully acknowledged.	Ambrosetti A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4865104; Bannwarth C, 2021, WIRES COMPUT MOL SCI, V11, DOI 10.1002/wcms.1493; Bilbao N, 2020, ACS NANO, V14, P2354, DOI 10.1021/acsnano.9b09520; Bin HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13651; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Cai ZF, 2019, J AM CHEM SOC, V141, P11404, DOI 10.1021/jacs.9b05265; Colson JW, 2013, NAT CHEM, V5, P453, DOI 10.1038/nchem.1628; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Crawford AG, 2012, CHEM-EUR J, V18, P5022, DOI 10.1002/chem.201103774; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; DeBlase CR, 2013, J AM CHEM SOC, V135, P16821, DOI 10.1021/ja409421d; Dienstmaier JF, 2012, ACS NANO, V6, P7234, DOI 10.1021/nn302363d; Schluter AD, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-0258-5; Ding SY, 2011, J AM CHEM SOC, V133, P19816, DOI 10.1021/ja206846p; Dogru M, 2013, ANGEW CHEM INT EDIT, V52, P2920, DOI 10.1002/anie.201208514; Dong RH, 2015, ANGEW CHEM INT EDIT, V54, P12058, DOI 10.1002/anie.201506048; Evans AM, 2019, J AM CHEM SOC, V141, P19728, DOI 10.1021/jacs.9b08815; Evans AM, 2018, SCIENCE, V361, P53, DOI 10.1126/science.aar7883; Feng XL, 2018, ANGEW CHEM INT EDIT, V57, P13748, DOI 10.1002/anie.201803456; Furukawa H, 2009, J AM CHEM SOC, V131, P8875, DOI 10.1021/ja9015765; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Grill L, 2020, NAT CHEM, V12, P115, DOI 10.1038/s41557-019-0392-9; Grimme S, 2017, J CHEM THEORY COMPUT, V13, P1989, DOI 10.1021/acs.jctc.7b00118; Grossmann L, 2021, NAT CHEM, V13, P730, DOI 10.1038/s41557-021-00709-y; Larsen AH, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa680e; Hourahine B, 2020, J CHEM PHYS, V152, DOI 10.1063/1.5143190; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kissel P, 2014, NAT CHEM, V6, P774, DOI 10.1038/nchem.2008; Kissel P, 2012, NAT CHEM, V4, P287, DOI 10.1038/nchem.1265; Kory MJ, 2014, NAT CHEM, V6, P779, DOI [10.1038/nchem.2007, 10.1038/NCHEM.2007]; Lange RZ, 2017, J AM CHEM SOC, V139, P2053, DOI 10.1021/jacs.6b11857; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Li HY, 2020, J AM CHEM SOC, V142, P1367, DOI 10.1021/jacs.9b10869; Li HY, 2017, J AM CHEM SOC, V139, P16310, DOI 10.1021/jacs.7b09169; Li X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04769-6; Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343; Liu CH, 2016, CHEM-EUR J, V22, P18412, DOI 10.1002/chem.201603547; Liu KJ, 2019, NAT CHEM, V11, P994, DOI 10.1038/s41557-019-0327-5; Liu W, 2017, NAT CHEM, V9, P563, DOI [10.1038/NCHEM.2696, 10.1038/nchem.2696]; Liu XH, 2013, J AM CHEM SOC, V135, P10470, DOI 10.1021/ja403464h; Marek A, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/21/213201; Martinez-Abadia M, 2020, ADV MATER, V32, DOI 10.1002/adma.202002366; Medina DD, 2015, J AM CHEM SOC, V137, P1016, DOI 10.1021/ja510895m; Payamyar P, 2016, CHEM COMMUN, V52, P18, DOI 10.1039/c5cc07381b; ROLLETT AD, 1989, ACTA METALL MATER, V37, P1227, DOI 10.1016/0001-6160(89)90117-X; Ruger R., 2021, AMS V 2021 1; Rupp M, 2012, PHYS REV LETT, V108, DOI [10.1103/PhysRevLett.108.236402, 10.1103/PhysRevLett.108.058301]; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sakamoto J, 2009, ANGEW CHEM INT EDIT, V48, P1030, DOI 10.1002/anie.200801863; Sassi M, 2009, CHEMPHYSCHEM, V10, P2480, DOI 10.1002/cphc.200900168; Schluter AD, 2020, CHEM SOC REV, V49, P5140, DOI 10.1039/d0cs00176g; Smith BJ, 2014, J AM CHEM SOC, V136, P8783, DOI 10.1021/ja5037868; Spicher S, 2020, ANGEW CHEM INT EDIT, V59, P15665, DOI 10.1002/anie.202004239; SUN RC, 1970, ACTA METALL MATER, V18, P639, DOI 10.1016/0001-6160(70)90093-3; VISWANATHAN R, 1973, ACTA METALL MATER, V21, P1099, DOI 10.1016/0001-6160(73)90026-6; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wan S, 2009, ANGEW CHEM INT EDIT, V48, P5439, DOI 10.1002/anie.200900881; Wang W, 2019, MACROMOL RAPID COMM, V40, DOI 10.1002/marc.201800719; Wang XR, 2016, J AM CHEM SOC, V138, P12332, DOI 10.1021/jacs.6b07714; Yu VWZ, 2018, COMPUT PHYS COMMUN, V222, P267, DOI 10.1016/j.cpc.2017.09.007; Zhan GL, 2020, J AM CHEM SOC, V142, P5964, DOI 10.1021/jacs.0c01270; Zhong Y, 2019, SCIENCE, V366, P1379, DOI 10.1126/science.aax9385	64	10	10	55	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					835	+		10.1038/s41586-022-04409-6	http://dx.doi.org/10.1038/s41586-022-04409-6			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35355001				2022-12-28	WOS:000776361600029
J	Bharati, BK; Gowder, M; Zheng, FF; Alzoubi, K; Svetlov, V; Kamarthapu, V; Weaver, JW; Epshtein, V; Vasilyev, N; Shen, LQ; Zhang, Y; Nudler, E				Bharati, Binod K.; Gowder, Manjunath; Zheng, Fangfang; Alzoubi, Khaled; Svetlov, Vladimir; Kamarthapu, Venu; Weaver, Jacob W.; Epshtein, Vitaly; Vasilyev, Nikita; Shen, Liqiang; Zhang, Yu; Nudler, Evgeny			Crucial role and mechanism of transcription-coupled DNA repair in bacteria	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; RNA-POLYMERASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN MODELS; UVRA PROVIDES; DAMAGE; SUBUNITS	Transcription-coupled DNA repair (TCR) is presumed to be a minor sub-pathway of nucleotide excision repair (NER) in bacteria. Global genomic repair is thought to perform the bulk of repair independently of transcription. TCR is also believed to be mediated exclusively by Mfd-a DNA translocase of a marginal NER phenotype(1-3). Here we combined in cellulo cross-linking mass spectrometry with structural, biochemical and genetic approaches to map the interactions within the TCR complex (TCRC) and to determine the actual sequence of events that leads to NER in vivo. We show that RNA polymerase (RNAP) serves as the primary sensor of DNA damage and acts as a platform for the recruitment of NER enzymes. UvrA and UvrD associate with RNAP continuously, forming a surveillance pre-TCRC. In response to DNA damage, pre-TCRC recruits a second UvrD monomer to form a helicase-competent UvrD dimer that promotes backtracking of the TCRC. The weakening of UvrD-RNAP interactions renders cells sensitive to genotoxic stress. TCRC then recruits a second UvrA molecule and UvrB to initiate the repair process. Contrary to the conventional view, we show that TCR accounts for the vast majority of chromosomal repair events; that is, TCR thoroughly dominates over global genomic repair. We also show that TCR is largely independent of Mfd. We propose that Mfd has an indirect role in this process: it participates in removing obstructive RNAPs in front of TCRCs and also in recovering TCRCs from backtracking after repair has been completed.	[Bharati, Binod K.; Gowder, Manjunath; Alzoubi, Khaled; Svetlov, Vladimir; Kamarthapu, Venu; Weaver, Jacob W.; Epshtein, Vitaly; Vasilyev, Nikita; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Bharati, Binod K.; Gowder, Manjunath; Kamarthapu, Venu; Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA; [Zheng, Fangfang; Shen, Liqiang; Zhang, Yu] Chinese Acad Sci, Inst Plant Physiol & Ecol, Ctr Excellence Mol Plant Sci, Key Lab Synthet Biol, Shanghai, Peoples R China	New York University; Howard Hughes Medical Institute; New York University; Chinese Academy of Sciences	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.; Nudler, E (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA.; Zhang, Y (corresponding author), Chinese Acad Sci, Inst Plant Physiol & Ecol, Ctr Excellence Mol Plant Sci, Key Lab Synthet Biol, Shanghai, Peoples R China.	yzhang@cemps.ac.cn; evgeny.nudler@nyulangone.org	Alzoubi, Khaled Jamal/GOP-1204-2022	Alzoubi, Khaled Jamal/0000-0002-3765-7933; Bharati, Binod Kumar/0000-0003-1112-8846	National Key Research and Development Program of China [2018YFA0903701]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29020302]; Chinese Natural Science Foundation of China [31822001]; Shanghai Science and Technology Innovation program [19JC1415900]; NIH [R01 GM126891]; Blavatnik Family Foundation; Howard Hughes Medical Institute	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blavatnik Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the staff at beamline BL17U1/BL18U1/BL19U1 of Shanghai Synchrotron Radiation Facility for assistance during data collection, and T. Artemev for his continued support. The work was supported by the National Key Research and Development Program of China (grant no. 2018YFA0903701), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020302), the Chinese Natural Science Foundation of China (31822001) and the Shanghai Science and Technology Innovation program (19JC1415900) (Y.Z.), and by NIH grant R01 GM126891, the Blavatnik Family Foundation and the Howard Hughes Medical Institute (E.N.).	Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Baba Tomoya, 2006, Mol Syst Biol, V2; Belogurov GA, 2019, J MOL BIOL, V431, P3975, DOI 10.1016/j.jmb.2019.05.042; Nguyen B, 2017, P NATL ACAD SCI USA, V114, P12178, DOI 10.1073/pnas.1712882114; Brugger C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17457-1; Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Bullock JMA, 2016, MOL CELL PROTEOMICS, V15, P2491, DOI 10.1074/mcp.M116.058560; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carter JD, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/926595; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Cohen SE, 2010, P NATL ACAD SCI USA, V107, P15517, DOI 10.1073/pnas.1005203107; Courcelle J, 2001, GENETICS, V158, P41; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crowley DJ, 1998, J BACTERIOL, V180, P3345, DOI 10.1128/JB.180.13.3345-3352.1998; Dannenmann B, 2017, ONCOTARGET, V8, P112417, DOI 10.18632/oncotarget.20112; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis SE, 2011, METHOD ENZYMOL, V498, P449, DOI 10.1016/B978-0-12-385120-8.00020-6; Deaconescu AM, 2012, P NATL ACAD SCI USA, V109, P3353, DOI 10.1073/pnas.1115105109; Duan MR, 2020, P NATL ACAD SCI USA, V117, P18608, DOI 10.1073/pnas.2003868117; Duchi D, 2018, NUCLEIC ACIDS RES, V46, P7284, DOI 10.1093/nar/gky482; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Gaul L, 2021, DNA REPAIR, V107, DOI 10.1016/j.dnarep.2021.103208; Ghosh SS, 1990, BIOCONJUGATE CHEM, V1, P71, DOI 10.1021/bc00001a009; Ghosh-Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072090; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P229, DOI 10.1016/B978-0-12-382239-0.00003-0; IKENAGA M, 1975, J MOL BIOL, V92, P341, DOI 10.1016/0022-2836(75)90233-8; Iyer S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw596; Jaciuk M, 2020, DNA REPAIR, V85, DOI 10.1016/j.dnarep.2019.102746; Jain S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09146-5; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kai-Feng H, 2020, P NATL ACAD SCI USA, V117, P12806, DOI 10.1073/pnas.1917196117; Kamarthapu V, 2016, SCIENCE, V352, P993, DOI 10.1126/science.aad6945; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Kawale AA, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01332-2; Kisker C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012591; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koehler DR, 1996, J BACTERIOL, V178, P1347, DOI 10.1128/jb.178.5.1347-1350.1996; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; KUNALA S, 1995, J MOL BIOL, V246, P264, DOI 10.1006/jmbi.1994.0082; Kuper J, 2012, CURR OPIN STRUC BIOL, V22, P88, DOI 10.1016/j.sbi.2011.12.002; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee SJ, 2019, RESEARCH-CHINA, V2019, DOI 10.34133/2019/5641746; Lehle S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1349; Li WT, 2017, PHOTOCHEM PHOTOBIOL, V93, P259, DOI 10.1111/php.12655; Lin CLG, 1998, NUCLEIC ACIDS RES, V26, P1466, DOI 10.1093/nar/26.6.1466; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; Lu L, 2018, J PROTEOME RES, V17, P2370, DOI 10.1021/acs.jproteome.8b00141; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Martin A. C. R., 2009, PROFIT V31; Martinez B, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28871-y; MAYNE LV, 1982, CANCER RES, V42, P1473; Meyer A, 2015, ACTA CRYSTALLOGR F, V71, P75, DOI 10.1107/S2053230X14027149; Mullenders L, 2015, DNA REPAIR, V36, P28, DOI 10.1016/j.dnarep.2015.09.005; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa N, 1999, J BIOCHEM, V126, P986, DOI 10.1093/oxfordjournals.jbchem.a022566; Oh J, 2021, BBA-GENE REGUL MECH, V1864, DOI 10.1016/j.bbagrm.2020.194659; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Orban-Nemeth Z, 2018, NAT PROTOC, V13, P478, DOI 10.1038/nprot.2017.146; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; Pakotiprapha D, 2012, NAT STRUCT MOL BIOL, V19, P291, DOI 10.1038/nsmb.2240; Pakotiprapha D, 2009, J BIOL CHEM, V284, P12837, DOI 10.1074/jbc.M900571200; Pani B, 2017, DNA REPAIR, V56, P42, DOI 10.1016/j.dnarep.2017.06.006; Perdiz D, 2000, J BIOL CHEM, V275, P26732; Ragheb MN, 2019, MOL CELL, V73, P157, DOI 10.1016/j.molcel.2018.10.015; Rasouly A, 2017, TRENDS GENET, V33, P58, DOI 10.1016/j.tig.2016.11.002; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Rossi F, 2011, NUCLEIC ACIDS RES, V39, P7316, DOI 10.1093/nar/gkr271; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sanders K, 2017, NUCLEIC ACIDS RES, V45, P3875, DOI 10.1093/nar/gkx074; Schalow BJ, 2012, J BACTERIOL, V194, P2637, DOI 10.1128/JB.06725-11; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Skubak P, 2018, IUCRJ, V5, P166, DOI 10.1107/S2052252517017961; Spivak G, 2016, ARCH TOXICOL, V90, P2583, DOI 10.1007/s00204-016-1820-x; Spivak Graciela, 1995, Methods (Orlando), V7, P147, DOI 10.1006/meth.1995.1021; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Thomassen GOS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015356; Urrutia-Irazabal I, 2021, ELIFE, V10, DOI 10.7554/eLife.68829; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; Vogel U, 1997, J BIOL CHEM, V272, P12265, DOI 10.1074/jbc.272.19.12265; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Wang CY, 2020, SCIENCE, V369, P1359, DOI 10.1126/science.abb5317; Wisniewski JR, 2017, METHOD ENZYMOL, V585, P49, DOI 10.1016/bs.mie.2016.10.002; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zdraveski ZZ, 2000, CHEM BIOL, V7, P39, DOI 10.1016/S1074-5521(00)00064-8; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhao DD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16998-8; Zhu Shusen, 2017, BMC Res Notes, V10, P269, DOI 10.1186/s13104-017-2593-x; Zou Y, 1999, EMBO J, V18, P4889, DOI 10.1093/emboj/18.17.4889; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	107	2	2	13	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					152	+		10.1038/s41586-022-04530-6	http://dx.doi.org/10.1038/s41586-022-04530-6		MAR 2022	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355008				2022-12-28	WOS:000776020400004
J	Scott, S; Forsyth, J				Scott, Sam; Forsyth, Jessica			Health think tanks: what are they and how they shape our NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Scott, Sam] Milton Keynes Univ Hosp, Milton Keynes MK6 5LD, Bucks, England; [Forsyth, Jessica] Barts Hlth NHS Trust, London, England	Barts Health NHS Trust	Scott, S (corresponding author), Milton Keynes Univ Hosp, Milton Keynes MK6 5LD, Bucks, England.; Forsyth, J (corresponding author), Barts Hlth NHS Trust, London, England.	Samuel.Scott@mkuh.nhs.uk; jessicarachel.Forsyth@nhs.net		Scott, Samuel/0000-0002-5462-5175					0	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o426	10.1136/bmj.o426	http://dx.doi.org/10.1136/bmj.o426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354609				2022-12-28	WOS:000779561800018
J	Dave, CV; Brittenham, GM; Carson, JL; Setoguchi, S				Dave, Chintan, V; Brittenham, Gary M.; Carson, Jeffrey L.; Setoguchi, Soko			Risks for Anaphylaxis With Intravenous Iron Formulations A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DEXTRAN; HYPERSENSITIVITY; FATALITIES; SAFETY	Background: The risks for anaphylaxis among intravenous (IV) iron products currently in use have not been assessed. Objective: To compare risks for anaphylaxis among 5 IV iron products that are used frequently. Design: Retrospective cohort study using a target trial emulation framework. Setting: Medicare fee-for-service data with Part D coverage between July 2013 and December 2018. Participants: Older adults receiving their first administration of IV iron. Measurements: The primary outcome was the occurrence of anaphylaxis within 1 day of IV iron administration, ascertained using a validated case definition. Analysis was adjusted for 40 baseline covariates using inverse probability of treatment weighting. The adjusted incidence rates (IRs) for anaphylaxis per 10000 first administrations and odds ratios (ORs) were computed. Results: The adjusted IRs for anaphylaxis per 10000 first administrations were 9.8 cases (95% CI, 6.2 to 15.3 cases) for iron dextran, 4.0 cases (CI, 2.5 to 6.6 cases) for ferumoxytol, 1.5 cases (CI, 0.3 to 6.6 cases) for ferric gluconate, 1.2 cases (CI, 0.6 to 2.5 cases) for iron sucrose, and 0.8 cases (CI, 0.3 to 2.6 cases) for ferric carboxymaltose. Using iron sucrose as the referent category, the adjusted ORs for anaphylaxis were 8.3 (CI, 3.5 to 19.8) for iron dextran and 3.4 (CI, 1.4 to 8.3) for ferumoxytol. When cohort entry was restricted to the period after withdrawal of high-molecular-weight iron dextran from the U.S. market in 2014, the risk for anaphylaxis associated with low molecular-weight iron dextran (OR, 8.4 [CI, 2.8 to 24.7]) did not change appreciably. Anaphylactic reactions requiring hospitalizations were observed only among patients using iron dextran or ferumoxytol. Limitation: Generalizability to non-Medicare populations. Conclusion: The rates of anaphylaxis were very low with all IV iron products but were 3-to 8-fold greater for iron dextran and ferumoxytol than for iron sucrose. Primary Funding Source: None.	[Dave, Chintan, V; Setoguchi, Soko] Rutgers State Univ, Ctr Pharmacoepidemiol & Treatment Sci, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ USA; [Dave, Chintan, V] Rutgers State Univ, Dept Pharm Practice & Adm, Ernest Mario Sch Pharm, Piscataway, NJ USA; [Dave, Chintan, V] Dept Vet Affairs New Jersey Hlth Care Syst, East Orange, NJ USA; [Brittenham, Gary M.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY USA; [Carson, Jeffrey L.; Setoguchi, Soko] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ USA; [Setoguchi, Soko] Rutgers Sch Publ Hlth, Dept Biostat & Epidemiol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dave, CV; Setoguchi, S (corresponding author), 112 Paterson St, New Brunswick, NJ 08901 USA.	cdave@ifh.rutgers.edu; ss2894@rwjms.rutgers.edu		Dave, Chintan/0000-0002-7160-9345				Adkinson NF, 2018, AM J HEMATOL, V93, P683, DOI 10.1002/ajh.25060; [Anonymous], 1991, Lancet, V337, P1308; Auerbach M, 2020, LANCET HAEMATOL, V7, pE342, DOI 10.1016/S2352-3026(19)30264-9; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bhandari S, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030082; Bircher AJ, 2014, IMMUNOL ALLERGY CLIN, V34, P707, DOI 10.1016/j.iac.2014.04.013; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Conover MM, 2018, PHARMACOEPIDEM DR S, V27, P771, DOI 10.1002/pds.4435; Critchley, 2007, TRANSFUS ALTERN TRAN; Durup D, 2020, EXPERT REV HEMATOL, V13, P557, DOI 10.1080/17474086.2020.1738215; Ehlken B, 2019, DRUG SAFETY, V42, P463, DOI 10.1007/s40264-018-0769-5; Fortuny J, 2021, PHARMACOEPIDEM DR S, V30, P1447, DOI 10.1002/pds.5319; Goldman SA, 1998, CLIN THER, V20, pC40, DOI 10.1016/S0149-2918(98)80007-6; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; Liew WK, 2009, J ALLERGY CLIN IMMUN, V123, P434, DOI 10.1016/j.jaci.2008.10.049; Macdougall IC, 2009, J REN CARE, V35, P8, DOI 10.1111/j.1755-6686.2009.00127.x; MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2; Neiser S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071185; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Pasricha SR, 2021, LANCET, V397, P233, DOI 10.1016/S0140-6736(20)32594-0; Rodgers GM, 2008, J AM SOC NEPHROL, V19, P833, DOI 10.1681/ASN.2008030255; Shin HW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215427; Singh A, 2008, AM J KIDNEY DIS, V52, P907, DOI 10.1053/j.ajkd.2008.08.001; Szebeni J, 2015, BRIT J PHARMACOL, V172, P5025, DOI 10.1111/bph.13268; Trumbo H, 2021, DRUG SAFETY, V44, DOI 10.1007/s40264-020-01022-2; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Van Wyck DB, 2000, AM J KIDNEY DIS, V36, P88, DOI 10.1053/ajkd.2000.8276; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Walsh, 2016, SENTINEL ASSESSMENT; Walsh Kathleen E, 2013, Pharmacoepidemiol Drug Saf, V22, P1205, DOI 10.1002/pds.3505; Wang CL, 2015, JAMA-J AM MED ASSOC, V314, P2062, DOI 10.1001/jama.2015.15572; Yoshida K, 2019, AM J EPIDEMIOL, V188, P609, DOI 10.1093/aje/kwy263	33	3	3	3	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					656	+		10.7326/M21-4009	http://dx.doi.org/10.7326/M21-4009		MAR 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35344378				2022-12-28	WOS:000779642000001
J	Edqvist, M; Dahlen, HG; Haggsgard, C; Tern, H; Angeby, K; Teleman, P; Ajne, G; Rubertsson, C				Edqvist, Malin; Dahlen, Hannah G.; Haggsgard, Cecilia; Tern, Helena; Angeby, Karin; Teleman, Pia; Ajne, Gunilla; Rubertsson, Christine			The effect of two midwives during the second stage of labour to reduce severe perineal trauma (Oneplus): a multicentre, randomised controlled trial in Sweden	LANCET			English	Article							ANAL-SPHINCTER INJURIES; TEARS; DELIVERY; CARE	Background Severe perineal trauma (SPT) affecting the anal sphincter muscle complex is a serious complication following childbirth, associated with short-term and long-term maternal morbidity. Effective preventive strategies are still scarce. The aim of the Oneplus trial was to test the hypothesis that the presence of a second midwife during the second stage of labour, with the purpose of preventing SPT, would result in fewer injuries affecting the anal sphincter than if attended by one midwife. Methods In this multicentre, randomised, controlled parallel group, unmasked trial done at five obstetric units in Sweden, women were randomly assigned to be assisted by either one or two midwives in late second stage. Nulliparous women and women planning the first vaginal birth after caesarean section who were age 18-47 years were randomly assigned to an intervention when reaching the second stage of 'about Further inclusion criteria were gestational week 37+0, carrying a singleton live fetus in vertex presentation, and proficiency in either Swedish, English, Arabic, or Farsi. Exclusion criteria were a multiple pregnancy, intrauterine fetal demise, a planned caesarean section, or women who were less than 37 weeks pregnant. Randomisation to the intervention group of two midwives or standard care group of one midwife (1:1) was done using a computer-based program and treatment groups were allocated by use of sealed opaque envelopes. All women and midwives were aware of the group assignment, but the statistician from Clinical Studies Forum South, who did the analyses, was masked to group assignment. Midwives were instructed to implement existing prevention models and the second midwife was to assist on instruction of the primary midwife, when asked. Midwives were also instructed to complete case report forms detailing assistance techniques and perinea' trauma prevention techniques. The primary outcome was the proportion of women who had SPT, for which odds ratios (ORs) and 95% CIs were calculated, and logistic regression was done to adjust for study site. All analyses were done according to intention to treat. The trial is registered with ClinicalTrials.gov , NCT0377096. Findings Between Dec 10, 2018, and March 21, 2020, 8866 women were assessed for eligibility, and 4264 met the inclusion criteria and agreed to participate. 3776 (88.5%) of 4264 women were randomly assigned to an intervention after reaching the second stage of labour. 1892 women were assigned to collegial assistance (two midwives) during the second stage of labour and 1884 women were assigned to standard care (one midwife). 13 women in each group did not meet the inclusion criteria and were excluded. After further exclusions, 1546 women spontaneously gave birth in the intervention group and 1513 in the standard care group. 1546 women in the intervention group and 1513 in the standard care group were induded in the intention-to-treat analysis of the primary outcome. There was a significant reduction in SPT in the intervention group (3 - 9% [61 of 1546] vs 5.7% [86 of 1513]; adjusted OR 0.69 (0.49-0.97). Interpretation The presence of two midwives during the active second stage can reduce SPT in women giving birth for the first time. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Edqvist, Malin] Karolinska Inst, Clin Epidemiol Div, Dept Med, S-17177 Stockholm, Sweden; [Ajne, Gunilla] Karolinska Inst, Div Obstet & Gynaecol, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Ajne, Gunilla] Karolinska Univ Hosp Huddinge, Dept Womens Hlth & Hlth Profess, Stockholm, Sweden; [Edqvist, Malin; Haggsgard, Cecilia; Tern, Helena; Rubertsson, Christine] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden; [Teleman, Pia] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden; [Dahlen, Hannah G.] Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Angeby, Karin] Reg Varmiand, Ctr Clin Res & Educ, Karlstad, Sweden; [Angeby, Karin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Teleman, Pia] Skane Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Lund University; Lund University; Western Sydney University; Dalarna University; Lund University; Skane University Hospital	Edqvist, M (corresponding author), Karolinska Inst, Clin Epidemiol Div, Dept Med, S-17177 Stockholm, Sweden.	malin.edqvist@ki.se		Angeby, Karin/0000-0001-7729-7912; Tern, Helena/0000-0002-6063-1432; Edqvist, Malin/0000-0002-0968-6534	Swedish Research Council for Health, Working Life and Welfare; Jan Hains Research Foundation; Skane County Council's Research and Development Foundation	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Jan Hains Research Foundation; Skane County Council's Research and Development Foundation	The Swedish Research Council for Health, Working Life and Welfare; Jan Hains Research Foundation; and Skane County Council's Research and Development Foundation.	Aasheim V, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006672.pub3; Andrews V, 2006, BJOG-INT J OBSTET GY, V113, P195, DOI 10.1111/j.1471-0528.2006.00799.x; Backenbottenutbildning LOF, 2021, NAT WEB BAS PROGR IN; Baghestan E, 2010, OBSTET GYNECOL, V116, P25, DOI 10.1097/AOG.0b013e3181e2f50b; Basu M, 2018, INT J GYNECOL OBSTET, V142, P295, DOI 10.1002/ijgo.12565; Basu M, 2016, EUR J OBSTET GYN R B, V202, P55, DOI 10.1016/j.ejogrb.2016.04.033; Bracken JN, 2008, INT UROGYNECOL J, V19, P1527, DOI 10.1007/s00192-008-0680-1; Edozien LC, 2014, BJOG-INT J OBSTET GY, V121, P1695, DOI 10.1111/1471-0528.12886; Edqvist M, 2020, TRIALS, V21, P1; Edqvist M, 2017, BIRTH-ISS PERINAT C, V44, P86, DOI 10.1111/birt.12267; Elvander C, 2019, BIRTH-ISS PERINAT C, V46, P379, DOI 10.1111/birt.12402; Fodstad K, 2016, INT UROGYNECOL J, V27, P1513, DOI 10.1007/s00192-016-3015-7; Gurol-Urganci I, 2021, BJOG-INT J OBSTET GY, V128, P584, DOI 10.1111/1471-0528.16396; Gurol-Urganci I, 2013, BJOG-INT J OBSTET GY, V120, P1516, DOI 10.1111/1471-0528.12363; Hagglund KM, 2011, SCAND J CARING SCI, V25, P325, DOI 10.1111/j.1471-6712.2010.00830.x; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jango H, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.030; Laine K, 2008, OBSTET GYNECOL, V111, P1053, DOI 10.1097/AOG.0b013e31816c4402; Liu YJ, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0410-2; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Priddis H, 2013, J ADV NURS, V69, P748, DOI 10.1111/jan.12005; Raisanen S, 2013, INT UROGYNECOL J, V24, P1331, DOI 10.1007/s00192-012-2006-6; Samuelsson E, 2002, ACTA OBSTET GYN SCAN, V81, P44, DOI 10.1046/j.0001-6349.2001.10182.x; Statistics Sweden, 2021, POP STAT; Stephansson O, 2018, ACTA OBSTET GYN SCAN, V97, P466, DOI 10.1111/aogs.13266; Swedish Associations of Midwives, 2018, DESCR REQ COMP REG M; The National Board of Health and Welfare, 2020, STAT DAT PREGN BIRTH; Tikkanen R., 2020, INT HLTH CARE SYSTEM; Woolner AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215180	30	2	2	4	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1242	1253		10.1016/S0140-6736(22)00188-X	http://dx.doi.org/10.1016/S0140-6736(22)00188-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35303474				2022-12-28	WOS:000779495000021
J	Dyer, O				Dyer, Owen			Long delayed publication of data on Alzheimer's drug Aduhelm leaves questions unanswered	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Biogen, 2022, LONGT PHAS 3 DAT SHO; Haeberlein SB, 2022, JPAD-J PREV ALZHEIM, V9, P197, DOI 10.14283/jpad.2022.30; Herman B., 2021, BIOGEN PULLED ADUHEL; U.S. Food and Drug Administration (FDA), 2020, PERIPHERAL CENTRAL N	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o808	10.1136/bmj.o808	http://dx.doi.org/10.1136/bmj.o808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1F9TL	35338031				2022-12-28	WOS:000795501900001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Who will be eligible for free testing from 1 April?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		All-Party Parliamentary Group on Vulnerable Groups to Pandemics, 2022, PLAN PRIOR PROT RED; Department of Health (Northern Ireland), 2022, TEST TRAC PROT PRIOR; HM Government, 2022, COV 19 RESP LIV COV; NHS Digital, DAT US; NHS Digital, SHIELD PAT LIST; NHS Digital, COR SHIELD PAT LIST; Scottish Government, 2022, UPD COV REG; Torjesen I, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o528; Welsh Government, 2022, SAF FUT WAL LONG TER	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o807	10.1136/bmj.o807	http://dx.doi.org/10.1136/bmj.o807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338052	Bronze			2022-12-28	WOS:000778396700016
J	Robinson, A				Robinson, Andrew			The Greatest Invention: A History of the World in Nine Mysterious Scripts	SCIENCE			English	Book Review												andrew@andrew-robinson.org						FERRARA S, 2022, GREATEST INVENTION H	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1361	1361		10.1126/science.abo7807	http://dx.doi.org/10.1126/science.abo7807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324297				2022-12-28	WOS:000778894800028
J	Magnus, MC; Ortqvist, AK; Dahlqwist, E; Ljung, R; Skar, F; Oakley, L; Macsali, F; Pasternak, B; Gjessing, HK; Haberg, SE; Stephansson, O				Magnus, Maria C.; Ortqvist, Anne K.; Dahlqwist, Elisabeth; Ljung, Rickard; Skar, Fredrik; Oakley, Laura; Macsali, Ferenc; Pasternak, Bjorn; Gjessing, Hakon K.; Haberg, Siri E.; Stephansson, Olof			Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Data about the safety of vaccines against SARS-CoV-2 during pregnancy are limited. OBJECTIVE To examine the risk of adverse pregnancy outcomes after vaccination against SARS-CoV-2 during pregnancy. DESIGN, SETTING, AND PARTICIPANTS This registry-based retrospective cohort study included 157 521 singleton pregnancies ending after 22 gestational weeks from January 1, 2021, until January 12, 2022 (Sweden), or January 15, 2022 (Norway). The Pregnancy Register in Sweden and the Medical Birth Registry of Norway were linked to vaccination and other registries for identification of exposure and background characteristics. EXPOSURES Data on mRNA vaccines-BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna)-and 1 viral vector vaccine-AZD1222 (AstraZeneca)-were collected from national vaccination registries. MAIN OUTCOMES AND MEASURES The risk of preterm birth and stillbirthwas evaluated using Cox regression models, with gestational day as the time metric and vaccination as a time-dependent exposure variable. The risk of small for gestational age, low Apgar score, and neonatal care admission was evaluated using logistic regression. Random-effects meta-analysis was used to combine results between countries. RESULTS Among the 157 521 singleton births included in the study (103 409 in Sweden and 54 112 in Norway), the mean maternal age at the time of delivery was 31 years, and 28 506 (18%) were vaccinated against SARS-CoV-2 (12.9% with BNT162b2, 4.8% with mRNA-1273, and 0.3% with AZD1222) while pregnant. A total of 0.7%, 8.3%, and 9.1% of individuals delivering were vaccinated during the first, second, and third trimester, respectively. Vaccination against SARS-CoV-2 was not significantly associated with increased risk of preterm birth (6.2 vs 4.9 per 10 000 pregnancy days; adjusted hazard ratio [aHR], 0.98 [95% CI, 0.91 to 1.05]; I-2 = 0%; P for heterogeneity =.60), stillbirth (2.1 vs 2.4 per 100 000 pregnancy days; aHR, 0.86 [95% CI, 0.63 to 1.17]), small for gestational age (7.8% vs 8.5%; difference, -0.6%[95% CI, -1.3% to 0.2%]; adjusted OR [aOR], 0.97 [95% CI, 0.90 to 1.04]), low Apgar score (1.5% vs 1.6%; difference, -0.05%[95% CI, -0.3% to 0.1%]; aOR, 0.97 [95% CI, 0.87 to 1.08]), or neonatal care admission (8.5% vs 8.5%; difference, 0.003% [95% CI, -0.9% to 0.9%]; aOR, 0.97 [95% CI, 0.86 to 1.10]). CONCLUSIONS AND RELEVANCE In this population-based study conducted in Sweden and Norway, vaccination against SARS-CoV-2 during pregnancy, compared with no SARS-CoV-2 vaccination during pregnancy, was not significantly associated with an increased risk of adverse pregnancy outcomes. The majority of the vaccinations were with mRNA vaccines during the second and third trimesters of pregnancy, which should be considered in interpreting the findings.	[Magnus, Maria C.; Oakley, Laura; Gjessing, Hakon K.; Haberg, Siri E.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, POB 222,Skoyen, N-0213 Oslo, Norway; [Ortqvist, Anne K.; Dahlqwist, Elisabeth; Pasternak, Bjorn; Stephansson, Olof] Karolinska Inst, Dept Med, Div Clin Epidemiol, Solna, Sweden; [Ortqvist, Anne K.] Visby Cty Hosp, Dept Obstet & Gynecol, Visby, Sweden; [Ljung, Rickard] Swedish Med Prod Agcy, Uppsala, Sweden; [Ljung, Rickard] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Skar, Fredrik] Norwegian Inst Publ Hlth, Dept Infect Control & Vaccines, Oslo, Norway; [Oakley, Laura] London Sch Hyg & Trop Med, Dept Non communicable Dis Epidemiol, London, England; [Macsali, Ferenc] Norwegian Inst Publ Hlth, Dept Hlth Registry Res & Dev, Bergen, Norway; [Macsali, Ferenc] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Pasternak, Bjorn] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Gjessing, Hakon K.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Stephansson, Olof] Karolinska Univ Hosp, Div Obstet, Dept Womens Hlth, Stockholm, Sweden	Norwegian Institute of Public Health (NIPH); Karolinska Institutet; Medical Products Agency; Karolinska Institutet; Norwegian Institute of Public Health (NIPH); University of London; London School of Hygiene & Tropical Medicine; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital; Statens Serum Institut; University of Bergen; Karolinska Institutet; Karolinska University Hospital	Magnus, MC (corresponding author), Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, POB 222,Skoyen, N-0213 Oslo, Norway.	Maria.Christine.Magnus@fhi.no	Örtqvist, Anne Kristina/P-6618-2019; Pasternak, Bjorn/H-5739-2012	Pasternak, Bjorn/0000-0002-2097-8466; Stephansson, Olof/0000-0003-1528-4563	Research Council of Norway [324312, 262700]; NordForsk [105545]; European Research Council under the European Union [947684]	Research Council of Norway(Research Council of Norway); NordForsk; European Research Council under the European Union(European Research Council (ERC))	This research was supported by the Research Council of Norway (project No. 324312) through its Centres of Excellence funding scheme (project No. 262700) and by NordForsk (project No. 105545). Dr Magnus received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant No. 947684).	Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; American College of Obstetricians and Gynecologists, COVID 19 VACC CONS O; Blakeway H, 2022, AM J OBSTET GYNECOL, V226, DOI 10.1016/j.ajog.2021.08.007; Centers for Disease Control and Prevention, INF COVID 19 VACC PE; Dagan N, 2021, NAT MED, V27, P1693, DOI 10.1038/s41591-021-01490-8; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Giesbers S, 2021, EUR J OBSTET GYN R B, V267, P120, DOI 10.1016/j.ejogrb.2021.10.007; Gill L, 2021, OBSTET GYNECOL, V137, P894, DOI 10.1097/AOG.0000000000004367; Gray KJ, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.023; Magnus MC, 2021, NEW ENGL J MED, V385, P2008, DOI 10.1056/NEJMc2114466; Martins I, 2021, EUR J OBSTET GYN R B, V262, P256, DOI 10.1016/j.ejogrb.2021.05.021; Norman M, 2021, JAMA-J AM MED ASSOC, V325, P2076, DOI 10.1001/jama.2021.5775; Paul G, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02618-y; Peretz SB, 2021, ULTRASOUND OBST GYN, V58, P450, DOI 10.1002/uog.23729; Rasmussen SA, 2021, OBSTET GYNECOL, V137, P408, DOI 10.1097/AOG.0000000000004290; Remschmidt C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1154-y; Rottenstreich M, 2022, BJOG-INT J OBSTET GY, V129, P248, DOI 10.1111/1471-0528.16941; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016]; Stephansson O, 2018, ACTA OBSTET GYN SCAN, V97, P466, DOI 10.1111/aogs.13266; Stock SJ, 2022, NAT MED, V28, P504, DOI 10.1038/s41591-021-01666-2; Theiler RN, 2021, AM J OBST GYNEC MFM, V3, DOI 10.1016/j.ajogmf.2021.100467; Wainstock T, 2021, VACCINE, V39, P6037, DOI 10.1016/j.vaccine.2021.09.012; Zauche LH, 2021, NEW ENGL J MED, V385, P1533, DOI 10.1056/NEJMc2113891	23	19	21	5	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1469	1477		10.1001/jama.2022.3271	http://dx.doi.org/10.1001/jama.2022.3271		MAR 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35323851	Green Published, Bronze			2022-12-28	WOS:000772988500003
J	Schrunk, B; Kushnirenko, Y; Kuthanazhi, B; Ahn, J; Wang, LL; O'Leary, E; Lee, K; Eaton, A; Fedorov, A; Lou, R; Voroshnin, V; Clark, OJ; Sanchez-Barriga, J; Bud'ko, SL; Slager, RJ; Canfield, PC; Kaminski, A				Schrunk, Benjamin; Kushnirenko, Yevhen; Kuthanazhi, Brinda; Ahn, Junyeong; Wang, Lin-Lin; O'Leary, Evan; Lee, Kyungchan; Eaton, Andrew; Fedorov, Alexander; Lou, Rui; Voroshnin, Vladimir; Clark, Oliver J.; Sanchez-Barriga, Jamie; Bud'ko, Sergey L.; Slager, Robert-Jan; Canfield, Paul C.; Kaminski, Adam			Emergence of Fermi arcs due to magnetic splitting in an antiferromagnet	NATURE			English	Article							SINGLE-CRYSTALS; SOLUTION GROWTH; SURFACE; SEMIMETAL	The Fermi surface plays an important role in controlling the electronic, transport and thermodynamic properties of materials. As the Fermi surface consists of closed contours in the momentum space for well-defined energy bands, disconnected sections known as Fermi arcs can be signatures of unusual electronic states, such as a pseudogap(1). Another way to obtain Fermi arcs is to break either the time-reversal symmetry(2) or the inversion symmetry(3) of a three-dimensional Dirac semimetal, which results in formation of pairs of Weyl nodes that have opposite chirality(4), and their projections are connected by Fermi arcs at the bulk boundary(3,5-12). Here, we present experimental evidence that pairs of hole- and electron-like Fermi arcs emerge below the Neel temperature (T-N) in the antiferromagnetic state of cubic NdBi due to a new magnetic splitting effect. The observed magnetic splitting is unusual, as it creates bands of opposing curvature, which change with temperature and follow the antiferromagnetic order parameter. This is different from previous theoretically considered(13,14) and experimentally reported cases(15,16) of magnetic splitting, such as traditional Zeeman and Rashba, in which the curvature of the bands is preserved. Therefore, our findings demonstrate a type of magnetic band splitting in the presence of a long-range antiferromagnetic order that is not readily explained by existing theoretical ideas.	[Schrunk, Benjamin; Kushnirenko, Yevhen; Kuthanazhi, Brinda; Wang, Lin-Lin; O'Leary, Evan; Lee, Kyungchan; Eaton, Andrew; Bud'ko, Sergey L.; Canfield, Paul C.; Kaminski, Adam] Ames Lab, Ames, IA 50011 USA; [Kushnirenko, Yevhen; Kuthanazhi, Brinda; O'Leary, Evan; Lee, Kyungchan; Eaton, Andrew; Bud'ko, Sergey L.; Canfield, Paul C.; Kaminski, Adam] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Ahn, Junyeong; Slager, Robert-Jan] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Fedorov, Alexander; Lou, Rui] Leibniz Inst Solid State & Mat Res, Dresden, Germany; [Fedorov, Alexander; Voroshnin, Vladimir; Clark, Oliver J.; Sanchez-Barriga, Jamie] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Lou, Rui] Lanzhou Univ, Sch Phys Sci & Technol, Lanzhou, Peoples R China; [Slager, Robert-Jan] Univ Cambridge, Cavendish Lab, TCM Grp, Cambridge, England; [Lee, Kyungchan] Univ Wurzburg, Phys Inst, Wurzburg, Germany; [Lee, Kyungchan] Univ Wurzburg, Wurzburg Dresden Cluster Excellence Ct Qmat, Wurzburg, Germany	United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Harvard University; Leibniz Institute for Solid State & Materials Research Dresden; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Lanzhou University; University of Cambridge; University of Wurzburg; University of Wurzburg	Canfield, PC; Kaminski, A (corresponding author), Ames Lab, Ames, IA 50011 USA.; Canfield, PC; Kaminski, A (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.; Slager, RJ (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Slager, RJ (corresponding author), Univ Cambridge, Cavendish Lab, TCM Grp, Cambridge, England.	rjs269@cam.ac.uk; canfield@ameslab.gov; adamkam@ameslab.gov	Lou, Rui/Q-8574-2017; Fedorov, Alexander/K-7062-2013; Sanchez-Barriga, Jaime/I-3493-2013	Lou, Rui/0000-0002-4852-6189; Fedorov, Alexander/0000-0002-9228-7082; Voroshnin, Vladimir/0000-0002-9320-1180; Sanchez-Barriga, Jaime/0000-0001-9947-6700; Ahn, Junyeong/0000-0001-7393-8823	US Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Science and Engineering; US Department of Energy [DE-AC02-07CH11358]; Center for the Advancement of Topological Semimetals (CATS), an Energy Frontier Research Center - US DOE, Office of Basic Energy Sciences; Marie Sklodowska-Curie programme under EC grant [842901]; Winton programme; Trinity College at the University of Cambridge; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2020R1A6A3A03037129]; CATS; Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat [SFB1143]; National Natural Science Foundation of China [11904144]; Impuls- und Vernetzungsfonds der Helmholtz-Gemeinschaft [HRSF-0067]	US Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); Center for the Advancement of Topological Semimetals (CATS), an Energy Frontier Research Center - US DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Marie Sklodowska-Curie programme under EC grant; Winton programme; Trinity College at the University of Cambridge; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); CATS; Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Impuls- und Vernetzungsfonds der Helmholtz-Gemeinschaft	We thank A. Vishwanath, A. Chubukov and J. Schmalian for useful discussions and comments. ARPES measurements were supported by the US Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Science and Engineering. Ames Laboratory is operated for the US Department of Energy by Iowa State University under contract no. DE-AC02-07CH11358. Crystal growth and characterization were supported by the Center for the Advancement of Topological Semimetals (CATS), an Energy Frontier Research Center funded by the US DOE, Office of Basic Energy Sciences. R.-J.S. acknowledges funding from the Marie Sklodowska-Curie programme under EC grant no. 842901 and the Winton programme, as well as Trinity College at the University of Cambridge. J.A. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no. 2020R1A6A3A03037129) and CATS. A.F. and R.L. acknowledge support from SFB1143 'Correlated Magnetism', Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat. R.L. acknowledges support from National Natural Science Foundation of China (grant no. 11904144). J.S.-B. gratefully acknowledges financial support from the Impuls- und Vernetzungsfonds der Helmholtz-Gemeinschaft under grant no. HRSF-0067 (Helmholtz-Russia Joint Research Group).	Ahn KH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.184432; Armitage NP, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015001; Bihlmayer G, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/050202; Canfield P. C., CANFIELD CRUCIBLE SE; Canfield PC, 2020, REP PROG PHYS, V83, DOI 10.1088/1361-6633/ab514b; Canfield PC, 2016, PHILOS MAG, V96, P84, DOI 10.1080/14786435.2015.1122248; CANFIELD PC, 1992, PHILOS MAG B, V65, P1117, DOI 10.1080/13642819208215073; Canfield PC, 2001, J CRYST GROWTH, V225, P155, DOI 10.1016/S0022-0248(01)00827-2; FISHER ME, 1962, PHILOS MAG, V7, P1731, DOI 10.1080/14786436208213705; FISHER ME, 1968, PHYS REV LETT, V20, P665, DOI 10.1103/PhysRevLett.20.665; Hirschberger M, 2016, NAT MATER, V15, P1161, DOI [10.1038/nmat4684, 10.1038/NMAT4684]; Huang Z, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.235167; Jiang R, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867517; Kumigashira H, 1996, PHYS REV B, V54, P9341, DOI 10.1103/PhysRevB.54.9341; Kuroda K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16707-6; Kuroda K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.086402; Matt C. E., 2020, SPIN POLARIZED IMAGI; Morali N, 2019, SCIENCE, V365, P1286, DOI 10.1126/science.aav2334; NERESON N, 1971, J APPL PHYS, V42, P1625, DOI 10.1063/1.1660369; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Oinuma H, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.125122; Petrovykh DY, 1998, APPL PHYS LETT, V73, P3459, DOI 10.1063/1.122796; SCHOBING.P, 1973, J PHYS C SOLID STATE, V6, P725, DOI 10.1088/0022-3719/6/4/020; Scholz MR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216801; Schroter NBM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd5000; Schulz S, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.035123; Sheka V, 1959, FIZ TVERD TELA+, V1, P162; Smejkal L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8809; Tamai A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031021; Topp A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041073; TSUCHIDA T, 1965, J CHEM PHYS, V43, P2087, DOI 10.1063/1.1697079; Usachov DY, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.237202; VENUS D, 1993, PHYS REV B, V48, P6144, DOI 10.1103/PhysRevB.48.6144; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang YH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207602; Wang ZJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.236401; Wu Y, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.035134; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Zeng M., 2015, TOPOLOGICAL SEMIMETA	46	4	4	12	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					610	+		10.1038/s41586-022-04412-x	http://dx.doi.org/10.1038/s41586-022-04412-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322253	Green Submitted			2022-12-28	WOS:000772661800015
J	Slomski, A				Slomski, Anita			Postantibiotic Microbiome Therapeutic Reduces C difficile Recurrence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1118	1118		10.1001/jama.2022.3753	http://dx.doi.org/10.1001/jama.2022.3753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315889				2022-12-28	WOS:000775589900011
J	Stead, W				Stead, Wendy			One Person	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, an infectious diseases physician recounts a minor breakthrough in her efforts to convince her patient to get a COVID-19 vaccination by relying on their 20-year relationship of care, trust, and love.	[Stead, Wendy] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stead, W (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St,LMOB Suite GB, Boston, MA 02215 USA.	wstead@bidmc.harvard.edu							0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2022	327	12					1131	1132		10.1001/jama.2022.3308	http://dx.doi.org/10.1001/jama.2022.3308			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0C8XO	35315881				2022-12-28	WOS:000775589900017
J	Musisi, NN				Musisi, Nakibuuka Noor			Uganda should reconsider its proposed public health legislation that places tough sanctions on people who are unvaccinated	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Musisi, Nakibuuka Noor] Ctr Hlth Human Rights & Dev CEHURD, Kampala, Uganda		Musisi, NN (corresponding author), Ctr Hlth Human Rights & Dev CEHURD, Kampala, Uganda.							[Anonymous], 2021, XINHUA 0809; Okiror S., 2021, GUARDIAN 0615; Twinomugisha BK., 2015, FUNDAMENTALS HLTH LA; Wagner RA, INFORM CONSENT	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o756	10.1136/bmj.o756	http://dx.doi.org/10.1136/bmj.o756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314425	Bronze			2022-12-28	WOS:000773915700007
J	Wise, J				Wise, Jacqui			Covid-19: Evusheld is approved in UK for prophylaxis in immunocompromised people	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3064; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2990; Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2319; www.gov.uk, GOVT NEWS	4	11	11	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o722	10.1136/bmj.o722	http://dx.doi.org/10.1136/bmj.o722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301227	Bronze			2022-12-28	WOS:000796719200012
J	Abubakar, I; Dalglish, SL; Angell, B; Sanuade, O; Abimbola, S; Adamu, AL; Adetifa, IMO; Colbourn, T; Ogunlesi, AO; Onwujekwe, O; Owoaje, ET; Okeke, IN; Adeyemo, A; Aliyu, G; Aliyu, MH; Aliyu, SH; Ameh, EA; Archibong, B; Ezeh, A; Gadanya, MA; Ihekweazu, C; Ihekweazu, V; Iliyasu, Z; Chiroma, AK; Mabayoje, DA; Sambo, MN; Obaro, S; Yinka-Ogunleye, A; Okonofua, F; Oni, T; Onyimadu, O; Pate, MA; Salako, BL; Shuaib, F; Tsiga-Ahmed, F; Zanna, FH				Abubakar, Ibrahim; Dalglish, Sarah L.; Angell, Blake; Sanuade, Olutobi; Abimbola, Seye; Adamu, Aishatu Lawal; Adetifa, Ifedayo M. O.; Colbourn, Tim; Ogunlesi, Afolabi Olaniyi; Onwujekwe, Obinna; Owoaje, Eme T.; Okeke, Iruka N.; Adeyemo, Adebowale; Aliyu, Gambo; Aliyu, Muktar H.; Aliyu, Sani Hussaini; Ameh, Emmanuel A.; Archibong, Belinda; Ezeh, Alex; Gadanya, Muktar A.; Ihekweazu, Chikwe; Ihekweazu, Vivianne; Iliyasu, Zubairu; Chiroma, Aminatu Kwaku; Mabayoje, Diana A.; Sambo, Mohammed Nasir; Obaro, Stephen; Yinka-Ogunleye, Adesola; Okonofua, Friday; Oni, Tolu; Onyimadu, Olu; Pate, Muhammad Ali; Salako, Babatunde L.; Shuaib, Faisal; Tsiga-Ahmed, Fatimah; Zanna, Fatima H.			The Lancet Nigeria Commission: investing in health and the future of the nation	LANCET			English	Review							REPRODUCTIVE HEALTH; RELIGIOUS LEADERS; CONTRACEPTIVE USE; OGUN STATE; CARE; SERVICES; COVERAGE; INFORMATION; WORKERS; SYSTEM		[Abubakar, Ibrahim; Dalglish, Sarah L.; Angell, Blake; Sanuade, Olutobi; Colbourn, Tim; Ogunlesi, Afolabi Olaniyi] UCL Inst Global Hlth, London, England; [Angell, Blake] UNSW Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Sanuade, Olutobi] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Abimbola, Seye] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Adamu, Aishatu Lawal; Gadanya, Muktar A.; Iliyasu, Zubairu; Chiroma, Aminatu Kwaku; Tsiga-Ahmed, Fatimah] Bayero Univ, Dept Community Med, Kano, Nigeria; [Adamu, Aishatu Lawal; Gadanya, Muktar A.; Chiroma, Aminatu Kwaku; Tsiga-Ahmed, Fatimah] Aminu Kano Teaching Hosp Kano, Kano, Nigeria; [Adamu, Aishatu Lawal; Adetifa, Ifedayo M. O.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Adamu, Aishatu Lawal; Adetifa, Ifedayo M. O.] KEMRI Wellcome Trust Res Programme, Dept Epidemiol & Demog, Kilifi, Kenya; [Adetifa, Ifedayo M. O.] Univ Lagos, Dept Paediat & Child Hlth, Coll Med, Lagos, Nigeria; [Ogunlesi, Afolabi Olaniyi] Vesta Healthcare Partners Nigeria Ltd, Lagos, Nigeria; [Onwujekwe, Obinna] Univ Nigeria Enugu Campus, Hlth Policy Res Grp, Enugu, Nigeria; [Owoaje, Eme T.] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria; [Okeke, Iruka N.] Univ Ibadan, Dept Pharmaceut Microbiol, Fac Pharm, Ibadan, Nigeria; [Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Aliyu, Gambo; Zanna, Fatima H.] Natl Agcy Control AIDS, Abuja, Nigeria; [Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Aliyu, Sani Hussaini] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Infect Dis & Microbiol, Cambridge, England; [Ameh, Emmanuel A.] Natl Hosp, Div Paediat Surg, Abuja, Nigeria; [Archibong, Belinda] Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA; [Ezeh, Alex] Drexel Univ, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Ihekweazu, Chikwe; Yinka-Ogunleye, Adesola] Nigeria Ctr Dis Control, Abuja, Nigeria; [Ihekweazu, Vivianne] Nigeria Hlth Watch, Abuja, Nigeria; [Mabayoje, Diana A.] Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England; [Sambo, Mohammed Nasir] Natl Hlth Insurance Scheme, Abuja, Nigeria; [Obaro, Stephen] Univ Nebraska Med Ctr, Dept Pediat Infect Dis, Omaha, NE USA; [Obaro, Stephen] Int Fdn Infect Dis Nigeria, Abuja, Nigeria; [Okonofua, Friday] Univ Benin, Ctr Excellence Reprod Hlth Innovat, Benin, Nigeria; [Okonofua, Friday] Univ Med Sci, Ondo City, Nigeria; [Oni, Tolu] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Oni, Tolu] Univ Cape Town, Res Initiat Cities Hlth & Equity, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Onyimadu, Olu] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pate, Muhammad Ali] World Bank, Hlth Nutr & Populat HNP Global Practice & Global, 1818 H St NW, Washington, DC 20433 USA; [Pate, Muhammad Ali] Harvard T Chan Sch Publ Hlth, Boston, MA USA; [Salako, Babatunde L.] Nigeria Inst Med Res, Lagos, Nigeria; [Shuaib, Faisal] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria	University of London; University College London; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Northwestern University; Feinberg School of Medicine; University of Sydney; Bayero University; University of London; London School of Hygiene & Tropical Medicine; University of Lagos; University of Nigeria; University of Ibadan; University of Ibadan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Columbia University; Drexel University; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University of Nebraska System; University of Nebraska Medical Center; University of Benin; University of Cambridge; University of Cape Town; University of Oxford; The World Bank; Harvard University; Harvard T.H. Chan School of Public Health	Abubakar, I (corresponding author), UCL Inst Global Hlth, London WC1N 1EH, England.	i.abubakar@ucl.ac.uk	Tsiga-Ahmed, Fatimah/ABA-2729-2021	Tsiga-Ahmed, Fatimah/0000-0003-4207-7981; Onyimadu, Oluchukwu/0000-0002-1724-3485; Angell, Blake/0000-0002-7188-7740; Abubakar, Ibrahim/0000-0002-0370-1430	Bill & Melinda Gates Foundation [003254]; National Institute for Health Research (NIHR) [SRF-2011-04-001, NF-SI-0616-10037]; UK Medical Research Council; UK Department of Health; Wellcome Trust; Department for International Development through an African Research Leader Fellowship [MR/S005293/1]; NIHR [16/137/34]; UK Government	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; Wellcome Trust(Wellcome Trust); Department for International Development through an African Research Leader Fellowship; NIHR(National Institute for Health Research (NIHR)); UK Government	We are grateful to the Bill & Melinda Gates Foundation for funding this Commission and to the UK Wellcome Trust and Wellcome Collection for hosting the first meeting of the Commission. We are also grateful to the following individuals for their contribution to various stages of the Commission and meetings: Sarah Sterlini for administrative support and project management; Kwame Sakyi, Prince Owusu, Janelle Zora, Fatema Tuz Zohra, and Paige Thieda (Ghana health insurance case study); Charles Ezenduka (Anambra health insurance case study); Jessica Moriera (financing case study); Engr. Emmanuel John (Ochenuel Mobility in Abuja); Olamide Udoma-Ejorh (Lagos Urban Development Initiative); Charles Orjiakor (policy landscape review); Loretta F Ntoimo (report of key informant interviews on the history of Nigeria's health-care system); David Adewole and Mutiat Oladejo (background research on history and policy); Mohsen Naghavi, Maha Ezalarab, Scott Glenn, and Ally Walker (Institute for Health Metrics and Evaluation-bespoke GBD analysis and comparison paper); Rukevwe Aliogo for her support mapping health facilities using ArcGIS; and Caroline Jehu-Appiah (BMGF). IA acknowledges funding from the National Institute for Health Research (NIHR; SRF-2011-04-001; NF-SI-0616-10037), the Bill & Melinda Gates Foundation (003254), the UK Medical Research Council, the UK Department of Health, and the Wellcome Trust. IMOA is funded by the UK Medical Research Council and Department for International Development through an African Research Leader Fellowship (MR/S005293/1). The funders of the Commission had no role in design, information, collection, analysis, interpretation, writing of the report, or the decision to submit the paper for publication. TO is supported by the NIHR (16/137/34) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR, or the UK Department of Health and Social Care.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abimbola JM, 2016, AFR HEALTH SCI, V16, P962, DOI 10.4314/ahs.v16i4.12; Abimbola S, 2017, INT J HEALTH PLAN M, V32, P492, DOI 10.1002/hpm.2356; Abua U. J., 2020, Journal of Pharmacy and Bioresources, V17, P44, DOI 10.4314/jpb.v17i1.8; Abubakar I, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004793; Abubakar U, 2015, EUR SCI J, V3, P173; Adedini SA, 2018, GLOB HEALTH-SCI PRAC, V6, P500, DOI 10.9745/GHSP-D-18-00135; Adeleke IT, 2015, HEALTH INF MANAG J, V44, P30, DOI 10.1177/183335831504400104; Adeloye A, 1974, Med Hist, V18, P275; Adeniyi Oluwafunmilayo Funke, 2019, Int J MCH AIDS, V8, P70, DOI 10.21106/ijma.273; Adepoju Ibukun-Oluwa Omolade, 2017, JMIR Mhealth Uhealth, V5, pe38, DOI 10.2196/mhealth.7185; Adetifa IMO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21837-5; Adewuya AO, 2019, J AFFECT DISORDERS, V253, P118, DOI 10.1016/j.jad.2019.04.025; Adewuyi EO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197324; Adeyemo A, 2013, J HYPERTENS, V31, P201, DOI 10.1097/HJH.0b013e32835b0842; Adeyi O, 2016, HEALTH SYST REFORM, V2, P285, DOI 10.1080/23288604.2016.1224023; African Development Bank Group, 2020, BUILD RES HLTH SYST; African Institute for Health and Leadership Development, 2015, BRAIN DRAIN BRAIN GA; Agho KE, 2018, INT HEALTH, V10, P172, DOI 10.1093/inthealth/ihy011; Aina M, 2017, VACCINE, V35, P2175, DOI 10.1016/j.vaccine.2016.11.100; Ajayi A., 1980, GROUNDWORK NIGERIAN; Ajiboye BA, 2014, INFORM HEALTH SOC CA, V39, P104, DOI 10.3109/17538157.2013.858044; Akeju DO, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0139-7; Akin-Otiko B, 2013, W AFRICAN J NURSING, V24, P28; Akinyemi JO, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1083-9; Alawode GO, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10133-5; Aliyu Alhaji Abubakar, 2017, Pan Afr Med J, V26, P124, DOI 10.11604/pamj.2017.26.124.9861; Aliyu MH, 2019, CONT CLIN TRIAL COMM, V15, DOI 10.1016/j.conctc.2019.100362; Aliyu MH, 2016, LANCET HIV, V3, pE202, DOI 10.1016/S2352-3018(16)00018-7; Aloh HE, 2019, AFR J REPROD HEALTH, V23, P57, DOI 10.29063/ajrh2019/v23i3.6; Alubo O, 2017, INT J HEALTH SERV, V47, P778, DOI 10.1177/0020731416675981; Amadi Ogechukwu F, 2019, Niger Med J, V60, P256, DOI 10.4103/nmj.NMJ_51_19; Angell B, 2022, LANCET, V399, P1117, DOI 10.1016/S0140-6736(21)02722-7; Angell BJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002759; [Anonymous], 2021, TEDROS ADHANOM GHEBR; [Anonymous], 2011, ABUJA DECLARATION 10; Anthony IO., 2018, INT J TROP DIS HLTH, V24, P1; Anyaehie UE, 2012, ANN MED HEALTH SCI R, V2, P19, DOI 10.4103/2141-9248.96931; Anyanwu SNC, 2011, BREAST, V20, pS51, DOI 10.1016/j.breast.2011.01.009; Appiah-Kubi SNK, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093715; Archibong B, 2018, OXF DEV STUD, V46, P325, DOI 10.1080/13600818.2017.1416072; Aregbeshola BS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00048; Aregbeshola BS, 2016, LANCET, V387, P2506, DOI 10.1016/S0140-6736(16)30798-X; Arnab Mukherji, 2012, Economic and Political Weekly, V47, P57; Asiwaju AI, 1972, AFR STUD REV, V15, P1; Asogwa MNO, 2016, EUR SCI J, V12, P175; Assefa Y, 2020, B WORLD HEALTH ORGAN, V98, P894, DOI 10.2471/BLT.19.248328; Awe G., 2018, THESIS WALDEN U, P1; Awosusi A, 2015, LANCET GLOB HEALTH, V3, pE514, DOI 10.1016/S2214-109X(15)00088-1; Awotiwon A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001079; Badejo O, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003349; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bawa S, 2019, B WORLD HEALTH ORGAN, V97, P24, DOI 10.2471/BLT.18.211565; Bawa S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6194-y; Bishara DB, 2020, J TROP DIS PUBLIC HL, V8, P6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Centre for Health Economics and Development, 2016, NAT HLTH ACC 2010 20; Chukwu E, 2016, JMIR MHEALTH UHEALTH, V4, P88, DOI 10.2196/mhealth.4342; Copenhagen Consensus Centre, 2015, NOB LAUR GUID SMART; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cottarelli C., 2011, REV MOB DEV COUNTR; Council on Foreign Relations, 2021, NIG SEC TRACK; CREHS Policy Brief, 2011, ASS US COST HEALTHC; Croitoru L., 2020, COST AIR POLLUTION L; Dahiru T, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.321.6527; Dan-Nwafor C, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020399; Davin Anna, 1997, TENSIONS EMPIRE COLO, P87; Dawodu ST., 2015, MAJOR GEN BABAGINDA; Delsen F, 2020, ZOOM WORKSHOP; Department of Health Research, 2021, HLTH TECHNOLOGY ASSE; Devadasan N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-43; dhis2, DHIS2 ACT; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Division UDoEaSAP, 2019, WORLD POPULATION PRO; Doherty J, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1461338; Ejughemre UJ, 2014, INT J HEALTH POLICY, V2, P13, DOI 10.15171/ijhpm.2014.04; Elimian KO, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08521-y; Erchick DJ, 2017, INT J HEALTH POLICY, V6, P403, DOI 10.15171/ijhpm.2016.150; Etiaba E, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000917; Ezeanolue EE, 2016, JAIDS-J ACQ IMM DEF, V72, pS161, DOI 10.1097/QAI.0000000000001066; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fadipe N. A., 1970, SOCIOLOGY YORUBA; Farotimi AA, 2018, IRAN J NURS MIDWIFE, V23, P471, DOI 10.4103/ijnmr.IJNMR_208_17; Federal Government of Nigeria, 2010, NIG VIS 20 2020 ABR; Federal Ministry of Health, 2021, NATL OVERPRESCRIBING; Federal Ministry of Water Resources, 2015, MAK NIG OP DEF FREE; Gaitonde R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008856.pub2; Galadanci NA, 2020, AM J HEMATOL, V95, pE247, DOI 10.1002/ajh.25900; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Ghafuri DL, 2022, J PEDIAT HEMATOL ONC, V44, pE56, DOI 10.1097/MPH.0000000000002179; Ghafuri DL, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010119; Ghoddoosi-Nejad D, 2017, BALI MED J, V6, P102, DOI 10.15562/bmj.v6i1.369; Githaiga C., UNMASKING NAIJA LIFE; Global Polio Eradication Initiative, 2018, REL LEAD FUELL DEM P; Goodkind D, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1423861; Government of India, 2018, AY BHAR; Government of the Federal Republic of Nigeria, 2019, NAT HLTH ACC; Green, 2019, FISTFUL SHELLS W AFR; Greszczuk C, 2019, IMPLEMENTING HLTH AL; Hanson K., 2020, RES PURCHASING ACHIE; Heller DJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16545; Hirose A, 2018, HEALTH POLICY PLANN, V33, P666, DOI 10.1093/heapol/czy032; Hiscock J, 1995, HEALTH POLICY PLANN, V10, P28; Horton R, 2018, LANCET, V392, P902, DOI 10.1016/S0140-6736(18)32211-6; Ibe O, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0711-y; Institute for Security Studies, 2015, POW INFL AFR ALG EG; Institute of Current World Affairs, 1964, 1963 CENS POL POP NI; Ishola F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174084; ITYAVYAR DA, 1987, SOC SCI MED, V24, P487, DOI 10.1016/0277-9536(87)90338-8; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jennings L, 2015, INT J MED INFORM, V84, P341, DOI 10.1016/j.ijmedinf.2015.01.016; Jimenez ER, 2017, ARISTOTLE'S CONCEPT OF MIND, P33; Jinadu KA, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.19.15828; Karan A, 2017, SOC SCI MED, V181, P83, DOI 10.1016/j.socscimed.2017.03.053; Kinyoki DK, 2020, NATURE, V577, P231, DOI 10.1038/s41586-019-1878-8; Klugman J., VOICE AGENCY EMPOWER; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kutzin J, 2013, B WORLD HEALTH ORGAN, V91, P602, DOI 10.2471/BLT.12.113985; LaForgia G, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-9618-6; Lagos State Ministry of Transportation Lagos Metropolitan Area Transport Authority United Nations Environment Programme Institute for Transportation and Development Policy, 2018, LAGOS NONMOTORISED T; Lassa S., 2016, THESIS U SHEFFIELD, P1; Llyod P, 1966, POLITICAL STRUCTURE; Maina J, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0142-2; Makinde O, 2012, ASS ROUTINE HLTH MAN; Makinde OA, 2011, AIDS, V25, P2289, DOI 10.1097/QAD.0b013e32834d6ad2; Makinde OA, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1811476; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mathauer I., 2017, Strategic purchasing for universal health coverage: key policy issues and questions: a summary from expert and practitioners' discussions; Maystadt JF, 2019, J ECON GEOGR, V19, P1119, DOI 10.1093/jeg/lby032; Mberu BU, 2014, POPUL REV, V53, P23; Ministry of Health and Family Welfare, 2018, OP GUID AYUSHM BHAR; Ministry of Health-Ethiopia, 2019, ESS HLTH PACK ETH; Molemodile S, 2017, GLOB PUBLIC HEALTH, V12, P601, DOI 10.1080/17441692.2017.1291700; Mume JOM, 1996, PRINCIPLES PRACTICE; National Population Commission (NPC) (Nigeria) and ICF International, 2019, FEDERAL REPUBLIC NIG; Ngwa MC, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009046; Nigeria Governors' forum, PREP MED TERM SECT S; Nigeria Health Watch, 2018, EM NIG MED DOCT SURV; Nigerian Communications Commission, 2020, STAT REP; Nnebue CC, 2013, NIGER J CLIN PRACT, V16, P483, DOI 10.4103/1119-3077.116894; NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97; Nwankwo B, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.289.15802; Oduwole AA, 2010, PROGRAM-ELECTRON LIB, V44, P109, DOI 10.1108/00330331011039472; OGBU O, 1992, SOC SCI MED, V34, P615, DOI 10.1016/0277-9536(92)90189-W; Ogbuabor DC, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3078-x; Ojo OE, 2020, HEALTH SECUR, V18, P16, DOI 10.1089/hs.2019.0051; Okafor IP, 2014, MALAWI MED J, V26, P45; Okeke EN, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2284-2; Okeke I. N., 2011, DIVINING SEEDS CASE; Okpani Arnold Ikedichi, 2015, Niger Med J, V56, P305, DOI 10.4103/0300-1652.170382; Okusanya BO, 2018, J COMM MED PRIMARY H, V30, P47; Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450; Olatunde A., 2016, EFFECTS COLONIALISM; Olowoporoku OluwaseunAyodele., 2011, AIR POLLUT 19, V147, P1; Olowoyeye AO, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4272-1; Olusanya GO, 1980, GROUNDWORK NIGERIAN, P545; Oni T, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001717; Onoka CA, 2011, TROP MED INT HEALTH, V16, P1334, DOI 10.1111/j.1365-3156.2011.02836.x; Ononokpono Dorothy Ngozi, 2014, Pan Afr Med J, V17 Suppl 1, P2, DOI 10.11694/pamj.supp.2014.17.1.3596; Onwujeirwe O, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00200; Onwujekwe O, 2019, NIGER J CLIN PRACT, V22, P1516, DOI 10.4103/njcp.njcp_503_18; Onwujekwe O, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.582072; Onwujekwe O, 2020, INT J HEALTH POLICY, V9, P286, DOI [10.15171/ijhpm.2019.128, 10.15171/IJHPM.2019.128]; Onwujekwe O, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4512-4; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Ope B.W., 2020, J GLOB HEALTH REP, V4, DOI [10.29392/001c.12733, DOI 10.29392/001C.12733]; Open Government Partnership, 2019, OP GOV PARTN GLOB RE; ORUBULOYE IO, 1991, STUD FAMILY PLANN, V22, P61, DOI 10.2307/1966777; Oruma P, 2019, NIGERIA HEALTHCARE S; Osakwe Adeline, 2013, Int J Risk Saf Med, V25, P219, DOI 10.3233/JRS-130605; Oxford Business Group, 2016, IMPR PUBL HLTH SERV; Oyedeji Remi, 2014, Niger Med J, V55, P519, DOI 10.4103/0300-1652.144715; Oyeyemi Adewale Luqman, 2018, Pan Afr Med J, V30, P175, DOI 10.11604/pamj.2018.30.175.12679; Ozoemena EL, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0349-x; Parkhurst JO, 2005, HEALTH POLICY, V73, P127, DOI 10.1016/j.healthpol.2004.11.001; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; PEARCE TO, 1980, SOC SCI MED-MED ANTH, V14, P91, DOI 10.1016/0160-7987(80)90057-5; Peters G, 2014, HEALTH POLICY PLANN, V29, P642, DOI 10.1093/heapol/czt052; Pongsiri MJ, 2017, LANCET PLANET HEALTH, V1, pE257, DOI 10.1016/S2542-5196(17)30116-X; Powell -Jackson T, 2012, FISCAL SPACE HLTH RE; Reiner RC, 2020, LANCET, V395, P1779, DOI 10.1016/S0140-6736(20)30114-8; Russell S., 1996, PRINCIPLES PRACTICE; Sakthivel Selvaraj, 2012, Economic and Political Weekly, V47, P60; Sato R, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4141-y; Satterthwaite David, 2007, HUMAN SETTLEMENTS DI; Savedoff WD, 2007, TRANSPARENCY CORRUPT; Schram R., 1971, HIST NIGERIA HLTH SE; Scott-Emuakpor A.J.N.M.J., 2010, NIGERIAN MED J, V51, P53; Selvaraj S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018020; Shankardass K, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0295-z; Shigute Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228558; Shuaib F, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002203; Silenou BC, 2020, EMERG INFECT DIS, V26, P345, DOI 10.3201/eid2602.191139; Singh P, 2017, CLIN EPIDEMIOL GLOB, V5, P33, DOI 10.1016/j.cegh.2016.03.002; Siribie M, 2016, CLIN INFECT DIS, V63, pS264, DOI 10.1093/cid/ciw624; Slaymaker E, 2020, LANCET GLOB HEALTH, V8, pE567, DOI 10.1016/S2214-109X(20)30060-7; Somefun GO, 1996, PRINCIPLES PRACTICE; State Ministry of Health, 2018, AN STAT STRAT HLTH D; Tandon A, 2010, ASSESSING PUBLIC EXP; Tangcharoensathien V, 2015, HEALTH POLICY PLANN, V30, P1152, DOI 10.1093/heapol/czu120; Tankwanchi ABS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001513; Tesema A, 2020, B WORLD HEALTH ORGAN, V98, P906, DOI 10.2471/BLT.20.271239; Tesema AG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240984; The Global Climate and Health Alliance, 2018, AR NAT CLIM COMM EN; The World Bank, 2020, NIG DEV UPD DEC 2020; The World Bank, 2021, CURR HLTH EXP GDP NI; The World Bank, 2021, OUT OF POCKET EXPEND; The World Bank, 2021, GDP CURR US NIG; The World Bank, 2011, HLTH PARTN GOV CAN E; The World Bank, 2019, BUILDING CLIMATE RES; The World Bank, 2021, GDP CAP CURR US NIG; The World Bank, RISK CAT EXP SURG CA; The World Bank Group, 2014, COST PLAN SCAL NUTR; Tom-Aba D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131000; Transparency International, 2017, CORRUPTION PERCEPTIO; Tsiga-Ahmed FI, 2020, ANN AFR MED, V19, P20, DOI 10.4103/aam.aam_9_19; Ucheaga DN, 2010, GLOB PUBLIC HEALTH, V5, P611, DOI 10.1080/17441690903463619; UN Department of Economic and Social Affairs Population Division, 2019, WORLD POPULATION PRO, V2; UN Inter -Agency for Child Mortality Estimation, 2020, REP 2020 EST DEV UNI; UN Research Institute for Social Development, 2013, HLTH ALL POLICIES SE; UN (United Nations Department of Economic and Social Affairs Population Division), 2019, STESASERA427 UN POP; UNAIDS, NEW SURV RES IND NIG; United Nations Population Fund, 2020, DEMOGRAPHIC DIVIDEND; Urdal H, 2006, INT STUD QUART, V50, P607, DOI 10.1111/j.1468-2478.2006.00416.x; Usifoh N., 2019, GLOB J HLTH SCI, V11, P109; Varrella S., 2021, DISTRIBUTION RELIGIO; Vaughan M, 2018, B HIST MED, V92, P172, DOI 10.1353/bhm.2018.0007; Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2; Watts N, 2021, LANCET, V397, P129, DOI 10.1016/S0140-6736(20)32290-X; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2021, SCORE NIG; WHO, 2006, EVALUATION COSTS BEN; WHO, 2019, TRENDS MAT MORT 2000; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Bank, 2020, COST AIR POLL LAG; World Bank, 2020, P174635 PID WORLD BA; World Bank, 2020, NIG HUM CAP IND 2020; World Bank, 2020, HUM CAP IND 2020 UPD; World Bank, 2021, CURR HLTH EXP GDP 20; World Economic Forum, 2014, PROSP REAP DEM DIV N; World Health Organization, 1999, WORLD HLTH REPORT 19; Yourkavitch J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010806	248	12	12	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1155	1200		10.1016/S0140-6736(21)02488-0	http://dx.doi.org/10.1016/S0140-6736(21)02488-0			46	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35303470	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000770814300024
J	Liu, ST; Lin, CC; Wei, JCC				Liu, Shu-Tsen; Lin, Chieh-Chung; Wei, James Cheng-Chung			Mediterranean Diet or Mindfulness-Based Stress Reduction and Prevention of Small-for-Gestational-Age BirthWeights in Newborns Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Liu, Shu-Tsen] China Med Univ Childrens Hosp, Dept Child & Adolescent Psychiat, Taichung, Taiwan; [Lin, Chieh-Chung] Taichung Vet Gen Hosp, Childrens Med Ctr, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Dept Med, 110 Jianguo N Rd,Sect 1, Taichung 40201, Taiwan.	jccwei@gmail.com						[Anonymous], 2018, PREGNANCY MONITORING, V3rd; Crovetto F, 2021, JAMA-J AM MED ASSOC, V326, P2150, DOI 10.1001/jama.2021.20178; Sevild CH, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09111-8	3	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1293	+						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380584				2022-12-28	WOS:000783965500038
J	Pal, N				Pal, Neha			A Love Letter to Grief	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pal, Neha] Texas A&M Coll Med, 8447 Riverside Pkwy, Bryan, TX 77807 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Pal, N (corresponding author), Texas A&M Coll Med, 8447 Riverside Pkwy, Bryan, TX 77807 USA.	npal@tamu.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1233	1233		10.1001/jama.2022.3478	http://dx.doi.org/10.1001/jama.2022.3478			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380581				2022-12-28	WOS:000783965500014
J	Plackett, B				Plackett, Benjamin			The Indigenous epicentre	NATURE			English	News Item						Diseases; Public health; Health care; Medical research		Hepatitis B is especially prevalent in Aboriginal Australians. Ranging from genes to geography, the reasons are interwoven and complex. By Benjamin Plackett										Davies J, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz469; Markham F., 2018, INCOME POVERTY INEQU; Qama A, 2021, INTERN MED J, V51, P910, DOI 10.1111/imj.15069; Wakerman J, 2019, MED J AUSTRALIA, V210, P202, DOI 10.5694/mja2.50041	4	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S62	S63		10.1038/d41586-022-00820-1	http://dx.doi.org/10.1038/d41586-022-00820-1			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354991	Bronze			2022-12-28	WOS:000776361600017
J	Sage, WM; Yang, YT				Sage, William M.; Yang, Y. Tony			Reducing "COVID-19 Misinformation" While Preserving Free Speech	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sage, William M.] Univ Texas Austin, Sch Law, Austin, TX 78712 USA; [Sage, William M.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Yang, Y. Tony] George Washington Univ, Ctr Hlth Policy & Media Engagement, Sch Nursing, Washington, DC 20037 USA; [Yang, Y. Tony] George Washington Univ, Dept Hlth Policy & Management, Milken Inst, Sch Publ Hlth, Washington, DC 20037 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; George Washington University; George Washington University	Sage, WM (corresponding author), 727 E Dean Keeton St, Austin, TX 78705 USA.	wsage@law.utexas.edu						Farmer B., 2022, KAISER HLTH NEWS; Rubin R, 2022, JAMA-J AM MED ASSOC, V327, P904, DOI 10.1001/jama.2022.1083; Schenker L., 2022, CHICAGO TRIBUNE	3	1	1	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1443	1444		10.1001/jama.2022.4231	http://dx.doi.org/10.1001/jama.2022.4231		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35357403				2022-12-28	WOS:000776736300002
J	Majeed, A; Tessier, E; Stowe, J; Mokdad, AH				Majeed, Azeem; Tessier, Elise; Stowe, Julia; Mokdad, Ali H.			How data from the United Kingdom has guided covid-19 vaccine policies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Tessier, Elise] UK Hlth Secur Agcy, Epidemiol Cell, 33-155 Waterloo Rd, London, England; [Stowe, Julia] UK Hlth Secur Agcy, Immunisat & Vaccine Preventable Dis Div, 61 Colindale Ave, London, England; [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Imperial College London; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Majeed, A (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.			Majeed, Azeem/0000-0002-2357-9858	NIHR Applied Research Collaboration NW London	NIHR Applied Research Collaboration NW London	AM is supported by the NIHR Applied Research Collaboration NW London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]; Dowd JB, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o496; Majeed A, 2021, J ROY SOC MED, V114, P337, DOI 10.1177/01410768211013437; Majeed A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4654; Murray CH, MANDATES END PREPARI; Office for National Statistics, COR COVID 19 LAT INS; Tapper J, DISMAY FUNDING UKS W; Walker P, DAVID NUK OVER 75S V	8	0	0	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o839	10.1136/bmj.o839	http://dx.doi.org/10.1136/bmj.o839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354582	Bronze			2022-12-28	WOS:000779561800016
J	Ekhart, C; van Hunsel, F; Sellick, V; de Vries, T				Ekhart, Corine; van Hunsel, Florence; Sellick, Vanessa; de Vries, Tjalling			Neuropsychiatric reactions with the use of montelukast	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ekhart, Corine; van Hunsel, Florence] Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands; [Sellick, Vanessa] Montelukast Singulair Side Effects Support & Disc, Int Grp, Melbourne, Vic, Australia; [de Vries, Tjalling] Med Ctr Leeuwarden MCL, Dept Paediat, Leeuwarden, Netherlands	Medical Center Leeuwarden	Ekhart, C (corresponding author), Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands.	c.ekhart@lareb.nl						Perona AA, 2016, DRUG SAFETY, V39, P69, DOI 10.1007/s40264-015-0360-2; [Anonymous], 2019, FDA BRIEF DOC; [Anonymous], 2021, EXPL ENGL PRESCR DAT; Australian Government Department of Health and Ageing Therapeutic Goods Administration, 2013, MED SAF UPD MONT NEU; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Bayer OY, 2022, J ASTHMA, V59, P580, DOI 10.1080/02770903.2020.1861626; Benard B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00148-2017; Chauhan BF, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010347.pub2; Chauhan BF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009585.pub2; Dixon EG, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-053112; Dykewicz MS, 2020, J ALLERGY CLIN IMMUN, V146, P721, DOI 10.1016/j.jaci.2020.07.007; European Medicines Agency, 2019, MONT CMDH SCI CONCL; Glockler-Lauf SD, 2019, J PEDIATR-US, V209, P176, DOI 10.1016/j.jpeds.2019.02.009; Joint Formulary Committee, BRIT NATL FORMULARY; Kang Sang Oh, 2021, Asthma Res Pract, V7, P4, DOI 10.1186/s40733-021-00070-4; Medicines and Healthcare products Regulatory Agency, 2019, DRUG SAF UPD MONT SI; National Institute for Health and Care Excellence: clinical guidelines, 2021, ASTHM DIAGN MON CHRO; Sansing-Foster V, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.07.052; Scadding GK, 2017, CLIN EXP ALLERGY, V47, P856, DOI 10.1111/cea.12953; US Food and Drug Administration, 2009, UPD INF LEUK INH MON; US Food and Drug Administration, 2020, FDA REQ BOX WARN SER; US Food and Drug Administration, 2008, EARL COMM ONG SAF RE	22	1	1	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								e067554	10.1136/bmj-2021-067554	http://dx.doi.org/10.1136/bmj-2021-067554			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351683				2022-12-28	WOS:000779544800006
J	Klass, P; Ratner, AJ				Klass, Perri; Ratner, Adam J.			"The Sombre Aspect of the Entire Landscape" - Epidemiology and the Faroe Islands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								"The Sombre Aspect of the Entire Landscape" In 1846, Peter Ludvig Panum investigated a measles epidemic in the Faroe Islands, where the unusual geography and isolated population facilitated analysis of the spread of a highly contagious disease. Today, study of Covid-19 in the Faroes offers new epidemiologic lessons.	[Klass, Perri] NYU, Arthur L Carter Journalism Inst, New York, NY 10012 USA; [Klass, Perri; Ratner, Adam J.] NYU, Grossman Sch Med, Dept Pediat, New York, NY 10012 USA; [Ratner, Adam J.] NYU, Grossman Sch Med, Dept Microbiol, New York, NY USA; [Ratner, Adam J.] NYU, Grossman Sch Med, Div Pediat Infect Dis, New York, NY USA	New York University; New York University; New York University; New York University	Klass, P (corresponding author), NYU, Arthur L Carter Journalism Inst, New York, NY 10012 USA.; Klass, P (corresponding author), NYU, Grossman Sch Med, Dept Pediat, New York, NY 10012 USA.			Ratner, Adam/0000-0003-1761-794X				Helmsdal G., 2021, OMICRON OUTBREAK PRI, DOI [10.1101/2021.12.22.21268021v1, DOI 10.1101/2021.12.22.21268021V1]; Katz AS, 2020, CRIT PUBLIC HEALTH, V30, P601, DOI 10.1080/09581596.2019.1656800; Klass P, 2021, NEW ENGL J MED, V384, P589, DOI 10.1056/NEJMp2034765; Panum, 1940, OBSERVATIONS MADE EP; Shanks D., 2016, HISTORY, V24, P71	5	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2022	386	13					1202	1205		10.1056/NEJMp2120194	http://dx.doi.org/10.1056/NEJMp2120194		MAR 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2H9PR	35333484	Bronze			2022-12-28	WOS:000782417000001
J	Budd, PM				Budd, Peter M.			Sieving gases with twisty polymers	SCIENCE			English	Editorial Material							LADDER POLYMERS; UPPER-BOUNDS		[Budd, Peter M.] Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England	University of Manchester	Budd, PM (corresponding author), Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England.	peter.budd@manchester.ac.uk						Bandehali S, 2022, SEP PURIF TECHNOL, V278, DOI 10.1016/j.seppur.2021.119513; Budd PM, 2005, J MEMBRANE SCI, V251, P263, DOI 10.1016/j.memsci.2005.01.009; Comesana-Gandara B, 2019, ENERG ENVIRON SCI, V12, P2733, DOI 10.1039/c9ee01384a; Foster AB, 2021, J MATER CHEM A, V9, P21807, DOI 10.1039/d1ta03712a; Foster AB, 2020, MACROMOLECULES, V53, P569, DOI 10.1021/acs.macromol.9b02185; Lai HWH, 2022, SCIENCE, V375, P1390, DOI 10.1126/science.abl7163; Lai HWH, 2019, MACROMOLECULES, V52, P6294, DOI 10.1021/acs.macromol.9b01155; Liu S, 2014, J AM CHEM SOC, V136, P17434, DOI 10.1021/ja5110415; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Swaidan R, 2015, ACS MACRO LETT, V4, P947, DOI 10.1021/acsmacrolett.5b00512; Wang Y, 2018, MATER TODAY NANO, V3, P69, DOI 10.1016/j.mtnano.2018.11.003	11	1	1	22	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1354	1355		10.1126/science.abm5103	http://dx.doi.org/10.1126/science.abm5103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324291	Green Submitted			2022-12-28	WOS:000778894800024
J	Dyer, C				Dyer, Clare			Radiologist who charged for scans he reported while at work is for three months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o802	10.1136/bmj.o802	http://dx.doi.org/10.1136/bmj.o802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338050				2022-12-28	WOS:000778396700017
J	Sucharitkul, PPJ; Shorrock, E; Lawson-Smith, E				Sucharitkul, Penelope P. J.; Shorrock, Emma; Lawson-Smith, Erin			The NHS what am I entitled to?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sucharitkul, Penelope P. J.; Shorrock, Emma] Univ Leeds, Sch Med, Leeds, W Yorkshire, England; [Lawson-Smith, Erin] Univ Birmingham, Sch Med & Dent Sci, Birmingham, W Midlands, England	University of Leeds; University of Birmingham	Sucharitkul, PPJ (corresponding author), Univ Leeds, Sch Med, Leeds, W Yorkshire, England.	ll16ppjs@leeds.ac.uk						[Anonymous], NHS BURSARY FUNDING; Medhealth-jadu, INT; NHSBSA, HELP GUID; UK government, BURS	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2022	376								o561	10.1136/bmj.o561	http://dx.doi.org/10.1136/bmj.o561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y0FE	35321871				2022-12-28	WOS:000790072700015
J	Perry, C; Liberto, J; Milliken, C; Burden, J; Hagedorn, H; Atkinson, T; McKay, JR; Mooney, L; Sall, J; Sasson, C; Saxon, A; Spevak, C; Gordon, AJ				Perry, Christopher; Liberto, Joseph; Milliken, Charles; Burden, Jennifer; Hagedorn, Hildi; Atkinson, Timothy; McKay, James R.; Mooney, Larissa; Sall, James; Sasson, Comilla; Saxon, Andrew; Spevak, Christopher; Gordon, Adam J.		VA DoD Guideline Dev Grp	The Management of Substance Use Disorders: Synopsis of the 2021 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; PRIMARY-CARE; AUDIT-C; CONTINGENCY MANAGEMENT; ALCOHOL-WITHDRAWAL; REINFORCEMENT THERAPY; BUPRENORPHINE TAPER; OPIOID DEPENDENCE; SCREENING-TEST	Description: In August 2021, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of substance use disorders (SUDs). This synopsis summarizes key recommendations. Methods: In March 2020, the VA/DoD Evidence-Based Practice Work Group assembled a team to update the 2015 VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders that included clinical stakeholders and conformed to the National Academy of Medicine's tenets for trustworthy CPGs. The guideline panel developed key questions, systematically searched and evaluated the literature, created two 1-page algorithms, and distilled 35 recommendations for care using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. This synopsis presents the recommendations that were believed to be the most clinically impactful. Recommendations: The scope of the CPG is broad; however, this synopsis focuses on key recommendations for the management of alcohol use disorder, use of buprenorphine in opioid use disorder, contingency management, and use of technology and telehealth to manage patients remotely.	[Perry, Christopher] Natl Capital Consortium, Bethesda, MD USA; [Liberto, Joseph] Vet Hlth Adm, Off Mental Hlth & Suicide Prevent, Washington, DC USA; [Milliken, Charles] US Army, Off Surg Gen, Bethesda, MD USA; [Burden, Jennifer] Vet Hlth Adm, Off Mental Hlth & Suicide Prevent, Salem, VA USA; [Hagedorn, Hildi] Minneapolis VA Med Ctr, Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA; [Atkinson, Timothy] VA Tennessee Valley Healthcare Syst, Murfreesboro, TN USA; [McKay, James R.] Corporal Michael J Crescenz Dept Vet Affairs Med, Ctr Excellence Subst Addict Treatment & Educ, Philadelphia, PA USA; [Mooney, Larissa] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Sall, James] Vet Adm Cent Off, Qual & Patient Safety, Washington, DC USA; [Sasson, Comilla] VA Med Ctr & Pharm Benefits Management, Med Advisory Panel, Denver, CO USA; [Saxon, Andrew] VA Puget Sound Hlth Care Syst, Ctr Excellence Subst Addict Treatment & Educ, Seattle, WA USA; [Spevak, Christopher] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Gordon, Adam J.] Univ Utah, Informat Decis Enhancement & Analyt Sci Ctr IDEAS, VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA; [Gordon, Adam J.] Univ Utah, Program Addict Res Clin Care Knowledge & Advocacy, Salt Lake City, UT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Walter Reed National Military Medical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sall, J (corresponding author), Dept Vet Affairs, 811 Vermont Ave NW, Washington, DC 20420 USA.	James.Sall@va.gov		Hagedorn, Hildi/0000-0002-5118-7624; McKay, James/0000-0001-5876-1687; Sall, James/0000-0001-8564-1314	U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	Financial support for development of the guideline was provided by the U.S. Department of Veterans Affairs.	Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008537.pub2; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Centers for Disease Control and Prevention, 2014, PLANNING IMPLEMENTIN; Gebara CFD, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-31; Debelak K, 2013, AM J ADDICTION, V22, P252, DOI 10.1111/j.1521-0391.2012.12005.x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Department of Defense, 2014, PROBL SUBST NCE US D; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Esser MB, 2020, MMWR-MORBID MORTAL W, V69, P981, DOI 10.15585/mmwr.mm6930a1; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Ginley MK, 2021, J CONSULT CLIN PSYCH, V89, P58, DOI 10.1037/ccp0000552; Hedegaard Holly, 2018, NCHS Data Brief, P1; Higgins ST, 2000, J CONSULT CLIN PSYCH, V68, P64, DOI 10.1037/0022-006X.68.1.64; Higgins ST, 2007, ADDICTION, V102, P271, DOI 10.1111/j.1360-0443.2006.01664.x; Hoggatt KJ, 2017, AM J ADDICTION, V26, P357, DOI 10.1111/ajad.12534; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jonas DE, 2012, AHRQ PUBLICATION; Jumah NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011774; Kirby KC, 2013, DRUG ALCOHOL DEPEN, V132, P639, DOI 10.1016/j.drugalcdep.2013.04.015; Lofwall MR, 2018, JAMA INTERN MED, V178, P764, DOI 10.1001/jamainternmed.2018.1052; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; MALCOLM R, 1989, AM J PSYCHIAT, V146, P617; Mayo-Smith MF, 2004, ARCH INTERN MED, V164, P1405, DOI 10.1001/archinte.164.13.1405; Myrick H, 2009, ALCOHOL CLIN EXP RES, V33, P1582, DOI 10.1111/j.1530-0277.2009.00986.x; National Institute of Alcohol Abuse and Alcoholism, DRINK LEV DEF; Nehlin C, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-23; Oliver I, 2012, IEEE IC COMP COM NET; Petry NM, 2005, ARCH GEN PSYCHIAT, V62, P1148, DOI 10.1001/archpsyc.62.10.1148; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Reoux JP, 2001, ALCOHOL CLIN EXP RES, V25, P1324, DOI 10.1097/00000374-200109000-00012; Richards JE, 2019, DRUG ALCOHOL DEPEN, V201, P134, DOI 10.1016/j.drugalcdep.2019.04.015; Roll JM, 2006, PSYCHIAT RES, V144, P91, DOI 10.1016/j.psychres.2005.12.003; Rubinsky AD, 2013, ALCOHOL CLIN EXP RES, V37, P1380, DOI 10.1111/acer.12092; SAMHSA, 2018, KEY SUBSTANCE USE ME; Schottenfeld RS, 2008, LANCET, V371, P2192, DOI 10.1016/S0140-6736(08)60954-X; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sigmon SC, 2013, JAMA PSYCHIAT, V70, P1347, DOI 10.1001/jamapsychiatry.2013.2216; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Substance Abuse and Mental Health Services Administration U.S. Department of Health and Human Services, 2019, NAT SURV DRUG US HLT, P2020; Timko C, 2019, J SUBST ABUSE TREAT, V99, P24, DOI 10.1016/j.jsat.2018.12.008; Timko C, 2019, DRUG ALCOHOL DEPEN, V194, P230, DOI 10.1016/j.drugalcdep.2018.09.010; Wiegand SL, 2015, OBSTET GYNECOL, V125, P363, DOI 10.1097/AOG.0000000000000640; Willenbring ML, 2009, AM FAM PHYSICIAN, V80, P44; Wood E, 2018, JAMA-J AM MED ASSOC, V320, P825, DOI 10.1001/jama.2018.10574	50	2	2	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2022	175	5					720	+		10.7326/M21-4011	http://dx.doi.org/10.7326/M21-4011		MAR 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1U2AQ	35313113				2022-12-28	WOS:000780411800001
J	Pollard, T				Pollard, Tom			Food bank use is a canary in the coal mine for mental health services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pollard, Tom] NHS, Reading, Berks, England		Pollard, T (corresponding author), NHS, Reading, Berks, England.							House of Commons Library, 2021, FOOD BANKS UK; IFAN, 2022, PUSH EDG POV FOOD BA; NHS Confederation, 2022, MENT HEALTHC REC PLA	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2022	376								o759	10.1136/bmj.o759	http://dx.doi.org/10.1136/bmj.o759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0E9XK	35318209	Bronze			2022-12-28	WOS:000777024700008
J	Dyer, C				Dyer, Clare			Statins: Dispute over benefits to be aired in High Court case brought by GP and researcher	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o741	10.1136/bmj.o741	http://dx.doi.org/10.1136/bmj.o741			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314438				2022-12-28	WOS:000773915700001
J	Meghrawi, K; Akinnawonu, O				Meghrawi, Khadija; Akinnawonu, Omolara			Recurrent oversubscription of the UK Foundation Programme reflects the government's failure to plan for the medical workforce	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Meghrawi, Khadija; Akinnawonu, Omolara] BMA Med Student Comm, London, England		Meghrawi, K (corresponding author), BMA Med Student Comm, London, England.							Lok P, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o650; NHS Digital, NHS WORKF STAT	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2022	376								o731	10.1136/bmj.o731	http://dx.doi.org/10.1136/bmj.o731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZZ8IH	35304868	Bronze			2022-12-28	WOS:000773507900004
J	Nyberg, T; Ferguson, NM; Nash, SG; Webster, HH; Flaxman, S; Andrews, N; Hinsley, W; Bernal, JL; Kall, M; Bhatt, S; Blomquist, P; Zaidi, A; Volz, E; Aziz, NA; Harman, K; Funk, S; Abbott, S; Hope, R; Charlett, A; Chand, M; Ghani, AC; Seaman, SR; Dabrera, G; De Angelis, D; Presanis, AM; Thelwall, S				Nyberg, Tommy; Ferguson, Neil M.; Nash, Sophie G.; Webster, Harriet H.; Flaxman, Seth; Andrews, Nick; Hinsley, Wes; Bernal, Jamie Lopez; Kall, Meaghan; Bhatt, Samir; Blomquist, Paula; Zaidi, Asad; Volz, Erik; Aziz, Nurin Abdul; Harman, Katie; Funk, Sebastian; Abbott, Sam; Hope, Russell; Charlett, Andre; Chand, Meera; Ghani, Azra C.; Seaman, Shaun R.; Dabrera, Gavin; De Angelis, Daniela; Presanis, Anne M.; Thelwall, Simon		COVID 19 Genom UK COG UK Consortiu	Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study	LANCET			English	Article								Background The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). We aimed to better characterise omicron severity relative to delta by assessing the relative risk of hospital attendance, hospital admission, or death in a large national cohort. Methods Individual-level data on laboratory-confirmed COVID-19 cases resident in England between Nov 29, 2021, and Jan 9, 2022, were linked to routine datasets on vaccination status, hospital attendance and admission, and mortality. The relative risk of hospital attendance or admission within 14 days, or death within 28 days after confirmed infection, was estimated using proportional hazards regression. Analyses were stratified by test date, 10-year age band, ethnicity, residential region, and vaccination status, and were further adjusted for sex, index of multiple deprivation decile, evidence of a previous infection, and year of age within each age band. A secondary analysis estimated variant-specific and vaccine-specific vaccine effectiveness and the intrinsic relative severity of omicron infection compared with delta (ie, the relative risk in unvaccinated cases). Findings The adjusted hazard ratio (HR) of hospital attendance (not necessarily resulting in admission) with omicron compared with delta was 0.56 (95% CI 0.54-0.58); for hospital admission and death, HR estimates were 0.41 (0.39-0.43) and 0.31 (0.26-0.37), respectively. Omicron versus delta HR estimates varied with age for all endpoints examined. The adjusted HR for hospital admission was 1.10 (0.85-1.42) in those younger than 10 years, decreasing to 0.25 (0.21-0.30) in 60-69-year-olds, and then increasing to 0.47 (0.40-0.56) in those aged at least 80 years. For both variants, past infection gave some protection against death both in vaccinated (HR 0.47 [0.32-0.68]) and unvaccinated (0.18 [0.06-0.57]) cases. In vaccinated cases, past infection offered no additional protection against hospital admission beyond that provided by vaccination (HR 0.96 [0.88-1.04]); however, for unvaccinated cases, past infection gave moderate protection (HR 0.55 [0.48-0.63]). Omicron versus delta HR estimates were lower for hospital admission (0.30 [0.28-0.32]) in unvaccinated cases than the corresponding HR estimated for all cases in the primary analysis. Booster vaccination with an mRNA vaccine was highly protective against hospitalisation and death in omicron cases (HR for hospital admission 8-11 weeks post-booster vs unvaccinated: 0.22 [0.20-0.24]), with the protection afforded after a booster not being affected by the vaccine used for doses 1 and 2. Interpretation The risk of severe outcomes following SARS-CoV-2 infection is substantially lower for omicron than for delta, with higher reductions for more severe endpoints and significant variation with age. Underlying the observed risks is a larger reduction in intrinsic severity (in unvaccinated individuals) counterbalanced by a reduction in vaccine effectiveness. Documented previous SARS-CoV-2 infection offered some protection against hospitalisation and high protection against death in unvaccinated individuals, but only offered additional protection in vaccinated individuals for the death endpoint. Booster vaccination with mRNA vaccines maintains over 70% protection against hospitalisation and death in breakthrough confirmed omicron infections. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Nyberg, Tommy; Seaman, Shaun R.; De Angelis, Daniela; Presanis, Anne M.] Univ Cambridge, MRC Biostat Unit, Cambridge CB2 0SR, England; [Ferguson, Neil M.; Hinsley, Wes; Volz, Erik; Abbott, Sam; Charlett, Andre; Ghani, Azra C.] NIHR Hlth Protect Res Unit Modelling & Hlth Econ, Jameel Inst, MRC Ctr Global Infect Dis Anal, London, England; [Bernal, Jamie Lopez] NIHR Hlth Protect Res Unit Resp Infect, London, England; [Nash, Sophie G.; Webster, Harriet H.; Kall, Meaghan; Zaidi, Asad; Aziz, Nurin Abdul; Harman, Katie; Hope, Russell; Dabrera, Gavin; Thelwall, Simon] Imperial Coll London, Natl Epidemiol Cell COVID 19, London, England; [Andrews, Nick; Bernal, Jamie Lopez] COVID 19 Surveillance Cell, London, England; [Blomquist, Paula] Outbreak Surveillance Team, London, England; [Chand, Meera] COVID19 Genom Cell, London, England; [Charlett, Andre; De Angelis, Daniela] UK Hlth Secur Agcy, Stat Modelling & Econ Dept, London, England; [Charlett, Andre; De Angelis, Daniela] UK Hlth Secur Agcy, Joint Modelling Team, London, England; [Flaxman, Seth] Univ Oxford, Dept Comp Sci, Oxford, England; [Funk, Sebastian; Abbott, Sam] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Charlett, Andre] Univ Bristol, Univ West England, NIHR Hlth Protect Res Unit Behav Sci & Evaluat, Bristol, Avon, England; [Charlett, Andre; De Angelis, Daniela] Univ Cambridge, Bristol, Avon, England	MRC Biostatistics Unit; University of Cambridge; Imperial College London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; University of West England; University of Cambridge	Nyberg, T (corresponding author), Univ Cambridge, MRC Biostat Unit, Cambridge CB2 0SR, England.	tommy.nyberg@mrc-bsu.cam.ac.uk	Nyberg, Tommy/AGG-2330-2022; Ferguson, Neil/B-8578-2008	Nyberg, Tommy/0000-0002-9436-0626; Bashton, Matthew/0000-0002-6847-1525; Presanis, Anne/0000-0003-3078-4427; Webster, Harriet/0000-0002-2145-8884; Abbott, Sam/0000-0001-8057-8037; Flaxman, Seth/0000-0002-2477-4217; Harman, Katie/0000-0003-1387-0200; Lopez Bernal, Jamie/0000-0002-1301-5653; Thelwall, Simon/0000-0002-0434-2724; Nash, Sophie/0000-0002-7717-6982; Bhatt, Samir/0000-0002-0891-4611; Zaidi, Asad/0000-0002-6420-2539; Ferguson, Neil/0000-0002-1154-8093; Nelson, Andrew/0000-0001-6665-4929; Kall, Meaghan/0000-0001-6971-427X; dabrera, gavin/0000-0003-4606-5945; Smith, Darren/0000-0003-4925-467X; Young, Gregory/0000-0001-5342-1421	Medical Research Council, UK Research and Innovation, Department of Health and Social Care, National Institute for Health Research, Community Jameel, and Engineering and Physical Sciences Research Council	Medical Research Council, UK Research and Innovation, Department of Health and Social Care, National Institute for Health Research, Community Jameel, and Engineering and Physical Sciences Research Council	Medical Research Council, UK Research and Innovation, Department of Health and Social Care, National Institute for Health Research, Community Jameel, and Engineering and Physical Sciences Research Council.	Abdullah F, 2022, INT J INFECT DIS, V116, P38, DOI 10.1016/j.ijid.2021.12.357; Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]; Bager P, 2022, REDUCED RISK HOSP AS, DOI [10.2139/ssrn.4008930, DOI 10.2139/SSRN.4008930]; Bager P, 2021, LANCET INFECT DIS, V21, P1351, DOI 10.1016/S1473-3099(21)00580-6; Bager P, 2021, LANCET INFECT DIS, V21, P1507, DOI 10.1016/S1473-3099(21)00290-5; Bhattacharya A, 2021, J INFECTION, V83, P565, DOI 10.1016/j.jinf.2021.08.039; Birrell P, 2021, REPORT NOWCASTING FO; Centers for Disease Control and Prevention, SCI BRIEF OM B 1 1 5; Clare T, 2021, PUBLIC HEALTH, V194, P163, DOI 10.1016/j.puhe.2021.03.012; Clark M, 2022, CLIN CHARACTERISTICS, DOI [10.2139/ssrn.4013461, DOI 10.2139/SSRN.4013461]; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Davies MA, 2022, TROP MED INT HEALTH, DOI [10.1111/tmi.13752, 10.1101/2022.01.12.22269148]; Ferguson N., 2021, REPORT 50 HOSPITALIS, DOI [10.25561/93035, DOI 10.25561/93035]; Fisman DN, 2021, CAN MED ASSOC J, V193, pE1619, DOI 10.1503/cmaj.211248; GISAID, TRACK VAR; Hui KPY, 2022, NATURE, V603, P715, DOI 10.1038/s41586-022-04479-6; Jassat W., 2021, CLIN SEVERITY COVID, DOI [10.2139/ssrn.3996320, DOI 10.2139/SSRN.3996320, 10.2139/ssrn. 3996320]; Vihta KD, 2022, medRxiv, DOI 10.1101/2022.01.18.22269082; Lee K, 2009, GLOB INST, P1; Lewnard JA., 2022, CLIN OUTCOMES PATIEN, DOI [10.1101/2022.01.11.22269045, DOI 10.1101/2022.01.11.22269045]; Meng B, 2022, NATURE, V603, P706, DOI 10.1038/s41586-022-04474-x; NHS, NAT VACC PROGR; NHS Digital, 2022, SEC US SERV SUS; NHS Digital, 2021, EM CAR DAT SET ECDS; NHS England, COVID 19 HOSP ACT; NHS Networks UK, 2022, US; Nyberg T, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1412; Peralta-Santos A, 2022, medRxiv, DOI 10.1101/2022.01.20.22269406; Seaman SR., 2021, ADJUSTING TIME INFEC, DOI [10.1101/2021.08.13.21262014, DOI 10.1101/2021.08.13.21262014]; Sheikh A., 2021, SEVERITY OMICRON VAR; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Twohig KA, 2022, LANCET INFECT DIS, V22, P35, DOI 10.1016/S1473-3099(21)00475-8; UK Health Security Agency, 2022, SARS COV 2 VAR DAT U; UK Health Security Agency, 2022, COVID 19 VACC SURV R; UKHSA, 2022, 35 UKHSA; Ulloa AC, 2022, JAMA-J AM MED ASSOC, V327, P1286, DOI 10.1001/jama.2022.2274; Veneti L, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.4.2200077; Wang Lindsey, 2022, medRxiv, DOI 10.1101/2022.01.12.22269179; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4	39	193	195	57	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1303	1312		10.1016/S0140-6736(22)00462-7	http://dx.doi.org/10.1016/S0140-6736(22)00462-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35305296	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000812828300022
J	Wise, J				Wise, Jacqui			Covid-19: NHS staff will still have access to free tests	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Government, 2022, COVID 19 RESP LIV CO; Prime Minister's Office, 2022, PRIM MIN SETS OUT PL	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2022	376								o851	10.1136/bmj.o851	http://dx.doi.org/10.1136/bmj.o851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6XR	35354577	Bronze			2022-12-28	WOS:000779561800015
J	Christie, B				Christie, Bryan			Sixty seconds on . .. sleepless nights	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Durham Infancy and Sleep Centre, 2021, SLEEP BAB YOU PRACT; Henderson JMT, 2010, PEDIATRICS, V126, pE1081, DOI 10.1542/peds.2010-0976; MOORE T, 1957, ARCH DIS CHILD, V32, P333, DOI 10.1136/adc.32.164.333	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o805	10.1136/bmj.o805	http://dx.doi.org/10.1136/bmj.o805			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35338083				2022-12-28	WOS:000778396700012
J	Kmietowicz, Z				Kmietowicz, Zosia			NICE recommends four tests to help diagnose pre-eclampsia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, DIAG CONS DOC PLGF B	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2022	376								o795	10.1136/bmj.o795	http://dx.doi.org/10.1136/bmj.o795			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0G9YB	35332035				2022-12-28	WOS:000778396700015
J	Hughes, RC; Absoud, M; Bhopal, SS				Hughes, Robert C.; Absoud, Michael; Bhopal, Sunil S.			Is the UK's covid inquiry at risk of forgetting about children and young people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hughes, Robert C.] London Sch Hyg & Trop Med, Dept Populat Hlth, Fac Epidemiol & Populat Hlth, London, England; [Absoud, Michael] Kings Coll London, Dept Women & Childrens Hlth, Fac Life Sci & Med, London, England; [Bhopal, Sunil S.] Newcastle Univ, Populat Hlth Sci Inst, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; Newcastle University - UK	Hughes, RC (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, Fac Epidemiol & Populat Hlth, London, England.			Hughes, Robert/0000-0002-1345-3063; Absoud, Michael/0000-0002-0577-1897				[Anonymous], BBC NEWS; Children's commissioner, CHILDH TIM COVID	2	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o785	10.1136/bmj.o785	http://dx.doi.org/10.1136/bmj.o785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35331988	Bronze			2022-12-28	WOS:000778460100016
J	Kharbanda, EO; Vazquez-Benitez, G				Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela			COVID-19 mRNA Vaccines During Pregnancy New Evidence to Help Address Vaccine Hesitancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOR-GESTATIONAL-AGE; UNITED-STATES; PRETERM; BIRTH		[Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela] Hlth Partners Inst, Minneapolis, MN USA		Kharbanda, EO (corresponding author), 8170 33rd Ave S,Mail stop 21112R, Minneapolis, MN 55425 USA.	Elyse.O.Kharbanda@HealthPartners.com						Battarbee AN, 2022, AM J PERINAT, V39, P75, DOI 10.1055/s-0041-1735878; Berman Institute of Bioethics Center for Immunization Research, COVID 19 MAT IMM TRA; Centers for Disease Control and Prevention, COVID 19 VACC PREGN; Dagan N, 2021, NAT MED, V27, P1693, DOI 10.1038/s41591-021-01490-8; Fell DB, 2022, JAMA-J AM MED ASSOC, V327, P1478, DOI 10.1001/jama.2022.4255; Fell DB, 2021, VACCINE, V39, P1882, DOI 10.1016/j.vaccine.2021.02.070; Goldshtein I, 2022, JAMA PEDIATR, V176, P470, DOI 10.1001/jamapediatrics.2022.0001; Kharbanda EO, 2021, JAMA-J AM MED ASSOC, V326, P1629, DOI 10.1001/jama.2021.15494; Lipkind HS, 2022, MMWR-MORBID MORTAL W, V7, P26, DOI 10.15585/mmwr.mm7101e1; Magnus MC, 2022, BJOG-INT J OBSTET GY, V129, P101, DOI 10.1111/1471-0528.16969; Magnus MC, 2022, JAMA-J AM MED ASSOC, V327, P1469, DOI 10.1001/jama.2022.3271; Magnus MC, 2021, NEW ENGL J MED, V385, P2008, DOI 10.1056/NEJMc2114466; Stock SJ, 2022, NAT MED, V28, P504, DOI 10.1038/s41591-021-01666-2; Vazquez-Benitez G, 2016, AM J EPIDEMIOL, V184, P176, DOI 10.1093/aje/kww043	15	6	6	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1451	1453		10.1001/jama.2022.2459	http://dx.doi.org/10.1001/jama.2022.2459		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35325030	Bronze			2022-12-28	WOS:000772988500001
J	Peeples, L				Peeples, Lynne			LESSONS FROM THE COVID DATA WIZARDS	NATURE			English	News Item																			0	1	1	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					564	567						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322256	hybrid			2022-12-28	WOS:000772661800009
J	Wise, J				Wise, Jacqui			Covid-19: Public inquiry must include effects on children, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabinet Office, 2022, UK COV 19 INQ DRAFT; Halfon R., DRAFT TERMS REFERENC; Hughes RC, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o785; Viner R, 2022, TIMES 0322	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2022	376								o777	10.1136/bmj.o777	http://dx.doi.org/10.1136/bmj.o777			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H0WE	35332052	Bronze			2022-12-28	WOS:000778460100010
J	Christie, B				Christie, Bryan			Sixty seconds on ... covid toe	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baeck M, 2021, INT J INFECT DIS, V102, P53, DOI 10.1016/j.ijid.2020.10.021; Frumholtz L, 2021, BRIT J DERMATOL, V185, P1176, DOI 10.1111/bjd.20707; Gehlhausen JR, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2122090119	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o742	10.1136/bmj.o742	http://dx.doi.org/10.1136/bmj.o742			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314478	Bronze			2022-12-28	WOS:000773915700003
J	Saul, H; Gursul, D; Kwint, J; O'Hara, J				Saul, Helen; Gursul, Deniz; Kwint, Jemma; O'Hara, James			Proton pump inhibitors should not be used to treat persistent throat symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Kwint, Jemma] NIHR Ctr Engagement & Disseminat, Twickenham, England; [O'Hara, James] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [O'Hara, James] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						O'Hara J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4903	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o652	10.1136/bmj.o652	http://dx.doi.org/10.1136/bmj.o652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35302048				2022-12-28	WOS:000796719200003
J	Wilkinson, E				Wilkinson, Emma			Covid-19: Doctors urge government to step up on global vaccine funding	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, ACT ACC CALLS FAIR S	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2022	376								o709	10.1136/bmj.o709	http://dx.doi.org/10.1136/bmj.o709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1H7KY	35301218	Bronze			2022-12-28	WOS:000796719200013
J	Studdert, DM; Zhang, YF; Holsinger, EE; Prince, L; Holsinger, AF; Jonathon, AR; Wintemute, GJ; Miller, M				Studdert, David M.; Zhang, Yifan; Holsinger, Erin E.; Prince, Lea; Holsinger, Alexander F.; Jonathon, A. Rodden; Wintemute, Garen J.; Miller, Matthew			Homicide Deaths Among Adult Cohabitants of Handgun Owners in California, 2004 to 2016 A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background:Although personal protection is a major motivation for purchasing firearms, existing studies suggest thatpeople living in homes withfirearms have higher risks for dying by homicide. Distribution of those risks among house-hold members is poorly understood. Objective:To estimate the association between living witha lawful handgun owner and risk for homicide victimization. Design:This retrospective cohort study followed 17.6 million adult residents of California for up to 12 years 2 months (18 October 2004 through 31 December 2016). Cohort members did not own handguns, but some started residing with lawful handgun owners during follow-up. Setting:California. Participants:17569096 voter registrants aged 21 years or older. Measurements:Homicide (overall, by firearm, and by other methods) and homicide occurring in the victim's home. Results:Of 595448 cohort members who commenced residing with handgun owners, two thirds were women. A total of 737012 cohort members died; 2293 died by homicide.Overall rates of homicide were more than twice as high among cohabitants of handgun owners than among cohabitants of non owners (adjusted hazard ratio, 2.33 [95% CI, 1.78to 3.05]). These elevated rates were driven largely by higher rates of homicide by firearm (adjusted hazard ratio, 2.83 [CI,2.05 to 3.91]). Among homicides occurring at home, cohabitants of owners had sevenfold higher rates of being fatally shot by a spouse or intimate partner (adjusted hazard ratio,7.16 [CI, 4.04 to 12.69]); 84% of these victims were female. Limitations:Some cohort members classified as unexposed may have lived in homes with handguns. Residents of homes with and without handguns may have differed on unobserved traits associated with homicide risk. Conclusion:Living with a handgun owner is associated with substantially elevated risk for dying by homicide. Women are disproportionately affected Primary Funding Source:The National Collaborative on Gun Violence Research, the Fund for a Safer Future, the Joyce Foundation, Stanford Law School, and the Stanford University School of Medicine.	[Studdert, David M.] 615 Crothers Way,Encina Commons, Stanford, CA 94305 USA; [Studdert, David M.; Zhang, Yifan; Holsinger, Erin E.; Prince, Lea; Holsinger, Alexander F.] Stanford Univ, Sch Med, Dept Hlth Policy, Stanford, CA USA; [Studdert, David M.] Stanford Law Sch, Stanford, CA USA; [Jonathon, A. Rodden] Stanford Univ, Dept Polit Sci, Stanford, CA USA; [Wintemute, Garen J.] Univ Calif Davis, Sch Med, Sacramento, CA USA; [Miller, Matthew] Northeastern Univ, Bouve Coll Hlth Sci, Dept Hlth Sci, Boston, MA USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Davis; Northeastern University	Studdert, DM (corresponding author), 615 Crothers Way,Encina Commons, Stanford, CA 94305 USA.			Studdert, David/0000-0003-0585-5537	National Collaborative on Gun Violence Research Fund for Safer Future [GA004696]; Joyce Foundation [17-37241]; Standford Law School; Stanford University School of Medicine	National Collaborative on Gun Violence Research Fund for Safer Future; Joyce Foundation; Standford Law School; Stanford University School of Medicine	By grants from the National Collaborative on Gun Violence Research, the Fund for a Safer Future (grant GA004696), and the Joyce Foundation (grant 17-37241) and internal funds from Stanford Law School and the Stanford University School of Medicine		0	1	1	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2022	175	6					804	+		10.7326/M21-3762	http://dx.doi.org/10.7326/M21-3762		APR 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2Z8GP	35377715				2022-12-28	WOS:000815158500001
J	Parcha, V; Malla, G; Ivin, MR; Armstrong, ND; Judd, SE; Lange, LA; Maurer, MS; Levitan, EB; Goyal, P; Arora, G; Arora, P				Parcha, Vibhu; Malla, Gargya; Ivin, Marguerite R.; Armstrong, Nicole D.; Judd, Suzanne E.; Lange, Leslie A.; Maurer, Mathew S.; Levitan, Emily B.; Goyal, Parag; Arora, Garima; Arora, Pankaj			Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	71st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)	APR 02-04, 2022	Washington, DC	Amer Coll Cardiol			AFRICAN; AMYLOIDOSIS; DISEASE; ALLELE; RISK	IMPORTANCE A genetic variant in the TTR gene (rs76992529; Val122Ile), present more commonly in individuals with African ancestry (population frequency: 3%-4%), causes misfolding of the tetrameric transthyretin protein complex that accumulates as extracellular amyloid fibrils and results in hereditary transthyretin amyloidosis. OBJECTIVE To estimate the association of the amyloidogenic Val122Ile TTR variant with the risk of heart failure and mortality in a large, geographically diverse cohort of Black individuals. DESIGN, SETTING, AND PARTICIPANTS Retrospective population-based cohort study of 7514 self-identified Black individuals living in the US participating in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study with genetic data available and without heart failure at baseline. The participants were enrolled at the baseline visit (2003-2007). The end of follow-up for the majority of outcomes was on December 31, 2018. All-cause mortality data were available through December 31, 2020. EXPOSURES TTR Val122Ile (rs76992529) genotype. MAIN OUTCOME AND MEASURES The primary outcome was incident heart failure (first hospitalization for heart failure or death due to heart failure). The secondary outcomes were heart failure mortality, cardiovascular mortality, and all-cause mortality. The multivariable Cox proportional hazards regression analyses were adjusted for genetic ancestry and demographic, clinical, and social factors. RESULTS Among 7514 Black participants (median age, 64 years [IQR, 57-70 years]; 61% women), the population frequency of the TTR Val122Ile variant was 3.1%(232 variant carriers and 7282 noncarriers). During a median follow-up of 11.1 years (IQR, 5.9-13.5 years), incident heart failure occurred in 535 individuals (34 variant carriers and 501 noncarriers) and the incidence of heart failure was 15.64 per 1000 person-years among variant carriers vs 7.16 per 1000 person-years among noncarriers (adjusted hazard ratio [HR], 2.43 [95% CI, 1.71-3.46]; P < .001). Deaths due to heart failure occurred in 141 individuals (13 variant carriers and 128 noncarriers) and the incidence of heart failure mortality was 6.11 per 1000 person-years among variant carriers vs 1.85 per 1000 person-years among noncarriers (adjusted HR, 4.19 [95% CI, 2.33-7.54]; P < .001). Deaths due to cardiovascular causes occurred in 793 individuals (34 variant carriers and 759 noncarriers) and the incidence of cardiovascular death was 15.18 per 1000 person-years among variant carriers vs 10.61 per 1000 person-years among noncarriers (adjusted HR, 1.69 [95% CI, 1.19-2.39]; P = .003). Deaths due to any cause occurred in 2715 individuals (100 variant carriers and 2615 noncarriers) and the incidence of all-cause mortality was 41.46 per 1000 person-years among variant carriers vs 33.94 per 1000 person-years among noncarriers (adjusted HR, 1.46 [95% CI, 1.19-1.78]; P < .001). There was no significant interaction between TTR variant carrier status and sex on incident heart failure and the secondary outcomes. CONCLUSIONS AND RELEVANCE Among a cohort of Black individuals living in the US, being a carrier of the TTR Val122Ile variant was significantly associated with an increased risk of heart failure.	[Parcha, Vibhu; Arora, Garima; Arora, Pankaj] Univ Alabama Birmingham, Div Cardiovasc Dis, 1670 Univ Blvd,Volker Hall B140, Birmingham, AL 35294 USA; [Malla, Gargya; Ivin, Marguerite R.; Armstrong, Nicole D.; Levitan, Emily B.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Judd, Suzanne E.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Lange, Leslie A.] Univ Colorado, Div Biomed Informat & Personalized Med, Dept Med, Sch Med, Aurora, CO USA; [Lange, Leslie A.] Univ Colorado, Dept Epidemiol, Sch Publ Hlth, Aurora, CO USA; [Maurer, Mathew S.] Columbia Univ Irving Med Ctr, Cardiac Amyloidosis Program, Div Cardiol, Dept Med, New York, NY USA; [Goyal, Parag] Cornell Univ, Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Arora, Pankaj] Birmingham Vet Affairs Med Ctr, Cardiol Sect, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; NewYork-Presbyterian Hospital; Cornell University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Arora, P (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, 1670 Univ Blvd,Volker Hall B140, Birmingham, AL 35294 USA.	parora@uabmc.edu		Davis Armstrong, Nicole/0000-0002-6483-4560	National Institute of Neurological Disorders and Stroke [U01 NS041588]; National Institute on Aging; National Institutes of Health; US Department of Health and Human Services; National Heart, Lung, and Blood Institute [R01HL13666, R01HL080477, R01HL160982, K23HL146887]; Doris Duke Charitable Foundation [2021255]; University of Alabama, Birmingham	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); University of Alabama, Birmingham	This research project was supported by cooperative agreement U01 NS041588 co-funded by the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institutes of Health, and the US Department of Health and Human Services. The genotyping was supported by grant R01HL13666 from the National Heart, Lung, and Blood Institute. Adjudication of heart failure events was supported by grant R01HL080477 from the National Heart, Lung, and Blood Institute. Dr P. Arora was supported by grants R01HL160982 and K23HL146887 from the National Heart, Lung, and Blood Institute, grant 2021255 from the Doris Duke Charitable Foundation COVID-19 Fund to Retain Clinician Scientists, and by funding from the University of Alabama, Birmingham, COVID-19 Caregiving Affected Early-career Research Scientists Retention Program.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bailey LN, 2019, JACC-HEART FAIL, V7, P394, DOI 10.1016/j.jchf.2019.01.016; Bajaj NS, 2018, JAMA CARDIOL, V3, P11, DOI 10.1001/jamacardio.2017.4207; Balakrishnan P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179234; Buxbaum J, 2010, AM HEART J, V159, P864, DOI 10.1016/j.ahj.2010.02.006; Buxbaum JN, 2017, GENET MED, V19, P733, DOI 10.1038/gim.2016.200; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Damrauer SM, 2019, JAMA-J AM MED ASSOC, V322, P2191, DOI 10.1001/jama.2019.17935; Feng KY, 2019, JACC-CARDIOONCOL, V1, P273, DOI 10.1016/j.jaccao.2019.11.006; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Goyal P, 2021, J CARD FAIL, V27, P512, DOI 10.1016/j.cardfail.2021.01.011; Goyal P, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-019-0890-x; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jacobson DR, 2015, AMYLOID, V22, P171, DOI 10.3109/13506129.2015.1051219; Keita AD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1319; Kittleson MM, 2020, CIRCULATION, V142, pE7, DOI 10.1161/CIR.0000000000000792; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Miller DT, 2021, GENET MED, V23, P1381, DOI 10.1038/s41436-021-01172-3; Mudd-Martin G, 2021, CIRC-GENOM PRECIS ME, V14, P547, DOI 10.1161/HCG.0000000000000084; Parcha V, 2021, MAYO CLIN PROC, V96, P1218, DOI 10.1016/j.mayocp.2020.08.036; Parcha V, 2021, MAYO CLIN PROC, V96, P1770, DOI 10.1016/j.mayocp.2020.12.034; Parcha V, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018689; Parcha Vibhu, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P703, DOI 10.1016/j.mayocpiqo.2020.09.005; Parcha V, 2020, CIRCULATION, V142, P1018, DOI 10.1161/CIRCULATIONAHA.120.046374; Patel N, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129979; Patel N, 2019, INT J CARDIOL, V286, P145, DOI 10.1016/j.ijcard.2019.02.034; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quarta CC, 2015, NEW ENGL J MED, V372, P21, DOI 10.1056/NEJMoa1404852; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; Rosenblum H, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004769; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Ruberg FL, 2019, J AM COLL CARDIOL, V73, P2872, DOI 10.1016/j.jacc.2019.04.003; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Sinha A, 2021, JAMA CARDIOL, V6, P718, DOI 10.1001/jamacardio.2020.6623; Zhao XY, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0462-7	38	4	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2022	327	14					1368	1378		10.1001/jama.2022.2896	http://dx.doi.org/10.1001/jama.2022.2896		APR 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	0P1FH	35377943	Green Published			2022-12-28	WOS:000779462400002
J	Binagwaho, A; Mathewos, K				Binagwaho, Agnes; Mathewos, Kedest			Rwanda's success in rolling out its covid-19 vaccination campaign is a lesson to us all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Binagwaho, Agnes; Mathewos, Kedest] Univ Global Hlth Equ, Kigali, Rwanda		Binagwaho, A (corresponding author), Univ Global Hlth Equ, Kigali, Rwanda.							Bao J, 2018, LANCET GLOB HEALTH, V6, pS47, DOI 10.1016/S2214-109X(18)30176-1; Ministry of Health Rwanda, TWITTER; Our World in Data, COR VACC; Tony Blair Institute for Global Change, VACC AFR WHAT GOV CA; Wang W, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4704; Wellcome, 2019, GLOB MON; World Health Organization, ROLL OUT COVID 19 VA	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2022	377								o881	10.1136/bmj.o881	http://dx.doi.org/10.1136/bmj.o881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0N9HX	35365461	Bronze			2022-12-28	WOS:000783141700018
J	Gershman, A; Sauria, MEG; Guitart, X; Vollger, MR; Hook, PW; Hoyt, SJ; Jain, M; Shumate, A; Razaghi, R; Koren, S; Altemose, N; Caldas, GV; Logsdon, GA; Rhie, A; Eichler, EE; Schatz, MC; O'Neill, RJ; Phillippy, AM; Miga, KH; Timp, W				Gershman, Ariel; Sauria, Michael E. G.; Guitart, Xavi; Vollger, Mitchell R.; Hook, Paul W.; Hoyt, Savannah J.; Jain, Miten; Shumate, Alaina; Razaghi, Roham; Koren, Sergey; Altemose, Nicolas; Caldas, Gina, V; Logsdon, Glennis A.; Rhie, Arang; Eichler, Evan E.; Schatz, Michael C.; O'Neill, Rachel J.; Phillippy, Adam M.; Miga, Karen H.; Timp, Winston			Epigenetic patterns in a complete human genome	SCIENCE			English	Article							COPY NUMBER VARIATION; DNA METHYLATION; TRANSPOSABLE ELEMENTS; CELL-LINES; CHROMATIN; CHROMOSOME; HETEROCHROMATIN; ORGANIZATION; ALIGNMENT; SEQUENCE	The completion of a telomere-to-telomere human reference genome, T2T-CHM13, has resolved complex regions of the genome, including repetitive and homologous regions. Here, we present a high-resolution epigenetic study of previously unresolved sequences, representing entire acrocentric chromosome short arms, gene family expansions, and a diverse collection of repeat classes. This resource precisely maps CpG methylation (32.28 million CpGs), DNA accessibility, and short-read datasets (166,058 previously unresolved chromatin immunoprecipitation sequencing peaks) to provide evidence of activity across previously unidentified or corrected genes and reveals clinically relevant paralog-specific regulation. Probing CpG methylation across human centromeres from six diverse individuals generated an estimate of variability in kinetochore localization. This analysis provides a framework with which to investigate the most elusive regions of the human genome, granting insights into epigenetic regulation.	[Gershman, Ariel; Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21218 USA; [Sauria, Michael E. G.; Schatz, Michael C.] Johns Hopkins Univ, Dept Biol & Comp Sci, Baltimore, MD USA; [Guitart, Xavi; Vollger, Mitchell R.; Logsdon, Glennis A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Hook, Paul W.; Shumate, Alaina; Razaghi, Roham; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Hoyt, Savannah J.; O'Neill, Rachel J.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA; [Hoyt, Savannah J.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Jain, Miten; Miga, Karen H.] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Koren, Sergey; Rhie, Arang; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Altemose, Nicolas] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Caldas, Gina, V] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Connecticut; University of Connecticut; University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Timp, W (corresponding author), Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21218 USA.; Timp, W (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Miga, KH (corresponding author), Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA.	khmiga@ucsc.edu; wtimp@jhu.edu	Altemose, Nicolas/EIR-2712-2022; Phillippy, Adam/U-5731-2018	Altemose, Nicolas/0000-0002-7231-6026; Shumate, Alaina/0000-0002-4450-1857; Vollger, Mitchell/0000-0002-8651-1615; Gershman, Ariel/0000-0001-8899-8781; Guitart, Xavi/0000-0002-4128-4375; Sauria, Michael/0000-0001-5556-9446; Phillippy, Adam/0000-0003-2983-8934; Hook, Paul/0000-0002-3912-1999	National Institutes of Health [R01HG009190, F32 GM134558, R24 DK106766-01A1, U24HG010263, 1R01HG011274-01, 1U01HG010971]; National Human Genome Research Institute; Damon Runyon Postdoctoral Fellowship; PEW Latin American Fellowship; Howard Hughes Medical Institute Hanna Gray Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Damon Runyon Postdoctoral Fellowship; PEW Latin American Fellowship; Howard Hughes Medical Institute Hanna Gray Fellowship	This study was supported by the National Institutes of Health (grant R01HG009190 to W.T., grant F32 GM134558 to G.A.L., grants R24 DK106766-01A1 and U24HG010263 to M.C.S., grants 1R01HG011274-01 and 1U01HG010971 to K.H.M., and an Intramural Research Program grant from the National Human Genome Research Institute to S.K., A.R., and A.M.P.); a Damon Runyon Postdoctoral Fellowship and PEW Latin American Fellowship to G.V.C.; and a Howard Hughes Medical Institute Hanna Gray Fellowship to N.A.	A. M.Phillippy, 2020, bioRxiv, DOI 10.1101/2020.11.01.363887; Aldrup-MacDonald ME, 2016, GENOME RES, V26, P1301, DOI 10.1101/gr.206706.116; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altemose N, 2022, SCIENCE, V376, P56, DOI 10.1126/science.abl4178; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ambrosini A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r151; Badyaev AV, 2014, J PHYSIOL-LONDON, V592, P2251, DOI 10.1113/jphysiol.2014.272625; Bansal P, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00328; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bruce HA, 2009, PSYCHIAT GENET, V19, P64, DOI 10.1097/YPG.0b013e3283207ff6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chen J, 2020, EUR REV MED PHARMACO, V24, P1807, DOI 10.26355/eurrev_202002_20358; Chen XJ, 2021, INT J GYNECOL PATHOL, V40, P333, DOI 10.1097/PGP.0000000000000697; Chen YT, 2006, GENE CHROMOSOME CANC, V45, P392, DOI 10.1002/gcc.20298; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Cruz-Tapias P., 2013, AUTOIMMUNITY BENCH B, P271; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Darrow EM, 2016, P NATL ACAD SCI USA, V113, pE4504, DOI 10.1073/pnas.1609643113; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; Dekker J, 2017, NATURE, V549, P219, DOI 10.1038/nature23884; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gershman A, ZENODO, V2022, DOI [10.5281/zenodo.6046354, DOI 10.5281/ZENODO.6046354]; Gershman A, 2022, SCIENCE, V376, P58, DOI 10.1126/science.abj5089; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Giannuzzi G, 2019, AM J HUM GENET, V105, P947, DOI 10.1016/j.ajhg.2019.09.023; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hassan KMA, 2001, HUM GENET, V109, P452; Hauke J, 2009, HUM MOL GENET, V18, P304, DOI 10.1093/hmg/ddn357; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hoyt SJ, 2022, SCIENCE, V376, P57, DOI 10.1126/science.abk3112; Ichikawa K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01982-7; Janssen A, 2018, ANNU REV CELL DEV BI, V34, P265, DOI 10.1146/annurev-cellbio-100617-062653; Jiang C, 1999, GENOMICS, V62, P508, DOI 10.1006/geno.1999.6052; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Jost D, 2018, NUCLEIC ACIDS RES, V46, P2252, DOI 10.1093/nar/gky009; Karimzadeh M, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky677; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kirsche M, 2021, BIOINFORMATICS, V37, P744, DOI 10.1093/bioinformatics/btaa911; Kokot M, 2017, BIOINFORMATICS, V33, P2759, DOI 10.1093/bioinformatics/btx304; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Kovaka S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1910-1; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langley SA, 2019, ELIFE, V8, DOI 10.7554/eLife.42989; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee I, 2020, NAT METHODS, V17, P1191, DOI 10.1038/s41592-020-01000-7; Lemmers RJLF, 2018, HUM MOL GENET, V27, P3488, DOI 10.1093/hmg/ddy236; Li CR, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0039-9; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Logsdon GA, 2021, NATURE, V593, P101, DOI 10.1038/s41586-021-03420-7; Logsdon GA, 2020, NAT REV GENET, V21, P597, DOI 10.1038/s41576-020-0236-x; Maggiolini FAM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008075; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; Miga KH, 2021, ANNU REV GENOM HUM G, V22, P81, DOI 10.1146/annurev-genom-120120-081921; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Miga KH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050352; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Nishibuchi G, 2017, CHROMOSOME RES, V25, P77, DOI 10.1007/s10577-016-9547-3; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; Prior TW, 2010, GENET MED, V12, P145, DOI 10.1097/GIM.0b013e3181c5e713; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shafin K, 2020, NAT BIOTECHNOL, V38, P1044, DOI 10.1038/s41587-020-0503-6; Shepelev VA, 2015, GENOM DATA, V5, P139, DOI 10.1016/j.gdata.2015.05.035; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Sobecki M, 2018, CELL REP, V25, P2891, DOI 10.1016/j.celrep.2018.11.027; Souri Z, 2020, CANCERS, V12, DOI 10.3390/cancers12123690; Stergachis AB, 2020, SCIENCE, V368, P1449, DOI 10.1126/science.aaz1646; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067; Tanaka Y, 2005, FEBS J, V272, P282, DOI 10.1111/j.1432-1033.2004.04406.x; Thakur J, 2018, GENE DEV, V32, P20, DOI 10.1101/gad.307736.117; Thoraval D, 1996, GENE CHROMOSOME CANC, V17, P234, DOI 10.1002/(SICI)1098-2264(199612)17:4<234::AID-GCC5>3.0.CO;2-4; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Van Hooser AA, 2001, J CELL SCI, V114, P3529; van Sluis M, 2019, GENE DEV, V33, P1688, DOI 10.1101/gad.331892.119; Vollger MR, 2022, SCIENCE, V376, P55, DOI 10.1126/science.abj6965; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; YUNIS JJ, 1971, SCIENCE, V174, P1200, DOI 10.1126/science.174.4015.1200; Zeileis A, 2005, J STAT SOFTW, V14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	96	23	23	25	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		58	+	eabj5089	10.1126/science.abj5089	http://dx.doi.org/10.1126/science.abj5089			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0J6ED	35357915	Green Accepted, Green Submitted			2022-12-28	WOS:000780195200026
J	Smith, FA				Smith, Felisa A.			The road to a larger brain	SCIENCE			English	Editorial Material							SIZE; EVOLUTION		[Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	fasmith@unm.edu						Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Benson-Amram S, 2016, P NATL ACAD SCI USA, V113, P2532, DOI 10.1073/pnas.1505913113; Bertrand OC, 2022, SCIENCE, V376, P80, DOI 10.1126/science.abl5584; Burger JR, 2019, J MAMMAL, V100, P276, DOI 10.1093/jmammal/gyz043; Hurlburt GR, 1995, J VERTEBR PALEONTOL, V15, p37A; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Marsh O. C, 1874, ANN MAG NAT HIST, V14, P167; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; PAGEL MD, 1988, AM NAT, V132, P344, DOI 10.1086/284857; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Smaers JB, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe2101; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Tsuboi M, 2018, NAT ECOL EVOL, V2, P1492, DOI 10.1038/s41559-018-0632-1	15	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		27	28		10.1126/science.abo1985	http://dx.doi.org/10.1126/science.abo1985			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357943				2022-12-28	WOS:000780195200010
J	Bender, E				Bender, Eric			Corinna Dan: Elimination enthusiast	NATURE			English	News Item						Diseases; Public health; Health care; Drug discovery; Therapeutics													0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					S57	S57		10.1038/d41586-022-00817-w	http://dx.doi.org/10.1038/d41586-022-00817-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354987	Bronze			2022-12-28	WOS:000776361600014
J	Sente, A; Desai, R; Naydenova, K; Malinauskas, T; Jounaidi, Y; Miehling, J; Zhou, XJ; Masiulis, S; Hardwick, SW; Chirgadze, DY; Miller, KW; Aricescu, AR				Sente, Andrija; Desai, Rooma; Naydenova, Katerina; Malinauskas, Tomas; Jounaidi, Youssef; Miehling, Jonas; Zhou, Xiaojuan; Masiulis, Simonas; Hardwick, Steven W.; Chirgadze, Dimitri Y.; Miller, Keith W.; Aricescu, A. Radu			Differential assembly diversifies GABA(A) receptor structures and signalling	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; BEAM-INDUCED MOTION; CRYO-EM; PHARMACOLOGICAL CHARACTERIZATION; A-RECEPTORS; BAYESIAN-APPROACH; DELTA-SUBUNIT; RAT-BRAIN; BINDING; STOICHIOMETRY	Type A gamma-aminobutyric acid receptors (GABA(A)Rs) are pentameric ligand-gated chloride channels that mediate fast inhibitory signalling in neural circuits(1,2) and can be modulated by essential medicines including general anaesthetics and benzodiazepines(3). Human GABA(A)R subunits are encoded by 19 paralogous genes that can, in theory, give rise to 495,235 receptor types. However, the principles that govern the formation of pentamers, the permutational landscape of receptors that may emerge from a subunit set and the effect that this has on GABAergic signalling remain largely unknown. Here we use cryogenic electron microscopy to determine the structures of extrasynaptic GABA(A)Rs assembled from alpha 4, beta 3 and delta subunits, and their counterparts incorporating gamma 2 instead of delta subunits. In each case, we identified two receptor subtypes with distinct stoichiometries and arrangements, all four differing from those previously observed for synaptic, alpha 1-containing receptors(4-7). This, in turn, affects receptor responses to physiological and synthetic modulators by creating or eliminating ligand-binding sites at subunit interfaces. We provide structural and functional evidence that selected GABA(A)R arrangements can act as coincidence detectors, simultaneously responding to two neurotransmitters: GABA and histamine. Using assembly simulations and single-cell RNA sequencing data(8,9), we calculated the upper bounds for receptor diversity in recombinant systems and in vivo. We propose that differential assembly is a pervasive mechanism for regulating the physiology and pharmacology of GABA(A)Rs.	[Sente, Andrija; Naydenova, Katerina; Miehling, Jonas; Masiulis, Simonas; Aricescu, A. Radu] MRC Lab Mol Biol, Cambridge, England; [Desai, Rooma; Jounaidi, Youssef; Zhou, Xiaojuan; Miller, Keith W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Malinauskas, Tomas] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England; [Hardwick, Steven W.; Chirgadze, Dimitri Y.] Thermo Fisher Sci, Mat & Struct Anal Div, Eindhoven, Netherlands; [Masiulis, Simonas] Univ Cambridge, Dept Biochem, Cambridge, England	MRC Laboratory Molecular Biology; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Oxford; Wellcome Centre for Human Genetics; Thermo Fisher Scientific; University of Cambridge	Sente, A; Aricescu, AR (corresponding author), MRC Lab Mol Biol, Cambridge, England.; Miller, KW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	asente@mrc-lmb.cam.ac.uk; k_miller@helix.mgh.harvard.edu; radu@mrc-lmb.cam.ac.uk		Chirgadze, Dimitri/0000-0001-9942-0993; Sente, Andrija/0000-0001-5407-9138	UK Medical Research Council [MR/L009609/1, MC_UP_1201/15]; National Institute for General Medical Sciences [1R01-GM135550]; Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital; MRC-LMB; Cambridge Trust (LMB Cambridge Scholarship); School of Clinical Medicine, University of Cambridge; Boehringer Ingelheim Fonds; Wellcome Trust [206171/Z/17/Z, 202905/Z/16/Z]; University of Cambridge	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital; MRC-LMB(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Trust (LMB Cambridge Scholarship); School of Clinical Medicine, University of Cambridge(University of Cambridge); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge)	We thank M. Madan Babu, D. Barford, T. Blundell, R. Calinescu, T. Flock, A. B. Kleist, A. Murzin, D. Malinverni, C. J. Russo, N. Unwin and the members of Aricescu laboratory for helpful discussions and comments on this work; V. B. Kasaragod for help with model building; T. Nakane and K. Yamashita for help with data processing; J. Grimmett and T. Darling for support with scientific computing; S. Chen, G. Cannone, G. Sharov, A. Yeates and B. Ahsan for electron microscopy support; T. Uchanski, E. Pardon and J. Steyaert for the Mb192 megabody. Cryo-EM datasets were collected at the MRC-LMB and Cambridge University Department of Biochemistry EM (BiocEM) facilities. We acknowledge funding from the UK Medical Research Council (MR/L009609/1 and MC_UP_1201/15 to A.R.A.), National Institute for General Medical Sciences (1R01-GM135550 to K.W.M. and A.R.A.), the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital (to K.W.M.), MRC-LMB and Cambridge Trust (LMB Cambridge Scholarship to A.S. and K.N.), School of Clinical Medicine, University of Cambridge (MB/PhD fellowship to A.S.), and Boehringer Ingelheim Fonds (PhD Fellowship to J.M.). The cryo-EM facility at the Department of Biochemistry is funded by the Wellcome Trust (206171/Z/17/Z and 202905/Z/16/Z) and the University of Cambridge.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; BAUDE A, 1992, NEUROSCIENCE, V51, P739, DOI 10.1016/0306-4522(92)90513-2; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bianchi MT, 2011, NEUROPHARMACOLOGY, V61, P747, DOI 10.1016/j.neuropharm.2011.05.020; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng, 2019, ZENODO, DOI DOI 10.5281/ZEN0D0.3576630; Datta D, 2015, CEREB CORTEX, V25, P2295, DOI 10.1093/cercor/bhu040; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Elegheert J, 2018, NAT PROTOC, V13, P2991, DOI 10.1038/s41596-018-0075-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALCH E, 1982, J NEUROCHEM, V38, P1123, DOI 10.1111/j.1471-4159.1982.tb05357.x; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fatemi SH., 2013, TRANSL PSYCHIAT, V3; Forman SA, 1999, BIOCHEMISTRY-US, V38, P14559, DOI 10.1021/bi9914457; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Hanchar HJ, 2006, P NATL ACAD SCI USA, V103, P8546, DOI 10.1073/pnas.0509903103; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hoerbelt P, 2016, NEUROPHARMACOLOGY, V108, P252, DOI 10.1016/j.neuropharm.2016.04.042; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Lee HJ, 2016, BRAIN RES, V1644, P222, DOI 10.1016/j.brainres.2016.05.019; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; Linden AM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00003; Marti-Solano M, 2020, NATURE, V587, P650, DOI 10.1038/s41586-020-2888-2; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; MERTENS S, 1993, J BIOL CHEM, V268, P5965; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mueller TM, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.102; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakane T, 2020, NATURE, V587, P152, DOI 10.1038/s41586-020-2829-0; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nusser Z, 1998, J NEUROSCI, V18, P1693; Olsen RW, 2007, ALCOHOL, V41, P201, DOI 10.1016/j.alcohol.2007.04.006; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scholze P, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.591129; Sente A., 2022, ZENODO, DOI [10.5281/zenodo.5884871, DOI 10.5281/ZENODO.5884871]; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sieghart W, 2018, PHARMACOL REV, V70, P836, DOI 10.1124/pr.117.014449; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Taylor PM, 1999, J NEUROSCI, V19, P6360; Uchanski T, 2021, NAT METHODS, V18, P60, DOI 10.1038/s41592-020-01001-6; Wafford KA, 2006, CURR OPIN PHARMACOL, V6, P30, DOI 10.1016/j.coph.2005.10.004; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wallner M, 2006, P NATL ACAD SCI USA, V103, P8540, DOI 10.1073/pnas.0600194103; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wongsamitkul N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15628-7; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191583; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	79	5	5	12	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					190	+		10.1038/s41586-022-04517-3	http://dx.doi.org/10.1038/s41586-022-04517-3		MAR 2022	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355020	Green Accepted			2022-12-28	WOS:000776020400010
J	Viegas, IJ; de Macedo, JP; Serra, L; De Niz, M; Temporao, A; Pereira, SS; Mirza, AH; Bergstrom, E; Rodrigues, JA; Aresta-Branco, F; Jaffrey, SR; Figueiredo, LM				Viegas, Idalio J.; de Macedo, Juan Pereira; Serra, Lucia; De Niz, Mariana; Temporao, Adriana; Pereira, Sara Silva; Mirza, Aashiq H.; Bergstrom, Ed; Rodrigues, Joao A.; Aresta-Branco, Francisco; Jaffrey, Samie R.; Figueiredo, Luisa M.			N-6-methyladenosine in poly(A) tails stabilize VSG transcripts	NATURE			English	Article							VARIANT SURFACE GLYCOPROTEIN; MESSENGER-RNA; GENE-EXPRESSION; NUCLEAR-RNA; REVEALS; PROCYCLIN; DEADENYLATION; METHYLATION; METHYLOMES; TURNOVER	RNA modifications are important regulators of gene expression(1). In Trypanosoma brucei, transcription is polycistronic and thus most regulation happens post-transcriptionally(2). N-6-methyladenosine (m(6)A) has been detected in this parasite, but its function remains unknown(3). Here we found that m(6)A is enriched in 342 transcripts using RNA immunoprecipitation, with an enrichment in transcripts encoding variant surface glycoproteins (VSGs). Approximately 50% of the m(6)A is located in the poly(A) tail of the actively expressed VSG transcripts. m(6)A residues are removed from the VSG poly(A) tail before deadenylation and mRNA degradation. Computational analysis revealed an association between m(6)A in the poly(A) tail and a 16-mer motif in the 3 ' untranslated region of VSG genes. Using genetic tools, we show that the 16-mer motif acts as a cis-acting motif that is required for inclusion of m(6)A in the poly(A) tail. Removal of this motif from the 3 ' untranslated region of VSG genes results in poly(A) tails lacking m(6)A, rapid deadenylation and mRNA degradation. To our knowledge, this is the first identification of an RNA modification in the poly(A) tail of any eukaryote, uncovering a post-transcriptional mechanism of gene regulation.	[Viegas, Idalio J.; de Macedo, Juan Pereira; Serra, Lucia; De Niz, Mariana; Temporao, Adriana; Pereira, Sara Silva; Rodrigues, Joao A.; Aresta-Branco, Francisco; Figueiredo, Luisa M.] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Mirza, Aashiq H.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Bergstrom, Ed] Univ York, Dept Chem, York, N Yorkshire, England; [Bergstrom, Ed] Univ York, Ctr Excellence Mass Spectrometry, York, N Yorkshire, England; [Rodrigues, Joao A.] Clarify Analyt, Evora, Portugal; [Aresta-Branco, Francisco] German Canc Res Ctr, Div Immune Divers, Heidelberg, Germany; [Aresta-Branco, Francisco] German Canc Res Ctr, Div Struct Biol Infect & Immun, Heidelberg, Germany	Universidade de Lisboa; Cornell University; University of York - UK; University of York - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Figueiredo, LM (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal.	lmf@medicina.ulisboa.pt	Figueiredo, Luisa M./C-3908-2018; Macedo, Juan/B-4151-2017	Figueiredo, Luisa M./0000-0002-5752-6586; Temporao, Adriana/0000-0002-1208-9984; Viegas, Idalio/0000-0001-8777-927X; De Niz, Mariana/0000-0001-6987-6789; Macedo, Juan/0000-0001-5759-1196; Silva Pereira, Sara/0000-0002-6590-6626	Howard Hughes Medical Institute International Early Career Scientist Program [55007419]; European Molecular Biology Organization Installation grant [2151]; La Caixa Foundation [HR20-00361]; ONEIDA project [LISBOA-01-0145-FEDER-016417]; Fundos Europeus Estruturais e de Investimento (FEEI) from 'Programa Operacional Regional Lisboa 2020'; Fundacao para a Ciencia e a Tecnologia (FCT); NIH [R35 NS111631]; FCT [PD/BD/105838/2014, 2020.06827.BD, SFRH/BD/80718/2011, PD/BD/138891/2018, CEECIND/03322/2018]; Novartis Foundation for Biomedical-Biological research; Human Frontier Science Programme long-term postdoctoral fellowship [LT000047/2019]; Marie Skodowska-Curie Individual Standard European Fellowship [839960]; GlycoPar Marie Curie Initial Training Network [GA 608295]; Northern Way Initiative; Yorkshire Forward; EPSRC [EP/K039660/1, EP/M028127/1]	Howard Hughes Medical Institute International Early Career Scientist Program; European Molecular Biology Organization Installation grant; La Caixa Foundation(La Caixa Foundation); ONEIDA project; Fundos Europeus Estruturais e de Investimento (FEEI) from 'Programa Operacional Regional Lisboa 2020'; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Novartis Foundation for Biomedical-Biological research; Human Frontier Science Programme long-term postdoctoral fellowship; Marie Skodowska-Curie Individual Standard European Fellowship; GlycoPar Marie Curie Initial Training Network; Northern Way Initiative; Yorkshire Forward; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to support from the Howard Hughes Medical Institute International Early Career Scientist Program (55007419), a European Molecular Biology Organization Installation grant (2151) and La Caixa Foundation (HR20-00361). This work was also partially supported by the ONEIDA project (LISBOA-01-0145-FEDER-016417) co-funded by Fundos Europeus Estruturais e de Investimento (FEEI) from 'Programa Operacional Regional Lisboa 2020' and by national funds from FundacAo para a Ciencia e a Tecnologia (FCT). S.R.J. was supported by NIH (R35 NS111631). Researchers were funded by individual fellowships from FCT (PD/BD/105838/2014 to I.J.V., 2020.06827.BD to L.S., SFRH/BD/80718/2011 to F.A.-B., PD/BD/138891/2018 to A.T. and CEECIND/03322/2018 to L.M.F.); a Novartis Foundation for Biomedical-Biological research to J.P.d.M.; a Human Frontier Science Programme long-term postdoctoral fellowship to M.D.N. (LT000047/2019); a Marie Skodowska-Curie Individual Standard European Fellowship to S.S.P. (grant no. 839960); the GlycoPar Marie Curie Initial Training Network (GA 608295) to J.A.R. We thank J. Thomas-Oates (University of York, Centre of Excellence in Mass Spectrometry, Department of Chemistry) for the mass spectrometry analysis. The York Centre of Excellence in Mass Spectrometry was created thanks to a major capital investment through Science City York, supported by Yorkshire Forward with funds from the Northern Way Initiative, and subsequent support from EPSRC (EP/K039660/1 and EP/M028127/1). We also thank A. Temudo, A. Nascimento and A. Lima for bioimaging assistance; the laboratories of A. Tomas and J. Kelly for providing RNA from Leishmania and T. cruzi, respectively; and A. Pena and members of the Figueiredo and Jaffrey laboratories for helpful discussions.	BANGS JD, 1992, J BIOL CHEM, V267, P9805; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; do Nascimento LM, 2021, ELIFE, V10, DOI 10.7554/eLife.68136; Domingo-Sananes MR, 2015, J CELL BIOL, V211, P455, DOI 10.1083/jcb.201506114; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; EHLERS B, 1987, MOL CELL BIOL, V7, P1242, DOI 10.1128/MCB.7.3.1242; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Fadda A, 2013, RNA, V19, P937, DOI 10.1261/rna.038430.113; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; FREISTADT MS, 1988, J BIOL CHEM, V263, P15071; Gallie DR, 2014, TRANSLATION, V2, DOI 10.4161/2169074X.2014.959378; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hauenschild R, 2015, NUCLEIC ACIDS RES, V43, P9950, DOI 10.1093/nar/gkv895; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kraus AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48692-2; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu LG, 2019, BIOCHEM BIOPH RES CO, V508, P1286, DOI 10.1016/j.bbrc.2018.12.043; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ridewood S, 2017, MOL MICROBIOL, V106, P614, DOI 10.1111/mmi.13838; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Tang TTL, 2019, NAT STRUCT MOL BIOL, V26, P433, DOI 10.1038/s41594-019-0227-9; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Xiang JF, 2018, MOL CELL, V69, P126, DOI 10.1016/j.molcel.2017.12.006; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	42	7	7	9	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 14	2022	604	7905					362	+		10.1038/s41586-022-04544-0	http://dx.doi.org/10.1038/s41586-022-04544-0		MAR 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0M9OF	35355019	Green Accepted, Green Submitted			2022-12-28	WOS:000776020400008
J	Dyer, O				Dyer, Owen			Covid-19: WHO set to reject Canadian plant based vaccine because of links with tobacco industry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ministry of Health Government of Ontario, 2022, COVID 19 VACC 3 DOS	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2022	376								o811	10.1136/bmj.o811	http://dx.doi.org/10.1136/bmj.o811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0H3MY	35346968	Bronze			2022-12-28	WOS:000778641000002
J	Bruxvoort, K; Slezak, J; Qian, L; Sy, LS; Ackerson, B; Reynolds, K; Huang, RX; Solano, Z; Towner, W; Mercado, C; Jacobsen, SJ				Bruxvoort, Katia; Slezak, Jeff; Qian, Lei; Sy, Lina S.; Ackerson, Bradley; Reynolds, Kristi; Huang, Runxin; Solano, Zendi; Towner, William; Mercado, Cheryl; Jacobsen, Steven J.			Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVISORY-COMMITTEE; UNITED-STATES; IMMUNIZATION PRACTICES; VIRUS INFECTION; RECOMMENDATIONS; IMMUNOGENICITY; COVERAGE	IMPORTANCE The 2-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG vaccine; Heplisav-B) generated higher seroprotection in prelicensure trials than did a 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (HepB-alum vaccine; Engerix-B). However, in 1 trial, a higher number of acutemyocardial infarction (MI) events were observed among those who received the HepB-CpG vaccine than among those who received the HepB-alum vaccine, an outcome requiring further study. OBJECTIVE To compare the rate of acute MI between recipients of HepB-CpG vaccine and HepB-alum vaccine. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort noninferiority studywas conducted at Kaiser Permanente Southern California (KPSC), an integrated health care system with 15 medical centers and approximately 4.7 million members. The study included 69 625 adults not undergoing dialysis who received at least 1 dose of a hepatitis B vaccine in either family medicine or internal medicine departments at KPSC from August 7, 2018, to October 31, 2019 (November 30, 2020, final follow-up). EXPOSURES Receipt of HepB-CpG vaccine vs HepB-alum vaccine. The first dose during the study period was the index dose. MAIN OUTCOMES AND MEASURES Individualswere followed up for 13 months after the index dose for occurrence of type 1 acute MI. Potential events were identified using diagnosis codes and adjudicated by cardiologists. The adjusted hazard ratio (HR) of acute MI was estimated comparing recipients of HepB-CpG vaccine with recipients of HepB-alum vaccine, with inverse probability of treatment weighting (IPTW) to adjust for demographic and clinical characteristics. The upper limit of the 1-sided 97.5% CI was compared with a noninferiority margin of 2. RESULTS Of the 31 183 recipients of HepB-CpG vaccine (median age, 49 years; IQR, 38-56 years), 51.2%(n = 15 965) were men, and 52.7%(n = 16 423) were Hispanic. Of the 38 442 recipients of HepB-alum (median age, 49 years; IQR, 39-56 years), 50.8%(19 533) were men, and 47.1%(n = 18 125) were Hispanic. Characteristics were well-balanced between vaccine groups after IPTW. Fifty-two type 1 acute MI events were confirmed among recipients of HepB-CpG vaccine for a rate of 1.67 per 1000-person-years, and 71 type 1 acute MI events were confirmed among recipients of HepB-alum vaccine for a rate of 1.86 per 1000 person-years (absolute rate difference, -0.19 [95% CI, -0.82 to 0.44]; adjusted HR, 0.92 [1-sided 97.5% CI, infinity to 1.32], which was below the noninferiority margin; P <.001 for noninferiority). CONCLUSIONS AND RELEVANCE In this cohort study, receipt of HepB-CpG vaccine compared with HepB-alum vaccine did not meet the statistical criterion for increased risk of acute myocardial infarction.	[Bruxvoort, Katia] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, 1665 Univ Blvd, Birmingham, AL 35233 USA; [Bruxvoort, Katia; Slezak, Jeff; Qian, Lei; Sy, Lina S.; Ackerson, Bradley; Reynolds, Kristi; Huang, Runxin; Solano, Zendi; Towner, William; Mercado, Cheryl; Jacobsen, Steven J.] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA; [Jacobsen, Steven J.] Marshfield Clin Res Inst, Marshfield, WI USA	University of Alabama System; University of Alabama Birmingham; Kaiser Permanente	Bruxvoort, K (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, 1665 Univ Blvd, Birmingham, AL 35233 USA.	kbruxvoort@uab.edu		Bruxvoort, Katia/0000-0001-8277-2431	Dynavax Technologies	Dynavax Technologies	This work was funded by Dynavax Technologies, manufacturers of HEPLISAV-B.	[Anonymous], 1985, THEORETICAL EPIDEMIO; [Anonymous], 2017, VACC REL BIOL PROD A; Bruxvoort K, 2021, VACCINE-X, V8, DOI 10.1016/j.jvacx.2021.100101; Bruxvoort K, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.27577; Centers for Disease Control and Prevention, 2018, VIR HEP SURV US; Chi GC, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013542; Heyward WL, 2013, VACCINE, V31, P5300, DOI 10.1016/j.vaccine.2013.05.068; Jackson S, 2018, VACCINE, V36, P668, DOI 10.1016/j.vaccine.2017.12.038; Lazarus JV, 2020, J HEPATOL, V73, P490, DOI 10.1016/j.jhep.2020.06.008; Lim JK, 2020, AM J GASTROENTEROL, V115, P1429, DOI 10.14309/ajg.0000000000000651; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lu PJ, 2011, VACCINE, V29, P7049, DOI 10.1016/j.vaccine.2011.07.030; McCarthy C, 2019, JAMA CARDIOL, V4, P460, DOI 10.1001/jamacardio.2019.0716; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Raphael CE, 2020, CIRCULATION, V141, P454, DOI 10.1161/CIRCULATIONAHA.119.043100; Schillie S, 2018, MMWR-MORBID MORTAL W, V67, P455, DOI 10.15585/mmwr.mm6715a5; Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1; Thygesen K, 2018, KARDIOL POL, V76, P1383, DOI [10.5603/KP.2018.0203, 10.1016/j.gheart.2018.08.004, 10.1161/CIR.0000000000000617]; Trantham L, 2018, VACCINE, V36, P5333, DOI 10.1016/j.vaccine.2018.05.111; US Food and Drug Administration, SUMM BAS REG ACT HEP; Williams WW, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6611a1	23	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1260	1268		10.1001/jama.2022.2540	http://dx.doi.org/10.1001/jama.2022.2540		MAR 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35333303	Bronze, Green Published			2022-12-28	WOS:000772989600001
J	Yin, JB; Tan, C; Barcons-Ruiz, D; Torre, I; Watanabe, K; Taniguchi, T; Song, JCW; Hone, J; Koppens, FHL				Yin, Jianbo; Tan, Cheng; Barcons-Ruiz, David; Torre, Iacopo; Watanabe, Kenji; Taniguchi, Takashi; Song, Justin C. W.; Hone, James; Koppens, Frank H. L.			Tunable and giant valley-selective Hall effect in gapped bilayer graphene	SCIENCE			English	Article							BERRY PHASE; TRANSPORT; MOS2; POLARIZATION; GENERATION	Berry curvature is analogous to magnetic field but in momentum space and is commonly present in materials with nontrivial quantum geometry. It endows Bloch electrons with transverse anomalous velocities to produce Hall-like currents even in the absence of a magnetic field. We report the direct observation of in situ tunable valley-selective Hall effect (VSHE), where inversion symmetry, and thus the geometric phase of electrons, is controllable by an out-of-plane electric field. We use high-quality bilayer graphene with an intrinsic and tunable bandgap, illuminated by circularly polarized midinfrared light, and confirm that the observed Hall voltage arises from an optically induced valley population. Compared with molybdenum disulfide (MoS2), we find orders of magnitude larger VSHE, attributed to the inverse scaling of the Berry curvature with bandgap. By monitoring the valley-selective Hall conductivity, we study the Berry curvature's evolution with bandgap. This in situ manipulation of VSHE paves the way for topological and quantum geometric optoelectronic devices, such as more robust switches and detectors.	[Yin, Jianbo; Barcons-Ruiz, David; Torre, Iacopo; Koppens, Frank H. L.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelldefels, Barcelona, Spain; [Yin, Jianbo] Beijing Graphene Inst, Beijing, Peoples R China; [Tan, Cheng; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Song, Justin C. W.] Nanyang Technol Univ, Div Phys & Appl Phys, Singapore 637371, Singapore; [Koppens, Frank H. L.] ICREA Inst Catalana Recerca & Estudis Avanc, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Columbia University; National Institute for Materials Science; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; ICREA	Yin, JB; Koppens, FHL (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelldefels, Barcelona, Spain.; Yin, JB (corresponding author), Beijing Graphene Inst, Beijing, Peoples R China.; Koppens, FHL (corresponding author), ICREA Inst Catalana Recerca & Estudis Avanc, Barcelona, Spain.	jyin@icfo.net; frank.koppens@icfo.eu	Torre, Iacopo/AAK-3233-2021; Song, Justin CW/M-1353-2017; Hone, James/E-1879-2011; Watanabe, Kenji/H-2825-2011	Torre, Iacopo/0000-0001-6515-181X; Song, Justin CW/0000-0002-5175-6970; Barcons Ruiz, David/0000-0002-6271-2244; Hone, James/0000-0002-8084-3301; Watanabe, Kenji/0000-0003-3701-8119	European Union [881603, 747927]; European Research Council (ERC) TOPONANOP [726001]; government of Spain [PID2019-106875GB-I00, FJC2018-037098-I]; MCIN/AEI [CEX2019-000910-S]; Fundacio Cellex, Fundacio Mir-Puig; Generalitat de Catalunya (CERCA, AGAUR [SGR 1656]; National Natural Science Foundation of China [52072043, T2188101]; National Key R&D Program of China [2020YFA0308900]; National Science Foundation program for Emerging Frontiers in Research and Innovation [EFRI-1741660]; Ministry of Education Singapore, under its MOE AcRF Tier 3 Award [MOE2018-T3-1-002]; Nanyang Technological University start-up grant (NTU-SUG)	European Union(European Commission); European Research Council (ERC) TOPONANOP(European Research Council (ERC)); government of Spain(Spanish Government); MCIN/AEI; Fundacio Cellex, Fundacio Mir-Puig; Generalitat de Catalunya (CERCA, AGAUR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Science Foundation program for Emerging Frontiers in Research and Innovation; Ministry of Education Singapore, under its MOE AcRF Tier 3 Award; Nanyang Technological University start-up grant (NTU-SUG)(Nanyang Technological University)	This work is supported by European Union's Horizon 2020 Research and Innovation Programme under grant agreement ref. 881603 (Graphene Flagship Core Project 3) (F.H.L.K.); European Research Council (ERC) TOPONANOP under grant agreement ref. 726001 (F.H.L.K.); the government of Spain [PID2019-106875GB-I00; FJC2018-037098-I; Severo Ochoa CEX2019-000910-S (MCIN/AEI/10.13039/501100011033)] (F.H.L.K.); Fundacio Cellex, Fundacio Mir-Puig (F.H.L.K.); Generalitat de Catalunya (CERCA, AGAUR, SGR 1656) (F.H.L.K.); European Union's Horizon 2020 Programme under the Marie Sklodowska-Curie grant agreements VHPC ref. 747927 (J.Y.); National Natural Science Foundation of China (grant refs. 52072043 and T2188101) (J.Y.); National Key R&D Program of China under grant ref. 2020YFA0308900 (J. Y.); National Science Foundation program for Emerging Frontiers in Research and Innovation (EFRI-1741660) (C.T. and J.H.); the Ministry of Education Singapore, under its MOE AcRF Tier 3 Award MOE2018-T3-1-002 (J. C.W.S.); and a Nanyang Technological University start-up grant (NTU-SUG) (J. C.W.S.).	Aharon-Steinberg A, 2021, NATURE, V593, P528, DOI 10.1038/s41586-021-03501-7; Aktor T, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.115406; Ando T, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.114705; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; CHANG MC, 1995, PHYS REV LETT, V75, P1348, DOI 10.1103/PhysRevLett.75.1348; Endo K, 2019, APPL PHYS LETT, V114, DOI 10.1063/1.5094456; Gabor NM, 2011, SCIENCE, V334, P648, DOI 10.1126/science.1211384; Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Ju L, 2017, SCIENCE, V358, P907, DOI 10.1126/science.aam9175; Ju L, 2015, NATURE, V520, P650, DOI 10.1038/nature14364; KARPLUS R, 1954, PHYS REV, V95, P1154, DOI 10.1103/PhysRev.95.1154; Komatsu K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0194; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; McIver JW, 2020, NAT PHYS, V16, P38, DOI 10.1038/s41567-019-0698-y; Onga M, 2017, NAT MATER, V16, P1193, DOI [10.1038/NMAT4996, 10.1038/nmat4996]; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Roche S., 2022, J PHYS-MATER, V5; Shimazaki Y, 2015, NAT PHYS, V11, P1032, DOI [10.1038/NPHYS3551, 10.1038/nphys3551]; Sinha S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19284-w; Slizovskiy S, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0268-8; Song JCW, 2016, NANO LETT, V16, P7346, DOI 10.1021/acs.nanolett.6b02559; Song JCW, 2015, P NATL ACAD SCI USA, V112, P10879, DOI 10.1073/pnas.1424760112; Sui MQ, 2015, NAT PHYS, V11, P1027, DOI [10.1038/nphys3485, 10.1038/NPHYS3485]; Ubrig N, 2017, NANO LETT, V17, P5719, DOI 10.1021/acs.nanolett.7b02666; Wu ZF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08629-9; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Yao W, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235406; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	34	3	3	27	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1398	+		10.1126/science.abl4266	http://dx.doi.org/10.1126/science.abl4266			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35324299	Green Submitted			2022-12-28	WOS:000778894800041
J	Cao, LX; Coventry, B; Goreshnik, I; Huang, BW; Sheffler, W; Park, JS; Jude, KM; Markovic, I; Kadam, RU; Verschueren, KHG; Verstraete, K; Walsh, STR; Bennett, N; Phal, A; Yang, A; Kozodoy, L; DeWitt, M; Picton, L; Miller, L; Strauch, EM; DeBouver, ND; Pires, A; Bera, AK; Halabiya, S; Hammerson, B; Yang, W; Bernard, S; Stewart, L; Wilson, IA; Ruohola-Baker, H; Schlessinger, J; Lee, S; Savvides, SN; Garcia, KC; Baker, D				Cao, Longxing; Coventry, Brian; Goreshnik, Inna; Huang, Buwei; Sheffler, William; Park, Joon Sung; Jude, Kevin M.; Markovic, Iva; Kadam, Rameshwar U.; Verschueren, Koen H. G.; Verstraete, Kenneth; Walsh, Scott Thomas Russell; Bennett, Nathaniel; Phal, Ashish; Yang, Aerin; Kozodoy, Lisa; DeWitt, Michelle; Picton, Lora; Miller, Lauren; Strauch, Eva-Maria; DeBouver, Nicholas D.; Pires, Allison; Bera, Asim K.; Halabiya, Samer; Hammerson, Bradley; Yang, Wei; Bernard, Steffen; Stewart, Lance; Wilson, Ian A.; Ruohola-Baker, Hannele; Schlessinger, Joseph; Lee, Sangwon; Savvides, Savvas N.; Garcia, K. Christopher; Baker, David			Design of protein-binding proteins from the target structure alone	NATURE			English	Article							NERVE GROWTH-FACTOR; CRYSTAL-STRUCTURE; COMPUTATIONAL DESIGN; STRUCTURE REFINEMENT; RECEPTOR ECTODOMAIN; ANTIBODY; COMPLEX; MODEL; HEMAGGLUTININ; DOMAIN	The design of proteinsthat bind to a specific site on the surface of a target protein using no information other than the three-dimensional structure of the target remains a challenge' 5 . Here we describe a general solution to this problem that starts with a broad exploration of the vast space of possible binding modes to a selected region of a protein surface, and then intensifiesthe search in the vicinity of the most promising binding modes. We demonstrate the broad applicability of this approach through the de novo design of binding proteins to 12 diverse protein targets with different shapes and surface properties. Biophysical characterization showsthat the binders, which are all smaller than 65 amino acids, are hyperstable and, following experimental optimization, bind their targets with nanomolar to picomolar affinities. We succeeded in solving crystal structures of five of the binder-target complexes, and all five closely match the corresponding computational design models. Experimental data on nearly half a million computational designs and hundreds of thousands of point mutants provide detailed feedback on the strengths and limitations of the method and of our current understanding of protein-protein interactions, and should guide improvements of both. Our approach enables the targeted design of bindersto sites of interest on a wide variety of proteins for therapeutic and diagnostic applications.	[Cao, Longxing; Coventry, Brian; Goreshnik, Inna; Huang, Buwei; Sheffler, William; Bennett, Nathaniel; Phal, Ashish; Kozodoy, Lisa; DeWitt, Michelle; Miller, Lauren; Bera, Asim K.; Yang, Wei; Ruohola-Baker, Hannele; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Cao, Longxing; Coventry, Brian; Goreshnik, Inna; Huang, Buwei; Sheffler, William; Bennett, Nathaniel; Kozodoy, Lisa; DeWitt, Michelle; Miller, Lauren; Bera, Asim K.; Yang, Wei; Stewart, Lance; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Coventry, Brian; Bennett, Nathaniel; Stewart, Lance] Univ Washington, Mol Engn Grad Program, Seattle, WA 98195 USA; [Huang, Buwei; Phal, Ashish] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Park, Joon Sung; Schlessinger, Joseph; Lee, Sangwon] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Jude, Kevin M.; Yang, Aerin; Picton, Lora; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Jude, Kevin M.; Yang, Aerin; Picton, Lora; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Jude, Kevin M.; Phal, Ashish; Picton, Lora; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Markovic, Iva; Verschueren, Koen H. G.; Verstraete, Kenneth; Savvides, Savvas N.] VIB UGent Ctr Inflammat Res, Ghent, Belgium; [Markovic, Iva; Verschueren, Koen H. G.; Verstraete, Kenneth; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, Unit Struct Biol, Ghent, Belgium; [Kadam, Rameshwar U.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Walsh, Scott Thomas Russell] NCI, Chem Biol Lab, NIH, Frederick, MD 21701 USA; [Walsh, Scott Thomas Russell] JAMES Farm, Clarksville, MD USA; [Phal, Ashish] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Strauch, Eva-Maria] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [DeBouver, Nicholas D.] UCB Pharma, Bainbridge Island, WA USA; [DeBouver, Nicholas D.; Pires, Allison] Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA; [Pires, Allison] Seattle Childrens Ctr Global Infect Dis Res, Seattle, WA USA; [Halabiya, Samer] Univ Washington, Dept Elect & Comp Engn, Seattle, WA 98195 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yale University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University System of Georgia; University of Georgia; University of Washington; University of Washington Seattle; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu		Yang, Aerin/0000-0002-8704-0288; Jude, Kevin/0000-0002-3675-5136; Park, Joon Sung/0000-0002-1575-1849; , Lauren/0000-0001-5935-4549	DARPA Synergistic Discovery and Design (SD2) [HR0011835403, FA8750-17-C-0219]; Audacious Project at the Institute for Protein Design; Open Philanthropy Project Improving Protein Design Fund; Eric and Wendy Schmidt; Microsoft; National Institute of Allergy and Infectious Diseases [HHSN272201700059C]; NIH [S10 OD012289]; National Institute on Aging [R01AG063845]; Defense Threat Reduction Agency [HDTRA1-16-C-0029]; Human Frontier Science Program; Howard Hughes Medical Research Institute; US Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10OD021527]; CCR intramural research programme of NCI-NIH - National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006, P30GM138396]; US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Research Foundation Flanders [G0C2214N, G0E1516N]; Hercules Foundation [11-029]; VIB (Belgium) - National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH), Department of Health and Human Services [HHSN272201700059C]; DOE Office of Science by Argonne National Laboratory [06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	DARPA Synergistic Discovery and Design (SD2); Audacious Project at the Institute for Protein Design; Open Philanthropy Project Improving Protein Design Fund; Eric and Wendy Schmidt; Microsoft(Microsoft); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Human Frontier Science Program(Human Frontier Science Program); Howard Hughes Medical Research Institute(Howard Hughes Medical Institute); US Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; CCR intramural research programme of NCI-NIH - National Cancer Institute; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Research Foundation Flanders(FWO); Hercules Foundation; VIB (Belgium) - National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	This work was supported by DARPA Synergistic Discovery and Design (SD2) HR0011835403 contract FA8750-17-C-0219 (to L.C., B.C., S.H. and D.B.); The Audacious Project at the Institute for Protein Design (to L.K.); the Open Philanthropy Project Improving Protein Design Fund (to B.C. and D.B.); funding from Eric and Wendy Schmidt by recommendation of the Schmidt Futures programme (to I.G. and L.M.); an Azure computing resource gift for COVID-19 research provided by Microsoft (to L.C. and B.C.); the National Institute of Allergy and Infectious Diseases (HHSN272201700059C to D.B., B.H. and L.S.; NIH R01 AI140245 to E.-M.S.; NIH R01 AI150855 to I.A.W.); the National Institute on Aging (R01AG063845 to B.H. and D.B.); the Defense Threat Reduction Agency (HDTRA1-16-C-0029 to D.B. and E.-M.S.); The Donald and Jo Anne Petersen Endowment for Accelerating Advancements in Alzheimer's Disease Research (to N.B.); a gift from Gates Ventures (to M.D.); The Human Frontier Science Program (to A.Y.); and The Howard Hughes Medical Research Institute (K.M.J., K.C.G. and D.B.). Use of SSRL at Stanford Linear Accelerator Center (SLAC) National Accelerator Laboratory is supported by the US Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE, Office of Biological and Environmental Research and the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). A part of this work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Eiger 16M detector on the 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S10OD021527). S.T.R.W. was supported by the CCR intramural research programme of NCI-NIH. GM/CA at the Advanced Photon Source at Argonne National Laboratory has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This research used resources of the Advanced Photon Source, a US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. S.N.S. acknowledges research support from Research Foundation Flanders (grants G0C2214N and G0E1516N) and the Hercules Foundation (no. AUGE- 11-029). S.N.S. is a principal investigator of the VIB (Belgium). SSGCID is funded by federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN272201700059C from 1 September 2017. APS/LSCAT research used resources of the Advanced Photon Source, a US DOE Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02- 06CH11357. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). We thank the staff of beamline ID23-2 (ESRF) for technical support and beamtime allocation; G. Ueda for providing the ANG1 protein for the TrkA competition assay; D. H. Fuller for providing the FI6v3 antibody for the HA competition assay; Y.-J. Park, A. Walls and D.; Veesler for their collaborative research and cryo-EM structure determination for minibinders targeting the SARS-CoV-2 spike; and K. Van Wormer and A. Curtis Smith for their laboratory support during COVID-19.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersson A, 2019, ENVIRON SCI-WAT RES, V5, P861, DOI 10.1039/c9ew00034h; [Anonymous], 2016, BUSTER V 2 10 2; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Baran D, 2017, P NATL ACAD SCI USA, V114, P10900, DOI 10.1073/pnas.1707171114; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Brunette TJ, 2020, P NATL ACAD SCI USA, V117, P8870, DOI 10.1073/pnas.1908768117; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Cao LX, 2020, SCIENCE, V370, P426, DOI 10.1126/science.abd9909; Case JB, 2021, CELL HOST MICROBE, V29, P1151, DOI 10.1016/j.chom.2021.06.008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chevalier A, 2017, NATURE, V550, P74, DOI 10.1038/nature23912; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Coventry B, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008061; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Divine R, 2021, SCIENCE, V372, P47, DOI 10.1126/science.abd9994; Dou JY, 2018, NATURE, V561, P485, DOI 10.1038/s41586-018-0509-0; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Frejd FY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.35; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gillespie JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01867-15; Grabowski M, 2019, STRUCT DYN-US, V6, DOI 10.1063/1.5128672; Grabowski M, 2016, ACTA CRYSTALLOGR D, V72, P1181, DOI 10.1107/S2059798316014716; Headd JJ, 2014, ACTA CRYSTALLOGR D, V70, P1346, DOI 10.1107/S1399004714003277; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Legrand P., 2010, XDSME XDS MADE EASIE; Lim Y, 2016, MOL CANCER THER, V15, P251, DOI 10.1158/1535-7163.MCT-15-0679; Linsky T., 2021, PREPRINT, DOI 10.1101/2021.03.10.434454; Mackenzie CO, 2016, P NATL ACAD SCI USA, V113, pE7438, DOI 10.1073/pnas.1607178113; Maguire JB, 2021, PROTEINS, V89, P436, DOI 10.1002/prot.26030; Markovic I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01557; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Quijano-Rubio A, 2021, NATURE, V591, P482, DOI 10.1038/s41586-021-03258-z; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Silva DA, 2016, METHODS MOL BIOL, V1414, P285, DOI 10.1007/978-1-4939-3569-7_17; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Strauch EM, 2017, NAT BIOTECHNOL, V35, P667, DOI 10.1038/nbt.3907; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Dongen MJP, 2019, SCIENCE, V363, P1056, DOI 10.1126/science.aar6221; Verstraete K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14937; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XU Y, 2018, NAT COMMUN, V9; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	88	20	20	48	104	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2022	605	7910					551	+		10.1038/s41586-022-04654-9	http://dx.doi.org/10.1038/s41586-022-04654-9		MAR 2022	39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J0US	35332283	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000793701400001
J	Yates, K				Yates, Kit			Closing our eyes to covid won't make it go away	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yates, Kit] Univ Bath, Dept Math Sci, Bath, Avon, England	University of Bath	Yates, K (corresponding author), Univ Bath, Dept Math Sci, Bath, Avon, England.		Yates, Christian/A-8863-2014	Yates, Christian/0000-0003-0461-7297				[Anonymous], BBC NEWS; [Anonymous], GUARDIAN; [Anonymous], FINANC TIMES; Mahase E., BMJ, V376, po738; UK Health Security Agency, COVID 19 VACC SURV R	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2022	376								o743	10.1136/bmj.o743	http://dx.doi.org/10.1136/bmj.o743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0A4GX	35314479	Green Submitted, Bronze			2022-12-28	WOS:000773915700013
J	Bick, D; Ram, U; Saravanan, P; Temmerman, M				Bick, Debra; Ram, Uma; Saravanan, Ponnusamy; Temmerman, Marleen			New global WHO postnatal guidance is welcome but misses the long-term perspective	LANCET			English	Editorial Material									[Bick, Debra] Univ Warwick, Warwick Clin Trials Unit, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Saravanan, Ponnusamy] Univ Warwick, Dept Populat Evidence & Technol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Ram, Uma] Seethapathy Clin & Hosp, Chennai, Tamil Nadu, India; [Temmerman, Marleen] Aga Khan Univ, Coll Med, Ctr Excellence Women & Child Hlth, Nairobi, Kenya; [Temmerman, Marleen] Univ Ghent, Dept Publ Hlth & Family Med, Ghent, Belgium	University of Warwick; University of Warwick; Aga Khan University; Ghent University	Bick, D (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	debra.bick@warwick.ac.uk						Nguyen B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187923; Chersich MF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-51; Davies SC, 2015, HLTH 51 WOMEN; Kassebaum NJ, 2014, LANCET, V384, P956; Rameez RM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13401; Saravanan P, 2020, LANCET DIABETES ENDO, V8, P793, DOI 10.1016/S2213-8587(20)30161-3; Soria-Contreras DC, 2021, PUBLIC HEALTH NUTR, V24, P4113, DOI 10.1017/S1368980020002803; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UK National Screening Committee UK Government., 2019, SCREEN ANT POSTN MEN; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; WHO, 2020, IMPR EARL CHIL WHO G; WHO, 2022, WHO RECOMM MAT NEWB; WHO UNICEF. Global Breastfeeding Collective., GLOB BREASTF SCOR 20; Woodley SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007471.pub4; World Health Organization (WHO), 2019, TUBERCULOSIS	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2022	399	10335					1578	1580		10.1016/S0140-6736(22)00616-X	http://dx.doi.org/10.1016/S0140-6736(22)00616-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JW	35378078				2022-12-28	WOS:000795612300007
J	Slomski, A				Slomski, Anita			While Suicide Attempts Have Increased, Treatment Has Not	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2022	327	13					1218	1218		10.1001/jama.2022.3350	http://dx.doi.org/10.1001/jama.2022.3350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0P1EM	35380594				2022-12-28	WOS:000783965500006
J	Bergmark, BA; Mathenge, N; Merlini, PA; Lawrence-Wright, MB; Giugliano, RP				Bergmark, Brian A.; Mathenge, Njambi; Merlini, Piera A.; Lawrence-Wright, Marilyn B.; Giugliano, Robert P.			Acute coronary syndromes	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; CARDIOVASCULAR EVENTS; CARDIOGENIC-SHOCK; OPEN-LABEL; CLOPIDOGREL; OUTCOMES; RISK; PCI; MANAGEMENT	Although substantial progress has been made in the diagnosis and treatment of acute coronary syndromes, cardiovascular disease remains the leading cause of death globally, with nearly half of these deaths due to ischaemic heart disease. The broadening availability of high-sensitivity troponin assays has allowed for rapid rule-out algorithms in patients with suspected non-ST-segment elevated myocardial infarction (NSTEMI). Dual antiplatelet therapy is recommended for 12 months following an acute coronary syndrome in most patients, and additional secondary prevention measures including intensive lipid-lowering therapy (LDL-C <1.4 mmol/L), neurohormonal agents, and lifestyle modification, are crucial. The scientific evidence for diagnosis and management of acute coronary syndromes continues to evolve rapidly, including adapting to the COVID-19 pandemic, which has impacted all aspects of care. This Seminar provides a clinically relevant overview of the pathobiology, diagnosis, and management of acute coronary syndromes, and describes key scientific advances.	[Bergmark, Brian A.; Giugliano, Robert P.] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 75 Francis St,60 Fenwood Rd Suite 7022, Boston, MA 02115 USA; [Bergmark, Brian A.; Giugliano, Robert P.] Harvard Med Sch, Div Cardiol, Boston, MA 02115 USA; [Mathenge, Njambi] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Merlini, Piera A.] ASST GOM Niguarda & Bicocca Univ, Cardiocenter Gasperis, Div Cardiol 4, Milan, Italy; [Lawrence-Wright, Marilyn B.] Univ West Indies Mona, Div Cardiol, Dept Med, Kingston, Jamaica	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University West Indies Mona Jamaica	Giugliano, RP (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 75 Francis St,60 Fenwood Rd Suite 7022, Boston, MA 02115 USA.	rgiugliano@bwh.harvard.edu						Abdelrahman KM, 2020, J AM COLL CARDIOL, V76, P1226, DOI 10.1016/j.jacc.2020.06.076; Alrwisan A, 2016, J EMERG MED, V50, P349, DOI 10.1016/j.jemermed.2015.07.033; Atri D, 2020, JACC-BASIC TRANSL SC, V5, P518, DOI 10.1016/j.jacbts.2020.04.002; Bahiru E, 2018, CARDIOVASC J AFR, V29, P225, DOI 10.5830/CVJA-2018-017; Bainey KR, 2020, JAMA CARDIOL, V5, P881, DOI 10.1001/jamacardio.2020.1251; Bhatt AS, 2020, J AM COLL CARDIOL, V76, P280, DOI 10.1016/j.jacc.2020.05.038; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Blackston JW, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006683; Boeddinghaus J, 2017, CIRCULATION, V135, P1597, DOI 10.1161/CIRCULATIONAHA.116.025661; Bogaty P, 2020, NEW ENGL J MED, V382, P1568, DOI [10.1056/NEJMoa1907775, 10.1056/NEJMc2000278]; Brush JE, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.119.005948; Bueno H, 2019, J AM COLL CARDIOL, V74, P1454, DOI 10.1016/j.jacc.2019.06.068; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Chandrashekhar Y, 2020, CIRCULATION, V141, P2004, DOI 10.1161/CIRCULATIONAHA.119.041297; Chapman AR, 2020, CIRCULATION, V141, P161, DOI 10.1161/CIRCULATIONAHA.119.042960; Chew DP, 2019, CIRCULATION, V140, P1543, DOI 10.1161/CIRCULATIONAHA.119.042891; Chieffo Alaide, 2020, Eur Heart J, V41, P1839, DOI 10.1093/eurheartj/ehaa381; Claassens DMF, 2019, NEW ENGL J MED, V381, P1621, DOI 10.1056/NEJMoa1907096; Dagenais GR, 2020, LANCET, V395, P785, DOI 10.1016/S0140-6736(19)32007-0; DeFilippis EM, 2020, EUR HEART J, V41, P4127, DOI 10.1093/eurheartj/ehaa662; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Fazel R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015186; Feigin V.L., 2019, LANCET NEUROL, V18, P459, DOI [DOI 10.1136/BMJ.L94, DOI 10.1136/bmj.l94]; Galli M, 2021, LANCET, V397, P1470, DOI 10.1016/S0140-6736(21)00533-X; Gaudet D, 2020, EUR HEART J, V41, P3936, DOI 10.1093/eurheartj/ehaa689; Gencer B, 2020, JAMA CARDIOL, V5, P952, DOI 10.1001/jamacardio.2020.0882; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gimbel M, 2020, LANCET, V395, P1374, DOI 10.1016/S0140-6736(20)30325-1; Gray A, 2020, CIRCULATION, V142, pe470; Gray AJ, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1717-2; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146; Hegele RA, 2019, CIRC RES, V124, P386, DOI 10.1161/CIRCRESAHA.118.313171; Hertz JT, 2020, INT HEALTH, V12, P148, DOI 10.1093/inthealth/ihz061; Hill JA, 2020, CIRCULATION, V142, P1127, DOI 10.1161/CIRCULATIONAHA.120.050670; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Jackson AM, 2020, EUR HEART J-QUAL CAR, V6, P156, DOI 10.1093/ehjqcco/qcz040; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; Kayani WT, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01298-x; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580; Kim Y, 2020, AM J CARDIOL, V125, P1782, DOI 10.1016/j.amjcard.2020.03.025; Kimenai DM, 2018, CLIN CHEM, V64, P1034, DOI 10.1373/clinchem.2018.286781; Kofoed KF, 2018, CIRCULATION, V138, P2741, DOI 10.1161/CIRCULATIONAHA.118.037152; Koskinas KC, 2019, J AM COLL CARDIOL, V74, P2452, DOI 10.1016/j.jacc.2019.08.010; Kwan GF, 2016, CIRCULATION, V133, P2561, DOI 10.1161/CIRCULATIONAHA.116.008731; Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005; Libby P, 2019, CIRC RES, V124, P150, DOI 10.1161/CIRCRESAHA.118.311098; Lichtman JH, 2018, CIRCULATION, V137, P781, DOI 10.1161/CIRCULATIONAHA.117.031650; Linde JJ, 2020, J AM COLL CARDIOL, V75, P453, DOI 10.1016/j.jacc.2019.12.012; Loh JP, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004699; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Lynch A, 2020, AFR J EMERG MED, V10, P243, DOI 10.1016/j.afjem.2020.08.001; Mani KA, 2014, W INDIAN MED J, V63, P424, DOI 10.7727/wimj.2013.293; McCann GP, 2015, J AM COLL CARDIOL, V66, P2713, DOI 10.1016/j.jacc.2015.09.099; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; Meyer MR, 2019, EUR HEART J-ACUTE CA, V8, P283, DOI 10.1177/2048872618810410; Morrow DA, 2020, CIRCULATION, V141, P172, DOI 10.1161/CIRCULATIONAHA.119.044125; Mukhopadhyay A, 2020, AM J EMERG MED, V38, P1373, DOI 10.1016/j.ajem.2019.11.018; Nanna MG, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005691; Neumann FJ, 2019, EUR HEART J, V40, P871; Neumann JT, 2019, NEW ENGL J MED, V380, P2529, DOI 10.1056/NEJMoa1803377; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Nishiguchi T, 2016, EUR HEART J-ACUTE CA, V5, P263, DOI 10.1177/2048872613504310; O'Donoghue ML, 2020, CIRCULATION, V142, P538, DOI 10.1161/CIRCULATIONAHA.120.046251; Omer MA, 2020, JACC-CARDIOVASC INTE, V13, P1211, DOI 10.1016/j.jcin.2020.04.004; Park DW, 2014, JAMA-J AM MED ASSOC, V312, P2019, DOI 10.1001/jama.2014.15095; Pereira NL, 2020, JAMA-J AM MED ASSOC, V324, P761, DOI 10.1001/jama.2020.12443; Peters SAE, 2021, CIRCULATION, V143, P650, DOI 10.1161/CIRCULATIONAHA.120.047065; Prabhakaran D, 2018, LANCET, V391, P1224, DOI 10.1016/S0140-6736(17)32471-6; Ray KK, 2019, NEW ENGL J MED, V380, P1022, DOI 10.1056/NEJMoa1803917; Reynolds HR, 2021, CIRCULATION, V143, P624, DOI 10.1161/CIRCULATIONAHA.120.052008; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Safdar B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009174; Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Srivastava PK, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012831; Steitieh DA, 2021, CARDIOVASC REVASCULA, V31, P41, DOI 10.1016/j.carrev.2020.12.016; Tahhan AS, 2020, JAMA CARDIOL, V5, P714, DOI 10.1001/jamacardio.2020.0359; Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388; Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261; Thygesen K, 2018, CIRCULATION, V138, pE618, DOI 10.1161/CIR.0000000000000617; Tong DC, 2020, CIRCULATION, V142, P1890, DOI 10.1161/CIRCULATIONAHA.120.050771; Tsao CW, 2022, CIRCULATION, V145, pE153, DOI 10.1161/CIR.0000000000001052; Twerenbold R, 2019, J AM COLL CARDIOL, V74, P483, DOI 10.1016/j.jacc.2019.05.046; Valgimigli M, 2021, NEW ENGL J MED, V385, P1643, DOI 10.1056/NEJMoa2108749; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145; White HD, 2019, EUR HEART J, V40, P2801, DOI 10.1093/eurheartj/ehz299; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yuyun MF, 2020, GLOB HEART, V15, DOI 10.5334/gh.403; Zeymer U, 2020, EUR HEART J-ACUTE CA, V9, P183, DOI 10.1177/2048872619894254	106	10	10	16	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2022	399	10332					1347	1358						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2F3QY	35367005	Green Published, Bronze			2022-12-28	WOS:000812828300026
J	Thompson, B; van Opheusden, B; Sumers, T; Griffiths, TL				Thompson, B.; van Opheusden, B.; Sumers, T.; Griffiths, T. L.			Complex cognitive algorithms preserved by selective social learning in experimental populations	SCIENCE			English	Article							CULTURAL-EVOLUTION; DEMOGRAPHY	Many human abilities rely on cognitive algorithms discovered by previous generations. Cultural accumulation of innovative algorithms is hard to explain because complex concepts are difficult to pass on. We found that selective social learning preserved rare discoveries of exceptional algorithms in a large experimental simulation of cultural evolution. Participants (N = 3450) faced a difficult sequential decision problem (sorting an unknown sequence of numbers) and transmitted solutions across 12 generations in 20 populations. Several known sorting algorithms were discovered. Complex algorithms persisted when participants could choose who to learn from but frequently became extinct in populations lacking this selection process, converging on highly transmissible lower-performance algorithms. These results provide experimental evidence for hypothesized links between sociality and cognitive function in humans.	[Thompson, B.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [van Opheusden, B.; Sumers, T.; Griffiths, T. L.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Griffiths, T. L.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; Princeton University; Princeton University	Thompson, B (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	wdt@berkeley.edu		Griffiths, Thomas/0000-0002-5138-7255; Sumers, Theodore/0000-0002-6128-0291; van Opheusden, Bas/0000-0002-7169-4885	Defense Advanced Research Projects Agency (DARPA) [D17AC00004]; Schmidt Family Foundation; National Defense Science and Engineering Graduate Fellowship	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Schmidt Family Foundation; National Defense Science and Engineering Graduate Fellowship	This work was supported by Defense Advanced Research Projects Agency (DARPA) agreement D17AC00004 and the Schmidt Family Foundation (T.L.G.) and a National Defense Science and Engineering Graduate Fellowship (T.S.).	Almaatouq A, 2020, P NATL ACAD SCI USA, V117, P11379, DOI 10.1073/pnas.1917687117; Boyd R., 1985, CULTURE EVOLUTIONARY; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; Caldwell CA, 2018, REV PHILOS PSYCHOL, V9, P751, DOI 10.1007/s13164-017-0346-3; Claidiere N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1541; Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich Joseph, 2002, J COGN CULT, P87; Heyes C, 2018, COGNITIVE GADGETS; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Kirby S, 2015, COGNITION, V141, P87, DOI 10.1016/j.cognition.2015.03.016; Knuth D. E., 2014, SEMINUMERICAL ALGORI, V2; Lake BM, 2015, SCIENCE, V350, P1332, DOI 10.1126/science.aab3050; Laland K., 2017, DARWINS UNFINISHED S; Legare CH, 2015, TRENDS COGN SCI, V19, P688, DOI 10.1016/j.tics.2015.08.005; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0053; Mesoudi A, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0712; Miton H, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0677; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Muthukrishna M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2511; Nettle D, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0358; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Scanlon L. A., 2019, EVOL HUMAN SCI, V1, pe17; Smaldino PE, 2019, TRENDS COGN SCI, V23, P818, DOI 10.1016/j.tics.2019.07.005; Sperber D, 2008, BIOL PHILOS, V23, P283, DOI 10.1007/s10539-005-9012-8; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Winters J., 2019, PALGR COMMUN, V5, P1, DOI [10.1057/s41599-018-0199-0, DOI 10.1057/S41599-018-0199-0]; Winters J, 2019, PALGR COMMUN, V5, DOI 10.1057/s41599-019-0361-3; Wu CM, 2018, NAT HUM BEHAV, V2, P915, DOI 10.1038/s41562-018-0467-4; Yeh DJ, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1951	34	3	3	13	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		95	+		10.1126/science.abn0915	http://dx.doi.org/10.1126/science.abn0915			78	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357938				2022-12-28	WOS:000780195200034
J	Buck, AH				Buck, Amy H.			Cells choose their words wisely	CELL			English	Editorial Material							MICRORNAS	In their recent Nature paper, Garcia-Martin et al. show that sequences within a microRNA influence how much of that microRNA is sent to another cell through extracellular vesicles. This supports a growing body of data demonstrating that cells use RNA to talk, but we know much less about how they listen.	[Buck, Amy H.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland	University of Edinburgh	Buck, AH (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland.	a.buck@ed.ac.uk			European Research Council [101002385]	European Research Council(European Research Council (ERC)European Commission)	A.H.B. is supported by European Research Council Consolidator Award 101002385. The author appreciates comments from the Buck lab as well as Julie Claycomb, Esther Nolte-`t Hoen, Cei AbreuGoodger, and Colin Campbell on this topic and preview.	Chen XM, 2022, NAT REV MOL CELL BIO, V23, P185, DOI 10.1038/s41580-021-00425-y; Garcia-Martin R, 2022, NATURE, V601, P446, DOI 10.1038/s41586-021-04234-3; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; La Rocca G, 2015, P NATL ACAD SCI USA, V112, P767, DOI 10.1073/pnas.1424217112; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Weaver AM, 2020, CANCER RES, V80, P379, DOI 10.1158/0008-5472.CAN-19-2782	10	1	1	4	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1114	1116		10.1016/j.cell.2022.03.010	http://dx.doi.org/10.1016/j.cell.2022.03.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J7WH	35364031				2022-12-28	WOS:000780311600005
J	Imai-Imada, M; Imada, H; Miwa, K; Tanaka, Y; Kimura, K; Zoh, I; Jaculbia, RB; Yoshino, H; Muranaka, A; Uchiyama, M; Kim, Y				Imai-Imada, Miyabi; Imada, Hiroshi; Miwa, Kuniyuki; Tanaka, Yusuke; Kimura, Kensuke; Zoh, Inhae; Jaculbia, Rafael B.; Yoshino, Hiroko; Muranaka, Atsuya; Uchiyama, Masanobu; Kim, Yousoo			Orbital-resolved visualization of single-molecule photocurrent channels	NATURE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; DENSITY-FUNCTIONAL THEORY; SOLAR-CELLS; TAUTOMERIZATION; SPECTROSCOPY	Given its central role in utilizing light energy, photoinduced electron transfer (PET) from an excited molecule has been widely studied(1)(-6). However, even though microscopic photocurrent measurement methods(7)(-11) have made it possible to correlate the efficiency of the process with local features, spatial resolution has been insufficient to resolve it at the molecular level. Recent work has, however, shown that single molecules can be efficiently excited and probed when combining a scanning tunnelling microscope (STM) with localized plasmon fields driven by a tunable laser(12)(,13). Here we use that approach to directly visualize with atomic-scale resolution the photocurrent channels through the molecular orbitals of a single free-base phthalocyanine (FBPc) molecule, by detecting electrons from its first excited state tunnelling through the STM tip. We find that the direction and the spatial distribution of the photocurrent depend sensitively on the bias voltage, and detect counter-flowing photocurrent channels even at a voltage where the averaged photocurrent is near zero. Moreover, we see evidence of competition between PET and photoluminescence(12), and find that we can control whether the excited molecule primarily relaxes through PET or photoluminescence by positioning the STM tip with three-dimensional, atomic precision. These observations suggest that specific photocurrent channels can be promoted or suppressed by tuning the coupling to excited-state molecular orbitals, and thus provide new perspectives for improving energy-conversion efficiencies by atomic-scale electronic and geometric engineering of molecular interfaces.	[Imai-Imada, Miyabi; Imada, Hiroshi; Miwa, Kuniyuki; Kimura, Kensuke; Zoh, Inhae; Jaculbia, Rafael B.; Yoshino, Hiroko; Kim, Yousoo] RIKEN, Surface & Interface Sci Lab, Wako, Saitama, Japan; [Imada, Hiroshi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Miwa, Kuniyuki] Inst Mol Sci, Okazaki, Aichi, Japan; [Tanaka, Yusuke; Muranaka, Atsuya; Uchiyama, Masanobu] RIKEN, Adv Elements Chem Lab, Wako, Saitama, Japan; [Tanaka, Yusuke; Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Zoh, Inhae] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul, South Korea	RIKEN; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); RIKEN; University of Tokyo; Seoul National University (SNU)	Imada, H; Kim, Y (corresponding author), RIKEN, Surface & Interface Sci Lab, Wako, Saitama, Japan.; Imada, H (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan.	himada@riken.jp; ykim@riken.jp	Uchiyama, Masanobu/B-7181-2015; Imada, Hiroshi/R-2939-2019; Miwa, Kuniyuki/G-6615-2017; Muranaka, Atsuya/V-1382-2019	Miwa, Kuniyuki/0000-0001-7311-0284; TANAKA, Yusuke/0000-0003-0405-616X; Jaculbia, Rafael/0000-0003-3156-2404; Imada, Hiroshi/0000-0001-8508-8563; Yoshino, Hiroko/0000-0002-2087-128X; Muranaka, Atsuya/0000-0002-3246-6003; Kimura, Kensuke/0000-0003-1270-5289; Imai-Imada, Miyabi/0000-0001-9053-7888	JST PRESTO [JPMJPR186225]; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K23591, JP19H04681, JP17H04796, JP20K22488, JP18K14153, JP18H05257, JP17H06173, JP17H05430, JP20H02728]	JST PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B.Yang, E.Kazuma, Y.Hasegawa and Y.Shimizu for supporting the preparation of the Au tips. Some of the numerical calculations were carried out using the HOKUSAI system at RIKEN. All experiments were conducted at RIKEN in Japan. This work was financially supported in part by JST PRESTO (grant no. JPMJPR186225 (H.I.)) and by Japan Society for the Promotion of Science (JSPS) KAKENHI: grant nos JP19K23591 (M.I.-I.), JP19H04681, JP17H04796 (H.I.), JP20K22488 (K.K.), JP18K14153 (R.B.J.), JP18H05257 (Y.K.), JP17H06173, JP17H05430 (M.U.), JP20H02728 (A.M.).	Baer R, 2010, ANNU REV PHYS CHEM, V61, P85, DOI 10.1146/annurev.physchem.012809.103321; Barone V, 2009, J CHEM THEORY COMPUT, V5, P540, DOI 10.1021/ct8004744; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bockmann H, 2016, NANO LETT, V16, P1034, DOI 10.1021/acs.nanolett.5b04092; Casida M. E., 1995, RECENT ADV DENSITY 1, P155, DOI DOI 10.1142/9789812830586_0005; Chen F, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4965825; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; Coffey DC, 2007, NANO LETT, V7, P738, DOI 10.1021/nl062989e; Cohen G, 2020, J CHEM PHYS, V152, DOI 10.1063/1.5145210; Doppagne B, 2020, NAT NANOTECHNOL, V15, P207, DOI 10.1038/s41565-019-0620-x; Doppagne B, 2018, SCIENCE, V361, P251, DOI 10.1126/science.aat1603; Doppagne B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.127401; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Ervasti MM, 2017, J ELECTRON SPECTROSC, V219, P63, DOI 10.1016/j.elspec.2016.11.004; Fatayer S, 2018, NAT NANOTECHNOL, V13, P376, DOI 10.1038/s41565-018-0087-1; Frisch M.J., 2016, GAUSSIAN 16; Galperin M, 2017, CHEM SOC REV, V46, P4000, DOI 10.1039/c7cs00067g; Garg M, 2020, SCIENCE, V367, P411, DOI 10.1126/science.aaz1098; Gerster D, 2012, NAT NANOTECHNOL, V7, P673, DOI [10.1038/NNANO.2012.165, 10.1038/nnano.2012.165]; Giridharagopal R, 2016, ACCOUNTS CHEM RES, V49, P1769, DOI 10.1021/acs.accounts.6b00255; Henderson TM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3185673; Hirata S, 1999, CHEM PHYS LETT, V314, P291, DOI 10.1016/S0009-2614(99)01149-5; Ikeda T, 2014, CHEM COMMUN, V50, P9443, DOI 10.1039/c4cc02574a; Imada H, 2021, SCIENCE, V373, P95, DOI 10.1126/science.abg8790; Imada H, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.013901; Imada H, 2016, NATURE, V538, P364, DOI 10.1038/nature19765; Imai-Imada M, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.201403; Jaculbia RB, 2020, NAT NANOTECHNOL, V15, P105, DOI 10.1038/s41565-019-0614-8; Jones AL, 2020, J AM CHEM SOC, V142, P12658, DOI 10.1021/jacs.0c03678; Kimura K, 2019, NATURE, V570, P210, DOI 10.1038/s41586-019-1284-2; Kuhnke K, 2017, CHEM REV, V117, P5174, DOI 10.1021/acs.chemrev.6b00645; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Lindstrom CD, 2006, CHEM REV, V106, P4281, DOI 10.1021/cr0501689; Ma W, 2019, NAT PROTOC, V14, P2672, DOI 10.1038/s41596-019-0197-8; Miwa K, 2019, J PHYS CHEM LETT, V10, P1550, DOI 10.1021/acs.jpclett.9b00270; Miwa K, 2019, NANO LETT, V19, P2803, DOI 10.1021/acs.nanolett.8b04484; Miwa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09060-0; Miwa K, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.165419; MURPHY CJ, 1993, SCIENCE, V262, P1025, DOI 10.1126/science.7802858; Murray C, 2011, PHYS CHEM CHEM PHYS, V13, P17543, DOI 10.1039/c1cp22039j; Murray C, 2010, PHYS CHEM CHEM PHYS, V12, P10406, DOI 10.1039/c0cp00055h; Neuman T, 2018, NANO LETT, V18, P2358, DOI 10.1021/acs.nanolett.7b05297; Novotny L., 2012, PRINCIPLES NANOOPTIC; O'Dea JR, 2012, MRS BULL, V37, P642, DOI 10.1557/mrs.2012.143; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; Santoro F, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2929846; Santoro F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2721539; Santoro F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437197; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Schulz F, 2015, NAT PHYS, V11, P229, DOI [10.1038/NPHYS3212, 10.1038/nphys3212]; Scivetti I, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa7c3a; Seldenthuis JS, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205430; Takeuchi O, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.021602; Tokita Y, 2008, J AM CHEM SOC, V130, P5302, DOI 10.1021/ja711324t; White AJ, 2014, J PHYS CHEM C, V118, P11159, DOI 10.1021/jp500880j; Wu SW, 2006, SCIENCE, V312, P1362, DOI 10.1126/science.1124881; Wu SW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236802; Yang B, 2020, NAT PHOTONICS, V14, P693, DOI 10.1038/s41566-020-0677-y; Yang B, 2018, J PHYS CHEM C, V122, P16950, DOI 10.1021/acs.jpcc.8b04078; Yoshioka K, 2016, NAT PHOTONICS, V10, P762, DOI [10.1038/nphoton.2016.205, 10.1038/NPHOTON.2016.205]; Yu P, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.056801; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151; Zhang Y, 2016, NATURE, V531, P623, DOI 10.1038/nature17428; Zhu SE, 2013, J AM CHEM SOC, V135, P15794, DOI 10.1021/ja4048569	66	3	3	32	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					829	+		10.1038/s41586-022-04401-0	http://dx.doi.org/10.1038/s41586-022-04401-0			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35354999				2022-12-28	WOS:000776361600028
J	Regnault, N; Xu, YF; Li, MR; Ma, DS; Jovanovic, M; Yazdani, A; Parkin, SSP; Felser, C; Schoop, LM; Ong, NP; Cava, RJ; Elcoro, L; Song, ZD; Bernevig, BA				Regnault, Nicolas; Xu, Yuanfeng; Li, Ming-Rui; Ma, Da-Shuai; Jovanovic, Milena; Yazdani, Ali; Parkin, Stuart S. P.; Felser, Claudia; Schoop, Leslie M.; Ong, N. Phuan; Cava, Robert J.; Elcoro, Luis; Song, Zhi-Da; Bernevig, B. Andrei			Catalogue of flat-band stoichiometric materials	NATURE			English	Article							SUPERCONDUCTIVITY; HYDRIDE	Topological electronic flattened bands near or at the Fermi level are a promising route towards unconventional superconductivity and correlated insulating states. However, the related experiments are mostly limited to engineered materials, such as moire systems(1,3). Here we present a catalogue ofthe naturally occu ring three-dimensional stoichiometric materials with flat bands around the Fermi level. We consider 55,206 materials from the Inorganic Crystal Structure Database catalogued using the Topological Quantum Chemistry website(4,5), which provides their structural parameters, space group, band structure, density of states and topological characterization. We combine several direct signatures and properties of band flatness with a high-throughput analysis of all crystal structures. In particular, we identify materials hosting line-graph or bipartite sublattices-in either two or three dimensions-that probably lead to flat bands. From this trove of information, we create the Materials Flatband Database website, a powerful search engine for future theoretical and experimental studies. We use the database to extract a curated list of 2,379 high-quality flat-band materials, from which we identify 345 promising candidates that potentially host flat bands with charge centresthat are not strongly localized on the atomic sites. We showcase five representative materials and provide a theoretical explanation for the origin oftheir flat bands close to the Fermi energy using the S-matrix method introduced in a parallel work(6).	[Regnault, Nicolas; Yazdani, Ali; Ong, N. Phuan; Song, Zhi-Da; Bernevig, B. Andrei] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Regnault, Nicolas] Univ Paris Diderot, Sorbonne Univ, Univ PSL,ENS, Lab Phys,Ecole Normale Super,Sorbonne Paris Cite, Paris, France; [Xu, Yuanfeng; Parkin, Stuart S. P.] Max Planck Inst Microstruct Phys, Halle, Germany; [Li, Ming-Rui] Tsinghua Univ, Dept Phys, Beijing, Peoples R China; [Ma, Da-Shuai] Beijing Inst Technol, Sch Phys, Beijing Key Lab Nanophoton & Ultrafine Optoelect, Beijing, Peoples R China; [Jovanovic, Milena; Schoop, Leslie M.; Cava, Robert J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Felser, Claudia] Max Planck Inst Chem Phys Solids, Dresden, Germany; [Elcoro, Luis] Univ Basque Country UPV EHU, Dept Condensed Matter Phys, Bilbao, Spain; [Bernevig, B. Andrei] Donostia Int Phys Ctr, Donostia San Sebastian, Spain; [Bernevig, B. Andrei] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Princeton University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Max Planck Society; Tsinghua University; Beijing Institute of Technology; Princeton University; Max Planck Society; University of Basque Country; Basque Foundation for Science	Regnault, N; Bernevig, BA (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.; Regnault, N (corresponding author), Univ Paris Diderot, Sorbonne Univ, Univ PSL,ENS, Lab Phys,Ecole Normale Super,Sorbonne Paris Cite, Paris, France.; Xu, YF (corresponding author), Max Planck Inst Microstruct Phys, Halle, Germany.; Bernevig, BA (corresponding author), Donostia Int Phys Ctr, Donostia San Sebastian, Spain.; Bernevig, BA (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.	regnault@princeton.edu; yfxu@mpi-halle.mpg.de; bernevig@princeton.edu	Xu, Yuanfeng/AAB-2525-2021; Schoop, Leslie M/A-4627-2013; Felser, Claudia/A-5779-2009; Parkin, Stuart/D-2521-2012	Xu, Yuanfeng/0000-0002-1390-2308; Schoop, Leslie M/0000-0003-3459-4241; Felser, Claudia/0000-0002-8200-2063; Parkin, Stuart/0000-0003-4702-6139; Ong, N. Phuan/0000-0001-7166-1058; Regnault, Nicolas/0000-0002-0210-2428; Li, Mingrui/0000-0001-5453-1948	National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; European Research Council (ERC) under the European Union [101020833, 742068]; US Department of Energy [DE-SC0016239]; National Science Foundation (EAGER) [DMR 1643312]; Simons Investigator grant [404513]; Office of Naval Research (ONR) [N00014-20-1-2303]; Packard Foundation; Schmidt Fund for Innovative Research; BSF Israel US foundation [2018226]; Gordon and Betty Moore Foundation [GBMF8685]; John Simon Guggenheim Memorial Foundation; NSF-MRSEC [DMR-2011750]; Schmidt DataX Fund at Princeton University; Packard and Sloan Foundation; Max Planck Society; Government of the Basque Country [IT1301-19]; Spanish Ministry of Science and Innovation [PID2019-106644GB-I00]; Deutsche Forschungsgemeinschaft (DFG) [SFB 1143]; Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat (EXC 2147) [390858490]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [314790414]; European Research Council (ERC) [742068];  [NSF-DMR-1904442]	National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility; European Research Council (ERC) under the European Union(European Research Council (ERC)); US Department of Energy(United States Department of Energy (DOE)); National Science Foundation (EAGER)(National Science Foundation (NSF)); Simons Investigator grant; Office of Naval Research (ONR)(Office of Naval Research); Packard Foundation(The David & Lucile Packard Foundation); Schmidt Fund for Innovative Research; BSF Israel US foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John Simon Guggenheim Memorial Foundation; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Schmidt DataX Fund at Princeton University; Packard and Sloan Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Government of the Basque Country; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat (EXC 2147); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); 	We thank X. Dai, D. Calugaru, A. Chew, M. Vergniory and C. Chiu for discussions. We acknowledge the computational resources Cobra/Draco in the Max Planck Computing and Data Facility (MPCDF) and Atlas in the Donostia International Physics Center (DIPC). This research also used the resources of the National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility operated under contract number DE-AC02-05CH11231. This work is part of a project that has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 101020833). B.A.B. and N.R. were also supported by the US Department of Energy (grant number DE-SC0016239), and were partially supported by the National Science Foundation (EAGER grant number DMR 1643312), a Simons Investigator grant (number 404513), the Office of Naval Research (ONR grant number N00014-20-1-2303), the Packard Foundation, the Schmidt Fund for Innovative Research, the BSF Israel US foundation (grant number 2018226), the Gordon and Betty Moore Foundation through grant number GBMF8685 towards the Princeton theory programme, and a Guggenheim Fellowship from the John Simon Guggenheim Memorial Foundation. A.Y., N.P.O., R.J.C., L.M.S., B.A.B. and N.R. were supported by the NSF-MRSEC (grant number DMR-2011750). A.Y. was supported by NSF-DMR-1904442. B.A.B., L.M.S. and N.R. acknowledge financial support from the Schmidt DataX Fund at Princeton University made possible through a major gift from the Schmidt Futures Foundation. L.M.S. acknowledges financial support from the Packard and Sloan Foundation. B.A.B. received additional support from the Max Planck Society. L.E. was supported by the Government of the Basque Country (Project IT1301-19) and the Spanish Ministry of Science and Innovation (PID2019-106644GB-I00). C.F. was supported by the European Research Council (ERC) advanced grant number 742068 'TOP-MAT', Deutsche Forschungsgemeinschaft (DFG) through SFB 1143, and the Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter-ct.qmat (EXC 2147, project number 390858490). S.S.P.P. acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-project number 314790414.	[Anonymous], 2015, INORGANIC CRYSTAL ST; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Bergman DL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125104; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Bradlyn B, 2017, NATURE, V547, P298, DOI 10.1038/nature23268; Calugaru D, 2022, NAT PHYS, V18, P185, DOI 10.1038/s41567-021-01445-3; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chiu CS, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.043414; Drozdov AP, 2019, NATURE, V569, P528, DOI 10.1038/s41586-019-1201-8; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Ivantchev S, 2000, J APPL CRYSTALLOGR, V33, P1190, DOI 10.1107/S0021889800007135; Ivantchev S., 2002, Journal of Applied Crystallography, V35, P511, DOI 10.1107/S002188980200732X; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Kumar P, 2021, PHYS REV A, V103, DOI 10.1103/PhysRevA.103.L031301; Liu Z, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/7/077308; Ma DS, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.266403; MIELKE A, 1992, J PHYS A-MATH GEN, V25, P4335, DOI 10.1088/0305-4470/25/16/011; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Neupert T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236804; Peri V, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.027002; Regnault N, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021014; Rhim JW, 2020, NATURE, V584, P59, DOI 10.1038/s41586-020-2540-1; Sheng DN, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1380; Souza I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035109; Tang E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236802; Tasaki H, 1998, PROG THEOR PHYS, V99, P489, DOI 10.1143/PTP.99.489; Vergniory MG, 2019, NATURE, V566, P480, DOI 10.1038/s41586-019-0954-4; Vergniory M. G., 2021, ALL TOPOLOGICAL BAND; Xu Y., 2021, FILLING ENFORCED OBS	37	13	13	27	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					824	+		10.1038/s41586-022-04519-1	http://dx.doi.org/10.1038/s41586-022-04519-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35355002	Green Submitted			2022-12-28	WOS:000776361600027
J	Mahase, E				Mahase, Elisabeth			Offer patients genetic tests to see if medicines are safe and effective, says Royal College of Physicians	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2015, NICE GUID; Royal College of Physicians and British Pharmacological Society, 2022, PERS PRESCR US PHARM	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o821	10.1136/bmj.o821	http://dx.doi.org/10.1136/bmj.o821			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351804				2022-12-28	WOS:000779544800010
J	Wrigley, D				Wrigley, David			Scrapping free covid tests for NHS staff is completely wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wrigley, David] BMA Council, London, England		Wrigley, D (corresponding author), BMA Council, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2022	376								o830	10.1136/bmj.o830	http://dx.doi.org/10.1136/bmj.o830			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I6RD	35351774	Bronze			2022-12-28	WOS:000779544800004
J	Moreira, ED; Kitchin, N; Xu, X; Dychter, SS; Lockhart, S; Gurtman, A; Perez, JL; Zerbini, C; Dever, ME; Jennings, TW; Brandon, DM; Cannon, KD; Koren, MJ; Denham, DS; Berhe, M; Fitz-Patrick, D; Hammitt, LL; Klein, NP; Nell, H; Keep, G; Wang, XB; Koury, K; Swanson, KA; Cooper, D; Lu, CR; Tuereci, O; Lagkadinou, E; Tresnan, DB; Dormitzer, PR; Sahin, U; Gruber, WC; Jansen, KU				Moreira, Edson D., Jr.; Kitchin, Nicholas; Xu, Xia; Dychter, Samuel S.; Lockhart, Stephen; Gurtman, Alejandra; Perez, John L.; Zerbini, Cristiano; Dever, Michael E.; Jennings, Timothy W.; Brandon, Donald M.; Cannon, Kevin D.; Koren, Michael J.; Denham, Douglas S.; Berhe, Mezgebe; Fitz-Patrick, David; Hammitt, Laura L.; Klein, Nicola P.; Nell, Haylene; Keep, Georgina; Wang, Xingbin; Koury, Kenneth; Swanson, Kena A.; Cooper, David; Lu, Claire; Tuereci, Oezlem; Lagkadinou, Eleni; Tresnan, Dina B.; Dormitzer, Philip R.; Sahin, Ugur; Gruber, William C.; Jansen, Kathrin U.		C4591031 Clinical Trial Grp	Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZATIONS	BACKGROUND & nbsp;Active immunization with the BNT162b2 vaccine (Pfizer-BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the coronavirus disease 2019 (Covid-19) pandemic. In light of reports of waning protection occurring 6 months after the primary two-dose vaccine series, data are needed on the safety and efficacy of offering a third (booster) dose in persons 16 years of age or older.& nbsp;METHODS & nbsp;In this ongoing, placebo-controlled, randomized, phase 3 trial, we assigned participants who had received two 30-mu g doses of the BNT162b2 vaccine at least 6 months earlier to be injected with a third dose of the BNT162b2 vaccine or with placebo. We assessed vaccine safety and efficacy against Covid-19 starting 7 days after the third dose.& nbsp;RESULTS & nbsp;A total of 5081 participants received a third BNT162b2 dose and 5044 received placebo. The median interval between dose 2 and dose 3 was 10.8 months in the vaccine group and 10.7 months in the placebo group; the median follow-up was 2.5 months. Local and systemic reactogenicity events from the third dose were generally of low grade. No new safety signals were identified, and no cases of myocarditis or pericarditis were reported. Among the participants without evidence of previous SARS-CoV-2 infection who could be evaluated, Covid-19 with onset at least 7 days after dose 3 was observed in 6 participants in the vaccine group and in 123 participants in the placebo group, which corresponded to a relative vaccine efficacy of 95.3% (95% confidence interval, 89.5 to 98.3).& nbsp;CONCLUSIONS & nbsp;A third dose of the BNT162b2 vaccine administered a median of 10.8 months after the second dose provided 95.3% efficacy against Covid-19 as compared with two doses of the BNT162b2 vaccine during a median follow-up of 2.5 months.	[Moreira, Edson D., Jr.] Associacao Obras Sociais Irma Dulce, Salvador, BA, Brazil; [Moreira, Edson D., Jr.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Zerbini, Cristiano] Ctr Paulista Invest Clin, Sao Paulo, Brazil; [Kitchin, Nicholas; Lockhart, Stephen; Keep, Georgina] Pfizer, Vaccine Res & Dev, Hurley, England; [Xu, Xia; Perez, John L.; Wang, Xingbin] Pfizer, Vaccine Res & Dev, Collegeville, PA USA; [Dychter, Samuel S.] Pfizer, Vaccine Res & Dev, San Diego, CA 92121 USA; [Brandon, Donald M.] Calif Res Fdn, San Diego, CA USA; [Klein, Nicola P.] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; [Gurtman, Alejandra; Koury, Kenneth; Swanson, Kena A.; Cooper, David; Lu, Claire; Dormitzer, Philip R.; Gruber, William C.; Jansen, Kathrin U.] Pfizer, Vaccine Res & Dev, Pearl River, NY USA; [Dever, Michael E.] Clin Neurosci Solut, Orlando, FL USA; [Koren, Michael J.] Jacksonville Ctr Clin Res, Jacksonville, FL USA; [Jennings, Timothy W.] Clin Res Profess, Chesterfield, MO USA; [Cannon, Kevin D.] Accellacare, Wilmington, NC USA; [Denham, Douglas S.] Clin Trials Texas, San Antonio, TX USA; [Berhe, Mezgebe] North Texas Infect Dis Consultants, Dallas, TX USA; [Fitz-Patrick, David] East West Med Res Inst, Honolulu, HI USA; [Hammitt, Laura L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Nell, Haylene] Karl Bremer Hosp, Tiervlei Trial Ctr, Cape Town, South Africa; [Tuereci, Oezlem; Lagkadinou, Eleni; Sahin, Ugur] BioNTech, Mainz, Germany; [Tresnan, Dina B.] Pfizer, Worldwide Safety Safety Surveillance & Risk Manag, Groton, CT USA	Fundacao Oswaldo Cruz; Pfizer; Pfizer; Pfizer; Kaiser Permanente; Pfizer; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; BioNTech SE; Pfizer	Dychter, SS (corresponding author), Pfizer, Vaccine Res & Dev, San Diego, CA 92121 USA.	samuel.dychter@pfizer.com	Moreira Jr, Edson Duarte/GRF-5620-2022	Moreira Jr, Edson Duarte/0000-0002-7081-8348	BioNTech; Pfizer	BioNTech; Pfizer(Pfizer)	Supported by BioNTech and Pfizer.	Andrews N, 2021, EFFECTIVENESS COVID, DOI [10.1101/2021.12.14.21267615v1, DOI 10.1101/2021.12.14.21267615V1]; Andrews N., 2021, EFFECTIVENESS BNT162, DOI [10.1101/2021.11.15.21266341v1, DOI 10.1101/2021.11.15.21266341V1]; Arbel R, 2021, NEW ENGL J MED, V385, P2413, DOI 10.1056/NEJMoa2115624; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; BioNTech, COM BNT162B2 SUMM PR; Centers for Disease Control and Prevention, COVID DATA TRACKER V; Centers for Disease Control and Protectio, COVID 19 VACC BOOST; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Federal Government Germany, MOST IMP QUEST ANSW; Food and Drug Administration, 2021, VACC REL BIOL PROD A; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; GISAID Initiative, TRACK VAR; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; Ledford H, 2021, NATURE, V599, P546, DOI 10.1038/d41586-021-03495-2; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Maltezou HC, 2021, VACCINE, V39, P7021, DOI 10.1016/j.vaccine.2021.10.054; McGill COVID19 Vaccine Tracker Team, PFIZ BIONTECH COM; Ministry of Health Singapore, COVID 19 VACC; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; National Health Service UK, GET BOOST DOS COR CO; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rosenberg ES, 2021, MMWR-MORBID MORTAL W, V70, P1306, DOI 10.15585/mmwr.mm7037a7; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Shah ASV, 2021, NEW ENGL J MED, V385, P1718, DOI 10.1056/NEJMc2106757; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345; US Centers for Disease Control and Protection, PEOPL CERT MED COND; US Food and Drug Administration, 2021, COVID 19 DEV DRUGS B; World Health Organization, 2021, 9 M INT HLTH REG 200	35	40	40	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2022	386	20					1910	1921		10.1056/NEJMoa2200674	http://dx.doi.org/10.1056/NEJMoa2200674		MAR 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1J8UI	35320659	Bronze, Green Published			2022-12-28	WOS:000786665900001
J	Angell, B; Sanuade, O; Adetifa, IMO; Okeke, IN; Adamu, AL; Aliyu, MH; Ameh, EA; Kyari, F; Gadanya, MA; Mabayoje, DA; Yinka-Ogunleye, A; Oni, T; Jalo, RI; Tsiga-Ahmed, FI; Dalglish, SL; Abimbola, S; Colbourn, T; Onwujekwe, O; Owoaje, ET; Aliyu, G; Aliyu, SH; Archibong, B; Ezeh, A; Ihekweazu, C; Iliyasu, Z; Obaro, S; Obadare, EB; Okonofua, F; Pate, M; Salako, BL; Zanna, FH; Glenn, S; Walker, A; Ezalarab, M; Naghavi, M; Abubakar, I				Angell, Blake; Sanuade, Olutobi; Adetifa, Ifedayo M. O.; Okeke, Iruka N.; Adamu, Aishatu Lawal; Aliyu, Muktar H.; Ameh, Emmanuel A.; Kyari, Fatima; Gadanya, Muktar A.; Mabayoje, Diana A.; Yinka-Ogunleye, Adesola; Oni, Tolu; Jalo, Rabiu Ibrahim; Tsiga-Ahmed, Fatimah I.; Dalglish, Sarah L.; Abimbola, Seye; Colbourn, Tim; Onwujekwe, Obinna; Owoaje, Eme Theodora; Aliyu, Gambo; Aliyu, Sani H.; Archibong, Belinda; Ezeh, Alex; Ihekweazu, Chikwe; Iliyasu, Zubairu; Obaro, Stephen; Obadare, Ebenezer Babatunde; Okonofua, Friday; Pate, Muhammed; Salako, Babatunde L.; Zanna, Fatima H.; Glenn, Scott; Walker, Ally; Ezalarab, Maha; Naghavi, Mohsen; Abubakar, Ibrahim			Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study	LANCET			English	Article							MIDDLE-INCOME; INTERVENTIONS; PERFORMANCE; PATH	Background Population-level health and mortality data are crucial for evidence-informed policy but scarce in Nigeria. To fill this gap, we undertook a comprehensive assessment of the burden of disease in Nigeria and compared outcomes to other west African countries. Methods In this systematic analysis, using data and results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019, we analysed patterns of mortality, years of life lost (YLLs), years lived with disability (YLDs), life expectancy, healthy life expectancy (HALE), and health system coverage for Nigeria and 15 other west African countries by gender in 1998 and 2019. Estimates of all-age and age-standardised disability-adjusted life-years for 369 diseases and injuries and 87 risk factors are presented for Nigeria. Health expenditure per person and gross domestic product were extracted from the World Bank repository. Findings Between 1998 and 2019, life expectancy and HALE increased in Nigeria by 18% to 64.3 years (95% uncertainty interval [UI] 62.2-66.6), mortality reduced for all age groups for both male and female individuals, and health expenditure per person increased from the 11th to third highest in west Africa by 2018 (US$18.6 in 2001 to $83.75 in 2018). Nonetheless, relative outcomes remained poor; Nigeria ranked sixth in west Africa for age-standardised mortality, seventh for HALE, tenth for YLLs, 12th for health system coverage, and 14th for YLDs in 2019. Malaria (5176.3 YLLs per 100 000 people, 95% UI 2464.0-9591.1) and neonatal disorders (4818.8 YLLs per 100 000, 3865.9-6064.2) were the leading causes of YLLs in Nigeria in 2019. Nigeria had the fourth-highest under-five mortality rate for male individuals (2491.8 deaths per 100 000, 95% UI 1986.1-3140.1) and female individuals (2117.7 deaths per 100 000, 1756.7-2569.1), but among the lowest mortality for men older than 55 years. There was evidence of a growing non-communicable disease burden facing older Nigerians. Interpretation Health outcomes remain poor in Nigeria despite higher expenditure since 2001. Better outcomes in countries with equivalent or lower health expenditure suggest health system strengthening and targeted intervention to address unsafe water sources, poor sanitation, malnutrition, and exposure to air pollution could substantially improve population health. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Angell, Blake; Sanuade, Olutobi; Yinka-Ogunleye, Adesola; Dalglish, Sarah L.; Colbourn, Tim; Abubakar, Ibrahim] UCL, UCL Inst Global Hlth, London WC1E 6JB, England; [Angell, Blake] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Sanuade, Olutobi] Northwestern Univ, Feinberg Sch Med, Ctr Global Cardiovasc Hlth, Chicago, IL 60611 USA; [Adetifa, Ifedayo M. O.; Adamu, Aishatu Lawal] London Sch Hyg & Trop, Dept Infect Dis Epidemiol, London, England; [Adetifa, Ifedayo M. O.; Adamu, Aishatu Lawal] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Dept Epidemiol & Demog, Kilifi, Kenya; [Adetifa, Ifedayo M. O.] Univ Lagos, Coll Med, Dept Paediat & Child Hlth, Lagos, Nigeria; [Okeke, Iruka N.] Univ Ibadan, Fac Pharm, Dept Pharmaceut Microbiol, Ibadan, Nigeria; [Adamu, Aishatu Lawal; Gadanya, Muktar A.; Jalo, Rabiu Ibrahim; Tsiga-Ahmed, Fatimah I.; Iliyasu, Zubairu] Bayero Univ, Aminu Kano Teaching Hosp, Dept Community Med, Kano, Nigeria; [Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Ameh, Emmanuel A.] Natl Hosp, Div Paediat Surg, Abuja, Nigeria; [Kyari, Fatima] Univ Abuja, Coll Hlth Sci, Abuja, Nigeria; [Mabayoje, Diana A.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Yinka-Ogunleye, Adesola; Ihekweazu, Chikwe] Nigeria Ctr Dis Control, Abuja, Nigeria; [Oni, Tolu] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Oni, Tolu] Univ Cape Town, Sch Publ Hlth & Family Med, Res Initiat Cities Hlth & Equ, Cape Town, South Africa; [Abimbola, Seye] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Onwujekwe, Obinna] Univ Nigeria Enugu Campus, Hlth Policy Res Grp, Enugu, Nigeria; [Owoaje, Eme Theodora] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria; [Aliyu, Gambo; Zanna, Fatima H.] Natl Agcy Control AIDS, Abuja, Nigeria; [Aliyu, Sani H.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Infect Dis & Microbiol, Cambridge, England; [Archibong, Belinda] Barnard Coll, New York, NY USA; [Ezeh, Alex] Drexel Univ, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Obaro, Stephen] Univ Nebraska Med Ctr, Dept Pediat Infect Dis, Omaha, NE USA; [Obadare, Ebenezer Babatunde] Univ Kansas, Dept Sociol, Lawrence, KS 66045 USA; [Okonofua, Friday] Univ Benin, Ctr Excellence Reprod Hlth Innovat, Benin, Edo State, Nigeria; [Onwujekwe, Obinna] Univ Med Sci, Ondo City, Nigeria; [Pate, Muhammed] World Bank, Hlth Nutr & Populat Global Practice & Global Fina, 1818 H St NW, Washington, DC 20433 USA; [Pate, Muhammed] Harvard TH Chan Sch Publ Hlth, Cambridge, MA USA; [Salako, Babatunde L.] Nigeria Inst Med Res, Lagos, Nigeria; [Glenn, Scott; Walker, Ally; Ezalarab, Maha; Naghavi, Mohsen] Univ Med Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA	University of London; University College London; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Northwestern University; Feinberg School of Medicine; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Lagos; University of Ibadan; Bayero University; Vanderbilt University; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Cambridge; University of Cape Town; University of Sydney; University of Nigeria; University of Ibadan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Drexel University; University of Nebraska System; University of Nebraska Medical Center; University of Kansas; University of Benin; The World Bank; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation	Abubakar, I (corresponding author), UCL, UCL Inst Global Hlth, London WC1E 6JB, England.	i.abubakar@ucl.ac.uk	Tsiga-Ahmed, Fatimah/ABA-2729-2021	Tsiga-Ahmed, Fatimah/0000-0003-4207-7981; Kyari, Fatima/0000-0002-5080-2154; Angell, Blake/0000-0002-7188-7740; Abubakar, Ibrahim/0000-0002-0370-1430	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was funded by the Bill & Melinda Gates Foundation. We would like to acknowledge the efforts of Rimamdeyati Yashe of the Surveillance and Epidemiology Department, Nigeria Centre for Disease Control, for assistance in searching for data.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abubakar I, LANCET; Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Aggarwal S, 2021, SOC PSYCHIAT PSYCHIA, V1, P1; Agyepong IA, 2017, LANCET, V390, P2803, DOI 10.1016/S0140-6736(17)31509-X; Akinyemi KO, 2018, AM J TROP MED HYG, V99, P41, DOI 10.4269/ajtmh.18-0045; Althaus CL, 2015, EPIDEMICS-NETH, V11, P80, DOI 10.1016/j.epidem.2015.03.001; Arthur E, 2017, AFR DEV REV, V29, P524, DOI 10.1111/1467-8268.12287; Bein MA, 2017, AFR HEALTH SCI, V17, P247, DOI 10.4314/ahs.v17i1.30; Croitoru L, 2019, COST AIR POLLUTION L; Evans DB, 2010, B WORLD HEALTH ORGAN, V88, P402, DOI 10.2471/BLT.10.078741; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Global Health Workforce Alliance, NIGERIA; Institute for Health Metrics and Evaluation, GHDX; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kiross GT, 2020, HEALTH ECON REV, V10, DOI 10.1186/s13561-020-00262-3; Kress DH, 2016, HEALTH SYST REFORM, V2, P302, DOI 10.1080/23288604.2016.1234861; Kutzin J, 2013, B WORLD HEALTH ORGAN, V91, P602, DOI 10.2471/BLT.12.113985; Makinde OA, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1811476; Matzopoulos R, 2010, HEALTH POLICY, V97, P62, DOI 10.1016/j.healthpol.2010.03.003; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; National Malaria Elimination Program, 2021, HMIS IND; Njidda AM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000712; Olaniran A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001388; Omoleke SA, 2016, J PUBLIC HEALTH AFR, V7, P27, DOI 10.4081/jphia.2016.534; Onwujekwe O, 2019, HEALTH POLICY PLANN, V34, P529, DOI 10.1093/heapol/czz070; Popoola O, 2019, CLIN INFECT DIS, V69, pS466, DOI 10.1093/cid/ciz516; Rahman MM, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0430-1; Shekar M, 2015, COSTED PLAN SCALING; Stevenson M, 2008, INJURY PREV, V14, P284, DOI 10.1136/ip.2008.018820; UNAIDS, AIDS INF 2021; Uneke CJ, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00605-z; United Nations, 2022, WORLD POP PROSP 2019; Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2; WHO, 2019, NATL SYSTEMS SUPPORT; World Bank, WORLD BANK OPEN DATA; World Bank, CURR HLTH EXP GDP; World Health Organization, 2014, MAKING FAIR CHOICES; World Health Organization, 2014, INJ VIOL FACTS; Yinka-Ogunleye A, 2019, LANCET INFECT DIS, V19, P872, DOI 10.1016/S1473-3099(19)30294-4	41	3	3	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1117	1129		10.1016/S0140-6736(21)02722-7	http://dx.doi.org/10.1016/S0140-6736(21)02722-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZV8ZO	35303469	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000770814300020
J	Watterberg, KL; Walsh, MC; Li, L; Chawla, S; D'Angio, CT; Goldberg, RN; Hintz, SR; Laughon, MM; Yoder, BA; Kennedy, KA; McDavid, GE; Backstrom-Lacy, C; Das, A; Crawford, MM; Keszler, M; Sokol, GM; Poindexter, BB; Ambalavanan, N; Hibbs, AM; Truog, WE; Schmidt, B; Wyckoff, MH; Khan, AM; Garg, M; Chess, PR; Reynolds, AM; Moallem, M; Bell, EF; Meyer, LR; Patel, RM; Van Meurs, KP; Cotten, CM; McGowan, EC; Hines, AC; Merhar, S; Peralta-Carcelen, M; Wilson-Costello, DE; Kilbride, HW; DeMauro, SB; Heyne, RJ; Mosquera, RA; Natarajan, G; Purdy, IB; Lowe, JR; Maitre, NL; Harmon, HM; Hogden, LA; Adams-Chapman, I; Winter, S; Malcolm, WF; Higgins, RD				Watterberg, K. L.; Walsh, M. C.; Li, L.; Chawla, S.; D'Angio, C. T.; Goldberg, R. N.; Hintz, S. R.; Laughon, M. M.; Yoder, B. A.; Kennedy, K. A.; McDavid, G. E.; Backstrom-Lacy, C.; Das, A.; Crawford, M. M.; Keszler, M.; Sokol, G. M.; Poindexter, B. B.; Ambalavanan, N.; Hibbs, A. M.; Truog, W. E.; Schmidt, B.; Wyckoff, M. H.; Khan, A. M.; Garg, M.; Chess, P. R.; Reynolds, A. M.; Moallem, M.; Bell, E. F.; Meyer, L. R.; Patel, R. M.; Van Meurs, K. P.; Cotten, C. M.; McGowan, E. C.; Hines, A. C.; Merhar, S.; Peralta-Carcelen, M.; Wilson-Costello, D. E.; Kilbride, H. W.; DeMauro, S. B.; Heyne, R. J.; Mosquera, R. A.; Natarajan, G.; Purdy, I. B.; Lowe, J. R.; Maitre, N. L.; Harmon, H. M.; Hogden, L. A.; Adams-Chapman, I; Winter, S.; Malcolm, W. F.; Higgins, R. D.		Eunice Kennedy Shriver NICHD Neona	Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTREMELY PRETERM INFANTS; MECHANICAL VENTILATION; CONTROLLED-TRIAL; INITIATED 7; BIRTH; DEXAMETHASONE; OUTCOMES; MORTALITY; DEFINITION; THERAPY	BACKGROUND Bronchopulmonary dysplasia is a prevalent complication after extremely preterm birth. Inflammation with mechanical ventilation may contribute to its development. Whether hydrocortisone treatment after the second postnatal week can improve survival without bronchopulmonary dysplasia and without adverse neurodevelopmental effects is unknown. METHODS We conducted a trial involving infants who had a gestational age of less than 30 weeks and who had been intubated for at least 7 days at 14 to 28 days. Infants were randomly assigned to receive either hydrocortisone (4 mg per kilogram of body weight per day tapered over a period of 10 days) or placebo. Mandatory extubation thresholds were specified. The primary efficacy outcome was survival without moderate or severe bronchopulmonary dysplasia at 36 weeks of postmenstrual age, and the primary safety outcome was survival without moderate or severe neurodevelopmental impairment at 22 to 26 months of corrected age. RESULTS We enrolled 800 infants (mean [+/- SD] birth weight, 715 +/- 167 g; mean gestational age, 24.9 +/- 1.5 weeks). Survival without moderate or severe bronchopulmonary dysplasia at 36 weeks occurred in 66 of 398 infants (16.6%) in the hydrocortisone group and in 53 of 402 (13.2%) in the placebo group (adjusted rate ratio, 1.27; 95% confidence interval [CI], 0.93 to 1.74). Two-year outcomes were known for 91.0% of the infants. Survival without moderate or severe neurodevelopmental impairment occurred in 132 of 358 infants (36.9%) in the hydrocortisone group and in 134 of 359 (37.3%) in the placebo group (adjusted rate ratio, 0.98; 95% CI, 0.81 to 1.18). Hypertension that was treated with medication occurred more frequently with hydrocortisone than with placebo (4.3% vs. 1.0%). Other adverse events were similar in the two groups. CONCLUSIONS In this trial involving preterm infants, hydrocortisone treatment starting on postnatal day 14 to 28 did not result in substantially higher survival without moderate or severe bronchopulmonary dysplasia than placebo. Survival without moderate or severe neurodevelopmental impairment did not differ substantially between the two groups.	[Watterberg, K. L.; Backstrom-Lacy, C.; Lowe, J. R.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Walsh, M. C.; Hibbs, A. M.; Wilson-Costello, D. E.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Poindexter, B. B.; Merhar, S.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Moallem, M.; Maitre, N. L.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43210 USA; [Li, L.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Goldberg, R. N.; Cotten, C. M.; Malcolm, W. F.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Laughon, M. M.] Univ N Carolina, Dept Pediat, Div Neonatal Perinatal Med, Chapel Hill, NC 27515 USA; [Chawla, S.; Natarajan, G.] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Chawla, S.] Cent Michigan Univ, Dept Pediat, Detroit, MI USA; [D'Angio, C. T.; Chess, P. R.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Reynolds, A. M.] Univ Buffalo, Womens & Childrens Hosp Buffalo, Dept Pediat, Buffalo, NY USA; [Hintz, S. R.; Van Meurs, K. P.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Hintz, S. R.; Van Meurs, K. P.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Garg, M.; Purdy, I. B.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Yoder, B. A.; Winter, S.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Kennedy, K. A.; McDavid, G. E.; Khan, A. M.; Mosquera, R. A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Wyckoff, M. H.; Heyne, R. J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Das, A.; Crawford, M. M.] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Higgins, R. D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Keszler, M.; McGowan, E. C.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Sokol, G. M.; Hines, A. C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Poindexter, B. B.; Patel, R. M.; Maitre, N. L.; Adams-Chapman, I] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA; [Ambalavanan, N.; Peralta-Carcelen, M.] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Truog, W. E.; Kilbride, H. W.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Schmidt, B.; DeMauro, S. B.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bell, E. F.; Harmon, H. M.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Meyer, L. R.; Hogden, L. A.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Higgins, R. D.] George Mason Univ, Coll Hlth & Human Serv, Fairfax, VA 22030 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Triangle Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Wayne State University; Central Michigan University; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; Stanford University; Lucile Packard Children's Hospital (LPCH); University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brown University; Women & Infants Hospital Rhode Island; Indiana University System; Indiana University Bloomington; Children's Healthcare of Atlanta (CHOA); Emory University; University of Alabama System; University of Alabama Birmingham; Children's Mercy Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; University of South Dakota; George Mason University	Watterberg, KL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Pediat, MSC10 5590, Albuquerque, NM 87131 USA.	kwatterberg@salud.unm.edu	Patel, Ravi/B-7218-2011; Das, Abhik/AAF-1883-2020	Patel, Ravi/0000-0002-7444-5550; Das, Abhik/0000-0003-2722-0479; Hintz, Susan/0000-0001-7023-4433	National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U10 HD21373, UG1 HD21364, UG1 HD21385, UG1 HD27851, UG1 HD27853, UG1 HD27856, UG1 HD27880, UG1 HD27904, UG1 HD34216, UG1 HD36790, UG1 HD40492, UG1 HD40689, UG1 HD53089, UG1 HD53109, UG1 HD68244, UG1 HD68270, UG1 HD68278, UG1 HD68263, UG1 HD68284, UG1 HD87226, UG1 HD87229]; National Center for Advancing Translational Sciences [UL1 TR6, UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR105, UL1 TR442, UL1 TR454, UL1 TR1117]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The National Institutes of Health, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10 HD21373, UG1 HD21364, UG1 HD21385, UG1 HD27851, UG1 HD27853, UG1 HD27856, UG1 HD27880, UG1 HD27904, UG1 HD34216, UG1 HD36790, UG1 HD40492, UG1 HD40689, UG1 HD53089, UG1 HD53109, UG1 HD68244, UG1 HD68270, UG1 HD68278, UG1 HD68263, UG1 HD68284; UG1 HD87226, and UG1 HD87229) and the National Center for Advancing Translational Sciences (UL1 TR6, UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR105, UL1 TR442, UL1 TR454, and UL1 TR1117), provided grant support for the Neonatal Research Network, including support for this trial.	Agresti A, 2003, CATEGORICAL DATA ANA; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; AVERY GB, 1985, PEDIATRICS, V75, P106; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Cheong JLY, 2018, SEMIN PERINATOL, V42, P478, DOI 10.1053/j.semperi.2018.09.013; CUMMINGS JJ, 1989, NEW ENGL J MED, V320, P1505, DOI 10.1056/NEJM198906083202301; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001145.pub4; Doyle LW, 2017, NEW ENGL J MED, V377, P329, DOI 10.1056/NEJMoa1700827; Feng YZ, 2015, PEDIATR RES, V77, P618, DOI 10.1038/pr.2015.19; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Hagman C, 2021, ACTA PAEDIATR, V110, P2084, DOI 10.1111/apa.15815; Halbmeijer NM, 2021, JAMA-J AM MED ASSOC, V326, P355, DOI 10.1001/jama.2021.9380; Higgins RD, 2018, J PEDIATR-US, V197, P300, DOI 10.1016/j.jpeds.2018.01.043; Jensen EA, 2019, AM J RESP CRIT CARE, V200, P751, DOI 10.1164/rccm.201812-2348OC; Jensen EA, 2015, JAMA PEDIATR, V169, P1011, DOI 10.1001/jamapediatrics.2015.2401; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lachin JM, 2005, STAT MED, V24, P2747, DOI 10.1002/sim.2151; Nakashima T, 2021, J PEDIATR-US, V230, P119, DOI 10.1016/j.jpeds.2020.11.041; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; Newman JE, 2012, J PEDIATR-US, V161, P1041, DOI 10.1016/j.jpeds.2012.05.048; Onland W, 2019, JAMA-J AM MED ASSOC, V321, P354, DOI 10.1001/jama.2018.21443; Onland W, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010941.pub2; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Peltoniemi OM, 2009, NEONATOLOGY, V95, P240, DOI 10.1159/000164150; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; SAS Institute, 2021, SAS STAT V14 3 US GU; Shaffer ML, 2019, J PEDIATR-US, V207, P136, DOI 10.1016/j.jpeds.2018.10.004; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Walsh MC, 2006, PEDIATRICS, V118, pE1328, DOI 10.1542/peds.2006-0359; Watterberg KL, 2000, PEDIATRICS, V105, P320, DOI 10.1542/peds.105.2.320; Watterberg KL, 2007, PEDIATRICS, V120, P40, DOI 10.1542/peds.2006-3158; Watterberg KL, 2016, J PEDIATR-US, V174, P23, DOI 10.1016/j.jpeds.2016.04.005; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yoder BA, 2009, PEDIATRICS, V124, P673, DOI 10.1542/peds.2008-2793; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556	40	8	9	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					1121	1131		10.1056/NEJMoa2114897	http://dx.doi.org/10.1056/NEJMoa2114897			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5R7CY	35320643	Green Accepted, Green Submitted			2022-12-28	WOS:000874665300001
J	Church, DM				Church, Deanna M.			A next-generation human genome sequence	SCIENCE			English	Editorial Material									[Church, Deanna M.] Inscripta Inc, Boulder, CO 80301 USA		Church, DM (corresponding author), Inscripta Inc, Boulder, CO 80301 USA.	deanna.church@inscripta.com						Altemose N, 2022, SCIENCE, V376, P56, DOI 10.1126/science.abl4178; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Miga KH, 2021, ANNU REV GENOM HUM G, V22, P81, DOI 10.1146/annurev-genom-120120-081921; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; Sheetal X, 2004, NATURE, V431, P927; Simon Tripp, 2011, EC IMPACT HUMAN GENO; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vollger M. R., 2022, SCIENCE, V376; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401	15	3	3	7	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2022	376	6588			SI		34	35		10.1126/science.abo5367	http://dx.doi.org/10.1126/science.abo5367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0J6ED	35357937				2022-12-28	WOS:000780195200015
J	Poholek, AC				Poholek, Amanda C.			CAR T cells are in it [CD]4 the long haul	CELL			English	Editorial Material								In a recent issue of Nature, Melenhorst et al. perform an extensive analysis of CAR T cells that persist for ten years in CLL patients. They find a dominant cytotoxic CD4+ population, raising the possibility that CD4+ T cells play an important role in durable CAR T cell therapy.	[Poholek, Amanda C.] Univ Pittsburgh, Dept Pediat, Dept Immunol, Div Pediat Rheumatol,Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Poholek, AC (corresponding author), Univ Pittsburgh, Dept Pediat, Dept Immunol, Div Pediat Rheumatol,Sch Med, Pittsburgh, PA 15224 USA.	poholeka@pitt.edu						Can I, 2022, EXP HEMATOL, V108, P1, DOI 10.1016/j.exphem.2022.02.001; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Larson RC, 2021, NAT REV CANCER, V21, P145, DOI 10.1038/s41568-020-00323-z; Melenhorst JJ, 2022, NATURE, V602, P503, DOI 10.1038/s41586-021-04390-6; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921	10	0	0	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2022	185	7					1112	1114		10.1016/j.cell.2022.03.004	http://dx.doi.org/10.1016/j.cell.2022.03.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	0J7WH	35364030				2022-12-28	WOS:000780311600004
J	Vize, R				Vize, Richard			Ockenden report exposes failures in leadership, teamwork, and listening to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								again exposes common problems underlying health service scandals: failures in leadership and teamwork, failure to follow clinical guidelines, failure to learn and improve, and a failure to listen to The inquiry identified "significant or major concerns" in the care involved in nine maternal deaths, 131 stillbirths, 29 cases of hypoxic ischaemic encephalopathy (HIE), and 70 neonatal deaths, as well as around 65 cases of brain damage which were often diagnosed years later. Failures identified by Ockenden include poor antenatal care for vulnerable women, repeated failures to correctly assess fetal growth, reluctance to refer women to tertiary centres to address fetal abnormalities, poor management of multiple pregnancies, poor management of gestational hypertension, failure to recognise sick or deteriorating women, failure to act on abnormal fetal heart patterns and failure to escalate concerns. Shortcomings in leadership and teamwork-important factors identified in Bill Kirkup's investigation into failings at the maternity unit in Furness General Hospital, Morecambe Bay-included a culture of bullying and a failure by the board to face up to problems.2 One staff member who tried to raise concerns "was referred straight to occupational health. It seemed that as I dared to raise a concern I must obviously be mentally unwell... This whole conversation was held in public." The board failed to understand the depth of the problems in the maternity service, was too willing to put a positive spin on repeated investigations, and lacked a coherent action plan. For two decades, the maternity service and the trust failed to learn from										[Anonymous], 2020, EMERGING FINDINGS RE; [Anonymous], 2021, REV HLTH SOCIAL CARE; [Anonymous], 2015, REPORT MORECAMBE BAY; [Anonymous], 2022, INDEPENDENT REV MATE; Cumberlege J, 2020, 1 NO HARM REPORT IND; Francis R., 2013, REP MIDST NHS FDN TR	6	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2022	376								o860	10.1136/bmj.o860	http://dx.doi.org/10.1136/bmj.o860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0J3FG	35361670	Bronze			2022-12-28	WOS:000779990000008
J	Murthy, PKL; Sontake, V; Tata, A; Kobayashi, Y; Macadlo, L; Okuda, K; Conchola, AS; Nakano, S; Gregory, S; Miller, LA; Spence, JR; Engelhardt, JF; Boucher, RC; Rock, JR; Randell, SH; Tata, PR				Murthy, Preetish Kadur Lakshminarasimha; Sontake, Vishwaraj; Tata, Aleksandra; Kobayashi, Yoshihiko; Macadlo, Lauren; Okuda, Kenichi; Conchola, Ansley S.; Nakano, Satoko; Gregory, Simon; Miller, Lisa A.; Spence, Jason R.; Engelhardt, John F.; Boucher, Richard C.; Rock, Jason R.; Randell, Scott H.; Tata, Purushothama Rao			Human distal lung maps and lineage hierarchies reveal a bipotent progenitor	NATURE			English	Article							AIRWAY-OBSTRUCTION; STEM-CELLS; IN-VITRO; INFERENCE	Mapping the spatial distribution and molecular identity of constituent cells is essential for understanding tissue dynamics in health and disease. We lack a comprehensive map of human distal airways, including the terminal and respiratory bronchioles (TRBs), which are implicated in respiratory diseases(1-4). Here, using spatial transcriptomics and single-cell profiling of microdissected distal airways, we identify molecularly distinct TRB cell types that have not-to our knowledge-been previously characterized. These include airway-associated LGR5(+) fibroblasts and TRB-specific alveolar type-0 (AT0) cells and TRB secretory cells (TRB-SCs). Connectome maps and organoid-based co-cultures reveal that LGR5(+) fibroblasts form a signalling hub in the airway niche. AT0 cells and TRB-SCs are conserved in primates and emerge dynamically during human lung development. Using a non-human primate model of lung injury, together with human organoids and tissue specimens, we show that alveolar type-2 cells in regenerating lungs transiently acquire an AT0 state from which they can differentiate into either alveolar type-1 cells or TRB-SCs. This differentiation programme is distinct from that identified in the mouse lung(5-7). Our study also reveals mechanisms that drive the differentiation of the bipotent AT0 cell state into normal or pathological states. In sum, our findings revise human lung cell maps and lineage trajectories, and implicate an epithelial transitional state in primate lung regeneration and disease.	[Murthy, Preetish Kadur Lakshminarasimha; Sontake, Vishwaraj; Tata, Aleksandra; Kobayashi, Yoshihiko; Macadlo, Lauren; Tata, Purushothama Rao] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Okuda, Kenichi; Nakano, Satoko; Boucher, Richard C.] Univ N Carolina, Mars Lung Inst, Chapel Hill, NC 27515 USA; [Conchola, Ansley S.] Univ Michigan, Med Sch, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Gregory, Simon] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Miller, Lisa A.] Calif Natl Primate Res Ctr, Davis, CA USA; [Miller, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Spence, Jason R.] Univ Michigan, Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Rock, Jason R.] Genentech Inc, Dept Immunol Discovery, San Francisco, CA USA; [Randell, Scott H.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Tata, Purushothama Rao] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC 27710 USA; [Tata, Purushothama Rao] Duke Univ, Duke Regenerat Ctr, Sch Med, Durham, NC 27710 USA; [Tata, Purushothama Rao] Duke Univ, Sch Med, Dept Med, Div Pulm Crit Care, Durham, NC 27710 USA; [Tata, Purushothama Rao] Duke Univ, Ctr Adv Genom Technol, Durham, NC 27708 USA; [Kobayashi, Yoshihiko] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Duke University; University of California System; University of California Davis; University of Michigan System; University of Michigan; University of Iowa; University of Iowa; Roche Holding; Genentech; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Kyoto University	Tata, PR (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.; Tata, PR (corresponding author), Duke Univ, Duke Canc Inst, Sch Med, Durham, NC 27710 USA.; Tata, PR (corresponding author), Duke Univ, Duke Regenerat Ctr, Sch Med, Durham, NC 27710 USA.; Tata, PR (corresponding author), Duke Univ, Sch Med, Dept Med, Div Pulm Crit Care, Durham, NC 27710 USA.; Tata, PR (corresponding author), Duke Univ, Ctr Adv Genom Technol, Durham, NC 27708 USA.	purushothamarao.tata@duke.edu	Kobayashi, Yoshihiko/AAH-7324-2019	Kobayashi, Yoshihiko/0000-0001-7031-1478; Conchola, Ansley/0000-0002-2385-6712; Kadur Lakshminarasimha Murthy, Preetish/0000-0002-9762-8376; Tata, Purushothama Rao/0000-0003-4837-0337	CF Foundation [BOUCHER19R0]; NIH [DK065988, P51OD011107, R01 DK047967-30]; Duke University Molecular Genomics Core Facility; Duke BRPC shared resource; Regeneration Next initiative at Duke University; Japan Society for the Promotion of Science Overseas Research; Chan Zuckerberg Initiative DAF [CZF2019-002440]; Silicon Valley Community Foundation; National Heart, Lung and Blood Institute (NHLBI) [R01HL119215]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [5R24HD000836]; NIH/NHLBI [R01 HL127002, U01HL134766]; NHLBI/NIH [R00HL127181, R01HL146557, R01HL153375]; NCI/NIH P30 Cancer Center Support Grant [P30CA014236]; Chan Zuckerberg Initiative Human Lung Cell Atlas pilot award; Regeneration NeXT and Kaganov MEDx Pulmonary Initiative; Whitehead foundation; Whitehead Scholar at Duke University	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Molecular Genomics Core Facility; Duke BRPC shared resource; Regeneration Next initiative at Duke University; Japan Society for the Promotion of Science Overseas Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chan Zuckerberg Initiative DAF; Silicon Valley Community Foundation; National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI/NIH P30 Cancer Center Support Grant; Chan Zuckerberg Initiative Human Lung Cell Atlas pilot award; Regeneration NeXT and Kaganov MEDx Pulmonary Initiative; Whitehead foundation; Whitehead Scholar at Duke University	We thank B. Hogan for advice and critical reading of the manuscript; members of the P.R.T. laboratory for discussions; the Human Cell Atlas community for discussions and feedback; and members of the S.H.R. laboratory at UNC Chapel Hill for providing human tissues (supported by grant BOUCHER19R0 from the CF Foundation and NIH grant DK065988). We acknowledge support from the Duke University Molecular Genomics Core Facility (for help with Visium experiments); and from the Duke BRPC shared resource (for providing lung tissue specimens). V.S. is supported by a fellowship from Regeneration Next initiative at Duke University. Y.K. was supported by a fellowship from Japan Society for the Promotion of Science Overseas Research. Human tissue procurement was supported by funding from the CF Foundation (BOUCHER19R0) and the NIH (DK065988). J.R.S. is supported by grant CZF2019-002440 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation, and by the National Heart, Lung and Blood Institute (NHLBI; R01HL119215). We also thank I. Glass and the University of Washington Laboratory of Developmental Biology, which is supported by NIH award 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This work was supported by funds from the NIH/NHLBI (R01 HL127002, U01HL134766) to J.R.R.; the NIH (P51OD011107) to L.A.M.; the NIH (R01 DK047967-30) to J.F.E.; a Pathways to Independence award from the NHLBI/NIH (R00HL127181, R01HL146557 and R01HL153375); a NCI/NIH P30 Cancer Center Support Grant (P30CA014236); funds from the Chan Zuckerberg Initiative Human Lung Cell Atlas pilot award to P.R.T.; and funds from Regeneration NeXT and Kaganov MEDx Pulmonary Initiative to P.R.T. at Duke University. This work was partially supported by funds from the Whitehead foundation and P.R.T. is a Whitehead Scholar at Duke University.	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bhandari A, 2013, SEMIN PERINATOL, V37, P132, DOI 10.1053/j.semperi.2013.01.010; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Carraro G, 2020, AM J RESP CRIT CARE, V202, P1540, DOI 10.1164/rccm.201904-0792OC; CASTLEMAN WL, 1975, AM J ANAT, V142, P107, DOI 10.1002/aja.1001420108; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Choi J, 2020, CELL STEM CELL, V27, P366, DOI 10.1016/j.stem.2020.06.020; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Deprez M, 2020, AM J RESP CRIT CARE, V202, P1636, DOI 10.1164/rccm.201911-2199OC; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hogg J C, 1967, Aspen Emphysema Conf, V10, P433; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HYDE D M, 1979, Scanning Electron Microscopy, P891; Jeffery PK, 1998, AM J RESP CRIT CARE, V157, pS174, DOI 10.1164/ajrccm.157.5.rsaa-1; Jiang Y., 2019, SCI REP-UK, V9; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; Jin SQ, 2018, BIOINFORMATICS, V34, P2077, DOI 10.1093/bioinformatics/bty058; Katsura H, 2020, CELL STEM CELL, V27, P890, DOI 10.1016/j.stem.2020.10.005; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Kwapiszewska G, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00564-2018; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Ma S, 2021, CELL RES, V31, P415, DOI 10.1038/s41422-020-00412-6; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Miller AJ, 2020, DEV CELL, V53, P117, DOI 10.1016/j.devcel.2020.01.033; Miller LA, 2017, ILAR J, V58, P269, DOI 10.1093/ilar/ilx030; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nagendran M, 2018, ELIFE, V7, DOI 10.7554/eLife.30510; Okuda K, 2021, AM J RESP CRIT CARE, V203, P1275, DOI 10.1164/rccm.202008-3198OC; Pan HQ, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0209-1; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; Regev Aviv, 2017, Elife, V6, DOI 10.7554/eLife.27041; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tanabe N, 2017, AM J RESP CRIT CARE, V195, P630, DOI 10.1164/rccm.201602-0278OC; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Verleden SE, 2020, LANCET RESP MED, V8, P573, DOI 10.1016/S2213-2600(19)30356-X; Weibel E.R, 1963, MORPHOMETRY HUMAN LU, P136, DOI [DOI 10.1007/978-3-642-87553-3, DOI 10.1016/B978-1-4832-0076-7.50016-8, 10.1007/978-3-642-87553-3]; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Weibel ER, 2013, AM J PHYSIOL-LUNG C, V305, pL405, DOI 10.1152/ajplung.00169.2013; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Young Matthew D, 2020, Gigascience, V9, DOI 10.1093/gigascience/giaa151; Zhou P., 2021, GLOB TUB REP 2012, V12	61	19	19	18	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					111	+		10.1038/s41586-022-04541-3	http://dx.doi.org/10.1038/s41586-022-04541-3		MAR 2022	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35355018	Green Accepted			2022-12-28	WOS:000776020400002
J	Hassan, R; Meng, LV; Ngee, KT; I-Vern, L; Sankaran, P; Hean, LC; Euxian, L; Mohamad, H; Dusa, NM; Subramaniam, M				Hassan, Razeen; Meng, Leow Voon; Ngee, Kee Thian; I-Vern, Lim; Sankaran, Padmaan; Hean, Lim Choon; Euxian, Lee; Mohamad, Haidi; Dusa, Noraini Mohd; Subramaniam, Manisekar			Extraskeletal Ewing sarcoma of the duodenum presenting as duodenojejunal intussusception	LANCET			English	Editorial Material									[Hassan, Razeen; Meng, Leow Voon; Ngee, Kee Thian; I-Vern, Lim; Sankaran, Padmaan; Hean, Lim Choon; Euxian, Lee; Subramaniam, Manisekar] Minist Hlth, Dept Surg, Hosp Sultanah Bahiyah, Alor Setar, Kedah, Malaysia; [Mohamad, Haidi] Minist Hlth, Dept Pathol, Hosp Sultanah Bahiyah, Alor Setar, Kedah, Malaysia; [Meng, Leow Voon] Univ Sains Malaysia, Adv Med & Dent Inst AMDI, George Town 13200, Kedah, Malaysia; [Dusa, Noraini Mohd] Minist Hlth, Dept Pathol, Hosp Kuala Lumpur, Alor Setar, Kedah, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Sains Malaysia; Kementerian Kesihatan Malaysia	Meng, LV (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst AMDI, George Town 13200, Kedah, Malaysia.	lvmeng74@gmail.com		Mohd Hassan, Mohd Razeen/0000-0002-4149-8023					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1265	1265						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0I5XZ	35339226				2022-12-28	WOS:000779495000023
J	Mosha, JF; Kulkarni, MA; Lukole, E; Matowo, NS; Pitt, C; Messenger, LA; Mallya, E; Jumanne, M; Aziz, T; Kaaya, R; Shirima, BA; Isaya, G; Taljaard, M; Martin, J; Hashim, R; Thickstun, C; Manjurano, A; Kleinschmidt, I; Mosha, FW; Rowland, M; Protopopoff, N				Mosha, Jacklin F.; Kulkarni, Manisha A.; Lukole, Eliud; Matowo, Nancy S.; Pitt, Catherine; Messenger, Louisa A.; Mallya, Elizabeth; Jumanne, Mohamed; Aziz, Tatu; Kaaya, Robert; Shirima, Boniface A.; Isaya, Gladness; Taljaard, Monica; Martin, Jacklin; Hashim, Ramadhan; Thickstun, Charles; Manjurano, Alphaxard; Kleinschmidt, Immo; Mosha, Franklin W.; Rowland, Mark; Protopopoff, Natacha			Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial	LANCET			English	Article							RESISTANCE	Background Long-lasting insecticidal nets (LLINs) have successfully reduced malaria in sub-Saharan Africa, but their effectiveness is now partly compromised by widespread resistance to insecticides among vectors. We evaluated new classes of LLINs with two active ingredients with differing modes of action against resistant malaria vectors. Methods We did a four-arm, cluster-randomised trial in Misungwi, Tanzania. Clusters were villages, or groups of hamlets, with at least 119 households containing children aged 6 months to 14 years living in the cluster's core area. Constrained randomisation was used to allocate dusters (1:1:1:1) to receive one of four types of LLIN treated with the following: alpha-cypermethrin only (pyrethroid-only [reference] group); pyriproxyfen and alpha-cypermethrin (pyriproxyfen group); chlorfenapyr and alpha-cypermethrin (chlorfenapyr group); or the synergist piperonyl butoxide and permethrin (piperonyl butoxide group). At least one LLIN was distributed for every two people. Community members and the field team were masked to group allocation. Malaria prevalence data were collected through cross-sectional surveys of randomly selected households from each cluster, in which children aged 6 months to 14 years were assessed for Plastnodiutn falciparum malaria infection by rapid diagnostic tests. The primary outcome was malaria infection prevalence at 24 months after LLIN distribution, comparing each of the dual-active-ingredient LLINs to the standard pyrethroid-only LLINs in the intention-to-treat population. The primary economic outcome was cost-effectiveness of dual-active-ingredient LLINs, based on incremental cost per disability-adjusted life-year (DALY) averted compared with pyrethroid-only LLINs, modelled over a 2-year period; we included costs of net procurement and malaria diagnosis and treatment, and estimated DALYs in all age groups. This study is registered with ClinicalTrials.gov (NCT03554616), and is ongoing but no longer recruiting. Findings 84 clusters comprising 39 307 households were included in the study between May 11 and July 2, 2018. 147 230 LLINs were distributed among households between Jan 26 and Jan 28, 2019. Use of study LLINs was reported in 3155 (72.1%) of 4378 participants surveyed at 3 months post-distribution and decreased to 8694 (40.9%) of 21 246 at 24 months, with varying rates of decline between groups. Malaria infection prevalence at 24 months was 549 (45.8%) of 1199 children in the pyrethroid-only reference group, 472 (37.5%) of 1258 in the pyriproxyfen group (adjusted odds ratio 0.79 [95% CI 0.54-1- 17], p=0.2354), 512 (40.7%) of 1259 in the piperonyl butoxide group (0.99 [0.67-1.45], p=0.9607), and 326 [25.6%] of 1272 in the chlorfenapyr group (0.45 [0. 30-0- 67], p=0.0001). Skin irritation or paraesthesia was the most commonly reported side-effect in all groups. Chlorfenapyr LLINs were the most cost-effective LLINs, costing only US$19 (95% uncertainty interval 1-105) more to public providers or $28 (11-120) more to donors per DALY averted over a 2-year period compared with pyrethroid-only LLINs, and saving costs from societal and household perspectives. Interpretation After 2 years, chlorfenapyr LLINs provided significantly better protection than pyrethroid-only LLINs against malaria in an area with pyrethroid-resistant mosquitoes, and the additional cost of these nets would be considerably below plausible cost-effectiveness thresholds ($292-393 per DALY averted). Before scale-up of chlorfenapyr LLINs, resistance management strategies are needed to preserve their effectiveness. Poor textile and active ingredient durability in the piperonyl butoxide and pyriproxyfen LLINs might have contributed to their relative lack of effectiveness compared with standard LLINs. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Mosha, Jacklin F.; Lukole, Eliud; Jumanne, Mohamed; Aziz, Tatu; Martin, Jacklin; Hashim, Ramadhan; Manjurano, Alphaxard] Mwanza Med Res Ctr, Natl Inst Med Res, Dept Parasitol, Mwanza, Tanzania; [Kulkarni, Manisha A.; Taljaard, Monica; Thickstun, Charles] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Matowo, Nancy S.; Messenger, Louisa A.; Rowland, Mark; Protopopoff, Natacha] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Pitt, Catherine] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, MRC Int Stat & Epidemiol Grp, London, England; [Mallya, Elizabeth; Kaaya, Robert; Shirima, Boniface A.; Isaya, Gladness; Martin, Jacklin; Mosha, Franklin W.] Kilimanjaro Christian Med Univ Coll, Dept Parasitol, Moshi, Tanzania; [Taljaard, Monica] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kleinschmidt, Immo] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa; [Kleinschmidt, Immo] Southern African Dev Community Malaria Eliminat E, Windhoek, Namibia	National Institute of Medical Research; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Ottawa; Ottawa Hospital Research Institute; University of Witwatersrand	Protopopoff, N (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.	natacha.protopopoff@lshtm.ac.uk	Messenger, Louisa/HGD-0180-2022	Protopopoff, Natacha/0000-0001-6698-4936; Mosha, Jacklin/0000-0001-7940-8903	UK Foreign, Commonwealth and Development Office; UK Medical Research Council; Wellcome; UK Department of Health and Social Care; US Agency for International Development, President's Malaria Initiative	UK Foreign, Commonwealth and Development Office; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; UK Department of Health and Social Care; US Agency for International Development, President's Malaria Initiative	Joint Global Health Trials scheme (UK Foreign, Commonwealth and Development Office; UK Medical Research Council; Wellcome; UK Department of Health and Social Care), US Agency for International Development, President's Malaria Initiative.	Bass C, 2008, ACTA TROP, V107, P50, DOI 10.1016/j.actatropica.2008.04.009; Bayili K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1846-4; Gleave K, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.C0012776.pub2, 10.1002/14651858.CD012776.pub2]; Hayes RJ, 2017, CHAPMAN HALL CRC BIO, V2nd, P129; Hooper R, 2016, STAT MED, V35, P4718, DOI 10.1002/sim.7028; Institute for Health Metrics and Evaluation, GBD RES TOOL GHDX; Kawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111195; Martin JL, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04641-5; Ministry of Health and Social Welfare United Republic of Tanzania, 2014, UN REP TANZ NAT MAL; Mosha JF, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046664; N'Guessan R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165925; Ngufor C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69109-5; Ngufor C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3270; Ochalek J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000964; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Staedke SG, 2020, LANCET, V395, P1292, DOI 10.1016/S0140-6736(20)30214-2; Tiono AB, 2018, LANCET, V392, P569, DOI 10.1016/S0140-6736(18)31711-2; Toe KH, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3018-1; Topazian HM, 2021, BMJ GLOB HEALTH, V6; Tungu PK, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03716-z; Vezenegho SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-282; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2011, EUR CTR ENV HLTH BUR; WHO, 2012, GLOBAL PLAN INSECTIC; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001	29	6	6	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2022	399	10331					1227	1241						15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0I5XZ	35339225	Green Published, hybrid			2022-12-28	WOS:000779495000020
J	Xiang, MS; Rix, HW				Xiang, Maosheng; Rix, Hans-Walter			A time-resolved picture of our Milky Way's early formation history	NATURE			English	Article							Y-2 ISOCHRONES; WAY DISC; STELLAR; EVOLUTION; LAMOST	The formation of our Milky Way can be split up qualitatively into different phases that resulted in its structurally different stellar populations:the halo and the disk components(1-3). Revealing a quantitative overall picture of our Galaxy's assembly requires a large sample of stars with very precise ages. Here we report an analysis of such a sample using subgiant stars. We find that the stellar age-metallicity distribution p(tau, [Fe/H]) splits into two almost disjoint parts, separated at age tau similar or equal to 8 Gyr. The younger part reflects a late phase of dynamically quiescent Galactic disk formation with manifest evidence for stellar radial orbit migration(4-6); the other part reflectsthe earlier phase, when the stellar halo(7) and the old alpha-process-enhanced (thick) disk(8,9) formed. Our results indicate that the formation of the Galaxy's old (thick) disk started approximately 13 Gyr ago, only 0.8 Gyr afterthe Big Bang, and 2 Gyr earlier than the final assembly ofthe inner Galactic halo. Most ofthese stars formed around 11 Gyr ago, when the Gaia-Sausage-Enceladus satellite merged with our Galaxy(10,11). Overthe next 5-6 Gyr, the Galaxy experienced continuous chemical element enrichment, ultimately by a factor of 10, while the star-forminggas managed to stay well mixed.	[Xiang, Maosheng; Rix, Hans-Walter] Max Planck Inst Astron, Koenigstuhl 17, Heidelberg, Germany	Max Planck Society	Xiang, MS; Rix, HW (corresponding author), Max Planck Inst Astron, Koenigstuhl 17, Heidelberg, Germany.	mxiang@mpia.de; rix@mpia.de		Rix, Hans-Walter/0000-0003-4996-9069	NSFC [11833006]; National Development and Reform Commission; National Aeronautics and Space Administration; National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); National Development and Reform Commission; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	We thank D. Xu and N. Frankel for helpful discussion, and J. Rybizki for his kind help with using the Gaia mock catalogues. M.X. acknowledges partial support from NSFC grant no. 11833006 for his academic visit to NAOC from November 2021 to January 2022. This work has used data products from the Guoshoujing Telescope (LAMOST). LAMOST is a National Major Scientific Project built by the Chinese Academy of Sciences. Funding for the project has been provided by the National Development and Reform Commission. LAMOST is operated and managed by the National Astronomical Observatories, Chinese Academy of Sciences. This work has made use of data products from the European Space Agency (ESA) space mission Gaia. Gaia data are being processed by the Gaia Data Processing and Analysis Consortium (DPAC). Funding for the DPAC is provided by national institutions, in particular the institutions participating in the Gaia MultiLateral Agreement. The Gaia mission website is https://www.cosmos.esa.int/gaia.The Gaia archive website is https://archives.esac.esa.int/gaia.This publication has also used data products from the 2MASS, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation.	Abuter R, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201935656; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Aguirre VS, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/173; [Anonymous], 2016, AA, DOI [10.1051/0004-6361/201629272, DOI 10.1051/0004-6361/201629272]; Belokurov V, 2018, MON NOT R ASTRON SOC, V478, P611, DOI 10.1093/mnras/sty982; Belokurov V, 2020, MON NOT R ASTRON SOC, V494, P3880, DOI 10.1093/mnras/staa876; Bland-Hawthorn J, 2016, ANNU REV ASTRON ASTR, V54, P529, DOI 10.1146/annurev-astro-081915-023441; Bonaca A, 2020, ASTROPHYS J LETT, V897, DOI 10.3847/2041-8213/ab9caa; Bonaca A, 2017, ASTROPHYS J, V845, DOI 10.3847/1538-4357/aa7d0c; Brown AGA, 2021, ASTRON ASTROPHYS, V649, DOI 10.1051/0004-6361/202039657; Cohen RE, 2021, ASTRON J, V162, DOI 10.3847/1538-3881/ac281f; Cui XQ, 2012, RES ASTRON ASTROPHYS, V12, P1197, DOI 10.1088/1674-4527/12/9/003; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Di Matteo P, 2019, ASTRON ASTROPHYS, V632, DOI 10.1051/0004-6361/201834929; Dotter A, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6d10; Dotter A, 2016, ASTROPHYS J SUPPL S, V222, DOI 10.3847/0067-0049/222/1/8; Feuillet DK, 2019, MON NOT R ASTRON SOC, V489, P1742, DOI 10.1093/mnras/stz2221; Feuillet DK, 2018, MON NOT R ASTRON SOC, V477, P2313, DOI 10.1093/mnras/sty779; Forbes DA, 2010, MON NOT R ASTRON SOC, V404, P1203, DOI 10.1111/j.1365-2966.2010.16373.x; Frankel N, 2020, ASTROPHYS J, V896, DOI 10.3847/1538-4357/ab910c; Frankel N, 2018, ASTROPHYS J, V865, DOI 10.3847/1538-4357/aadba5; Hayden MR, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/2/132; Haywood M, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321397; Helmi A, 2020, ANNU REV ASTRON ASTR, V58, P205, DOI 10.1146/annurev-astro-032620-021917; Helmi A, 2018, NATURE, V563, P85, DOI 10.1038/s41586-018-0625-x; Koppelman H, 2018, ASTROPHYS J LETT, V860, DOI 10.3847/2041-8213/aac882; Maoz D, 2017, ASTROPHYS J, V848, DOI 10.3847/1538-4357/aa8b6e; Montalban J, 2021, NAT ASTRON, V5, P640, DOI 10.1038/s41550-021-01347-7; Nissen PE, 2020, ASTRON ASTROPHYS, V640, DOI 10.1051/0004-6361/202038300; Rybizki J, 2022, MON NOT R ASTRON SOC, V510, P2597, DOI 10.1093/mnras/stab3588; Rybizki J, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aabd70; Schonrich R, 2009, MON NOT R ASTRON SOC, V396, P203, DOI 10.1111/j.1365-2966.2009.14750.x; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Spitoni E, 2019, ASTRON ASTROPHYS, V623, DOI 10.1051/0004-6361/201834188; VandenBerg DA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/134; Wang S, 2022, MON NOT R ASTRON SOC, V509, P3148, DOI 10.1093/mnras/stab3167; Wu YQ, 2021, MON NOT R ASTRON SOC, V501, P4917, DOI 10.1093/mnras/staa3949; Xiang MS, 2015, RES ASTRON ASTROPHYS, V15, P1209, DOI 10.1088/1674-4527/15/8/009; Xiang MS, 2021, ASTROPHYS J SUPPL S, V253, DOI 10.3847/1538-4365/abd6ba; Xiang MS, 2019, ASTROPHYS J SUPPL S, V245, DOI 10.3847/1538-4365/ab5364; Xiang MS, 2018, ASTROPHYS J SUPPL S, V237, DOI 10.3847/1538-4365/aad237; Xiang MS, 2017, ASTROPHYS J SUPPL S, V232, DOI 10.3847/1538-4365/aa80e4; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795; Zhao G, 2012, RES ASTRON ASTROPHYS, V12, P723, DOI 10.1088/1674-4527/12/7/002	47	7	7	1	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					599	+		10.1038/s41586-022-04496-5	http://dx.doi.org/10.1038/s41586-022-04496-5			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35322254	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000772661800013
J	Lai, Y; Fois, G; Flores, JR; Tuvim, MJ; Zhou, QJ; Yang, KL; Leitz, J; Peters, J; Zhang, YX; Pfuetzner, RA; Esquivies, L; Jones, P; Frick, M; Dickey, BF; Brunger, AT				Lai, Ying; Fois, Giorgio; Flores, Jose R.; Tuvim, Michael J.; Zhou, Qiangjun; Yang, Kailu; Leitz, Jeremy; Peters, John; Zhang, Yunxiang; Pfuetzner, Richard A.; Esquivies, Luis; Jones, Philip; Frick, Manfred; Dickey, Burton F.; Brunger, Axel T.			Inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides	NATURE			English	Article							NEUROTRANSMITTER RELEASE; MOLECULAR-MECHANISMS; MUCIN SECRETION; MUNC13; MEMBRANE; VIRUS; SNARE; EXOCYTOSIS; SYSTEM; MUCUS	Membrane fusion triggered by Ca2+ is orchestrated by a conserved set of proteins to mediate synaptic neurotransmitter release, mucin secretion and other regulated exocytic processes(1-4). For neurotransmitter release, the Ca2+ sensitivity is introduced by interactions between the Ca2+ sensor synaptotagmin and the SNARE complex', and sequence conservation and functional studies suggest that this mechanism is also conserved for mucin secretion'. Disruption of Ca2+ ttriggered membrane fusion by a pharmacological agent would have therapeutic value for mucus hypersecretion as it is the major cause of airway obstruction in the pathophysiology of respiratoryviral infection, asthma, chronic obstructive pulmonary disease and cystic fibrosis(7-)(11). Here we designed a hydrocarbon-stapled peptide that specifically disrupts Ca2+-triggered membrane fusion by interfering with the so-called primary interface between the neuronal SNARE complex and the Ca2+-binding C2B domain of synaptotagmin-1. In reconstituted systems with these neuronal synaptic proteins or with their airway homologues syntaxin-3, SNAP-23, VAMPS, synaptotagmin-2, along with Munc13-2 and Munc18-2, the stapled peptide strongly suppressed Ca2+ ttriggered fusion at physiological Ca2+ concentrations. Conjugation of cell-penetrating peptidesto the stapled peptide resulted in efficient delivery into cultured human airway epithelial cells and mouse airway epithelium, where it markedly and specifically reduced stimulated mucin secretion in both systems, and substantially attenuated mucus occlusion of mouse airways. Taken together, peptides that disrupt Ca2+-triggered membrane fusion may enable the therapeutic modulation of mucin secretory pathways.	[Lai, Ying; Zhou, Qiangjun; Yang, Kailu; Leitz, Jeremy; Peters, John; Zhang, Yunxiang; Pfuetzner, Richard A.; Esquivies, Luis; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Fois, Giorgio; Frick, Manfred] Ulm Univ, Inst Gen Physiol, Ulm, Germany; [Flores, Jose R.; Tuvim, Michael J.; Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Yang, Kailu; Pfuetzner, Richard A.; Esquivies, Luis; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Jones, Philip] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Lai, Ying] Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Lai, Ying] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Zhou, Qiangjun] Vanderbilt Univ, Ctr Struct Biol, Vanderbilt Brain Inst, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Peters, John] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhang, Yunxiang] Fudan Univ, Dept Chem, Shanghai, Peoples R China	Stanford University; Ulm University; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Sichuan University; Sichuan University; Vanderbilt University; Harvard University; Harvard Medical School; Fudan University	Lai, Y; Brunger, AT (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Frick, M (corresponding author), Ulm Univ, Inst Gen Physiol, Ulm, Germany.; Dickey, BF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.; Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Lai, Y (corresponding author), Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.; Lai, Y (corresponding author), Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.	ylai@scu.edu.cn; manfred.frick@uni-ulm.de; bdickey@mdanderson.org; brunger@stanford.edu	Frick, Manfred/E-1374-2012; Fois, Giorgio/AAD-5657-2022	Frick, Manfred/0000-0002-4763-1104; Fois, Giorgio/0000-0001-5414-1149; Yang, Kailu/0000-0002-8234-1997; Peters, John/0000-0002-3192-7824; Zhang, Yunxiang/0000-0002-6635-6443; Brunger, Axel/0000-0001-5121-2036; Tuvim, Michael/0000-0001-8126-7716; Zhou, Qiangjun/0000-0003-1789-9588	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [251293561 (SFB1149), 175083951]; National Institutes of Health (NIH) [R37MH63105, R01 HL129795, R21 AI137319]; Cystic Fibrosis Foundation [DICKEY18G0, DICKEY19P0]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	We thank R. Adachi, M. Singh, T. Sudhof, T. Velkov and C. Wang for discussions; T. Sudhof for providing the Syt2 conditional knockout mice; Z. Azzegagh and V. Oren for technical assistance with mucin secretion in mice; H. Barth and M. Fellermann for providing bacterial toxins (C2 and CRM197); P. Braubach for providing donor tissue; C. Schilpp for isolation of HAE cells; S. Lynch for performing the NMR experiments for SP9; H. Chong and colleagues at Vivitide for their expertise in peptide synthesis and collaborative efforts; K. Marcus for providing script files for the molecular dynamics simulations; and C. Mayne for providing parameters for the molecular dynamics simulations. We acknowledge the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (251293561 (SFB1149) and 175083951, to M.F.), the National Institutes of Health (NIH) (R37MH63105 to A.T.B.; R01 HL129795 and R21 AI137319 to B.F.D.) and the Cystic Fibrosis Foundation (DICKEY18G0 and DICKEY19P0) for support. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Abdullah LH, 2012, METHODS MOL BIOL, V842, P259, DOI 10.1007/978-1-61779-513-8_16; Ali AM, 2019, COMPUT STRUCT BIOTEC, V17, P263, DOI 10.1016/j.csbj.2019.01.012; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Blanco M. R., 2013, ENCY BIOPHYSICS, P971; Bosse Y, 2010, ANNU REV PHYSIOL, V72, P437, DOI 10.1146/annurev-physiol-021909-135851; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 2018, ANNU REV BIOPHYS, V47, P469, DOI 10.1146/annurev-biophys-070816-034117; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Choi UB, 2018, ELIFE, V7, DOI 10.7554/eLife.36497; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Diao JJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1054; Dresser L, 2021, METHODS, V193, P80, DOI 10.1016/j.ymeth.2020.06.007; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Evans JH, 1999, AM J PHYSIOL-LUNG C, V277, pL30, DOI 10.1152/ajplung.1999.277.1.L30; Fahrer J, 2013, BIOCONJUGATE CHEM, V24, P595, DOI 10.1021/bc300563c; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fellermann M, 2020, ARCH TOXICOL, V94, P1753, DOI 10.1007/s00204-020-02731-4; Goldblatt DL, 2020, BRIT J PHARMACOL, V177, P2256, DOI 10.1111/bph.14977; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hays SR, 2003, AM J MED, V115, P68, DOI 10.1016/S0002-9343(03)00260-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaramillo AM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124815; Jaramillo AM, 2018, ANN AM THORAC SOC, V15, pS164, DOI 10.1513/AnnalsATS.201806-371AW; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Kim TD, 1997, J BIOL CHEM, V272, P31225, DOI 10.1074/jbc.272.50.31225; Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lai, 2022, SCREENING HYDROCARBO, DOI 10.1101/2022.03.21.484632; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Lai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03756; Lau JL, 2018, BIOORGAN MED CHEM, V26, P2700, DOI 10.1016/j.bmc.2017.06.052; Lee KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2882; Li HG, 2008, GENESIS, V46, P300, DOI 10.1002/dvg.20396; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu J, 2015, CELL REP, V10, P1599, DOI 10.1016/j.celrep.2015.02.014; Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067; Luo FJ, 2017, NEURON, V94, P826, DOI 10.1016/j.neuron.2017.04.020; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Messina TC, 2006, J PHYS CHEM B, V110, P16366, DOI 10.1021/jp063367k; Moiola M, 2019, MOLECULES, V24, DOI 10.3390/molecules24203654; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Ren BH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150004; Riento K, 1998, J CELL SCI, V111, P2681; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schmidt H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133222; Speltz TE, 2016, ANGEW CHEM INT EDIT, V55, P4252, DOI 10.1002/anie.201510557; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thorn P, 2016, J NEUROCHEM, V137, P849, DOI 10.1111/jnc.13602; Turner J, 2011, AM J RESP CELL MOL, V44, P276, DOI 10.1165/rcmb.2009-0304OC; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Voleti R, 2020, ELIFE, V9, DOI 10.7554/eLife.57154; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Winkelmann VE, 2019, AM J PHYSIOL-LUNG C, V316, pL58, DOI 10.1152/ajplung.00157.2018; Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2; Yang CN, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001127.pub4; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038; Zhou QJ, 2017, NATURE, V548, P420, DOI 10.1038/nature23484; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zhu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119705; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	76	7	7	18	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					949	+		10.1038/s41586-022-04543-1	http://dx.doi.org/10.1038/s41586-022-04543-1		MAR 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35322233	Green Published, hybrid			2022-12-28	WOS:000772363100004
J	Kleinmans, R; Pinkert, T; Dutta, S; Paulisch, TO; Keum, H; Daniliuc, CG; Glorius, F				Kleinmans, Roman; Pinkert, Tobias; Dutta, Subhabrata; Paulisch, Tiffany O.; Keum, Hyeyun; Daniliuc, Constantin G.; Glorius, Frank			Intermolecular [2 pi+2 sigma]-photocycloaddition enabled by triplet energy transfer	NATURE			English	Article							STRAIN-RELEASE; CYCLOADDITION; PHOTODIMERIZATION	For more than one century, photochemical [2+2]-cycloadditions have been used by synthetic chemiststo make cyclobutanes, four-membered carbon-based rings. In this reaction, typically two olefin subunits (two sigma-electrons per olefin) cyclize to form two new C-C sigma-bonds. Although the development of photochemical [2+2]-cycloadditions has made enormous progress within the last century, research has been focused on such [2 pi-2 pi]-systems, in which two pi-bonds are converted into two new sigma-bonds(1,2). Here we report an intermolecular [2+2]-photocycloaddition that uses bicyclo[1.1.0]butanes as 2 sigma-electron reactants(3,7). This strain-release-driven [2/T+20]-photocycloaddition reaction was realized by visible-light-mediated triplet energytransfer catalysis(8,9). A simple, modular and diastereoselective synthesis of bicyclo[2.1.1]hexanes from heterocyclic olefin coupling partners, namely coumarins, flavones and indoles, is disclosed. Given the increasing importance of bicyclo[2.1.1] hexanes as bioisosteres-groupsthat convey similar biological propertiesto those they replace-in pharmaceutical research and considering their limited access(10,11), there remains a need for new synthetic methodologies. Applying this strategy enabled us to extend the intermolecular [2+2]-photocycloadditionsto a-bonds and provides previously inaccessible structural motifs.	[Kleinmans, Roman; Pinkert, Tobias; Dutta, Subhabrata; Paulisch, Tiffany O.; Keum, Hyeyun; Daniliuc, Constantin G.; Glorius, Frank] Westfal Wilhelms Univ Munster, Organisch Chem Inst, Munster, Germany; [Keum, Hyeyun] Inst for Basic Sci Korea, Ctr Catalyt Hydrocarbon Functionalizat, Daejeon, South Korea; [Keum, Hyeyun] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea	University of Munster; Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST)	Glorius, F (corresponding author), Westfal Wilhelms Univ Munster, Organisch Chem Inst, Munster, Germany.	glorius@uni-muenster.de	Daniliuc, Constantin G./B-5073-2011; Glorius, Frank/K-6385-2015	Daniliuc, Constantin G./0000-0002-6709-3673; Glorius, Frank/0000-0002-0648-956X; Keum, Hyeyun/0000-0001-8508-9259	Fonds der Chemischen Industrie [106151]; Deutsche Forschungsgemeinschaft [SFB 858]; Institute for Basic Science in the Republic of Korea [IBS-R010-D1]; KAIST	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute for Basic Science in the Republic of Korea; KAIST	We thank J.-H. Ye, J. L. Schwarz, F. Schafers, A. Heusler, F. R. Schafer and F. Strieth-Kalthoff for helpful discussions, and K. Bergander for the NMR analysis (all at WWU). We acknowledge Fonds der Chemischen Industrie (R.K., Kekule Scholarship no. 106151) and Deutsche Forschungsgemeinschaft (Leibniz Award, SFB 858, ChemBion) for generous financial support. H.K. thanks S. Chang (KAIST) and the Institute for Basic Science (grant no. IBS-R010-D1) in the Republic of Korea for financial support.	Bach T., 1998, SYNTHESIS; Becker MR, 2020, NAT CHEM, V12, P898, DOI 10.1038/s41557-020-0541-1; Bennett SH, 2020, J AM CHEM SOC, V142, P16766, DOI 10.1021/jacs.0c07357; Blum TR, 2016, SCIENCE, V354, P1391, DOI 10.1126/science.aai8228; CAIRNCROSS A, 1966, J AM CHEM SOC, V88, P496, DOI 10.1021/ja00955a021; Ciamician G, 1908, BER DTSCH CHEM GES, V41, P1928, DOI 10.1002/cber.19080410272; Denisenko A, 2020, ANGEW CHEM INT EDIT, V59, P20515, DOI 10.1002/anie.202004183; Dhake K, 2022, ANGEW CHEM INT EDIT, V61, DOI 10.1002/anie.202204719; EATON PE, 1962, J AM CHEM SOC, V84, P2454, DOI 10.1021/ja00871a039; Ernouf G, 2020, ANGEW CHEM INT EDIT, V59, P2618, DOI 10.1002/anie.201908951; Fawcett A, 2019, NAT CHEM, V11, P117, DOI 10.1038/s41557-018-0181-x; GASSMAN PG, 1971, ACCOUNTS CHEM RES, V4, P128, DOI 10.1021/ar50040a002; Gianatassio R, 2016, SCIENCE, V351, P241, DOI 10.1126/science.aad6252; Guo L, 2021, ANGEW CHEM INT EDIT, V60, P212, DOI 10.1002/anie.202011739; KLAUS M, 1971, ANGEW CHEM INT EDIT, V10, P273, DOI 10.1002/anie.197102731; Lefarth J, 2021, MOLBANK, V2021, DOI 10.3390/M1256; Levterov VV, 2018, J ORG CHEM, V83, P14350, DOI 10.1021/acs.joc.8b02071; Liebermann C., 1877, BER DTSCH CHEM GES, V10, P2177; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Murray PRD, 2021, J AM CHEM SOC, V143, P4055, DOI 10.1021/jacs.1c01173; Mykhailiuk PK, 2019, ORG BIOMOL CHEM, V17, P2839, DOI 10.1039/c8ob02812e; Nikitas NF, 2021, ORG BIOMOL CHEM, V19, P5237, DOI 10.1039/d1ob00221j; Ociepa M, 2020, J AM CHEM SOC, V142, P5355, DOI 10.1021/jacs.0c00245; Oderinde MS, 2021, J ORG CHEM, V86, P1730, DOI 10.1021/acs.joc.0c02547; Pitzer L, 2019, ANGEW CHEM INT EDIT, V58, P8572, DOI 10.1002/anie.201901935; Poplata S, 2016, CHEM REV, V116, P9748, DOI 10.1021/acs.chemrev.5b00723; PRINZBAC.H, 1965, ANGEW CHEM INT EDIT, V4, P436, DOI 10.1002/anie.196504362; PRINZBACH H, 1969, ANGEW CHEM INT EDIT, V8, P276, DOI 10.1002/anie.196902761; Sarkar D, 2020, EUR J ORG CHEM, V2020, P1310, DOI 10.1002/ejoc.201901143; SCHENCK GO, 1962, CHEM BER-RECL, V95, P1642, DOI 10.1002/cber.19620950711; Silvi M, 2019, J AM CHEM SOC, V141, P9511, DOI 10.1021/jacs.9b03653; Strieth-Kalthoff F, 2020, CHEM-US, V6, P1888, DOI 10.1016/j.chempr.2020.07.010; Strieth-Kalthoff F, 2018, CHEM SOC REV, V47, P7190, DOI 10.1039/c8cs00054a; TOLBERT LM, 1982, J AM CHEM SOC, V104, P1742, DOI 10.1021/ja00370a053; Troster A, 2016, J AM CHEM SOC, V138, P7808, DOI 10.1021/jacs.6b03221; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Turkowska J, 2020, CHEM COMMUN, V56, P5718, DOI 10.1039/d0cc01771j; Wolff T, 2004, PHYS CHEM CHEM PHYS, V6, P368, DOI 10.1039/b312335a; Yang YY, 2021, NAT CHEM, V13, P950, DOI 10.1038/s41557-021-00786-z	39	19	19	46	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2022	605	7910					477	+		10.1038/s41586-022-04636-x	http://dx.doi.org/10.1038/s41586-022-04636-x		MAR 2022	7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J0US	35314833				2022-12-28	WOS:000793701100001
J	Karagounis, T; Belmont, M; Caplan, AS; Walter, K				Karagounis, Theodora; Belmont, Michael; Caplan, Avrom S.; Walter, Kristin			AWomanWith Painful Digital Ulcers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENE 5; DERMATOMYOSITIS ASSOCIATION	A 66-year-oldwoman with a history of hypertension, type 2 diabetes, and chronic hepatitis-Btreated with tenofovir presented to the emergency department for evaluation of digital erythema and painful finger ulcers, which developed 6 months prior but which had increased in number and become more painful in the past several weeks. She also reported dyspnea on exertion, which developed 6 months prior to presentation. Onphysical examination, her peripheral oxygen saturation was 95% on room air. Auscultation of her lungs revealed crackles at the bases bilaterally. She had normal strength throughout all muscle groups and full range of motion in the joints of her hands. The palmar surfaces of her hands revealed livedo racemosa, erythema, and retiform purpura; ulcers overlying her phalangeal joint creases and fingertips; and scale and fissures on several digits (Figure). On the dorsal surfaces there was a large ulcer on the right second metacarpophalangeal joint and erythematous papules over several metacarpophalangeal joints. Ulcers were also noted on her elbows. Laboratory testing showed a hemoglobin level of 10.5 g/dL and normal creatine kinase level. The patient was admitted to the hospital for pain management and expedited workup of her progressive finger ulcerations.	[Karagounis, Theodora; Caplan, Avrom S.] NYU, Ronald O Perelman Dept Dermatol, Grossman Sch Med, New York, NY 10016 USA; [Belmont, Michael] NYU, Div Rheumatol, Dept Med, Grossman Sch Med, New York, NY USA	New York University; New York University	Caplan, AS (corresponding author), NYU, Ronald O Perelman Dept Dermatol, Grossman Sch Med, New York, NY 10016 USA.	avrom.caplan@nyulangone.org; kristin.walter@jamanetwork.org						Cobos GA, 2020, AM J CLIN DERMATOL, V21, P339, DOI 10.1007/s40257-020-00502-6; Hodgkinson LM, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-5175; Kurtzman DJB, 2018, J AM ACAD DERMATOL, V78, P776, DOI 10.1016/j.jaad.2017.12.010; Lian XY, 2020, CHEST, V158, P1535, DOI 10.1016/j.chest.2020.04.057; Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468; Narang NS, 2015, ARTHRIT CARE RES, V67, P667, DOI 10.1002/acr.22498; Patel B, 2018, J AM ACAD DERMATOL, V79, P77, DOI 10.1016/j.jaad.2017.12.055; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Shakshouk H, 2022, CLIN EXP DERMATOL, V47, P282, DOI 10.1111/ced.14870; Tsuji H, 2020, ARTHRITIS RHEUMATOL, V72, P488, DOI 10.1002/art.41105	10	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2022	327	16					1608	1609		10.1001/jama.2022.3667	http://dx.doi.org/10.1001/jama.2022.3667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0W7TZ	35344026				2022-12-28	WOS:000789226500032
J	Karagounis, T; Belmont, HM; Caplan, AS				Karagounis, Theodora; Belmont, H. Michael; Caplan, Avrom S.			A Woman With Painful Digital Ulcers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material; Early Access							GENE 5; DERMATOMYOSITIS ASSOCIATION	A woman had 6 months of digital erythema and painful finger ulcers that had increased in number and become more painful in the past several weeks, along with erythematous and scaly papules and scale and fissures on the lateral aspect of several digits. She had normal strength throughout all muscle groups and a normal creatine kinase level. What is the diagnosis and what would you do next?	[Karagounis, Theodora; Caplan, Avrom S.] New York Univ Grossman Sch Med, Ronald O Perelman Dept Dermatol, 240 E 38th St,11th Floor, New York, NY 10016 USA; [Belmont, H. Michael] New York Univ Grossman Sch Med, Div Rheumatol, Dept Med, New York, NY USA		Caplan, AS (corresponding author), New York Univ Grossman Sch Med, Ronald O Perelman Dept Dermatol, 240 E 38th St,11th Floor, New York, NY 10016 USA.	avrom.caplan@nyulangone.org						Cobos GA, 2020, AM J CLIN DERMATOL, V21, P339, DOI 10.1007/s40257-020-00502-6; Hodgkinson LM, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-5175; Kurtzman DJB, 2018, J AM ACAD DERMATOL, V78, P776, DOI 10.1016/j.jaad.2017.12.010; Lian XY, 2020, CHEST, V158, P1535, DOI 10.1016/j.chest.2020.04.057; Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468; Narang NS, 2015, ARTHRIT CARE RES, V67, P667, DOI 10.1002/acr.22498; Patel B, 2018, J AM ACAD DERMATOL, V79, P77, DOI 10.1016/j.jaad.2017.12.055; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Shakshouk H, 2022, CLIN EXP DERMATOL, V47, P282, DOI 10.1111/ced.14870; Tsuji H, 2020, ARTHRITIS RHEUMATOL, V72, P488, DOI 10.1002/art.41105	10	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.3667	http://dx.doi.org/10.1001/jama.2022.3667		MAR 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E5QT	35344026				2022-12-28	WOS:000776736700001
J	Kuehn, BM				Kuehn, Bridget M.			Medical Groups Defend Patient-Physician Relationship and Access to Adolescent Gender-Affirming Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2022	327	15					1432	1432						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1C3PR	35353160				2022-12-28	WOS:000793035800007
J	Kuehn, BM				Kuehn, Bridget M.			Medical Groups Defend Patient-Physician Relationship and Access to Adolescent Gender-Affirming Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item; Early Access								This Medical News article discusses physicians' advocacy to protect patients and the patient-physician relationship amid efforts by politicians to limit access or criminalize gender-affirming care.											0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2022.4617	http://dx.doi.org/10.1001/jama.2022.4617		MAR 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0E9DJ	35353160				2022-12-28	WOS:000776972600002
